data_2kkn_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kkn _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 54.9 mttp . . . . . 0 CA--C 1.517 -0.291 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.434 ' HG3' ' CD1' ' A' ' 30' ' ' TYR . 0.2 OUTLIER -145.79 132.49 19.96 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.486 0.66 . . . . 0.0 111.539 -174.137 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.743 ' HE2' HD11 ' A' ' 145' ' ' LEU . 87.0 m-85 -101.66 128.01 48.15 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.306 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.48 HD11 HD11 ' A' ' 23' ' ' ILE . 43.5 tp -91.75 108.06 19.65 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.308 177.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.594 ' HB3' ' HB3' ' A' ' 141' ' ' ALA . 51.0 tp -94.39 118.14 31.17 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.566 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 22.4 pt -101.12 115.58 43.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 174.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.8 m -54.94 -69.55 0.13 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.692 -1.14 . . . . 0.0 113.104 -169.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.567 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 26.1 t70 -153.19 105.24 2.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.867 0.365 . . . . 0.0 110.417 -175.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.867 ' H ' ' HA3' ' A' ' 37' ' ' GLY . 5.7 m -110.5 134.45 52.35 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.661 -175.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 13.0 m170 -130.76 86.77 2.41 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 173.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.474 ' O ' HG21 ' A' ' 40' ' ' VAL . 48.0 t -128.96 125.68 22.94 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.456 -175.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -78.97 -48.11 0.28 Allowed 'Cis proline' 0 CA--C 1.532 0.389 0 C-N-CA 122.904 -1.707 . . . . 0.0 112.8 -2.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.414 ' CG2' HG13 ' A' ' 40' ' ' VAL . 37.9 t 51.46 -94.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 123.53 0.732 . . . . 0.0 111.605 -178.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.435 ' HD2' ' HA ' ' A' ' 15' ' ' ARG . 17.5 tpt180 -148.43 22.81 1.04 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.535 0.684 . . . . 0.0 109.391 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.496 ' C ' ' H ' ' A' ' 18' ' ' SER . 53.5 ttp -119.63 -72.42 0.69 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.688 178.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 64.67 -12.94 0.11 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.552 0.741 . . . . 0.0 112.788 178.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.496 ' H ' ' C ' ' A' ' 16' ' ' MET . 11.9 m -83.64 58.03 4.39 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.263 0.554 . . . . 0.0 110.875 -177.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.892 ' HG ' HD13 ' A' ' 135' ' ' LEU . 6.5 tt -107.84 119.04 51.45 Favored Pre-proline 0 C--N 1.321 -0.632 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 177.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -61.1 111.04 0.97 Allowed 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.286 1.99 . . . . 0.0 111.411 176.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -71.65 -7.08 45.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.415 -174.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -56.42 -43.08 79.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.174 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.48 HD11 HD11 ' A' ' 5' ' ' LEU . 9.7 tt -70.82 -35.84 61.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.515 0.674 . . . . 0.0 110.19 -178.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.716 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 59.4 tp -63.0 -32.0 73.27 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.454 177.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -75.27 -19.39 59.74 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.704 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 64.0 m -93.11 12.21 25.03 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.152 -174.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.716 ' HG ' ' O ' ' A' ' 24' ' ' LEU . 9.9 mt -63.96 -19.1 64.9 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.979 0.419 . . . . 0.0 110.349 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -52.88 -36.06 58.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.999 176.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -94.11 3.48 55.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.332 -174.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.463 ' CD1' ' HB2' ' A' ' 5' ' ' LEU . 90.6 m-85 -118.38 106.67 12.98 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.181 0.515 . . . . 0.0 110.341 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -75.62 4.92 6.77 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.873 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.57 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -163.74 109.49 0.38 Allowed Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 175.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 90.8 t -100.08 126.52 53.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 O-C-N 122.458 -0.436 . . . . 0.0 110.119 178.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 51.4 mt -105.33 123.51 59.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 120.87 0.366 . . . . 0.0 110.158 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -114.64 103.06 1.23 Allowed Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 120.512 -0.852 . . . . 0.0 112.648 -177.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.476 HD21 ' HB3' ' A' ' 86' ' ' MET . 70.9 mt -85.3 -30.95 23.33 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 172.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.867 ' HA3' ' H ' ' A' ' 10' ' ' SER . . . -112.1 123.1 6.21 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 171.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -99.88 164.77 11.87 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.551 0.691 . . . . 0.0 112.754 -169.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.409 ' CD1' HD21 ' A' ' 48' ' ' LEU . 60.0 m-85 -85.85 127.13 34.5 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 168.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.474 HG21 ' O ' ' A' ' 12' ' ' VAL . 3.8 m -80.96 -9.5 11.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -165.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.492 ' O ' HG22 ' A' ' 45' ' ' VAL . 2.3 m-20 -86.9 125.87 34.3 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 176.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 38.9 tp -60.75 -36.0 77.79 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.369 0.604 . . . . 0.0 109.503 178.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -57.28 -44.95 84.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.227 175.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.48 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 14.9 m -71.98 -25.09 61.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.023 -177.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.492 HG22 ' O ' ' A' ' 41' ' ' ASP . 61.0 t -62.66 -42.71 97.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.075 0.464 . . . . 0.0 110.174 175.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.45 ' N ' HD13 ' A' ' 46' ' ' ILE . 1.7 mp -66.45 -36.55 77.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-O 121.263 0.554 . . . . 0.0 109.724 175.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.59 -32.97 74.6 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.455 175.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 44' ' ' THR . 89.0 mt -64.46 -43.07 95.38 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 176.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.475 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 29.6 tt0 -69.41 -14.87 63.13 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.02 178.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -85.21 -49.73 7.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.662 178.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.433 ' CB ' HD13 ' A' ' 27' ' ' LEU . 28.3 m-85 -65.29 -57.01 9.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.842 178.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.598 ' HB3' HD12 ' A' ' 27' ' ' LEU . 83.0 p -77.62 -38.65 47.55 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.709 0.29 . . . . 0.0 111.214 -175.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 53.6 mttp 69.67 7.79 6.41 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.721 -178.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 179.0 111.01 0.03 OUTLIER 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.805 174.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -136.71 152.83 50.8 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.999 0.428 . . . . 0.0 110.682 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.547 ' HE2' ' HE1' ' A' ' 4' ' ' PHE . 40.2 m-85 -118.18 113.79 22.08 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 176.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -116.53 152.51 17.87 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.198 -1.001 . . . . 0.0 112.84 -174.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.608 HG21 ' HB2' ' A' ' 86' ' ' MET . 31.0 t -128.92 113.63 29.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 175.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 14.5 t-80 -94.24 104.18 16.19 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.896 -172.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.43 ' HA3' ' O ' ' A' ' 88' ' ' HIS . . . -132.54 32.16 2.86 Favored Glycine 0 N--CA 1.444 -0.816 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 174.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -101.23 154.85 18.41 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.608 -0.796 . . . . 0.0 109.957 -178.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 94.8 mmm -90.47 39.73 0.99 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.497 -172.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.501 ' HB3' ' H ' ' A' ' 64' ' ' TYR . 8.7 m-20 -118.76 -143.81 0.37 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.702 0.287 . . . . 0.0 111.556 -178.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.501 ' H ' ' HB3' ' A' ' 63' ' ' ASP . 78.7 m-85 -69.86 127.33 92.56 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.114 0.483 . . . . 0.0 111.85 -169.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 64' ' ' TYR . 11.8 Cg_exo -71.1 -14.35 31.83 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.353 2.702 . . . . 0.0 111.995 179.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -60.86 -32.91 72.32 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.459 0.647 . . . . 0.0 110.567 178.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.432 HG12 HD22 ' A' ' 71' ' ' LEU . 47.0 t -73.09 -20.07 18.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.678 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.467 ' HE2' ' HB2' ' A' ' 73' ' ' PHE . 64.5 tttm -72.88 -12.44 60.97 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.676 -174.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -84.15 -10.01 58.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.003 0.43 . . . . 0.0 111.001 177.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 57.4 m-70 -103.36 -28.94 11.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.147 0.498 . . . . 0.0 109.861 177.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.432 HD22 HG12 ' A' ' 67' ' ' VAL . 0.3 OUTLIER -138.99 119.51 9.68 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.671 174.708 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -66.56 177.26 3.47 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 123.167 2.578 . . . . 0.0 112.938 -175.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.467 ' HB2' ' HE2' ' A' ' 68' ' ' LYS . 70.5 t80 -70.26 -29.15 65.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.141 0.496 . . . . 0.0 110.552 -177.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.489 ' HA ' HG13 ' A' ' 58' ' ' VAL . 10.2 p -147.74 142.06 26.27 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.948 178.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 32.1 tttm -142.41 141.08 32.19 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.807 -178.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.523 HG21 ' CE1' ' A' ' 104' ' ' PHE . 56.6 t -114.53 139.28 41.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.896 174.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 58.6 mt -114.45 144.22 43.67 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.17 177.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 54.9 tp -109.52 96.24 6.14 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 175.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 24.0 t -111.68 96.09 4.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.914 -173.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.41 ' OE1' ' HA2' ' A' ' 148' ' ' GLY . 42.6 mt-10 54.13 38.66 29.56 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.132 175.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 107.99 -31.57 7.83 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.343 177.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 60.2 t -81.66 115.1 23.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.005 0.431 . . . . 0.0 110.937 -177.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.07 105.64 14.22 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.071 176.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.434 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 15.8 mt -94.8 106.85 18.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.625 -177.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.496 ' HA2' HG22 ' A' ' 76' ' ' VAL . . . -93.09 110.19 3.91 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 176.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.608 ' HB2' HG21 ' A' ' 58' ' ' VAL . 43.5 mtm -107.99 129.71 55.1 Favored 'General case' 0 C--N 1.317 -0.834 0 O-C-N 122.419 -0.46 . . . . 0.0 110.822 -174.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 79.0 m -149.34 116.9 6.17 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.534 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.43 ' O ' ' HA3' ' A' ' 60' ' ' GLY . 41.8 t-80 -97.07 127.88 43.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.233 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 169.32 -125.53 1.27 Allowed Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.395 178.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 29.2 p90 -153.71 165.89 34.56 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.676 0.274 . . . . 0.0 110.488 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 171.61 148.21 6.01 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.877 177.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -76.43 155.36 83.84 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 176.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_exo -51.76 -33.56 50.68 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.67 2.247 . . . . 0.0 112.542 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -76.38 -53.97 7.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.926 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -62.68 -37.68 87.38 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.022 -176.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 30.5 tp -51.42 -60.71 2.83 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 122.705 0.402 . . . . 0.0 112.0 -171.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -60.68 -41.46 95.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.44 -176.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -73.81 -39.52 64.04 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.992 0.425 . . . . 0.0 111.325 -176.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.403 ' O ' HG21 ' A' ' 103' ' ' VAL . 74.5 ttt180 -68.36 -40.96 81.29 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.827 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.497 HD12 HG22 ' A' ' 111' ' ' ILE . 89.5 mt -70.23 -32.6 70.53 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.027 -178.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 96.8 mt -78.21 -11.55 59.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.332 0.587 . . . . 0.0 110.221 175.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -86.21 -47.54 9.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.942 173.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.403 HG21 ' O ' ' A' ' 99' ' ' ARG . 89.0 t -63.21 -46.25 96.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.087 177.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.523 ' CE1' HG21 ' A' ' 76' ' ' VAL . 25.6 m-85 -101.61 102.63 13.37 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.227 176.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -59.8 -36.06 75.97 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.584 -177.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -100.97 125.86 47.58 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 172.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.472 ' HD2' ' O ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -60.78 126.7 85.97 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.779 -173.989 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 107' ' ' LYS . 5.4 Cg_exo -75.13 150.18 37.23 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.696 2.264 . . . . 0.0 110.558 173.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -75.54 -48.9 20.44 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.338 0.59 . . . . 0.0 109.66 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 66.0 t -126.68 131.1 71.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.549 178.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.497 HG22 HD12 ' A' ' 100' ' ' LEU . 57.5 mt -114.82 134.25 58.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 120.686 0.279 . . . . 0.0 110.94 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.581 HD23 ' HB2' ' A' ' 130' ' ' LEU . 82.8 mt -105.04 118.52 36.73 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.243 177.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.414 ' CE1' ' HB3' ' A' ' 129' ' ' PHE . 16.9 p90 -133.91 127.47 32.55 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.094 0.473 . . . . 0.0 110.054 177.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -106.11 126.78 8.67 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.777 -0.725 . . . . 0.0 111.805 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 21.6 t60 -172.42 -44.42 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.27 0.557 . . . . 0.0 109.772 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.7 t -92.68 142.11 27.73 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.529 175.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 1.0 ' HA ' ' HA2' ' A' ' 133' ' ' GLY . 23.3 p-80 -97.87 4.66 49.6 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.044 0.45 . . . . 0.0 110.762 -178.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -108.19 106.41 58.54 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.441 174.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.27 127.19 13.85 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.961 2.441 . . . . 0.0 112.603 -174.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -142.27 139.87 32.04 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.361 173.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -78.28 103.91 8.52 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 175.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.504 ' HB ' ' HE2' ' A' ' 124' ' ' LYS . 60.8 p -111.91 121.42 45.0 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.597 -172.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.8 p -106.94 110.31 31.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.294 0.568 . . . . 0.0 110.244 176.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.51 ' HB2' ' CE1' ' A' ' 129' ' ' PHE . 72.5 mmtt -123.9 127.36 47.88 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.805 -178.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 65.6 13.14 8.73 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 123.465 0.478 . . . . 0.0 111.773 177.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 94.31 4.46 62.64 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.511 -178.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 43.3 t -106.44 140.26 25.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 177.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -94.0 113.41 25.39 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.86 0.362 . . . . 0.0 110.249 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.51 ' CE1' ' HB2' ' A' ' 124' ' ' LYS . 76.9 m-85 -103.03 124.69 49.0 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.259 -178.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.581 ' HB2' HD23 ' A' ' 112' ' ' LEU . 83.5 mt -108.87 130.86 55.43 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.737 176.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -122.84 111.51 31.0 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.195 -176.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -82.28 152.7 16.04 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.737 2.291 . . . . 0.0 111.568 173.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 1.0 ' HA2' ' HA ' ' A' ' 117' ' ' HIS . . . -67.49 -129.01 0.03 OUTLIER Glycine 0 CA--C 1.524 0.619 0 O-C-N 123.506 0.504 . . . . 0.0 114.138 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 7.9 m -128.44 179.61 5.55 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 122.224 -0.574 . . . . 0.0 111.159 -176.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.892 HD13 ' HG ' ' A' ' 19' ' ' LEU . 1.1 tm? -73.22 -69.3 0.43 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.7 -179.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -75.0 13.2 0.71 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.606 -171.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -107.69 6.97 28.22 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.921 0.391 . . . . 0.0 110.512 177.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 69.47 42.37 73.62 Favored Glycine 0 C--N 1.332 0.346 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.981 174.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 13.0 p -132.98 99.17 4.5 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.901 0.382 . . . . 0.0 111.272 -178.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -113.51 155.5 25.24 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 174.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.594 ' HB3' ' HB3' ' A' ' 6' ' ' LEU . . . -114.49 128.39 56.31 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.115 0.483 . . . . 0.0 111.03 -176.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 40.2 t -111.46 117.48 55.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.6 175.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.747 HD21 ' HA ' ' A' ' 152' ' ' PHE . 57.7 mt -96.67 113.64 25.22 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.077 177.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -108.04 130.55 55.07 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.735 -176.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.743 HD11 ' HE2' ' A' ' 4' ' ' PHE . 74.0 mt -99.14 116.44 31.35 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.028 -177.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.472 ' HB3' ' NH1' ' A' ' 151' ' ' ARG . 27.3 t70 -146.83 130.78 17.19 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.693 177.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.85 11.31 60.35 Favored Glycine 0 CA--C 1.521 0.445 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.974 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.41 ' HA2' ' OE1' ' A' ' 80' ' ' GLU . . . 84.12 30.89 27.16 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.318 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -126.99 135.14 50.44 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.718 0.295 . . . . 0.0 110.817 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 44.3 t -84.38 108.31 16.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 174.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.472 ' NH1' ' HB3' ' A' ' 146' ' ' ASP . 96.5 mtt180 -106.18 120.62 42.3 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.053 0.454 . . . . 0.0 111.011 -174.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . 0.747 ' HA ' HD21 ' A' ' 143' ' ' LEU . 74.0 t80 -92.62 112.89 25.0 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.216 -173.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -122.04 103.8 9.06 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.852 0.358 . . . . 0.0 110.588 173.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 20.2 tp -79.0 100.38 7.29 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 174.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -93.9 138.02 32.49 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.499 -173.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 34.9 p -94.03 150.57 20.22 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.352 -174.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 10.1 mp . . . . . 0 C--O 1.245 0.866 0 CA-C-O 118.62 -0.705 . . . . 0.0 109.49 175.725 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 61.6 mttm . . . . . 0 CA--C 1.518 -0.28 0 CA-C-O 120.752 0.31 . . . . 0.0 110.576 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 89.2 mtt-85 -123.41 132.53 53.99 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.218 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -118.06 128.06 54.39 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.846 174.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.512 ' HB3' HG22 ' A' ' 33' ' ' VAL . 33.9 tp -89.57 134.23 34.22 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.789 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.453 ' HB3' ' HB2' ' A' ' 141' ' ' ALA . 50.3 tp -119.32 109.16 15.48 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.193 0.521 . . . . 0.0 111.314 -178.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.4 pt -102.24 112.39 35.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 172.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.406 ' HB2' ' H ' ' A' ' 9' ' ' ASP . 1.1 m -76.05 -90.17 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -166.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.406 ' H ' ' HB2' ' A' ' 8' ' ' SER . 24.3 t70 -108.54 110.83 22.4 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.611 -173.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.768 ' HB2' HD13 ' A' ' 135' ' ' LEU . 42.2 t -123.9 134.08 53.61 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 121.477 0.656 . . . . 0.0 110.215 178.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 26.6 m170 -125.55 38.22 4.21 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.57 HG23 HD11 ' A' ' 19' ' ' LEU . 61.3 t -94.11 138.13 22.69 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.927 -175.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.448 ' HA ' HG12 ' A' ' 12' ' ' VAL . 5.3 Cg_exo -80.27 -60.64 0.04 OUTLIER 'Cis proline' 0 C--N 1.345 0.365 0 C-N-CA 123.526 -1.447 . . . . 0.0 112.072 -3.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 26.4 t 54.16 -86.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 O-C-N 123.882 0.739 . . . . 0.0 111.462 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 29.2 ttt180 -144.73 12.74 1.48 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.163 0.506 . . . . 0.0 109.915 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 43.0 ttp -131.39 105.1 7.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.797 -176.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -97.31 13.25 30.2 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.017 0.437 . . . . 0.0 110.854 177.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.9 m -81.95 40.68 0.62 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.864 -175.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.752 ' HG ' HD11 ' A' ' 135' ' ' LEU . 3.6 tt -107.75 104.3 52.57 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 174.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -61.88 124.57 14.75 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 123.036 2.491 . . . . 0.0 112.564 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -71.93 -8.03 52.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.753 -176.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -61.04 -49.59 76.74 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.253 -177.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.452 HD13 HD13 ' A' ' 5' ' ' LEU . 6.9 tt -71.93 -31.58 41.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.714 0.769 . . . . 0.0 110.085 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.467 ' HA ' HD23 ' A' ' 27' ' ' LEU . 59.1 tp -56.9 -33.09 66.58 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.182 -1.372 . . . . 0.0 110.915 178.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -74.27 -36.45 63.82 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.676 178.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.6 m -76.53 7.75 4.19 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.875 -175.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.901 HD11 ' HB3' ' A' ' 52' ' ' SER . 1.4 mm? -53.68 -33.66 56.12 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.008 0.432 . . . . 0.0 111.579 176.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 28.2 mttp -87.21 7.51 28.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.487 -170.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -95.6 -18.94 20.16 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -176.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -105.63 156.15 18.54 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.926 0.393 . . . . 0.0 111.806 -170.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -60.96 -54.5 44.29 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.854 177.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -143.51 151.57 23.41 Favored Glycine 0 N--CA 1.44 -1.068 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.993 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.609 HG23 HD13 ' A' ' 27' ' ' LEU . 99.3 t -122.58 136.4 59.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-O 120.731 0.3 . . . . 0.0 110.216 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.559 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 45.9 mt -107.98 120.97 60.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.376 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -108.13 111.14 3.28 Favored Glycine 0 N--CA 1.442 -0.945 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 176.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.501 ' HA ' HG21 ' A' ' 58' ' ' VAL . 81.5 mt -85.91 27.59 0.87 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.903 0.382 . . . . 0.0 110.175 -178.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 117.74 81.91 0.84 Allowed Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -174.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.759 ' HA ' ' HB3' ' A' ' 10' ' ' SER . 3.2 p-10 -96.6 -95.11 0.2 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -173.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.471 ' H ' ' CG ' ' A' ' 38' ' ' ASP . 79.9 m-85 -95.4 138.17 33.45 Favored 'General case' 0 C--N 1.318 -0.792 0 O-C-N 121.897 -0.502 . . . . 0.0 110.313 -178.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.7 m -79.05 -9.88 12.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.364 0.602 . . . . 0.0 109.906 178.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.531 ' O ' HG21 ' A' ' 45' ' ' VAL . 43.0 m-20 -86.59 121.68 29.45 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.598 177.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.487 HD23 ' HB3' ' A' ' 66' ' ' ASP . 47.1 tp -57.45 -43.1 83.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.416 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -52.22 -45.02 65.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.561 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.1 m -78.55 -27.45 45.88 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.278 -175.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.531 HG21 ' O ' ' A' ' 41' ' ' ASP . 94.6 t -61.77 -44.43 98.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.174 0.511 . . . . 0.0 109.742 174.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.451 ' N ' HD13 ' A' ' 46' ' ' ILE . 1.7 mp -65.02 -36.58 78.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.7 176.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.36 -37.57 83.8 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.674 175.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 22.9 mt -73.85 -37.09 64.92 Favored 'General case' 0 CA--C 1.514 -0.426 0 C-N-CA 120.434 -0.507 . . . . 0.0 110.158 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.464 ' HA ' ' HB2' ' A' ' 55' ' ' PHE . 32.9 tt0 -63.64 -26.36 68.64 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.824 175.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -84.03 -49.65 8.73 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.513 178.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.494 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . 4.7 m-85 -54.62 -55.61 27.72 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 177.158 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.901 ' HB3' HD11 ' A' ' 27' ' ' LEU . 78.7 p -77.59 -20.25 54.3 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 52' ' ' SER . 96.5 mttt 72.97 -56.5 0.66 Allowed 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.638 0.775 . . . . 0.0 110.529 -173.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -106.63 90.55 3.36 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.859 177.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.464 ' HB2' ' HA ' ' A' ' 49' ' ' GLU . 58.4 t80 -106.04 117.03 32.97 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.476 -178.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.559 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 87.7 m-85 -108.13 108.07 18.98 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 176.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -125.15 164.51 18.7 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 119.854 -1.165 . . . . 0.0 113.508 -173.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.501 HG21 ' HA ' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -136.12 -174.42 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.115 -0.542 . . . . 0.0 109.914 175.096 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.695 ' CE1' ' HA ' ' A' ' 68' ' ' LYS . 7.0 t60 -94.12 125.52 38.8 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.619 -171.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -98.47 -53.58 1.22 Allowed Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.792 -0.718 . . . . 0.0 113.316 -174.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -110.07 -154.01 0.53 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -176.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 70.3 mtm -71.66 -43.56 65.83 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 164.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 60.45 -173.15 0.12 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 114.537 -1.211 . . . . 0.0 111.515 175.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -92.2 155.19 42.97 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.365 177.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -52.54 -31.94 51.29 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 123.285 2.656 . . . . 0.0 112.999 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.487 ' HB3' HD23 ' A' ' 42' ' ' LEU . 29.2 m-20 -66.62 -42.57 86.58 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.32 0.581 . . . . 0.0 110.371 178.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 42.8 t -72.97 -27.01 23.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.754 177.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.695 ' HA ' ' CE1' ' A' ' 59' ' ' HIS . 88.4 tttt -62.54 -28.4 69.83 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.712 177.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -94.36 -44.87 7.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.375 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -72.32 -30.7 65.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.061 -174.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 58.5 mt -117.56 103.92 50.29 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 177.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -63.65 157.0 53.92 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 123.308 2.672 . . . . 0.0 112.526 -177.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -66.85 -40.32 87.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.618 -177.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.1 m -145.43 130.13 18.05 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.217 177.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 53.7 tttp -129.66 159.56 36.05 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 12.5 t -134.34 120.41 33.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 177.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.444 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 96.1 mt -98.7 140.89 32.24 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.933 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 51.0 tp -111.62 94.97 5.22 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 173.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 46.4 t -115.26 107.05 21.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.407 -174.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 58.54 31.73 21.36 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.985 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.59 -10.66 70.74 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.582 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.4 t -88.14 125.48 41.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.939 0.4 . . . . 0.0 111.045 -178.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 50.6 p -88.19 125.27 34.53 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.269 176.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.515 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 29.2 mt -116.21 103.98 15.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -83.97 114.17 3.85 Favored Glycine 0 C--O 1.223 -0.563 0 N-CA-C 111.307 -0.717 . . . . 0.0 111.307 177.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.482 ' HE1' HG12 ' A' ' 58' ' ' VAL . 21.4 mtp -107.09 118.43 36.68 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.575 0.187 . . . . 0.0 110.897 -174.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 113' ' ' PHE . 11.6 t -148.1 165.08 31.92 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.423 ' HB3' ' O ' ' A' ' 59' ' ' HIS . 3.3 t-160 -156.16 109.51 2.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.618 0.246 . . . . 0.0 110.359 -178.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 152.18 -173.96 31.24 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.363 -0.922 . . . . 0.0 112.336 176.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 6.5 m0 66.59 -173.46 0.19 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.45 0.643 . . . . 0.0 112.168 177.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -170.85 177.63 43.78 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.673 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.472 ' HB1' ' CD1' ' A' ' 94' ' ' TRP . . . 62.59 96.3 0.05 OUTLIER Pre-proline 0 N--CA 1.464 0.262 0 CA-C-O 121.396 0.617 . . . . 0.0 110.65 -175.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.435 ' HA ' ' HB3' ' A' ' 96' ' ' LEU . 7.5 Cg_exo -73.2 7.66 2.05 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 123.375 2.717 . . . . 0.0 113.666 -172.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.472 ' CD1' ' HB1' ' A' ' 92' ' ' ALA . 52.5 m95 -59.31 -54.57 45.25 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.132 0.491 . . . . 0.0 110.544 -178.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -117.44 7.64 12.81 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.321 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.435 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . 29.5 tp -60.85 -46.72 89.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.739 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.519 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 58.7 mttp -58.49 -44.48 89.4 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.174 0.512 . . . . 0.0 110.254 179.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -70.64 -30.65 67.34 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.051 -177.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 25.8 ttm180 -71.74 -40.89 69.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.462 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.476 HD11 HG22 ' A' ' 111' ' ' ILE . 66.7 mt -67.9 -27.34 66.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.803 178.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 97' ' ' LYS . 96.6 mt -70.08 -24.29 63.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.038 0.446 . . . . 0.0 110.742 175.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -77.32 -30.61 54.15 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.9 t -76.17 -49.29 25.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.955 174.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -99.67 85.96 3.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.054 177.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -76.79 -2.56 33.8 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.919 -173.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -79.93 -13.14 59.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.357 174.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 14.7 ttpp 57.15 83.2 0.23 Allowed Pre-proline 0 C--O 1.235 0.319 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.728 -171.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.21 174.6 10.49 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.503 2.135 . . . . 0.0 112.715 -174.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -89.63 -49.06 6.88 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.524 177.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.489 HG21 HG13 ' A' ' 150' ' ' VAL . 66.7 t -121.75 131.77 72.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.718 -177.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.476 HG22 HD11 ' A' ' 100' ' ' LEU . 53.2 mt -122.81 125.12 71.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.954 0.407 . . . . 0.0 110.455 174.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 85.7 mt -101.91 115.66 31.02 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.71 177.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.494 ' CZ ' ' HB2' ' A' ' 131' ' ' ASN . 18.2 p90 -127.4 134.75 49.88 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 175.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -105.92 114.87 4.63 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 119.997 -1.097 . . . . 0.0 112.249 -177.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 53.9 t60 -145.16 105.95 4.13 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 176.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 88.0 m -52.7 113.37 1.06 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.974 -177.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 14.3 t-80 -171.25 -79.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.299 177.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.444 ' HA ' ' HD3' ' A' ' 119' ' ' PRO . 50.3 mt-10 -147.69 142.32 16.58 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.24 178.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.642 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 5.6 Cg_exo -78.05 126.72 8.04 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.706 2.27 . . . . 0.0 111.058 172.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -154.6 148.44 25.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.872 0.368 . . . . 0.0 111.299 -179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -99.66 121.28 41.0 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.723 175.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.522 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 73.3 p -129.01 149.98 50.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.839 0.352 . . . . 0.0 111.879 -173.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.6 p -147.64 149.33 15.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.077 177.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -163.23 -55.56 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.627 0.727 . . . . 0.0 110.309 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.505 ' CB ' HD12 ' A' ' 101' ' ' LEU . . . -93.83 23.58 4.72 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.316 -173.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 74.96 1.07 61.73 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 -173.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 21.9 t -106.12 139.83 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 177.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 51.6 ttt180 -96.31 110.4 22.73 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.062 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.522 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 78.1 m-85 -95.66 117.43 30.47 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.705 -178.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 78.7 mt -113.0 116.26 29.67 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.437 -176.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.642 ' O ' ' HA ' ' A' ' 119' ' ' PRO . 9.1 t30 -109.14 107.82 60.06 Favored Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 172.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -83.11 -173.38 1.66 Allowed 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 123.171 2.581 . . . . 0.0 112.817 -176.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -85.32 161.28 35.51 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.592 -178.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.418 ' HB2' ' HG2' ' A' ' 137' ' ' GLU . 18.1 m -97.37 159.72 14.75 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.703 0.287 . . . . 0.0 110.559 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.768 HD13 ' HB2' ' A' ' 10' ' ' SER . 12.3 mt -61.5 -49.35 77.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.68 -172.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -66.81 -17.08 64.7 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.419 -177.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.418 ' HG2' ' HB2' ' A' ' 134' ' ' SER . 8.2 mm-40 -86.22 -1.36 57.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.724 -178.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 70.8 29.48 69.33 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.466 177.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 22.2 t -138.28 122.01 17.54 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.022 0.439 . . . . 0.0 110.792 -177.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.556 ' CE2' HD22 ' A' ' 135' ' ' LEU . 22.6 m-85 -116.47 177.94 4.51 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.384 175.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.453 ' HB2' ' HB3' ' A' ' 6' ' ' LEU . . . -126.76 132.83 50.98 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.985 0.422 . . . . 0.0 111.198 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 58.9 t -113.54 119.13 60.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 174.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.453 ' HA ' ' O ' ' A' ' 151' ' ' ARG . 3.3 tt -95.9 116.08 28.39 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.747 ' HB2' ' HB2' ' A' ' 151' ' ' ARG . 56.6 mt-10 -100.89 139.87 35.98 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.906 -177.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 47.7 mt -110.57 90.14 3.24 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 166.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -104.93 113.2 26.66 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.293 -176.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.92 -67.51 0.32 Allowed Glycine 0 CA--C 1.52 0.348 0 O-C-N 123.527 0.517 . . . . 0.0 112.288 -174.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -174.77 25.52 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 178.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -110.41 133.81 52.92 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 -177.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.489 HG13 HG21 ' A' ' 110' ' ' VAL . 21.5 t -79.64 103.52 6.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 176.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.747 ' HB2' ' HB2' ' A' ' 144' ' ' GLU . 56.6 mtt180 -110.02 148.03 32.44 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.084 -174.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -143.01 123.3 13.8 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.556 175.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -119.02 132.27 56.04 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.846 0.355 . . . . 0.0 110.334 178.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -76.01 113.63 13.74 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.455 176.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -96.38 119.04 34.14 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.248 -177.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.4 m -93.21 147.21 23.09 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.853 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 10.2 mp . . . . . 0 C--O 1.247 0.957 0 CA-C-O 118.827 -0.606 . . . . 0.0 110.623 -177.716 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.429 ' HD2' HG12 ' A' ' 79' ' ' VAL . 50.0 mttp . . . . . 0 N--CA 1.452 -0.352 0 CA-C-O 121.084 0.469 . . . . 0.0 110.882 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 56.1 mtt180 -107.66 112.32 24.97 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.62 176.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.616 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 53.7 m-85 -101.79 129.49 48.0 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.442 0.639 . . . . 0.0 111.518 -175.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.517 ' HB3' HG21 ' A' ' 33' ' ' VAL . 27.3 tp -89.18 114.76 26.1 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.094 174.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.623 HD11 ' HG ' ' A' ' 36' ' ' LEU . 45.0 tp -100.4 111.9 24.2 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.93 0.395 . . . . 0.0 110.668 -177.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.449 HG13 ' HA2' ' A' ' 35' ' ' GLY . 23.9 pt -100.98 120.12 50.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 176.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.753 ' HB2' ' HA ' ' A' ' 134' ' ' SER . 13.2 m -75.87 -169.04 1.0 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.799 -172.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.764 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 11.2 t70 -59.42 98.6 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.293 -179.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.0 m -109.26 128.46 55.09 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.852 -175.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.706 ' HB3' ' HB ' ' A' ' 14' ' ' VAL . 24.3 m170 -102.26 76.0 1.54 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.421 0.629 . . . . 0.0 109.696 179.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.478 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -135.74 127.14 17.27 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.1 -179.091 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.478 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 34.9 Cg_endo -93.19 91.68 0.14 OUTLIER 'Cis proline' 0 N--CA 1.45 -1.055 0 C-N-CA 123.013 -1.661 . . . . 0.0 113.049 -2.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.706 ' HB ' ' HB3' ' A' ' 11' ' ' HIS . 3.0 t -120.27 -170.1 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 173.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 55.2 mtt180 -68.73 83.94 0.3 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 118.91 0.777 . . . . 0.0 111.099 177.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.414 ' HE3' HG13 ' A' ' 12' ' ' VAL . 39.9 ttp -165.13 -71.5 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.658 -1.155 . . . . 0.0 108.444 177.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 58.94 9.06 1.1 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.671 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.0 m -76.54 15.82 0.57 Allowed 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 112.432 0.531 . . . . 0.0 112.432 -176.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.534 HD22 ' HH ' ' A' ' 39' ' ' TYR . 5.1 tt -107.64 102.18 43.53 Favored Pre-proline 0 C--N 1.323 -0.568 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -88.92 167.22 5.73 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.905 2.403 . . . . 0.0 113.548 -175.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -60.59 -23.58 64.78 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.242 178.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -62.07 -13.26 24.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.368 -176.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 tt -102.03 -33.4 3.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.298 0.57 . . . . 0.0 109.869 174.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.628 ' HA ' HD22 ' A' ' 27' ' ' LEU . 47.1 tp -72.13 -30.78 65.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.814 -176.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -66.48 -28.9 68.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.195 0.522 . . . . 0.0 110.338 177.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.9 m -72.96 -8.28 54.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.518 -176.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.735 HD11 HG22 ' A' ' 33' ' ' VAL . 4.3 mm? -58.87 -27.69 65.41 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.012 0.434 . . . . 0.0 110.959 176.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -85.31 -7.88 58.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.848 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -98.58 -39.96 8.45 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.208 -176.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.476 ' CD2' ' HB2' ' A' ' 5' ' ' LEU . 89.0 m-85 -86.98 147.12 25.88 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -92.13 -18.31 23.71 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.886 0.374 . . . . 0.0 110.435 -179.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.616 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -135.92 143.25 14.69 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 175.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.735 HG22 HD11 ' A' ' 27' ' ' LEU . 64.3 t -136.3 137.36 48.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 117.093 0.447 . . . . 0.0 110.485 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.57 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 39.0 mt -121.91 129.24 75.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.843 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.449 ' HA2' HG13 ' A' ' 7' ' ' ILE . . . -112.07 102.26 1.35 Allowed Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.918 177.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.623 ' HG ' HD11 ' A' ' 6' ' ' LEU . 85.8 mt -80.31 -32.61 37.98 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 176.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.764 ' HA3' ' HA ' ' A' ' 9' ' ' ASP . . . -138.16 62.78 0.57 Allowed Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 175.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -70.5 -172.5 0.61 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.024 0.44 . . . . 0.0 111.476 -175.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.573 ' HD1' HD11 ' A' ' 48' ' ' LEU . 81.2 m-85 -58.76 142.18 50.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.095 -177.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.566 ' HB ' ' HB3' ' A' ' 63' ' ' ASP . 15.7 m -85.59 16.14 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.318 0.58 . . . . 0.0 110.816 -176.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.449 ' O ' HG22 ' A' ' 45' ' ' VAL . 12.5 t70 -119.94 124.81 46.9 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.463 -178.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 53.2 tp -61.34 -39.49 90.77 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.079 -174.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -61.08 -42.46 98.55 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.119 0.485 . . . . 0.0 110.588 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.504 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 16.7 m -68.6 -29.43 67.95 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.118 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.482 HG21 HG11 ' A' ' 67' ' ' VAL . 65.5 t -59.25 -43.46 89.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 121.24 0.543 . . . . 0.0 109.965 174.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.491 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 1.7 mp -63.47 -38.74 83.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.027 176.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.23 -33.59 76.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.529 175.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.573 HD11 ' HD1' ' A' ' 39' ' ' TYR . 92.7 mt -67.97 -32.35 72.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.113 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -79.21 -16.28 56.76 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.195 177.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.491 ' HG3' ' O ' ' A' ' 46' ' ' ILE . 53.9 mtpt -76.61 -54.24 6.94 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 174.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.504 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . 62.9 m-85 -65.45 -63.8 1.01 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.716 176.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.524 ' HB2' HD12 ' A' ' 27' ' ' LEU . 41.6 t -84.25 96.56 9.03 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.725 175.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 53.0 mttp -64.01 -35.04 79.43 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.192 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -105.45 75.52 1.15 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.33 0.586 . . . . 0.0 109.704 171.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -101.58 125.18 48.19 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.462 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.57 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 91.3 m-85 -121.81 143.98 49.09 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 176.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.508 ' HA3' HD12 ' A' ' 71' ' ' LEU . . . -159.22 164.83 34.07 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 119.444 -1.36 . . . . 0.0 113.506 -176.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.484 HG12 ' HE3' ' A' ' 86' ' ' MET . 2.3 m -138.0 97.75 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.344 0.592 . . . . 0.0 109.447 176.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.508 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 11.9 t60 -94.38 146.97 23.68 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.377 -167.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -87.49 -163.22 38.76 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.179 179.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.531 ' HB3' ' HD2' ' A' ' 68' ' ' LYS . 2.0 p-10 -124.65 31.72 5.63 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.956 0.407 . . . . 0.0 110.973 -177.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 2.8 mpp? -76.12 -32.25 59.07 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.286 0.565 . . . . 0.0 109.824 178.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.566 ' HB3' ' HB ' ' A' ' 40' ' ' VAL . 3.8 p-10 -104.81 -111.14 0.26 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.759 -177.004 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -104.36 135.72 19.29 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.71 0.291 . . . . 0.0 110.78 -174.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.01 -28.2 87.2 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.695 2.264 . . . . 0.0 111.902 178.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -55.77 -38.95 70.55 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.227 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.482 HG11 HG21 ' A' ' 45' ' ' VAL . 16.7 t -76.41 -33.38 23.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.531 -178.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.531 ' HD2' ' HB3' ' A' ' 61' ' ' ASN . 86.3 tttt -73.17 -25.41 60.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.107 0.48 . . . . 0.0 110.374 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -78.28 -19.73 53.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.016 0.436 . . . . 0.0 109.98 173.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 9.3 m80 -84.2 -51.4 7.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.189 176.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.508 HD12 ' HA3' ' A' ' 57' ' ' GLY . 11.3 mt -107.5 108.41 61.64 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 176.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -54.76 153.85 22.97 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.758 2.305 . . . . 0.0 112.38 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -70.46 -18.48 62.99 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.12 0.486 . . . . 0.0 110.761 -177.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 51.1 m -150.84 131.27 13.77 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.133 178.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 44.7 tttp -149.45 133.15 16.85 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.373 -178.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.492 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 19.7 t -106.43 123.69 61.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 178.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 64.6 mt -102.02 157.22 17.02 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.545 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 60.3 tp -123.43 100.73 6.97 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 175.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.429 HG12 ' HD2' ' A' ' 2' ' ' LYS . 61.6 t -113.4 102.85 14.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.663 -176.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 51.63 42.22 29.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.68 176.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.97 0.15 64.0 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.754 -0.657 . . . . 0.0 113.215 175.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 96.0 t -105.94 129.78 58.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.751 0.31 . . . . 0.0 110.972 178.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.2 p -91.47 123.87 35.21 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.701 176.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.492 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 25.2 mt -116.92 98.28 6.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.451 -176.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.409 ' O ' HG21 ' A' ' 111' ' ' ILE . . . -85.61 98.85 2.31 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.338 178.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.484 ' HE3' HG12 ' A' ' 58' ' ' VAL . 35.8 mtm -90.75 131.81 36.21 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -178.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 34.7 t -149.65 165.07 33.44 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -125.72 29.19 6.01 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -66.9 167.5 38.43 Favored Glycine 0 N--CA 1.451 -0.321 0 CA-C-N 115.341 -0.845 . . . . 0.0 113.576 -175.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 54.3 p-90 -126.27 166.01 17.91 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.814 0.34 . . . . 0.0 110.573 -177.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 127.85 170.64 12.87 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.084 -0.579 . . . . 0.0 111.949 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -89.08 164.86 29.27 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 177.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_exo -53.2 -21.12 16.09 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.995 2.463 . . . . 0.0 113.268 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 11.7 m95 -70.66 -34.05 71.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.886 0.374 . . . . 0.0 110.379 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -101.31 -27.38 13.21 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.556 -178.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 37.4 tp -50.65 -57.29 8.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.175 -173.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -62.12 -44.1 97.39 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.075 -177.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -71.9 -14.76 62.03 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.338 -177.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.405 ' O ' HG21 ' A' ' 103' ' ' VAL . 29.0 ttt85 -95.33 -49.95 5.23 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.538 -178.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.493 HD12 HG23 ' A' ' 111' ' ' ILE . 79.6 mt -70.3 -34.5 72.81 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.62 -176.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.598 HD23 HG23 ' A' ' 127' ' ' VAL . 96.2 mt -75.24 -9.89 58.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.172 0.511 . . . . 0.0 110.411 177.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -91.34 -40.17 11.62 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.854 175.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.405 HG21 ' O ' ' A' ' 99' ' ' ARG . 94.8 t -64.23 -48.12 86.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.108 175.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -87.2 122.89 31.61 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.844 176.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -75.97 -30.83 58.75 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.138 0.494 . . . . 0.0 110.158 -178.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -93.67 179.77 5.26 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.622 175.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -109.35 106.25 58.35 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-O 120.956 0.407 . . . . 0.0 110.917 -178.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -76.51 131.52 12.67 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 123.103 2.535 . . . . 0.0 111.619 178.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -67.84 -40.32 83.74 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.266 178.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.872 HG21 HG21 ' A' ' 150' ' ' VAL . 89.3 t -126.02 135.96 62.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.179 179.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.493 HG23 HD12 ' A' ' 100' ' ' LEU . 44.3 mt -125.48 125.48 68.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.894 0.378 . . . . 0.0 110.406 176.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.678 HD22 ' HB2' ' A' ' 130' ' ' LEU . 95.6 mt -104.05 127.94 51.63 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.075 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -155.6 175.64 13.64 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.613 177.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -145.53 114.72 0.78 Allowed Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.731 178.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -165.72 -57.3 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.775 0.321 . . . . 0.0 110.924 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.6 p -82.88 -23.13 33.76 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -177.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 61.97 85.42 0.12 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 122.728 0.411 . . . . 0.0 110.559 -179.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -127.14 94.69 38.39 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.215 -178.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -68.4 67.23 1.08 Allowed 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.612 2.208 . . . . 0.0 111.793 178.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -161.92 153.59 18.77 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.484 -174.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -78.13 95.01 4.8 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 170.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.529 ' HB ' ' HZ3' ' A' ' 124' ' ' LYS . 51.2 p -92.17 114.42 26.95 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.51 0.671 . . . . 0.0 110.984 -169.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.2 p -98.96 95.84 4.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-O 121.946 0.879 . . . . 0.0 110.253 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.641 ' HB2' ' CE1' ' A' ' 129' ' ' PHE . 60.8 mttp -110.81 119.01 37.71 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.517 -178.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 64.32 23.26 13.0 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.009 0.433 . . . . 0.0 111.529 178.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 94.64 -12.98 68.06 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.607 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.598 HG23 HD23 ' A' ' 101' ' ' LEU . 43.2 t -93.6 137.9 21.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.662 0.268 . . . . 0.0 110.41 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -91.79 99.44 12.32 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.239 0.542 . . . . 0.0 110.118 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.641 ' CE1' ' HB2' ' A' ' 124' ' ' LYS . 91.1 m-85 -90.83 136.46 33.05 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.156 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.678 ' HB2' HD22 ' A' ' 112' ' ' LEU . 85.4 mt -122.84 109.02 13.66 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.269 0.557 . . . . 0.0 109.849 177.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 -131.33 103.15 15.23 Favored Pre-proline 0 C--N 1.318 -0.764 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.875 177.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -91.45 -177.66 1.05 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.753 2.302 . . . . 0.0 113.906 -170.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -73.98 149.2 40.79 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 173.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.753 ' HA ' ' HB2' ' A' ' 8' ' ' SER . 22.3 m -91.89 170.47 9.84 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 120.963 0.411 . . . . 0.0 111.449 -175.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -60.41 -29.84 69.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.906 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -67.81 -22.81 65.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.022 178.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -94.52 -6.07 44.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.467 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 79.98 39.6 16.25 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.964 -0.562 . . . . 0.0 113.155 176.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 64.5 m -153.73 156.22 37.39 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.714 0.293 . . . . 0.0 110.748 178.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -144.14 168.87 19.0 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 174.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.469 ' HB3' HD21 ' A' ' 6' ' ' LEU . . . -114.58 140.86 48.44 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.045 0.45 . . . . 0.0 111.379 -174.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 40.1 t -112.21 123.75 68.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 173.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.723 HD21 HG11 ' A' ' 150' ' ' VAL . 2.6 tt -107.9 104.76 14.31 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -104.74 113.79 27.59 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.536 -178.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.2 mp -97.1 93.55 6.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.066 0.46 . . . . 0.0 110.454 176.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.522 ' HB3' ' NH1' ' A' ' 151' ' ' ARG . 17.0 t70 -87.72 123.12 32.21 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 175.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 68.14 -62.93 0.38 Allowed Glycine 0 CA--C 1.523 0.534 0 O-C-N 123.403 0.439 . . . . 0.0 112.441 -172.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 171.24 34.5 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.534 -0.626 . . . . 0.0 111.534 177.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -121.96 140.33 52.58 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.872 HG21 HG21 ' A' ' 110' ' ' VAL . 90.6 t -80.97 115.44 23.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.595 -175.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.522 ' NH1' ' HB3' ' A' ' 146' ' ' ASP . 78.9 mtt85 -107.82 101.81 11.07 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.92 173.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -90.11 103.65 16.3 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.996 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -120.57 119.35 32.67 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.117 0.484 . . . . 0.0 110.48 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 24.8 tp -88.98 130.82 35.39 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.093 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -121.94 139.62 53.44 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.04 0.448 . . . . 0.0 110.566 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 9.5 p -84.23 162.85 20.02 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.797 -178.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 75.5 mt . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.529 -0.748 . . . . 0.0 109.865 175.571 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 43.9 mttm . . . . . 0 C--O 1.233 0.235 0 CA-C-O 120.719 0.295 . . . . 0.0 110.353 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.476 ' HG2' ' HG3' ' A' ' 144' ' ' GLU . 49.9 mtm-85 -127.15 124.82 39.96 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.702 178.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.412 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 95.4 m-85 -108.18 128.04 54.35 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.226 176.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.516 ' HB3' HG21 ' A' ' 33' ' ' VAL . 48.5 tp -89.31 112.1 23.1 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.577 -176.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.465 HD12 ' HG ' ' A' ' 36' ' ' LEU . 60.4 tp -97.64 110.03 22.67 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.037 0.446 . . . . 0.0 110.518 -179.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.419 HG13 ' HA2' ' A' ' 35' ' ' GLY . 33.2 pt -101.33 134.74 40.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 176.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.6 m -77.05 -167.6 0.91 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.927 -173.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -53.92 117.19 3.0 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.264 178.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.854 ' H ' ' HA3' ' A' ' 37' ' ' GLY . 20.1 m -115.48 127.7 55.5 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.497 -178.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 62.0 m170 -116.39 44.47 1.98 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 175.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.694 HG23 ' HB2' ' A' ' 19' ' ' LEU . 56.1 t -113.12 129.78 24.21 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.871 -175.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 59.3 Cg_endo -103.13 94.43 0.12 OUTLIER 'Cis proline' 0 N--CA 1.449 -1.094 0 C-N-CA 123.574 -1.428 . . . . 0.0 112.61 -7.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.579 HG12 ' HG3' ' A' ' 15' ' ' ARG . 14.6 t -100.23 -77.82 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 175.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.579 ' HG3' HG12 ' A' ' 14' ' ' VAL . 60.6 mtt180 -130.77 15.73 5.31 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.444 ' HE1' HD11 ' A' ' 135' ' ' LEU . 37.1 ttp -143.13 130.07 20.58 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.828 -177.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -122.27 12.08 10.17 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.142 0.496 . . . . 0.0 110.372 178.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.9 m -78.73 41.22 0.41 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.978 -176.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.694 ' HB2' HG23 ' A' ' 12' ' ' VAL . 4.5 tt -107.65 106.69 59.06 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.474 ' HD2' ' HH ' ' A' ' 140' ' ' TYR . 51.4 Cg_exo -56.33 122.74 12.31 Favored 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 122.905 2.404 . . . . 0.0 112.515 178.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -73.9 -10.79 60.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.184 -176.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -55.2 -52.01 64.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.357 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.5 tt -69.4 -27.06 32.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.212 0.529 . . . . 0.0 110.446 -177.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.418 ' O ' HD23 ' A' ' 27' ' ' LEU . 52.3 tp -70.37 -16.43 62.97 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.619 178.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -89.59 -25.36 21.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.989 178.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.0 p -83.61 24.31 0.87 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.834 0.349 . . . . 0.0 111.913 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.451 ' HB3' ' HB3' ' A' ' 51' ' ' PHE . 3.0 mm? -69.58 -8.57 48.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.855 0.359 . . . . 0.0 111.493 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -98.83 -13.13 20.24 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.26 0.552 . . . . 0.0 110.284 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -92.51 -11.32 34.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.185 -175.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -109.46 161.9 14.87 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.799 0.333 . . . . 0.0 110.737 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -86.58 -50.25 6.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.408 0.623 . . . . 0.0 109.894 179.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -139.5 156.55 24.71 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.115 178.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.516 HG21 ' HB3' ' A' ' 5' ' ' LEU . 84.0 t -125.25 137.94 55.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 120.745 0.307 . . . . 0.0 110.412 -179.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.519 HG12 ' HB2' ' A' ' 56' ' ' TYR . 34.0 mt -114.59 126.3 72.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.886 177.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.419 ' HA2' HG13 ' A' ' 7' ' ' ILE . . . -112.49 107.02 1.97 Allowed Glycine 0 N--CA 1.439 -1.132 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.345 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.465 ' HG ' HD12 ' A' ' 6' ' ' LEU . 89.5 mt -73.96 -24.48 59.63 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 171.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.854 ' HA3' ' H ' ' A' ' 10' ' ' SER . . . -140.25 132.59 5.57 Favored Glycine 0 N--CA 1.438 -1.17 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 170.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.526 ' OD2' HG11 ' A' ' 67' ' ' VAL . 18.2 p-10 -112.95 -173.34 2.23 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.311 0.577 . . . . 0.0 111.429 -172.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -84.24 116.7 23.1 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 172.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.838 ' HB ' ' HD2' ' A' ' 64' ' ' TYR . 35.4 m -64.96 -5.87 2.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -168.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.446 ' O ' HG23 ' A' ' 45' ' ' VAL . 19.7 t70 -86.7 120.51 28.07 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 177.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 45.3 tp -56.73 -46.18 81.47 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -172.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -66.34 -33.98 76.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.911 0.386 . . . . 0.0 110.603 -178.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.585 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 30.5 m -67.71 -29.23 68.43 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.658 176.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 41' ' ' ASP . 74.7 t -62.95 -41.82 94.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 121.058 0.456 . . . . 0.0 110.153 175.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.414 ' N ' HD13 ' A' ' 46' ' ' ILE . 1.7 mp -65.02 -36.06 76.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.808 175.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.56 -29.8 69.28 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.776 175.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 44' ' ' THR . 92.0 mt -65.28 -34.54 78.58 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 176.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -76.24 -21.91 55.79 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.958 175.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -72.87 -35.87 67.25 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.749 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.451 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . 70.3 m-85 -81.56 -67.05 0.81 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.18 172.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 38.2 t -86.2 96.05 9.79 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.717 176.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.627 ' HD2' ' H ' ' A' ' 53' ' ' LYS . 8.7 mptt -60.18 -31.26 69.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.681 -177.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -110.62 82.85 1.66 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.419 0.628 . . . . 0.0 109.974 169.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -100.48 112.55 24.92 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.966 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.519 ' HB2' HG12 ' A' ' 34' ' ' ILE . 33.5 m-85 -96.55 133.03 41.54 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 177.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -144.76 158.44 27.58 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 119.556 -1.307 . . . . 0.0 112.972 -177.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.439 HG11 ' HE3' ' A' ' 86' ' ' MET . 0.1 OUTLIER -136.26 155.2 34.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 122.756 0.422 . . . . 0.0 109.986 175.298 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.847 ' CE1' ' HB ' ' A' ' 67' ' ' VAL . 0.2 OUTLIER -128.22 171.57 11.83 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -174.317 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 121.94 39.66 0.55 Allowed Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.796 173.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -122.04 -86.92 0.65 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 117.455 0.628 . . . . 0.0 110.992 177.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 67.8 mtt -135.69 31.68 3.06 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.416 ' HB2' ' CE1' ' A' ' 59' ' ' HIS . 1.3 p30 -93.17 -178.32 4.74 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.299 -1.318 . . . . 0.0 112.212 -171.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.838 ' HD2' ' HB ' ' A' ' 40' ' ' VAL . 80.2 m-85 -94.3 138.21 22.54 Favored Pre-proline 0 C--O 1.232 0.182 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.477 176.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 64' ' ' TYR . 21.1 Cg_exo -67.4 -9.15 24.32 Favored 'Trans proline' 0 N--CA 1.474 0.368 0 C-N-CA 123.562 2.842 . . . . 0.0 113.913 -175.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -70.97 -42.38 69.79 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.12 0.486 . . . . 0.0 110.785 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.847 ' HB ' ' CE1' ' A' ' 59' ' ' HIS . 65.4 t -68.71 -11.04 14.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.617 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.817 ' HZ3' ' HB3' ' A' ' 68' ' ' LYS . 5.1 ttpm? -56.88 -30.7 64.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.885 176.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -70.08 -17.55 63.23 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.049 0.452 . . . . 0.0 110.836 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -105.81 -50.63 3.15 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.901 -178.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.584 ' HG ' HG13 ' A' ' 67' ' ' VAL . 4.4 mt -107.98 112.01 61.87 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.397 -178.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -74.08 170.95 18.95 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.768 2.312 . . . . 0.0 111.648 178.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -74.82 -21.11 59.47 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.244 0.545 . . . . 0.0 109.83 178.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' A' ' 86' ' ' MET . 55.1 m -150.63 124.69 9.33 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.022 175.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 42.3 tttp -132.86 129.48 38.5 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.736 -179.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 17.3 t -106.35 122.92 60.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 120.961 0.41 . . . . 0.0 110.221 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.526 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 59.7 mt -99.32 152.51 19.85 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.215 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 47.0 tp -124.63 97.39 5.27 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 174.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 37.6 t -112.8 104.94 17.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.439 -175.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 54.11 43.25 30.97 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.234 178.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.81 -25.73 23.71 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.904 177.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 63.6 t -81.03 129.95 36.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.816 0.341 . . . . 0.0 111.204 -176.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 28.2 p -91.76 129.53 37.71 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.439 177.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.526 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 34.6 mt -124.09 99.22 6.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.88 0.372 . . . . 0.0 110.178 -177.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -87.59 102.05 2.76 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.405 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.529 ' HG2' HD12 ' A' ' 112' ' ' LEU . 22.8 mtm -94.96 127.08 40.74 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 113' ' ' PHE . 42.4 t -141.73 154.72 45.47 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 16.1 p80 -63.46 -26.51 68.76 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 175.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.564 ' HA3' ' HB2' ' A' ' 113' ' ' PHE . . . 57.62 59.69 10.37 Favored Glycine 0 C--N 1.335 0.487 0 CA-C-N 115.965 -0.561 . . . . 0.0 114.432 170.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 81.3 t90 -97.48 127.56 43.54 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 174.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 163.99 -177.27 39.83 Favored Glycine 0 N--CA 1.444 -0.779 0 N-CA-C 111.301 -0.719 . . . . 0.0 111.301 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.54 139.21 44.24 Favored Pre-proline 0 C--N 1.32 -0.693 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 178.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -62.63 -25.83 75.46 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.935 2.423 . . . . 0.0 113.208 -175.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -67.22 -47.2 71.53 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.947 0.404 . . . . 0.0 110.616 -175.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -101.74 9.03 41.28 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.785 -177.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 26.8 tp -60.08 -47.53 85.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.535 -173.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -63.85 -45.48 89.28 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.178 0.513 . . . . 0.0 110.365 -177.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -65.55 -36.65 84.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.909 179.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.505 ' O ' HG23 ' A' ' 103' ' ' VAL . 21.3 ttt180 -67.96 -49.25 62.85 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.254 179.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.641 HD21 HG22 ' A' ' 111' ' ' ILE . 7.6 mp -62.8 -35.45 79.92 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.544 0.202 . . . . 0.0 111.544 -176.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.754 HD22 HG21 ' A' ' 127' ' ' VAL . 84.5 mt -71.77 -16.35 62.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.026 0.441 . . . . 0.0 110.659 176.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 48.5 tttp -96.26 -17.15 20.95 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.354 178.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 99' ' ' ARG . 92.0 t -74.43 -45.86 44.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.11 0.481 . . . . 0.0 109.75 175.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -80.82 155.45 26.61 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.44 176.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -84.0 -22.49 31.35 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.245 0.545 . . . . 0.0 109.94 178.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 14.8 mp0 -105.11 -174.47 2.54 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.461 177.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 47.8 pttt -119.24 91.67 44.26 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-O 121.491 0.662 . . . . 0.0 109.504 172.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.07 154.48 67.06 Favored 'Trans proline' 0 N--CA 1.464 -0.224 0 C-N-CA 123.086 2.524 . . . . 0.0 112.63 -174.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -82.06 -46.34 14.03 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.959 177.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.7 t -116.87 133.32 63.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.903 176.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.641 HG22 HD21 ' A' ' 100' ' ' LEU . 56.0 mt -129.71 134.81 62.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.855 0.359 . . . . 0.0 110.765 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.646 HD21 ' HB2' ' A' ' 130' ' ' LEU . 86.5 mt -108.22 135.05 50.2 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.767 178.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.564 ' HB2' ' HA3' ' A' ' 89' ' ' GLY . 47.1 p90 -142.62 162.64 34.93 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.744 177.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.24 114.97 1.31 Allowed Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.331 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -169.06 -54.56 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.2 p -85.92 159.43 19.66 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.159 171.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 22.0 p-80 -123.99 21.14 9.06 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.174 0.511 . . . . 0.0 110.53 -178.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 11.2 mp0 -87.68 107.96 18.07 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.619 176.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -64.66 95.67 0.23 Allowed 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.345 2.03 . . . . 0.0 111.814 -178.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -152.32 141.83 21.7 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.361 -176.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -95.16 123.15 38.5 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 171.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.627 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 73.2 p -112.23 144.97 40.75 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.273 -171.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 14.8 p -148.93 139.74 16.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.011 177.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -158.04 -48.55 0.06 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.13 0.491 . . . . 0.0 110.603 -178.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -97.0 24.43 6.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.395 -177.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 75.02 25.46 69.01 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.749 -0.738 . . . . 0.0 111.903 -175.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.754 HG21 HD22 ' A' ' 101' ' ' LEU . 52.8 t -132.78 137.02 54.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -100.0 104.97 16.6 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.109 0.48 . . . . 0.0 110.19 -177.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.627 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 60.0 m-85 -93.92 135.54 35.15 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.789 -179.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.646 ' HB2' HD21 ' A' ' 112' ' ' LEU . 86.9 mt -118.51 137.05 53.47 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.879 0.371 . . . . 0.0 111.326 -177.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.465 ' HA ' ' HD3' ' A' ' 132' ' ' PRO . 0.1 OUTLIER -150.32 125.64 4.86 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.23 173.388 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 131' ' ' ASN . 88.1 Cg_endo -101.86 -176.71 0.13 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 123.546 2.831 . . . . 0.0 112.56 175.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -81.58 171.14 52.65 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 174.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 75.6 p -85.38 173.9 9.95 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 117.515 0.658 . . . . 0.0 111.259 -177.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.605 HD13 ' HG ' ' A' ' 19' ' ' LEU . 21.2 mt -57.35 -49.54 75.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.718 -174.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -67.83 -10.91 56.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.03 -173.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -92.39 -3.79 54.77 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.981 0.419 . . . . 0.0 110.757 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.495 ' HA2' HD11 ' A' ' 157' ' ' LEU . . . 71.67 34.0 63.15 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.417 178.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 37.4 t -126.32 121.34 32.3 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.935 0.397 . . . . 0.0 110.539 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.474 ' HH ' ' HD2' ' A' ' 20' ' ' PRO . 86.5 m-85 -125.49 159.52 31.78 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.527 174.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.454 ' HB1' HD23 ' A' ' 6' ' ' LEU . . . -121.55 140.18 52.55 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.836 0.351 . . . . 0.0 110.137 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 62.1 t -122.68 121.55 63.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 175.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.798 HD23 HG11 ' A' ' 150' ' ' VAL . 3.5 tt -94.73 105.98 17.95 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.476 ' HG3' ' HG2' ' A' ' 3' ' ' ARG . 29.8 tt0 -102.94 145.55 29.67 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.457 -178.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 58.7 mt -117.23 105.97 12.78 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.975 0.416 . . . . 0.0 111.214 -177.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -118.31 130.57 56.1 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.973 175.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.51 11.01 59.0 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.169 -177.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 84.24 6.62 86.08 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.096 -177.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -97.54 158.09 15.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.825 0.345 . . . . 0.0 110.663 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.798 HG11 HD23 ' A' ' 143' ' ' LEU . 51.7 t -87.52 109.94 20.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.798 -178.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 43.8 ttt180 -107.18 113.66 27.23 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.158 0.504 . . . . 0.0 110.549 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -84.26 108.67 17.26 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.022 177.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -106.65 105.45 15.49 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 23.6 tp -83.66 109.92 17.85 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 119.951 -0.7 . . . . 0.0 110.256 -177.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -88.78 118.88 28.79 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.512 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 21.4 p -111.64 148.46 33.32 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.437 -173.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.495 HD11 ' HA2' ' A' ' 138' ' ' GLY . 74.7 mt . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.576 -0.726 . . . . 0.0 109.644 178.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 60.9 mttp . . . . . 0 N--CA 1.454 -0.242 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.515 ' HG3' ' HA ' ' A' ' 30' ' ' TYR . 0.1 OUTLIER -124.45 129.93 51.55 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.043 -175.765 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.482 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 16.6 m-85 -119.06 132.05 56.0 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.803 -179.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 28.2 tp -89.05 122.84 32.79 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.031 178.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.521 HD11 ' HG ' ' A' ' 36' ' ' LEU . 62.4 tp -104.7 111.79 24.64 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.039 0.447 . . . . 0.0 110.461 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.9 pt -101.16 138.62 24.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.785 176.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.5 m -77.34 -178.59 5.23 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.404 -175.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -63.84 104.61 0.71 Allowed 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.466 -176.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.8 m -95.45 83.99 3.92 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.833 -175.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 28.3 m80 -75.03 76.25 2.22 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 175.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.639 HG21 HD13 ' A' ' 19' ' ' LEU . 40.7 t -125.9 128.36 24.56 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.069 -177.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -76.36 -61.58 0.05 OUTLIER 'Cis proline' 0 CA--C 1.529 0.264 0 C-N-CA 122.818 -1.742 . . . . 0.0 112.928 -1.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 53.4 t 56.81 -87.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 122.865 0.466 . . . . 0.0 111.612 179.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 81.6 mtt180 -139.8 6.63 2.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.941 0.4 . . . . 0.0 110.097 177.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 52.9 ttp -135.79 98.97 4.04 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.782 -173.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -99.66 -1.46 37.91 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.326 0.584 . . . . 0.0 110.354 177.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.0 m -82.72 58.98 4.52 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.403 -176.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.639 HD13 HG21 ' A' ' 12' ' ' VAL . 4.9 tt -107.66 109.75 62.47 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.721 ' HG2' HD12 ' A' ' 157' ' ' LEU . 31.3 Cg_exo -60.64 123.95 14.06 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 123.096 2.531 . . . . 0.0 112.585 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -62.53 -15.33 50.05 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.127 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -56.76 -33.99 67.14 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.379 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.6 tt -75.63 -32.89 25.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.374 0.606 . . . . 0.0 110.086 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.499 ' O ' HD23 ' A' ' 27' ' ' LEU . 45.7 tp -71.99 -17.37 62.06 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.292 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -91.52 -2.01 57.33 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.661 177.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 46.9 m -93.77 -0.7 55.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.662 -176.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.57 ' CD1' HG21 ' A' ' 33' ' ' VAL . 4.0 mm? -65.16 -10.34 30.3 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.0 0.429 . . . . 0.0 111.053 179.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.5 mttm -76.41 -30.86 57.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.149 -174.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -111.03 27.26 9.86 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -166.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.515 ' HA ' ' HG3' ' A' ' 3' ' ' ARG . 91.6 m-85 -136.22 152.09 50.39 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.778 178.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -79.28 -43.98 22.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.573 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -138.98 164.19 25.83 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.098 178.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.57 HG21 ' CD1' ' A' ' 27' ' ' LEU . 98.7 t -134.11 137.96 51.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.049 0.452 . . . . 0.0 110.874 -177.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.7 mt -118.43 135.63 58.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.82 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.496 ' O ' ' HA2' ' A' ' 57' ' ' GLY . . . -124.21 123.37 5.13 Favored Glycine 0 N--CA 1.44 -1.04 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.031 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.521 ' HG ' HD11 ' A' ' 6' ' ' LEU . 98.7 mt -81.52 34.63 0.38 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.188 0.518 . . . . 0.0 109.87 177.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.443 ' H ' ' C ' ' A' ' 35' ' ' GLY . . . 118.7 103.85 2.14 Favored Glycine 0 N--CA 1.44 -1.063 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 -173.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.526 ' OD2' HG11 ' A' ' 45' ' ' VAL . 6.5 p-10 -97.88 -156.25 0.53 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.863 0.332 . . . . 0.0 110.488 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -58.5 153.75 15.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.262 0.553 . . . . 0.0 111.945 -173.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 12' ' ' VAL . 21.2 m -94.84 -1.79 10.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.098 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.629 ' O ' HG23 ' A' ' 45' ' ' VAL . 16.2 t70 -93.45 120.26 33.52 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 173.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.423 HD22 ' HB3' ' A' ' 66' ' ' ASP . 38.3 tp -57.98 -42.63 85.51 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 123.426 0.453 . . . . 0.0 111.888 -170.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -62.21 -44.82 95.73 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.727 0.299 . . . . 0.0 110.53 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.7 m -67.11 -28.8 68.46 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.091 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.629 HG23 ' O ' ' A' ' 41' ' ' ASP . 61.5 t -59.63 -50.39 80.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 121.371 0.605 . . . . 0.0 110.302 175.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.506 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 1.8 mp -68.64 -34.13 63.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.837 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -58.08 -39.11 77.74 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.427 174.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.57 -42.63 70.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.148 0.499 . . . . 0.0 109.777 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.0 tt0 -56.92 -40.26 76.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.754 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.506 ' HG3' ' O ' ' A' ' 46' ' ' ILE . 94.1 mttt -63.72 -45.81 88.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.962 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.554 ' HB3' ' HG ' ' A' ' 27' ' ' LEU . 17.9 m-85 -62.78 -42.75 99.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.834 0.35 . . . . 0.0 111.388 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.507 ' HB2' ' HB2' ' A' ' 55' ' ' PHE . 15.6 m -71.28 -28.11 63.9 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.313 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 68.4 mttm 71.49 -49.52 0.68 Allowed 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.855 0.862 . . . . 0.0 110.557 -175.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -124.46 91.84 3.53 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 172.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.507 ' HB2' ' HB2' ' A' ' 52' ' ' SER . 81.8 t80 -106.33 122.19 45.74 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.881 -176.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -114.67 115.27 26.84 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.665 177.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.496 ' HA2' ' O ' ' A' ' 35' ' ' GLY . . . -121.35 160.17 15.76 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 119.975 -1.107 . . . . 0.0 113.614 -175.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.595 HG23 ' HB3' ' A' ' 86' ' ' MET . 0.1 OUTLIER -140.76 106.99 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 123.251 0.621 . . . . 0.0 110.217 173.222 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.579 ' HB2' ' HG ' ' A' ' 71' ' ' LEU . 52.7 t-80 -102.05 117.29 34.48 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.151 -173.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -107.07 -14.4 18.94 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.454 -0.879 . . . . 0.0 113.444 -175.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -76.74 156.08 32.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.756 0.312 . . . . 0.0 110.389 -179.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 82.4 mtp -108.28 81.27 1.46 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.307 0.575 . . . . 0.0 109.93 175.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -106.9 -78.3 0.59 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.72 179.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.477 ' HD1' ' HB ' ' A' ' 40' ' ' VAL . 92.3 m-85 -107.45 154.37 40.73 Favored Pre-proline 0 C--N 1.323 -0.556 0 N-CA-C 110.318 -0.252 . . . . 0.0 110.318 178.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -74.42 -38.88 1.73 Allowed 'Trans proline' 0 CA--C 1.53 0.279 0 C-N-CA 122.49 2.126 . . . . 0.0 112.799 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.423 ' HB3' HD22 ' A' ' 42' ' ' LEU . 13.0 m-20 -60.38 -45.13 94.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.217 0.532 . . . . 0.0 111.482 -175.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.426 HG22 ' HA ' ' A' ' 40' ' ' VAL . 45.3 t -65.68 -27.94 42.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.546 -174.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 46.6 mttp -64.81 -25.66 68.01 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.871 0.367 . . . . 0.0 110.933 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -85.02 -28.43 25.72 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.795 -176.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.509 ' HD1' HD22 ' A' ' 71' ' ' LEU . 58.9 t-80 -69.79 -45.04 68.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.116 0.484 . . . . 0.0 109.95 177.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.579 ' HG ' ' HB2' ' A' ' 59' ' ' HIS . 1.3 pt? -140.02 113.05 7.55 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.421 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.29 -172.74 1.24 Allowed 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 123.099 2.533 . . . . 0.0 113.209 -176.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.412 ' CZ ' ' HA3' ' A' ' 89' ' ' GLY . 59.7 t80 -75.08 -43.48 52.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.545 -173.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.0 m -136.94 140.78 42.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.967 0.413 . . . . 0.0 111.579 -177.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.0 ttpm? -160.26 132.74 6.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.529 176.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.617 HG21 ' CE1' ' A' ' 104' ' ' PHE . 43.5 t -93.77 131.75 39.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.765 0.317 . . . . 0.0 110.249 173.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 38.5 mt -108.04 152.11 24.94 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 174.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 37.2 tp -122.41 96.11 4.91 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 175.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 60.4 t -102.25 95.45 3.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.685 -175.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 55.52 32.31 18.8 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.634 0.731 . . . . 0.0 111.054 175.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 114.53 -33.59 5.31 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.565 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 85.2 t -72.38 120.09 20.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.826 0.346 . . . . 0.0 110.695 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.9 101.73 13.44 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.048 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.419 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 19.0 mt -95.08 105.27 16.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.358 -176.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.487 ' HA2' HG22 ' A' ' 76' ' ' VAL . . . -89.5 94.36 1.98 Allowed Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.783 -0.723 . . . . 0.0 111.347 178.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.595 ' HB3' HG23 ' A' ' 58' ' ' VAL . 35.8 mtm -91.21 107.77 19.43 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.844 0.354 . . . . 0.0 110.687 -176.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 37.0 t -125.53 85.44 2.4 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 175.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 79.9 t60 -84.7 89.7 7.55 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.92 -173.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.412 ' HA3' ' CZ ' ' A' ' 73' ' ' PHE . . . -148.53 172.3 28.76 Favored Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.4 176.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 75.4 t-105 -76.52 106.85 8.41 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.951 0.405 . . . . 0.0 110.525 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -130.06 152.12 19.6 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 177.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -112.06 162.86 19.38 Favored Pre-proline 0 C--N 1.319 -0.721 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.32 -12.72 21.21 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.423 2.082 . . . . 0.0 112.514 178.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 14.0 m95 -80.47 -51.7 8.5 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.275 -178.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.463 ' OD2' ' HD3' ' A' ' 99' ' ' ARG . 12.0 p-10 -94.9 -0.58 53.87 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.159 -176.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 22.5 tp -50.52 -64.84 0.68 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.128 -0.487 . . . . 0.0 112.199 -174.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.488 ' HD2' ' HB2' ' A' ' 125' ' ' ALA . 42.5 mtmt -61.73 -54.37 43.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.365 0.602 . . . . 0.0 110.727 -176.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -61.08 -45.96 92.58 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.818 -1.083 . . . . 0.0 112.28 -171.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.463 ' HD3' ' OD2' ' A' ' 95' ' ' ASP . 34.0 ttt180 -79.37 -46.22 18.04 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.967 -173.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.444 HD13 HG23 ' A' ' 111' ' ' ILE . 47.3 mt -66.09 -29.45 69.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.687 0.279 . . . . 0.0 111.519 -176.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.59 HD22 ' HE3' ' A' ' 107' ' ' LYS . 86.0 mt -78.98 -13.28 59.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.687 0.28 . . . . 0.0 111.149 177.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -84.52 -31.74 24.29 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.83 0.348 . . . . 0.0 110.268 173.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.3 t -63.58 -49.72 81.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.254 177.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.617 ' CE1' HG21 ' A' ' 76' ' ' VAL . 20.3 m-85 -105.68 116.01 31.22 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.551 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -72.87 -29.16 62.96 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 170.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -76.48 97.63 4.37 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.853 171.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.59 ' HE3' HD22 ' A' ' 101' ' ' LEU . 13.0 mptt -63.24 113.93 11.11 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-O 120.996 0.426 . . . . 0.0 110.975 -178.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 107' ' ' LYS . 1.0 OUTLIER -85.32 158.86 11.13 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.581 2.854 . . . . 0.0 112.642 -175.944 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -79.38 -53.24 7.11 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.032 177.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 74.8 t -120.42 128.6 76.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.865 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.462 HD11 ' CE2' ' A' ' 129' ' ' PHE . 48.6 mt -114.65 129.21 71.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.083 0.468 . . . . 0.0 110.797 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.43 HD23 ' HB2' ' A' ' 130' ' ' LEU . 81.4 mt -102.31 120.53 40.64 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.03 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -132.38 -169.61 2.26 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 -178.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -137.03 126.79 3.81 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.634 -0.794 . . . . 0.0 112.645 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 20.4 t60 -167.62 -71.86 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.183 0.516 . . . . 0.0 110.143 176.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.427 HG23 ' H ' ' A' ' 118' ' ' GLU . 6.6 m -83.05 143.2 30.76 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.118 -177.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.423 ' HB3' ' OE1' ' A' ' 137' ' ' GLU . 61.6 m-70 -90.31 -21.46 22.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.304 0.573 . . . . 0.0 110.168 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.429 ' HA ' ' HD3' ' A' ' 119' ' ' PRO . 48.6 mt-10 -87.01 121.0 71.78 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.169 173.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.729 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 23.5 Cg_exo -61.76 101.25 0.21 Allowed 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.704 2.269 . . . . 0.0 112.399 -175.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -111.41 127.34 55.64 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.851 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -79.84 103.23 9.59 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 174.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.604 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 38.5 p -99.5 113.81 26.4 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.248 -176.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 6.9 p -109.7 97.71 6.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-O 122.168 0.985 . . . . 0.0 109.686 177.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.469 ' HB3' ' HD3' ' A' ' 97' ' ' LYS . 58.5 mttp -129.61 137.37 50.65 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.581 -176.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.488 ' HB2' ' HD2' ' A' ' 97' ' ' LYS . . . 64.96 13.38 8.59 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 123.616 0.572 . . . . 0.0 110.917 -176.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 89.74 -9.59 76.63 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.294 -178.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 38.8 t -93.04 141.34 14.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 14.8 ttt180 -100.54 102.16 13.26 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.25 0.548 . . . . 0.0 110.428 -177.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.604 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 18.2 m-85 -92.09 142.86 27.04 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.235 178.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.43 ' HB2' HD23 ' A' ' 112' ' ' LEU . 86.1 mt -124.4 136.45 54.07 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.925 0.393 . . . . 0.0 110.917 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.729 ' O ' ' HA ' ' A' ' 119' ' ' PRO . 4.1 p30 -130.01 103.8 16.99 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.844 176.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -94.37 154.85 2.05 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.002 2.468 . . . . 0.0 113.297 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -71.93 159.06 53.65 Favored Glycine 0 N--CA 1.452 -0.289 0 N-CA-C 111.409 -0.676 . . . . 0.0 111.409 175.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 13.4 t -83.54 176.3 9.14 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 117.304 0.552 . . . . 0.0 111.251 -175.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 20.7 mt -70.81 -34.82 72.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.003 -170.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -77.03 -7.14 55.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.145 0.498 . . . . 0.0 110.69 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.423 ' OE1' ' HB3' ' A' ' 117' ' ' HIS . 42.2 mt-10 -92.6 1.12 57.43 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.003 176.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 73.34 39.6 50.99 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.678 -0.692 . . . . 0.0 113.08 174.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 50.2 m -150.08 144.29 25.65 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.763 0.316 . . . . 0.0 110.678 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -143.95 166.16 25.74 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.591 176.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -114.47 134.89 54.67 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.258 0.551 . . . . 0.0 111.411 -175.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 152' ' ' PHE . 89.4 t -116.47 121.43 67.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.572 175.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 5.2 tt -110.61 107.35 16.92 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -104.87 142.45 34.72 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.961 176.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.0 mp -90.74 94.28 9.61 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.218 0.532 . . . . 0.0 109.689 172.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -87.19 113.38 22.87 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.4 -178.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 68.35 -62.96 0.41 Allowed Glycine 0 CA--C 1.52 0.36 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.562 -169.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 179.38 27.77 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 175.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -127.1 160.53 30.89 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -175.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 47.6 t -77.76 108.88 11.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.844 0.354 . . . . 0.0 111.426 -176.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 151' ' ' ARG . 15.2 ttm180 -107.7 96.07 6.13 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 173.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . 0.424 ' HA ' ' O ' ' A' ' 142' ' ' VAL . 40.1 p90 -102.41 127.53 49.4 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.928 -178.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -120.32 140.72 50.84 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.849 176.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -100.58 97.54 8.22 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.519 176.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -92.28 140.86 29.18 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.088 -177.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 18.1 p -89.62 155.58 19.15 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.617 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.721 HD12 ' HG2' ' A' ' 20' ' ' PRO . 83.0 mt . . . . . 0 C--O 1.247 0.952 0 CA-C-O 118.334 -0.841 . . . . 0.0 109.865 177.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 60.1 mttp . . . . . 0 N--CA 1.455 -0.21 0 CA-C-O 120.677 0.275 . . . . 0.0 110.293 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.548 ' HG2' ' HG2' ' A' ' 144' ' ' GLU . 79.5 mtt180 -104.92 111.28 23.98 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.629 172.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.547 ' HE2' HG12 ' A' ' 79' ' ' VAL . 70.4 m-85 -101.59 129.73 47.76 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.028 0.442 . . . . 0.0 111.036 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.53 ' HB3' HG21 ' A' ' 33' ' ' VAL . 36.8 tp -89.57 112.25 23.4 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.611 176.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.411 ' HB3' ' HB1' ' A' ' 141' ' ' ALA . 51.5 tp -96.76 102.23 13.98 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.116 0.484 . . . . 0.0 110.045 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.474 HG13 ' HA2' ' A' ' 35' ' ' GLY . 11.5 pt -101.47 126.29 55.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.493 176.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.578 ' HB3' ' OG1' ' A' ' 116' ' ' THR . 14.0 m -68.62 179.65 1.66 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.028 -176.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -78.4 79.82 4.82 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 122.053 0.93 . . . . 0.0 110.811 -177.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.573 ' HG ' ' CG ' ' A' ' 38' ' ' ASP . 10.6 p -80.53 133.87 35.87 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 176.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 74.3 m-70 -99.57 80.09 2.34 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.363 0.602 . . . . 0.0 109.617 -177.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.467 ' HB ' ' HD1' ' A' ' 39' ' ' TYR . 38.6 t -114.87 137.62 22.93 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.617 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -82.79 -58.71 0.07 OUTLIER 'Cis proline' 0 N--CA 1.461 -0.4 0 C-N-CA 123.666 -1.389 . . . . 0.0 112.887 -2.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER 35.05 -96.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -173.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 40.9 mtm180 -127.33 20.66 6.76 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 15.6 tmm? -144.16 100.25 3.52 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.246 0.546 . . . . 0.0 109.987 173.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -110.08 16.02 22.11 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.825 176.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 27.9 p -84.67 39.33 0.74 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.078 -177.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.424 HD23 ' HH ' ' A' ' 39' ' ' TYR . 9.0 tt -97.16 119.92 62.26 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.547 ' HG3' HD12 ' A' ' 157' ' ' LEU . 26.9 Cg_endo -61.66 130.39 31.31 Favored 'Trans proline' 0 C--O 1.234 0.291 0 C-N-CA 123.092 2.528 . . . . 0.0 112.552 -178.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -63.44 -18.57 63.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.885 -179.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -52.62 -49.26 65.47 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.769 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.0 tt -70.38 -36.32 66.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.345 0.593 . . . . 0.0 110.34 -176.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.677 HD12 HD23 ' A' ' 27' ' ' LEU . 58.3 tp -69.81 -33.79 72.82 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.131 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -71.09 -36.61 72.27 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.327 178.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 75.6 m -80.69 7.53 10.02 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.752 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.677 HD23 HD12 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -50.56 -41.48 54.2 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.592 0.71 . . . . 0.0 110.724 176.896 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 71.3 mttt -90.99 11.15 23.83 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.173 -171.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -104.28 7.94 35.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.038 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -126.02 158.77 34.48 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.4 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -72.0 -53.19 13.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.176 0.512 . . . . 0.0 109.968 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.532 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -138.12 151.96 21.64 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.194 179.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.53 HG21 ' HB3' ' A' ' 5' ' ' LEU . 97.8 t -118.96 135.89 57.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-O 120.703 0.287 . . . . 0.0 110.482 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.424 HG12 ' HB2' ' A' ' 56' ' ' TYR . 37.0 mt -111.56 116.62 53.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.854 176.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.474 ' HA2' HG13 ' A' ' 7' ' ' ILE . . . -104.25 119.66 6.36 Favored Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 177.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 94.3 mt -92.81 24.07 3.82 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.122 0.487 . . . . 0.0 110.552 -179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 121.55 21.91 2.9 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.828 -178.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.573 ' CG ' ' HG ' ' A' ' 10' ' ' SER . 10.9 t70 -81.14 134.03 35.57 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.611 ' HD2' HD13 ' A' ' 48' ' ' LEU . 25.7 m-85 64.6 105.73 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 O-C-N 123.872 0.732 . . . . 0.0 110.924 -175.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.412 HG22 ' O ' ' A' ' 12' ' ' VAL . 35.9 m -86.77 0.22 6.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.332 -176.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.539 ' O ' HG21 ' A' ' 45' ' ' VAL . 16.0 t70 -86.65 135.93 33.22 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.792 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 54.3 tp -62.7 -49.49 74.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.702 -175.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -63.1 -35.31 79.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.823 0.344 . . . . 0.0 110.752 -177.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.437 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 14.1 m -68.6 -33.06 73.4 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.21 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.539 HG21 ' O ' ' A' ' 41' ' ' ASP . 93.4 t -60.2 -46.12 95.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.369 0.604 . . . . 0.0 109.888 175.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.471 HD12 ' N ' ' A' ' 46' ' ' ILE . 1.7 mp -66.23 -38.0 80.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.89 177.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.24 -33.8 72.79 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.801 176.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.611 HD13 ' HD2' ' A' ' 39' ' ' TYR . 83.3 mt -66.95 -38.13 85.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.26 0.552 . . . . 0.0 109.996 178.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.677 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 35.8 tt0 -77.23 -11.39 59.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.331 176.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -92.5 -36.4 13.09 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.643 0.259 . . . . 0.0 110.945 -178.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.469 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . 6.4 m-30 -65.69 -67.37 0.45 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.4 178.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.5 ' OG ' HD12 ' A' ' 27' ' ' LEU . 5.1 m -73.49 -23.66 60.08 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.53 177.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.677 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 60.7 mttp 70.51 4.01 4.75 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.382 0.673 . . . . 0.0 111.785 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -144.83 105.07 4.07 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 172.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -128.89 133.23 47.85 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.189 0.519 . . . . 0.0 111.242 -173.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.424 ' HB2' HG12 ' A' ' 34' ' ' ILE . 88.1 m-85 -113.7 118.92 35.68 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 173.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -131.12 132.2 6.72 Favored Glycine 0 N--CA 1.44 -1.081 0 C-N-CA 119.606 -1.283 . . . . 0.0 113.925 -171.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.5 m -130.92 147.84 33.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 168.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.543 ' HB3' ' HB2' ' A' ' 71' ' ' LEU . 2.9 p80 -94.34 142.5 27.34 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 119.489 -0.884 . . . . 0.0 110.666 -173.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -81.29 -107.29 0.34 Allowed Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 115.618 -0.719 . . . . 0.0 113.538 -172.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.87 HD22 ' HA ' ' A' ' 115' ' ' HIS . 43.0 m-80 -95.62 -83.95 0.35 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.785 0.326 . . . . 0.0 111.264 -173.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 51.4 ttm -112.74 122.98 49.26 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.232 0.539 . . . . 0.0 110.682 -178.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -145.89 -174.25 4.37 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.288 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -74.88 144.51 79.88 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-O 120.673 0.273 . . . . 0.0 111.372 -176.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -47.06 -38.29 24.14 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.843 3.029 . . . . 0.0 114.161 -175.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -70.11 -46.54 64.61 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.214 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 39.9 t -63.66 -32.6 57.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.594 -177.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.413 ' HE2' ' HB3' ' A' ' 68' ' ' LYS . 31.8 ttpt -50.12 -40.36 45.8 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.809 177.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -104.12 -14.61 15.82 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.121 0.486 . . . . 0.0 110.136 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -75.44 -40.21 57.86 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -179.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.543 ' HB2' ' HB3' ' A' ' 59' ' ' HIS . 80.8 mt -102.64 117.94 59.67 Favored Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 170.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -56.44 156.2 22.66 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 123.129 2.553 . . . . 0.0 113.504 -174.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -77.11 -16.92 59.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.519 177.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.7 p -157.89 139.37 13.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.099 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.2 mttm -144.43 142.49 30.34 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.524 176.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 21.7 t -121.39 110.54 28.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.159 0.504 . . . . 0.0 109.913 172.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 37.3 mt -92.95 147.99 22.38 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.401 -177.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 55.1 tp -117.83 98.01 6.13 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 175.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.547 HG12 ' HE2' ' A' ' 4' ' ' PHE . 48.5 t -105.49 96.26 4.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.629 -174.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 57.31 27.62 14.01 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.624 175.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 114.35 -24.22 11.64 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.542 178.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.5 t -83.04 128.44 38.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.567 0.222 . . . . 0.0 110.809 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 40.0 p -91.48 131.24 37.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.538 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 42.0 mt -124.51 104.72 14.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.883 0.373 . . . . 0.0 110.215 -178.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -91.71 104.8 3.21 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.877 -0.677 . . . . 0.0 111.447 178.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 22.1 mtm -103.95 118.11 35.9 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -178.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 113' ' ' PHE . 46.0 t -156.96 158.29 36.34 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.925 0.393 . . . . 0.0 110.717 -177.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 15.0 t60 -65.64 -32.81 74.58 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.259 175.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.29 -94.88 0.57 Allowed Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 -173.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.428 ' HE3' ' H ' ' A' ' 92' ' ' ALA . 17.0 t90 -173.71 -69.24 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 172.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 155.14 -34.47 0.66 Allowed Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.994 -0.622 . . . . 0.0 111.77 -178.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 96' ' ' LEU . . . -78.61 115.1 49.03 Favored Pre-proline 0 C--N 1.327 -0.397 0 N-CA-C 110.487 -0.19 . . . . 0.0 110.487 178.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -81.22 5.18 6.42 Favored 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 123.427 2.752 . . . . 0.0 113.149 -175.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -80.74 -54.67 5.42 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.267 0.556 . . . . 0.0 109.942 -176.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 38.3 p30 -112.04 19.27 18.0 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.943 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.449 ' HB2' ' O ' ' A' ' 92' ' ' ALA . 50.8 tp -54.47 -51.13 66.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.478 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -60.53 -45.38 94.07 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.926 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -61.37 -47.12 87.31 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.157 0.503 . . . . 0.0 110.844 -177.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.538 ' O ' HG23 ' A' ' 103' ' ' VAL . 36.3 ttm105 -67.0 -42.15 85.49 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.56 178.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.932 HD22 HG21 ' A' ' 111' ' ' ILE . 17.1 tp -67.57 -41.8 83.59 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.134 -176.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.425 HD21 HG22 ' A' ' 127' ' ' VAL . 93.7 mt -75.8 -5.74 47.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.528 178.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -95.38 -29.94 14.17 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.962 174.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 99' ' ' ARG . 94.8 t -62.68 -53.0 52.68 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 174.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -82.52 146.49 29.2 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 174.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -87.59 -27.11 22.74 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.897 0.38 . . . . 0.0 110.755 -177.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -113.64 177.65 4.56 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.532 177.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.825 ' HD2' ' H ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -95.91 113.27 61.77 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.08 -175.133 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.47 ' HG2' HD11 ' A' ' 111' ' ' ILE . 1.2 Cg_endo -85.37 156.08 10.84 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.375 2.717 . . . . 0.0 111.854 177.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -90.7 -59.49 2.16 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.95 0.405 . . . . 0.0 110.771 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.626 HG21 HG22 ' A' ' 150' ' ' VAL . 57.3 t -105.15 119.54 54.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.331 -178.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.932 HG21 HD22 ' A' ' 100' ' ' LEU . 55.4 mt -116.46 128.69 73.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.079 0.466 . . . . 0.0 111.202 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.653 HD22 ' HB2' ' A' ' 130' ' ' LEU . 86.9 mt -107.61 124.72 50.37 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.011 176.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.496 ' HA ' ' O ' ' A' ' 87' ' ' CYS . 40.7 p90 -117.15 172.66 7.14 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 119.636 -0.825 . . . . 0.0 111.07 178.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -105.8 -165.18 23.32 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.442 -172.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.87 ' HA ' HD22 ' A' ' 61' ' ' ASN . 18.0 t60 69.06 41.73 1.37 Allowed 'General case' 0 C--O 1.233 0.191 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -173.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.578 ' OG1' ' HB3' ' A' ' 8' ' ' SER . 36.5 p -63.51 119.33 9.58 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 114.263 -1.335 . . . . 0.0 112.113 -171.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.432 ' HA ' ' OE2' ' A' ' 137' ' ' GLU . 0.0 OUTLIER -171.87 128.42 0.62 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.886 179.269 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 59.26 84.67 0.2 Allowed Pre-proline 0 N--CA 1.465 0.287 0 O-C-N 123.543 0.527 . . . . 0.0 110.791 -175.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -61.13 143.35 98.78 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 123.075 2.517 . . . . 0.0 113.014 -175.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -162.13 146.15 12.22 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.924 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -94.12 114.35 26.48 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.586 175.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.468 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 67.5 p -119.82 144.16 47.48 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.694 0.283 . . . . 0.0 111.405 -176.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.7 p -138.8 124.3 22.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.127 0.489 . . . . 0.0 110.976 178.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.485 ' HB2' ' HE2' ' A' ' 129' ' ' PHE . 88.1 mttt -140.9 139.42 34.35 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.536 176.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 66.94 14.04 9.68 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 123.485 0.491 . . . . 0.0 111.626 177.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 90.18 -2.82 81.87 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.234 -177.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.425 HG22 HD21 ' A' ' 101' ' ' LEU . 33.1 t -100.34 137.9 26.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -98.23 120.12 38.09 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.66 -176.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.485 ' HE2' ' HB2' ' A' ' 124' ' ' LYS . 34.9 m-85 -108.48 121.15 44.37 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.805 -178.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.653 ' HB2' HD22 ' A' ' 112' ' ' LEU . 78.1 mt -107.88 138.76 43.56 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-O 121.459 0.647 . . . . 0.0 111.146 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.457 ' HB3' ' CZ ' ' A' ' 113' ' ' PHE . 7.4 p30 -139.39 116.16 8.49 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.355 173.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.522 ' HD2' HG22 ' A' ' 116' ' ' THR . 86.2 Cg_endo -88.17 168.62 6.43 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.712 2.275 . . . . 0.0 112.502 178.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -85.28 147.77 22.62 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 176.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.563 ' HA ' ' HB2' ' A' ' 8' ' ' SER . 81.1 p -75.56 168.76 19.4 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.087 0.47 . . . . 0.0 111.077 -176.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.503 HD23 ' HB3' ' A' ' 10' ' ' SER . 4.2 mm? -64.82 -24.16 67.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.068 178.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -75.56 -14.36 60.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.036 0.446 . . . . 0.0 110.676 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.432 ' OE2' ' HA ' ' A' ' 117' ' ' HIS . 33.1 mt-10 -98.39 -2.23 39.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.192 178.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.501 ' HA2' HD13 ' A' ' 157' ' ' LEU . . . 70.78 45.45 52.17 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.925 177.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.6 p -150.81 153.92 36.32 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.597 0.199 . . . . 0.0 110.753 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -154.25 159.59 41.37 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 175.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.411 ' HB1' ' HB3' ' A' ' 6' ' ' LEU . . . -114.6 131.21 56.77 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.826 0.346 . . . . 0.0 111.384 -175.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 61.9 t -108.53 107.78 23.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 173.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 152' ' ' PHE . 6.7 tt -96.97 105.14 17.23 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.196 0.522 . . . . 0.0 110.106 -176.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.548 ' HG2' ' HG2' ' A' ' 3' ' ' ARG . 34.1 mt-10 -100.19 149.75 23.23 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.583 176.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.9 mp -90.49 90.12 7.87 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 166.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -101.23 112.48 24.98 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.732 -170.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.75 10.97 59.49 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.067 -174.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 91.65 5.07 67.1 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.238 -0.506 . . . . 0.0 112.086 -178.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -108.63 161.83 14.72 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 176.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.626 HG22 HG21 ' A' ' 110' ' ' VAL . 50.0 t -81.49 101.61 6.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.08 0.467 . . . . 0.0 110.593 -176.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 31.0 tpt180 -103.57 87.49 2.85 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.077 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . 0.494 ' HA ' ' HA ' ' A' ' 143' ' ' LEU . 12.0 p90 -91.37 101.5 14.18 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.295 0.569 . . . . 0.0 110.02 177.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -91.06 101.49 14.25 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.359 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 48.2 tp -75.62 99.93 4.46 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 175.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -93.94 133.82 36.97 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.912 -177.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.6 m -98.42 150.33 21.74 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.407 -175.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.547 HD12 ' HG3' ' A' ' 20' ' ' PRO . 83.1 mt . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.37 -0.824 . . . . 0.0 109.897 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.2 mptt . . . . . 0 CA--C 1.519 -0.224 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 52.8 mtp180 -106.51 116.57 32.16 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.09 178.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.522 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 73.1 m-85 -105.51 124.06 48.92 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.113 0.482 . . . . 0.0 111.487 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.504 ' HB3' HG21 ' A' ' 33' ' ' VAL . 37.9 tp -89.18 121.35 31.4 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.86 177.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.468 ' HB3' ' HB3' ' A' ' 141' ' ' ALA . 45.0 tp -110.95 106.46 15.57 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.181 0.515 . . . . 0.0 111.207 -177.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 19.7 pt -101.35 129.96 51.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.192 173.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.519 ' H ' HD22 ' A' ' 135' ' ' LEU . 9.1 p -85.27 -177.8 6.59 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.978 0.418 . . . . 0.0 111.954 -173.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.64 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.2 m-20 -65.39 104.22 0.94 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.31 -177.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.632 ' HB3' HD11 ' A' ' 135' ' ' LEU . 10.5 p -104.07 175.38 5.5 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 177.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -135.05 75.42 1.57 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.345 0.593 . . . . 0.0 110.098 176.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.411 ' O ' HG22 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -135.13 147.56 62.96 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.542 178.522 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -87.53 104.0 0.47 Allowed 'Cis proline' 0 N--CA 1.46 -0.463 0 C-N-CA 123.322 -1.532 . . . . 0.0 112.374 -2.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.3 t -135.34 -133.59 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -178.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 22.0 ttm-85 -87.73 4.22 45.04 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.096 0.474 . . . . 0.0 110.812 -177.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.518 ' HE1' ' HB2' ' A' ' 10' ' ' SER . 30.3 ttp -84.86 -76.23 0.32 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 62.72 2.93 1.03 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.222 0.609 . . . . 0.0 112.41 178.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.54 ' HG ' ' HB3' ' A' ' 136' ' ' ALA . 12.9 p -95.39 38.42 1.15 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.955 0.407 . . . . 0.0 111.519 -177.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.2 tt -107.84 111.11 62.51 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 177.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -70.57 141.24 41.48 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 122.734 2.289 . . . . 0.0 113.012 -177.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -63.8 -19.76 65.25 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.379 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -52.8 -42.66 65.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.898 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -68.66 -32.21 54.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.121 0.486 . . . . 0.0 110.514 -177.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.436 ' O ' HD23 ' A' ' 27' ' ' LEU . 58.3 tp -76.87 -31.97 57.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.412 -176.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -76.49 -23.47 53.76 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.555 178.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.9 m -78.49 0.85 24.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.766 -177.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.501 HD13 HG22 ' A' ' 33' ' ' VAL . 2.0 mm? -56.6 -28.98 61.6 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.884 0.373 . . . . 0.0 111.726 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 42.5 mttp -85.14 0.44 51.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.535 -174.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -113.12 17.49 18.7 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -171.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -137.45 168.43 19.66 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.672 0.272 . . . . 0.0 110.71 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -91.28 -52.75 4.66 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-O 121.512 0.672 . . . . 0.0 110.0 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -129.38 137.63 9.7 Favored Glycine 0 N--CA 1.441 -0.982 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.292 179.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.504 HG21 ' HB3' ' A' ' 5' ' ' LEU . 79.8 t -113.42 129.53 69.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.6 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 38.9 mt -105.99 122.74 59.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.527 -179.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -104.21 103.97 2.36 Favored Glycine 0 N--CA 1.44 -1.071 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.265 177.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.488 ' HB3' ' HE1' ' A' ' 88' ' ' HIS . 81.8 mt -80.42 -30.67 37.67 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 175.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.64 ' HA3' ' HA ' ' A' ' 9' ' ' ASP . . . -166.42 56.49 0.24 Allowed Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 177.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -57.61 -73.34 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.182 -0.509 . . . . 0.0 112.274 -171.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.51 ' CD1' HD13 ' A' ' 48' ' ' LEU . 78.5 m-85 -135.91 156.43 48.77 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.927 0.394 . . . . 0.0 110.686 178.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.411 HG22 ' O ' ' A' ' 12' ' ' VAL . 22.6 m -92.58 -3.02 10.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.335 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.584 ' O ' HG21 ' A' ' 45' ' ' VAL . 23.5 t70 -100.64 129.51 46.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.675 -178.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.503 HD23 ' HB3' ' A' ' 66' ' ' ASP . 51.0 tp -57.47 -52.14 66.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.456 . . . . 0.0 112.056 -174.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -68.29 -32.07 71.96 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.796 0.331 . . . . 0.0 110.948 -172.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.3 m -70.68 -33.16 70.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.916 178.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.584 HG21 ' O ' ' A' ' 41' ' ' ASP . 87.4 t -61.97 -44.21 98.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 121.357 0.598 . . . . 0.0 110.067 175.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.448 ' N ' HD13 ' A' ' 46' ' ' ILE . 1.7 mp -71.19 -31.79 45.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.269 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -58.65 -37.51 76.11 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 174.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.51 HD13 ' CD1' ' A' ' 39' ' ' TYR . 85.1 mt -69.68 -37.58 76.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.211 177.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -71.33 -12.6 61.52 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.663 -177.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -79.76 -47.58 15.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.836 0.351 . . . . 0.0 110.499 173.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.496 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . 76.0 m-85 -75.82 -42.71 49.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.949 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.2 t -71.17 104.69 3.15 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.004 175.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -49.77 -43.74 48.39 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.645 177.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -130.08 104.24 7.22 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.577 175.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -100.3 121.76 42.01 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.313 -176.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.6 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 91.9 m-85 -114.82 108.0 16.17 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -126.12 151.21 17.82 Favored Glycine 0 N--CA 1.442 -0.959 0 C-N-CA 119.872 -1.156 . . . . 0.0 112.734 -175.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.472 HG11 ' HE2' ' A' ' 86' ' ' MET . 0.9 OUTLIER -127.69 172.77 14.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 173.028 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.447 ' HB2' ' O ' ' A' ' 71' ' ' LEU . 10.7 t-80 -94.3 118.79 32.12 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.522 -172.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -82.51 -148.25 7.15 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.691 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -118.04 120.91 39.22 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.578 0.228 . . . . 0.0 111.512 -176.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 84.4 mtp 73.84 95.78 0.07 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.797 176.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.402 ' OD2' ' HB ' ' A' ' 67' ' ' VAL . 8.4 p-10 -160.4 -173.99 4.27 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.531 -177.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.401 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 15.1 m-30 -77.83 140.99 63.39 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.722 0.296 . . . . 0.0 111.01 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.411 ' O ' ' HB3' ' A' ' 68' ' ' LYS . 51.0 Cg_exo -57.46 -16.0 21.8 Favored 'Trans proline' 0 N--CA 1.474 0.37 0 C-N-CA 123.26 2.64 . . . . 0.0 112.915 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.503 ' HB3' HD23 ' A' ' 42' ' ' LEU . 8.5 m-20 -68.64 -41.57 79.2 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.252 0.548 . . . . 0.0 110.21 177.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.402 ' HB ' ' OD2' ' A' ' 63' ' ' ASP . 25.3 t -73.38 -23.61 19.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.96 -178.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.411 ' HB3' ' O ' ' A' ' 65' ' ' PRO . 63.9 tttp -52.78 -34.15 51.94 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.28 -178.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -108.36 2.31 22.42 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -176.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -98.76 -34.83 10.36 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 175.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.447 ' O ' ' HB2' ' A' ' 59' ' ' HIS . 51.2 mt -107.36 116.13 58.49 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.956 177.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -64.11 159.22 43.93 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.999 2.466 . . . . 0.0 112.751 -178.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.424 ' HZ ' HH22 ' A' ' 99' ' ' ARG . 64.7 t80 -79.85 -29.81 40.18 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.494 -176.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.0 p -148.7 126.27 11.7 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.507 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.7 tttm -141.54 128.42 20.58 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 12.0 t -109.65 118.17 56.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.844 0.354 . . . . 0.0 110.149 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 38.7 mt -93.01 153.27 18.82 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.656 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -118.3 108.99 15.77 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 171.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 22.2 t -122.21 102.09 11.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.148 -174.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 56.43 25.0 9.09 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.408 -0.814 . . . . 0.0 112.188 174.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 114.15 -10.57 22.49 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.96 177.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 46.5 t -103.84 134.63 44.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 122.645 -0.326 . . . . 0.0 110.948 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.6 p -93.83 133.35 37.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.656 177.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 27.1 mt -129.01 99.34 4.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.812 0.339 . . . . 0.0 110.357 -176.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -89.59 110.25 3.7 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.852 -0.69 . . . . 0.0 111.785 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.489 ' HG2' ' HB2' ' A' ' 112' ' ' LEU . 32.6 mtm -99.91 123.25 43.96 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 -179.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 34.2 t -145.83 163.07 36.2 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.488 ' HE1' ' HB3' ' A' ' 36' ' ' LEU . 7.2 m80 -141.0 -165.27 1.92 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.989 0.423 . . . . 0.0 111.424 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 112.48 169.33 17.85 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -177.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 17.3 p90 -81.81 96.7 7.69 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.502 0.668 . . . . 0.0 110.546 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -122.98 115.66 2.75 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.036 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.45 153.91 81.62 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 178.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.99 -7.45 6.28 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.013 2.475 . . . . 0.0 113.603 -175.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -81.72 -52.78 6.8 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.197 0.522 . . . . 0.0 109.978 -178.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -103.55 -4.87 23.34 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.823 -174.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 40.9 tp -52.41 -56.69 13.3 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.797 -176.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 45.9 pttt -57.39 -42.97 83.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.446 -177.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -69.37 -41.69 76.2 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.642 -178.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.475 ' O ' HG22 ' A' ' 103' ' ' VAL . 42.7 ttt-85 -62.05 -47.53 84.33 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.006 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.486 HD13 HG22 ' A' ' 111' ' ' ILE . 94.2 mt -66.47 -38.41 87.27 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.27 -176.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.782 HD23 HG21 ' A' ' 127' ' ' VAL . 86.6 mt -76.16 -13.25 60.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.011 0.434 . . . . 0.0 110.888 177.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -82.89 -39.89 20.94 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.008 176.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.475 HG22 ' O ' ' A' ' 99' ' ' ARG . 90.8 t -66.24 -50.93 64.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.194 -178.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -87.38 111.92 21.6 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 121.066 -0.254 . . . . 0.0 110.967 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -57.82 -52.89 63.6 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 174.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -80.77 94.96 6.51 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 170.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.652 ' HD2' ' H ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -59.95 123.15 70.77 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.217 -179.279 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 107' ' ' LYS . 2.2 Cg_endo -82.08 157.15 17.68 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 123.754 2.969 . . . . 0.0 112.699 -172.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -73.51 -44.94 56.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.946 177.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 65.4 t -118.78 140.67 41.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.948 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.486 HG22 HD13 ' A' ' 100' ' ' LEU . 40.9 mt -129.86 131.99 66.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.74 0.305 . . . . 0.0 110.474 177.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.636 HD22 ' HB2' ' A' ' 130' ' ' LEU . 75.3 mt -105.24 127.34 52.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.64 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -147.21 147.24 30.26 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.686 176.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -130.96 114.79 1.64 Allowed Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.332 -0.937 . . . . 0.0 111.814 179.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 17.2 t60 -178.45 21.59 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 177.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.503 HG23 ' H ' ' A' ' 117' ' ' HIS . 0.2 OUTLIER -101.65 -176.03 3.02 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.142 -174.564 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.503 ' H ' HG23 ' A' ' 116' ' ' THR . 49.4 m-70 -111.63 -43.19 3.69 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.756 0.312 . . . . 0.0 110.562 178.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -124.58 149.21 61.23 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.913 175.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.547 ' HG3' HD22 ' A' ' 154' ' ' LEU . 74.4 Cg_endo -74.83 138.51 23.58 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.713 2.275 . . . . 0.0 111.988 178.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -150.58 125.95 10.1 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.374 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -78.26 94.47 4.8 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 177.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.489 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 68.6 p -103.46 119.19 38.4 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.837 -174.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.48 HG13 ' O ' ' A' ' 123' ' ' VAL . 8.9 p -107.25 88.89 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 122.336 1.065 . . . . 0.0 109.113 170.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -127.27 146.24 50.5 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.701 -174.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 61.8 15.25 6.89 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 123.724 0.64 . . . . 0.0 110.893 -174.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 83.91 9.87 81.9 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.52 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.782 HG21 HD23 ' A' ' 101' ' ' LEU . 47.7 t -119.21 140.83 41.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.698 0.285 . . . . 0.0 110.307 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.638 ' NH1' HD22 ' A' ' 130' ' ' LEU . 26.9 ttt-85 -89.36 94.16 9.79 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.489 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 89.3 m-85 -83.44 126.14 32.44 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.638 HD22 ' NH1' ' A' ' 128' ' ' ARG . 50.2 mt -112.01 122.43 47.74 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.385 0.612 . . . . 0.0 110.965 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.501 ' HA ' ' HD3' ' A' ' 132' ' ' PRO . 5.1 p30 -129.22 122.95 21.37 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.821 178.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.501 ' HD3' ' HA ' ' A' ' 131' ' ' ASN . 5.4 Cg_endo -87.15 169.64 7.33 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.238 2.625 . . . . 0.0 112.288 179.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -89.05 -160.23 36.23 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.27 178.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 48.2 t -88.19 139.3 30.64 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.825 0.345 . . . . 0.0 110.637 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.632 HD11 ' HB3' ' A' ' 10' ' ' SER . 58.3 mt -66.17 -19.74 65.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.28 178.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.54 ' HB3' ' HG ' ' A' ' 18' ' ' SER . . . -78.76 -12.53 60.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.348 -178.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -87.52 -4.62 58.98 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.417 -176.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 77.9 25.75 61.71 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.335 178.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 7.3 t -139.46 132.32 29.25 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 178.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -126.32 173.25 9.46 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -177.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.468 ' HB3' ' HB3' ' A' ' 6' ' ' LEU . . . -114.38 134.94 54.61 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.689 -174.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.481 HG12 ' HG3' ' A' ' 144' ' ' GLU . 47.3 t -128.83 124.08 60.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.881 176.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.515 HD22 HG11 ' A' ' 150' ' ' VAL . 5.8 tt -101.87 106.47 17.43 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.481 ' HG3' HG12 ' A' ' 142' ' ' VAL . 45.2 mt-10 -113.3 131.42 55.94 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.521 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 21.2 mt -93.07 90.74 7.02 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.887 -178.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -87.54 111.47 21.25 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.832 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.74 -69.02 0.29 Allowed Glycine 0 CA--C 1.52 0.384 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.633 -175.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -171.17 25.46 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 111.665 -0.574 . . . . 0.0 111.665 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -110.37 143.04 41.21 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.515 HG11 HD22 ' A' ' 143' ' ' LEU . 46.5 t -86.03 89.07 2.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 177.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 67.6 mtp180 -90.02 98.44 11.77 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.337 0.589 . . . . 0.0 110.644 -175.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -83.37 93.99 7.87 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.12 175.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -97.46 112.52 24.33 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.845 0.355 . . . . 0.0 110.988 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.547 HD22 ' HG3' ' A' ' 119' ' ' PRO . 15.9 tp -83.6 92.4 7.65 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 171.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -83.78 145.69 28.56 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.598 -174.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 18.7 p -91.47 145.05 24.94 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.545 178.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 79.8 mt . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.688 -0.673 . . . . 0.0 110.388 178.714 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 55.1 mttm . . . . . 0 N--CA 1.452 -0.358 0 CA-C-O 120.823 0.344 . . . . 0.0 110.706 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 50.3 mtp180 -115.57 123.19 47.85 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -119.52 135.07 54.93 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.979 0.419 . . . . 0.0 110.533 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.415 ' HB2' ' CD2' ' A' ' 30' ' ' TYR . 32.6 tp -89.33 127.2 35.78 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.158 179.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.552 ' HB3' ' HB1' ' A' ' 141' ' ' ALA . 47.8 tp -106.84 109.88 21.9 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.974 0.416 . . . . 0.0 110.547 -178.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.402 HG13 ' HA2' ' A' ' 35' ' ' GLY . 7.4 pt -101.35 128.62 53.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.771 177.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.3 m -89.4 -171.32 3.18 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.14 -171.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -47.97 117.16 1.77 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.165 -178.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.65 ' HB2' ' HA ' ' A' ' 38' ' ' ASP . 37.0 m -137.35 160.38 39.24 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.856 -1.065 . . . . 0.0 108.806 174.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 32.2 m80 -127.35 58.4 1.46 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.288 0.566 . . . . 0.0 109.579 -179.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.459 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . 2.9 t -108.67 134.02 20.44 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.845 -177.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.459 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 72.4 Cg_endo -103.08 51.82 1.45 Allowed 'Cis proline' 0 N--CA 1.448 -1.183 0 C-N-CA 124.078 -1.218 . . . . 0.0 111.995 -4.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.454 HG22 HG21 ' A' ' 40' ' ' VAL . 10.9 t -58.14 -39.99 75.3 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-O 121.531 0.681 . . . . 0.0 109.999 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 31.9 ttt85 -177.19 -33.97 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.374 -1.285 . . . . 0.0 108.681 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.483 ' HE1' ' HB3' ' A' ' 10' ' ' SER . 32.0 ttp -74.17 122.92 23.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.013 178.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -130.13 13.01 5.66 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.085 0.469 . . . . 0.0 110.339 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.0 p -82.66 33.74 0.43 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.418 -177.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.8 tt -99.67 114.22 65.48 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.421 ' O ' HG23 ' A' ' 23' ' ' ILE . 36.6 Cg_exo -60.95 130.01 31.12 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 123.278 2.652 . . . . 0.0 113.016 -176.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -67.33 -23.36 65.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.271 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -58.87 -34.68 71.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.358 -178.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.421 HG23 ' O ' ' A' ' 20' ' ' PRO . 6.3 tt -65.59 -38.39 82.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.538 0.685 . . . . 0.0 109.662 178.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.671 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 46.0 tp -70.34 -32.01 69.54 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.303 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -71.62 -24.39 61.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.801 178.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.0 m -85.94 7.61 23.58 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -171.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.685 HD11 ' HB3' ' A' ' 52' ' ' SER . 4.3 mt -64.91 -19.77 66.1 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.509 0.671 . . . . 0.0 109.401 178.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -56.58 -23.8 43.11 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 114.563 -1.199 . . . . 0.0 111.835 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -82.34 -21.53 35.96 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -178.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.415 ' CD2' ' HB2' ' A' ' 5' ' ' LEU . 30.3 m-85 -113.87 159.75 19.5 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -162.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -71.94 -30.0 64.87 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.637 176.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -175.69 178.59 47.2 Favored Glycine 0 N--CA 1.439 -1.149 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.334 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.453 HG23 HD11 ' A' ' 27' ' ' LEU . 93.3 t -123.58 144.72 32.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 110.305 -0.257 . . . . 0.0 110.305 -178.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.455 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 55.0 mt -113.07 116.45 52.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.071 176.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.402 ' HA2' HG13 ' A' ' 7' ' ' ILE . . . -99.03 124.59 8.28 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.699 176.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.414 HD13 HD13 ' A' ' 6' ' ' LEU . 84.7 mt -98.39 3.19 48.47 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 122.624 -0.339 . . . . 0.0 111.087 -178.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 128.98 79.02 0.23 Allowed Glycine 0 CA--C 1.505 -0.582 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 -176.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.65 ' HA ' ' HB2' ' A' ' 10' ' ' SER . 0.4 OUTLIER -135.9 -70.26 0.48 Allowed 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.413 -0.394 . . . . 0.0 111.043 -169.402 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.408 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 96.9 m-85 -90.51 105.01 17.52 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 174.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.454 HG21 HG22 ' A' ' 14' ' ' VAL . 11.2 m -82.25 -12.36 12.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.298 -173.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.484 ' O ' HG21 ' A' ' 45' ' ' VAL . 11.4 t70 -86.65 127.52 34.94 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.339 -178.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 51.8 tp -61.13 -45.18 95.73 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.689 -174.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -62.87 -36.74 84.29 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.209 0.528 . . . . 0.0 110.252 -178.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.442 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 16.5 m -68.64 -33.26 73.69 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.617 176.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.484 HG21 ' O ' ' A' ' 41' ' ' ASP . 85.0 t -59.97 -41.88 87.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-O 121.109 0.481 . . . . 0.0 110.179 173.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -67.46 -34.8 70.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.185 0.517 . . . . 0.0 110.123 177.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.67 -33.75 75.69 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.062 174.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 44' ' ' THR . 98.3 mt -64.63 -36.43 84.23 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 175.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.711 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 37.3 mt-10 -77.49 -4.8 47.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.738 176.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -86.69 -41.07 14.48 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 173.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.462 ' CB ' HD12 ' A' ' 27' ' ' LEU . 74.5 m-85 -76.79 -51.44 11.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.178 178.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.685 ' HB3' HD11 ' A' ' 27' ' ' LEU . 78.6 p -90.62 -25.12 20.3 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 121.071 -0.252 . . . . 0.0 111.616 -178.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.711 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 68.0 mttm 71.6 -50.35 0.69 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.413 0.685 . . . . 0.0 111.712 -177.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -105.02 101.89 11.42 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.511 0.672 . . . . 0.0 109.728 175.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.57 ' HB3' ' HG2' ' A' ' 49' ' ' GLU . 89.7 t80 -114.82 124.61 52.19 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.806 -176.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.455 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 93.5 m-85 -112.76 165.8 11.95 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 174.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 163.45 174.21 33.05 Favored Glycine 0 N--CA 1.442 -0.959 0 C-N-CA 119.211 -1.471 . . . . 0.0 113.604 176.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.437 HG12 ' HE1' ' A' ' 86' ' ' MET . 2.8 m -146.68 118.75 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 114.791 -0.705 . . . . 0.0 109.167 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -94.53 176.39 6.31 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.167 -175.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -109.44 -171.4 20.57 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.332 -0.937 . . . . 0.0 112.216 -176.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -88.68 40.77 0.98 Allowed 'General case' 0 C--N 1.321 -0.654 0 O-C-N 122.424 -0.456 . . . . 0.0 110.065 178.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 57.5 mtm -132.66 4.8 3.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.524 -179.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -107.87 -169.09 1.46 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.375 -175.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -81.0 135.85 51.09 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.231 176.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.18 -36.53 93.41 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 123.336 2.691 . . . . 0.0 113.386 -177.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -69.14 -24.53 64.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.85 0.357 . . . . 0.0 111.306 -177.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 41.0 t -65.16 -21.69 29.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-O 121.29 0.566 . . . . 0.0 110.388 177.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.767 ' HB3' ' HZ2' ' A' ' 68' ' ' LYS . 4.6 ttpm? -62.41 -25.29 67.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.838 -178.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -68.04 -53.85 22.69 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.49 -174.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 22.2 t60 -74.3 -38.09 63.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.659 0.266 . . . . 0.0 110.824 -178.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -133.76 121.87 16.28 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-O 120.865 0.364 . . . . 0.0 110.285 177.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -81.24 -160.71 0.13 Allowed 'Trans proline' 0 CA--C 1.529 0.266 0 C-N-CA 123.003 2.469 . . . . 0.0 112.821 -176.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -96.6 -24.9 15.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.331 0.586 . . . . 0.0 109.719 177.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.7 m -142.38 125.39 16.24 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.333 -178.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 22.2 ttmm -150.05 136.62 19.11 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.023 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 13.5 t -105.07 118.67 52.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 177.15 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.524 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 91.5 mt -87.77 136.14 33.08 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.048 177.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 33.9 tp -111.43 97.45 6.76 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 173.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 29.2 t -123.28 111.13 28.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.445 -174.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 57.11 33.57 23.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.541 178.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.9 -19.24 55.34 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.713 177.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.601 HG22 HD23 ' A' ' 145' ' ' LEU . 56.9 t -82.0 132.05 32.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.869 0.366 . . . . 0.0 111.179 -176.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.6 p -95.13 116.06 28.23 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.832 176.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.524 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 26.5 mt -111.91 92.83 2.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.988 0.423 . . . . 0.0 110.019 -178.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -81.53 99.81 2.0 Allowed Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.437 ' HE1' HG12 ' A' ' 58' ' ' VAL . 29.7 mtm -97.75 121.57 39.83 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -177.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 47.0 t -146.14 109.76 4.81 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 15.3 t60 -91.79 65.36 4.98 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.224 0.535 . . . . 0.0 110.887 -174.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -103.12 160.84 16.61 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.733 177.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 89.0 m95 -116.1 104.84 11.96 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.993 0.425 . . . . 0.0 110.784 -179.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -155.57 -173.12 23.87 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 178.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.47 142.17 42.92 Favored Pre-proline 0 C--N 1.321 -0.654 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.61 -20.85 59.76 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 123.041 2.494 . . . . 0.0 112.968 -176.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -69.45 -52.1 29.92 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.243 0.544 . . . . 0.0 109.986 -178.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -77.02 -30.79 55.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.079 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.411 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 36.2 tp -50.35 -55.24 16.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.83 -175.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.45 ' HG3' ' N ' ' A' ' 98' ' ' ASP . 19.2 pttp -58.28 -41.76 85.08 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.876 0.369 . . . . 0.0 111.098 -177.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.45 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 29.5 t70 -69.26 -43.89 73.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.881 -175.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.503 ' O ' HG22 ' A' ' 103' ' ' VAL . 82.1 mtp180 -70.53 -41.87 71.97 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.141 -177.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.482 HD12 HD12 ' A' ' 111' ' ' ILE . 85.1 mt -61.49 -39.3 90.44 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.568 0.223 . . . . 0.0 111.505 -177.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 87.7 mt -67.04 -22.91 65.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.85 0.357 . . . . 0.0 111.063 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -91.45 -28.21 17.78 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.962 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.503 HG22 ' O ' ' A' ' 99' ' ' ARG . 89.7 t -67.6 -44.1 86.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.08 0.467 . . . . 0.0 109.837 175.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -85.09 168.95 14.4 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.544 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -97.34 -20.26 17.96 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.103 -177.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -135.59 165.98 24.28 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.454 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 13.8 ptmt -74.47 120.21 80.36 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-O 121.021 0.439 . . . . 0.0 110.17 176.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 107' ' ' LYS . 3.7 Cg_exo -80.69 131.95 8.52 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 122.738 2.292 . . . . 0.0 111.163 176.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -66.3 -39.39 89.29 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 176.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.502 ' CG2' HG21 ' A' ' 150' ' ' VAL . 94.8 t -124.19 138.61 53.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.393 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.482 HD12 HD12 ' A' ' 100' ' ' LEU . 25.1 mt -129.32 126.41 63.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.907 0.384 . . . . 0.0 110.398 174.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.574 HD23 ' HB2' ' A' ' 130' ' ' LEU . 90.3 mt -101.71 119.75 39.27 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.429 ' CE1' ' HB3' ' A' ' 129' ' ' PHE . 20.0 p90 -133.11 173.45 11.42 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.868 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -122.22 114.67 2.55 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.601 -0.809 . . . . 0.0 111.957 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -166.7 35.95 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.912 ' HA ' HD22 ' A' ' 131' ' ' ASN . 53.3 m -53.21 109.87 0.48 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.55 -1.204 . . . . 0.0 113.819 -169.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 28.4 m80 -111.08 -45.53 3.43 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 162.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -147.67 142.32 16.59 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 114.593 -1.185 . . . . 0.0 109.024 172.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.458 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 16.5 Cg_endo -59.45 113.08 1.46 Allowed 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 122.173 1.916 . . . . 0.0 110.941 173.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -146.21 140.04 26.28 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.89 0.376 . . . . 0.0 111.319 -169.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -107.33 122.7 47.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.894 176.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 59.6 p -130.79 130.6 43.89 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -173.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.1 p -99.1 122.63 51.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 172.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.575 ' HZ2' ' HB2' ' A' ' 124' ' ' LYS . 3.0 ttpm? -151.34 123.05 8.0 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.367 -174.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 66.22 20.68 11.1 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.588 -177.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 80.92 7.79 88.19 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.912 -177.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.466 HG12 HD13 ' A' ' 111' ' ' ILE . 61.2 t -109.46 136.22 46.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 177.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -95.47 104.15 16.05 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.196 0.522 . . . . 0.0 110.037 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.429 ' HB3' ' CE1' ' A' ' 113' ' ' PHE . 98.1 m-85 -89.94 124.2 34.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.187 -178.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.574 ' HB2' HD23 ' A' ' 112' ' ' LEU . 81.8 mt -109.99 125.38 52.83 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-O 121.333 0.587 . . . . 0.0 111.159 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.912 HD22 ' HA ' ' A' ' 116' ' ' THR . 7.6 t30 -127.9 105.36 20.52 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.579 174.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -86.93 179.18 3.36 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 123.008 2.472 . . . . 0.0 113.112 -177.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -85.46 165.39 38.9 Favored Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.758 178.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.407 ' O ' ' HB3' ' A' ' 137' ' ' GLU . 15.6 m -87.33 156.96 19.39 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.948 0.374 . . . . 0.0 111.534 -175.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -61.95 -44.49 96.66 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.818 0.342 . . . . 0.0 110.959 177.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -68.61 -17.42 64.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.239 0.542 . . . . 0.0 110.738 178.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.407 ' HB3' ' O ' ' A' ' 134' ' ' SER . 77.5 tt0 -79.32 -34.27 42.43 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.03 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.478 ' HA2' HD13 ' A' ' 157' ' ' LEU . . . 107.32 31.79 3.66 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.95 176.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 31.2 p -148.05 154.76 40.67 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.805 0.336 . . . . 0.0 110.81 177.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.411 ' O ' HD11 ' A' ' 154' ' ' LEU . 30.6 p90 -149.75 162.96 39.23 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.77 175.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.552 ' HB1' ' HB3' ' A' ' 6' ' ' LEU . . . -114.43 138.27 50.79 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.18 0.514 . . . . 0.0 111.802 -169.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.74 ' HB ' ' HB2' ' A' ' 153' ' ' GLU . 97.5 t -117.72 124.12 72.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.071 173.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.846 HD21 HG12 ' A' ' 150' ' ' VAL . 1.6 tt -107.34 115.96 31.1 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -178.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -107.28 116.81 32.6 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.081 0.467 . . . . 0.0 109.763 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.601 HD23 HG22 ' A' ' 82' ' ' VAL . 74.5 mt -96.79 109.56 22.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.969 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -126.08 120.98 31.61 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.746 -175.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.82 10.93 59.57 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.87 178.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 92.03 5.66 65.8 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.759 -177.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -102.99 145.61 29.61 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.084 0.468 . . . . 0.0 110.496 178.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.846 HG12 HD21 ' A' ' 143' ' ' LEU . 62.1 t -94.85 119.01 42.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.074 -175.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 64.7 mtt180 -124.42 143.05 50.84 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.091 0.472 . . . . 0.0 110.418 178.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . 0.428 ' HE2' ' HB2' ' A' ' 154' ' ' LEU . 58.7 t80 -118.3 116.75 27.4 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.291 -168.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.74 ' HB2' ' HB ' ' A' ' 142' ' ' VAL . 45.5 mt-10 -102.77 111.2 23.42 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 174.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.428 ' HB2' ' HE2' ' A' ' 152' ' ' PHE . 32.5 tp -97.28 115.59 27.92 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.113 179.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -105.95 153.13 22.42 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.051 0.453 . . . . 0.0 110.878 -178.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 36.7 p -108.73 152.39 24.91 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.187 -177.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.478 HD13 ' HA2' ' A' ' 138' ' ' GLY . 97.0 mt . . . . . 0 C--O 1.247 0.949 0 CA-C-O 118.475 -0.774 . . . . 0.0 109.835 175.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 86.6 mttt . . . . . 0 CA--C 1.52 -0.183 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 74.0 mtm-85 -110.27 116.18 31.01 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.811 -175.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -110.76 131.32 55.15 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.854 0.359 . . . . 0.0 110.792 178.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.487 ' HB2' ' CD2' ' A' ' 30' ' ' TYR . 38.6 tp -89.23 119.82 30.06 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.451 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.59 HD22 ' HB1' ' A' ' 141' ' ' ALA . 64.6 tp -106.05 115.65 30.58 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.017 0.437 . . . . 0.0 110.494 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.485 HG21 HD13 ' A' ' 23' ' ' ILE . 11.6 pt -101.09 125.8 54.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 177.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.0 m -65.43 177.51 1.13 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.2 -172.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -49.02 104.72 0.07 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.748 176.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.821 ' HB2' ' HA ' ' A' ' 38' ' ' ASP . 19.5 m -99.06 166.87 11.05 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.274 -177.109 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 69.9 m-70 -144.7 35.6 1.16 Allowed 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -176.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.64 HG23 HD13 ' A' ' 19' ' ' LEU . 14.6 t -102.68 138.53 19.65 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.493 -174.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.8 -56.84 0.14 OUTLIER 'Cis proline' 0 C--N 1.345 0.352 0 C-N-CA 123.382 -1.508 . . . . 0.0 112.242 -3.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.541 HG13 ' HG3' ' A' ' 15' ' ' ARG . 31.5 t 49.68 -94.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 O-C-N 123.815 0.697 . . . . 0.0 111.427 -178.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.541 ' HG3' HG13 ' A' ' 14' ' ' VAL . 54.9 mtp85 -138.44 13.53 2.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.259 0.552 . . . . 0.0 109.763 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 30.2 ttp -142.58 100.57 3.71 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.358 -177.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -101.72 14.33 32.29 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.254 0.55 . . . . 0.0 109.879 177.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.6 m -77.44 54.74 1.18 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.129 -179.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.854 ' HG ' HD13 ' A' ' 135' ' ' LEU . 2.0 tt -107.86 105.57 56.54 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 177.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.791 ' HG2' HD12 ' A' ' 157' ' ' LEU . 77.3 Cg_exo -52.08 123.47 12.6 Favored 'Trans proline' 0 C--O 1.236 0.398 0 C-N-CA 122.913 2.408 . . . . 0.0 112.375 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -68.62 -9.56 50.6 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.612 -178.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -52.88 -38.01 61.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.202 174.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.485 HD13 HG21 ' A' ' 7' ' ' ILE . 0.4 OUTLIER -82.45 -24.74 8.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.597 -179.006 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.461 ' O ' HD21 ' A' ' 27' ' ' LEU . 49.9 tp -81.96 -16.64 49.75 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.924 -177.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -86.3 -22.48 26.75 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.132 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.411 ' HB2' ' CE2' ' A' ' 30' ' ' TYR . 1.3 p -84.01 9.36 12.58 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -176.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.629 HD12 HG21 ' A' ' 33' ' ' VAL . 4.5 mm? -61.52 -19.96 62.68 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.234 0.54 . . . . 0.0 110.318 173.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 47.5 mttm -98.85 -0.34 42.63 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.857 -176.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -102.43 -49.32 3.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.803 0.335 . . . . 0.0 111.23 -173.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.487 ' CD2' ' HB2' ' A' ' 5' ' ' LEU . 93.4 m-85 -81.44 169.37 17.26 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.839 -173.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -88.24 -17.27 31.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.381 -177.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -168.67 162.27 36.03 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.629 HG21 HD12 ' A' ' 27' ' ' LEU . 61.2 t -132.01 147.47 32.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 -178.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.42 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 42.0 mt -123.73 124.78 70.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 175.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -106.48 114.69 4.49 Favored Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 111.564 -0.614 . . . . 0.0 111.564 177.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.608 ' HB3' ' HE1' ' A' ' 88' ' ' HIS . 99.3 mt -84.46 27.04 0.73 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.019 0.438 . . . . 0.0 110.733 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 110.46 60.54 0.49 Allowed Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 -173.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.821 ' HA ' ' HB2' ' A' ' 10' ' ' SER . 0.7 OUTLIER -76.53 -83.2 0.07 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.263 -0.469 . . . . 0.0 112.227 -173.829 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.467 ' HD1' HD13 ' A' ' 48' ' ' LEU . 75.5 m-85 -100.5 128.78 46.46 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.232 0.539 . . . . 0.0 110.995 -177.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.422 HG11 ' HB3' ' A' ' 63' ' ' ASP . 17.4 m -79.08 7.33 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.606 177.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.516 ' O ' HG23 ' A' ' 45' ' ' VAL . 13.6 t70 -110.17 130.01 55.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.964 -179.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.505 HD22 ' HB3' ' A' ' 66' ' ' ASP . 57.2 tp -65.63 -42.72 91.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.568 -175.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -59.51 -39.46 83.92 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.971 0.415 . . . . 0.0 111.274 -177.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 11.7 m -75.21 -27.02 59.39 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.213 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 41' ' ' ASP . 89.1 t -59.8 -43.3 91.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 121.391 0.615 . . . . 0.0 109.804 173.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.471 HD12 ' N ' ' A' ' 46' ' ' ILE . 1.7 mp -70.02 -34.55 60.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.91 178.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -60.94 -40.94 95.2 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.444 174.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.467 HD13 ' HD1' ' A' ' 39' ' ' TYR . 83.2 mt -69.11 -38.68 79.05 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.066 0.46 . . . . 0.0 110.174 179.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -62.13 -39.43 92.54 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.471 177.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -69.19 -36.1 76.96 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.752 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -71.61 -64.62 0.89 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.809 178.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.625 ' HB3' HD13 ' A' ' 27' ' ' LEU . 59.9 p -64.11 -40.85 97.1 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.217 -176.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 92.5 mttt 66.06 6.6 4.21 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.416 0.627 . . . . 0.0 110.425 -174.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -171.46 95.41 0.18 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.151 -0.932 . . . . 0.0 109.271 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.446 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 2.4 p90 -145.69 144.97 30.7 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.008 0.433 . . . . 0.0 109.927 178.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.42 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 56.1 m-85 -114.8 136.4 53.12 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 177.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.699 ' HA3' HD22 ' A' ' 71' ' ' LEU . . . -133.08 156.78 22.35 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 119.827 -1.178 . . . . 0.0 112.812 -177.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.84 164.25 30.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.132 0.491 . . . . 0.0 110.836 175.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.497 ' HB3' ' HA ' ' A' ' 73' ' ' PHE . 74.3 t60 -94.6 104.52 16.46 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.696 -175.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -115.72 -5.58 18.11 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.495 -0.775 . . . . 0.0 113.031 -176.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -115.16 -166.76 1.15 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.102 0.477 . . . . 0.0 110.234 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 97.0 mmm -98.98 34.86 2.0 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 169.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.422 ' HB3' HG11 ' A' ' 40' ' ' VAL . 1.8 p-10 -60.08 157.7 12.5 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.666 -177.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -62.21 155.62 64.46 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.924 -171.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.528 ' HA ' ' HB3' ' A' ' 68' ' ' LYS . 72.5 Cg_exo -50.47 -31.01 29.3 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 123.406 2.737 . . . . 0.0 112.948 178.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.505 ' HB3' HD22 ' A' ' 42' ' ' LEU . 32.2 m-20 -56.61 -48.4 77.54 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.342 0.591 . . . . 0.0 110.434 176.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 40.5 t -75.85 -38.94 37.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.819 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.528 ' HB3' ' HA ' ' A' ' 65' ' ' PRO . 48.5 tttp -57.59 -34.0 68.77 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.364 176.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -68.92 -33.94 74.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.069 0.461 . . . . 0.0 110.652 178.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.473 ' CE1' HD13 ' A' ' 42' ' ' LEU . 18.9 m80 -84.53 -50.89 7.32 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.167 -178.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.699 HD22 ' HA3' ' A' ' 57' ' ' GLY . 22.6 mt -100.38 113.8 65.54 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.899 -177.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.632 ' HG2' ' HB2' ' A' ' 75' ' ' LYS . 46.0 Cg_endo -69.42 153.98 69.72 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 122.491 2.127 . . . . 0.0 112.308 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.497 ' HA ' ' HB3' ' A' ' 59' ' ' HIS . 82.6 t80 -61.96 -32.77 73.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.343 0.592 . . . . 0.0 109.952 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.3 t -146.36 137.51 24.42 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.3 176.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.632 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 39.5 tttp -148.92 128.44 13.12 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.507 -176.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.441 ' HA ' ' HA2' ' A' ' 85' ' ' GLY . 46.5 t -99.75 117.03 44.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.095 0.474 . . . . 0.0 109.837 174.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.483 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 86.7 mt -87.71 138.48 31.43 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.408 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 42.9 tp -109.73 99.57 8.71 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 176.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 44.0 t -108.92 91.34 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.364 -177.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 57.33 30.31 18.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.662 175.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 114.54 -23.53 12.08 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.99 178.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.8 t -84.01 126.81 40.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.597 0.237 . . . . 0.0 110.556 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.2 p -95.72 117.96 31.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.944 0.402 . . . . 0.0 111.304 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.483 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 18.1 mt -111.62 93.14 2.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.946 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 76' ' ' VAL . . . -84.02 106.35 2.86 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 111.731 -0.548 . . . . 0.0 111.731 -179.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 53.5 mtm -98.93 125.86 44.47 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -178.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 35.3 t -149.97 133.73 16.82 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.608 ' HE1' ' HB3' ' A' ' 36' ' ' LEU . 17.6 m80 -113.31 93.3 4.34 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.099 0.476 . . . . 0.0 111.444 178.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -136.21 154.81 22.14 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 175.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 10.6 p-90 -135.51 152.06 50.96 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 168.5 -137.23 4.46 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 -179.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.484 ' HB1' ' NE1' ' A' ' 94' ' ' TRP . . . -75.54 119.33 76.55 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-O 120.875 0.369 . . . . 0.0 110.578 178.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 92' ' ' ALA . 10.7 Cg_exo -72.48 -23.71 19.88 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.929 2.419 . . . . 0.0 112.933 -177.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.503 ' CE3' ' HB3' ' A' ' 95' ' ' ASP . 57.8 p-90 -70.72 -21.63 62.53 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -176.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.503 ' HB3' ' CE3' ' A' ' 94' ' ' TRP . 3.3 p-10 -126.44 20.51 7.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.001 0.429 . . . . 0.0 110.338 176.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 59.3 tp -57.08 -39.77 75.64 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.515 178.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.418 ' HD2' ' HB3' ' A' ' 124' ' ' LYS . 48.8 mtpt -54.4 -51.8 63.73 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.21 174.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -62.04 -39.46 92.42 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.767 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.458 ' HG3' ' O ' ' A' ' 95' ' ' ASP . 52.5 mtt180 -63.43 -48.65 76.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.09 179.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 76.9 mt -67.65 -34.25 76.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.879 0.371 . . . . 0.0 111.094 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 96.9 mt -80.79 -4.84 56.04 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.858 0.361 . . . . 0.0 110.841 178.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 37.8 mttp -89.57 -22.07 22.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.485 170.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 64.6 t -68.74 -47.68 75.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.97 0.414 . . . . 0.0 110.189 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -108.91 169.87 8.4 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.715 177.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -95.35 -47.33 6.34 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -90.69 137.72 32.13 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.725 175.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.444 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 24.2 pttm -70.21 125.37 91.97 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-O 120.986 0.422 . . . . 0.0 110.629 -178.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 107' ' ' LYS . 9.0 Cg_exo -72.4 134.47 22.71 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.617 2.212 . . . . 0.0 110.368 174.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -60.5 -41.84 95.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.964 0.411 . . . . 0.0 110.437 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.8 t -122.46 140.96 44.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.767 177.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.446 HD12 ' CE2' ' A' ' 129' ' ' PHE . 42.0 mt -129.71 137.12 57.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 176.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.581 HD22 ' HB2' ' A' ' 130' ' ' LEU . 86.7 mt -114.11 130.57 56.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.326 -177.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.502 ' O ' ' HD2' ' A' ' 132' ' ' PRO . 51.4 p90 -155.65 -178.34 7.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.851 172.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -105.78 127.87 9.14 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.552 -0.832 . . . . 0.0 111.784 -177.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.521 ' HB2' ' HB2' ' A' ' 131' ' ' ASN . 1.1 t60 -83.69 -14.65 51.25 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.797 0.332 . . . . 0.0 110.536 -175.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 5.9 m 63.69 12.66 6.77 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.995 0.902 . . . . 0.0 110.18 -176.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.598 ' HB3' ' OE1' ' A' ' 118' ' ' GLU . 34.8 m80 -148.18 -160.76 1.21 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.997 -176.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.598 ' OE1' ' HB3' ' A' ' 117' ' ' HIS . 0.8 OUTLIER -69.32 144.28 94.58 Favored Pre-proline 0 C--N 1.326 -0.434 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.432 -179.917 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -51.68 134.66 47.64 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.161 2.574 . . . . 0.0 112.586 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.449 ' HG2' HG22 ' A' ' 122' ' ' THR . 36.9 tt0 -142.55 127.29 18.12 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.837 -174.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.734 ' HB2' ' HZ ' ' A' ' 152' ' ' PHE . 19.5 t70 -86.92 107.36 18.33 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 177.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.546 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 27.7 p -116.16 118.73 33.63 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.815 -174.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.9 p -106.26 106.98 21.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.428 0.632 . . . . 0.0 110.321 176.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.583 ' HB2' ' HE1' ' A' ' 129' ' ' PHE . 62.4 mttm -127.24 129.24 47.4 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.023 -176.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 62.54 22.23 13.16 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 123.347 0.405 . . . . 0.0 111.415 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 87.42 -5.38 85.15 Favored Glycine 0 CA--C 1.518 0.244 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.071 -178.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 90.4 t -94.92 135.45 28.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -97.22 107.32 19.81 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.159 0.504 . . . . 0.0 109.912 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.583 ' HE1' ' HB2' ' A' ' 124' ' ' LYS . 75.4 m-85 -92.48 119.06 31.61 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.717 -179.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.581 ' HB2' HD22 ' A' ' 112' ' ' LEU . 50.5 mt -103.31 117.37 34.35 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 177.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.521 ' HB2' ' HB2' ' A' ' 115' ' ' HIS . 2.5 p30 -130.03 110.11 16.87 Favored Pre-proline 0 C--N 1.317 -0.843 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.998 -177.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.502 ' HD2' ' O ' ' A' ' 113' ' ' PHE . 89.9 Cg_endo -82.46 -172.16 1.35 Allowed 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.783 2.322 . . . . 0.0 111.853 174.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -99.19 -97.65 2.13 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.558 -0.83 . . . . 0.0 112.904 -177.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 41.8 t -161.87 163.5 29.22 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 -176.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.854 HD13 ' HG ' ' A' ' 19' ' ' LEU . 57.3 mt -65.0 -49.75 69.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.115 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -65.1 -26.69 68.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.168 -178.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -88.87 4.3 48.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.875 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.534 ' HA2' HD13 ' A' ' 157' ' ' LEU . . . 58.67 43.67 96.15 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 116.083 -0.508 . . . . 0.0 113.354 175.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 3.9 p -137.24 110.39 7.8 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.039 0.447 . . . . 0.0 111.675 -178.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -132.19 -172.09 2.8 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 175.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.59 ' HB1' HD22 ' A' ' 6' ' ' LEU . . . -143.72 153.09 42.08 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.2 0.524 . . . . 0.0 111.46 -177.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 70.9 t -126.23 117.26 48.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 172.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.647 HD22 HG13 ' A' ' 150' ' ' VAL . 2.3 tt -94.62 106.52 18.51 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.254 0.55 . . . . 0.0 109.87 -175.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -97.97 119.06 35.92 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.702 177.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.2 mp -95.61 106.45 18.55 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 177.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -109.25 110.31 21.47 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.796 177.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 68.05 11.12 60.53 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.108 -176.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 94.55 5.18 61.81 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.758 -0.537 . . . . 0.0 111.758 -177.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -89.2 133.37 34.45 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 178.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.647 HG13 HD22 ' A' ' 143' ' ' LEU . 62.4 t -76.9 103.64 4.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.17 -177.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 78.4 mtt-85 -115.88 89.59 3.14 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.973 178.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . 0.734 ' HZ ' ' HB2' ' A' ' 121' ' ' ASP . 3.5 p90 -95.04 123.28 38.44 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.125 0.488 . . . . 0.0 110.682 -178.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -91.45 123.56 34.97 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.069 177.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -83.98 81.69 8.67 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 176.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -80.72 131.84 35.49 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.907 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 26.5 p -109.14 150.72 27.45 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.794 -175.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.791 HD12 ' HG2' ' A' ' 20' ' ' PRO . 90.5 mt . . . . . 0 C--N 1.315 -0.905 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 177.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.4 tttm . . . . . 0 N--CA 1.452 -0.349 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.67 ' HB3' ' HD1' ' A' ' 30' ' ' TYR . 56.6 mtt-85 -108.29 117.8 35.1 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.618 0.247 . . . . 0.0 111.33 -175.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.546 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 67.8 m-85 -112.43 113.94 26.39 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.203 0.525 . . . . 0.0 111.006 177.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.507 ' HB3' HG23 ' A' ' 33' ' ' VAL . 32.1 tp -89.24 121.04 31.14 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.021 178.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.745 HD12 ' HG ' ' A' ' 36' ' ' LEU . 41.4 tp -107.39 121.09 43.9 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.259 0.552 . . . . 0.0 111.211 -178.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.7 pt -101.18 119.38 49.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 171.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.494 ' O ' ' HB2' ' A' ' 36' ' ' LEU . 5.7 p -67.17 -87.71 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -164.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.483 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 36.2 t70 -142.32 94.06 2.61 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.287 0.565 . . . . 0.0 110.226 -176.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.959 ' HG ' HD13 ' A' ' 19' ' ' LEU . 23.0 t -107.86 158.47 17.3 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.802 -179.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 11.0 m80 -135.09 77.33 1.67 Allowed 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -178.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.446 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . 9.1 t -129.8 132.26 24.06 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.109 -177.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.446 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 41.2 Cg_endo -95.4 91.58 0.14 OUTLIER 'Cis proline' 0 N--CA 1.449 -1.092 0 C-N-CA 123.403 -1.499 . . . . 0.0 112.554 -2.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.5 t -114.85 -165.07 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 175.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 85.1 mtt180 -72.43 75.92 1.04 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 118.611 0.642 . . . . 0.0 110.758 177.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.446 ' HE3' ' OG ' ' A' ' 10' ' ' SER . 28.0 ttp -165.65 -77.12 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.467 178.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 59.2 12.05 2.36 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.554 -178.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.0 m -79.81 35.78 0.31 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.184 -177.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.959 HD13 ' HG ' ' A' ' 10' ' ' SER . 4.1 tt -107.75 111.02 62.7 Favored Pre-proline 0 C--N 1.327 -0.406 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.509 ' HG3' HD13 ' A' ' 157' ' ' LEU . 60.7 Cg_endo -74.06 133.43 18.09 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.623 2.215 . . . . 0.0 112.014 178.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -77.11 -5.81 50.43 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.925 0.393 . . . . 0.0 110.263 -177.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -55.93 -40.81 73.68 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.543 174.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.0 tt -70.38 -33.39 53.79 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-O 121.748 0.785 . . . . 0.0 109.98 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.515 ' O ' HD23 ' A' ' 27' ' ' LEU . 49.0 tp -66.64 -17.89 65.08 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.842 -178.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -80.47 -24.87 39.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.894 0.378 . . . . 0.0 110.966 177.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.3 m -80.28 2.81 23.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.48 -176.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.653 HD11 ' HB3' ' A' ' 52' ' ' SER . 4.4 mm? -59.98 -22.37 62.45 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.59 178.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -79.4 -14.26 59.06 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.323 -177.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -91.62 -23.61 19.81 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.968 0.413 . . . . 0.0 110.848 -178.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.67 ' HD1' ' HB3' ' A' ' 3' ' ' ARG . 38.3 m-85 -111.49 126.08 54.59 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.949 0.405 . . . . 0.0 110.678 -174.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -78.98 -29.97 44.14 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.868 -176.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.546 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -123.34 138.33 11.52 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 177.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.531 HG21 ' CD1' ' A' ' 27' ' ' LEU . 93.5 t -130.37 135.09 61.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 120.845 0.355 . . . . 0.0 110.574 -178.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.567 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 48.1 mt -112.32 131.59 63.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.435 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -118.41 98.28 0.74 Allowed Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.109 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.745 ' HG ' HD12 ' A' ' 6' ' ' LEU . 85.0 mt -77.65 -33.8 53.36 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 175.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.483 ' HA3' ' HA ' ' A' ' 9' ' ' ASP . . . -150.47 83.01 0.18 Allowed Glycine 0 N--CA 1.44 -1.087 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.494 177.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -94.75 -145.3 0.26 Allowed 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.44 ' HD1' HD13 ' A' ' 48' ' ' LEU . 78.2 m-85 -73.49 148.87 42.74 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 178.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.7 m -98.06 5.56 9.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.132 0.491 . . . . 0.0 110.748 -177.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.535 ' O ' HG22 ' A' ' 45' ' ' VAL . 17.3 t70 -102.9 132.34 49.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.874 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.508 HD21 ' HB3' ' A' ' 66' ' ' ASP . 65.6 tp -57.84 -54.23 49.22 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.171 -175.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -59.22 -35.71 74.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.156 0.503 . . . . 0.0 111.105 -176.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.422 HG23 ' CD2' ' A' ' 39' ' ' TYR . 17.6 m -72.01 -28.22 63.25 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.312 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.535 HG22 ' O ' ' A' ' 41' ' ' ASP . 94.8 t -65.01 -37.4 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 121.205 0.526 . . . . 0.0 109.913 174.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.512 ' O ' ' HG2' ' A' ' 50' ' ' LYS . 1.7 mp -65.5 -37.15 79.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.56 175.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.447 ' O ' ' HB2' ' A' ' 50' ' ' LYS . 3.2 tm? -61.82 -34.04 75.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.767 174.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.44 HD13 ' HD1' ' A' ' 39' ' ' TYR . 96.4 mt -67.97 -40.44 83.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.324 177.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.552 ' HA ' ' O ' ' A' ' 52' ' ' SER . 44.6 mt-10 -78.68 -2.39 38.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.348 177.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.512 ' HG2' ' O ' ' A' ' 46' ' ' ILE . 32.2 mmtp -75.43 -53.67 8.3 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 170.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -70.95 -66.22 0.64 Allowed 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.101 177.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.653 ' HB3' HD11 ' A' ' 27' ' ' LEU . 15.7 p -95.36 92.99 6.98 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.214 175.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.508 ' HG2' ' O ' ' A' ' 49' ' ' GLU . 63.3 mttp -70.41 -15.67 62.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.142 0.496 . . . . 0.0 110.431 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -101.4 68.15 1.19 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.409 171.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -100.37 108.73 20.82 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.173 -178.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.567 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 12.2 m-85 -102.75 108.01 19.09 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.614 ' HA3' HD23 ' A' ' 71' ' ' LEU . . . -125.55 165.03 18.9 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 119.869 -1.158 . . . . 0.0 112.716 -176.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.456 HG11 ' HE3' ' A' ' 86' ' ' MET . 2.1 m -141.66 127.63 18.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.557 -0.321 . . . . 0.0 110.341 177.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -129.73 166.97 18.77 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.137 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.589 ' HA2' ' HD1' ' A' ' 73' ' ' PHE . . . -104.3 -169.27 24.86 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.308 -0.948 . . . . 0.0 112.906 -173.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -84.07 5.5 25.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.058 0.456 . . . . 0.0 110.48 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 87.1 mtp -103.55 -5.71 22.45 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.889 178.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -94.38 168.28 10.99 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.058 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -65.33 126.0 90.57 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.155 176.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.478 ' HA ' ' HB3' ' A' ' 68' ' ' LYS . 53.1 Cg_exo -57.04 -25.68 64.54 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.216 2.61 . . . . 0.0 112.507 -179.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.508 ' HB3' HD21 ' A' ' 42' ' ' LEU . 2.6 m-20 -58.38 -41.97 85.99 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.916 175.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 84.0 t -78.09 -37.96 23.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.862 177.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.478 ' HB3' ' HA ' ' A' ' 65' ' ' PRO . 63.6 tttm -63.19 -22.06 66.62 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.353 -178.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -60.4 -44.02 96.11 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.189 0.519 . . . . 0.0 110.077 173.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 64.6 m-70 -82.04 -39.1 23.98 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.929 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.614 HD23 ' HA3' ' A' ' 57' ' ' GLY . 7.3 mt -115.98 101.16 54.01 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.68 -173.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.485 ' HG2' ' HB2' ' A' ' 75' ' ' LYS . 69.4 Cg_endo -74.87 174.98 11.8 Favored 'Trans proline' 0 CA--C 1.528 0.2 0 C-N-CA 122.701 2.267 . . . . 0.0 112.283 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.589 ' HD1' ' HA2' ' A' ' 60' ' ' GLY . 76.7 t80 -81.2 -21.81 39.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.262 0.553 . . . . 0.0 110.502 -178.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 39.6 m -144.48 119.14 9.78 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.043 178.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.485 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 40.2 tttp -139.59 135.92 33.85 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.321 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 77.8 t -108.75 132.99 55.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.931 0.396 . . . . 0.0 110.145 174.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.487 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 84.9 mt -106.81 132.82 52.34 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.9 176.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 42.2 tp -109.26 100.47 9.59 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.652 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.5 t -116.42 102.94 14.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.585 -175.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 54.57 31.37 14.85 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.705 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.72 -22.27 37.76 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.454 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.539 ' HA ' ' OE1' ' A' ' 109' ' ' GLN . 99.1 t -71.31 122.68 23.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.772 0.32 . . . . 0.0 110.347 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.29 102.94 14.82 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.5 -178.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.487 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 20.4 mt -93.85 110.19 23.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.4 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -93.36 109.47 3.81 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.764 -0.731 . . . . 0.0 111.395 177.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.456 ' HE3' HG11 ' A' ' 58' ' ' VAL . 30.0 mtm -107.11 119.77 40.28 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.716 0.293 . . . . 0.0 110.772 -177.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 49.6 t -145.35 104.43 3.93 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 175.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 49.8 t60 -84.87 66.1 9.51 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.184 0.516 . . . . 0.0 110.368 -177.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -113.78 -145.1 9.03 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.756 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 28.2 t-105 -139.15 164.76 28.94 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -178.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 165.83 161.33 14.62 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.511 -0.852 . . . . 0.0 113.087 177.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.513 ' HB1' ' HD2' ' A' ' 93' ' ' PRO . . . -88.46 162.45 39.54 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 175.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.513 ' HD2' ' HB1' ' A' ' 92' ' ' ALA . 0.9 OUTLIER -43.97 -49.44 8.37 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.366 2.71 . . . . 0.0 113.656 -178.14 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 18.3 p-90 -81.85 -44.18 17.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.877 0.37 . . . . 0.0 111.363 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -59.44 -37.01 77.01 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.543 -177.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 19.9 tp -60.85 -49.18 78.5 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.277 178.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -58.44 -42.62 87.77 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.748 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -64.55 -53.58 45.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.552 -177.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 21.9 ttp-105 -68.79 -40.04 79.84 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -174.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.473 HD11 HG22 ' A' ' 111' ' ' ILE . 65.7 mt -71.71 -32.56 67.91 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.541 -0.464 . . . . 0.0 111.446 -176.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.578 HD22 HG21 ' A' ' 127' ' ' VAL . 86.8 mt -80.62 -12.49 59.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.177 0.513 . . . . 0.0 110.268 175.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -79.78 -40.46 28.64 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.523 173.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 80.3 t -73.75 -52.3 21.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.535 177.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -91.41 103.68 16.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.07 0.462 . . . . 0.0 110.874 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -76.9 -22.92 52.67 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.668 -177.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -66.94 -28.51 68.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.019 176.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.481 ' HG3' HD21 ' A' ' 101' ' ' LEU . 39.5 ttpt 63.76 92.84 0.06 OUTLIER Pre-proline 0 CA--C 1.529 0.162 0 O-C-N 123.985 0.803 . . . . 0.0 109.896 -170.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.438 ' O ' HG23 ' A' ' 127' ' ' VAL . 13.6 Cg_exo -69.37 166.75 26.03 Favored 'Trans proline' 0 N--CA 1.464 -0.228 0 C-N-CA 123.023 2.482 . . . . 0.0 112.859 -174.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.539 ' OE1' ' HA ' ' A' ' 82' ' ' VAL . 75.1 mt-30 -85.32 -49.94 7.75 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.273 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 58.7 t -122.67 132.02 72.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.911 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.473 HG22 HD11 ' A' ' 100' ' ' LEU . 35.3 mt -126.71 132.13 70.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.071 0.462 . . . . 0.0 110.911 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.43 ' HB3' HD11 ' A' ' 36' ' ' LEU . 78.2 mt -105.68 121.18 43.48 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.067 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -132.06 -178.77 5.04 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.747 -178.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -125.69 131.97 7.77 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 121.057 -0.592 . . . . 0.0 111.785 178.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 39.9 t60 -139.57 -68.02 0.43 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 177.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.0 p -143.85 -80.69 0.19 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.851 178.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.413 ' O ' ' HD3' ' A' ' 119' ' ' PRO . 16.5 p-80 -172.24 41.79 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.121 -178.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -103.12 102.02 25.58 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.286 -173.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.69 ' HB3' HD21 ' A' ' 154' ' ' LEU . 59.9 Cg_endo -77.44 41.94 1.06 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.782 2.321 . . . . 0.0 111.469 177.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -97.48 132.46 43.16 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.127 -176.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -78.52 107.07 10.9 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.267 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.586 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 67.8 p -105.35 114.49 28.7 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.141 0.496 . . . . 0.0 110.069 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.2 p -136.51 145.05 31.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.691 -175.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -159.28 -55.98 0.06 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.112 175.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -85.1 23.88 1.18 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.939 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 86.92 -16.93 44.21 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 121.083 -0.58 . . . . 0.0 111.707 -176.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.578 HG21 HD22 ' A' ' 101' ' ' LEU . 15.3 t -87.54 134.05 28.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.636 -0.282 . . . . 0.0 110.618 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 76.9 mtp180 -98.92 104.52 16.56 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.051 175.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.586 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 69.4 m-85 -87.72 124.78 33.93 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.412 HD11 ' CD2' ' A' ' 152' ' ' PHE . 67.8 mt -124.8 134.91 52.59 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.937 0.399 . . . . 0.0 111.454 -174.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -118.08 106.05 46.0 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.569 177.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.423 ' HB2' ' HB3' ' A' ' 8' ' ' SER . 61.3 Cg_endo -75.86 146.27 29.52 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 122.239 1.959 . . . . 0.0 112.683 179.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -73.35 141.76 30.41 Favored Glycine 0 C--N 1.331 0.279 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.809 177.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.434 ' HA ' ' OG ' ' A' ' 8' ' ' SER . 31.1 t -70.14 159.6 33.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.598 0.713 . . . . 0.0 112.632 -174.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.429 ' HG ' ' HG ' ' A' ' 19' ' ' LEU . 3.6 mm? -61.16 -26.65 67.84 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.149 174.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.9 -25.68 67.99 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.344 -178.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -105.02 6.56 33.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.106 0.479 . . . . 0.0 110.351 178.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.424 ' HA2' HD11 ' A' ' 157' ' ' LEU . . . 73.72 44.67 31.06 Favored Glycine 0 N--CA 1.451 -0.352 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.904 177.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 24.6 m -132.0 144.15 50.58 Favored 'General case' 0 C--N 1.321 -0.631 0 O-C-N 122.664 -0.315 . . . . 0.0 110.744 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 44.1 p90 -145.02 160.04 41.99 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 173.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.525 ' HB1' HD21 ' A' ' 6' ' ' LEU . . . -115.72 142.81 46.25 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.722 -175.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.792 ' HB ' ' HE3' ' A' ' 155' ' ' LYS . 51.1 t -126.98 124.8 65.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 175.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.516 HD22 HG11 ' A' ' 150' ' ' VAL . 5.3 tt -109.69 108.0 18.22 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.474 ' HG3' HG13 ' A' ' 142' ' ' VAL . 40.3 mt-10 -110.51 127.09 55.01 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.033 -178.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.7 mp -90.79 105.77 18.05 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.894 0.378 . . . . 0.0 110.385 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -105.6 109.2 21.08 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.744 178.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 68.2 10.69 60.06 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.539 -177.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 98.84 -3.2 58.71 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.369 -177.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -85.1 147.26 26.73 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.723 0.297 . . . . 0.0 110.296 177.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.516 HG11 HD22 ' A' ' 143' ' ' LEU . 60.2 t -88.87 102.97 13.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.965 -175.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 47.6 mtp180 -98.66 94.0 6.41 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 176.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . 0.412 ' CD2' HD11 ' A' ' 130' ' ' LEU . 73.9 t80 -99.83 99.89 10.75 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.971 -179.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -110.88 119.56 39.49 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.203 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.69 HD21 ' HB3' ' A' ' 119' ' ' PRO . 23.2 tp -78.38 109.17 12.3 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 171.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.792 ' HE3' ' HB ' ' A' ' 142' ' ' VAL . 73.7 mttt -105.76 138.83 41.3 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.334 -175.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.7 p -97.55 155.29 17.03 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.224 0.535 . . . . 0.0 112.294 -171.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.509 HD13 ' HG3' ' A' ' 20' ' ' PRO . 61.5 mt . . . . . 0 C--O 1.247 0.959 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.134 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.541 ' HB2' HD11 ' A' ' 145' ' ' LEU . 6.1 mtpm? . . . . . 0 C--O 1.233 0.209 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.679 ' HB3' ' CD2' ' A' ' 30' ' ' TYR . 92.9 mtt180 -118.7 129.76 55.46 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.747 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.67 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 85.2 m-85 -125.08 119.78 29.61 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.173 0.511 . . . . 0.0 110.557 176.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.514 ' HB3' HG21 ' A' ' 33' ' ' VAL . 23.7 tp -89.19 124.35 34.27 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 178.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.531 HD23 ' HB1' ' A' ' 141' ' ' ALA . 33.5 tp -104.22 98.82 8.57 Favored 'General case' 0 C--O 1.241 0.605 0 CA-C-O 121.584 0.707 . . . . 0.0 111.251 -175.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.467 ' HB ' HD11 ' A' ' 135' ' ' LEU . 13.6 pt -101.17 110.69 28.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 173.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.453 ' HA ' ' HB2' ' A' ' 36' ' ' LEU . 16.2 m -94.36 -97.33 0.16 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -165.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -98.18 120.7 39.05 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.742 0.306 . . . . 0.0 110.365 -171.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.492 ' HB2' HD13 ' A' ' 135' ' ' LEU . 28.8 t -157.45 164.71 37.16 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.946 0.403 . . . . 0.0 111.085 -174.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -138.03 74.72 1.49 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.462 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -126.14 138.42 32.16 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-O 120.841 0.353 . . . . 0.0 110.745 174.297 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.4 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 38.2 Cg_endo -96.22 75.08 0.14 OUTLIER 'Cis proline' 0 N--CA 1.451 -1.022 0 C-N-CA 123.445 -1.481 . . . . 0.0 113.027 -2.31 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -103.89 -153.57 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 174.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -77.28 82.28 3.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.357 0.598 . . . . 0.0 110.299 178.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.452 ' HE3' ' OG ' ' A' ' 10' ' ' SER . 39.2 ttp -161.99 -76.98 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.814 177.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 60.0 10.27 2.13 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.501 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.416 ' O ' ' HD3' ' A' ' 20' ' ' PRO . 3.8 m -80.6 15.25 1.75 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.451 -176.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -102.5 102.59 26.64 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.416 ' HD3' ' O ' ' A' ' 18' ' ' SER . 3.9 Cg_exo -74.32 156.76 46.03 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.879 2.386 . . . . 0.0 112.466 -176.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -63.35 -14.56 51.38 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.75 178.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -61.09 -21.85 64.07 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.943 -177.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -99.62 -28.76 3.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.218 0.532 . . . . 0.0 110.309 176.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.454 ' O ' HD22 ' A' ' 27' ' ' LEU . 48.8 tp -73.03 -28.38 62.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.038 -173.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 -82.06 -11.45 58.78 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.929 0.395 . . . . 0.0 110.425 178.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.476 ' O ' ' HD1' ' A' ' 30' ' ' TYR . 38.8 m -77.78 -5.3 50.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.729 175.002 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.704 HD12 HG22 ' A' ' 33' ' ' VAL . 3.5 mm? -58.37 -27.09 63.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.45 0.643 . . . . 0.0 109.855 170.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -90.43 9.97 27.02 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.495 -178.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -119.23 -16.06 9.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.899 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.679 ' CD2' ' HB3' ' A' ' 3' ' ' ARG . 89.5 m-85 -119.95 135.62 54.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.965 -178.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -81.81 -23.11 36.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.04 0.448 . . . . 0.0 110.707 -179.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.67 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -130.72 144.94 16.38 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.678 175.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.704 HG22 HD12 ' A' ' 27' ' ' LEU . 95.4 t -139.41 141.18 35.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.538 HG12 ' HB2' ' A' ' 56' ' ' TYR . 48.6 mt -120.55 124.31 72.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.741 -178.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -109.19 104.28 1.9 Allowed Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 111.614 -0.594 . . . . 0.0 111.614 177.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.453 ' HB2' ' HA ' ' A' ' 8' ' ' SER . 87.5 mt -84.98 4.22 34.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.915 0.388 . . . . 0.0 111.191 -176.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 153.52 48.64 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.979 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -127.61 155.79 43.31 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 -178.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.497 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 53.3 m-85 49.91 87.81 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.89 0.852 . . . . 0.0 111.753 -173.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.2 m -80.45 3.18 2.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.496 -174.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.476 ' O ' HG21 ' A' ' 45' ' ' VAL . 21.7 t70 -94.36 121.61 36.06 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.251 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.487 HD21 ' HB3' ' A' ' 66' ' ' ASP . 59.8 tp -58.69 -45.4 89.56 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.598 -174.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -54.7 -46.38 74.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.164 0.506 . . . . 0.0 110.601 178.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.573 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 27.1 m -65.46 -31.12 72.04 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.376 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.476 HG21 ' O ' ' A' ' 41' ' ' ASP . 84.7 t -59.77 -44.38 93.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 121.013 0.435 . . . . 0.0 110.57 177.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.445 HD12 ' N ' ' A' ' 46' ' ' ILE . 1.7 mp -67.02 -40.0 84.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-O 121.198 0.523 . . . . 0.0 109.898 177.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -61.32 -35.0 76.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.697 176.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.573 ' HG ' ' O ' ' A' ' 44' ' ' THR . 83.1 mt -66.39 -35.92 81.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.687 179.136 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -78.0 -13.87 59.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.1 0.476 . . . . 0.0 110.575 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -81.23 -16.38 52.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.124 0.487 . . . . 0.0 110.394 173.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.541 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . 27.8 m-85 -100.52 -58.76 1.83 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.01 174.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 41.7 t -77.02 101.44 6.03 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.711 174.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -55.85 -40.09 72.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.824 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -113.71 89.85 3.19 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.037 0.446 . . . . 0.0 109.965 172.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -100.25 121.75 41.96 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.147 0.499 . . . . 0.0 110.77 -177.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.538 ' HB2' HG12 ' A' ' 34' ' ' ILE . 92.6 m-85 -118.88 178.44 4.48 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.426 -0.807 . . . . 0.0 109.307 176.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.441 ' C ' HD13 ' A' ' 71' ' ' LEU . . . 159.65 -179.68 35.06 Favored Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 120.141 -1.028 . . . . 0.0 112.685 176.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 15.8 t -140.51 148.37 22.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 -94.66 104.49 16.42 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.027 0.442 . . . . 0.0 110.316 -175.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -116.05 -5.16 17.85 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.155 177.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.487 ' HB3' ' OD1' ' A' ' 63' ' ' ASP . 6.7 m120 -83.4 133.68 34.92 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 74.1 mtm -96.73 10.23 39.34 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.235 0.54 . . . . 0.0 109.804 176.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.487 ' OD1' ' HB3' ' A' ' 61' ' ' ASN . 4.7 m-20 -66.66 -68.32 0.38 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.069 -177.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.479 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 91.8 m-85 -124.52 131.16 24.12 Favored Pre-proline 0 C--O 1.237 0.418 0 CA-C-O 121.167 0.508 . . . . 0.0 111.383 -177.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 64' ' ' TYR . 1.2 Cg_endo -83.74 -3.26 10.54 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 123.725 2.95 . . . . 0.0 112.478 -179.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.487 ' HB3' HD21 ' A' ' 42' ' ' LEU . 8.0 m-20 -67.68 -36.25 80.34 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.448 0.642 . . . . 0.0 109.958 179.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.51 HG11 HD22 ' A' ' 71' ' ' LEU . 30.3 t -76.36 -13.73 14.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.554 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.431 ' HB3' ' O ' ' A' ' 65' ' ' PRO . 87.6 tttt -70.59 -15.99 62.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.492 -175.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -90.36 0.42 57.27 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.82 0.343 . . . . 0.0 111.435 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -123.3 -39.04 2.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.03 0.443 . . . . 0.0 110.611 177.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.51 HD22 HG11 ' A' ' 67' ' ' VAL . 3.4 mm? -103.0 124.25 39.19 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 176.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -84.88 -175.08 1.93 Allowed 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.86 2.374 . . . . 0.0 113.115 -175.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -80.4 -29.46 37.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.38 0.609 . . . . 0.0 110.066 179.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.504 ' HB3' ' CZ ' ' A' ' 104' ' ' PHE . 26.5 m -152.07 137.51 17.66 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.121 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 34.7 tttp -139.29 116.56 11.16 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.926 -176.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 46.6 t -100.25 125.54 53.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 176.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 44.8 mt -103.14 153.58 20.17 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.06 178.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 37.4 tp -115.28 93.45 4.3 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 171.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 46.5 t -106.33 104.2 16.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.354 -173.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 57.21 29.26 16.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.441 178.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.45 -16.18 52.79 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.613 177.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 54.0 t -89.55 123.95 42.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.887 0.375 . . . . 0.0 110.832 -178.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.414 ' HB ' ' HA ' ' A' ' 108' ' ' PRO . 0.0 OUTLIER -80.73 115.87 20.45 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.858 177.259 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.481 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 21.0 mt -111.56 99.16 8.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.779 0.324 . . . . 0.0 110.489 -178.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.442 ' HA2' HG22 ' A' ' 76' ' ' VAL . . . -85.12 98.82 2.27 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 178.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 48.8 mtm -90.71 126.46 36.0 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.19 0.519 . . . . 0.0 110.896 -176.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.47 ' SG ' ' HB3' ' A' ' 113' ' ' PHE . 28.5 p -135.73 164.91 26.8 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 9.3 t-80 -83.49 -23.68 32.07 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 119.841 -0.743 . . . . 0.0 109.936 178.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.439 ' HA3' ' HB2' ' A' ' 113' ' ' PHE . . . 82.02 118.07 0.5 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.094 176.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 63.2 t90 -156.24 126.84 6.74 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 176.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 133.07 -166.93 23.55 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.407 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . . . -88.08 124.94 65.79 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.024 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 92' ' ' ALA . 33.7 Cg_exo -58.75 -15.61 27.14 Favored 'Trans proline' 0 N--CA 1.475 0.39 0 C-N-CA 123.224 2.616 . . . . 0.0 113.009 -177.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 4.4 m0 -66.14 -43.14 87.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.79 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -123.95 13.29 9.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.981 0.419 . . . . 0.0 111.23 -177.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 54.8 tp -66.32 -35.37 80.21 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.815 177.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.472 ' HD3' ' HB3' ' A' ' 124' ' ' LYS . 52.1 mttp -59.64 -49.42 77.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.804 177.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -68.17 -36.35 79.49 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.063 -0.972 . . . . 0.0 111.068 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.42 ' O ' HG21 ' A' ' 103' ' ' VAL . 45.8 ttt180 -64.85 -42.39 94.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.922 178.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.476 HD11 HG21 ' A' ' 111' ' ' ILE . 72.9 mt -67.78 -29.19 68.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.683 0.278 . . . . 0.0 111.241 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.497 HD22 HG23 ' A' ' 127' ' ' VAL . 92.2 mt -72.71 -13.72 61.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.014 0.435 . . . . 0.0 110.496 175.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -94.05 -30.88 14.46 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.782 175.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.42 HG21 ' O ' ' A' ' 99' ' ' ARG . 83.9 t -59.59 -50.98 77.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.1 175.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.504 ' CZ ' ' HB3' ' A' ' 74' ' ' SER . 55.8 m-85 -92.34 161.44 14.67 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.389 177.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -94.79 -26.73 16.11 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.303 0.573 . . . . 0.0 110.237 -179.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.417 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 43.2 mt-10 -111.81 152.36 27.97 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.127 175.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -83.34 113.87 49.32 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-O 120.797 0.332 . . . . 0.0 110.919 -178.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.441 ' O ' HG12 ' A' ' 127' ' ' VAL . 2.7 Cg_exo -76.04 124.43 7.96 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.774 2.316 . . . . 0.0 110.465 175.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -61.61 -37.12 82.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.988 0.423 . . . . 0.0 111.389 -176.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 88.7 t -123.94 132.59 71.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 175.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.476 HG21 HD11 ' A' ' 100' ' ' LEU . 37.7 mt -125.17 134.62 66.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.923 0.392 . . . . 0.0 110.651 179.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.54 HD21 ' HB2' ' A' ' 130' ' ' LEU . 96.2 mt -109.29 139.05 44.73 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.928 178.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.49 ' CZ ' ' HB2' ' A' ' 131' ' ' ASN . 6.5 p90 -155.53 122.96 5.54 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 175.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -122.67 114.5 2.47 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.615 -177.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -173.53 21.04 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.495 0.664 . . . . 0.0 109.365 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.454 HG22 ' H ' ' A' ' 118' ' ' GLU . 16.9 m -117.38 154.38 31.42 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.015 -175.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 32.5 m80 -80.85 -27.57 36.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.922 0.391 . . . . 0.0 110.356 -177.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.454 ' H ' HG22 ' A' ' 116' ' ' THR . 46.0 mt-10 -122.03 111.13 32.53 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.263 177.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -57.49 141.94 95.21 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.767 2.312 . . . . 0.0 111.897 177.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -154.68 142.29 19.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.973 0.416 . . . . 0.0 111.367 -173.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -98.24 124.3 42.77 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.382 172.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.544 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 69.8 p -129.11 129.7 45.52 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.06 0.457 . . . . 0.0 111.48 -176.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.7 p -126.86 140.66 48.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.668 175.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.472 ' HB3' ' HD3' ' A' ' 97' ' ' LYS . 71.5 tttt -155.79 -56.34 0.09 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.416 0.627 . . . . 0.0 110.308 -179.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -94.88 30.85 1.97 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.746 -175.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 79.54 -42.21 2.4 Favored Glycine 0 N--CA 1.451 -0.304 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 -173.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.497 HG23 HD22 ' A' ' 101' ' ' LEU . 89.3 t -60.24 136.68 23.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-N 115.213 -0.494 . . . . 0.0 110.825 176.146 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.402 ' HE ' ' HB2' ' A' ' 128' ' ' ARG . 20.3 ttm180 -97.21 112.55 24.3 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.947 178.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.544 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 82.7 m-85 -97.76 108.26 20.94 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.102 -178.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.54 ' HB2' HD21 ' A' ' 112' ' ' LEU . 81.9 mt -99.8 115.6 29.93 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.294 -178.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.49 ' HB2' ' CZ ' ' A' ' 113' ' ' PHE . 22.7 t-20 -108.2 112.11 61.48 Favored Pre-proline 0 C--N 1.32 -0.713 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.187 -178.116 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -92.1 174.95 2.1 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 123.435 2.757 . . . . 0.0 111.413 169.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -112.85 -172.38 18.54 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.411 -0.899 . . . . 0.0 112.739 -177.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 38.0 m -78.9 153.94 30.1 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.642 0.258 . . . . 0.0 110.508 178.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.492 HD13 ' HB2' ' A' ' 10' ' ' SER . 73.5 mt -78.38 -10.69 59.79 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -173.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -96.49 -60.3 1.64 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.958 0.408 . . . . 0.0 111.412 -177.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -106.02 22.09 16.23 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.216 -173.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.462 ' O ' ' HB2' ' A' ' 157' ' ' LEU . . . -146.72 -164.76 11.23 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.348 -178.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 15.2 p -112.66 148.84 33.82 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.722 -0.103 . . . . 0.0 110.722 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -97.2 168.83 10.19 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 -177.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.531 ' HB1' HD23 ' A' ' 6' ' ' LEU . . . -121.27 149.43 42.9 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.016 0.436 . . . . 0.0 111.171 -174.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 69.5 t -122.36 126.98 74.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 173.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.704 HD21 HG12 ' A' ' 150' ' ' VAL . 3.7 tt -110.19 104.55 13.4 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -109.28 143.86 38.2 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.541 HD11 ' HB2' ' A' ' 2' ' ' LYS . 91.1 mt -98.66 101.66 13.15 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.199 0.523 . . . . 0.0 110.667 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.638 ' HB3' ' HE ' ' A' ' 151' ' ' ARG . 12.2 t70 -96.35 114.55 26.24 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.879 178.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.83 -69.06 0.3 Allowed Glycine 0 C--N 1.331 0.287 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.596 -175.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -174.92 26.92 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 178.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -126.78 147.01 50.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.834 0.349 . . . . 0.0 110.22 -177.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.704 HG12 HD21 ' A' ' 143' ' ' LEU . 92.2 t -76.83 113.35 15.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.342 -176.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.638 ' HE ' ' HB3' ' A' ' 146' ' ' ASP . 38.8 mmt180 -97.09 108.84 21.65 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.154 176.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -90.66 94.5 9.72 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 177.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -100.67 102.69 13.87 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.01 -178.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 26.7 tp -83.72 130.51 34.95 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.173 -178.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -123.52 138.89 54.48 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 3.1 m -81.91 156.36 24.82 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.191 0.519 . . . . 0.0 111.705 -169.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.462 ' HB2' ' O ' ' A' ' 138' ' ' GLY . 88.6 mt . . . . . 0 C--O 1.247 0.945 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.496 176.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.603 ' HB2' ' HB2' ' A' ' 145' ' ' LEU . 92.7 mttt . . . . . 0 CA--C 1.516 -0.329 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.499 ' O ' ' HB3' ' A' ' 30' ' ' TYR . 96.1 mtt180 -133.58 113.89 12.93 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.064 0.459 . . . . 0.0 110.841 178.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.518 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 49.3 m-85 -104.3 125.85 50.9 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.166 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.441 HD23 ' HB2' ' A' ' 26' ' ' SER . 37.8 tp -89.75 120.05 30.68 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.143 176.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.554 ' HB3' ' HB2' ' A' ' 141' ' ' ALA . 57.6 tp -102.57 110.74 22.78 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.875 0.369 . . . . 0.0 110.266 178.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.492 HG22 HD13 ' A' ' 23' ' ' ILE . 18.1 pt -101.18 122.03 52.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.462 0.649 . . . . 0.0 109.601 177.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.3 m -77.81 -165.37 0.62 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.94 -173.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -55.03 122.48 11.02 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.433 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.477 ' HB2' ' O ' ' A' ' 38' ' ' ASP . 19.3 m -126.99 159.23 34.72 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.622 178.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.635 ' H ' ' HE3' ' A' ' 16' ' ' MET . 89.4 m-70 -140.49 43.7 1.87 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 -176.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.51 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . 46.0 t -93.1 129.76 38.32 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.147 -179.435 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.51 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 83.8 Cg_endo -103.38 27.75 10.8 Favored 'Cis proline' 0 N--CA 1.455 -0.754 0 C-N-CA 124.44 -1.067 . . . . 0.0 112.36 -3.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.8 t -47.55 -60.74 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 O-C-N 123.744 0.653 . . . . 0.0 111.996 -175.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 62.3 ttt180 -142.49 11.23 1.89 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.722 0.773 . . . . 0.0 109.619 -178.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.635 ' HE3' ' H ' ' A' ' 11' ' ' HIS . 58.0 ttp -143.08 121.52 12.39 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.216 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -117.57 -0.49 11.87 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.994 0.426 . . . . 0.0 110.805 -177.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.0 t -108.4 88.66 2.78 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.623 -178.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.0 tt -107.88 120.45 47.05 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 175.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.55 ' HG2' HD13 ' A' ' 157' ' ' LEU . 76.4 Cg_exo -41.17 116.89 0.49 Allowed 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 124.107 3.205 . . . . 0.0 114.213 -174.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -61.22 -30.37 70.39 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.596 176.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -54.63 -36.71 64.8 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.095 178.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.492 HD13 HG22 ' A' ' 7' ' ' ILE . 0.6 OUTLIER -85.11 -28.69 6.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.192 0.52 . . . . 0.0 110.334 -178.711 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 44.7 tp -70.6 -30.01 66.57 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.944 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -72.48 -21.33 61.23 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.373 175.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.538 ' HB3' ' CD2' ' A' ' 30' ' ' TYR . 59.4 m -71.16 -9.69 58.5 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.566 -178.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.513 ' HB3' ' HB3' ' A' ' 51' ' ' PHE . 2.7 mm? -63.48 -24.93 68.03 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 121.159 0.504 . . . . 0.0 109.95 172.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -91.15 -33.2 15.52 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.04 178.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -68.59 -55.52 11.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.644 -178.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.538 ' CD2' ' HB3' ' A' ' 26' ' ' SER . 27.5 m-85 -94.83 150.8 19.81 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.825 -169.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -98.61 7.0 46.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.859 -176.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.518 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -154.39 139.03 6.49 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 175.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.49 HG22 HD13 ' A' ' 27' ' ' LEU . 60.5 t -134.75 140.61 45.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 117.259 0.529 . . . . 0.0 110.649 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.615 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 17.3 mt -125.17 132.76 70.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.467 175.186 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.07 129.66 8.61 Favored Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 174.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 90.9 mt -97.11 -7.2 33.24 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.59 0.709 . . . . 0.0 110.341 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 166.52 58.31 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 -177.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.477 ' O ' ' HB2' ' A' ' 10' ' ' SER . 6.1 p-10 -72.27 -111.42 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 123.371 0.668 . . . . 0.0 112.741 -171.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.456 ' H ' ' CG ' ' A' ' 38' ' ' ASP . 96.3 m-85 -89.84 148.64 23.06 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.108 -0.331 . . . . 0.0 110.108 -177.106 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 19.2 m -89.91 -7.78 10.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.265 0.555 . . . . 0.0 110.147 178.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.498 ' O ' HG22 ' A' ' 45' ' ' VAL . 9.2 m-20 -86.6 120.44 27.91 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.666 177.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.528 HD23 ' HB3' ' A' ' 66' ' ' ASP . 43.7 tp -59.74 -42.3 92.87 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.037 0.446 . . . . 0.0 110.12 178.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -57.85 -38.92 76.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.964 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.537 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 17.5 m -74.68 -30.44 61.57 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.18 -178.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.498 HG22 ' O ' ' A' ' 41' ' ' ASP . 48.7 t -66.44 -40.2 85.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.177 0.513 . . . . 0.0 109.915 176.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.17 -35.79 76.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.677 174.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -64.46 -31.58 72.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.007 176.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 44' ' ' THR . 87.9 mt -67.69 -46.91 70.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.947 0.403 . . . . 0.0 110.579 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.503 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 65.4 mt-10 -70.32 -16.4 62.99 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.499 177.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -81.57 -23.36 37.2 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.057 0.456 . . . . 0.0 109.961 177.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.513 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . 2.0 m-85 -86.51 -67.33 0.82 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.424 178.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.506 ' HB3' HD11 ' A' ' 27' ' ' LEU . 70.7 p -73.0 -34.26 66.3 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.972 -177.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 34.5 mtmm 66.28 12.94 8.93 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.379 -175.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -150.71 102.17 2.99 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.496 178.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.476 ' HB3' ' HG2' ' A' ' 49' ' ' GLU . 74.4 t80 -138.61 121.46 16.54 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.345 0.593 . . . . 0.0 111.275 -173.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.615 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 92.2 m-85 -114.81 167.7 10.55 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 171.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 145.01 -165.65 27.67 Favored Glycine 0 N--CA 1.438 -1.204 0 C-N-CA 119.13 -1.509 . . . . 0.0 113.502 174.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.0 m -153.21 175.54 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 114.555 -0.823 . . . . 0.0 109.117 -175.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.491 ' CD2' ' HG ' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -125.69 104.26 8.27 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 120.426 -0.51 . . . . 0.0 109.9 171.672 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.67 ' HA2' ' HB3' ' A' ' 88' ' ' HIS . . . -86.36 -28.96 26.12 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.555 -177.045 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 19.9 p30 -85.87 -177.93 6.46 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.93 0.395 . . . . 0.0 111.001 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 64.7 mtt -94.71 127.85 40.98 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.0 0.428 . . . . 0.0 110.791 -176.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.513 ' OD2' ' HB ' ' A' ' 67' ' ' VAL . 4.6 p-10 -149.87 -171.03 3.8 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.936 -175.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -74.23 142.06 78.23 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.737 -176.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.1 -27.95 39.0 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.146 2.564 . . . . 0.0 112.83 -176.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.528 ' HB3' HD23 ' A' ' 42' ' ' LEU . 2.1 m-20 -60.05 -45.31 93.28 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.5 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.513 ' HB ' ' OD2' ' A' ' 63' ' ' ASP . 87.9 t -69.09 -36.28 72.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.104 0.478 . . . . 0.0 110.804 -177.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.648 ' HD3' ' HE1' ' A' ' 73' ' ' PHE . 61.3 mttm -70.75 -2.8 15.86 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.457 -175.237 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -81.89 -42.88 18.93 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 172.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 52.7 t60 -87.53 -30.01 20.9 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.47 -176.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.491 ' HG ' ' CD2' ' A' ' 59' ' ' HIS . 4.2 mm? -103.02 109.31 61.23 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.041 177.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 71' ' ' LEU . 22.0 Cg_exo -65.4 165.72 21.63 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 123.101 2.534 . . . . 0.0 112.729 -177.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.648 ' HE1' ' HD3' ' A' ' 68' ' ' LYS . 80.3 m-85 -91.28 -23.68 20.08 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.135 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.0 t -155.34 111.83 3.2 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.115 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.0 tttm -131.0 136.98 49.0 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -177.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 14.1 t -117.28 112.25 38.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 120.972 0.415 . . . . 0.0 110.13 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 63.1 mt -87.77 151.52 22.82 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.5 -178.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 49.5 tp -116.71 96.22 5.39 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 173.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.58 HG12 ' HG2' ' A' ' 80' ' ' GLU . 62.1 t -113.91 108.13 24.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.69 -173.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.58 ' HG2' HG12 ' A' ' 79' ' ' VAL . 13.2 mm-40 63.63 16.34 9.61 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.271 176.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 109.56 -17.97 30.28 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 121.109 -0.567 . . . . 0.0 111.983 -179.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 57.1 t -86.32 133.19 30.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.739 0.304 . . . . 0.0 110.678 -178.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.9 p -89.36 128.16 35.88 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.923 178.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.484 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 36.8 mt -119.72 98.62 6.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.845 0.355 . . . . 0.0 110.244 -177.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -87.39 103.19 2.86 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.974 -0.631 . . . . 0.0 111.697 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 40.7 mtm -101.19 114.77 29.04 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 9.2 t -144.73 162.19 37.34 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.833 0.349 . . . . 0.0 110.817 -173.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.67 ' HB3' ' HA2' ' A' ' 60' ' ' GLY . 41.4 p-80 -84.22 94.54 8.43 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.438 0.637 . . . . 0.0 110.43 178.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -81.0 75.98 2.21 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.461 -0.79 . . . . 0.0 113.005 -176.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -95.11 75.2 3.46 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.893 0.378 . . . . 0.0 110.411 176.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -163.26 175.28 39.56 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.866 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.18 151.35 97.27 Favored Pre-proline 0 C--N 1.326 -0.456 0 C-N-CA 122.171 0.188 . . . . 0.0 110.86 178.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -57.28 -18.75 31.66 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.074 2.516 . . . . 0.0 113.188 -178.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -91.64 -52.64 4.66 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.983 0.42 . . . . 0.0 110.05 178.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -72.5 -11.62 60.74 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.243 -176.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 24.7 tp -56.53 -43.67 80.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.396 177.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 22.2 ttpt -56.83 -49.25 75.97 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.341 177.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.438 ' O ' ' HB2' ' A' ' 102' ' ' LYS . 16.1 t70 -58.06 -51.06 71.23 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.463 -178.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -71.52 -53.22 14.57 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.187 -0.461 . . . . 0.0 112.006 -173.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 49.8 mt -60.63 -48.9 79.71 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 -173.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 90.6 mt -72.68 -11.47 60.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.004 0.431 . . . . 0.0 111.175 -176.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 98' ' ' ASP . 33.6 ttmt -85.47 -26.27 26.4 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.228 0.537 . . . . 0.0 109.633 177.013 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 84.1 t -79.36 -37.79 19.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.138 176.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -76.21 144.57 40.36 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.351 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -82.35 -44.43 16.18 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.865 -179.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.421 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 63.7 mm-40 -111.03 -178.61 3.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.481 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -83.53 112.85 42.8 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.781 177.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.486 ' O ' HG13 ' A' ' 127' ' ' VAL . 1.5 Cg_endo -83.16 119.02 2.72 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.814 2.343 . . . . 0.0 110.969 174.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -64.93 -40.73 95.51 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.26 0.553 . . . . 0.0 109.8 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 93.2 t -121.32 129.46 75.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.221 178.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 29.1 mt -118.87 131.76 70.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 175.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.447 HD22 ' HB2' ' A' ' 130' ' ' LEU . 89.0 mt -110.43 124.52 51.89 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.178 179.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.43 ' CE1' ' HB3' ' A' ' 129' ' ' PHE . 27.9 p90 -145.49 170.64 15.99 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.254 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -131.18 121.64 3.24 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 176.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -163.0 -36.86 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.929 0.395 . . . . 0.0 110.16 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.555 ' HB ' ' ND2' ' A' ' 131' ' ' ASN . 20.8 m -94.07 149.48 21.2 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.908 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 26.9 m80 -79.99 -47.63 14.64 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.929 0.395 . . . . 0.0 110.268 -178.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -82.96 155.77 67.51 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.648 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -66.96 128.9 19.57 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.563 2.175 . . . . 0.0 111.492 176.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -145.08 138.75 26.88 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.502 -178.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -118.52 128.82 54.94 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 174.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.573 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 72.2 p -128.5 116.21 19.33 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.212 0.53 . . . . 0.0 111.219 -176.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 127' ' ' VAL . 8.6 p -111.61 117.59 55.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 176.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -126.49 -74.57 0.59 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.083 -174.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -85.12 32.28 0.55 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.892 0.377 . . . . 0.0 111.195 -178.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 83.82 -5.69 77.78 Favored Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 -174.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.486 HG13 ' O ' ' A' ' 108' ' ' PRO . 96.8 t -99.28 134.72 37.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.104 -0.548 . . . . 0.0 109.863 178.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -102.43 105.72 16.34 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.095 0.474 . . . . 0.0 110.43 179.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.573 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 51.6 m-85 -84.85 122.12 28.7 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.21 177.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.447 ' HB2' HD22 ' A' ' 112' ' ' LEU . 87.9 mt -109.34 124.06 50.33 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.826 0.346 . . . . 0.0 110.983 -178.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.555 ' ND2' ' HB ' ' A' ' 116' ' ' THR . 4.7 t30 -113.75 111.64 48.55 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.44 174.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -86.58 165.09 9.27 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.921 2.414 . . . . 0.0 112.052 174.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -89.61 139.89 15.35 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.548 -177.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 15.8 m -59.87 156.16 14.89 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.898 0.38 . . . . 0.0 111.324 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -68.05 -3.77 11.27 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 -174.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -86.78 -60.6 1.94 Allowed 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.589 -177.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -125.1 2.01 7.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.818 0.342 . . . . 0.0 111.657 -177.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -106.76 173.36 19.23 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.758 -173.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.544 ' HB3' ' HA ' ' A' ' 156' ' ' THR . 12.5 p -98.6 134.56 41.37 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.526 0.203 . . . . 0.0 110.62 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -84.48 177.18 8.21 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.387 -178.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.554 ' HB2' ' HB3' ' A' ' 6' ' ' LEU . . . -123.31 135.81 54.38 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.2 0.524 . . . . 0.0 111.962 -176.183 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 74.1 t -118.5 120.33 63.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 173.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.67 ' HA ' ' O ' ' A' ' 151' ' ' ARG . 10.0 mp -111.17 111.08 21.91 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.119 0.485 . . . . 0.0 111.124 -178.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -98.75 134.16 42.05 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.427 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.603 ' HB2' ' HB2' ' A' ' 2' ' ' LYS . 94.2 mt -105.02 102.9 12.38 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.915 177.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -135.23 130.38 35.14 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.878 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.89 11.14 60.15 Favored Glycine 0 CA--C 1.517 0.161 0 C-N-CA 121.178 -0.534 . . . . 0.0 112.443 -176.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 96.47 -13.82 65.06 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.791 178.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -95.34 159.5 14.98 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.047 0.451 . . . . 0.0 111.053 -178.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 10.9 t -101.23 138.0 26.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.584 -177.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.67 ' O ' ' HA ' ' A' ' 143' ' ' LEU . 12.5 tpt180 -109.92 99.5 8.61 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -83.84 104.5 13.98 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.638 178.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.446 ' O ' ' HA ' ' A' ' 141' ' ' ALA . 40.0 mt-10 -116.56 128.99 55.92 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.67 0.271 . . . . 0.0 111.03 176.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -102.17 106.81 17.71 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 174.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -102.17 130.53 48.83 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.789 0.328 . . . . 0.0 110.56 -175.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.544 ' HA ' ' HB3' ' A' ' 139' ' ' SER . 14.1 p -81.3 145.69 30.77 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -169.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.55 HD13 ' HG2' ' A' ' 20' ' ' PRO . 84.5 mt . . . . . 0 C--O 1.25 1.127 0 CA-C-N 115.142 -0.936 . . . . 0.0 109.68 178.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 95.4 mttt . . . . . 0 CA--C 1.517 -0.296 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.449 ' HG2' ' HG2' ' A' ' 144' ' ' GLU . 92.7 mtt180 -126.89 117.45 22.61 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.125 0.488 . . . . 0.0 111.206 -178.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -107.18 129.88 54.79 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.946 178.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.535 ' HB3' HG21 ' A' ' 33' ' ' VAL . 44.0 tp -89.27 113.31 24.54 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.648 -176.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 64.7 tp -99.16 107.6 20.0 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.196 0.522 . . . . 0.0 110.936 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.425 HG13 ' HA2' ' A' ' 35' ' ' GLY . 27.4 pt -101.32 132.38 47.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 173.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.7 t -81.66 -168.05 1.74 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.822 0.344 . . . . 0.0 110.238 -178.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -63.62 128.04 34.07 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.715 0.769 . . . . 0.0 111.632 -176.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.514 ' OG ' HG13 ' A' ' 12' ' ' VAL . 33.4 t -100.15 155.38 17.78 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.783 176.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 50.3 m-70 -132.62 23.2 4.32 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.172 -177.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.514 HG13 ' OG ' ' A' ' 10' ' ' SER . 7.8 p -114.65 144.65 32.27 Favored Pre-proline 0 C--O 1.241 0.622 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.308 -176.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.487 ' HA ' ' CG2' ' A' ' 12' ' ' VAL . 12.0 Cg_endo -93.59 93.81 0.14 OUTLIER 'Cis proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.847 -1.314 . . . . 0.0 112.816 -5.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.54 HG23 HG11 ' A' ' 40' ' ' VAL . 1.9 t -138.36 -71.89 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.363 0.601 . . . . 0.0 109.678 176.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 40.3 mtp180 -125.08 73.91 1.33 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.297 178.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.45 ' SD ' ' HB2' ' A' ' 19' ' ' LEU . 14.4 ttm -177.13 -80.68 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.495 178.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 58.08 14.57 2.76 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.969 -176.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.4 m -120.0 32.9 5.83 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.532 -176.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.584 HD13 HD21 ' A' ' 135' ' ' LEU . 7.5 tt -89.17 120.64 69.84 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.708 -179.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 19' ' ' LEU . 16.7 Cg_exo -68.57 126.69 14.45 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 123.114 2.543 . . . . 0.0 112.348 -179.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -66.52 -12.24 56.61 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.777 -177.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.499 ' HB2' HD23 ' A' ' 157' ' ' LEU . 43.6 mt-10 -58.48 -38.26 77.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.264 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.442 HD12 HD12 ' A' ' 5' ' ' LEU . 0.4 OUTLIER -67.52 -29.27 44.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.4 0.619 . . . . 0.0 110.282 -178.59 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.519 ' O ' HD23 ' A' ' 27' ' ' LEU . 38.9 tp -78.27 -12.55 60.01 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.264 -177.179 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -84.85 -27.39 26.75 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.735 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.428 ' HB3' ' CE2' ' A' ' 30' ' ' TYR . 15.3 m -69.42 -6.37 29.74 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.934 -175.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.647 HD13 HG22 ' A' ' 33' ' ' VAL . 4.4 mm? -58.35 -26.0 62.64 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.745 0.307 . . . . 0.0 111.594 178.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.7 mttp -85.32 -8.27 58.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.286 -175.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -106.54 -22.46 12.77 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -168.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.499 ' CD2' ' HB2' ' A' ' 5' ' ' LEU . 29.5 m-85 -112.2 156.19 22.73 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.476 -0.489 . . . . 0.0 111.79 -172.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -67.03 -55.15 15.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.616 -177.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -136.2 158.51 23.98 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.569 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.647 HG22 HD13 ' A' ' 27' ' ' LEU . 89.2 t -123.4 136.02 61.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 120.996 0.427 . . . . 0.0 110.415 -179.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.46 HG23 ' SD ' ' A' ' 86' ' ' MET . 70.5 mt -115.74 128.88 72.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.919 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.425 ' HA2' HG13 ' A' ' 7' ' ' ILE . . . -121.84 117.82 3.51 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.846 178.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.1 mt -83.69 19.39 1.66 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.418 0.628 . . . . 0.0 110.26 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.405 ' H ' ' C ' ' A' ' 35' ' ' GLY . . . 153.59 84.78 0.05 OUTLIER Glycine 0 N--CA 1.44 -1.074 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 -177.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.512 ' CG ' ' H ' ' A' ' 39' ' ' TYR . 9.2 t70 -74.75 -165.33 0.35 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.821 0.344 . . . . 0.0 110.829 -173.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.512 ' H ' ' CG ' ' A' ' 38' ' ' ASP . 37.2 m-85 -68.82 149.32 49.1 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.089 -0.338 . . . . 0.0 110.089 -177.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.54 HG11 HG23 ' A' ' 14' ' ' VAL . 24.6 m -68.46 -17.17 21.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -176.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -93.66 125.3 38.2 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.703 0.287 . . . . 0.0 110.481 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.524 HD13 ' CD2' ' A' ' 70' ' ' HIS . 50.8 tp -63.84 -33.46 75.72 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.416 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -59.68 -34.38 72.79 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.36 178.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 20.9 m -78.28 -31.72 49.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.612 178.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.47 HG21 HG13 ' A' ' 67' ' ' VAL . 46.4 t -60.29 -41.38 86.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.38 0.609 . . . . 0.0 109.705 173.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.6 mp -66.27 -34.28 69.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.07 175.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -61.89 -37.13 83.43 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 174.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -71.52 -42.27 68.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.519 178.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -70.85 -19.57 62.63 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.342 0.592 . . . . 0.0 110.605 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.4 tptm -78.27 -46.88 19.12 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.96 178.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.51 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . 32.4 m-85 -73.36 -55.25 6.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.449 176.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.573 ' HB2' HD11 ' A' ' 27' ' ' LEU . 22.7 t -90.7 98.87 12.03 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.71 174.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -56.14 -35.69 67.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.954 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -110.77 82.75 1.64 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.145 179.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -101.55 124.84 47.87 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.533 -178.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.416 ' HB2' HG12 ' A' ' 34' ' ' ILE . 54.4 m-85 -106.92 117.02 32.95 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.642 ' HA3' HD21 ' A' ' 71' ' ' LEU . . . -117.98 144.12 18.01 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.079 -1.058 . . . . 0.0 113.028 -175.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.406 HG21 ' CB ' ' A' ' 86' ' ' MET . 15.3 t -128.58 144.66 37.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 175.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -97.36 112.57 24.34 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.982 -175.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.687 ' HA3' ' HB3' ' A' ' 88' ' ' HIS . . . -152.53 22.9 0.84 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.407 -0.901 . . . . 0.0 112.556 178.079 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 23.9 p-10 -136.48 174.25 10.82 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 110.41 -0.218 . . . . 0.0 110.41 -178.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 66.8 mtm -92.55 119.96 32.53 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.669 ' OD2' ' HB ' ' A' ' 67' ' ' VAL . 17.7 p-10 -149.27 -173.5 4.4 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.77 -169.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -81.34 145.26 55.26 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.87 175.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -57.28 -20.74 40.59 Favored 'Trans proline' 0 CA--C 1.532 0.401 0 C-N-CA 122.89 2.393 . . . . 0.0 113.426 -176.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.507 ' HB3' HD23 ' A' ' 42' ' ' LEU . 3.0 m-20 -70.41 -27.69 64.48 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.31 -0.405 . . . . 0.0 112.037 -177.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.669 ' HB ' ' OD2' ' A' ' 63' ' ' ASP . 38.1 t -74.77 -19.15 16.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.113 0.482 . . . . 0.0 110.539 -178.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 63.9 tttt -53.38 -36.39 61.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.702 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -69.84 -27.97 65.29 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.518 -176.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.524 ' CD2' HD13 ' A' ' 42' ' ' LEU . 29.6 m-70 -95.86 -30.65 13.54 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 121.111 -0.235 . . . . 0.0 111.138 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.642 HD21 ' HA3' ' A' ' 57' ' ' GLY . 13.1 mt -110.26 102.36 50.99 Favored Pre-proline 0 C--N 1.326 -0.443 0 C-N-CA 120.931 -0.308 . . . . 0.0 110.755 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.494 ' HD2' ' O ' ' A' ' 57' ' ' GLY . 46.9 Cg_endo -70.12 151.3 66.98 Favored 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.379 2.053 . . . . 0.0 110.734 172.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -63.42 -22.54 66.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.84 0.352 . . . . 0.0 111.635 -175.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 38.6 m -153.82 141.7 20.15 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 175.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 36.1 tttp -144.33 125.32 14.42 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.345 -177.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 11.4 t -111.65 112.61 41.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.865 0.364 . . . . 0.0 110.574 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 94.0 mt -87.69 144.81 26.45 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.986 -179.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 59.7 tp -112.14 97.37 6.6 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 170.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 41.4 t -110.9 93.45 2.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.091 -176.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 51.18 63.25 2.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.907 179.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.16 -9.43 47.31 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.912 -0.661 . . . . 0.0 113.206 176.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 60.8 t -99.89 115.21 40.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.887 0.375 . . . . 0.0 110.732 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.5 p -86.84 127.06 35.02 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.317 176.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.472 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 18.8 mt -119.36 93.25 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -176.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.454 ' O ' HG21 ' A' ' 111' ' ' ILE . . . -81.21 96.09 1.7 Allowed Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.47 ' HG2' HD12 ' A' ' 112' ' ' LEU . 38.3 mtm -96.06 119.13 34.01 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 120.896 0.379 . . . . 0.0 110.242 -176.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 39.2 t -153.22 107.05 3.05 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.993 -178.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.687 ' HB3' ' HA3' ' A' ' 60' ' ' GLY . 64.8 t-80 -91.26 69.27 6.04 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -179.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -85.01 178.73 51.03 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.63 -178.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -132.28 142.98 49.59 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 148.74 -172.68 28.86 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 121.081 -0.58 . . . . 0.0 111.808 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.41 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . . . -76.95 146.1 75.06 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 120.519 0.2 . . . . 0.0 110.741 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 92' ' ' ALA . 15.5 Cg_exo -69.2 -10.55 29.3 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.953 2.435 . . . . 0.0 112.859 -178.351 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 5.7 m0 -68.48 -44.47 74.68 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.996 0.427 . . . . 0.0 110.625 -178.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -91.49 11.66 23.29 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.807 -178.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 28.3 tp -58.66 -49.54 77.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.047 -178.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.462 ' HD2' ' HB3' ' A' ' 125' ' ' ALA . 28.5 ttpt -61.89 -50.35 72.56 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.65 179.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -60.72 -53.23 59.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.654 -174.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.422 ' O ' HG22 ' A' ' 103' ' ' VAL . 26.8 mtm105 -65.18 -46.36 81.1 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -176.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.494 HD12 HG23 ' A' ' 111' ' ' ILE . 83.5 mt -65.8 -36.76 84.41 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.474 -176.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.651 HD23 HG22 ' A' ' 127' ' ' VAL . 79.6 mt -78.77 -15.69 58.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.778 0.323 . . . . 0.0 110.91 178.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.472 ' HD2' ' HA ' ' A' ' 102' ' ' LYS . 33.4 tptt -86.21 -34.7 20.4 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.076 0.465 . . . . 0.0 110.039 177.102 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 99' ' ' ARG . 73.8 t -74.19 -43.95 50.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.571 174.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -104.54 87.32 2.68 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.88 176.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -71.78 -19.2 62.05 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.423 -173.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -77.4 -14.65 59.66 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.256 -179.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt 63.86 99.29 0.04 OUTLIER Pre-proline 0 C--O 1.232 0.182 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.096 -175.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -76.24 144.36 26.25 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.601 2.201 . . . . 0.0 110.938 175.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -72.49 -41.9 65.47 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.137 0.494 . . . . 0.0 109.836 178.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 90.0 t -116.32 130.14 71.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.583 177.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.494 HG23 HD12 ' A' ' 100' ' ' LEU . 30.6 mt -125.08 128.45 72.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 120.774 0.321 . . . . 0.0 110.677 178.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.47 HD12 ' HG2' ' A' ' 86' ' ' MET . 92.1 mt -99.98 119.22 37.91 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -138.59 -174.74 3.91 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.81 -175.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.566 ' HA2' ' ND2' ' A' ' 131' ' ' ASN . . . -147.75 151.77 23.96 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 175.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -136.64 179.1 6.57 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 117.195 0.498 . . . . 0.0 109.937 177.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.3 p -73.92 11.26 0.92 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -171.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 -144.75 -172.12 3.76 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 122.131 -0.356 . . . . 0.0 111.045 -178.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -60.6 155.48 49.86 Favored Pre-proline 0 C--N 1.329 -0.316 0 O-C-N 123.839 0.712 . . . . 0.0 112.695 -172.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -47.03 144.78 8.09 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 124.441 3.428 . . . . 0.0 113.266 178.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -165.7 144.03 5.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.267 -176.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -102.54 135.78 43.56 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 173.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.47 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 57.8 p -137.72 158.02 45.25 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.908 -174.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.495 ' HA ' ' O ' ' A' ' 127' ' ' VAL . 85.2 t -132.54 115.2 24.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.939 0.4 . . . . 0.0 110.425 176.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.632 ' HB2' ' HE2' ' A' ' 129' ' ' PHE . 75.4 mmtt -125.58 125.62 43.47 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.483 177.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.462 ' HB3' ' HD2' ' A' ' 97' ' ' LYS . . . 65.1 9.24 5.36 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 123.64 0.588 . . . . 0.0 111.779 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 104.11 -4.2 44.86 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.409 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.651 HG22 HD23 ' A' ' 101' ' ' LEU . 52.5 t -90.19 134.36 29.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 179.097 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 51.8 ttt180 -96.45 105.82 17.96 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.147 0.499 . . . . 0.0 110.18 -177.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.632 ' HE2' ' HB2' ' A' ' 124' ' ' LYS . 58.7 m-85 -94.63 126.52 39.98 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.88 -178.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.441 ' HB2' HD21 ' A' ' 112' ' ' LEU . 53.6 mt -115.26 120.91 41.26 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.754 0.311 . . . . 0.0 110.638 -178.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.566 ' ND2' ' HA2' ' A' ' 114' ' ' GLY . 3.7 t-20 -108.02 115.99 57.72 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.471 174.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -83.78 164.87 13.84 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.745 2.297 . . . . 0.0 112.234 174.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -73.99 153.71 47.25 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.442 175.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 96.0 p -81.28 160.33 24.25 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.061 0.458 . . . . 0.0 110.999 -176.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.584 HD21 HD13 ' A' ' 19' ' ' LEU . 5.9 mp -74.11 -0.17 15.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.1 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -97.19 -10.57 25.6 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.586 178.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -100.83 -6.03 25.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.108 0.48 . . . . 0.0 110.816 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 74.86 38.45 41.71 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.19 -179.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 25.2 m -139.31 145.84 39.59 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.438 ' O ' HD13 ' A' ' 154' ' ' LEU . 23.9 p90 -139.73 160.03 40.83 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 178.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -114.33 125.97 54.48 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.051 0.453 . . . . 0.0 110.352 -175.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 48.0 t -102.99 121.44 54.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 177.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.406 HD21 HG11 ' A' ' 150' ' ' VAL . 6.3 tt -94.67 101.21 13.05 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.449 ' HG2' ' HG2' ' A' ' 3' ' ' ARG . 60.1 mt-10 -95.32 117.62 30.63 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.459 -178.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 72.0 mt -90.67 90.19 7.85 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 172.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.486 ' HB3' ' HD3' ' A' ' 151' ' ' ARG . 35.3 t70 -115.57 130.11 56.75 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.844 -174.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 68.13 -59.51 0.4 Allowed Glycine 0 CA--C 1.521 0.446 0 O-C-N 123.584 0.553 . . . . 0.0 112.337 -171.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 164.9 33.39 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 176.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -126.53 155.55 42.2 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.631 0.253 . . . . 0.0 110.675 -176.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.406 HG11 HD21 ' A' ' 143' ' ' LEU . 29.0 t -86.88 95.03 4.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.524 176.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.486 ' HD3' ' HB3' ' A' ' 146' ' ' ASP . 35.0 mtp-105 -105.82 92.31 4.11 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.53 -175.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -90.54 122.17 33.12 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.198 0.523 . . . . 0.0 109.774 178.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.42 ' HB2' ' HE3' ' A' ' 155' ' ' LYS . 57.9 mt-10 -116.04 127.38 54.85 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.132 177.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.438 HD13 ' O ' ' A' ' 140' ' ' TYR . 38.7 tp -90.49 112.17 23.72 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.172 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.42 ' HE3' ' HB2' ' A' ' 153' ' ' GLU . 85.8 mttt -117.09 145.49 43.73 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.78 -173.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 3.5 p -96.65 150.58 20.51 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.321 0.581 . . . . 0.0 112.37 -171.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.499 HD23 ' HB2' ' A' ' 22' ' ' GLU . 91.1 mt . . . . . 0 C--O 1.249 1.03 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.952 177.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.5 ' HB2' HD11 ' A' ' 145' ' ' LEU . 98.8 mttt . . . . . 0 N--CA 1.451 -0.418 0 CA-C-O 121.151 0.501 . . . . 0.0 110.288 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 56.0 mtp180 -111.2 116.88 31.81 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.947 -178.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.565 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 18.3 m-85 -103.93 125.51 50.38 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.452 0.644 . . . . 0.0 111.102 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.507 ' HB3' HG21 ' A' ' 33' ' ' VAL . 36.0 tp -89.12 133.22 34.47 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.078 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.443 ' HB2' HD21 ' A' ' 143' ' ' LEU . 56.0 tp -121.72 111.96 17.81 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.835 0.35 . . . . 0.0 110.789 178.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.407 HG13 ' HA2' ' A' ' 35' ' ' GLY . 27.9 pt -101.45 128.74 53.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 174.016 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.553 ' H ' HD23 ' A' ' 135' ' ' LEU . 12.2 t -76.06 -171.44 1.69 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.852 -174.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.645 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 18.0 t0 -62.14 104.46 0.48 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.757 -177.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.465 ' H ' ' HA3' ' A' ' 37' ' ' GLY . 26.7 t -97.18 153.79 17.78 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.625 -177.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 13.8 m80 -134.8 65.39 1.57 Allowed 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.427 ' O ' HG21 ' A' ' 40' ' ' VAL . 64.8 t -118.8 130.09 25.02 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.617 -176.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -76.41 -52.12 0.16 OUTLIER 'Cis proline' 0 C--N 1.343 0.254 0 C-N-CA 123.192 -1.587 . . . . 0.0 112.21 -3.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 37.9 t 49.14 -93.37 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 O-C-N 123.858 0.724 . . . . 0.0 110.81 -178.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -155.56 25.93 0.4 Allowed 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.453 0.644 . . . . 0.0 109.773 171.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.423 ' C ' ' H ' ' A' ' 18' ' ' SER . 52.5 ttp -109.75 -75.74 0.62 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 176.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 63.45 -6.48 0.21 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.443 -0.799 . . . . 0.0 113.133 175.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.423 ' H ' ' C ' ' A' ' 16' ' ' MET . 2.3 p -78.63 58.06 2.16 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.64 0.733 . . . . 0.0 111.094 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.8 tt -107.93 112.78 61.59 Favored Pre-proline 0 N--CA 1.447 -0.604 0 CA-C-N 115.116 -0.947 . . . . 0.0 108.544 176.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -53.51 120.62 8.1 Favored 'Trans proline' 0 CA--C 1.528 0.202 0 C-N-CA 123.063 2.509 . . . . 0.0 112.868 -177.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -61.01 -29.8 69.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.174 -177.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -64.78 -25.01 67.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.663 -177.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.5 HD12 ' CG ' ' A' ' 140' ' ' TYR . 1.2 tt -68.49 -32.52 55.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.266 0.555 . . . . 0.0 109.531 178.159 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.542 ' HA ' HD21 ' A' ' 27' ' ' LEU . 24.4 tp -77.79 -35.33 51.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.104 -177.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -71.47 -26.44 62.71 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.626 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 42.9 m -81.69 2.05 31.45 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.588 -177.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.555 ' CD1' HG22 ' A' ' 33' ' ' VAL . 2.9 mm? -54.52 -31.31 56.0 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.043 0.449 . . . . 0.0 111.203 177.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -74.35 -15.98 60.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.275 -175.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -96.16 5.29 51.39 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.941 0.401 . . . . 0.0 111.679 -175.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -119.67 169.9 9.68 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 177.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -105.19 -56.2 2.21 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.233 0.54 . . . . 0.0 109.913 -178.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.565 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -117.36 146.7 18.79 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 175.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.555 HG22 ' CD1' ' A' ' 27' ' ' LEU . 72.8 t -130.03 134.87 62.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 117.315 0.557 . . . . 0.0 111.109 -177.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.525 HG12 ' HB2' ' A' ' 56' ' ' TYR . 36.2 mt -114.91 125.71 72.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.373 177.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.407 ' HA2' HG13 ' A' ' 7' ' ' ILE . . . -109.41 103.43 1.76 Allowed Glycine 0 N--CA 1.441 -0.979 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.716 174.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.414 ' HG ' HD12 ' A' ' 6' ' ' LEU . 84.5 mt -74.1 -28.69 61.48 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.645 ' HA3' ' HA ' ' A' ' 9' ' ' ASP . . . -145.92 109.12 0.49 Allowed Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.063 173.31 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.407 ' OD2' HG23 ' A' ' 45' ' ' VAL . 15.2 p-10 -98.98 -154.39 0.46 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 120.843 0.354 . . . . 0.0 110.893 -175.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.405 ' HE2' HD22 ' A' ' 48' ' ' LEU . 97.3 m-85 -88.83 137.35 32.4 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 -179.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.427 HG21 ' O ' ' A' ' 12' ' ' VAL . 11.5 m -76.18 4.83 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.029 0.442 . . . . 0.0 111.611 -174.321 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.503 ' O ' HG22 ' A' ' 45' ' ' VAL . 17.5 t70 -105.63 123.76 48.44 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.148 177.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.485 HD22 ' HB3' ' A' ' 66' ' ' ASP . 44.8 tp -59.04 -43.49 91.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 0.0 112.278 -172.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -62.03 -37.72 85.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.1 0.476 . . . . 0.0 110.57 -178.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 20.8 m -70.82 -27.96 64.26 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.844 178.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.503 HG22 ' O ' ' A' ' 41' ' ' ASP . 61.8 t -62.88 -40.71 89.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-O 121.487 0.66 . . . . 0.0 109.588 173.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.36 -35.26 74.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.143 177.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.79 -31.92 72.99 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.596 175.39 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.405 HD22 ' HE2' ' A' ' 39' ' ' TYR . 95.3 mt -67.69 -41.74 83.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.098 0.475 . . . . 0.0 110.061 178.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -71.97 -14.89 62.03 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.108 176.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -82.47 -45.69 14.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.33 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -70.85 -65.43 0.74 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.991 0.424 . . . . 0.0 110.408 173.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.493 ' HB3' HD13 ' A' ' 27' ' ' LEU . 8.9 p -90.44 96.17 10.53 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.92 174.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -62.31 -33.03 73.89 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.459 -179.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -98.3 79.36 2.53 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.495 0.664 . . . . 0.0 109.457 171.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -100.33 127.6 46.6 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.612 -177.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.525 ' HB2' HG12 ' A' ' 34' ' ' ILE . 76.1 m-85 -117.28 169.94 9.08 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 175.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 153.96 -172.22 32.64 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 119.355 -1.402 . . . . 0.0 113.609 175.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.49 HG13 ' HE1' ' A' ' 86' ' ' MET . 0.2 OUTLIER -144.27 -169.2 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 114.856 -0.672 . . . . 0.0 109.871 -177.494 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.49 ' HE2' ' CG ' ' A' ' 63' ' ' ASP . 57.0 t-80 -94.48 130.83 40.71 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.798 0.332 . . . . 0.0 111.235 -173.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -75.15 -158.83 7.02 Favored Glycine 0 CA--C 1.522 0.471 0 CA-C-N 115.731 -0.668 . . . . 0.0 113.249 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -73.05 -73.12 0.22 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -176.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 50.0 ttm -131.71 129.48 40.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.821 0.344 . . . . 0.0 110.361 -177.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.506 ' OD2' ' HB ' ' A' ' 67' ' ' VAL . 23.0 p-10 -145.52 -162.93 1.61 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.681 -173.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.409 ' HD2' ' O ' ' A' ' 40' ' ' VAL . 76.5 m-85 -103.44 155.19 37.14 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.521 173.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -48.88 -34.47 28.53 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.281 2.654 . . . . 0.0 113.374 -176.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.485 ' HB3' HD22 ' A' ' 42' ' ' LEU . 35.7 m-20 -58.09 -39.18 77.94 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.558 -177.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.506 ' HB ' ' OD2' ' A' ' 63' ' ' ASP . 60.7 t -80.08 -31.15 13.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.518 -177.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.456 ' HG2' ' NE2' ' A' ' 59' ' ' HIS . 93.5 mttt -60.05 -28.03 67.43 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.494 0.664 . . . . 0.0 110.233 175.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -72.8 -47.28 47.87 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.177 177.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -84.16 -35.44 23.58 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.868 -0.606 . . . . 0.0 112.278 -169.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.473 HD23 HG13 ' A' ' 67' ' ' VAL . 4.5 mm? -100.56 117.06 63.54 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-O 120.635 0.255 . . . . 0.0 110.995 -178.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -68.86 146.25 65.14 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.808 2.339 . . . . 0.0 111.398 176.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -72.75 -29.65 63.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.856 0.36 . . . . 0.0 110.931 -176.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 18.1 m -150.02 132.77 15.94 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.404 178.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -150.65 144.35 25.16 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 5.9 t -110.0 133.23 55.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 175.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 69.8 mt -111.63 153.97 25.56 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.584 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 45.0 tp -116.69 99.23 6.99 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 174.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 63.8 t -113.58 109.19 27.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.712 -175.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.676 ' HG3' HD13 ' A' ' 145' ' ' LEU . 5.0 mm-40 57.25 30.27 18.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.137 178.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.72 -7.91 59.58 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.006 -0.616 . . . . 0.0 113.064 178.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.566 HG22 HG21 ' A' ' 150' ' ' VAL . 61.5 t -101.56 136.19 34.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.864 0.332 . . . . 0.0 111.256 -176.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -88.51 130.15 35.29 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.331 178.231 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.461 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 20.0 mt -118.78 99.62 8.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.892 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -84.27 106.66 2.92 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 111.084 -0.807 . . . . 0.0 111.084 177.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.49 ' HE1' HG13 ' A' ' 58' ' ' VAL . 36.5 mtm -104.12 132.05 50.77 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.997 0.427 . . . . 0.0 111.104 -175.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 113' ' ' PHE . 37.6 t -155.61 165.17 37.36 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 175.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 31.9 t-80 -76.5 -36.81 57.57 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.52 175.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.2 128.94 1.7 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.473 178.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 31.8 t-105 -156.67 141.08 16.67 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 178.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 123.46 177.53 15.14 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.601 -177.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.14 139.06 92.41 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.637 0.218 . . . . 0.0 110.499 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -56.79 -23.1 48.44 Favored 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 123.126 2.551 . . . . 0.0 113.206 -175.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -77.12 -54.34 6.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.224 0.535 . . . . 0.0 110.294 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -87.73 -8.1 56.5 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.717 -174.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 59.4 tp -59.18 -39.07 81.37 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.416 176.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -60.93 -40.63 93.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.992 178.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -69.62 -39.86 76.92 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.628 177.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.444 ' O ' HG21 ' A' ' 103' ' ' VAL . 78.4 ttt180 -67.89 -41.49 82.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.248 -177.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.483 HD11 HG23 ' A' ' 111' ' ' ILE . 78.1 mt -69.54 -31.64 69.97 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.618 0.247 . . . . 0.0 111.017 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.612 HD22 HG21 ' A' ' 127' ' ' VAL . 83.4 mt -74.62 -23.37 58.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.138 0.494 . . . . 0.0 110.225 174.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -74.6 -33.47 62.63 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.538 175.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.444 HG21 ' O ' ' A' ' 99' ' ' ARG . 98.5 t -71.9 -55.97 11.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.053 175.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -92.94 91.95 7.64 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.462 177.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -67.5 -25.26 65.77 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.174 -177.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -67.52 -24.18 65.53 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.942 176.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 32.8 mtmm 62.49 93.98 0.05 OUTLIER Pre-proline 0 N--CA 1.463 0.19 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.721 -177.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -76.8 156.85 35.21 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 123.161 2.574 . . . . 0.0 111.721 -177.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -66.03 -42.66 89.31 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.213 0.53 . . . . 0.0 110.16 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 53.8 t -128.15 139.3 52.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.605 -178.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.483 HG23 HD11 ' A' ' 100' ' ' LEU . 61.0 mt -125.08 130.52 73.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.949 0.404 . . . . 0.0 110.268 176.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.418 HD23 ' HB2' ' A' ' 130' ' ' LEU . 98.0 mt -110.85 131.19 55.25 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.108 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.473 ' HA ' ' O ' ' A' ' 87' ' ' CYS . 37.8 p90 -155.18 172.24 18.47 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.169 -0.468 . . . . 0.0 109.95 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -133.15 114.61 1.41 Allowed Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.385 176.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 63.8 t-80 -171.91 -39.73 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.625 0.25 . . . . 0.0 110.698 -176.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.567 HG23 ' H ' ' A' ' 117' ' ' HIS . 0.2 OUTLIER -75.25 -165.52 0.41 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.987 0.423 . . . . 0.0 111.373 -174.168 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.567 ' H ' HG23 ' A' ' 116' ' ' THR . 93.1 m-70 -94.55 -54.75 3.4 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 111.946 0.351 . . . . 0.0 111.946 -171.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -116.24 167.84 9.69 Favored Pre-proline 0 C--N 1.323 -0.578 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.52 -172.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.7 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 16.2 Cg_exo -69.54 76.56 1.05 Allowed 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.641 2.227 . . . . 0.0 110.092 166.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -108.89 142.03 40.1 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.719 -170.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -94.01 99.99 12.2 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.333 175.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.606 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 80.7 p -104.63 113.07 26.42 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.318 0.58 . . . . 0.0 110.677 -178.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 39.6 t -121.81 97.06 4.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.22 -178.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -137.16 33.93 2.57 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.792 177.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.452 ' C ' ' H ' ' A' ' 127' ' ' VAL . . . -166.74 14.88 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.221 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 80.25 -27.64 2.75 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.518 -172.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.612 HG21 HD22 ' A' ' 101' ' ' LEU . 42.3 t -85.82 138.7 18.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.28 -0.46 . . . . 0.0 110.409 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -87.48 107.64 18.66 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 174.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.606 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 92.8 m-85 -88.95 104.18 16.72 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 174.176 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.418 ' HB2' HD23 ' A' ' 112' ' ' LEU . 49.7 mt -109.19 134.66 51.45 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.181 -173.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.7 ' O ' ' HA ' ' A' ' 119' ' ' PRO . 5.8 t30 -117.76 104.91 48.55 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.268 178.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -70.59 142.72 44.97 Favored 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.805 2.336 . . . . 0.0 112.176 177.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -66.61 152.21 52.4 Favored Glycine 0 N--CA 1.452 -0.285 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.71 -178.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 39.9 m -64.28 138.49 58.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.962 0.411 . . . . 0.0 111.405 -178.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.553 HD23 ' H ' ' A' ' 8' ' ' SER . 74.6 mt -62.47 -31.1 71.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.376 -177.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -66.92 -16.16 64.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.633 -178.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 36.6 tp10 -90.88 1.0 57.34 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.287 0.565 . . . . 0.0 110.478 -178.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 74.94 43.2 28.02 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.248 178.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 57.5 m -152.22 142.17 22.13 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.754 0.311 . . . . 0.0 110.324 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.5 ' CG ' HD12 ' A' ' 23' ' ' ILE . 27.9 p90 -141.43 175.77 9.4 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 177.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.435 ' HB1' HD22 ' A' ' 6' ' ' LEU . . . -114.5 136.66 52.78 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.117 -175.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.449 HG11 ' HG3' ' A' ' 144' ' ' GLU . 21.5 t -118.44 105.86 18.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.879 176.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.728 ' HA ' ' O ' ' A' ' 151' ' ' ARG . 0.3 OUTLIER -95.75 109.4 21.71 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.438 0.637 . . . . 0.0 110.067 176.132 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.449 ' HG3' HG11 ' A' ' 142' ' ' VAL . 47.6 mt-10 -107.11 144.12 34.28 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.157 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.676 HD13 ' HG3' ' A' ' 80' ' ' GLU . 22.0 mt -90.7 90.33 7.91 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.777 -176.065 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -92.14 101.77 14.3 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.397 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.87 10.18 58.04 Favored Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.996 178.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 110.21 -18.14 28.49 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.821 -177.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -85.22 117.91 24.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.792 0.33 . . . . 0.0 110.482 177.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.566 HG21 HG22 ' A' ' 82' ' ' VAL . 5.3 t -80.31 124.39 38.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.2 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.728 ' O ' ' HA ' ' A' ' 143' ' ' LEU . 59.0 ttt85 -119.35 107.85 13.88 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 177.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . 0.546 ' CE2' HD13 ' A' ' 143' ' ' LEU . 9.3 m-85 -83.16 86.62 6.99 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 177.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -102.5 127.72 49.43 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.418 -175.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.598 HD22 ' HG2' ' A' ' 119' ' ' PRO . 9.2 tp -73.29 139.33 46.03 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.478 -178.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -118.71 132.02 56.15 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.741 176.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 21.0 p -88.57 146.36 25.18 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.162 -179.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 74.2 mt . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.337 -0.84 . . . . 0.0 109.633 178.517 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.87 ' HB2' ' HB2' ' A' ' 145' ' ' LEU . 72.4 mmtt . . . . . 0 N--CA 1.452 -0.361 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.496 ' HG2' ' HG2' ' A' ' 144' ' ' GLU . 41.1 mtt180 -110.28 120.59 42.94 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.014 0.435 . . . . 0.0 111.191 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.464 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 86.7 m-85 -116.57 131.25 57.0 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.683 178.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.514 ' HB3' HG21 ' A' ' 33' ' ' VAL . 36.4 tp -89.21 118.78 29.15 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.015 178.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 51.2 tp -106.11 102.01 11.46 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.066 0.46 . . . . 0.0 110.391 -179.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.3 pt -101.6 121.66 52.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.928 177.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.773 ' HB2' ' HA ' ' A' ' 134' ' ' SER . 16.2 m -68.5 171.17 7.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.039 -179.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -64.02 144.06 57.39 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.287 0.565 . . . . 0.0 110.221 -179.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.507 ' HB3' ' HE1' ' A' ' 16' ' ' MET . 68.7 m -143.23 178.96 7.37 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.984 -174.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 32.4 m80 -129.22 79.17 1.9 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.154 0.502 . . . . 0.0 110.472 178.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.06 142.65 33.96 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.379 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -93.72 97.23 0.14 OUTLIER 'Cis proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.299 -1.542 . . . . 0.0 112.056 -3.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.6 t -116.64 -88.09 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 121.19 -0.204 . . . . 0.0 110.896 -178.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -134.67 -14.39 2.18 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 120.949 0.404 . . . . 0.0 111.077 178.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.568 ' SD ' ' HB1' ' A' ' 136' ' ' ALA . 33.8 ttp -64.9 -71.03 0.2 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.405 177.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 63.16 5.6 2.0 Allowed 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.701 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.3 m -85.43 15.32 4.54 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.632 ' HG ' ' HG ' ' A' ' 135' ' ' LEU . 6.2 tt -90.5 111.71 48.99 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.4 132.41 35.8 Favored 'Trans proline' 0 C--O 1.234 0.318 0 C-N-CA 122.815 2.343 . . . . 0.0 112.703 -174.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -68.66 -19.28 64.39 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.302 177.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -56.37 -44.81 80.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.107 175.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.1 tt -70.22 -29.17 38.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.343 -177.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.483 ' O ' HD23 ' A' ' 27' ' ' LEU . 58.8 tp -71.07 -22.87 62.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.251 179.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -82.32 -20.79 36.67 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.184 175.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.8 m -74.02 -9.47 58.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.53 -177.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 1.017 HD12 HG22 ' A' ' 33' ' ' VAL . 2.6 mm? -51.67 -38.66 55.97 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.321 0.582 . . . . 0.0 110.727 176.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -80.36 -17.45 51.9 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.729 -174.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -95.47 2.82 54.58 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -172.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.43 ' CD2' ' HB2' ' A' ' 5' ' ' LEU . 43.2 m-85 -124.27 -176.65 3.56 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.675 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -96.29 -37.99 10.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.034 0.445 . . . . 0.0 110.521 -178.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -151.58 158.67 27.87 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 1.017 HG22 HD12 ' A' ' 27' ' ' LEU . 92.3 t -126.36 136.93 59.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 120.938 0.399 . . . . 0.0 110.691 -178.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.513 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 57.4 mt -115.81 112.58 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.097 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -98.21 126.47 8.9 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 178.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.7 mt -99.67 10.85 40.62 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.884 0.342 . . . . 0.0 110.884 -177.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 122.59 43.31 0.39 Allowed Glycine 0 C--N 1.329 0.143 0 C-N-CA 120.995 -0.621 . . . . 0.0 111.733 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.47 -76.01 0.18 Allowed 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 123.24 0.616 . . . . 0.0 112.369 -174.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.491 ' HD2' HD11 ' A' ' 48' ' ' LEU . 92.9 m-85 -86.19 128.48 34.9 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.994 0.426 . . . . 0.0 110.774 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.1 m -91.26 1.34 8.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.375 0.607 . . . . 0.0 110.311 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.504 ' O ' HG21 ' A' ' 45' ' ' VAL . 26.8 t70 -95.73 126.05 40.73 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.815 -178.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.411 HD11 ' HB3' ' A' ' 66' ' ' ASP . 62.3 tp -58.41 -49.64 76.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.589 -176.1 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -58.14 -42.47 85.92 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.987 -177.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.478 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 10.4 m -67.95 -35.34 78.23 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.156 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.504 HG21 ' O ' ' A' ' 41' ' ' ASP . 89.2 t -61.21 -41.13 88.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 121.272 0.558 . . . . 0.0 110.247 175.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.508 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 1.7 mp -66.99 -38.11 80.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.026 177.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.5 -34.15 73.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.563 176.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.491 HD11 ' HD2' ' A' ' 39' ' ' TYR . 94.8 mt -67.68 -35.61 79.15 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.547 0.689 . . . . 0.0 109.432 177.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.653 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 13.2 tt0 -78.51 -6.24 54.89 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.869 178.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.508 ' HG3' ' O ' ' A' ' 46' ' ' ILE . 29.9 mtpp -95.04 -44.02 7.87 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.605 174.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.483 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . 3.8 m-85 -58.66 -67.9 0.31 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.984 -179.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 51.5 m -87.09 -26.67 23.55 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.559 179.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.653 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 46.4 mttp 72.47 -47.89 0.67 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.266 0.626 . . . . 0.0 111.082 -178.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -81.79 86.58 6.44 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 172.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -119.69 130.11 54.87 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.942 -175.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.513 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 90.7 m-85 -121.26 131.56 54.29 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.089 174.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.477 ' HA3' HD21 ' A' ' 71' ' ' LEU . . . -140.02 151.19 21.99 Favored Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 119.982 -1.104 . . . . 0.0 112.739 -177.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.474 HG22 ' HE3' ' A' ' 86' ' ' MET . 0.5 OUTLIER -112.62 176.47 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 174.65 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.627 ' CD2' ' HA ' ' A' ' 68' ' ' LYS . 61.6 t-80 -94.34 135.38 35.81 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.774 0.321 . . . . 0.0 110.409 -177.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -82.27 -130.98 1.43 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.997 178.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -101.24 -79.21 0.51 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.712 0.292 . . . . 0.0 111.01 -178.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 67.1 mtt -120.68 107.71 13.13 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.984 0.421 . . . . 0.0 110.587 -178.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -132.93 -167.77 1.97 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.213 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -91.23 148.37 37.62 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.863 -179.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -49.33 -36.43 37.96 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.822 3.015 . . . . 0.0 114.296 -174.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.411 ' HB3' HD11 ' A' ' 42' ' ' LEU . 13.1 m-20 -70.22 -36.97 74.91 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.776 0.322 . . . . 0.0 111.251 -178.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 58.6 t -72.11 -41.69 67.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 174.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.627 ' HA ' ' CD2' ' A' ' 59' ' ' HIS . 79.1 tttt -53.99 -35.7 62.13 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.216 -1.356 . . . . 0.0 111.994 177.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -93.9 -24.07 17.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.645 -176.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -82.95 -36.27 25.32 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.445 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.477 HD21 ' HA3' ' A' ' 57' ' ' GLY . 72.4 mt -103.72 110.59 64.18 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.021 177.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -61.05 146.91 97.09 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.965 2.444 . . . . 0.0 112.688 -176.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.562 ' HA ' ' HB3' ' A' ' 59' ' ' HIS . 94.2 m-85 -59.97 -34.37 73.19 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.789 -178.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 63.3 m -152.93 146.46 25.0 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 174.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.505 ' HG2' ' N ' ' A' ' 76' ' ' VAL . 41.7 tttm -150.74 171.54 17.02 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -176.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.505 ' N ' ' HG2' ' A' ' 75' ' ' LYS . 38.6 t -125.35 133.77 68.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 169.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.752 ' HB2' ' SD ' ' A' ' 86' ' ' MET . 1.9 tp -105.54 111.55 24.29 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.32 -177.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 47.8 tp -93.34 103.46 15.69 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.729 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 43.3 t -114.78 109.63 29.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.644 -178.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 61.01 13.45 4.6 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.022 177.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 112.48 -10.07 26.19 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.422 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 60.4 t -87.63 134.54 27.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.708 0.29 . . . . 0.0 110.574 178.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.4 p -91.19 118.98 30.9 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.267 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.556 ' HB ' ' HB3' ' A' ' 77' ' ' LEU . 71.1 mt -118.44 104.14 15.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.034 0.445 . . . . 0.0 110.057 179.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -63.31 130.11 40.83 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.708 178.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.752 ' SD ' ' HB2' ' A' ' 77' ' ' LEU . 65.6 mtp -116.73 97.87 6.22 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 -177.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.552 ' O ' ' HA ' ' A' ' 113' ' ' PHE . 31.7 t -143.06 157.59 44.39 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 176.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 8.4 t-160 -92.23 -21.15 20.51 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.193 -0.603 . . . . 0.0 110.184 177.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 117.07 -179.08 17.39 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.084 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 75.6 t-105 -140.1 -69.72 0.4 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.914 0.388 . . . . 0.0 110.245 -179.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 173.52 169.91 36.42 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 53.78 82.22 0.25 Allowed Pre-proline 0 CA--C 1.529 0.167 0 C-N-CA 122.773 0.429 . . . . 0.0 111.221 -178.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -52.17 -33.67 55.34 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.269 2.646 . . . . 0.0 113.188 -174.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 35.5 p90 -67.98 -35.31 78.13 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.469 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -102.74 -16.73 15.89 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.255 0.55 . . . . 0.0 110.652 -173.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 39.5 tp -55.45 -35.25 65.27 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.222 -179.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 42.3 mttm -59.04 -45.9 89.56 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.59 0.71 . . . . 0.0 109.624 178.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -69.91 -38.83 76.39 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.346 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.494 ' O ' HG21 ' A' ' 103' ' ' VAL . 29.6 mmt180 -61.15 -48.95 79.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.007 177.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.474 HD12 HG21 ' A' ' 111' ' ' ILE . 67.6 mt -61.66 -33.98 74.91 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.692 -177.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 70.3 mt -67.21 -15.24 63.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.793 0.33 . . . . 0.0 111.427 177.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 23.4 mtmm -104.71 -6.15 20.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.117 174.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.494 HG21 ' O ' ' A' ' 99' ' ' ARG . 90.0 t -85.22 -40.13 14.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.25 0.548 . . . . 0.0 109.545 175.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -85.12 171.21 12.2 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.889 178.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 30.8 t30 -91.91 -61.38 1.64 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.091 -176.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -107.6 -176.42 3.06 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.401 -177.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.421 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 96.4 mttt -81.34 111.1 21.96 Favored Pre-proline 0 C--O 1.234 0.282 0 CA-C-O 120.768 0.318 . . . . 0.0 111.101 -175.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 107' ' ' LYS . 3.8 Cg_endo -85.78 147.97 9.57 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.308 2.672 . . . . 0.0 111.847 179.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -81.18 -47.74 13.04 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.259 0.552 . . . . 0.0 110.416 177.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 44.0 t -122.02 147.33 26.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.843 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.474 HG21 HD12 ' A' ' 100' ' ' LEU . 66.3 mt -136.62 130.6 46.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.66 0.267 . . . . 0.0 110.622 175.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.614 HD22 ' HB2' ' A' ' 130' ' ' LEU . 95.0 mt -101.32 141.85 33.58 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.013 175.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.552 ' HA ' ' O ' ' A' ' 87' ' ' CYS . 14.3 p90 -155.85 176.65 12.36 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 172.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -105.56 135.87 12.86 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.807 -177.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.513 ' HB3' ' HB2' ' A' ' 131' ' ' ASN . 11.5 t-160 -151.47 128.4 11.01 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.599 0.237 . . . . 0.0 110.715 -174.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.0 p -74.1 84.3 1.81 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.228 0.537 . . . . 0.0 111.267 178.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 60.7 t60 -176.36 153.55 1.22 Allowed 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -55.97 123.81 55.34 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 174.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.593 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 91.8 Cg_exo -43.13 129.47 5.91 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 124.002 3.134 . . . . 0.0 114.172 -172.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -142.42 155.1 45.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.661 -177.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -95.96 115.44 27.43 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 176.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.495 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 40.5 p -116.41 116.82 28.39 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.121 0.486 . . . . 0.0 112.078 -175.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 43.6 t -114.32 98.25 6.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.969 178.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.442 ' O ' ' HB1' ' A' ' 125' ' ' ALA . 28.4 tptp -144.25 65.44 1.29 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.442 ' HB1' ' O ' ' A' ' 124' ' ' LYS . . . 167.22 -13.07 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.895 -176.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 101.49 -12.06 58.21 Favored Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -173.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 47.3 t -107.18 140.67 24.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 114.965 -0.617 . . . . 0.0 110.061 -178.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 55.7 mtt180 -80.3 108.12 13.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.662 0.268 . . . . 0.0 110.654 176.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.495 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 98.2 m-85 -92.89 107.79 19.49 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 176.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.614 ' HB2' HD22 ' A' ' 112' ' ' LEU . 93.0 mt -99.24 116.71 32.06 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.157 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.593 ' O ' ' HA ' ' A' ' 119' ' ' PRO . 4.3 p30 -122.91 109.79 31.82 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.652 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.527 ' HA ' ' HG3' ' A' ' 119' ' ' PRO . 83.7 Cg_endo -88.86 178.36 2.76 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.072 2.514 . . . . 0.0 111.886 175.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.584 ' HA3' ' OE1' ' A' ' 137' ' ' GLU . . . -90.22 -109.01 1.35 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.216 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.773 ' HA ' ' HB2' ' A' ' 8' ' ' SER . 40.4 t -167.8 162.97 14.06 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.337 -0.246 . . . . 0.0 110.337 -179.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.632 ' HG ' ' HG ' ' A' ' 19' ' ' LEU . 3.7 mm? -71.48 -15.67 62.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.093 0.473 . . . . 0.0 109.957 176.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.568 ' HB1' ' SD ' ' A' ' 16' ' ' MET . . . -84.52 -6.82 59.4 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.356 175.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.584 ' OE1' ' HA3' ' A' ' 133' ' ' GLY . 1.8 tm-20 -113.43 -34.67 5.52 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.883 -178.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.514 ' HA2' HD13 ' A' ' 157' ' ' LEU . . . 127.78 -44.53 1.23 Allowed Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.327 -0.939 . . . . 0.0 113.681 175.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.488 ' HB3' HD11 ' A' ' 154' ' ' LEU . 18.6 m -76.81 113.63 14.69 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -175.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.464 ' O ' HD13 ' A' ' 154' ' ' LEU . 54.7 p90 -115.71 156.76 25.36 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 172.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -114.4 138.0 51.12 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.206 0.527 . . . . 0.0 112.016 -169.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 38.3 t -114.74 116.47 52.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 173.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.61 HD22 HG11 ' A' ' 150' ' ' VAL . 3.4 tt -94.72 107.46 19.46 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -177.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.496 ' HG2' ' HG2' ' A' ' 3' ' ' ARG . 32.4 mt-10 -104.06 121.58 43.49 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.35 178.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.87 ' HB2' ' HB2' ' A' ' 2' ' ' LYS . 55.3 mt -96.81 89.97 5.09 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.708 174.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -86.8 124.29 32.88 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.674 179.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 68.01 -68.94 0.32 Allowed Glycine 0 CA--C 1.52 0.401 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.381 -174.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -179.89 30.38 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 121.087 -0.577 . . . . 0.0 111.774 179.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -126.93 145.63 50.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.681 0.277 . . . . 0.0 110.608 -179.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.61 HG11 HD22 ' A' ' 143' ' ' LEU . 58.1 t -77.08 111.96 14.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.669 -179.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 19.8 mtm180 -115.95 115.81 26.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.379 0.609 . . . . 0.0 110.263 177.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -90.92 105.53 17.89 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.948 -176.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.32 113.76 26.69 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -178.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.502 HD21 ' HB2' ' A' ' 119' ' ' PRO . 44.9 tp -94.33 127.15 40.03 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.32 -173.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -114.92 135.42 54.22 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 175.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.2 m -108.22 148.93 29.25 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.764 0.316 . . . . 0.0 110.526 -177.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.514 HD13 ' HA2' ' A' ' 138' ' ' GLY . 97.5 mt . . . . . 0 C--O 1.247 0.965 0 CA-C-O 118.284 -0.865 . . . . 0.0 110.319 179.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 89.8 mttt . . . . . 0 CA--C 1.52 -0.192 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.601 ' HB3' ' HD1' ' A' ' 30' ' ' TYR . 47.3 mtt85 -115.62 111.65 20.97 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.113 0.482 . . . . 0.0 110.631 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.478 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 73.7 m-85 -102.11 121.63 42.57 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.892 -178.298 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 38.0 tp -89.35 119.33 29.72 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.068 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.703 HD11 ' HG ' ' A' ' 36' ' ' LEU . 59.8 tp -106.05 112.37 25.38 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.088 0.47 . . . . 0.0 111.3 -176.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 27.8 pt -101.43 140.44 20.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.628 175.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.8 p -99.53 -159.5 0.74 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.43 -176.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -48.62 100.6 0.02 OUTLIER 'General case' 0 C--O 1.236 0.375 0 O-C-N 123.803 0.689 . . . . 0.0 112.146 -177.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.467 ' HB2' ' C ' ' A' ' 38' ' ' ASP . 6.9 m -92.51 83.05 4.88 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.963 177.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.544 ' HB2' ' SD ' ' A' ' 16' ' ' MET . 37.2 m80 -76.83 55.68 1.11 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.156 0.503 . . . . 0.0 110.228 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.405 ' CG1' ' HA ' ' A' ' 13' ' ' PRO . 2.8 t -127.69 138.31 32.59 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -177.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.405 ' HA ' ' CG1' ' A' ' 12' ' ' VAL . 27.9 Cg_endo -94.84 56.38 0.87 Allowed 'Cis proline' 0 N--CA 1.453 -0.907 0 C-N-CA 123.61 -1.413 . . . . 0.0 112.724 -2.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.451 HG22 HG23 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -86.0 -162.53 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 176.527 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 66.3 mtt85 -77.31 81.74 3.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.83 0.824 . . . . 0.0 110.828 -176.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.544 ' SD ' ' HB2' ' A' ' 11' ' ' HIS . 51.1 ttp -164.04 -70.79 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.186 -1.37 . . . . 0.0 108.15 179.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 61.25 2.49 0.62 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.932 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.416 ' H ' ' C ' ' A' ' 16' ' ' MET . 8.5 m -82.57 38.17 0.55 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.58 -176.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.0 tt -107.96 103.62 50.5 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.451 ' HB2' HD12 ' A' ' 157' ' ' LEU . 23.4 Cg_exo -65.51 126.65 16.55 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.278 1.985 . . . . 0.0 110.89 174.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -64.19 -10.66 24.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.877 -174.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -53.88 -35.29 61.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.986 0.422 . . . . 0.0 110.836 177.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 tt -69.26 -27.98 36.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.453 0.644 . . . . 0.0 110.573 -177.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 55.5 tp -72.64 -29.49 63.5 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.605 -179.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -72.73 -31.02 64.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.927 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.7 p -77.79 1.89 18.8 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -176.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.449 ' HA ' HD12 ' A' ' 27' ' ' LEU . 2.2 mm? -58.05 -36.14 72.35 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.204 0.526 . . . . 0.0 110.714 176.058 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.412 ' H ' ' HG3' ' A' ' 28' ' ' LYS . 32.2 mttt -75.34 -24.43 57.36 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.925 -175.52 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -88.36 -6.39 57.74 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.162 -165.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.601 ' HD1' ' HB3' ' A' ' 3' ' ' ARG . 98.0 m-85 -122.03 142.04 50.75 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.783 0.325 . . . . 0.0 110.571 -179.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -84.79 -12.75 52.99 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.978 -176.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -138.42 131.83 5.54 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 175.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 56.2 t -122.58 128.68 75.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 117.119 0.459 . . . . 0.0 110.554 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.554 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 32.1 mt -120.29 133.57 66.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.745 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.68 120.4 3.99 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.57 177.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.703 ' HG ' HD11 ' A' ' 6' ' ' LEU . 82.0 mt -89.73 7.62 35.85 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.272 0.558 . . . . 0.0 110.071 179.135 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 152.11 78.66 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.229 -178.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.467 ' C ' ' HB2' ' A' ' 10' ' ' SER . 8.4 p-10 -82.38 -146.93 0.07 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.46 0.171 . . . . 0.0 111.107 -175.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.526 ' HD2' HD12 ' A' ' 48' ' ' LEU . 77.1 m-85 -60.64 144.8 51.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.168 0.508 . . . . 0.0 111.739 -173.079 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.451 HG23 HG22 ' A' ' 14' ' ' VAL . 27.7 m -82.55 -1.86 5.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.056 -178.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.569 ' O ' HG23 ' A' ' 45' ' ' VAL . 16.0 t70 -103.38 122.16 44.27 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.007 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.478 ' HB2' ' HB3' ' A' ' 66' ' ' ASP . 54.7 tp -55.68 -48.82 74.44 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 123.563 0.54 . . . . 0.0 112.125 -172.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -63.88 -32.17 73.6 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.74 0.305 . . . . 0.0 111.291 -176.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.9 m -76.12 -27.31 57.04 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.731 178.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 41' ' ' ASP . 61.6 t -63.32 -47.54 91.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 121.463 0.649 . . . . 0.0 109.962 174.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.601 HG21 ' HE3' ' A' ' 50' ' ' LYS . 1.7 mp -65.59 -31.83 55.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.842 179.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -57.46 -40.58 78.82 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 173.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.526 HD12 ' HD2' ' A' ' 39' ' ' TYR . 64.3 mt -70.7 -40.72 72.7 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 120.981 0.42 . . . . 0.0 110.316 178.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -61.81 -28.78 69.71 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.785 -178.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.601 ' HE3' HG21 ' A' ' 46' ' ' ILE . 98.4 mttt -72.36 -47.64 47.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.969 177.172 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -65.99 -48.14 72.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.889 0.376 . . . . 0.0 111.041 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 9.1 m -60.29 -43.05 96.63 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.335 177.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 98.0 mttt 69.52 -53.69 0.6 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.678 0.791 . . . . 0.0 109.942 -171.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.4 mm-40 -107.71 84.71 2.0 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.332 173.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -100.33 114.27 27.63 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.897 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.554 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 25.1 m-85 -105.07 107.93 19.17 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 176.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.435 ' O ' ' HD2' ' A' ' 72' ' ' PRO . . . -129.78 154.26 20.38 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 119.666 -1.254 . . . . 0.0 113.57 -173.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.591 HG23 ' HB3' ' A' ' 86' ' ' MET . 4.8 m -141.48 157.25 21.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 123.067 0.547 . . . . 0.0 109.719 174.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.51 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 64.4 t60 -94.74 104.6 16.52 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.197 0.522 . . . . 0.0 110.373 -178.159 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 1.019 ' HA2' ' HB3' ' A' ' 88' ' ' HIS . . . -113.58 -29.21 2.98 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.231 175.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 22.4 p-10 -79.67 -169.11 1.81 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.033 -0.583 . . . . 0.0 110.784 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 67.3 mtt -117.54 90.02 3.24 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.003 175.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -107.89 -170.32 1.67 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.022 -177.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -82.44 152.73 67.71 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.52 178.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.505 ' HA ' ' HB3' ' A' ' 68' ' ' LYS . 81.4 Cg_exo -47.07 -32.19 12.91 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.492 2.795 . . . . 0.0 113.772 -178.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.478 ' HB3' ' HB2' ' A' ' 42' ' ' LEU . 3.5 m-20 -58.63 -52.37 65.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.327 0.584 . . . . 0.0 110.668 177.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 19.3 t -75.27 -32.97 27.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.709 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.505 ' HB3' ' HA ' ' A' ' 65' ' ' PRO . 87.7 tttt -60.07 -24.17 64.38 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.067 176.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -93.84 -30.65 14.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.609 176.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -65.56 -43.15 90.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.213 0.53 . . . . 0.0 109.903 175.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.51 ' HB2' ' HB2' ' A' ' 59' ' ' HIS . 78.4 mt -97.89 121.65 57.03 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.326 -179.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.435 ' HD2' ' O ' ' A' ' 57' ' ' GLY . 22.0 Cg_exo -65.88 164.57 26.62 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.867 2.378 . . . . 0.0 112.295 178.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -78.46 -31.68 48.02 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.044 0.449 . . . . 0.0 110.093 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.5 m -151.72 135.49 16.35 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.214 178.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 37.0 tttp -148.37 135.71 20.41 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 10.5 t -115.3 123.77 71.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.884 0.373 . . . . 0.0 110.256 178.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.532 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 78.2 mt -95.62 139.28 32.1 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.223 178.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 37.3 tp -112.31 98.6 7.41 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 174.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.428 HG13 ' CE1' ' A' ' 4' ' ' PHE . 41.0 t -115.1 100.3 10.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.592 -174.198 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 61.51 28.9 18.1 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.35 178.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.64 -15.71 58.3 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.303 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 57.3 t -83.0 121.69 36.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 120.861 0.362 . . . . 0.0 110.365 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.0 p -87.53 123.28 32.26 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.879 178.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.532 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 24.4 mt -116.02 95.63 3.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -178.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -84.8 109.44 3.27 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.384 179.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.591 ' HB3' HG23 ' A' ' 58' ' ' VAL . 46.8 mtm -106.52 123.73 48.53 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.795 0.331 . . . . 0.0 110.306 -178.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 48.0 t -161.06 165.21 30.08 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.602 -177.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 1.019 ' HB3' ' HA2' ' A' ' 60' ' ' GLY . 10.4 p-80 -88.72 95.81 10.42 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.323 0.582 . . . . 0.0 110.494 176.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.513 ' H ' ' HB2' ' A' ' 113' ' ' PHE . . . -83.29 68.22 3.59 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.793 -177.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.427 ' CD1' ' HB2' ' A' ' 88' ' ' HIS . 88.3 m95 -86.13 85.5 7.35 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.225 0.536 . . . . 0.0 110.185 177.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -176.0 -174.96 42.98 Favored Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.565 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -81.24 140.31 49.06 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -62.85 -14.62 41.99 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.841 2.361 . . . . 0.0 112.522 -176.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 4.0 m0 -73.97 -48.77 28.14 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.489 -178.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -96.77 -1.23 46.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.358 178.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 33.6 tp -59.75 -39.32 84.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.509 179.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -59.87 -42.59 94.07 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.257 178.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.421 ' O ' ' HB2' ' A' ' 102' ' ' LYS . 10.6 t70 -64.58 -49.11 72.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.299 179.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 47.2 ttt85 -60.47 -49.64 76.73 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.735 -176.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.48 HD11 HG21 ' A' ' 111' ' ' ILE . 81.6 mt -78.06 -36.11 48.77 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -174.031 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.708 HD21 HG21 ' A' ' 127' ' ' VAL . 85.2 mt -76.53 -18.75 58.54 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.025 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 98' ' ' ASP . 79.6 tttt -74.1 -29.55 61.9 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.373 0.606 . . . . 0.0 109.461 176.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 70.9 t -86.89 -45.98 16.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.018 176.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -90.99 86.9 6.4 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.847 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -68.27 -21.98 64.77 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.532 -178.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -72.55 -18.66 61.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.442 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 78.1 tttt 62.39 95.84 0.05 OUTLIER Pre-proline 0 N--CA 1.465 0.319 0 O-C-N 123.583 0.552 . . . . 0.0 110.636 -173.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.461 ' O ' HG13 ' A' ' 127' ' ' VAL . 5.6 Cg_exo -79.98 134.9 10.84 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.844 2.363 . . . . 0.0 111.851 178.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -70.8 -35.9 72.76 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.34 0.591 . . . . 0.0 109.533 177.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.574 HG22 HG11 ' A' ' 150' ' ' VAL . 53.5 t -122.87 128.59 75.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.028 178.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.48 HG21 HD11 ' A' ' 100' ' ' LEU . 24.4 mt -122.89 127.99 75.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 120.91 0.386 . . . . 0.0 110.826 177.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 89.3 mt -104.52 124.84 50.0 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.494 176.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.513 ' HB2' ' H ' ' A' ' 89' ' ' GLY . 5.2 p90 -146.88 160.05 42.78 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.807 0.337 . . . . 0.0 110.684 -178.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -105.95 125.74 8.31 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 175.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.463 ' HB2' ' CE2' ' A' ' 113' ' ' PHE . 10.4 t-160 -141.1 -54.84 0.48 Allowed 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 111.744 0.276 . . . . 0.0 111.744 -175.172 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 20.6 p -123.47 -100.03 0.41 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -173.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.473 ' O ' ' HA2' ' A' ' 133' ' ' GLY . 0.1 OUTLIER -166.66 -43.39 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.798 0.333 . . . . 0.0 111.214 -172.442 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -85.17 165.26 37.47 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.3 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.86 ' HG3' HD21 ' A' ' 154' ' ' LEU . 21.6 Cg_exo -63.23 87.38 0.13 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.281 1.987 . . . . 0.0 111.225 174.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.679 ' HB3' ' HB3' ' A' ' 131' ' ' ASN . 19.3 tt0 -82.34 105.59 13.53 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.541 -176.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -104.87 99.49 9.12 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.418 -175.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.461 ' HG1' ' HB2' ' A' ' 129' ' ' PHE . 77.2 p -121.22 118.74 30.37 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.454 -177.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.4 p -116.51 115.44 49.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.35 0.595 . . . . 0.0 110.667 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -137.3 136.08 37.69 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.912 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 65.81 17.86 10.97 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 123.604 0.565 . . . . 0.0 111.199 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 88.23 -7.0 82.85 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.951 -0.642 . . . . 0.0 111.769 -176.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.708 HG21 HD21 ' A' ' 101' ' ' LEU . 63.3 t -93.82 126.91 46.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 35.7 ttt180 -103.66 111.08 23.4 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.068 0.461 . . . . 0.0 110.844 -176.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.461 ' HB2' ' HG1' ' A' ' 122' ' ' THR . 19.3 m-85 -92.08 127.15 37.44 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.231 178.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 88.6 mt -120.2 116.76 26.25 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.758 0.313 . . . . 0.0 111.692 -176.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.679 ' HB3' ' HB3' ' A' ' 120' ' ' GLU . 7.3 t30 -94.8 122.51 60.32 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 170.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.526 ' HG3' HD12 ' A' ' 36' ' ' LEU . 84.1 Cg_endo -81.17 167.48 17.74 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.86 2.373 . . . . 0.0 113.165 -177.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.473 ' HA2' ' O ' ' A' ' 117' ' ' HIS . . . -77.96 145.99 30.39 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.631 177.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.512 ' HB2' ' HG2' ' A' ' 137' ' ' GLU . 15.5 m -78.58 140.45 38.49 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.858 0.361 . . . . 0.0 111.534 -177.179 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 62.0 mt -56.38 -37.67 70.4 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.476 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.41 -13.79 53.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.835 -176.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.512 ' HG2' ' HB2' ' A' ' 134' ' ' SER . 23.1 mm-40 -97.53 1.1 48.57 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.582 -178.177 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 71.37 35.73 63.36 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.635 -177.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 18.1 m -139.55 132.74 29.76 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.619 0.247 . . . . 0.0 110.371 -179.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -130.94 164.72 24.7 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 176.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -114.24 143.22 45.19 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.924 0.393 . . . . 0.0 110.731 -173.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 63.0 t -130.82 122.96 53.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.869 178.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 5.8 tt -99.59 105.39 17.25 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 177.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -100.26 112.57 24.9 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.458 -178.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 59.8 mt -90.71 90.33 7.9 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.782 176.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -101.2 122.63 43.99 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 68.21 -68.92 0.35 Allowed Glycine 0 CA--C 1.519 0.308 0 C-N-CA 121.462 -0.399 . . . . 0.0 112.151 -173.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -176.1 25.9 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 175.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -105.83 134.87 48.26 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 -177.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.574 HG11 HG22 ' A' ' 110' ' ' VAL . 41.1 t -83.82 89.63 2.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.1 0.476 . . . . 0.0 109.869 177.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 27.8 mtp-105 -95.37 96.1 8.9 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.295 -177.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -92.36 104.48 16.81 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.076 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -109.46 154.29 22.84 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.864 -179.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.86 HD21 ' HG3' ' A' ' 119' ' ' PRO . 18.8 tp -114.72 117.16 30.02 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 172.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -104.86 135.12 46.82 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.257 -177.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 16.9 p -96.76 142.08 29.21 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.045 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.451 HD12 ' HB2' ' A' ' 20' ' ' PRO . 82.0 mt . . . . . 0 C--O 1.246 0.895 0 CA-C-O 118.555 -0.736 . . . . 0.0 110.405 -179.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.407 ' HZ1' ' CD ' ' A' ' 80' ' ' GLU . 46.5 mttp . . . . . 0 N--CA 1.452 -0.374 0 CA-C-O 120.893 0.378 . . . . 0.0 110.048 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.518 ' HG2' ' HG2' ' A' ' 144' ' ' GLU . 59.6 mtt180 -115.1 117.3 30.18 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.472 178.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.47 ' HE2' ' HE2' ' A' ' 56' ' ' TYR . 65.6 m-85 -103.67 132.21 50.13 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.854 -179.127 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.497 HD13 HD13 ' A' ' 23' ' ' ILE . 50.1 tp -88.98 114.32 25.48 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.033 179.309 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 63.3 tp -102.73 107.16 17.95 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.862 0.363 . . . . 0.0 110.703 -178.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 28.7 pt -104.41 126.42 59.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-O 121.342 0.591 . . . . 0.0 109.527 173.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.537 ' HA ' HD13 ' A' ' 36' ' ' LEU . 14.4 m -77.76 -175.57 3.98 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.03 -173.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -69.24 119.38 13.44 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.652 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.59 ' HB3' ' SD ' ' A' ' 16' ' ' MET . 70.3 m -156.72 80.62 0.94 Allowed 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.388 -0.824 . . . . 0.0 108.819 178.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.506 ' HB3' HG22 ' A' ' 14' ' ' VAL . 24.1 m80 -60.15 106.77 0.55 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.234 -1.348 . . . . 0.0 113.022 -171.182 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.607 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 2.6 p -140.4 138.07 18.49 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.98 176.089 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.53 ' HA ' HG21 ' A' ' 12' ' ' VAL . 60.5 Cg_endo -89.42 104.06 0.44 Allowed 'Cis proline' 0 N--CA 1.456 -0.701 0 C-N-CA 123.551 -1.437 . . . . 0.0 112.449 -1.366 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.506 HG22 ' HB3' ' A' ' 11' ' ' HIS . 13.3 t -128.37 -77.25 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.882 178.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 59.2 mtt180 -134.36 -4.78 2.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.502 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.59 ' SD ' ' HB3' ' A' ' 10' ' ' SER . 56.8 ttp -91.94 -64.51 1.11 Allowed 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 173.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.501 ' HA ' HG21 ' A' ' 12' ' ' VAL . . . 69.39 -21.16 0.16 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.58 176.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.457 ' H ' ' C ' ' A' ' 16' ' ' MET . 22.8 t -105.27 78.55 1.39 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.047 0.451 . . . . 0.0 110.959 -176.166 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.2 tt -108.04 116.78 56.45 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 173.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.414 ' O ' HG23 ' A' ' 23' ' ' ILE . 32.5 Cg_exo -59.74 111.34 0.93 Allowed 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.564 2.176 . . . . 0.0 111.667 177.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -79.48 7.56 7.9 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -172.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -64.76 -35.38 80.9 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.337 0.589 . . . . 0.0 109.794 173.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.497 HD13 HD13 ' A' ' 5' ' ' LEU . 12.9 tt -70.33 -39.92 77.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.758 0.789 . . . . 0.0 109.807 177.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.457 ' O ' HD22 ' A' ' 27' ' ' LEU . 40.5 tp -73.04 -3.99 29.65 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.327 -1.306 . . . . 0.0 110.594 177.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -100.23 -24.81 14.46 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.289 0.566 . . . . 0.0 110.117 175.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 25.9 m -97.03 -6.81 34.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.829 -174.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.907 ' HA ' ' HD2' ' A' ' 30' ' ' TYR . 1.5 pt? -66.45 -13.27 60.55 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.941 0.401 . . . . 0.0 111.316 -175.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -65.43 -27.35 68.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.31 -178.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -94.4 -0.67 54.67 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -177.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.907 ' HD2' ' HA ' ' A' ' 27' ' ' LEU . 84.9 m-85 -91.24 138.51 31.53 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 178.205 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -64.62 -36.99 86.03 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.215 0.531 . . . . 0.0 110.257 -178.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -146.3 154.22 25.82 Favored Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 177.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.451 HG21 ' HB3' ' A' ' 5' ' ' LEU . 88.4 t -132.2 134.82 59.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.909 0.355 . . . . 0.0 110.221 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.53 HG12 ' HB2' ' A' ' 56' ' ' TYR . 52.0 mt -115.46 120.65 65.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.724 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -102.73 105.46 2.75 Favored Glycine 0 N--CA 1.444 -0.779 0 N-CA-C 111.019 -0.833 . . . . 0.0 111.019 174.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.537 HD13 ' HA ' ' A' ' 8' ' ' SER . 76.8 mt -75.91 -24.73 55.6 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 122.716 -0.285 . . . . 0.0 111.509 -176.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 162.97 57.1 0.02 OUTLIER Glycine 0 CA--C 1.51 -0.242 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.563 -178.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.454 ' CG ' ' H ' ' A' ' 39' ' ' TYR . 1.5 p-10 -99.3 -87.84 0.35 Allowed 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -175.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.607 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 93.9 m-85 -82.36 115.49 21.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.362 0.601 . . . . 0.0 110.951 -177.152 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.3 m -91.55 6.43 5.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.509 -0.768 . . . . 0.0 111.634 -177.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.505 ' O ' HG23 ' A' ' 45' ' ' VAL . 13.2 t70 -86.44 120.39 27.73 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.3 -0.409 . . . . 0.0 109.949 179.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.5 HD22 ' HB3' ' A' ' 66' ' ' ASP . 51.5 tp -54.01 -45.86 71.62 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.851 -174.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -63.39 -39.48 94.62 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.133 0.492 . . . . 0.0 110.609 -178.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 24.2 m -68.64 -30.48 69.2 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.021 178.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 41' ' ' ASP . 83.9 t -61.11 -45.82 97.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 121.099 0.476 . . . . 0.0 110.337 176.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.44 HD12 ' N ' ' A' ' 46' ' ' ILE . 1.7 mp -67.27 -38.97 81.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.806 177.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.08 -32.88 73.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.465 176.175 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.37 -34.54 76.25 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.961 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -77.35 -15.2 59.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.17 0.509 . . . . 0.0 110.062 177.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -80.43 -48.19 13.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.502 175.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -69.89 -42.41 73.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.009 0.433 . . . . 0.0 110.79 175.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.534 ' HB2' ' HB2' ' A' ' 55' ' ' PHE . 5.4 m -94.39 97.99 10.58 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.617 176.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -61.22 -26.36 67.69 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.844 -176.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -118.81 88.51 2.94 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 166.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.534 ' HB2' ' HB2' ' A' ' 52' ' ' SER . 88.6 t80 -100.31 124.28 45.58 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.829 -177.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.53 ' HB2' HG12 ' A' ' 34' ' ' ILE . 54.0 m-85 -117.9 146.76 43.7 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 174.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.469 ' HA3' HD21 ' A' ' 71' ' ' LEU . . . -158.62 161.83 32.05 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.248 -0.977 . . . . 0.0 112.119 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.478 HG11 ' HE3' ' A' ' 86' ' ' MET . 0.7 OUTLIER -140.23 169.37 16.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.916 0.389 . . . . 0.0 111.014 178.279 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.535 ' HB3' ' HA ' ' A' ' 73' ' ' PHE . 53.4 t-80 -94.4 143.71 26.17 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.062 -175.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -90.89 -129.93 4.45 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.951 -0.642 . . . . 0.0 111.874 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -88.46 -68.89 0.74 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.827 0.346 . . . . 0.0 110.764 178.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 66.6 mtt -125.71 102.28 7.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.328 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -118.56 179.22 4.19 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.922 -178.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -72.38 140.52 82.32 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 176.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -57.43 -31.55 91.58 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.945 2.43 . . . . 0.0 112.147 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.5 ' HB3' HD22 ' A' ' 42' ' ' LEU . 5.1 m-20 -63.19 -35.97 82.07 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.922 179.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 58.4 t -73.6 -27.18 22.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.399 -178.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.9 ttpm? -61.24 -28.21 69.0 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.04 0.448 . . . . 0.0 110.721 179.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -75.08 -13.04 60.45 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.163 -175.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -117.58 -38.03 3.37 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.73 179.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.469 HD21 ' HA3' ' A' ' 57' ' ' GLY . 15.8 mt -107.87 107.79 60.69 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.274 -178.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -72.04 158.07 53.14 Favored 'Trans proline' 0 N--CA 1.464 -0.228 0 C-N-CA 122.952 2.435 . . . . 0.0 112.003 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.535 ' HA ' ' HB3' ' A' ' 59' ' ' HIS . 91.4 m-85 -62.17 -33.24 74.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.22 0.533 . . . . 0.0 110.56 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 18.2 m -148.58 132.33 16.96 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.574 178.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.7 ttmm -140.0 125.7 19.34 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.356 178.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 11.8 t -101.07 122.32 52.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 175.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.441 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 68.3 mt -87.7 149.55 24.17 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.28 179.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 53.4 tp -121.04 94.05 4.22 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 172.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.665 HG11 ' HG2' ' A' ' 80' ' ' GLU . 21.6 t -121.87 116.73 50.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.084 -173.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.665 ' HG2' HG11 ' A' ' 79' ' ' VAL . 4.2 mm-40 61.46 21.13 11.79 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.278 179.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.91 -0.82 67.42 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.209 -179.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 65.9 t -96.55 128.95 47.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.754 0.311 . . . . 0.0 110.342 178.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.9 p -91.2 119.77 31.56 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.765 177.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.441 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 45.7 mt -118.04 98.74 6.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.504 -176.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -86.22 111.52 3.62 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.062 -178.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.543 ' HG2' HD12 ' A' ' 112' ' ' LEU . 49.3 mtm -97.4 119.69 36.38 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 49.0 t -144.0 160.71 40.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.062 0.458 . . . . 0.0 110.773 -176.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 25.8 m-70 -119.19 153.32 35.1 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.837 173.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 155.25 -158.33 28.33 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.427 -0.892 . . . . 0.0 112.357 178.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 49.4 p90 -155.25 175.97 13.17 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -178.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 149.12 169.12 15.37 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.912 178.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.43 ' HB3' ' HD2' ' A' ' 93' ' ' PRO . . . -85.06 164.07 43.08 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 177.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.43 ' HD2' ' HB3' ' A' ' 92' ' ' ALA . 90.7 Cg_exo -46.29 -38.29 20.01 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.209 2.606 . . . . 0.0 113.832 -178.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.792 ' HA ' ' HE3' ' A' ' 97' ' ' LYS . 42.0 p90 -79.71 -40.1 29.71 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 121.102 -0.239 . . . . 0.0 111.175 -179.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -66.55 -35.08 79.35 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.01 0.433 . . . . 0.0 110.521 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 30.2 tp -54.64 -47.65 73.25 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.908 -177.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.792 ' HE3' ' HA ' ' A' ' 94' ' ' TRP . 8.9 mtmp? -57.86 -56.65 19.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.641 0.734 . . . . 0.0 110.085 178.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.63 -48.7 79.69 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.325 -1.307 . . . . 0.0 112.175 -172.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.531 ' O ' HG23 ' A' ' 103' ' ' VAL . 98.1 mtt180 -67.6 -46.53 72.33 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.525 -174.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.496 HD12 HG21 ' A' ' 111' ' ' ILE . 61.2 mt -67.75 -40.75 84.07 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 -177.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.704 HD23 HG22 ' A' ' 127' ' ' VAL . 95.3 mt -75.39 -13.32 60.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.777 0.322 . . . . 0.0 111.048 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -90.15 -22.18 21.86 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 175.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 99' ' ' ARG . 73.6 t -78.21 -50.29 19.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.911 174.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -96.62 108.26 20.83 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.63 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -82.75 1.49 38.56 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.9 0.381 . . . . 0.0 110.729 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 11.5 mp0 -84.96 -22.62 29.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.473 176.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 87.5 tttt 56.87 85.96 0.18 Allowed Pre-proline 0 N--CA 1.466 0.364 0 O-C-N 123.85 0.719 . . . . 0.0 110.258 -170.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -71.88 152.72 58.21 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.945 2.43 . . . . 0.0 112.366 -177.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -77.27 -37.55 52.71 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.663 176.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.545 HG22 HG23 ' A' ' 150' ' ' VAL . 71.7 t -127.89 137.38 57.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.18 178.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.496 HG21 HD12 ' A' ' 100' ' ' LEU . 55.2 mt -127.43 133.06 68.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.841 0.353 . . . . 0.0 110.599 176.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.596 HD21 ' HB2' ' A' ' 130' ' ' LEU . 93.3 mt -102.08 122.44 44.13 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.704 177.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.464 ' CZ ' ' HB2' ' A' ' 131' ' ' ASN . 36.0 p90 -128.27 124.27 36.18 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.243 0.544 . . . . 0.0 110.631 177.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -105.91 114.78 4.6 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.642 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -165.4 -29.65 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.847 0.356 . . . . 0.0 110.526 -177.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.487 HG21 ' OE1' ' A' ' 118' ' ' GLU . 0.2 OUTLIER -92.42 176.97 6.28 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.398 179.969 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 60.3 m80 -105.58 -38.82 6.3 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.103 0.478 . . . . 0.0 110.609 -177.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.487 ' OE1' HG21 ' A' ' 116' ' ' THR . 1.2 pm0 -96.64 144.6 28.12 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.802 -178.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.559 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 4.7 Cg_exo -80.4 144.74 16.33 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 123.126 2.551 . . . . 0.0 112.953 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -160.01 146.14 15.71 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.435 177.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.546 ' HB2' ' HZ ' ' A' ' 152' ' ' PHE . 17.3 t70 -96.24 122.19 38.84 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 175.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.588 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 74.7 p -125.54 142.15 51.66 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.735 0.302 . . . . 0.0 111.343 -176.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 14.9 p -150.35 138.82 14.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 176.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -141.53 -72.6 0.33 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.847 0.356 . . . . 0.0 111.1 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -89.13 46.82 1.42 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.916 0.389 . . . . 0.0 110.836 -177.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 79.32 -42.31 2.37 Favored Glycine 0 N--CA 1.452 -0.24 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.295 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.704 HG22 HD23 ' A' ' 101' ' ' LEU . 41.7 t -63.72 131.3 29.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.895 0.379 . . . . 0.0 110.747 178.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.412 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 75.9 ttt180 -94.35 114.11 26.11 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.802 179.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.588 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 45.8 m-85 -99.09 125.96 44.72 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -178.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.596 ' HB2' HD21 ' A' ' 112' ' ' LEU . 64.5 mt -103.47 120.68 41.31 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.431 0.634 . . . . 0.0 110.695 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.559 ' O ' ' HA ' ' A' ' 119' ' ' PRO . 49.3 t30 -104.35 107.83 58.72 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 114.865 -1.062 . . . . 0.0 109.223 176.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -89.63 165.62 5.16 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.806 2.337 . . . . 0.0 113.188 -177.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -88.88 146.3 19.13 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.986 179.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.875 ' HB2' ' HG2' ' A' ' 137' ' ' GLU . 9.2 m -68.93 142.83 54.61 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.618 0.209 . . . . 0.0 110.904 -178.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.589 HD11 ' HB2' ' A' ' 10' ' ' SER . 21.0 mt -63.85 -35.26 80.05 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.143 0.497 . . . . 0.0 110.177 -178.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.414 ' HB3' ' SD ' ' A' ' 16' ' ' MET . . . -65.09 -24.22 67.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.434 178.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.875 ' HG2' ' HB2' ' A' ' 134' ' ' SER . 51.8 mm-40 -79.86 -13.81 59.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.869 0.366 . . . . 0.0 110.48 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 89.03 34.26 9.0 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.745 178.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 23.0 t -149.84 150.06 31.4 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.743 0.306 . . . . 0.0 110.313 178.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.409 ' CE1' ' HB3' ' A' ' 155' ' ' LYS . 50.3 p90 -145.55 177.68 8.68 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.662 177.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -121.51 132.73 54.87 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.084 0.469 . . . . 0.0 111.672 -176.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 44.8 t -104.09 114.3 43.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 172.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 6.5 tt -94.57 104.97 16.91 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -177.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.518 ' HG2' ' HG2' ' A' ' 3' ' ' ARG . 37.4 mt-10 -95.17 124.85 39.43 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.106 178.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 81.6 mt -91.38 98.78 11.9 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.133 0.492 . . . . 0.0 110.05 175.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -86.78 100.94 12.88 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.802 -178.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.71 -68.8 0.29 Allowed Glycine 0 CA--C 1.52 0.399 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.446 -172.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -162.31 26.57 0.24 Allowed Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 177.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -123.94 144.14 49.97 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.415 -0.392 . . . . 0.0 110.285 -175.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.545 HG23 HG22 ' A' ' 110' ' ' VAL . 92.8 t -83.37 111.84 20.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.346 -177.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -120.65 93.41 4.03 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 177.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . 0.546 ' HZ ' ' HB2' ' A' ' 121' ' ' ASP . 17.4 p90 -90.29 132.33 35.6 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.058 0.456 . . . . 0.0 110.538 -178.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -116.96 135.37 53.76 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.579 178.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -89.83 131.42 35.78 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.892 0.377 . . . . 0.0 110.666 -178.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.409 ' HB3' ' CE1' ' A' ' 140' ' ' TYR . 10.5 tptt -122.05 154.02 37.84 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.403 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 4.2 p -111.15 152.12 27.38 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.923 0.392 . . . . 0.0 111.319 178.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 94.5 mt . . . . . 0 C--O 1.251 1.139 0 CA-C-O 118.29 -0.862 . . . . 0.0 110.346 -179.275 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.499 ' HD3' ' CZ ' ' A' ' 4' ' ' PHE . 20.9 ttmm . . . . . 0 C--O 1.235 0.328 0 CA-C-O 120.803 0.335 . . . . 0.0 110.248 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.409 ' HD3' ' OE2' ' A' ' 144' ' ' GLU . 38.8 mtt180 -117.02 125.58 51.58 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.532 -178.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.571 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 64.4 m-85 -102.98 124.14 47.92 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.063 0.459 . . . . 0.0 110.695 177.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 48.5 tp -89.27 136.59 32.94 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 175.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.499 HD22 ' HB3' ' A' ' 141' ' ' ALA . 50.3 tp -117.68 103.93 10.51 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.285 0.564 . . . . 0.0 112.077 -177.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.481 HG13 ' HA2' ' A' ' 35' ' ' GLY . 23.5 pt -101.33 138.65 24.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 168.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.632 ' HA ' ' HB2' ' A' ' 36' ' ' LEU . 20.6 m -127.61 -68.18 0.79 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -164.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.454 ' HA ' ' HE1' ' A' ' 88' ' ' HIS . 37.3 t70 -111.44 105.49 14.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.417 0.627 . . . . 0.0 111.099 -176.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.837 ' HB3' ' HA ' ' A' ' 38' ' ' ASP . 29.5 t -141.05 155.88 46.1 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.285 -0.87 . . . . 0.0 108.874 174.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.573 ' H ' ' HE1' ' A' ' 16' ' ' MET . 11.5 m80 -141.59 57.11 1.51 Allowed 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -174.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.482 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . 40.7 t -110.19 126.95 27.89 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.236 -174.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.482 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 60.1 Cg_endo -105.2 91.87 0.06 OUTLIER 'Cis proline' 0 N--CA 1.45 -1.077 0 C-N-CA 124.011 -1.246 . . . . 0.0 112.874 -7.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 41.7 t -92.19 -63.6 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 175.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 58.7 ttm-85 -144.49 12.7 1.53 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.886 0.851 . . . . 0.0 108.758 173.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.573 ' HE1' ' H ' ' A' ' 11' ' ' HIS . 50.6 ttp -131.74 121.88 24.95 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.527 -177.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -126.11 -0.31 7.14 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.916 -0.583 . . . . 0.0 109.959 178.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.5 p -80.77 63.81 5.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.022 -178.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.412 HD12 HG22 ' A' ' 12' ' ' VAL . 4.2 tt -102.1 111.48 64.35 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -62.18 125.63 16.81 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.919 2.413 . . . . 0.0 112.744 -177.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -56.62 -28.83 61.33 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.284 177.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -49.87 -50.4 45.91 Favored 'General case' 0 C--N 1.331 -0.225 0 O-C-N 123.438 0.462 . . . . 0.0 111.846 -175.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.0 tt -66.59 -39.93 85.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.848 0.832 . . . . 0.0 110.252 -177.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.481 ' O ' HD22 ' A' ' 27' ' ' LEU . 35.5 tp -73.97 -3.74 30.99 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.107 -1.406 . . . . 0.0 111.036 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -100.3 -41.39 7.08 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.326 0.584 . . . . 0.0 109.741 172.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 56.9 p -69.43 -14.99 63.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.932 -175.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.565 HD11 ' HB3' ' A' ' 52' ' ' SER . 1.1 pt? -68.46 -9.2 47.21 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.799 0.333 . . . . 0.0 111.118 -176.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -65.82 -35.08 79.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.47 175.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -72.06 -23.29 61.34 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.204 0.526 . . . . 0.0 110.393 -178.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.497 ' HD2' ' HA ' ' A' ' 27' ' ' LEU . 86.0 m-85 -96.16 114.25 25.93 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.523 -176.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -78.31 -4.17 46.64 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.818 -176.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.571 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -142.19 129.58 3.96 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 173.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.41 HG22 ' HB3' ' A' ' 52' ' ' SER . 57.7 t -120.26 142.73 34.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 O-C-N 122.391 -0.476 . . . . 0.0 110.558 -179.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 70.1 mt -125.56 131.15 72.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.352 -0.386 . . . . 0.0 109.967 178.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.481 ' HA2' HG13 ' A' ' 7' ' ' ILE . . . -122.21 123.28 5.37 Favored Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 111.421 -0.672 . . . . 0.0 111.421 178.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.632 ' HB2' ' HA ' ' A' ' 8' ' ' SER . 87.4 mt -95.16 6.4 49.16 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.792 0.296 . . . . 0.0 111.643 -174.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 133.97 87.51 0.29 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.783 -0.723 . . . . 0.0 111.411 178.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.837 ' HA ' ' HB3' ' A' ' 10' ' ' SER . 6.2 m-20 -127.38 -66.52 0.88 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.076 0.465 . . . . 0.0 112.117 -169.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.431 ' CE2' ' HG ' ' A' ' 48' ' ' LEU . 80.3 m-85 -94.25 131.55 39.73 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.871 -174.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 12.7 m -110.04 7.15 8.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.159 -178.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.548 ' O ' HG22 ' A' ' 45' ' ' VAL . 15.1 t70 -111.96 129.94 56.02 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.172 179.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 49.9 tp -60.33 -49.71 76.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.553 -174.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -55.25 -45.38 76.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.999 0.428 . . . . 0.0 111.065 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.7 m -65.68 -29.52 70.09 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.157 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.548 HG22 ' O ' ' A' ' 41' ' ' ASP . 85.1 t -66.43 -42.62 90.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-O 120.891 0.376 . . . . 0.0 110.497 175.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.404 HD11 ' N ' ' A' ' 46' ' ' ILE . 1.7 mp -67.16 -37.93 80.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.285 0.564 . . . . 0.0 110.23 178.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.81 -34.18 76.24 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.393 174.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.431 ' HG ' ' CE2' ' A' ' 39' ' ' TYR . 2.6 tm? -65.72 -35.67 81.4 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 178.249 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.544 ' HA ' ' HE2' ' A' ' 55' ' ' PHE . 0.3 OUTLIER -63.37 -30.54 71.65 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.651 172.767 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.404 ' HD3' ' HA ' ' A' ' 50' ' ' LYS . 42.9 mmtm -70.12 -39.16 75.63 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 120.869 -0.333 . . . . 0.0 110.805 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.429 ' HB3' HD12 ' A' ' 27' ' ' LEU . 82.5 m-85 -73.57 -67.66 0.57 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.855 0.36 . . . . 0.0 110.636 174.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.565 ' HB3' HD11 ' A' ' 27' ' ' LEU . 5.1 p -86.98 96.61 10.33 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 175.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -71.58 -7.39 47.41 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.253 -172.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -151.73 100.57 2.69 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.123 0.487 . . . . 0.0 109.972 171.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.544 ' HE2' ' HA ' ' A' ' 49' ' ' GLU . 50.4 p90 -127.99 163.09 25.3 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.863 179.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.522 ' HE2' ' HE1' ' A' ' 4' ' ' PHE . 37.2 m-85 -117.9 118.59 32.39 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 174.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.552 ' O ' ' HD2' ' A' ' 72' ' ' PRO . . . -106.23 149.31 16.63 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.217 -0.992 . . . . 0.0 112.734 -176.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.464 HG23 ' CB ' ' A' ' 86' ' ' MET . 3.5 t -129.53 154.54 40.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 174.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.848 ' HB3' ' HA ' ' A' ' 73' ' ' PHE . 24.4 t-80 -99.24 150.88 21.63 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.7 -176.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 1.065 ' HA3' ' HB3' ' A' ' 88' ' ' HIS . . . 169.71 53.99 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.128 177.168 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -171.79 160.84 5.74 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 67.0 mtp -80.0 107.3 12.68 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.147 0.499 . . . . 0.0 109.925 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.577 ' CG ' ' HE2' ' A' ' 59' ' ' HIS . 38.1 p-10 -123.47 -156.24 0.7 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.243 -171.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -108.35 154.21 41.54 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.592 175.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -46.73 -44.55 21.72 Favored 'Trans proline' 0 N--CA 1.475 0.407 0 C-N-CA 123.46 2.774 . . . . 0.0 114.089 -176.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -63.24 -26.0 68.59 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.862 0.363 . . . . 0.0 111.842 -176.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 51.7 t -79.6 -32.18 14.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.777 -176.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -62.6 -20.84 65.14 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.412 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -73.47 -47.76 38.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.115 0.484 . . . . 0.0 110.945 178.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -85.05 -21.72 29.28 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.426 -173.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.568 ' O ' ' HB2' ' A' ' 59' ' ' HIS . 3.6 mm? -110.99 94.36 20.32 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.48 173.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.552 ' HD2' ' O ' ' A' ' 57' ' ' GLY . 26.8 Cg_exo -62.62 138.1 67.94 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.825 2.35 . . . . 0.0 111.85 179.094 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.848 ' HA ' ' HB3' ' A' ' 59' ' ' HIS . 40.4 p90 -52.46 -33.04 42.6 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.307 0.379 . . . . 0.0 111.869 -175.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.5 m -155.14 145.65 22.14 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 175.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.4 tttm -144.21 150.24 37.66 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -177.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.5 t -127.34 118.31 49.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 176.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 83.0 mt -90.93 147.89 22.82 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.256 178.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 24.9 tp -115.93 95.42 5.1 Favored 'General case' 0 C--N 1.315 -0.935 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 175.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 47.0 t -99.29 93.99 3.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.211 -177.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 64.17 18.24 11.14 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.662 178.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 114.41 -20.91 15.46 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.97 -177.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.54 ' HA ' ' OE1' ' A' ' 109' ' ' GLN . 55.0 t -76.48 114.91 17.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.822 0.344 . . . . 0.0 110.329 177.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.41 ' HB ' ' HB3' ' A' ' 108' ' ' PRO . 0.9 OUTLIER -83.04 125.65 31.69 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.261 178.931 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.8 mt -117.76 94.91 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.582 -179.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' A' ' 111' ' ' ILE . . . -81.87 126.22 7.31 Favored Glycine 0 N--CA 1.442 -0.939 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.464 ' CB ' HG23 ' A' ' 58' ' ' VAL . 44.0 mtm -126.14 129.8 49.77 Favored 'General case' 0 C--N 1.313 -0.979 0 O-C-N 122.69 -0.3 . . . . 0.0 110.823 -175.077 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 48.5 t -159.57 116.69 2.64 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.652 179.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 1.065 ' HB3' ' HA3' ' A' ' 60' ' ' GLY . 3.3 t-160 -84.6 85.16 7.46 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 -177.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -133.59 165.73 24.08 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.094 -177.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 26.2 m-90 -122.28 -174.21 2.85 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.84 0.353 . . . . 0.0 110.897 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 127.01 -163.05 21.03 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 -176.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.421 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . . . -79.17 124.25 84.52 Favored Pre-proline 0 C--N 1.322 -0.599 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 177.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 92' ' ' ALA . 49.2 Cg_exo -55.22 -30.6 72.33 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.053 2.502 . . . . 0.0 112.967 -175.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -70.94 -54.29 11.88 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.215 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -69.94 -29.14 66.22 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.943 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.432 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 35.0 tp -59.68 -45.84 90.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.036 -177.198 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.818 ' HZ1' ' HB ' ' A' ' 122' ' ' THR . 79.2 mttt -59.15 -49.3 78.38 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.657 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.13 -27.84 66.8 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.216 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -74.02 -42.34 60.48 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.498 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 95.4 mt -66.64 -29.91 70.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.925 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.432 HD21 HG21 ' A' ' 127' ' ' VAL . 84.0 mt -69.22 -15.43 63.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.813 0.34 . . . . 0.0 111.087 176.253 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -101.27 -2.39 31.27 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.369 0.604 . . . . 0.0 110.119 177.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 64.5 t -92.47 -44.06 13.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 169.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -106.62 90.11 3.23 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.445 172.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -69.17 -15.84 63.49 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.194 -177.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -73.16 -21.85 60.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.14 175.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.41 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 94.2 mttt 63.81 99.09 0.04 OUTLIER Pre-proline 0 N--CA 1.465 0.305 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.127 175.128 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.41 ' HB3' ' HB ' ' A' ' 83' ' ' THR . 4.8 Cg_exo -79.6 163.02 24.34 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 123.546 2.83 . . . . 0.0 112.759 -177.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.54 ' OE1' ' HA ' ' A' ' 82' ' ' VAL . 91.1 mt-30 -79.52 -41.6 27.0 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.158 176.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 54.9 t -123.85 140.29 47.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.196 -178.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.496 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 54.9 mt -130.72 130.83 64.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.129 0.49 . . . . 0.0 110.791 176.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 94.0 mt -114.25 135.05 54.48 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.342 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.423 ' CE2' ' HB3' ' A' ' 129' ' ' PHE . 28.6 p90 -151.38 159.11 44.42 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.884 176.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -105.91 114.79 4.61 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 173.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.652 ' HD2' HG21 ' A' ' 116' ' ' THR . 11.0 t60 -122.61 -82.79 0.65 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.758 0.313 . . . . 0.0 110.808 -172.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.652 HG21 ' HD2' ' A' ' 115' ' ' HIS . 10.8 p -101.57 160.57 14.33 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 177.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.43 ' HB3' ' OE2' ' A' ' 137' ' ' GLU . 34.6 m170 -87.39 71.69 9.87 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.381 0.61 . . . . 0.0 110.902 -177.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -171.47 130.12 0.72 Allowed Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 114.622 -1.172 . . . . 0.0 108.62 176.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.447 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 34.7 Cg_exo -58.71 107.41 0.34 Allowed 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.426 2.084 . . . . 0.0 111.731 178.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.498 ' HG2' HG23 ' A' ' 122' ' ' THR . 43.6 tt0 -121.49 128.07 51.7 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.203 -174.113 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.445 ' HA ' HD23 ' A' ' 130' ' ' LEU . 11.2 t70 -104.41 125.13 50.34 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 175.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.818 ' HB ' ' HZ1' ' A' ' 97' ' ' LYS . 33.3 p -135.64 154.54 51.28 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.544 0.688 . . . . 0.0 112.431 -175.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 10.0 p -145.09 162.95 13.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.647 175.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.604 ' HB3' ' HD3' ' A' ' 97' ' ' LYS . 64.8 tttm -176.94 -59.85 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.529 0.68 . . . . 0.0 109.82 -179.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.45 ' C ' ' H ' ' A' ' 127' ' ' VAL . . . -95.55 30.58 2.24 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.029 -175.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 78.55 -33.36 1.84 Allowed Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 121.039 -0.601 . . . . 0.0 111.701 -174.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.45 ' H ' ' C ' ' A' ' 125' ' ' ALA . 28.7 t -70.88 141.86 16.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 122.978 0.511 . . . . 0.0 110.301 176.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -95.49 125.52 40.15 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 177.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.564 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 75.9 m-85 -112.43 128.26 56.26 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -177.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 121' ' ' ASP . 60.3 mt -120.37 132.45 55.28 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.107 0.479 . . . . 0.0 111.604 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.48 ' HB3' ' HB3' ' A' ' 120' ' ' GLU . 25.0 t30 -117.8 105.34 47.76 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.837 176.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.491 ' HG2' ' OG ' ' A' ' 8' ' ' SER . 5.9 Cg_exo -82.36 -172.25 1.38 Allowed 'Trans proline' 0 CA--C 1.531 0.326 0 C-N-CA 123.45 2.767 . . . . 0.0 112.692 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -100.43 -174.12 29.81 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.125 -179.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.607 ' OG ' ' HB2' ' A' ' 137' ' ' GLU . 28.9 p -95.9 160.27 14.56 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 122.605 -0.35 . . . . 0.0 110.951 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 35.7 mt -64.7 -45.58 86.0 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -176.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -75.45 1.69 13.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.316 0.579 . . . . 0.0 111.198 -178.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.607 ' HB2' ' OG ' ' A' ' 134' ' ' SER . 10.5 tt0 -95.89 -15.96 22.09 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.711 -178.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.511 ' HA2' ' HB2' ' A' ' 157' ' ' LEU . . . 72.64 43.0 45.31 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.538 179.137 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.8 m -149.17 98.26 2.79 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 176.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.453 ' O ' HD13 ' A' ' 154' ' ' LEU . 27.5 p90 -116.66 164.15 15.05 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.914 -0.315 . . . . 0.0 110.155 -178.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.499 ' HB3' HD22 ' A' ' 6' ' ' LEU . . . -114.45 150.77 34.24 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.11 0.481 . . . . 0.0 110.803 -174.179 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.461 HG11 ' HG3' ' A' ' 144' ' ' GLU . 67.1 t -125.74 134.55 66.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.605 177.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.693 HD21 HG12 ' A' ' 150' ' ' VAL . 4.5 tt -122.9 103.89 8.91 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.157 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.461 ' HG3' HG11 ' A' ' 142' ' ' VAL . 60.8 mt-10 -108.78 148.26 30.8 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 120.918 0.389 . . . . 0.0 110.461 -177.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.426 HD13 ' HB3' ' A' ' 2' ' ' LYS . 67.2 mt -94.16 90.49 6.38 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.247 0.546 . . . . 0.0 109.61 176.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -124.53 126.17 45.4 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.141 -176.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.95 11.19 60.39 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.006 -175.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 81.48 -7.59 60.98 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 111.792 -0.523 . . . . 0.0 111.792 -176.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -84.64 158.65 20.78 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 120.917 0.389 . . . . 0.0 110.547 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.693 HG12 HD21 ' A' ' 143' ' ' LEU . 15.6 t -83.79 100.36 7.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.211 176.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.432 ' O ' ' HA ' ' A' ' 143' ' ' LEU . 32.6 ttt180 -92.5 99.78 12.44 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.093 -171.463 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . 0.407 ' HA ' ' O ' ' A' ' 142' ' ' VAL . 43.1 m-85 -93.74 107.75 19.59 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.971 177.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -110.39 116.38 31.32 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.561 174.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.453 HD13 ' O ' ' A' ' 140' ' ' TYR . 41.5 tp -89.81 123.17 33.55 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 177.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -120.95 148.15 44.48 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.98 0.419 . . . . 0.0 110.876 -177.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 13.7 p -105.83 156.97 17.8 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.005 -174.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.511 ' HB2' ' HA2' ' A' ' 138' ' ' GLY . 79.2 mt . . . . . 0 C--O 1.25 1.099 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.747 178.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 46.1 mttp . . . . . 0 CA--C 1.518 -0.281 0 CA-C-O 120.745 0.307 . . . . 0.0 110.438 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.498 ' HB3' ' HD1' ' A' ' 30' ' ' TYR . 88.0 mtt180 -130.57 115.38 16.68 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.87 -178.213 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.654 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 91.7 m-85 -101.64 114.65 28.88 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.223 0.535 . . . . 0.0 110.669 178.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.508 ' HB3' HG22 ' A' ' 33' ' ' VAL . 47.2 tp -89.55 110.65 21.48 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.333 -179.127 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.641 HD12 ' HG ' ' A' ' 36' ' ' LEU . 60.2 tp -96.02 114.91 26.67 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.018 0.437 . . . . 0.0 111.104 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 26.9 pt -101.03 125.76 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 171.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.555 ' HB3' ' HG2' ' A' ' 132' ' ' PRO . 11.1 p -80.6 -94.21 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -168.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.46 75.15 1.0 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.984 0.421 . . . . 0.0 111.673 -173.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.2 m -79.95 119.23 22.51 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 173.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 65.0 m-70 -134.33 73.12 1.48 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.516 0.674 . . . . 0.0 109.33 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.462 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . 48.7 t -120.79 131.15 24.55 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.247 -176.446 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.462 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 70.7 Cg_endo -102.25 90.19 0.08 OUTLIER 'Cis proline' 0 N--CA 1.451 -1.001 0 C-N-CA 123.781 -1.341 . . . . 0.0 112.438 -5.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.499 HG11 ' HG2' ' A' ' 15' ' ' ARG . 27.3 t -97.75 -84.94 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.649 -179.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.499 ' HG2' HG11 ' A' ' 14' ' ' VAL . 12.6 mmm180 -121.05 -25.59 5.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.178 0.513 . . . . 0.0 110.204 177.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.463 ' C ' ' H ' ' A' ' 18' ' ' SER . 51.1 ttp -80.43 -72.92 0.39 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.117 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 70.3 -33.71 0.27 Allowed 'General case' 0 N--CA 1.469 0.516 0 O-C-N 123.872 0.733 . . . . 0.0 112.077 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.463 ' H ' ' C ' ' A' ' 16' ' ' MET . 29.7 p -75.15 81.84 2.31 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.087 0.47 . . . . 0.0 111.572 -178.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.414 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 8.0 tt -107.55 110.68 62.9 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 173.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.593 ' CG ' HD12 ' A' ' 157' ' ' LEU . 19.6 Cg_endo -59.13 142.24 99.04 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 123.152 2.568 . . . . 0.0 112.936 -176.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -71.73 -20.83 61.85 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.109 -173.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -57.17 -46.72 82.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.432 -177.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.5 tt -71.2 -32.14 46.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.466 0.65 . . . . 0.0 110.293 -177.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.457 ' O ' HD21 ' A' ' 27' ' ' LEU . 58.4 tp -72.84 -25.14 61.01 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.69 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -81.47 -29.33 33.76 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.476 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.4 p -83.51 8.82 12.85 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -174.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.567 HD12 ' HB2' ' A' ' 52' ' ' SER . 3.2 mm? -56.31 -27.8 56.75 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.839 0.352 . . . . 0.0 111.494 176.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -78.14 -24.31 47.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.367 -177.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -92.85 -3.74 54.12 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.16 0.505 . . . . 0.0 111.177 -172.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.498 ' HD1' ' HB3' ' A' ' 3' ' ' ARG . 99.0 m-85 -123.44 120.22 32.31 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.28 176.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -78.8 -29.93 45.15 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.973 -173.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.654 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -120.91 126.62 6.67 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 174.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.508 HG22 ' HB3' ' A' ' 5' ' ' LEU . 97.0 t -119.61 134.71 62.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 117.426 0.613 . . . . 0.0 110.603 -179.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.515 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 71.2 mt -116.82 131.76 68.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.234 -177.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -125.77 107.41 0.95 Allowed Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.411 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.641 ' HG ' HD12 ' A' ' 6' ' ' LEU . 95.0 mt -74.2 -22.8 59.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.697 0.761 . . . . 0.0 109.385 176.154 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -152.39 125.06 1.74 Allowed Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 174.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -119.72 -169.57 1.79 Allowed 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -174.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -65.33 145.39 56.26 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 19.9 m -84.41 27.26 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.12 0.486 . . . . 0.0 111.672 -171.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -146.3 139.35 25.66 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 121.029 0.442 . . . . 0.0 110.389 177.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.709 ' HB2' ' HB3' ' A' ' 66' ' ' ASP . 43.4 tp -66.34 -28.9 69.02 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.519 -173.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.47 -35.63 78.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.175 0.512 . . . . 0.0 110.482 -177.099 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.2 m -83.24 -30.84 27.36 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.341 -178.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 98.2 t -58.43 -42.54 84.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.039 0.447 . . . . 0.0 110.285 174.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.415 HD12 ' HG ' ' A' ' 42' ' ' LEU . 1.7 mp -68.85 -35.72 70.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.202 177.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -61.25 -37.8 84.41 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.914 175.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 46.8 mt -80.11 -33.33 38.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.732 0.301 . . . . 0.0 110.684 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -65.32 -21.6 66.73 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.129 174.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -81.41 -36.17 29.82 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.043 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.42 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . 39.2 m-85 -75.16 -62.58 1.51 Allowed 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.057 174.059 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.567 ' HB2' HD12 ' A' ' 27' ' ' LEU . 33.4 t -90.8 98.71 11.94 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 173.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 42.7 mttm -78.05 15.18 0.95 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.767 -178.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -146.95 77.58 1.46 Allowed 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 168.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -101.82 123.5 45.88 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.532 -175.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.547 ' HE2' ' HE1' ' A' ' 4' ' ' PHE . 26.5 m-85 -104.41 107.9 19.05 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 175.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.822 ' HA3' HD23 ' A' ' 71' ' ' LEU . . . -116.64 156.49 15.59 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.1 -1.047 . . . . 0.0 112.708 -176.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 15.0 t -128.08 146.08 34.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 177.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 56.8 t60 -94.57 104.53 16.48 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.459 0.647 . . . . 0.0 109.458 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.59 ' HA3' ' HB2' ' A' ' 88' ' ' HIS . . . -135.38 23.15 3.48 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.966 177.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -121.72 -176.07 3.24 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 51.2 mtp -98.91 36.19 1.73 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.393 0.616 . . . . 0.0 109.36 173.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.426 ' OD2' ' HB ' ' A' ' 67' ' ' VAL . 3.8 p-10 -68.62 156.11 38.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.419 178.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.518 ' HB3' ' HD2' ' A' ' 65' ' ' PRO . 89.5 m-85 -70.05 162.97 65.38 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.239 -175.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.518 ' HD2' ' HB3' ' A' ' 64' ' ' TYR . 9.9 Cg_endo -51.91 -23.92 17.65 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.173 2.582 . . . . 0.0 112.602 177.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.709 ' HB3' ' HB2' ' A' ' 42' ' ' LEU . 5.9 m-20 -54.83 -50.31 68.92 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.251 0.548 . . . . 0.0 110.412 175.281 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.426 ' HB ' ' OD2' ' A' ' 63' ' ' ASP . 29.1 t -77.94 -34.44 19.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.057 -178.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.454 ' HB3' ' HA ' ' A' ' 65' ' ' PRO . 57.8 tttm -62.72 -24.4 67.66 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.105 177.23 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -64.48 -41.09 96.69 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.262 0.553 . . . . 0.0 109.59 175.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -83.42 -38.61 21.69 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.11 -178.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.822 HD23 ' HA3' ' A' ' 57' ' ' GLY . 14.8 mt -114.13 120.7 38.05 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.07 -173.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.479 ' HG2' ' HB2' ' A' ' 75' ' ' LYS . 72.6 Cg_endo -79.79 157.76 24.46 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.793 2.329 . . . . 0.0 111.426 175.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -60.03 -34.78 73.85 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.906 0.384 . . . . 0.0 111.061 -177.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 17.3 m -142.8 137.55 29.76 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 174.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.479 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 43.0 tttp -136.24 126.28 26.1 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.549 0.214 . . . . 0.0 110.627 -176.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 26.8 t -103.18 125.07 57.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.787 0.327 . . . . 0.0 110.29 177.103 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.524 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 89.9 mt -100.43 159.72 14.92 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.784 178.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 46.6 tp -130.78 99.61 5.0 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 175.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.529 HG12 ' HG2' ' A' ' 80' ' ' GLU . 58.2 t -117.04 112.67 40.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.684 -176.004 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.529 ' HG2' HG12 ' A' ' 79' ' ' VAL . 4.5 mm-40 60.06 19.57 8.76 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.57 178.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.55 -3.7 50.18 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.333 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.3 t -93.68 128.23 45.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.664 0.269 . . . . 0.0 110.56 178.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 33.9 p -88.49 126.72 35.38 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.605 178.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.524 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 19.6 mt -118.33 95.85 3.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.82 0.343 . . . . 0.0 110.218 -178.347 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -80.23 98.12 1.72 Allowed Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 178.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 32.2 mtm -96.8 120.73 37.68 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.135 0.493 . . . . 0.0 110.999 -175.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 26.4 t -139.38 165.19 27.85 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 174.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.59 ' HB2' ' HA3' ' A' ' 60' ' ' GLY . 4.6 t60 -81.51 -21.12 38.85 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 119.669 -0.812 . . . . 0.0 109.667 178.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.88 -155.5 33.37 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.53 177.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 73.8 t-105 -159.74 -73.2 0.07 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.95 0.405 . . . . 0.0 110.513 -177.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 161.77 -174.21 38.24 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 -178.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 55.17 81.86 0.25 Allowed Pre-proline 0 N--CA 1.463 0.21 0 C-N-CA 122.631 0.372 . . . . 0.0 111.341 -179.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -54.77 -30.75 68.8 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.399 2.733 . . . . 0.0 113.262 -173.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -72.53 -13.62 61.45 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.185 -0.461 . . . . 0.0 112.228 -177.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -121.6 -25.18 5.16 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.189 0.519 . . . . 0.0 110.417 177.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 48.2 tp -60.19 -41.29 92.6 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.006 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -58.36 -41.62 85.11 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.159 0.504 . . . . 0.0 109.835 178.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.428 ' O ' ' HG3' ' A' ' 102' ' ' LYS . 9.1 m-20 -69.58 -47.67 62.79 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.058 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.527 ' O ' HG21 ' A' ' 103' ' ' VAL . 19.0 ttm180 -58.71 -46.74 86.66 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.151 -177.03 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.46 HD11 HG22 ' A' ' 111' ' ' ILE . 91.7 mt -66.4 -36.45 82.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.72 0.295 . . . . 0.0 111.287 -179.125 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 93.8 mt -75.12 -11.35 60.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.857 0.36 . . . . 0.0 111.127 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.428 ' HG3' ' O ' ' A' ' 98' ' ' ASP . 96.1 mttt -100.07 -8.87 23.26 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.122 0.487 . . . . 0.0 110.179 175.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.527 HG21 ' O ' ' A' ' 99' ' ' ARG . 90.9 t -81.29 -48.07 19.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 170.025 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -101.09 106.71 18.01 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.175 173.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 -57.44 -37.7 73.24 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.804 0.335 . . . . 0.0 111.631 -175.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -96.17 133.83 39.98 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 174.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.46 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 60.1 pttt -71.86 126.66 91.35 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-O 121.148 0.499 . . . . 0.0 111.185 -174.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 107' ' ' LYS . 3.7 Cg_exo -81.8 169.48 14.95 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 123.393 2.729 . . . . 0.0 111.473 175.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -87.36 -45.33 10.65 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.112 0.482 . . . . 0.0 109.97 178.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 63.3 t -120.63 136.74 56.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.279 178.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.46 HG22 HD11 ' A' ' 100' ' ' LEU . 59.6 mt -130.02 133.87 63.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.881 0.372 . . . . 0.0 110.386 177.084 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.47 HD23 ' HB2' ' A' ' 130' ' ' LEU . 95.3 mt -109.26 146.36 34.38 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.375 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.42 ' CZ ' ' HB3' ' A' ' 131' ' ' ASN . 29.8 p90 -155.69 163.79 39.44 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 174.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -147.11 125.48 2.19 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.681 -177.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 36.5 t-80 -177.5 -37.14 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 177.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.3 p -79.86 127.34 32.12 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.522 177.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.456 ' O ' ' HD3' ' A' ' 119' ' ' PRO . 24.1 m170 -87.71 7.3 30.75 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.263 0.554 . . . . 0.0 110.206 176.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -106.4 91.69 6.1 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.756 171.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.456 ' HD3' ' O ' ' A' ' 117' ' ' HIS . 22.5 Cg_exo -63.51 129.51 25.4 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.75 2.3 . . . . 0.0 111.661 -175.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -149.26 136.74 20.18 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.968 0.414 . . . . 0.0 111.314 -172.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.439 ' OD1' ' HD2' ' A' ' 128' ' ' ARG . 6.7 t70 -90.44 119.78 31.0 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.482 174.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.471 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 44.3 p -132.66 129.52 38.94 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.108 0.48 . . . . 0.0 112.049 -173.497 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 6.2 p -120.54 105.81 17.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 169.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 50.0 mttp -109.11 -67.34 0.99 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.264 -172.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -92.18 33.0 1.1 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.101 0.476 . . . . 0.0 110.992 -176.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 83.03 -14.92 35.57 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 -175.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 41.8 t -96.23 144.87 9.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.439 ' HD2' ' OD1' ' A' ' 121' ' ' ASP . 6.4 tpp180 -87.24 109.54 19.56 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.391 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.471 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 92.0 m-85 -98.15 121.17 39.75 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 177.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.502 HD12 ' CD1' ' A' ' 152' ' ' PHE . 64.8 mt -121.5 129.66 53.07 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.872 0.367 . . . . 0.0 111.327 -174.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.44 ' HA ' ' HD3' ' A' ' 132' ' ' PRO . 8.5 p30 -131.82 122.31 18.5 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.156 177.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.555 ' HG2' ' HB3' ' A' ' 8' ' ' SER . 87.4 Cg_endo -98.41 168.54 0.66 Allowed 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 123.48 2.787 . . . . 0.0 113.057 178.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -80.67 166.57 49.24 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.787 -0.721 . . . . 0.0 111.351 175.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.494 ' HA ' ' OG ' ' A' ' 8' ' ' SER . 39.5 m -90.32 177.39 6.42 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 117.2 0.5 . . . . 0.0 111.181 -177.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.412 HD21 ' N ' ' A' ' 135' ' ' LEU . 3.1 mm? -73.09 -18.13 61.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.335 -176.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -73.26 -47.4 43.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.759 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.49 ' OE1' ' HB2' ' A' ' 134' ' ' SER . 1.8 mp0 -66.49 -32.13 73.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.148 177.082 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.504 ' HA2' HD13 ' A' ' 157' ' ' LEU . . . 96.58 51.75 1.65 Allowed Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.211 178.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 23.1 t -145.97 153.89 41.3 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 178.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -154.36 167.09 31.13 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.779 177.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.434 ' HB2' ' HB3' ' A' ' 6' ' ' LEU . . . -114.26 135.95 53.5 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.849 0.356 . . . . 0.0 111.041 -174.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 79.4 t -121.27 120.55 62.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.169 176.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.775 HD21 HG11 ' A' ' 150' ' ' VAL . 5.5 tt -104.5 103.95 13.73 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 177.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -106.39 135.91 47.06 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.876 -178.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.483 ' HA ' ' O ' ' A' ' 149' ' ' GLU . 5.1 mp -112.13 98.7 7.51 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.944 0.402 . . . . 0.0 110.512 178.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -101.26 121.54 42.06 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.367 0.603 . . . . 0.0 109.426 178.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 68.09 1.56 20.29 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.835 -175.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 104.57 0.58 43.18 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 121.155 -0.545 . . . . 0.0 112.235 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.483 ' O ' ' HA ' ' A' ' 145' ' ' LEU . 8.7 mm-40 -88.76 132.95 34.4 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.925 0.393 . . . . 0.0 110.511 177.13 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.775 HG11 HD21 ' A' ' 143' ' ' LEU . 98.3 t -80.75 113.97 20.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.021 -178.107 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 11.1 mtm180 -110.54 107.07 16.58 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 176.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . 0.502 ' CD1' HD12 ' A' ' 130' ' ' LEU . 84.5 t80 -89.45 96.29 10.64 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 176.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -107.24 109.49 21.29 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.414 -174.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 33.9 tp -80.02 118.97 22.23 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.557 177.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -111.03 160.45 16.84 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.055 -178.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 16.5 p -107.39 165.6 11.27 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.334 176.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.593 HD12 ' CG ' ' A' ' 20' ' ' PRO . 39.4 mt . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.422 -0.799 . . . . 0.0 110.011 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.512 ' HB2' HD12 ' A' ' 145' ' ' LEU . 50.1 mttm . . . . . 0 CA--C 1.518 -0.254 0 CA-C-O 120.958 0.409 . . . . 0.0 110.91 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.482 ' HB3' ' HD2' ' A' ' 30' ' ' TYR . 88.9 mtt180 -117.2 133.65 55.73 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.163 -178.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -120.29 121.14 38.0 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.866 0.365 . . . . 0.0 110.065 175.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.424 ' HB3' HG22 ' A' ' 33' ' ' VAL . 38.7 tp -93.0 121.05 33.94 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.863 -178.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.547 HD12 ' HG ' ' A' ' 36' ' ' LEU . 51.7 tp -103.98 120.94 42.11 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.952 0.406 . . . . 0.0 110.508 178.252 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.5 pt -101.33 123.96 54.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 173.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.422 ' HB3' ' HB2' ' A' ' 132' ' ' PRO . 5.9 p -66.0 -79.31 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.578 -169.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.783 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 26.9 t70 -148.0 124.13 10.79 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.135 -177.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.704 ' HA ' ' HE2' ' A' ' 16' ' ' MET . 9.0 p -156.91 88.46 1.04 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.123 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 62.4 m-70 -83.69 85.85 7.22 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.307 -0.406 . . . . 0.0 109.973 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.461 ' O ' HG21 ' A' ' 40' ' ' VAL . 59.9 t -107.7 135.04 19.82 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.026 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -78.23 -62.56 0.03 OUTLIER 'Cis proline' 0 C--N 1.345 0.384 0 C-N-CA 123.75 -1.354 . . . . 0.0 112.571 0.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.76 HG13 ' HG3' ' A' ' 15' ' ' ARG . 19.6 t 52.13 -93.0 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 123.464 0.705 . . . . 0.0 112.031 177.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.76 ' HG3' HG13 ' A' ' 14' ' ' VAL . 97.8 mtt180 -134.01 4.37 3.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.869 0.366 . . . . 0.0 110.564 -175.297 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.704 ' HE2' ' HA ' ' A' ' 10' ' ' SER . 32.3 ttp -137.77 112.46 8.87 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.511 -176.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -116.89 19.69 14.26 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.203 0.525 . . . . 0.0 110.344 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 35.6 p -99.9 29.9 3.97 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.379 -176.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.686 HD13 ' HB2' ' A' ' 10' ' ' SER . 7.1 tt -83.27 116.96 67.08 Favored Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 179.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -68.86 118.14 5.47 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 122.45 2.1 . . . . 0.0 112.187 178.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.56 -7.8 5.29 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.442 -177.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -61.12 -36.97 81.15 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.808 0.337 . . . . 0.0 110.796 179.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 11.1 tp -64.75 -39.19 84.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.937 0.875 . . . . 0.0 109.761 178.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 44.4 tp -78.37 -10.25 59.61 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.051 -1.432 . . . . 0.0 110.978 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -100.32 -6.55 25.68 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.106 0.479 . . . . 0.0 110.816 -176.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 68.4 m -121.68 0.5 9.86 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.988 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.433 HD13 HG23 ' A' ' 33' ' ' VAL . 1.4 pt? -72.65 -19.26 61.47 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.065 -174.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -72.94 -13.9 61.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.961 -177.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -73.77 -26.08 60.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.114 0.483 . . . . 0.0 110.547 177.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.482 ' HD2' ' HB3' ' A' ' 3' ' ' ARG . 85.7 m-85 -83.87 156.95 22.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.211 -173.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -86.94 -6.6 58.72 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.01 -178.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -174.52 149.01 10.19 Favored Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.726 177.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.433 HG23 HD13 ' A' ' 27' ' ' LEU . 69.7 t -124.71 135.98 62.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-O 120.976 0.417 . . . . 0.0 110.494 -179.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.533 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 49.4 mt -113.85 134.44 56.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.769 179.178 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -125.6 117.2 2.85 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.14 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.547 ' HG ' HD12 ' A' ' 6' ' ' LEU . 95.9 mt -95.79 -9.96 30.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.854 0.835 . . . . 0.0 109.246 175.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.783 ' HA3' ' HA ' ' A' ' 9' ' ' ASP . . . -151.43 60.93 0.41 Allowed Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.238 178.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -73.83 178.85 4.59 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.252 -0.474 . . . . 0.0 111.695 -175.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.518 ' HD1' HD11 ' A' ' 48' ' ' LEU . 71.2 m-85 -63.43 145.62 55.24 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.558 179.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.538 ' HB ' ' CD1' ' A' ' 64' ' ' TYR . 18.1 m -83.79 -9.01 11.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.802 -173.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.484 ' HB2' ' OG1' ' A' ' 44' ' ' THR . 19.4 m-20 -86.62 120.4 27.89 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.013 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.519 HD23 ' HB3' ' A' ' 66' ' ' ASP . 48.9 tp -53.38 -42.24 66.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.026 0.441 . . . . 0.0 110.432 178.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -59.06 -38.7 80.02 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.923 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.496 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 7.6 m -75.74 -28.72 58.62 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.663 -178.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 41' ' ' ASP . 65.6 t -62.22 -46.77 95.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.055 0.455 . . . . 0.0 110.159 175.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.424 HD12 ' N ' ' A' ' 46' ' ' ILE . 1.7 mp -65.07 -36.34 77.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.844 176.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -59.64 -35.42 74.35 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.785 175.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.518 HD11 ' HD1' ' A' ' 39' ' ' TYR . 91.1 mt -71.25 -38.34 71.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.407 178.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.682 ' HG2' ' HB3' ' A' ' 55' ' ' PHE . 49.2 mt-10 -69.05 -17.1 63.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.984 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -82.53 -41.31 19.81 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.856 176.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -68.83 -46.47 68.47 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.903 0.382 . . . . 0.0 111.536 178.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 51.1 p -83.38 -14.81 51.96 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.544 -176.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 93.5 mttt 70.4 -54.11 0.64 Allowed 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.509 0.723 . . . . 0.0 110.368 -172.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -123.68 109.57 13.88 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.193 0.521 . . . . 0.0 109.735 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.682 ' HB3' ' HG2' ' A' ' 49' ' ' GLU . 84.1 t80 -111.4 139.25 46.96 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.479 -175.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.533 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 93.5 m-85 -119.77 116.49 26.02 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 174.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.485 ' HA3' HD13 ' A' ' 71' ' ' LEU . . . -124.91 141.89 13.47 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 119.566 -1.302 . . . . 0.0 113.739 -173.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.409 ' CG2' ' HE1' ' A' ' 86' ' ' MET . 16.5 t -132.24 123.03 49.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 170.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -94.39 147.06 23.61 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 120.095 -0.642 . . . . 0.0 110.339 -173.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.607 ' HA2' ' HB3' ' A' ' 88' ' ' HIS . . . -80.83 -123.06 0.54 Allowed Glycine 0 C--N 1.331 0.261 0 N-CA-C 114.475 0.55 . . . . 0.0 114.475 -171.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -74.23 -164.12 0.23 Allowed 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 122.419 0.288 . . . . 0.0 111.053 -175.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 46.9 mtm -56.46 113.94 1.81 Allowed 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 120.991 0.424 . . . . 0.0 110.264 178.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -141.09 -160.77 1.12 Allowed 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -175.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.538 ' CD1' ' HB ' ' A' ' 40' ' ' VAL . 12.3 m-85 -67.04 125.28 90.68 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 121.113 0.482 . . . . 0.0 111.308 -177.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.66 -38.36 95.78 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 123.869 3.046 . . . . 0.0 113.797 -174.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.519 ' HB3' HD23 ' A' ' 42' ' ' LEU . 5.4 m-20 -59.5 -36.54 76.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.099 0.476 . . . . 0.0 111.024 -178.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 11.9 t -76.53 -26.08 16.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.261 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -63.51 -31.1 72.16 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.194 0.521 . . . . 0.0 110.264 176.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -86.2 -19.47 29.97 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.095 -178.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 11.7 t60 -91.24 -40.31 11.59 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.09 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.485 HD13 ' HA3' ' A' ' 57' ' ' GLY . 31.1 mt -117.74 136.26 23.61 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.985 179.116 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.408 ' HD2' ' O ' ' A' ' 57' ' ' GLY . 63.9 Cg_endo -74.34 177.29 8.51 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 122.486 2.124 . . . . 0.0 112.525 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -95.98 -12.97 24.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.212 0.529 . . . . 0.0 110.172 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 10.0 p -155.63 124.1 5.93 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.321 175.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 40.5 tttp -131.83 132.59 43.83 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.509 0.195 . . . . 0.0 110.674 -176.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 20.3 t -110.83 121.68 63.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.873 0.368 . . . . 0.0 110.498 179.039 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.443 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 72.3 mt -101.28 158.81 15.77 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.337 178.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 59.6 tp -127.0 102.11 6.84 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 175.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.497 HG12 ' HG2' ' A' ' 80' ' ' GLU . 35.6 t -124.01 116.12 46.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.468 -177.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.497 ' HG2' HG12 ' A' ' 79' ' ' VAL . 20.2 mm-40 59.78 27.16 16.41 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.477 177.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.31 -15.32 63.5 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.195 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 52.4 t -87.41 126.37 41.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.76 0.314 . . . . 0.0 110.189 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 40.9 p -85.93 134.35 33.88 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.181 177.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.443 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 37.0 mt -118.17 94.81 3.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -178.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -85.29 95.31 1.97 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.444 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.561 ' HG2' HD11 ' A' ' 112' ' ' LEU . 30.0 mtm -95.98 118.93 33.57 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.953 0.406 . . . . 0.0 110.439 -176.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.667 ' O ' ' HA ' ' A' ' 113' ' ' PHE . 52.7 t -140.27 153.69 46.59 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 178.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.607 ' HB3' ' HA2' ' A' ' 60' ' ' GLY . 4.1 p-80 -72.23 1.55 7.46 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.879 -0.329 . . . . 0.0 111.849 176.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.35 176.72 50.34 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.494 176.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -116.73 -99.5 0.44 Allowed 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.548 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -109.69 -94.71 2.32 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.311 -0.947 . . . . 0.0 113.434 -173.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -112.7 172.67 3.35 Favored Pre-proline 0 C--N 1.321 -0.656 0 C-N-CA 122.456 0.302 . . . . 0.0 110.622 -172.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -61.24 -11.79 20.64 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.612 2.208 . . . . 0.0 113.061 177.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 1.5 m0 -77.51 -54.59 6.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.286 0.565 . . . . 0.0 109.701 -179.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.465 ' OD2' ' HD2' ' A' ' 99' ' ' ARG . 7.3 p-10 -82.72 -3.32 56.29 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.703 -177.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 28.0 tp -50.51 -56.34 12.06 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.775 178.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.9 ptmm? -66.44 -48.28 70.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.264 -178.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -62.49 -59.07 5.48 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.792 -175.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.519 ' O ' HG23 ' A' ' 103' ' ' VAL . 94.3 mtt180 -69.31 -38.21 78.16 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -171.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.466 HD12 HG23 ' A' ' 111' ' ' ILE . 46.5 mt -70.03 -37.13 75.5 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.386 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.52 HD23 HG22 ' A' ' 127' ' ' VAL . 87.0 mt -79.3 -14.23 59.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.81 0.338 . . . . 0.0 111.117 178.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.595 ' HA ' ' ND2' ' A' ' 105' ' ' ASN . 97.0 mttt -90.41 -14.54 32.72 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.634 173.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 99' ' ' ARG . 84.2 t -81.43 -49.08 18.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 167.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -100.23 75.22 1.8 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.385 174.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.595 ' ND2' ' HA ' ' A' ' 102' ' ' LYS . 7.4 m120 -60.75 -28.57 68.81 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.5 -173.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -78.23 -6.54 55.24 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.875 0.369 . . . . 0.0 110.686 -178.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.409 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 5.0 tmmm? 64.91 109.09 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.468 0 C-N-CA 123.589 0.755 . . . . 0.0 112.444 174.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 107' ' ' LYS . 8.8 Cg_endo -88.39 178.38 2.97 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.392 2.728 . . . . 0.0 112.102 177.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 14.4 mp0 -88.73 -45.83 9.48 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.865 0.364 . . . . 0.0 110.414 176.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.4 t -124.29 133.61 68.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.748 -178.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.466 HG23 HD12 ' A' ' 100' ' ' LEU . 58.9 mt -124.15 127.14 73.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.296 176.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.611 HD21 ' HB2' ' A' ' 130' ' ' LEU . 87.4 mt -101.13 134.38 44.24 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 178.152 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.667 ' HA ' ' O ' ' A' ' 87' ' ' CYS . 24.7 p90 -144.03 142.1 30.48 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.937 0.399 . . . . 0.0 110.593 176.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -105.68 135.99 12.94 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.914 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -147.62 157.34 43.51 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.8 p -80.1 61.88 4.09 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.378 0.609 . . . . 0.0 111.084 178.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -154.81 152.6 30.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.653 -176.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -57.76 145.88 68.73 Favored Pre-proline 0 C--N 1.329 -0.307 0 O-C-N 123.574 0.546 . . . . 0.0 111.096 177.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.18 149.09 74.66 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 123.122 2.548 . . . . 0.0 112.693 -178.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -151.84 142.38 22.65 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.495 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -78.52 94.04 4.9 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 176.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.8 p -103.5 135.22 45.5 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.998 -176.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 14.1 p -150.34 121.55 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.083 0.468 . . . . 0.0 110.593 176.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.446 ' HB2' ' HE2' ' A' ' 129' ' ' PHE . 95.9 mttt -142.04 144.41 33.59 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.191 -0.458 . . . . 0.0 109.992 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 62.75 19.09 11.18 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 123.5 0.5 . . . . 0.0 111.636 179.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 86.89 -5.7 84.54 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.054 -178.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.52 HG22 HD23 ' A' ' 101' ' ' LEU . 33.0 t -97.6 129.44 47.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 120.833 0.349 . . . . 0.0 110.141 -178.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 38.1 ttm-85 -84.19 122.1 28.38 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.574 178.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.446 ' HE2' ' HB2' ' A' ' 124' ' ' LYS . 82.3 m-85 -103.43 138.97 39.44 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 175.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.611 ' HB2' HD21 ' A' ' 112' ' ' LEU . 95.7 mt -128.18 121.45 29.49 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.91 0.386 . . . . 0.0 111.069 -179.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.443 ' HB3' ' CZ ' ' A' ' 113' ' ' PHE . 8.1 p30 -121.57 117.36 30.19 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.95 176.157 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.422 ' HB2' ' HB3' ' A' ' 8' ' ' SER . 33.6 Cg_endo -96.82 147.38 0.97 Allowed 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 123.344 2.696 . . . . 0.0 112.627 176.111 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -69.51 152.97 52.24 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.207 175.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 82.8 p -70.65 175.47 4.88 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.435 0.636 . . . . 0.0 111.938 -173.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -69.77 -25.56 63.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.394 176.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.603 ' HB1' ' SD ' ' A' ' 16' ' ' MET . . . -72.99 -31.72 64.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.27 0.557 . . . . 0.0 110.336 177.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -83.34 -20.04 35.05 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.109 177.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 89.08 45.94 4.61 Favored Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.944 175.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' ' 156' ' ' THR . 26.4 t -137.0 149.03 47.23 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.841 0.353 . . . . 0.0 110.393 178.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.402 ' CD1' ' HG ' ' A' ' 157' ' ' LEU . 7.5 p90 -147.74 178.0 8.84 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 176.113 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.465 ' HB3' ' HB3' ' A' ' 6' ' ' LEU . . . -132.86 135.26 45.51 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.955 0.407 . . . . 0.0 111.18 -179.183 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 99.3 t -119.7 112.01 35.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.871 175.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.688 ' HA ' ' O ' ' A' ' 151' ' ' ARG . 0.2 OUTLIER -102.85 110.83 22.89 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.6 0.714 . . . . 0.0 110.239 175.513 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -105.18 145.0 31.2 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.687 -178.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.512 HD12 ' HB2' ' A' ' 2' ' ' LYS . 87.4 mt -90.8 90.16 7.8 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.527 0.68 . . . . 0.0 109.952 178.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -95.04 113.97 25.73 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.556 -179.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 68.48 -69.24 0.38 Allowed Glycine 0 CA--C 1.524 0.628 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.598 -175.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -172.52 25.25 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.959 -0.639 . . . . 0.0 111.749 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -124.11 133.6 53.56 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 120.811 0.339 . . . . 0.0 110.404 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.417 HG23 HD22 ' A' ' 145' ' ' LEU . 9.3 t -81.0 98.39 3.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.688 ' O ' ' HA ' ' A' ' 143' ' ' LEU . 38.8 mtp85 -101.13 106.39 17.63 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.794 0.33 . . . . 0.0 110.939 -175.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . 0.517 ' CE2' HD13 ' A' ' 143' ' ' LEU . 18.0 m-85 -83.56 105.49 14.53 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.467 178.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -96.41 112.06 23.94 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.818 0.342 . . . . 0.0 110.719 178.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -72.49 124.42 25.15 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 174.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -133.42 171.27 14.29 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -177.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 139' ' ' SER . 15.1 p -120.69 150.55 40.77 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.853 0.358 . . . . 0.0 111.729 -176.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.402 ' HG ' ' CD1' ' A' ' 140' ' ' TYR . 92.1 mt . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.447 175.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 83.9 t . . . . . 0 N--CA 1.482 1.164 0 CA-C-O 120.703 0.287 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -85.32 150.89 24.44 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 174.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.434 ' HG3' ' CD1' ' A' ' 30' ' ' TYR . 0.2 OUTLIER -145.79 132.49 19.96 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.486 0.66 . . . . 0.0 111.539 -174.137 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.743 ' HE2' HD11 ' A' ' 145' ' ' LEU . 87.0 m-85 -101.66 128.01 48.15 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.306 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.48 HD11 HD11 ' A' ' 23' ' ' ILE . 43.5 tp -91.75 108.06 19.65 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.308 177.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.594 ' HB3' ' HB3' ' A' ' 141' ' ' ALA . 51.0 tp -94.39 118.14 31.17 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.566 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 22.4 pt -101.12 115.58 43.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 174.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.8 m -54.94 -69.55 0.13 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.692 -1.14 . . . . 0.0 113.104 -169.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.567 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 26.1 t70 -153.19 105.24 2.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.867 0.365 . . . . 0.0 110.417 -175.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.867 ' H ' ' HA3' ' A' ' 37' ' ' GLY . 5.7 m -110.5 134.45 52.35 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.661 -175.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 13.0 m170 -130.76 86.77 2.41 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 173.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.474 ' O ' HG21 ' A' ' 40' ' ' VAL . 48.0 t -128.96 125.68 22.94 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.456 -175.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -78.97 -48.11 0.28 Allowed 'Cis proline' 0 CA--C 1.532 0.389 0 C-N-CA 122.904 -1.707 . . . . 0.0 112.8 -2.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.414 ' CG2' HG13 ' A' ' 40' ' ' VAL . 37.9 t 51.46 -94.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 123.53 0.732 . . . . 0.0 111.605 -178.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.435 ' HD2' ' HA ' ' A' ' 15' ' ' ARG . 17.5 tpt180 -148.43 22.81 1.04 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.535 0.684 . . . . 0.0 109.391 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.496 ' C ' ' H ' ' A' ' 18' ' ' SER . 53.5 ttp -119.63 -72.42 0.69 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.688 178.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 64.67 -12.94 0.11 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.552 0.741 . . . . 0.0 112.788 178.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.496 ' H ' ' C ' ' A' ' 16' ' ' MET . 11.9 m -83.64 58.03 4.39 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.263 0.554 . . . . 0.0 110.875 -177.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.892 ' HG ' HD13 ' A' ' 135' ' ' LEU . 6.5 tt -107.84 119.04 51.45 Favored Pre-proline 0 C--N 1.321 -0.632 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 177.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -61.1 111.04 0.97 Allowed 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.286 1.99 . . . . 0.0 111.411 176.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -71.65 -7.08 45.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.415 -174.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -56.42 -43.08 79.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.174 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.48 HD11 HD11 ' A' ' 5' ' ' LEU . 9.7 tt -70.82 -35.84 61.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.515 0.674 . . . . 0.0 110.19 -178.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.716 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 59.4 tp -63.0 -32.0 73.27 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.454 177.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -75.27 -19.39 59.74 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.704 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 64.0 m -93.11 12.21 25.03 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.152 -174.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.716 ' HG ' ' O ' ' A' ' 24' ' ' LEU . 9.9 mt -63.96 -19.1 64.9 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.979 0.419 . . . . 0.0 110.349 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -52.88 -36.06 58.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.999 176.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -94.11 3.48 55.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.332 -174.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.463 ' CD1' ' HB2' ' A' ' 5' ' ' LEU . 90.6 m-85 -118.38 106.67 12.98 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.181 0.515 . . . . 0.0 110.341 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -75.62 4.92 6.77 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.873 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.57 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -163.74 109.49 0.38 Allowed Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 175.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 90.8 t -100.08 126.52 53.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 O-C-N 122.458 -0.436 . . . . 0.0 110.119 178.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 51.4 mt -105.33 123.51 59.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 120.87 0.366 . . . . 0.0 110.158 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -114.64 103.06 1.23 Allowed Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 120.512 -0.852 . . . . 0.0 112.648 -177.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.476 HD21 ' HB3' ' A' ' 86' ' ' MET . 70.9 mt -85.3 -30.95 23.33 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 172.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.867 ' HA3' ' H ' ' A' ' 10' ' ' SER . . . -112.1 123.1 6.21 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 171.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -99.88 164.77 11.87 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.551 0.691 . . . . 0.0 112.754 -169.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.409 ' CD1' HD21 ' A' ' 48' ' ' LEU . 60.0 m-85 -85.85 127.13 34.5 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 168.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.474 HG21 ' O ' ' A' ' 12' ' ' VAL . 3.8 m -80.96 -9.5 11.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -165.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.492 ' O ' HG22 ' A' ' 45' ' ' VAL . 2.3 m-20 -86.9 125.87 34.3 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 176.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 38.9 tp -60.75 -36.0 77.79 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.369 0.604 . . . . 0.0 109.503 178.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -57.28 -44.95 84.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.227 175.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.48 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 14.9 m -71.98 -25.09 61.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.023 -177.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.492 HG22 ' O ' ' A' ' 41' ' ' ASP . 61.0 t -62.66 -42.71 97.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.075 0.464 . . . . 0.0 110.174 175.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.45 ' N ' HD13 ' A' ' 46' ' ' ILE . 1.7 mp -66.45 -36.55 77.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-O 121.263 0.554 . . . . 0.0 109.724 175.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.59 -32.97 74.6 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.455 175.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 44' ' ' THR . 89.0 mt -64.46 -43.07 95.38 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 176.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.475 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 29.6 tt0 -69.41 -14.87 63.13 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.02 178.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -85.21 -49.73 7.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.662 178.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.433 ' CB ' HD13 ' A' ' 27' ' ' LEU . 28.3 m-85 -65.29 -57.01 9.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.842 178.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.598 ' HB3' HD12 ' A' ' 27' ' ' LEU . 83.0 p -77.62 -38.65 47.55 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.709 0.29 . . . . 0.0 111.214 -175.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 53.6 mttp 69.67 7.79 6.41 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.721 -178.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 179.0 111.01 0.03 OUTLIER 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.805 174.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -136.71 152.83 50.8 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.999 0.428 . . . . 0.0 110.682 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.547 ' HE2' ' HE1' ' A' ' 4' ' ' PHE . 40.2 m-85 -118.18 113.79 22.08 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 176.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -116.53 152.51 17.87 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.198 -1.001 . . . . 0.0 112.84 -174.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.608 HG21 ' HB2' ' A' ' 86' ' ' MET . 31.0 t -128.92 113.63 29.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 175.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 14.5 t-80 -94.24 104.18 16.19 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.896 -172.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.43 ' HA3' ' O ' ' A' ' 88' ' ' HIS . . . -132.54 32.16 2.86 Favored Glycine 0 N--CA 1.444 -0.816 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 174.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -101.23 154.85 18.41 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.608 -0.796 . . . . 0.0 109.957 -178.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 94.8 mmm -90.47 39.73 0.99 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.497 -172.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.501 ' HB3' ' H ' ' A' ' 64' ' ' TYR . 8.7 m-20 -118.76 -143.81 0.37 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.702 0.287 . . . . 0.0 111.556 -178.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.501 ' H ' ' HB3' ' A' ' 63' ' ' ASP . 78.7 m-85 -69.86 127.33 92.56 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.114 0.483 . . . . 0.0 111.85 -169.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 64' ' ' TYR . 11.8 Cg_exo -71.1 -14.35 31.83 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.353 2.702 . . . . 0.0 111.995 179.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -60.86 -32.91 72.32 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.459 0.647 . . . . 0.0 110.567 178.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.432 HG12 HD22 ' A' ' 71' ' ' LEU . 47.0 t -73.09 -20.07 18.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.678 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.467 ' HE2' ' HB2' ' A' ' 73' ' ' PHE . 64.5 tttm -72.88 -12.44 60.97 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.676 -174.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -84.15 -10.01 58.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.003 0.43 . . . . 0.0 111.001 177.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 57.4 m-70 -103.36 -28.94 11.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.147 0.498 . . . . 0.0 109.861 177.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.432 HD22 HG12 ' A' ' 67' ' ' VAL . 0.3 OUTLIER -138.99 119.51 9.68 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.671 174.708 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -66.56 177.26 3.47 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 123.167 2.578 . . . . 0.0 112.938 -175.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.467 ' HB2' ' HE2' ' A' ' 68' ' ' LYS . 70.5 t80 -70.26 -29.15 65.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.141 0.496 . . . . 0.0 110.552 -177.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.489 ' HA ' HG13 ' A' ' 58' ' ' VAL . 10.2 p -147.74 142.06 26.27 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.948 178.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 32.1 tttm -142.41 141.08 32.19 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.807 -178.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.523 HG21 ' CE1' ' A' ' 104' ' ' PHE . 56.6 t -114.53 139.28 41.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.896 174.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 58.6 mt -114.45 144.22 43.67 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.17 177.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 54.9 tp -109.52 96.24 6.14 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 175.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 24.0 t -111.68 96.09 4.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.914 -173.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.41 ' OE1' ' HA2' ' A' ' 148' ' ' GLY . 42.6 mt-10 54.13 38.66 29.56 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.132 175.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 107.99 -31.57 7.83 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.343 177.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 60.2 t -81.66 115.1 23.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.005 0.431 . . . . 0.0 110.937 -177.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.07 105.64 14.22 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.071 176.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.434 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 15.8 mt -94.8 106.85 18.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.625 -177.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.496 ' HA2' HG22 ' A' ' 76' ' ' VAL . . . -93.09 110.19 3.91 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 176.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.608 ' HB2' HG21 ' A' ' 58' ' ' VAL . 43.5 mtm -107.99 129.71 55.1 Favored 'General case' 0 C--N 1.317 -0.834 0 O-C-N 122.419 -0.46 . . . . 0.0 110.822 -174.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 79.0 m -149.34 116.9 6.17 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.534 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.43 ' O ' ' HA3' ' A' ' 60' ' ' GLY . 41.8 t-80 -97.07 127.88 43.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.233 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 169.32 -125.53 1.27 Allowed Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.395 178.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 29.2 p90 -153.71 165.89 34.56 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.676 0.274 . . . . 0.0 110.488 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 171.61 148.21 6.01 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.877 177.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -76.43 155.36 83.84 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 176.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_exo -51.76 -33.56 50.68 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.67 2.247 . . . . 0.0 112.542 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -76.38 -53.97 7.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.926 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -62.68 -37.68 87.38 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.022 -176.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 30.5 tp -51.42 -60.71 2.83 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 122.705 0.402 . . . . 0.0 112.0 -171.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -60.68 -41.46 95.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.44 -176.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -73.81 -39.52 64.04 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.992 0.425 . . . . 0.0 111.325 -176.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.403 ' O ' HG21 ' A' ' 103' ' ' VAL . 74.5 ttt180 -68.36 -40.96 81.29 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.827 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.497 HD12 HG22 ' A' ' 111' ' ' ILE . 89.5 mt -70.23 -32.6 70.53 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.027 -178.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 96.8 mt -78.21 -11.55 59.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.332 0.587 . . . . 0.0 110.221 175.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -86.21 -47.54 9.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.942 173.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.403 HG21 ' O ' ' A' ' 99' ' ' ARG . 89.0 t -63.21 -46.25 96.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.087 177.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.523 ' CE1' HG21 ' A' ' 76' ' ' VAL . 25.6 m-85 -101.61 102.63 13.37 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.227 176.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -59.8 -36.06 75.97 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.584 -177.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -100.97 125.86 47.58 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 172.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.472 ' HD2' ' O ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -60.78 126.7 85.97 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.779 -173.989 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 107' ' ' LYS . 5.4 Cg_exo -75.13 150.18 37.23 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.696 2.264 . . . . 0.0 110.558 173.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -75.54 -48.9 20.44 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.338 0.59 . . . . 0.0 109.66 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 66.0 t -126.68 131.1 71.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.549 178.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.497 HG22 HD12 ' A' ' 100' ' ' LEU . 57.5 mt -114.82 134.25 58.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 120.686 0.279 . . . . 0.0 110.94 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.581 HD23 ' HB2' ' A' ' 130' ' ' LEU . 82.8 mt -105.04 118.52 36.73 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.243 177.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.414 ' CE1' ' HB3' ' A' ' 129' ' ' PHE . 16.9 p90 -133.91 127.47 32.55 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.094 0.473 . . . . 0.0 110.054 177.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -106.11 126.78 8.67 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.777 -0.725 . . . . 0.0 111.805 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 21.6 t60 -172.42 -44.42 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.27 0.557 . . . . 0.0 109.772 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.7 t -92.68 142.11 27.73 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.529 175.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 1.0 ' HA ' ' HA2' ' A' ' 133' ' ' GLY . 23.3 p-80 -97.87 4.66 49.6 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.044 0.45 . . . . 0.0 110.762 -178.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -108.19 106.41 58.54 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.441 174.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.27 127.19 13.85 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.961 2.441 . . . . 0.0 112.603 -174.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -142.27 139.87 32.04 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.361 173.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -78.28 103.91 8.52 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 175.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.504 ' HB ' ' HE2' ' A' ' 124' ' ' LYS . 60.8 p -111.91 121.42 45.0 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.597 -172.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.8 p -106.94 110.31 31.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.294 0.568 . . . . 0.0 110.244 176.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.51 ' HB2' ' CE1' ' A' ' 129' ' ' PHE . 72.5 mmtt -123.9 127.36 47.88 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.805 -178.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 65.6 13.14 8.73 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 123.465 0.478 . . . . 0.0 111.773 177.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 94.31 4.46 62.64 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.511 -178.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 43.3 t -106.44 140.26 25.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 177.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -94.0 113.41 25.39 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.86 0.362 . . . . 0.0 110.249 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.51 ' CE1' ' HB2' ' A' ' 124' ' ' LYS . 76.9 m-85 -103.03 124.69 49.0 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.259 -178.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.581 ' HB2' HD23 ' A' ' 112' ' ' LEU . 83.5 mt -108.87 130.86 55.43 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.737 176.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -122.84 111.51 31.0 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.195 -176.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -82.28 152.7 16.04 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.737 2.291 . . . . 0.0 111.568 173.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 1.0 ' HA2' ' HA ' ' A' ' 117' ' ' HIS . . . -67.49 -129.01 0.03 OUTLIER Glycine 0 CA--C 1.524 0.619 0 O-C-N 123.506 0.504 . . . . 0.0 114.138 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 7.9 m -128.44 179.61 5.55 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 122.224 -0.574 . . . . 0.0 111.159 -176.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.892 HD13 ' HG ' ' A' ' 19' ' ' LEU . 1.1 tm? -73.22 -69.3 0.43 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.7 -179.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -75.0 13.2 0.71 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.606 -171.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -107.69 6.97 28.22 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.921 0.391 . . . . 0.0 110.512 177.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 69.47 42.37 73.62 Favored Glycine 0 C--N 1.332 0.346 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.981 174.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 13.0 p -132.98 99.17 4.5 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.901 0.382 . . . . 0.0 111.272 -178.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -113.51 155.5 25.24 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 174.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.594 ' HB3' ' HB3' ' A' ' 6' ' ' LEU . . . -114.49 128.39 56.31 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.115 0.483 . . . . 0.0 111.03 -176.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 40.2 t -111.46 117.48 55.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.6 175.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.747 HD21 ' HA ' ' A' ' 152' ' ' PHE . 57.7 mt -96.67 113.64 25.22 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.077 177.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -108.04 130.55 55.07 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.735 -176.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.743 HD11 ' HE2' ' A' ' 4' ' ' PHE . 74.0 mt -99.14 116.44 31.35 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.028 -177.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.472 ' HB3' ' NH1' ' A' ' 151' ' ' ARG . 27.3 t70 -146.83 130.78 17.19 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.693 177.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.85 11.31 60.35 Favored Glycine 0 CA--C 1.521 0.445 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.974 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.41 ' HA2' ' OE1' ' A' ' 80' ' ' GLU . . . 84.12 30.89 27.16 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.318 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -126.99 135.14 50.44 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.718 0.295 . . . . 0.0 110.817 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 44.3 t -84.38 108.31 16.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 174.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.472 ' NH1' ' HB3' ' A' ' 146' ' ' ASP . 96.5 mtt180 -106.18 120.62 42.3 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.053 0.454 . . . . 0.0 111.011 -174.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . 0.747 ' HA ' HD21 ' A' ' 143' ' ' LEU . 74.0 t80 -92.62 112.89 25.0 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.216 -173.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -122.04 103.8 9.06 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.852 0.358 . . . . 0.0 110.588 173.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 20.2 tp -79.0 100.38 7.29 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 174.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -93.9 138.02 32.49 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.499 -173.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 34.9 p -94.03 150.57 20.22 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.352 -174.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 10.1 mp . . . . . 0 C--O 1.245 0.866 0 CA-C-O 118.62 -0.705 . . . . 0.0 109.49 175.725 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 59.2 t . . . . . 0 N--CA 1.479 0.999 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -133.85 155.65 49.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.576 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 89.2 mtt-85 -123.41 132.53 53.99 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.218 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -118.06 128.06 54.39 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.846 174.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.512 ' HB3' HG22 ' A' ' 33' ' ' VAL . 33.9 tp -89.57 134.23 34.22 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.789 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.453 ' HB3' ' HB2' ' A' ' 141' ' ' ALA . 50.3 tp -119.32 109.16 15.48 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.193 0.521 . . . . 0.0 111.314 -178.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.4 pt -102.24 112.39 35.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 172.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.406 ' HB2' ' H ' ' A' ' 9' ' ' ASP . 1.1 m -76.05 -90.17 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -166.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.406 ' H ' ' HB2' ' A' ' 8' ' ' SER . 24.3 t70 -108.54 110.83 22.4 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.611 -173.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.768 ' HB2' HD13 ' A' ' 135' ' ' LEU . 42.2 t -123.9 134.08 53.61 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 121.477 0.656 . . . . 0.0 110.215 178.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 26.6 m170 -125.55 38.22 4.21 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.57 HG23 HD11 ' A' ' 19' ' ' LEU . 61.3 t -94.11 138.13 22.69 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.927 -175.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.448 ' HA ' HG12 ' A' ' 12' ' ' VAL . 5.3 Cg_exo -80.27 -60.64 0.04 OUTLIER 'Cis proline' 0 C--N 1.345 0.365 0 C-N-CA 123.526 -1.447 . . . . 0.0 112.072 -3.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 26.4 t 54.16 -86.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 O-C-N 123.882 0.739 . . . . 0.0 111.462 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 29.2 ttt180 -144.73 12.74 1.48 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.163 0.506 . . . . 0.0 109.915 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 43.0 ttp -131.39 105.1 7.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.797 -176.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -97.31 13.25 30.2 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.017 0.437 . . . . 0.0 110.854 177.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.9 m -81.95 40.68 0.62 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.864 -175.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.752 ' HG ' HD11 ' A' ' 135' ' ' LEU . 3.6 tt -107.75 104.3 52.57 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 174.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -61.88 124.57 14.75 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 123.036 2.491 . . . . 0.0 112.564 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -71.93 -8.03 52.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.753 -176.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -61.04 -49.59 76.74 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.253 -177.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.452 HD13 HD13 ' A' ' 5' ' ' LEU . 6.9 tt -71.93 -31.58 41.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.714 0.769 . . . . 0.0 110.085 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.467 ' HA ' HD23 ' A' ' 27' ' ' LEU . 59.1 tp -56.9 -33.09 66.58 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.182 -1.372 . . . . 0.0 110.915 178.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -74.27 -36.45 63.82 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.676 178.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.6 m -76.53 7.75 4.19 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.875 -175.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.901 HD11 ' HB3' ' A' ' 52' ' ' SER . 1.4 mm? -53.68 -33.66 56.12 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.008 0.432 . . . . 0.0 111.579 176.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 28.2 mttp -87.21 7.51 28.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.487 -170.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -95.6 -18.94 20.16 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -176.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -105.63 156.15 18.54 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.926 0.393 . . . . 0.0 111.806 -170.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -60.96 -54.5 44.29 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.854 177.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -143.51 151.57 23.41 Favored Glycine 0 N--CA 1.44 -1.068 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.993 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.609 HG23 HD13 ' A' ' 27' ' ' LEU . 99.3 t -122.58 136.4 59.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-O 120.731 0.3 . . . . 0.0 110.216 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.559 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 45.9 mt -107.98 120.97 60.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.376 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -108.13 111.14 3.28 Favored Glycine 0 N--CA 1.442 -0.945 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 176.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.501 ' HA ' HG21 ' A' ' 58' ' ' VAL . 81.5 mt -85.91 27.59 0.87 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.903 0.382 . . . . 0.0 110.175 -178.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 117.74 81.91 0.84 Allowed Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -174.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.759 ' HA ' ' HB3' ' A' ' 10' ' ' SER . 3.2 p-10 -96.6 -95.11 0.2 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -173.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.471 ' H ' ' CG ' ' A' ' 38' ' ' ASP . 79.9 m-85 -95.4 138.17 33.45 Favored 'General case' 0 C--N 1.318 -0.792 0 O-C-N 121.897 -0.502 . . . . 0.0 110.313 -178.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.7 m -79.05 -9.88 12.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.364 0.602 . . . . 0.0 109.906 178.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.531 ' O ' HG21 ' A' ' 45' ' ' VAL . 43.0 m-20 -86.59 121.68 29.45 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.598 177.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.487 HD23 ' HB3' ' A' ' 66' ' ' ASP . 47.1 tp -57.45 -43.1 83.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.416 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -52.22 -45.02 65.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.561 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.1 m -78.55 -27.45 45.88 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.278 -175.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.531 HG21 ' O ' ' A' ' 41' ' ' ASP . 94.6 t -61.77 -44.43 98.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.174 0.511 . . . . 0.0 109.742 174.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.451 ' N ' HD13 ' A' ' 46' ' ' ILE . 1.7 mp -65.02 -36.58 78.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.7 176.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.36 -37.57 83.8 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.674 175.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 22.9 mt -73.85 -37.09 64.92 Favored 'General case' 0 CA--C 1.514 -0.426 0 C-N-CA 120.434 -0.507 . . . . 0.0 110.158 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.464 ' HA ' ' HB2' ' A' ' 55' ' ' PHE . 32.9 tt0 -63.64 -26.36 68.64 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.824 175.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -84.03 -49.65 8.73 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.513 178.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.494 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . 4.7 m-85 -54.62 -55.61 27.72 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 177.158 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.901 ' HB3' HD11 ' A' ' 27' ' ' LEU . 78.7 p -77.59 -20.25 54.3 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 52' ' ' SER . 96.5 mttt 72.97 -56.5 0.66 Allowed 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.638 0.775 . . . . 0.0 110.529 -173.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -106.63 90.55 3.36 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.859 177.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.464 ' HB2' ' HA ' ' A' ' 49' ' ' GLU . 58.4 t80 -106.04 117.03 32.97 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.476 -178.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.559 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 87.7 m-85 -108.13 108.07 18.98 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 176.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -125.15 164.51 18.7 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 119.854 -1.165 . . . . 0.0 113.508 -173.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.501 HG21 ' HA ' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -136.12 -174.42 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.115 -0.542 . . . . 0.0 109.914 175.096 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.695 ' CE1' ' HA ' ' A' ' 68' ' ' LYS . 7.0 t60 -94.12 125.52 38.8 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.619 -171.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -98.47 -53.58 1.22 Allowed Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.792 -0.718 . . . . 0.0 113.316 -174.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -110.07 -154.01 0.53 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -176.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 70.3 mtm -71.66 -43.56 65.83 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 164.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 60.45 -173.15 0.12 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 114.537 -1.211 . . . . 0.0 111.515 175.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -92.2 155.19 42.97 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.365 177.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -52.54 -31.94 51.29 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 123.285 2.656 . . . . 0.0 112.999 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.487 ' HB3' HD23 ' A' ' 42' ' ' LEU . 29.2 m-20 -66.62 -42.57 86.58 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.32 0.581 . . . . 0.0 110.371 178.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 42.8 t -72.97 -27.01 23.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.754 177.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.695 ' HA ' ' CE1' ' A' ' 59' ' ' HIS . 88.4 tttt -62.54 -28.4 69.83 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.712 177.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -94.36 -44.87 7.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.375 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -72.32 -30.7 65.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.061 -174.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 58.5 mt -117.56 103.92 50.29 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 177.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -63.65 157.0 53.92 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 123.308 2.672 . . . . 0.0 112.526 -177.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -66.85 -40.32 87.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.618 -177.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.1 m -145.43 130.13 18.05 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.217 177.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 53.7 tttp -129.66 159.56 36.05 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 12.5 t -134.34 120.41 33.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 177.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.444 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 96.1 mt -98.7 140.89 32.24 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.933 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 51.0 tp -111.62 94.97 5.22 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 173.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 46.4 t -115.26 107.05 21.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.407 -174.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 58.54 31.73 21.36 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.985 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.59 -10.66 70.74 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.582 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.4 t -88.14 125.48 41.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.939 0.4 . . . . 0.0 111.045 -178.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 50.6 p -88.19 125.27 34.53 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.269 176.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.515 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 29.2 mt -116.21 103.98 15.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -83.97 114.17 3.85 Favored Glycine 0 C--O 1.223 -0.563 0 N-CA-C 111.307 -0.717 . . . . 0.0 111.307 177.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.482 ' HE1' HG12 ' A' ' 58' ' ' VAL . 21.4 mtp -107.09 118.43 36.68 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.575 0.187 . . . . 0.0 110.897 -174.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 113' ' ' PHE . 11.6 t -148.1 165.08 31.92 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.423 ' HB3' ' O ' ' A' ' 59' ' ' HIS . 3.3 t-160 -156.16 109.51 2.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.618 0.246 . . . . 0.0 110.359 -178.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 152.18 -173.96 31.24 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.363 -0.922 . . . . 0.0 112.336 176.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 6.5 m0 66.59 -173.46 0.19 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.45 0.643 . . . . 0.0 112.168 177.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -170.85 177.63 43.78 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.673 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.472 ' HB1' ' CD1' ' A' ' 94' ' ' TRP . . . 62.59 96.3 0.05 OUTLIER Pre-proline 0 N--CA 1.464 0.262 0 CA-C-O 121.396 0.617 . . . . 0.0 110.65 -175.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.435 ' HA ' ' HB3' ' A' ' 96' ' ' LEU . 7.5 Cg_exo -73.2 7.66 2.05 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 123.375 2.717 . . . . 0.0 113.666 -172.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.472 ' CD1' ' HB1' ' A' ' 92' ' ' ALA . 52.5 m95 -59.31 -54.57 45.25 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.132 0.491 . . . . 0.0 110.544 -178.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -117.44 7.64 12.81 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.321 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.435 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . 29.5 tp -60.85 -46.72 89.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.739 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.519 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 58.7 mttp -58.49 -44.48 89.4 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.174 0.512 . . . . 0.0 110.254 179.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -70.64 -30.65 67.34 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.051 -177.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 25.8 ttm180 -71.74 -40.89 69.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.462 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.476 HD11 HG22 ' A' ' 111' ' ' ILE . 66.7 mt -67.9 -27.34 66.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.803 178.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 97' ' ' LYS . 96.6 mt -70.08 -24.29 63.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.038 0.446 . . . . 0.0 110.742 175.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -77.32 -30.61 54.15 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.9 t -76.17 -49.29 25.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.955 174.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -99.67 85.96 3.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.054 177.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -76.79 -2.56 33.8 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.919 -173.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -79.93 -13.14 59.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.357 174.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 14.7 ttpp 57.15 83.2 0.23 Allowed Pre-proline 0 C--O 1.235 0.319 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.728 -171.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.21 174.6 10.49 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.503 2.135 . . . . 0.0 112.715 -174.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -89.63 -49.06 6.88 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.524 177.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.489 HG21 HG13 ' A' ' 150' ' ' VAL . 66.7 t -121.75 131.77 72.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.718 -177.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.476 HG22 HD11 ' A' ' 100' ' ' LEU . 53.2 mt -122.81 125.12 71.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.954 0.407 . . . . 0.0 110.455 174.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 85.7 mt -101.91 115.66 31.02 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.71 177.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.494 ' CZ ' ' HB2' ' A' ' 131' ' ' ASN . 18.2 p90 -127.4 134.75 49.88 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 175.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -105.92 114.87 4.63 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 119.997 -1.097 . . . . 0.0 112.249 -177.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 53.9 t60 -145.16 105.95 4.13 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 176.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 88.0 m -52.7 113.37 1.06 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.974 -177.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 14.3 t-80 -171.25 -79.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.299 177.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.444 ' HA ' ' HD3' ' A' ' 119' ' ' PRO . 50.3 mt-10 -147.69 142.32 16.58 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.24 178.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.642 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 5.6 Cg_exo -78.05 126.72 8.04 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.706 2.27 . . . . 0.0 111.058 172.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -154.6 148.44 25.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.872 0.368 . . . . 0.0 111.299 -179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -99.66 121.28 41.0 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.723 175.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.522 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 73.3 p -129.01 149.98 50.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.839 0.352 . . . . 0.0 111.879 -173.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.6 p -147.64 149.33 15.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.077 177.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -163.23 -55.56 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.627 0.727 . . . . 0.0 110.309 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.505 ' CB ' HD12 ' A' ' 101' ' ' LEU . . . -93.83 23.58 4.72 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.316 -173.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 74.96 1.07 61.73 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 -173.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 21.9 t -106.12 139.83 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 177.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 51.6 ttt180 -96.31 110.4 22.73 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.062 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.522 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 78.1 m-85 -95.66 117.43 30.47 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.705 -178.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 78.7 mt -113.0 116.26 29.67 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.437 -176.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.642 ' O ' ' HA ' ' A' ' 119' ' ' PRO . 9.1 t30 -109.14 107.82 60.06 Favored Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 172.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -83.11 -173.38 1.66 Allowed 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 123.171 2.581 . . . . 0.0 112.817 -176.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -85.32 161.28 35.51 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.592 -178.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.418 ' HB2' ' HG2' ' A' ' 137' ' ' GLU . 18.1 m -97.37 159.72 14.75 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.703 0.287 . . . . 0.0 110.559 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.768 HD13 ' HB2' ' A' ' 10' ' ' SER . 12.3 mt -61.5 -49.35 77.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.68 -172.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -66.81 -17.08 64.7 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.419 -177.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.418 ' HG2' ' HB2' ' A' ' 134' ' ' SER . 8.2 mm-40 -86.22 -1.36 57.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.724 -178.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 70.8 29.48 69.33 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.466 177.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 22.2 t -138.28 122.01 17.54 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.022 0.439 . . . . 0.0 110.792 -177.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.556 ' CE2' HD22 ' A' ' 135' ' ' LEU . 22.6 m-85 -116.47 177.94 4.51 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.384 175.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.453 ' HB2' ' HB3' ' A' ' 6' ' ' LEU . . . -126.76 132.83 50.98 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.985 0.422 . . . . 0.0 111.198 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 58.9 t -113.54 119.13 60.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 174.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.453 ' HA ' ' O ' ' A' ' 151' ' ' ARG . 3.3 tt -95.9 116.08 28.39 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.747 ' HB2' ' HB2' ' A' ' 151' ' ' ARG . 56.6 mt-10 -100.89 139.87 35.98 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.906 -177.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 47.7 mt -110.57 90.14 3.24 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 166.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -104.93 113.2 26.66 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.293 -176.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.92 -67.51 0.32 Allowed Glycine 0 CA--C 1.52 0.348 0 O-C-N 123.527 0.517 . . . . 0.0 112.288 -174.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -174.77 25.52 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 178.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -110.41 133.81 52.92 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 -177.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.489 HG13 HG21 ' A' ' 110' ' ' VAL . 21.5 t -79.64 103.52 6.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 176.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.747 ' HB2' ' HB2' ' A' ' 144' ' ' GLU . 56.6 mtt180 -110.02 148.03 32.44 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.084 -174.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -143.01 123.3 13.8 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.556 175.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -119.02 132.27 56.04 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.846 0.355 . . . . 0.0 110.334 178.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -76.01 113.63 13.74 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.455 176.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -96.38 119.04 34.14 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.248 -177.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.4 m -93.21 147.21 23.09 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.853 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 10.2 mp . . . . . 0 C--O 1.247 0.957 0 CA-C-O 118.827 -0.606 . . . . 0.0 110.623 -177.716 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 31.4 t . . . . . 0 N--CA 1.476 0.847 0 CA-C-O 121.033 0.444 . . . . 0.0 110.081 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.429 ' HD2' HG12 ' A' ' 79' ' ' VAL . 50.0 mttp -92.03 129.61 37.95 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.084 0.469 . . . . 0.0 110.882 177.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 56.1 mtt180 -107.66 112.32 24.97 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.62 176.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.616 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 53.7 m-85 -101.79 129.49 48.0 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.442 0.639 . . . . 0.0 111.518 -175.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.517 ' HB3' HG21 ' A' ' 33' ' ' VAL . 27.3 tp -89.18 114.76 26.1 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.094 174.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.623 HD11 ' HG ' ' A' ' 36' ' ' LEU . 45.0 tp -100.4 111.9 24.2 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.93 0.395 . . . . 0.0 110.668 -177.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.449 HG13 ' HA2' ' A' ' 35' ' ' GLY . 23.9 pt -100.98 120.12 50.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 176.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.753 ' HB2' ' HA ' ' A' ' 134' ' ' SER . 13.2 m -75.87 -169.04 1.0 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.799 -172.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.764 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 11.2 t70 -59.42 98.6 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.293 -179.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.0 m -109.26 128.46 55.09 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.852 -175.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.706 ' HB3' ' HB ' ' A' ' 14' ' ' VAL . 24.3 m170 -102.26 76.0 1.54 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.421 0.629 . . . . 0.0 109.696 179.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.478 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -135.74 127.14 17.27 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.1 -179.091 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.478 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 34.9 Cg_endo -93.19 91.68 0.14 OUTLIER 'Cis proline' 0 N--CA 1.45 -1.055 0 C-N-CA 123.013 -1.661 . . . . 0.0 113.049 -2.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.706 ' HB ' ' HB3' ' A' ' 11' ' ' HIS . 3.0 t -120.27 -170.1 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 173.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 55.2 mtt180 -68.73 83.94 0.3 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 118.91 0.777 . . . . 0.0 111.099 177.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.414 ' HE3' HG13 ' A' ' 12' ' ' VAL . 39.9 ttp -165.13 -71.5 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.658 -1.155 . . . . 0.0 108.444 177.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 58.94 9.06 1.1 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.671 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.0 m -76.54 15.82 0.57 Allowed 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 112.432 0.531 . . . . 0.0 112.432 -176.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.534 HD22 ' HH ' ' A' ' 39' ' ' TYR . 5.1 tt -107.64 102.18 43.53 Favored Pre-proline 0 C--N 1.323 -0.568 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -88.92 167.22 5.73 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.905 2.403 . . . . 0.0 113.548 -175.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -60.59 -23.58 64.78 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.242 178.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -62.07 -13.26 24.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.368 -176.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 tt -102.03 -33.4 3.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.298 0.57 . . . . 0.0 109.869 174.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.628 ' HA ' HD22 ' A' ' 27' ' ' LEU . 47.1 tp -72.13 -30.78 65.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.814 -176.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -66.48 -28.9 68.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.195 0.522 . . . . 0.0 110.338 177.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.9 m -72.96 -8.28 54.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.518 -176.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.735 HD11 HG22 ' A' ' 33' ' ' VAL . 4.3 mm? -58.87 -27.69 65.41 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.012 0.434 . . . . 0.0 110.959 176.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -85.31 -7.88 58.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.848 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -98.58 -39.96 8.45 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.208 -176.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.476 ' CD2' ' HB2' ' A' ' 5' ' ' LEU . 89.0 m-85 -86.98 147.12 25.88 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -92.13 -18.31 23.71 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.886 0.374 . . . . 0.0 110.435 -179.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.616 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -135.92 143.25 14.69 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 175.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.735 HG22 HD11 ' A' ' 27' ' ' LEU . 64.3 t -136.3 137.36 48.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 117.093 0.447 . . . . 0.0 110.485 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.57 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 39.0 mt -121.91 129.24 75.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.843 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.449 ' HA2' HG13 ' A' ' 7' ' ' ILE . . . -112.07 102.26 1.35 Allowed Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.918 177.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.623 ' HG ' HD11 ' A' ' 6' ' ' LEU . 85.8 mt -80.31 -32.61 37.98 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 176.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.764 ' HA3' ' HA ' ' A' ' 9' ' ' ASP . . . -138.16 62.78 0.57 Allowed Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 175.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -70.5 -172.5 0.61 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.024 0.44 . . . . 0.0 111.476 -175.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.573 ' HD1' HD11 ' A' ' 48' ' ' LEU . 81.2 m-85 -58.76 142.18 50.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.095 -177.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.566 ' HB ' ' HB3' ' A' ' 63' ' ' ASP . 15.7 m -85.59 16.14 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.318 0.58 . . . . 0.0 110.816 -176.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.449 ' O ' HG22 ' A' ' 45' ' ' VAL . 12.5 t70 -119.94 124.81 46.9 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.463 -178.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 53.2 tp -61.34 -39.49 90.77 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.079 -174.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -61.08 -42.46 98.55 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.119 0.485 . . . . 0.0 110.588 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.504 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 16.7 m -68.6 -29.43 67.95 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.118 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.482 HG21 HG11 ' A' ' 67' ' ' VAL . 65.5 t -59.25 -43.46 89.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 121.24 0.543 . . . . 0.0 109.965 174.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.491 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 1.7 mp -63.47 -38.74 83.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.027 176.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.23 -33.59 76.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.529 175.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.573 HD11 ' HD1' ' A' ' 39' ' ' TYR . 92.7 mt -67.97 -32.35 72.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.113 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -79.21 -16.28 56.76 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.195 177.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.491 ' HG3' ' O ' ' A' ' 46' ' ' ILE . 53.9 mtpt -76.61 -54.24 6.94 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 174.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.504 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . 62.9 m-85 -65.45 -63.8 1.01 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.716 176.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.524 ' HB2' HD12 ' A' ' 27' ' ' LEU . 41.6 t -84.25 96.56 9.03 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.725 175.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 53.0 mttp -64.01 -35.04 79.43 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.192 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -105.45 75.52 1.15 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.33 0.586 . . . . 0.0 109.704 171.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -101.58 125.18 48.19 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.462 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.57 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 91.3 m-85 -121.81 143.98 49.09 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 176.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.508 ' HA3' HD12 ' A' ' 71' ' ' LEU . . . -159.22 164.83 34.07 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 119.444 -1.36 . . . . 0.0 113.506 -176.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.484 HG12 ' HE3' ' A' ' 86' ' ' MET . 2.3 m -138.0 97.75 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.344 0.592 . . . . 0.0 109.447 176.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.508 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 11.9 t60 -94.38 146.97 23.68 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.377 -167.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -87.49 -163.22 38.76 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.179 179.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.531 ' HB3' ' HD2' ' A' ' 68' ' ' LYS . 2.0 p-10 -124.65 31.72 5.63 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.956 0.407 . . . . 0.0 110.973 -177.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 2.8 mpp? -76.12 -32.25 59.07 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.286 0.565 . . . . 0.0 109.824 178.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.566 ' HB3' ' HB ' ' A' ' 40' ' ' VAL . 3.8 p-10 -104.81 -111.14 0.26 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.759 -177.004 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -104.36 135.72 19.29 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.71 0.291 . . . . 0.0 110.78 -174.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.01 -28.2 87.2 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.695 2.264 . . . . 0.0 111.902 178.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -55.77 -38.95 70.55 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.227 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.482 HG11 HG21 ' A' ' 45' ' ' VAL . 16.7 t -76.41 -33.38 23.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.531 -178.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.531 ' HD2' ' HB3' ' A' ' 61' ' ' ASN . 86.3 tttt -73.17 -25.41 60.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.107 0.48 . . . . 0.0 110.374 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -78.28 -19.73 53.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.016 0.436 . . . . 0.0 109.98 173.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 9.3 m80 -84.2 -51.4 7.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.189 176.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.508 HD12 ' HA3' ' A' ' 57' ' ' GLY . 11.3 mt -107.5 108.41 61.64 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 176.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -54.76 153.85 22.97 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.758 2.305 . . . . 0.0 112.38 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -70.46 -18.48 62.99 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.12 0.486 . . . . 0.0 110.761 -177.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 51.1 m -150.84 131.27 13.77 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.133 178.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 44.7 tttp -149.45 133.15 16.85 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.373 -178.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.492 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 19.7 t -106.43 123.69 61.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 178.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 64.6 mt -102.02 157.22 17.02 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.545 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 60.3 tp -123.43 100.73 6.97 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 175.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.429 HG12 ' HD2' ' A' ' 2' ' ' LYS . 61.6 t -113.4 102.85 14.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.663 -176.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 51.63 42.22 29.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.68 176.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.97 0.15 64.0 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.754 -0.657 . . . . 0.0 113.215 175.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 96.0 t -105.94 129.78 58.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.751 0.31 . . . . 0.0 110.972 178.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.2 p -91.47 123.87 35.21 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.701 176.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.492 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 25.2 mt -116.92 98.28 6.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.451 -176.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.409 ' O ' HG21 ' A' ' 111' ' ' ILE . . . -85.61 98.85 2.31 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.338 178.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.484 ' HE3' HG12 ' A' ' 58' ' ' VAL . 35.8 mtm -90.75 131.81 36.21 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -178.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 34.7 t -149.65 165.07 33.44 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -125.72 29.19 6.01 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -66.9 167.5 38.43 Favored Glycine 0 N--CA 1.451 -0.321 0 CA-C-N 115.341 -0.845 . . . . 0.0 113.576 -175.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 54.3 p-90 -126.27 166.01 17.91 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.814 0.34 . . . . 0.0 110.573 -177.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 127.85 170.64 12.87 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.084 -0.579 . . . . 0.0 111.949 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -89.08 164.86 29.27 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 177.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_exo -53.2 -21.12 16.09 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.995 2.463 . . . . 0.0 113.268 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 11.7 m95 -70.66 -34.05 71.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.886 0.374 . . . . 0.0 110.379 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -101.31 -27.38 13.21 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.556 -178.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 37.4 tp -50.65 -57.29 8.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.175 -173.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -62.12 -44.1 97.39 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.075 -177.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -71.9 -14.76 62.03 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.338 -177.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.405 ' O ' HG21 ' A' ' 103' ' ' VAL . 29.0 ttt85 -95.33 -49.95 5.23 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.538 -178.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.493 HD12 HG23 ' A' ' 111' ' ' ILE . 79.6 mt -70.3 -34.5 72.81 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.62 -176.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.598 HD23 HG23 ' A' ' 127' ' ' VAL . 96.2 mt -75.24 -9.89 58.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.172 0.511 . . . . 0.0 110.411 177.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -91.34 -40.17 11.62 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.854 175.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.405 HG21 ' O ' ' A' ' 99' ' ' ARG . 94.8 t -64.23 -48.12 86.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.108 175.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -87.2 122.89 31.61 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.844 176.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -75.97 -30.83 58.75 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.138 0.494 . . . . 0.0 110.158 -178.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -93.67 179.77 5.26 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.622 175.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -109.35 106.25 58.35 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-O 120.956 0.407 . . . . 0.0 110.917 -178.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -76.51 131.52 12.67 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 123.103 2.535 . . . . 0.0 111.619 178.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -67.84 -40.32 83.74 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.266 178.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.872 HG21 HG21 ' A' ' 150' ' ' VAL . 89.3 t -126.02 135.96 62.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.179 179.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.493 HG23 HD12 ' A' ' 100' ' ' LEU . 44.3 mt -125.48 125.48 68.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.894 0.378 . . . . 0.0 110.406 176.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.678 HD22 ' HB2' ' A' ' 130' ' ' LEU . 95.6 mt -104.05 127.94 51.63 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.075 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -155.6 175.64 13.64 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.613 177.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -145.53 114.72 0.78 Allowed Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.731 178.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -165.72 -57.3 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.775 0.321 . . . . 0.0 110.924 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.6 p -82.88 -23.13 33.76 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -177.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 61.97 85.42 0.12 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 122.728 0.411 . . . . 0.0 110.559 -179.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -127.14 94.69 38.39 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.215 -178.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -68.4 67.23 1.08 Allowed 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.612 2.208 . . . . 0.0 111.793 178.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -161.92 153.59 18.77 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.484 -174.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -78.13 95.01 4.8 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 170.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.529 ' HB ' ' HZ3' ' A' ' 124' ' ' LYS . 51.2 p -92.17 114.42 26.95 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.51 0.671 . . . . 0.0 110.984 -169.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.2 p -98.96 95.84 4.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-O 121.946 0.879 . . . . 0.0 110.253 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.641 ' HB2' ' CE1' ' A' ' 129' ' ' PHE . 60.8 mttp -110.81 119.01 37.71 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.517 -178.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 64.32 23.26 13.0 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.009 0.433 . . . . 0.0 111.529 178.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 94.64 -12.98 68.06 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.607 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.598 HG23 HD23 ' A' ' 101' ' ' LEU . 43.2 t -93.6 137.9 21.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.662 0.268 . . . . 0.0 110.41 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -91.79 99.44 12.32 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.239 0.542 . . . . 0.0 110.118 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.641 ' CE1' ' HB2' ' A' ' 124' ' ' LYS . 91.1 m-85 -90.83 136.46 33.05 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.156 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.678 ' HB2' HD22 ' A' ' 112' ' ' LEU . 85.4 mt -122.84 109.02 13.66 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.269 0.557 . . . . 0.0 109.849 177.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 -131.33 103.15 15.23 Favored Pre-proline 0 C--N 1.318 -0.764 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.875 177.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -91.45 -177.66 1.05 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.753 2.302 . . . . 0.0 113.906 -170.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -73.98 149.2 40.79 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 173.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.753 ' HA ' ' HB2' ' A' ' 8' ' ' SER . 22.3 m -91.89 170.47 9.84 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 120.963 0.411 . . . . 0.0 111.449 -175.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -60.41 -29.84 69.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.906 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -67.81 -22.81 65.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.022 178.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -94.52 -6.07 44.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.467 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 79.98 39.6 16.25 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.964 -0.562 . . . . 0.0 113.155 176.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 64.5 m -153.73 156.22 37.39 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.714 0.293 . . . . 0.0 110.748 178.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -144.14 168.87 19.0 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 174.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.469 ' HB3' HD21 ' A' ' 6' ' ' LEU . . . -114.58 140.86 48.44 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.045 0.45 . . . . 0.0 111.379 -174.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 40.1 t -112.21 123.75 68.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 173.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.723 HD21 HG11 ' A' ' 150' ' ' VAL . 2.6 tt -107.9 104.76 14.31 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -104.74 113.79 27.59 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.536 -178.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.433 ' O ' ' HA ' ' A' ' 1' ' ' VAL . 4.2 mp -97.1 93.55 6.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.066 0.46 . . . . 0.0 110.454 176.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.522 ' HB3' ' NH1' ' A' ' 151' ' ' ARG . 17.0 t70 -87.72 123.12 32.21 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 175.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 68.14 -62.93 0.38 Allowed Glycine 0 CA--C 1.523 0.534 0 O-C-N 123.403 0.439 . . . . 0.0 112.441 -172.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 171.24 34.5 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.534 -0.626 . . . . 0.0 111.534 177.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -121.96 140.33 52.58 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.872 HG21 HG21 ' A' ' 110' ' ' VAL . 90.6 t -80.97 115.44 23.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.595 -175.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.522 ' NH1' ' HB3' ' A' ' 146' ' ' ASP . 78.9 mtt85 -107.82 101.81 11.07 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.92 173.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -90.11 103.65 16.3 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.996 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -120.57 119.35 32.67 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.117 0.484 . . . . 0.0 110.48 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 24.8 tp -88.98 130.82 35.39 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.093 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -121.94 139.62 53.44 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.04 0.448 . . . . 0.0 110.566 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 9.5 p -84.23 162.85 20.02 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.797 -178.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 75.5 mt . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.529 -0.748 . . . . 0.0 109.865 175.571 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 72.3 t . . . . . 0 N--CA 1.482 1.157 0 CA-C-O 120.746 0.307 . . . . 0.0 111.131 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 43.9 mttm -102.3 159.46 15.39 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.353 171.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.476 ' HG2' ' HG3' ' A' ' 144' ' ' GLU . 49.9 mtm-85 -127.15 124.82 39.96 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.702 178.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.412 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 95.4 m-85 -108.18 128.04 54.35 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.226 176.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.516 ' HB3' HG21 ' A' ' 33' ' ' VAL . 48.5 tp -89.31 112.1 23.1 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.577 -176.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.465 HD12 ' HG ' ' A' ' 36' ' ' LEU . 60.4 tp -97.64 110.03 22.67 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.037 0.446 . . . . 0.0 110.518 -179.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.419 HG13 ' HA2' ' A' ' 35' ' ' GLY . 33.2 pt -101.33 134.74 40.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 176.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.6 m -77.05 -167.6 0.91 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.927 -173.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -53.92 117.19 3.0 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.264 178.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.854 ' H ' ' HA3' ' A' ' 37' ' ' GLY . 20.1 m -115.48 127.7 55.5 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.497 -178.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 62.0 m170 -116.39 44.47 1.98 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 175.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.694 HG23 ' HB2' ' A' ' 19' ' ' LEU . 56.1 t -113.12 129.78 24.21 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.871 -175.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 59.3 Cg_endo -103.13 94.43 0.12 OUTLIER 'Cis proline' 0 N--CA 1.449 -1.094 0 C-N-CA 123.574 -1.428 . . . . 0.0 112.61 -7.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.579 HG12 ' HG3' ' A' ' 15' ' ' ARG . 14.6 t -100.23 -77.82 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 175.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.579 ' HG3' HG12 ' A' ' 14' ' ' VAL . 60.6 mtt180 -130.77 15.73 5.31 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.444 ' HE1' HD11 ' A' ' 135' ' ' LEU . 37.1 ttp -143.13 130.07 20.58 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.828 -177.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -122.27 12.08 10.17 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.142 0.496 . . . . 0.0 110.372 178.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.9 m -78.73 41.22 0.41 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.978 -176.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.694 ' HB2' HG23 ' A' ' 12' ' ' VAL . 4.5 tt -107.65 106.69 59.06 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.474 ' HD2' ' HH ' ' A' ' 140' ' ' TYR . 51.4 Cg_exo -56.33 122.74 12.31 Favored 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 122.905 2.404 . . . . 0.0 112.515 178.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -73.9 -10.79 60.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.184 -176.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -55.2 -52.01 64.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.357 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.5 tt -69.4 -27.06 32.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.212 0.529 . . . . 0.0 110.446 -177.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.418 ' O ' HD23 ' A' ' 27' ' ' LEU . 52.3 tp -70.37 -16.43 62.97 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.619 178.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -89.59 -25.36 21.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.989 178.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.0 p -83.61 24.31 0.87 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.834 0.349 . . . . 0.0 111.913 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.451 ' HB3' ' HB3' ' A' ' 51' ' ' PHE . 3.0 mm? -69.58 -8.57 48.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.855 0.359 . . . . 0.0 111.493 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -98.83 -13.13 20.24 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.26 0.552 . . . . 0.0 110.284 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -92.51 -11.32 34.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.185 -175.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -109.46 161.9 14.87 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.799 0.333 . . . . 0.0 110.737 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -86.58 -50.25 6.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.408 0.623 . . . . 0.0 109.894 179.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -139.5 156.55 24.71 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.115 178.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.516 HG21 ' HB3' ' A' ' 5' ' ' LEU . 84.0 t -125.25 137.94 55.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 120.745 0.307 . . . . 0.0 110.412 -179.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.519 HG12 ' HB2' ' A' ' 56' ' ' TYR . 34.0 mt -114.59 126.3 72.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.886 177.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.419 ' HA2' HG13 ' A' ' 7' ' ' ILE . . . -112.49 107.02 1.97 Allowed Glycine 0 N--CA 1.439 -1.132 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.345 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.465 ' HG ' HD12 ' A' ' 6' ' ' LEU . 89.5 mt -73.96 -24.48 59.63 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 171.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.854 ' HA3' ' H ' ' A' ' 10' ' ' SER . . . -140.25 132.59 5.57 Favored Glycine 0 N--CA 1.438 -1.17 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 170.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.526 ' OD2' HG11 ' A' ' 67' ' ' VAL . 18.2 p-10 -112.95 -173.34 2.23 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.311 0.577 . . . . 0.0 111.429 -172.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -84.24 116.7 23.1 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 172.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.838 ' HB ' ' HD2' ' A' ' 64' ' ' TYR . 35.4 m -64.96 -5.87 2.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -168.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.446 ' O ' HG23 ' A' ' 45' ' ' VAL . 19.7 t70 -86.7 120.51 28.07 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 177.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 45.3 tp -56.73 -46.18 81.47 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -172.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -66.34 -33.98 76.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.911 0.386 . . . . 0.0 110.603 -178.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.585 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 30.5 m -67.71 -29.23 68.43 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.658 176.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 41' ' ' ASP . 74.7 t -62.95 -41.82 94.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 121.058 0.456 . . . . 0.0 110.153 175.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.414 ' N ' HD13 ' A' ' 46' ' ' ILE . 1.7 mp -65.02 -36.06 76.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.808 175.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.56 -29.8 69.28 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.776 175.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 44' ' ' THR . 92.0 mt -65.28 -34.54 78.58 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 176.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -76.24 -21.91 55.79 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.958 175.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -72.87 -35.87 67.25 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.749 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.451 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . 70.3 m-85 -81.56 -67.05 0.81 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.18 172.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 38.2 t -86.2 96.05 9.79 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.717 176.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.627 ' HD2' ' H ' ' A' ' 53' ' ' LYS . 8.7 mptt -60.18 -31.26 69.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.681 -177.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -110.62 82.85 1.66 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.419 0.628 . . . . 0.0 109.974 169.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -100.48 112.55 24.92 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.966 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.519 ' HB2' HG12 ' A' ' 34' ' ' ILE . 33.5 m-85 -96.55 133.03 41.54 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 177.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -144.76 158.44 27.58 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 119.556 -1.307 . . . . 0.0 112.972 -177.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.439 HG11 ' HE3' ' A' ' 86' ' ' MET . 0.1 OUTLIER -136.26 155.2 34.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 122.756 0.422 . . . . 0.0 109.986 175.298 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.847 ' CE1' ' HB ' ' A' ' 67' ' ' VAL . 0.2 OUTLIER -128.22 171.57 11.83 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -174.317 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 121.94 39.66 0.55 Allowed Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.796 173.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -122.04 -86.92 0.65 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 117.455 0.628 . . . . 0.0 110.992 177.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 67.8 mtt -135.69 31.68 3.06 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.416 ' HB2' ' CE1' ' A' ' 59' ' ' HIS . 1.3 p30 -93.17 -178.32 4.74 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.299 -1.318 . . . . 0.0 112.212 -171.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.838 ' HD2' ' HB ' ' A' ' 40' ' ' VAL . 80.2 m-85 -94.3 138.21 22.54 Favored Pre-proline 0 C--O 1.232 0.182 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.477 176.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 64' ' ' TYR . 21.1 Cg_exo -67.4 -9.15 24.32 Favored 'Trans proline' 0 N--CA 1.474 0.368 0 C-N-CA 123.562 2.842 . . . . 0.0 113.913 -175.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -70.97 -42.38 69.79 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.12 0.486 . . . . 0.0 110.785 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.847 ' HB ' ' CE1' ' A' ' 59' ' ' HIS . 65.4 t -68.71 -11.04 14.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.617 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.817 ' HZ3' ' HB3' ' A' ' 68' ' ' LYS . 5.1 ttpm? -56.88 -30.7 64.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.885 176.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -70.08 -17.55 63.23 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.049 0.452 . . . . 0.0 110.836 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -105.81 -50.63 3.15 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.901 -178.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.584 ' HG ' HG13 ' A' ' 67' ' ' VAL . 4.4 mt -107.98 112.01 61.87 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.397 -178.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -74.08 170.95 18.95 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.768 2.312 . . . . 0.0 111.648 178.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -74.82 -21.11 59.47 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.244 0.545 . . . . 0.0 109.83 178.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' A' ' 86' ' ' MET . 55.1 m -150.63 124.69 9.33 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.022 175.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 42.3 tttp -132.86 129.48 38.5 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.736 -179.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 17.3 t -106.35 122.92 60.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 120.961 0.41 . . . . 0.0 110.221 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.526 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 59.7 mt -99.32 152.51 19.85 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.215 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 47.0 tp -124.63 97.39 5.27 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 174.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 37.6 t -112.8 104.94 17.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.439 -175.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 54.11 43.25 30.97 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.234 178.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.81 -25.73 23.71 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.904 177.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 63.6 t -81.03 129.95 36.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.816 0.341 . . . . 0.0 111.204 -176.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 28.2 p -91.76 129.53 37.71 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.439 177.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.526 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 34.6 mt -124.09 99.22 6.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.88 0.372 . . . . 0.0 110.178 -177.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -87.59 102.05 2.76 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.405 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.529 ' HG2' HD12 ' A' ' 112' ' ' LEU . 22.8 mtm -94.96 127.08 40.74 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 113' ' ' PHE . 42.4 t -141.73 154.72 45.47 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 16.1 p80 -63.46 -26.51 68.76 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 175.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.564 ' HA3' ' HB2' ' A' ' 113' ' ' PHE . . . 57.62 59.69 10.37 Favored Glycine 0 C--N 1.335 0.487 0 CA-C-N 115.965 -0.561 . . . . 0.0 114.432 170.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 81.3 t90 -97.48 127.56 43.54 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 174.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 163.99 -177.27 39.83 Favored Glycine 0 N--CA 1.444 -0.779 0 N-CA-C 111.301 -0.719 . . . . 0.0 111.301 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.54 139.21 44.24 Favored Pre-proline 0 C--N 1.32 -0.693 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 178.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -62.63 -25.83 75.46 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.935 2.423 . . . . 0.0 113.208 -175.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -67.22 -47.2 71.53 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.947 0.404 . . . . 0.0 110.616 -175.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -101.74 9.03 41.28 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.785 -177.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 26.8 tp -60.08 -47.53 85.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.535 -173.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -63.85 -45.48 89.28 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.178 0.513 . . . . 0.0 110.365 -177.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -65.55 -36.65 84.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.909 179.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.505 ' O ' HG23 ' A' ' 103' ' ' VAL . 21.3 ttt180 -67.96 -49.25 62.85 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.254 179.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.641 HD21 HG22 ' A' ' 111' ' ' ILE . 7.6 mp -62.8 -35.45 79.92 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.544 0.202 . . . . 0.0 111.544 -176.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.754 HD22 HG21 ' A' ' 127' ' ' VAL . 84.5 mt -71.77 -16.35 62.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.026 0.441 . . . . 0.0 110.659 176.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 48.5 tttp -96.26 -17.15 20.95 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.354 178.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 99' ' ' ARG . 92.0 t -74.43 -45.86 44.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.11 0.481 . . . . 0.0 109.75 175.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -80.82 155.45 26.61 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.44 176.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -84.0 -22.49 31.35 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.245 0.545 . . . . 0.0 109.94 178.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 14.8 mp0 -105.11 -174.47 2.54 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.461 177.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 47.8 pttt -119.24 91.67 44.26 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-O 121.491 0.662 . . . . 0.0 109.504 172.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.07 154.48 67.06 Favored 'Trans proline' 0 N--CA 1.464 -0.224 0 C-N-CA 123.086 2.524 . . . . 0.0 112.63 -174.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -82.06 -46.34 14.03 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.959 177.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.7 t -116.87 133.32 63.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.903 176.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.641 HG22 HD21 ' A' ' 100' ' ' LEU . 56.0 mt -129.71 134.81 62.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.855 0.359 . . . . 0.0 110.765 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.646 HD21 ' HB2' ' A' ' 130' ' ' LEU . 86.5 mt -108.22 135.05 50.2 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.767 178.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.564 ' HB2' ' HA3' ' A' ' 89' ' ' GLY . 47.1 p90 -142.62 162.64 34.93 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.744 177.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.24 114.97 1.31 Allowed Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.331 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -169.06 -54.56 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.2 p -85.92 159.43 19.66 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.159 171.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 22.0 p-80 -123.99 21.14 9.06 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.174 0.511 . . . . 0.0 110.53 -178.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 11.2 mp0 -87.68 107.96 18.07 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.619 176.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -64.66 95.67 0.23 Allowed 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.345 2.03 . . . . 0.0 111.814 -178.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -152.32 141.83 21.7 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.361 -176.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -95.16 123.15 38.5 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 171.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.627 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 73.2 p -112.23 144.97 40.75 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.273 -171.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 14.8 p -148.93 139.74 16.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.011 177.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -158.04 -48.55 0.06 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.13 0.491 . . . . 0.0 110.603 -178.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -97.0 24.43 6.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.395 -177.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 75.02 25.46 69.01 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.749 -0.738 . . . . 0.0 111.903 -175.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.754 HG21 HD22 ' A' ' 101' ' ' LEU . 52.8 t -132.78 137.02 54.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -100.0 104.97 16.6 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.109 0.48 . . . . 0.0 110.19 -177.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.627 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 60.0 m-85 -93.92 135.54 35.15 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.789 -179.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.646 ' HB2' HD21 ' A' ' 112' ' ' LEU . 86.9 mt -118.51 137.05 53.47 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.879 0.371 . . . . 0.0 111.326 -177.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.465 ' HA ' ' HD3' ' A' ' 132' ' ' PRO . 0.1 OUTLIER -150.32 125.64 4.86 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.23 173.388 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 131' ' ' ASN . 88.1 Cg_endo -101.86 -176.71 0.13 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 123.546 2.831 . . . . 0.0 112.56 175.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -81.58 171.14 52.65 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 174.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 75.6 p -85.38 173.9 9.95 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 117.515 0.658 . . . . 0.0 111.259 -177.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.605 HD13 ' HG ' ' A' ' 19' ' ' LEU . 21.2 mt -57.35 -49.54 75.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.718 -174.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -67.83 -10.91 56.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.03 -173.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -92.39 -3.79 54.77 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.981 0.419 . . . . 0.0 110.757 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.495 ' HA2' HD11 ' A' ' 157' ' ' LEU . . . 71.67 34.0 63.15 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.417 178.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 37.4 t -126.32 121.34 32.3 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.935 0.397 . . . . 0.0 110.539 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.474 ' HH ' ' HD2' ' A' ' 20' ' ' PRO . 86.5 m-85 -125.49 159.52 31.78 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.527 174.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.454 ' HB1' HD23 ' A' ' 6' ' ' LEU . . . -121.55 140.18 52.55 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.836 0.351 . . . . 0.0 110.137 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 62.1 t -122.68 121.55 63.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 175.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.798 HD23 HG11 ' A' ' 150' ' ' VAL . 3.5 tt -94.73 105.98 17.95 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.476 ' HG3' ' HG2' ' A' ' 3' ' ' ARG . 29.8 tt0 -102.94 145.55 29.67 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.457 -178.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.506 ' O ' ' HA ' ' A' ' 1' ' ' VAL . 58.7 mt -117.23 105.97 12.78 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.975 0.416 . . . . 0.0 111.214 -177.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -118.31 130.57 56.1 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.973 175.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.51 11.01 59.0 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.169 -177.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 84.24 6.62 86.08 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.096 -177.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -97.54 158.09 15.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.825 0.345 . . . . 0.0 110.663 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.798 HG11 HD23 ' A' ' 143' ' ' LEU . 51.7 t -87.52 109.94 20.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.798 -178.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 43.8 ttt180 -107.18 113.66 27.23 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.158 0.504 . . . . 0.0 110.549 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -84.26 108.67 17.26 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.022 177.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -106.65 105.45 15.49 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 23.6 tp -83.66 109.92 17.85 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 119.951 -0.7 . . . . 0.0 110.256 -177.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -88.78 118.88 28.79 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.512 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 21.4 p -111.64 148.46 33.32 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.437 -173.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.495 HD11 ' HA2' ' A' ' 138' ' ' GLY . 74.7 mt . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.576 -0.726 . . . . 0.0 109.644 178.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 84.4 t . . . . . 0 N--CA 1.481 1.119 0 CA-C-O 120.748 0.309 . . . . 0.0 110.517 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -129.87 125.25 35.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.766 174.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.515 ' HG3' ' HA ' ' A' ' 30' ' ' TYR . 0.1 OUTLIER -124.45 129.93 51.55 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.043 -175.765 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.482 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 16.6 m-85 -119.06 132.05 56.0 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.803 -179.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 28.2 tp -89.05 122.84 32.79 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.031 178.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.521 HD11 ' HG ' ' A' ' 36' ' ' LEU . 62.4 tp -104.7 111.79 24.64 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.039 0.447 . . . . 0.0 110.461 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.9 pt -101.16 138.62 24.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.785 176.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.5 m -77.34 -178.59 5.23 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.404 -175.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -63.84 104.61 0.71 Allowed 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.466 -176.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.8 m -95.45 83.99 3.92 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.833 -175.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 28.3 m80 -75.03 76.25 2.22 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 175.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.639 HG21 HD13 ' A' ' 19' ' ' LEU . 40.7 t -125.9 128.36 24.56 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.069 -177.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -76.36 -61.58 0.05 OUTLIER 'Cis proline' 0 CA--C 1.529 0.264 0 C-N-CA 122.818 -1.742 . . . . 0.0 112.928 -1.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 53.4 t 56.81 -87.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 122.865 0.466 . . . . 0.0 111.612 179.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 81.6 mtt180 -139.8 6.63 2.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.941 0.4 . . . . 0.0 110.097 177.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 52.9 ttp -135.79 98.97 4.04 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.782 -173.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -99.66 -1.46 37.91 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.326 0.584 . . . . 0.0 110.354 177.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.0 m -82.72 58.98 4.52 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.403 -176.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.639 HD13 HG21 ' A' ' 12' ' ' VAL . 4.9 tt -107.66 109.75 62.47 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.721 ' HG2' HD12 ' A' ' 157' ' ' LEU . 31.3 Cg_exo -60.64 123.95 14.06 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 123.096 2.531 . . . . 0.0 112.585 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -62.53 -15.33 50.05 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.127 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -56.76 -33.99 67.14 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.379 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.6 tt -75.63 -32.89 25.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.374 0.606 . . . . 0.0 110.086 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.499 ' O ' HD23 ' A' ' 27' ' ' LEU . 45.7 tp -71.99 -17.37 62.06 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.292 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -91.52 -2.01 57.33 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.661 177.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 46.9 m -93.77 -0.7 55.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.662 -176.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.57 ' CD1' HG21 ' A' ' 33' ' ' VAL . 4.0 mm? -65.16 -10.34 30.3 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.0 0.429 . . . . 0.0 111.053 179.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.5 mttm -76.41 -30.86 57.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.149 -174.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -111.03 27.26 9.86 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -166.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.515 ' HA ' ' HG3' ' A' ' 3' ' ' ARG . 91.6 m-85 -136.22 152.09 50.39 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.778 178.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -79.28 -43.98 22.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.573 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -138.98 164.19 25.83 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.098 178.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.57 HG21 ' CD1' ' A' ' 27' ' ' LEU . 98.7 t -134.11 137.96 51.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.049 0.452 . . . . 0.0 110.874 -177.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.7 mt -118.43 135.63 58.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.82 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.496 ' O ' ' HA2' ' A' ' 57' ' ' GLY . . . -124.21 123.37 5.13 Favored Glycine 0 N--CA 1.44 -1.04 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.031 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.521 ' HG ' HD11 ' A' ' 6' ' ' LEU . 98.7 mt -81.52 34.63 0.38 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.188 0.518 . . . . 0.0 109.87 177.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.443 ' H ' ' C ' ' A' ' 35' ' ' GLY . . . 118.7 103.85 2.14 Favored Glycine 0 N--CA 1.44 -1.063 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 -173.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.526 ' OD2' HG11 ' A' ' 45' ' ' VAL . 6.5 p-10 -97.88 -156.25 0.53 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.863 0.332 . . . . 0.0 110.488 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -58.5 153.75 15.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.262 0.553 . . . . 0.0 111.945 -173.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 12' ' ' VAL . 21.2 m -94.84 -1.79 10.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.098 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.629 ' O ' HG23 ' A' ' 45' ' ' VAL . 16.2 t70 -93.45 120.26 33.52 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 173.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.423 HD22 ' HB3' ' A' ' 66' ' ' ASP . 38.3 tp -57.98 -42.63 85.51 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 123.426 0.453 . . . . 0.0 111.888 -170.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -62.21 -44.82 95.73 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.727 0.299 . . . . 0.0 110.53 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.7 m -67.11 -28.8 68.46 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.091 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.629 HG23 ' O ' ' A' ' 41' ' ' ASP . 61.5 t -59.63 -50.39 80.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 121.371 0.605 . . . . 0.0 110.302 175.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.506 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 1.8 mp -68.64 -34.13 63.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.837 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -58.08 -39.11 77.74 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.427 174.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.57 -42.63 70.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.148 0.499 . . . . 0.0 109.777 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.0 tt0 -56.92 -40.26 76.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.754 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.506 ' HG3' ' O ' ' A' ' 46' ' ' ILE . 94.1 mttt -63.72 -45.81 88.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.962 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.554 ' HB3' ' HG ' ' A' ' 27' ' ' LEU . 17.9 m-85 -62.78 -42.75 99.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.834 0.35 . . . . 0.0 111.388 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.507 ' HB2' ' HB2' ' A' ' 55' ' ' PHE . 15.6 m -71.28 -28.11 63.9 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.313 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 68.4 mttm 71.49 -49.52 0.68 Allowed 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.855 0.862 . . . . 0.0 110.557 -175.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -124.46 91.84 3.53 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 172.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.507 ' HB2' ' HB2' ' A' ' 52' ' ' SER . 81.8 t80 -106.33 122.19 45.74 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.881 -176.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -114.67 115.27 26.84 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.665 177.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.496 ' HA2' ' O ' ' A' ' 35' ' ' GLY . . . -121.35 160.17 15.76 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 119.975 -1.107 . . . . 0.0 113.614 -175.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.595 HG23 ' HB3' ' A' ' 86' ' ' MET . 0.1 OUTLIER -140.76 106.99 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 123.251 0.621 . . . . 0.0 110.217 173.222 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.579 ' HB2' ' HG ' ' A' ' 71' ' ' LEU . 52.7 t-80 -102.05 117.29 34.48 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.151 -173.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -107.07 -14.4 18.94 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.454 -0.879 . . . . 0.0 113.444 -175.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -76.74 156.08 32.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.756 0.312 . . . . 0.0 110.389 -179.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 82.4 mtp -108.28 81.27 1.46 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.307 0.575 . . . . 0.0 109.93 175.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -106.9 -78.3 0.59 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.72 179.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.477 ' HD1' ' HB ' ' A' ' 40' ' ' VAL . 92.3 m-85 -107.45 154.37 40.73 Favored Pre-proline 0 C--N 1.323 -0.556 0 N-CA-C 110.318 -0.252 . . . . 0.0 110.318 178.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -74.42 -38.88 1.73 Allowed 'Trans proline' 0 CA--C 1.53 0.279 0 C-N-CA 122.49 2.126 . . . . 0.0 112.799 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.423 ' HB3' HD22 ' A' ' 42' ' ' LEU . 13.0 m-20 -60.38 -45.13 94.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.217 0.532 . . . . 0.0 111.482 -175.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.426 HG22 ' HA ' ' A' ' 40' ' ' VAL . 45.3 t -65.68 -27.94 42.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.546 -174.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 46.6 mttp -64.81 -25.66 68.01 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.871 0.367 . . . . 0.0 110.933 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -85.02 -28.43 25.72 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.795 -176.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.509 ' HD1' HD22 ' A' ' 71' ' ' LEU . 58.9 t-80 -69.79 -45.04 68.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.116 0.484 . . . . 0.0 109.95 177.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.579 ' HG ' ' HB2' ' A' ' 59' ' ' HIS . 1.3 pt? -140.02 113.05 7.55 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.421 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.29 -172.74 1.24 Allowed 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 123.099 2.533 . . . . 0.0 113.209 -176.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.412 ' CZ ' ' HA3' ' A' ' 89' ' ' GLY . 59.7 t80 -75.08 -43.48 52.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.545 -173.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.0 m -136.94 140.78 42.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.967 0.413 . . . . 0.0 111.579 -177.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.0 ttpm? -160.26 132.74 6.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.529 176.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.617 HG21 ' CE1' ' A' ' 104' ' ' PHE . 43.5 t -93.77 131.75 39.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.765 0.317 . . . . 0.0 110.249 173.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 38.5 mt -108.04 152.11 24.94 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 174.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 37.2 tp -122.41 96.11 4.91 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 175.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 60.4 t -102.25 95.45 3.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.685 -175.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 55.52 32.31 18.8 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.634 0.731 . . . . 0.0 111.054 175.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 114.53 -33.59 5.31 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.565 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 85.2 t -72.38 120.09 20.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.826 0.346 . . . . 0.0 110.695 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.9 101.73 13.44 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.048 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.419 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 19.0 mt -95.08 105.27 16.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.358 -176.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.487 ' HA2' HG22 ' A' ' 76' ' ' VAL . . . -89.5 94.36 1.98 Allowed Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.783 -0.723 . . . . 0.0 111.347 178.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.595 ' HB3' HG23 ' A' ' 58' ' ' VAL . 35.8 mtm -91.21 107.77 19.43 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.844 0.354 . . . . 0.0 110.687 -176.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 37.0 t -125.53 85.44 2.4 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 175.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 79.9 t60 -84.7 89.7 7.55 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.92 -173.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.412 ' HA3' ' CZ ' ' A' ' 73' ' ' PHE . . . -148.53 172.3 28.76 Favored Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.4 176.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 75.4 t-105 -76.52 106.85 8.41 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.951 0.405 . . . . 0.0 110.525 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -130.06 152.12 19.6 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 177.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -112.06 162.86 19.38 Favored Pre-proline 0 C--N 1.319 -0.721 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.32 -12.72 21.21 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.423 2.082 . . . . 0.0 112.514 178.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 14.0 m95 -80.47 -51.7 8.5 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.275 -178.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.463 ' OD2' ' HD3' ' A' ' 99' ' ' ARG . 12.0 p-10 -94.9 -0.58 53.87 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.159 -176.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 22.5 tp -50.52 -64.84 0.68 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.128 -0.487 . . . . 0.0 112.199 -174.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.488 ' HD2' ' HB2' ' A' ' 125' ' ' ALA . 42.5 mtmt -61.73 -54.37 43.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.365 0.602 . . . . 0.0 110.727 -176.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -61.08 -45.96 92.58 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.818 -1.083 . . . . 0.0 112.28 -171.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.463 ' HD3' ' OD2' ' A' ' 95' ' ' ASP . 34.0 ttt180 -79.37 -46.22 18.04 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.967 -173.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.444 HD13 HG23 ' A' ' 111' ' ' ILE . 47.3 mt -66.09 -29.45 69.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.687 0.279 . . . . 0.0 111.519 -176.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.59 HD22 ' HE3' ' A' ' 107' ' ' LYS . 86.0 mt -78.98 -13.28 59.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.687 0.28 . . . . 0.0 111.149 177.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -84.52 -31.74 24.29 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.83 0.348 . . . . 0.0 110.268 173.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.3 t -63.58 -49.72 81.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.254 177.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.617 ' CE1' HG21 ' A' ' 76' ' ' VAL . 20.3 m-85 -105.68 116.01 31.22 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.551 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -72.87 -29.16 62.96 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 170.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -76.48 97.63 4.37 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.853 171.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.59 ' HE3' HD22 ' A' ' 101' ' ' LEU . 13.0 mptt -63.24 113.93 11.11 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-O 120.996 0.426 . . . . 0.0 110.975 -178.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 107' ' ' LYS . 1.0 OUTLIER -85.32 158.86 11.13 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.581 2.854 . . . . 0.0 112.642 -175.944 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -79.38 -53.24 7.11 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.032 177.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 74.8 t -120.42 128.6 76.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.865 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.462 HD11 ' CE2' ' A' ' 129' ' ' PHE . 48.6 mt -114.65 129.21 71.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.083 0.468 . . . . 0.0 110.797 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.43 HD23 ' HB2' ' A' ' 130' ' ' LEU . 81.4 mt -102.31 120.53 40.64 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.03 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -132.38 -169.61 2.26 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 -178.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -137.03 126.79 3.81 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.634 -0.794 . . . . 0.0 112.645 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 20.4 t60 -167.62 -71.86 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.183 0.516 . . . . 0.0 110.143 176.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.427 HG23 ' H ' ' A' ' 118' ' ' GLU . 6.6 m -83.05 143.2 30.76 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.118 -177.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.423 ' HB3' ' OE1' ' A' ' 137' ' ' GLU . 61.6 m-70 -90.31 -21.46 22.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.304 0.573 . . . . 0.0 110.168 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.429 ' HA ' ' HD3' ' A' ' 119' ' ' PRO . 48.6 mt-10 -87.01 121.0 71.78 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.169 173.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.729 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 23.5 Cg_exo -61.76 101.25 0.21 Allowed 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.704 2.269 . . . . 0.0 112.399 -175.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -111.41 127.34 55.64 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.851 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -79.84 103.23 9.59 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 174.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.604 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 38.5 p -99.5 113.81 26.4 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.248 -176.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 6.9 p -109.7 97.71 6.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-O 122.168 0.985 . . . . 0.0 109.686 177.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.469 ' HB3' ' HD3' ' A' ' 97' ' ' LYS . 58.5 mttp -129.61 137.37 50.65 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.581 -176.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.488 ' HB2' ' HD2' ' A' ' 97' ' ' LYS . . . 64.96 13.38 8.59 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 123.616 0.572 . . . . 0.0 110.917 -176.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 89.74 -9.59 76.63 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.294 -178.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 38.8 t -93.04 141.34 14.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 14.8 ttt180 -100.54 102.16 13.26 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.25 0.548 . . . . 0.0 110.428 -177.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.604 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 18.2 m-85 -92.09 142.86 27.04 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.235 178.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.43 ' HB2' HD23 ' A' ' 112' ' ' LEU . 86.1 mt -124.4 136.45 54.07 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.925 0.393 . . . . 0.0 110.917 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.729 ' O ' ' HA ' ' A' ' 119' ' ' PRO . 4.1 p30 -130.01 103.8 16.99 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.844 176.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -94.37 154.85 2.05 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.002 2.468 . . . . 0.0 113.297 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -71.93 159.06 53.65 Favored Glycine 0 N--CA 1.452 -0.289 0 N-CA-C 111.409 -0.676 . . . . 0.0 111.409 175.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 13.4 t -83.54 176.3 9.14 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 117.304 0.552 . . . . 0.0 111.251 -175.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 20.7 mt -70.81 -34.82 72.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.003 -170.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -77.03 -7.14 55.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.145 0.498 . . . . 0.0 110.69 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.423 ' OE1' ' HB3' ' A' ' 117' ' ' HIS . 42.2 mt-10 -92.6 1.12 57.43 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.003 176.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 73.34 39.6 50.99 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.678 -0.692 . . . . 0.0 113.08 174.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 50.2 m -150.08 144.29 25.65 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.763 0.316 . . . . 0.0 110.678 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -143.95 166.16 25.74 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.591 176.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -114.47 134.89 54.67 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.258 0.551 . . . . 0.0 111.411 -175.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 152' ' ' PHE . 89.4 t -116.47 121.43 67.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.572 175.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 5.2 tt -110.61 107.35 16.92 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -104.87 142.45 34.72 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.961 176.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.0 mp -90.74 94.28 9.61 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.218 0.532 . . . . 0.0 109.689 172.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -87.19 113.38 22.87 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.4 -178.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 68.35 -62.96 0.41 Allowed Glycine 0 CA--C 1.52 0.36 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.562 -169.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 179.38 27.77 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 175.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -127.1 160.53 30.89 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -175.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 47.6 t -77.76 108.88 11.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.844 0.354 . . . . 0.0 111.426 -176.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 151' ' ' ARG . 15.2 ttm180 -107.7 96.07 6.13 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 173.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . 0.424 ' HA ' ' O ' ' A' ' 142' ' ' VAL . 40.1 p90 -102.41 127.53 49.4 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.928 -178.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -120.32 140.72 50.84 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.849 176.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -100.58 97.54 8.22 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.519 176.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -92.28 140.86 29.18 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.088 -177.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 18.1 p -89.62 155.58 19.15 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.617 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.721 HD12 ' HG2' ' A' ' 20' ' ' PRO . 83.0 mt . . . . . 0 C--O 1.247 0.952 0 CA-C-O 118.334 -0.841 . . . . 0.0 109.865 177.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 86.5 t . . . . . 0 N--CA 1.479 1.023 0 CA-C-O 120.835 0.35 . . . . 0.0 110.443 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -129.56 146.88 51.33 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.293 177.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.548 ' HG2' ' HG2' ' A' ' 144' ' ' GLU . 79.5 mtt180 -104.92 111.28 23.98 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.629 172.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.547 ' HE2' HG12 ' A' ' 79' ' ' VAL . 70.4 m-85 -101.59 129.73 47.76 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.028 0.442 . . . . 0.0 111.036 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.53 ' HB3' HG21 ' A' ' 33' ' ' VAL . 36.8 tp -89.57 112.25 23.4 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.611 176.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.411 ' HB3' ' HB1' ' A' ' 141' ' ' ALA . 51.5 tp -96.76 102.23 13.98 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.116 0.484 . . . . 0.0 110.045 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.474 HG13 ' HA2' ' A' ' 35' ' ' GLY . 11.5 pt -101.47 126.29 55.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.493 176.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.578 ' HB3' ' OG1' ' A' ' 116' ' ' THR . 14.0 m -68.62 179.65 1.66 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.028 -176.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -78.4 79.82 4.82 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 122.053 0.93 . . . . 0.0 110.811 -177.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.573 ' HG ' ' CG ' ' A' ' 38' ' ' ASP . 10.6 p -80.53 133.87 35.87 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 176.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 74.3 m-70 -99.57 80.09 2.34 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.363 0.602 . . . . 0.0 109.617 -177.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.467 ' HB ' ' HD1' ' A' ' 39' ' ' TYR . 38.6 t -114.87 137.62 22.93 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.617 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -82.79 -58.71 0.07 OUTLIER 'Cis proline' 0 N--CA 1.461 -0.4 0 C-N-CA 123.666 -1.389 . . . . 0.0 112.887 -2.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER 35.05 -96.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -173.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 40.9 mtm180 -127.33 20.66 6.76 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 15.6 tmm? -144.16 100.25 3.52 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.246 0.546 . . . . 0.0 109.987 173.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -110.08 16.02 22.11 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.825 176.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 27.9 p -84.67 39.33 0.74 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.078 -177.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.424 HD23 ' HH ' ' A' ' 39' ' ' TYR . 9.0 tt -97.16 119.92 62.26 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.547 ' HG3' HD12 ' A' ' 157' ' ' LEU . 26.9 Cg_endo -61.66 130.39 31.31 Favored 'Trans proline' 0 C--O 1.234 0.291 0 C-N-CA 123.092 2.528 . . . . 0.0 112.552 -178.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -63.44 -18.57 63.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.885 -179.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -52.62 -49.26 65.47 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.769 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.0 tt -70.38 -36.32 66.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.345 0.593 . . . . 0.0 110.34 -176.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.677 HD12 HD23 ' A' ' 27' ' ' LEU . 58.3 tp -69.81 -33.79 72.82 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.131 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -71.09 -36.61 72.27 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.327 178.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 75.6 m -80.69 7.53 10.02 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.752 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.677 HD23 HD12 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -50.56 -41.48 54.2 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.592 0.71 . . . . 0.0 110.724 176.896 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 71.3 mttt -90.99 11.15 23.83 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.173 -171.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -104.28 7.94 35.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.038 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -126.02 158.77 34.48 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.4 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -72.0 -53.19 13.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.176 0.512 . . . . 0.0 109.968 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.532 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -138.12 151.96 21.64 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.194 179.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.53 HG21 ' HB3' ' A' ' 5' ' ' LEU . 97.8 t -118.96 135.89 57.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-O 120.703 0.287 . . . . 0.0 110.482 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.424 HG12 ' HB2' ' A' ' 56' ' ' TYR . 37.0 mt -111.56 116.62 53.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.854 176.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.474 ' HA2' HG13 ' A' ' 7' ' ' ILE . . . -104.25 119.66 6.36 Favored Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 177.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 94.3 mt -92.81 24.07 3.82 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.122 0.487 . . . . 0.0 110.552 -179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 121.55 21.91 2.9 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.828 -178.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.573 ' CG ' ' HG ' ' A' ' 10' ' ' SER . 10.9 t70 -81.14 134.03 35.57 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.611 ' HD2' HD13 ' A' ' 48' ' ' LEU . 25.7 m-85 64.6 105.73 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 O-C-N 123.872 0.732 . . . . 0.0 110.924 -175.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.412 HG22 ' O ' ' A' ' 12' ' ' VAL . 35.9 m -86.77 0.22 6.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.332 -176.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.539 ' O ' HG21 ' A' ' 45' ' ' VAL . 16.0 t70 -86.65 135.93 33.22 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.792 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 54.3 tp -62.7 -49.49 74.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.702 -175.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -63.1 -35.31 79.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.823 0.344 . . . . 0.0 110.752 -177.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.437 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 14.1 m -68.6 -33.06 73.4 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.21 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.539 HG21 ' O ' ' A' ' 41' ' ' ASP . 93.4 t -60.2 -46.12 95.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.369 0.604 . . . . 0.0 109.888 175.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.471 HD12 ' N ' ' A' ' 46' ' ' ILE . 1.7 mp -66.23 -38.0 80.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.89 177.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.24 -33.8 72.79 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.801 176.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.611 HD13 ' HD2' ' A' ' 39' ' ' TYR . 83.3 mt -66.95 -38.13 85.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.26 0.552 . . . . 0.0 109.996 178.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.677 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 35.8 tt0 -77.23 -11.39 59.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.331 176.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -92.5 -36.4 13.09 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.643 0.259 . . . . 0.0 110.945 -178.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.469 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . 6.4 m-30 -65.69 -67.37 0.45 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.4 178.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.5 ' OG ' HD12 ' A' ' 27' ' ' LEU . 5.1 m -73.49 -23.66 60.08 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.53 177.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.677 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 60.7 mttp 70.51 4.01 4.75 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.382 0.673 . . . . 0.0 111.785 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -144.83 105.07 4.07 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 172.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -128.89 133.23 47.85 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.189 0.519 . . . . 0.0 111.242 -173.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.424 ' HB2' HG12 ' A' ' 34' ' ' ILE . 88.1 m-85 -113.7 118.92 35.68 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 173.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -131.12 132.2 6.72 Favored Glycine 0 N--CA 1.44 -1.081 0 C-N-CA 119.606 -1.283 . . . . 0.0 113.925 -171.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.5 m -130.92 147.84 33.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 168.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.543 ' HB3' ' HB2' ' A' ' 71' ' ' LEU . 2.9 p80 -94.34 142.5 27.34 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 119.489 -0.884 . . . . 0.0 110.666 -173.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -81.29 -107.29 0.34 Allowed Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 115.618 -0.719 . . . . 0.0 113.538 -172.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.87 HD22 ' HA ' ' A' ' 115' ' ' HIS . 43.0 m-80 -95.62 -83.95 0.35 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.785 0.326 . . . . 0.0 111.264 -173.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 51.4 ttm -112.74 122.98 49.26 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.232 0.539 . . . . 0.0 110.682 -178.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -145.89 -174.25 4.37 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.288 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -74.88 144.51 79.88 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-O 120.673 0.273 . . . . 0.0 111.372 -176.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -47.06 -38.29 24.14 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.843 3.029 . . . . 0.0 114.161 -175.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -70.11 -46.54 64.61 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.214 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 39.9 t -63.66 -32.6 57.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.594 -177.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.413 ' HE2' ' HB3' ' A' ' 68' ' ' LYS . 31.8 ttpt -50.12 -40.36 45.8 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.809 177.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -104.12 -14.61 15.82 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.121 0.486 . . . . 0.0 110.136 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -75.44 -40.21 57.86 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -179.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.543 ' HB2' ' HB3' ' A' ' 59' ' ' HIS . 80.8 mt -102.64 117.94 59.67 Favored Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 170.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -56.44 156.2 22.66 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 123.129 2.553 . . . . 0.0 113.504 -174.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -77.11 -16.92 59.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.519 177.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.7 p -157.89 139.37 13.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.099 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.2 mttm -144.43 142.49 30.34 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.524 176.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 21.7 t -121.39 110.54 28.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.159 0.504 . . . . 0.0 109.913 172.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 37.3 mt -92.95 147.99 22.38 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.401 -177.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 55.1 tp -117.83 98.01 6.13 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 175.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.547 HG12 ' HE2' ' A' ' 4' ' ' PHE . 48.5 t -105.49 96.26 4.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.629 -174.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 57.31 27.62 14.01 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.624 175.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 114.35 -24.22 11.64 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.542 178.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.5 t -83.04 128.44 38.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.567 0.222 . . . . 0.0 110.809 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 40.0 p -91.48 131.24 37.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.538 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 42.0 mt -124.51 104.72 14.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.883 0.373 . . . . 0.0 110.215 -178.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -91.71 104.8 3.21 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.877 -0.677 . . . . 0.0 111.447 178.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 22.1 mtm -103.95 118.11 35.9 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -178.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 113' ' ' PHE . 46.0 t -156.96 158.29 36.34 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.925 0.393 . . . . 0.0 110.717 -177.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 15.0 t60 -65.64 -32.81 74.58 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.259 175.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.29 -94.88 0.57 Allowed Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 -173.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.428 ' HE3' ' H ' ' A' ' 92' ' ' ALA . 17.0 t90 -173.71 -69.24 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 172.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 155.14 -34.47 0.66 Allowed Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.994 -0.622 . . . . 0.0 111.77 -178.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 96' ' ' LEU . . . -78.61 115.1 49.03 Favored Pre-proline 0 C--N 1.327 -0.397 0 N-CA-C 110.487 -0.19 . . . . 0.0 110.487 178.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -81.22 5.18 6.42 Favored 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 123.427 2.752 . . . . 0.0 113.149 -175.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -80.74 -54.67 5.42 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.267 0.556 . . . . 0.0 109.942 -176.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 38.3 p30 -112.04 19.27 18.0 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.943 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.449 ' HB2' ' O ' ' A' ' 92' ' ' ALA . 50.8 tp -54.47 -51.13 66.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.478 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -60.53 -45.38 94.07 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.926 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -61.37 -47.12 87.31 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.157 0.503 . . . . 0.0 110.844 -177.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.538 ' O ' HG23 ' A' ' 103' ' ' VAL . 36.3 ttm105 -67.0 -42.15 85.49 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.56 178.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.932 HD22 HG21 ' A' ' 111' ' ' ILE . 17.1 tp -67.57 -41.8 83.59 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.134 -176.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.425 HD21 HG22 ' A' ' 127' ' ' VAL . 93.7 mt -75.8 -5.74 47.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.528 178.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -95.38 -29.94 14.17 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.962 174.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 99' ' ' ARG . 94.8 t -62.68 -53.0 52.68 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 174.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -82.52 146.49 29.2 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 174.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -87.59 -27.11 22.74 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.897 0.38 . . . . 0.0 110.755 -177.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -113.64 177.65 4.56 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.532 177.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.825 ' HD2' ' H ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -95.91 113.27 61.77 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.08 -175.133 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.47 ' HG2' HD11 ' A' ' 111' ' ' ILE . 1.2 Cg_endo -85.37 156.08 10.84 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.375 2.717 . . . . 0.0 111.854 177.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -90.7 -59.49 2.16 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.95 0.405 . . . . 0.0 110.771 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.626 HG21 HG22 ' A' ' 150' ' ' VAL . 57.3 t -105.15 119.54 54.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.331 -178.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.932 HG21 HD22 ' A' ' 100' ' ' LEU . 55.4 mt -116.46 128.69 73.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.079 0.466 . . . . 0.0 111.202 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.653 HD22 ' HB2' ' A' ' 130' ' ' LEU . 86.9 mt -107.61 124.72 50.37 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.011 176.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.496 ' HA ' ' O ' ' A' ' 87' ' ' CYS . 40.7 p90 -117.15 172.66 7.14 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 119.636 -0.825 . . . . 0.0 111.07 178.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -105.8 -165.18 23.32 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.442 -172.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.87 ' HA ' HD22 ' A' ' 61' ' ' ASN . 18.0 t60 69.06 41.73 1.37 Allowed 'General case' 0 C--O 1.233 0.191 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -173.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.578 ' OG1' ' HB3' ' A' ' 8' ' ' SER . 36.5 p -63.51 119.33 9.58 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 114.263 -1.335 . . . . 0.0 112.113 -171.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.432 ' HA ' ' OE2' ' A' ' 137' ' ' GLU . 0.0 OUTLIER -171.87 128.42 0.62 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.886 179.269 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 59.26 84.67 0.2 Allowed Pre-proline 0 N--CA 1.465 0.287 0 O-C-N 123.543 0.527 . . . . 0.0 110.791 -175.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -61.13 143.35 98.78 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 123.075 2.517 . . . . 0.0 113.014 -175.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -162.13 146.15 12.22 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.924 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -94.12 114.35 26.48 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.586 175.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.468 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 67.5 p -119.82 144.16 47.48 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.694 0.283 . . . . 0.0 111.405 -176.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.7 p -138.8 124.3 22.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.127 0.489 . . . . 0.0 110.976 178.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.485 ' HB2' ' HE2' ' A' ' 129' ' ' PHE . 88.1 mttt -140.9 139.42 34.35 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.536 176.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 66.94 14.04 9.68 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 123.485 0.491 . . . . 0.0 111.626 177.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 90.18 -2.82 81.87 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.234 -177.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.425 HG22 HD21 ' A' ' 101' ' ' LEU . 33.1 t -100.34 137.9 26.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -98.23 120.12 38.09 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.66 -176.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.485 ' HE2' ' HB2' ' A' ' 124' ' ' LYS . 34.9 m-85 -108.48 121.15 44.37 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.805 -178.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.653 ' HB2' HD22 ' A' ' 112' ' ' LEU . 78.1 mt -107.88 138.76 43.56 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-O 121.459 0.647 . . . . 0.0 111.146 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.457 ' HB3' ' CZ ' ' A' ' 113' ' ' PHE . 7.4 p30 -139.39 116.16 8.49 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.355 173.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.522 ' HD2' HG22 ' A' ' 116' ' ' THR . 86.2 Cg_endo -88.17 168.62 6.43 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.712 2.275 . . . . 0.0 112.502 178.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -85.28 147.77 22.62 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 176.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.563 ' HA ' ' HB2' ' A' ' 8' ' ' SER . 81.1 p -75.56 168.76 19.4 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.087 0.47 . . . . 0.0 111.077 -176.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.503 HD23 ' HB3' ' A' ' 10' ' ' SER . 4.2 mm? -64.82 -24.16 67.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.068 178.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -75.56 -14.36 60.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.036 0.446 . . . . 0.0 110.676 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.432 ' OE2' ' HA ' ' A' ' 117' ' ' HIS . 33.1 mt-10 -98.39 -2.23 39.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.192 178.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.501 ' HA2' HD13 ' A' ' 157' ' ' LEU . . . 70.78 45.45 52.17 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.925 177.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.6 p -150.81 153.92 36.32 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.597 0.199 . . . . 0.0 110.753 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -154.25 159.59 41.37 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 175.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.411 ' HB1' ' HB3' ' A' ' 6' ' ' LEU . . . -114.6 131.21 56.77 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.826 0.346 . . . . 0.0 111.384 -175.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 61.9 t -108.53 107.78 23.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 173.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 152' ' ' PHE . 6.7 tt -96.97 105.14 17.23 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.196 0.522 . . . . 0.0 110.106 -176.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.548 ' HG2' ' HG2' ' A' ' 3' ' ' ARG . 34.1 mt-10 -100.19 149.75 23.23 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.583 176.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.9 mp -90.49 90.12 7.87 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 166.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -101.23 112.48 24.98 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.732 -170.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.75 10.97 59.49 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.067 -174.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 91.65 5.07 67.1 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.238 -0.506 . . . . 0.0 112.086 -178.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -108.63 161.83 14.72 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 176.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.626 HG22 HG21 ' A' ' 110' ' ' VAL . 50.0 t -81.49 101.61 6.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.08 0.467 . . . . 0.0 110.593 -176.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 31.0 tpt180 -103.57 87.49 2.85 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.077 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . 0.494 ' HA ' ' HA ' ' A' ' 143' ' ' LEU . 12.0 p90 -91.37 101.5 14.18 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.295 0.569 . . . . 0.0 110.02 177.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -91.06 101.49 14.25 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.359 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 48.2 tp -75.62 99.93 4.46 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 175.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -93.94 133.82 36.97 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.912 -177.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.6 m -98.42 150.33 21.74 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.407 -175.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.547 HD12 ' HG3' ' A' ' 20' ' ' PRO . 83.1 mt . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.37 -0.824 . . . . 0.0 109.897 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 50.2 t . . . . . 0 N--CA 1.479 1.017 0 CA-C-O 120.766 0.317 . . . . 0.0 110.853 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -122.23 149.5 43.59 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 171.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 52.8 mtp180 -106.51 116.57 32.16 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.09 178.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.522 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 73.1 m-85 -105.51 124.06 48.92 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.113 0.482 . . . . 0.0 111.487 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.504 ' HB3' HG21 ' A' ' 33' ' ' VAL . 37.9 tp -89.18 121.35 31.4 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.86 177.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.468 ' HB3' ' HB3' ' A' ' 141' ' ' ALA . 45.0 tp -110.95 106.46 15.57 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.181 0.515 . . . . 0.0 111.207 -177.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 19.7 pt -101.35 129.96 51.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.192 173.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.519 ' H ' HD22 ' A' ' 135' ' ' LEU . 9.1 p -85.27 -177.8 6.59 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.978 0.418 . . . . 0.0 111.954 -173.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.64 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.2 m-20 -65.39 104.22 0.94 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.31 -177.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.632 ' HB3' HD11 ' A' ' 135' ' ' LEU . 10.5 p -104.07 175.38 5.5 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 177.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -135.05 75.42 1.57 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.345 0.593 . . . . 0.0 110.098 176.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.411 ' O ' HG22 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -135.13 147.56 62.96 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.542 178.522 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -87.53 104.0 0.47 Allowed 'Cis proline' 0 N--CA 1.46 -0.463 0 C-N-CA 123.322 -1.532 . . . . 0.0 112.374 -2.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.3 t -135.34 -133.59 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -178.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 22.0 ttm-85 -87.73 4.22 45.04 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.096 0.474 . . . . 0.0 110.812 -177.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.518 ' HE1' ' HB2' ' A' ' 10' ' ' SER . 30.3 ttp -84.86 -76.23 0.32 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 62.72 2.93 1.03 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.222 0.609 . . . . 0.0 112.41 178.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.54 ' HG ' ' HB3' ' A' ' 136' ' ' ALA . 12.9 p -95.39 38.42 1.15 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.955 0.407 . . . . 0.0 111.519 -177.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.2 tt -107.84 111.11 62.51 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 177.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -70.57 141.24 41.48 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 122.734 2.289 . . . . 0.0 113.012 -177.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -63.8 -19.76 65.25 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.379 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -52.8 -42.66 65.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.898 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -68.66 -32.21 54.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.121 0.486 . . . . 0.0 110.514 -177.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.436 ' O ' HD23 ' A' ' 27' ' ' LEU . 58.3 tp -76.87 -31.97 57.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.412 -176.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -76.49 -23.47 53.76 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.555 178.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.9 m -78.49 0.85 24.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.766 -177.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.501 HD13 HG22 ' A' ' 33' ' ' VAL . 2.0 mm? -56.6 -28.98 61.6 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.884 0.373 . . . . 0.0 111.726 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 42.5 mttp -85.14 0.44 51.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.535 -174.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -113.12 17.49 18.7 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -171.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -137.45 168.43 19.66 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.672 0.272 . . . . 0.0 110.71 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -91.28 -52.75 4.66 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-O 121.512 0.672 . . . . 0.0 110.0 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -129.38 137.63 9.7 Favored Glycine 0 N--CA 1.441 -0.982 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.292 179.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.504 HG21 ' HB3' ' A' ' 5' ' ' LEU . 79.8 t -113.42 129.53 69.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.6 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 38.9 mt -105.99 122.74 59.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.527 -179.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -104.21 103.97 2.36 Favored Glycine 0 N--CA 1.44 -1.071 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.265 177.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.488 ' HB3' ' HE1' ' A' ' 88' ' ' HIS . 81.8 mt -80.42 -30.67 37.67 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 175.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.64 ' HA3' ' HA ' ' A' ' 9' ' ' ASP . . . -166.42 56.49 0.24 Allowed Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 177.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -57.61 -73.34 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.182 -0.509 . . . . 0.0 112.274 -171.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.51 ' CD1' HD13 ' A' ' 48' ' ' LEU . 78.5 m-85 -135.91 156.43 48.77 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.927 0.394 . . . . 0.0 110.686 178.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.411 HG22 ' O ' ' A' ' 12' ' ' VAL . 22.6 m -92.58 -3.02 10.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.335 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.584 ' O ' HG21 ' A' ' 45' ' ' VAL . 23.5 t70 -100.64 129.51 46.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.675 -178.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.503 HD23 ' HB3' ' A' ' 66' ' ' ASP . 51.0 tp -57.47 -52.14 66.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.456 . . . . 0.0 112.056 -174.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -68.29 -32.07 71.96 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.796 0.331 . . . . 0.0 110.948 -172.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.3 m -70.68 -33.16 70.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.916 178.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.584 HG21 ' O ' ' A' ' 41' ' ' ASP . 87.4 t -61.97 -44.21 98.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 121.357 0.598 . . . . 0.0 110.067 175.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.448 ' N ' HD13 ' A' ' 46' ' ' ILE . 1.7 mp -71.19 -31.79 45.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.269 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -58.65 -37.51 76.11 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 174.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.51 HD13 ' CD1' ' A' ' 39' ' ' TYR . 85.1 mt -69.68 -37.58 76.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.211 177.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -71.33 -12.6 61.52 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.663 -177.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -79.76 -47.58 15.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.836 0.351 . . . . 0.0 110.499 173.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.496 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . 76.0 m-85 -75.82 -42.71 49.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.949 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.2 t -71.17 104.69 3.15 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.004 175.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -49.77 -43.74 48.39 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.645 177.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -130.08 104.24 7.22 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.577 175.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -100.3 121.76 42.01 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.313 -176.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.6 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 91.9 m-85 -114.82 108.0 16.17 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -126.12 151.21 17.82 Favored Glycine 0 N--CA 1.442 -0.959 0 C-N-CA 119.872 -1.156 . . . . 0.0 112.734 -175.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.472 HG11 ' HE2' ' A' ' 86' ' ' MET . 0.9 OUTLIER -127.69 172.77 14.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 173.028 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.447 ' HB2' ' O ' ' A' ' 71' ' ' LEU . 10.7 t-80 -94.3 118.79 32.12 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.522 -172.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -82.51 -148.25 7.15 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.691 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -118.04 120.91 39.22 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.578 0.228 . . . . 0.0 111.512 -176.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 84.4 mtp 73.84 95.78 0.07 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.797 176.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.402 ' OD2' ' HB ' ' A' ' 67' ' ' VAL . 8.4 p-10 -160.4 -173.99 4.27 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.531 -177.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.401 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 15.1 m-30 -77.83 140.99 63.39 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.722 0.296 . . . . 0.0 111.01 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.411 ' O ' ' HB3' ' A' ' 68' ' ' LYS . 51.0 Cg_exo -57.46 -16.0 21.8 Favored 'Trans proline' 0 N--CA 1.474 0.37 0 C-N-CA 123.26 2.64 . . . . 0.0 112.915 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.503 ' HB3' HD23 ' A' ' 42' ' ' LEU . 8.5 m-20 -68.64 -41.57 79.2 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.252 0.548 . . . . 0.0 110.21 177.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.402 ' HB ' ' OD2' ' A' ' 63' ' ' ASP . 25.3 t -73.38 -23.61 19.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.96 -178.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.411 ' HB3' ' O ' ' A' ' 65' ' ' PRO . 63.9 tttp -52.78 -34.15 51.94 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.28 -178.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -108.36 2.31 22.42 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -176.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -98.76 -34.83 10.36 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 175.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.447 ' O ' ' HB2' ' A' ' 59' ' ' HIS . 51.2 mt -107.36 116.13 58.49 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.956 177.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -64.11 159.22 43.93 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.999 2.466 . . . . 0.0 112.751 -178.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.424 ' HZ ' HH22 ' A' ' 99' ' ' ARG . 64.7 t80 -79.85 -29.81 40.18 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.494 -176.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.0 p -148.7 126.27 11.7 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.507 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.7 tttm -141.54 128.42 20.58 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 12.0 t -109.65 118.17 56.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.844 0.354 . . . . 0.0 110.149 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 38.7 mt -93.01 153.27 18.82 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.656 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -118.3 108.99 15.77 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 171.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 22.2 t -122.21 102.09 11.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.148 -174.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 56.43 25.0 9.09 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.408 -0.814 . . . . 0.0 112.188 174.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 114.15 -10.57 22.49 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.96 177.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 46.5 t -103.84 134.63 44.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 122.645 -0.326 . . . . 0.0 110.948 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.6 p -93.83 133.35 37.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.656 177.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 27.1 mt -129.01 99.34 4.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.812 0.339 . . . . 0.0 110.357 -176.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -89.59 110.25 3.7 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.852 -0.69 . . . . 0.0 111.785 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.489 ' HG2' ' HB2' ' A' ' 112' ' ' LEU . 32.6 mtm -99.91 123.25 43.96 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 -179.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 34.2 t -145.83 163.07 36.2 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.488 ' HE1' ' HB3' ' A' ' 36' ' ' LEU . 7.2 m80 -141.0 -165.27 1.92 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.989 0.423 . . . . 0.0 111.424 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 112.48 169.33 17.85 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -177.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 17.3 p90 -81.81 96.7 7.69 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.502 0.668 . . . . 0.0 110.546 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -122.98 115.66 2.75 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.036 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.45 153.91 81.62 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 178.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.99 -7.45 6.28 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.013 2.475 . . . . 0.0 113.603 -175.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -81.72 -52.78 6.8 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.197 0.522 . . . . 0.0 109.978 -178.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -103.55 -4.87 23.34 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.823 -174.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 40.9 tp -52.41 -56.69 13.3 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.797 -176.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 45.9 pttt -57.39 -42.97 83.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.446 -177.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -69.37 -41.69 76.2 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.642 -178.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.475 ' O ' HG22 ' A' ' 103' ' ' VAL . 42.7 ttt-85 -62.05 -47.53 84.33 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.006 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.486 HD13 HG22 ' A' ' 111' ' ' ILE . 94.2 mt -66.47 -38.41 87.27 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.27 -176.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.782 HD23 HG21 ' A' ' 127' ' ' VAL . 86.6 mt -76.16 -13.25 60.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.011 0.434 . . . . 0.0 110.888 177.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -82.89 -39.89 20.94 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.008 176.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.475 HG22 ' O ' ' A' ' 99' ' ' ARG . 90.8 t -66.24 -50.93 64.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.194 -178.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -87.38 111.92 21.6 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 121.066 -0.254 . . . . 0.0 110.967 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -57.82 -52.89 63.6 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 174.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -80.77 94.96 6.51 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 170.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.652 ' HD2' ' H ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -59.95 123.15 70.77 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.217 -179.279 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 107' ' ' LYS . 2.2 Cg_endo -82.08 157.15 17.68 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 123.754 2.969 . . . . 0.0 112.699 -172.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -73.51 -44.94 56.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.946 177.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 65.4 t -118.78 140.67 41.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.948 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.486 HG22 HD13 ' A' ' 100' ' ' LEU . 40.9 mt -129.86 131.99 66.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.74 0.305 . . . . 0.0 110.474 177.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.636 HD22 ' HB2' ' A' ' 130' ' ' LEU . 75.3 mt -105.24 127.34 52.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.64 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -147.21 147.24 30.26 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.686 176.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -130.96 114.79 1.64 Allowed Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.332 -0.937 . . . . 0.0 111.814 179.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 17.2 t60 -178.45 21.59 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 177.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.503 HG23 ' H ' ' A' ' 117' ' ' HIS . 0.2 OUTLIER -101.65 -176.03 3.02 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.142 -174.564 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.503 ' H ' HG23 ' A' ' 116' ' ' THR . 49.4 m-70 -111.63 -43.19 3.69 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.756 0.312 . . . . 0.0 110.562 178.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -124.58 149.21 61.23 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.913 175.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.547 ' HG3' HD22 ' A' ' 154' ' ' LEU . 74.4 Cg_endo -74.83 138.51 23.58 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.713 2.275 . . . . 0.0 111.988 178.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -150.58 125.95 10.1 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.374 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -78.26 94.47 4.8 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 177.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.489 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 68.6 p -103.46 119.19 38.4 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.837 -174.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.48 HG13 ' O ' ' A' ' 123' ' ' VAL . 8.9 p -107.25 88.89 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 122.336 1.065 . . . . 0.0 109.113 170.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -127.27 146.24 50.5 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.701 -174.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 61.8 15.25 6.89 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 123.724 0.64 . . . . 0.0 110.893 -174.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 83.91 9.87 81.9 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.52 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.782 HG21 HD23 ' A' ' 101' ' ' LEU . 47.7 t -119.21 140.83 41.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.698 0.285 . . . . 0.0 110.307 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.638 ' NH1' HD22 ' A' ' 130' ' ' LEU . 26.9 ttt-85 -89.36 94.16 9.79 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.489 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 89.3 m-85 -83.44 126.14 32.44 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.638 HD22 ' NH1' ' A' ' 128' ' ' ARG . 50.2 mt -112.01 122.43 47.74 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.385 0.612 . . . . 0.0 110.965 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.501 ' HA ' ' HD3' ' A' ' 132' ' ' PRO . 5.1 p30 -129.22 122.95 21.37 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.821 178.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.501 ' HD3' ' HA ' ' A' ' 131' ' ' ASN . 5.4 Cg_endo -87.15 169.64 7.33 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.238 2.625 . . . . 0.0 112.288 179.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -89.05 -160.23 36.23 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.27 178.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 48.2 t -88.19 139.3 30.64 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.825 0.345 . . . . 0.0 110.637 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.632 HD11 ' HB3' ' A' ' 10' ' ' SER . 58.3 mt -66.17 -19.74 65.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.28 178.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.54 ' HB3' ' HG ' ' A' ' 18' ' ' SER . . . -78.76 -12.53 60.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.348 -178.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -87.52 -4.62 58.98 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.417 -176.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 77.9 25.75 61.71 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.335 178.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 7.3 t -139.46 132.32 29.25 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 178.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -126.32 173.25 9.46 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -177.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.468 ' HB3' ' HB3' ' A' ' 6' ' ' LEU . . . -114.38 134.94 54.61 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.689 -174.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.481 HG12 ' HG3' ' A' ' 144' ' ' GLU . 47.3 t -128.83 124.08 60.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.881 176.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.515 HD22 HG11 ' A' ' 150' ' ' VAL . 5.8 tt -101.87 106.47 17.43 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.481 ' HG3' HG12 ' A' ' 142' ' ' VAL . 45.2 mt-10 -113.3 131.42 55.94 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.521 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 21.2 mt -93.07 90.74 7.02 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.887 -178.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -87.54 111.47 21.25 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.832 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.74 -69.02 0.29 Allowed Glycine 0 CA--C 1.52 0.384 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.633 -175.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -171.17 25.46 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 111.665 -0.574 . . . . 0.0 111.665 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -110.37 143.04 41.21 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.515 HG11 HD22 ' A' ' 143' ' ' LEU . 46.5 t -86.03 89.07 2.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 177.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 67.6 mtp180 -90.02 98.44 11.77 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.337 0.589 . . . . 0.0 110.644 -175.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -83.37 93.99 7.87 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.12 175.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -97.46 112.52 24.33 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.845 0.355 . . . . 0.0 110.988 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.547 HD22 ' HG3' ' A' ' 119' ' ' PRO . 15.9 tp -83.6 92.4 7.65 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 171.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -83.78 145.69 28.56 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.598 -174.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 18.7 p -91.47 145.05 24.94 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.545 178.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 79.8 mt . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.688 -0.673 . . . . 0.0 110.388 178.714 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.648 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 38.9 t . . . . . 0 N--CA 1.478 0.925 0 CA-C-O 120.879 0.371 . . . . 0.0 110.18 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 55.1 mttm -110.69 142.89 41.98 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.706 178.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 50.3 mtp180 -115.57 123.19 47.85 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -119.52 135.07 54.93 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.979 0.419 . . . . 0.0 110.533 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.415 ' HB2' ' CD2' ' A' ' 30' ' ' TYR . 32.6 tp -89.33 127.2 35.78 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.158 179.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.552 ' HB3' ' HB1' ' A' ' 141' ' ' ALA . 47.8 tp -106.84 109.88 21.9 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.974 0.416 . . . . 0.0 110.547 -178.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.402 HG13 ' HA2' ' A' ' 35' ' ' GLY . 7.4 pt -101.35 128.62 53.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.771 177.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.3 m -89.4 -171.32 3.18 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.14 -171.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -47.97 117.16 1.77 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.165 -178.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.65 ' HB2' ' HA ' ' A' ' 38' ' ' ASP . 37.0 m -137.35 160.38 39.24 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.856 -1.065 . . . . 0.0 108.806 174.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 32.2 m80 -127.35 58.4 1.46 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.288 0.566 . . . . 0.0 109.579 -179.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.459 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . 2.9 t -108.67 134.02 20.44 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.845 -177.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.459 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 72.4 Cg_endo -103.08 51.82 1.45 Allowed 'Cis proline' 0 N--CA 1.448 -1.183 0 C-N-CA 124.078 -1.218 . . . . 0.0 111.995 -4.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.454 HG22 HG21 ' A' ' 40' ' ' VAL . 10.9 t -58.14 -39.99 75.3 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-O 121.531 0.681 . . . . 0.0 109.999 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 31.9 ttt85 -177.19 -33.97 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.374 -1.285 . . . . 0.0 108.681 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.483 ' HE1' ' HB3' ' A' ' 10' ' ' SER . 32.0 ttp -74.17 122.92 23.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.013 178.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -130.13 13.01 5.66 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.085 0.469 . . . . 0.0 110.339 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.0 p -82.66 33.74 0.43 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.418 -177.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.8 tt -99.67 114.22 65.48 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.421 ' O ' HG23 ' A' ' 23' ' ' ILE . 36.6 Cg_exo -60.95 130.01 31.12 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 123.278 2.652 . . . . 0.0 113.016 -176.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -67.33 -23.36 65.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.271 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -58.87 -34.68 71.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.358 -178.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.421 HG23 ' O ' ' A' ' 20' ' ' PRO . 6.3 tt -65.59 -38.39 82.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.538 0.685 . . . . 0.0 109.662 178.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.671 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 46.0 tp -70.34 -32.01 69.54 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.303 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -71.62 -24.39 61.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.801 178.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.0 m -85.94 7.61 23.58 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -171.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.685 HD11 ' HB3' ' A' ' 52' ' ' SER . 4.3 mt -64.91 -19.77 66.1 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.509 0.671 . . . . 0.0 109.401 178.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -56.58 -23.8 43.11 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 114.563 -1.199 . . . . 0.0 111.835 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -82.34 -21.53 35.96 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -178.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.415 ' CD2' ' HB2' ' A' ' 5' ' ' LEU . 30.3 m-85 -113.87 159.75 19.5 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -162.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -71.94 -30.0 64.87 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.637 176.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -175.69 178.59 47.2 Favored Glycine 0 N--CA 1.439 -1.149 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.334 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.453 HG23 HD11 ' A' ' 27' ' ' LEU . 93.3 t -123.58 144.72 32.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 110.305 -0.257 . . . . 0.0 110.305 -178.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.455 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 55.0 mt -113.07 116.45 52.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.071 176.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.402 ' HA2' HG13 ' A' ' 7' ' ' ILE . . . -99.03 124.59 8.28 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.699 176.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.414 HD13 HD13 ' A' ' 6' ' ' LEU . 84.7 mt -98.39 3.19 48.47 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 122.624 -0.339 . . . . 0.0 111.087 -178.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 128.98 79.02 0.23 Allowed Glycine 0 CA--C 1.505 -0.582 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 -176.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.65 ' HA ' ' HB2' ' A' ' 10' ' ' SER . 0.4 OUTLIER -135.9 -70.26 0.48 Allowed 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.413 -0.394 . . . . 0.0 111.043 -169.402 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.408 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 96.9 m-85 -90.51 105.01 17.52 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 174.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.454 HG21 HG22 ' A' ' 14' ' ' VAL . 11.2 m -82.25 -12.36 12.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.298 -173.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.484 ' O ' HG21 ' A' ' 45' ' ' VAL . 11.4 t70 -86.65 127.52 34.94 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.339 -178.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 51.8 tp -61.13 -45.18 95.73 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.689 -174.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -62.87 -36.74 84.29 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.209 0.528 . . . . 0.0 110.252 -178.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.442 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 16.5 m -68.64 -33.26 73.69 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.617 176.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.484 HG21 ' O ' ' A' ' 41' ' ' ASP . 85.0 t -59.97 -41.88 87.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-O 121.109 0.481 . . . . 0.0 110.179 173.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -67.46 -34.8 70.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.185 0.517 . . . . 0.0 110.123 177.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.67 -33.75 75.69 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.062 174.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 44' ' ' THR . 98.3 mt -64.63 -36.43 84.23 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 175.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.711 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 37.3 mt-10 -77.49 -4.8 47.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.738 176.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -86.69 -41.07 14.48 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 173.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.462 ' CB ' HD12 ' A' ' 27' ' ' LEU . 74.5 m-85 -76.79 -51.44 11.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.178 178.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.685 ' HB3' HD11 ' A' ' 27' ' ' LEU . 78.6 p -90.62 -25.12 20.3 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 121.071 -0.252 . . . . 0.0 111.616 -178.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.711 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 68.0 mttm 71.6 -50.35 0.69 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.413 0.685 . . . . 0.0 111.712 -177.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -105.02 101.89 11.42 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.511 0.672 . . . . 0.0 109.728 175.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.57 ' HB3' ' HG2' ' A' ' 49' ' ' GLU . 89.7 t80 -114.82 124.61 52.19 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.806 -176.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.455 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 93.5 m-85 -112.76 165.8 11.95 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 174.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 163.45 174.21 33.05 Favored Glycine 0 N--CA 1.442 -0.959 0 C-N-CA 119.211 -1.471 . . . . 0.0 113.604 176.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.437 HG12 ' HE1' ' A' ' 86' ' ' MET . 2.8 m -146.68 118.75 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 114.791 -0.705 . . . . 0.0 109.167 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -94.53 176.39 6.31 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.167 -175.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -109.44 -171.4 20.57 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.332 -0.937 . . . . 0.0 112.216 -176.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -88.68 40.77 0.98 Allowed 'General case' 0 C--N 1.321 -0.654 0 O-C-N 122.424 -0.456 . . . . 0.0 110.065 178.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 57.5 mtm -132.66 4.8 3.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.524 -179.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -107.87 -169.09 1.46 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.375 -175.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -81.0 135.85 51.09 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.231 176.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.18 -36.53 93.41 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 123.336 2.691 . . . . 0.0 113.386 -177.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -69.14 -24.53 64.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.85 0.357 . . . . 0.0 111.306 -177.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 41.0 t -65.16 -21.69 29.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-O 121.29 0.566 . . . . 0.0 110.388 177.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.767 ' HB3' ' HZ2' ' A' ' 68' ' ' LYS . 4.6 ttpm? -62.41 -25.29 67.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.838 -178.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -68.04 -53.85 22.69 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.49 -174.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 22.2 t60 -74.3 -38.09 63.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.659 0.266 . . . . 0.0 110.824 -178.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -133.76 121.87 16.28 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-O 120.865 0.364 . . . . 0.0 110.285 177.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -81.24 -160.71 0.13 Allowed 'Trans proline' 0 CA--C 1.529 0.266 0 C-N-CA 123.003 2.469 . . . . 0.0 112.821 -176.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -96.6 -24.9 15.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.331 0.586 . . . . 0.0 109.719 177.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.7 m -142.38 125.39 16.24 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.333 -178.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 22.2 ttmm -150.05 136.62 19.11 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.023 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 13.5 t -105.07 118.67 52.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 177.15 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.524 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 91.5 mt -87.77 136.14 33.08 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.048 177.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 33.9 tp -111.43 97.45 6.76 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 173.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 29.2 t -123.28 111.13 28.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.445 -174.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 57.11 33.57 23.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.541 178.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.9 -19.24 55.34 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.713 177.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.601 HG22 HD23 ' A' ' 145' ' ' LEU . 56.9 t -82.0 132.05 32.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.869 0.366 . . . . 0.0 111.179 -176.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.6 p -95.13 116.06 28.23 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.832 176.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.524 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 26.5 mt -111.91 92.83 2.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.988 0.423 . . . . 0.0 110.019 -178.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -81.53 99.81 2.0 Allowed Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.437 ' HE1' HG12 ' A' ' 58' ' ' VAL . 29.7 mtm -97.75 121.57 39.83 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -177.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 47.0 t -146.14 109.76 4.81 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 15.3 t60 -91.79 65.36 4.98 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.224 0.535 . . . . 0.0 110.887 -174.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -103.12 160.84 16.61 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.733 177.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 89.0 m95 -116.1 104.84 11.96 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.993 0.425 . . . . 0.0 110.784 -179.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -155.57 -173.12 23.87 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 178.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.47 142.17 42.92 Favored Pre-proline 0 C--N 1.321 -0.654 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.61 -20.85 59.76 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 123.041 2.494 . . . . 0.0 112.968 -176.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -69.45 -52.1 29.92 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.243 0.544 . . . . 0.0 109.986 -178.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -77.02 -30.79 55.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.079 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.411 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 36.2 tp -50.35 -55.24 16.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.83 -175.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.45 ' HG3' ' N ' ' A' ' 98' ' ' ASP . 19.2 pttp -58.28 -41.76 85.08 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.876 0.369 . . . . 0.0 111.098 -177.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.45 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 29.5 t70 -69.26 -43.89 73.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.881 -175.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.503 ' O ' HG22 ' A' ' 103' ' ' VAL . 82.1 mtp180 -70.53 -41.87 71.97 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.141 -177.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.482 HD12 HD12 ' A' ' 111' ' ' ILE . 85.1 mt -61.49 -39.3 90.44 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.568 0.223 . . . . 0.0 111.505 -177.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 87.7 mt -67.04 -22.91 65.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.85 0.357 . . . . 0.0 111.063 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -91.45 -28.21 17.78 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.962 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.503 HG22 ' O ' ' A' ' 99' ' ' ARG . 89.7 t -67.6 -44.1 86.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.08 0.467 . . . . 0.0 109.837 175.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -85.09 168.95 14.4 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.544 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -97.34 -20.26 17.96 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.103 -177.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -135.59 165.98 24.28 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.454 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 13.8 ptmt -74.47 120.21 80.36 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-O 121.021 0.439 . . . . 0.0 110.17 176.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 107' ' ' LYS . 3.7 Cg_exo -80.69 131.95 8.52 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 122.738 2.292 . . . . 0.0 111.163 176.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -66.3 -39.39 89.29 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 176.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.502 ' CG2' HG21 ' A' ' 150' ' ' VAL . 94.8 t -124.19 138.61 53.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.393 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.482 HD12 HD12 ' A' ' 100' ' ' LEU . 25.1 mt -129.32 126.41 63.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.907 0.384 . . . . 0.0 110.398 174.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.574 HD23 ' HB2' ' A' ' 130' ' ' LEU . 90.3 mt -101.71 119.75 39.27 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.429 ' CE1' ' HB3' ' A' ' 129' ' ' PHE . 20.0 p90 -133.11 173.45 11.42 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.868 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -122.22 114.67 2.55 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.601 -0.809 . . . . 0.0 111.957 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -166.7 35.95 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.912 ' HA ' HD22 ' A' ' 131' ' ' ASN . 53.3 m -53.21 109.87 0.48 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.55 -1.204 . . . . 0.0 113.819 -169.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 28.4 m80 -111.08 -45.53 3.43 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 162.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -147.67 142.32 16.59 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 114.593 -1.185 . . . . 0.0 109.024 172.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.458 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 16.5 Cg_endo -59.45 113.08 1.46 Allowed 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 122.173 1.916 . . . . 0.0 110.941 173.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -146.21 140.04 26.28 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.89 0.376 . . . . 0.0 111.319 -169.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -107.33 122.7 47.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.894 176.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 59.6 p -130.79 130.6 43.89 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -173.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.1 p -99.1 122.63 51.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 172.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.575 ' HZ2' ' HB2' ' A' ' 124' ' ' LYS . 3.0 ttpm? -151.34 123.05 8.0 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.367 -174.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 66.22 20.68 11.1 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.588 -177.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 80.92 7.79 88.19 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.912 -177.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.466 HG12 HD13 ' A' ' 111' ' ' ILE . 61.2 t -109.46 136.22 46.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 177.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -95.47 104.15 16.05 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.196 0.522 . . . . 0.0 110.037 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.429 ' HB3' ' CE1' ' A' ' 113' ' ' PHE . 98.1 m-85 -89.94 124.2 34.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.187 -178.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.574 ' HB2' HD23 ' A' ' 112' ' ' LEU . 81.8 mt -109.99 125.38 52.83 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-O 121.333 0.587 . . . . 0.0 111.159 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.912 HD22 ' HA ' ' A' ' 116' ' ' THR . 7.6 t30 -127.9 105.36 20.52 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.579 174.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -86.93 179.18 3.36 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 123.008 2.472 . . . . 0.0 113.112 -177.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -85.46 165.39 38.9 Favored Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.758 178.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.407 ' O ' ' HB3' ' A' ' 137' ' ' GLU . 15.6 m -87.33 156.96 19.39 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.948 0.374 . . . . 0.0 111.534 -175.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -61.95 -44.49 96.66 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.818 0.342 . . . . 0.0 110.959 177.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -68.61 -17.42 64.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.239 0.542 . . . . 0.0 110.738 178.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.407 ' HB3' ' O ' ' A' ' 134' ' ' SER . 77.5 tt0 -79.32 -34.27 42.43 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.03 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.478 ' HA2' HD13 ' A' ' 157' ' ' LEU . . . 107.32 31.79 3.66 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.95 176.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 31.2 p -148.05 154.76 40.67 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.805 0.336 . . . . 0.0 110.81 177.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.411 ' O ' HD11 ' A' ' 154' ' ' LEU . 30.6 p90 -149.75 162.96 39.23 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.77 175.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.552 ' HB1' ' HB3' ' A' ' 6' ' ' LEU . . . -114.43 138.27 50.79 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.18 0.514 . . . . 0.0 111.802 -169.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.74 ' HB ' ' HB2' ' A' ' 153' ' ' GLU . 97.5 t -117.72 124.12 72.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.071 173.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.846 HD21 HG12 ' A' ' 150' ' ' VAL . 1.6 tt -107.34 115.96 31.1 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -178.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -107.28 116.81 32.6 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.081 0.467 . . . . 0.0 109.763 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.648 ' O ' ' HA ' ' A' ' 1' ' ' VAL . 74.5 mt -96.79 109.56 22.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.969 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -126.08 120.98 31.61 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.746 -175.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.82 10.93 59.57 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.87 178.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 92.03 5.66 65.8 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.759 -177.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -102.99 145.61 29.61 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.084 0.468 . . . . 0.0 110.496 178.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.846 HG12 HD21 ' A' ' 143' ' ' LEU . 62.1 t -94.85 119.01 42.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.074 -175.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 64.7 mtt180 -124.42 143.05 50.84 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.091 0.472 . . . . 0.0 110.418 178.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . 0.428 ' HE2' ' HB2' ' A' ' 154' ' ' LEU . 58.7 t80 -118.3 116.75 27.4 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.291 -168.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.74 ' HB2' ' HB ' ' A' ' 142' ' ' VAL . 45.5 mt-10 -102.77 111.2 23.42 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 174.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.428 ' HB2' ' HE2' ' A' ' 152' ' ' PHE . 32.5 tp -97.28 115.59 27.92 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.113 179.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -105.95 153.13 22.42 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.051 0.453 . . . . 0.0 110.878 -178.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 36.7 p -108.73 152.39 24.91 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.187 -177.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.478 HD13 ' HA2' ' A' ' 138' ' ' GLY . 97.0 mt . . . . . 0 C--O 1.247 0.949 0 CA-C-O 118.475 -0.774 . . . . 0.0 109.835 175.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 93.9 t . . . . . 0 N--CA 1.481 1.094 0 CA-C-O 120.727 0.298 . . . . 0.0 111.051 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -114.17 139.25 49.5 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 171.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 74.0 mtm-85 -110.27 116.18 31.01 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.811 -175.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -110.76 131.32 55.15 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.854 0.359 . . . . 0.0 110.792 178.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.487 ' HB2' ' CD2' ' A' ' 30' ' ' TYR . 38.6 tp -89.23 119.82 30.06 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.451 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.59 HD22 ' HB1' ' A' ' 141' ' ' ALA . 64.6 tp -106.05 115.65 30.58 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.017 0.437 . . . . 0.0 110.494 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.485 HG21 HD13 ' A' ' 23' ' ' ILE . 11.6 pt -101.09 125.8 54.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 177.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.0 m -65.43 177.51 1.13 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.2 -172.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -49.02 104.72 0.07 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.748 176.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.821 ' HB2' ' HA ' ' A' ' 38' ' ' ASP . 19.5 m -99.06 166.87 11.05 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.274 -177.109 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 69.9 m-70 -144.7 35.6 1.16 Allowed 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -176.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.64 HG23 HD13 ' A' ' 19' ' ' LEU . 14.6 t -102.68 138.53 19.65 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.493 -174.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.8 -56.84 0.14 OUTLIER 'Cis proline' 0 C--N 1.345 0.352 0 C-N-CA 123.382 -1.508 . . . . 0.0 112.242 -3.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.541 HG13 ' HG3' ' A' ' 15' ' ' ARG . 31.5 t 49.68 -94.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 O-C-N 123.815 0.697 . . . . 0.0 111.427 -178.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.541 ' HG3' HG13 ' A' ' 14' ' ' VAL . 54.9 mtp85 -138.44 13.53 2.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.259 0.552 . . . . 0.0 109.763 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 30.2 ttp -142.58 100.57 3.71 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.358 -177.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -101.72 14.33 32.29 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.254 0.55 . . . . 0.0 109.879 177.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.6 m -77.44 54.74 1.18 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.129 -179.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.854 ' HG ' HD13 ' A' ' 135' ' ' LEU . 2.0 tt -107.86 105.57 56.54 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 177.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.791 ' HG2' HD12 ' A' ' 157' ' ' LEU . 77.3 Cg_exo -52.08 123.47 12.6 Favored 'Trans proline' 0 C--O 1.236 0.398 0 C-N-CA 122.913 2.408 . . . . 0.0 112.375 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -68.62 -9.56 50.6 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.612 -178.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -52.88 -38.01 61.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.202 174.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.485 HD13 HG21 ' A' ' 7' ' ' ILE . 0.4 OUTLIER -82.45 -24.74 8.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.597 -179.006 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.461 ' O ' HD21 ' A' ' 27' ' ' LEU . 49.9 tp -81.96 -16.64 49.75 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.924 -177.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -86.3 -22.48 26.75 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.132 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.411 ' HB2' ' CE2' ' A' ' 30' ' ' TYR . 1.3 p -84.01 9.36 12.58 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -176.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.629 HD12 HG21 ' A' ' 33' ' ' VAL . 4.5 mm? -61.52 -19.96 62.68 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.234 0.54 . . . . 0.0 110.318 173.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 47.5 mttm -98.85 -0.34 42.63 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.857 -176.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -102.43 -49.32 3.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.803 0.335 . . . . 0.0 111.23 -173.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.487 ' CD2' ' HB2' ' A' ' 5' ' ' LEU . 93.4 m-85 -81.44 169.37 17.26 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.839 -173.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -88.24 -17.27 31.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.381 -177.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -168.67 162.27 36.03 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.629 HG21 HD12 ' A' ' 27' ' ' LEU . 61.2 t -132.01 147.47 32.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 -178.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.42 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 42.0 mt -123.73 124.78 70.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 175.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -106.48 114.69 4.49 Favored Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 111.564 -0.614 . . . . 0.0 111.564 177.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.608 ' HB3' ' HE1' ' A' ' 88' ' ' HIS . 99.3 mt -84.46 27.04 0.73 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.019 0.438 . . . . 0.0 110.733 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 110.46 60.54 0.49 Allowed Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 -173.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.821 ' HA ' ' HB2' ' A' ' 10' ' ' SER . 0.7 OUTLIER -76.53 -83.2 0.07 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.263 -0.469 . . . . 0.0 112.227 -173.829 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.467 ' HD1' HD13 ' A' ' 48' ' ' LEU . 75.5 m-85 -100.5 128.78 46.46 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.232 0.539 . . . . 0.0 110.995 -177.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.422 HG11 ' HB3' ' A' ' 63' ' ' ASP . 17.4 m -79.08 7.33 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.606 177.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.516 ' O ' HG23 ' A' ' 45' ' ' VAL . 13.6 t70 -110.17 130.01 55.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.964 -179.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.505 HD22 ' HB3' ' A' ' 66' ' ' ASP . 57.2 tp -65.63 -42.72 91.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.568 -175.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -59.51 -39.46 83.92 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.971 0.415 . . . . 0.0 111.274 -177.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 11.7 m -75.21 -27.02 59.39 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.213 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 41' ' ' ASP . 89.1 t -59.8 -43.3 91.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 121.391 0.615 . . . . 0.0 109.804 173.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.471 HD12 ' N ' ' A' ' 46' ' ' ILE . 1.7 mp -70.02 -34.55 60.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.91 178.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -60.94 -40.94 95.2 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.444 174.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.467 HD13 ' HD1' ' A' ' 39' ' ' TYR . 83.2 mt -69.11 -38.68 79.05 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.066 0.46 . . . . 0.0 110.174 179.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -62.13 -39.43 92.54 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.471 177.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -69.19 -36.1 76.96 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.752 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -71.61 -64.62 0.89 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.809 178.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.625 ' HB3' HD13 ' A' ' 27' ' ' LEU . 59.9 p -64.11 -40.85 97.1 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.217 -176.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 92.5 mttt 66.06 6.6 4.21 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.416 0.627 . . . . 0.0 110.425 -174.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -171.46 95.41 0.18 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.151 -0.932 . . . . 0.0 109.271 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.446 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 2.4 p90 -145.69 144.97 30.7 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.008 0.433 . . . . 0.0 109.927 178.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.42 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 56.1 m-85 -114.8 136.4 53.12 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 177.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.699 ' HA3' HD22 ' A' ' 71' ' ' LEU . . . -133.08 156.78 22.35 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 119.827 -1.178 . . . . 0.0 112.812 -177.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.84 164.25 30.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.132 0.491 . . . . 0.0 110.836 175.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.497 ' HB3' ' HA ' ' A' ' 73' ' ' PHE . 74.3 t60 -94.6 104.52 16.46 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.696 -175.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -115.72 -5.58 18.11 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.495 -0.775 . . . . 0.0 113.031 -176.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -115.16 -166.76 1.15 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.102 0.477 . . . . 0.0 110.234 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 97.0 mmm -98.98 34.86 2.0 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 169.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.422 ' HB3' HG11 ' A' ' 40' ' ' VAL . 1.8 p-10 -60.08 157.7 12.5 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.666 -177.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -62.21 155.62 64.46 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.924 -171.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.528 ' HA ' ' HB3' ' A' ' 68' ' ' LYS . 72.5 Cg_exo -50.47 -31.01 29.3 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 123.406 2.737 . . . . 0.0 112.948 178.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.505 ' HB3' HD22 ' A' ' 42' ' ' LEU . 32.2 m-20 -56.61 -48.4 77.54 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.342 0.591 . . . . 0.0 110.434 176.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 40.5 t -75.85 -38.94 37.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.819 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.528 ' HB3' ' HA ' ' A' ' 65' ' ' PRO . 48.5 tttp -57.59 -34.0 68.77 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.364 176.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -68.92 -33.94 74.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.069 0.461 . . . . 0.0 110.652 178.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.473 ' CE1' HD13 ' A' ' 42' ' ' LEU . 18.9 m80 -84.53 -50.89 7.32 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.167 -178.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.699 HD22 ' HA3' ' A' ' 57' ' ' GLY . 22.6 mt -100.38 113.8 65.54 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.899 -177.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.632 ' HG2' ' HB2' ' A' ' 75' ' ' LYS . 46.0 Cg_endo -69.42 153.98 69.72 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 122.491 2.127 . . . . 0.0 112.308 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.497 ' HA ' ' HB3' ' A' ' 59' ' ' HIS . 82.6 t80 -61.96 -32.77 73.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.343 0.592 . . . . 0.0 109.952 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.3 t -146.36 137.51 24.42 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.3 176.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.632 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 39.5 tttp -148.92 128.44 13.12 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.507 -176.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.441 ' HA ' ' HA2' ' A' ' 85' ' ' GLY . 46.5 t -99.75 117.03 44.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.095 0.474 . . . . 0.0 109.837 174.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.483 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 86.7 mt -87.71 138.48 31.43 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.408 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 42.9 tp -109.73 99.57 8.71 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 176.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 44.0 t -108.92 91.34 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.364 -177.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 57.33 30.31 18.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.662 175.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 114.54 -23.53 12.08 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.99 178.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.8 t -84.01 126.81 40.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.597 0.237 . . . . 0.0 110.556 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.2 p -95.72 117.96 31.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.944 0.402 . . . . 0.0 111.304 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.483 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 18.1 mt -111.62 93.14 2.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.946 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 76' ' ' VAL . . . -84.02 106.35 2.86 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 111.731 -0.548 . . . . 0.0 111.731 -179.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 53.5 mtm -98.93 125.86 44.47 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -178.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 35.3 t -149.97 133.73 16.82 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.608 ' HE1' ' HB3' ' A' ' 36' ' ' LEU . 17.6 m80 -113.31 93.3 4.34 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.099 0.476 . . . . 0.0 111.444 178.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -136.21 154.81 22.14 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 175.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 10.6 p-90 -135.51 152.06 50.96 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 168.5 -137.23 4.46 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 -179.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.484 ' HB1' ' NE1' ' A' ' 94' ' ' TRP . . . -75.54 119.33 76.55 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-O 120.875 0.369 . . . . 0.0 110.578 178.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 92' ' ' ALA . 10.7 Cg_exo -72.48 -23.71 19.88 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.929 2.419 . . . . 0.0 112.933 -177.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.503 ' CE3' ' HB3' ' A' ' 95' ' ' ASP . 57.8 p-90 -70.72 -21.63 62.53 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -176.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.503 ' HB3' ' CE3' ' A' ' 94' ' ' TRP . 3.3 p-10 -126.44 20.51 7.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.001 0.429 . . . . 0.0 110.338 176.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 59.3 tp -57.08 -39.77 75.64 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.515 178.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.418 ' HD2' ' HB3' ' A' ' 124' ' ' LYS . 48.8 mtpt -54.4 -51.8 63.73 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.21 174.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -62.04 -39.46 92.42 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.767 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.458 ' HG3' ' O ' ' A' ' 95' ' ' ASP . 52.5 mtt180 -63.43 -48.65 76.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.09 179.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 76.9 mt -67.65 -34.25 76.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.879 0.371 . . . . 0.0 111.094 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 96.9 mt -80.79 -4.84 56.04 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.858 0.361 . . . . 0.0 110.841 178.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 37.8 mttp -89.57 -22.07 22.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.485 170.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 64.6 t -68.74 -47.68 75.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.97 0.414 . . . . 0.0 110.189 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -108.91 169.87 8.4 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.715 177.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -95.35 -47.33 6.34 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -90.69 137.72 32.13 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.725 175.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.444 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 24.2 pttm -70.21 125.37 91.97 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-O 120.986 0.422 . . . . 0.0 110.629 -178.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 107' ' ' LYS . 9.0 Cg_exo -72.4 134.47 22.71 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.617 2.212 . . . . 0.0 110.368 174.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -60.5 -41.84 95.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.964 0.411 . . . . 0.0 110.437 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.8 t -122.46 140.96 44.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.767 177.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.446 HD12 ' CE2' ' A' ' 129' ' ' PHE . 42.0 mt -129.71 137.12 57.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 176.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.581 HD22 ' HB2' ' A' ' 130' ' ' LEU . 86.7 mt -114.11 130.57 56.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.326 -177.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.502 ' O ' ' HD2' ' A' ' 132' ' ' PRO . 51.4 p90 -155.65 -178.34 7.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.851 172.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -105.78 127.87 9.14 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.552 -0.832 . . . . 0.0 111.784 -177.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.521 ' HB2' ' HB2' ' A' ' 131' ' ' ASN . 1.1 t60 -83.69 -14.65 51.25 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.797 0.332 . . . . 0.0 110.536 -175.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 5.9 m 63.69 12.66 6.77 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.995 0.902 . . . . 0.0 110.18 -176.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.598 ' HB3' ' OE1' ' A' ' 118' ' ' GLU . 34.8 m80 -148.18 -160.76 1.21 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.997 -176.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.598 ' OE1' ' HB3' ' A' ' 117' ' ' HIS . 0.8 OUTLIER -69.32 144.28 94.58 Favored Pre-proline 0 C--N 1.326 -0.434 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.432 -179.917 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -51.68 134.66 47.64 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.161 2.574 . . . . 0.0 112.586 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.449 ' HG2' HG22 ' A' ' 122' ' ' THR . 36.9 tt0 -142.55 127.29 18.12 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.837 -174.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.734 ' HB2' ' HZ ' ' A' ' 152' ' ' PHE . 19.5 t70 -86.92 107.36 18.33 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 177.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.546 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 27.7 p -116.16 118.73 33.63 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.815 -174.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.9 p -106.26 106.98 21.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.428 0.632 . . . . 0.0 110.321 176.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.583 ' HB2' ' HE1' ' A' ' 129' ' ' PHE . 62.4 mttm -127.24 129.24 47.4 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.023 -176.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 62.54 22.23 13.16 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 123.347 0.405 . . . . 0.0 111.415 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 87.42 -5.38 85.15 Favored Glycine 0 CA--C 1.518 0.244 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.071 -178.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 90.4 t -94.92 135.45 28.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -97.22 107.32 19.81 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.159 0.504 . . . . 0.0 109.912 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.583 ' HE1' ' HB2' ' A' ' 124' ' ' LYS . 75.4 m-85 -92.48 119.06 31.61 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.717 -179.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.581 ' HB2' HD22 ' A' ' 112' ' ' LEU . 50.5 mt -103.31 117.37 34.35 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 177.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.521 ' HB2' ' HB2' ' A' ' 115' ' ' HIS . 2.5 p30 -130.03 110.11 16.87 Favored Pre-proline 0 C--N 1.317 -0.843 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.998 -177.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.502 ' HD2' ' O ' ' A' ' 113' ' ' PHE . 89.9 Cg_endo -82.46 -172.16 1.35 Allowed 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.783 2.322 . . . . 0.0 111.853 174.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -99.19 -97.65 2.13 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.558 -0.83 . . . . 0.0 112.904 -177.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 41.8 t -161.87 163.5 29.22 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 -176.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.854 HD13 ' HG ' ' A' ' 19' ' ' LEU . 57.3 mt -65.0 -49.75 69.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.115 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -65.1 -26.69 68.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.168 -178.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -88.87 4.3 48.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.875 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.534 ' HA2' HD13 ' A' ' 157' ' ' LEU . . . 58.67 43.67 96.15 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 116.083 -0.508 . . . . 0.0 113.354 175.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 3.9 p -137.24 110.39 7.8 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.039 0.447 . . . . 0.0 111.675 -178.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -132.19 -172.09 2.8 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 175.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.59 ' HB1' HD22 ' A' ' 6' ' ' LEU . . . -143.72 153.09 42.08 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.2 0.524 . . . . 0.0 111.46 -177.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 70.9 t -126.23 117.26 48.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 172.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.647 HD22 HG13 ' A' ' 150' ' ' VAL . 2.3 tt -94.62 106.52 18.51 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.254 0.55 . . . . 0.0 109.87 -175.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -97.97 119.06 35.92 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.702 177.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.491 ' O ' ' HA ' ' A' ' 1' ' ' VAL . 6.2 mp -95.61 106.45 18.55 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 177.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -109.25 110.31 21.47 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.796 177.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 68.05 11.12 60.53 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.108 -176.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 94.55 5.18 61.81 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.758 -0.537 . . . . 0.0 111.758 -177.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -89.2 133.37 34.45 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 178.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.647 HG13 HD22 ' A' ' 143' ' ' LEU . 62.4 t -76.9 103.64 4.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.17 -177.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 78.4 mtt-85 -115.88 89.59 3.14 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.973 178.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . 0.734 ' HZ ' ' HB2' ' A' ' 121' ' ' ASP . 3.5 p90 -95.04 123.28 38.44 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.125 0.488 . . . . 0.0 110.682 -178.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -91.45 123.56 34.97 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.069 177.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -83.98 81.69 8.67 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 176.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -80.72 131.84 35.49 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.907 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 26.5 p -109.14 150.72 27.45 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.794 -175.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.791 HD12 ' HG2' ' A' ' 20' ' ' PRO . 90.5 mt . . . . . 0 C--N 1.315 -0.905 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 177.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.546 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 98.0 t . . . . . 0 N--CA 1.477 0.889 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.4 tttm -113.72 138.0 50.84 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.67 ' HB3' ' HD1' ' A' ' 30' ' ' TYR . 56.6 mtt-85 -108.29 117.8 35.1 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.618 0.247 . . . . 0.0 111.33 -175.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.546 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 67.8 m-85 -112.43 113.94 26.39 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.203 0.525 . . . . 0.0 111.006 177.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.507 ' HB3' HG23 ' A' ' 33' ' ' VAL . 32.1 tp -89.24 121.04 31.14 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.021 178.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.745 HD12 ' HG ' ' A' ' 36' ' ' LEU . 41.4 tp -107.39 121.09 43.9 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.259 0.552 . . . . 0.0 111.211 -178.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.7 pt -101.18 119.38 49.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 171.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.494 ' O ' ' HB2' ' A' ' 36' ' ' LEU . 5.7 p -67.17 -87.71 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -164.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.483 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 36.2 t70 -142.32 94.06 2.61 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.287 0.565 . . . . 0.0 110.226 -176.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.959 ' HG ' HD13 ' A' ' 19' ' ' LEU . 23.0 t -107.86 158.47 17.3 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.802 -179.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 11.0 m80 -135.09 77.33 1.67 Allowed 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -178.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.446 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . 9.1 t -129.8 132.26 24.06 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.109 -177.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.446 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 41.2 Cg_endo -95.4 91.58 0.14 OUTLIER 'Cis proline' 0 N--CA 1.449 -1.092 0 C-N-CA 123.403 -1.499 . . . . 0.0 112.554 -2.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.5 t -114.85 -165.07 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 175.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 85.1 mtt180 -72.43 75.92 1.04 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 118.611 0.642 . . . . 0.0 110.758 177.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.446 ' HE3' ' OG ' ' A' ' 10' ' ' SER . 28.0 ttp -165.65 -77.12 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.467 178.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 59.2 12.05 2.36 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.554 -178.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.0 m -79.81 35.78 0.31 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.184 -177.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.959 HD13 ' HG ' ' A' ' 10' ' ' SER . 4.1 tt -107.75 111.02 62.7 Favored Pre-proline 0 C--N 1.327 -0.406 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.509 ' HG3' HD13 ' A' ' 157' ' ' LEU . 60.7 Cg_endo -74.06 133.43 18.09 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.623 2.215 . . . . 0.0 112.014 178.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -77.11 -5.81 50.43 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.925 0.393 . . . . 0.0 110.263 -177.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -55.93 -40.81 73.68 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.543 174.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.0 tt -70.38 -33.39 53.79 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-O 121.748 0.785 . . . . 0.0 109.98 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.515 ' O ' HD23 ' A' ' 27' ' ' LEU . 49.0 tp -66.64 -17.89 65.08 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.842 -178.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -80.47 -24.87 39.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.894 0.378 . . . . 0.0 110.966 177.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.3 m -80.28 2.81 23.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.48 -176.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.653 HD11 ' HB3' ' A' ' 52' ' ' SER . 4.4 mm? -59.98 -22.37 62.45 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.59 178.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -79.4 -14.26 59.06 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.323 -177.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -91.62 -23.61 19.81 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.968 0.413 . . . . 0.0 110.848 -178.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.67 ' HD1' ' HB3' ' A' ' 3' ' ' ARG . 38.3 m-85 -111.49 126.08 54.59 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.949 0.405 . . . . 0.0 110.678 -174.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -78.98 -29.97 44.14 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.868 -176.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.546 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -123.34 138.33 11.52 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 177.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.531 HG21 ' CD1' ' A' ' 27' ' ' LEU . 93.5 t -130.37 135.09 61.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 120.845 0.355 . . . . 0.0 110.574 -178.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.567 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 48.1 mt -112.32 131.59 63.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.435 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -118.41 98.28 0.74 Allowed Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.109 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.745 ' HG ' HD12 ' A' ' 6' ' ' LEU . 85.0 mt -77.65 -33.8 53.36 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 175.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.483 ' HA3' ' HA ' ' A' ' 9' ' ' ASP . . . -150.47 83.01 0.18 Allowed Glycine 0 N--CA 1.44 -1.087 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.494 177.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -94.75 -145.3 0.26 Allowed 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.44 ' HD1' HD13 ' A' ' 48' ' ' LEU . 78.2 m-85 -73.49 148.87 42.74 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 178.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.7 m -98.06 5.56 9.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.132 0.491 . . . . 0.0 110.748 -177.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.535 ' O ' HG22 ' A' ' 45' ' ' VAL . 17.3 t70 -102.9 132.34 49.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.874 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.508 HD21 ' HB3' ' A' ' 66' ' ' ASP . 65.6 tp -57.84 -54.23 49.22 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.171 -175.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -59.22 -35.71 74.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.156 0.503 . . . . 0.0 111.105 -176.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.422 HG23 ' CD2' ' A' ' 39' ' ' TYR . 17.6 m -72.01 -28.22 63.25 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.312 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.535 HG22 ' O ' ' A' ' 41' ' ' ASP . 94.8 t -65.01 -37.4 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 121.205 0.526 . . . . 0.0 109.913 174.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.512 ' O ' ' HG2' ' A' ' 50' ' ' LYS . 1.7 mp -65.5 -37.15 79.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.56 175.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.447 ' O ' ' HB2' ' A' ' 50' ' ' LYS . 3.2 tm? -61.82 -34.04 75.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.767 174.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.44 HD13 ' HD1' ' A' ' 39' ' ' TYR . 96.4 mt -67.97 -40.44 83.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.324 177.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.552 ' HA ' ' O ' ' A' ' 52' ' ' SER . 44.6 mt-10 -78.68 -2.39 38.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.348 177.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.512 ' HG2' ' O ' ' A' ' 46' ' ' ILE . 32.2 mmtp -75.43 -53.67 8.3 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 170.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -70.95 -66.22 0.64 Allowed 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.101 177.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.653 ' HB3' HD11 ' A' ' 27' ' ' LEU . 15.7 p -95.36 92.99 6.98 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.214 175.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.508 ' HG2' ' O ' ' A' ' 49' ' ' GLU . 63.3 mttp -70.41 -15.67 62.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.142 0.496 . . . . 0.0 110.431 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -101.4 68.15 1.19 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.409 171.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -100.37 108.73 20.82 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.173 -178.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.567 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 12.2 m-85 -102.75 108.01 19.09 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.614 ' HA3' HD23 ' A' ' 71' ' ' LEU . . . -125.55 165.03 18.9 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 119.869 -1.158 . . . . 0.0 112.716 -176.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.456 HG11 ' HE3' ' A' ' 86' ' ' MET . 2.1 m -141.66 127.63 18.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.557 -0.321 . . . . 0.0 110.341 177.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -129.73 166.97 18.77 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.137 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.589 ' HA2' ' HD1' ' A' ' 73' ' ' PHE . . . -104.3 -169.27 24.86 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.308 -0.948 . . . . 0.0 112.906 -173.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -84.07 5.5 25.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.058 0.456 . . . . 0.0 110.48 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 87.1 mtp -103.55 -5.71 22.45 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.889 178.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -94.38 168.28 10.99 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.058 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -65.33 126.0 90.57 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.155 176.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.478 ' HA ' ' HB3' ' A' ' 68' ' ' LYS . 53.1 Cg_exo -57.04 -25.68 64.54 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.216 2.61 . . . . 0.0 112.507 -179.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.508 ' HB3' HD21 ' A' ' 42' ' ' LEU . 2.6 m-20 -58.38 -41.97 85.99 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.916 175.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 84.0 t -78.09 -37.96 23.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.862 177.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.478 ' HB3' ' HA ' ' A' ' 65' ' ' PRO . 63.6 tttm -63.19 -22.06 66.62 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.353 -178.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -60.4 -44.02 96.11 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.189 0.519 . . . . 0.0 110.077 173.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 64.6 m-70 -82.04 -39.1 23.98 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.929 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.614 HD23 ' HA3' ' A' ' 57' ' ' GLY . 7.3 mt -115.98 101.16 54.01 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.68 -173.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.485 ' HG2' ' HB2' ' A' ' 75' ' ' LYS . 69.4 Cg_endo -74.87 174.98 11.8 Favored 'Trans proline' 0 CA--C 1.528 0.2 0 C-N-CA 122.701 2.267 . . . . 0.0 112.283 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.589 ' HD1' ' HA2' ' A' ' 60' ' ' GLY . 76.7 t80 -81.2 -21.81 39.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.262 0.553 . . . . 0.0 110.502 -178.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 39.6 m -144.48 119.14 9.78 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.043 178.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.485 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 40.2 tttp -139.59 135.92 33.85 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.321 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 77.8 t -108.75 132.99 55.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.931 0.396 . . . . 0.0 110.145 174.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.487 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 84.9 mt -106.81 132.82 52.34 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.9 176.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 42.2 tp -109.26 100.47 9.59 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.652 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.5 t -116.42 102.94 14.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.585 -175.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 54.57 31.37 14.85 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.705 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.72 -22.27 37.76 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.454 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.539 ' HA ' ' OE1' ' A' ' 109' ' ' GLN . 99.1 t -71.31 122.68 23.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.772 0.32 . . . . 0.0 110.347 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.29 102.94 14.82 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.5 -178.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.487 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 20.4 mt -93.85 110.19 23.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.4 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -93.36 109.47 3.81 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.764 -0.731 . . . . 0.0 111.395 177.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.456 ' HE3' HG11 ' A' ' 58' ' ' VAL . 30.0 mtm -107.11 119.77 40.28 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.716 0.293 . . . . 0.0 110.772 -177.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 49.6 t -145.35 104.43 3.93 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 175.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 49.8 t60 -84.87 66.1 9.51 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.184 0.516 . . . . 0.0 110.368 -177.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -113.78 -145.1 9.03 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.756 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 28.2 t-105 -139.15 164.76 28.94 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -178.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 165.83 161.33 14.62 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.511 -0.852 . . . . 0.0 113.087 177.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.513 ' HB1' ' HD2' ' A' ' 93' ' ' PRO . . . -88.46 162.45 39.54 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 175.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.513 ' HD2' ' HB1' ' A' ' 92' ' ' ALA . 0.9 OUTLIER -43.97 -49.44 8.37 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.366 2.71 . . . . 0.0 113.656 -178.14 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 18.3 p-90 -81.85 -44.18 17.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.877 0.37 . . . . 0.0 111.363 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -59.44 -37.01 77.01 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.543 -177.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 19.9 tp -60.85 -49.18 78.5 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.277 178.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -58.44 -42.62 87.77 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.748 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -64.55 -53.58 45.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.552 -177.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 21.9 ttp-105 -68.79 -40.04 79.84 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -174.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.473 HD11 HG22 ' A' ' 111' ' ' ILE . 65.7 mt -71.71 -32.56 67.91 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.541 -0.464 . . . . 0.0 111.446 -176.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.578 HD22 HG21 ' A' ' 127' ' ' VAL . 86.8 mt -80.62 -12.49 59.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.177 0.513 . . . . 0.0 110.268 175.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -79.78 -40.46 28.64 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.523 173.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 80.3 t -73.75 -52.3 21.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.535 177.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -91.41 103.68 16.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.07 0.462 . . . . 0.0 110.874 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -76.9 -22.92 52.67 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.668 -177.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -66.94 -28.51 68.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.019 176.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.481 ' HG3' HD21 ' A' ' 101' ' ' LEU . 39.5 ttpt 63.76 92.84 0.06 OUTLIER Pre-proline 0 CA--C 1.529 0.162 0 O-C-N 123.985 0.803 . . . . 0.0 109.896 -170.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.438 ' O ' HG23 ' A' ' 127' ' ' VAL . 13.6 Cg_exo -69.37 166.75 26.03 Favored 'Trans proline' 0 N--CA 1.464 -0.228 0 C-N-CA 123.023 2.482 . . . . 0.0 112.859 -174.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.539 ' OE1' ' HA ' ' A' ' 82' ' ' VAL . 75.1 mt-30 -85.32 -49.94 7.75 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.273 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 58.7 t -122.67 132.02 72.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.911 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.473 HG22 HD11 ' A' ' 100' ' ' LEU . 35.3 mt -126.71 132.13 70.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.071 0.462 . . . . 0.0 110.911 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.43 ' HB3' HD11 ' A' ' 36' ' ' LEU . 78.2 mt -105.68 121.18 43.48 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.067 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -132.06 -178.77 5.04 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.747 -178.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -125.69 131.97 7.77 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 121.057 -0.592 . . . . 0.0 111.785 178.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 39.9 t60 -139.57 -68.02 0.43 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 177.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.0 p -143.85 -80.69 0.19 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.851 178.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.413 ' O ' ' HD3' ' A' ' 119' ' ' PRO . 16.5 p-80 -172.24 41.79 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.121 -178.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -103.12 102.02 25.58 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.286 -173.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.69 ' HB3' HD21 ' A' ' 154' ' ' LEU . 59.9 Cg_endo -77.44 41.94 1.06 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.782 2.321 . . . . 0.0 111.469 177.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -97.48 132.46 43.16 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.127 -176.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -78.52 107.07 10.9 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.267 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.586 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 67.8 p -105.35 114.49 28.7 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.141 0.496 . . . . 0.0 110.069 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.2 p -136.51 145.05 31.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.691 -175.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -159.28 -55.98 0.06 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.112 175.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -85.1 23.88 1.18 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.939 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 86.92 -16.93 44.21 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 121.083 -0.58 . . . . 0.0 111.707 -176.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.578 HG21 HD22 ' A' ' 101' ' ' LEU . 15.3 t -87.54 134.05 28.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.636 -0.282 . . . . 0.0 110.618 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 76.9 mtp180 -98.92 104.52 16.56 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.051 175.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.586 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 69.4 m-85 -87.72 124.78 33.93 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.412 HD11 ' CD2' ' A' ' 152' ' ' PHE . 67.8 mt -124.8 134.91 52.59 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.937 0.399 . . . . 0.0 111.454 -174.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -118.08 106.05 46.0 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.569 177.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.423 ' HB2' ' HB3' ' A' ' 8' ' ' SER . 61.3 Cg_endo -75.86 146.27 29.52 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 122.239 1.959 . . . . 0.0 112.683 179.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -73.35 141.76 30.41 Favored Glycine 0 C--N 1.331 0.279 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.809 177.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.434 ' HA ' ' OG ' ' A' ' 8' ' ' SER . 31.1 t -70.14 159.6 33.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.598 0.713 . . . . 0.0 112.632 -174.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.429 ' HG ' ' HG ' ' A' ' 19' ' ' LEU . 3.6 mm? -61.16 -26.65 67.84 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.149 174.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.9 -25.68 67.99 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.344 -178.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -105.02 6.56 33.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.106 0.479 . . . . 0.0 110.351 178.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.424 ' HA2' HD11 ' A' ' 157' ' ' LEU . . . 73.72 44.67 31.06 Favored Glycine 0 N--CA 1.451 -0.352 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.904 177.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 24.6 m -132.0 144.15 50.58 Favored 'General case' 0 C--N 1.321 -0.631 0 O-C-N 122.664 -0.315 . . . . 0.0 110.744 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 44.1 p90 -145.02 160.04 41.99 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 173.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.525 ' HB1' HD21 ' A' ' 6' ' ' LEU . . . -115.72 142.81 46.25 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.722 -175.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.792 ' HB ' ' HE3' ' A' ' 155' ' ' LYS . 51.1 t -126.98 124.8 65.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 175.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.516 HD22 HG11 ' A' ' 150' ' ' VAL . 5.3 tt -109.69 108.0 18.22 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.474 ' HG3' HG13 ' A' ' 142' ' ' VAL . 40.3 mt-10 -110.51 127.09 55.01 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.033 -178.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.546 ' O ' ' HA ' ' A' ' 1' ' ' VAL . 6.7 mp -90.79 105.77 18.05 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.894 0.378 . . . . 0.0 110.385 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -105.6 109.2 21.08 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.744 178.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 68.2 10.69 60.06 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.539 -177.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 98.84 -3.2 58.71 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.369 -177.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -85.1 147.26 26.73 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.723 0.297 . . . . 0.0 110.296 177.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.516 HG11 HD22 ' A' ' 143' ' ' LEU . 60.2 t -88.87 102.97 13.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.965 -175.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 47.6 mtp180 -98.66 94.0 6.41 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 176.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . 0.412 ' CD2' HD11 ' A' ' 130' ' ' LEU . 73.9 t80 -99.83 99.89 10.75 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.971 -179.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -110.88 119.56 39.49 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.203 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.69 HD21 ' HB3' ' A' ' 119' ' ' PRO . 23.2 tp -78.38 109.17 12.3 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 171.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.792 ' HE3' ' HB ' ' A' ' 142' ' ' VAL . 73.7 mttt -105.76 138.83 41.3 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.334 -175.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.7 p -97.55 155.29 17.03 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.224 0.535 . . . . 0.0 112.294 -171.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.509 HD13 ' HG3' ' A' ' 20' ' ' PRO . 61.5 mt . . . . . 0 C--O 1.247 0.959 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.134 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 87.7 t . . . . . 0 N--CA 1.482 1.146 0 CA-C-O 120.811 0.339 . . . . 0.0 110.57 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.541 ' HB2' HD11 ' A' ' 145' ' ' LEU . 6.1 mtpm? -134.12 161.81 33.84 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 176.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.679 ' HB3' ' CD2' ' A' ' 30' ' ' TYR . 92.9 mtt180 -118.7 129.76 55.46 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.747 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.67 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 85.2 m-85 -125.08 119.78 29.61 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.173 0.511 . . . . 0.0 110.557 176.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.514 ' HB3' HG21 ' A' ' 33' ' ' VAL . 23.7 tp -89.19 124.35 34.27 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 178.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.531 HD23 ' HB1' ' A' ' 141' ' ' ALA . 33.5 tp -104.22 98.82 8.57 Favored 'General case' 0 C--O 1.241 0.605 0 CA-C-O 121.584 0.707 . . . . 0.0 111.251 -175.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.467 ' HB ' HD11 ' A' ' 135' ' ' LEU . 13.6 pt -101.17 110.69 28.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 173.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.453 ' HA ' ' HB2' ' A' ' 36' ' ' LEU . 16.2 m -94.36 -97.33 0.16 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -165.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -98.18 120.7 39.05 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.742 0.306 . . . . 0.0 110.365 -171.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.492 ' HB2' HD13 ' A' ' 135' ' ' LEU . 28.8 t -157.45 164.71 37.16 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.946 0.403 . . . . 0.0 111.085 -174.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -138.03 74.72 1.49 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.462 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -126.14 138.42 32.16 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-O 120.841 0.353 . . . . 0.0 110.745 174.297 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.4 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 38.2 Cg_endo -96.22 75.08 0.14 OUTLIER 'Cis proline' 0 N--CA 1.451 -1.022 0 C-N-CA 123.445 -1.481 . . . . 0.0 113.027 -2.31 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -103.89 -153.57 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 174.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -77.28 82.28 3.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.357 0.598 . . . . 0.0 110.299 178.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.452 ' HE3' ' OG ' ' A' ' 10' ' ' SER . 39.2 ttp -161.99 -76.98 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.814 177.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 60.0 10.27 2.13 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.501 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.416 ' O ' ' HD3' ' A' ' 20' ' ' PRO . 3.8 m -80.6 15.25 1.75 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.451 -176.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -102.5 102.59 26.64 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.416 ' HD3' ' O ' ' A' ' 18' ' ' SER . 3.9 Cg_exo -74.32 156.76 46.03 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.879 2.386 . . . . 0.0 112.466 -176.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -63.35 -14.56 51.38 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.75 178.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -61.09 -21.85 64.07 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.943 -177.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -99.62 -28.76 3.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.218 0.532 . . . . 0.0 110.309 176.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.454 ' O ' HD22 ' A' ' 27' ' ' LEU . 48.8 tp -73.03 -28.38 62.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.038 -173.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 -82.06 -11.45 58.78 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.929 0.395 . . . . 0.0 110.425 178.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.476 ' O ' ' HD1' ' A' ' 30' ' ' TYR . 38.8 m -77.78 -5.3 50.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.729 175.002 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.704 HD12 HG22 ' A' ' 33' ' ' VAL . 3.5 mm? -58.37 -27.09 63.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.45 0.643 . . . . 0.0 109.855 170.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -90.43 9.97 27.02 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.495 -178.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -119.23 -16.06 9.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.899 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.679 ' CD2' ' HB3' ' A' ' 3' ' ' ARG . 89.5 m-85 -119.95 135.62 54.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.965 -178.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -81.81 -23.11 36.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.04 0.448 . . . . 0.0 110.707 -179.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.67 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -130.72 144.94 16.38 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.678 175.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.704 HG22 HD12 ' A' ' 27' ' ' LEU . 95.4 t -139.41 141.18 35.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.538 HG12 ' HB2' ' A' ' 56' ' ' TYR . 48.6 mt -120.55 124.31 72.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.741 -178.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -109.19 104.28 1.9 Allowed Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 111.614 -0.594 . . . . 0.0 111.614 177.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.453 ' HB2' ' HA ' ' A' ' 8' ' ' SER . 87.5 mt -84.98 4.22 34.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.915 0.388 . . . . 0.0 111.191 -176.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 153.52 48.64 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.979 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -127.61 155.79 43.31 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 -178.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.497 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 53.3 m-85 49.91 87.81 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.89 0.852 . . . . 0.0 111.753 -173.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.2 m -80.45 3.18 2.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.496 -174.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.476 ' O ' HG21 ' A' ' 45' ' ' VAL . 21.7 t70 -94.36 121.61 36.06 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.251 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.487 HD21 ' HB3' ' A' ' 66' ' ' ASP . 59.8 tp -58.69 -45.4 89.56 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.598 -174.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -54.7 -46.38 74.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.164 0.506 . . . . 0.0 110.601 178.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.573 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 27.1 m -65.46 -31.12 72.04 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.376 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.476 HG21 ' O ' ' A' ' 41' ' ' ASP . 84.7 t -59.77 -44.38 93.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 121.013 0.435 . . . . 0.0 110.57 177.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.445 HD12 ' N ' ' A' ' 46' ' ' ILE . 1.7 mp -67.02 -40.0 84.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-O 121.198 0.523 . . . . 0.0 109.898 177.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -61.32 -35.0 76.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.697 176.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.573 ' HG ' ' O ' ' A' ' 44' ' ' THR . 83.1 mt -66.39 -35.92 81.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.687 179.136 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -78.0 -13.87 59.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.1 0.476 . . . . 0.0 110.575 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -81.23 -16.38 52.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.124 0.487 . . . . 0.0 110.394 173.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.541 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . 27.8 m-85 -100.52 -58.76 1.83 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.01 174.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 41.7 t -77.02 101.44 6.03 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.711 174.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -55.85 -40.09 72.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.824 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -113.71 89.85 3.19 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.037 0.446 . . . . 0.0 109.965 172.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -100.25 121.75 41.96 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.147 0.499 . . . . 0.0 110.77 -177.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.538 ' HB2' HG12 ' A' ' 34' ' ' ILE . 92.6 m-85 -118.88 178.44 4.48 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.426 -0.807 . . . . 0.0 109.307 176.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.441 ' C ' HD13 ' A' ' 71' ' ' LEU . . . 159.65 -179.68 35.06 Favored Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 120.141 -1.028 . . . . 0.0 112.685 176.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 15.8 t -140.51 148.37 22.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 -94.66 104.49 16.42 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.027 0.442 . . . . 0.0 110.316 -175.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -116.05 -5.16 17.85 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.155 177.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.487 ' HB3' ' OD1' ' A' ' 63' ' ' ASP . 6.7 m120 -83.4 133.68 34.92 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 74.1 mtm -96.73 10.23 39.34 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.235 0.54 . . . . 0.0 109.804 176.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.487 ' OD1' ' HB3' ' A' ' 61' ' ' ASN . 4.7 m-20 -66.66 -68.32 0.38 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.069 -177.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.479 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 91.8 m-85 -124.52 131.16 24.12 Favored Pre-proline 0 C--O 1.237 0.418 0 CA-C-O 121.167 0.508 . . . . 0.0 111.383 -177.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 64' ' ' TYR . 1.2 Cg_endo -83.74 -3.26 10.54 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 123.725 2.95 . . . . 0.0 112.478 -179.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.487 ' HB3' HD21 ' A' ' 42' ' ' LEU . 8.0 m-20 -67.68 -36.25 80.34 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.448 0.642 . . . . 0.0 109.958 179.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.51 HG11 HD22 ' A' ' 71' ' ' LEU . 30.3 t -76.36 -13.73 14.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.554 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.431 ' HB3' ' O ' ' A' ' 65' ' ' PRO . 87.6 tttt -70.59 -15.99 62.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.492 -175.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -90.36 0.42 57.27 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.82 0.343 . . . . 0.0 111.435 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -123.3 -39.04 2.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.03 0.443 . . . . 0.0 110.611 177.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.51 HD22 HG11 ' A' ' 67' ' ' VAL . 3.4 mm? -103.0 124.25 39.19 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 176.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -84.88 -175.08 1.93 Allowed 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.86 2.374 . . . . 0.0 113.115 -175.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -80.4 -29.46 37.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.38 0.609 . . . . 0.0 110.066 179.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.504 ' HB3' ' CZ ' ' A' ' 104' ' ' PHE . 26.5 m -152.07 137.51 17.66 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.121 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 34.7 tttp -139.29 116.56 11.16 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.926 -176.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 46.6 t -100.25 125.54 53.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 176.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 44.8 mt -103.14 153.58 20.17 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.06 178.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 37.4 tp -115.28 93.45 4.3 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 171.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 46.5 t -106.33 104.2 16.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.354 -173.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 57.21 29.26 16.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.441 178.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.45 -16.18 52.79 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.613 177.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 54.0 t -89.55 123.95 42.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.887 0.375 . . . . 0.0 110.832 -178.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.414 ' HB ' ' HA ' ' A' ' 108' ' ' PRO . 0.0 OUTLIER -80.73 115.87 20.45 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.858 177.259 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.481 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 21.0 mt -111.56 99.16 8.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.779 0.324 . . . . 0.0 110.489 -178.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.442 ' HA2' HG22 ' A' ' 76' ' ' VAL . . . -85.12 98.82 2.27 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 178.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 48.8 mtm -90.71 126.46 36.0 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.19 0.519 . . . . 0.0 110.896 -176.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.47 ' SG ' ' HB3' ' A' ' 113' ' ' PHE . 28.5 p -135.73 164.91 26.8 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 9.3 t-80 -83.49 -23.68 32.07 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 119.841 -0.743 . . . . 0.0 109.936 178.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.439 ' HA3' ' HB2' ' A' ' 113' ' ' PHE . . . 82.02 118.07 0.5 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.094 176.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 63.2 t90 -156.24 126.84 6.74 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 176.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 133.07 -166.93 23.55 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.407 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . . . -88.08 124.94 65.79 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.024 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 92' ' ' ALA . 33.7 Cg_exo -58.75 -15.61 27.14 Favored 'Trans proline' 0 N--CA 1.475 0.39 0 C-N-CA 123.224 2.616 . . . . 0.0 113.009 -177.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 4.4 m0 -66.14 -43.14 87.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.79 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -123.95 13.29 9.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.981 0.419 . . . . 0.0 111.23 -177.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 54.8 tp -66.32 -35.37 80.21 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.815 177.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.472 ' HD3' ' HB3' ' A' ' 124' ' ' LYS . 52.1 mttp -59.64 -49.42 77.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.804 177.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -68.17 -36.35 79.49 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.063 -0.972 . . . . 0.0 111.068 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.42 ' O ' HG21 ' A' ' 103' ' ' VAL . 45.8 ttt180 -64.85 -42.39 94.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.922 178.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.476 HD11 HG21 ' A' ' 111' ' ' ILE . 72.9 mt -67.78 -29.19 68.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.683 0.278 . . . . 0.0 111.241 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.497 HD22 HG23 ' A' ' 127' ' ' VAL . 92.2 mt -72.71 -13.72 61.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.014 0.435 . . . . 0.0 110.496 175.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -94.05 -30.88 14.46 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.782 175.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.42 HG21 ' O ' ' A' ' 99' ' ' ARG . 83.9 t -59.59 -50.98 77.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.1 175.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.504 ' CZ ' ' HB3' ' A' ' 74' ' ' SER . 55.8 m-85 -92.34 161.44 14.67 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.389 177.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -94.79 -26.73 16.11 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.303 0.573 . . . . 0.0 110.237 -179.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.417 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 43.2 mt-10 -111.81 152.36 27.97 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.127 175.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -83.34 113.87 49.32 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-O 120.797 0.332 . . . . 0.0 110.919 -178.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.441 ' O ' HG12 ' A' ' 127' ' ' VAL . 2.7 Cg_exo -76.04 124.43 7.96 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.774 2.316 . . . . 0.0 110.465 175.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -61.61 -37.12 82.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.988 0.423 . . . . 0.0 111.389 -176.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 88.7 t -123.94 132.59 71.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 175.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.476 HG21 HD11 ' A' ' 100' ' ' LEU . 37.7 mt -125.17 134.62 66.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.923 0.392 . . . . 0.0 110.651 179.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.54 HD21 ' HB2' ' A' ' 130' ' ' LEU . 96.2 mt -109.29 139.05 44.73 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.928 178.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.49 ' CZ ' ' HB2' ' A' ' 131' ' ' ASN . 6.5 p90 -155.53 122.96 5.54 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 175.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -122.67 114.5 2.47 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.615 -177.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -173.53 21.04 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.495 0.664 . . . . 0.0 109.365 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.454 HG22 ' H ' ' A' ' 118' ' ' GLU . 16.9 m -117.38 154.38 31.42 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.015 -175.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 32.5 m80 -80.85 -27.57 36.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.922 0.391 . . . . 0.0 110.356 -177.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.454 ' H ' HG22 ' A' ' 116' ' ' THR . 46.0 mt-10 -122.03 111.13 32.53 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.263 177.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -57.49 141.94 95.21 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.767 2.312 . . . . 0.0 111.897 177.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -154.68 142.29 19.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.973 0.416 . . . . 0.0 111.367 -173.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -98.24 124.3 42.77 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.382 172.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.544 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 69.8 p -129.11 129.7 45.52 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.06 0.457 . . . . 0.0 111.48 -176.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.7 p -126.86 140.66 48.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.668 175.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.472 ' HB3' ' HD3' ' A' ' 97' ' ' LYS . 71.5 tttt -155.79 -56.34 0.09 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.416 0.627 . . . . 0.0 110.308 -179.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -94.88 30.85 1.97 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.746 -175.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 79.54 -42.21 2.4 Favored Glycine 0 N--CA 1.451 -0.304 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 -173.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.497 HG23 HD22 ' A' ' 101' ' ' LEU . 89.3 t -60.24 136.68 23.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-N 115.213 -0.494 . . . . 0.0 110.825 176.146 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.402 ' HE ' ' HB2' ' A' ' 128' ' ' ARG . 20.3 ttm180 -97.21 112.55 24.3 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.947 178.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.544 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 82.7 m-85 -97.76 108.26 20.94 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.102 -178.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.54 ' HB2' HD21 ' A' ' 112' ' ' LEU . 81.9 mt -99.8 115.6 29.93 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.294 -178.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.49 ' HB2' ' CZ ' ' A' ' 113' ' ' PHE . 22.7 t-20 -108.2 112.11 61.48 Favored Pre-proline 0 C--N 1.32 -0.713 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.187 -178.116 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -92.1 174.95 2.1 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 123.435 2.757 . . . . 0.0 111.413 169.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -112.85 -172.38 18.54 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.411 -0.899 . . . . 0.0 112.739 -177.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 38.0 m -78.9 153.94 30.1 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.642 0.258 . . . . 0.0 110.508 178.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.492 HD13 ' HB2' ' A' ' 10' ' ' SER . 73.5 mt -78.38 -10.69 59.79 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -173.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -96.49 -60.3 1.64 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.958 0.408 . . . . 0.0 111.412 -177.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -106.02 22.09 16.23 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.216 -173.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.462 ' O ' ' HB2' ' A' ' 157' ' ' LEU . . . -146.72 -164.76 11.23 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.348 -178.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 15.2 p -112.66 148.84 33.82 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.722 -0.103 . . . . 0.0 110.722 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -97.2 168.83 10.19 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 -177.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.531 ' HB1' HD23 ' A' ' 6' ' ' LEU . . . -121.27 149.43 42.9 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.016 0.436 . . . . 0.0 111.171 -174.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 69.5 t -122.36 126.98 74.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 173.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.704 HD21 HG12 ' A' ' 150' ' ' VAL . 3.7 tt -110.19 104.55 13.4 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -109.28 143.86 38.2 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.541 HD11 ' HB2' ' A' ' 2' ' ' LYS . 91.1 mt -98.66 101.66 13.15 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.199 0.523 . . . . 0.0 110.667 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.638 ' HB3' ' HE ' ' A' ' 151' ' ' ARG . 12.2 t70 -96.35 114.55 26.24 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.879 178.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.83 -69.06 0.3 Allowed Glycine 0 C--N 1.331 0.287 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.596 -175.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -174.92 26.92 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 178.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -126.78 147.01 50.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.834 0.349 . . . . 0.0 110.22 -177.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.704 HG12 HD21 ' A' ' 143' ' ' LEU . 92.2 t -76.83 113.35 15.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.342 -176.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.638 ' HE ' ' HB3' ' A' ' 146' ' ' ASP . 38.8 mmt180 -97.09 108.84 21.65 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.154 176.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -90.66 94.5 9.72 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 177.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -100.67 102.69 13.87 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.01 -178.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 26.7 tp -83.72 130.51 34.95 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.173 -178.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -123.52 138.89 54.48 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 3.1 m -81.91 156.36 24.82 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.191 0.519 . . . . 0.0 111.705 -169.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.462 ' HB2' ' O ' ' A' ' 138' ' ' GLY . 88.6 mt . . . . . 0 C--O 1.247 0.945 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.496 176.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 47.1 t . . . . . 0 N--CA 1.477 0.896 0 CA-C-O 120.982 0.42 . . . . 0.0 110.867 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.603 ' HB2' ' HB2' ' A' ' 145' ' ' LEU . 92.7 mttt -109.47 151.02 27.27 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 170.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.499 ' O ' ' HB3' ' A' ' 30' ' ' TYR . 96.1 mtt180 -133.58 113.89 12.93 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.064 0.459 . . . . 0.0 110.841 178.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.518 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 49.3 m-85 -104.3 125.85 50.9 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.166 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.441 HD23 ' HB2' ' A' ' 26' ' ' SER . 37.8 tp -89.75 120.05 30.68 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.143 176.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.554 ' HB3' ' HB2' ' A' ' 141' ' ' ALA . 57.6 tp -102.57 110.74 22.78 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.875 0.369 . . . . 0.0 110.266 178.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.492 HG22 HD13 ' A' ' 23' ' ' ILE . 18.1 pt -101.18 122.03 52.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.462 0.649 . . . . 0.0 109.601 177.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.3 m -77.81 -165.37 0.62 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.94 -173.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -55.03 122.48 11.02 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.433 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.477 ' HB2' ' O ' ' A' ' 38' ' ' ASP . 19.3 m -126.99 159.23 34.72 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.622 178.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.635 ' H ' ' HE3' ' A' ' 16' ' ' MET . 89.4 m-70 -140.49 43.7 1.87 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 -176.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.51 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . 46.0 t -93.1 129.76 38.32 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.147 -179.435 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.51 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 83.8 Cg_endo -103.38 27.75 10.8 Favored 'Cis proline' 0 N--CA 1.455 -0.754 0 C-N-CA 124.44 -1.067 . . . . 0.0 112.36 -3.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.8 t -47.55 -60.74 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 O-C-N 123.744 0.653 . . . . 0.0 111.996 -175.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 62.3 ttt180 -142.49 11.23 1.89 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.722 0.773 . . . . 0.0 109.619 -178.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.635 ' HE3' ' H ' ' A' ' 11' ' ' HIS . 58.0 ttp -143.08 121.52 12.39 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.216 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -117.57 -0.49 11.87 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.994 0.426 . . . . 0.0 110.805 -177.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.0 t -108.4 88.66 2.78 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.623 -178.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.0 tt -107.88 120.45 47.05 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 175.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.55 ' HG2' HD13 ' A' ' 157' ' ' LEU . 76.4 Cg_exo -41.17 116.89 0.49 Allowed 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 124.107 3.205 . . . . 0.0 114.213 -174.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -61.22 -30.37 70.39 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.596 176.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -54.63 -36.71 64.8 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.095 178.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.492 HD13 HG22 ' A' ' 7' ' ' ILE . 0.6 OUTLIER -85.11 -28.69 6.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.192 0.52 . . . . 0.0 110.334 -178.711 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 44.7 tp -70.6 -30.01 66.57 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.944 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -72.48 -21.33 61.23 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.373 175.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.538 ' HB3' ' CD2' ' A' ' 30' ' ' TYR . 59.4 m -71.16 -9.69 58.5 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.566 -178.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.513 ' HB3' ' HB3' ' A' ' 51' ' ' PHE . 2.7 mm? -63.48 -24.93 68.03 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 121.159 0.504 . . . . 0.0 109.95 172.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -91.15 -33.2 15.52 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.04 178.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -68.59 -55.52 11.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.644 -178.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.538 ' CD2' ' HB3' ' A' ' 26' ' ' SER . 27.5 m-85 -94.83 150.8 19.81 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.825 -169.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -98.61 7.0 46.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.859 -176.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.518 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -154.39 139.03 6.49 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 175.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.49 HG22 HD13 ' A' ' 27' ' ' LEU . 60.5 t -134.75 140.61 45.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 117.259 0.529 . . . . 0.0 110.649 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.615 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 17.3 mt -125.17 132.76 70.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.467 175.186 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.07 129.66 8.61 Favored Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 174.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 90.9 mt -97.11 -7.2 33.24 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.59 0.709 . . . . 0.0 110.341 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 166.52 58.31 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 -177.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.477 ' O ' ' HB2' ' A' ' 10' ' ' SER . 6.1 p-10 -72.27 -111.42 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 123.371 0.668 . . . . 0.0 112.741 -171.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.456 ' H ' ' CG ' ' A' ' 38' ' ' ASP . 96.3 m-85 -89.84 148.64 23.06 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.108 -0.331 . . . . 0.0 110.108 -177.106 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 19.2 m -89.91 -7.78 10.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.265 0.555 . . . . 0.0 110.147 178.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.498 ' O ' HG22 ' A' ' 45' ' ' VAL . 9.2 m-20 -86.6 120.44 27.91 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.666 177.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.528 HD23 ' HB3' ' A' ' 66' ' ' ASP . 43.7 tp -59.74 -42.3 92.87 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.037 0.446 . . . . 0.0 110.12 178.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -57.85 -38.92 76.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.964 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.537 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 17.5 m -74.68 -30.44 61.57 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.18 -178.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.498 HG22 ' O ' ' A' ' 41' ' ' ASP . 48.7 t -66.44 -40.2 85.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.177 0.513 . . . . 0.0 109.915 176.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.17 -35.79 76.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.677 174.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -64.46 -31.58 72.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.007 176.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 44' ' ' THR . 87.9 mt -67.69 -46.91 70.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.947 0.403 . . . . 0.0 110.579 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.503 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 65.4 mt-10 -70.32 -16.4 62.99 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.499 177.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -81.57 -23.36 37.2 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.057 0.456 . . . . 0.0 109.961 177.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.513 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . 2.0 m-85 -86.51 -67.33 0.82 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.424 178.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.506 ' HB3' HD11 ' A' ' 27' ' ' LEU . 70.7 p -73.0 -34.26 66.3 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.972 -177.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 34.5 mtmm 66.28 12.94 8.93 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.379 -175.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -150.71 102.17 2.99 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.496 178.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.476 ' HB3' ' HG2' ' A' ' 49' ' ' GLU . 74.4 t80 -138.61 121.46 16.54 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.345 0.593 . . . . 0.0 111.275 -173.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.615 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 92.2 m-85 -114.81 167.7 10.55 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 171.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 145.01 -165.65 27.67 Favored Glycine 0 N--CA 1.438 -1.204 0 C-N-CA 119.13 -1.509 . . . . 0.0 113.502 174.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.0 m -153.21 175.54 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 114.555 -0.823 . . . . 0.0 109.117 -175.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.491 ' CD2' ' HG ' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -125.69 104.26 8.27 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 120.426 -0.51 . . . . 0.0 109.9 171.672 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.67 ' HA2' ' HB3' ' A' ' 88' ' ' HIS . . . -86.36 -28.96 26.12 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.555 -177.045 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 19.9 p30 -85.87 -177.93 6.46 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.93 0.395 . . . . 0.0 111.001 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 64.7 mtt -94.71 127.85 40.98 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.0 0.428 . . . . 0.0 110.791 -176.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.513 ' OD2' ' HB ' ' A' ' 67' ' ' VAL . 4.6 p-10 -149.87 -171.03 3.8 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.936 -175.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -74.23 142.06 78.23 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.737 -176.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.1 -27.95 39.0 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.146 2.564 . . . . 0.0 112.83 -176.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.528 ' HB3' HD23 ' A' ' 42' ' ' LEU . 2.1 m-20 -60.05 -45.31 93.28 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.5 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.513 ' HB ' ' OD2' ' A' ' 63' ' ' ASP . 87.9 t -69.09 -36.28 72.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.104 0.478 . . . . 0.0 110.804 -177.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.648 ' HD3' ' HE1' ' A' ' 73' ' ' PHE . 61.3 mttm -70.75 -2.8 15.86 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.457 -175.237 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -81.89 -42.88 18.93 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 172.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 52.7 t60 -87.53 -30.01 20.9 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.47 -176.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.491 ' HG ' ' CD2' ' A' ' 59' ' ' HIS . 4.2 mm? -103.02 109.31 61.23 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.041 177.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 71' ' ' LEU . 22.0 Cg_exo -65.4 165.72 21.63 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 123.101 2.534 . . . . 0.0 112.729 -177.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.648 ' HE1' ' HD3' ' A' ' 68' ' ' LYS . 80.3 m-85 -91.28 -23.68 20.08 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.135 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.0 t -155.34 111.83 3.2 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.115 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.0 tttm -131.0 136.98 49.0 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -177.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 14.1 t -117.28 112.25 38.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 120.972 0.415 . . . . 0.0 110.13 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 63.1 mt -87.77 151.52 22.82 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.5 -178.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 49.5 tp -116.71 96.22 5.39 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 173.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.58 HG12 ' HG2' ' A' ' 80' ' ' GLU . 62.1 t -113.91 108.13 24.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.69 -173.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.58 ' HG2' HG12 ' A' ' 79' ' ' VAL . 13.2 mm-40 63.63 16.34 9.61 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.271 176.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 109.56 -17.97 30.28 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 121.109 -0.567 . . . . 0.0 111.983 -179.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 57.1 t -86.32 133.19 30.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.739 0.304 . . . . 0.0 110.678 -178.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.9 p -89.36 128.16 35.88 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.923 178.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.484 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 36.8 mt -119.72 98.62 6.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.845 0.355 . . . . 0.0 110.244 -177.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -87.39 103.19 2.86 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.974 -0.631 . . . . 0.0 111.697 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 40.7 mtm -101.19 114.77 29.04 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 9.2 t -144.73 162.19 37.34 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.833 0.349 . . . . 0.0 110.817 -173.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.67 ' HB3' ' HA2' ' A' ' 60' ' ' GLY . 41.4 p-80 -84.22 94.54 8.43 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.438 0.637 . . . . 0.0 110.43 178.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -81.0 75.98 2.21 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.461 -0.79 . . . . 0.0 113.005 -176.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -95.11 75.2 3.46 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.893 0.378 . . . . 0.0 110.411 176.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -163.26 175.28 39.56 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.866 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.18 151.35 97.27 Favored Pre-proline 0 C--N 1.326 -0.456 0 C-N-CA 122.171 0.188 . . . . 0.0 110.86 178.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -57.28 -18.75 31.66 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.074 2.516 . . . . 0.0 113.188 -178.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -91.64 -52.64 4.66 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.983 0.42 . . . . 0.0 110.05 178.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -72.5 -11.62 60.74 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.243 -176.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 24.7 tp -56.53 -43.67 80.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.396 177.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 22.2 ttpt -56.83 -49.25 75.97 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.341 177.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.438 ' O ' ' HB2' ' A' ' 102' ' ' LYS . 16.1 t70 -58.06 -51.06 71.23 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.463 -178.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -71.52 -53.22 14.57 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.187 -0.461 . . . . 0.0 112.006 -173.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 49.8 mt -60.63 -48.9 79.71 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 -173.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 90.6 mt -72.68 -11.47 60.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.004 0.431 . . . . 0.0 111.175 -176.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 98' ' ' ASP . 33.6 ttmt -85.47 -26.27 26.4 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.228 0.537 . . . . 0.0 109.633 177.013 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 84.1 t -79.36 -37.79 19.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.138 176.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -76.21 144.57 40.36 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.351 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -82.35 -44.43 16.18 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.865 -179.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.421 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 63.7 mm-40 -111.03 -178.61 3.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.481 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -83.53 112.85 42.8 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.781 177.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.486 ' O ' HG13 ' A' ' 127' ' ' VAL . 1.5 Cg_endo -83.16 119.02 2.72 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.814 2.343 . . . . 0.0 110.969 174.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -64.93 -40.73 95.51 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.26 0.553 . . . . 0.0 109.8 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 93.2 t -121.32 129.46 75.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.221 178.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 29.1 mt -118.87 131.76 70.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 175.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.447 HD22 ' HB2' ' A' ' 130' ' ' LEU . 89.0 mt -110.43 124.52 51.89 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.178 179.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.43 ' CE1' ' HB3' ' A' ' 129' ' ' PHE . 27.9 p90 -145.49 170.64 15.99 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.254 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -131.18 121.64 3.24 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 176.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -163.0 -36.86 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.929 0.395 . . . . 0.0 110.16 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.555 ' HB ' ' ND2' ' A' ' 131' ' ' ASN . 20.8 m -94.07 149.48 21.2 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.908 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 26.9 m80 -79.99 -47.63 14.64 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.929 0.395 . . . . 0.0 110.268 -178.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -82.96 155.77 67.51 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.648 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -66.96 128.9 19.57 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.563 2.175 . . . . 0.0 111.492 176.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -145.08 138.75 26.88 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.502 -178.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -118.52 128.82 54.94 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 174.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.573 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 72.2 p -128.5 116.21 19.33 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.212 0.53 . . . . 0.0 111.219 -176.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 127' ' ' VAL . 8.6 p -111.61 117.59 55.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 176.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -126.49 -74.57 0.59 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.083 -174.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -85.12 32.28 0.55 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.892 0.377 . . . . 0.0 111.195 -178.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 83.82 -5.69 77.78 Favored Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 -174.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.486 HG13 ' O ' ' A' ' 108' ' ' PRO . 96.8 t -99.28 134.72 37.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.104 -0.548 . . . . 0.0 109.863 178.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -102.43 105.72 16.34 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.095 0.474 . . . . 0.0 110.43 179.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.573 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 51.6 m-85 -84.85 122.12 28.7 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.21 177.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.447 ' HB2' HD22 ' A' ' 112' ' ' LEU . 87.9 mt -109.34 124.06 50.33 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.826 0.346 . . . . 0.0 110.983 -178.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.555 ' ND2' ' HB ' ' A' ' 116' ' ' THR . 4.7 t30 -113.75 111.64 48.55 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.44 174.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -86.58 165.09 9.27 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.921 2.414 . . . . 0.0 112.052 174.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -89.61 139.89 15.35 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.548 -177.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 15.8 m -59.87 156.16 14.89 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.898 0.38 . . . . 0.0 111.324 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -68.05 -3.77 11.27 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 -174.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -86.78 -60.6 1.94 Allowed 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.589 -177.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -125.1 2.01 7.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.818 0.342 . . . . 0.0 111.657 -177.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -106.76 173.36 19.23 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.758 -173.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.544 ' HB3' ' HA ' ' A' ' 156' ' ' THR . 12.5 p -98.6 134.56 41.37 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.526 0.203 . . . . 0.0 110.62 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -84.48 177.18 8.21 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.387 -178.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.554 ' HB2' ' HB3' ' A' ' 6' ' ' LEU . . . -123.31 135.81 54.38 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.2 0.524 . . . . 0.0 111.962 -176.183 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 74.1 t -118.5 120.33 63.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 173.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.67 ' HA ' ' O ' ' A' ' 151' ' ' ARG . 10.0 mp -111.17 111.08 21.91 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.119 0.485 . . . . 0.0 111.124 -178.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -98.75 134.16 42.05 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.427 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.603 ' HB2' ' HB2' ' A' ' 2' ' ' LYS . 94.2 mt -105.02 102.9 12.38 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.915 177.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -135.23 130.38 35.14 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.878 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.89 11.14 60.15 Favored Glycine 0 CA--C 1.517 0.161 0 C-N-CA 121.178 -0.534 . . . . 0.0 112.443 -176.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 96.47 -13.82 65.06 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.791 178.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -95.34 159.5 14.98 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.047 0.451 . . . . 0.0 111.053 -178.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 10.9 t -101.23 138.0 26.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.584 -177.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.67 ' O ' ' HA ' ' A' ' 143' ' ' LEU . 12.5 tpt180 -109.92 99.5 8.61 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -83.84 104.5 13.98 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.638 178.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.446 ' O ' ' HA ' ' A' ' 141' ' ' ALA . 40.0 mt-10 -116.56 128.99 55.92 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.67 0.271 . . . . 0.0 111.03 176.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -102.17 106.81 17.71 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 174.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -102.17 130.53 48.83 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.789 0.328 . . . . 0.0 110.56 -175.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.544 ' HA ' ' HB3' ' A' ' 139' ' ' SER . 14.1 p -81.3 145.69 30.77 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -169.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.55 HD13 ' HG2' ' A' ' 20' ' ' PRO . 84.5 mt . . . . . 0 C--O 1.25 1.127 0 CA-C-N 115.142 -0.936 . . . . 0.0 109.68 178.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 38.8 t . . . . . 0 N--CA 1.476 0.865 0 CA-C-O 120.935 0.398 . . . . 0.0 110.04 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -108.67 140.71 41.69 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 178.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.449 ' HG2' ' HG2' ' A' ' 144' ' ' GLU . 92.7 mtt180 -126.89 117.45 22.61 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.125 0.488 . . . . 0.0 111.206 -178.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -107.18 129.88 54.79 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.946 178.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.535 ' HB3' HG21 ' A' ' 33' ' ' VAL . 44.0 tp -89.27 113.31 24.54 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.648 -176.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 64.7 tp -99.16 107.6 20.0 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.196 0.522 . . . . 0.0 110.936 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.425 HG13 ' HA2' ' A' ' 35' ' ' GLY . 27.4 pt -101.32 132.38 47.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 173.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.7 t -81.66 -168.05 1.74 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.822 0.344 . . . . 0.0 110.238 -178.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -63.62 128.04 34.07 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.715 0.769 . . . . 0.0 111.632 -176.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.514 ' OG ' HG13 ' A' ' 12' ' ' VAL . 33.4 t -100.15 155.38 17.78 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.783 176.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 50.3 m-70 -132.62 23.2 4.32 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.172 -177.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.514 HG13 ' OG ' ' A' ' 10' ' ' SER . 7.8 p -114.65 144.65 32.27 Favored Pre-proline 0 C--O 1.241 0.622 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.308 -176.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.487 ' HA ' ' CG2' ' A' ' 12' ' ' VAL . 12.0 Cg_endo -93.59 93.81 0.14 OUTLIER 'Cis proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.847 -1.314 . . . . 0.0 112.816 -5.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.54 HG23 HG11 ' A' ' 40' ' ' VAL . 1.9 t -138.36 -71.89 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.363 0.601 . . . . 0.0 109.678 176.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 40.3 mtp180 -125.08 73.91 1.33 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.297 178.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.45 ' SD ' ' HB2' ' A' ' 19' ' ' LEU . 14.4 ttm -177.13 -80.68 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.495 178.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 58.08 14.57 2.76 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.969 -176.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.4 m -120.0 32.9 5.83 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.532 -176.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.584 HD13 HD21 ' A' ' 135' ' ' LEU . 7.5 tt -89.17 120.64 69.84 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.708 -179.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 19' ' ' LEU . 16.7 Cg_exo -68.57 126.69 14.45 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 123.114 2.543 . . . . 0.0 112.348 -179.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -66.52 -12.24 56.61 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.777 -177.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.499 ' HB2' HD23 ' A' ' 157' ' ' LEU . 43.6 mt-10 -58.48 -38.26 77.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.264 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.442 HD12 HD12 ' A' ' 5' ' ' LEU . 0.4 OUTLIER -67.52 -29.27 44.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.4 0.619 . . . . 0.0 110.282 -178.59 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.519 ' O ' HD23 ' A' ' 27' ' ' LEU . 38.9 tp -78.27 -12.55 60.01 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.264 -177.179 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -84.85 -27.39 26.75 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.735 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.428 ' HB3' ' CE2' ' A' ' 30' ' ' TYR . 15.3 m -69.42 -6.37 29.74 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.934 -175.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.647 HD13 HG22 ' A' ' 33' ' ' VAL . 4.4 mm? -58.35 -26.0 62.64 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.745 0.307 . . . . 0.0 111.594 178.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.7 mttp -85.32 -8.27 58.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.286 -175.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -106.54 -22.46 12.77 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -168.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.499 ' CD2' ' HB2' ' A' ' 5' ' ' LEU . 29.5 m-85 -112.2 156.19 22.73 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.476 -0.489 . . . . 0.0 111.79 -172.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -67.03 -55.15 15.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.616 -177.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -136.2 158.51 23.98 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.569 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.647 HG22 HD13 ' A' ' 27' ' ' LEU . 89.2 t -123.4 136.02 61.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 120.996 0.427 . . . . 0.0 110.415 -179.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.46 HG23 ' SD ' ' A' ' 86' ' ' MET . 70.5 mt -115.74 128.88 72.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.919 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.425 ' HA2' HG13 ' A' ' 7' ' ' ILE . . . -121.84 117.82 3.51 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.846 178.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.1 mt -83.69 19.39 1.66 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.418 0.628 . . . . 0.0 110.26 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.405 ' H ' ' C ' ' A' ' 35' ' ' GLY . . . 153.59 84.78 0.05 OUTLIER Glycine 0 N--CA 1.44 -1.074 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 -177.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.512 ' CG ' ' H ' ' A' ' 39' ' ' TYR . 9.2 t70 -74.75 -165.33 0.35 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.821 0.344 . . . . 0.0 110.829 -173.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.512 ' H ' ' CG ' ' A' ' 38' ' ' ASP . 37.2 m-85 -68.82 149.32 49.1 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.089 -0.338 . . . . 0.0 110.089 -177.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.54 HG11 HG23 ' A' ' 14' ' ' VAL . 24.6 m -68.46 -17.17 21.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -176.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -93.66 125.3 38.2 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.703 0.287 . . . . 0.0 110.481 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.524 HD13 ' CD2' ' A' ' 70' ' ' HIS . 50.8 tp -63.84 -33.46 75.72 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.416 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -59.68 -34.38 72.79 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.36 178.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 20.9 m -78.28 -31.72 49.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.612 178.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.47 HG21 HG13 ' A' ' 67' ' ' VAL . 46.4 t -60.29 -41.38 86.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.38 0.609 . . . . 0.0 109.705 173.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.6 mp -66.27 -34.28 69.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.07 175.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -61.89 -37.13 83.43 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 174.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -71.52 -42.27 68.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.519 178.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -70.85 -19.57 62.63 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.342 0.592 . . . . 0.0 110.605 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.4 tptm -78.27 -46.88 19.12 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.96 178.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.51 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . 32.4 m-85 -73.36 -55.25 6.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.449 176.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.573 ' HB2' HD11 ' A' ' 27' ' ' LEU . 22.7 t -90.7 98.87 12.03 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.71 174.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -56.14 -35.69 67.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.954 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -110.77 82.75 1.64 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.145 179.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -101.55 124.84 47.87 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.533 -178.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.416 ' HB2' HG12 ' A' ' 34' ' ' ILE . 54.4 m-85 -106.92 117.02 32.95 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.642 ' HA3' HD21 ' A' ' 71' ' ' LEU . . . -117.98 144.12 18.01 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.079 -1.058 . . . . 0.0 113.028 -175.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.406 HG21 ' CB ' ' A' ' 86' ' ' MET . 15.3 t -128.58 144.66 37.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 175.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -97.36 112.57 24.34 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.982 -175.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.687 ' HA3' ' HB3' ' A' ' 88' ' ' HIS . . . -152.53 22.9 0.84 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.407 -0.901 . . . . 0.0 112.556 178.079 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 23.9 p-10 -136.48 174.25 10.82 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 110.41 -0.218 . . . . 0.0 110.41 -178.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 66.8 mtm -92.55 119.96 32.53 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.669 ' OD2' ' HB ' ' A' ' 67' ' ' VAL . 17.7 p-10 -149.27 -173.5 4.4 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.77 -169.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -81.34 145.26 55.26 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.87 175.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -57.28 -20.74 40.59 Favored 'Trans proline' 0 CA--C 1.532 0.401 0 C-N-CA 122.89 2.393 . . . . 0.0 113.426 -176.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.507 ' HB3' HD23 ' A' ' 42' ' ' LEU . 3.0 m-20 -70.41 -27.69 64.48 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.31 -0.405 . . . . 0.0 112.037 -177.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.669 ' HB ' ' OD2' ' A' ' 63' ' ' ASP . 38.1 t -74.77 -19.15 16.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.113 0.482 . . . . 0.0 110.539 -178.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 63.9 tttt -53.38 -36.39 61.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.702 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -69.84 -27.97 65.29 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.518 -176.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.524 ' CD2' HD13 ' A' ' 42' ' ' LEU . 29.6 m-70 -95.86 -30.65 13.54 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 121.111 -0.235 . . . . 0.0 111.138 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.642 HD21 ' HA3' ' A' ' 57' ' ' GLY . 13.1 mt -110.26 102.36 50.99 Favored Pre-proline 0 C--N 1.326 -0.443 0 C-N-CA 120.931 -0.308 . . . . 0.0 110.755 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.494 ' HD2' ' O ' ' A' ' 57' ' ' GLY . 46.9 Cg_endo -70.12 151.3 66.98 Favored 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.379 2.053 . . . . 0.0 110.734 172.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -63.42 -22.54 66.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.84 0.352 . . . . 0.0 111.635 -175.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 38.6 m -153.82 141.7 20.15 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 175.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 36.1 tttp -144.33 125.32 14.42 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.345 -177.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 11.4 t -111.65 112.61 41.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.865 0.364 . . . . 0.0 110.574 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 94.0 mt -87.69 144.81 26.45 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.986 -179.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 59.7 tp -112.14 97.37 6.6 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 170.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 41.4 t -110.9 93.45 2.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.091 -176.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 51.18 63.25 2.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.907 179.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.16 -9.43 47.31 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.912 -0.661 . . . . 0.0 113.206 176.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 60.8 t -99.89 115.21 40.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.887 0.375 . . . . 0.0 110.732 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.5 p -86.84 127.06 35.02 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.317 176.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.472 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 18.8 mt -119.36 93.25 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -176.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.454 ' O ' HG21 ' A' ' 111' ' ' ILE . . . -81.21 96.09 1.7 Allowed Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.47 ' HG2' HD12 ' A' ' 112' ' ' LEU . 38.3 mtm -96.06 119.13 34.01 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 120.896 0.379 . . . . 0.0 110.242 -176.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 39.2 t -153.22 107.05 3.05 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.993 -178.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.687 ' HB3' ' HA3' ' A' ' 60' ' ' GLY . 64.8 t-80 -91.26 69.27 6.04 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -179.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -85.01 178.73 51.03 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.63 -178.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -132.28 142.98 49.59 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 148.74 -172.68 28.86 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 121.081 -0.58 . . . . 0.0 111.808 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.41 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . . . -76.95 146.1 75.06 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 120.519 0.2 . . . . 0.0 110.741 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 92' ' ' ALA . 15.5 Cg_exo -69.2 -10.55 29.3 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.953 2.435 . . . . 0.0 112.859 -178.351 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 5.7 m0 -68.48 -44.47 74.68 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.996 0.427 . . . . 0.0 110.625 -178.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -91.49 11.66 23.29 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.807 -178.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 28.3 tp -58.66 -49.54 77.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.047 -178.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.462 ' HD2' ' HB3' ' A' ' 125' ' ' ALA . 28.5 ttpt -61.89 -50.35 72.56 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.65 179.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -60.72 -53.23 59.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.654 -174.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.422 ' O ' HG22 ' A' ' 103' ' ' VAL . 26.8 mtm105 -65.18 -46.36 81.1 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -176.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.494 HD12 HG23 ' A' ' 111' ' ' ILE . 83.5 mt -65.8 -36.76 84.41 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.474 -176.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.651 HD23 HG22 ' A' ' 127' ' ' VAL . 79.6 mt -78.77 -15.69 58.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.778 0.323 . . . . 0.0 110.91 178.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.472 ' HD2' ' HA ' ' A' ' 102' ' ' LYS . 33.4 tptt -86.21 -34.7 20.4 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.076 0.465 . . . . 0.0 110.039 177.102 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 99' ' ' ARG . 73.8 t -74.19 -43.95 50.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.571 174.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -104.54 87.32 2.68 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.88 176.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -71.78 -19.2 62.05 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.423 -173.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -77.4 -14.65 59.66 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.256 -179.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt 63.86 99.29 0.04 OUTLIER Pre-proline 0 C--O 1.232 0.182 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.096 -175.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -76.24 144.36 26.25 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.601 2.201 . . . . 0.0 110.938 175.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -72.49 -41.9 65.47 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.137 0.494 . . . . 0.0 109.836 178.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 90.0 t -116.32 130.14 71.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.583 177.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.494 HG23 HD12 ' A' ' 100' ' ' LEU . 30.6 mt -125.08 128.45 72.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 120.774 0.321 . . . . 0.0 110.677 178.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.47 HD12 ' HG2' ' A' ' 86' ' ' MET . 92.1 mt -99.98 119.22 37.91 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -138.59 -174.74 3.91 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.81 -175.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.566 ' HA2' ' ND2' ' A' ' 131' ' ' ASN . . . -147.75 151.77 23.96 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 175.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -136.64 179.1 6.57 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 117.195 0.498 . . . . 0.0 109.937 177.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.3 p -73.92 11.26 0.92 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -171.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 -144.75 -172.12 3.76 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 122.131 -0.356 . . . . 0.0 111.045 -178.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -60.6 155.48 49.86 Favored Pre-proline 0 C--N 1.329 -0.316 0 O-C-N 123.839 0.712 . . . . 0.0 112.695 -172.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -47.03 144.78 8.09 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 124.441 3.428 . . . . 0.0 113.266 178.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -165.7 144.03 5.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.267 -176.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -102.54 135.78 43.56 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 173.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.47 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 57.8 p -137.72 158.02 45.25 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.908 -174.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.495 ' HA ' ' O ' ' A' ' 127' ' ' VAL . 85.2 t -132.54 115.2 24.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.939 0.4 . . . . 0.0 110.425 176.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.632 ' HB2' ' HE2' ' A' ' 129' ' ' PHE . 75.4 mmtt -125.58 125.62 43.47 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.483 177.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.462 ' HB3' ' HD2' ' A' ' 97' ' ' LYS . . . 65.1 9.24 5.36 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 123.64 0.588 . . . . 0.0 111.779 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 104.11 -4.2 44.86 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.409 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.651 HG22 HD23 ' A' ' 101' ' ' LEU . 52.5 t -90.19 134.36 29.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 179.097 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 51.8 ttt180 -96.45 105.82 17.96 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.147 0.499 . . . . 0.0 110.18 -177.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.632 ' HE2' ' HB2' ' A' ' 124' ' ' LYS . 58.7 m-85 -94.63 126.52 39.98 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.88 -178.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.441 ' HB2' HD21 ' A' ' 112' ' ' LEU . 53.6 mt -115.26 120.91 41.26 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.754 0.311 . . . . 0.0 110.638 -178.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.566 ' ND2' ' HA2' ' A' ' 114' ' ' GLY . 3.7 t-20 -108.02 115.99 57.72 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.471 174.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -83.78 164.87 13.84 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.745 2.297 . . . . 0.0 112.234 174.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -73.99 153.71 47.25 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.442 175.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 96.0 p -81.28 160.33 24.25 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.061 0.458 . . . . 0.0 110.999 -176.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.584 HD21 HD13 ' A' ' 19' ' ' LEU . 5.9 mp -74.11 -0.17 15.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.1 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -97.19 -10.57 25.6 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.586 178.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -100.83 -6.03 25.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.108 0.48 . . . . 0.0 110.816 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 74.86 38.45 41.71 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.19 -179.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 25.2 m -139.31 145.84 39.59 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.438 ' O ' HD13 ' A' ' 154' ' ' LEU . 23.9 p90 -139.73 160.03 40.83 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 178.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -114.33 125.97 54.48 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.051 0.453 . . . . 0.0 110.352 -175.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 48.0 t -102.99 121.44 54.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 177.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.406 HD21 HG11 ' A' ' 150' ' ' VAL . 6.3 tt -94.67 101.21 13.05 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.449 ' HG2' ' HG2' ' A' ' 3' ' ' ARG . 60.1 mt-10 -95.32 117.62 30.63 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.459 -178.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 72.0 mt -90.67 90.19 7.85 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 172.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.486 ' HB3' ' HD3' ' A' ' 151' ' ' ARG . 35.3 t70 -115.57 130.11 56.75 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.844 -174.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 68.13 -59.51 0.4 Allowed Glycine 0 CA--C 1.521 0.446 0 O-C-N 123.584 0.553 . . . . 0.0 112.337 -171.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 164.9 33.39 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 176.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -126.53 155.55 42.2 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.631 0.253 . . . . 0.0 110.675 -176.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.406 HG11 HD21 ' A' ' 143' ' ' LEU . 29.0 t -86.88 95.03 4.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.524 176.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.486 ' HD3' ' HB3' ' A' ' 146' ' ' ASP . 35.0 mtp-105 -105.82 92.31 4.11 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.53 -175.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -90.54 122.17 33.12 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.198 0.523 . . . . 0.0 109.774 178.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.42 ' HB2' ' HE3' ' A' ' 155' ' ' LYS . 57.9 mt-10 -116.04 127.38 54.85 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.132 177.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.438 HD13 ' O ' ' A' ' 140' ' ' TYR . 38.7 tp -90.49 112.17 23.72 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.172 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.42 ' HE3' ' HB2' ' A' ' 153' ' ' GLU . 85.8 mttt -117.09 145.49 43.73 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.78 -173.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 3.5 p -96.65 150.58 20.51 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.321 0.581 . . . . 0.0 112.37 -171.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.499 HD23 ' HB2' ' A' ' 22' ' ' GLU . 91.1 mt . . . . . 0 C--O 1.249 1.03 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.952 177.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 60.3 t . . . . . 0 N--CA 1.48 1.03 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.5 ' HB2' HD11 ' A' ' 145' ' ' LEU . 98.8 mttt -85.47 130.42 34.59 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.151 0.501 . . . . 0.0 110.288 178.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 56.0 mtp180 -111.2 116.88 31.81 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.947 -178.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.565 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 18.3 m-85 -103.93 125.51 50.38 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.452 0.644 . . . . 0.0 111.102 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.507 ' HB3' HG21 ' A' ' 33' ' ' VAL . 36.0 tp -89.12 133.22 34.47 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.078 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.443 ' HB2' HD21 ' A' ' 143' ' ' LEU . 56.0 tp -121.72 111.96 17.81 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.835 0.35 . . . . 0.0 110.789 178.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.407 HG13 ' HA2' ' A' ' 35' ' ' GLY . 27.9 pt -101.45 128.74 53.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 174.016 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.553 ' H ' HD23 ' A' ' 135' ' ' LEU . 12.2 t -76.06 -171.44 1.69 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.852 -174.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.645 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 18.0 t0 -62.14 104.46 0.48 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.757 -177.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.465 ' H ' ' HA3' ' A' ' 37' ' ' GLY . 26.7 t -97.18 153.79 17.78 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.625 -177.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 13.8 m80 -134.8 65.39 1.57 Allowed 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.427 ' O ' HG21 ' A' ' 40' ' ' VAL . 64.8 t -118.8 130.09 25.02 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.617 -176.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -76.41 -52.12 0.16 OUTLIER 'Cis proline' 0 C--N 1.343 0.254 0 C-N-CA 123.192 -1.587 . . . . 0.0 112.21 -3.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 37.9 t 49.14 -93.37 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 O-C-N 123.858 0.724 . . . . 0.0 110.81 -178.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -155.56 25.93 0.4 Allowed 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.453 0.644 . . . . 0.0 109.773 171.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.423 ' C ' ' H ' ' A' ' 18' ' ' SER . 52.5 ttp -109.75 -75.74 0.62 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 176.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 63.45 -6.48 0.21 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.443 -0.799 . . . . 0.0 113.133 175.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.423 ' H ' ' C ' ' A' ' 16' ' ' MET . 2.3 p -78.63 58.06 2.16 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.64 0.733 . . . . 0.0 111.094 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.8 tt -107.93 112.78 61.59 Favored Pre-proline 0 N--CA 1.447 -0.604 0 CA-C-N 115.116 -0.947 . . . . 0.0 108.544 176.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -53.51 120.62 8.1 Favored 'Trans proline' 0 CA--C 1.528 0.202 0 C-N-CA 123.063 2.509 . . . . 0.0 112.868 -177.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -61.01 -29.8 69.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.174 -177.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -64.78 -25.01 67.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.663 -177.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.5 HD12 ' CG ' ' A' ' 140' ' ' TYR . 1.2 tt -68.49 -32.52 55.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.266 0.555 . . . . 0.0 109.531 178.159 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.542 ' HA ' HD21 ' A' ' 27' ' ' LEU . 24.4 tp -77.79 -35.33 51.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.104 -177.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -71.47 -26.44 62.71 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.626 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 42.9 m -81.69 2.05 31.45 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.588 -177.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.555 ' CD1' HG22 ' A' ' 33' ' ' VAL . 2.9 mm? -54.52 -31.31 56.0 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.043 0.449 . . . . 0.0 111.203 177.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -74.35 -15.98 60.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.275 -175.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -96.16 5.29 51.39 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.941 0.401 . . . . 0.0 111.679 -175.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -119.67 169.9 9.68 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 177.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -105.19 -56.2 2.21 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.233 0.54 . . . . 0.0 109.913 -178.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.565 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -117.36 146.7 18.79 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 175.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.555 HG22 ' CD1' ' A' ' 27' ' ' LEU . 72.8 t -130.03 134.87 62.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 117.315 0.557 . . . . 0.0 111.109 -177.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.525 HG12 ' HB2' ' A' ' 56' ' ' TYR . 36.2 mt -114.91 125.71 72.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.373 177.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.407 ' HA2' HG13 ' A' ' 7' ' ' ILE . . . -109.41 103.43 1.76 Allowed Glycine 0 N--CA 1.441 -0.979 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.716 174.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.414 ' HG ' HD12 ' A' ' 6' ' ' LEU . 84.5 mt -74.1 -28.69 61.48 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.645 ' HA3' ' HA ' ' A' ' 9' ' ' ASP . . . -145.92 109.12 0.49 Allowed Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.063 173.31 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.407 ' OD2' HG23 ' A' ' 45' ' ' VAL . 15.2 p-10 -98.98 -154.39 0.46 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 120.843 0.354 . . . . 0.0 110.893 -175.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.405 ' HE2' HD22 ' A' ' 48' ' ' LEU . 97.3 m-85 -88.83 137.35 32.4 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 -179.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.427 HG21 ' O ' ' A' ' 12' ' ' VAL . 11.5 m -76.18 4.83 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.029 0.442 . . . . 0.0 111.611 -174.321 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.503 ' O ' HG22 ' A' ' 45' ' ' VAL . 17.5 t70 -105.63 123.76 48.44 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.148 177.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.485 HD22 ' HB3' ' A' ' 66' ' ' ASP . 44.8 tp -59.04 -43.49 91.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 0.0 112.278 -172.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -62.03 -37.72 85.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.1 0.476 . . . . 0.0 110.57 -178.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 20.8 m -70.82 -27.96 64.26 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.844 178.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.503 HG22 ' O ' ' A' ' 41' ' ' ASP . 61.8 t -62.88 -40.71 89.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-O 121.487 0.66 . . . . 0.0 109.588 173.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.36 -35.26 74.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.143 177.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.79 -31.92 72.99 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.596 175.39 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.405 HD22 ' HE2' ' A' ' 39' ' ' TYR . 95.3 mt -67.69 -41.74 83.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.098 0.475 . . . . 0.0 110.061 178.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -71.97 -14.89 62.03 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.108 176.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -82.47 -45.69 14.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.33 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -70.85 -65.43 0.74 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.991 0.424 . . . . 0.0 110.408 173.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.493 ' HB3' HD13 ' A' ' 27' ' ' LEU . 8.9 p -90.44 96.17 10.53 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.92 174.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -62.31 -33.03 73.89 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.459 -179.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -98.3 79.36 2.53 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.495 0.664 . . . . 0.0 109.457 171.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -100.33 127.6 46.6 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.612 -177.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.525 ' HB2' HG12 ' A' ' 34' ' ' ILE . 76.1 m-85 -117.28 169.94 9.08 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 175.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 153.96 -172.22 32.64 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 119.355 -1.402 . . . . 0.0 113.609 175.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.49 HG13 ' HE1' ' A' ' 86' ' ' MET . 0.2 OUTLIER -144.27 -169.2 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 114.856 -0.672 . . . . 0.0 109.871 -177.494 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.49 ' HE2' ' CG ' ' A' ' 63' ' ' ASP . 57.0 t-80 -94.48 130.83 40.71 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.798 0.332 . . . . 0.0 111.235 -173.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -75.15 -158.83 7.02 Favored Glycine 0 CA--C 1.522 0.471 0 CA-C-N 115.731 -0.668 . . . . 0.0 113.249 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -73.05 -73.12 0.22 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -176.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 50.0 ttm -131.71 129.48 40.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.821 0.344 . . . . 0.0 110.361 -177.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.506 ' OD2' ' HB ' ' A' ' 67' ' ' VAL . 23.0 p-10 -145.52 -162.93 1.61 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.681 -173.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.409 ' HD2' ' O ' ' A' ' 40' ' ' VAL . 76.5 m-85 -103.44 155.19 37.14 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.521 173.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -48.88 -34.47 28.53 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.281 2.654 . . . . 0.0 113.374 -176.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.485 ' HB3' HD22 ' A' ' 42' ' ' LEU . 35.7 m-20 -58.09 -39.18 77.94 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.558 -177.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.506 ' HB ' ' OD2' ' A' ' 63' ' ' ASP . 60.7 t -80.08 -31.15 13.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.518 -177.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.456 ' HG2' ' NE2' ' A' ' 59' ' ' HIS . 93.5 mttt -60.05 -28.03 67.43 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.494 0.664 . . . . 0.0 110.233 175.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -72.8 -47.28 47.87 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.177 177.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -84.16 -35.44 23.58 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.868 -0.606 . . . . 0.0 112.278 -169.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.473 HD23 HG13 ' A' ' 67' ' ' VAL . 4.5 mm? -100.56 117.06 63.54 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-O 120.635 0.255 . . . . 0.0 110.995 -178.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -68.86 146.25 65.14 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.808 2.339 . . . . 0.0 111.398 176.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -72.75 -29.65 63.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.856 0.36 . . . . 0.0 110.931 -176.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 18.1 m -150.02 132.77 15.94 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.404 178.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -150.65 144.35 25.16 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 5.9 t -110.0 133.23 55.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 175.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 69.8 mt -111.63 153.97 25.56 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.584 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 45.0 tp -116.69 99.23 6.99 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 174.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 63.8 t -113.58 109.19 27.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.712 -175.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.676 ' HG3' HD13 ' A' ' 145' ' ' LEU . 5.0 mm-40 57.25 30.27 18.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.137 178.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.72 -7.91 59.58 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.006 -0.616 . . . . 0.0 113.064 178.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.566 HG22 HG21 ' A' ' 150' ' ' VAL . 61.5 t -101.56 136.19 34.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.864 0.332 . . . . 0.0 111.256 -176.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -88.51 130.15 35.29 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.331 178.231 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.461 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 20.0 mt -118.78 99.62 8.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.892 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -84.27 106.66 2.92 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 111.084 -0.807 . . . . 0.0 111.084 177.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.49 ' HE1' HG13 ' A' ' 58' ' ' VAL . 36.5 mtm -104.12 132.05 50.77 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.997 0.427 . . . . 0.0 111.104 -175.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 113' ' ' PHE . 37.6 t -155.61 165.17 37.36 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 175.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 31.9 t-80 -76.5 -36.81 57.57 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.52 175.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.2 128.94 1.7 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.473 178.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 31.8 t-105 -156.67 141.08 16.67 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 178.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 123.46 177.53 15.14 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.601 -177.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.14 139.06 92.41 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.637 0.218 . . . . 0.0 110.499 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -56.79 -23.1 48.44 Favored 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 123.126 2.551 . . . . 0.0 113.206 -175.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -77.12 -54.34 6.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.224 0.535 . . . . 0.0 110.294 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -87.73 -8.1 56.5 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.717 -174.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 59.4 tp -59.18 -39.07 81.37 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.416 176.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -60.93 -40.63 93.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.992 178.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -69.62 -39.86 76.92 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.628 177.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.444 ' O ' HG21 ' A' ' 103' ' ' VAL . 78.4 ttt180 -67.89 -41.49 82.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.248 -177.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.483 HD11 HG23 ' A' ' 111' ' ' ILE . 78.1 mt -69.54 -31.64 69.97 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.618 0.247 . . . . 0.0 111.017 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.612 HD22 HG21 ' A' ' 127' ' ' VAL . 83.4 mt -74.62 -23.37 58.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.138 0.494 . . . . 0.0 110.225 174.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -74.6 -33.47 62.63 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.538 175.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.444 HG21 ' O ' ' A' ' 99' ' ' ARG . 98.5 t -71.9 -55.97 11.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.053 175.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -92.94 91.95 7.64 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.462 177.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -67.5 -25.26 65.77 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.174 -177.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -67.52 -24.18 65.53 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.942 176.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 32.8 mtmm 62.49 93.98 0.05 OUTLIER Pre-proline 0 N--CA 1.463 0.19 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.721 -177.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -76.8 156.85 35.21 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 123.161 2.574 . . . . 0.0 111.721 -177.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -66.03 -42.66 89.31 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.213 0.53 . . . . 0.0 110.16 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 53.8 t -128.15 139.3 52.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.605 -178.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.483 HG23 HD11 ' A' ' 100' ' ' LEU . 61.0 mt -125.08 130.52 73.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.949 0.404 . . . . 0.0 110.268 176.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.418 HD23 ' HB2' ' A' ' 130' ' ' LEU . 98.0 mt -110.85 131.19 55.25 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.108 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.473 ' HA ' ' O ' ' A' ' 87' ' ' CYS . 37.8 p90 -155.18 172.24 18.47 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.169 -0.468 . . . . 0.0 109.95 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -133.15 114.61 1.41 Allowed Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.385 176.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 63.8 t-80 -171.91 -39.73 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.625 0.25 . . . . 0.0 110.698 -176.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.567 HG23 ' H ' ' A' ' 117' ' ' HIS . 0.2 OUTLIER -75.25 -165.52 0.41 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.987 0.423 . . . . 0.0 111.373 -174.168 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.567 ' H ' HG23 ' A' ' 116' ' ' THR . 93.1 m-70 -94.55 -54.75 3.4 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 111.946 0.351 . . . . 0.0 111.946 -171.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -116.24 167.84 9.69 Favored Pre-proline 0 C--N 1.323 -0.578 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.52 -172.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.7 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 16.2 Cg_exo -69.54 76.56 1.05 Allowed 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.641 2.227 . . . . 0.0 110.092 166.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -108.89 142.03 40.1 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.719 -170.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -94.01 99.99 12.2 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.333 175.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.606 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 80.7 p -104.63 113.07 26.42 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.318 0.58 . . . . 0.0 110.677 -178.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 39.6 t -121.81 97.06 4.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.22 -178.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -137.16 33.93 2.57 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.792 177.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.452 ' C ' ' H ' ' A' ' 127' ' ' VAL . . . -166.74 14.88 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.221 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 80.25 -27.64 2.75 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.518 -172.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.612 HG21 HD22 ' A' ' 101' ' ' LEU . 42.3 t -85.82 138.7 18.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.28 -0.46 . . . . 0.0 110.409 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -87.48 107.64 18.66 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 174.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.606 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 92.8 m-85 -88.95 104.18 16.72 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 174.176 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.418 ' HB2' HD23 ' A' ' 112' ' ' LEU . 49.7 mt -109.19 134.66 51.45 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.181 -173.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.7 ' O ' ' HA ' ' A' ' 119' ' ' PRO . 5.8 t30 -117.76 104.91 48.55 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.268 178.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -70.59 142.72 44.97 Favored 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.805 2.336 . . . . 0.0 112.176 177.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -66.61 152.21 52.4 Favored Glycine 0 N--CA 1.452 -0.285 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.71 -178.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 39.9 m -64.28 138.49 58.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.962 0.411 . . . . 0.0 111.405 -178.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.553 HD23 ' H ' ' A' ' 8' ' ' SER . 74.6 mt -62.47 -31.1 71.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.376 -177.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -66.92 -16.16 64.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.633 -178.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 36.6 tp10 -90.88 1.0 57.34 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.287 0.565 . . . . 0.0 110.478 -178.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 74.94 43.2 28.02 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.248 178.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 57.5 m -152.22 142.17 22.13 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.754 0.311 . . . . 0.0 110.324 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.5 ' CG ' HD12 ' A' ' 23' ' ' ILE . 27.9 p90 -141.43 175.77 9.4 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 177.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.435 ' HB1' HD22 ' A' ' 6' ' ' LEU . . . -114.5 136.66 52.78 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.117 -175.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.449 HG11 ' HG3' ' A' ' 144' ' ' GLU . 21.5 t -118.44 105.86 18.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.879 176.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.728 ' HA ' ' O ' ' A' ' 151' ' ' ARG . 0.3 OUTLIER -95.75 109.4 21.71 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.438 0.637 . . . . 0.0 110.067 176.132 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.449 ' HG3' HG11 ' A' ' 142' ' ' VAL . 47.6 mt-10 -107.11 144.12 34.28 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.157 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.676 HD13 ' HG3' ' A' ' 80' ' ' GLU . 22.0 mt -90.7 90.33 7.91 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.777 -176.065 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -92.14 101.77 14.3 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.397 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.87 10.18 58.04 Favored Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.996 178.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 110.21 -18.14 28.49 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.821 -177.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -85.22 117.91 24.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.792 0.33 . . . . 0.0 110.482 177.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.566 HG21 HG22 ' A' ' 82' ' ' VAL . 5.3 t -80.31 124.39 38.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.2 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.728 ' O ' ' HA ' ' A' ' 143' ' ' LEU . 59.0 ttt85 -119.35 107.85 13.88 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 177.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . 0.546 ' CE2' HD13 ' A' ' 143' ' ' LEU . 9.3 m-85 -83.16 86.62 6.99 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 177.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -102.5 127.72 49.43 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.418 -175.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.598 HD22 ' HG2' ' A' ' 119' ' ' PRO . 9.2 tp -73.29 139.33 46.03 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.478 -178.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -118.71 132.02 56.15 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.741 176.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 21.0 p -88.57 146.36 25.18 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.162 -179.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 74.2 mt . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.337 -0.84 . . . . 0.0 109.633 178.517 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 95.2 t . . . . . 0 N--CA 1.48 1.06 0 CA-C-O 120.801 0.334 . . . . 0.0 110.391 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.87 ' HB2' ' HB2' ' A' ' 145' ' ' LEU . 72.4 mmtt -122.4 101.7 7.65 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 173.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.496 ' HG2' ' HG2' ' A' ' 144' ' ' GLU . 41.1 mtt180 -110.28 120.59 42.94 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.014 0.435 . . . . 0.0 111.191 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.464 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 86.7 m-85 -116.57 131.25 57.0 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.683 178.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.514 ' HB3' HG21 ' A' ' 33' ' ' VAL . 36.4 tp -89.21 118.78 29.15 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.015 178.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 51.2 tp -106.11 102.01 11.46 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.066 0.46 . . . . 0.0 110.391 -179.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.3 pt -101.6 121.66 52.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.928 177.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.773 ' HB2' ' HA ' ' A' ' 134' ' ' SER . 16.2 m -68.5 171.17 7.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.039 -179.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -64.02 144.06 57.39 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.287 0.565 . . . . 0.0 110.221 -179.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.507 ' HB3' ' HE1' ' A' ' 16' ' ' MET . 68.7 m -143.23 178.96 7.37 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.984 -174.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 32.4 m80 -129.22 79.17 1.9 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.154 0.502 . . . . 0.0 110.472 178.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.06 142.65 33.96 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.379 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -93.72 97.23 0.14 OUTLIER 'Cis proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.299 -1.542 . . . . 0.0 112.056 -3.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.6 t -116.64 -88.09 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 121.19 -0.204 . . . . 0.0 110.896 -178.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -134.67 -14.39 2.18 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 120.949 0.404 . . . . 0.0 111.077 178.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.568 ' SD ' ' HB1' ' A' ' 136' ' ' ALA . 33.8 ttp -64.9 -71.03 0.2 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.405 177.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 63.16 5.6 2.0 Allowed 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.701 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.3 m -85.43 15.32 4.54 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.632 ' HG ' ' HG ' ' A' ' 135' ' ' LEU . 6.2 tt -90.5 111.71 48.99 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.4 132.41 35.8 Favored 'Trans proline' 0 C--O 1.234 0.318 0 C-N-CA 122.815 2.343 . . . . 0.0 112.703 -174.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -68.66 -19.28 64.39 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.302 177.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -56.37 -44.81 80.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.107 175.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.1 tt -70.22 -29.17 38.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.343 -177.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.483 ' O ' HD23 ' A' ' 27' ' ' LEU . 58.8 tp -71.07 -22.87 62.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.251 179.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -82.32 -20.79 36.67 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.184 175.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.8 m -74.02 -9.47 58.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.53 -177.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 1.017 HD12 HG22 ' A' ' 33' ' ' VAL . 2.6 mm? -51.67 -38.66 55.97 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.321 0.582 . . . . 0.0 110.727 176.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -80.36 -17.45 51.9 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.729 -174.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -95.47 2.82 54.58 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -172.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.43 ' CD2' ' HB2' ' A' ' 5' ' ' LEU . 43.2 m-85 -124.27 -176.65 3.56 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.675 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -96.29 -37.99 10.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.034 0.445 . . . . 0.0 110.521 -178.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -151.58 158.67 27.87 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 1.017 HG22 HD12 ' A' ' 27' ' ' LEU . 92.3 t -126.36 136.93 59.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 120.938 0.399 . . . . 0.0 110.691 -178.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.513 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 57.4 mt -115.81 112.58 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.097 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -98.21 126.47 8.9 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 178.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.7 mt -99.67 10.85 40.62 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.884 0.342 . . . . 0.0 110.884 -177.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 122.59 43.31 0.39 Allowed Glycine 0 C--N 1.329 0.143 0 C-N-CA 120.995 -0.621 . . . . 0.0 111.733 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.47 -76.01 0.18 Allowed 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 123.24 0.616 . . . . 0.0 112.369 -174.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.491 ' HD2' HD11 ' A' ' 48' ' ' LEU . 92.9 m-85 -86.19 128.48 34.9 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.994 0.426 . . . . 0.0 110.774 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.1 m -91.26 1.34 8.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.375 0.607 . . . . 0.0 110.311 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.504 ' O ' HG21 ' A' ' 45' ' ' VAL . 26.8 t70 -95.73 126.05 40.73 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.815 -178.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.411 HD11 ' HB3' ' A' ' 66' ' ' ASP . 62.3 tp -58.41 -49.64 76.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.589 -176.1 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -58.14 -42.47 85.92 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.987 -177.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.478 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 10.4 m -67.95 -35.34 78.23 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.156 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.504 HG21 ' O ' ' A' ' 41' ' ' ASP . 89.2 t -61.21 -41.13 88.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 121.272 0.558 . . . . 0.0 110.247 175.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.508 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 1.7 mp -66.99 -38.11 80.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.026 177.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.5 -34.15 73.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.563 176.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.491 HD11 ' HD2' ' A' ' 39' ' ' TYR . 94.8 mt -67.68 -35.61 79.15 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.547 0.689 . . . . 0.0 109.432 177.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.653 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 13.2 tt0 -78.51 -6.24 54.89 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.869 178.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.508 ' HG3' ' O ' ' A' ' 46' ' ' ILE . 29.9 mtpp -95.04 -44.02 7.87 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.605 174.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.483 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . 3.8 m-85 -58.66 -67.9 0.31 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.984 -179.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 51.5 m -87.09 -26.67 23.55 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.559 179.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.653 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 46.4 mttp 72.47 -47.89 0.67 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.266 0.626 . . . . 0.0 111.082 -178.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -81.79 86.58 6.44 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 172.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -119.69 130.11 54.87 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.942 -175.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.513 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 90.7 m-85 -121.26 131.56 54.29 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.089 174.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.477 ' HA3' HD21 ' A' ' 71' ' ' LEU . . . -140.02 151.19 21.99 Favored Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 119.982 -1.104 . . . . 0.0 112.739 -177.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.474 HG22 ' HE3' ' A' ' 86' ' ' MET . 0.5 OUTLIER -112.62 176.47 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 174.65 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.627 ' CD2' ' HA ' ' A' ' 68' ' ' LYS . 61.6 t-80 -94.34 135.38 35.81 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.774 0.321 . . . . 0.0 110.409 -177.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -82.27 -130.98 1.43 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.997 178.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -101.24 -79.21 0.51 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.712 0.292 . . . . 0.0 111.01 -178.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 67.1 mtt -120.68 107.71 13.13 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.984 0.421 . . . . 0.0 110.587 -178.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -132.93 -167.77 1.97 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.213 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -91.23 148.37 37.62 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.863 -179.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -49.33 -36.43 37.96 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.822 3.015 . . . . 0.0 114.296 -174.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.411 ' HB3' HD11 ' A' ' 42' ' ' LEU . 13.1 m-20 -70.22 -36.97 74.91 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.776 0.322 . . . . 0.0 111.251 -178.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 58.6 t -72.11 -41.69 67.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 174.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.627 ' HA ' ' CD2' ' A' ' 59' ' ' HIS . 79.1 tttt -53.99 -35.7 62.13 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.216 -1.356 . . . . 0.0 111.994 177.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -93.9 -24.07 17.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.645 -176.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -82.95 -36.27 25.32 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.445 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.477 HD21 ' HA3' ' A' ' 57' ' ' GLY . 72.4 mt -103.72 110.59 64.18 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.021 177.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -61.05 146.91 97.09 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.965 2.444 . . . . 0.0 112.688 -176.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.562 ' HA ' ' HB3' ' A' ' 59' ' ' HIS . 94.2 m-85 -59.97 -34.37 73.19 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.789 -178.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 63.3 m -152.93 146.46 25.0 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 174.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.505 ' HG2' ' N ' ' A' ' 76' ' ' VAL . 41.7 tttm -150.74 171.54 17.02 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -176.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.505 ' N ' ' HG2' ' A' ' 75' ' ' LYS . 38.6 t -125.35 133.77 68.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 169.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.752 ' HB2' ' SD ' ' A' ' 86' ' ' MET . 1.9 tp -105.54 111.55 24.29 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.32 -177.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 47.8 tp -93.34 103.46 15.69 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.729 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 43.3 t -114.78 109.63 29.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.644 -178.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 61.01 13.45 4.6 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.022 177.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 112.48 -10.07 26.19 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.422 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 60.4 t -87.63 134.54 27.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.708 0.29 . . . . 0.0 110.574 178.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.4 p -91.19 118.98 30.9 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.267 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.556 ' HB ' ' HB3' ' A' ' 77' ' ' LEU . 71.1 mt -118.44 104.14 15.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.034 0.445 . . . . 0.0 110.057 179.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -63.31 130.11 40.83 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.708 178.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.752 ' SD ' ' HB2' ' A' ' 77' ' ' LEU . 65.6 mtp -116.73 97.87 6.22 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 -177.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.552 ' O ' ' HA ' ' A' ' 113' ' ' PHE . 31.7 t -143.06 157.59 44.39 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 176.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 8.4 t-160 -92.23 -21.15 20.51 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.193 -0.603 . . . . 0.0 110.184 177.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 117.07 -179.08 17.39 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.084 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 75.6 t-105 -140.1 -69.72 0.4 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.914 0.388 . . . . 0.0 110.245 -179.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 173.52 169.91 36.42 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 53.78 82.22 0.25 Allowed Pre-proline 0 CA--C 1.529 0.167 0 C-N-CA 122.773 0.429 . . . . 0.0 111.221 -178.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -52.17 -33.67 55.34 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.269 2.646 . . . . 0.0 113.188 -174.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 35.5 p90 -67.98 -35.31 78.13 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.469 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -102.74 -16.73 15.89 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.255 0.55 . . . . 0.0 110.652 -173.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 39.5 tp -55.45 -35.25 65.27 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.222 -179.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 42.3 mttm -59.04 -45.9 89.56 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.59 0.71 . . . . 0.0 109.624 178.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -69.91 -38.83 76.39 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.346 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.494 ' O ' HG21 ' A' ' 103' ' ' VAL . 29.6 mmt180 -61.15 -48.95 79.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.007 177.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.474 HD12 HG21 ' A' ' 111' ' ' ILE . 67.6 mt -61.66 -33.98 74.91 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.692 -177.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 70.3 mt -67.21 -15.24 63.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.793 0.33 . . . . 0.0 111.427 177.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 23.4 mtmm -104.71 -6.15 20.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.117 174.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.494 HG21 ' O ' ' A' ' 99' ' ' ARG . 90.0 t -85.22 -40.13 14.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.25 0.548 . . . . 0.0 109.545 175.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -85.12 171.21 12.2 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.889 178.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 30.8 t30 -91.91 -61.38 1.64 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.091 -176.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -107.6 -176.42 3.06 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.401 -177.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.421 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 96.4 mttt -81.34 111.1 21.96 Favored Pre-proline 0 C--O 1.234 0.282 0 CA-C-O 120.768 0.318 . . . . 0.0 111.101 -175.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 107' ' ' LYS . 3.8 Cg_endo -85.78 147.97 9.57 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.308 2.672 . . . . 0.0 111.847 179.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -81.18 -47.74 13.04 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.259 0.552 . . . . 0.0 110.416 177.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 44.0 t -122.02 147.33 26.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.843 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.474 HG21 HD12 ' A' ' 100' ' ' LEU . 66.3 mt -136.62 130.6 46.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.66 0.267 . . . . 0.0 110.622 175.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.614 HD22 ' HB2' ' A' ' 130' ' ' LEU . 95.0 mt -101.32 141.85 33.58 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.013 175.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.552 ' HA ' ' O ' ' A' ' 87' ' ' CYS . 14.3 p90 -155.85 176.65 12.36 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 172.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -105.56 135.87 12.86 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.807 -177.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.513 ' HB3' ' HB2' ' A' ' 131' ' ' ASN . 11.5 t-160 -151.47 128.4 11.01 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.599 0.237 . . . . 0.0 110.715 -174.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.0 p -74.1 84.3 1.81 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.228 0.537 . . . . 0.0 111.267 178.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 60.7 t60 -176.36 153.55 1.22 Allowed 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -55.97 123.81 55.34 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 174.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.593 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 91.8 Cg_exo -43.13 129.47 5.91 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 124.002 3.134 . . . . 0.0 114.172 -172.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -142.42 155.1 45.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.661 -177.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -95.96 115.44 27.43 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 176.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.495 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 40.5 p -116.41 116.82 28.39 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.121 0.486 . . . . 0.0 112.078 -175.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 43.6 t -114.32 98.25 6.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.969 178.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.442 ' O ' ' HB1' ' A' ' 125' ' ' ALA . 28.4 tptp -144.25 65.44 1.29 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.442 ' HB1' ' O ' ' A' ' 124' ' ' LYS . . . 167.22 -13.07 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.895 -176.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 101.49 -12.06 58.21 Favored Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -173.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 47.3 t -107.18 140.67 24.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 114.965 -0.617 . . . . 0.0 110.061 -178.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 55.7 mtt180 -80.3 108.12 13.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.662 0.268 . . . . 0.0 110.654 176.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.495 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 98.2 m-85 -92.89 107.79 19.49 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 176.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.614 ' HB2' HD22 ' A' ' 112' ' ' LEU . 93.0 mt -99.24 116.71 32.06 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.157 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.593 ' O ' ' HA ' ' A' ' 119' ' ' PRO . 4.3 p30 -122.91 109.79 31.82 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.652 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.527 ' HA ' ' HG3' ' A' ' 119' ' ' PRO . 83.7 Cg_endo -88.86 178.36 2.76 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.072 2.514 . . . . 0.0 111.886 175.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.584 ' HA3' ' OE1' ' A' ' 137' ' ' GLU . . . -90.22 -109.01 1.35 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.216 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.773 ' HA ' ' HB2' ' A' ' 8' ' ' SER . 40.4 t -167.8 162.97 14.06 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.337 -0.246 . . . . 0.0 110.337 -179.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.632 ' HG ' ' HG ' ' A' ' 19' ' ' LEU . 3.7 mm? -71.48 -15.67 62.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.093 0.473 . . . . 0.0 109.957 176.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.568 ' HB1' ' SD ' ' A' ' 16' ' ' MET . . . -84.52 -6.82 59.4 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.356 175.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.584 ' OE1' ' HA3' ' A' ' 133' ' ' GLY . 1.8 tm-20 -113.43 -34.67 5.52 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.883 -178.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.514 ' HA2' HD13 ' A' ' 157' ' ' LEU . . . 127.78 -44.53 1.23 Allowed Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.327 -0.939 . . . . 0.0 113.681 175.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.488 ' HB3' HD11 ' A' ' 154' ' ' LEU . 18.6 m -76.81 113.63 14.69 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -175.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.464 ' O ' HD13 ' A' ' 154' ' ' LEU . 54.7 p90 -115.71 156.76 25.36 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 172.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -114.4 138.0 51.12 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.206 0.527 . . . . 0.0 112.016 -169.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 38.3 t -114.74 116.47 52.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 173.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.61 HD22 HG11 ' A' ' 150' ' ' VAL . 3.4 tt -94.72 107.46 19.46 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -177.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.496 ' HG2' ' HG2' ' A' ' 3' ' ' ARG . 32.4 mt-10 -104.06 121.58 43.49 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.35 178.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.87 ' HB2' ' HB2' ' A' ' 2' ' ' LYS . 55.3 mt -96.81 89.97 5.09 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.708 174.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -86.8 124.29 32.88 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.674 179.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 68.01 -68.94 0.32 Allowed Glycine 0 CA--C 1.52 0.401 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.381 -174.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -179.89 30.38 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 121.087 -0.577 . . . . 0.0 111.774 179.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -126.93 145.63 50.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.681 0.277 . . . . 0.0 110.608 -179.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.61 HG11 HD22 ' A' ' 143' ' ' LEU . 58.1 t -77.08 111.96 14.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.669 -179.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 19.8 mtm180 -115.95 115.81 26.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.379 0.609 . . . . 0.0 110.263 177.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -90.92 105.53 17.89 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.948 -176.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.32 113.76 26.69 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -178.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.502 HD21 ' HB2' ' A' ' 119' ' ' PRO . 44.9 tp -94.33 127.15 40.03 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.32 -173.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -114.92 135.42 54.22 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 175.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.2 m -108.22 148.93 29.25 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.764 0.316 . . . . 0.0 110.526 -177.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.514 HD13 ' HA2' ' A' ' 138' ' ' GLY . 97.5 mt . . . . . 0 C--O 1.247 0.965 0 CA-C-O 118.284 -0.865 . . . . 0.0 110.319 179.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.607 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 80.1 t . . . . . 0 N--CA 1.476 0.859 0 CA-C-O 120.858 0.361 . . . . 0.0 110.81 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -126.46 138.71 53.55 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.79 174.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.601 ' HB3' ' HD1' ' A' ' 30' ' ' TYR . 47.3 mtt85 -115.62 111.65 20.97 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.113 0.482 . . . . 0.0 110.631 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.478 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 73.7 m-85 -102.11 121.63 42.57 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.892 -178.298 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 38.0 tp -89.35 119.33 29.72 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.068 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.703 HD11 ' HG ' ' A' ' 36' ' ' LEU . 59.8 tp -106.05 112.37 25.38 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.088 0.47 . . . . 0.0 111.3 -176.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 27.8 pt -101.43 140.44 20.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.628 175.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.8 p -99.53 -159.5 0.74 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.43 -176.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -48.62 100.6 0.02 OUTLIER 'General case' 0 C--O 1.236 0.375 0 O-C-N 123.803 0.689 . . . . 0.0 112.146 -177.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.467 ' HB2' ' C ' ' A' ' 38' ' ' ASP . 6.9 m -92.51 83.05 4.88 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.963 177.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.544 ' HB2' ' SD ' ' A' ' 16' ' ' MET . 37.2 m80 -76.83 55.68 1.11 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.156 0.503 . . . . 0.0 110.228 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.405 ' CG1' ' HA ' ' A' ' 13' ' ' PRO . 2.8 t -127.69 138.31 32.59 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -177.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.405 ' HA ' ' CG1' ' A' ' 12' ' ' VAL . 27.9 Cg_endo -94.84 56.38 0.87 Allowed 'Cis proline' 0 N--CA 1.453 -0.907 0 C-N-CA 123.61 -1.413 . . . . 0.0 112.724 -2.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.451 HG22 HG23 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -86.0 -162.53 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 176.527 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 66.3 mtt85 -77.31 81.74 3.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.83 0.824 . . . . 0.0 110.828 -176.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.544 ' SD ' ' HB2' ' A' ' 11' ' ' HIS . 51.1 ttp -164.04 -70.79 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.186 -1.37 . . . . 0.0 108.15 179.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 61.25 2.49 0.62 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.932 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.416 ' H ' ' C ' ' A' ' 16' ' ' MET . 8.5 m -82.57 38.17 0.55 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.58 -176.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.0 tt -107.96 103.62 50.5 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.451 ' HB2' HD12 ' A' ' 157' ' ' LEU . 23.4 Cg_exo -65.51 126.65 16.55 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.278 1.985 . . . . 0.0 110.89 174.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -64.19 -10.66 24.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.877 -174.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -53.88 -35.29 61.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.986 0.422 . . . . 0.0 110.836 177.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 tt -69.26 -27.98 36.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.453 0.644 . . . . 0.0 110.573 -177.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 55.5 tp -72.64 -29.49 63.5 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.605 -179.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -72.73 -31.02 64.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.927 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.7 p -77.79 1.89 18.8 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -176.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.449 ' HA ' HD12 ' A' ' 27' ' ' LEU . 2.2 mm? -58.05 -36.14 72.35 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.204 0.526 . . . . 0.0 110.714 176.058 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.412 ' H ' ' HG3' ' A' ' 28' ' ' LYS . 32.2 mttt -75.34 -24.43 57.36 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.925 -175.52 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -88.36 -6.39 57.74 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.162 -165.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.601 ' HD1' ' HB3' ' A' ' 3' ' ' ARG . 98.0 m-85 -122.03 142.04 50.75 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.783 0.325 . . . . 0.0 110.571 -179.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -84.79 -12.75 52.99 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.978 -176.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -138.42 131.83 5.54 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 175.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 56.2 t -122.58 128.68 75.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 117.119 0.459 . . . . 0.0 110.554 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.554 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 32.1 mt -120.29 133.57 66.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.745 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.68 120.4 3.99 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.57 177.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.703 ' HG ' HD11 ' A' ' 6' ' ' LEU . 82.0 mt -89.73 7.62 35.85 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.272 0.558 . . . . 0.0 110.071 179.135 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 152.11 78.66 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.229 -178.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.467 ' C ' ' HB2' ' A' ' 10' ' ' SER . 8.4 p-10 -82.38 -146.93 0.07 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.46 0.171 . . . . 0.0 111.107 -175.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.526 ' HD2' HD12 ' A' ' 48' ' ' LEU . 77.1 m-85 -60.64 144.8 51.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.168 0.508 . . . . 0.0 111.739 -173.079 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.451 HG23 HG22 ' A' ' 14' ' ' VAL . 27.7 m -82.55 -1.86 5.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.056 -178.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.569 ' O ' HG23 ' A' ' 45' ' ' VAL . 16.0 t70 -103.38 122.16 44.27 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.007 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.478 ' HB2' ' HB3' ' A' ' 66' ' ' ASP . 54.7 tp -55.68 -48.82 74.44 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 123.563 0.54 . . . . 0.0 112.125 -172.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -63.88 -32.17 73.6 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.74 0.305 . . . . 0.0 111.291 -176.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.9 m -76.12 -27.31 57.04 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.731 178.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 41' ' ' ASP . 61.6 t -63.32 -47.54 91.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 121.463 0.649 . . . . 0.0 109.962 174.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.601 HG21 ' HE3' ' A' ' 50' ' ' LYS . 1.7 mp -65.59 -31.83 55.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.842 179.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -57.46 -40.58 78.82 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 173.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.526 HD12 ' HD2' ' A' ' 39' ' ' TYR . 64.3 mt -70.7 -40.72 72.7 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 120.981 0.42 . . . . 0.0 110.316 178.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -61.81 -28.78 69.71 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.785 -178.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.601 ' HE3' HG21 ' A' ' 46' ' ' ILE . 98.4 mttt -72.36 -47.64 47.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.969 177.172 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -65.99 -48.14 72.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.889 0.376 . . . . 0.0 111.041 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 9.1 m -60.29 -43.05 96.63 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.335 177.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 98.0 mttt 69.52 -53.69 0.6 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.678 0.791 . . . . 0.0 109.942 -171.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.4 mm-40 -107.71 84.71 2.0 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.332 173.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -100.33 114.27 27.63 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.897 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.554 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 25.1 m-85 -105.07 107.93 19.17 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 176.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.435 ' O ' ' HD2' ' A' ' 72' ' ' PRO . . . -129.78 154.26 20.38 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 119.666 -1.254 . . . . 0.0 113.57 -173.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.591 HG23 ' HB3' ' A' ' 86' ' ' MET . 4.8 m -141.48 157.25 21.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 123.067 0.547 . . . . 0.0 109.719 174.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.51 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 64.4 t60 -94.74 104.6 16.52 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.197 0.522 . . . . 0.0 110.373 -178.159 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 1.019 ' HA2' ' HB3' ' A' ' 88' ' ' HIS . . . -113.58 -29.21 2.98 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.231 175.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 22.4 p-10 -79.67 -169.11 1.81 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.033 -0.583 . . . . 0.0 110.784 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 67.3 mtt -117.54 90.02 3.24 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.003 175.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -107.89 -170.32 1.67 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.022 -177.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -82.44 152.73 67.71 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.52 178.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.505 ' HA ' ' HB3' ' A' ' 68' ' ' LYS . 81.4 Cg_exo -47.07 -32.19 12.91 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.492 2.795 . . . . 0.0 113.772 -178.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.478 ' HB3' ' HB2' ' A' ' 42' ' ' LEU . 3.5 m-20 -58.63 -52.37 65.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.327 0.584 . . . . 0.0 110.668 177.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 19.3 t -75.27 -32.97 27.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.709 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.505 ' HB3' ' HA ' ' A' ' 65' ' ' PRO . 87.7 tttt -60.07 -24.17 64.38 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.067 176.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -93.84 -30.65 14.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.609 176.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -65.56 -43.15 90.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.213 0.53 . . . . 0.0 109.903 175.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.51 ' HB2' ' HB2' ' A' ' 59' ' ' HIS . 78.4 mt -97.89 121.65 57.03 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.326 -179.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.435 ' HD2' ' O ' ' A' ' 57' ' ' GLY . 22.0 Cg_exo -65.88 164.57 26.62 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.867 2.378 . . . . 0.0 112.295 178.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -78.46 -31.68 48.02 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.044 0.449 . . . . 0.0 110.093 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.5 m -151.72 135.49 16.35 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.214 178.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 37.0 tttp -148.37 135.71 20.41 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 10.5 t -115.3 123.77 71.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.884 0.373 . . . . 0.0 110.256 178.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.532 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 78.2 mt -95.62 139.28 32.1 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.223 178.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 37.3 tp -112.31 98.6 7.41 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 174.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.428 HG13 ' CE1' ' A' ' 4' ' ' PHE . 41.0 t -115.1 100.3 10.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.592 -174.198 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 61.51 28.9 18.1 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.35 178.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.64 -15.71 58.3 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.303 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 57.3 t -83.0 121.69 36.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 120.861 0.362 . . . . 0.0 110.365 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.0 p -87.53 123.28 32.26 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.879 178.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.532 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 24.4 mt -116.02 95.63 3.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -178.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -84.8 109.44 3.27 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.384 179.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.591 ' HB3' HG23 ' A' ' 58' ' ' VAL . 46.8 mtm -106.52 123.73 48.53 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.795 0.331 . . . . 0.0 110.306 -178.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 48.0 t -161.06 165.21 30.08 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.602 -177.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 1.019 ' HB3' ' HA2' ' A' ' 60' ' ' GLY . 10.4 p-80 -88.72 95.81 10.42 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.323 0.582 . . . . 0.0 110.494 176.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.513 ' H ' ' HB2' ' A' ' 113' ' ' PHE . . . -83.29 68.22 3.59 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.793 -177.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.427 ' CD1' ' HB2' ' A' ' 88' ' ' HIS . 88.3 m95 -86.13 85.5 7.35 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.225 0.536 . . . . 0.0 110.185 177.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -176.0 -174.96 42.98 Favored Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.565 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -81.24 140.31 49.06 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -62.85 -14.62 41.99 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.841 2.361 . . . . 0.0 112.522 -176.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 4.0 m0 -73.97 -48.77 28.14 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.489 -178.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -96.77 -1.23 46.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.358 178.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 33.6 tp -59.75 -39.32 84.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.509 179.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -59.87 -42.59 94.07 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.257 178.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.421 ' O ' ' HB2' ' A' ' 102' ' ' LYS . 10.6 t70 -64.58 -49.11 72.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.299 179.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 47.2 ttt85 -60.47 -49.64 76.73 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.735 -176.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.48 HD11 HG21 ' A' ' 111' ' ' ILE . 81.6 mt -78.06 -36.11 48.77 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -174.031 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.708 HD21 HG21 ' A' ' 127' ' ' VAL . 85.2 mt -76.53 -18.75 58.54 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.025 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 98' ' ' ASP . 79.6 tttt -74.1 -29.55 61.9 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.373 0.606 . . . . 0.0 109.461 176.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 70.9 t -86.89 -45.98 16.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.018 176.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -90.99 86.9 6.4 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.847 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -68.27 -21.98 64.77 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.532 -178.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -72.55 -18.66 61.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.442 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 78.1 tttt 62.39 95.84 0.05 OUTLIER Pre-proline 0 N--CA 1.465 0.319 0 O-C-N 123.583 0.552 . . . . 0.0 110.636 -173.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.461 ' O ' HG13 ' A' ' 127' ' ' VAL . 5.6 Cg_exo -79.98 134.9 10.84 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.844 2.363 . . . . 0.0 111.851 178.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -70.8 -35.9 72.76 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.34 0.591 . . . . 0.0 109.533 177.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.574 HG22 HG11 ' A' ' 150' ' ' VAL . 53.5 t -122.87 128.59 75.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.028 178.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.48 HG21 HD11 ' A' ' 100' ' ' LEU . 24.4 mt -122.89 127.99 75.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 120.91 0.386 . . . . 0.0 110.826 177.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 89.3 mt -104.52 124.84 50.0 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.494 176.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.513 ' HB2' ' H ' ' A' ' 89' ' ' GLY . 5.2 p90 -146.88 160.05 42.78 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.807 0.337 . . . . 0.0 110.684 -178.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -105.95 125.74 8.31 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 175.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.463 ' HB2' ' CE2' ' A' ' 113' ' ' PHE . 10.4 t-160 -141.1 -54.84 0.48 Allowed 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 111.744 0.276 . . . . 0.0 111.744 -175.172 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 20.6 p -123.47 -100.03 0.41 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -173.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.473 ' O ' ' HA2' ' A' ' 133' ' ' GLY . 0.1 OUTLIER -166.66 -43.39 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.798 0.333 . . . . 0.0 111.214 -172.442 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -85.17 165.26 37.47 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.3 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.86 ' HG3' HD21 ' A' ' 154' ' ' LEU . 21.6 Cg_exo -63.23 87.38 0.13 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.281 1.987 . . . . 0.0 111.225 174.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.679 ' HB3' ' HB3' ' A' ' 131' ' ' ASN . 19.3 tt0 -82.34 105.59 13.53 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.541 -176.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -104.87 99.49 9.12 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.418 -175.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.461 ' HG1' ' HB2' ' A' ' 129' ' ' PHE . 77.2 p -121.22 118.74 30.37 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.454 -177.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.4 p -116.51 115.44 49.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.35 0.595 . . . . 0.0 110.667 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -137.3 136.08 37.69 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.912 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 65.81 17.86 10.97 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 123.604 0.565 . . . . 0.0 111.199 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 88.23 -7.0 82.85 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.951 -0.642 . . . . 0.0 111.769 -176.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.708 HG21 HD21 ' A' ' 101' ' ' LEU . 63.3 t -93.82 126.91 46.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 35.7 ttt180 -103.66 111.08 23.4 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.068 0.461 . . . . 0.0 110.844 -176.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.461 ' HB2' ' HG1' ' A' ' 122' ' ' THR . 19.3 m-85 -92.08 127.15 37.44 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.231 178.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 88.6 mt -120.2 116.76 26.25 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.758 0.313 . . . . 0.0 111.692 -176.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.679 ' HB3' ' HB3' ' A' ' 120' ' ' GLU . 7.3 t30 -94.8 122.51 60.32 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 170.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.526 ' HG3' HD12 ' A' ' 36' ' ' LEU . 84.1 Cg_endo -81.17 167.48 17.74 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.86 2.373 . . . . 0.0 113.165 -177.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.473 ' HA2' ' O ' ' A' ' 117' ' ' HIS . . . -77.96 145.99 30.39 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.631 177.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.512 ' HB2' ' HG2' ' A' ' 137' ' ' GLU . 15.5 m -78.58 140.45 38.49 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.858 0.361 . . . . 0.0 111.534 -177.179 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 62.0 mt -56.38 -37.67 70.4 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.476 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.41 -13.79 53.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.835 -176.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.512 ' HG2' ' HB2' ' A' ' 134' ' ' SER . 23.1 mm-40 -97.53 1.1 48.57 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.582 -178.177 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 71.37 35.73 63.36 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.635 -177.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 18.1 m -139.55 132.74 29.76 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.619 0.247 . . . . 0.0 110.371 -179.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -130.94 164.72 24.7 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 176.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -114.24 143.22 45.19 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.924 0.393 . . . . 0.0 110.731 -173.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 63.0 t -130.82 122.96 53.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.869 178.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 5.8 tt -99.59 105.39 17.25 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 177.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -100.26 112.57 24.9 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.458 -178.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.607 ' O ' ' HA ' ' A' ' 1' ' ' VAL . 59.8 mt -90.71 90.33 7.9 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.782 176.001 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.504 ' HA ' HG21 ' A' ' 1' ' ' VAL . 26.7 t70 -101.2 122.63 43.99 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 68.21 -68.92 0.35 Allowed Glycine 0 CA--C 1.519 0.308 0 C-N-CA 121.462 -0.399 . . . . 0.0 112.151 -173.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -176.1 25.9 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 175.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -105.83 134.87 48.26 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 -177.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.574 HG11 HG22 ' A' ' 110' ' ' VAL . 41.1 t -83.82 89.63 2.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.1 0.476 . . . . 0.0 109.869 177.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 27.8 mtp-105 -95.37 96.1 8.9 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.295 -177.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -92.36 104.48 16.81 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.076 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -109.46 154.29 22.84 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.864 -179.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.86 HD21 ' HG3' ' A' ' 119' ' ' PRO . 18.8 tp -114.72 117.16 30.02 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 172.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -104.86 135.12 46.82 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.257 -177.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 16.9 p -96.76 142.08 29.21 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.045 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.451 HD12 ' HB2' ' A' ' 20' ' ' PRO . 82.0 mt . . . . . 0 C--O 1.246 0.895 0 CA-C-O 118.555 -0.736 . . . . 0.0 110.405 -179.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.408 HG11 ' H ' ' A' ' 2' ' ' LYS . 1.4 t . . . . . 0 N--CA 1.481 1.094 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.408 ' H ' HG11 ' A' ' 1' ' ' VAL . 46.5 mttp -128.25 111.93 13.94 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.893 0.378 . . . . 0.0 110.048 168.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.518 ' HG2' ' HG2' ' A' ' 144' ' ' GLU . 59.6 mtt180 -115.1 117.3 30.18 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.472 178.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.47 ' HE2' ' HE2' ' A' ' 56' ' ' TYR . 65.6 m-85 -103.67 132.21 50.13 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.854 -179.127 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.497 HD13 HD13 ' A' ' 23' ' ' ILE . 50.1 tp -88.98 114.32 25.48 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.033 179.309 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 63.3 tp -102.73 107.16 17.95 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.862 0.363 . . . . 0.0 110.703 -178.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 28.7 pt -104.41 126.42 59.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-O 121.342 0.591 . . . . 0.0 109.527 173.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.537 ' HA ' HD13 ' A' ' 36' ' ' LEU . 14.4 m -77.76 -175.57 3.98 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.03 -173.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -69.24 119.38 13.44 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.652 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.59 ' HB3' ' SD ' ' A' ' 16' ' ' MET . 70.3 m -156.72 80.62 0.94 Allowed 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.388 -0.824 . . . . 0.0 108.819 178.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.506 ' HB3' HG22 ' A' ' 14' ' ' VAL . 24.1 m80 -60.15 106.77 0.55 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.234 -1.348 . . . . 0.0 113.022 -171.182 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.607 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 2.6 p -140.4 138.07 18.49 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.98 176.089 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.53 ' HA ' HG21 ' A' ' 12' ' ' VAL . 60.5 Cg_endo -89.42 104.06 0.44 Allowed 'Cis proline' 0 N--CA 1.456 -0.701 0 C-N-CA 123.551 -1.437 . . . . 0.0 112.449 -1.366 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.506 HG22 ' HB3' ' A' ' 11' ' ' HIS . 13.3 t -128.37 -77.25 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.882 178.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 59.2 mtt180 -134.36 -4.78 2.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.502 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.59 ' SD ' ' HB3' ' A' ' 10' ' ' SER . 56.8 ttp -91.94 -64.51 1.11 Allowed 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 173.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.501 ' HA ' HG21 ' A' ' 12' ' ' VAL . . . 69.39 -21.16 0.16 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.58 176.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.457 ' H ' ' C ' ' A' ' 16' ' ' MET . 22.8 t -105.27 78.55 1.39 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.047 0.451 . . . . 0.0 110.959 -176.166 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.2 tt -108.04 116.78 56.45 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 173.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.414 ' O ' HG23 ' A' ' 23' ' ' ILE . 32.5 Cg_exo -59.74 111.34 0.93 Allowed 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.564 2.176 . . . . 0.0 111.667 177.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -79.48 7.56 7.9 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -172.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -64.76 -35.38 80.9 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.337 0.589 . . . . 0.0 109.794 173.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.497 HD13 HD13 ' A' ' 5' ' ' LEU . 12.9 tt -70.33 -39.92 77.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.758 0.789 . . . . 0.0 109.807 177.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.457 ' O ' HD22 ' A' ' 27' ' ' LEU . 40.5 tp -73.04 -3.99 29.65 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.327 -1.306 . . . . 0.0 110.594 177.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -100.23 -24.81 14.46 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.289 0.566 . . . . 0.0 110.117 175.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 25.9 m -97.03 -6.81 34.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.829 -174.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.907 ' HA ' ' HD2' ' A' ' 30' ' ' TYR . 1.5 pt? -66.45 -13.27 60.55 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.941 0.401 . . . . 0.0 111.316 -175.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -65.43 -27.35 68.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.31 -178.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -94.4 -0.67 54.67 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -177.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.907 ' HD2' ' HA ' ' A' ' 27' ' ' LEU . 84.9 m-85 -91.24 138.51 31.53 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 178.205 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -64.62 -36.99 86.03 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.215 0.531 . . . . 0.0 110.257 -178.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -146.3 154.22 25.82 Favored Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 177.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.451 HG21 ' HB3' ' A' ' 5' ' ' LEU . 88.4 t -132.2 134.82 59.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.909 0.355 . . . . 0.0 110.221 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.53 HG12 ' HB2' ' A' ' 56' ' ' TYR . 52.0 mt -115.46 120.65 65.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.724 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -102.73 105.46 2.75 Favored Glycine 0 N--CA 1.444 -0.779 0 N-CA-C 111.019 -0.833 . . . . 0.0 111.019 174.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.537 HD13 ' HA ' ' A' ' 8' ' ' SER . 76.8 mt -75.91 -24.73 55.6 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 122.716 -0.285 . . . . 0.0 111.509 -176.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 162.97 57.1 0.02 OUTLIER Glycine 0 CA--C 1.51 -0.242 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.563 -178.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.454 ' CG ' ' H ' ' A' ' 39' ' ' TYR . 1.5 p-10 -99.3 -87.84 0.35 Allowed 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -175.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.607 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 93.9 m-85 -82.36 115.49 21.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.362 0.601 . . . . 0.0 110.951 -177.152 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.3 m -91.55 6.43 5.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.509 -0.768 . . . . 0.0 111.634 -177.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.505 ' O ' HG23 ' A' ' 45' ' ' VAL . 13.2 t70 -86.44 120.39 27.73 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.3 -0.409 . . . . 0.0 109.949 179.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.5 HD22 ' HB3' ' A' ' 66' ' ' ASP . 51.5 tp -54.01 -45.86 71.62 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.851 -174.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -63.39 -39.48 94.62 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.133 0.492 . . . . 0.0 110.609 -178.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 24.2 m -68.64 -30.48 69.2 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.021 178.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 41' ' ' ASP . 83.9 t -61.11 -45.82 97.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 121.099 0.476 . . . . 0.0 110.337 176.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.44 HD12 ' N ' ' A' ' 46' ' ' ILE . 1.7 mp -67.27 -38.97 81.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.806 177.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.08 -32.88 73.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.465 176.175 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.37 -34.54 76.25 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.961 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -77.35 -15.2 59.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.17 0.509 . . . . 0.0 110.062 177.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -80.43 -48.19 13.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.502 175.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -69.89 -42.41 73.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.009 0.433 . . . . 0.0 110.79 175.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.534 ' HB2' ' HB2' ' A' ' 55' ' ' PHE . 5.4 m -94.39 97.99 10.58 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.617 176.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -61.22 -26.36 67.69 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.844 -176.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -118.81 88.51 2.94 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 166.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.534 ' HB2' ' HB2' ' A' ' 52' ' ' SER . 88.6 t80 -100.31 124.28 45.58 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.829 -177.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.53 ' HB2' HG12 ' A' ' 34' ' ' ILE . 54.0 m-85 -117.9 146.76 43.7 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 174.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.469 ' HA3' HD21 ' A' ' 71' ' ' LEU . . . -158.62 161.83 32.05 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.248 -0.977 . . . . 0.0 112.119 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.478 HG11 ' HE3' ' A' ' 86' ' ' MET . 0.7 OUTLIER -140.23 169.37 16.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.916 0.389 . . . . 0.0 111.014 178.279 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.535 ' HB3' ' HA ' ' A' ' 73' ' ' PHE . 53.4 t-80 -94.4 143.71 26.17 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.062 -175.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -90.89 -129.93 4.45 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.951 -0.642 . . . . 0.0 111.874 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -88.46 -68.89 0.74 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.827 0.346 . . . . 0.0 110.764 178.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 66.6 mtt -125.71 102.28 7.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.328 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -118.56 179.22 4.19 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.922 -178.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -72.38 140.52 82.32 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 176.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -57.43 -31.55 91.58 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.945 2.43 . . . . 0.0 112.147 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.5 ' HB3' HD22 ' A' ' 42' ' ' LEU . 5.1 m-20 -63.19 -35.97 82.07 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.922 179.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 58.4 t -73.6 -27.18 22.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.399 -178.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.9 ttpm? -61.24 -28.21 69.0 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.04 0.448 . . . . 0.0 110.721 179.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -75.08 -13.04 60.45 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.163 -175.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -117.58 -38.03 3.37 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.73 179.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.469 HD21 ' HA3' ' A' ' 57' ' ' GLY . 15.8 mt -107.87 107.79 60.69 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.274 -178.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -72.04 158.07 53.14 Favored 'Trans proline' 0 N--CA 1.464 -0.228 0 C-N-CA 122.952 2.435 . . . . 0.0 112.003 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.535 ' HA ' ' HB3' ' A' ' 59' ' ' HIS . 91.4 m-85 -62.17 -33.24 74.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.22 0.533 . . . . 0.0 110.56 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 18.2 m -148.58 132.33 16.96 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.574 178.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.7 ttmm -140.0 125.7 19.34 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.356 178.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 11.8 t -101.07 122.32 52.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 175.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.441 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 68.3 mt -87.7 149.55 24.17 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.28 179.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 53.4 tp -121.04 94.05 4.22 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 172.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.665 HG11 ' HG2' ' A' ' 80' ' ' GLU . 21.6 t -121.87 116.73 50.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.084 -173.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.665 ' HG2' HG11 ' A' ' 79' ' ' VAL . 4.2 mm-40 61.46 21.13 11.79 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.278 179.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.91 -0.82 67.42 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.209 -179.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 65.9 t -96.55 128.95 47.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.754 0.311 . . . . 0.0 110.342 178.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.9 p -91.2 119.77 31.56 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.765 177.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.441 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 45.7 mt -118.04 98.74 6.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.504 -176.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -86.22 111.52 3.62 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.062 -178.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.543 ' HG2' HD12 ' A' ' 112' ' ' LEU . 49.3 mtm -97.4 119.69 36.38 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 49.0 t -144.0 160.71 40.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.062 0.458 . . . . 0.0 110.773 -176.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 25.8 m-70 -119.19 153.32 35.1 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.837 173.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 155.25 -158.33 28.33 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.427 -0.892 . . . . 0.0 112.357 178.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 49.4 p90 -155.25 175.97 13.17 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -178.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 149.12 169.12 15.37 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.912 178.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.43 ' HB3' ' HD2' ' A' ' 93' ' ' PRO . . . -85.06 164.07 43.08 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 177.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.43 ' HD2' ' HB3' ' A' ' 92' ' ' ALA . 90.7 Cg_exo -46.29 -38.29 20.01 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.209 2.606 . . . . 0.0 113.832 -178.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.792 ' HA ' ' HE3' ' A' ' 97' ' ' LYS . 42.0 p90 -79.71 -40.1 29.71 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 121.102 -0.239 . . . . 0.0 111.175 -179.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -66.55 -35.08 79.35 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.01 0.433 . . . . 0.0 110.521 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 30.2 tp -54.64 -47.65 73.25 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.908 -177.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.792 ' HE3' ' HA ' ' A' ' 94' ' ' TRP . 8.9 mtmp? -57.86 -56.65 19.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.641 0.734 . . . . 0.0 110.085 178.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.63 -48.7 79.69 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.325 -1.307 . . . . 0.0 112.175 -172.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.531 ' O ' HG23 ' A' ' 103' ' ' VAL . 98.1 mtt180 -67.6 -46.53 72.33 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.525 -174.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.496 HD12 HG21 ' A' ' 111' ' ' ILE . 61.2 mt -67.75 -40.75 84.07 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 -177.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.704 HD23 HG22 ' A' ' 127' ' ' VAL . 95.3 mt -75.39 -13.32 60.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.777 0.322 . . . . 0.0 111.048 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -90.15 -22.18 21.86 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 175.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 99' ' ' ARG . 73.6 t -78.21 -50.29 19.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.911 174.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -96.62 108.26 20.83 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.63 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -82.75 1.49 38.56 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.9 0.381 . . . . 0.0 110.729 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 11.5 mp0 -84.96 -22.62 29.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.473 176.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 87.5 tttt 56.87 85.96 0.18 Allowed Pre-proline 0 N--CA 1.466 0.364 0 O-C-N 123.85 0.719 . . . . 0.0 110.258 -170.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -71.88 152.72 58.21 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.945 2.43 . . . . 0.0 112.366 -177.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -77.27 -37.55 52.71 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.663 176.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.545 HG22 HG23 ' A' ' 150' ' ' VAL . 71.7 t -127.89 137.38 57.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.18 178.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.496 HG21 HD12 ' A' ' 100' ' ' LEU . 55.2 mt -127.43 133.06 68.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.841 0.353 . . . . 0.0 110.599 176.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.596 HD21 ' HB2' ' A' ' 130' ' ' LEU . 93.3 mt -102.08 122.44 44.13 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.704 177.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.464 ' CZ ' ' HB2' ' A' ' 131' ' ' ASN . 36.0 p90 -128.27 124.27 36.18 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.243 0.544 . . . . 0.0 110.631 177.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -105.91 114.78 4.6 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.642 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -165.4 -29.65 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.847 0.356 . . . . 0.0 110.526 -177.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.487 HG21 ' OE1' ' A' ' 118' ' ' GLU . 0.2 OUTLIER -92.42 176.97 6.28 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.398 179.969 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 60.3 m80 -105.58 -38.82 6.3 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.103 0.478 . . . . 0.0 110.609 -177.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.487 ' OE1' HG21 ' A' ' 116' ' ' THR . 1.2 pm0 -96.64 144.6 28.12 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.802 -178.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.559 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 4.7 Cg_exo -80.4 144.74 16.33 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 123.126 2.551 . . . . 0.0 112.953 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -160.01 146.14 15.71 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.435 177.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.546 ' HB2' ' HZ ' ' A' ' 152' ' ' PHE . 17.3 t70 -96.24 122.19 38.84 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 175.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.588 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 74.7 p -125.54 142.15 51.66 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.735 0.302 . . . . 0.0 111.343 -176.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 14.9 p -150.35 138.82 14.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 176.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -141.53 -72.6 0.33 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.847 0.356 . . . . 0.0 111.1 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -89.13 46.82 1.42 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.916 0.389 . . . . 0.0 110.836 -177.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 79.32 -42.31 2.37 Favored Glycine 0 N--CA 1.452 -0.24 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.295 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.704 HG22 HD23 ' A' ' 101' ' ' LEU . 41.7 t -63.72 131.3 29.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.895 0.379 . . . . 0.0 110.747 178.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.412 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 75.9 ttt180 -94.35 114.11 26.11 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.802 179.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.588 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 45.8 m-85 -99.09 125.96 44.72 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -178.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.596 ' HB2' HD21 ' A' ' 112' ' ' LEU . 64.5 mt -103.47 120.68 41.31 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.431 0.634 . . . . 0.0 110.695 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.559 ' O ' ' HA ' ' A' ' 119' ' ' PRO . 49.3 t30 -104.35 107.83 58.72 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 114.865 -1.062 . . . . 0.0 109.223 176.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -89.63 165.62 5.16 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.806 2.337 . . . . 0.0 113.188 -177.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -88.88 146.3 19.13 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.986 179.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.875 ' HB2' ' HG2' ' A' ' 137' ' ' GLU . 9.2 m -68.93 142.83 54.61 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.618 0.209 . . . . 0.0 110.904 -178.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.589 HD11 ' HB2' ' A' ' 10' ' ' SER . 21.0 mt -63.85 -35.26 80.05 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.143 0.497 . . . . 0.0 110.177 -178.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.414 ' HB3' ' SD ' ' A' ' 16' ' ' MET . . . -65.09 -24.22 67.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.434 178.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.875 ' HG2' ' HB2' ' A' ' 134' ' ' SER . 51.8 mm-40 -79.86 -13.81 59.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.869 0.366 . . . . 0.0 110.48 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 89.03 34.26 9.0 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.745 178.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 23.0 t -149.84 150.06 31.4 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.743 0.306 . . . . 0.0 110.313 178.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.409 ' CE1' ' HB3' ' A' ' 155' ' ' LYS . 50.3 p90 -145.55 177.68 8.68 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.662 177.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -121.51 132.73 54.87 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.084 0.469 . . . . 0.0 111.672 -176.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 44.8 t -104.09 114.3 43.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 172.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 6.5 tt -94.57 104.97 16.91 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -177.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.518 ' HG2' ' HG2' ' A' ' 3' ' ' ARG . 37.4 mt-10 -95.17 124.85 39.43 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.106 178.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 81.6 mt -91.38 98.78 11.9 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.133 0.492 . . . . 0.0 110.05 175.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -86.78 100.94 12.88 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.802 -178.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.71 -68.8 0.29 Allowed Glycine 0 CA--C 1.52 0.399 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.446 -172.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -162.31 26.57 0.24 Allowed Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 177.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -123.94 144.14 49.97 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.415 -0.392 . . . . 0.0 110.285 -175.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.545 HG23 HG22 ' A' ' 110' ' ' VAL . 92.8 t -83.37 111.84 20.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.346 -177.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -120.65 93.41 4.03 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 177.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . 0.546 ' HZ ' ' HB2' ' A' ' 121' ' ' ASP . 17.4 p90 -90.29 132.33 35.6 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.058 0.456 . . . . 0.0 110.538 -178.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -116.96 135.37 53.76 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.579 178.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -89.83 131.42 35.78 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.892 0.377 . . . . 0.0 110.666 -178.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.409 ' HB3' ' CE1' ' A' ' 140' ' ' TYR . 10.5 tptt -122.05 154.02 37.84 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.403 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 4.2 p -111.15 152.12 27.38 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.923 0.392 . . . . 0.0 111.319 178.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 94.5 mt . . . . . 0 C--O 1.251 1.139 0 CA-C-O 118.29 -0.862 . . . . 0.0 110.346 -179.275 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 46.3 t . . . . . 0 N--CA 1.479 0.989 0 CA-C-O 120.789 0.328 . . . . 0.0 110.238 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.499 ' HD3' ' CZ ' ' A' ' 4' ' ' PHE . 20.9 ttmm -102.43 129.68 48.99 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.248 177.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.409 ' HD3' ' OE2' ' A' ' 144' ' ' GLU . 38.8 mtt180 -117.02 125.58 51.58 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.532 -178.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.571 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 64.4 m-85 -102.98 124.14 47.92 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.063 0.459 . . . . 0.0 110.695 177.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 48.5 tp -89.27 136.59 32.94 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 175.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.499 HD22 ' HB3' ' A' ' 141' ' ' ALA . 50.3 tp -117.68 103.93 10.51 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.285 0.564 . . . . 0.0 112.077 -177.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.481 HG13 ' HA2' ' A' ' 35' ' ' GLY . 23.5 pt -101.33 138.65 24.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 168.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.632 ' HA ' ' HB2' ' A' ' 36' ' ' LEU . 20.6 m -127.61 -68.18 0.79 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -164.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.454 ' HA ' ' HE1' ' A' ' 88' ' ' HIS . 37.3 t70 -111.44 105.49 14.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.417 0.627 . . . . 0.0 111.099 -176.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.837 ' HB3' ' HA ' ' A' ' 38' ' ' ASP . 29.5 t -141.05 155.88 46.1 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.285 -0.87 . . . . 0.0 108.874 174.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.573 ' H ' ' HE1' ' A' ' 16' ' ' MET . 11.5 m80 -141.59 57.11 1.51 Allowed 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -174.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.482 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . 40.7 t -110.19 126.95 27.89 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.236 -174.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.482 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 60.1 Cg_endo -105.2 91.87 0.06 OUTLIER 'Cis proline' 0 N--CA 1.45 -1.077 0 C-N-CA 124.011 -1.246 . . . . 0.0 112.874 -7.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 41.7 t -92.19 -63.6 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 175.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 58.7 ttm-85 -144.49 12.7 1.53 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.886 0.851 . . . . 0.0 108.758 173.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.573 ' HE1' ' H ' ' A' ' 11' ' ' HIS . 50.6 ttp -131.74 121.88 24.95 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.527 -177.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -126.11 -0.31 7.14 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.916 -0.583 . . . . 0.0 109.959 178.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.5 p -80.77 63.81 5.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.022 -178.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.412 HD12 HG22 ' A' ' 12' ' ' VAL . 4.2 tt -102.1 111.48 64.35 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -62.18 125.63 16.81 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.919 2.413 . . . . 0.0 112.744 -177.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -56.62 -28.83 61.33 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.284 177.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -49.87 -50.4 45.91 Favored 'General case' 0 C--N 1.331 -0.225 0 O-C-N 123.438 0.462 . . . . 0.0 111.846 -175.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.0 tt -66.59 -39.93 85.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.848 0.832 . . . . 0.0 110.252 -177.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.481 ' O ' HD22 ' A' ' 27' ' ' LEU . 35.5 tp -73.97 -3.74 30.99 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.107 -1.406 . . . . 0.0 111.036 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -100.3 -41.39 7.08 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.326 0.584 . . . . 0.0 109.741 172.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 56.9 p -69.43 -14.99 63.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.932 -175.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.565 HD11 ' HB3' ' A' ' 52' ' ' SER . 1.1 pt? -68.46 -9.2 47.21 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.799 0.333 . . . . 0.0 111.118 -176.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -65.82 -35.08 79.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.47 175.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -72.06 -23.29 61.34 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.204 0.526 . . . . 0.0 110.393 -178.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.497 ' HD2' ' HA ' ' A' ' 27' ' ' LEU . 86.0 m-85 -96.16 114.25 25.93 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.523 -176.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -78.31 -4.17 46.64 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.818 -176.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.571 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -142.19 129.58 3.96 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 173.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.41 HG22 ' HB3' ' A' ' 52' ' ' SER . 57.7 t -120.26 142.73 34.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 O-C-N 122.391 -0.476 . . . . 0.0 110.558 -179.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 70.1 mt -125.56 131.15 72.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.352 -0.386 . . . . 0.0 109.967 178.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.481 ' HA2' HG13 ' A' ' 7' ' ' ILE . . . -122.21 123.28 5.37 Favored Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 111.421 -0.672 . . . . 0.0 111.421 178.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.632 ' HB2' ' HA ' ' A' ' 8' ' ' SER . 87.4 mt -95.16 6.4 49.16 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.792 0.296 . . . . 0.0 111.643 -174.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 133.97 87.51 0.29 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.783 -0.723 . . . . 0.0 111.411 178.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.837 ' HA ' ' HB3' ' A' ' 10' ' ' SER . 6.2 m-20 -127.38 -66.52 0.88 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.076 0.465 . . . . 0.0 112.117 -169.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.431 ' CE2' ' HG ' ' A' ' 48' ' ' LEU . 80.3 m-85 -94.25 131.55 39.73 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.871 -174.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 12.7 m -110.04 7.15 8.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.159 -178.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.548 ' O ' HG22 ' A' ' 45' ' ' VAL . 15.1 t70 -111.96 129.94 56.02 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.172 179.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 49.9 tp -60.33 -49.71 76.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.553 -174.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -55.25 -45.38 76.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.999 0.428 . . . . 0.0 111.065 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.7 m -65.68 -29.52 70.09 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.157 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.548 HG22 ' O ' ' A' ' 41' ' ' ASP . 85.1 t -66.43 -42.62 90.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-O 120.891 0.376 . . . . 0.0 110.497 175.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.404 HD11 ' N ' ' A' ' 46' ' ' ILE . 1.7 mp -67.16 -37.93 80.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.285 0.564 . . . . 0.0 110.23 178.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.81 -34.18 76.24 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.393 174.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.431 ' HG ' ' CE2' ' A' ' 39' ' ' TYR . 2.6 tm? -65.72 -35.67 81.4 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 178.249 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.544 ' HA ' ' HE2' ' A' ' 55' ' ' PHE . 0.3 OUTLIER -63.37 -30.54 71.65 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.651 172.767 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.404 ' HD3' ' HA ' ' A' ' 50' ' ' LYS . 42.9 mmtm -70.12 -39.16 75.63 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 120.869 -0.333 . . . . 0.0 110.805 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.429 ' HB3' HD12 ' A' ' 27' ' ' LEU . 82.5 m-85 -73.57 -67.66 0.57 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.855 0.36 . . . . 0.0 110.636 174.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.565 ' HB3' HD11 ' A' ' 27' ' ' LEU . 5.1 p -86.98 96.61 10.33 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 175.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -71.58 -7.39 47.41 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.253 -172.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -151.73 100.57 2.69 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.123 0.487 . . . . 0.0 109.972 171.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.544 ' HE2' ' HA ' ' A' ' 49' ' ' GLU . 50.4 p90 -127.99 163.09 25.3 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.863 179.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.522 ' HE2' ' HE1' ' A' ' 4' ' ' PHE . 37.2 m-85 -117.9 118.59 32.39 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 174.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.552 ' O ' ' HD2' ' A' ' 72' ' ' PRO . . . -106.23 149.31 16.63 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.217 -0.992 . . . . 0.0 112.734 -176.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.464 HG23 ' CB ' ' A' ' 86' ' ' MET . 3.5 t -129.53 154.54 40.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 174.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.848 ' HB3' ' HA ' ' A' ' 73' ' ' PHE . 24.4 t-80 -99.24 150.88 21.63 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.7 -176.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 1.065 ' HA3' ' HB3' ' A' ' 88' ' ' HIS . . . 169.71 53.99 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.128 177.168 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -171.79 160.84 5.74 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 67.0 mtp -80.0 107.3 12.68 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.147 0.499 . . . . 0.0 109.925 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.577 ' CG ' ' HE2' ' A' ' 59' ' ' HIS . 38.1 p-10 -123.47 -156.24 0.7 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.243 -171.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -108.35 154.21 41.54 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.592 175.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -46.73 -44.55 21.72 Favored 'Trans proline' 0 N--CA 1.475 0.407 0 C-N-CA 123.46 2.774 . . . . 0.0 114.089 -176.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -63.24 -26.0 68.59 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.862 0.363 . . . . 0.0 111.842 -176.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 51.7 t -79.6 -32.18 14.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.777 -176.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -62.6 -20.84 65.14 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.412 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -73.47 -47.76 38.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.115 0.484 . . . . 0.0 110.945 178.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -85.05 -21.72 29.28 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.426 -173.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.568 ' O ' ' HB2' ' A' ' 59' ' ' HIS . 3.6 mm? -110.99 94.36 20.32 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.48 173.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.552 ' HD2' ' O ' ' A' ' 57' ' ' GLY . 26.8 Cg_exo -62.62 138.1 67.94 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.825 2.35 . . . . 0.0 111.85 179.094 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.848 ' HA ' ' HB3' ' A' ' 59' ' ' HIS . 40.4 p90 -52.46 -33.04 42.6 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.307 0.379 . . . . 0.0 111.869 -175.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.5 m -155.14 145.65 22.14 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 175.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.4 tttm -144.21 150.24 37.66 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -177.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.5 t -127.34 118.31 49.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 176.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 83.0 mt -90.93 147.89 22.82 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.256 178.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 24.9 tp -115.93 95.42 5.1 Favored 'General case' 0 C--N 1.315 -0.935 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 175.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 47.0 t -99.29 93.99 3.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.211 -177.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 64.17 18.24 11.14 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.662 178.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 114.41 -20.91 15.46 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.97 -177.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.54 ' HA ' ' OE1' ' A' ' 109' ' ' GLN . 55.0 t -76.48 114.91 17.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.822 0.344 . . . . 0.0 110.329 177.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.41 ' HB ' ' HB3' ' A' ' 108' ' ' PRO . 0.9 OUTLIER -83.04 125.65 31.69 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.261 178.931 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.8 mt -117.76 94.91 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.582 -179.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' A' ' 111' ' ' ILE . . . -81.87 126.22 7.31 Favored Glycine 0 N--CA 1.442 -0.939 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.464 ' CB ' HG23 ' A' ' 58' ' ' VAL . 44.0 mtm -126.14 129.8 49.77 Favored 'General case' 0 C--N 1.313 -0.979 0 O-C-N 122.69 -0.3 . . . . 0.0 110.823 -175.077 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 48.5 t -159.57 116.69 2.64 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.652 179.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 1.065 ' HB3' ' HA3' ' A' ' 60' ' ' GLY . 3.3 t-160 -84.6 85.16 7.46 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 -177.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -133.59 165.73 24.08 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.094 -177.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 26.2 m-90 -122.28 -174.21 2.85 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.84 0.353 . . . . 0.0 110.897 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 127.01 -163.05 21.03 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 -176.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.421 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . . . -79.17 124.25 84.52 Favored Pre-proline 0 C--N 1.322 -0.599 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 177.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 92' ' ' ALA . 49.2 Cg_exo -55.22 -30.6 72.33 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.053 2.502 . . . . 0.0 112.967 -175.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -70.94 -54.29 11.88 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.215 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -69.94 -29.14 66.22 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.943 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.432 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 35.0 tp -59.68 -45.84 90.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.036 -177.198 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.818 ' HZ1' ' HB ' ' A' ' 122' ' ' THR . 79.2 mttt -59.15 -49.3 78.38 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.657 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.13 -27.84 66.8 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.216 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -74.02 -42.34 60.48 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.498 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 95.4 mt -66.64 -29.91 70.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.925 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.432 HD21 HG21 ' A' ' 127' ' ' VAL . 84.0 mt -69.22 -15.43 63.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.813 0.34 . . . . 0.0 111.087 176.253 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -101.27 -2.39 31.27 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.369 0.604 . . . . 0.0 110.119 177.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 64.5 t -92.47 -44.06 13.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 169.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -106.62 90.11 3.23 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.445 172.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -69.17 -15.84 63.49 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.194 -177.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -73.16 -21.85 60.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.14 175.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.41 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 94.2 mttt 63.81 99.09 0.04 OUTLIER Pre-proline 0 N--CA 1.465 0.305 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.127 175.128 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.41 ' HB3' ' HB ' ' A' ' 83' ' ' THR . 4.8 Cg_exo -79.6 163.02 24.34 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 123.546 2.83 . . . . 0.0 112.759 -177.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.54 ' OE1' ' HA ' ' A' ' 82' ' ' VAL . 91.1 mt-30 -79.52 -41.6 27.0 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.158 176.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 54.9 t -123.85 140.29 47.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.196 -178.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.496 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 54.9 mt -130.72 130.83 64.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.129 0.49 . . . . 0.0 110.791 176.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 94.0 mt -114.25 135.05 54.48 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.342 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.423 ' CE2' ' HB3' ' A' ' 129' ' ' PHE . 28.6 p90 -151.38 159.11 44.42 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.884 176.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -105.91 114.79 4.61 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 173.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.652 ' HD2' HG21 ' A' ' 116' ' ' THR . 11.0 t60 -122.61 -82.79 0.65 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.758 0.313 . . . . 0.0 110.808 -172.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.652 HG21 ' HD2' ' A' ' 115' ' ' HIS . 10.8 p -101.57 160.57 14.33 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 177.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.43 ' HB3' ' OE2' ' A' ' 137' ' ' GLU . 34.6 m170 -87.39 71.69 9.87 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.381 0.61 . . . . 0.0 110.902 -177.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -171.47 130.12 0.72 Allowed Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 114.622 -1.172 . . . . 0.0 108.62 176.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.447 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 34.7 Cg_exo -58.71 107.41 0.34 Allowed 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.426 2.084 . . . . 0.0 111.731 178.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.498 ' HG2' HG23 ' A' ' 122' ' ' THR . 43.6 tt0 -121.49 128.07 51.7 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.203 -174.113 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.445 ' HA ' HD23 ' A' ' 130' ' ' LEU . 11.2 t70 -104.41 125.13 50.34 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 175.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.818 ' HB ' ' HZ1' ' A' ' 97' ' ' LYS . 33.3 p -135.64 154.54 51.28 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.544 0.688 . . . . 0.0 112.431 -175.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 10.0 p -145.09 162.95 13.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.647 175.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.604 ' HB3' ' HD3' ' A' ' 97' ' ' LYS . 64.8 tttm -176.94 -59.85 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.529 0.68 . . . . 0.0 109.82 -179.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.45 ' C ' ' H ' ' A' ' 127' ' ' VAL . . . -95.55 30.58 2.24 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.029 -175.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 78.55 -33.36 1.84 Allowed Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 121.039 -0.601 . . . . 0.0 111.701 -174.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.45 ' H ' ' C ' ' A' ' 125' ' ' ALA . 28.7 t -70.88 141.86 16.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 122.978 0.511 . . . . 0.0 110.301 176.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -95.49 125.52 40.15 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 177.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.564 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 75.9 m-85 -112.43 128.26 56.26 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -177.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 121' ' ' ASP . 60.3 mt -120.37 132.45 55.28 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.107 0.479 . . . . 0.0 111.604 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.48 ' HB3' ' HB3' ' A' ' 120' ' ' GLU . 25.0 t30 -117.8 105.34 47.76 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.837 176.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.491 ' HG2' ' OG ' ' A' ' 8' ' ' SER . 5.9 Cg_exo -82.36 -172.25 1.38 Allowed 'Trans proline' 0 CA--C 1.531 0.326 0 C-N-CA 123.45 2.767 . . . . 0.0 112.692 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -100.43 -174.12 29.81 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.125 -179.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.607 ' OG ' ' HB2' ' A' ' 137' ' ' GLU . 28.9 p -95.9 160.27 14.56 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 122.605 -0.35 . . . . 0.0 110.951 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 35.7 mt -64.7 -45.58 86.0 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -176.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -75.45 1.69 13.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.316 0.579 . . . . 0.0 111.198 -178.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.607 ' HB2' ' OG ' ' A' ' 134' ' ' SER . 10.5 tt0 -95.89 -15.96 22.09 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.711 -178.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.511 ' HA2' ' HB2' ' A' ' 157' ' ' LEU . . . 72.64 43.0 45.31 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.538 179.137 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.8 m -149.17 98.26 2.79 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 176.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.453 ' O ' HD13 ' A' ' 154' ' ' LEU . 27.5 p90 -116.66 164.15 15.05 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.914 -0.315 . . . . 0.0 110.155 -178.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.499 ' HB3' HD22 ' A' ' 6' ' ' LEU . . . -114.45 150.77 34.24 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.11 0.481 . . . . 0.0 110.803 -174.179 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.461 HG11 ' HG3' ' A' ' 144' ' ' GLU . 67.1 t -125.74 134.55 66.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.605 177.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.693 HD21 HG12 ' A' ' 150' ' ' VAL . 4.5 tt -122.9 103.89 8.91 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.157 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.461 ' HG3' HG11 ' A' ' 142' ' ' VAL . 60.8 mt-10 -108.78 148.26 30.8 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 120.918 0.389 . . . . 0.0 110.461 -177.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.426 HD13 ' HB3' ' A' ' 2' ' ' LYS . 67.2 mt -94.16 90.49 6.38 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.247 0.546 . . . . 0.0 109.61 176.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -124.53 126.17 45.4 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.141 -176.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.95 11.19 60.39 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.006 -175.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 81.48 -7.59 60.98 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 111.792 -0.523 . . . . 0.0 111.792 -176.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -84.64 158.65 20.78 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 120.917 0.389 . . . . 0.0 110.547 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.693 HG12 HD21 ' A' ' 143' ' ' LEU . 15.6 t -83.79 100.36 7.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.211 176.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.432 ' O ' ' HA ' ' A' ' 143' ' ' LEU . 32.6 ttt180 -92.5 99.78 12.44 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.093 -171.463 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . 0.407 ' HA ' ' O ' ' A' ' 142' ' ' VAL . 43.1 m-85 -93.74 107.75 19.59 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.971 177.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -110.39 116.38 31.32 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.561 174.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.453 HD13 ' O ' ' A' ' 140' ' ' TYR . 41.5 tp -89.81 123.17 33.55 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 177.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -120.95 148.15 44.48 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.98 0.419 . . . . 0.0 110.876 -177.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 13.7 p -105.83 156.97 17.8 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.005 -174.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.511 ' HB2' ' HA2' ' A' ' 138' ' ' GLY . 79.2 mt . . . . . 0 C--O 1.25 1.099 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.747 178.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 N--CA 1.48 1.035 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 46.1 mttp -90.58 112.4 24.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.745 0.307 . . . . 0.0 110.438 177.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.498 ' HB3' ' HD1' ' A' ' 30' ' ' TYR . 88.0 mtt180 -130.57 115.38 16.68 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.87 -178.213 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.654 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 91.7 m-85 -101.64 114.65 28.88 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.223 0.535 . . . . 0.0 110.669 178.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.508 ' HB3' HG22 ' A' ' 33' ' ' VAL . 47.2 tp -89.55 110.65 21.48 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.333 -179.127 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.641 HD12 ' HG ' ' A' ' 36' ' ' LEU . 60.2 tp -96.02 114.91 26.67 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.018 0.437 . . . . 0.0 111.104 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 26.9 pt -101.03 125.76 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 171.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.555 ' HB3' ' HG2' ' A' ' 132' ' ' PRO . 11.1 p -80.6 -94.21 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -168.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.46 75.15 1.0 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.984 0.421 . . . . 0.0 111.673 -173.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.2 m -79.95 119.23 22.51 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 173.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 65.0 m-70 -134.33 73.12 1.48 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.516 0.674 . . . . 0.0 109.33 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.462 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . 48.7 t -120.79 131.15 24.55 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.247 -176.446 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.462 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 70.7 Cg_endo -102.25 90.19 0.08 OUTLIER 'Cis proline' 0 N--CA 1.451 -1.001 0 C-N-CA 123.781 -1.341 . . . . 0.0 112.438 -5.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.499 HG11 ' HG2' ' A' ' 15' ' ' ARG . 27.3 t -97.75 -84.94 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.649 -179.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.499 ' HG2' HG11 ' A' ' 14' ' ' VAL . 12.6 mmm180 -121.05 -25.59 5.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.178 0.513 . . . . 0.0 110.204 177.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.463 ' C ' ' H ' ' A' ' 18' ' ' SER . 51.1 ttp -80.43 -72.92 0.39 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.117 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 70.3 -33.71 0.27 Allowed 'General case' 0 N--CA 1.469 0.516 0 O-C-N 123.872 0.733 . . . . 0.0 112.077 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.463 ' H ' ' C ' ' A' ' 16' ' ' MET . 29.7 p -75.15 81.84 2.31 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.087 0.47 . . . . 0.0 111.572 -178.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.414 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 8.0 tt -107.55 110.68 62.9 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 173.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.593 ' CG ' HD12 ' A' ' 157' ' ' LEU . 19.6 Cg_endo -59.13 142.24 99.04 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 123.152 2.568 . . . . 0.0 112.936 -176.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -71.73 -20.83 61.85 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.109 -173.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -57.17 -46.72 82.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.432 -177.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.5 tt -71.2 -32.14 46.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.466 0.65 . . . . 0.0 110.293 -177.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.457 ' O ' HD21 ' A' ' 27' ' ' LEU . 58.4 tp -72.84 -25.14 61.01 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.69 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -81.47 -29.33 33.76 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.476 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.4 p -83.51 8.82 12.85 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -174.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.567 HD12 ' HB2' ' A' ' 52' ' ' SER . 3.2 mm? -56.31 -27.8 56.75 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.839 0.352 . . . . 0.0 111.494 176.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -78.14 -24.31 47.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.367 -177.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -92.85 -3.74 54.12 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.16 0.505 . . . . 0.0 111.177 -172.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.498 ' HD1' ' HB3' ' A' ' 3' ' ' ARG . 99.0 m-85 -123.44 120.22 32.31 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.28 176.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -78.8 -29.93 45.15 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.973 -173.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.654 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -120.91 126.62 6.67 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 174.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.508 HG22 ' HB3' ' A' ' 5' ' ' LEU . 97.0 t -119.61 134.71 62.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 117.426 0.613 . . . . 0.0 110.603 -179.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.515 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 71.2 mt -116.82 131.76 68.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.234 -177.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -125.77 107.41 0.95 Allowed Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.411 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.641 ' HG ' HD12 ' A' ' 6' ' ' LEU . 95.0 mt -74.2 -22.8 59.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.697 0.761 . . . . 0.0 109.385 176.154 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -152.39 125.06 1.74 Allowed Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 174.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -119.72 -169.57 1.79 Allowed 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -174.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -65.33 145.39 56.26 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 19.9 m -84.41 27.26 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.12 0.486 . . . . 0.0 111.672 -171.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -146.3 139.35 25.66 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 121.029 0.442 . . . . 0.0 110.389 177.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.709 ' HB2' ' HB3' ' A' ' 66' ' ' ASP . 43.4 tp -66.34 -28.9 69.02 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.519 -173.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.47 -35.63 78.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.175 0.512 . . . . 0.0 110.482 -177.099 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.2 m -83.24 -30.84 27.36 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.341 -178.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 98.2 t -58.43 -42.54 84.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.039 0.447 . . . . 0.0 110.285 174.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.415 HD12 ' HG ' ' A' ' 42' ' ' LEU . 1.7 mp -68.85 -35.72 70.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.202 177.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -61.25 -37.8 84.41 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.914 175.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 46.8 mt -80.11 -33.33 38.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.732 0.301 . . . . 0.0 110.684 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -65.32 -21.6 66.73 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.129 174.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -81.41 -36.17 29.82 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.043 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.42 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . 39.2 m-85 -75.16 -62.58 1.51 Allowed 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.057 174.059 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.567 ' HB2' HD12 ' A' ' 27' ' ' LEU . 33.4 t -90.8 98.71 11.94 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 173.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 42.7 mttm -78.05 15.18 0.95 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.767 -178.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -146.95 77.58 1.46 Allowed 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 168.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -101.82 123.5 45.88 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.532 -175.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.547 ' HE2' ' HE1' ' A' ' 4' ' ' PHE . 26.5 m-85 -104.41 107.9 19.05 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 175.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.822 ' HA3' HD23 ' A' ' 71' ' ' LEU . . . -116.64 156.49 15.59 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.1 -1.047 . . . . 0.0 112.708 -176.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 15.0 t -128.08 146.08 34.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 177.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 56.8 t60 -94.57 104.53 16.48 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.459 0.647 . . . . 0.0 109.458 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.59 ' HA3' ' HB2' ' A' ' 88' ' ' HIS . . . -135.38 23.15 3.48 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.966 177.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -121.72 -176.07 3.24 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 51.2 mtp -98.91 36.19 1.73 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.393 0.616 . . . . 0.0 109.36 173.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.426 ' OD2' ' HB ' ' A' ' 67' ' ' VAL . 3.8 p-10 -68.62 156.11 38.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.419 178.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.518 ' HB3' ' HD2' ' A' ' 65' ' ' PRO . 89.5 m-85 -70.05 162.97 65.38 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.239 -175.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.518 ' HD2' ' HB3' ' A' ' 64' ' ' TYR . 9.9 Cg_endo -51.91 -23.92 17.65 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.173 2.582 . . . . 0.0 112.602 177.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.709 ' HB3' ' HB2' ' A' ' 42' ' ' LEU . 5.9 m-20 -54.83 -50.31 68.92 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.251 0.548 . . . . 0.0 110.412 175.281 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.426 ' HB ' ' OD2' ' A' ' 63' ' ' ASP . 29.1 t -77.94 -34.44 19.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.057 -178.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.454 ' HB3' ' HA ' ' A' ' 65' ' ' PRO . 57.8 tttm -62.72 -24.4 67.66 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.105 177.23 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -64.48 -41.09 96.69 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.262 0.553 . . . . 0.0 109.59 175.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -83.42 -38.61 21.69 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.11 -178.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.822 HD23 ' HA3' ' A' ' 57' ' ' GLY . 14.8 mt -114.13 120.7 38.05 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.07 -173.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.479 ' HG2' ' HB2' ' A' ' 75' ' ' LYS . 72.6 Cg_endo -79.79 157.76 24.46 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.793 2.329 . . . . 0.0 111.426 175.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -60.03 -34.78 73.85 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.906 0.384 . . . . 0.0 111.061 -177.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 17.3 m -142.8 137.55 29.76 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 174.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.479 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 43.0 tttp -136.24 126.28 26.1 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.549 0.214 . . . . 0.0 110.627 -176.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 26.8 t -103.18 125.07 57.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.787 0.327 . . . . 0.0 110.29 177.103 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.524 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 89.9 mt -100.43 159.72 14.92 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.784 178.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 46.6 tp -130.78 99.61 5.0 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 175.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.529 HG12 ' HG2' ' A' ' 80' ' ' GLU . 58.2 t -117.04 112.67 40.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.684 -176.004 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.529 ' HG2' HG12 ' A' ' 79' ' ' VAL . 4.5 mm-40 60.06 19.57 8.76 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.57 178.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.55 -3.7 50.18 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.333 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.3 t -93.68 128.23 45.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.664 0.269 . . . . 0.0 110.56 178.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 33.9 p -88.49 126.72 35.38 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.605 178.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.524 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 19.6 mt -118.33 95.85 3.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.82 0.343 . . . . 0.0 110.218 -178.347 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -80.23 98.12 1.72 Allowed Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 178.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 32.2 mtm -96.8 120.73 37.68 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.135 0.493 . . . . 0.0 110.999 -175.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 26.4 t -139.38 165.19 27.85 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 174.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.59 ' HB2' ' HA3' ' A' ' 60' ' ' GLY . 4.6 t60 -81.51 -21.12 38.85 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 119.669 -0.812 . . . . 0.0 109.667 178.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.88 -155.5 33.37 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.53 177.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 73.8 t-105 -159.74 -73.2 0.07 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.95 0.405 . . . . 0.0 110.513 -177.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 161.77 -174.21 38.24 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 -178.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 55.17 81.86 0.25 Allowed Pre-proline 0 N--CA 1.463 0.21 0 C-N-CA 122.631 0.372 . . . . 0.0 111.341 -179.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -54.77 -30.75 68.8 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.399 2.733 . . . . 0.0 113.262 -173.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -72.53 -13.62 61.45 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.185 -0.461 . . . . 0.0 112.228 -177.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -121.6 -25.18 5.16 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.189 0.519 . . . . 0.0 110.417 177.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 48.2 tp -60.19 -41.29 92.6 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.006 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -58.36 -41.62 85.11 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.159 0.504 . . . . 0.0 109.835 178.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.428 ' O ' ' HG3' ' A' ' 102' ' ' LYS . 9.1 m-20 -69.58 -47.67 62.79 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.058 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.527 ' O ' HG21 ' A' ' 103' ' ' VAL . 19.0 ttm180 -58.71 -46.74 86.66 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.151 -177.03 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.46 HD11 HG22 ' A' ' 111' ' ' ILE . 91.7 mt -66.4 -36.45 82.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.72 0.295 . . . . 0.0 111.287 -179.125 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 93.8 mt -75.12 -11.35 60.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.857 0.36 . . . . 0.0 111.127 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.428 ' HG3' ' O ' ' A' ' 98' ' ' ASP . 96.1 mttt -100.07 -8.87 23.26 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.122 0.487 . . . . 0.0 110.179 175.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.527 HG21 ' O ' ' A' ' 99' ' ' ARG . 90.9 t -81.29 -48.07 19.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 170.025 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -101.09 106.71 18.01 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.175 173.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 -57.44 -37.7 73.24 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.804 0.335 . . . . 0.0 111.631 -175.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -96.17 133.83 39.98 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 174.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.46 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 60.1 pttt -71.86 126.66 91.35 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-O 121.148 0.499 . . . . 0.0 111.185 -174.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 107' ' ' LYS . 3.7 Cg_exo -81.8 169.48 14.95 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 123.393 2.729 . . . . 0.0 111.473 175.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -87.36 -45.33 10.65 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.112 0.482 . . . . 0.0 109.97 178.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 63.3 t -120.63 136.74 56.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.279 178.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.46 HG22 HD11 ' A' ' 100' ' ' LEU . 59.6 mt -130.02 133.87 63.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.881 0.372 . . . . 0.0 110.386 177.084 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.47 HD23 ' HB2' ' A' ' 130' ' ' LEU . 95.3 mt -109.26 146.36 34.38 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.375 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.42 ' CZ ' ' HB3' ' A' ' 131' ' ' ASN . 29.8 p90 -155.69 163.79 39.44 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 174.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -147.11 125.48 2.19 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.681 -177.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 36.5 t-80 -177.5 -37.14 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 177.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.3 p -79.86 127.34 32.12 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.522 177.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.456 ' O ' ' HD3' ' A' ' 119' ' ' PRO . 24.1 m170 -87.71 7.3 30.75 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.263 0.554 . . . . 0.0 110.206 176.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -106.4 91.69 6.1 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.756 171.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.456 ' HD3' ' O ' ' A' ' 117' ' ' HIS . 22.5 Cg_exo -63.51 129.51 25.4 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.75 2.3 . . . . 0.0 111.661 -175.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -149.26 136.74 20.18 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.968 0.414 . . . . 0.0 111.314 -172.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.439 ' OD1' ' HD2' ' A' ' 128' ' ' ARG . 6.7 t70 -90.44 119.78 31.0 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.482 174.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.471 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 44.3 p -132.66 129.52 38.94 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.108 0.48 . . . . 0.0 112.049 -173.497 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 6.2 p -120.54 105.81 17.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 169.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 50.0 mttp -109.11 -67.34 0.99 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.264 -172.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -92.18 33.0 1.1 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.101 0.476 . . . . 0.0 110.992 -176.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 83.03 -14.92 35.57 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 -175.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 41.8 t -96.23 144.87 9.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.439 ' HD2' ' OD1' ' A' ' 121' ' ' ASP . 6.4 tpp180 -87.24 109.54 19.56 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.391 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.471 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 92.0 m-85 -98.15 121.17 39.75 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 177.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.502 HD12 ' CD1' ' A' ' 152' ' ' PHE . 64.8 mt -121.5 129.66 53.07 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.872 0.367 . . . . 0.0 111.327 -174.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.44 ' HA ' ' HD3' ' A' ' 132' ' ' PRO . 8.5 p30 -131.82 122.31 18.5 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.156 177.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.555 ' HG2' ' HB3' ' A' ' 8' ' ' SER . 87.4 Cg_endo -98.41 168.54 0.66 Allowed 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 123.48 2.787 . . . . 0.0 113.057 178.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -80.67 166.57 49.24 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.787 -0.721 . . . . 0.0 111.351 175.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.494 ' HA ' ' OG ' ' A' ' 8' ' ' SER . 39.5 m -90.32 177.39 6.42 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 117.2 0.5 . . . . 0.0 111.181 -177.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.412 HD21 ' N ' ' A' ' 135' ' ' LEU . 3.1 mm? -73.09 -18.13 61.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.335 -176.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -73.26 -47.4 43.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.759 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.49 ' OE1' ' HB2' ' A' ' 134' ' ' SER . 1.8 mp0 -66.49 -32.13 73.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.148 177.082 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.504 ' HA2' HD13 ' A' ' 157' ' ' LEU . . . 96.58 51.75 1.65 Allowed Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.211 178.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 23.1 t -145.97 153.89 41.3 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 178.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -154.36 167.09 31.13 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.779 177.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.434 ' HB2' ' HB3' ' A' ' 6' ' ' LEU . . . -114.26 135.95 53.5 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.849 0.356 . . . . 0.0 111.041 -174.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 79.4 t -121.27 120.55 62.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.169 176.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.775 HD21 HG11 ' A' ' 150' ' ' VAL . 5.5 tt -104.5 103.95 13.73 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 177.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -106.39 135.91 47.06 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.876 -178.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.483 ' HA ' ' O ' ' A' ' 149' ' ' GLU . 5.1 mp -112.13 98.7 7.51 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.944 0.402 . . . . 0.0 110.512 178.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -101.26 121.54 42.06 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.367 0.603 . . . . 0.0 109.426 178.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 68.09 1.56 20.29 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.835 -175.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 104.57 0.58 43.18 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 121.155 -0.545 . . . . 0.0 112.235 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.483 ' O ' ' HA ' ' A' ' 145' ' ' LEU . 8.7 mm-40 -88.76 132.95 34.4 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.925 0.393 . . . . 0.0 110.511 177.13 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.775 HG11 HD21 ' A' ' 143' ' ' LEU . 98.3 t -80.75 113.97 20.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.021 -178.107 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 11.1 mtm180 -110.54 107.07 16.58 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 176.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . 0.502 ' CD1' HD12 ' A' ' 130' ' ' LEU . 84.5 t80 -89.45 96.29 10.64 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 176.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -107.24 109.49 21.29 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.414 -174.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 33.9 tp -80.02 118.97 22.23 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.557 177.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -111.03 160.45 16.84 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.055 -178.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 16.5 p -107.39 165.6 11.27 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.334 176.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.593 HD12 ' CG ' ' A' ' 20' ' ' PRO . 39.4 mt . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.422 -0.799 . . . . 0.0 110.011 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 70.1 t . . . . . 0 N--CA 1.479 0.982 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.512 ' HB2' HD12 ' A' ' 145' ' ' LEU . 50.1 mttm -105.33 148.62 26.86 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.958 0.409 . . . . 0.0 110.91 178.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.482 ' HB3' ' HD2' ' A' ' 30' ' ' TYR . 88.9 mtt180 -117.2 133.65 55.73 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.163 -178.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -120.29 121.14 38.0 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.866 0.365 . . . . 0.0 110.065 175.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.424 ' HB3' HG22 ' A' ' 33' ' ' VAL . 38.7 tp -93.0 121.05 33.94 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.863 -178.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.547 HD12 ' HG ' ' A' ' 36' ' ' LEU . 51.7 tp -103.98 120.94 42.11 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.952 0.406 . . . . 0.0 110.508 178.252 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.5 pt -101.33 123.96 54.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 173.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.422 ' HB3' ' HB2' ' A' ' 132' ' ' PRO . 5.9 p -66.0 -79.31 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.578 -169.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.783 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 26.9 t70 -148.0 124.13 10.79 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.135 -177.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.704 ' HA ' ' HE2' ' A' ' 16' ' ' MET . 9.0 p -156.91 88.46 1.04 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.123 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 62.4 m-70 -83.69 85.85 7.22 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.307 -0.406 . . . . 0.0 109.973 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.461 ' O ' HG21 ' A' ' 40' ' ' VAL . 59.9 t -107.7 135.04 19.82 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.026 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -78.23 -62.56 0.03 OUTLIER 'Cis proline' 0 C--N 1.345 0.384 0 C-N-CA 123.75 -1.354 . . . . 0.0 112.571 0.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.76 HG13 ' HG3' ' A' ' 15' ' ' ARG . 19.6 t 52.13 -93.0 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 123.464 0.705 . . . . 0.0 112.031 177.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.76 ' HG3' HG13 ' A' ' 14' ' ' VAL . 97.8 mtt180 -134.01 4.37 3.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.869 0.366 . . . . 0.0 110.564 -175.297 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.704 ' HE2' ' HA ' ' A' ' 10' ' ' SER . 32.3 ttp -137.77 112.46 8.87 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.511 -176.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -116.89 19.69 14.26 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.203 0.525 . . . . 0.0 110.344 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 35.6 p -99.9 29.9 3.97 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.379 -176.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.686 HD13 ' HB2' ' A' ' 10' ' ' SER . 7.1 tt -83.27 116.96 67.08 Favored Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 179.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -68.86 118.14 5.47 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 122.45 2.1 . . . . 0.0 112.187 178.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.56 -7.8 5.29 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.442 -177.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -61.12 -36.97 81.15 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.808 0.337 . . . . 0.0 110.796 179.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 11.1 tp -64.75 -39.19 84.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.937 0.875 . . . . 0.0 109.761 178.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 44.4 tp -78.37 -10.25 59.61 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.051 -1.432 . . . . 0.0 110.978 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -100.32 -6.55 25.68 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.106 0.479 . . . . 0.0 110.816 -176.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 68.4 m -121.68 0.5 9.86 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.988 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.433 HD13 HG23 ' A' ' 33' ' ' VAL . 1.4 pt? -72.65 -19.26 61.47 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.065 -174.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -72.94 -13.9 61.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.961 -177.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -73.77 -26.08 60.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.114 0.483 . . . . 0.0 110.547 177.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.482 ' HD2' ' HB3' ' A' ' 3' ' ' ARG . 85.7 m-85 -83.87 156.95 22.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.211 -173.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -86.94 -6.6 58.72 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.01 -178.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -174.52 149.01 10.19 Favored Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.726 177.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.433 HG23 HD13 ' A' ' 27' ' ' LEU . 69.7 t -124.71 135.98 62.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-O 120.976 0.417 . . . . 0.0 110.494 -179.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.533 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 49.4 mt -113.85 134.44 56.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.769 179.178 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -125.6 117.2 2.85 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.14 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.547 ' HG ' HD12 ' A' ' 6' ' ' LEU . 95.9 mt -95.79 -9.96 30.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.854 0.835 . . . . 0.0 109.246 175.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.783 ' HA3' ' HA ' ' A' ' 9' ' ' ASP . . . -151.43 60.93 0.41 Allowed Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.238 178.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -73.83 178.85 4.59 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.252 -0.474 . . . . 0.0 111.695 -175.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.518 ' HD1' HD11 ' A' ' 48' ' ' LEU . 71.2 m-85 -63.43 145.62 55.24 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.558 179.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.538 ' HB ' ' CD1' ' A' ' 64' ' ' TYR . 18.1 m -83.79 -9.01 11.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.802 -173.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.484 ' HB2' ' OG1' ' A' ' 44' ' ' THR . 19.4 m-20 -86.62 120.4 27.89 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.013 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.519 HD23 ' HB3' ' A' ' 66' ' ' ASP . 48.9 tp -53.38 -42.24 66.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.026 0.441 . . . . 0.0 110.432 178.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -59.06 -38.7 80.02 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.923 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.496 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 7.6 m -75.74 -28.72 58.62 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.663 -178.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 41' ' ' ASP . 65.6 t -62.22 -46.77 95.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.055 0.455 . . . . 0.0 110.159 175.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.424 HD12 ' N ' ' A' ' 46' ' ' ILE . 1.7 mp -65.07 -36.34 77.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.844 176.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -59.64 -35.42 74.35 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.785 175.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.518 HD11 ' HD1' ' A' ' 39' ' ' TYR . 91.1 mt -71.25 -38.34 71.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.407 178.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.682 ' HG2' ' HB3' ' A' ' 55' ' ' PHE . 49.2 mt-10 -69.05 -17.1 63.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.984 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -82.53 -41.31 19.81 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.856 176.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -68.83 -46.47 68.47 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.903 0.382 . . . . 0.0 111.536 178.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 51.1 p -83.38 -14.81 51.96 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.544 -176.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 93.5 mttt 70.4 -54.11 0.64 Allowed 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.509 0.723 . . . . 0.0 110.368 -172.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -123.68 109.57 13.88 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.193 0.521 . . . . 0.0 109.735 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.682 ' HB3' ' HG2' ' A' ' 49' ' ' GLU . 84.1 t80 -111.4 139.25 46.96 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.479 -175.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.533 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 93.5 m-85 -119.77 116.49 26.02 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 174.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.485 ' HA3' HD13 ' A' ' 71' ' ' LEU . . . -124.91 141.89 13.47 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 119.566 -1.302 . . . . 0.0 113.739 -173.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.409 ' CG2' ' HE1' ' A' ' 86' ' ' MET . 16.5 t -132.24 123.03 49.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 170.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -94.39 147.06 23.61 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 120.095 -0.642 . . . . 0.0 110.339 -173.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.607 ' HA2' ' HB3' ' A' ' 88' ' ' HIS . . . -80.83 -123.06 0.54 Allowed Glycine 0 C--N 1.331 0.261 0 N-CA-C 114.475 0.55 . . . . 0.0 114.475 -171.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -74.23 -164.12 0.23 Allowed 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 122.419 0.288 . . . . 0.0 111.053 -175.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 46.9 mtm -56.46 113.94 1.81 Allowed 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 120.991 0.424 . . . . 0.0 110.264 178.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -141.09 -160.77 1.12 Allowed 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -175.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.538 ' CD1' ' HB ' ' A' ' 40' ' ' VAL . 12.3 m-85 -67.04 125.28 90.68 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 121.113 0.482 . . . . 0.0 111.308 -177.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.66 -38.36 95.78 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 123.869 3.046 . . . . 0.0 113.797 -174.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.519 ' HB3' HD23 ' A' ' 42' ' ' LEU . 5.4 m-20 -59.5 -36.54 76.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.099 0.476 . . . . 0.0 111.024 -178.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 11.9 t -76.53 -26.08 16.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.261 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -63.51 -31.1 72.16 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.194 0.521 . . . . 0.0 110.264 176.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -86.2 -19.47 29.97 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.095 -178.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 11.7 t60 -91.24 -40.31 11.59 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.09 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.485 HD13 ' HA3' ' A' ' 57' ' ' GLY . 31.1 mt -117.74 136.26 23.61 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.985 179.116 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.408 ' HD2' ' O ' ' A' ' 57' ' ' GLY . 63.9 Cg_endo -74.34 177.29 8.51 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 122.486 2.124 . . . . 0.0 112.525 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -95.98 -12.97 24.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.212 0.529 . . . . 0.0 110.172 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 10.0 p -155.63 124.1 5.93 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.321 175.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 40.5 tttp -131.83 132.59 43.83 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.509 0.195 . . . . 0.0 110.674 -176.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 20.3 t -110.83 121.68 63.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.873 0.368 . . . . 0.0 110.498 179.039 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.443 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 72.3 mt -101.28 158.81 15.77 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.337 178.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 59.6 tp -127.0 102.11 6.84 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 175.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.497 HG12 ' HG2' ' A' ' 80' ' ' GLU . 35.6 t -124.01 116.12 46.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.468 -177.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.497 ' HG2' HG12 ' A' ' 79' ' ' VAL . 20.2 mm-40 59.78 27.16 16.41 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.477 177.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.31 -15.32 63.5 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.195 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 52.4 t -87.41 126.37 41.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.76 0.314 . . . . 0.0 110.189 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 40.9 p -85.93 134.35 33.88 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.181 177.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.443 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 37.0 mt -118.17 94.81 3.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -178.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -85.29 95.31 1.97 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.444 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.561 ' HG2' HD11 ' A' ' 112' ' ' LEU . 30.0 mtm -95.98 118.93 33.57 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.953 0.406 . . . . 0.0 110.439 -176.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.667 ' O ' ' HA ' ' A' ' 113' ' ' PHE . 52.7 t -140.27 153.69 46.59 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 178.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.607 ' HB3' ' HA2' ' A' ' 60' ' ' GLY . 4.1 p-80 -72.23 1.55 7.46 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.879 -0.329 . . . . 0.0 111.849 176.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.35 176.72 50.34 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.494 176.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -116.73 -99.5 0.44 Allowed 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.548 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -109.69 -94.71 2.32 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.311 -0.947 . . . . 0.0 113.434 -173.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -112.7 172.67 3.35 Favored Pre-proline 0 C--N 1.321 -0.656 0 C-N-CA 122.456 0.302 . . . . 0.0 110.622 -172.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -61.24 -11.79 20.64 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.612 2.208 . . . . 0.0 113.061 177.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 1.5 m0 -77.51 -54.59 6.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.286 0.565 . . . . 0.0 109.701 -179.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.465 ' OD2' ' HD2' ' A' ' 99' ' ' ARG . 7.3 p-10 -82.72 -3.32 56.29 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.703 -177.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 28.0 tp -50.51 -56.34 12.06 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.775 178.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.9 ptmm? -66.44 -48.28 70.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.264 -178.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -62.49 -59.07 5.48 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.792 -175.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.519 ' O ' HG23 ' A' ' 103' ' ' VAL . 94.3 mtt180 -69.31 -38.21 78.16 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -171.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.466 HD12 HG23 ' A' ' 111' ' ' ILE . 46.5 mt -70.03 -37.13 75.5 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.386 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.52 HD23 HG22 ' A' ' 127' ' ' VAL . 87.0 mt -79.3 -14.23 59.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.81 0.338 . . . . 0.0 111.117 178.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.595 ' HA ' ' ND2' ' A' ' 105' ' ' ASN . 97.0 mttt -90.41 -14.54 32.72 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.634 173.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 99' ' ' ARG . 84.2 t -81.43 -49.08 18.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 167.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -100.23 75.22 1.8 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.385 174.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.595 ' ND2' ' HA ' ' A' ' 102' ' ' LYS . 7.4 m120 -60.75 -28.57 68.81 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.5 -173.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -78.23 -6.54 55.24 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.875 0.369 . . . . 0.0 110.686 -178.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.409 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 5.0 tmmm? 64.91 109.09 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.468 0 C-N-CA 123.589 0.755 . . . . 0.0 112.444 174.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 107' ' ' LYS . 8.8 Cg_endo -88.39 178.38 2.97 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.392 2.728 . . . . 0.0 112.102 177.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 14.4 mp0 -88.73 -45.83 9.48 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.865 0.364 . . . . 0.0 110.414 176.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.4 t -124.29 133.61 68.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.748 -178.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.466 HG23 HD12 ' A' ' 100' ' ' LEU . 58.9 mt -124.15 127.14 73.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.296 176.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.611 HD21 ' HB2' ' A' ' 130' ' ' LEU . 87.4 mt -101.13 134.38 44.24 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 178.152 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.667 ' HA ' ' O ' ' A' ' 87' ' ' CYS . 24.7 p90 -144.03 142.1 30.48 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.937 0.399 . . . . 0.0 110.593 176.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -105.68 135.99 12.94 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.914 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -147.62 157.34 43.51 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.8 p -80.1 61.88 4.09 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.378 0.609 . . . . 0.0 111.084 178.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -154.81 152.6 30.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.653 -176.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -57.76 145.88 68.73 Favored Pre-proline 0 C--N 1.329 -0.307 0 O-C-N 123.574 0.546 . . . . 0.0 111.096 177.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.18 149.09 74.66 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 123.122 2.548 . . . . 0.0 112.693 -178.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -151.84 142.38 22.65 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.495 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -78.52 94.04 4.9 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 176.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.8 p -103.5 135.22 45.5 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.998 -176.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 14.1 p -150.34 121.55 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.083 0.468 . . . . 0.0 110.593 176.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.446 ' HB2' ' HE2' ' A' ' 129' ' ' PHE . 95.9 mttt -142.04 144.41 33.59 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.191 -0.458 . . . . 0.0 109.992 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 62.75 19.09 11.18 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 123.5 0.5 . . . . 0.0 111.636 179.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 86.89 -5.7 84.54 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.054 -178.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.52 HG22 HD23 ' A' ' 101' ' ' LEU . 33.0 t -97.6 129.44 47.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 120.833 0.349 . . . . 0.0 110.141 -178.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 38.1 ttm-85 -84.19 122.1 28.38 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.574 178.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.446 ' HE2' ' HB2' ' A' ' 124' ' ' LYS . 82.3 m-85 -103.43 138.97 39.44 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 175.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.611 ' HB2' HD21 ' A' ' 112' ' ' LEU . 95.7 mt -128.18 121.45 29.49 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.91 0.386 . . . . 0.0 111.069 -179.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.443 ' HB3' ' CZ ' ' A' ' 113' ' ' PHE . 8.1 p30 -121.57 117.36 30.19 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.95 176.157 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.422 ' HB2' ' HB3' ' A' ' 8' ' ' SER . 33.6 Cg_endo -96.82 147.38 0.97 Allowed 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 123.344 2.696 . . . . 0.0 112.627 176.111 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -69.51 152.97 52.24 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.207 175.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 82.8 p -70.65 175.47 4.88 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.435 0.636 . . . . 0.0 111.938 -173.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -69.77 -25.56 63.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.394 176.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.603 ' HB1' ' SD ' ' A' ' 16' ' ' MET . . . -72.99 -31.72 64.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.27 0.557 . . . . 0.0 110.336 177.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -83.34 -20.04 35.05 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.109 177.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 89.08 45.94 4.61 Favored Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.944 175.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' ' 156' ' ' THR . 26.4 t -137.0 149.03 47.23 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.841 0.353 . . . . 0.0 110.393 178.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.402 ' CD1' ' HG ' ' A' ' 157' ' ' LEU . 7.5 p90 -147.74 178.0 8.84 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 176.113 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.465 ' HB3' ' HB3' ' A' ' 6' ' ' LEU . . . -132.86 135.26 45.51 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.955 0.407 . . . . 0.0 111.18 -179.183 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 99.3 t -119.7 112.01 35.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.871 175.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.688 ' HA ' ' O ' ' A' ' 151' ' ' ARG . 0.2 OUTLIER -102.85 110.83 22.89 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.6 0.714 . . . . 0.0 110.239 175.513 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -105.18 145.0 31.2 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.687 -178.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.512 HD12 ' HB2' ' A' ' 2' ' ' LYS . 87.4 mt -90.8 90.16 7.8 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.527 0.68 . . . . 0.0 109.952 178.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -95.04 113.97 25.73 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.556 -179.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 68.48 -69.24 0.38 Allowed Glycine 0 CA--C 1.524 0.628 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.598 -175.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -172.52 25.25 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.959 -0.639 . . . . 0.0 111.749 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -124.11 133.6 53.56 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 120.811 0.339 . . . . 0.0 110.404 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.417 HG23 HD22 ' A' ' 145' ' ' LEU . 9.3 t -81.0 98.39 3.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.688 ' O ' ' HA ' ' A' ' 143' ' ' LEU . 38.8 mtp85 -101.13 106.39 17.63 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.794 0.33 . . . . 0.0 110.939 -175.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . 0.517 ' CE2' HD13 ' A' ' 143' ' ' LEU . 18.0 m-85 -83.56 105.49 14.53 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.467 178.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -96.41 112.06 23.94 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.818 0.342 . . . . 0.0 110.719 178.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -72.49 124.42 25.15 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 174.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -133.42 171.27 14.29 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -177.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 139' ' ' SER . 15.1 p -120.69 150.55 40.77 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.853 0.358 . . . . 0.0 111.729 -176.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.402 ' HG ' ' CD1' ' A' ' 140' ' ' TYR . 92.1 mt . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.447 175.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 54.9 mttp . . . . . 0 CA--C 1.517 -0.291 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.449 ' HG3' ' CD1' ' A' ' 30' ' ' TYR . 0.2 OUTLIER -145.79 132.49 19.96 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.486 0.66 . . . . 0.0 111.539 -174.137 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.751 ' HE2' HD11 ' A' ' 145' ' ' LEU . 87.0 m-85 -101.66 128.01 48.15 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.306 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.566 HD11 HD11 ' A' ' 23' ' ' ILE . 43.5 tp -91.75 108.06 19.65 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.308 177.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.592 ' HB3' ' HB3' ' A' ' 141' ' ' ALA . 51.0 tp -94.39 118.14 31.17 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.566 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.4 ' CG1' ' HA2' ' A' ' 35' ' ' GLY . 22.4 pt -101.12 115.58 43.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 174.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.8 m -54.94 -69.55 0.13 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.692 -1.14 . . . . 0.0 113.104 -169.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.58 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 26.1 t70 -153.19 105.24 2.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.867 0.365 . . . . 0.0 110.417 -175.068 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.879 ' H ' ' HA3' ' A' ' 37' ' ' GLY . 5.7 m -110.5 134.45 52.35 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.661 -175.682 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 13.0 m170 -130.76 86.77 2.41 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 173.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.483 ' O ' HG22 ' A' ' 40' ' ' VAL . 48.0 t -128.96 125.68 22.94 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.456 -175.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -78.97 -48.11 0.28 Allowed 'Cis proline' 0 CA--C 1.532 0.389 0 C-N-CA 122.904 -1.707 . . . . 0.0 112.8 -2.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.433 ' CG2' HG11 ' A' ' 40' ' ' VAL . 37.9 t 51.46 -94.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 123.53 0.732 . . . . 0.0 111.605 -178.247 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.46 ' HA ' ' HD2' ' A' ' 15' ' ' ARG . 17.5 tpt180 -148.43 22.81 1.04 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.535 0.684 . . . . 0.0 109.391 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.455 ' C ' ' H ' ' A' ' 18' ' ' SER . 53.5 ttp -119.63 -72.42 0.69 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.688 178.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 64.67 -12.94 0.11 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.552 0.741 . . . . 0.0 112.788 178.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.455 ' H ' ' C ' ' A' ' 16' ' ' MET . 11.9 m -83.64 58.03 4.39 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.263 0.554 . . . . 0.0 110.875 -177.195 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.92 ' HG ' HD11 ' A' ' 135' ' ' LEU . 6.5 tt -107.84 119.04 51.45 Favored Pre-proline 0 C--N 1.321 -0.632 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 177.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 19' ' ' LEU . 18.1 Cg_endo -61.1 111.04 0.97 Allowed 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.286 1.99 . . . . 0.0 111.411 176.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -71.65 -7.08 45.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.415 -174.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -56.42 -43.08 79.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.174 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.566 HD11 HD11 ' A' ' 5' ' ' LEU . 9.7 tt -70.82 -35.84 61.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.515 0.674 . . . . 0.0 110.19 -178.021 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.725 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 59.4 tp -63.0 -32.0 73.27 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.454 177.28 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -75.27 -19.39 59.74 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.704 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 64.0 m -93.11 12.21 25.03 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.152 -174.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.725 ' HG ' ' O ' ' A' ' 24' ' ' LEU . 9.9 mt -63.96 -19.1 64.9 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.979 0.419 . . . . 0.0 110.349 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -52.88 -36.06 58.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.999 176.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -94.11 3.48 55.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.332 -174.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.472 ' CD1' ' HB2' ' A' ' 5' ' ' LEU . 90.6 m-85 -118.38 106.67 12.98 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.181 0.515 . . . . 0.0 110.341 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -75.62 4.92 6.77 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.873 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.577 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -163.74 109.49 0.38 Allowed Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 175.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 90.8 t -100.08 126.52 53.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 O-C-N 122.458 -0.436 . . . . 0.0 110.119 178.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 51.4 mt -105.33 123.51 59.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 120.87 0.366 . . . . 0.0 110.158 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.4 ' HA2' ' CG1' ' A' ' 7' ' ' ILE . . . -114.64 103.06 1.23 Allowed Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 120.512 -0.852 . . . . 0.0 112.648 -177.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.493 HD21 ' HB3' ' A' ' 86' ' ' MET . 70.9 mt -85.3 -30.95 23.33 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 172.241 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.879 ' HA3' ' H ' ' A' ' 10' ' ' SER . . . -112.1 123.1 6.21 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 171.018 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -99.88 164.77 11.87 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.551 0.691 . . . . 0.0 112.754 -169.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.414 ' CD1' HD21 ' A' ' 48' ' ' LEU . 60.0 m-85 -85.85 127.13 34.5 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 168.113 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.483 HG22 ' O ' ' A' ' 12' ' ' VAL . 3.8 m -80.96 -9.5 11.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -165.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.502 ' O ' HG23 ' A' ' 45' ' ' VAL . 2.3 m-20 -86.9 125.87 34.3 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 176.036 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 38.9 tp -60.75 -36.0 77.79 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.369 0.604 . . . . 0.0 109.503 178.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -57.28 -44.95 84.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.227 175.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.492 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 14.9 m -71.98 -25.09 61.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.023 -177.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 41' ' ' ASP . 61.0 t -62.66 -42.71 97.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.075 0.464 . . . . 0.0 110.174 175.526 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.45 -36.55 77.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-O 121.263 0.554 . . . . 0.0 109.724 175.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.59 -32.97 74.6 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.455 175.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 44' ' ' THR . 89.0 mt -64.46 -43.07 95.38 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 176.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.471 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 29.6 tt0 -69.41 -14.87 63.13 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.02 178.032 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -85.21 -49.73 7.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.662 178.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.457 ' CB ' HD12 ' A' ' 27' ' ' LEU . 28.3 m-85 -65.29 -57.01 9.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.842 178.289 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.645 ' HB3' HD13 ' A' ' 27' ' ' LEU . 83.0 p -77.62 -38.65 47.55 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.709 0.29 . . . . 0.0 111.214 -175.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.471 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 53.6 mttp 69.67 7.79 6.41 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.721 -178.045 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 179.0 111.01 0.03 OUTLIER 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.805 174.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -136.71 152.83 50.8 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.999 0.428 . . . . 0.0 110.682 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.545 ' HE2' ' HE1' ' A' ' 4' ' ' PHE . 40.2 m-85 -118.18 113.79 22.08 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 176.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -116.53 152.51 17.87 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.198 -1.001 . . . . 0.0 112.84 -174.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.635 HG21 ' HB2' ' A' ' 86' ' ' MET . 31.0 t -128.92 113.63 29.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 175.113 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 14.5 t-80 -94.24 104.18 16.19 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.896 -172.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.437 ' HA3' ' O ' ' A' ' 88' ' ' HIS . . . -132.54 32.16 2.86 Favored Glycine 0 N--CA 1.444 -0.816 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 174.547 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -101.23 154.85 18.41 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.608 -0.796 . . . . 0.0 109.957 -178.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 94.8 mmm -90.47 39.73 0.99 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.497 -172.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.45 ' HB3' ' H ' ' A' ' 64' ' ' TYR . 8.7 m-20 -118.76 -143.81 0.37 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.702 0.287 . . . . 0.0 111.556 -178.53 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.453 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 78.7 m-85 -69.86 127.33 92.56 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.114 0.483 . . . . 0.0 111.85 -169.123 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 64' ' ' TYR . 11.8 Cg_exo -71.1 -14.35 31.83 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.353 2.702 . . . . 0.0 111.995 179.028 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -60.86 -32.91 72.32 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.459 0.647 . . . . 0.0 110.567 178.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.442 HG12 HD21 ' A' ' 71' ' ' LEU . 47.0 t -73.09 -20.07 18.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.678 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.489 ' HE2' ' HB2' ' A' ' 73' ' ' PHE . 64.5 tttm -72.88 -12.44 60.97 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.676 -174.43 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -84.15 -10.01 58.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.003 0.43 . . . . 0.0 111.001 177.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 57.4 m-70 -103.36 -28.94 11.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.147 0.498 . . . . 0.0 109.861 177.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.442 HD21 HG12 ' A' ' 67' ' ' VAL . 0.3 OUTLIER -138.99 119.51 9.68 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.671 174.708 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -66.56 177.26 3.47 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 123.167 2.578 . . . . 0.0 112.938 -175.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.489 ' HB2' ' HE2' ' A' ' 68' ' ' LYS . 70.5 t80 -70.26 -29.15 65.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.141 0.496 . . . . 0.0 110.552 -177.163 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.482 ' HA ' HG13 ' A' ' 58' ' ' VAL . 10.2 p -147.74 142.06 26.27 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.948 178.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 32.1 tttm -142.41 141.08 32.19 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.807 -178.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.539 HG23 ' CE1' ' A' ' 104' ' ' PHE . 56.6 t -114.53 139.28 41.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.896 174.28 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 58.6 mt -114.45 144.22 43.67 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.17 177.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 54.9 tp -109.52 96.24 6.14 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 175.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 24.0 t -111.68 96.09 4.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.914 -173.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.424 ' OE1' ' HA2' ' A' ' 148' ' ' GLY . 42.6 mt-10 54.13 38.66 29.56 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.132 175.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 107.99 -31.57 7.83 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.343 177.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 60.2 t -81.66 115.1 23.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.005 0.431 . . . . 0.0 110.937 -177.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.07 105.64 14.22 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.071 176.107 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.427 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 15.8 mt -94.8 106.85 18.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.625 -177.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.536 ' HA2' HG22 ' A' ' 76' ' ' VAL . . . -93.09 110.19 3.91 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 176.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.635 ' HB2' HG21 ' A' ' 58' ' ' VAL . 43.5 mtm -107.99 129.71 55.1 Favored 'General case' 0 C--N 1.317 -0.834 0 O-C-N 122.419 -0.46 . . . . 0.0 110.822 -174.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 79.0 m -149.34 116.9 6.17 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.534 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.437 ' O ' ' HA3' ' A' ' 60' ' ' GLY . 41.8 t-80 -97.07 127.88 43.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.233 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 169.32 -125.53 1.27 Allowed Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.395 178.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 29.2 p90 -153.71 165.89 34.56 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.676 0.274 . . . . 0.0 110.488 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 171.61 148.21 6.01 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.877 177.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -76.43 155.36 83.84 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 176.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_exo -51.76 -33.56 50.68 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.67 2.247 . . . . 0.0 112.542 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -76.38 -53.97 7.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.926 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -62.68 -37.68 87.38 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.022 -176.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 30.5 tp -51.42 -60.71 2.83 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 122.705 0.402 . . . . 0.0 112.0 -171.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -60.68 -41.46 95.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.44 -176.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -73.81 -39.52 64.04 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.992 0.425 . . . . 0.0 111.325 -176.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.412 ' O ' HG23 ' A' ' 103' ' ' VAL . 74.5 ttt180 -68.36 -40.96 81.29 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.827 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.551 HD13 HG21 ' A' ' 111' ' ' ILE . 89.5 mt -70.23 -32.6 70.53 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.027 -178.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 96.8 mt -78.21 -11.55 59.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.332 0.587 . . . . 0.0 110.221 175.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -86.21 -47.54 9.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.942 173.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 99' ' ' ARG . 89.0 t -63.21 -46.25 96.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.087 177.099 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.539 ' CE1' HG23 ' A' ' 76' ' ' VAL . 25.6 m-85 -101.61 102.63 13.37 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.227 176.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -59.8 -36.06 75.97 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.584 -177.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -100.97 125.86 47.58 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 172.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.502 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 0.0 OUTLIER -60.78 126.7 85.97 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.779 -173.989 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.502 ' HD3' ' HA ' ' A' ' 107' ' ' LYS . 5.4 Cg_exo -75.13 150.18 37.23 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.696 2.264 . . . . 0.0 110.558 173.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -75.54 -48.9 20.44 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.338 0.59 . . . . 0.0 109.66 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 66.0 t -126.68 131.1 71.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.549 178.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.551 HG21 HD13 ' A' ' 100' ' ' LEU . 57.5 mt -114.82 134.25 58.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 120.686 0.279 . . . . 0.0 110.94 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.599 HD23 ' HB2' ' A' ' 130' ' ' LEU . 82.8 mt -105.04 118.52 36.73 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.243 177.309 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.431 ' CE1' ' HB3' ' A' ' 129' ' ' PHE . 16.9 p90 -133.91 127.47 32.55 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.094 0.473 . . . . 0.0 110.054 177.13 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -106.11 126.78 8.67 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.777 -0.725 . . . . 0.0 111.805 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 21.6 t60 -172.42 -44.42 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.27 0.557 . . . . 0.0 109.772 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.7 t -92.68 142.11 27.73 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.529 175.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 1.02 ' HA ' ' HA2' ' A' ' 133' ' ' GLY . 23.3 p-80 -97.87 4.66 49.6 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.044 0.45 . . . . 0.0 110.762 -178.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -108.19 106.41 58.54 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.441 174.316 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.27 127.19 13.85 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.961 2.441 . . . . 0.0 112.603 -174.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -142.27 139.87 32.04 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.361 173.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -78.28 103.91 8.52 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 175.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.532 ' HB ' ' HE2' ' A' ' 124' ' ' LYS . 60.8 p -111.91 121.42 45.0 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.597 -172.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.8 p -106.94 110.31 31.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.294 0.568 . . . . 0.0 110.244 176.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.532 ' HE2' ' HB ' ' A' ' 122' ' ' THR . 72.5 mmtt -123.9 127.36 47.88 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.805 -178.007 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 65.6 13.14 8.73 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 123.465 0.478 . . . . 0.0 111.773 177.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 94.31 4.46 62.64 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.511 -178.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 43.3 t -106.44 140.26 25.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 177.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -94.0 113.41 25.39 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.86 0.362 . . . . 0.0 110.249 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.513 ' CE1' ' HB2' ' A' ' 124' ' ' LYS . 76.9 m-85 -103.03 124.69 49.0 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.259 -178.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.599 ' HB2' HD23 ' A' ' 112' ' ' LEU . 83.5 mt -108.87 130.86 55.43 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.737 176.351 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -122.84 111.51 31.0 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.195 -176.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -82.28 152.7 16.04 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.737 2.291 . . . . 0.0 111.568 173.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 1.02 ' HA2' ' HA ' ' A' ' 117' ' ' HIS . . . -67.49 -129.01 0.03 OUTLIER Glycine 0 CA--C 1.524 0.619 0 O-C-N 123.506 0.504 . . . . 0.0 114.138 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 7.9 m -128.44 179.61 5.55 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 122.224 -0.574 . . . . 0.0 111.159 -176.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.92 HD11 ' HG ' ' A' ' 19' ' ' LEU . 1.1 tm? -73.22 -69.3 0.43 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.7 -179.351 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -75.0 13.2 0.71 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.606 -171.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -107.69 6.97 28.22 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.921 0.391 . . . . 0.0 110.512 177.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 69.47 42.37 73.62 Favored Glycine 0 C--N 1.332 0.346 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.981 174.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 13.0 p -132.98 99.17 4.5 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.901 0.382 . . . . 0.0 111.272 -178.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -113.51 155.5 25.24 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 174.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.592 ' HB3' ' HB3' ' A' ' 6' ' ' LEU . . . -114.49 128.39 56.31 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.115 0.483 . . . . 0.0 111.03 -176.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 40.2 t -111.46 117.48 55.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.6 175.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.749 HD23 ' HA ' ' A' ' 152' ' ' PHE . 57.7 mt -96.67 113.64 25.22 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.077 177.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -108.04 130.55 55.07 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.735 -176.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.751 HD11 ' HE2' ' A' ' 4' ' ' PHE . 74.0 mt -99.14 116.44 31.35 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.028 -177.26 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.473 ' HB3' ' NH1' ' A' ' 151' ' ' ARG . 27.3 t70 -146.83 130.78 17.19 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.693 177.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.85 11.31 60.35 Favored Glycine 0 CA--C 1.521 0.445 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.974 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.424 ' HA2' ' OE1' ' A' ' 80' ' ' GLU . . . 84.12 30.89 27.16 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.318 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -126.99 135.14 50.44 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.718 0.295 . . . . 0.0 110.817 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 44.3 t -84.38 108.31 16.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 174.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.473 ' NH1' ' HB3' ' A' ' 146' ' ' ASP . 96.5 mtt180 -106.18 120.62 42.3 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.053 0.454 . . . . 0.0 111.011 -174.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' PHE . . . . . 0.749 ' HA ' HD23 ' A' ' 143' ' ' LEU . 74.0 t80 -92.62 112.89 25.0 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.216 -173.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -122.04 103.8 9.06 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.852 0.358 . . . . 0.0 110.588 173.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 20.2 tp -79.0 100.38 7.29 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 174.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -93.9 138.02 32.49 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.499 -173.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 34.9 p -94.03 150.57 20.22 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.352 -174.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 10.1 mp . . . . . 0 C--O 1.245 0.866 0 CA-C-O 118.62 -0.705 . . . . 0.0 109.49 175.725 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 61.6 mttm . . . . . 0 CA--C 1.518 -0.28 0 CA-C-O 120.752 0.31 . . . . 0.0 110.576 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 89.2 mtt-85 -123.41 132.53 53.99 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.218 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.408 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 74.2 m-85 -118.06 128.06 54.39 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.846 174.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.557 ' HB3' HG22 ' A' ' 33' ' ' VAL . 33.9 tp -89.57 134.23 34.22 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.789 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.408 ' HB3' ' HB3' ' A' ' 141' ' ' ALA . 50.3 tp -119.32 109.16 15.48 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.193 0.521 . . . . 0.0 111.314 -178.56 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.417 HG13 ' HA2' ' A' ' 35' ' ' GLY . 17.4 pt -102.24 112.39 35.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 172.032 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.426 ' HB2' ' H ' ' A' ' 9' ' ' ASP . 1.1 m -76.05 -90.17 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -166.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.426 ' H ' ' HB2' ' A' ' 8' ' ' SER . 24.3 t70 -108.54 110.83 22.4 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.611 -173.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.795 ' HB3' ' HA ' ' A' ' 38' ' ' ASP . 42.2 t -123.9 134.08 53.61 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 121.477 0.656 . . . . 0.0 110.215 178.234 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 26.6 m170 -125.55 38.22 4.21 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.583 HG21 HD12 ' A' ' 19' ' ' LEU . 61.3 t -94.11 138.13 22.69 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.927 -175.225 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.444 ' HA ' HG13 ' A' ' 12' ' ' VAL . 5.3 Cg_exo -80.27 -60.64 0.04 OUTLIER 'Cis proline' 0 C--N 1.345 0.365 0 C-N-CA 123.526 -1.447 . . . . 0.0 112.072 -3.165 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 26.4 t 54.16 -86.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 O-C-N 123.882 0.739 . . . . 0.0 111.462 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 29.2 ttt180 -144.73 12.74 1.48 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.163 0.506 . . . . 0.0 109.915 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 43.0 ttp -131.39 105.1 7.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.797 -176.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -97.31 13.25 30.2 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.017 0.437 . . . . 0.0 110.854 177.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.9 m -81.95 40.68 0.62 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.864 -175.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.759 ' HG ' HD13 ' A' ' 135' ' ' LEU . 3.6 tt -107.75 104.3 52.57 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 174.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -61.88 124.57 14.75 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 123.036 2.491 . . . . 0.0 112.564 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -71.93 -8.03 52.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.753 -176.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -61.04 -49.59 76.74 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.253 -177.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.482 HD11 HD11 ' A' ' 5' ' ' LEU . 6.9 tt -71.93 -31.58 41.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.714 0.769 . . . . 0.0 110.085 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.494 ' HA ' HD23 ' A' ' 27' ' ' LEU . 59.1 tp -56.9 -33.09 66.58 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.182 -1.372 . . . . 0.0 110.915 178.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -74.27 -36.45 63.82 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.676 178.035 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.6 m -76.53 7.75 4.19 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.875 -175.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.908 HD12 ' HB3' ' A' ' 52' ' ' SER . 1.4 mm? -53.68 -33.66 56.12 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.008 0.432 . . . . 0.0 111.579 176.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 28.2 mttp -87.21 7.51 28.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.487 -170.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -95.6 -18.94 20.16 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -176.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -105.63 156.15 18.54 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.926 0.393 . . . . 0.0 111.806 -170.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -60.96 -54.5 44.29 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.854 177.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -143.51 151.57 23.41 Favored Glycine 0 N--CA 1.44 -1.068 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.993 178.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.621 HG21 HD13 ' A' ' 27' ' ' LEU . 99.3 t -122.58 136.4 59.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-O 120.731 0.3 . . . . 0.0 110.216 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.555 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 45.9 mt -107.98 120.97 60.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.376 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.417 ' HA2' HG13 ' A' ' 7' ' ' ILE . . . -108.13 111.14 3.28 Favored Glycine 0 N--CA 1.442 -0.945 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 176.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.522 ' HA ' HG23 ' A' ' 58' ' ' VAL . 81.5 mt -85.91 27.59 0.87 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.903 0.382 . . . . 0.0 110.175 -178.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 117.74 81.91 0.84 Allowed Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -174.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.795 ' HA ' ' HB3' ' A' ' 10' ' ' SER . 3.2 p-10 -96.6 -95.11 0.2 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -173.588 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.429 ' H ' ' CG ' ' A' ' 38' ' ' ASP . 79.9 m-85 -95.4 138.17 33.45 Favored 'General case' 0 C--N 1.318 -0.792 0 O-C-N 121.897 -0.502 . . . . 0.0 110.313 -178.418 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.7 m -79.05 -9.88 12.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.364 0.602 . . . . 0.0 109.906 178.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.536 ' O ' HG23 ' A' ' 45' ' ' VAL . 43.0 m-20 -86.59 121.68 29.45 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.598 177.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.51 ' O ' HD13 ' A' ' 46' ' ' ILE . 47.1 tp -57.45 -43.1 83.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.416 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -52.22 -45.02 65.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.561 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.1 m -78.55 -27.45 45.88 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.278 -175.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 41' ' ' ASP . 94.6 t -61.77 -44.43 98.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.174 0.511 . . . . 0.0 109.742 174.044 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.51 HD13 ' O ' ' A' ' 42' ' ' LEU . 1.7 mp -65.02 -36.58 78.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.7 176.464 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.36 -37.57 83.8 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.674 175.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 22.9 mt -73.85 -37.09 64.92 Favored 'General case' 0 CA--C 1.514 -0.426 0 C-N-CA 120.434 -0.507 . . . . 0.0 110.158 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.486 ' HA ' ' HB2' ' A' ' 55' ' ' PHE . 32.9 tt0 -63.64 -26.36 68.64 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.824 175.014 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -84.03 -49.65 8.73 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.513 178.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.524 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . 4.7 m-85 -54.62 -55.61 27.72 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 177.158 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.908 ' HB3' HD12 ' A' ' 27' ' ' LEU . 78.7 p -77.59 -20.25 54.3 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.213 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 52' ' ' SER . 96.5 mttt 72.97 -56.5 0.66 Allowed 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.638 0.775 . . . . 0.0 110.529 -173.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -106.63 90.55 3.36 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.859 177.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.486 ' HB2' ' HA ' ' A' ' 49' ' ' GLU . 58.4 t80 -106.04 117.03 32.97 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.476 -178.479 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.555 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 87.7 m-85 -108.13 108.07 18.98 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 176.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -125.15 164.51 18.7 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 119.854 -1.165 . . . . 0.0 113.508 -173.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.522 HG23 ' HA ' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -136.12 -174.42 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.115 -0.542 . . . . 0.0 109.914 175.096 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.685 ' CE1' ' HA ' ' A' ' 68' ' ' LYS . 7.0 t60 -94.12 125.52 38.8 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.619 -171.321 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -98.47 -53.58 1.22 Allowed Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.792 -0.718 . . . . 0.0 113.316 -174.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -110.07 -154.01 0.53 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -176.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 70.3 mtm -71.66 -43.56 65.83 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 164.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 60.45 -173.15 0.12 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 114.537 -1.211 . . . . 0.0 111.515 175.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -92.2 155.19 42.97 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.365 177.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -52.54 -31.94 51.29 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 123.285 2.656 . . . . 0.0 112.999 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.496 ' HB3' HD22 ' A' ' 42' ' ' LEU . 29.2 m-20 -66.62 -42.57 86.58 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.32 0.581 . . . . 0.0 110.371 178.15 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 42.8 t -72.97 -27.01 23.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.754 177.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.685 ' HA ' ' CE1' ' A' ' 59' ' ' HIS . 88.4 tttt -62.54 -28.4 69.83 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.712 177.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -94.36 -44.87 7.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.375 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -72.32 -30.7 65.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.061 -174.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 58.5 mt -117.56 103.92 50.29 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 177.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -63.65 157.0 53.92 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 123.308 2.672 . . . . 0.0 112.526 -177.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -66.85 -40.32 87.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.618 -177.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.1 m -145.43 130.13 18.05 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.217 177.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.401 ' HG2' ' N ' ' A' ' 76' ' ' VAL . 53.7 tttp -129.66 159.56 36.05 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.201 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 12.5 t -134.34 120.41 33.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 177.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.456 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 96.1 mt -98.7 140.89 32.24 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.933 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 51.0 tp -111.62 94.97 5.22 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 173.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 46.4 t -115.26 107.05 21.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.407 -174.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 58.54 31.73 21.36 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.985 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.59 -10.66 70.74 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.582 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.4 t -88.14 125.48 41.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.939 0.4 . . . . 0.0 111.045 -178.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 50.6 p -88.19 125.27 34.53 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.269 176.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.505 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 29.2 mt -116.21 103.98 15.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -83.97 114.17 3.85 Favored Glycine 0 C--O 1.223 -0.563 0 N-CA-C 111.307 -0.717 . . . . 0.0 111.307 177.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.442 ' SD ' ' HG ' ' A' ' 77' ' ' LEU . 21.4 mtp -107.09 118.43 36.68 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.575 0.187 . . . . 0.0 110.897 -174.084 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 113' ' ' PHE . 11.6 t -148.1 165.08 31.92 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.236 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.434 ' HB3' ' O ' ' A' ' 59' ' ' HIS . 3.3 t-160 -156.16 109.51 2.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.618 0.246 . . . . 0.0 110.359 -178.169 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 152.18 -173.96 31.24 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.363 -0.922 . . . . 0.0 112.336 176.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 6.5 m0 66.59 -173.46 0.19 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.45 0.643 . . . . 0.0 112.168 177.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -170.85 177.63 43.78 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.673 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.486 ' HB1' ' CD1' ' A' ' 94' ' ' TRP . . . 62.59 96.3 0.05 OUTLIER Pre-proline 0 N--CA 1.464 0.262 0 CA-C-O 121.396 0.617 . . . . 0.0 110.65 -175.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.483 ' HA ' ' HB3' ' A' ' 96' ' ' LEU . 7.5 Cg_exo -73.2 7.66 2.05 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 123.375 2.717 . . . . 0.0 113.666 -172.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.486 ' CD1' ' HB1' ' A' ' 92' ' ' ALA . 52.5 m95 -59.31 -54.57 45.25 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.132 0.491 . . . . 0.0 110.544 -178.319 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -117.44 7.64 12.81 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.321 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.483 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . 29.5 tp -60.85 -46.72 89.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.739 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.527 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 58.7 mttp -58.49 -44.48 89.4 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.174 0.512 . . . . 0.0 110.254 179.174 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.4 ' HA ' HD12 ' A' ' 101' ' ' LEU . 7.7 m-20 -70.64 -30.65 67.34 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.051 -177.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 25.8 ttm180 -71.74 -40.89 69.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.462 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.495 HD13 HG21 ' A' ' 111' ' ' ILE . 66.7 mt -67.9 -27.34 66.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.803 178.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' A' ' 97' ' ' LYS . 96.6 mt -70.08 -24.29 63.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.038 0.446 . . . . 0.0 110.742 175.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -77.32 -30.61 54.15 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.9 t -76.17 -49.29 25.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.955 174.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -99.67 85.96 3.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.054 177.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -76.79 -2.56 33.8 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.919 -173.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -79.93 -13.14 59.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.357 174.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 14.7 ttpp 57.15 83.2 0.23 Allowed Pre-proline 0 C--O 1.235 0.319 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.728 -171.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.21 174.6 10.49 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.503 2.135 . . . . 0.0 112.715 -174.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -89.63 -49.06 6.88 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.524 177.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.513 HG21 HG11 ' A' ' 150' ' ' VAL . 66.7 t -121.75 131.77 72.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.718 -177.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.495 HG21 HD13 ' A' ' 100' ' ' LEU . 53.2 mt -122.81 125.12 71.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.954 0.407 . . . . 0.0 110.455 174.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 85.7 mt -101.91 115.66 31.02 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.71 177.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.508 ' CZ ' ' HB2' ' A' ' 131' ' ' ASN . 18.2 p90 -127.4 134.75 49.88 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 175.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -105.92 114.87 4.63 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 119.997 -1.097 . . . . 0.0 112.249 -177.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 53.9 t60 -145.16 105.95 4.13 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 176.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 88.0 m -52.7 113.37 1.06 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.974 -177.031 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 14.3 t-80 -171.25 -79.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.299 177.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.449 ' HA ' ' HD3' ' A' ' 119' ' ' PRO . 50.3 mt-10 -147.69 142.32 16.58 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.24 178.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.654 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 5.6 Cg_exo -78.05 126.72 8.04 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.706 2.27 . . . . 0.0 111.058 172.007 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -154.6 148.44 25.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.872 0.368 . . . . 0.0 111.299 -179.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -99.66 121.28 41.0 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.723 175.037 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.541 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 73.3 p -129.01 149.98 50.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.839 0.352 . . . . 0.0 111.879 -173.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.6 p -147.64 149.33 15.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.077 177.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -163.23 -55.56 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.627 0.727 . . . . 0.0 110.309 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.527 ' CB ' HD11 ' A' ' 101' ' ' LEU . . . -93.83 23.58 4.72 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.316 -173.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 74.96 1.07 61.73 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 -173.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 21.9 t -106.12 139.83 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 177.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 51.6 ttt180 -96.31 110.4 22.73 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.062 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.541 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 78.1 m-85 -95.66 117.43 30.47 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.705 -178.385 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 78.7 mt -113.0 116.26 29.67 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.437 -176.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.654 ' O ' ' HA ' ' A' ' 119' ' ' PRO . 9.1 t30 -109.14 107.82 60.06 Favored Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 172.324 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -83.11 -173.38 1.66 Allowed 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 123.171 2.581 . . . . 0.0 112.817 -176.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -85.32 161.28 35.51 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.592 -178.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.459 ' HB2' ' HG2' ' A' ' 137' ' ' GLU . 18.1 m -97.37 159.72 14.75 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.703 0.287 . . . . 0.0 110.559 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.76 HD11 ' HB2' ' A' ' 10' ' ' SER . 12.3 mt -61.5 -49.35 77.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.68 -172.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -66.81 -17.08 64.7 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.419 -177.061 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.459 ' HG2' ' HB2' ' A' ' 134' ' ' SER . 8.2 mm-40 -86.22 -1.36 57.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.724 -178.055 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 70.8 29.48 69.33 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.466 177.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 22.2 t -138.28 122.01 17.54 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.022 0.439 . . . . 0.0 110.792 -177.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.565 ' CE2' HD22 ' A' ' 135' ' ' LEU . 22.6 m-85 -116.47 177.94 4.51 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.384 175.041 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.408 ' HB3' ' HB3' ' A' ' 6' ' ' LEU . . . -126.76 132.83 50.98 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.985 0.422 . . . . 0.0 111.198 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 58.9 t -113.54 119.13 60.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 174.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.477 ' HA ' ' O ' ' A' ' 151' ' ' ARG . 3.3 tt -95.9 116.08 28.39 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.186 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.772 ' HB2' ' HB2' ' A' ' 151' ' ' ARG . 56.6 mt-10 -100.89 139.87 35.98 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.906 -177.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 47.7 mt -110.57 90.14 3.24 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 166.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -104.93 113.2 26.66 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.293 -176.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.92 -67.51 0.32 Allowed Glycine 0 CA--C 1.52 0.348 0 O-C-N 123.527 0.517 . . . . 0.0 112.288 -174.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -174.77 25.52 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 178.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -110.41 133.81 52.92 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 -177.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.513 HG11 HG21 ' A' ' 110' ' ' VAL . 21.5 t -79.64 103.52 6.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 176.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.772 ' HB2' ' HB2' ' A' ' 144' ' ' GLU . 56.6 mtt180 -110.02 148.03 32.44 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.084 -174.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -143.01 123.3 13.8 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.556 175.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -119.02 132.27 56.04 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.846 0.355 . . . . 0.0 110.334 178.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -76.01 113.63 13.74 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.455 176.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -96.38 119.04 34.14 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.248 -177.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.4 m -93.21 147.21 23.09 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.853 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 10.2 mp . . . . . 0 C--O 1.247 0.957 0 CA-C-O 118.827 -0.606 . . . . 0.0 110.623 -177.716 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.461 ' HD2' HG13 ' A' ' 79' ' ' VAL . 50.0 mttp . . . . . 0 N--CA 1.452 -0.352 0 CA-C-O 121.084 0.469 . . . . 0.0 110.882 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 56.1 mtt180 -107.66 112.32 24.97 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.62 176.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.627 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 53.7 m-85 -101.79 129.49 48.0 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.442 0.639 . . . . 0.0 111.518 -175.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.556 ' HB3' HG22 ' A' ' 33' ' ' VAL . 27.3 tp -89.18 114.76 26.1 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.094 174.021 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.623 HD11 ' HG ' ' A' ' 36' ' ' LEU . 45.0 tp -100.4 111.9 24.2 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.93 0.395 . . . . 0.0 110.668 -177.256 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.485 HG13 ' HA2' ' A' ' 35' ' ' GLY . 23.9 pt -100.98 120.12 50.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 176.162 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.772 ' HB2' ' HA ' ' A' ' 134' ' ' SER . 13.2 m -75.87 -169.04 1.0 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.799 -172.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.776 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 11.2 t70 -59.42 98.6 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.293 -179.148 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.0 m -109.26 128.46 55.09 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.852 -175.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.72 ' HB3' ' HB ' ' A' ' 14' ' ' VAL . 24.3 m170 -102.26 76.0 1.54 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.421 0.629 . . . . 0.0 109.696 179.069 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.493 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -135.74 127.14 17.27 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.1 -179.091 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 34.9 Cg_endo -93.19 91.68 0.14 OUTLIER 'Cis proline' 0 N--CA 1.45 -1.055 0 C-N-CA 123.013 -1.661 . . . . 0.0 113.049 -2.471 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.72 ' HB ' ' HB3' ' A' ' 11' ' ' HIS . 3.0 t -120.27 -170.1 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 173.056 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.694 ' H ' HG12 ' A' ' 14' ' ' VAL . 55.2 mtt180 -68.73 83.94 0.3 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 118.91 0.777 . . . . 0.0 111.099 177.254 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 39.9 ttp -165.13 -71.5 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.658 -1.155 . . . . 0.0 108.444 177.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 58.94 9.06 1.1 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.671 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.0 m -76.54 15.82 0.57 Allowed 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 112.432 0.531 . . . . 0.0 112.432 -176.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.1 tt -107.64 102.18 43.53 Favored Pre-proline 0 C--N 1.323 -0.568 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -88.92 167.22 5.73 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.905 2.403 . . . . 0.0 113.548 -175.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -60.59 -23.58 64.78 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.242 178.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -62.07 -13.26 24.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.368 -176.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 tt -102.03 -33.4 3.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.298 0.57 . . . . 0.0 109.869 174.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.657 ' HA ' HD23 ' A' ' 27' ' ' LEU . 47.1 tp -72.13 -30.78 65.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.814 -176.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -66.48 -28.9 68.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.195 0.522 . . . . 0.0 110.338 177.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.9 m -72.96 -8.28 54.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.518 -176.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.757 HD13 HG21 ' A' ' 33' ' ' VAL . 4.3 mm? -58.87 -27.69 65.41 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.012 0.434 . . . . 0.0 110.959 176.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -85.31 -7.88 58.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.848 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -98.58 -39.96 8.45 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.208 -176.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.49 ' CD2' ' HB2' ' A' ' 5' ' ' LEU . 89.0 m-85 -86.98 147.12 25.88 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -92.13 -18.31 23.71 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.886 0.374 . . . . 0.0 110.435 -179.006 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.627 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -135.92 143.25 14.69 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 175.141 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.757 HG21 HD13 ' A' ' 27' ' ' LEU . 64.3 t -136.3 137.36 48.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 117.093 0.447 . . . . 0.0 110.485 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.567 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 39.0 mt -121.91 129.24 75.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.843 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.485 ' HA2' HG13 ' A' ' 7' ' ' ILE . . . -112.07 102.26 1.35 Allowed Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.918 177.383 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.623 ' HG ' HD11 ' A' ' 6' ' ' LEU . 85.8 mt -80.31 -32.61 37.98 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 176.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.776 ' HA3' ' HA ' ' A' ' 9' ' ' ASP . . . -138.16 62.78 0.57 Allowed Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 175.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -70.5 -172.5 0.61 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.024 0.44 . . . . 0.0 111.476 -175.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.578 ' HD1' HD11 ' A' ' 48' ' ' LEU . 81.2 m-85 -58.76 142.18 50.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.095 -177.028 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.585 ' HB ' ' HB3' ' A' ' 63' ' ' ASP . 15.7 m -85.59 16.14 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.318 0.58 . . . . 0.0 110.816 -176.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.461 ' O ' HG23 ' A' ' 45' ' ' VAL . 12.5 t70 -119.94 124.81 46.9 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.463 -178.212 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 53.2 tp -61.34 -39.49 90.77 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.079 -174.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -61.08 -42.46 98.55 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.119 0.485 . . . . 0.0 110.588 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.516 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 16.7 m -68.6 -29.43 67.95 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.118 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.564 HG21 HG13 ' A' ' 67' ' ' VAL . 65.5 t -59.25 -43.46 89.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 121.24 0.543 . . . . 0.0 109.965 174.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.497 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 1.7 mp -63.47 -38.74 83.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.027 176.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.23 -33.59 76.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.529 175.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.578 HD11 ' HD1' ' A' ' 39' ' ' TYR . 92.7 mt -67.97 -32.35 72.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.113 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -79.21 -16.28 56.76 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.195 177.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.497 ' HG3' ' O ' ' A' ' 46' ' ' ILE . 53.9 mtpt -76.61 -54.24 6.94 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 174.154 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.53 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . 62.9 m-85 -65.45 -63.8 1.01 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.716 176.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.535 ' HB2' HD12 ' A' ' 27' ' ' LEU . 41.6 t -84.25 96.56 9.03 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.725 175.235 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 53.0 mttp -64.01 -35.04 79.43 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.192 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -105.45 75.52 1.15 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.33 0.586 . . . . 0.0 109.704 171.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -101.58 125.18 48.19 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.462 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.567 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 91.3 m-85 -121.81 143.98 49.09 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 176.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.517 ' HA3' HD13 ' A' ' 71' ' ' LEU . . . -159.22 164.83 34.07 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 119.444 -1.36 . . . . 0.0 113.506 -176.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 72' ' ' PRO . 2.3 m -138.0 97.75 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.344 0.592 . . . . 0.0 109.447 176.365 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.543 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 11.9 t60 -94.38 146.97 23.68 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.377 -167.519 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -87.49 -163.22 38.76 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.179 179.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.555 ' HB3' ' HD2' ' A' ' 68' ' ' LYS . 2.0 p-10 -124.65 31.72 5.63 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.956 0.407 . . . . 0.0 110.973 -177.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 2.8 mpp? -76.12 -32.25 59.07 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.286 0.565 . . . . 0.0 109.824 178.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.585 ' HB3' ' HB ' ' A' ' 40' ' ' VAL . 3.8 p-10 -104.81 -111.14 0.26 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.759 -177.004 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.418 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 38.3 m-85 -104.36 135.72 19.29 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.71 0.291 . . . . 0.0 110.78 -174.466 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 64' ' ' TYR . 31.8 Cg_exo -59.01 -28.2 87.2 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.695 2.264 . . . . 0.0 111.902 178.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -55.77 -38.95 70.55 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.227 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.564 HG13 HG21 ' A' ' 45' ' ' VAL . 16.7 t -76.41 -33.38 23.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.531 -178.227 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.555 ' HD2' ' HB3' ' A' ' 61' ' ' ASN . 86.3 tttt -73.17 -25.41 60.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.107 0.48 . . . . 0.0 110.374 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -78.28 -19.73 53.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.016 0.436 . . . . 0.0 109.98 173.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 9.3 m80 -84.2 -51.4 7.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.189 176.007 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.543 ' HB2' ' HB2' ' A' ' 59' ' ' HIS . 11.3 mt -107.5 108.41 61.64 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 176.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.412 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 52.8 Cg_exo -54.76 153.85 22.97 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.758 2.305 . . . . 0.0 112.38 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -70.46 -18.48 62.99 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.12 0.486 . . . . 0.0 110.761 -177.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 51.1 m -150.84 131.27 13.77 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.133 178.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 44.7 tttp -149.45 133.15 16.85 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.373 -178.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 19.7 t -106.43 123.69 61.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 178.033 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 64.6 mt -102.02 157.22 17.02 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.545 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 60.3 tp -123.43 100.73 6.97 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 175.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.461 HG13 ' HD2' ' A' ' 2' ' ' LYS . 61.6 t -113.4 102.85 14.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.663 -176.126 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 51.63 42.22 29.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.68 176.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.97 0.15 64.0 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.754 -0.657 . . . . 0.0 113.215 175.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 96.0 t -105.94 129.78 58.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.751 0.31 . . . . 0.0 110.972 178.065 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.2 p -91.47 123.87 35.21 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.701 176.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.483 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 25.2 mt -116.92 98.28 6.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.451 -176.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.416 ' O ' HG23 ' A' ' 111' ' ' ILE . . . -85.61 98.85 2.31 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.338 178.231 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 35.8 mtm -90.75 131.81 36.21 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -178.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 34.7 t -149.65 165.07 33.44 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -125.72 29.19 6.01 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -66.9 167.5 38.43 Favored Glycine 0 N--CA 1.451 -0.321 0 CA-C-N 115.341 -0.845 . . . . 0.0 113.576 -175.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 54.3 p-90 -126.27 166.01 17.91 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.814 0.34 . . . . 0.0 110.573 -177.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 127.85 170.64 12.87 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.084 -0.579 . . . . 0.0 111.949 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -89.08 164.86 29.27 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 177.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_exo -53.2 -21.12 16.09 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.995 2.463 . . . . 0.0 113.268 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 11.7 m95 -70.66 -34.05 71.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.886 0.374 . . . . 0.0 110.379 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -101.31 -27.38 13.21 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.556 -178.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 37.4 tp -50.65 -57.29 8.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.175 -173.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -62.12 -44.1 97.39 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.075 -177.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -71.9 -14.76 62.03 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.338 -177.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.415 ' O ' HG23 ' A' ' 103' ' ' VAL . 29.0 ttt85 -95.33 -49.95 5.23 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.538 -178.091 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.519 HD13 HG21 ' A' ' 111' ' ' ILE . 79.6 mt -70.3 -34.5 72.81 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.62 -176.294 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.611 HD21 HG21 ' A' ' 127' ' ' VAL . 96.2 mt -75.24 -9.89 58.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.172 0.511 . . . . 0.0 110.411 177.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -91.34 -40.17 11.62 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.854 175.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 99' ' ' ARG . 94.8 t -64.23 -48.12 86.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.108 175.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -87.2 122.89 31.61 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.844 176.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -75.97 -30.83 58.75 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.138 0.494 . . . . 0.0 110.158 -178.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -93.67 179.77 5.26 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.622 175.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -109.35 106.25 58.35 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-O 120.956 0.407 . . . . 0.0 110.917 -178.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -76.51 131.52 12.67 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 123.103 2.535 . . . . 0.0 111.619 178.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -67.84 -40.32 83.74 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.266 178.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.88 HG21 HG21 ' A' ' 150' ' ' VAL . 89.3 t -126.02 135.96 62.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.179 179.285 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.519 HG21 HD13 ' A' ' 100' ' ' LEU . 44.3 mt -125.48 125.48 68.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.894 0.378 . . . . 0.0 110.406 176.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.699 HD23 ' HB2' ' A' ' 130' ' ' LEU . 95.6 mt -104.05 127.94 51.63 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.075 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -155.6 175.64 13.64 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.613 177.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -145.53 114.72 0.78 Allowed Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.731 178.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -165.72 -57.3 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.775 0.321 . . . . 0.0 110.924 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.6 p -82.88 -23.13 33.76 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -177.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 61.97 85.42 0.12 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 122.728 0.411 . . . . 0.0 110.559 -179.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -127.14 94.69 38.39 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.215 -178.23 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -68.4 67.23 1.08 Allowed 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.612 2.208 . . . . 0.0 111.793 178.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -161.92 153.59 18.77 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.484 -174.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -78.13 95.01 4.8 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 170.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.5 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 51.2 p -92.17 114.42 26.95 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.51 0.671 . . . . 0.0 110.984 -169.087 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.2 p -98.96 95.84 4.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-O 121.946 0.879 . . . . 0.0 110.253 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.654 ' HB2' ' CE1' ' A' ' 129' ' ' PHE . 60.8 mttp -110.81 119.01 37.71 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.517 -178.519 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 64.32 23.26 13.0 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.009 0.433 . . . . 0.0 111.529 178.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 94.64 -12.98 68.06 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.607 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.611 HG21 HD21 ' A' ' 101' ' ' LEU . 43.2 t -93.6 137.9 21.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.662 0.268 . . . . 0.0 110.41 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -91.79 99.44 12.32 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.239 0.542 . . . . 0.0 110.118 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.654 ' CE1' ' HB2' ' A' ' 124' ' ' LYS . 91.1 m-85 -90.83 136.46 33.05 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.156 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.699 ' HB2' HD23 ' A' ' 112' ' ' LEU . 85.4 mt -122.84 109.02 13.66 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.269 0.557 . . . . 0.0 109.849 177.015 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 -131.33 103.15 15.23 Favored Pre-proline 0 C--N 1.318 -0.764 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.875 177.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -91.45 -177.66 1.05 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.753 2.302 . . . . 0.0 113.906 -170.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -73.98 149.2 40.79 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 173.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.772 ' HA ' ' HB2' ' A' ' 8' ' ' SER . 22.3 m -91.89 170.47 9.84 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 120.963 0.411 . . . . 0.0 111.449 -175.367 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -60.41 -29.84 69.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.906 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -67.81 -22.81 65.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.022 178.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -94.52 -6.07 44.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.467 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 79.98 39.6 16.25 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.964 -0.562 . . . . 0.0 113.155 176.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 64.5 m -153.73 156.22 37.39 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.714 0.293 . . . . 0.0 110.748 178.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -144.14 168.87 19.0 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 174.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.468 ' HB3' HD23 ' A' ' 6' ' ' LEU . . . -114.58 140.86 48.44 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.045 0.45 . . . . 0.0 111.379 -174.535 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 40.1 t -112.21 123.75 68.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 173.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.734 HD21 HG13 ' A' ' 150' ' ' VAL . 2.6 tt -107.9 104.76 14.31 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -104.74 113.79 27.59 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.536 -178.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.2 mp -97.1 93.55 6.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.066 0.46 . . . . 0.0 110.454 176.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.535 ' HB3' ' NH1' ' A' ' 151' ' ' ARG . 17.0 t70 -87.72 123.12 32.21 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 175.143 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 68.14 -62.93 0.38 Allowed Glycine 0 CA--C 1.523 0.534 0 O-C-N 123.403 0.439 . . . . 0.0 112.441 -172.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 171.24 34.5 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.534 -0.626 . . . . 0.0 111.534 177.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -121.96 140.33 52.58 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.88 HG21 HG21 ' A' ' 110' ' ' VAL . 90.6 t -80.97 115.44 23.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.595 -175.485 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.535 ' NH1' ' HB3' ' A' ' 146' ' ' ASP . 78.9 mtt85 -107.82 101.81 11.07 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.92 173.667 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -90.11 103.65 16.3 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.996 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -120.57 119.35 32.67 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.117 0.484 . . . . 0.0 110.48 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 24.8 tp -88.98 130.82 35.39 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.093 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -121.94 139.62 53.44 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.04 0.448 . . . . 0.0 110.566 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 9.5 p -84.23 162.85 20.02 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.797 -178.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 75.5 mt . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.529 -0.748 . . . . 0.0 109.865 175.571 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 43.9 mttm . . . . . 0 C--O 1.233 0.235 0 CA-C-O 120.719 0.295 . . . . 0.0 110.353 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.489 ' HG2' ' HG3' ' A' ' 144' ' ' GLU . 49.9 mtm-85 -127.15 124.82 39.96 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.702 178.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 95.4 m-85 -108.18 128.04 54.35 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.226 176.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.552 ' HB3' HG22 ' A' ' 33' ' ' VAL . 48.5 tp -89.31 112.1 23.1 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.577 -176.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.458 HD11 ' HG ' ' A' ' 36' ' ' LEU . 60.4 tp -97.64 110.03 22.67 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.037 0.446 . . . . 0.0 110.518 -179.152 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.45 HG13 ' HA2' ' A' ' 35' ' ' GLY . 33.2 pt -101.33 134.74 40.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 176.375 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.6 m -77.05 -167.6 0.91 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.927 -173.135 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -53.92 117.19 3.0 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.264 178.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.843 ' H ' ' HA3' ' A' ' 37' ' ' GLY . 20.1 m -115.48 127.7 55.5 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.497 -178.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 62.0 m170 -116.39 44.47 1.98 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 175.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.715 HG21 ' HB2' ' A' ' 19' ' ' LEU . 56.1 t -113.12 129.78 24.21 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.871 -175.439 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 59.3 Cg_endo -103.13 94.43 0.12 OUTLIER 'Cis proline' 0 N--CA 1.449 -1.094 0 C-N-CA 123.574 -1.428 . . . . 0.0 112.61 -7.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.606 HG12 ' HG3' ' A' ' 15' ' ' ARG . 14.6 t -100.23 -77.82 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 175.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.606 ' HG3' HG12 ' A' ' 14' ' ' VAL . 60.6 mtt180 -130.77 15.73 5.31 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.432 ' HG2' ' H ' ' A' ' 18' ' ' SER . 37.1 ttp -143.13 130.07 20.58 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.828 -177.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -122.27 12.08 10.17 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.142 0.496 . . . . 0.0 110.372 178.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.432 ' H ' ' HG2' ' A' ' 16' ' ' MET . 3.9 m -78.73 41.22 0.41 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.978 -176.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.715 ' HB2' HG21 ' A' ' 12' ' ' VAL . 4.5 tt -107.65 106.69 59.06 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.308 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.451 ' HD2' ' OH ' ' A' ' 140' ' ' TYR . 51.4 Cg_exo -56.33 122.74 12.31 Favored 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 122.905 2.404 . . . . 0.0 112.515 178.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -73.9 -10.79 60.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.184 -176.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -55.2 -52.01 64.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.357 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.5 tt -69.4 -27.06 32.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.212 0.529 . . . . 0.0 110.446 -177.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.422 ' O ' HD23 ' A' ' 27' ' ' LEU . 52.3 tp -70.37 -16.43 62.97 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.619 178.13 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -89.59 -25.36 21.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.989 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.0 p -83.61 24.31 0.87 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.834 0.349 . . . . 0.0 111.913 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.462 ' CD1' HG21 ' A' ' 33' ' ' VAL . 3.0 mm? -69.58 -8.57 48.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.855 0.359 . . . . 0.0 111.493 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -98.83 -13.13 20.24 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.26 0.552 . . . . 0.0 110.284 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -92.51 -11.32 34.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.185 -175.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -109.46 161.9 14.87 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.799 0.333 . . . . 0.0 110.737 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -86.58 -50.25 6.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.408 0.623 . . . . 0.0 109.894 179.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -139.5 156.55 24.71 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.115 178.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.552 HG22 ' HB3' ' A' ' 5' ' ' LEU . 84.0 t -125.25 137.94 55.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 120.745 0.307 . . . . 0.0 110.412 -179.155 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.526 HG12 ' HB2' ' A' ' 56' ' ' TYR . 34.0 mt -114.59 126.3 72.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.886 177.483 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.45 ' HA2' HG13 ' A' ' 7' ' ' ILE . . . -112.49 107.02 1.97 Allowed Glycine 0 N--CA 1.439 -1.132 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.345 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.458 ' HG ' HD11 ' A' ' 6' ' ' LEU . 89.5 mt -73.96 -24.48 59.63 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 171.4 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.843 ' HA3' ' H ' ' A' ' 10' ' ' SER . . . -140.25 132.59 5.57 Favored Glycine 0 N--CA 1.438 -1.17 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 170.324 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.522 ' OD2' HG11 ' A' ' 67' ' ' VAL . 18.2 p-10 -112.95 -173.34 2.23 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.311 0.577 . . . . 0.0 111.429 -172.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -84.24 116.7 23.1 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 172.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.85 ' HB ' ' HD2' ' A' ' 64' ' ' TYR . 35.4 m -64.96 -5.87 2.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -168.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.459 ' O ' HG23 ' A' ' 45' ' ' VAL . 19.7 t70 -86.7 120.51 28.07 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 177.258 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 45.3 tp -56.73 -46.18 81.47 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -172.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -66.34 -33.98 76.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.911 0.386 . . . . 0.0 110.603 -178.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.597 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 30.5 m -67.71 -29.23 68.43 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.658 176.067 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 41' ' ' ASP . 74.7 t -62.95 -41.82 94.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 121.058 0.456 . . . . 0.0 110.153 175.082 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.02 -36.06 76.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.808 175.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.56 -29.8 69.28 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.776 175.462 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.597 ' HG ' ' O ' ' A' ' 44' ' ' THR . 92.0 mt -65.28 -34.54 78.58 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 176.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.414 ' HA ' ' O ' ' A' ' 52' ' ' SER . 36.9 tt0 -76.24 -21.91 55.79 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.958 175.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -72.87 -35.87 67.25 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.749 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.462 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . 70.3 m-85 -81.56 -67.05 0.81 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.18 172.276 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 49' ' ' GLU . 38.2 t -86.2 96.05 9.79 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.717 176.143 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.69 ' H ' ' HD2' ' A' ' 53' ' ' LYS . 8.7 mptt -60.18 -31.26 69.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.681 -177.294 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -110.62 82.85 1.66 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.419 0.628 . . . . 0.0 109.974 169.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -100.48 112.55 24.92 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.966 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.526 ' HB2' HG12 ' A' ' 34' ' ' ILE . 33.5 m-85 -96.55 133.03 41.54 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 177.469 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -144.76 158.44 27.58 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 119.556 -1.307 . . . . 0.0 112.972 -177.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -136.26 155.2 34.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 122.756 0.422 . . . . 0.0 109.986 175.298 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.861 ' CE1' ' HB ' ' A' ' 67' ' ' VAL . 0.2 OUTLIER -128.22 171.57 11.83 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -174.317 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 121.94 39.66 0.55 Allowed Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.796 173.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -122.04 -86.92 0.65 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 117.455 0.628 . . . . 0.0 110.992 177.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 67.8 mtt -135.69 31.68 3.06 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.42 ' HB2' ' CE1' ' A' ' 59' ' ' HIS . 1.3 p30 -93.17 -178.32 4.74 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.299 -1.318 . . . . 0.0 112.212 -171.173 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.85 ' HD2' ' HB ' ' A' ' 40' ' ' VAL . 80.2 m-85 -94.3 138.21 22.54 Favored Pre-proline 0 C--O 1.232 0.182 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.477 176.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 64' ' ' TYR . 21.1 Cg_exo -67.4 -9.15 24.32 Favored 'Trans proline' 0 N--CA 1.474 0.368 0 C-N-CA 123.562 2.842 . . . . 0.0 113.913 -175.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -70.97 -42.38 69.79 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.12 0.486 . . . . 0.0 110.785 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.861 ' HB ' ' CE1' ' A' ' 59' ' ' HIS . 65.4 t -68.71 -11.04 14.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.617 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.48 ' HB3' ' NZ ' ' A' ' 68' ' ' LYS . 5.1 ttpm? -56.88 -30.7 64.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.885 176.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -70.08 -17.55 63.23 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.049 0.452 . . . . 0.0 110.836 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -105.81 -50.63 3.15 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.901 -178.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.6 ' HG ' HG12 ' A' ' 67' ' ' VAL . 4.4 mt -107.98 112.01 61.87 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.397 -178.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -74.08 170.95 18.95 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.768 2.312 . . . . 0.0 111.648 178.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -74.82 -21.11 59.47 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.244 0.545 . . . . 0.0 109.83 178.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.428 ' HA ' ' O ' ' A' ' 86' ' ' MET . 55.1 m -150.63 124.69 9.33 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.022 175.298 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 42.3 tttp -132.86 129.48 38.5 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.736 -179.004 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 17.3 t -106.35 122.92 60.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 120.961 0.41 . . . . 0.0 110.221 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.542 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 59.7 mt -99.32 152.51 19.85 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.215 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 47.0 tp -124.63 97.39 5.27 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 174.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 37.6 t -112.8 104.94 17.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.439 -175.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 54.11 43.25 30.97 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.234 178.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.81 -25.73 23.71 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.904 177.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 63.6 t -81.03 129.95 36.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.816 0.341 . . . . 0.0 111.204 -176.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 28.2 p -91.76 129.53 37.71 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.439 177.061 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.542 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 34.6 mt -124.09 99.22 6.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.88 0.372 . . . . 0.0 110.178 -177.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -87.59 102.05 2.76 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.405 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.525 ' HG2' HD12 ' A' ' 112' ' ' LEU . 22.8 mtm -94.96 127.08 40.74 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.108 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 113' ' ' PHE . 42.4 t -141.73 154.72 45.47 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.496 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 16.1 p80 -63.46 -26.51 68.76 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 175.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.595 ' HA3' ' HB2' ' A' ' 113' ' ' PHE . . . 57.62 59.69 10.37 Favored Glycine 0 C--N 1.335 0.487 0 CA-C-N 115.965 -0.561 . . . . 0.0 114.432 170.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 81.3 t90 -97.48 127.56 43.54 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 174.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 163.99 -177.27 39.83 Favored Glycine 0 N--CA 1.444 -0.779 0 N-CA-C 111.301 -0.719 . . . . 0.0 111.301 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.54 139.21 44.24 Favored Pre-proline 0 C--N 1.32 -0.693 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 178.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -62.63 -25.83 75.46 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.935 2.423 . . . . 0.0 113.208 -175.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -67.22 -47.2 71.53 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.947 0.404 . . . . 0.0 110.616 -175.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -101.74 9.03 41.28 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.785 -177.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 26.8 tp -60.08 -47.53 85.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.535 -173.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -63.85 -45.48 89.28 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.178 0.513 . . . . 0.0 110.365 -177.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -65.55 -36.65 84.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.909 179.076 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.514 ' O ' HG23 ' A' ' 103' ' ' VAL . 21.3 ttt180 -67.96 -49.25 62.85 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.254 179.258 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.655 HD23 HG21 ' A' ' 111' ' ' ILE . 7.6 mp -62.8 -35.45 79.92 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.544 0.202 . . . . 0.0 111.544 -176.29 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.773 HD21 HG21 ' A' ' 127' ' ' VAL . 84.5 mt -71.77 -16.35 62.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.026 0.441 . . . . 0.0 110.659 176.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 48.5 tttp -96.26 -17.15 20.95 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.354 178.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 99' ' ' ARG . 92.0 t -74.43 -45.86 44.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.11 0.481 . . . . 0.0 109.75 175.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -80.82 155.45 26.61 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.44 176.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -84.0 -22.49 31.35 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.245 0.545 . . . . 0.0 109.94 178.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 14.8 mp0 -105.11 -174.47 2.54 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.461 177.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 47.8 pttt -119.24 91.67 44.26 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-O 121.491 0.662 . . . . 0.0 109.504 172.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.07 154.48 67.06 Favored 'Trans proline' 0 N--CA 1.464 -0.224 0 C-N-CA 123.086 2.524 . . . . 0.0 112.63 -174.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -82.06 -46.34 14.03 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.959 177.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.7 t -116.87 133.32 63.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.903 176.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.655 HG21 HD23 ' A' ' 100' ' ' LEU . 56.0 mt -129.71 134.81 62.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.855 0.359 . . . . 0.0 110.765 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.664 HD23 ' HB2' ' A' ' 130' ' ' LEU . 86.5 mt -108.22 135.05 50.2 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.767 178.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.595 ' HB2' ' HA3' ' A' ' 89' ' ' GLY . 47.1 p90 -142.62 162.64 34.93 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.744 177.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.24 114.97 1.31 Allowed Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.331 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -169.06 -54.56 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.2 p -85.92 159.43 19.66 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.159 171.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 22.0 p-80 -123.99 21.14 9.06 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.174 0.511 . . . . 0.0 110.53 -178.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 11.2 mp0 -87.68 107.96 18.07 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.619 176.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 30.8 Cg_endo -64.66 95.67 0.23 Allowed 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.345 2.03 . . . . 0.0 111.814 -178.407 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -152.32 141.83 21.7 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.361 -176.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -95.16 123.15 38.5 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 171.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.641 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 73.2 p -112.23 144.97 40.75 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.273 -171.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 14.8 p -148.93 139.74 16.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.011 177.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -158.04 -48.55 0.06 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.13 0.491 . . . . 0.0 110.603 -178.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -97.0 24.43 6.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.395 -177.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 75.02 25.46 69.01 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.749 -0.738 . . . . 0.0 111.903 -175.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.773 HG21 HD21 ' A' ' 101' ' ' LEU . 52.8 t -132.78 137.02 54.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.274 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -100.0 104.97 16.6 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.109 0.48 . . . . 0.0 110.19 -177.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.641 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 60.0 m-85 -93.92 135.54 35.15 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.789 -179.574 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.664 ' HB2' HD23 ' A' ' 112' ' ' LEU . 86.9 mt -118.51 137.05 53.47 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.879 0.371 . . . . 0.0 111.326 -177.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.467 ' HA ' ' HD3' ' A' ' 132' ' ' PRO . 0.1 OUTLIER -150.32 125.64 4.86 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.23 173.388 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 131' ' ' ASN . 88.1 Cg_endo -101.86 -176.71 0.13 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 123.546 2.831 . . . . 0.0 112.56 175.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -81.58 171.14 52.65 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 174.113 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 75.6 p -85.38 173.9 9.95 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 117.515 0.658 . . . . 0.0 111.259 -177.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.604 HD13 ' HG ' ' A' ' 19' ' ' LEU . 21.2 mt -57.35 -49.54 75.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.718 -174.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -67.83 -10.91 56.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.03 -173.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -92.39 -3.79 54.77 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.981 0.419 . . . . 0.0 110.757 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.528 ' HA2' HD12 ' A' ' 157' ' ' LEU . . . 71.67 34.0 63.15 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.417 178.23 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 37.4 t -126.32 121.34 32.3 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.935 0.397 . . . . 0.0 110.539 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.451 ' OH ' ' HD2' ' A' ' 20' ' ' PRO . 86.5 m-85 -125.49 159.52 31.78 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.527 174.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.454 ' HB3' HD23 ' A' ' 6' ' ' LEU . . . -121.55 140.18 52.55 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.836 0.351 . . . . 0.0 110.137 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 62.1 t -122.68 121.55 63.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 175.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.818 HD21 HG13 ' A' ' 150' ' ' VAL . 3.5 tt -94.73 105.98 17.95 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.557 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.489 ' HG3' ' HG2' ' A' ' 3' ' ' ARG . 29.8 tt0 -102.94 145.55 29.67 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.457 -178.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 58.7 mt -117.23 105.97 12.78 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.975 0.416 . . . . 0.0 111.214 -177.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -118.31 130.57 56.1 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.973 175.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.51 11.01 59.0 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.169 -177.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 84.24 6.62 86.08 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.096 -177.257 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -97.54 158.09 15.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.825 0.345 . . . . 0.0 110.663 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.818 HG13 HD21 ' A' ' 143' ' ' LEU . 51.7 t -87.52 109.94 20.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.798 -178.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 43.8 ttt180 -107.18 113.66 27.23 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.158 0.504 . . . . 0.0 110.549 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -84.26 108.67 17.26 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.022 177.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -106.65 105.45 15.49 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 23.6 tp -83.66 109.92 17.85 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 119.951 -0.7 . . . . 0.0 110.256 -177.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -88.78 118.88 28.79 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.512 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 21.4 p -111.64 148.46 33.32 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.437 -173.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.528 HD12 ' HA2' ' A' ' 138' ' ' GLY . 74.7 mt . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.576 -0.726 . . . . 0.0 109.644 178.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 60.9 mttp . . . . . 0 N--CA 1.454 -0.242 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.544 ' HG3' ' HA ' ' A' ' 30' ' ' TYR . 0.1 OUTLIER -124.45 129.93 51.55 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.043 -175.765 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.495 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 16.6 m-85 -119.06 132.05 56.0 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.803 -179.043 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 28.2 tp -89.05 122.84 32.79 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.031 178.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.523 HD11 ' HG ' ' A' ' 36' ' ' LEU . 62.4 tp -104.7 111.79 24.64 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.039 0.447 . . . . 0.0 110.461 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.9 pt -101.16 138.62 24.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.785 176.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.5 m -77.34 -178.59 5.23 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.404 -175.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -63.84 104.61 0.71 Allowed 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.466 -176.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.8 m -95.45 83.99 3.92 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.833 -175.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 28.3 m80 -75.03 76.25 2.22 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 175.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.646 HG21 HD12 ' A' ' 19' ' ' LEU . 40.7 t -125.9 128.36 24.56 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.069 -177.312 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.414 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 58.2 Cg_endo -76.36 -61.58 0.05 OUTLIER 'Cis proline' 0 CA--C 1.529 0.264 0 C-N-CA 122.818 -1.742 . . . . 0.0 112.928 -1.416 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 53.4 t 56.81 -87.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 122.865 0.466 . . . . 0.0 111.612 179.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 81.6 mtt180 -139.8 6.63 2.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.941 0.4 . . . . 0.0 110.097 177.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 52.9 ttp -135.79 98.97 4.04 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.782 -173.295 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -99.66 -1.46 37.91 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.326 0.584 . . . . 0.0 110.354 177.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.0 m -82.72 58.98 4.52 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.403 -176.146 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.646 HD12 HG21 ' A' ' 12' ' ' VAL . 4.9 tt -107.66 109.75 62.47 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.051 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.728 ' HG2' HD13 ' A' ' 157' ' ' LEU . 31.3 Cg_exo -60.64 123.95 14.06 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 123.096 2.531 . . . . 0.0 112.585 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -62.53 -15.33 50.05 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.127 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -56.76 -33.99 67.14 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.379 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.6 tt -75.63 -32.89 25.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.374 0.606 . . . . 0.0 110.086 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.51 ' O ' HD23 ' A' ' 27' ' ' LEU . 45.7 tp -71.99 -17.37 62.06 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.292 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -91.52 -2.01 57.33 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.661 177.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 46.9 m -93.77 -0.7 55.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.662 -176.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.589 ' HG ' ' HB3' ' A' ' 51' ' ' PHE . 4.0 mm? -65.16 -10.34 30.3 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.0 0.429 . . . . 0.0 111.053 179.119 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.5 mttm -76.41 -30.86 57.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.149 -174.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -111.03 27.26 9.86 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -166.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.544 ' HA ' ' HG3' ' A' ' 3' ' ' ARG . 91.6 m-85 -136.22 152.09 50.39 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.778 178.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.415 ' OD2' ' HG2' ' A' ' 3' ' ' ARG . 10.1 m-20 -79.28 -43.98 22.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.573 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.495 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -138.98 164.19 25.83 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.098 178.207 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.58 HG21 ' CD1' ' A' ' 27' ' ' LEU . 98.7 t -134.11 137.96 51.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.049 0.452 . . . . 0.0 110.874 -177.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.7 mt -118.43 135.63 58.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.82 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.509 ' O ' ' HA2' ' A' ' 57' ' ' GLY . . . -124.21 123.37 5.13 Favored Glycine 0 N--CA 1.44 -1.04 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.031 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.523 ' HG ' HD11 ' A' ' 6' ' ' LEU . 98.7 mt -81.52 34.63 0.38 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.188 0.518 . . . . 0.0 109.87 177.402 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 118.7 103.85 2.14 Favored Glycine 0 N--CA 1.44 -1.063 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 -173.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.535 ' OD2' HG13 ' A' ' 45' ' ' VAL . 6.5 p-10 -97.88 -156.25 0.53 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.863 0.332 . . . . 0.0 110.488 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -58.5 153.75 15.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.262 0.553 . . . . 0.0 111.945 -173.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.514 HG22 ' O ' ' A' ' 12' ' ' VAL . 21.2 m -94.84 -1.79 10.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.098 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.641 ' O ' HG23 ' A' ' 45' ' ' VAL . 16.2 t70 -93.45 120.26 33.52 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 173.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.443 HD22 ' HB3' ' A' ' 66' ' ' ASP . 38.3 tp -57.98 -42.63 85.51 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 123.426 0.453 . . . . 0.0 111.888 -170.303 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -62.21 -44.82 95.73 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.727 0.299 . . . . 0.0 110.53 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.7 m -67.11 -28.8 68.46 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.091 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 41' ' ' ASP . 61.5 t -59.63 -50.39 80.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 121.371 0.605 . . . . 0.0 110.302 175.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.511 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 1.8 mp -68.64 -34.13 63.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.837 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -58.08 -39.11 77.74 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.427 174.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.57 -42.63 70.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.148 0.499 . . . . 0.0 109.777 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.0 tt0 -56.92 -40.26 76.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.754 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.511 ' HG3' ' O ' ' A' ' 46' ' ' ILE . 94.1 mttt -63.72 -45.81 88.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.962 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.589 ' HB3' ' HG ' ' A' ' 27' ' ' LEU . 17.9 m-85 -62.78 -42.75 99.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.834 0.35 . . . . 0.0 111.388 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.526 ' HB2' ' HB2' ' A' ' 55' ' ' PHE . 15.6 m -71.28 -28.11 63.9 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.313 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 68.4 mttm 71.49 -49.52 0.68 Allowed 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.855 0.862 . . . . 0.0 110.557 -175.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -124.46 91.84 3.53 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 172.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.526 ' HB2' ' HB2' ' A' ' 52' ' ' SER . 81.8 t80 -106.33 122.19 45.74 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.881 -176.204 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -114.67 115.27 26.84 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.665 177.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.509 ' HA2' ' O ' ' A' ' 35' ' ' GLY . . . -121.35 160.17 15.76 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 119.975 -1.107 . . . . 0.0 113.614 -175.532 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.636 HG21 ' HB3' ' A' ' 86' ' ' MET . 0.1 OUTLIER -140.76 106.99 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 123.251 0.621 . . . . 0.0 110.217 173.222 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.578 ' HB2' ' HG ' ' A' ' 71' ' ' LEU . 52.7 t-80 -102.05 117.29 34.48 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.151 -173.324 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -107.07 -14.4 18.94 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.454 -0.879 . . . . 0.0 113.444 -175.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -76.74 156.08 32.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.756 0.312 . . . . 0.0 110.389 -179.276 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 82.4 mtp -108.28 81.27 1.46 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.307 0.575 . . . . 0.0 109.93 175.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -106.9 -78.3 0.59 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.72 179.102 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.49 ' HD1' ' HB ' ' A' ' 40' ' ' VAL . 92.3 m-85 -107.45 154.37 40.73 Favored Pre-proline 0 C--N 1.323 -0.556 0 N-CA-C 110.318 -0.252 . . . . 0.0 110.318 178.517 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -74.42 -38.88 1.73 Allowed 'Trans proline' 0 CA--C 1.53 0.279 0 C-N-CA 122.49 2.126 . . . . 0.0 112.799 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.443 ' HB3' HD22 ' A' ' 42' ' ' LEU . 13.0 m-20 -60.38 -45.13 94.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.217 0.532 . . . . 0.0 111.482 -175.079 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.429 HG21 ' HA ' ' A' ' 40' ' ' VAL . 45.3 t -65.68 -27.94 42.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.546 -174.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 46.6 mttp -64.81 -25.66 68.01 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.871 0.367 . . . . 0.0 110.933 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -85.02 -28.43 25.72 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.795 -176.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.464 ' HB3' HD23 ' A' ' 71' ' ' LEU . 58.9 t-80 -69.79 -45.04 68.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.116 0.484 . . . . 0.0 109.95 177.493 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.578 ' HG ' ' HB2' ' A' ' 59' ' ' HIS . 1.3 pt? -140.02 113.05 7.55 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.421 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.29 -172.74 1.24 Allowed 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 123.099 2.533 . . . . 0.0 113.209 -176.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.431 ' CZ ' ' HA3' ' A' ' 89' ' ' GLY . 59.7 t80 -75.08 -43.48 52.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.545 -173.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 86' ' ' MET . 22.0 m -136.94 140.78 42.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.967 0.413 . . . . 0.0 111.579 -177.396 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.0 ttpm? -160.26 132.74 6.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.529 176.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.642 HG23 ' CE1' ' A' ' 104' ' ' PHE . 43.5 t -93.77 131.75 39.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.765 0.317 . . . . 0.0 110.249 173.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 38.5 mt -108.04 152.11 24.94 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 174.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 37.2 tp -122.41 96.11 4.91 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 175.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 60.4 t -102.25 95.45 3.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.685 -175.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 55.52 32.31 18.8 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.634 0.731 . . . . 0.0 111.054 175.097 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 114.53 -33.59 5.31 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.565 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 85.2 t -72.38 120.09 20.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.826 0.346 . . . . 0.0 110.695 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.9 101.73 13.44 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.048 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 19.0 mt -95.08 105.27 16.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.358 -176.109 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.569 ' HA2' HG22 ' A' ' 76' ' ' VAL . . . -89.5 94.36 1.98 Allowed Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.783 -0.723 . . . . 0.0 111.347 178.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.636 ' HB3' HG21 ' A' ' 58' ' ' VAL . 35.8 mtm -91.21 107.77 19.43 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.844 0.354 . . . . 0.0 110.687 -176.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 37.0 t -125.53 85.44 2.4 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 175.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 79.9 t60 -84.7 89.7 7.55 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.92 -173.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.431 ' HA3' ' CZ ' ' A' ' 73' ' ' PHE . . . -148.53 172.3 28.76 Favored Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.4 176.457 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 75.4 t-105 -76.52 106.85 8.41 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.951 0.405 . . . . 0.0 110.525 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -130.06 152.12 19.6 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 177.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -112.06 162.86 19.38 Favored Pre-proline 0 C--N 1.319 -0.721 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.32 -12.72 21.21 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.423 2.082 . . . . 0.0 112.514 178.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 14.0 m95 -80.47 -51.7 8.5 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.275 -178.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.483 ' OD2' ' HD3' ' A' ' 99' ' ' ARG . 12.0 p-10 -94.9 -0.58 53.87 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.159 -176.368 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 22.5 tp -50.52 -64.84 0.68 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.128 -0.487 . . . . 0.0 112.199 -174.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.485 ' HD2' ' HB2' ' A' ' 125' ' ' ALA . 42.5 mtmt -61.73 -54.37 43.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.365 0.602 . . . . 0.0 110.727 -176.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -61.08 -45.96 92.58 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.818 -1.083 . . . . 0.0 112.28 -171.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.483 ' HD3' ' OD2' ' A' ' 95' ' ' ASP . 34.0 ttt180 -79.37 -46.22 18.04 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.967 -173.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.457 HD13 HG21 ' A' ' 111' ' ' ILE . 47.3 mt -66.09 -29.45 69.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.687 0.279 . . . . 0.0 111.519 -176.36 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.608 HD22 ' HE3' ' A' ' 107' ' ' LYS . 86.0 mt -78.98 -13.28 59.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.687 0.28 . . . . 0.0 111.149 177.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -84.52 -31.74 24.29 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.83 0.348 . . . . 0.0 110.268 173.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.3 t -63.58 -49.72 81.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.254 177.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.642 ' CE1' HG23 ' A' ' 76' ' ' VAL . 20.3 m-85 -105.68 116.01 31.22 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.551 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -72.87 -29.16 62.96 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 170.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -76.48 97.63 4.37 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.853 171.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.608 ' HE3' HD22 ' A' ' 101' ' ' LEU . 13.0 mptt -63.24 113.93 11.11 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-O 120.996 0.426 . . . . 0.0 110.975 -178.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.493 ' HD3' ' HA ' ' A' ' 107' ' ' LYS . 1.0 OUTLIER -85.32 158.86 11.13 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.581 2.854 . . . . 0.0 112.642 -175.944 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -79.38 -53.24 7.11 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.032 177.444 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 74.8 t -120.42 128.6 76.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.865 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.476 HD12 ' CE2' ' A' ' 129' ' ' PHE . 48.6 mt -114.65 129.21 71.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.083 0.468 . . . . 0.0 110.797 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.444 HD23 ' HB2' ' A' ' 130' ' ' LEU . 81.4 mt -102.31 120.53 40.64 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.03 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -132.38 -169.61 2.26 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 -178.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -137.03 126.79 3.81 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.634 -0.794 . . . . 0.0 112.645 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 20.4 t60 -167.62 -71.86 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.183 0.516 . . . . 0.0 110.143 176.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.482 HG22 ' H ' ' A' ' 118' ' ' GLU . 6.6 m -83.05 143.2 30.76 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.118 -177.007 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.422 ' HB3' ' OE1' ' A' ' 137' ' ' GLU . 61.6 m-70 -90.31 -21.46 22.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.304 0.573 . . . . 0.0 110.168 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.482 ' H ' HG22 ' A' ' 116' ' ' THR . 48.6 mt-10 -87.01 121.0 71.78 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.169 173.101 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.742 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 23.5 Cg_exo -61.76 101.25 0.21 Allowed 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.704 2.269 . . . . 0.0 112.399 -175.307 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -111.41 127.34 55.64 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.851 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -79.84 103.23 9.59 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 174.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.617 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 38.5 p -99.5 113.81 26.4 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.248 -176.086 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.407 HG13 ' O ' ' A' ' 123' ' ' VAL . 6.9 p -109.7 97.71 6.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-O 122.168 0.985 . . . . 0.0 109.686 177.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.473 ' HB3' ' HD3' ' A' ' 97' ' ' LYS . 58.5 mttp -129.61 137.37 50.65 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.581 -176.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.485 ' HB2' ' HD2' ' A' ' 97' ' ' LYS . . . 64.96 13.38 8.59 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 123.616 0.572 . . . . 0.0 110.917 -176.389 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 89.74 -9.59 76.63 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.294 -178.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 38.8 t -93.04 141.34 14.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 128' ' ' ARG . 14.8 ttt180 -100.54 102.16 13.26 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.25 0.548 . . . . 0.0 110.428 -177.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.617 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 18.2 m-85 -92.09 142.86 27.04 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.235 178.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.444 ' HB2' HD23 ' A' ' 112' ' ' LEU . 86.1 mt -124.4 136.45 54.07 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.925 0.393 . . . . 0.0 110.917 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.742 ' O ' ' HA ' ' A' ' 119' ' ' PRO . 4.1 p30 -130.01 103.8 16.99 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.844 176.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -94.37 154.85 2.05 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.002 2.468 . . . . 0.0 113.297 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -71.93 159.06 53.65 Favored Glycine 0 N--CA 1.452 -0.289 0 N-CA-C 111.409 -0.676 . . . . 0.0 111.409 175.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 13.4 t -83.54 176.3 9.14 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 117.304 0.552 . . . . 0.0 111.251 -175.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 20.7 mt -70.81 -34.82 72.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.003 -170.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -77.03 -7.14 55.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.145 0.498 . . . . 0.0 110.69 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.422 ' OE1' ' HB3' ' A' ' 117' ' ' HIS . 42.2 mt-10 -92.6 1.12 57.43 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.003 176.361 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 73.34 39.6 50.99 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.678 -0.692 . . . . 0.0 113.08 174.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 50.2 m -150.08 144.29 25.65 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.763 0.316 . . . . 0.0 110.678 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -143.95 166.16 25.74 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.591 176.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -114.47 134.89 54.67 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.258 0.551 . . . . 0.0 111.411 -175.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 152' ' ' PHE . 89.4 t -116.47 121.43 67.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.572 175.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 5.2 tt -110.61 107.35 16.92 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -104.87 142.45 34.72 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.961 176.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.0 mp -90.74 94.28 9.61 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.218 0.532 . . . . 0.0 109.689 172.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -87.19 113.38 22.87 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.4 -178.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 68.35 -62.96 0.41 Allowed Glycine 0 CA--C 1.52 0.36 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.562 -169.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 179.38 27.77 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 175.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -127.1 160.53 30.89 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -175.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 47.6 t -77.76 108.88 11.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.844 0.354 . . . . 0.0 111.426 -176.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.429 HH11 ' HD3' ' A' ' 151' ' ' ARG . 15.2 ttm180 -107.7 96.07 6.13 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 173.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' PHE . . . . . 0.436 ' HA ' ' O ' ' A' ' 142' ' ' VAL . 40.1 p90 -102.41 127.53 49.4 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.928 -178.173 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -120.32 140.72 50.84 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.849 176.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -100.58 97.54 8.22 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.519 176.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -92.28 140.86 29.18 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.088 -177.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 18.1 p -89.62 155.58 19.15 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.617 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.728 HD13 ' HG2' ' A' ' 20' ' ' PRO . 83.0 mt . . . . . 0 C--O 1.247 0.952 0 CA-C-O 118.334 -0.841 . . . . 0.0 109.865 177.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 60.1 mttp . . . . . 0 N--CA 1.455 -0.21 0 CA-C-O 120.677 0.275 . . . . 0.0 110.293 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.539 ' HG2' ' HG2' ' A' ' 144' ' ' GLU . 79.5 mtt180 -104.92 111.28 23.98 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.629 172.215 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.545 ' HE2' HG11 ' A' ' 79' ' ' VAL . 70.4 m-85 -101.59 129.73 47.76 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.028 0.442 . . . . 0.0 111.036 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.572 ' HB3' HG22 ' A' ' 33' ' ' VAL . 36.8 tp -89.57 112.25 23.4 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.611 176.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.403 ' HB3' ' HB3' ' A' ' 141' ' ' ALA . 51.5 tp -96.76 102.23 13.98 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.116 0.484 . . . . 0.0 110.045 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.503 HG13 ' HA2' ' A' ' 35' ' ' GLY . 11.5 pt -101.47 126.29 55.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.493 176.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.592 ' HB3' ' OG1' ' A' ' 116' ' ' THR . 14.0 m -68.62 179.65 1.66 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.028 -176.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -78.4 79.82 4.82 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 122.053 0.93 . . . . 0.0 110.811 -177.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.524 ' HB3' HD23 ' A' ' 135' ' ' LEU . 10.6 p -80.53 133.87 35.87 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 176.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 74.3 m-70 -99.57 80.09 2.34 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.363 0.602 . . . . 0.0 109.617 -177.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.476 ' HB ' ' HD1' ' A' ' 39' ' ' TYR . 38.6 t -114.87 137.62 22.93 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.617 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -82.79 -58.71 0.07 OUTLIER 'Cis proline' 0 N--CA 1.461 -0.4 0 C-N-CA 123.666 -1.389 . . . . 0.0 112.887 -2.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER 35.05 -96.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -173.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 40.9 mtm180 -127.33 20.66 6.76 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 15.6 tmm? -144.16 100.25 3.52 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.246 0.546 . . . . 0.0 109.987 173.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -110.08 16.02 22.11 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.825 176.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 27.9 p -84.67 39.33 0.74 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.078 -177.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.0 tt -97.16 119.92 62.26 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.563 ' HG3' HD13 ' A' ' 157' ' ' LEU . 26.9 Cg_endo -61.66 130.39 31.31 Favored 'Trans proline' 0 C--O 1.234 0.291 0 C-N-CA 123.092 2.528 . . . . 0.0 112.552 -178.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -63.44 -18.57 63.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.885 -179.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -52.62 -49.26 65.47 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.769 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.0 tt -70.38 -36.32 66.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.345 0.593 . . . . 0.0 110.34 -176.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.689 HD12 HD23 ' A' ' 27' ' ' LEU . 58.3 tp -69.81 -33.79 72.82 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.131 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -71.09 -36.61 72.27 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.327 178.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 75.6 m -80.69 7.53 10.02 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.752 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.689 HD23 HD12 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -50.56 -41.48 54.2 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.592 0.71 . . . . 0.0 110.724 176.896 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 71.3 mttt -90.99 11.15 23.83 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.173 -171.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -104.28 7.94 35.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.038 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -126.02 158.77 34.48 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.4 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -72.0 -53.19 13.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.176 0.512 . . . . 0.0 109.968 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.539 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -138.12 151.96 21.64 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.194 179.105 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.572 HG22 ' HB3' ' A' ' 5' ' ' LEU . 97.8 t -118.96 135.89 57.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-O 120.703 0.287 . . . . 0.0 110.482 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.456 HG12 ' HB2' ' A' ' 56' ' ' TYR . 37.0 mt -111.56 116.62 53.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.854 176.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.503 ' HA2' HG13 ' A' ' 7' ' ' ILE . . . -104.25 119.66 6.36 Favored Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 177.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 94.3 mt -92.81 24.07 3.82 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.122 0.487 . . . . 0.0 110.552 -179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 121.55 21.91 2.9 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.828 -178.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.405 ' HB3' HD12 ' A' ' 7' ' ' ILE . 10.9 t70 -81.14 134.03 35.57 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.613 ' HD2' HD11 ' A' ' 48' ' ' LEU . 25.7 m-85 64.6 105.73 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 O-C-N 123.872 0.732 . . . . 0.0 110.924 -175.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.417 HG22 ' O ' ' A' ' 12' ' ' VAL . 35.9 m -86.77 0.22 6.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.332 -176.167 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.549 ' O ' HG23 ' A' ' 45' ' ' VAL . 16.0 t70 -86.65 135.93 33.22 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.792 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 54.3 tp -62.7 -49.49 74.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.702 -175.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -63.1 -35.31 79.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.823 0.344 . . . . 0.0 110.752 -177.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.451 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 14.1 m -68.6 -33.06 73.4 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.21 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 41' ' ' ASP . 93.4 t -60.2 -46.12 95.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.369 0.604 . . . . 0.0 109.888 175.353 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.23 -38.0 80.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.89 177.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.24 -33.8 72.79 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.801 176.519 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.613 HD11 ' HD2' ' A' ' 39' ' ' TYR . 83.3 mt -66.95 -38.13 85.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.26 0.552 . . . . 0.0 109.996 178.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.681 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 35.8 tt0 -77.23 -11.39 59.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.331 176.489 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -92.5 -36.4 13.09 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.643 0.259 . . . . 0.0 110.945 -178.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.483 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . 6.4 m-30 -65.69 -67.37 0.45 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.4 178.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.49 ' OG ' HD12 ' A' ' 27' ' ' LEU . 5.1 m -73.49 -23.66 60.08 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.53 177.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.681 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 60.7 mttp 70.51 4.01 4.75 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.382 0.673 . . . . 0.0 111.785 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -144.83 105.07 4.07 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 172.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -128.89 133.23 47.85 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.189 0.519 . . . . 0.0 111.242 -173.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.456 ' HB2' HG12 ' A' ' 34' ' ' ILE . 88.1 m-85 -113.7 118.92 35.68 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 173.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -131.12 132.2 6.72 Favored Glycine 0 N--CA 1.44 -1.081 0 C-N-CA 119.606 -1.283 . . . . 0.0 113.925 -171.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.5 m -130.92 147.84 33.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 168.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.566 ' HB3' ' HB2' ' A' ' 71' ' ' LEU . 2.9 p80 -94.34 142.5 27.34 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 119.489 -0.884 . . . . 0.0 110.666 -173.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -81.29 -107.29 0.34 Allowed Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 115.618 -0.719 . . . . 0.0 113.538 -172.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.938 HD21 ' HA ' ' A' ' 115' ' ' HIS . 43.0 m-80 -95.62 -83.95 0.35 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.785 0.326 . . . . 0.0 111.264 -173.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 51.4 ttm -112.74 122.98 49.26 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.232 0.539 . . . . 0.0 110.682 -178.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -145.89 -174.25 4.37 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.288 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -74.88 144.51 79.88 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-O 120.673 0.273 . . . . 0.0 111.372 -176.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -47.06 -38.29 24.14 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.843 3.029 . . . . 0.0 114.161 -175.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -70.11 -46.54 64.61 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.214 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 39.9 t -63.66 -32.6 57.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.594 -177.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.414 ' HE2' ' HB3' ' A' ' 68' ' ' LYS . 31.8 ttpt -50.12 -40.36 45.8 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.809 177.318 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -104.12 -14.61 15.82 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.121 0.486 . . . . 0.0 110.136 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -75.44 -40.21 57.86 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -179.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.566 ' HB2' ' HB3' ' A' ' 59' ' ' HIS . 80.8 mt -102.64 117.94 59.67 Favored Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 170.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -56.44 156.2 22.66 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 123.129 2.553 . . . . 0.0 113.504 -174.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -77.11 -16.92 59.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.519 177.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.7 p -157.89 139.37 13.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.099 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.2 mttm -144.43 142.49 30.34 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.524 176.243 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 21.7 t -121.39 110.54 28.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.159 0.504 . . . . 0.0 109.913 172.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 37.3 mt -92.95 147.99 22.38 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.401 -177.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 55.1 tp -117.83 98.01 6.13 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 175.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.545 HG11 ' HE2' ' A' ' 4' ' ' PHE . 48.5 t -105.49 96.26 4.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.629 -174.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 57.31 27.62 14.01 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.624 175.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 114.35 -24.22 11.64 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.542 178.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.5 t -83.04 128.44 38.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.567 0.222 . . . . 0.0 110.809 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 40.0 p -91.48 131.24 37.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.538 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 42.0 mt -124.51 104.72 14.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.883 0.373 . . . . 0.0 110.215 -178.145 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -91.71 104.8 3.21 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.877 -0.677 . . . . 0.0 111.447 178.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 22.1 mtm -103.95 118.11 35.9 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -178.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 113' ' ' PHE . 46.0 t -156.96 158.29 36.34 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.925 0.393 . . . . 0.0 110.717 -177.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 15.0 t60 -65.64 -32.81 74.58 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.259 175.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.29 -94.88 0.57 Allowed Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 -173.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.423 ' HE3' ' H ' ' A' ' 92' ' ' ALA . 17.0 t90 -173.71 -69.24 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 172.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 155.14 -34.47 0.66 Allowed Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.994 -0.622 . . . . 0.0 111.77 -178.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.452 ' O ' ' HB2' ' A' ' 96' ' ' LEU . . . -78.61 115.1 49.03 Favored Pre-proline 0 C--N 1.327 -0.397 0 N-CA-C 110.487 -0.19 . . . . 0.0 110.487 178.113 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.469 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . 3.5 Cg_exo -81.22 5.18 6.42 Favored 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 123.427 2.752 . . . . 0.0 113.149 -175.538 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -80.74 -54.67 5.42 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.267 0.556 . . . . 0.0 109.942 -176.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 38.3 p30 -112.04 19.27 18.0 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.943 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.469 ' HB2' ' HA ' ' A' ' 93' ' ' PRO . 50.8 tp -54.47 -51.13 66.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.478 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -60.53 -45.38 94.07 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.926 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -61.37 -47.12 87.31 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.157 0.503 . . . . 0.0 110.844 -177.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.548 ' O ' HG23 ' A' ' 103' ' ' VAL . 36.3 ttm105 -67.0 -42.15 85.49 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.56 178.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.955 HD21 HG21 ' A' ' 111' ' ' ILE . 17.1 tp -67.57 -41.8 83.59 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.134 -176.281 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.432 HD21 HG21 ' A' ' 127' ' ' VAL . 93.7 mt -75.8 -5.74 47.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.528 178.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -95.38 -29.94 14.17 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.962 174.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 99' ' ' ARG . 94.8 t -62.68 -53.0 52.68 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 174.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -82.52 146.49 29.2 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 174.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -87.59 -27.11 22.74 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.897 0.38 . . . . 0.0 110.755 -177.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -113.64 177.65 4.56 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.532 177.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.866 ' H ' ' HD2' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -95.91 113.27 61.77 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.08 -175.133 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.478 ' HG2' HD11 ' A' ' 111' ' ' ILE . 1.2 Cg_endo -85.37 156.08 10.84 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.375 2.717 . . . . 0.0 111.854 177.209 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -90.7 -59.49 2.16 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.95 0.405 . . . . 0.0 110.771 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.635 HG21 HG21 ' A' ' 150' ' ' VAL . 57.3 t -105.15 119.54 54.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.331 -178.645 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.955 HG21 HD21 ' A' ' 100' ' ' LEU . 55.4 mt -116.46 128.69 73.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.079 0.466 . . . . 0.0 111.202 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.667 HD23 ' HB2' ' A' ' 130' ' ' LEU . 86.9 mt -107.61 124.72 50.37 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.011 176.217 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.515 ' HA ' ' O ' ' A' ' 87' ' ' CYS . 40.7 p90 -117.15 172.66 7.14 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 119.636 -0.825 . . . . 0.0 111.07 178.031 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -105.8 -165.18 23.32 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.442 -172.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.938 ' HA ' HD21 ' A' ' 61' ' ' ASN . 18.0 t60 69.06 41.73 1.37 Allowed 'General case' 0 C--O 1.233 0.191 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -173.517 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.592 ' OG1' ' HB3' ' A' ' 8' ' ' SER . 36.5 p -63.51 119.33 9.58 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 114.263 -1.335 . . . . 0.0 112.113 -171.334 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.442 ' HA ' ' OE2' ' A' ' 137' ' ' GLU . 0.1 OUTLIER -171.87 128.42 0.62 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.886 179.269 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 59.26 84.67 0.2 Allowed Pre-proline 0 N--CA 1.465 0.287 0 O-C-N 123.543 0.527 . . . . 0.0 110.791 -175.067 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -61.13 143.35 98.78 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 123.075 2.517 . . . . 0.0 113.014 -175.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -162.13 146.15 12.22 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.924 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -94.12 114.35 26.48 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.586 175.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.482 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 67.5 p -119.82 144.16 47.48 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.694 0.283 . . . . 0.0 111.405 -176.167 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.7 p -138.8 124.3 22.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.127 0.489 . . . . 0.0 110.976 178.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.481 ' HB2' ' HE2' ' A' ' 129' ' ' PHE . 88.1 mttt -140.9 139.42 34.35 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.536 176.354 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 66.94 14.04 9.68 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 123.485 0.491 . . . . 0.0 111.626 177.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 90.18 -2.82 81.87 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.234 -177.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.432 HG21 HD21 ' A' ' 101' ' ' LEU . 33.1 t -100.34 137.9 26.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -98.23 120.12 38.09 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.66 -176.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.482 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 34.9 m-85 -108.48 121.15 44.37 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.805 -178.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.667 ' HB2' HD23 ' A' ' 112' ' ' LEU . 78.1 mt -107.88 138.76 43.56 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-O 121.459 0.647 . . . . 0.0 111.146 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.462 ' HB3' ' CZ ' ' A' ' 113' ' ' PHE . 7.4 p30 -139.39 116.16 8.49 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.355 173.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.547 ' HD2' HG22 ' A' ' 116' ' ' THR . 86.2 Cg_endo -88.17 168.62 6.43 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.712 2.275 . . . . 0.0 112.502 178.672 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -85.28 147.77 22.62 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 176.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.58 ' HA ' ' HB2' ' A' ' 8' ' ' SER . 81.1 p -75.56 168.76 19.4 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.087 0.47 . . . . 0.0 111.077 -176.568 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.524 HD23 ' HB3' ' A' ' 10' ' ' SER . 4.2 mm? -64.82 -24.16 67.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.068 178.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -75.56 -14.36 60.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.036 0.446 . . . . 0.0 110.676 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.442 ' OE2' ' HA ' ' A' ' 117' ' ' HIS . 33.1 mt-10 -98.39 -2.23 39.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.192 178.041 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.518 ' HA2' HD12 ' A' ' 157' ' ' LEU . . . 70.78 45.45 52.17 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.925 177.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.6 p -150.81 153.92 36.32 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.597 0.199 . . . . 0.0 110.753 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -154.25 159.59 41.37 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 175.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.403 ' HB3' ' HB3' ' A' ' 6' ' ' LEU . . . -114.6 131.21 56.77 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.826 0.346 . . . . 0.0 111.384 -175.114 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 61.9 t -108.53 107.78 23.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 173.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.505 ' HA ' ' HA ' ' A' ' 152' ' ' PHE . 6.7 tt -96.97 105.14 17.23 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.196 0.522 . . . . 0.0 110.106 -176.189 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.539 ' HG2' ' HG2' ' A' ' 3' ' ' ARG . 34.1 mt-10 -100.19 149.75 23.23 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.583 176.103 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.9 mp -90.49 90.12 7.87 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 166.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -101.23 112.48 24.98 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.732 -170.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.75 10.97 59.49 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.067 -174.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 91.65 5.07 67.1 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.238 -0.506 . . . . 0.0 112.086 -178.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -108.63 161.83 14.72 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 176.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.635 HG21 HG21 ' A' ' 110' ' ' VAL . 50.0 t -81.49 101.61 6.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.08 0.467 . . . . 0.0 110.593 -176.493 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 31.0 tpt180 -103.57 87.49 2.85 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.077 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' PHE . . . . . 0.505 ' HA ' ' HA ' ' A' ' 143' ' ' LEU . 12.0 p90 -91.37 101.5 14.18 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.295 0.569 . . . . 0.0 110.02 177.439 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -91.06 101.49 14.25 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.359 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 48.2 tp -75.62 99.93 4.46 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 175.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -93.94 133.82 36.97 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.912 -177.01 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.6 m -98.42 150.33 21.74 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.407 -175.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.563 HD13 ' HG3' ' A' ' 20' ' ' PRO . 83.1 mt . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.37 -0.824 . . . . 0.0 109.897 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.2 mptt . . . . . 0 CA--C 1.519 -0.224 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 52.8 mtp180 -106.51 116.57 32.16 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.09 178.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.535 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 73.1 m-85 -105.51 124.06 48.92 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.113 0.482 . . . . 0.0 111.487 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.528 ' HB3' HG22 ' A' ' 33' ' ' VAL . 37.9 tp -89.18 121.35 31.4 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.86 177.36 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.445 ' HB3' ' HB3' ' A' ' 141' ' ' ALA . 45.0 tp -110.95 106.46 15.57 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.181 0.515 . . . . 0.0 111.207 -177.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 19.7 pt -101.35 129.96 51.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.192 173.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.556 ' H ' HD21 ' A' ' 135' ' ' LEU . 9.1 p -85.27 -177.8 6.59 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.978 0.418 . . . . 0.0 111.954 -173.402 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.625 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.2 m-20 -65.39 104.22 0.94 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.31 -177.607 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.658 ' HB3' HD12 ' A' ' 135' ' ' LEU . 10.5 p -104.07 175.38 5.5 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 177.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -135.05 75.42 1.57 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.345 0.593 . . . . 0.0 110.098 176.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.419 ' O ' HG22 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -135.13 147.56 62.96 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.542 178.522 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -87.53 104.0 0.47 Allowed 'Cis proline' 0 N--CA 1.46 -0.463 0 C-N-CA 123.322 -1.532 . . . . 0.0 112.374 -2.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.405 ' H ' ' HA ' ' A' ' 12' ' ' VAL . 2.3 t -135.34 -133.59 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -178.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 22.0 ttm-85 -87.73 4.22 45.04 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.096 0.474 . . . . 0.0 110.812 -177.034 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.523 ' HG2' ' OG ' ' A' ' 18' ' ' SER . 30.3 ttp -84.86 -76.23 0.32 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.183 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 62.72 2.93 1.03 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.222 0.609 . . . . 0.0 112.41 178.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.523 ' OG ' ' HG2' ' A' ' 16' ' ' MET . 12.9 p -95.39 38.42 1.15 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.955 0.407 . . . . 0.0 111.519 -177.029 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.2 tt -107.84 111.11 62.51 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 177.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -70.57 141.24 41.48 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 122.734 2.289 . . . . 0.0 113.012 -177.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -63.8 -19.76 65.25 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.379 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -52.8 -42.66 65.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.898 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -68.66 -32.21 54.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.121 0.486 . . . . 0.0 110.514 -177.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.447 ' O ' HD23 ' A' ' 27' ' ' LEU . 58.3 tp -76.87 -31.97 57.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.412 -176.458 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -76.49 -23.47 53.76 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.555 178.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.9 m -78.49 0.85 24.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.766 -177.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.532 ' HB3' ' HB3' ' A' ' 51' ' ' PHE . 2.0 mm? -56.6 -28.98 61.6 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.884 0.373 . . . . 0.0 111.726 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 42.5 mttp -85.14 0.44 51.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.535 -174.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -113.12 17.49 18.7 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -171.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -137.45 168.43 19.66 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.672 0.272 . . . . 0.0 110.71 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -91.28 -52.75 4.66 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-O 121.512 0.672 . . . . 0.0 110.0 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.535 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -129.38 137.63 9.7 Favored Glycine 0 N--CA 1.441 -0.982 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.292 179.222 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.528 HG22 ' HB3' ' A' ' 5' ' ' LEU . 79.8 t -113.42 129.53 69.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.598 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 38.9 mt -105.99 122.74 59.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.527 -179.025 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -104.21 103.97 2.36 Favored Glycine 0 N--CA 1.44 -1.071 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.265 177.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.483 ' HB3' ' HE1' ' A' ' 88' ' ' HIS . 81.8 mt -80.42 -30.67 37.67 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 175.502 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.625 ' HA3' ' HA ' ' A' ' 9' ' ' ASP . . . -166.42 56.49 0.24 Allowed Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 177.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -57.61 -73.34 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.182 -0.509 . . . . 0.0 112.274 -171.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.518 ' CD1' HD11 ' A' ' 48' ' ' LEU . 78.5 m-85 -135.91 156.43 48.77 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.927 0.394 . . . . 0.0 110.686 178.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.419 HG22 ' O ' ' A' ' 12' ' ' VAL . 22.6 m -92.58 -3.02 10.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.335 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.593 ' O ' HG23 ' A' ' 45' ' ' VAL . 23.5 t70 -100.64 129.51 46.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.675 -178.49 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.52 HD22 ' HB3' ' A' ' 66' ' ' ASP . 51.0 tp -57.47 -52.14 66.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.456 . . . . 0.0 112.056 -174.125 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -68.29 -32.07 71.96 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.796 0.331 . . . . 0.0 110.948 -172.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.3 m -70.68 -33.16 70.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.916 178.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 41' ' ' ASP . 87.4 t -61.97 -44.21 98.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 121.357 0.598 . . . . 0.0 110.067 175.369 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -71.19 -31.79 45.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.269 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -58.65 -37.51 76.11 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 174.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.518 HD11 ' CD1' ' A' ' 39' ' ' TYR . 85.1 mt -69.68 -37.58 76.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.211 177.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.414 ' HG3' ' HB3' ' A' ' 55' ' ' PHE . 23.9 tt0 -71.33 -12.6 61.52 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.663 -177.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -79.76 -47.58 15.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.836 0.351 . . . . 0.0 110.499 173.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.532 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . 76.0 m-85 -75.82 -42.71 49.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.949 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.2 t -71.17 104.69 3.15 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.004 175.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -49.77 -43.74 48.39 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.645 177.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -130.08 104.24 7.22 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.577 175.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.414 ' HB3' ' HG3' ' A' ' 49' ' ' GLU . 74.3 t80 -100.3 121.76 42.01 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.313 -176.075 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.598 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 91.9 m-85 -114.82 108.0 16.17 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.568 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -126.12 151.21 17.82 Favored Glycine 0 N--CA 1.442 -0.959 0 C-N-CA 119.872 -1.156 . . . . 0.0 112.734 -175.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -127.69 172.77 14.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 173.028 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.45 ' HB2' ' O ' ' A' ' 71' ' ' LEU . 10.7 t-80 -94.3 118.79 32.12 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.522 -172.191 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.4 ' HA2' ' CD2' ' A' ' 88' ' ' HIS . . . -82.51 -148.25 7.15 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.691 -179.119 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -118.04 120.91 39.22 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.578 0.228 . . . . 0.0 111.512 -176.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 84.4 mtp 73.84 95.78 0.07 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.797 176.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.412 ' OD2' ' HB ' ' A' ' 67' ' ' VAL . 8.4 p-10 -160.4 -173.99 4.27 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.531 -177.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.414 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 15.1 m-30 -77.83 140.99 63.39 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.722 0.296 . . . . 0.0 111.01 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.426 ' O ' ' HB3' ' A' ' 68' ' ' LYS . 51.0 Cg_exo -57.46 -16.0 21.8 Favored 'Trans proline' 0 N--CA 1.474 0.37 0 C-N-CA 123.26 2.64 . . . . 0.0 112.915 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.52 ' HB3' HD22 ' A' ' 42' ' ' LEU . 8.5 m-20 -68.64 -41.57 79.2 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.252 0.548 . . . . 0.0 110.21 177.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.412 ' HB ' ' OD2' ' A' ' 63' ' ' ASP . 25.3 t -73.38 -23.61 19.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.96 -178.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.426 ' HB3' ' O ' ' A' ' 65' ' ' PRO . 63.9 tttp -52.78 -34.15 51.94 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.28 -178.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -108.36 2.31 22.42 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -176.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -98.76 -34.83 10.36 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 175.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.45 ' O ' ' HB2' ' A' ' 59' ' ' HIS . 51.2 mt -107.36 116.13 58.49 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.956 177.41 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -64.11 159.22 43.93 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.999 2.466 . . . . 0.0 112.751 -178.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.428 ' HZ ' HH22 ' A' ' 99' ' ' ARG . 64.7 t80 -79.85 -29.81 40.18 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.494 -176.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.0 p -148.7 126.27 11.7 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.507 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.7 tttm -141.54 128.42 20.58 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 12.0 t -109.65 118.17 56.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.844 0.354 . . . . 0.0 110.149 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 38.7 mt -93.01 153.27 18.82 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.656 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -118.3 108.99 15.77 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 171.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 22.2 t -122.21 102.09 11.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.148 -174.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 56.43 25.0 9.09 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.408 -0.814 . . . . 0.0 112.188 174.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 114.15 -10.57 22.49 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.96 177.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 46.5 t -103.84 134.63 44.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 122.645 -0.326 . . . . 0.0 110.948 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.6 p -93.83 133.35 37.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.656 177.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 27.1 mt -129.01 99.34 4.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.812 0.339 . . . . 0.0 110.357 -176.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -89.59 110.25 3.7 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.852 -0.69 . . . . 0.0 111.785 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.495 ' HG2' ' HB2' ' A' ' 112' ' ' LEU . 32.6 mtm -99.91 123.25 43.96 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 -179.098 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 34.2 t -145.83 163.07 36.2 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.483 ' HE1' ' HB3' ' A' ' 36' ' ' LEU . 7.2 m80 -141.0 -165.27 1.92 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.989 0.423 . . . . 0.0 111.424 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 112.48 169.33 17.85 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -177.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 17.3 p90 -81.81 96.7 7.69 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.502 0.668 . . . . 0.0 110.546 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -122.98 115.66 2.75 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.036 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.45 153.91 81.62 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 178.106 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.99 -7.45 6.28 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.013 2.475 . . . . 0.0 113.603 -175.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -81.72 -52.78 6.8 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.197 0.522 . . . . 0.0 109.978 -178.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -103.55 -4.87 23.34 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.823 -174.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 40.9 tp -52.41 -56.69 13.3 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.797 -176.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 45.9 pttt -57.39 -42.97 83.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.446 -177.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -69.37 -41.69 76.2 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.642 -178.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.482 ' O ' HG23 ' A' ' 103' ' ' VAL . 42.7 ttt-85 -62.05 -47.53 84.33 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.006 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.524 HD13 HG21 ' A' ' 111' ' ' ILE . 94.2 mt -66.47 -38.41 87.27 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.27 -176.679 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.798 HD21 HG21 ' A' ' 127' ' ' VAL . 86.6 mt -76.16 -13.25 60.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.011 0.434 . . . . 0.0 110.888 177.43 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -82.89 -39.89 20.94 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.008 176.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 99' ' ' ARG . 90.8 t -66.24 -50.93 64.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.194 -178.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -87.38 111.92 21.6 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 121.066 -0.254 . . . . 0.0 110.967 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -57.82 -52.89 63.6 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 174.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -80.77 94.96 6.51 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 170.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.702 ' H ' ' HD2' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -59.95 123.15 70.77 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.217 -179.279 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 107' ' ' LYS . 2.2 Cg_endo -82.08 157.15 17.68 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 123.754 2.969 . . . . 0.0 112.699 -172.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -73.51 -44.94 56.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.946 177.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 65.4 t -118.78 140.67 41.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.948 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.524 HG21 HD13 ' A' ' 100' ' ' LEU . 40.9 mt -129.86 131.99 66.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.74 0.305 . . . . 0.0 110.474 177.588 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.661 HD23 ' HB2' ' A' ' 130' ' ' LEU . 75.3 mt -105.24 127.34 52.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.64 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.405 ' HE1' ' HB3' ' A' ' 129' ' ' PHE . 13.9 p90 -147.21 147.24 30.26 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.686 176.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -130.96 114.79 1.64 Allowed Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.332 -0.937 . . . . 0.0 111.814 179.023 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 17.2 t60 -178.45 21.59 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 177.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.495 HG22 ' H ' ' A' ' 117' ' ' HIS . 0.2 OUTLIER -101.65 -176.03 3.02 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.142 -174.564 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.495 ' H ' HG22 ' A' ' 116' ' ' THR . 49.4 m-70 -111.63 -43.19 3.69 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.756 0.312 . . . . 0.0 110.562 178.029 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -124.58 149.21 61.23 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.913 175.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.566 ' HG3' HD22 ' A' ' 154' ' ' LEU . 74.4 Cg_endo -74.83 138.51 23.58 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.713 2.275 . . . . 0.0 111.988 178.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -150.58 125.95 10.1 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.374 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -78.26 94.47 4.8 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 177.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.504 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 68.6 p -103.46 119.19 38.4 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.837 -174.376 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.493 HG13 ' O ' ' A' ' 123' ' ' VAL . 8.9 p -107.25 88.89 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 122.336 1.065 . . . . 0.0 109.113 170.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -127.27 146.24 50.5 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.701 -174.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 61.8 15.25 6.89 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 123.724 0.64 . . . . 0.0 110.893 -174.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 83.91 9.87 81.9 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.52 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.798 HG21 HD21 ' A' ' 101' ' ' LEU . 47.7 t -119.21 140.83 41.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.698 0.285 . . . . 0.0 110.307 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.643 ' NH1' HD21 ' A' ' 130' ' ' LEU . 26.9 ttt-85 -89.36 94.16 9.79 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.504 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 89.3 m-85 -83.44 126.14 32.44 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.661 ' HB2' HD23 ' A' ' 112' ' ' LEU . 50.2 mt -112.01 122.43 47.74 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.385 0.612 . . . . 0.0 110.965 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.511 ' HA ' ' HD3' ' A' ' 132' ' ' PRO . 5.1 p30 -129.22 122.95 21.37 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.821 178.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.511 ' HD3' ' HA ' ' A' ' 131' ' ' ASN . 5.4 Cg_endo -87.15 169.64 7.33 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.238 2.625 . . . . 0.0 112.288 179.151 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -89.05 -160.23 36.23 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.27 178.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 48.2 t -88.19 139.3 30.64 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.825 0.345 . . . . 0.0 110.637 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.658 HD12 ' HB3' ' A' ' 10' ' ' SER . 58.3 mt -66.17 -19.74 65.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.28 178.312 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -78.76 -12.53 60.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.348 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -87.52 -4.62 58.98 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.417 -176.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 77.9 25.75 61.71 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.335 178.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 7.3 t -139.46 132.32 29.25 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 178.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -126.32 173.25 9.46 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -177.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.445 ' HB3' ' HB3' ' A' ' 6' ' ' LEU . . . -114.38 134.94 54.61 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.689 -174.094 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.537 HG12 ' HG3' ' A' ' 144' ' ' GLU . 47.3 t -128.83 124.08 60.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.881 176.509 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.529 HD21 HG13 ' A' ' 150' ' ' VAL . 5.8 tt -101.87 106.47 17.43 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.537 ' HG3' HG12 ' A' ' 142' ' ' VAL . 45.2 mt-10 -113.3 131.42 55.94 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.521 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 21.2 mt -93.07 90.74 7.02 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.887 -178.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -87.54 111.47 21.25 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.832 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.74 -69.02 0.29 Allowed Glycine 0 CA--C 1.52 0.384 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.633 -175.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -171.17 25.46 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 111.665 -0.574 . . . . 0.0 111.665 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -110.37 143.04 41.21 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.529 HG13 HD21 ' A' ' 143' ' ' LEU . 46.5 t -86.03 89.07 2.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 177.204 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 67.6 mtp180 -90.02 98.44 11.77 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.337 0.589 . . . . 0.0 110.644 -175.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -83.37 93.99 7.87 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.12 175.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -97.46 112.52 24.33 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.845 0.355 . . . . 0.0 110.988 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.566 HD22 ' HG3' ' A' ' 119' ' ' PRO . 15.9 tp -83.6 92.4 7.65 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 171.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -83.78 145.69 28.56 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.598 -174.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 18.7 p -91.47 145.05 24.94 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.545 178.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 79.8 mt . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.688 -0.673 . . . . 0.0 110.388 178.714 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 55.1 mttm . . . . . 0 N--CA 1.452 -0.358 0 CA-C-O 120.823 0.344 . . . . 0.0 110.706 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 50.3 mtp180 -115.57 123.19 47.85 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.405 ' HE2' HG11 ' A' ' 79' ' ' VAL . 77.6 m-85 -119.52 135.07 54.93 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.979 0.419 . . . . 0.0 110.533 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.428 ' HB2' ' CD2' ' A' ' 30' ' ' TYR . 32.6 tp -89.33 127.2 35.78 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.158 179.133 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.535 ' HB3' ' HB3' ' A' ' 141' ' ' ALA . 47.8 tp -106.84 109.88 21.9 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.974 0.416 . . . . 0.0 110.547 -178.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.433 HG13 ' HA2' ' A' ' 35' ' ' GLY . 7.4 pt -101.35 128.62 53.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.771 177.02 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.3 m -89.4 -171.32 3.18 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.14 -171.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -47.97 117.16 1.77 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.165 -178.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.665 ' HB2' ' HA ' ' A' ' 38' ' ' ASP . 37.0 m -137.35 160.38 39.24 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.856 -1.065 . . . . 0.0 108.806 174.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.61 ' H ' ' HE2' ' A' ' 16' ' ' MET . 32.2 m80 -127.35 58.4 1.46 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.288 0.566 . . . . 0.0 109.579 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.426 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . 2.9 t -108.67 134.02 20.44 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.845 -177.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.426 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 72.4 Cg_endo -103.08 51.82 1.45 Allowed 'Cis proline' 0 N--CA 1.448 -1.183 0 C-N-CA 124.078 -1.218 . . . . 0.0 111.995 -4.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.466 HG22 HG21 ' A' ' 40' ' ' VAL . 10.9 t -58.14 -39.99 75.3 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-O 121.531 0.681 . . . . 0.0 109.999 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 31.9 ttt85 -177.19 -33.97 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.374 -1.285 . . . . 0.0 108.681 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.61 ' HE2' ' H ' ' A' ' 11' ' ' HIS . 32.0 ttp -74.17 122.92 23.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.013 178.125 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -130.13 13.01 5.66 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.085 0.469 . . . . 0.0 110.339 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.0 p -82.66 33.74 0.43 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.418 -177.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.8 tt -99.67 114.22 65.48 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.435 ' HG2' HD22 ' A' ' 157' ' ' LEU . 36.6 Cg_exo -60.95 130.01 31.12 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 123.278 2.652 . . . . 0.0 113.016 -176.488 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -67.33 -23.36 65.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.271 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -58.87 -34.68 71.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.358 -178.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.43 HG22 ' O ' ' A' ' 20' ' ' PRO . 6.3 tt -65.59 -38.39 82.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.538 0.685 . . . . 0.0 109.662 178.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.681 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 46.0 tp -70.34 -32.01 69.54 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.303 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -71.62 -24.39 61.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.801 178.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.0 m -85.94 7.61 23.58 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -171.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.729 HD13 ' HB3' ' A' ' 52' ' ' SER . 4.3 mt -64.91 -19.77 66.1 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.509 0.671 . . . . 0.0 109.401 178.014 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -56.58 -23.8 43.11 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 114.563 -1.199 . . . . 0.0 111.835 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -82.34 -21.53 35.96 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -178.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.428 ' CD2' ' HB2' ' A' ' 5' ' ' LEU . 30.3 m-85 -113.87 159.75 19.5 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -162.571 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -71.94 -30.0 64.87 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.637 176.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -175.69 178.59 47.2 Favored Glycine 0 N--CA 1.439 -1.149 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.334 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.425 HG21 HD13 ' A' ' 27' ' ' LEU . 93.3 t -123.58 144.72 32.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 110.305 -0.257 . . . . 0.0 110.305 -178.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.452 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 55.0 mt -113.07 116.45 52.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.071 176.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.433 ' HA2' HG13 ' A' ' 7' ' ' ILE . . . -99.03 124.59 8.28 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.699 176.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.417 HD11 HD11 ' A' ' 6' ' ' LEU . 84.7 mt -98.39 3.19 48.47 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 122.624 -0.339 . . . . 0.0 111.087 -178.374 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 128.98 79.02 0.23 Allowed Glycine 0 CA--C 1.505 -0.582 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 -176.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.665 ' HA ' ' HB2' ' A' ' 10' ' ' SER . 0.4 OUTLIER -135.9 -70.26 0.48 Allowed 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.413 -0.394 . . . . 0.0 111.043 -169.402 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 96.9 m-85 -90.51 105.01 17.52 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 174.315 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.466 HG21 HG22 ' A' ' 14' ' ' VAL . 11.2 m -82.25 -12.36 12.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.298 -173.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.493 ' O ' HG23 ' A' ' 45' ' ' VAL . 11.4 t70 -86.65 127.52 34.94 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.339 -178.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 51.8 tp -61.13 -45.18 95.73 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.689 -174.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -62.87 -36.74 84.29 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.209 0.528 . . . . 0.0 110.252 -178.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.454 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 16.5 m -68.64 -33.26 73.69 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.617 176.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 41' ' ' ASP . 85.0 t -59.97 -41.88 87.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-O 121.109 0.481 . . . . 0.0 110.179 173.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -67.46 -34.8 70.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.185 0.517 . . . . 0.0 110.123 177.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.67 -33.75 75.69 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.062 174.09 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' A' ' 44' ' ' THR . 98.3 mt -64.63 -36.43 84.23 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 175.561 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.709 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 37.3 mt-10 -77.49 -4.8 47.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.738 176.198 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -86.69 -41.07 14.48 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 173.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.503 ' CB ' HD12 ' A' ' 27' ' ' LEU . 74.5 m-85 -76.79 -51.44 11.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.178 178.397 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.729 ' HB3' HD13 ' A' ' 27' ' ' LEU . 78.6 p -90.62 -25.12 20.3 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 121.071 -0.252 . . . . 0.0 111.616 -178.319 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.709 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 68.0 mttm 71.6 -50.35 0.69 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.413 0.685 . . . . 0.0 111.712 -177.052 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -105.02 101.89 11.42 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.511 0.672 . . . . 0.0 109.728 175.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.608 ' HB3' ' HG2' ' A' ' 49' ' ' GLU . 89.7 t80 -114.82 124.61 52.19 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.806 -176.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.452 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 93.5 m-85 -112.76 165.8 11.95 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 174.387 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 163.45 174.21 33.05 Favored Glycine 0 N--CA 1.442 -0.959 0 C-N-CA 119.211 -1.471 . . . . 0.0 113.604 176.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.449 HG21 ' HB3' ' A' ' 86' ' ' MET . 2.8 m -146.68 118.75 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 114.791 -0.705 . . . . 0.0 109.167 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -94.53 176.39 6.31 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.167 -175.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -109.44 -171.4 20.57 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.332 -0.937 . . . . 0.0 112.216 -176.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -88.68 40.77 0.98 Allowed 'General case' 0 C--N 1.321 -0.654 0 O-C-N 122.424 -0.456 . . . . 0.0 110.065 178.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 57.5 mtm -132.66 4.8 3.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.524 -179.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -107.87 -169.09 1.46 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.375 -175.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.416 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 95.9 m-85 -81.0 135.85 51.09 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.231 176.476 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 64' ' ' TYR . 50.2 Cg_exo -55.18 -36.53 93.41 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 123.336 2.691 . . . . 0.0 113.386 -177.347 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -69.14 -24.53 64.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.85 0.357 . . . . 0.0 111.306 -177.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.402 HG13 HD21 ' A' ' 71' ' ' LEU . 41.0 t -65.16 -21.69 29.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-O 121.29 0.566 . . . . 0.0 110.388 177.234 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.485 ' HB3' ' NZ ' ' A' ' 68' ' ' LYS . 4.6 ttpm? -62.41 -25.29 67.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.838 -178.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -68.04 -53.85 22.69 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.49 -174.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 22.2 t60 -74.3 -38.09 63.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.659 0.266 . . . . 0.0 110.824 -178.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.402 HD21 HG13 ' A' ' 67' ' ' VAL . 1.0 OUTLIER -133.76 121.87 16.28 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-O 120.865 0.364 . . . . 0.0 110.285 177.056 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -81.24 -160.71 0.13 Allowed 'Trans proline' 0 CA--C 1.529 0.266 0 C-N-CA 123.003 2.469 . . . . 0.0 112.821 -176.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -96.6 -24.9 15.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.331 0.586 . . . . 0.0 109.719 177.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 86' ' ' MET . 15.7 m -142.38 125.39 16.24 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.333 -178.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 22.2 ttmm -150.05 136.62 19.11 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.023 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 13.5 t -105.07 118.67 52.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 177.15 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.541 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 91.5 mt -87.77 136.14 33.08 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.048 177.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 33.9 tp -111.43 97.45 6.76 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 173.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.405 HG11 ' HE2' ' A' ' 4' ' ' PHE . 29.2 t -123.28 111.13 28.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.445 -174.197 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 57.11 33.57 23.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.541 178.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.9 -19.24 55.34 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.713 177.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.622 HG21 HD22 ' A' ' 145' ' ' LEU . 56.9 t -82.0 132.05 32.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.869 0.366 . . . . 0.0 111.179 -176.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.6 p -95.13 116.06 28.23 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.832 176.02 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.541 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 26.5 mt -111.91 92.83 2.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.988 0.423 . . . . 0.0 110.019 -178.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -81.53 99.81 2.0 Allowed Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.449 ' HB3' HG21 ' A' ' 58' ' ' VAL . 29.7 mtm -97.75 121.57 39.83 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -177.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 47.0 t -146.14 109.76 4.81 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 15.3 t60 -91.79 65.36 4.98 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.224 0.535 . . . . 0.0 110.887 -174.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -103.12 160.84 16.61 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.733 177.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 89.0 m95 -116.1 104.84 11.96 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.993 0.425 . . . . 0.0 110.784 -179.062 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -155.57 -173.12 23.87 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 178.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.47 142.17 42.92 Favored Pre-proline 0 C--N 1.321 -0.654 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.61 -20.85 59.76 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 123.041 2.494 . . . . 0.0 112.968 -176.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -69.45 -52.1 29.92 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.243 0.544 . . . . 0.0 109.986 -178.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -77.02 -30.79 55.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.079 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.422 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 36.2 tp -50.35 -55.24 16.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.83 -175.361 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.456 ' HG3' ' N ' ' A' ' 98' ' ' ASP . 19.2 pttp -58.28 -41.76 85.08 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.876 0.369 . . . . 0.0 111.098 -177.029 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.456 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 29.5 t70 -69.26 -43.89 73.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.881 -175.032 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.512 ' O ' HG23 ' A' ' 103' ' ' VAL . 82.1 mtp180 -70.53 -41.87 71.97 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.141 -177.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.503 HD13 HD13 ' A' ' 111' ' ' ILE . 85.1 mt -61.49 -39.3 90.44 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.568 0.223 . . . . 0.0 111.505 -177.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 97' ' ' LYS . 87.7 mt -67.04 -22.91 65.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.85 0.357 . . . . 0.0 111.063 179.185 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -91.45 -28.21 17.78 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.962 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 99' ' ' ARG . 89.7 t -67.6 -44.1 86.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.08 0.467 . . . . 0.0 109.837 175.183 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -85.09 168.95 14.4 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.544 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -97.34 -20.26 17.96 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.103 -177.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -135.59 165.98 24.28 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.45 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 13.8 ptmt -74.47 120.21 80.36 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-O 121.021 0.439 . . . . 0.0 110.17 176.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.452 ' HG2' HD11 ' A' ' 111' ' ' ILE . 3.7 Cg_exo -80.69 131.95 8.52 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 122.738 2.292 . . . . 0.0 111.163 176.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -66.3 -39.39 89.29 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 176.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.518 HG21 HG21 ' A' ' 150' ' ' VAL . 94.8 t -124.19 138.61 53.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.393 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.503 HD13 HD13 ' A' ' 100' ' ' LEU . 25.1 mt -129.32 126.41 63.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.907 0.384 . . . . 0.0 110.398 174.217 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.59 HD23 ' HB2' ' A' ' 130' ' ' LEU . 90.3 mt -101.71 119.75 39.27 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.257 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.442 ' CE1' ' HB3' ' A' ' 129' ' ' PHE . 20.0 p90 -133.11 173.45 11.42 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.868 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -122.22 114.67 2.55 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.601 -0.809 . . . . 0.0 111.957 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -166.7 35.95 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.93 ' HA ' HD21 ' A' ' 131' ' ' ASN . 53.3 m -53.21 109.87 0.48 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.55 -1.204 . . . . 0.0 113.819 -169.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 28.4 m80 -111.08 -45.53 3.43 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 162.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -147.67 142.32 16.59 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 114.593 -1.185 . . . . 0.0 109.024 172.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.494 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 16.5 Cg_endo -59.45 113.08 1.46 Allowed 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 122.173 1.916 . . . . 0.0 110.941 173.336 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -146.21 140.04 26.28 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.89 0.376 . . . . 0.0 111.319 -169.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -107.33 122.7 47.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.894 176.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 59.6 p -130.79 130.6 43.89 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -173.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.1 p -99.1 122.63 51.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 172.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.0 ttpm? -151.34 123.05 8.0 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.367 -174.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 66.22 20.68 11.1 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.588 -177.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 80.92 7.79 88.19 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.912 -177.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.482 HG11 HD12 ' A' ' 111' ' ' ILE . 61.2 t -109.46 136.22 46.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 177.054 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -95.47 104.15 16.05 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.196 0.522 . . . . 0.0 110.037 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.442 ' HB3' ' CE1' ' A' ' 113' ' ' PHE . 98.1 m-85 -89.94 124.2 34.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.187 -178.049 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.59 ' HB2' HD23 ' A' ' 112' ' ' LEU . 81.8 mt -109.99 125.38 52.83 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-O 121.333 0.587 . . . . 0.0 111.159 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.93 HD21 ' HA ' ' A' ' 116' ' ' THR . 7.6 t30 -127.9 105.36 20.52 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.579 174.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -86.93 179.18 3.36 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 123.008 2.472 . . . . 0.0 113.112 -177.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -85.46 165.39 38.9 Favored Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.758 178.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.42 ' O ' ' HB3' ' A' ' 137' ' ' GLU . 15.6 m -87.33 156.96 19.39 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.948 0.374 . . . . 0.0 111.534 -175.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -61.95 -44.49 96.66 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.818 0.342 . . . . 0.0 110.959 177.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -68.61 -17.42 64.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.239 0.542 . . . . 0.0 110.738 178.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.42 ' HB3' ' O ' ' A' ' 134' ' ' SER . 77.5 tt0 -79.32 -34.27 42.43 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.03 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.481 ' HA2' HD12 ' A' ' 157' ' ' LEU . . . 107.32 31.79 3.66 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.95 176.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 31.2 p -148.05 154.76 40.67 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.805 0.336 . . . . 0.0 110.81 177.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.422 ' O ' HD12 ' A' ' 154' ' ' LEU . 30.6 p90 -149.75 162.96 39.23 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.77 175.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.535 ' HB3' ' HB3' ' A' ' 6' ' ' LEU . . . -114.43 138.27 50.79 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.18 0.514 . . . . 0.0 111.802 -169.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.763 ' HB ' ' HB2' ' A' ' 153' ' ' GLU . 97.5 t -117.72 124.12 72.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.071 173.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.877 HD21 HG13 ' A' ' 150' ' ' VAL . 1.6 tt -107.34 115.96 31.1 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -178.375 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -107.28 116.81 32.6 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.081 0.467 . . . . 0.0 109.763 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.622 HD22 HG21 ' A' ' 82' ' ' VAL . 74.5 mt -96.79 109.56 22.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.969 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -126.08 120.98 31.61 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.746 -175.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.82 10.93 59.57 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.87 178.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 92.03 5.66 65.8 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.759 -177.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -102.99 145.61 29.61 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.084 0.468 . . . . 0.0 110.496 178.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.877 HG13 HD21 ' A' ' 143' ' ' LEU . 62.1 t -94.85 119.01 42.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.074 -175.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 64.7 mtt180 -124.42 143.05 50.84 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.091 0.472 . . . . 0.0 110.418 178.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' PHE . . . . . 0.428 ' HE2' ' HB2' ' A' ' 154' ' ' LEU . 58.7 t80 -118.3 116.75 27.4 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.291 -168.12 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.763 ' HB2' ' HB ' ' A' ' 142' ' ' VAL . 45.5 mt-10 -102.77 111.2 23.42 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 174.357 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.428 ' HB2' ' HE2' ' A' ' 152' ' ' PHE . 32.5 tp -97.28 115.59 27.92 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.113 179.096 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -105.95 153.13 22.42 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.051 0.453 . . . . 0.0 110.878 -178.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 36.7 p -108.73 152.39 24.91 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.187 -177.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.481 HD12 ' HA2' ' A' ' 138' ' ' GLY . 97.0 mt . . . . . 0 C--O 1.247 0.949 0 CA-C-O 118.475 -0.774 . . . . 0.0 109.835 175.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 86.6 mttt . . . . . 0 CA--C 1.52 -0.183 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 74.0 mtm-85 -110.27 116.18 31.01 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.811 -175.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -110.76 131.32 55.15 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.854 0.359 . . . . 0.0 110.792 178.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.498 ' HB2' ' CD2' ' A' ' 30' ' ' TYR . 38.6 tp -89.23 119.82 30.06 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.451 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.606 HD23 ' HB3' ' A' ' 141' ' ' ALA . 64.6 tp -106.05 115.65 30.58 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.017 0.437 . . . . 0.0 110.494 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.543 HG22 HD13 ' A' ' 23' ' ' ILE . 11.6 pt -101.09 125.8 54.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 177.327 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.0 m -65.43 177.51 1.13 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.2 -172.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -49.02 104.72 0.07 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.748 176.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.85 ' HB2' ' HA ' ' A' ' 38' ' ' ASP . 19.5 m -99.06 166.87 11.05 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.274 -177.109 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 69.9 m-70 -144.7 35.6 1.16 Allowed 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -176.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.657 HG21 HD12 ' A' ' 19' ' ' LEU . 14.6 t -102.68 138.53 19.65 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.493 -174.179 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.8 -56.84 0.14 OUTLIER 'Cis proline' 0 C--N 1.345 0.352 0 C-N-CA 123.382 -1.508 . . . . 0.0 112.242 -3.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.559 HG12 ' HG3' ' A' ' 15' ' ' ARG . 31.5 t 49.68 -94.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 O-C-N 123.815 0.697 . . . . 0.0 111.427 -178.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.559 ' HG3' HG12 ' A' ' 14' ' ' VAL . 54.9 mtp85 -138.44 13.53 2.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.259 0.552 . . . . 0.0 109.763 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 30.2 ttp -142.58 100.57 3.71 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.358 -177.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -101.72 14.33 32.29 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.254 0.55 . . . . 0.0 109.879 177.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.6 m -77.44 54.74 1.18 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.129 -179.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.866 ' HG ' HD13 ' A' ' 135' ' ' LEU . 2.0 tt -107.86 105.57 56.54 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 177.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.815 ' HG2' HD13 ' A' ' 157' ' ' LEU . 77.3 Cg_exo -52.08 123.47 12.6 Favored 'Trans proline' 0 C--O 1.236 0.398 0 C-N-CA 122.913 2.408 . . . . 0.0 112.375 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -68.62 -9.56 50.6 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.612 -178.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -52.88 -38.01 61.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.202 174.093 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.543 HD13 HG22 ' A' ' 7' ' ' ILE . 0.4 OUTLIER -82.45 -24.74 8.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.597 -179.006 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.472 ' O ' HD23 ' A' ' 27' ' ' LEU . 49.9 tp -81.96 -16.64 49.75 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.924 -177.096 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -86.3 -22.48 26.75 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.132 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.421 ' HB2' ' CE2' ' A' ' 30' ' ' TYR . 1.3 p -84.01 9.36 12.58 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -176.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.648 HD13 HG21 ' A' ' 33' ' ' VAL . 4.5 mm? -61.52 -19.96 62.68 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.234 0.54 . . . . 0.0 110.318 173.256 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 47.5 mttm -98.85 -0.34 42.63 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.857 -176.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -102.43 -49.32 3.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.803 0.335 . . . . 0.0 111.23 -173.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.498 ' CD2' ' HB2' ' A' ' 5' ' ' LEU . 93.4 m-85 -81.44 169.37 17.26 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.839 -173.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -88.24 -17.27 31.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.381 -177.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -168.67 162.27 36.03 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.648 HG21 HD13 ' A' ' 27' ' ' LEU . 61.2 t -132.01 147.47 32.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 -178.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.404 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 42.0 mt -123.73 124.78 70.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 175.15 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -106.48 114.69 4.49 Favored Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 111.564 -0.614 . . . . 0.0 111.564 177.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.605 ' HB3' ' HE1' ' A' ' 88' ' ' HIS . 99.3 mt -84.46 27.04 0.73 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.019 0.438 . . . . 0.0 110.733 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 110.46 60.54 0.49 Allowed Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 -173.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.85 ' HA ' ' HB2' ' A' ' 10' ' ' SER . 0.7 OUTLIER -76.53 -83.2 0.07 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.263 -0.469 . . . . 0.0 112.227 -173.829 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.478 ' HD1' HD11 ' A' ' 48' ' ' LEU . 75.5 m-85 -100.5 128.78 46.46 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.232 0.539 . . . . 0.0 110.995 -177.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.447 HG12 ' HB3' ' A' ' 63' ' ' ASP . 17.4 m -79.08 7.33 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.606 177.398 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.525 ' O ' HG23 ' A' ' 45' ' ' VAL . 13.6 t70 -110.17 130.01 55.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.964 -179.034 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.51 HD22 ' HB3' ' A' ' 66' ' ' ASP . 57.2 tp -65.63 -42.72 91.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.568 -175.098 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -59.51 -39.46 83.92 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.971 0.415 . . . . 0.0 111.274 -177.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 11.7 m -75.21 -27.02 59.39 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.213 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 41' ' ' ASP . 89.1 t -59.8 -43.3 91.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 121.391 0.615 . . . . 0.0 109.804 173.247 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -70.02 -34.55 60.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.91 178.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -60.94 -40.94 95.2 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.444 174.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.478 HD11 ' HD1' ' A' ' 39' ' ' TYR . 83.2 mt -69.11 -38.68 79.05 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.066 0.46 . . . . 0.0 110.174 179.289 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -62.13 -39.43 92.54 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.471 177.168 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -69.19 -36.1 76.96 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.752 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -71.61 -64.62 0.89 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.809 178.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.634 ' HB3' HD12 ' A' ' 27' ' ' LEU . 59.9 p -64.11 -40.85 97.1 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.217 -176.535 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 92.5 mttt 66.06 6.6 4.21 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.416 0.627 . . . . 0.0 110.425 -174.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -171.46 95.41 0.18 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.151 -0.932 . . . . 0.0 109.271 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.466 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 2.4 p90 -145.69 144.97 30.7 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.008 0.433 . . . . 0.0 109.927 178.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.404 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 56.1 m-85 -114.8 136.4 53.12 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 177.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.699 ' HA3' HD22 ' A' ' 71' ' ' LEU . . . -133.08 156.78 22.35 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 119.827 -1.178 . . . . 0.0 112.812 -177.315 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.402 HG13 ' HE3' ' A' ' 86' ' ' MET . 0.2 OUTLIER -136.84 164.25 30.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.132 0.491 . . . . 0.0 110.836 175.698 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.503 ' HB3' ' HA ' ' A' ' 73' ' ' PHE . 74.3 t60 -94.6 104.52 16.46 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.696 -175.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -115.72 -5.58 18.11 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.495 -0.775 . . . . 0.0 113.031 -176.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -115.16 -166.76 1.15 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.102 0.477 . . . . 0.0 110.234 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 97.0 mmm -98.98 34.86 2.0 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 169.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.447 ' HB3' HG12 ' A' ' 40' ' ' VAL . 1.8 p-10 -60.08 157.7 12.5 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.666 -177.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -62.21 155.62 64.46 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.924 -171.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.62 ' HA ' ' HB3' ' A' ' 68' ' ' LYS . 72.5 Cg_exo -50.47 -31.01 29.3 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 123.406 2.737 . . . . 0.0 112.948 178.135 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.51 ' HB3' HD22 ' A' ' 42' ' ' LEU . 32.2 m-20 -56.61 -48.4 77.54 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.342 0.591 . . . . 0.0 110.434 176.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 40.5 t -75.85 -38.94 37.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.819 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.62 ' HB3' ' HA ' ' A' ' 65' ' ' PRO . 48.5 tttp -57.59 -34.0 68.77 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.364 176.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -68.92 -33.94 74.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.069 0.461 . . . . 0.0 110.652 178.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -84.53 -50.89 7.32 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.167 -178.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.699 HD22 ' HA3' ' A' ' 57' ' ' GLY . 22.6 mt -100.38 113.8 65.54 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.899 -177.39 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.677 ' HG2' ' HB2' ' A' ' 75' ' ' LYS . 46.0 Cg_endo -69.42 153.98 69.72 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 122.491 2.127 . . . . 0.0 112.308 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.503 ' HA ' ' HB3' ' A' ' 59' ' ' HIS . 82.6 t80 -61.96 -32.77 73.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.343 0.592 . . . . 0.0 109.952 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.3 t -146.36 137.51 24.42 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.3 176.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.677 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 39.5 tttp -148.92 128.44 13.12 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.507 -176.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.472 ' HA ' ' HA2' ' A' ' 85' ' ' GLY . 46.5 t -99.75 117.03 44.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.095 0.474 . . . . 0.0 109.837 174.529 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.505 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 86.7 mt -87.71 138.48 31.43 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.408 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 42.9 tp -109.73 99.57 8.71 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 176.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 44.0 t -108.92 91.34 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.364 -177.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 57.33 30.31 18.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.662 175.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 114.54 -23.53 12.08 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.99 178.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.8 t -84.01 126.81 40.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.597 0.237 . . . . 0.0 110.556 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.2 p -95.72 117.96 31.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.944 0.402 . . . . 0.0 111.304 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.505 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 18.1 mt -111.62 93.14 2.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.946 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.472 ' HA2' ' HA ' ' A' ' 76' ' ' VAL . . . -84.02 106.35 2.86 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 111.731 -0.548 . . . . 0.0 111.731 -179.091 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.453 ' HE1' HD11 ' A' ' 77' ' ' LEU . 53.5 mtm -98.93 125.86 44.47 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -178.474 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 35.3 t -149.97 133.73 16.82 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.605 ' HE1' ' HB3' ' A' ' 36' ' ' LEU . 17.6 m80 -113.31 93.3 4.34 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.099 0.476 . . . . 0.0 111.444 178.29 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -136.21 154.81 22.14 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 175.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 10.6 p-90 -135.51 152.06 50.96 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 168.5 -137.23 4.46 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 -179.052 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.482 ' HB1' ' NE1' ' A' ' 94' ' ' TRP . . . -75.54 119.33 76.55 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-O 120.875 0.369 . . . . 0.0 110.578 178.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 92' ' ' ALA . 10.7 Cg_exo -72.48 -23.71 19.88 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.929 2.419 . . . . 0.0 112.933 -177.337 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.508 ' CE3' ' HB3' ' A' ' 95' ' ' ASP . 57.8 p-90 -70.72 -21.63 62.53 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -176.275 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.508 ' HB3' ' CE3' ' A' ' 94' ' ' TRP . 3.3 p-10 -126.44 20.51 7.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.001 0.429 . . . . 0.0 110.338 176.249 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 59.3 tp -57.08 -39.77 75.64 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.515 178.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.414 ' HD2' ' HB3' ' A' ' 124' ' ' LYS . 48.8 mtpt -54.4 -51.8 63.73 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.21 174.079 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -62.04 -39.46 92.42 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.767 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' A' ' 95' ' ' ASP . 52.5 mtt180 -63.43 -48.65 76.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.09 179.289 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 76.9 mt -67.65 -34.25 76.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.879 0.371 . . . . 0.0 111.094 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 96.9 mt -80.79 -4.84 56.04 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.858 0.361 . . . . 0.0 110.841 178.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 37.8 mttp -89.57 -22.07 22.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.485 170.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 64.6 t -68.74 -47.68 75.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.97 0.414 . . . . 0.0 110.189 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -108.91 169.87 8.4 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.715 177.282 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -95.35 -47.33 6.34 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -90.69 137.72 32.13 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.725 175.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.453 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 24.2 pttm -70.21 125.37 91.97 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-O 120.986 0.422 . . . . 0.0 110.629 -178.399 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 107' ' ' LYS . 9.0 Cg_exo -72.4 134.47 22.71 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.617 2.212 . . . . 0.0 110.368 174.42 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -60.5 -41.84 95.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.964 0.411 . . . . 0.0 110.437 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.8 t -122.46 140.96 44.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.767 177.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.442 HD12 ' CE2' ' A' ' 129' ' ' PHE . 42.0 mt -129.71 137.12 57.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 176.204 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.598 HD23 ' HB2' ' A' ' 130' ' ' LEU . 86.7 mt -114.11 130.57 56.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.326 -177.224 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.523 ' O ' ' HD2' ' A' ' 132' ' ' PRO . 51.4 p90 -155.65 -178.34 7.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.851 172.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -105.78 127.87 9.14 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.552 -0.832 . . . . 0.0 111.784 -177.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.509 ' HB2' ' HB2' ' A' ' 131' ' ' ASN . 1.1 t60 -83.69 -14.65 51.25 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.797 0.332 . . . . 0.0 110.536 -175.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 5.9 m 63.69 12.66 6.77 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.995 0.902 . . . . 0.0 110.18 -176.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.613 ' HB3' ' OE1' ' A' ' 118' ' ' GLU . 34.8 m80 -148.18 -160.76 1.21 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.997 -176.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.613 ' OE1' ' HB3' ' A' ' 117' ' ' HIS . 0.8 OUTLIER -69.32 144.28 94.58 Favored Pre-proline 0 C--N 1.326 -0.434 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.432 -179.917 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.416 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 77.9 Cg_exo -51.68 134.66 47.64 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.161 2.574 . . . . 0.0 112.586 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.46 ' HG2' HG23 ' A' ' 122' ' ' THR . 36.9 tt0 -142.55 127.29 18.12 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.837 -174.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.735 ' HB2' ' HZ ' ' A' ' 152' ' ' PHE . 19.5 t70 -86.92 107.36 18.33 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 177.569 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.562 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 27.7 p -116.16 118.73 33.63 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.815 -174.31 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.9 p -106.26 106.98 21.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.428 0.632 . . . . 0.0 110.321 176.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.584 ' HB2' ' HE1' ' A' ' 129' ' ' PHE . 62.4 mttm -127.24 129.24 47.4 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.023 -176.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 62.54 22.23 13.16 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 123.347 0.405 . . . . 0.0 111.415 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 87.42 -5.38 85.15 Favored Glycine 0 CA--C 1.518 0.244 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.071 -178.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.405 HG13 ' O ' ' A' ' 108' ' ' PRO . 90.4 t -94.92 135.45 28.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -97.22 107.32 19.81 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.159 0.504 . . . . 0.0 109.912 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.584 ' HE1' ' HB2' ' A' ' 124' ' ' LYS . 75.4 m-85 -92.48 119.06 31.61 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.717 -179.215 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.598 ' HB2' HD23 ' A' ' 112' ' ' LEU . 50.5 mt -103.31 117.37 34.35 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 177.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.509 ' HB2' ' HB2' ' A' ' 115' ' ' HIS . 2.5 p30 -130.03 110.11 16.87 Favored Pre-proline 0 C--N 1.317 -0.843 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.998 -177.081 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.523 ' HD2' ' O ' ' A' ' 113' ' ' PHE . 89.9 Cg_endo -82.46 -172.16 1.35 Allowed 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.783 2.322 . . . . 0.0 111.853 174.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -99.19 -97.65 2.13 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.558 -0.83 . . . . 0.0 112.904 -177.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 41.8 t -161.87 163.5 29.22 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 -176.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.866 HD13 ' HG ' ' A' ' 19' ' ' LEU . 57.3 mt -65.0 -49.75 69.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.115 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -65.1 -26.69 68.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.168 -178.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -88.87 4.3 48.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.875 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.555 ' HA2' HD12 ' A' ' 157' ' ' LEU . . . 58.67 43.67 96.15 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 116.083 -0.508 . . . . 0.0 113.354 175.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 3.9 p -137.24 110.39 7.8 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.039 0.447 . . . . 0.0 111.675 -178.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -132.19 -172.09 2.8 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 175.391 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.606 ' HB3' HD23 ' A' ' 6' ' ' LEU . . . -143.72 153.09 42.08 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.2 0.524 . . . . 0.0 111.46 -177.301 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 70.9 t -126.23 117.26 48.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 172.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.657 HD21 HG13 ' A' ' 150' ' ' VAL . 2.3 tt -94.62 106.52 18.51 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.254 0.55 . . . . 0.0 109.87 -175.235 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -97.97 119.06 35.92 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.702 177.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.2 mp -95.61 106.45 18.55 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 177.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -109.25 110.31 21.47 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.796 177.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 68.05 11.12 60.53 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.108 -176.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 94.55 5.18 61.81 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.758 -0.537 . . . . 0.0 111.758 -177.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -89.2 133.37 34.45 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 178.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.657 HG13 HD21 ' A' ' 143' ' ' LEU . 62.4 t -76.9 103.64 4.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.17 -177.336 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 78.4 mtt-85 -115.88 89.59 3.14 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.973 178.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' PHE . . . . . 0.735 ' HZ ' ' HB2' ' A' ' 121' ' ' ASP . 3.5 p90 -95.04 123.28 38.44 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.125 0.488 . . . . 0.0 110.682 -178.068 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -91.45 123.56 34.97 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.069 177.074 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -83.98 81.69 8.67 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 176.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -80.72 131.84 35.49 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.907 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 26.5 p -109.14 150.72 27.45 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.794 -175.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.815 HD13 ' HG2' ' A' ' 20' ' ' PRO . 90.5 mt . . . . . 0 C--N 1.315 -0.905 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 177.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.4 tttm . . . . . 0 N--CA 1.452 -0.349 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.677 ' HB3' ' HD1' ' A' ' 30' ' ' TYR . 56.6 mtt-85 -108.29 117.8 35.1 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.618 0.247 . . . . 0.0 111.33 -175.125 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.557 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 67.8 m-85 -112.43 113.94 26.39 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.203 0.525 . . . . 0.0 111.006 177.045 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.53 ' HB3' HG22 ' A' ' 33' ' ' VAL . 32.1 tp -89.24 121.04 31.14 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.021 178.06 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.748 HD11 ' HG ' ' A' ' 36' ' ' LEU . 41.4 tp -107.39 121.09 43.9 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.259 0.552 . . . . 0.0 111.211 -178.33 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.7 pt -101.18 119.38 49.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 171.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.508 ' O ' ' HB2' ' A' ' 36' ' ' LEU . 5.7 p -67.17 -87.71 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -164.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.485 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 36.2 t70 -142.32 94.06 2.61 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.287 0.565 . . . . 0.0 110.226 -176.285 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.46 ' OG ' HD12 ' A' ' 19' ' ' LEU . 23.0 t -107.86 158.47 17.3 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.802 -179.192 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.502 ' H ' ' HE1' ' A' ' 16' ' ' MET . 11.0 m80 -135.09 77.33 1.67 Allowed 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -178.295 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . 9.1 t -129.8 132.26 24.06 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.109 -177.381 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.47 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 41.2 Cg_endo -95.4 91.58 0.14 OUTLIER 'Cis proline' 0 N--CA 1.449 -1.092 0 C-N-CA 123.403 -1.499 . . . . 0.0 112.554 -2.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.726 HG12 ' H ' ' A' ' 15' ' ' ARG . 2.5 t -114.85 -165.07 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 175.12 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.726 ' H ' HG12 ' A' ' 14' ' ' VAL . 85.1 mtt180 -72.43 75.92 1.04 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 118.611 0.642 . . . . 0.0 110.758 177.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.502 ' HE1' ' H ' ' A' ' 11' ' ' HIS . 28.0 ttp -165.65 -77.12 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.467 178.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 59.2 12.05 2.36 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.554 -178.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.0 m -79.81 35.78 0.31 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.184 -177.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.46 HD12 ' OG ' ' A' ' 10' ' ' SER . 4.1 tt -107.75 111.02 62.7 Favored Pre-proline 0 C--N 1.327 -0.406 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.043 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.548 ' HG3' HD13 ' A' ' 157' ' ' LEU . 60.7 Cg_endo -74.06 133.43 18.09 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.623 2.215 . . . . 0.0 112.014 178.615 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -77.11 -5.81 50.43 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.925 0.393 . . . . 0.0 110.263 -177.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -55.93 -40.81 73.68 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.543 174.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.0 tt -70.38 -33.39 53.79 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-O 121.748 0.785 . . . . 0.0 109.98 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.526 ' O ' HD23 ' A' ' 27' ' ' LEU . 49.0 tp -66.64 -17.89 65.08 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.842 -178.348 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -80.47 -24.87 39.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.894 0.378 . . . . 0.0 110.966 177.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.3 m -80.28 2.81 23.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.48 -176.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.653 HD12 ' HB3' ' A' ' 52' ' ' SER . 4.4 mm? -59.98 -22.37 62.45 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.59 178.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -79.4 -14.26 59.06 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.323 -177.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -91.62 -23.61 19.81 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.968 0.413 . . . . 0.0 110.848 -178.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.677 ' HD1' ' HB3' ' A' ' 3' ' ' ARG . 38.3 m-85 -111.49 126.08 54.59 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.949 0.405 . . . . 0.0 110.678 -174.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -78.98 -29.97 44.14 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.868 -176.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.557 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -123.34 138.33 11.52 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 177.274 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.541 HG21 ' CD1' ' A' ' 27' ' ' LEU . 93.5 t -130.37 135.09 61.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 120.845 0.355 . . . . 0.0 110.574 -178.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.566 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 48.1 mt -112.32 131.59 63.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.435 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -118.41 98.28 0.74 Allowed Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.109 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.748 ' HG ' HD11 ' A' ' 6' ' ' LEU . 85.0 mt -77.65 -33.8 53.36 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 175.09 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.485 ' HA3' ' HA ' ' A' ' 9' ' ' ASP . . . -150.47 83.01 0.18 Allowed Glycine 0 N--CA 1.44 -1.087 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.494 177.271 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -94.75 -145.3 0.26 Allowed 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.447 ' HD1' HD11 ' A' ' 48' ' ' LEU . 78.2 m-85 -73.49 148.87 42.74 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 178.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.7 m -98.06 5.56 9.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.132 0.491 . . . . 0.0 110.748 -177.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.546 ' O ' HG23 ' A' ' 45' ' ' VAL . 17.3 t70 -102.9 132.34 49.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.874 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.539 HD22 ' HB3' ' A' ' 66' ' ' ASP . 65.6 tp -57.84 -54.23 49.22 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.171 -175.49 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -59.22 -35.71 74.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.156 0.503 . . . . 0.0 111.105 -176.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.429 HG21 ' CD2' ' A' ' 39' ' ' TYR . 17.6 m -72.01 -28.22 63.25 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.312 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.546 HG23 ' O ' ' A' ' 41' ' ' ASP . 94.8 t -65.01 -37.4 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 121.205 0.526 . . . . 0.0 109.913 174.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.521 ' O ' ' HG2' ' A' ' 50' ' ' LYS . 1.7 mp -65.5 -37.15 79.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.56 175.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.447 ' O ' ' HB2' ' A' ' 50' ' ' LYS . 3.2 tm? -61.82 -34.04 75.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.767 174.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.447 HD11 ' HD1' ' A' ' 39' ' ' TYR . 96.4 mt -67.97 -40.44 83.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.324 177.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.562 ' HA ' ' O ' ' A' ' 52' ' ' SER . 44.6 mt-10 -78.68 -2.39 38.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.348 177.297 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.521 ' HG2' ' O ' ' A' ' 46' ' ' ILE . 32.2 mmtp -75.43 -53.67 8.3 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 170.456 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -70.95 -66.22 0.64 Allowed 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.101 177.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.653 ' HB3' HD12 ' A' ' 27' ' ' LEU . 15.7 p -95.36 92.99 6.98 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.214 175.275 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.526 ' HG2' ' O ' ' A' ' 49' ' ' GLU . 63.3 mttp -70.41 -15.67 62.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.142 0.496 . . . . 0.0 110.431 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -101.4 68.15 1.19 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.409 171.003 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -100.37 108.73 20.82 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.173 -178.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.566 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 12.2 m-85 -102.75 108.01 19.09 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.609 ' HA3' HD22 ' A' ' 71' ' ' LEU . . . -125.55 165.03 18.9 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 119.869 -1.158 . . . . 0.0 112.716 -176.638 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.1 m -141.66 127.63 18.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.557 -0.321 . . . . 0.0 110.341 177.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -129.73 166.97 18.77 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.137 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.605 ' HA2' ' HD1' ' A' ' 73' ' ' PHE . . . -104.3 -169.27 24.86 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.308 -0.948 . . . . 0.0 112.906 -173.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -84.07 5.5 25.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.058 0.456 . . . . 0.0 110.48 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 87.1 mtp -103.55 -5.71 22.45 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.889 178.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -94.38 168.28 10.99 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.058 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -65.33 126.0 90.57 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.155 176.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.56 ' HA ' ' HB3' ' A' ' 68' ' ' LYS . 53.1 Cg_exo -57.04 -25.68 64.54 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.216 2.61 . . . . 0.0 112.507 -179.063 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.539 ' HB3' HD22 ' A' ' 42' ' ' LEU . 2.6 m-20 -58.38 -41.97 85.99 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.916 175.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 84.0 t -78.09 -37.96 23.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.862 177.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.56 ' HB3' ' HA ' ' A' ' 65' ' ' PRO . 63.6 tttm -63.19 -22.06 66.62 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.353 -178.316 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -60.4 -44.02 96.11 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.189 0.519 . . . . 0.0 110.077 173.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 64.6 m-70 -82.04 -39.1 23.98 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.929 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.609 HD22 ' HA3' ' A' ' 57' ' ' GLY . 7.3 mt -115.98 101.16 54.01 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.68 -173.511 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.526 ' HG2' ' HB2' ' A' ' 75' ' ' LYS . 69.4 Cg_endo -74.87 174.98 11.8 Favored 'Trans proline' 0 CA--C 1.528 0.2 0 C-N-CA 122.701 2.267 . . . . 0.0 112.283 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.605 ' HD1' ' HA2' ' A' ' 60' ' ' GLY . 76.7 t80 -81.2 -21.81 39.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.262 0.553 . . . . 0.0 110.502 -178.358 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 39.6 m -144.48 119.14 9.78 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.043 178.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.526 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 40.2 tttp -139.59 135.92 33.85 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.321 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 77.8 t -108.75 132.99 55.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.931 0.396 . . . . 0.0 110.145 174.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.508 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 84.9 mt -106.81 132.82 52.34 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.9 176.202 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 42.2 tp -109.26 100.47 9.59 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.652 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.5 t -116.42 102.94 14.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.585 -175.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 54.57 31.37 14.85 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.705 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.72 -22.27 37.76 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.454 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.541 ' HA ' ' OE1' ' A' ' 109' ' ' GLN . 99.1 t -71.31 122.68 23.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.772 0.32 . . . . 0.0 110.347 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.29 102.94 14.82 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.5 -178.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.508 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 20.4 mt -93.85 110.19 23.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.4 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -93.36 109.47 3.81 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.764 -0.731 . . . . 0.0 111.395 177.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 30.0 mtm -107.11 119.77 40.28 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.716 0.293 . . . . 0.0 110.772 -177.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 49.6 t -145.35 104.43 3.93 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 175.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 49.8 t60 -84.87 66.1 9.51 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.184 0.516 . . . . 0.0 110.368 -177.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -113.78 -145.1 9.03 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.756 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 28.2 t-105 -139.15 164.76 28.94 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -178.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 165.83 161.33 14.62 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.511 -0.852 . . . . 0.0 113.087 177.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.502 ' HB1' ' HD2' ' A' ' 93' ' ' PRO . . . -88.46 162.45 39.54 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 175.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.502 ' HD2' ' HB1' ' A' ' 92' ' ' ALA . 0.9 OUTLIER -43.97 -49.44 8.37 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.366 2.71 . . . . 0.0 113.656 -178.14 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 18.3 p-90 -81.85 -44.18 17.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.877 0.37 . . . . 0.0 111.363 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -59.44 -37.01 77.01 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.543 -177.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 19.9 tp -60.85 -49.18 78.5 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.277 178.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -58.44 -42.62 87.77 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.748 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -64.55 -53.58 45.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.552 -177.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 21.9 ttp-105 -68.79 -40.04 79.84 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -174.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.568 HD13 HG21 ' A' ' 111' ' ' ILE . 65.7 mt -71.71 -32.56 67.91 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.541 -0.464 . . . . 0.0 111.446 -176.161 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.588 HD21 HG21 ' A' ' 127' ' ' VAL . 86.8 mt -80.62 -12.49 59.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.177 0.513 . . . . 0.0 110.268 175.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -79.78 -40.46 28.64 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.523 173.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 80.3 t -73.75 -52.3 21.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.535 177.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -91.41 103.68 16.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.07 0.462 . . . . 0.0 110.874 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -76.9 -22.92 52.67 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.668 -177.395 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -66.94 -28.51 68.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.019 176.065 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.484 ' HG3' HD22 ' A' ' 101' ' ' LEU . 39.5 ttpt 63.76 92.84 0.06 OUTLIER Pre-proline 0 CA--C 1.529 0.162 0 O-C-N 123.985 0.803 . . . . 0.0 109.896 -170.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.445 ' O ' HG22 ' A' ' 127' ' ' VAL . 13.6 Cg_exo -69.37 166.75 26.03 Favored 'Trans proline' 0 N--CA 1.464 -0.228 0 C-N-CA 123.023 2.482 . . . . 0.0 112.859 -174.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.541 ' OE1' ' HA ' ' A' ' 82' ' ' VAL . 75.1 mt-30 -85.32 -49.94 7.75 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.273 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 58.7 t -122.67 132.02 72.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.911 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.568 HG21 HD13 ' A' ' 100' ' ' LEU . 35.3 mt -126.71 132.13 70.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.071 0.462 . . . . 0.0 110.911 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.456 ' HB3' HD11 ' A' ' 36' ' ' LEU . 78.2 mt -105.68 121.18 43.48 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.067 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -132.06 -178.77 5.04 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.747 -178.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -125.69 131.97 7.77 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 121.057 -0.592 . . . . 0.0 111.785 178.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 60.5 t-80 -139.57 -68.02 0.43 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 177.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.0 p -143.85 -80.69 0.19 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.851 178.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.435 ' O ' ' HD3' ' A' ' 119' ' ' PRO . 16.5 p-80 -172.24 41.79 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.121 -178.638 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -103.12 102.02 25.58 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.286 -173.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.698 ' HB3' HD22 ' A' ' 154' ' ' LEU . 59.9 Cg_endo -77.44 41.94 1.06 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.782 2.321 . . . . 0.0 111.469 177.341 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -97.48 132.46 43.16 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.127 -176.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -78.52 107.07 10.9 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.267 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.601 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 67.8 p -105.35 114.49 28.7 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.141 0.496 . . . . 0.0 110.069 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.2 p -136.51 145.05 31.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.691 -175.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -159.28 -55.98 0.06 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.112 175.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.401 ' O ' ' HD2' ' A' ' 107' ' ' LYS . . . -85.1 23.88 1.18 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.939 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 86.92 -16.93 44.21 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 121.083 -0.58 . . . . 0.0 111.707 -176.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.588 HG21 HD21 ' A' ' 101' ' ' LEU . 15.3 t -87.54 134.05 28.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.636 -0.282 . . . . 0.0 110.618 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 76.9 mtp180 -98.92 104.52 16.56 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.051 175.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.601 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 69.4 m-85 -87.72 124.78 33.93 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.398 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.423 HD13 ' CD2' ' A' ' 152' ' ' PHE . 67.8 mt -124.8 134.91 52.59 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.937 0.399 . . . . 0.0 111.454 -174.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -118.08 106.05 46.0 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.569 177.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.448 ' HB2' ' HB3' ' A' ' 8' ' ' SER . 61.3 Cg_endo -75.86 146.27 29.52 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 122.239 1.959 . . . . 0.0 112.683 179.316 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -73.35 141.76 30.41 Favored Glycine 0 C--N 1.331 0.279 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.809 177.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.462 ' HA ' ' OG ' ' A' ' 8' ' ' SER . 31.1 t -70.14 159.6 33.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.598 0.713 . . . . 0.0 112.632 -174.038 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.435 ' HG ' ' HG ' ' A' ' 19' ' ' LEU . 3.6 mm? -61.16 -26.65 67.84 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.149 174.377 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.9 -25.68 67.99 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.344 -178.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -105.02 6.56 33.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.106 0.479 . . . . 0.0 110.351 178.455 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.435 ' HA2' HD12 ' A' ' 157' ' ' LEU . . . 73.72 44.67 31.06 Favored Glycine 0 N--CA 1.451 -0.352 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.904 177.161 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 24.6 m -132.0 144.15 50.58 Favored 'General case' 0 C--N 1.321 -0.631 0 O-C-N 122.664 -0.315 . . . . 0.0 110.744 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 44.1 p90 -145.02 160.04 41.99 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 173.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.521 ' HB3' HD23 ' A' ' 6' ' ' LEU . . . -115.72 142.81 46.25 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.722 -175.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.8 ' HB ' ' HE3' ' A' ' 155' ' ' LYS . 51.1 t -126.98 124.8 65.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 175.451 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.537 HD21 HG13 ' A' ' 150' ' ' VAL . 5.3 tt -109.69 108.0 18.22 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.351 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.507 ' HG3' HG12 ' A' ' 142' ' ' VAL . 40.3 mt-10 -110.51 127.09 55.01 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.033 -178.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.7 mp -90.79 105.77 18.05 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.894 0.378 . . . . 0.0 110.385 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -105.6 109.2 21.08 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.744 178.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 68.2 10.69 60.06 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.539 -177.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 98.84 -3.2 58.71 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.369 -177.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -85.1 147.26 26.73 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.723 0.297 . . . . 0.0 110.296 177.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.537 HG13 HD21 ' A' ' 143' ' ' LEU . 60.2 t -88.87 102.97 13.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.965 -175.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 47.6 mtp180 -98.66 94.0 6.41 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 176.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' PHE . . . . . 0.423 ' CD2' HD13 ' A' ' 130' ' ' LEU . 73.9 t80 -99.83 99.89 10.75 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.971 -179.301 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.424 ' HB2' ' HE2' ' A' ' 155' ' ' LYS . 49.1 mt-10 -110.88 119.56 39.49 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.203 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.698 HD22 ' HB3' ' A' ' 119' ' ' PRO . 23.2 tp -78.38 109.17 12.3 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 171.26 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.8 ' HE3' ' HB ' ' A' ' 142' ' ' VAL . 73.7 mttt -105.76 138.83 41.3 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.334 -175.091 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.7 p -97.55 155.29 17.03 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.224 0.535 . . . . 0.0 112.294 -171.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.548 HD13 ' HG3' ' A' ' 20' ' ' PRO . 61.5 mt . . . . . 0 C--O 1.247 0.959 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.134 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.568 ' HB2' HD12 ' A' ' 145' ' ' LEU . 6.1 mtpm? . . . . . 0 C--O 1.233 0.209 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.69 ' HB3' ' CD2' ' A' ' 30' ' ' TYR . 92.9 mtt180 -118.7 129.76 55.46 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.747 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.676 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 85.2 m-85 -125.08 119.78 29.61 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.173 0.511 . . . . 0.0 110.557 176.106 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.562 ' HB3' HG22 ' A' ' 33' ' ' VAL . 23.7 tp -89.19 124.35 34.27 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 178.193 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.527 HD23 ' HB3' ' A' ' 141' ' ' ALA . 33.5 tp -104.22 98.82 8.57 Favored 'General case' 0 C--O 1.241 0.605 0 CA-C-O 121.584 0.707 . . . . 0.0 111.251 -175.501 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.473 ' HB ' HD11 ' A' ' 135' ' ' LEU . 13.6 pt -101.17 110.69 28.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 173.217 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.474 ' HA ' ' HB2' ' A' ' 36' ' ' LEU . 16.2 m -94.36 -97.33 0.16 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -165.617 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -98.18 120.7 39.05 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.742 0.306 . . . . 0.0 110.365 -171.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.5 ' HB2' HD12 ' A' ' 135' ' ' LEU . 28.8 t -157.45 164.71 37.16 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.946 0.403 . . . . 0.0 111.085 -174.456 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -138.03 74.72 1.49 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.462 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -126.14 138.42 32.16 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-O 120.841 0.353 . . . . 0.0 110.745 174.297 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.431 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 38.2 Cg_endo -96.22 75.08 0.14 OUTLIER 'Cis proline' 0 N--CA 1.451 -1.022 0 C-N-CA 123.445 -1.481 . . . . 0.0 113.027 -2.31 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -103.89 -153.57 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 174.022 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -77.28 82.28 3.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.357 0.598 . . . . 0.0 110.299 178.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 39.2 ttp -161.99 -76.98 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.814 177.365 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 60.0 10.27 2.13 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.501 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.416 ' O ' ' HD3' ' A' ' 20' ' ' PRO . 3.8 m -80.6 15.25 1.75 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.451 -176.839 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.406 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 0.7 OUTLIER -102.5 102.59 26.64 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -179.902 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.416 ' HD3' ' O ' ' A' ' 18' ' ' SER . 3.9 Cg_exo -74.32 156.76 46.03 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.879 2.386 . . . . 0.0 112.466 -176.512 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -63.35 -14.56 51.38 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.75 178.073 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -61.09 -21.85 64.07 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.943 -177.315 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -99.62 -28.76 3.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.218 0.532 . . . . 0.0 110.309 176.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.46 ' O ' HD23 ' A' ' 27' ' ' LEU . 48.8 tp -73.03 -28.38 62.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.038 -173.308 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 -82.06 -11.45 58.78 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.929 0.395 . . . . 0.0 110.425 178.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.477 ' O ' ' HD1' ' A' ' 30' ' ' TYR . 38.8 m -77.78 -5.3 50.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.729 175.002 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.734 HD13 HG21 ' A' ' 33' ' ' VAL . 3.5 mm? -58.37 -27.09 63.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.45 0.643 . . . . 0.0 109.855 170.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -90.43 9.97 27.02 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.495 -178.448 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -119.23 -16.06 9.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.899 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.69 ' CD2' ' HB3' ' A' ' 3' ' ' ARG . 89.5 m-85 -119.95 135.62 54.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.965 -178.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -81.81 -23.11 36.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.04 0.448 . . . . 0.0 110.707 -179.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.676 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -130.72 144.94 16.38 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.678 175.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.734 HG21 HD13 ' A' ' 27' ' ' LEU . 95.4 t -139.41 141.18 35.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.143 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.56 HG12 ' HB2' ' A' ' 56' ' ' TYR . 48.6 mt -120.55 124.31 72.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.741 -178.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.416 ' HA2' HG13 ' A' ' 7' ' ' ILE . . . -109.19 104.28 1.9 Allowed Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 111.614 -0.594 . . . . 0.0 111.614 177.176 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.474 ' HB2' ' HA ' ' A' ' 8' ' ' SER . 87.5 mt -84.98 4.22 34.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.915 0.388 . . . . 0.0 111.191 -176.353 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 153.52 48.64 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.979 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -127.61 155.79 43.31 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 -178.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.507 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 53.3 m-85 49.91 87.81 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.89 0.852 . . . . 0.0 111.753 -173.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.2 m -80.45 3.18 2.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.496 -174.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.489 ' O ' HG23 ' A' ' 45' ' ' VAL . 21.7 t70 -94.36 121.61 36.06 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.251 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.513 HD22 ' HB3' ' A' ' 66' ' ' ASP . 59.8 tp -58.69 -45.4 89.56 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.598 -174.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -54.7 -46.38 74.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.164 0.506 . . . . 0.0 110.601 178.048 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.585 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 27.1 m -65.46 -31.12 72.04 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.376 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 41' ' ' ASP . 84.7 t -59.77 -44.38 93.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 121.013 0.435 . . . . 0.0 110.57 177.118 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -67.02 -40.0 84.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-O 121.198 0.523 . . . . 0.0 109.898 177.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -61.32 -35.0 76.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.697 176.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 44' ' ' THR . 83.1 mt -66.39 -35.92 81.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.687 179.136 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -78.0 -13.87 59.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.1 0.476 . . . . 0.0 110.575 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -81.23 -16.38 52.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.124 0.487 . . . . 0.0 110.394 173.238 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.56 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . 27.8 m-85 -100.52 -58.76 1.83 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.01 174.384 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 41.7 t -77.02 101.44 6.03 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.711 174.216 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -55.85 -40.09 72.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.824 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -113.71 89.85 3.19 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.037 0.446 . . . . 0.0 109.965 172.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -100.25 121.75 41.96 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.147 0.499 . . . . 0.0 110.77 -177.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.56 ' HB2' HG12 ' A' ' 34' ' ' ILE . 92.6 m-85 -118.88 178.44 4.48 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.426 -0.807 . . . . 0.0 109.307 176.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.441 ' C ' HD12 ' A' ' 71' ' ' LEU . . . 159.65 -179.68 35.06 Favored Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 120.141 -1.028 . . . . 0.0 112.685 176.613 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 15.8 t -140.51 148.37 22.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 -94.66 104.49 16.42 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.027 0.442 . . . . 0.0 110.316 -175.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -116.05 -5.16 17.85 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.155 177.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.493 ' HB3' ' OD1' ' A' ' 63' ' ' ASP . 6.7 m120 -83.4 133.68 34.92 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 74.1 mtm -96.73 10.23 39.34 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.235 0.54 . . . . 0.0 109.804 176.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.493 ' OD1' ' HB3' ' A' ' 61' ' ' ASN . 4.7 m-20 -66.66 -68.32 0.38 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.069 -177.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.479 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 91.8 m-85 -124.52 131.16 24.12 Favored Pre-proline 0 C--O 1.237 0.418 0 CA-C-O 121.167 0.508 . . . . 0.0 111.383 -177.262 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 64' ' ' TYR . 1.2 Cg_endo -83.74 -3.26 10.54 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 123.725 2.95 . . . . 0.0 112.478 -179.363 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.513 ' HB3' HD22 ' A' ' 42' ' ' LEU . 8.0 m-20 -67.68 -36.25 80.34 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.448 0.642 . . . . 0.0 109.958 179.219 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.525 HG12 HD23 ' A' ' 71' ' ' LEU . 30.3 t -76.36 -13.73 14.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.554 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.445 ' HB3' ' O ' ' A' ' 65' ' ' PRO . 87.6 tttt -70.59 -15.99 62.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.492 -175.054 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -90.36 0.42 57.27 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.82 0.343 . . . . 0.0 111.435 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 44.7 m80 -123.3 -39.04 2.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.03 0.443 . . . . 0.0 110.611 177.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.525 HD23 HG12 ' A' ' 67' ' ' VAL . 3.4 mm? -103.0 124.25 39.19 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 176.584 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -84.88 -175.08 1.93 Allowed 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.86 2.374 . . . . 0.0 113.115 -175.435 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -80.4 -29.46 37.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.38 0.609 . . . . 0.0 110.066 179.109 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.523 ' HB3' ' CZ ' ' A' ' 104' ' ' PHE . 26.5 m -152.07 137.51 17.66 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.121 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 34.7 tttp -139.29 116.56 11.16 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.926 -176.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.473 HG22 ' HA2' ' A' ' 85' ' ' GLY . 46.6 t -100.25 125.54 53.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 176.036 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 44.8 mt -103.14 153.58 20.17 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.06 178.217 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 37.4 tp -115.28 93.45 4.3 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 171.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 46.5 t -106.33 104.2 16.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.354 -173.193 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 57.21 29.26 16.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.441 178.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.45 -16.18 52.79 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.613 177.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 54.0 t -89.55 123.95 42.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.887 0.375 . . . . 0.0 110.832 -178.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.445 ' HB ' ' HA ' ' A' ' 108' ' ' PRO . 0.0 OUTLIER -80.73 115.87 20.45 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.858 177.259 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 21.0 mt -111.56 99.16 8.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.779 0.324 . . . . 0.0 110.489 -178.698 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.473 ' HA2' HG22 ' A' ' 76' ' ' VAL . . . -85.12 98.82 2.27 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 178.246 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 48.8 mtm -90.71 126.46 36.0 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.19 0.519 . . . . 0.0 110.896 -176.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.489 ' SG ' ' HB3' ' A' ' 113' ' ' PHE . 28.5 p -135.73 164.91 26.8 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.72 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 9.3 t-80 -83.49 -23.68 32.07 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 119.841 -0.743 . . . . 0.0 109.936 178.006 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.461 ' HA3' ' HB2' ' A' ' 113' ' ' PHE . . . 82.02 118.07 0.5 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.094 176.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 63.2 t90 -156.24 126.84 6.74 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 176.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 133.07 -166.93 23.55 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.425 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . . . -88.08 124.94 65.79 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.024 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 92' ' ' ALA . 33.7 Cg_exo -58.75 -15.61 27.14 Favored 'Trans proline' 0 N--CA 1.475 0.39 0 C-N-CA 123.224 2.616 . . . . 0.0 113.009 -177.153 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 4.4 m0 -66.14 -43.14 87.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.79 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -123.95 13.29 9.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.981 0.419 . . . . 0.0 111.23 -177.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 54.8 tp -66.32 -35.37 80.21 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.815 177.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.511 ' HD3' ' HB3' ' A' ' 124' ' ' LYS . 52.1 mttp -59.64 -49.42 77.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.804 177.698 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -68.17 -36.35 79.49 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.063 -0.972 . . . . 0.0 111.068 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.429 ' O ' HG23 ' A' ' 103' ' ' VAL . 45.8 ttt180 -64.85 -42.39 94.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.922 178.616 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.509 HD13 HG21 ' A' ' 111' ' ' ILE . 72.9 mt -67.78 -29.19 68.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.683 0.278 . . . . 0.0 111.241 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.512 HD21 HG21 ' A' ' 127' ' ' VAL . 92.2 mt -72.71 -13.72 61.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.014 0.435 . . . . 0.0 110.496 175.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -94.05 -30.88 14.46 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.782 175.043 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 99' ' ' ARG . 83.9 t -59.59 -50.98 77.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.1 175.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.523 ' CZ ' ' HB3' ' A' ' 74' ' ' SER . 55.8 m-85 -92.34 161.44 14.67 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.389 177.324 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -94.79 -26.73 16.11 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.303 0.573 . . . . 0.0 110.237 -179.136 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.405 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 43.2 mt-10 -111.81 152.36 27.97 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.127 175.672 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.409 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 45.2 mtmt -83.34 113.87 49.32 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-O 120.797 0.332 . . . . 0.0 110.919 -178.213 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.445 ' HA ' ' HB ' ' A' ' 83' ' ' THR . 2.7 Cg_exo -76.04 124.43 7.96 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.774 2.316 . . . . 0.0 110.465 175.434 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -61.61 -37.12 82.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.988 0.423 . . . . 0.0 111.389 -176.056 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 88.7 t -123.94 132.59 71.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 175.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.509 HG21 HD13 ' A' ' 100' ' ' LEU . 37.7 mt -125.17 134.62 66.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.923 0.392 . . . . 0.0 110.651 179.437 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.555 HD23 ' HB2' ' A' ' 130' ' ' LEU . 96.2 mt -109.29 139.05 44.73 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.928 178.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.503 ' CZ ' ' HB2' ' A' ' 131' ' ' ASN . 6.5 p90 -155.53 122.96 5.54 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 175.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -122.67 114.5 2.47 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.615 -177.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -173.53 21.04 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.495 0.664 . . . . 0.0 109.365 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.497 HG22 ' H ' ' A' ' 118' ' ' GLU . 16.9 m -117.38 154.38 31.42 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.015 -175.288 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 32.5 m80 -80.85 -27.57 36.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.922 0.391 . . . . 0.0 110.356 -177.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.497 ' H ' HG22 ' A' ' 116' ' ' THR . 46.0 mt-10 -122.03 111.13 32.53 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.263 177.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -57.49 141.94 95.21 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.767 2.312 . . . . 0.0 111.897 177.113 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -154.68 142.29 19.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.973 0.416 . . . . 0.0 111.367 -173.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -98.24 124.3 42.77 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.382 172.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.562 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 69.8 p -129.11 129.7 45.52 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.06 0.457 . . . . 0.0 111.48 -176.412 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.7 p -126.86 140.66 48.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.668 175.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.511 ' HB3' ' HD3' ' A' ' 97' ' ' LYS . 71.5 tttt -155.79 -56.34 0.09 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.416 0.627 . . . . 0.0 110.308 -179.454 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -94.88 30.85 1.97 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.746 -175.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 79.54 -42.21 2.4 Favored Glycine 0 N--CA 1.451 -0.304 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 -173.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.512 HG21 HD21 ' A' ' 101' ' ' LEU . 89.3 t -60.24 136.68 23.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-N 115.213 -0.494 . . . . 0.0 110.825 176.146 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.402 ' HE ' ' HB2' ' A' ' 128' ' ' ARG . 20.3 ttm180 -97.21 112.55 24.3 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.947 178.494 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.562 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 82.7 m-85 -97.76 108.26 20.94 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.102 -178.497 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.555 ' HB2' HD23 ' A' ' 112' ' ' LEU . 81.9 mt -99.8 115.6 29.93 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.294 -178.195 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.503 ' HB2' ' CZ ' ' A' ' 113' ' ' PHE . 22.7 t-20 -108.2 112.11 61.48 Favored Pre-proline 0 C--N 1.32 -0.713 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.187 -178.116 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -92.1 174.95 2.1 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 123.435 2.757 . . . . 0.0 111.413 169.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -112.85 -172.38 18.54 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.411 -0.899 . . . . 0.0 112.739 -177.194 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 38.0 m -78.9 153.94 30.1 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.642 0.258 . . . . 0.0 110.508 178.069 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.5 HD12 ' HB2' ' A' ' 10' ' ' SER . 73.5 mt -78.38 -10.69 59.79 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -173.692 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -96.49 -60.3 1.64 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.958 0.408 . . . . 0.0 111.412 -177.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -106.02 22.09 16.23 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.216 -173.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.471 ' O ' ' HB2' ' A' ' 157' ' ' LEU . . . -146.72 -164.76 11.23 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.348 -178.608 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 15.2 p -112.66 148.84 33.82 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.722 -0.103 . . . . 0.0 110.722 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -97.2 168.83 10.19 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 -177.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.527 ' HB3' HD23 ' A' ' 6' ' ' LEU . . . -121.27 149.43 42.9 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.016 0.436 . . . . 0.0 111.171 -174.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 69.5 t -122.36 126.98 74.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 173.366 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.739 HD21 HG13 ' A' ' 150' ' ' VAL . 3.7 tt -110.19 104.55 13.4 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -109.28 143.86 38.2 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.568 HD12 ' HB2' ' A' ' 2' ' ' LYS . 91.1 mt -98.66 101.66 13.15 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.199 0.523 . . . . 0.0 110.667 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.668 ' HB3' ' HE ' ' A' ' 151' ' ' ARG . 12.2 t70 -96.35 114.55 26.24 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.879 178.16 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.83 -69.06 0.3 Allowed Glycine 0 C--N 1.331 0.287 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.596 -175.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -174.92 26.92 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 178.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -126.78 147.01 50.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.834 0.349 . . . . 0.0 110.22 -177.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.739 HG13 HD21 ' A' ' 143' ' ' LEU . 92.2 t -76.83 113.35 15.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.342 -176.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.668 ' HE ' ' HB3' ' A' ' 146' ' ' ASP . 38.8 mmt180 -97.09 108.84 21.65 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.154 176.016 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -90.66 94.5 9.72 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 177.032 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -100.67 102.69 13.87 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.01 -178.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 26.7 tp -83.72 130.51 34.95 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.173 -178.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -123.52 138.89 54.48 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.033 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 3.1 m -81.91 156.36 24.82 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.191 0.519 . . . . 0.0 111.705 -169.45 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.471 ' HB2' ' O ' ' A' ' 138' ' ' GLY . 88.6 mt . . . . . 0 C--O 1.247 0.945 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.496 176.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.615 ' HB2' ' HB2' ' A' ' 145' ' ' LEU . 92.7 mttt . . . . . 0 CA--C 1.516 -0.329 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.51 ' O ' ' HB3' ' A' ' 30' ' ' TYR . 96.1 mtt180 -133.58 113.89 12.93 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.064 0.459 . . . . 0.0 110.841 178.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.527 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 49.3 m-85 -104.3 125.85 50.9 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.166 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.484 HD22 ' HB2' ' A' ' 26' ' ' SER . 37.8 tp -89.75 120.05 30.68 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.143 176.373 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.542 ' HB3' ' HB3' ' A' ' 141' ' ' ALA . 57.6 tp -102.57 110.74 22.78 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.875 0.369 . . . . 0.0 110.266 178.023 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.572 HG22 HD13 ' A' ' 23' ' ' ILE . 18.1 pt -101.18 122.03 52.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.462 0.649 . . . . 0.0 109.601 177.636 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.3 m -77.81 -165.37 0.62 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.94 -173.226 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -55.03 122.48 11.02 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.433 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.496 ' HB2' ' O ' ' A' ' 38' ' ' ASP . 19.3 m -126.99 159.23 34.72 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.622 178.63 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.481 ' H ' ' HE1' ' A' ' 16' ' ' MET . 89.4 m-70 -140.49 43.7 1.87 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 -176.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.499 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . 46.0 t -93.1 129.76 38.32 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.147 -179.435 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.499 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 83.8 Cg_endo -103.38 27.75 10.8 Favored 'Cis proline' 0 N--CA 1.455 -0.754 0 C-N-CA 124.44 -1.067 . . . . 0.0 112.36 -3.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.8 t -47.55 -60.74 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 O-C-N 123.744 0.653 . . . . 0.0 111.996 -175.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 62.3 ttt180 -142.49 11.23 1.89 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.722 0.773 . . . . 0.0 109.619 -178.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.481 ' HE1' ' H ' ' A' ' 11' ' ' HIS . 58.0 ttp -143.08 121.52 12.39 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.216 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -117.57 -0.49 11.87 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.994 0.426 . . . . 0.0 110.805 -177.045 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.0 t -108.4 88.66 2.78 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.623 -178.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.0 tt -107.88 120.45 47.05 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 175.183 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.577 ' HG2' HD13 ' A' ' 157' ' ' LEU . 76.4 Cg_exo -41.17 116.89 0.49 Allowed 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 124.107 3.205 . . . . 0.0 114.213 -174.503 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -61.22 -30.37 70.39 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.596 176.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -54.63 -36.71 64.8 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.095 178.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.572 HD13 HG22 ' A' ' 7' ' ' ILE . 0.6 OUTLIER -85.11 -28.69 6.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.192 0.52 . . . . 0.0 110.334 -178.711 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 44.7 tp -70.6 -30.01 66.57 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.944 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -72.48 -21.33 61.23 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.373 175.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.548 ' HB3' ' CD2' ' A' ' 30' ' ' TYR . 59.4 m -71.16 -9.69 58.5 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.566 -178.403 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.521 ' HB3' ' HB3' ' A' ' 51' ' ' PHE . 2.7 mm? -63.48 -24.93 68.03 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 121.159 0.504 . . . . 0.0 109.95 172.652 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -91.15 -33.2 15.52 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.04 178.181 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -68.59 -55.52 11.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.644 -178.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.548 ' CD2' ' HB3' ' A' ' 26' ' ' SER . 27.5 m-85 -94.83 150.8 19.81 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.825 -169.156 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -98.61 7.0 46.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.859 -176.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.527 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -154.39 139.03 6.49 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 175.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.51 HG21 HD13 ' A' ' 27' ' ' LEU . 60.5 t -134.75 140.61 45.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 117.259 0.529 . . . . 0.0 110.649 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.609 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 17.3 mt -125.17 132.76 70.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.467 175.186 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.409 ' HA2' HG13 ' A' ' 7' ' ' ILE . . . -116.07 129.66 8.61 Favored Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 174.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 90.9 mt -97.11 -7.2 33.24 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.59 0.709 . . . . 0.0 110.341 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 166.52 58.31 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 -177.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.496 ' O ' ' HB2' ' A' ' 10' ' ' SER . 6.1 p-10 -72.27 -111.42 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 123.371 0.668 . . . . 0.0 112.741 -171.524 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -89.84 148.64 23.06 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.108 -0.331 . . . . 0.0 110.108 -177.106 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 19.2 m -89.91 -7.78 10.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.265 0.555 . . . . 0.0 110.147 178.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.506 ' O ' HG23 ' A' ' 45' ' ' VAL . 9.2 m-20 -86.6 120.44 27.91 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.666 177.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.559 HD22 ' HB3' ' A' ' 66' ' ' ASP . 43.7 tp -59.74 -42.3 92.87 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.037 0.446 . . . . 0.0 110.12 178.409 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -57.85 -38.92 76.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.964 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.548 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 17.5 m -74.68 -30.44 61.57 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.18 -178.353 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 41' ' ' ASP . 48.7 t -66.44 -40.2 85.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.177 0.513 . . . . 0.0 109.915 176.472 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.17 -35.79 76.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.677 174.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -64.46 -31.58 72.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.007 176.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 44' ' ' THR . 87.9 mt -67.69 -46.91 70.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.947 0.403 . . . . 0.0 110.579 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.51 ' HG2' ' HB3' ' A' ' 55' ' ' PHE . 65.4 mt-10 -70.32 -16.4 62.99 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.499 177.755 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -81.57 -23.36 37.2 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.057 0.456 . . . . 0.0 109.961 177.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.521 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . 2.0 m-85 -86.51 -67.33 0.82 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.424 178.496 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.504 ' HB3' HD12 ' A' ' 27' ' ' LEU . 70.7 p -73.0 -34.26 66.3 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.972 -177.234 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 34.5 mtmm 66.28 12.94 8.93 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.379 -175.584 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -150.71 102.17 2.99 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.496 178.025 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.51 ' HB3' ' HG2' ' A' ' 49' ' ' GLU . 74.4 t80 -138.61 121.46 16.54 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.345 0.593 . . . . 0.0 111.275 -173.702 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.609 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 92.2 m-85 -114.81 167.7 10.55 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 171.346 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 145.01 -165.65 27.67 Favored Glycine 0 N--CA 1.438 -1.204 0 C-N-CA 119.13 -1.509 . . . . 0.0 113.502 174.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.0 m -153.21 175.54 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 114.555 -0.823 . . . . 0.0 109.117 -175.153 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.506 ' CD2' ' HG ' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -125.69 104.26 8.27 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 120.426 -0.51 . . . . 0.0 109.9 171.672 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.705 ' HA2' ' HB3' ' A' ' 88' ' ' HIS . . . -86.36 -28.96 26.12 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.555 -177.045 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 19.9 p30 -85.87 -177.93 6.46 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.93 0.395 . . . . 0.0 111.001 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 64.7 mtt -94.71 127.85 40.98 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.0 0.428 . . . . 0.0 110.791 -176.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.522 ' OD2' ' HB ' ' A' ' 67' ' ' VAL . 4.6 p-10 -149.87 -171.03 3.8 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.936 -175.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -74.23 142.06 78.23 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.737 -176.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.1 -27.95 39.0 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.146 2.564 . . . . 0.0 112.83 -176.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.559 ' HB3' HD22 ' A' ' 42' ' ' LEU . 2.1 m-20 -60.05 -45.31 93.28 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.5 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.522 ' HB ' ' OD2' ' A' ' 63' ' ' ASP . 87.9 t -69.09 -36.28 72.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.104 0.478 . . . . 0.0 110.804 -177.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.653 ' HD3' ' HE1' ' A' ' 73' ' ' PHE . 61.3 mttm -70.75 -2.8 15.86 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.457 -175.237 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -81.89 -42.88 18.93 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 172.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 52.7 t60 -87.53 -30.01 20.9 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.47 -176.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.506 ' HG ' ' CD2' ' A' ' 59' ' ' HIS . 4.2 mm? -103.02 109.31 61.23 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.041 177.682 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 71' ' ' LEU . 22.0 Cg_exo -65.4 165.72 21.63 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 123.101 2.534 . . . . 0.0 112.729 -177.176 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.653 ' HE1' ' HD3' ' A' ' 68' ' ' LYS . 80.3 m-85 -91.28 -23.68 20.08 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.135 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.0 t -155.34 111.83 3.2 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.115 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.0 tttm -131.0 136.98 49.0 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -177.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 14.1 t -117.28 112.25 38.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 120.972 0.415 . . . . 0.0 110.13 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.404 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 63.1 mt -87.77 151.52 22.82 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.5 -178.712 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 49.5 tp -116.71 96.22 5.39 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 173.097 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.602 HG12 ' HG2' ' A' ' 80' ' ' GLU . 62.1 t -113.91 108.13 24.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.69 -173.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.602 ' HG2' HG12 ' A' ' 79' ' ' VAL . 13.2 mm-40 63.63 16.34 9.61 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.271 176.193 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 109.56 -17.97 30.28 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 121.109 -0.567 . . . . 0.0 111.983 -179.124 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 57.1 t -86.32 133.19 30.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.739 0.304 . . . . 0.0 110.678 -178.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.9 p -89.36 128.16 35.88 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.923 178.107 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.476 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 36.8 mt -119.72 98.62 6.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.845 0.355 . . . . 0.0 110.244 -177.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -87.39 103.19 2.86 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.974 -0.631 . . . . 0.0 111.697 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 40.7 mtm -101.19 114.77 29.04 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 9.2 t -144.73 162.19 37.34 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.833 0.349 . . . . 0.0 110.817 -173.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.705 ' HB3' ' HA2' ' A' ' 60' ' ' GLY . 41.4 p-80 -84.22 94.54 8.43 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.438 0.637 . . . . 0.0 110.43 178.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -81.0 75.98 2.21 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.461 -0.79 . . . . 0.0 113.005 -176.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -95.11 75.2 3.46 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.893 0.378 . . . . 0.0 110.411 176.163 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -163.26 175.28 39.56 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.866 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.18 151.35 97.27 Favored Pre-proline 0 C--N 1.326 -0.456 0 C-N-CA 122.171 0.188 . . . . 0.0 110.86 178.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -57.28 -18.75 31.66 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.074 2.516 . . . . 0.0 113.188 -178.398 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -91.64 -52.64 4.66 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.983 0.42 . . . . 0.0 110.05 178.324 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -72.5 -11.62 60.74 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.243 -176.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 24.7 tp -56.53 -43.67 80.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.396 177.141 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 22.2 ttpt -56.83 -49.25 75.97 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.341 177.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.458 ' O ' ' HB2' ' A' ' 102' ' ' LYS . 16.1 t70 -58.06 -51.06 71.23 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.463 -178.306 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -71.52 -53.22 14.57 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.187 -0.461 . . . . 0.0 112.006 -173.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 49.8 mt -60.63 -48.9 79.71 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 -173.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 90.6 mt -72.68 -11.47 60.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.004 0.431 . . . . 0.0 111.175 -176.405 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 98' ' ' ASP . 33.6 ttmt -85.47 -26.27 26.4 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.228 0.537 . . . . 0.0 109.633 177.013 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 84.1 t -79.36 -37.79 19.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.138 176.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -76.21 144.57 40.36 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.351 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -82.35 -44.43 16.18 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.865 -179.1 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.409 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 63.7 mm-40 -111.03 -178.61 3.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.481 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -83.53 112.85 42.8 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.781 177.145 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.494 ' O ' HG13 ' A' ' 127' ' ' VAL . 1.5 Cg_endo -83.16 119.02 2.72 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.814 2.343 . . . . 0.0 110.969 174.321 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -64.93 -40.73 95.51 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.26 0.553 . . . . 0.0 109.8 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 93.2 t -121.32 129.46 75.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.221 178.063 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 29.1 mt -118.87 131.76 70.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 175.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.464 HD23 ' HB2' ' A' ' 130' ' ' LEU . 89.0 mt -110.43 124.52 51.89 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.178 179.394 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.445 ' CE1' ' HB3' ' A' ' 129' ' ' PHE . 27.9 p90 -145.49 170.64 15.99 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.254 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -131.18 121.64 3.24 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 176.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -163.0 -36.86 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.929 0.395 . . . . 0.0 110.16 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.57 ' HB ' ' ND2' ' A' ' 131' ' ' ASN . 20.8 m -94.07 149.48 21.2 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.908 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 26.9 m80 -79.99 -47.63 14.64 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.929 0.395 . . . . 0.0 110.268 -178.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -82.96 155.77 67.51 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.648 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.408 ' HB3' ' HG ' ' A' ' 154' ' ' LEU . 15.0 Cg_exo -66.96 128.9 19.57 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.563 2.175 . . . . 0.0 111.492 176.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -145.08 138.75 26.88 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.502 -178.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -118.52 128.82 54.94 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 174.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.579 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 72.2 p -128.5 116.21 19.33 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.212 0.53 . . . . 0.0 111.219 -176.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 127' ' ' VAL . 8.6 p -111.61 117.59 55.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 176.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -126.49 -74.57 0.59 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.083 -174.517 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -85.12 32.28 0.55 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.892 0.377 . . . . 0.0 111.195 -178.387 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 83.82 -5.69 77.78 Favored Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 -174.471 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.494 HG13 ' O ' ' A' ' 108' ' ' PRO . 96.8 t -99.28 134.72 37.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.104 -0.548 . . . . 0.0 109.863 178.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -102.43 105.72 16.34 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.095 0.474 . . . . 0.0 110.43 179.192 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.579 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 51.6 m-85 -84.85 122.12 28.7 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.21 177.619 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.464 ' HB2' HD23 ' A' ' 112' ' ' LEU . 87.9 mt -109.34 124.06 50.33 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.826 0.346 . . . . 0.0 110.983 -178.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.57 ' ND2' ' HB ' ' A' ' 116' ' ' THR . 4.7 t30 -113.75 111.64 48.55 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.44 174.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -86.58 165.09 9.27 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.921 2.414 . . . . 0.0 112.052 174.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -89.61 139.89 15.35 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.548 -177.444 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 15.8 m -59.87 156.16 14.89 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.898 0.38 . . . . 0.0 111.324 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -68.05 -3.77 11.27 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 -174.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -86.78 -60.6 1.94 Allowed 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.589 -177.33 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -125.1 2.01 7.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.818 0.342 . . . . 0.0 111.657 -177.247 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -106.76 173.36 19.23 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.758 -173.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.563 ' HB3' ' HA ' ' A' ' 156' ' ' THR . 12.5 p -98.6 134.56 41.37 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.526 0.203 . . . . 0.0 110.62 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -84.48 177.18 8.21 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.387 -178.109 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.542 ' HB3' ' HB3' ' A' ' 6' ' ' LEU . . . -123.31 135.81 54.38 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.2 0.524 . . . . 0.0 111.962 -176.183 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 74.1 t -118.5 120.33 63.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 173.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.677 ' HA ' ' O ' ' A' ' 151' ' ' ARG . 10.0 mp -111.17 111.08 21.91 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.119 0.485 . . . . 0.0 111.124 -178.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -98.75 134.16 42.05 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.427 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.615 ' HB2' ' HB2' ' A' ' 2' ' ' LYS . 94.2 mt -105.02 102.9 12.38 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.915 177.252 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -135.23 130.38 35.14 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.878 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.89 11.14 60.15 Favored Glycine 0 CA--C 1.517 0.161 0 C-N-CA 121.178 -0.534 . . . . 0.0 112.443 -176.071 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 96.47 -13.82 65.06 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.791 178.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -95.34 159.5 14.98 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.047 0.451 . . . . 0.0 111.053 -178.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 10.9 t -101.23 138.0 26.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.584 -177.283 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.677 ' O ' ' HA ' ' A' ' 143' ' ' LEU . 12.5 tpt180 -109.92 99.5 8.61 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -83.84 104.5 13.98 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.638 178.191 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.456 ' O ' ' HA ' ' A' ' 141' ' ' ALA . 40.0 mt-10 -116.56 128.99 55.92 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.67 0.271 . . . . 0.0 111.03 176.412 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.408 ' HG ' ' HB3' ' A' ' 119' ' ' PRO . 3.7 mm? -102.17 106.81 17.71 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 174.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -102.17 130.53 48.83 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.789 0.328 . . . . 0.0 110.56 -175.068 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.563 ' HA ' ' HB3' ' A' ' 139' ' ' SER . 14.1 p -81.3 145.69 30.77 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -169.03 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.577 HD13 ' HG2' ' A' ' 20' ' ' PRO . 84.5 mt . . . . . 0 C--O 1.25 1.127 0 CA-C-N 115.142 -0.936 . . . . 0.0 109.68 178.259 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 95.4 mttt . . . . . 0 CA--C 1.517 -0.296 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.446 ' HG2' ' HG2' ' A' ' 144' ' ' GLU . 92.7 mtt180 -126.89 117.45 22.61 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.125 0.488 . . . . 0.0 111.206 -178.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -107.18 129.88 54.79 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.946 178.412 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.562 ' HB3' HG22 ' A' ' 33' ' ' VAL . 44.0 tp -89.27 113.31 24.54 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.648 -176.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 64.7 tp -99.16 107.6 20.0 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.196 0.522 . . . . 0.0 110.936 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.466 HG13 ' HA2' ' A' ' 35' ' ' GLY . 27.4 pt -101.32 132.38 47.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 173.537 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.7 t -81.66 -168.05 1.74 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.822 0.344 . . . . 0.0 110.238 -178.263 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -63.62 128.04 34.07 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.715 0.769 . . . . 0.0 111.632 -176.393 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.525 ' OG ' HG12 ' A' ' 12' ' ' VAL . 33.4 t -100.15 155.38 17.78 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.783 176.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.455 ' H ' ' CE ' ' A' ' 16' ' ' MET . 50.3 m-70 -132.62 23.2 4.32 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.172 -177.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.525 HG12 ' OG ' ' A' ' 10' ' ' SER . 7.8 p -114.65 144.65 32.27 Favored Pre-proline 0 C--O 1.241 0.622 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.308 -176.375 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.435 ' HA ' ' CG2' ' A' ' 12' ' ' VAL . 12.0 Cg_endo -93.59 93.81 0.14 OUTLIER 'Cis proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.847 -1.314 . . . . 0.0 112.816 -5.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.561 HG21 HG11 ' A' ' 40' ' ' VAL . 1.9 t -138.36 -71.89 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.363 0.601 . . . . 0.0 109.678 176.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 40.3 mtp180 -125.08 73.91 1.33 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.297 178.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.455 ' CE ' ' H ' ' A' ' 11' ' ' HIS . 14.4 ttm -177.13 -80.68 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.495 178.147 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 58.08 14.57 2.76 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.969 -176.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.42 ' H ' ' HG2' ' A' ' 16' ' ' MET . 15.4 m -120.0 32.9 5.83 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.532 -176.441 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.598 HD11 HD23 ' A' ' 135' ' ' LEU . 7.5 tt -89.17 120.64 69.84 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.708 -179.144 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 19' ' ' LEU . 16.7 Cg_exo -68.57 126.69 14.45 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 123.114 2.543 . . . . 0.0 112.348 -179.279 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -66.52 -12.24 56.61 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.777 -177.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.531 ' HB2' HD22 ' A' ' 157' ' ' LEU . 43.6 mt-10 -58.48 -38.26 77.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.264 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.456 HD11 HD11 ' A' ' 5' ' ' LEU . 0.4 OUTLIER -67.52 -29.27 44.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.4 0.619 . . . . 0.0 110.282 -178.59 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.53 ' O ' HD23 ' A' ' 27' ' ' LEU . 38.9 tp -78.27 -12.55 60.01 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.264 -177.179 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -84.85 -27.39 26.75 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.735 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.447 ' HB3' ' CE2' ' A' ' 30' ' ' TYR . 15.3 m -69.42 -6.37 29.74 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.934 -175.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.666 HD13 HG21 ' A' ' 33' ' ' VAL . 4.4 mm? -58.35 -26.0 62.64 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.745 0.307 . . . . 0.0 111.594 178.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.7 mttp -85.32 -8.27 58.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.286 -175.236 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -106.54 -22.46 12.77 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -168.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.509 ' CD2' ' HB2' ' A' ' 5' ' ' LEU . 29.5 m-85 -112.2 156.19 22.73 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.476 -0.489 . . . . 0.0 111.79 -172.648 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -67.03 -55.15 15.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.616 -177.376 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -136.2 158.51 23.98 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.569 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.666 HG21 HD13 ' A' ' 27' ' ' LEU . 89.2 t -123.4 136.02 61.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 120.996 0.427 . . . . 0.0 110.415 -179.216 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.466 HG21 ' SD ' ' A' ' 86' ' ' MET . 70.5 mt -115.74 128.88 72.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.919 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.466 ' HA2' HG13 ' A' ' 7' ' ' ILE . . . -121.84 117.82 3.51 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.846 178.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.1 mt -83.69 19.39 1.66 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.418 0.628 . . . . 0.0 110.26 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 153.59 84.78 0.05 OUTLIER Glycine 0 N--CA 1.44 -1.074 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 -177.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.473 ' CG ' ' H ' ' A' ' 39' ' ' TYR . 9.2 t70 -74.75 -165.33 0.35 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.821 0.344 . . . . 0.0 110.829 -173.391 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.473 ' H ' ' CG ' ' A' ' 38' ' ' ASP . 37.2 m-85 -68.82 149.32 49.1 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.089 -0.338 . . . . 0.0 110.089 -177.167 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.561 HG11 HG21 ' A' ' 14' ' ' VAL . 24.6 m -68.46 -17.17 21.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -176.512 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -93.66 125.3 38.2 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.703 0.287 . . . . 0.0 110.481 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.647 HD22 ' HB3' ' A' ' 66' ' ' ASP . 50.8 tp -63.84 -33.46 75.72 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.416 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -59.68 -34.38 72.79 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.36 178.266 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 20.9 m -78.28 -31.72 49.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.612 178.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.506 HG21 HG13 ' A' ' 67' ' ' VAL . 46.4 t -60.29 -41.38 86.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.38 0.609 . . . . 0.0 109.705 173.288 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.421 HD13 ' O ' ' A' ' 42' ' ' LEU . 1.6 mp -66.27 -34.28 69.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.07 175.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -61.89 -37.13 83.43 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 174.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -71.52 -42.27 68.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.519 178.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -70.85 -19.57 62.63 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.342 0.592 . . . . 0.0 110.605 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.4 tptm -78.27 -46.88 19.12 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.96 178.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.532 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . 32.4 m-85 -73.36 -55.25 6.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.449 176.393 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.589 ' HB2' HD12 ' A' ' 27' ' ' LEU . 22.7 t -90.7 98.87 12.03 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.71 174.466 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -56.14 -35.69 67.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.954 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -110.77 82.75 1.64 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.145 179.011 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -101.55 124.84 47.87 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.533 -178.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.423 ' HB2' HG12 ' A' ' 34' ' ' ILE . 54.4 m-85 -106.92 117.02 32.95 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.208 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.655 ' HA3' HD22 ' A' ' 71' ' ' LEU . . . -117.98 144.12 18.01 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.079 -1.058 . . . . 0.0 113.028 -175.239 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.414 HG21 ' CB ' ' A' ' 86' ' ' MET . 15.3 t -128.58 144.66 37.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 175.332 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -97.36 112.57 24.34 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.982 -175.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.697 ' HA3' ' HB3' ' A' ' 88' ' ' HIS . . . -152.53 22.9 0.84 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.407 -0.901 . . . . 0.0 112.556 178.079 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 23.9 p-10 -136.48 174.25 10.82 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 110.41 -0.218 . . . . 0.0 110.41 -178.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 66.8 mtm -92.55 119.96 32.53 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.678 ' OD2' ' HB ' ' A' ' 67' ' ' VAL . 17.7 p-10 -149.27 -173.5 4.4 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.77 -169.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -81.34 145.26 55.26 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.87 175.291 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -57.28 -20.74 40.59 Favored 'Trans proline' 0 CA--C 1.532 0.401 0 C-N-CA 122.89 2.393 . . . . 0.0 113.426 -176.004 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.647 ' HB3' HD22 ' A' ' 42' ' ' LEU . 3.0 m-20 -70.41 -27.69 64.48 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.31 -0.405 . . . . 0.0 112.037 -177.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.678 ' HB ' ' OD2' ' A' ' 63' ' ' ASP . 38.1 t -74.77 -19.15 16.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.113 0.482 . . . . 0.0 110.539 -178.182 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 63.9 tttt -53.38 -36.39 61.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.702 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -69.84 -27.97 65.29 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.518 -176.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -95.86 -30.65 13.54 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 121.111 -0.235 . . . . 0.0 111.138 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.655 HD22 ' HA3' ' A' ' 57' ' ' GLY . 13.1 mt -110.26 102.36 50.99 Favored Pre-proline 0 C--N 1.326 -0.443 0 C-N-CA 120.931 -0.308 . . . . 0.0 110.755 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.493 ' HD2' ' O ' ' A' ' 57' ' ' GLY . 46.9 Cg_endo -70.12 151.3 66.98 Favored 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.379 2.053 . . . . 0.0 110.734 172.216 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -63.42 -22.54 66.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.84 0.352 . . . . 0.0 111.635 -175.107 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 38.6 m -153.82 141.7 20.15 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 175.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 36.1 tttp -144.33 125.32 14.42 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.345 -177.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 11.4 t -111.65 112.61 41.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.865 0.364 . . . . 0.0 110.574 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.417 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 94.0 mt -87.69 144.81 26.45 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.986 -179.063 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 59.7 tp -112.14 97.37 6.6 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 170.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 41.4 t -110.9 93.45 2.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.091 -176.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 51.18 63.25 2.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.907 179.075 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.16 -9.43 47.31 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.912 -0.661 . . . . 0.0 113.206 176.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 60.8 t -99.89 115.21 40.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.887 0.375 . . . . 0.0 110.732 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.5 p -86.84 127.06 35.02 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.317 176.109 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 18.8 mt -119.36 93.25 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -176.35 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.446 ' O ' HG23 ' A' ' 111' ' ' ILE . . . -81.21 96.09 1.7 Allowed Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.474 ' HG2' HD12 ' A' ' 112' ' ' LEU . 38.3 mtm -96.06 119.13 34.01 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 120.896 0.379 . . . . 0.0 110.242 -176.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 39.2 t -153.22 107.05 3.05 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.993 -178.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.697 ' HB3' ' HA3' ' A' ' 60' ' ' GLY . 64.8 t-80 -91.26 69.27 6.04 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -179.482 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -85.01 178.73 51.03 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.63 -178.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -132.28 142.98 49.59 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 148.74 -172.68 28.86 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 121.081 -0.58 . . . . 0.0 111.808 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.442 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . . . -76.95 146.1 75.06 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 120.519 0.2 . . . . 0.0 110.741 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 92' ' ' ALA . 15.5 Cg_exo -69.2 -10.55 29.3 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.953 2.435 . . . . 0.0 112.859 -178.351 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 5.7 m0 -68.48 -44.47 74.68 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.996 0.427 . . . . 0.0 110.625 -178.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -91.49 11.66 23.29 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.807 -178.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 28.3 tp -58.66 -49.54 77.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.047 -178.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.473 ' HD2' ' HB2' ' A' ' 125' ' ' ALA . 28.5 ttpt -61.89 -50.35 72.56 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.65 179.319 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -60.72 -53.23 59.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.654 -174.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.43 ' O ' HG23 ' A' ' 103' ' ' VAL . 26.8 mtm105 -65.18 -46.36 81.1 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -176.548 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.529 HD13 HG21 ' A' ' 111' ' ' ILE . 83.5 mt -65.8 -36.76 84.41 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.474 -176.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.672 HD21 HG21 ' A' ' 127' ' ' VAL . 79.6 mt -78.77 -15.69 58.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.778 0.323 . . . . 0.0 110.91 178.377 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.467 ' HA ' ' HD2' ' A' ' 102' ' ' LYS . 33.4 tptt -86.21 -34.7 20.4 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.076 0.465 . . . . 0.0 110.039 177.102 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 99' ' ' ARG . 73.8 t -74.19 -43.95 50.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.571 174.45 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -104.54 87.32 2.68 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.88 176.262 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -71.78 -19.2 62.05 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.423 -173.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -77.4 -14.65 59.66 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.256 -179.127 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt 63.86 99.29 0.04 OUTLIER Pre-proline 0 C--O 1.232 0.182 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.096 -175.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -76.24 144.36 26.25 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.601 2.201 . . . . 0.0 110.938 175.011 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -72.49 -41.9 65.47 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.137 0.494 . . . . 0.0 109.836 178.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 90.0 t -116.32 130.14 71.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.583 177.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.529 HG21 HD13 ' A' ' 100' ' ' LEU . 30.6 mt -125.08 128.45 72.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 120.774 0.321 . . . . 0.0 110.677 178.3 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.474 HD12 ' HG2' ' A' ' 86' ' ' MET . 92.1 mt -99.98 119.22 37.91 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -138.59 -174.74 3.91 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.81 -175.236 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.581 ' HA2' ' ND2' ' A' ' 131' ' ' ASN . . . -147.75 151.77 23.96 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 175.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -136.64 179.1 6.57 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 117.195 0.498 . . . . 0.0 109.937 177.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.3 p -73.92 11.26 0.92 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -171.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 -144.75 -172.12 3.76 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 122.131 -0.356 . . . . 0.0 111.045 -178.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -60.6 155.48 49.86 Favored Pre-proline 0 C--N 1.329 -0.316 0 O-C-N 123.839 0.712 . . . . 0.0 112.695 -172.249 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -47.03 144.78 8.09 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 124.441 3.428 . . . . 0.0 113.266 178.173 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -165.7 144.03 5.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.267 -176.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -102.54 135.78 43.56 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 173.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.479 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 57.8 p -137.72 158.02 45.25 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.908 -174.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.495 ' HA ' ' O ' ' A' ' 127' ' ' VAL . 85.2 t -132.54 115.2 24.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.939 0.4 . . . . 0.0 110.425 176.556 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.632 ' HB2' ' HE2' ' A' ' 129' ' ' PHE . 75.4 mmtt -125.58 125.62 43.47 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.483 177.47 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.473 ' HB2' ' HD2' ' A' ' 97' ' ' LYS . . . 65.1 9.24 5.36 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 123.64 0.588 . . . . 0.0 111.779 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 104.11 -4.2 44.86 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.409 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.672 HG21 HD21 ' A' ' 101' ' ' LEU . 52.5 t -90.19 134.36 29.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 179.097 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 51.8 ttt180 -96.45 105.82 17.96 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.147 0.499 . . . . 0.0 110.18 -177.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.632 ' HE2' ' HB2' ' A' ' 124' ' ' LYS . 58.7 m-85 -94.63 126.52 39.98 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.88 -178.547 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.449 ' HB2' HD23 ' A' ' 112' ' ' LEU . 53.6 mt -115.26 120.91 41.26 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.754 0.311 . . . . 0.0 110.638 -178.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.581 ' ND2' ' HA2' ' A' ' 114' ' ' GLY . 3.7 t-20 -108.02 115.99 57.72 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.471 174.589 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.413 ' HD2' HD22 ' A' ' 131' ' ' ASN . 85.8 Cg_endo -83.78 164.87 13.84 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.745 2.297 . . . . 0.0 112.234 174.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -73.99 153.71 47.25 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.442 175.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 96.0 p -81.28 160.33 24.25 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.061 0.458 . . . . 0.0 110.999 -176.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.598 HD23 HD11 ' A' ' 19' ' ' LEU . 5.9 mp -74.11 -0.17 15.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.1 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -97.19 -10.57 25.6 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.586 178.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -100.83 -6.03 25.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.108 0.48 . . . . 0.0 110.816 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 74.86 38.45 41.71 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.19 -179.223 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 25.2 m -139.31 145.84 39.59 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.447 ' O ' HD12 ' A' ' 154' ' ' LEU . 23.9 p90 -139.73 160.03 40.83 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 178.202 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -114.33 125.97 54.48 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.051 0.453 . . . . 0.0 110.352 -175.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 48.0 t -102.99 121.44 54.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 177.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.417 HD21 HG13 ' A' ' 150' ' ' VAL . 6.3 tt -94.67 101.21 13.05 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.353 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.446 ' HG2' ' HG2' ' A' ' 3' ' ' ARG . 60.1 mt-10 -95.32 117.62 30.63 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.459 -178.158 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 72.0 mt -90.67 90.19 7.85 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 172.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.526 ' HB3' ' HD3' ' A' ' 151' ' ' ARG . 35.3 t70 -115.57 130.11 56.75 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.844 -174.767 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 68.13 -59.51 0.4 Allowed Glycine 0 CA--C 1.521 0.446 0 O-C-N 123.584 0.553 . . . . 0.0 112.337 -171.312 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 164.9 33.39 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 176.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -126.53 155.55 42.2 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.631 0.253 . . . . 0.0 110.675 -176.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.417 HG13 HD21 ' A' ' 143' ' ' LEU . 29.0 t -86.88 95.03 4.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.524 176.433 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.526 ' HD3' ' HB3' ' A' ' 146' ' ' ASP . 35.0 mtp-105 -105.82 92.31 4.11 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.53 -175.402 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -90.54 122.17 33.12 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.198 0.523 . . . . 0.0 109.774 178.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.461 ' HB2' ' HE3' ' A' ' 155' ' ' LYS . 57.9 mt-10 -116.04 127.38 54.85 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.132 177.436 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.447 HD12 ' O ' ' A' ' 140' ' ' TYR . 38.7 tp -90.49 112.17 23.72 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.172 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.461 ' HE3' ' HB2' ' A' ' 153' ' ' GLU . 85.8 mttt -117.09 145.49 43.73 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.78 -173.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 3.5 p -96.65 150.58 20.51 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.321 0.581 . . . . 0.0 112.37 -171.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.531 HD22 ' HB2' ' A' ' 22' ' ' GLU . 91.1 mt . . . . . 0 C--O 1.249 1.03 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.952 177.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.662 ' HB2' HD12 ' A' ' 145' ' ' LEU . 98.8 mttt . . . . . 0 N--CA 1.451 -0.418 0 CA-C-O 121.151 0.501 . . . . 0.0 110.288 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 56.0 mtp180 -111.2 116.88 31.81 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.947 -178.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.576 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 18.3 m-85 -103.93 125.51 50.38 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.452 0.644 . . . . 0.0 111.102 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.535 ' HB3' HG22 ' A' ' 33' ' ' VAL . 36.0 tp -89.12 133.22 34.47 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.078 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.491 ' HB2' HD21 ' A' ' 143' ' ' LEU . 56.0 tp -121.72 111.96 17.81 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.835 0.35 . . . . 0.0 110.789 178.557 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.446 HG13 ' HA2' ' A' ' 35' ' ' GLY . 27.9 pt -101.45 128.74 53.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 174.016 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.556 ' H ' HD21 ' A' ' 135' ' ' LEU . 12.2 t -76.06 -171.44 1.69 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.852 -174.515 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.654 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 18.0 t0 -62.14 104.46 0.48 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.757 -177.464 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.434 ' H ' ' HA3' ' A' ' 37' ' ' GLY . 26.7 t -97.18 153.79 17.78 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.625 -177.558 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 13.8 m80 -134.8 65.39 1.57 Allowed 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.436 ' O ' HG22 ' A' ' 40' ' ' VAL . 64.8 t -118.8 130.09 25.02 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.617 -176.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -76.41 -52.12 0.16 OUTLIER 'Cis proline' 0 C--N 1.343 0.254 0 C-N-CA 123.192 -1.587 . . . . 0.0 112.21 -3.136 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 37.9 t 49.14 -93.37 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 O-C-N 123.858 0.724 . . . . 0.0 110.81 -178.001 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -155.56 25.93 0.4 Allowed 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.453 0.644 . . . . 0.0 109.773 171.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 52.5 ttp -109.75 -75.74 0.62 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 176.432 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.407 ' HA ' HG22 ' A' ' 12' ' ' VAL . . . 63.45 -6.48 0.21 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.443 -0.799 . . . . 0.0 113.133 175.46 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.3 p -78.63 58.06 2.16 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.64 0.733 . . . . 0.0 111.094 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.8 tt -107.93 112.78 61.59 Favored Pre-proline 0 N--CA 1.447 -0.604 0 CA-C-N 115.116 -0.947 . . . . 0.0 108.544 176.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -53.51 120.62 8.1 Favored 'Trans proline' 0 CA--C 1.528 0.202 0 C-N-CA 123.063 2.509 . . . . 0.0 112.868 -177.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -61.01 -29.8 69.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.174 -177.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -64.78 -25.01 67.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.663 -177.387 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.509 HD11 ' CG ' ' A' ' 140' ' ' TYR . 1.2 tt -68.49 -32.52 55.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.266 0.555 . . . . 0.0 109.531 178.159 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.566 ' HA ' HD23 ' A' ' 27' ' ' LEU . 24.4 tp -77.79 -35.33 51.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.104 -177.295 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -71.47 -26.44 62.71 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.626 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 42.9 m -81.69 2.05 31.45 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.588 -177.157 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.566 HD23 ' HA ' ' A' ' 24' ' ' LEU . 2.9 mm? -54.52 -31.31 56.0 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.043 0.449 . . . . 0.0 111.203 177.306 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -74.35 -15.98 60.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.275 -175.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -96.16 5.29 51.39 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.941 0.401 . . . . 0.0 111.679 -175.463 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -119.67 169.9 9.68 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 177.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -105.19 -56.2 2.21 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.233 0.54 . . . . 0.0 109.913 -178.242 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.576 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -117.36 146.7 18.79 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 175.525 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.561 HG21 ' CD1' ' A' ' 27' ' ' LEU . 72.8 t -130.03 134.87 62.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 117.315 0.557 . . . . 0.0 111.109 -177.357 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.567 HG12 ' HB2' ' A' ' 56' ' ' TYR . 36.2 mt -114.91 125.71 72.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.373 177.719 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.446 ' HA2' HG13 ' A' ' 7' ' ' ILE . . . -109.41 103.43 1.76 Allowed Glycine 0 N--CA 1.441 -0.979 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.716 174.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.4 ' HG ' HD11 ' A' ' 6' ' ' LEU . 84.5 mt -74.1 -28.69 61.48 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.08 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.654 ' HA3' ' HA ' ' A' ' 9' ' ' ASP . . . -145.92 109.12 0.49 Allowed Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.063 173.31 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.417 ' OD2' HG22 ' A' ' 45' ' ' VAL . 15.2 p-10 -98.98 -154.39 0.46 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 120.843 0.354 . . . . 0.0 110.893 -175.639 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.412 ' HE2' HD21 ' A' ' 48' ' ' LEU . 97.3 m-85 -88.83 137.35 32.4 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 -179.193 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.436 HG22 ' O ' ' A' ' 12' ' ' VAL . 11.5 m -76.18 4.83 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.029 0.442 . . . . 0.0 111.611 -174.321 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.513 ' O ' HG23 ' A' ' 45' ' ' VAL . 17.5 t70 -105.63 123.76 48.44 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.148 177.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.491 HD22 ' HB3' ' A' ' 66' ' ' ASP . 44.8 tp -59.04 -43.49 91.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 0.0 112.278 -172.587 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -62.03 -37.72 85.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.1 0.476 . . . . 0.0 110.57 -178.249 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 20.8 m -70.82 -27.96 64.26 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.844 178.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 41' ' ' ASP . 61.8 t -62.88 -40.71 89.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-O 121.487 0.66 . . . . 0.0 109.588 173.408 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.36 -35.26 74.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.143 177.046 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.79 -31.92 72.99 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.596 175.39 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.412 HD21 ' HE2' ' A' ' 39' ' ' TYR . 95.3 mt -67.69 -41.74 83.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.098 0.475 . . . . 0.0 110.061 178.191 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -71.97 -14.89 62.03 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.108 176.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -82.47 -45.69 14.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.33 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -70.85 -65.43 0.74 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.991 0.424 . . . . 0.0 110.408 173.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.492 ' HB3' HD12 ' A' ' 27' ' ' LEU . 8.9 p -90.44 96.17 10.53 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.92 174.622 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -62.31 -33.03 73.89 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.459 -179.074 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -98.3 79.36 2.53 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.495 0.664 . . . . 0.0 109.457 171.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -100.33 127.6 46.6 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.612 -177.426 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.567 ' HB2' HG12 ' A' ' 34' ' ' ILE . 76.1 m-85 -117.28 169.94 9.08 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 175.809 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 153.96 -172.22 32.64 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 119.355 -1.402 . . . . 0.0 113.609 175.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.504 HG13 ' HE3' ' A' ' 86' ' ' MET . 0.2 OUTLIER -144.27 -169.2 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 114.856 -0.672 . . . . 0.0 109.871 -177.494 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.472 ' NE2' ' HG2' ' A' ' 68' ' ' LYS . 57.0 t-80 -94.48 130.83 40.71 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.798 0.332 . . . . 0.0 111.235 -173.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -75.15 -158.83 7.02 Favored Glycine 0 CA--C 1.522 0.471 0 CA-C-N 115.731 -0.668 . . . . 0.0 113.249 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -73.05 -73.12 0.22 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -176.377 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 50.0 ttm -131.71 129.48 40.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.821 0.344 . . . . 0.0 110.361 -177.383 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.522 ' OD2' ' HB ' ' A' ' 67' ' ' VAL . 23.0 p-10 -145.52 -162.93 1.61 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.681 -173.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.407 ' HD2' ' O ' ' A' ' 40' ' ' VAL . 76.5 m-85 -103.44 155.19 37.14 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.521 173.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -48.88 -34.47 28.53 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.281 2.654 . . . . 0.0 113.374 -176.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.491 ' HB3' HD22 ' A' ' 42' ' ' LEU . 35.7 m-20 -58.09 -39.18 77.94 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.558 -177.745 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.522 ' HB ' ' OD2' ' A' ' 63' ' ' ASP . 60.7 t -80.08 -31.15 13.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.518 -177.496 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.472 ' HG2' ' NE2' ' A' ' 59' ' ' HIS . 93.5 mttt -60.05 -28.03 67.43 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.494 0.664 . . . . 0.0 110.233 175.379 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -72.8 -47.28 47.87 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.177 177.565 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -84.16 -35.44 23.58 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.868 -0.606 . . . . 0.0 112.278 -169.677 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.49 HD23 HG13 ' A' ' 67' ' ' VAL . 4.5 mm? -100.56 117.06 63.54 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-O 120.635 0.255 . . . . 0.0 110.995 -178.797 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -68.86 146.25 65.14 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.808 2.339 . . . . 0.0 111.398 176.505 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -72.75 -29.65 63.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.856 0.36 . . . . 0.0 110.931 -176.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 18.1 m -150.02 132.77 15.94 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.404 178.228 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -150.65 144.35 25.16 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 5.9 t -110.0 133.23 55.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 175.541 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 69.8 mt -111.63 153.97 25.56 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.584 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 45.0 tp -116.69 99.23 6.99 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 174.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 63.8 t -113.58 109.19 27.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.712 -175.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.82 ' HG3' HD13 ' A' ' 145' ' ' LEU . 5.0 mm-40 57.25 30.27 18.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.137 178.063 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.72 -7.91 59.58 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.006 -0.616 . . . . 0.0 113.064 178.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.587 HG21 HG23 ' A' ' 150' ' ' VAL . 61.5 t -101.56 136.19 34.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.864 0.332 . . . . 0.0 111.256 -176.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -88.51 130.15 35.29 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.331 178.231 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 20.0 mt -118.78 99.62 8.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.892 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -84.27 106.66 2.92 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 111.084 -0.807 . . . . 0.0 111.084 177.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.504 ' HE3' HG13 ' A' ' 58' ' ' VAL . 36.5 mtm -104.12 132.05 50.77 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.997 0.427 . . . . 0.0 111.104 -175.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.484 ' O ' ' HA ' ' A' ' 113' ' ' PHE . 37.6 t -155.61 165.17 37.36 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 175.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 31.9 t-80 -76.5 -36.81 57.57 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.52 175.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.2 128.94 1.7 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.473 178.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 31.8 t-105 -156.67 141.08 16.67 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 178.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 123.46 177.53 15.14 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.601 -177.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.14 139.06 92.41 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.637 0.218 . . . . 0.0 110.499 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -56.79 -23.1 48.44 Favored 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 123.126 2.551 . . . . 0.0 113.206 -175.403 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -77.12 -54.34 6.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.224 0.535 . . . . 0.0 110.294 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -87.73 -8.1 56.5 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.717 -174.093 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 59.4 tp -59.18 -39.07 81.37 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.416 176.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -60.93 -40.63 93.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.992 178.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -69.62 -39.86 76.92 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.628 177.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.455 ' O ' HG23 ' A' ' 103' ' ' VAL . 78.4 ttt180 -67.89 -41.49 82.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.248 -177.603 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.536 HD13 HG21 ' A' ' 111' ' ' ILE . 78.1 mt -69.54 -31.64 69.97 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.618 0.247 . . . . 0.0 111.017 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.63 HD21 HG21 ' A' ' 127' ' ' VAL . 83.4 mt -74.62 -23.37 58.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.138 0.494 . . . . 0.0 110.225 174.514 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -74.6 -33.47 62.63 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.538 175.425 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 99' ' ' ARG . 98.5 t -71.9 -55.97 11.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.053 175.66 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -92.94 91.95 7.64 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.462 177.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -67.5 -25.26 65.77 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.174 -177.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -67.52 -24.18 65.53 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.942 176.415 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 32.8 mtmm 62.49 93.98 0.05 OUTLIER Pre-proline 0 N--CA 1.463 0.19 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.721 -177.371 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -76.8 156.85 35.21 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 123.161 2.574 . . . . 0.0 111.721 -177.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -66.03 -42.66 89.31 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.213 0.53 . . . . 0.0 110.16 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.409 HG11 ' CZ ' ' A' ' 152' ' ' PHE . 53.8 t -128.15 139.3 52.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.605 -178.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.536 HG21 HD13 ' A' ' 100' ' ' LEU . 61.0 mt -125.08 130.52 73.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.949 0.404 . . . . 0.0 110.268 176.29 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.432 HD23 ' HB2' ' A' ' 130' ' ' LEU . 98.0 mt -110.85 131.19 55.25 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.108 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.484 ' HA ' ' O ' ' A' ' 87' ' ' CYS . 37.8 p90 -155.18 172.24 18.47 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.169 -0.468 . . . . 0.0 109.95 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -133.15 114.61 1.41 Allowed Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.385 176.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 63.8 t-80 -171.91 -39.73 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.625 0.25 . . . . 0.0 110.698 -176.255 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.574 HG22 ' H ' ' A' ' 117' ' ' HIS . 0.2 OUTLIER -75.25 -165.52 0.41 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.987 0.423 . . . . 0.0 111.373 -174.168 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.574 ' H ' HG22 ' A' ' 116' ' ' THR . 93.1 m-70 -94.55 -54.75 3.4 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 111.946 0.351 . . . . 0.0 111.946 -171.13 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -116.24 167.84 9.69 Favored Pre-proline 0 C--N 1.323 -0.578 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.52 -172.307 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.696 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 16.2 Cg_exo -69.54 76.56 1.05 Allowed 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.641 2.227 . . . . 0.0 110.092 166.631 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.446 ' H ' ' HG2' ' A' ' 120' ' ' GLU . 6.9 pt-20 -108.89 142.03 40.1 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.719 -170.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -94.01 99.99 12.2 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.333 175.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.625 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 80.7 p -104.63 113.07 26.42 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.318 0.58 . . . . 0.0 110.677 -178.392 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 39.6 t -121.81 97.06 4.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.22 -178.431 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -137.16 33.93 2.57 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.792 177.497 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.424 ' C ' ' H ' ' A' ' 127' ' ' VAL . . . -166.74 14.88 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.221 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 80.25 -27.64 2.75 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.518 -172.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.63 HG21 HD21 ' A' ' 101' ' ' LEU . 42.3 t -85.82 138.7 18.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.28 -0.46 . . . . 0.0 110.409 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -87.48 107.64 18.66 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 174.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.625 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 92.8 m-85 -88.95 104.18 16.72 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 174.176 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.432 ' HB2' HD23 ' A' ' 112' ' ' LEU . 49.7 mt -109.19 134.66 51.45 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.181 -173.602 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.696 ' O ' ' HA ' ' A' ' 119' ' ' PRO . 5.8 t30 -117.76 104.91 48.55 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.268 178.295 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -70.59 142.72 44.97 Favored 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.805 2.336 . . . . 0.0 112.176 177.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -66.61 152.21 52.4 Favored Glycine 0 N--CA 1.452 -0.285 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.71 -178.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 39.9 m -64.28 138.49 58.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.962 0.411 . . . . 0.0 111.405 -178.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.556 HD21 ' H ' ' A' ' 8' ' ' SER . 74.6 mt -62.47 -31.1 71.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.376 -177.769 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -66.92 -16.16 64.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.633 -178.219 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 36.6 tp10 -90.88 1.0 57.34 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.287 0.565 . . . . 0.0 110.478 -178.467 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 74.94 43.2 28.02 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.248 178.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 57.5 m -152.22 142.17 22.13 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.754 0.311 . . . . 0.0 110.324 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.509 ' CG ' HD11 ' A' ' 23' ' ' ILE . 27.9 p90 -141.43 175.77 9.4 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 177.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.445 ' HB3' HD23 ' A' ' 6' ' ' LEU . . . -114.5 136.66 52.78 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.117 -175.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.477 HG12 ' HG3' ' A' ' 144' ' ' GLU . 21.5 t -118.44 105.86 18.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.879 176.672 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.742 ' HA ' ' O ' ' A' ' 151' ' ' ARG . 0.3 OUTLIER -95.75 109.4 21.71 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.438 0.637 . . . . 0.0 110.067 176.132 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.477 ' HG3' HG12 ' A' ' 142' ' ' VAL . 47.6 mt-10 -107.11 144.12 34.28 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.157 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.82 HD13 ' HG3' ' A' ' 80' ' ' GLU . 22.0 mt -90.7 90.33 7.91 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.777 -176.065 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -92.14 101.77 14.3 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.397 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.87 10.18 58.04 Favored Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.996 178.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 110.21 -18.14 28.49 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.821 -177.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -85.22 117.91 24.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.792 0.33 . . . . 0.0 110.482 177.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.587 HG23 HG21 ' A' ' 82' ' ' VAL . 5.3 t -80.31 124.39 38.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.2 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.742 ' O ' ' HA ' ' A' ' 143' ' ' LEU . 59.0 ttt85 -119.35 107.85 13.88 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 177.083 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' PHE . . . . . 0.553 ' CE2' HD13 ' A' ' 143' ' ' LEU . 9.3 m-85 -83.16 86.62 6.99 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 177.423 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -102.5 127.72 49.43 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.418 -175.357 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.632 HD22 ' HG2' ' A' ' 119' ' ' PRO . 9.2 tp -73.29 139.33 46.03 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.478 -178.152 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -118.71 132.02 56.15 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.741 176.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 21.0 p -88.57 146.36 25.18 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.162 -179.064 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 74.2 mt . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.337 -0.84 . . . . 0.0 109.633 178.517 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.909 ' HB2' ' HB2' ' A' ' 145' ' ' LEU . 72.4 mmtt . . . . . 0 N--CA 1.452 -0.361 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.518 ' HG2' ' HG2' ' A' ' 144' ' ' GLU . 41.1 mtt180 -110.28 120.59 42.94 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.014 0.435 . . . . 0.0 111.191 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.479 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 86.7 m-85 -116.57 131.25 57.0 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.683 178.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.534 ' HB3' HG22 ' A' ' 33' ' ' VAL . 36.4 tp -89.21 118.78 29.15 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.015 178.547 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.406 HD11 HD11 ' A' ' 36' ' ' LEU . 51.2 tp -106.11 102.01 11.46 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.066 0.46 . . . . 0.0 110.391 -179.326 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.3 pt -101.6 121.66 52.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.928 177.107 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.797 ' HB2' ' HA ' ' A' ' 134' ' ' SER . 16.2 m -68.5 171.17 7.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.039 -179.238 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -64.02 144.06 57.39 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.287 0.565 . . . . 0.0 110.221 -179.341 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 68.7 m -143.23 178.96 7.37 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.984 -174.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 32.4 m80 -129.22 79.17 1.9 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.154 0.502 . . . . 0.0 110.472 178.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.431 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -139.06 142.65 33.96 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.379 179.525 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.431 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 18.1 Cg_endo -93.72 97.23 0.14 OUTLIER 'Cis proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.299 -1.542 . . . . 0.0 112.056 -3.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.6 t -116.64 -88.09 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 121.19 -0.204 . . . . 0.0 110.896 -178.235 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 15' ' ' ARG . 37.9 ttm180 -134.67 -14.39 2.18 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 120.949 0.404 . . . . 0.0 111.077 178.413 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.58 ' SD ' ' HB2' ' A' ' 136' ' ' ALA . 33.8 ttp -64.9 -71.03 0.2 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.405 177.166 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 63.16 5.6 2.0 Allowed 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.701 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.438 ' H ' ' HG2' ' A' ' 16' ' ' MET . 49.3 m -85.43 15.32 4.54 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.063 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.636 ' HG ' ' HG ' ' A' ' 135' ' ' LEU . 6.2 tt -90.5 111.71 48.99 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.44 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.4 132.41 35.8 Favored 'Trans proline' 0 C--O 1.234 0.318 0 C-N-CA 122.815 2.343 . . . . 0.0 112.703 -174.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -68.66 -19.28 64.39 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.302 177.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -56.37 -44.81 80.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.107 175.193 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.1 tt -70.22 -29.17 38.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.343 -177.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.491 ' O ' HD23 ' A' ' 27' ' ' LEU . 58.8 tp -71.07 -22.87 62.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.251 179.253 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -82.32 -20.79 36.67 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.184 175.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.8 m -74.02 -9.47 58.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.53 -177.476 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 1.035 HD13 HG21 ' A' ' 33' ' ' VAL . 2.6 mm? -51.67 -38.66 55.97 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.321 0.582 . . . . 0.0 110.727 176.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -80.36 -17.45 51.9 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.729 -174.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -95.47 2.82 54.58 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -172.147 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.448 ' HD1' ' HB3' ' A' ' 3' ' ' ARG . 43.2 m-85 -124.27 -176.65 3.56 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.675 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -96.29 -37.99 10.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.034 0.445 . . . . 0.0 110.521 -178.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.479 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -151.58 158.67 27.87 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.035 HG21 HD13 ' A' ' 27' ' ' LEU . 92.3 t -126.36 136.93 59.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 120.938 0.399 . . . . 0.0 110.691 -178.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.511 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 57.4 mt -115.81 112.58 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.097 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -98.21 126.47 8.9 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 178.119 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.406 HD11 HD11 ' A' ' 6' ' ' LEU . 84.7 mt -99.67 10.85 40.62 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.884 0.342 . . . . 0.0 110.884 -177.494 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 122.59 43.31 0.39 Allowed Glycine 0 C--N 1.329 0.143 0 C-N-CA 120.995 -0.621 . . . . 0.0 111.733 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.47 -76.01 0.18 Allowed 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 123.24 0.616 . . . . 0.0 112.369 -174.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.505 ' HD2' HD11 ' A' ' 48' ' ' LEU . 92.9 m-85 -86.19 128.48 34.9 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.994 0.426 . . . . 0.0 110.774 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.1 m -91.26 1.34 8.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.375 0.607 . . . . 0.0 110.311 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.513 ' O ' HG23 ' A' ' 45' ' ' VAL . 26.8 t70 -95.73 126.05 40.73 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.815 -178.355 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.436 HD13 ' HB3' ' A' ' 66' ' ' ASP . 62.3 tp -58.41 -49.64 76.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.589 -176.1 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -58.14 -42.47 85.92 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.987 -177.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.488 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 10.4 m -67.95 -35.34 78.23 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.156 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 41' ' ' ASP . 89.2 t -61.21 -41.13 88.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 121.272 0.558 . . . . 0.0 110.247 175.622 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.51 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 1.7 mp -66.99 -38.11 80.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.026 177.015 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.5 -34.15 73.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.563 176.03 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.505 HD11 ' HD2' ' A' ' 39' ' ' TYR . 94.8 mt -67.68 -35.61 79.15 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.547 0.689 . . . . 0.0 109.432 177.33 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.66 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 13.2 tt0 -78.51 -6.24 54.89 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.869 178.453 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.51 ' HG3' ' O ' ' A' ' 46' ' ' ILE . 29.9 mtpp -95.04 -44.02 7.87 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.605 174.379 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.517 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . 3.8 m-85 -58.66 -67.9 0.31 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.984 -179.225 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 51.5 m -87.09 -26.67 23.55 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.559 179.349 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.66 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 46.4 mttp 72.47 -47.89 0.67 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.266 0.626 . . . . 0.0 111.082 -178.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -81.79 86.58 6.44 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 172.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -119.69 130.11 54.87 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.942 -175.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.511 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 90.7 m-85 -121.26 131.56 54.29 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.089 174.531 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.475 ' HA3' HD22 ' A' ' 71' ' ' LEU . . . -140.02 151.19 21.99 Favored Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 119.982 -1.104 . . . . 0.0 112.739 -177.228 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.4 HG12 ' H ' ' A' ' 59' ' ' HIS . 0.5 OUTLIER -112.62 176.47 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 174.65 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.637 ' CD2' ' HA ' ' A' ' 68' ' ' LYS . 61.6 t-80 -94.34 135.38 35.81 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.774 0.321 . . . . 0.0 110.409 -177.686 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -82.27 -130.98 1.43 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.997 178.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -101.24 -79.21 0.51 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.712 0.292 . . . . 0.0 111.01 -178.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 67.1 mtt -120.68 107.71 13.13 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.984 0.421 . . . . 0.0 110.587 -178.226 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -132.93 -167.77 1.97 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.213 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -91.23 148.37 37.62 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.863 -179.065 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.502 ' HA ' ' HB3' ' A' ' 68' ' ' LYS . 6.7 Cg_endo -49.33 -36.43 37.96 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.822 3.015 . . . . 0.0 114.296 -174.286 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.436 ' HB3' HD13 ' A' ' 42' ' ' LEU . 13.1 m-20 -70.22 -36.97 74.91 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.776 0.322 . . . . 0.0 111.251 -178.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 58.6 t -72.11 -41.69 67.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 174.243 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.637 ' HA ' ' CD2' ' A' ' 59' ' ' HIS . 79.1 tttt -53.99 -35.7 62.13 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.216 -1.356 . . . . 0.0 111.994 177.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -93.9 -24.07 17.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.645 -176.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -82.95 -36.27 25.32 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.445 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.475 HD22 ' HA3' ' A' ' 57' ' ' GLY . 72.4 mt -103.72 110.59 64.18 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.021 177.31 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 71' ' ' LEU . 22.9 Cg_endo -61.05 146.91 97.09 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.965 2.444 . . . . 0.0 112.688 -176.653 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.591 ' HA ' ' HB3' ' A' ' 59' ' ' HIS . 94.2 m-85 -59.97 -34.37 73.19 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.789 -178.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 63.3 m -152.93 146.46 25.0 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 174.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.521 ' HG2' ' N ' ' A' ' 76' ' ' VAL . 41.7 tttm -150.74 171.54 17.02 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -176.663 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.521 ' N ' ' HG2' ' A' ' 75' ' ' LYS . 38.6 t -125.35 133.77 68.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 169.456 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.757 ' HB2' ' SD ' ' A' ' 86' ' ' MET . 1.9 tp -105.54 111.55 24.29 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.32 -177.648 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 47.8 tp -93.34 103.46 15.69 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.729 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 43.3 t -114.78 109.63 29.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.644 -178.432 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 61.01 13.45 4.6 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.022 177.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 112.48 -10.07 26.19 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.422 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 60.4 t -87.63 134.54 27.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.708 0.29 . . . . 0.0 110.574 178.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.4 p -91.19 118.98 30.9 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.267 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.583 ' HB ' ' HB3' ' A' ' 77' ' ' LEU . 71.1 mt -118.44 104.14 15.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.034 0.445 . . . . 0.0 110.057 179.35 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -63.31 130.11 40.83 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.708 178.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.757 ' SD ' ' HB2' ' A' ' 77' ' ' LEU . 65.6 mtp -116.73 97.87 6.22 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 -177.61 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.566 ' O ' ' HA ' ' A' ' 113' ' ' PHE . 31.7 t -143.06 157.59 44.39 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 176.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 8.4 t-160 -92.23 -21.15 20.51 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.193 -0.603 . . . . 0.0 110.184 177.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 117.07 -179.08 17.39 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.084 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 75.6 t-105 -140.1 -69.72 0.4 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.914 0.388 . . . . 0.0 110.245 -179.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 173.52 169.91 36.42 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 53.78 82.22 0.25 Allowed Pre-proline 0 CA--C 1.529 0.167 0 C-N-CA 122.773 0.429 . . . . 0.0 111.221 -178.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -52.17 -33.67 55.34 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.269 2.646 . . . . 0.0 113.188 -174.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 35.5 p90 -67.98 -35.31 78.13 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.469 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -102.74 -16.73 15.89 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.255 0.55 . . . . 0.0 110.652 -173.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 39.5 tp -55.45 -35.25 65.27 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.222 -179.075 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.423 ' H ' ' HG3' ' A' ' 97' ' ' LYS . 42.3 mttm -59.04 -45.9 89.56 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.59 0.71 . . . . 0.0 109.624 178.434 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -69.91 -38.83 76.39 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.346 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.504 ' O ' HG23 ' A' ' 103' ' ' VAL . 29.6 mmt180 -61.15 -48.95 79.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.007 177.161 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.502 HD13 HG21 ' A' ' 111' ' ' ILE . 67.6 mt -61.66 -33.98 74.91 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.692 -177.663 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 70.3 mt -67.21 -15.24 63.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.793 0.33 . . . . 0.0 111.427 177.516 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 23.4 mtmm -104.71 -6.15 20.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.117 174.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 99' ' ' ARG . 90.0 t -85.22 -40.13 14.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.25 0.548 . . . . 0.0 109.545 175.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -85.12 171.21 12.2 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.889 178.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 30.8 t30 -91.91 -61.38 1.64 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.091 -176.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -107.6 -176.42 3.06 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.401 -177.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.432 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 96.4 mttt -81.34 111.1 21.96 Favored Pre-proline 0 C--O 1.234 0.282 0 CA-C-O 120.768 0.318 . . . . 0.0 111.101 -175.386 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 107' ' ' LYS . 3.8 Cg_endo -85.78 147.97 9.57 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.308 2.672 . . . . 0.0 111.847 179.033 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -81.18 -47.74 13.04 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.259 0.552 . . . . 0.0 110.416 177.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 44.0 t -122.02 147.33 26.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.843 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.502 HG21 HD13 ' A' ' 100' ' ' LEU . 66.3 mt -136.62 130.6 46.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.66 0.267 . . . . 0.0 110.622 175.56 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.634 HD23 ' HB2' ' A' ' 130' ' ' LEU . 95.0 mt -101.32 141.85 33.58 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.013 175.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.566 ' HA ' ' O ' ' A' ' 87' ' ' CYS . 14.3 p90 -155.85 176.65 12.36 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 172.624 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -105.56 135.87 12.86 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.807 -177.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.536 ' HB3' ' HB2' ' A' ' 131' ' ' ASN . 11.5 t-160 -151.47 128.4 11.01 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.599 0.237 . . . . 0.0 110.715 -174.382 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.0 p -74.1 84.3 1.81 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.228 0.537 . . . . 0.0 111.267 178.596 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 60.7 t60 -176.36 153.55 1.22 Allowed 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -55.97 123.81 55.34 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 174.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.575 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 91.8 Cg_exo -43.13 129.47 5.91 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 124.002 3.134 . . . . 0.0 114.172 -172.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -142.42 155.1 45.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.661 -177.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -95.96 115.44 27.43 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 176.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.517 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 40.5 p -116.41 116.82 28.39 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.121 0.486 . . . . 0.0 112.078 -175.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 43.6 t -114.32 98.25 6.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.969 178.071 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.425 ' O ' ' HB2' ' A' ' 125' ' ' ALA . 28.4 tptp -144.25 65.44 1.29 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.425 ' HB2' ' O ' ' A' ' 124' ' ' LYS . . . 167.22 -13.07 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.895 -176.206 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.4 ' H ' ' H ' ' A' ' 125' ' ' ALA . . . 101.49 -12.06 58.21 Favored Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -173.167 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 47.3 t -107.18 140.67 24.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 114.965 -0.617 . . . . 0.0 110.061 -178.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 55.7 mtt180 -80.3 108.12 13.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.662 0.268 . . . . 0.0 110.654 176.268 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.517 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 98.2 m-85 -92.89 107.79 19.49 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 176.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.634 ' HB2' HD23 ' A' ' 112' ' ' LEU . 93.0 mt -99.24 116.71 32.06 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.157 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.575 ' O ' ' HA ' ' A' ' 119' ' ' PRO . 4.3 p30 -122.91 109.79 31.82 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.652 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.564 ' HA ' ' HG3' ' A' ' 119' ' ' PRO . 83.7 Cg_endo -88.86 178.36 2.76 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.072 2.514 . . . . 0.0 111.886 175.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.591 ' HA3' ' OE1' ' A' ' 137' ' ' GLU . . . -90.22 -109.01 1.35 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.216 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.797 ' HA ' ' HB2' ' A' ' 8' ' ' SER . 40.4 t -167.8 162.97 14.06 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.337 -0.246 . . . . 0.0 110.337 -179.147 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.636 ' HG ' ' HG ' ' A' ' 19' ' ' LEU . 3.7 mm? -71.48 -15.67 62.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.093 0.473 . . . . 0.0 109.957 176.264 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.58 ' HB2' ' SD ' ' A' ' 16' ' ' MET . . . -84.52 -6.82 59.4 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.356 175.047 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.591 ' OE1' ' HA3' ' A' ' 133' ' ' GLY . 1.8 tm-20 -113.43 -34.67 5.52 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.883 -178.334 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.537 ' HA2' HD12 ' A' ' 157' ' ' LEU . . . 127.78 -44.53 1.23 Allowed Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.327 -0.939 . . . . 0.0 113.681 175.693 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.507 ' HB3' HD11 ' A' ' 154' ' ' LEU . 18.6 m -76.81 113.63 14.69 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -175.467 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.467 ' O ' HD12 ' A' ' 154' ' ' LEU . 54.7 p90 -115.71 156.76 25.36 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 172.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -114.4 138.0 51.12 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.206 0.527 . . . . 0.0 112.016 -169.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 38.3 t -114.74 116.47 52.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 173.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.628 HD21 HG13 ' A' ' 150' ' ' VAL . 3.4 tt -94.72 107.46 19.46 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -177.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.518 ' HG2' ' HG2' ' A' ' 3' ' ' ARG . 32.4 mt-10 -104.06 121.58 43.49 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.35 178.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.909 ' HB2' ' HB2' ' A' ' 2' ' ' LYS . 55.3 mt -96.81 89.97 5.09 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.708 174.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -86.8 124.29 32.88 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.674 179.101 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 68.01 -68.94 0.32 Allowed Glycine 0 CA--C 1.52 0.401 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.381 -174.302 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -179.89 30.38 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 121.087 -0.577 . . . . 0.0 111.774 179.035 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -126.93 145.63 50.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.681 0.277 . . . . 0.0 110.608 -179.013 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.628 HG13 HD21 ' A' ' 143' ' ' LEU . 58.1 t -77.08 111.96 14.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.669 -179.154 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 19.8 mtm180 -115.95 115.81 26.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.379 0.609 . . . . 0.0 110.263 177.137 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -90.92 105.53 17.89 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.948 -176.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.32 113.76 26.69 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -178.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.537 HD22 ' HB2' ' A' ' 119' ' ' PRO . 44.9 tp -94.33 127.15 40.03 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.32 -173.666 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -114.92 135.42 54.22 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 175.053 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.2 m -108.22 148.93 29.25 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.764 0.316 . . . . 0.0 110.526 -177.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.537 HD12 ' HA2' ' A' ' 138' ' ' GLY . 97.5 mt . . . . . 0 C--O 1.247 0.965 0 CA-C-O 118.284 -0.865 . . . . 0.0 110.319 179.271 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 89.8 mttt . . . . . 0 CA--C 1.52 -0.192 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.623 ' HB3' ' HD1' ' A' ' 30' ' ' TYR . 47.3 mtt85 -115.62 111.65 20.97 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.113 0.482 . . . . 0.0 110.631 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.495 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 73.7 m-85 -102.11 121.63 42.57 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.892 -178.298 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 38.0 tp -89.35 119.33 29.72 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.068 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.706 HD11 ' HG ' ' A' ' 36' ' ' LEU . 59.8 tp -106.05 112.37 25.38 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.088 0.47 . . . . 0.0 111.3 -176.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 27.8 pt -101.43 140.44 20.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.628 175.117 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.8 p -99.53 -159.5 0.74 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.43 -176.023 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -48.62 100.6 0.02 OUTLIER 'General case' 0 C--O 1.236 0.375 0 O-C-N 123.803 0.689 . . . . 0.0 112.146 -177.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.47 ' HB2' ' C ' ' A' ' 38' ' ' ASP . 6.9 m -92.51 83.05 4.88 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.963 177.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.539 ' HB2' ' SD ' ' A' ' 16' ' ' MET . 37.2 m80 -76.83 55.68 1.11 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.156 0.503 . . . . 0.0 110.228 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . 2.8 t -127.69 138.31 32.59 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -177.64 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 27.9 Cg_endo -94.84 56.38 0.87 Allowed 'Cis proline' 0 N--CA 1.453 -0.907 0 C-N-CA 123.61 -1.413 . . . . 0.0 112.724 -2.302 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.482 HG22 HG21 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -86.0 -162.53 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 176.527 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.401 ' H ' HG12 ' A' ' 14' ' ' VAL . 66.3 mtt85 -77.31 81.74 3.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.83 0.824 . . . . 0.0 110.828 -176.036 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.539 ' SD ' ' HB2' ' A' ' 11' ' ' HIS . 51.1 ttp -164.04 -70.79 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.186 -1.37 . . . . 0.0 108.15 179.301 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 61.25 2.49 0.62 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.932 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.42 ' H ' ' HG2' ' A' ' 16' ' ' MET . 8.5 m -82.57 38.17 0.55 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.58 -176.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.0 tt -107.96 103.62 50.5 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.483 ' HB2' HD13 ' A' ' 157' ' ' LEU . 23.4 Cg_exo -65.51 126.65 16.55 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.278 1.985 . . . . 0.0 110.89 174.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -64.19 -10.66 24.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.877 -174.352 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -53.88 -35.29 61.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.986 0.422 . . . . 0.0 110.836 177.166 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 tt -69.26 -27.98 36.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.453 0.644 . . . . 0.0 110.573 -177.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.413 ' HA ' HD23 ' A' ' 27' ' ' LEU . 55.5 tp -72.64 -29.49 63.5 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.605 -179.102 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -72.73 -31.02 64.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.927 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.7 p -77.79 1.89 18.8 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -176.039 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.458 ' HA ' HD13 ' A' ' 27' ' ' LEU . 2.2 mm? -58.05 -36.14 72.35 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.204 0.526 . . . . 0.0 110.714 176.058 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 32.2 mttt -75.34 -24.43 57.36 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.925 -175.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -88.36 -6.39 57.74 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.162 -165.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.623 ' HD1' ' HB3' ' A' ' 3' ' ' ARG . 98.0 m-85 -122.03 142.04 50.75 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.783 0.325 . . . . 0.0 110.571 -179.57 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -84.79 -12.75 52.99 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.978 -176.356 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.495 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -138.42 131.83 5.54 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 175.407 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 56.2 t -122.58 128.68 75.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 117.119 0.459 . . . . 0.0 110.554 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.548 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 32.1 mt -120.29 133.57 66.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.745 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.68 120.4 3.99 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.57 177.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.706 ' HG ' HD11 ' A' ' 6' ' ' LEU . 82.0 mt -89.73 7.62 35.85 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.272 0.558 . . . . 0.0 110.071 179.135 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 152.11 78.66 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.229 -178.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.47 ' C ' ' HB2' ' A' ' 10' ' ' SER . 8.4 p-10 -82.38 -146.93 0.07 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.46 0.171 . . . . 0.0 111.107 -175.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.523 ' HD2' HD11 ' A' ' 48' ' ' LEU . 77.1 m-85 -60.64 144.8 51.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.168 0.508 . . . . 0.0 111.739 -173.079 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.482 HG21 HG22 ' A' ' 14' ' ' VAL . 27.7 m -82.55 -1.86 5.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.056 -178.572 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.576 ' O ' HG23 ' A' ' 45' ' ' VAL . 16.0 t70 -103.38 122.16 44.27 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.007 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.502 ' HB2' ' HB3' ' A' ' 66' ' ' ASP . 54.7 tp -55.68 -48.82 74.44 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 123.563 0.54 . . . . 0.0 112.125 -172.575 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -63.88 -32.17 73.6 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.74 0.305 . . . . 0.0 111.291 -176.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.9 m -76.12 -27.31 57.04 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.731 178.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 41' ' ' ASP . 61.6 t -63.32 -47.54 91.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 121.463 0.649 . . . . 0.0 109.962 174.372 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.616 HG22 ' HE3' ' A' ' 50' ' ' LYS . 1.7 mp -65.59 -31.83 55.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.842 179.385 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -57.46 -40.58 78.82 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 173.408 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.523 HD11 ' HD2' ' A' ' 39' ' ' TYR . 64.3 mt -70.7 -40.72 72.7 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 120.981 0.42 . . . . 0.0 110.316 178.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -61.81 -28.78 69.71 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.785 -178.578 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.616 ' HE3' HG22 ' A' ' 46' ' ' ILE . 98.4 mttt -72.36 -47.64 47.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.969 177.172 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -65.99 -48.14 72.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.889 0.376 . . . . 0.0 111.041 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 9.1 m -60.29 -43.05 96.63 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.335 177.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 98.0 mttt 69.52 -53.69 0.6 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.678 0.791 . . . . 0.0 109.942 -171.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.4 mm-40 -107.71 84.71 2.0 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.332 173.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -100.33 114.27 27.63 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.897 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.548 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 25.1 m-85 -105.07 107.93 19.17 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 176.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.461 ' O ' ' HD2' ' A' ' 72' ' ' PRO . . . -129.78 154.26 20.38 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 119.666 -1.254 . . . . 0.0 113.57 -173.427 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.65 HG21 ' HB3' ' A' ' 86' ' ' MET . 4.8 m -141.48 157.25 21.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 123.067 0.547 . . . . 0.0 109.719 174.224 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.539 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 64.4 t60 -94.74 104.6 16.52 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.197 0.522 . . . . 0.0 110.373 -178.159 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 1.036 ' HA2' ' HB3' ' A' ' 88' ' ' HIS . . . -113.58 -29.21 2.98 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.231 175.511 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 22.4 p-10 -79.67 -169.11 1.81 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.033 -0.583 . . . . 0.0 110.784 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 67.3 mtt -117.54 90.02 3.24 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.003 175.295 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -107.89 -170.32 1.67 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.022 -177.528 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -82.44 152.73 67.71 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.52 178.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.605 ' HA ' ' HB3' ' A' ' 68' ' ' LYS . 81.4 Cg_exo -47.07 -32.19 12.91 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.492 2.795 . . . . 0.0 113.772 -178.269 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.502 ' HB3' ' HB2' ' A' ' 42' ' ' LEU . 3.5 m-20 -58.63 -52.37 65.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.327 0.584 . . . . 0.0 110.668 177.576 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 19.3 t -75.27 -32.97 27.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.709 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.605 ' HB3' ' HA ' ' A' ' 65' ' ' PRO . 87.7 tttt -60.07 -24.17 64.38 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.067 176.714 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -93.84 -30.65 14.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.609 176.061 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -65.56 -43.15 90.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.213 0.53 . . . . 0.0 109.903 175.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.539 ' HB2' ' HB2' ' A' ' 59' ' ' HIS . 78.4 mt -97.89 121.65 57.03 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.326 -179.051 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.461 ' HD2' ' O ' ' A' ' 57' ' ' GLY . 22.0 Cg_exo -65.88 164.57 26.62 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.867 2.378 . . . . 0.0 112.295 178.315 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -78.46 -31.68 48.02 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.044 0.449 . . . . 0.0 110.093 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.5 m -151.72 135.49 16.35 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.214 178.082 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 37.0 tttp -148.37 135.71 20.41 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.294 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 10.5 t -115.3 123.77 71.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.884 0.373 . . . . 0.0 110.256 178.075 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.551 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 78.2 mt -95.62 139.28 32.1 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.223 178.447 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 37.3 tp -112.31 98.6 7.41 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 174.497 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.435 HG11 ' CE1' ' A' ' 4' ' ' PHE . 41.0 t -115.1 100.3 10.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.592 -174.198 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 61.51 28.9 18.1 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.35 178.072 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.64 -15.71 58.3 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.303 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 57.3 t -83.0 121.69 36.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 120.861 0.362 . . . . 0.0 110.365 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.0 p -87.53 123.28 32.26 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.879 178.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.551 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 24.4 mt -116.02 95.63 3.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -178.511 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -84.8 109.44 3.27 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.384 179.383 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.65 ' HB3' HG21 ' A' ' 58' ' ' VAL . 46.8 mtm -106.52 123.73 48.53 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.795 0.331 . . . . 0.0 110.306 -178.24 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 48.0 t -161.06 165.21 30.08 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.602 -177.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 1.036 ' HB3' ' HA2' ' A' ' 60' ' ' GLY . 10.4 p-80 -88.72 95.81 10.42 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.323 0.582 . . . . 0.0 110.494 176.452 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.593 ' H ' ' HB2' ' A' ' 113' ' ' PHE . . . -83.29 68.22 3.59 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.793 -177.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.433 ' CD1' ' HB2' ' A' ' 88' ' ' HIS . 88.3 m95 -86.13 85.5 7.35 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.225 0.536 . . . . 0.0 110.185 177.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -176.0 -174.96 42.98 Favored Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.565 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -81.24 140.31 49.06 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.123 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -62.85 -14.62 41.99 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.841 2.361 . . . . 0.0 112.522 -176.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 4.0 m0 -73.97 -48.77 28.14 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.489 -178.051 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -96.77 -1.23 46.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.358 178.601 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 33.6 tp -59.75 -39.32 84.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.509 179.198 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -59.87 -42.59 94.07 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.257 178.064 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.44 ' O ' ' HB2' ' A' ' 102' ' ' LYS . 10.6 t70 -64.58 -49.11 72.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.299 179.239 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 47.2 ttt85 -60.47 -49.64 76.73 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.735 -176.146 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.516 HD13 HG21 ' A' ' 111' ' ' ILE . 81.6 mt -78.06 -36.11 48.77 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -174.031 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.726 HD21 HG21 ' A' ' 127' ' ' VAL . 85.2 mt -76.53 -18.75 58.54 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.025 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 98' ' ' ASP . 79.6 tttt -74.1 -29.55 61.9 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.373 0.606 . . . . 0.0 109.461 176.419 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 70.9 t -86.89 -45.98 16.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.018 176.149 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -90.99 86.9 6.4 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.847 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -68.27 -21.98 64.77 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.532 -178.366 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -72.55 -18.66 61.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.442 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 78.1 tttt 62.39 95.84 0.05 OUTLIER Pre-proline 0 N--CA 1.465 0.319 0 O-C-N 123.583 0.552 . . . . 0.0 110.636 -173.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.466 ' O ' HG13 ' A' ' 127' ' ' VAL . 5.6 Cg_exo -79.98 134.9 10.84 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.844 2.363 . . . . 0.0 111.851 178.349 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -70.8 -35.9 72.76 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.34 0.591 . . . . 0.0 109.533 177.248 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.604 HG21 HG11 ' A' ' 150' ' ' VAL . 53.5 t -122.87 128.59 75.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.028 178.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.516 HG21 HD13 ' A' ' 100' ' ' LEU . 24.4 mt -122.89 127.99 75.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 120.91 0.386 . . . . 0.0 110.826 177.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 89.3 mt -104.52 124.84 50.0 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.494 176.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.593 ' HB2' ' H ' ' A' ' 89' ' ' GLY . 5.2 p90 -146.88 160.05 42.78 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.807 0.337 . . . . 0.0 110.684 -178.222 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -105.95 125.74 8.31 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 175.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.475 ' HB2' ' CE2' ' A' ' 113' ' ' PHE . 10.4 t-160 -141.1 -54.84 0.48 Allowed 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 111.744 0.276 . . . . 0.0 111.744 -175.172 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 20.6 p -123.47 -100.03 0.41 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -173.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.48 ' O ' ' HA2' ' A' ' 133' ' ' GLY . 0.1 OUTLIER -166.66 -43.39 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.798 0.333 . . . . 0.0 111.214 -172.442 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -85.17 165.26 37.47 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.3 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.887 ' HG3' HD22 ' A' ' 154' ' ' LEU . 21.6 Cg_exo -63.23 87.38 0.13 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.281 1.987 . . . . 0.0 111.225 174.78 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.722 ' HB3' ' HB3' ' A' ' 131' ' ' ASN . 19.3 tt0 -82.34 105.59 13.53 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.541 -176.553 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -104.87 99.49 9.12 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.418 -175.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.44 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 77.2 p -121.22 118.74 30.37 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.454 -177.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.4 p -116.51 115.44 49.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.35 0.595 . . . . 0.0 110.667 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -137.3 136.08 37.69 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.912 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 65.81 17.86 10.97 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 123.604 0.565 . . . . 0.0 111.199 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 88.23 -7.0 82.85 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.951 -0.642 . . . . 0.0 111.769 -176.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.726 HG21 HD21 ' A' ' 101' ' ' LEU . 63.3 t -93.82 126.91 46.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 35.7 ttt180 -103.66 111.08 23.4 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.068 0.461 . . . . 0.0 110.844 -176.24 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.442 ' CE1' HD12 ' A' ' 111' ' ' ILE . 19.3 m-85 -92.08 127.15 37.44 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.231 178.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 88.6 mt -120.2 116.76 26.25 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.758 0.313 . . . . 0.0 111.692 -176.486 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.722 ' HB3' ' HB3' ' A' ' 120' ' ' GLU . 7.3 t30 -94.8 122.51 60.32 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 170.71 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.559 ' HG3' HD12 ' A' ' 36' ' ' LEU . 84.1 Cg_endo -81.17 167.48 17.74 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.86 2.373 . . . . 0.0 113.165 -177.632 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 117' ' ' HIS . . . -77.96 145.99 30.39 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.631 177.577 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.546 ' HB2' ' HG2' ' A' ' 137' ' ' GLU . 15.5 m -78.58 140.45 38.49 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.858 0.361 . . . . 0.0 111.534 -177.179 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 62.0 mt -56.38 -37.67 70.4 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.476 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.41 -13.79 53.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.835 -176.571 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.546 ' HG2' ' HB2' ' A' ' 134' ' ' SER . 23.1 mm-40 -97.53 1.1 48.57 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.582 -178.177 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 71.37 35.73 63.36 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.635 -177.224 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 18.1 m -139.55 132.74 29.76 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.619 0.247 . . . . 0.0 110.371 -179.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -130.94 164.72 24.7 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 176.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -114.24 143.22 45.19 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.924 0.393 . . . . 0.0 110.731 -173.717 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 63.0 t -130.82 122.96 53.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.869 178.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.416 HD21 HG13 ' A' ' 150' ' ' VAL . 5.8 tt -99.59 105.39 17.25 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 177.019 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -100.26 112.57 24.9 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.458 -178.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 59.8 mt -90.71 90.33 7.9 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.782 176.001 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -101.2 122.63 43.99 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 68.21 -68.92 0.35 Allowed Glycine 0 CA--C 1.519 0.308 0 C-N-CA 121.462 -0.399 . . . . 0.0 112.151 -173.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -176.1 25.9 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 175.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -105.83 134.87 48.26 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 -177.078 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.604 HG11 HG21 ' A' ' 110' ' ' VAL . 41.1 t -83.82 89.63 2.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.1 0.476 . . . . 0.0 109.869 177.451 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 27.8 mtp-105 -95.37 96.1 8.9 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.295 -177.389 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -92.36 104.48 16.81 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.076 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -109.46 154.29 22.84 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.864 -179.32 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.887 HD22 ' HG3' ' A' ' 119' ' ' PRO . 18.8 tp -114.72 117.16 30.02 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 172.576 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -104.86 135.12 46.82 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.257 -177.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 16.9 p -96.76 142.08 29.21 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.045 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.483 HD13 ' HB2' ' A' ' 20' ' ' PRO . 82.0 mt . . . . . 0 C--O 1.246 0.895 0 CA-C-O 118.555 -0.736 . . . . 0.0 110.405 -179.362 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 46.5 mttp . . . . . 0 N--CA 1.452 -0.374 0 CA-C-O 120.893 0.378 . . . . 0.0 110.048 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.524 ' HG2' ' HG2' ' A' ' 144' ' ' GLU . 59.6 mtt180 -115.1 117.3 30.18 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.472 178.551 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.476 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 65.6 m-85 -103.67 132.21 50.13 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.854 -179.127 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.517 HD11 HD11 ' A' ' 23' ' ' ILE . 50.1 tp -88.98 114.32 25.48 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.033 179.309 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 63.3 tp -102.73 107.16 17.95 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.862 0.363 . . . . 0.0 110.703 -178.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.408 ' HB ' HD11 ' A' ' 135' ' ' LEU . 28.7 pt -104.41 126.42 59.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-O 121.342 0.591 . . . . 0.0 109.527 173.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.558 ' HA ' HD12 ' A' ' 36' ' ' LEU . 14.4 m -77.76 -175.57 3.98 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.03 -173.124 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -69.24 119.38 13.44 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.652 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.605 ' HB2' HD12 ' A' ' 135' ' ' LEU . 70.3 m -156.72 80.62 0.94 Allowed 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.388 -0.824 . . . . 0.0 108.819 178.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.553 ' HB3' HG21 ' A' ' 14' ' ' VAL . 24.1 m80 -60.15 106.77 0.55 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.234 -1.348 . . . . 0.0 113.022 -171.182 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.621 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 2.6 p -140.4 138.07 18.49 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.98 176.089 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -89.42 104.06 0.44 Allowed 'Cis proline' 0 N--CA 1.456 -0.701 0 C-N-CA 123.551 -1.437 . . . . 0.0 112.449 -1.366 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.553 HG21 ' HB3' ' A' ' 11' ' ' HIS . 13.3 t -128.37 -77.25 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.882 178.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 59.2 mtt180 -134.36 -4.78 2.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.502 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.592 ' SD ' ' HB3' ' A' ' 10' ' ' SER . 56.8 ttp -91.94 -64.51 1.11 Allowed 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 173.084 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.605 ' HA ' HG23 ' A' ' 12' ' ' VAL . . . 69.39 -21.16 0.16 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.58 176.269 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.416 ' H ' ' C ' ' A' ' 16' ' ' MET . 22.8 t -105.27 78.55 1.39 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.047 0.451 . . . . 0.0 110.959 -176.166 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.2 tt -108.04 116.78 56.45 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 173.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.423 ' O ' HG22 ' A' ' 23' ' ' ILE . 32.5 Cg_exo -59.74 111.34 0.93 Allowed 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.564 2.176 . . . . 0.0 111.667 177.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -79.48 7.56 7.9 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -172.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -64.76 -35.38 80.9 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.337 0.589 . . . . 0.0 109.794 173.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.517 HD11 HD11 ' A' ' 5' ' ' LEU . 12.9 tt -70.33 -39.92 77.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.758 0.789 . . . . 0.0 109.807 177.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.463 ' O ' HD22 ' A' ' 27' ' ' LEU . 40.5 tp -73.04 -3.99 29.65 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.327 -1.306 . . . . 0.0 110.594 177.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -100.23 -24.81 14.46 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.289 0.566 . . . . 0.0 110.117 175.457 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 25.9 m -97.03 -6.81 34.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.829 -174.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.918 ' HA ' ' HD2' ' A' ' 30' ' ' TYR . 1.5 pt? -66.45 -13.27 60.55 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.941 0.401 . . . . 0.0 111.316 -175.604 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -65.43 -27.35 68.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.31 -178.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -94.4 -0.67 54.67 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -177.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.918 ' HD2' ' HA ' ' A' ' 27' ' ' LEU . 84.9 m-85 -91.24 138.51 31.53 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 178.205 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -64.62 -36.99 86.03 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.215 0.531 . . . . 0.0 110.257 -178.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -146.3 154.22 25.82 Favored Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 177.685 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.476 HG22 ' HB3' ' A' ' 5' ' ' LEU . 88.4 t -132.2 134.82 59.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.909 0.355 . . . . 0.0 110.221 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.558 HG12 ' HB2' ' A' ' 56' ' ' TYR . 52.0 mt -115.46 120.65 65.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.724 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -102.73 105.46 2.75 Favored Glycine 0 N--CA 1.444 -0.779 0 N-CA-C 111.019 -0.833 . . . . 0.0 111.019 174.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.558 HD12 ' HA ' ' A' ' 8' ' ' SER . 76.8 mt -75.91 -24.73 55.6 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 122.716 -0.285 . . . . 0.0 111.509 -176.252 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 162.97 57.1 0.02 OUTLIER Glycine 0 CA--C 1.51 -0.242 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.563 -178.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.414 ' CG ' ' H ' ' A' ' 39' ' ' TYR . 1.5 p-10 -99.3 -87.84 0.35 Allowed 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -175.363 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.621 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 93.9 m-85 -82.36 115.49 21.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.362 0.601 . . . . 0.0 110.951 -177.152 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.3 m -91.55 6.43 5.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.509 -0.768 . . . . 0.0 111.634 -177.04 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.516 ' O ' HG23 ' A' ' 45' ' ' VAL . 13.2 t70 -86.44 120.39 27.73 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.3 -0.409 . . . . 0.0 109.949 179.464 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.529 HD22 ' HB3' ' A' ' 66' ' ' ASP . 51.5 tp -54.01 -45.86 71.62 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.851 -174.525 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -63.39 -39.48 94.62 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.133 0.492 . . . . 0.0 110.609 -178.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 24.2 m -68.64 -30.48 69.2 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.021 178.387 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 41' ' ' ASP . 83.9 t -61.11 -45.82 97.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 121.099 0.476 . . . . 0.0 110.337 176.198 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -67.27 -38.97 81.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.806 177.65 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.08 -32.88 73.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.465 176.175 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.37 -34.54 76.25 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.961 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -77.35 -15.2 59.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.17 0.509 . . . . 0.0 110.062 177.11 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -80.43 -48.19 13.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.502 175.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -69.89 -42.41 73.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.009 0.433 . . . . 0.0 110.79 175.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.556 ' HB2' ' HB2' ' A' ' 55' ' ' PHE . 5.4 m -94.39 97.99 10.58 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.617 176.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -61.22 -26.36 67.69 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.844 -176.346 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -118.81 88.51 2.94 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 166.128 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.556 ' HB2' ' HB2' ' A' ' 52' ' ' SER . 88.6 t80 -100.31 124.28 45.58 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.829 -177.613 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.558 ' HB2' HG12 ' A' ' 34' ' ' ILE . 54.0 m-85 -117.9 146.76 43.7 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 174.035 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.48 ' HA3' HD22 ' A' ' 71' ' ' LEU . . . -158.62 161.83 32.05 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.248 -0.977 . . . . 0.0 112.119 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -140.23 169.37 16.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.916 0.389 . . . . 0.0 111.014 178.279 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.561 ' HB3' ' HA ' ' A' ' 73' ' ' PHE . 53.4 t-80 -94.4 143.71 26.17 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.062 -175.641 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -90.89 -129.93 4.45 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.951 -0.642 . . . . 0.0 111.874 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -88.46 -68.89 0.74 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.827 0.346 . . . . 0.0 110.764 178.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 66.6 mtt -125.71 102.28 7.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.328 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -118.56 179.22 4.19 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.922 -178.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -72.38 140.52 82.32 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 176.281 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -57.43 -31.55 91.58 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.945 2.43 . . . . 0.0 112.147 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.529 ' HB3' HD22 ' A' ' 42' ' ' LEU . 5.1 m-20 -63.19 -35.97 82.07 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.922 179.362 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 58.4 t -73.6 -27.18 22.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.399 -178.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.9 ttpm? -61.24 -28.21 69.0 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.04 0.448 . . . . 0.0 110.721 179.216 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -75.08 -13.04 60.45 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.163 -175.468 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -117.58 -38.03 3.37 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.73 179.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.48 HD22 ' HA3' ' A' ' 57' ' ' GLY . 15.8 mt -107.87 107.79 60.69 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.274 -178.453 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -72.04 158.07 53.14 Favored 'Trans proline' 0 N--CA 1.464 -0.228 0 C-N-CA 122.952 2.435 . . . . 0.0 112.003 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.561 ' HA ' ' HB3' ' A' ' 59' ' ' HIS . 91.4 m-85 -62.17 -33.24 74.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.22 0.533 . . . . 0.0 110.56 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 18.2 m -148.58 132.33 16.96 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.574 178.039 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.7 ttmm -140.0 125.7 19.34 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.356 178.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.418 ' HA ' ' HA2' ' A' ' 85' ' ' GLY . 11.8 t -101.07 122.32 52.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 175.386 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.459 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 68.3 mt -87.7 149.55 24.17 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.28 179.163 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 53.4 tp -121.04 94.05 4.22 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 172.172 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.683 HG12 ' HG2' ' A' ' 80' ' ' GLU . 21.6 t -121.87 116.73 50.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.084 -173.475 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.683 ' HG2' HG12 ' A' ' 79' ' ' VAL . 4.2 mm-40 61.46 21.13 11.79 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.278 179.477 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.91 -0.82 67.42 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.209 -179.504 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 65.9 t -96.55 128.95 47.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.754 0.311 . . . . 0.0 110.342 178.643 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.9 p -91.2 119.77 31.56 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.765 177.632 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.459 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 45.7 mt -118.04 98.74 6.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.504 -176.481 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.418 ' HA2' ' HA ' ' A' ' 76' ' ' VAL . . . -86.22 111.52 3.62 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.062 -178.559 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.561 ' HG2' HD12 ' A' ' 112' ' ' LEU . 49.3 mtm -97.4 119.69 36.38 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 49.0 t -144.0 160.71 40.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.062 0.458 . . . . 0.0 110.773 -176.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 25.8 m-70 -119.19 153.32 35.1 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.837 173.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 155.25 -158.33 28.33 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.427 -0.892 . . . . 0.0 112.357 178.033 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 49.4 p90 -155.25 175.97 13.17 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -178.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 149.12 169.12 15.37 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.912 178.324 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.454 ' HB1' ' HD2' ' A' ' 93' ' ' PRO . . . -85.06 164.07 43.08 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 177.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.454 ' HD2' ' HB1' ' A' ' 92' ' ' ALA . 90.7 Cg_exo -46.29 -38.29 20.01 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.209 2.606 . . . . 0.0 113.832 -178.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.814 ' HA ' ' HE3' ' A' ' 97' ' ' LYS . 42.0 p90 -79.71 -40.1 29.71 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 121.102 -0.239 . . . . 0.0 111.175 -179.462 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -66.55 -35.08 79.35 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.01 0.433 . . . . 0.0 110.521 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 30.2 tp -54.64 -47.65 73.25 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.908 -177.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.814 ' HE3' ' HA ' ' A' ' 94' ' ' TRP . 8.9 mtmp? -57.86 -56.65 19.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.641 0.734 . . . . 0.0 110.085 178.311 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.63 -48.7 79.69 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.325 -1.307 . . . . 0.0 112.175 -172.73 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.541 ' O ' HG23 ' A' ' 103' ' ' VAL . 98.1 mtt180 -67.6 -46.53 72.33 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.525 -174.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.547 HD13 HG21 ' A' ' 111' ' ' ILE . 61.2 mt -67.75 -40.75 84.07 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 -177.355 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.724 HD21 HG21 ' A' ' 127' ' ' VAL . 95.3 mt -75.39 -13.32 60.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.777 0.322 . . . . 0.0 111.048 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -90.15 -22.18 21.86 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 175.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 99' ' ' ARG . 73.6 t -78.21 -50.29 19.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.911 174.757 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -96.62 108.26 20.83 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.63 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -82.75 1.49 38.56 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.9 0.381 . . . . 0.0 110.729 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 11.5 mp0 -84.96 -22.62 29.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.473 176.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 87.5 tttt 56.87 85.96 0.18 Allowed Pre-proline 0 N--CA 1.466 0.364 0 O-C-N 123.85 0.719 . . . . 0.0 110.258 -170.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -71.88 152.72 58.21 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.945 2.43 . . . . 0.0 112.366 -177.186 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -77.27 -37.55 52.71 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.663 176.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.56 HG21 HG21 ' A' ' 150' ' ' VAL . 71.7 t -127.89 137.38 57.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.18 178.807 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.547 HG21 HD13 ' A' ' 100' ' ' LEU . 55.2 mt -127.43 133.06 68.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.841 0.353 . . . . 0.0 110.599 176.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.614 HD23 ' HB2' ' A' ' 130' ' ' LEU . 93.3 mt -102.08 122.44 44.13 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.704 177.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.463 ' CZ ' ' HB2' ' A' ' 131' ' ' ASN . 36.0 p90 -128.27 124.27 36.18 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.243 0.544 . . . . 0.0 110.631 177.267 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -105.91 114.78 4.6 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.642 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -165.4 -29.65 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.847 0.356 . . . . 0.0 110.526 -177.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.501 HG22 ' OE1' ' A' ' 118' ' ' GLU . 0.2 OUTLIER -92.42 176.97 6.28 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.398 179.969 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 60.3 m80 -105.58 -38.82 6.3 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.103 0.478 . . . . 0.0 110.609 -177.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.501 ' OE1' HG22 ' A' ' 116' ' ' THR . 1.2 pm0 -96.64 144.6 28.12 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.802 -178.62 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.55 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 4.7 Cg_exo -80.4 144.74 16.33 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 123.126 2.551 . . . . 0.0 112.953 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -160.01 146.14 15.71 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.435 177.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.549 ' HB2' ' HZ ' ' A' ' 152' ' ' PHE . 17.3 t70 -96.24 122.19 38.84 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 175.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.603 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 74.7 p -125.54 142.15 51.66 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.735 0.302 . . . . 0.0 111.343 -176.13 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 14.9 p -150.35 138.82 14.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 176.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -141.53 -72.6 0.33 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.847 0.356 . . . . 0.0 111.1 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -89.13 46.82 1.42 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.916 0.389 . . . . 0.0 110.836 -177.434 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 79.32 -42.31 2.37 Favored Glycine 0 N--CA 1.452 -0.24 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.295 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.724 HG21 HD21 ' A' ' 101' ' ' LEU . 41.7 t -63.72 131.3 29.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.895 0.379 . . . . 0.0 110.747 178.837 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.412 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 75.9 ttt180 -94.35 114.11 26.11 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.802 179.677 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.603 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 45.8 m-85 -99.09 125.96 44.72 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -178.027 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.614 ' HB2' HD23 ' A' ' 112' ' ' LEU . 64.5 mt -103.47 120.68 41.31 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.431 0.634 . . . . 0.0 110.695 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.55 ' O ' ' HA ' ' A' ' 119' ' ' PRO . 49.3 t30 -104.35 107.83 58.72 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 114.865 -1.062 . . . . 0.0 109.223 176.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -89.63 165.62 5.16 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.806 2.337 . . . . 0.0 113.188 -177.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -88.88 146.3 19.13 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.986 179.363 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.895 ' HB2' ' HG2' ' A' ' 137' ' ' GLU . 9.2 m -68.93 142.83 54.61 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.618 0.209 . . . . 0.0 110.904 -178.657 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.605 HD12 ' HB2' ' A' ' 10' ' ' SER . 21.0 mt -63.85 -35.26 80.05 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.143 0.497 . . . . 0.0 110.177 -178.613 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.432 ' HB2' ' SD ' ' A' ' 16' ' ' MET . . . -65.09 -24.22 67.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.434 178.76 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.895 ' HG2' ' HB2' ' A' ' 134' ' ' SER . 51.8 mm-40 -79.86 -13.81 59.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.869 0.366 . . . . 0.0 110.48 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 89.03 34.26 9.0 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.745 178.083 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 23.0 t -149.84 150.06 31.4 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.743 0.306 . . . . 0.0 110.313 178.551 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.424 ' CE1' ' HB3' ' A' ' 155' ' ' LYS . 50.3 p90 -145.55 177.68 8.68 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.662 177.547 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -121.51 132.73 54.87 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.084 0.469 . . . . 0.0 111.672 -176.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 44.8 t -104.09 114.3 43.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 172.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 6.5 tt -94.57 104.97 16.91 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -177.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.524 ' HG2' ' HG2' ' A' ' 3' ' ' ARG . 37.4 mt-10 -95.17 124.85 39.43 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.106 178.458 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 81.6 mt -91.38 98.78 11.9 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.133 0.492 . . . . 0.0 110.05 175.05 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -86.78 100.94 12.88 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.802 -178.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.71 -68.8 0.29 Allowed Glycine 0 CA--C 1.52 0.399 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.446 -172.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -162.31 26.57 0.24 Allowed Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 177.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -123.94 144.14 49.97 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.415 -0.392 . . . . 0.0 110.285 -175.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.56 HG21 HG21 ' A' ' 110' ' ' VAL . 92.8 t -83.37 111.84 20.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.346 -177.437 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -120.65 93.41 4.03 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 177.333 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' PHE . . . . . 0.549 ' HZ ' ' HB2' ' A' ' 121' ' ' ASP . 17.4 p90 -90.29 132.33 35.6 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.058 0.456 . . . . 0.0 110.538 -178.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -116.96 135.37 53.76 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.579 178.292 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -89.83 131.42 35.78 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.892 0.377 . . . . 0.0 110.666 -178.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.424 ' HB3' ' CE1' ' A' ' 140' ' ' TYR . 10.5 tptt -122.05 154.02 37.84 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.403 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 4.2 p -111.15 152.12 27.38 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.923 0.392 . . . . 0.0 111.319 178.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 94.5 mt . . . . . 0 C--O 1.251 1.139 0 CA-C-O 118.29 -0.862 . . . . 0.0 110.346 -179.275 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.513 ' HD3' ' CZ ' ' A' ' 4' ' ' PHE . 20.9 ttmm . . . . . 0 C--O 1.235 0.328 0 CA-C-O 120.803 0.335 . . . . 0.0 110.248 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.414 ' HD3' ' OE2' ' A' ' 144' ' ' GLU . 38.8 mtt180 -117.02 125.58 51.58 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.532 -178.621 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.58 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 64.4 m-85 -102.98 124.14 47.92 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.063 0.459 . . . . 0.0 110.695 177.58 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 48.5 tp -89.27 136.59 32.94 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 175.335 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.501 HD23 ' HB3' ' A' ' 141' ' ' ALA . 50.3 tp -117.68 103.93 10.51 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.285 0.564 . . . . 0.0 112.077 -177.087 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.528 HG13 ' HA2' ' A' ' 35' ' ' GLY . 23.5 pt -101.33 138.65 24.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 168.667 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.643 ' HA ' ' HB2' ' A' ' 36' ' ' LEU . 20.6 m -127.61 -68.18 0.79 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -164.52 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.465 ' HA ' ' HE1' ' A' ' 88' ' ' HIS . 37.3 t70 -111.44 105.49 14.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.417 0.627 . . . . 0.0 111.099 -176.559 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.822 ' HB3' ' HA ' ' A' ' 38' ' ' ASP . 29.5 t -141.05 155.88 46.1 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.285 -0.87 . . . . 0.0 108.874 174.723 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.871 ' H ' ' HE2' ' A' ' 16' ' ' MET . 11.5 m80 -141.59 57.11 1.51 Allowed 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -174.687 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.496 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . 40.7 t -110.19 126.95 27.89 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.236 -174.123 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.496 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 60.1 Cg_endo -105.2 91.87 0.06 OUTLIER 'Cis proline' 0 N--CA 1.45 -1.077 0 C-N-CA 124.011 -1.246 . . . . 0.0 112.874 -7.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 41.7 t -92.19 -63.6 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 175.088 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 58.7 ttm-85 -144.49 12.7 1.53 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.886 0.851 . . . . 0.0 108.758 173.319 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.871 ' HE2' ' H ' ' A' ' 11' ' ' HIS . 50.6 ttp -131.74 121.88 24.95 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.527 -177.616 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -126.11 -0.31 7.14 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.916 -0.583 . . . . 0.0 109.959 178.177 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.5 p -80.77 63.81 5.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.022 -178.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.43 HD12 HG21 ' A' ' 12' ' ' VAL . 4.2 tt -102.1 111.48 64.35 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.584 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 19' ' ' LEU . 23.5 Cg_endo -62.18 125.63 16.81 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.919 2.413 . . . . 0.0 112.744 -177.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -56.62 -28.83 61.33 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.284 177.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -49.87 -50.4 45.91 Favored 'General case' 0 C--N 1.331 -0.225 0 O-C-N 123.438 0.462 . . . . 0.0 111.846 -175.209 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.0 tt -66.59 -39.93 85.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.848 0.832 . . . . 0.0 110.252 -177.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.486 ' O ' HD22 ' A' ' 27' ' ' LEU . 35.5 tp -73.97 -3.74 30.99 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.107 -1.406 . . . . 0.0 111.036 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -100.3 -41.39 7.08 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.326 0.584 . . . . 0.0 109.741 172.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 56.9 p -69.43 -14.99 63.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.932 -175.271 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.516 HD12 ' HB3' ' A' ' 52' ' ' SER . 1.1 pt? -68.46 -9.2 47.21 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.799 0.333 . . . . 0.0 111.118 -176.737 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -65.82 -35.08 79.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.47 175.507 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -72.06 -23.29 61.34 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.204 0.526 . . . . 0.0 110.393 -178.519 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.504 ' HD2' ' HA ' ' A' ' 27' ' ' LEU . 86.0 m-85 -96.16 114.25 25.93 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.523 -176.359 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -78.31 -4.17 46.64 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.818 -176.65 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.58 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -142.19 129.58 3.96 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 173.645 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.453 HG21 ' HB3' ' A' ' 52' ' ' SER . 57.7 t -120.26 142.73 34.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 O-C-N 122.391 -0.476 . . . . 0.0 110.558 -179.498 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 70.1 mt -125.56 131.15 72.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.352 -0.386 . . . . 0.0 109.967 178.012 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.528 ' HA2' HG13 ' A' ' 7' ' ' ILE . . . -122.21 123.28 5.37 Favored Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 111.421 -0.672 . . . . 0.0 111.421 178.367 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.643 ' HB2' ' HA ' ' A' ' 8' ' ' SER . 87.4 mt -95.16 6.4 49.16 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.792 0.296 . . . . 0.0 111.643 -174.479 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 133.97 87.51 0.29 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.783 -0.723 . . . . 0.0 111.411 178.209 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.822 ' HA ' ' HB3' ' A' ' 10' ' ' SER . 6.2 m-20 -127.38 -66.52 0.88 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.076 0.465 . . . . 0.0 112.117 -169.646 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.434 ' CE2' ' HG ' ' A' ' 48' ' ' LEU . 80.3 m-85 -94.25 131.55 39.73 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.871 -174.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 12.7 m -110.04 7.15 8.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.159 -178.497 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.558 ' O ' HG23 ' A' ' 45' ' ' VAL . 15.1 t70 -111.96 129.94 56.02 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.172 179.455 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 49.9 tp -60.33 -49.71 76.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.553 -174.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -55.25 -45.38 76.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.999 0.428 . . . . 0.0 111.065 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.7 m -65.68 -29.52 70.09 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.157 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 41' ' ' ASP . 85.1 t -66.43 -42.62 90.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-O 120.891 0.376 . . . . 0.0 110.497 175.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -67.16 -37.93 80.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.285 0.564 . . . . 0.0 110.23 178.218 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.81 -34.18 76.24 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.393 174.787 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.434 ' HG ' ' CE2' ' A' ' 39' ' ' TYR . 2.6 tm? -65.72 -35.67 81.4 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 178.249 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.53 ' HA ' ' HE2' ' A' ' 55' ' ' PHE . 0.3 OUTLIER -63.37 -30.54 71.65 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.651 172.767 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.411 ' HD3' ' HA ' ' A' ' 50' ' ' LYS . 42.9 mmtm -70.12 -39.16 75.63 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 120.869 -0.333 . . . . 0.0 110.805 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.428 ' HB3' HD11 ' A' ' 27' ' ' LEU . 82.5 m-85 -73.57 -67.66 0.57 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.855 0.36 . . . . 0.0 110.636 174.367 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.516 ' HB3' HD12 ' A' ' 27' ' ' LEU . 5.1 p -86.98 96.61 10.33 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 175.743 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -71.58 -7.39 47.41 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.253 -172.205 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -151.73 100.57 2.69 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.123 0.487 . . . . 0.0 109.972 171.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.53 ' HE2' ' HA ' ' A' ' 49' ' ' GLU . 50.4 p90 -127.99 163.09 25.3 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.863 179.525 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.522 ' HE2' ' HE1' ' A' ' 4' ' ' PHE . 37.2 m-85 -117.9 118.59 32.39 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 174.595 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.567 ' O ' ' HD2' ' A' ' 72' ' ' PRO . . . -106.23 149.31 16.63 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.217 -0.992 . . . . 0.0 112.734 -176.469 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.467 HG21 ' CB ' ' A' ' 86' ' ' MET . 3.5 t -129.53 154.54 40.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 174.764 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.872 ' HB3' ' HA ' ' A' ' 73' ' ' PHE . 24.4 t-80 -99.24 150.88 21.63 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.7 -176.526 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 1.045 ' HA3' ' HB3' ' A' ' 88' ' ' HIS . . . 169.71 53.99 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.128 177.168 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -171.79 160.84 5.74 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 67.0 mtp -80.0 107.3 12.68 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.147 0.499 . . . . 0.0 109.925 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.403 ' OD2' ' HB ' ' A' ' 67' ' ' VAL . 38.1 p-10 -123.47 -156.24 0.7 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.243 -171.709 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -108.35 154.21 41.54 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.592 175.067 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -46.73 -44.55 21.72 Favored 'Trans proline' 0 N--CA 1.475 0.407 0 C-N-CA 123.46 2.774 . . . . 0.0 114.089 -176.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -63.24 -26.0 68.59 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.862 0.363 . . . . 0.0 111.842 -176.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.403 ' HB ' ' OD2' ' A' ' 63' ' ' ASP . 51.7 t -79.6 -32.18 14.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.777 -176.183 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -62.6 -20.84 65.14 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.412 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -73.47 -47.76 38.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.115 0.484 . . . . 0.0 110.945 178.054 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -85.05 -21.72 29.28 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.426 -173.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.57 ' O ' ' HB2' ' A' ' 59' ' ' HIS . 3.6 mm? -110.99 94.36 20.32 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.48 173.462 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.567 ' HD2' ' O ' ' A' ' 57' ' ' GLY . 26.8 Cg_exo -62.62 138.1 67.94 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.825 2.35 . . . . 0.0 111.85 179.094 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.872 ' HA ' ' HB3' ' A' ' 59' ' ' HIS . 40.4 p90 -52.46 -33.04 42.6 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.307 0.379 . . . . 0.0 111.869 -175.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.5 m -155.14 145.65 22.14 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 175.15 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.4 tttm -144.21 150.24 37.66 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -177.469 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.5 t -127.34 118.31 49.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 176.06 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 83.0 mt -90.93 147.89 22.82 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.256 178.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 24.9 tp -115.93 95.42 5.1 Favored 'General case' 0 C--N 1.315 -0.935 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 175.071 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 47.0 t -99.29 93.99 3.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.211 -177.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 64.17 18.24 11.14 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.662 178.101 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 114.41 -20.91 15.46 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.97 -177.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.547 ' HA ' ' OE1' ' A' ' 109' ' ' GLN . 55.0 t -76.48 114.91 17.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.822 0.344 . . . . 0.0 110.329 177.698 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.409 ' HB ' ' HB3' ' A' ' 108' ' ' PRO . 0.9 OUTLIER -83.04 125.65 31.69 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.261 178.931 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.8 mt -117.76 94.91 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.582 -179.232 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.498 ' O ' ' HA ' ' A' ' 111' ' ' ILE . . . -81.87 126.22 7.31 Favored Glycine 0 N--CA 1.442 -0.939 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.012 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.467 ' CB ' HG21 ' A' ' 58' ' ' VAL . 44.0 mtm -126.14 129.8 49.77 Favored 'General case' 0 C--N 1.313 -0.979 0 O-C-N 122.69 -0.3 . . . . 0.0 110.823 -175.077 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 48.5 t -159.57 116.69 2.64 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.652 179.04 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 1.045 ' HB3' ' HA3' ' A' ' 60' ' ' GLY . 3.3 t-160 -84.6 85.16 7.46 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 -177.803 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -133.59 165.73 24.08 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.094 -177.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 26.2 m-90 -122.28 -174.21 2.85 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.84 0.353 . . . . 0.0 110.897 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 127.01 -163.05 21.03 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 -176.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.443 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . . . -79.17 124.25 84.52 Favored Pre-proline 0 C--N 1.322 -0.599 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 177.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 92' ' ' ALA . 49.2 Cg_exo -55.22 -30.6 72.33 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.053 2.502 . . . . 0.0 112.967 -175.29 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.408 ' CD1' ' HB1' ' A' ' 92' ' ' ALA . 0.1 OUTLIER -70.94 -54.29 11.88 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.215 -179.467 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -69.94 -29.14 66.22 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.943 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.446 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 35.0 tp -59.68 -45.84 90.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.036 -177.198 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.63 ' HD3' ' HB3' ' A' ' 124' ' ' LYS . 79.2 mttt -59.15 -49.3 78.38 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.657 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.13 -27.84 66.8 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.216 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -74.02 -42.34 60.48 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.498 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 95.4 mt -66.64 -29.91 70.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.925 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.451 HD21 HG21 ' A' ' 127' ' ' VAL . 84.0 mt -69.22 -15.43 63.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.813 0.34 . . . . 0.0 111.087 176.253 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -101.27 -2.39 31.27 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.369 0.604 . . . . 0.0 110.119 177.427 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 64.5 t -92.47 -44.06 13.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 169.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -106.62 90.11 3.23 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.445 172.554 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -69.17 -15.84 63.49 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.194 -177.362 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -73.16 -21.85 60.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.14 175.039 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.424 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 94.2 mttt 63.81 99.09 0.04 OUTLIER Pre-proline 0 N--CA 1.465 0.305 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.127 175.128 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 107' ' ' LYS . 4.8 Cg_exo -79.6 163.02 24.34 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 123.546 2.83 . . . . 0.0 112.759 -177.601 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.547 ' OE1' ' HA ' ' A' ' 82' ' ' VAL . 91.1 mt-30 -79.52 -41.6 27.0 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.158 176.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 54.9 t -123.85 140.29 47.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.196 -178.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.498 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 54.9 mt -130.72 130.83 64.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.129 0.49 . . . . 0.0 110.791 176.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 94.0 mt -114.25 135.05 54.48 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.342 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.43 ' CE2' ' HB3' ' A' ' 129' ' ' PHE . 28.6 p90 -151.38 159.11 44.42 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.884 176.426 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -105.91 114.79 4.61 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 173.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -122.61 -82.79 0.65 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.758 0.313 . . . . 0.0 110.808 -172.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 10.8 p -101.57 160.57 14.33 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 177.346 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.433 ' HB3' ' OE2' ' A' ' 137' ' ' GLU . 34.6 m170 -87.39 71.69 9.87 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.381 0.61 . . . . 0.0 110.902 -177.781 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -171.47 130.12 0.72 Allowed Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 114.622 -1.172 . . . . 0.0 108.62 176.355 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.491 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 34.7 Cg_exo -58.71 107.41 0.34 Allowed 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.426 2.084 . . . . 0.0 111.731 178.746 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.515 ' HG2' HG23 ' A' ' 122' ' ' THR . 43.6 tt0 -121.49 128.07 51.7 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.203 -174.113 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.469 ' HA ' HD23 ' A' ' 130' ' ' LEU . 11.2 t70 -104.41 125.13 50.34 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 175.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.584 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 33.3 p -135.64 154.54 51.28 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.544 0.688 . . . . 0.0 112.431 -175.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 10.0 p -145.09 162.95 13.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.647 175.418 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.63 ' HB3' ' HD3' ' A' ' 97' ' ' LYS . 64.8 tttm -176.94 -59.85 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.529 0.68 . . . . 0.0 109.82 -179.272 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.426 ' C ' ' H ' ' A' ' 127' ' ' VAL . . . -95.55 30.58 2.24 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.029 -175.321 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 78.55 -33.36 1.84 Allowed Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 121.039 -0.601 . . . . 0.0 111.701 -174.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.451 HG21 HD21 ' A' ' 101' ' ' LEU . 28.7 t -70.88 141.86 16.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 122.978 0.511 . . . . 0.0 110.301 176.592 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -95.49 125.52 40.15 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 177.575 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.584 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 75.9 m-85 -112.43 128.26 56.26 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -177.173 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.469 HD23 ' HA ' ' A' ' 121' ' ' ASP . 60.3 mt -120.37 132.45 55.28 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.107 0.479 . . . . 0.0 111.604 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.496 ' HB3' ' HB3' ' A' ' 120' ' ' GLU . 25.0 t30 -117.8 105.34 47.76 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.837 176.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.491 ' HG2' ' OG ' ' A' ' 8' ' ' SER . 5.9 Cg_exo -82.36 -172.25 1.38 Allowed 'Trans proline' 0 CA--C 1.531 0.326 0 C-N-CA 123.45 2.767 . . . . 0.0 112.692 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -100.43 -174.12 29.81 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.125 -179.072 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.623 ' OG ' ' HB2' ' A' ' 137' ' ' GLU . 28.9 p -95.9 160.27 14.56 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 122.605 -0.35 . . . . 0.0 110.951 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 35.7 mt -64.7 -45.58 86.0 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -176.475 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -75.45 1.69 13.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.316 0.579 . . . . 0.0 111.198 -178.415 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.623 ' HB2' ' OG ' ' A' ' 134' ' ' SER . 10.5 tt0 -95.89 -15.96 22.09 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.711 -178.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.536 ' HA2' ' HB2' ' A' ' 157' ' ' LEU . . . 72.64 43.0 45.31 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.538 179.137 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.8 m -149.17 98.26 2.79 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 176.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.458 ' O ' HD12 ' A' ' 154' ' ' LEU . 27.5 p90 -116.66 164.15 15.05 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.914 -0.315 . . . . 0.0 110.155 -178.324 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.501 ' HB3' HD23 ' A' ' 6' ' ' LEU . . . -114.45 150.77 34.24 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.11 0.481 . . . . 0.0 110.803 -174.179 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.5 HG12 ' HG3' ' A' ' 144' ' ' GLU . 67.1 t -125.74 134.55 66.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.605 177.345 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.7 HD21 HG13 ' A' ' 150' ' ' VAL . 4.5 tt -122.9 103.89 8.91 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.157 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.5 ' HG3' HG12 ' A' ' 142' ' ' VAL . 60.8 mt-10 -108.78 148.26 30.8 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 120.918 0.389 . . . . 0.0 110.461 -177.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.435 HD12 ' HB3' ' A' ' 2' ' ' LYS . 67.2 mt -94.16 90.49 6.38 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.247 0.546 . . . . 0.0 109.61 176.726 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.41 ' HB3' ' HD2' ' A' ' 151' ' ' ARG . 33.4 t70 -124.53 126.17 45.4 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.141 -176.139 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.95 11.19 60.39 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.006 -175.341 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 81.48 -7.59 60.98 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 111.792 -0.523 . . . . 0.0 111.792 -176.334 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -84.64 158.65 20.78 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 120.917 0.389 . . . . 0.0 110.547 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.7 HG13 HD21 ' A' ' 143' ' ' LEU . 15.6 t -83.79 100.36 7.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.211 176.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.432 ' O ' ' HA ' ' A' ' 143' ' ' LEU . 32.6 ttt180 -92.5 99.78 12.44 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.093 -171.463 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' PHE . . . . . 0.413 ' HA ' ' O ' ' A' ' 142' ' ' VAL . 43.1 m-85 -93.74 107.75 19.59 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.971 177.292 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -110.39 116.38 31.32 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.561 174.397 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.458 HD12 ' O ' ' A' ' 140' ' ' TYR . 41.5 tp -89.81 123.17 33.55 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 177.738 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -120.95 148.15 44.48 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.98 0.419 . . . . 0.0 110.876 -177.126 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 13.7 p -105.83 156.97 17.8 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.005 -174.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.536 ' HB2' ' HA2' ' A' ' 138' ' ' GLY . 79.2 mt . . . . . 0 C--O 1.25 1.099 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.747 178.334 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 46.1 mttp . . . . . 0 CA--C 1.518 -0.281 0 CA-C-O 120.745 0.307 . . . . 0.0 110.438 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.518 ' HB3' ' HD1' ' A' ' 30' ' ' TYR . 88.0 mtt180 -130.57 115.38 16.68 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.87 -178.213 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.662 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 91.7 m-85 -101.64 114.65 28.88 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.223 0.535 . . . . 0.0 110.669 178.628 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.531 ' HB3' HG22 ' A' ' 33' ' ' VAL . 47.2 tp -89.55 110.65 21.48 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.333 -179.127 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.653 HD11 ' HG ' ' A' ' 36' ' ' LEU . 60.2 tp -96.02 114.91 26.67 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.018 0.437 . . . . 0.0 111.104 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.428 HG22 HD13 ' A' ' 23' ' ' ILE . 26.9 pt -101.03 125.76 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 171.537 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.584 ' HB3' ' HG2' ' A' ' 132' ' ' PRO . 11.1 p -80.6 -94.21 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -168.055 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.46 75.15 1.0 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.984 0.421 . . . . 0.0 111.673 -173.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.2 m -79.95 119.23 22.51 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 173.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 65.0 m-70 -134.33 73.12 1.48 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.516 0.674 . . . . 0.0 109.33 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.499 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . 48.7 t -120.79 131.15 24.55 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.247 -176.446 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.499 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 70.7 Cg_endo -102.25 90.19 0.08 OUTLIER 'Cis proline' 0 N--CA 1.451 -1.001 0 C-N-CA 123.781 -1.341 . . . . 0.0 112.438 -5.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.512 HG12 ' HG2' ' A' ' 15' ' ' ARG . 27.3 t -97.75 -84.94 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.649 -179.172 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.512 ' HG2' HG12 ' A' ' 14' ' ' VAL . 12.6 mmm180 -121.05 -25.59 5.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.178 0.513 . . . . 0.0 110.204 177.597 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.44 ' C ' ' H ' ' A' ' 18' ' ' SER . 51.1 ttp -80.43 -72.92 0.39 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.117 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 70.3 -33.71 0.27 Allowed 'General case' 0 N--CA 1.469 0.516 0 O-C-N 123.872 0.733 . . . . 0.0 112.077 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.44 ' H ' ' C ' ' A' ' 16' ' ' MET . 29.7 p -75.15 81.84 2.31 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.087 0.47 . . . . 0.0 111.572 -178.66 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.433 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 8.0 tt -107.55 110.68 62.9 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 173.543 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.603 ' CG ' HD13 ' A' ' 157' ' ' LEU . 19.6 Cg_endo -59.13 142.24 99.04 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 123.152 2.568 . . . . 0.0 112.936 -176.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -71.73 -20.83 61.85 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.109 -173.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -57.17 -46.72 82.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.432 -177.287 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.428 HD13 HG22 ' A' ' 7' ' ' ILE . 3.5 tt -71.2 -32.14 46.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.466 0.65 . . . . 0.0 110.293 -177.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.468 ' O ' HD23 ' A' ' 27' ' ' LEU . 58.4 tp -72.84 -25.14 61.01 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.69 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -81.47 -29.33 33.76 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.476 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.4 p -83.51 8.82 12.85 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -174.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.597 HD12 ' HB2' ' A' ' 52' ' ' SER . 3.2 mm? -56.31 -27.8 56.75 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.839 0.352 . . . . 0.0 111.494 176.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -78.14 -24.31 47.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.367 -177.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -92.85 -3.74 54.12 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.16 0.505 . . . . 0.0 111.177 -172.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.518 ' HD1' ' HB3' ' A' ' 3' ' ' ARG . 99.0 m-85 -123.44 120.22 32.31 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.28 176.251 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -78.8 -29.93 45.15 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.973 -173.479 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.662 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -120.91 126.62 6.67 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 174.402 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.531 HG22 ' HB3' ' A' ' 5' ' ' LEU . 97.0 t -119.61 134.71 62.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 117.426 0.613 . . . . 0.0 110.603 -179.285 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.517 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 71.2 mt -116.82 131.76 68.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.234 -177.543 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -125.77 107.41 0.95 Allowed Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.411 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.653 ' HG ' HD11 ' A' ' 6' ' ' LEU . 95.0 mt -74.2 -22.8 59.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.697 0.761 . . . . 0.0 109.385 176.154 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -152.39 125.06 1.74 Allowed Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 174.205 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -119.72 -169.57 1.79 Allowed 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -174.188 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -65.33 145.39 56.26 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.297 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 19.9 m -84.41 27.26 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.12 0.486 . . . . 0.0 111.672 -171.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -146.3 139.35 25.66 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 121.029 0.442 . . . . 0.0 110.389 177.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.741 ' HB2' ' HB3' ' A' ' 66' ' ' ASP . 43.4 tp -66.34 -28.9 69.02 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.519 -173.791 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.47 -35.63 78.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.175 0.512 . . . . 0.0 110.482 -177.099 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.2 m -83.24 -30.84 27.36 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.341 -178.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 98.2 t -58.43 -42.54 84.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.039 0.447 . . . . 0.0 110.285 174.041 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.413 HD13 ' O ' ' A' ' 42' ' ' LEU . 1.7 mp -68.85 -35.72 70.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.202 177.639 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -61.25 -37.8 84.41 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.914 175.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 46.8 mt -80.11 -33.33 38.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.732 0.301 . . . . 0.0 110.684 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -65.32 -21.6 66.73 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.129 174.111 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -81.41 -36.17 29.82 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.043 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.444 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . 39.2 m-85 -75.16 -62.58 1.51 Allowed 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.057 174.059 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.597 ' HB2' HD12 ' A' ' 27' ' ' LEU . 33.4 t -90.8 98.71 11.94 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 173.36 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 42.7 mttm -78.05 15.18 0.95 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.767 -178.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -146.95 77.58 1.46 Allowed 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 168.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -101.82 123.5 45.88 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.532 -175.62 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.543 ' HE2' ' HE1' ' A' ' 4' ' ' PHE . 26.5 m-85 -104.41 107.9 19.05 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 175.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.826 ' HA3' HD22 ' A' ' 71' ' ' LEU . . . -116.64 156.49 15.59 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.1 -1.047 . . . . 0.0 112.708 -176.391 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 15.0 t -128.08 146.08 34.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 177.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 56.8 t60 -94.57 104.53 16.48 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.459 0.647 . . . . 0.0 109.458 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.61 ' HA3' ' HB2' ' A' ' 88' ' ' HIS . . . -135.38 23.15 3.48 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.966 177.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -121.72 -176.07 3.24 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 51.2 mtp -98.91 36.19 1.73 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.393 0.616 . . . . 0.0 109.36 173.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.436 ' OD2' ' HB ' ' A' ' 67' ' ' VAL . 3.8 p-10 -68.62 156.11 38.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.419 178.342 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.502 ' HB3' ' HD2' ' A' ' 65' ' ' PRO . 89.5 m-85 -70.05 162.97 65.38 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.239 -175.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.528 ' HA ' ' HB3' ' A' ' 68' ' ' LYS . 9.9 Cg_endo -51.91 -23.92 17.65 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.173 2.582 . . . . 0.0 112.602 177.401 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.741 ' HB3' ' HB2' ' A' ' 42' ' ' LEU . 5.9 m-20 -54.83 -50.31 68.92 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.251 0.548 . . . . 0.0 110.412 175.281 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.436 ' HB ' ' OD2' ' A' ' 63' ' ' ASP . 29.1 t -77.94 -34.44 19.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.057 -178.232 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.528 ' HB3' ' HA ' ' A' ' 65' ' ' PRO . 57.8 tttm -62.72 -24.4 67.66 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.105 177.23 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -64.48 -41.09 96.69 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.262 0.553 . . . . 0.0 109.59 175.077 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -83.42 -38.61 21.69 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.11 -178.381 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.826 HD22 ' HA3' ' A' ' 57' ' ' GLY . 14.8 mt -114.13 120.7 38.05 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.07 -173.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.5 ' HG2' ' HB2' ' A' ' 75' ' ' LYS . 72.6 Cg_endo -79.79 157.76 24.46 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.793 2.329 . . . . 0.0 111.426 175.764 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -60.03 -34.78 73.85 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.906 0.384 . . . . 0.0 111.061 -177.433 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 17.3 m -142.8 137.55 29.76 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 174.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.5 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 43.0 tttp -136.24 126.28 26.1 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.549 0.214 . . . . 0.0 110.627 -176.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 26.8 t -103.18 125.07 57.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.787 0.327 . . . . 0.0 110.29 177.103 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.544 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 89.9 mt -100.43 159.72 14.92 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.784 178.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 46.6 tp -130.78 99.61 5.0 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 175.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.544 HG12 ' HG2' ' A' ' 80' ' ' GLU . 58.2 t -117.04 112.67 40.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.684 -176.004 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.544 ' HG2' HG12 ' A' ' 79' ' ' VAL . 4.5 mm-40 60.06 19.57 8.76 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.57 178.104 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.55 -3.7 50.18 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.333 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.3 t -93.68 128.23 45.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.664 0.269 . . . . 0.0 110.56 178.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 33.9 p -88.49 126.72 35.38 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.605 178.548 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.544 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 19.6 mt -118.33 95.85 3.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.82 0.343 . . . . 0.0 110.218 -178.347 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -80.23 98.12 1.72 Allowed Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 178.008 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 32.2 mtm -96.8 120.73 37.68 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.135 0.493 . . . . 0.0 110.999 -175.351 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 26.4 t -139.38 165.19 27.85 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 174.145 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.61 ' HB2' ' HA3' ' A' ' 60' ' ' GLY . 4.6 t60 -81.51 -21.12 38.85 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 119.669 -0.812 . . . . 0.0 109.667 178.186 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.427 ' HA3' ' HB2' ' A' ' 113' ' ' PHE . . . 82.88 -155.5 33.37 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.53 177.768 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 73.8 t-105 -159.74 -73.2 0.07 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.95 0.405 . . . . 0.0 110.513 -177.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 161.77 -174.21 38.24 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 -178.566 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 55.17 81.86 0.25 Allowed Pre-proline 0 N--CA 1.463 0.21 0 C-N-CA 122.631 0.372 . . . . 0.0 111.341 -179.388 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -54.77 -30.75 68.8 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.399 2.733 . . . . 0.0 113.262 -173.304 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -72.53 -13.62 61.45 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.185 -0.461 . . . . 0.0 112.228 -177.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -121.6 -25.18 5.16 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.189 0.519 . . . . 0.0 110.417 177.017 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 48.2 tp -60.19 -41.29 92.6 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.006 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -58.36 -41.62 85.11 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.159 0.504 . . . . 0.0 109.835 178.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.422 ' O ' ' HG3' ' A' ' 102' ' ' LYS . 9.1 m-20 -69.58 -47.67 62.79 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.058 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.536 ' O ' HG23 ' A' ' 103' ' ' VAL . 19.0 ttm180 -58.71 -46.74 86.66 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.151 -177.03 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.501 HD13 HG21 ' A' ' 111' ' ' ILE . 91.7 mt -66.4 -36.45 82.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.72 0.295 . . . . 0.0 111.287 -179.125 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 93.8 mt -75.12 -11.35 60.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.857 0.36 . . . . 0.0 111.127 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.422 ' HG3' ' O ' ' A' ' 98' ' ' ASP . 96.1 mttt -100.07 -8.87 23.26 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.122 0.487 . . . . 0.0 110.179 175.064 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 99' ' ' ARG . 90.9 t -81.29 -48.07 19.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 170.025 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -101.09 106.71 18.01 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.175 173.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 -57.44 -37.7 73.24 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.804 0.335 . . . . 0.0 111.631 -175.231 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -96.17 133.83 39.98 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 174.32 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.468 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 60.1 pttt -71.86 126.66 91.35 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-O 121.148 0.499 . . . . 0.0 111.185 -174.383 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 107' ' ' LYS . 3.7 Cg_exo -81.8 169.48 14.95 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 123.393 2.729 . . . . 0.0 111.473 175.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -87.36 -45.33 10.65 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.112 0.482 . . . . 0.0 109.97 178.425 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 63.3 t -120.63 136.74 56.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.279 178.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.501 HG21 HD13 ' A' ' 100' ' ' LEU . 59.6 mt -130.02 133.87 63.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.881 0.372 . . . . 0.0 110.386 177.084 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.483 HD23 ' HB2' ' A' ' 130' ' ' LEU . 95.3 mt -109.26 146.36 34.38 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.375 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.427 ' HB2' ' HA3' ' A' ' 89' ' ' GLY . 29.8 p90 -155.69 163.79 39.44 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 174.508 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -147.11 125.48 2.19 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.681 -177.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 36.5 t-80 -177.5 -37.14 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 177.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.3 p -79.86 127.34 32.12 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.522 177.282 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.468 ' O ' ' HD3' ' A' ' 119' ' ' PRO . 24.1 m170 -87.71 7.3 30.75 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.263 0.554 . . . . 0.0 110.206 176.656 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -106.4 91.69 6.1 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.756 171.082 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' A' ' 117' ' ' HIS . 22.5 Cg_exo -63.51 129.51 25.4 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.75 2.3 . . . . 0.0 111.661 -175.621 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -149.26 136.74 20.18 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.968 0.414 . . . . 0.0 111.314 -172.072 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.453 ' OD1' ' HD2' ' A' ' 128' ' ' ARG . 6.7 t70 -90.44 119.78 31.0 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.482 174.8 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.49 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 44.3 p -132.66 129.52 38.94 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.108 0.48 . . . . 0.0 112.049 -173.497 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 6.2 p -120.54 105.81 17.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 169.203 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 50.0 mttp -109.11 -67.34 0.99 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.264 -172.272 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -92.18 33.0 1.1 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.101 0.476 . . . . 0.0 110.992 -176.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 83.03 -14.92 35.57 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 -175.419 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 41.8 t -96.23 144.87 9.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.453 ' HD2' ' OD1' ' A' ' 121' ' ' ASP . 6.4 tpp180 -87.24 109.54 19.56 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.391 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.49 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 92.0 m-85 -98.15 121.17 39.75 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 177.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.515 HD13 ' CD1' ' A' ' 152' ' ' PHE . 64.8 mt -121.5 129.66 53.07 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.872 0.367 . . . . 0.0 111.327 -174.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.453 ' HA ' ' HD3' ' A' ' 132' ' ' PRO . 8.5 p30 -131.82 122.31 18.5 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.156 177.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.584 ' HG2' ' HB3' ' A' ' 8' ' ' SER . 87.4 Cg_endo -98.41 168.54 0.66 Allowed 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 123.48 2.787 . . . . 0.0 113.057 178.259 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -80.67 166.57 49.24 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.787 -0.721 . . . . 0.0 111.351 175.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.505 ' HA ' ' OG ' ' A' ' 8' ' ' SER . 39.5 m -90.32 177.39 6.42 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 117.2 0.5 . . . . 0.0 111.181 -177.773 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -73.09 -18.13 61.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.335 -176.583 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -73.26 -47.4 43.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.759 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.498 ' OE1' ' HB2' ' A' ' 134' ' ' SER . 1.8 mp0 -66.49 -32.13 73.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.148 177.082 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.515 ' HA2' HD12 ' A' ' 157' ' ' LEU . . . 96.58 51.75 1.65 Allowed Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.211 178.815 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 156' ' ' THR . 23.1 t -145.97 153.89 41.3 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 178.247 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -154.36 167.09 31.13 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.779 177.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.436 ' HB3' ' HB3' ' A' ' 6' ' ' LEU . . . -114.26 135.95 53.5 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.849 0.356 . . . . 0.0 111.041 -174.494 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 79.4 t -121.27 120.55 62.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.169 176.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.78 HD21 HG13 ' A' ' 150' ' ' VAL . 5.5 tt -104.5 103.95 13.73 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 177.369 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -106.39 135.91 47.06 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.876 -178.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.487 ' HA ' ' O ' ' A' ' 149' ' ' GLU . 5.1 mp -112.13 98.7 7.51 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.944 0.402 . . . . 0.0 110.512 178.592 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -101.26 121.54 42.06 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.367 0.603 . . . . 0.0 109.426 178.2 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 68.09 1.56 20.29 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.835 -175.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 104.57 0.58 43.18 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 121.155 -0.545 . . . . 0.0 112.235 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.487 ' O ' ' HA ' ' A' ' 145' ' ' LEU . 8.7 mm-40 -88.76 132.95 34.4 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.925 0.393 . . . . 0.0 110.511 177.13 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.78 HG13 HD21 ' A' ' 143' ' ' LEU . 98.3 t -80.75 113.97 20.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.021 -178.107 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 11.1 mtm180 -110.54 107.07 16.58 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 176.388 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' PHE . . . . . 0.515 ' CD1' HD13 ' A' ' 130' ' ' LEU . 84.5 t80 -89.45 96.29 10.64 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 176.258 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -107.24 109.49 21.29 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.414 -174.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 33.9 tp -80.02 118.97 22.23 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.557 177.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -111.03 160.45 16.84 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.055 -178.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 139' ' ' SER . 16.5 p -107.39 165.6 11.27 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.334 176.634 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.603 HD13 ' CG ' ' A' ' 20' ' ' PRO . 39.4 mt . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.422 -0.799 . . . . 0.0 110.011 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.543 ' HB2' HD12 ' A' ' 145' ' ' LEU . 50.1 mttm . . . . . 0 CA--C 1.518 -0.254 0 CA-C-O 120.958 0.409 . . . . 0.0 110.91 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.503 ' HB3' ' HD2' ' A' ' 30' ' ' TYR . 88.9 mtt180 -117.2 133.65 55.73 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.163 -178.718 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.428 ' HB2' ' HG ' ' A' ' 143' ' ' LEU . 93.8 m-85 -120.29 121.14 38.0 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.866 0.365 . . . . 0.0 110.065 175.147 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.442 ' HB3' HG22 ' A' ' 33' ' ' VAL . 38.7 tp -93.0 121.05 33.94 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.863 -178.15 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.558 HD11 ' HG ' ' A' ' 36' ' ' LEU . 51.7 tp -103.98 120.94 42.11 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.952 0.406 . . . . 0.0 110.508 178.252 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.5 pt -101.33 123.96 54.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 173.3 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.448 ' HB3' ' HB2' ' A' ' 132' ' ' PRO . 5.9 p -66.0 -79.31 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.578 -169.658 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.794 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 26.9 t70 -148.0 124.13 10.79 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.135 -177.688 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.706 ' HB2' HD12 ' A' ' 19' ' ' LEU . 9.0 p -156.91 88.46 1.04 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.123 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 62.4 m-70 -83.69 85.85 7.22 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.307 -0.406 . . . . 0.0 109.973 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.471 ' O ' HG22 ' A' ' 40' ' ' VAL . 59.9 t -107.7 135.04 19.82 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.026 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -78.23 -62.56 0.03 OUTLIER 'Cis proline' 0 C--N 1.345 0.384 0 C-N-CA 123.75 -1.354 . . . . 0.0 112.571 0.145 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.767 HG12 ' HG3' ' A' ' 15' ' ' ARG . 19.6 t 52.13 -93.0 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 123.464 0.705 . . . . 0.0 112.031 177.802 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.767 ' HG3' HG12 ' A' ' 14' ' ' VAL . 97.8 mtt180 -134.01 4.37 3.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.869 0.366 . . . . 0.0 110.564 -175.297 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.607 ' SD ' ' HB2' ' A' ' 136' ' ' ALA . 32.3 ttp -137.77 112.46 8.87 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.511 -176.672 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -116.89 19.69 14.26 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.203 0.525 . . . . 0.0 110.344 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 35.6 p -99.9 29.9 3.97 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.379 -176.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.706 HD12 ' HB2' ' A' ' 10' ' ' SER . 7.1 tt -83.27 116.96 67.08 Favored Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 179.266 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -68.86 118.14 5.47 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 122.45 2.1 . . . . 0.0 112.187 178.617 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.56 -7.8 5.29 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.442 -177.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -61.12 -36.97 81.15 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.808 0.337 . . . . 0.0 110.796 179.335 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 11.1 tp -64.75 -39.19 84.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.937 0.875 . . . . 0.0 109.761 178.487 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 44.4 tp -78.37 -10.25 59.61 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.051 -1.432 . . . . 0.0 110.978 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -100.32 -6.55 25.68 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.106 0.479 . . . . 0.0 110.816 -176.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 68.4 m -121.68 0.5 9.86 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.988 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.446 HD12 HG21 ' A' ' 33' ' ' VAL . 1.4 pt? -72.65 -19.26 61.47 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.065 -174.671 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -72.94 -13.9 61.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.961 -177.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -73.77 -26.08 60.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.114 0.483 . . . . 0.0 110.547 177.163 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.503 ' HD2' ' HB3' ' A' ' 3' ' ' ARG . 85.7 m-85 -83.87 156.95 22.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.211 -173.182 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -86.94 -6.6 58.72 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.01 -178.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -174.52 149.01 10.19 Favored Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.726 177.801 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.446 HG21 HD12 ' A' ' 27' ' ' LEU . 69.7 t -124.71 135.98 62.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-O 120.976 0.417 . . . . 0.0 110.494 -179.617 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.544 HG12 ' HB2' ' A' ' 56' ' ' TYR . 49.4 mt -113.85 134.44 56.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.769 179.178 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -125.6 117.2 2.85 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.14 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.558 ' HG ' HD11 ' A' ' 6' ' ' LEU . 95.9 mt -95.79 -9.96 30.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.854 0.835 . . . . 0.0 109.246 175.212 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.794 ' HA3' ' HA ' ' A' ' 9' ' ' ASP . . . -151.43 60.93 0.41 Allowed Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.238 178.321 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -73.83 178.85 4.59 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.252 -0.474 . . . . 0.0 111.695 -175.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.531 ' HD1' HD11 ' A' ' 48' ' ' LEU . 71.2 m-85 -63.43 145.62 55.24 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.558 179.386 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.551 ' HB ' ' CD1' ' A' ' 64' ' ' TYR . 18.1 m -83.79 -9.01 11.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.802 -173.392 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.493 ' HB2' ' OG1' ' A' ' 44' ' ' THR . 19.4 m-20 -86.62 120.4 27.89 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.013 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.534 HD22 ' HB3' ' A' ' 66' ' ' ASP . 48.9 tp -53.38 -42.24 66.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.026 0.441 . . . . 0.0 110.432 178.362 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -59.06 -38.7 80.02 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.923 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.51 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 7.6 m -75.74 -28.72 58.62 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.663 -178.451 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 41' ' ' ASP . 65.6 t -62.22 -46.77 95.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.055 0.455 . . . . 0.0 110.159 175.514 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.07 -36.34 77.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.844 176.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -59.64 -35.42 74.35 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.785 175.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.531 HD11 ' HD1' ' A' ' 39' ' ' TYR . 91.1 mt -71.25 -38.34 71.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.407 178.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.701 ' HG2' ' HB3' ' A' ' 55' ' ' PHE . 49.2 mt-10 -69.05 -17.1 63.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.984 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -82.53 -41.31 19.81 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.856 176.281 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -68.83 -46.47 68.47 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.903 0.382 . . . . 0.0 111.536 178.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 51.1 p -83.38 -14.81 51.96 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.544 -176.13 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 93.5 mttt 70.4 -54.11 0.64 Allowed 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.509 0.723 . . . . 0.0 110.368 -172.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -123.68 109.57 13.88 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.193 0.521 . . . . 0.0 109.735 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.701 ' HB3' ' HG2' ' A' ' 49' ' ' GLU . 84.1 t80 -111.4 139.25 46.96 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.479 -175.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.544 ' HB2' HG12 ' A' ' 34' ' ' ILE . 93.5 m-85 -119.77 116.49 26.02 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 174.745 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.528 ' HA3' HD13 ' A' ' 71' ' ' LEU . . . -124.91 141.89 13.47 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 119.566 -1.302 . . . . 0.0 113.739 -173.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.428 HG23 ' HE3' ' A' ' 86' ' ' MET . 16.5 t -132.24 123.03 49.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 170.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -94.39 147.06 23.61 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 120.095 -0.642 . . . . 0.0 110.339 -173.226 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.626 ' HA2' ' HB3' ' A' ' 88' ' ' HIS . . . -80.83 -123.06 0.54 Allowed Glycine 0 C--N 1.331 0.261 0 N-CA-C 114.475 0.55 . . . . 0.0 114.475 -171.65 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -74.23 -164.12 0.23 Allowed 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 122.419 0.288 . . . . 0.0 111.053 -175.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 46.9 mtm -56.46 113.94 1.81 Allowed 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 120.991 0.424 . . . . 0.0 110.264 178.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -141.09 -160.77 1.12 Allowed 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -175.056 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.551 ' CD1' ' HB ' ' A' ' 40' ' ' VAL . 12.3 m-85 -67.04 125.28 90.68 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 121.113 0.482 . . . . 0.0 111.308 -177.373 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 64' ' ' TYR . 52.7 Cg_exo -56.66 -38.36 95.78 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 123.869 3.046 . . . . 0.0 113.797 -174.73 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.534 ' HB3' HD22 ' A' ' 42' ' ' LEU . 5.4 m-20 -59.5 -36.54 76.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.099 0.476 . . . . 0.0 111.024 -178.603 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 11.9 t -76.53 -26.08 16.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.261 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -63.51 -31.1 72.16 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.194 0.521 . . . . 0.0 110.264 176.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -86.2 -19.47 29.97 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.095 -178.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 11.7 t60 -91.24 -40.31 11.59 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.09 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.528 HD13 ' HA3' ' A' ' 57' ' ' GLY . 31.1 mt -117.74 136.26 23.61 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.985 179.116 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.411 ' HD2' ' O ' ' A' ' 57' ' ' GLY . 63.9 Cg_endo -74.34 177.29 8.51 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 122.486 2.124 . . . . 0.0 112.525 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -95.98 -12.97 24.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.212 0.529 . . . . 0.0 110.172 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 10.0 p -155.63 124.1 5.93 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.321 175.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 40.5 tttp -131.83 132.59 43.83 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.509 0.195 . . . . 0.0 110.674 -176.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 20.3 t -110.83 121.68 63.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.873 0.368 . . . . 0.0 110.498 179.039 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.462 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 72.3 mt -101.28 158.81 15.77 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.337 178.596 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 59.6 tp -127.0 102.11 6.84 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 175.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.525 HG12 ' HG2' ' A' ' 80' ' ' GLU . 35.6 t -124.01 116.12 46.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.468 -177.224 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.525 ' HG2' HG12 ' A' ' 79' ' ' VAL . 20.2 mm-40 59.78 27.16 16.41 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.477 177.614 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.31 -15.32 63.5 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.195 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 52.4 t -87.41 126.37 41.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.76 0.314 . . . . 0.0 110.189 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 40.9 p -85.93 134.35 33.88 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.181 177.319 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.462 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 37.0 mt -118.17 94.81 3.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -178.77 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -85.29 95.31 1.97 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.444 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.549 ' HG2' HD12 ' A' ' 112' ' ' LEU . 30.0 mtm -95.98 118.93 33.57 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.953 0.406 . . . . 0.0 110.439 -176.305 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.681 ' O ' ' HA ' ' A' ' 113' ' ' PHE . 52.7 t -140.27 153.69 46.59 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 178.813 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.626 ' HB3' ' HA2' ' A' ' 60' ' ' GLY . 4.1 p-80 -72.23 1.55 7.46 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.879 -0.329 . . . . 0.0 111.849 176.58 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.35 176.72 50.34 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.494 176.138 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -116.73 -99.5 0.44 Allowed 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.548 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -109.69 -94.71 2.32 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.311 -0.947 . . . . 0.0 113.434 -173.53 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.436 ' HB1' ' HD2' ' A' ' 93' ' ' PRO . . . -112.7 172.67 3.35 Favored Pre-proline 0 C--N 1.321 -0.656 0 C-N-CA 122.456 0.302 . . . . 0.0 110.622 -172.199 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.436 ' HD2' ' HB1' ' A' ' 92' ' ' ALA . 31.5 Cg_exo -61.24 -11.79 20.64 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.612 2.208 . . . . 0.0 113.061 177.227 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 1.5 m0 -77.51 -54.59 6.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.286 0.565 . . . . 0.0 109.701 -179.401 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.476 ' OD2' ' HD2' ' A' ' 99' ' ' ARG . 7.3 p-10 -82.72 -3.32 56.29 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.703 -177.744 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 28.0 tp -50.51 -56.34 12.06 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.775 178.196 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.9 ptmm? -66.44 -48.28 70.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.264 -178.545 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -62.49 -59.07 5.48 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.792 -175.426 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.528 ' O ' HG23 ' A' ' 103' ' ' VAL . 94.3 mtt180 -69.31 -38.21 78.16 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -171.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.51 HD13 HG21 ' A' ' 111' ' ' ILE . 46.5 mt -70.03 -37.13 75.5 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.386 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.542 HD21 HG21 ' A' ' 127' ' ' VAL . 87.0 mt -79.3 -14.23 59.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.81 0.338 . . . . 0.0 111.117 178.547 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.452 ' HA ' ' OD1' ' A' ' 105' ' ' ASN . 97.0 mttt -90.41 -14.54 32.72 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.634 173.65 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 99' ' ' ARG . 84.2 t -81.43 -49.08 18.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 167.298 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -100.23 75.22 1.8 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.385 174.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.452 ' OD1' ' HA ' ' A' ' 102' ' ' LYS . 74.3 m-20 -60.75 -28.57 68.81 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.5 -173.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -78.23 -6.54 55.24 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.875 0.369 . . . . 0.0 110.686 -178.199 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.426 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 5.0 tmmm? 64.91 109.09 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.468 0 C-N-CA 123.589 0.755 . . . . 0.0 112.444 174.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 107' ' ' LYS . 8.8 Cg_endo -88.39 178.38 2.97 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.392 2.728 . . . . 0.0 112.102 177.488 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 14.4 mp0 -88.73 -45.83 9.48 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.865 0.364 . . . . 0.0 110.414 176.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.4 t -124.29 133.61 68.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.748 -178.264 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.51 HG21 HD13 ' A' ' 100' ' ' LEU . 58.9 mt -124.15 127.14 73.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.296 176.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.622 HD23 ' HB2' ' A' ' 130' ' ' LEU . 87.4 mt -101.13 134.38 44.24 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 178.152 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.681 ' HA ' ' O ' ' A' ' 87' ' ' CYS . 24.7 p90 -144.03 142.1 30.48 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.937 0.399 . . . . 0.0 110.593 176.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -105.68 135.99 12.94 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.914 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -147.62 157.34 43.51 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.8 p -80.1 61.88 4.09 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.378 0.609 . . . . 0.0 111.084 178.611 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -154.81 152.6 30.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.653 -176.12 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -57.76 145.88 68.73 Favored Pre-proline 0 C--N 1.329 -0.307 0 O-C-N 123.574 0.546 . . . . 0.0 111.096 177.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.18 149.09 74.66 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 123.122 2.548 . . . . 0.0 112.693 -178.158 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -151.84 142.38 22.65 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.495 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -78.52 94.04 4.9 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 176.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.8 p -103.5 135.22 45.5 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.998 -176.691 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 14.1 p -150.34 121.55 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.083 0.468 . . . . 0.0 110.593 176.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.447 ' HB2' ' HE2' ' A' ' 129' ' ' PHE . 95.9 mttt -142.04 144.41 33.59 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.191 -0.458 . . . . 0.0 109.992 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 62.75 19.09 11.18 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 123.5 0.5 . . . . 0.0 111.636 179.139 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 86.89 -5.7 84.54 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.054 -178.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.542 HG21 HD21 ' A' ' 101' ' ' LEU . 33.0 t -97.6 129.44 47.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 120.833 0.349 . . . . 0.0 110.141 -178.545 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 38.1 ttm-85 -84.19 122.1 28.38 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.574 178.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.447 ' HE2' ' HB2' ' A' ' 124' ' ' LYS . 82.3 m-85 -103.43 138.97 39.44 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 175.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.622 ' HB2' HD23 ' A' ' 112' ' ' LEU . 95.7 mt -128.18 121.45 29.49 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.91 0.386 . . . . 0.0 111.069 -179.158 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.447 ' HB3' ' CZ ' ' A' ' 113' ' ' PHE . 8.1 p30 -121.57 117.36 30.19 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.95 176.157 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.448 ' HB2' ' HB3' ' A' ' 8' ' ' SER . 33.6 Cg_endo -96.82 147.38 0.97 Allowed 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 123.344 2.696 . . . . 0.0 112.627 176.111 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -69.51 152.97 52.24 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.207 175.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 82.8 p -70.65 175.47 4.88 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.435 0.636 . . . . 0.0 111.938 -173.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.409 ' HB2' ' HB3' ' A' ' 10' ' ' SER . 4.5 mm? -69.77 -25.56 63.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.394 176.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.607 ' HB2' ' SD ' ' A' ' 16' ' ' MET . . . -72.99 -31.72 64.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.27 0.557 . . . . 0.0 110.336 177.37 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -83.34 -20.04 35.05 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.109 177.381 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 89.08 45.94 4.61 Favored Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.944 175.062 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 156' ' ' THR . 26.4 t -137.0 149.03 47.23 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.841 0.353 . . . . 0.0 110.393 178.293 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.402 ' CD1' ' HG ' ' A' ' 157' ' ' LEU . 7.5 p90 -147.74 178.0 8.84 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 176.113 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.445 ' HB3' ' HB3' ' A' ' 6' ' ' LEU . . . -132.86 135.26 45.51 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.955 0.407 . . . . 0.0 111.18 -179.183 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 99.3 t -119.7 112.01 35.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.871 175.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.696 ' HA ' ' O ' ' A' ' 151' ' ' ARG . 0.2 OUTLIER -102.85 110.83 22.89 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.6 0.714 . . . . 0.0 110.239 175.513 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -105.18 145.0 31.2 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.687 -178.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.543 HD12 ' HB2' ' A' ' 2' ' ' LYS . 87.4 mt -90.8 90.16 7.8 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.527 0.68 . . . . 0.0 109.952 178.323 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -95.04 113.97 25.73 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.556 -179.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 68.48 -69.24 0.38 Allowed Glycine 0 CA--C 1.524 0.628 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.598 -175.131 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -172.52 25.25 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.959 -0.639 . . . . 0.0 111.749 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -124.11 133.6 53.56 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 120.811 0.339 . . . . 0.0 110.404 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.434 HG22 HD21 ' A' ' 145' ' ' LEU . 9.3 t -81.0 98.39 3.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.293 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.696 ' O ' ' HA ' ' A' ' 143' ' ' LEU . 38.8 mtp85 -101.13 106.39 17.63 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.794 0.33 . . . . 0.0 110.939 -175.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' PHE . . . . . 0.522 ' CE2' HD13 ' A' ' 143' ' ' LEU . 18.0 m-85 -83.56 105.49 14.53 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.467 178.827 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -96.41 112.06 23.94 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.818 0.342 . . . . 0.0 110.719 178.401 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -72.49 124.42 25.15 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 174.525 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -133.42 171.27 14.29 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -177.401 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 139' ' ' SER . 15.1 p -120.69 150.55 40.77 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.853 0.358 . . . . 0.0 111.729 -176.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.402 ' HG ' ' CD1' ' A' ' 140' ' ' TYR . 92.1 mt . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.447 175.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 83.9 t . . . . . 0 N--CA 1.482 1.164 0 CA-C-O 120.703 0.287 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -85.32 150.89 24.44 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 174.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.449 ' HG3' ' CD1' ' A' ' 30' ' ' TYR . 0.2 OUTLIER -145.79 132.49 19.96 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.486 0.66 . . . . 0.0 111.539 -174.137 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.751 ' HE2' HD11 ' A' ' 145' ' ' LEU . 87.0 m-85 -101.66 128.01 48.15 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.306 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.566 HD11 HD11 ' A' ' 23' ' ' ILE . 43.5 tp -91.75 108.06 19.65 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.308 177.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.592 ' HB3' ' HB3' ' A' ' 141' ' ' ALA . 51.0 tp -94.39 118.14 31.17 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.566 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.4 ' CG1' ' HA2' ' A' ' 35' ' ' GLY . 22.4 pt -101.12 115.58 43.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 174.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.8 m -54.94 -69.55 0.13 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.692 -1.14 . . . . 0.0 113.104 -169.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.58 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 26.1 t70 -153.19 105.24 2.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.867 0.365 . . . . 0.0 110.417 -175.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.879 ' H ' ' HA3' ' A' ' 37' ' ' GLY . 5.7 m -110.5 134.45 52.35 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.661 -175.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 13.0 m170 -130.76 86.77 2.41 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 173.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.483 ' O ' HG22 ' A' ' 40' ' ' VAL . 48.0 t -128.96 125.68 22.94 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.456 -175.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -78.97 -48.11 0.28 Allowed 'Cis proline' 0 CA--C 1.532 0.389 0 C-N-CA 122.904 -1.707 . . . . 0.0 112.8 -2.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.433 ' CG2' HG11 ' A' ' 40' ' ' VAL . 37.9 t 51.46 -94.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 123.53 0.732 . . . . 0.0 111.605 -178.247 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.46 ' HA ' ' HD2' ' A' ' 15' ' ' ARG . 17.5 tpt180 -148.43 22.81 1.04 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.535 0.684 . . . . 0.0 109.391 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.455 ' C ' ' H ' ' A' ' 18' ' ' SER . 53.5 ttp -119.63 -72.42 0.69 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.688 178.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 64.67 -12.94 0.11 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.552 0.741 . . . . 0.0 112.788 178.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.455 ' H ' ' C ' ' A' ' 16' ' ' MET . 11.9 m -83.64 58.03 4.39 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.263 0.554 . . . . 0.0 110.875 -177.195 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.92 ' HG ' HD11 ' A' ' 135' ' ' LEU . 6.5 tt -107.84 119.04 51.45 Favored Pre-proline 0 C--N 1.321 -0.632 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 177.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 19' ' ' LEU . 18.1 Cg_endo -61.1 111.04 0.97 Allowed 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.286 1.99 . . . . 0.0 111.411 176.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -71.65 -7.08 45.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.415 -174.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -56.42 -43.08 79.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.174 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.566 HD11 HD11 ' A' ' 5' ' ' LEU . 9.7 tt -70.82 -35.84 61.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.515 0.674 . . . . 0.0 110.19 -178.021 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.725 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 59.4 tp -63.0 -32.0 73.27 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.454 177.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -75.27 -19.39 59.74 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.704 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 64.0 m -93.11 12.21 25.03 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.152 -174.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.725 ' HG ' ' O ' ' A' ' 24' ' ' LEU . 9.9 mt -63.96 -19.1 64.9 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.979 0.419 . . . . 0.0 110.349 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -52.88 -36.06 58.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.999 176.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -94.11 3.48 55.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.332 -174.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.472 ' CD1' ' HB2' ' A' ' 5' ' ' LEU . 90.6 m-85 -118.38 106.67 12.98 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.181 0.515 . . . . 0.0 110.341 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -75.62 4.92 6.77 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.873 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.577 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -163.74 109.49 0.38 Allowed Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 175.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 90.8 t -100.08 126.52 53.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 O-C-N 122.458 -0.436 . . . . 0.0 110.119 178.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 51.4 mt -105.33 123.51 59.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 120.87 0.366 . . . . 0.0 110.158 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.4 ' HA2' ' CG1' ' A' ' 7' ' ' ILE . . . -114.64 103.06 1.23 Allowed Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 120.512 -0.852 . . . . 0.0 112.648 -177.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.493 HD21 ' HB3' ' A' ' 86' ' ' MET . 70.9 mt -85.3 -30.95 23.33 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 172.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.879 ' HA3' ' H ' ' A' ' 10' ' ' SER . . . -112.1 123.1 6.21 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 171.018 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -99.88 164.77 11.87 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.551 0.691 . . . . 0.0 112.754 -169.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.414 ' CD1' HD21 ' A' ' 48' ' ' LEU . 60.0 m-85 -85.85 127.13 34.5 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 168.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.483 HG22 ' O ' ' A' ' 12' ' ' VAL . 3.8 m -80.96 -9.5 11.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -165.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.502 ' O ' HG23 ' A' ' 45' ' ' VAL . 2.3 m-20 -86.9 125.87 34.3 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 176.036 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 38.9 tp -60.75 -36.0 77.79 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.369 0.604 . . . . 0.0 109.503 178.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -57.28 -44.95 84.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.227 175.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.492 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 14.9 m -71.98 -25.09 61.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.023 -177.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 41' ' ' ASP . 61.0 t -62.66 -42.71 97.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.075 0.464 . . . . 0.0 110.174 175.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.45 -36.55 77.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-O 121.263 0.554 . . . . 0.0 109.724 175.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.59 -32.97 74.6 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.455 175.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 44' ' ' THR . 89.0 mt -64.46 -43.07 95.38 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 176.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.471 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 29.6 tt0 -69.41 -14.87 63.13 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.02 178.032 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -85.21 -49.73 7.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.662 178.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.457 ' CB ' HD12 ' A' ' 27' ' ' LEU . 28.3 m-85 -65.29 -57.01 9.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.842 178.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.645 ' HB3' HD13 ' A' ' 27' ' ' LEU . 83.0 p -77.62 -38.65 47.55 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.709 0.29 . . . . 0.0 111.214 -175.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.471 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 53.6 mttp 69.67 7.79 6.41 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.721 -178.045 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 179.0 111.01 0.03 OUTLIER 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.805 174.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -136.71 152.83 50.8 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.999 0.428 . . . . 0.0 110.682 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.545 ' HE2' ' HE1' ' A' ' 4' ' ' PHE . 40.2 m-85 -118.18 113.79 22.08 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 176.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -116.53 152.51 17.87 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.198 -1.001 . . . . 0.0 112.84 -174.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.635 HG21 ' HB2' ' A' ' 86' ' ' MET . 31.0 t -128.92 113.63 29.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 175.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 14.5 t-80 -94.24 104.18 16.19 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.896 -172.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.437 ' HA3' ' O ' ' A' ' 88' ' ' HIS . . . -132.54 32.16 2.86 Favored Glycine 0 N--CA 1.444 -0.816 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 174.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -101.23 154.85 18.41 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.608 -0.796 . . . . 0.0 109.957 -178.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 94.8 mmm -90.47 39.73 0.99 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.497 -172.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.45 ' HB3' ' H ' ' A' ' 64' ' ' TYR . 8.7 m-20 -118.76 -143.81 0.37 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.702 0.287 . . . . 0.0 111.556 -178.53 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.453 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 78.7 m-85 -69.86 127.33 92.56 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.114 0.483 . . . . 0.0 111.85 -169.123 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 64' ' ' TYR . 11.8 Cg_exo -71.1 -14.35 31.83 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.353 2.702 . . . . 0.0 111.995 179.028 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -60.86 -32.91 72.32 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.459 0.647 . . . . 0.0 110.567 178.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.442 HG12 HD21 ' A' ' 71' ' ' LEU . 47.0 t -73.09 -20.07 18.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.678 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.489 ' HE2' ' HB2' ' A' ' 73' ' ' PHE . 64.5 tttm -72.88 -12.44 60.97 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.676 -174.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -84.15 -10.01 58.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.003 0.43 . . . . 0.0 111.001 177.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 57.4 m-70 -103.36 -28.94 11.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.147 0.498 . . . . 0.0 109.861 177.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.442 HD21 HG12 ' A' ' 67' ' ' VAL . 0.3 OUTLIER -138.99 119.51 9.68 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.671 174.708 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -66.56 177.26 3.47 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 123.167 2.578 . . . . 0.0 112.938 -175.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.489 ' HB2' ' HE2' ' A' ' 68' ' ' LYS . 70.5 t80 -70.26 -29.15 65.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.141 0.496 . . . . 0.0 110.552 -177.163 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.482 ' HA ' HG13 ' A' ' 58' ' ' VAL . 10.2 p -147.74 142.06 26.27 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.948 178.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 32.1 tttm -142.41 141.08 32.19 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.807 -178.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.539 HG23 ' CE1' ' A' ' 104' ' ' PHE . 56.6 t -114.53 139.28 41.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.896 174.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 58.6 mt -114.45 144.22 43.67 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.17 177.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 54.9 tp -109.52 96.24 6.14 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 175.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 24.0 t -111.68 96.09 4.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.914 -173.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.424 ' OE1' ' HA2' ' A' ' 148' ' ' GLY . 42.6 mt-10 54.13 38.66 29.56 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.132 175.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 107.99 -31.57 7.83 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.343 177.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 60.2 t -81.66 115.1 23.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.005 0.431 . . . . 0.0 110.937 -177.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.07 105.64 14.22 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.071 176.107 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.427 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 15.8 mt -94.8 106.85 18.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.625 -177.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.536 ' HA2' HG22 ' A' ' 76' ' ' VAL . . . -93.09 110.19 3.91 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 176.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.635 ' HB2' HG21 ' A' ' 58' ' ' VAL . 43.5 mtm -107.99 129.71 55.1 Favored 'General case' 0 C--N 1.317 -0.834 0 O-C-N 122.419 -0.46 . . . . 0.0 110.822 -174.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 79.0 m -149.34 116.9 6.17 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.534 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.437 ' O ' ' HA3' ' A' ' 60' ' ' GLY . 41.8 t-80 -97.07 127.88 43.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.233 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 169.32 -125.53 1.27 Allowed Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.395 178.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 29.2 p90 -153.71 165.89 34.56 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.676 0.274 . . . . 0.0 110.488 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 171.61 148.21 6.01 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.877 177.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -76.43 155.36 83.84 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 176.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_exo -51.76 -33.56 50.68 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.67 2.247 . . . . 0.0 112.542 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -76.38 -53.97 7.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.926 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -62.68 -37.68 87.38 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.022 -176.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 30.5 tp -51.42 -60.71 2.83 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 122.705 0.402 . . . . 0.0 112.0 -171.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -60.68 -41.46 95.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.44 -176.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -73.81 -39.52 64.04 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.992 0.425 . . . . 0.0 111.325 -176.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.412 ' O ' HG23 ' A' ' 103' ' ' VAL . 74.5 ttt180 -68.36 -40.96 81.29 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.827 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.551 HD13 HG21 ' A' ' 111' ' ' ILE . 89.5 mt -70.23 -32.6 70.53 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.027 -178.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 96.8 mt -78.21 -11.55 59.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.332 0.587 . . . . 0.0 110.221 175.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -86.21 -47.54 9.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.942 173.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 99' ' ' ARG . 89.0 t -63.21 -46.25 96.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.087 177.099 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.539 ' CE1' HG23 ' A' ' 76' ' ' VAL . 25.6 m-85 -101.61 102.63 13.37 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.227 176.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -59.8 -36.06 75.97 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.584 -177.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -100.97 125.86 47.58 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 172.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.502 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 0.0 OUTLIER -60.78 126.7 85.97 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.779 -173.989 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.502 ' HD3' ' HA ' ' A' ' 107' ' ' LYS . 5.4 Cg_exo -75.13 150.18 37.23 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.696 2.264 . . . . 0.0 110.558 173.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -75.54 -48.9 20.44 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.338 0.59 . . . . 0.0 109.66 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 66.0 t -126.68 131.1 71.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.549 178.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.551 HG21 HD13 ' A' ' 100' ' ' LEU . 57.5 mt -114.82 134.25 58.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 120.686 0.279 . . . . 0.0 110.94 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.599 HD23 ' HB2' ' A' ' 130' ' ' LEU . 82.8 mt -105.04 118.52 36.73 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.243 177.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.431 ' CE1' ' HB3' ' A' ' 129' ' ' PHE . 16.9 p90 -133.91 127.47 32.55 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.094 0.473 . . . . 0.0 110.054 177.13 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -106.11 126.78 8.67 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.777 -0.725 . . . . 0.0 111.805 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 21.6 t60 -172.42 -44.42 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.27 0.557 . . . . 0.0 109.772 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.7 t -92.68 142.11 27.73 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.529 175.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 1.02 ' HA ' ' HA2' ' A' ' 133' ' ' GLY . 23.3 p-80 -97.87 4.66 49.6 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.044 0.45 . . . . 0.0 110.762 -178.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -108.19 106.41 58.54 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.441 174.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.27 127.19 13.85 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.961 2.441 . . . . 0.0 112.603 -174.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -142.27 139.87 32.04 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.361 173.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -78.28 103.91 8.52 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 175.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.532 ' HB ' ' HE2' ' A' ' 124' ' ' LYS . 60.8 p -111.91 121.42 45.0 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.597 -172.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.8 p -106.94 110.31 31.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.294 0.568 . . . . 0.0 110.244 176.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.532 ' HE2' ' HB ' ' A' ' 122' ' ' THR . 72.5 mmtt -123.9 127.36 47.88 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.805 -178.007 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 65.6 13.14 8.73 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 123.465 0.478 . . . . 0.0 111.773 177.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 94.31 4.46 62.64 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.511 -178.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 43.3 t -106.44 140.26 25.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 177.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -94.0 113.41 25.39 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.86 0.362 . . . . 0.0 110.249 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.513 ' CE1' ' HB2' ' A' ' 124' ' ' LYS . 76.9 m-85 -103.03 124.69 49.0 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.259 -178.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.599 ' HB2' HD23 ' A' ' 112' ' ' LEU . 83.5 mt -108.87 130.86 55.43 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.737 176.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -122.84 111.51 31.0 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.195 -176.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -82.28 152.7 16.04 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.737 2.291 . . . . 0.0 111.568 173.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 1.02 ' HA2' ' HA ' ' A' ' 117' ' ' HIS . . . -67.49 -129.01 0.03 OUTLIER Glycine 0 CA--C 1.524 0.619 0 O-C-N 123.506 0.504 . . . . 0.0 114.138 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 7.9 m -128.44 179.61 5.55 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 122.224 -0.574 . . . . 0.0 111.159 -176.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.92 HD11 ' HG ' ' A' ' 19' ' ' LEU . 1.1 tm? -73.22 -69.3 0.43 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.7 -179.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -75.0 13.2 0.71 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.606 -171.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -107.69 6.97 28.22 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.921 0.391 . . . . 0.0 110.512 177.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 69.47 42.37 73.62 Favored Glycine 0 C--N 1.332 0.346 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.981 174.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 13.0 p -132.98 99.17 4.5 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.901 0.382 . . . . 0.0 111.272 -178.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -113.51 155.5 25.24 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 174.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.592 ' HB3' ' HB3' ' A' ' 6' ' ' LEU . . . -114.49 128.39 56.31 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.115 0.483 . . . . 0.0 111.03 -176.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 40.2 t -111.46 117.48 55.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.6 175.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.749 HD23 ' HA ' ' A' ' 152' ' ' PHE . 57.7 mt -96.67 113.64 25.22 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.077 177.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -108.04 130.55 55.07 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.735 -176.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.751 HD11 ' HE2' ' A' ' 4' ' ' PHE . 74.0 mt -99.14 116.44 31.35 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.028 -177.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.473 ' HB3' ' NH1' ' A' ' 151' ' ' ARG . 27.3 t70 -146.83 130.78 17.19 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.693 177.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.85 11.31 60.35 Favored Glycine 0 CA--C 1.521 0.445 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.974 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.424 ' HA2' ' OE1' ' A' ' 80' ' ' GLU . . . 84.12 30.89 27.16 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.318 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -126.99 135.14 50.44 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.718 0.295 . . . . 0.0 110.817 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 44.3 t -84.38 108.31 16.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 174.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.473 ' NH1' ' HB3' ' A' ' 146' ' ' ASP . 96.5 mtt180 -106.18 120.62 42.3 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.053 0.454 . . . . 0.0 111.011 -174.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' PHE . . . . . 0.749 ' HA ' HD23 ' A' ' 143' ' ' LEU . 74.0 t80 -92.62 112.89 25.0 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.216 -173.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -122.04 103.8 9.06 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.852 0.358 . . . . 0.0 110.588 173.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 20.2 tp -79.0 100.38 7.29 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 174.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -93.9 138.02 32.49 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.499 -173.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 34.9 p -94.03 150.57 20.22 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.352 -174.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 10.1 mp . . . . . 0 C--O 1.245 0.866 0 CA-C-O 118.62 -0.705 . . . . 0.0 109.49 175.725 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 59.2 t . . . . . 0 N--CA 1.479 0.999 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -133.85 155.65 49.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.576 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 89.2 mtt-85 -123.41 132.53 53.99 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.218 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.408 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 74.2 m-85 -118.06 128.06 54.39 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.846 174.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.557 ' HB3' HG22 ' A' ' 33' ' ' VAL . 33.9 tp -89.57 134.23 34.22 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.789 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.408 ' HB3' ' HB3' ' A' ' 141' ' ' ALA . 50.3 tp -119.32 109.16 15.48 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.193 0.521 . . . . 0.0 111.314 -178.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.417 HG13 ' HA2' ' A' ' 35' ' ' GLY . 17.4 pt -102.24 112.39 35.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 172.032 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.426 ' HB2' ' H ' ' A' ' 9' ' ' ASP . 1.1 m -76.05 -90.17 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -166.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.426 ' H ' ' HB2' ' A' ' 8' ' ' SER . 24.3 t70 -108.54 110.83 22.4 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.611 -173.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.795 ' HB3' ' HA ' ' A' ' 38' ' ' ASP . 42.2 t -123.9 134.08 53.61 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 121.477 0.656 . . . . 0.0 110.215 178.234 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 26.6 m170 -125.55 38.22 4.21 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.583 HG21 HD12 ' A' ' 19' ' ' LEU . 61.3 t -94.11 138.13 22.69 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.927 -175.225 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.444 ' HA ' HG13 ' A' ' 12' ' ' VAL . 5.3 Cg_exo -80.27 -60.64 0.04 OUTLIER 'Cis proline' 0 C--N 1.345 0.365 0 C-N-CA 123.526 -1.447 . . . . 0.0 112.072 -3.165 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 26.4 t 54.16 -86.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 O-C-N 123.882 0.739 . . . . 0.0 111.462 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 29.2 ttt180 -144.73 12.74 1.48 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.163 0.506 . . . . 0.0 109.915 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 43.0 ttp -131.39 105.1 7.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.797 -176.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -97.31 13.25 30.2 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.017 0.437 . . . . 0.0 110.854 177.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.9 m -81.95 40.68 0.62 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.864 -175.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.759 ' HG ' HD13 ' A' ' 135' ' ' LEU . 3.6 tt -107.75 104.3 52.57 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 174.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -61.88 124.57 14.75 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 123.036 2.491 . . . . 0.0 112.564 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -71.93 -8.03 52.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.753 -176.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -61.04 -49.59 76.74 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.253 -177.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.482 HD11 HD11 ' A' ' 5' ' ' LEU . 6.9 tt -71.93 -31.58 41.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.714 0.769 . . . . 0.0 110.085 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.494 ' HA ' HD23 ' A' ' 27' ' ' LEU . 59.1 tp -56.9 -33.09 66.58 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.182 -1.372 . . . . 0.0 110.915 178.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -74.27 -36.45 63.82 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.676 178.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.6 m -76.53 7.75 4.19 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.875 -175.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.908 HD12 ' HB3' ' A' ' 52' ' ' SER . 1.4 mm? -53.68 -33.66 56.12 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.008 0.432 . . . . 0.0 111.579 176.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 28.2 mttp -87.21 7.51 28.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.487 -170.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -95.6 -18.94 20.16 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -176.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -105.63 156.15 18.54 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.926 0.393 . . . . 0.0 111.806 -170.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -60.96 -54.5 44.29 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.854 177.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -143.51 151.57 23.41 Favored Glycine 0 N--CA 1.44 -1.068 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.993 178.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.621 HG21 HD13 ' A' ' 27' ' ' LEU . 99.3 t -122.58 136.4 59.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-O 120.731 0.3 . . . . 0.0 110.216 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.555 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 45.9 mt -107.98 120.97 60.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.376 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.417 ' HA2' HG13 ' A' ' 7' ' ' ILE . . . -108.13 111.14 3.28 Favored Glycine 0 N--CA 1.442 -0.945 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 176.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.522 ' HA ' HG23 ' A' ' 58' ' ' VAL . 81.5 mt -85.91 27.59 0.87 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.903 0.382 . . . . 0.0 110.175 -178.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 117.74 81.91 0.84 Allowed Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -174.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.795 ' HA ' ' HB3' ' A' ' 10' ' ' SER . 3.2 p-10 -96.6 -95.11 0.2 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -173.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.429 ' H ' ' CG ' ' A' ' 38' ' ' ASP . 79.9 m-85 -95.4 138.17 33.45 Favored 'General case' 0 C--N 1.318 -0.792 0 O-C-N 121.897 -0.502 . . . . 0.0 110.313 -178.418 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.7 m -79.05 -9.88 12.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.364 0.602 . . . . 0.0 109.906 178.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.536 ' O ' HG23 ' A' ' 45' ' ' VAL . 43.0 m-20 -86.59 121.68 29.45 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.598 177.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.51 ' O ' HD13 ' A' ' 46' ' ' ILE . 47.1 tp -57.45 -43.1 83.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.416 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -52.22 -45.02 65.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.561 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.1 m -78.55 -27.45 45.88 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.278 -175.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 41' ' ' ASP . 94.6 t -61.77 -44.43 98.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.174 0.511 . . . . 0.0 109.742 174.044 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.51 HD13 ' O ' ' A' ' 42' ' ' LEU . 1.7 mp -65.02 -36.58 78.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.7 176.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.36 -37.57 83.8 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.674 175.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 22.9 mt -73.85 -37.09 64.92 Favored 'General case' 0 CA--C 1.514 -0.426 0 C-N-CA 120.434 -0.507 . . . . 0.0 110.158 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.486 ' HA ' ' HB2' ' A' ' 55' ' ' PHE . 32.9 tt0 -63.64 -26.36 68.64 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.824 175.014 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -84.03 -49.65 8.73 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.513 178.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.524 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . 4.7 m-85 -54.62 -55.61 27.72 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 177.158 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.908 ' HB3' HD12 ' A' ' 27' ' ' LEU . 78.7 p -77.59 -20.25 54.3 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.213 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 52' ' ' SER . 96.5 mttt 72.97 -56.5 0.66 Allowed 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.638 0.775 . . . . 0.0 110.529 -173.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -106.63 90.55 3.36 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.859 177.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.486 ' HB2' ' HA ' ' A' ' 49' ' ' GLU . 58.4 t80 -106.04 117.03 32.97 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.476 -178.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.555 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 87.7 m-85 -108.13 108.07 18.98 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 176.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -125.15 164.51 18.7 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 119.854 -1.165 . . . . 0.0 113.508 -173.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.522 HG23 ' HA ' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -136.12 -174.42 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.115 -0.542 . . . . 0.0 109.914 175.096 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.685 ' CE1' ' HA ' ' A' ' 68' ' ' LYS . 7.0 t60 -94.12 125.52 38.8 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.619 -171.321 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -98.47 -53.58 1.22 Allowed Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.792 -0.718 . . . . 0.0 113.316 -174.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -110.07 -154.01 0.53 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -176.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 70.3 mtm -71.66 -43.56 65.83 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 164.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 60.45 -173.15 0.12 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 114.537 -1.211 . . . . 0.0 111.515 175.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -92.2 155.19 42.97 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.365 177.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -52.54 -31.94 51.29 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 123.285 2.656 . . . . 0.0 112.999 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.496 ' HB3' HD22 ' A' ' 42' ' ' LEU . 29.2 m-20 -66.62 -42.57 86.58 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.32 0.581 . . . . 0.0 110.371 178.15 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 42.8 t -72.97 -27.01 23.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.754 177.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.685 ' HA ' ' CE1' ' A' ' 59' ' ' HIS . 88.4 tttt -62.54 -28.4 69.83 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.712 177.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -94.36 -44.87 7.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.375 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -72.32 -30.7 65.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.061 -174.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 58.5 mt -117.56 103.92 50.29 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 177.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -63.65 157.0 53.92 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 123.308 2.672 . . . . 0.0 112.526 -177.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -66.85 -40.32 87.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.618 -177.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.1 m -145.43 130.13 18.05 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.217 177.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.401 ' HG2' ' N ' ' A' ' 76' ' ' VAL . 53.7 tttp -129.66 159.56 36.05 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.201 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 12.5 t -134.34 120.41 33.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 177.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.456 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 96.1 mt -98.7 140.89 32.24 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.933 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 51.0 tp -111.62 94.97 5.22 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 173.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 46.4 t -115.26 107.05 21.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.407 -174.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 58.54 31.73 21.36 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.985 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.59 -10.66 70.74 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.582 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.4 t -88.14 125.48 41.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.939 0.4 . . . . 0.0 111.045 -178.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 50.6 p -88.19 125.27 34.53 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.269 176.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.505 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 29.2 mt -116.21 103.98 15.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -83.97 114.17 3.85 Favored Glycine 0 C--O 1.223 -0.563 0 N-CA-C 111.307 -0.717 . . . . 0.0 111.307 177.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.442 ' SD ' ' HG ' ' A' ' 77' ' ' LEU . 21.4 mtp -107.09 118.43 36.68 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.575 0.187 . . . . 0.0 110.897 -174.084 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 113' ' ' PHE . 11.6 t -148.1 165.08 31.92 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.236 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.434 ' HB3' ' O ' ' A' ' 59' ' ' HIS . 3.3 t-160 -156.16 109.51 2.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.618 0.246 . . . . 0.0 110.359 -178.169 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 152.18 -173.96 31.24 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.363 -0.922 . . . . 0.0 112.336 176.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 6.5 m0 66.59 -173.46 0.19 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.45 0.643 . . . . 0.0 112.168 177.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -170.85 177.63 43.78 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.673 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.486 ' HB1' ' CD1' ' A' ' 94' ' ' TRP . . . 62.59 96.3 0.05 OUTLIER Pre-proline 0 N--CA 1.464 0.262 0 CA-C-O 121.396 0.617 . . . . 0.0 110.65 -175.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.483 ' HA ' ' HB3' ' A' ' 96' ' ' LEU . 7.5 Cg_exo -73.2 7.66 2.05 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 123.375 2.717 . . . . 0.0 113.666 -172.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.486 ' CD1' ' HB1' ' A' ' 92' ' ' ALA . 52.5 m95 -59.31 -54.57 45.25 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.132 0.491 . . . . 0.0 110.544 -178.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -117.44 7.64 12.81 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.321 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.483 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . 29.5 tp -60.85 -46.72 89.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.739 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.527 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 58.7 mttp -58.49 -44.48 89.4 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.174 0.512 . . . . 0.0 110.254 179.174 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.4 ' HA ' HD12 ' A' ' 101' ' ' LEU . 7.7 m-20 -70.64 -30.65 67.34 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.051 -177.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 25.8 ttm180 -71.74 -40.89 69.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.462 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.495 HD13 HG21 ' A' ' 111' ' ' ILE . 66.7 mt -67.9 -27.34 66.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.803 178.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' A' ' 97' ' ' LYS . 96.6 mt -70.08 -24.29 63.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.038 0.446 . . . . 0.0 110.742 175.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -77.32 -30.61 54.15 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.9 t -76.17 -49.29 25.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.955 174.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -99.67 85.96 3.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.054 177.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -76.79 -2.56 33.8 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.919 -173.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -79.93 -13.14 59.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.357 174.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 14.7 ttpp 57.15 83.2 0.23 Allowed Pre-proline 0 C--O 1.235 0.319 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.728 -171.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.21 174.6 10.49 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.503 2.135 . . . . 0.0 112.715 -174.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -89.63 -49.06 6.88 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.524 177.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.513 HG21 HG11 ' A' ' 150' ' ' VAL . 66.7 t -121.75 131.77 72.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.718 -177.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.495 HG21 HD13 ' A' ' 100' ' ' LEU . 53.2 mt -122.81 125.12 71.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.954 0.407 . . . . 0.0 110.455 174.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 85.7 mt -101.91 115.66 31.02 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.71 177.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.508 ' CZ ' ' HB2' ' A' ' 131' ' ' ASN . 18.2 p90 -127.4 134.75 49.88 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 175.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -105.92 114.87 4.63 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 119.997 -1.097 . . . . 0.0 112.249 -177.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 53.9 t60 -145.16 105.95 4.13 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 176.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 88.0 m -52.7 113.37 1.06 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.974 -177.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 14.3 t-80 -171.25 -79.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.299 177.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.449 ' HA ' ' HD3' ' A' ' 119' ' ' PRO . 50.3 mt-10 -147.69 142.32 16.58 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.24 178.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.654 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 5.6 Cg_exo -78.05 126.72 8.04 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.706 2.27 . . . . 0.0 111.058 172.007 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -154.6 148.44 25.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.872 0.368 . . . . 0.0 111.299 -179.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -99.66 121.28 41.0 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.723 175.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.541 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 73.3 p -129.01 149.98 50.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.839 0.352 . . . . 0.0 111.879 -173.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.6 p -147.64 149.33 15.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.077 177.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -163.23 -55.56 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.627 0.727 . . . . 0.0 110.309 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.527 ' CB ' HD11 ' A' ' 101' ' ' LEU . . . -93.83 23.58 4.72 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.316 -173.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 74.96 1.07 61.73 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 -173.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 21.9 t -106.12 139.83 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 177.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 51.6 ttt180 -96.31 110.4 22.73 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.062 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.541 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 78.1 m-85 -95.66 117.43 30.47 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.705 -178.385 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 78.7 mt -113.0 116.26 29.67 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.437 -176.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.654 ' O ' ' HA ' ' A' ' 119' ' ' PRO . 9.1 t30 -109.14 107.82 60.06 Favored Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 172.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -83.11 -173.38 1.66 Allowed 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 123.171 2.581 . . . . 0.0 112.817 -176.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -85.32 161.28 35.51 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.592 -178.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.459 ' HB2' ' HG2' ' A' ' 137' ' ' GLU . 18.1 m -97.37 159.72 14.75 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.703 0.287 . . . . 0.0 110.559 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.76 HD11 ' HB2' ' A' ' 10' ' ' SER . 12.3 mt -61.5 -49.35 77.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.68 -172.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -66.81 -17.08 64.7 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.419 -177.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.459 ' HG2' ' HB2' ' A' ' 134' ' ' SER . 8.2 mm-40 -86.22 -1.36 57.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.724 -178.055 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 70.8 29.48 69.33 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.466 177.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 22.2 t -138.28 122.01 17.54 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.022 0.439 . . . . 0.0 110.792 -177.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.565 ' CE2' HD22 ' A' ' 135' ' ' LEU . 22.6 m-85 -116.47 177.94 4.51 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.384 175.041 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.408 ' HB3' ' HB3' ' A' ' 6' ' ' LEU . . . -126.76 132.83 50.98 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.985 0.422 . . . . 0.0 111.198 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 58.9 t -113.54 119.13 60.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 174.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.477 ' HA ' ' O ' ' A' ' 151' ' ' ARG . 3.3 tt -95.9 116.08 28.39 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.186 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.772 ' HB2' ' HB2' ' A' ' 151' ' ' ARG . 56.6 mt-10 -100.89 139.87 35.98 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.906 -177.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 47.7 mt -110.57 90.14 3.24 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 166.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -104.93 113.2 26.66 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.293 -176.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.92 -67.51 0.32 Allowed Glycine 0 CA--C 1.52 0.348 0 O-C-N 123.527 0.517 . . . . 0.0 112.288 -174.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -174.77 25.52 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 178.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -110.41 133.81 52.92 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 -177.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.513 HG11 HG21 ' A' ' 110' ' ' VAL . 21.5 t -79.64 103.52 6.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 176.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.772 ' HB2' ' HB2' ' A' ' 144' ' ' GLU . 56.6 mtt180 -110.02 148.03 32.44 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.084 -174.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -143.01 123.3 13.8 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.556 175.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -119.02 132.27 56.04 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.846 0.355 . . . . 0.0 110.334 178.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -76.01 113.63 13.74 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.455 176.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -96.38 119.04 34.14 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.248 -177.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.4 m -93.21 147.21 23.09 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.853 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 10.2 mp . . . . . 0 C--O 1.247 0.957 0 CA-C-O 118.827 -0.606 . . . . 0.0 110.623 -177.716 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 31.4 t . . . . . 0 N--CA 1.476 0.847 0 CA-C-O 121.033 0.444 . . . . 0.0 110.081 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.461 ' HD2' HG13 ' A' ' 79' ' ' VAL . 50.0 mttp -92.03 129.61 37.95 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.084 0.469 . . . . 0.0 110.882 177.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 56.1 mtt180 -107.66 112.32 24.97 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.62 176.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.627 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 53.7 m-85 -101.79 129.49 48.0 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.442 0.639 . . . . 0.0 111.518 -175.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.556 ' HB3' HG22 ' A' ' 33' ' ' VAL . 27.3 tp -89.18 114.76 26.1 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.094 174.021 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.623 HD11 ' HG ' ' A' ' 36' ' ' LEU . 45.0 tp -100.4 111.9 24.2 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.93 0.395 . . . . 0.0 110.668 -177.256 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.485 HG13 ' HA2' ' A' ' 35' ' ' GLY . 23.9 pt -100.98 120.12 50.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 176.162 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.772 ' HB2' ' HA ' ' A' ' 134' ' ' SER . 13.2 m -75.87 -169.04 1.0 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.799 -172.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.776 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 11.2 t70 -59.42 98.6 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.293 -179.148 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.0 m -109.26 128.46 55.09 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.852 -175.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.72 ' HB3' ' HB ' ' A' ' 14' ' ' VAL . 24.3 m170 -102.26 76.0 1.54 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.421 0.629 . . . . 0.0 109.696 179.069 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.493 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -135.74 127.14 17.27 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.1 -179.091 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 34.9 Cg_endo -93.19 91.68 0.14 OUTLIER 'Cis proline' 0 N--CA 1.45 -1.055 0 C-N-CA 123.013 -1.661 . . . . 0.0 113.049 -2.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.72 ' HB ' ' HB3' ' A' ' 11' ' ' HIS . 3.0 t -120.27 -170.1 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 173.056 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.694 ' H ' HG12 ' A' ' 14' ' ' VAL . 55.2 mtt180 -68.73 83.94 0.3 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 118.91 0.777 . . . . 0.0 111.099 177.254 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 39.9 ttp -165.13 -71.5 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.658 -1.155 . . . . 0.0 108.444 177.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 58.94 9.06 1.1 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.671 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.0 m -76.54 15.82 0.57 Allowed 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 112.432 0.531 . . . . 0.0 112.432 -176.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.1 tt -107.64 102.18 43.53 Favored Pre-proline 0 C--N 1.323 -0.568 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -88.92 167.22 5.73 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.905 2.403 . . . . 0.0 113.548 -175.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -60.59 -23.58 64.78 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.242 178.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -62.07 -13.26 24.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.368 -176.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 tt -102.03 -33.4 3.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.298 0.57 . . . . 0.0 109.869 174.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.657 ' HA ' HD23 ' A' ' 27' ' ' LEU . 47.1 tp -72.13 -30.78 65.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.814 -176.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -66.48 -28.9 68.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.195 0.522 . . . . 0.0 110.338 177.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.9 m -72.96 -8.28 54.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.518 -176.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.757 HD13 HG21 ' A' ' 33' ' ' VAL . 4.3 mm? -58.87 -27.69 65.41 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.012 0.434 . . . . 0.0 110.959 176.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -85.31 -7.88 58.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.848 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -98.58 -39.96 8.45 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.208 -176.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.49 ' CD2' ' HB2' ' A' ' 5' ' ' LEU . 89.0 m-85 -86.98 147.12 25.88 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -92.13 -18.31 23.71 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.886 0.374 . . . . 0.0 110.435 -179.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.627 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -135.92 143.25 14.69 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 175.141 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.757 HG21 HD13 ' A' ' 27' ' ' LEU . 64.3 t -136.3 137.36 48.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 117.093 0.447 . . . . 0.0 110.485 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.567 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 39.0 mt -121.91 129.24 75.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.843 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.485 ' HA2' HG13 ' A' ' 7' ' ' ILE . . . -112.07 102.26 1.35 Allowed Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.918 177.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.623 ' HG ' HD11 ' A' ' 6' ' ' LEU . 85.8 mt -80.31 -32.61 37.98 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 176.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.776 ' HA3' ' HA ' ' A' ' 9' ' ' ASP . . . -138.16 62.78 0.57 Allowed Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 175.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -70.5 -172.5 0.61 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.024 0.44 . . . . 0.0 111.476 -175.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.578 ' HD1' HD11 ' A' ' 48' ' ' LEU . 81.2 m-85 -58.76 142.18 50.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.095 -177.028 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.585 ' HB ' ' HB3' ' A' ' 63' ' ' ASP . 15.7 m -85.59 16.14 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.318 0.58 . . . . 0.0 110.816 -176.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.461 ' O ' HG23 ' A' ' 45' ' ' VAL . 12.5 t70 -119.94 124.81 46.9 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.463 -178.212 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 53.2 tp -61.34 -39.49 90.77 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.079 -174.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -61.08 -42.46 98.55 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.119 0.485 . . . . 0.0 110.588 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.516 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 16.7 m -68.6 -29.43 67.95 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.118 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.564 HG21 HG13 ' A' ' 67' ' ' VAL . 65.5 t -59.25 -43.46 89.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 121.24 0.543 . . . . 0.0 109.965 174.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.497 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 1.7 mp -63.47 -38.74 83.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.027 176.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.23 -33.59 76.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.529 175.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.578 HD11 ' HD1' ' A' ' 39' ' ' TYR . 92.7 mt -67.97 -32.35 72.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.113 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -79.21 -16.28 56.76 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.195 177.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.497 ' HG3' ' O ' ' A' ' 46' ' ' ILE . 53.9 mtpt -76.61 -54.24 6.94 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 174.154 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.53 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . 62.9 m-85 -65.45 -63.8 1.01 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.716 176.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.535 ' HB2' HD12 ' A' ' 27' ' ' LEU . 41.6 t -84.25 96.56 9.03 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.725 175.235 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 53.0 mttp -64.01 -35.04 79.43 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.192 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -105.45 75.52 1.15 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.33 0.586 . . . . 0.0 109.704 171.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -101.58 125.18 48.19 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.462 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.567 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 91.3 m-85 -121.81 143.98 49.09 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 176.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.517 ' HA3' HD13 ' A' ' 71' ' ' LEU . . . -159.22 164.83 34.07 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 119.444 -1.36 . . . . 0.0 113.506 -176.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 72' ' ' PRO . 2.3 m -138.0 97.75 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.344 0.592 . . . . 0.0 109.447 176.365 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.543 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 11.9 t60 -94.38 146.97 23.68 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.377 -167.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -87.49 -163.22 38.76 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.179 179.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.555 ' HB3' ' HD2' ' A' ' 68' ' ' LYS . 2.0 p-10 -124.65 31.72 5.63 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.956 0.407 . . . . 0.0 110.973 -177.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 2.8 mpp? -76.12 -32.25 59.07 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.286 0.565 . . . . 0.0 109.824 178.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.585 ' HB3' ' HB ' ' A' ' 40' ' ' VAL . 3.8 p-10 -104.81 -111.14 0.26 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.759 -177.004 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.418 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 38.3 m-85 -104.36 135.72 19.29 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.71 0.291 . . . . 0.0 110.78 -174.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 64' ' ' TYR . 31.8 Cg_exo -59.01 -28.2 87.2 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.695 2.264 . . . . 0.0 111.902 178.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -55.77 -38.95 70.55 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.227 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.564 HG13 HG21 ' A' ' 45' ' ' VAL . 16.7 t -76.41 -33.38 23.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.531 -178.227 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.555 ' HD2' ' HB3' ' A' ' 61' ' ' ASN . 86.3 tttt -73.17 -25.41 60.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.107 0.48 . . . . 0.0 110.374 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -78.28 -19.73 53.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.016 0.436 . . . . 0.0 109.98 173.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 9.3 m80 -84.2 -51.4 7.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.189 176.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.543 ' HB2' ' HB2' ' A' ' 59' ' ' HIS . 11.3 mt -107.5 108.41 61.64 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 176.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.412 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 52.8 Cg_exo -54.76 153.85 22.97 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.758 2.305 . . . . 0.0 112.38 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -70.46 -18.48 62.99 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.12 0.486 . . . . 0.0 110.761 -177.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 51.1 m -150.84 131.27 13.77 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.133 178.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 44.7 tttp -149.45 133.15 16.85 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.373 -178.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 19.7 t -106.43 123.69 61.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 178.033 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 64.6 mt -102.02 157.22 17.02 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.545 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 60.3 tp -123.43 100.73 6.97 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 175.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.461 HG13 ' HD2' ' A' ' 2' ' ' LYS . 61.6 t -113.4 102.85 14.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.663 -176.126 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 51.63 42.22 29.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.68 176.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.97 0.15 64.0 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.754 -0.657 . . . . 0.0 113.215 175.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 96.0 t -105.94 129.78 58.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.751 0.31 . . . . 0.0 110.972 178.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.2 p -91.47 123.87 35.21 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.701 176.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.483 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 25.2 mt -116.92 98.28 6.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.451 -176.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.416 ' O ' HG23 ' A' ' 111' ' ' ILE . . . -85.61 98.85 2.31 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.338 178.231 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 35.8 mtm -90.75 131.81 36.21 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -178.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 34.7 t -149.65 165.07 33.44 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -125.72 29.19 6.01 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -66.9 167.5 38.43 Favored Glycine 0 N--CA 1.451 -0.321 0 CA-C-N 115.341 -0.845 . . . . 0.0 113.576 -175.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 54.3 p-90 -126.27 166.01 17.91 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.814 0.34 . . . . 0.0 110.573 -177.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 127.85 170.64 12.87 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.084 -0.579 . . . . 0.0 111.949 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -89.08 164.86 29.27 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 177.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_exo -53.2 -21.12 16.09 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.995 2.463 . . . . 0.0 113.268 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 11.7 m95 -70.66 -34.05 71.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.886 0.374 . . . . 0.0 110.379 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -101.31 -27.38 13.21 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.556 -178.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 37.4 tp -50.65 -57.29 8.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.175 -173.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -62.12 -44.1 97.39 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.075 -177.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -71.9 -14.76 62.03 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.338 -177.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.415 ' O ' HG23 ' A' ' 103' ' ' VAL . 29.0 ttt85 -95.33 -49.95 5.23 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.538 -178.091 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.519 HD13 HG21 ' A' ' 111' ' ' ILE . 79.6 mt -70.3 -34.5 72.81 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.62 -176.294 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.611 HD21 HG21 ' A' ' 127' ' ' VAL . 96.2 mt -75.24 -9.89 58.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.172 0.511 . . . . 0.0 110.411 177.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -91.34 -40.17 11.62 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.854 175.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 99' ' ' ARG . 94.8 t -64.23 -48.12 86.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.108 175.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -87.2 122.89 31.61 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.844 176.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -75.97 -30.83 58.75 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.138 0.494 . . . . 0.0 110.158 -178.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -93.67 179.77 5.26 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.622 175.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -109.35 106.25 58.35 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-O 120.956 0.407 . . . . 0.0 110.917 -178.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -76.51 131.52 12.67 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 123.103 2.535 . . . . 0.0 111.619 178.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -67.84 -40.32 83.74 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.266 178.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.88 HG21 HG21 ' A' ' 150' ' ' VAL . 89.3 t -126.02 135.96 62.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.179 179.285 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.519 HG21 HD13 ' A' ' 100' ' ' LEU . 44.3 mt -125.48 125.48 68.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.894 0.378 . . . . 0.0 110.406 176.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.699 HD23 ' HB2' ' A' ' 130' ' ' LEU . 95.6 mt -104.05 127.94 51.63 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.075 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -155.6 175.64 13.64 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.613 177.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -145.53 114.72 0.78 Allowed Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.731 178.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -165.72 -57.3 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.775 0.321 . . . . 0.0 110.924 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.6 p -82.88 -23.13 33.76 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -177.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 61.97 85.42 0.12 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 122.728 0.411 . . . . 0.0 110.559 -179.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -127.14 94.69 38.39 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.215 -178.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -68.4 67.23 1.08 Allowed 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.612 2.208 . . . . 0.0 111.793 178.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -161.92 153.59 18.77 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.484 -174.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -78.13 95.01 4.8 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 170.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.5 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 51.2 p -92.17 114.42 26.95 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.51 0.671 . . . . 0.0 110.984 -169.087 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.2 p -98.96 95.84 4.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-O 121.946 0.879 . . . . 0.0 110.253 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.654 ' HB2' ' CE1' ' A' ' 129' ' ' PHE . 60.8 mttp -110.81 119.01 37.71 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.517 -178.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 64.32 23.26 13.0 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.009 0.433 . . . . 0.0 111.529 178.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 94.64 -12.98 68.06 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.607 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.611 HG21 HD21 ' A' ' 101' ' ' LEU . 43.2 t -93.6 137.9 21.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.662 0.268 . . . . 0.0 110.41 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -91.79 99.44 12.32 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.239 0.542 . . . . 0.0 110.118 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.654 ' CE1' ' HB2' ' A' ' 124' ' ' LYS . 91.1 m-85 -90.83 136.46 33.05 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.156 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.699 ' HB2' HD23 ' A' ' 112' ' ' LEU . 85.4 mt -122.84 109.02 13.66 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.269 0.557 . . . . 0.0 109.849 177.015 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 -131.33 103.15 15.23 Favored Pre-proline 0 C--N 1.318 -0.764 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.875 177.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -91.45 -177.66 1.05 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.753 2.302 . . . . 0.0 113.906 -170.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -73.98 149.2 40.79 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 173.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.772 ' HA ' ' HB2' ' A' ' 8' ' ' SER . 22.3 m -91.89 170.47 9.84 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 120.963 0.411 . . . . 0.0 111.449 -175.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -60.41 -29.84 69.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.906 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -67.81 -22.81 65.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.022 178.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -94.52 -6.07 44.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.467 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 79.98 39.6 16.25 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.964 -0.562 . . . . 0.0 113.155 176.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 64.5 m -153.73 156.22 37.39 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.714 0.293 . . . . 0.0 110.748 178.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -144.14 168.87 19.0 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 174.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.468 ' HB3' HD23 ' A' ' 6' ' ' LEU . . . -114.58 140.86 48.44 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.045 0.45 . . . . 0.0 111.379 -174.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 40.1 t -112.21 123.75 68.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 173.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.734 HD21 HG13 ' A' ' 150' ' ' VAL . 2.6 tt -107.9 104.76 14.31 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -104.74 113.79 27.59 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.536 -178.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.433 ' O ' ' HA ' ' A' ' 1' ' ' VAL . 4.2 mp -97.1 93.55 6.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.066 0.46 . . . . 0.0 110.454 176.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.535 ' HB3' ' NH1' ' A' ' 151' ' ' ARG . 17.0 t70 -87.72 123.12 32.21 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 175.143 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 68.14 -62.93 0.38 Allowed Glycine 0 CA--C 1.523 0.534 0 O-C-N 123.403 0.439 . . . . 0.0 112.441 -172.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 171.24 34.5 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.534 -0.626 . . . . 0.0 111.534 177.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -121.96 140.33 52.58 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.88 HG21 HG21 ' A' ' 110' ' ' VAL . 90.6 t -80.97 115.44 23.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.595 -175.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.535 ' NH1' ' HB3' ' A' ' 146' ' ' ASP . 78.9 mtt85 -107.82 101.81 11.07 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.92 173.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -90.11 103.65 16.3 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.996 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -120.57 119.35 32.67 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.117 0.484 . . . . 0.0 110.48 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 24.8 tp -88.98 130.82 35.39 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.093 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -121.94 139.62 53.44 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.04 0.448 . . . . 0.0 110.566 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 9.5 p -84.23 162.85 20.02 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.797 -178.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 75.5 mt . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.529 -0.748 . . . . 0.0 109.865 175.571 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 72.3 t . . . . . 0 N--CA 1.482 1.157 0 CA-C-O 120.746 0.307 . . . . 0.0 111.131 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 43.9 mttm -102.3 159.46 15.39 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.353 171.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.489 ' HG2' ' HG3' ' A' ' 144' ' ' GLU . 49.9 mtm-85 -127.15 124.82 39.96 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.702 178.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 95.4 m-85 -108.18 128.04 54.35 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.226 176.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.552 ' HB3' HG22 ' A' ' 33' ' ' VAL . 48.5 tp -89.31 112.1 23.1 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.577 -176.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.458 HD11 ' HG ' ' A' ' 36' ' ' LEU . 60.4 tp -97.64 110.03 22.67 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.037 0.446 . . . . 0.0 110.518 -179.152 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.45 HG13 ' HA2' ' A' ' 35' ' ' GLY . 33.2 pt -101.33 134.74 40.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 176.375 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.6 m -77.05 -167.6 0.91 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.927 -173.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -53.92 117.19 3.0 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.264 178.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.843 ' H ' ' HA3' ' A' ' 37' ' ' GLY . 20.1 m -115.48 127.7 55.5 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.497 -178.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 62.0 m170 -116.39 44.47 1.98 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 175.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.715 HG21 ' HB2' ' A' ' 19' ' ' LEU . 56.1 t -113.12 129.78 24.21 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.871 -175.439 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 59.3 Cg_endo -103.13 94.43 0.12 OUTLIER 'Cis proline' 0 N--CA 1.449 -1.094 0 C-N-CA 123.574 -1.428 . . . . 0.0 112.61 -7.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.606 HG12 ' HG3' ' A' ' 15' ' ' ARG . 14.6 t -100.23 -77.82 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 175.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.606 ' HG3' HG12 ' A' ' 14' ' ' VAL . 60.6 mtt180 -130.77 15.73 5.31 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.432 ' HG2' ' H ' ' A' ' 18' ' ' SER . 37.1 ttp -143.13 130.07 20.58 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.828 -177.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -122.27 12.08 10.17 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.142 0.496 . . . . 0.0 110.372 178.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.432 ' H ' ' HG2' ' A' ' 16' ' ' MET . 3.9 m -78.73 41.22 0.41 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.978 -176.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.715 ' HB2' HG21 ' A' ' 12' ' ' VAL . 4.5 tt -107.65 106.69 59.06 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.308 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.451 ' HD2' ' OH ' ' A' ' 140' ' ' TYR . 51.4 Cg_exo -56.33 122.74 12.31 Favored 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 122.905 2.404 . . . . 0.0 112.515 178.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -73.9 -10.79 60.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.184 -176.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -55.2 -52.01 64.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.357 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.5 tt -69.4 -27.06 32.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.212 0.529 . . . . 0.0 110.446 -177.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.422 ' O ' HD23 ' A' ' 27' ' ' LEU . 52.3 tp -70.37 -16.43 62.97 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.619 178.13 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -89.59 -25.36 21.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.989 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.0 p -83.61 24.31 0.87 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.834 0.349 . . . . 0.0 111.913 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.462 ' CD1' HG21 ' A' ' 33' ' ' VAL . 3.0 mm? -69.58 -8.57 48.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.855 0.359 . . . . 0.0 111.493 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -98.83 -13.13 20.24 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.26 0.552 . . . . 0.0 110.284 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -92.51 -11.32 34.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.185 -175.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -109.46 161.9 14.87 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.799 0.333 . . . . 0.0 110.737 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -86.58 -50.25 6.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.408 0.623 . . . . 0.0 109.894 179.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -139.5 156.55 24.71 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.115 178.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.552 HG22 ' HB3' ' A' ' 5' ' ' LEU . 84.0 t -125.25 137.94 55.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 120.745 0.307 . . . . 0.0 110.412 -179.155 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.526 HG12 ' HB2' ' A' ' 56' ' ' TYR . 34.0 mt -114.59 126.3 72.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.886 177.483 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.45 ' HA2' HG13 ' A' ' 7' ' ' ILE . . . -112.49 107.02 1.97 Allowed Glycine 0 N--CA 1.439 -1.132 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.345 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.458 ' HG ' HD11 ' A' ' 6' ' ' LEU . 89.5 mt -73.96 -24.48 59.63 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 171.4 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.843 ' HA3' ' H ' ' A' ' 10' ' ' SER . . . -140.25 132.59 5.57 Favored Glycine 0 N--CA 1.438 -1.17 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 170.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.522 ' OD2' HG11 ' A' ' 67' ' ' VAL . 18.2 p-10 -112.95 -173.34 2.23 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.311 0.577 . . . . 0.0 111.429 -172.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -84.24 116.7 23.1 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 172.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.85 ' HB ' ' HD2' ' A' ' 64' ' ' TYR . 35.4 m -64.96 -5.87 2.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -168.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.459 ' O ' HG23 ' A' ' 45' ' ' VAL . 19.7 t70 -86.7 120.51 28.07 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 177.258 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 45.3 tp -56.73 -46.18 81.47 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -172.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -66.34 -33.98 76.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.911 0.386 . . . . 0.0 110.603 -178.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.597 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 30.5 m -67.71 -29.23 68.43 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.658 176.067 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 41' ' ' ASP . 74.7 t -62.95 -41.82 94.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 121.058 0.456 . . . . 0.0 110.153 175.082 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.02 -36.06 76.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.808 175.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.56 -29.8 69.28 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.776 175.462 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.597 ' HG ' ' O ' ' A' ' 44' ' ' THR . 92.0 mt -65.28 -34.54 78.58 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 176.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.414 ' HA ' ' O ' ' A' ' 52' ' ' SER . 36.9 tt0 -76.24 -21.91 55.79 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.958 175.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -72.87 -35.87 67.25 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.749 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.462 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . 70.3 m-85 -81.56 -67.05 0.81 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.18 172.276 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 49' ' ' GLU . 38.2 t -86.2 96.05 9.79 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.717 176.143 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.69 ' H ' ' HD2' ' A' ' 53' ' ' LYS . 8.7 mptt -60.18 -31.26 69.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.681 -177.294 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -110.62 82.85 1.66 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.419 0.628 . . . . 0.0 109.974 169.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -100.48 112.55 24.92 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.966 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.526 ' HB2' HG12 ' A' ' 34' ' ' ILE . 33.5 m-85 -96.55 133.03 41.54 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 177.469 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -144.76 158.44 27.58 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 119.556 -1.307 . . . . 0.0 112.972 -177.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -136.26 155.2 34.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 122.756 0.422 . . . . 0.0 109.986 175.298 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.861 ' CE1' ' HB ' ' A' ' 67' ' ' VAL . 0.2 OUTLIER -128.22 171.57 11.83 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -174.317 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 121.94 39.66 0.55 Allowed Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.796 173.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -122.04 -86.92 0.65 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 117.455 0.628 . . . . 0.0 110.992 177.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 67.8 mtt -135.69 31.68 3.06 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.42 ' HB2' ' CE1' ' A' ' 59' ' ' HIS . 1.3 p30 -93.17 -178.32 4.74 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.299 -1.318 . . . . 0.0 112.212 -171.173 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.85 ' HD2' ' HB ' ' A' ' 40' ' ' VAL . 80.2 m-85 -94.3 138.21 22.54 Favored Pre-proline 0 C--O 1.232 0.182 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.477 176.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 64' ' ' TYR . 21.1 Cg_exo -67.4 -9.15 24.32 Favored 'Trans proline' 0 N--CA 1.474 0.368 0 C-N-CA 123.562 2.842 . . . . 0.0 113.913 -175.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -70.97 -42.38 69.79 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.12 0.486 . . . . 0.0 110.785 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.861 ' HB ' ' CE1' ' A' ' 59' ' ' HIS . 65.4 t -68.71 -11.04 14.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.617 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.48 ' HB3' ' NZ ' ' A' ' 68' ' ' LYS . 5.1 ttpm? -56.88 -30.7 64.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.885 176.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -70.08 -17.55 63.23 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.049 0.452 . . . . 0.0 110.836 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -105.81 -50.63 3.15 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.901 -178.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.6 ' HG ' HG12 ' A' ' 67' ' ' VAL . 4.4 mt -107.98 112.01 61.87 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.397 -178.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -74.08 170.95 18.95 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.768 2.312 . . . . 0.0 111.648 178.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -74.82 -21.11 59.47 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.244 0.545 . . . . 0.0 109.83 178.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.428 ' HA ' ' O ' ' A' ' 86' ' ' MET . 55.1 m -150.63 124.69 9.33 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.022 175.298 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 42.3 tttp -132.86 129.48 38.5 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.736 -179.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 17.3 t -106.35 122.92 60.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 120.961 0.41 . . . . 0.0 110.221 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.542 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 59.7 mt -99.32 152.51 19.85 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.215 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 47.0 tp -124.63 97.39 5.27 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 174.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 37.6 t -112.8 104.94 17.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.439 -175.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 54.11 43.25 30.97 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.234 178.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.81 -25.73 23.71 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.904 177.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 63.6 t -81.03 129.95 36.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.816 0.341 . . . . 0.0 111.204 -176.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 28.2 p -91.76 129.53 37.71 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.439 177.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.542 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 34.6 mt -124.09 99.22 6.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.88 0.372 . . . . 0.0 110.178 -177.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -87.59 102.05 2.76 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.405 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.525 ' HG2' HD12 ' A' ' 112' ' ' LEU . 22.8 mtm -94.96 127.08 40.74 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.108 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 113' ' ' PHE . 42.4 t -141.73 154.72 45.47 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 16.1 p80 -63.46 -26.51 68.76 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 175.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.595 ' HA3' ' HB2' ' A' ' 113' ' ' PHE . . . 57.62 59.69 10.37 Favored Glycine 0 C--N 1.335 0.487 0 CA-C-N 115.965 -0.561 . . . . 0.0 114.432 170.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 81.3 t90 -97.48 127.56 43.54 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 174.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 163.99 -177.27 39.83 Favored Glycine 0 N--CA 1.444 -0.779 0 N-CA-C 111.301 -0.719 . . . . 0.0 111.301 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.54 139.21 44.24 Favored Pre-proline 0 C--N 1.32 -0.693 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 178.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -62.63 -25.83 75.46 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.935 2.423 . . . . 0.0 113.208 -175.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -67.22 -47.2 71.53 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.947 0.404 . . . . 0.0 110.616 -175.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -101.74 9.03 41.28 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.785 -177.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 26.8 tp -60.08 -47.53 85.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.535 -173.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -63.85 -45.48 89.28 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.178 0.513 . . . . 0.0 110.365 -177.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -65.55 -36.65 84.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.909 179.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.514 ' O ' HG23 ' A' ' 103' ' ' VAL . 21.3 ttt180 -67.96 -49.25 62.85 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.254 179.258 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.655 HD23 HG21 ' A' ' 111' ' ' ILE . 7.6 mp -62.8 -35.45 79.92 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.544 0.202 . . . . 0.0 111.544 -176.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.773 HD21 HG21 ' A' ' 127' ' ' VAL . 84.5 mt -71.77 -16.35 62.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.026 0.441 . . . . 0.0 110.659 176.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 48.5 tttp -96.26 -17.15 20.95 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.354 178.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 99' ' ' ARG . 92.0 t -74.43 -45.86 44.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.11 0.481 . . . . 0.0 109.75 175.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -80.82 155.45 26.61 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.44 176.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -84.0 -22.49 31.35 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.245 0.545 . . . . 0.0 109.94 178.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 14.8 mp0 -105.11 -174.47 2.54 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.461 177.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 47.8 pttt -119.24 91.67 44.26 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-O 121.491 0.662 . . . . 0.0 109.504 172.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.07 154.48 67.06 Favored 'Trans proline' 0 N--CA 1.464 -0.224 0 C-N-CA 123.086 2.524 . . . . 0.0 112.63 -174.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -82.06 -46.34 14.03 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.959 177.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.7 t -116.87 133.32 63.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.903 176.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.655 HG21 HD23 ' A' ' 100' ' ' LEU . 56.0 mt -129.71 134.81 62.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.855 0.359 . . . . 0.0 110.765 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.664 HD23 ' HB2' ' A' ' 130' ' ' LEU . 86.5 mt -108.22 135.05 50.2 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.767 178.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.595 ' HB2' ' HA3' ' A' ' 89' ' ' GLY . 47.1 p90 -142.62 162.64 34.93 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.744 177.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.24 114.97 1.31 Allowed Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.331 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -169.06 -54.56 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.2 p -85.92 159.43 19.66 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.159 171.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 22.0 p-80 -123.99 21.14 9.06 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.174 0.511 . . . . 0.0 110.53 -178.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 11.2 mp0 -87.68 107.96 18.07 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.619 176.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 30.8 Cg_endo -64.66 95.67 0.23 Allowed 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.345 2.03 . . . . 0.0 111.814 -178.407 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -152.32 141.83 21.7 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.361 -176.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -95.16 123.15 38.5 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 171.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.641 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 73.2 p -112.23 144.97 40.75 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.273 -171.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 14.8 p -148.93 139.74 16.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.011 177.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -158.04 -48.55 0.06 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.13 0.491 . . . . 0.0 110.603 -178.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -97.0 24.43 6.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.395 -177.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 75.02 25.46 69.01 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.749 -0.738 . . . . 0.0 111.903 -175.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.773 HG21 HD21 ' A' ' 101' ' ' LEU . 52.8 t -132.78 137.02 54.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.274 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -100.0 104.97 16.6 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.109 0.48 . . . . 0.0 110.19 -177.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.641 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 60.0 m-85 -93.92 135.54 35.15 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.789 -179.574 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.664 ' HB2' HD23 ' A' ' 112' ' ' LEU . 86.9 mt -118.51 137.05 53.47 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.879 0.371 . . . . 0.0 111.326 -177.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.467 ' HA ' ' HD3' ' A' ' 132' ' ' PRO . 0.1 OUTLIER -150.32 125.64 4.86 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.23 173.388 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 131' ' ' ASN . 88.1 Cg_endo -101.86 -176.71 0.13 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 123.546 2.831 . . . . 0.0 112.56 175.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -81.58 171.14 52.65 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 174.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 75.6 p -85.38 173.9 9.95 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 117.515 0.658 . . . . 0.0 111.259 -177.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.604 HD13 ' HG ' ' A' ' 19' ' ' LEU . 21.2 mt -57.35 -49.54 75.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.718 -174.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -67.83 -10.91 56.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.03 -173.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -92.39 -3.79 54.77 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.981 0.419 . . . . 0.0 110.757 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.528 ' HA2' HD12 ' A' ' 157' ' ' LEU . . . 71.67 34.0 63.15 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.417 178.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 37.4 t -126.32 121.34 32.3 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.935 0.397 . . . . 0.0 110.539 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.451 ' OH ' ' HD2' ' A' ' 20' ' ' PRO . 86.5 m-85 -125.49 159.52 31.78 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.527 174.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.454 ' HB3' HD23 ' A' ' 6' ' ' LEU . . . -121.55 140.18 52.55 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.836 0.351 . . . . 0.0 110.137 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 62.1 t -122.68 121.55 63.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 175.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.818 HD21 HG13 ' A' ' 150' ' ' VAL . 3.5 tt -94.73 105.98 17.95 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.557 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.489 ' HG3' ' HG2' ' A' ' 3' ' ' ARG . 29.8 tt0 -102.94 145.55 29.67 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.457 -178.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.502 ' O ' ' HA ' ' A' ' 1' ' ' VAL . 58.7 mt -117.23 105.97 12.78 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.975 0.416 . . . . 0.0 111.214 -177.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -118.31 130.57 56.1 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.973 175.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.51 11.01 59.0 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.169 -177.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 84.24 6.62 86.08 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.096 -177.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -97.54 158.09 15.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.825 0.345 . . . . 0.0 110.663 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.818 HG13 HD21 ' A' ' 143' ' ' LEU . 51.7 t -87.52 109.94 20.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.798 -178.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 43.8 ttt180 -107.18 113.66 27.23 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.158 0.504 . . . . 0.0 110.549 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -84.26 108.67 17.26 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.022 177.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -106.65 105.45 15.49 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 23.6 tp -83.66 109.92 17.85 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 119.951 -0.7 . . . . 0.0 110.256 -177.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -88.78 118.88 28.79 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.512 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 21.4 p -111.64 148.46 33.32 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.437 -173.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.528 HD12 ' HA2' ' A' ' 138' ' ' GLY . 74.7 mt . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.576 -0.726 . . . . 0.0 109.644 178.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 84.4 t . . . . . 0 N--CA 1.481 1.119 0 CA-C-O 120.748 0.309 . . . . 0.0 110.517 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -129.87 125.25 35.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.766 174.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.544 ' HG3' ' HA ' ' A' ' 30' ' ' TYR . 0.1 OUTLIER -124.45 129.93 51.55 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.043 -175.765 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.495 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 16.6 m-85 -119.06 132.05 56.0 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.803 -179.043 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 28.2 tp -89.05 122.84 32.79 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.031 178.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.523 HD11 ' HG ' ' A' ' 36' ' ' LEU . 62.4 tp -104.7 111.79 24.64 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.039 0.447 . . . . 0.0 110.461 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.9 pt -101.16 138.62 24.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.785 176.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.5 m -77.34 -178.59 5.23 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.404 -175.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -63.84 104.61 0.71 Allowed 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.466 -176.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.8 m -95.45 83.99 3.92 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.833 -175.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 28.3 m80 -75.03 76.25 2.22 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 175.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.646 HG21 HD12 ' A' ' 19' ' ' LEU . 40.7 t -125.9 128.36 24.56 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.069 -177.312 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.414 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 58.2 Cg_endo -76.36 -61.58 0.05 OUTLIER 'Cis proline' 0 CA--C 1.529 0.264 0 C-N-CA 122.818 -1.742 . . . . 0.0 112.928 -1.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 53.4 t 56.81 -87.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 122.865 0.466 . . . . 0.0 111.612 179.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 81.6 mtt180 -139.8 6.63 2.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.941 0.4 . . . . 0.0 110.097 177.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 52.9 ttp -135.79 98.97 4.04 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.782 -173.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -99.66 -1.46 37.91 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.326 0.584 . . . . 0.0 110.354 177.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.0 m -82.72 58.98 4.52 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.403 -176.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.646 HD12 HG21 ' A' ' 12' ' ' VAL . 4.9 tt -107.66 109.75 62.47 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.051 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.728 ' HG2' HD13 ' A' ' 157' ' ' LEU . 31.3 Cg_exo -60.64 123.95 14.06 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 123.096 2.531 . . . . 0.0 112.585 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -62.53 -15.33 50.05 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.127 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -56.76 -33.99 67.14 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.379 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.6 tt -75.63 -32.89 25.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.374 0.606 . . . . 0.0 110.086 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.51 ' O ' HD23 ' A' ' 27' ' ' LEU . 45.7 tp -71.99 -17.37 62.06 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.292 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -91.52 -2.01 57.33 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.661 177.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 46.9 m -93.77 -0.7 55.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.662 -176.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.589 ' HG ' ' HB3' ' A' ' 51' ' ' PHE . 4.0 mm? -65.16 -10.34 30.3 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.0 0.429 . . . . 0.0 111.053 179.119 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.5 mttm -76.41 -30.86 57.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.149 -174.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -111.03 27.26 9.86 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -166.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.544 ' HA ' ' HG3' ' A' ' 3' ' ' ARG . 91.6 m-85 -136.22 152.09 50.39 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.778 178.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.415 ' OD2' ' HG2' ' A' ' 3' ' ' ARG . 10.1 m-20 -79.28 -43.98 22.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.573 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.495 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -138.98 164.19 25.83 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.098 178.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.58 HG21 ' CD1' ' A' ' 27' ' ' LEU . 98.7 t -134.11 137.96 51.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.049 0.452 . . . . 0.0 110.874 -177.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.7 mt -118.43 135.63 58.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.82 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.509 ' O ' ' HA2' ' A' ' 57' ' ' GLY . . . -124.21 123.37 5.13 Favored Glycine 0 N--CA 1.44 -1.04 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.031 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.523 ' HG ' HD11 ' A' ' 6' ' ' LEU . 98.7 mt -81.52 34.63 0.38 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.188 0.518 . . . . 0.0 109.87 177.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 118.7 103.85 2.14 Favored Glycine 0 N--CA 1.44 -1.063 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 -173.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.535 ' OD2' HG13 ' A' ' 45' ' ' VAL . 6.5 p-10 -97.88 -156.25 0.53 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.863 0.332 . . . . 0.0 110.488 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -58.5 153.75 15.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.262 0.553 . . . . 0.0 111.945 -173.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.514 HG22 ' O ' ' A' ' 12' ' ' VAL . 21.2 m -94.84 -1.79 10.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.098 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.641 ' O ' HG23 ' A' ' 45' ' ' VAL . 16.2 t70 -93.45 120.26 33.52 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 173.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.443 HD22 ' HB3' ' A' ' 66' ' ' ASP . 38.3 tp -57.98 -42.63 85.51 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 123.426 0.453 . . . . 0.0 111.888 -170.303 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -62.21 -44.82 95.73 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.727 0.299 . . . . 0.0 110.53 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.7 m -67.11 -28.8 68.46 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.091 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 41' ' ' ASP . 61.5 t -59.63 -50.39 80.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 121.371 0.605 . . . . 0.0 110.302 175.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.511 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 1.8 mp -68.64 -34.13 63.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.837 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -58.08 -39.11 77.74 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.427 174.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.57 -42.63 70.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.148 0.499 . . . . 0.0 109.777 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.0 tt0 -56.92 -40.26 76.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.754 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.511 ' HG3' ' O ' ' A' ' 46' ' ' ILE . 94.1 mttt -63.72 -45.81 88.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.962 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.589 ' HB3' ' HG ' ' A' ' 27' ' ' LEU . 17.9 m-85 -62.78 -42.75 99.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.834 0.35 . . . . 0.0 111.388 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.526 ' HB2' ' HB2' ' A' ' 55' ' ' PHE . 15.6 m -71.28 -28.11 63.9 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.313 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 68.4 mttm 71.49 -49.52 0.68 Allowed 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.855 0.862 . . . . 0.0 110.557 -175.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -124.46 91.84 3.53 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 172.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.526 ' HB2' ' HB2' ' A' ' 52' ' ' SER . 81.8 t80 -106.33 122.19 45.74 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.881 -176.204 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -114.67 115.27 26.84 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.665 177.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.509 ' HA2' ' O ' ' A' ' 35' ' ' GLY . . . -121.35 160.17 15.76 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 119.975 -1.107 . . . . 0.0 113.614 -175.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.636 HG21 ' HB3' ' A' ' 86' ' ' MET . 0.1 OUTLIER -140.76 106.99 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 123.251 0.621 . . . . 0.0 110.217 173.222 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.578 ' HB2' ' HG ' ' A' ' 71' ' ' LEU . 52.7 t-80 -102.05 117.29 34.48 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.151 -173.324 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -107.07 -14.4 18.94 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.454 -0.879 . . . . 0.0 113.444 -175.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -76.74 156.08 32.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.756 0.312 . . . . 0.0 110.389 -179.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 82.4 mtp -108.28 81.27 1.46 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.307 0.575 . . . . 0.0 109.93 175.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -106.9 -78.3 0.59 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.72 179.102 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.49 ' HD1' ' HB ' ' A' ' 40' ' ' VAL . 92.3 m-85 -107.45 154.37 40.73 Favored Pre-proline 0 C--N 1.323 -0.556 0 N-CA-C 110.318 -0.252 . . . . 0.0 110.318 178.517 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -74.42 -38.88 1.73 Allowed 'Trans proline' 0 CA--C 1.53 0.279 0 C-N-CA 122.49 2.126 . . . . 0.0 112.799 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.443 ' HB3' HD22 ' A' ' 42' ' ' LEU . 13.0 m-20 -60.38 -45.13 94.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.217 0.532 . . . . 0.0 111.482 -175.079 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.429 HG21 ' HA ' ' A' ' 40' ' ' VAL . 45.3 t -65.68 -27.94 42.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.546 -174.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 46.6 mttp -64.81 -25.66 68.01 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.871 0.367 . . . . 0.0 110.933 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -85.02 -28.43 25.72 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.795 -176.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.464 ' HB3' HD23 ' A' ' 71' ' ' LEU . 58.9 t-80 -69.79 -45.04 68.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.116 0.484 . . . . 0.0 109.95 177.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.578 ' HG ' ' HB2' ' A' ' 59' ' ' HIS . 1.3 pt? -140.02 113.05 7.55 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.421 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.29 -172.74 1.24 Allowed 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 123.099 2.533 . . . . 0.0 113.209 -176.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.431 ' CZ ' ' HA3' ' A' ' 89' ' ' GLY . 59.7 t80 -75.08 -43.48 52.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.545 -173.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 86' ' ' MET . 22.0 m -136.94 140.78 42.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.967 0.413 . . . . 0.0 111.579 -177.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.0 ttpm? -160.26 132.74 6.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.529 176.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.642 HG23 ' CE1' ' A' ' 104' ' ' PHE . 43.5 t -93.77 131.75 39.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.765 0.317 . . . . 0.0 110.249 173.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 38.5 mt -108.04 152.11 24.94 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 174.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 37.2 tp -122.41 96.11 4.91 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 175.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 60.4 t -102.25 95.45 3.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.685 -175.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 55.52 32.31 18.8 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.634 0.731 . . . . 0.0 111.054 175.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 114.53 -33.59 5.31 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.565 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 85.2 t -72.38 120.09 20.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.826 0.346 . . . . 0.0 110.695 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.9 101.73 13.44 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.048 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 19.0 mt -95.08 105.27 16.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.358 -176.109 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.569 ' HA2' HG22 ' A' ' 76' ' ' VAL . . . -89.5 94.36 1.98 Allowed Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.783 -0.723 . . . . 0.0 111.347 178.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.636 ' HB3' HG21 ' A' ' 58' ' ' VAL . 35.8 mtm -91.21 107.77 19.43 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.844 0.354 . . . . 0.0 110.687 -176.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 37.0 t -125.53 85.44 2.4 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 175.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 79.9 t60 -84.7 89.7 7.55 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.92 -173.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.431 ' HA3' ' CZ ' ' A' ' 73' ' ' PHE . . . -148.53 172.3 28.76 Favored Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.4 176.457 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 75.4 t-105 -76.52 106.85 8.41 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.951 0.405 . . . . 0.0 110.525 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -130.06 152.12 19.6 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 177.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -112.06 162.86 19.38 Favored Pre-proline 0 C--N 1.319 -0.721 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.32 -12.72 21.21 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.423 2.082 . . . . 0.0 112.514 178.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 14.0 m95 -80.47 -51.7 8.5 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.275 -178.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.483 ' OD2' ' HD3' ' A' ' 99' ' ' ARG . 12.0 p-10 -94.9 -0.58 53.87 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.159 -176.368 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 22.5 tp -50.52 -64.84 0.68 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.128 -0.487 . . . . 0.0 112.199 -174.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.485 ' HD2' ' HB2' ' A' ' 125' ' ' ALA . 42.5 mtmt -61.73 -54.37 43.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.365 0.602 . . . . 0.0 110.727 -176.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -61.08 -45.96 92.58 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.818 -1.083 . . . . 0.0 112.28 -171.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.483 ' HD3' ' OD2' ' A' ' 95' ' ' ASP . 34.0 ttt180 -79.37 -46.22 18.04 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.967 -173.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.457 HD13 HG21 ' A' ' 111' ' ' ILE . 47.3 mt -66.09 -29.45 69.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.687 0.279 . . . . 0.0 111.519 -176.36 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.608 HD22 ' HE3' ' A' ' 107' ' ' LYS . 86.0 mt -78.98 -13.28 59.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.687 0.28 . . . . 0.0 111.149 177.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -84.52 -31.74 24.29 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.83 0.348 . . . . 0.0 110.268 173.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.3 t -63.58 -49.72 81.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.254 177.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.642 ' CE1' HG23 ' A' ' 76' ' ' VAL . 20.3 m-85 -105.68 116.01 31.22 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.551 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -72.87 -29.16 62.96 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 170.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -76.48 97.63 4.37 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.853 171.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.608 ' HE3' HD22 ' A' ' 101' ' ' LEU . 13.0 mptt -63.24 113.93 11.11 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-O 120.996 0.426 . . . . 0.0 110.975 -178.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.493 ' HD3' ' HA ' ' A' ' 107' ' ' LYS . 1.0 OUTLIER -85.32 158.86 11.13 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.581 2.854 . . . . 0.0 112.642 -175.944 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -79.38 -53.24 7.11 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.032 177.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 74.8 t -120.42 128.6 76.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.865 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.476 HD12 ' CE2' ' A' ' 129' ' ' PHE . 48.6 mt -114.65 129.21 71.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.083 0.468 . . . . 0.0 110.797 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.444 HD23 ' HB2' ' A' ' 130' ' ' LEU . 81.4 mt -102.31 120.53 40.64 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.03 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -132.38 -169.61 2.26 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 -178.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -137.03 126.79 3.81 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.634 -0.794 . . . . 0.0 112.645 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 20.4 t60 -167.62 -71.86 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.183 0.516 . . . . 0.0 110.143 176.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.482 HG22 ' H ' ' A' ' 118' ' ' GLU . 6.6 m -83.05 143.2 30.76 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.118 -177.007 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.422 ' HB3' ' OE1' ' A' ' 137' ' ' GLU . 61.6 m-70 -90.31 -21.46 22.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.304 0.573 . . . . 0.0 110.168 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.482 ' H ' HG22 ' A' ' 116' ' ' THR . 48.6 mt-10 -87.01 121.0 71.78 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.169 173.101 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.742 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 23.5 Cg_exo -61.76 101.25 0.21 Allowed 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.704 2.269 . . . . 0.0 112.399 -175.307 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -111.41 127.34 55.64 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.851 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -79.84 103.23 9.59 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 174.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.617 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 38.5 p -99.5 113.81 26.4 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.248 -176.086 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.407 HG13 ' O ' ' A' ' 123' ' ' VAL . 6.9 p -109.7 97.71 6.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-O 122.168 0.985 . . . . 0.0 109.686 177.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.473 ' HB3' ' HD3' ' A' ' 97' ' ' LYS . 58.5 mttp -129.61 137.37 50.65 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.581 -176.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.485 ' HB2' ' HD2' ' A' ' 97' ' ' LYS . . . 64.96 13.38 8.59 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 123.616 0.572 . . . . 0.0 110.917 -176.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 89.74 -9.59 76.63 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.294 -178.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 38.8 t -93.04 141.34 14.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 128' ' ' ARG . 14.8 ttt180 -100.54 102.16 13.26 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.25 0.548 . . . . 0.0 110.428 -177.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.617 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 18.2 m-85 -92.09 142.86 27.04 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.235 178.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.444 ' HB2' HD23 ' A' ' 112' ' ' LEU . 86.1 mt -124.4 136.45 54.07 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.925 0.393 . . . . 0.0 110.917 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.742 ' O ' ' HA ' ' A' ' 119' ' ' PRO . 4.1 p30 -130.01 103.8 16.99 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.844 176.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -94.37 154.85 2.05 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.002 2.468 . . . . 0.0 113.297 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -71.93 159.06 53.65 Favored Glycine 0 N--CA 1.452 -0.289 0 N-CA-C 111.409 -0.676 . . . . 0.0 111.409 175.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 13.4 t -83.54 176.3 9.14 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 117.304 0.552 . . . . 0.0 111.251 -175.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 20.7 mt -70.81 -34.82 72.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.003 -170.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -77.03 -7.14 55.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.145 0.498 . . . . 0.0 110.69 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.422 ' OE1' ' HB3' ' A' ' 117' ' ' HIS . 42.2 mt-10 -92.6 1.12 57.43 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.003 176.361 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 73.34 39.6 50.99 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.678 -0.692 . . . . 0.0 113.08 174.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 50.2 m -150.08 144.29 25.65 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.763 0.316 . . . . 0.0 110.678 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -143.95 166.16 25.74 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.591 176.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -114.47 134.89 54.67 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.258 0.551 . . . . 0.0 111.411 -175.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 152' ' ' PHE . 89.4 t -116.47 121.43 67.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.572 175.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 5.2 tt -110.61 107.35 16.92 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -104.87 142.45 34.72 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.961 176.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.0 mp -90.74 94.28 9.61 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.218 0.532 . . . . 0.0 109.689 172.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -87.19 113.38 22.87 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.4 -178.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 68.35 -62.96 0.41 Allowed Glycine 0 CA--C 1.52 0.36 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.562 -169.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 179.38 27.77 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 175.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -127.1 160.53 30.89 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -175.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 47.6 t -77.76 108.88 11.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.844 0.354 . . . . 0.0 111.426 -176.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.429 HH11 ' HD3' ' A' ' 151' ' ' ARG . 15.2 ttm180 -107.7 96.07 6.13 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 173.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' PHE . . . . . 0.436 ' HA ' ' O ' ' A' ' 142' ' ' VAL . 40.1 p90 -102.41 127.53 49.4 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.928 -178.173 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -120.32 140.72 50.84 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.849 176.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -100.58 97.54 8.22 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.519 176.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -92.28 140.86 29.18 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.088 -177.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 18.1 p -89.62 155.58 19.15 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.617 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.728 HD13 ' HG2' ' A' ' 20' ' ' PRO . 83.0 mt . . . . . 0 C--O 1.247 0.952 0 CA-C-O 118.334 -0.841 . . . . 0.0 109.865 177.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 86.5 t . . . . . 0 N--CA 1.479 1.023 0 CA-C-O 120.835 0.35 . . . . 0.0 110.443 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -129.56 146.88 51.33 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.293 177.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.539 ' HG2' ' HG2' ' A' ' 144' ' ' GLU . 79.5 mtt180 -104.92 111.28 23.98 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.629 172.215 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.545 ' HE2' HG11 ' A' ' 79' ' ' VAL . 70.4 m-85 -101.59 129.73 47.76 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.028 0.442 . . . . 0.0 111.036 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.572 ' HB3' HG22 ' A' ' 33' ' ' VAL . 36.8 tp -89.57 112.25 23.4 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.611 176.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.403 ' HB3' ' HB3' ' A' ' 141' ' ' ALA . 51.5 tp -96.76 102.23 13.98 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.116 0.484 . . . . 0.0 110.045 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.503 HG13 ' HA2' ' A' ' 35' ' ' GLY . 11.5 pt -101.47 126.29 55.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.493 176.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.592 ' HB3' ' OG1' ' A' ' 116' ' ' THR . 14.0 m -68.62 179.65 1.66 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.028 -176.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -78.4 79.82 4.82 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 122.053 0.93 . . . . 0.0 110.811 -177.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.524 ' HB3' HD23 ' A' ' 135' ' ' LEU . 10.6 p -80.53 133.87 35.87 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 176.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 74.3 m-70 -99.57 80.09 2.34 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.363 0.602 . . . . 0.0 109.617 -177.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.476 ' HB ' ' HD1' ' A' ' 39' ' ' TYR . 38.6 t -114.87 137.62 22.93 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.617 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -82.79 -58.71 0.07 OUTLIER 'Cis proline' 0 N--CA 1.461 -0.4 0 C-N-CA 123.666 -1.389 . . . . 0.0 112.887 -2.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER 35.05 -96.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -173.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 40.9 mtm180 -127.33 20.66 6.76 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 15.6 tmm? -144.16 100.25 3.52 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.246 0.546 . . . . 0.0 109.987 173.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -110.08 16.02 22.11 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.825 176.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 27.9 p -84.67 39.33 0.74 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.078 -177.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.0 tt -97.16 119.92 62.26 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.563 ' HG3' HD13 ' A' ' 157' ' ' LEU . 26.9 Cg_endo -61.66 130.39 31.31 Favored 'Trans proline' 0 C--O 1.234 0.291 0 C-N-CA 123.092 2.528 . . . . 0.0 112.552 -178.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -63.44 -18.57 63.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.885 -179.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -52.62 -49.26 65.47 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.769 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.0 tt -70.38 -36.32 66.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.345 0.593 . . . . 0.0 110.34 -176.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.689 HD12 HD23 ' A' ' 27' ' ' LEU . 58.3 tp -69.81 -33.79 72.82 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.131 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -71.09 -36.61 72.27 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.327 178.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 75.6 m -80.69 7.53 10.02 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.752 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.689 HD23 HD12 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -50.56 -41.48 54.2 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.592 0.71 . . . . 0.0 110.724 176.896 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 71.3 mttt -90.99 11.15 23.83 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.173 -171.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -104.28 7.94 35.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.038 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -126.02 158.77 34.48 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.4 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -72.0 -53.19 13.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.176 0.512 . . . . 0.0 109.968 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.539 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -138.12 151.96 21.64 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.194 179.105 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.572 HG22 ' HB3' ' A' ' 5' ' ' LEU . 97.8 t -118.96 135.89 57.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-O 120.703 0.287 . . . . 0.0 110.482 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.456 HG12 ' HB2' ' A' ' 56' ' ' TYR . 37.0 mt -111.56 116.62 53.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.854 176.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.503 ' HA2' HG13 ' A' ' 7' ' ' ILE . . . -104.25 119.66 6.36 Favored Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 177.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 94.3 mt -92.81 24.07 3.82 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.122 0.487 . . . . 0.0 110.552 -179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 121.55 21.91 2.9 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.828 -178.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.405 ' HB3' HD12 ' A' ' 7' ' ' ILE . 10.9 t70 -81.14 134.03 35.57 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.613 ' HD2' HD11 ' A' ' 48' ' ' LEU . 25.7 m-85 64.6 105.73 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 O-C-N 123.872 0.732 . . . . 0.0 110.924 -175.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.417 HG22 ' O ' ' A' ' 12' ' ' VAL . 35.9 m -86.77 0.22 6.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.332 -176.167 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.549 ' O ' HG23 ' A' ' 45' ' ' VAL . 16.0 t70 -86.65 135.93 33.22 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.792 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 54.3 tp -62.7 -49.49 74.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.702 -175.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -63.1 -35.31 79.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.823 0.344 . . . . 0.0 110.752 -177.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.451 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 14.1 m -68.6 -33.06 73.4 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.21 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 41' ' ' ASP . 93.4 t -60.2 -46.12 95.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.369 0.604 . . . . 0.0 109.888 175.353 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.23 -38.0 80.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.89 177.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.24 -33.8 72.79 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.801 176.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.613 HD11 ' HD2' ' A' ' 39' ' ' TYR . 83.3 mt -66.95 -38.13 85.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.26 0.552 . . . . 0.0 109.996 178.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.681 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 35.8 tt0 -77.23 -11.39 59.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.331 176.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -92.5 -36.4 13.09 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.643 0.259 . . . . 0.0 110.945 -178.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.483 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . 6.4 m-30 -65.69 -67.37 0.45 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.4 178.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.49 ' OG ' HD12 ' A' ' 27' ' ' LEU . 5.1 m -73.49 -23.66 60.08 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.53 177.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.681 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 60.7 mttp 70.51 4.01 4.75 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.382 0.673 . . . . 0.0 111.785 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -144.83 105.07 4.07 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 172.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -128.89 133.23 47.85 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.189 0.519 . . . . 0.0 111.242 -173.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.456 ' HB2' HG12 ' A' ' 34' ' ' ILE . 88.1 m-85 -113.7 118.92 35.68 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 173.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -131.12 132.2 6.72 Favored Glycine 0 N--CA 1.44 -1.081 0 C-N-CA 119.606 -1.283 . . . . 0.0 113.925 -171.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.5 m -130.92 147.84 33.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 168.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.566 ' HB3' ' HB2' ' A' ' 71' ' ' LEU . 2.9 p80 -94.34 142.5 27.34 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 119.489 -0.884 . . . . 0.0 110.666 -173.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -81.29 -107.29 0.34 Allowed Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 115.618 -0.719 . . . . 0.0 113.538 -172.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.938 HD21 ' HA ' ' A' ' 115' ' ' HIS . 43.0 m-80 -95.62 -83.95 0.35 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.785 0.326 . . . . 0.0 111.264 -173.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 51.4 ttm -112.74 122.98 49.26 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.232 0.539 . . . . 0.0 110.682 -178.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -145.89 -174.25 4.37 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.288 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -74.88 144.51 79.88 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-O 120.673 0.273 . . . . 0.0 111.372 -176.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -47.06 -38.29 24.14 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.843 3.029 . . . . 0.0 114.161 -175.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -70.11 -46.54 64.61 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.214 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 39.9 t -63.66 -32.6 57.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.594 -177.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.414 ' HE2' ' HB3' ' A' ' 68' ' ' LYS . 31.8 ttpt -50.12 -40.36 45.8 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.809 177.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -104.12 -14.61 15.82 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.121 0.486 . . . . 0.0 110.136 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -75.44 -40.21 57.86 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -179.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.566 ' HB2' ' HB3' ' A' ' 59' ' ' HIS . 80.8 mt -102.64 117.94 59.67 Favored Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 170.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -56.44 156.2 22.66 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 123.129 2.553 . . . . 0.0 113.504 -174.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -77.11 -16.92 59.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.519 177.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.7 p -157.89 139.37 13.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.099 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.2 mttm -144.43 142.49 30.34 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.524 176.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 21.7 t -121.39 110.54 28.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.159 0.504 . . . . 0.0 109.913 172.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 37.3 mt -92.95 147.99 22.38 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.401 -177.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 55.1 tp -117.83 98.01 6.13 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 175.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.545 HG11 ' HE2' ' A' ' 4' ' ' PHE . 48.5 t -105.49 96.26 4.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.629 -174.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 57.31 27.62 14.01 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.624 175.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 114.35 -24.22 11.64 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.542 178.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.5 t -83.04 128.44 38.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.567 0.222 . . . . 0.0 110.809 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 40.0 p -91.48 131.24 37.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.538 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 42.0 mt -124.51 104.72 14.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.883 0.373 . . . . 0.0 110.215 -178.145 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -91.71 104.8 3.21 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.877 -0.677 . . . . 0.0 111.447 178.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 22.1 mtm -103.95 118.11 35.9 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -178.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 113' ' ' PHE . 46.0 t -156.96 158.29 36.34 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.925 0.393 . . . . 0.0 110.717 -177.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 15.0 t60 -65.64 -32.81 74.58 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.259 175.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.29 -94.88 0.57 Allowed Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 -173.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.423 ' HE3' ' H ' ' A' ' 92' ' ' ALA . 17.0 t90 -173.71 -69.24 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 172.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 155.14 -34.47 0.66 Allowed Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.994 -0.622 . . . . 0.0 111.77 -178.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.452 ' O ' ' HB2' ' A' ' 96' ' ' LEU . . . -78.61 115.1 49.03 Favored Pre-proline 0 C--N 1.327 -0.397 0 N-CA-C 110.487 -0.19 . . . . 0.0 110.487 178.113 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.469 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . 3.5 Cg_exo -81.22 5.18 6.42 Favored 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 123.427 2.752 . . . . 0.0 113.149 -175.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -80.74 -54.67 5.42 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.267 0.556 . . . . 0.0 109.942 -176.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 38.3 p30 -112.04 19.27 18.0 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.943 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.469 ' HB2' ' HA ' ' A' ' 93' ' ' PRO . 50.8 tp -54.47 -51.13 66.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.478 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -60.53 -45.38 94.07 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.926 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -61.37 -47.12 87.31 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.157 0.503 . . . . 0.0 110.844 -177.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.548 ' O ' HG23 ' A' ' 103' ' ' VAL . 36.3 ttm105 -67.0 -42.15 85.49 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.56 178.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.955 HD21 HG21 ' A' ' 111' ' ' ILE . 17.1 tp -67.57 -41.8 83.59 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.134 -176.281 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.432 HD21 HG21 ' A' ' 127' ' ' VAL . 93.7 mt -75.8 -5.74 47.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.528 178.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -95.38 -29.94 14.17 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.962 174.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 99' ' ' ARG . 94.8 t -62.68 -53.0 52.68 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 174.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -82.52 146.49 29.2 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 174.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -87.59 -27.11 22.74 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.897 0.38 . . . . 0.0 110.755 -177.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -113.64 177.65 4.56 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.532 177.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.866 ' H ' ' HD2' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -95.91 113.27 61.77 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.08 -175.133 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.478 ' HG2' HD11 ' A' ' 111' ' ' ILE . 1.2 Cg_endo -85.37 156.08 10.84 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.375 2.717 . . . . 0.0 111.854 177.209 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -90.7 -59.49 2.16 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.95 0.405 . . . . 0.0 110.771 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.635 HG21 HG21 ' A' ' 150' ' ' VAL . 57.3 t -105.15 119.54 54.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.331 -178.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.955 HG21 HD21 ' A' ' 100' ' ' LEU . 55.4 mt -116.46 128.69 73.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.079 0.466 . . . . 0.0 111.202 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.667 HD23 ' HB2' ' A' ' 130' ' ' LEU . 86.9 mt -107.61 124.72 50.37 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.011 176.217 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.515 ' HA ' ' O ' ' A' ' 87' ' ' CYS . 40.7 p90 -117.15 172.66 7.14 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 119.636 -0.825 . . . . 0.0 111.07 178.031 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -105.8 -165.18 23.32 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.442 -172.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.938 ' HA ' HD21 ' A' ' 61' ' ' ASN . 18.0 t60 69.06 41.73 1.37 Allowed 'General case' 0 C--O 1.233 0.191 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -173.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.592 ' OG1' ' HB3' ' A' ' 8' ' ' SER . 36.5 p -63.51 119.33 9.58 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 114.263 -1.335 . . . . 0.0 112.113 -171.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.442 ' HA ' ' OE2' ' A' ' 137' ' ' GLU . 0.1 OUTLIER -171.87 128.42 0.62 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.886 179.269 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 59.26 84.67 0.2 Allowed Pre-proline 0 N--CA 1.465 0.287 0 O-C-N 123.543 0.527 . . . . 0.0 110.791 -175.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -61.13 143.35 98.78 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 123.075 2.517 . . . . 0.0 113.014 -175.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -162.13 146.15 12.22 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.924 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -94.12 114.35 26.48 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.586 175.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.482 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 67.5 p -119.82 144.16 47.48 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.694 0.283 . . . . 0.0 111.405 -176.167 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.7 p -138.8 124.3 22.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.127 0.489 . . . . 0.0 110.976 178.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.481 ' HB2' ' HE2' ' A' ' 129' ' ' PHE . 88.1 mttt -140.9 139.42 34.35 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.536 176.354 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 66.94 14.04 9.68 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 123.485 0.491 . . . . 0.0 111.626 177.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 90.18 -2.82 81.87 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.234 -177.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.432 HG21 HD21 ' A' ' 101' ' ' LEU . 33.1 t -100.34 137.9 26.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -98.23 120.12 38.09 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.66 -176.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.482 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 34.9 m-85 -108.48 121.15 44.37 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.805 -178.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.667 ' HB2' HD23 ' A' ' 112' ' ' LEU . 78.1 mt -107.88 138.76 43.56 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-O 121.459 0.647 . . . . 0.0 111.146 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.462 ' HB3' ' CZ ' ' A' ' 113' ' ' PHE . 7.4 p30 -139.39 116.16 8.49 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.355 173.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.547 ' HD2' HG22 ' A' ' 116' ' ' THR . 86.2 Cg_endo -88.17 168.62 6.43 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.712 2.275 . . . . 0.0 112.502 178.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -85.28 147.77 22.62 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 176.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.58 ' HA ' ' HB2' ' A' ' 8' ' ' SER . 81.1 p -75.56 168.76 19.4 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.087 0.47 . . . . 0.0 111.077 -176.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.524 HD23 ' HB3' ' A' ' 10' ' ' SER . 4.2 mm? -64.82 -24.16 67.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.068 178.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -75.56 -14.36 60.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.036 0.446 . . . . 0.0 110.676 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.442 ' OE2' ' HA ' ' A' ' 117' ' ' HIS . 33.1 mt-10 -98.39 -2.23 39.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.192 178.041 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.518 ' HA2' HD12 ' A' ' 157' ' ' LEU . . . 70.78 45.45 52.17 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.925 177.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.6 p -150.81 153.92 36.32 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.597 0.199 . . . . 0.0 110.753 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -154.25 159.59 41.37 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 175.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.403 ' HB3' ' HB3' ' A' ' 6' ' ' LEU . . . -114.6 131.21 56.77 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.826 0.346 . . . . 0.0 111.384 -175.114 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 61.9 t -108.53 107.78 23.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 173.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.505 ' HA ' ' HA ' ' A' ' 152' ' ' PHE . 6.7 tt -96.97 105.14 17.23 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.196 0.522 . . . . 0.0 110.106 -176.189 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.539 ' HG2' ' HG2' ' A' ' 3' ' ' ARG . 34.1 mt-10 -100.19 149.75 23.23 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.583 176.103 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.9 mp -90.49 90.12 7.87 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 166.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -101.23 112.48 24.98 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.732 -170.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.75 10.97 59.49 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.067 -174.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 91.65 5.07 67.1 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.238 -0.506 . . . . 0.0 112.086 -178.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -108.63 161.83 14.72 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 176.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.635 HG21 HG21 ' A' ' 110' ' ' VAL . 50.0 t -81.49 101.61 6.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.08 0.467 . . . . 0.0 110.593 -176.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 31.0 tpt180 -103.57 87.49 2.85 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.077 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' PHE . . . . . 0.505 ' HA ' ' HA ' ' A' ' 143' ' ' LEU . 12.0 p90 -91.37 101.5 14.18 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.295 0.569 . . . . 0.0 110.02 177.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -91.06 101.49 14.25 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.359 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 48.2 tp -75.62 99.93 4.46 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 175.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -93.94 133.82 36.97 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.912 -177.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.6 m -98.42 150.33 21.74 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.407 -175.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.563 HD13 ' HG3' ' A' ' 20' ' ' PRO . 83.1 mt . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.37 -0.824 . . . . 0.0 109.897 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 50.2 t . . . . . 0 N--CA 1.479 1.017 0 CA-C-O 120.766 0.317 . . . . 0.0 110.853 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -122.23 149.5 43.59 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 171.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 52.8 mtp180 -106.51 116.57 32.16 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.09 178.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.535 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 73.1 m-85 -105.51 124.06 48.92 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.113 0.482 . . . . 0.0 111.487 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.528 ' HB3' HG22 ' A' ' 33' ' ' VAL . 37.9 tp -89.18 121.35 31.4 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.86 177.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.445 ' HB3' ' HB3' ' A' ' 141' ' ' ALA . 45.0 tp -110.95 106.46 15.57 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.181 0.515 . . . . 0.0 111.207 -177.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 19.7 pt -101.35 129.96 51.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.192 173.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.556 ' H ' HD21 ' A' ' 135' ' ' LEU . 9.1 p -85.27 -177.8 6.59 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.978 0.418 . . . . 0.0 111.954 -173.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.625 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.2 m-20 -65.39 104.22 0.94 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.31 -177.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.658 ' HB3' HD12 ' A' ' 135' ' ' LEU . 10.5 p -104.07 175.38 5.5 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 177.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -135.05 75.42 1.57 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.345 0.593 . . . . 0.0 110.098 176.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.419 ' O ' HG22 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -135.13 147.56 62.96 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.542 178.522 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -87.53 104.0 0.47 Allowed 'Cis proline' 0 N--CA 1.46 -0.463 0 C-N-CA 123.322 -1.532 . . . . 0.0 112.374 -2.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.405 ' H ' ' HA ' ' A' ' 12' ' ' VAL . 2.3 t -135.34 -133.59 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -178.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 22.0 ttm-85 -87.73 4.22 45.04 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.096 0.474 . . . . 0.0 110.812 -177.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.523 ' HG2' ' OG ' ' A' ' 18' ' ' SER . 30.3 ttp -84.86 -76.23 0.32 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.183 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 62.72 2.93 1.03 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.222 0.609 . . . . 0.0 112.41 178.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.523 ' OG ' ' HG2' ' A' ' 16' ' ' MET . 12.9 p -95.39 38.42 1.15 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.955 0.407 . . . . 0.0 111.519 -177.029 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.2 tt -107.84 111.11 62.51 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 177.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -70.57 141.24 41.48 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 122.734 2.289 . . . . 0.0 113.012 -177.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -63.8 -19.76 65.25 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.379 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -52.8 -42.66 65.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.898 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -68.66 -32.21 54.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.121 0.486 . . . . 0.0 110.514 -177.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.447 ' O ' HD23 ' A' ' 27' ' ' LEU . 58.3 tp -76.87 -31.97 57.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.412 -176.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -76.49 -23.47 53.76 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.555 178.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.9 m -78.49 0.85 24.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.766 -177.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.532 ' HB3' ' HB3' ' A' ' 51' ' ' PHE . 2.0 mm? -56.6 -28.98 61.6 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.884 0.373 . . . . 0.0 111.726 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 42.5 mttp -85.14 0.44 51.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.535 -174.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -113.12 17.49 18.7 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -171.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -137.45 168.43 19.66 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.672 0.272 . . . . 0.0 110.71 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -91.28 -52.75 4.66 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-O 121.512 0.672 . . . . 0.0 110.0 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.535 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -129.38 137.63 9.7 Favored Glycine 0 N--CA 1.441 -0.982 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.292 179.222 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.528 HG22 ' HB3' ' A' ' 5' ' ' LEU . 79.8 t -113.42 129.53 69.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.598 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 38.9 mt -105.99 122.74 59.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.527 -179.025 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -104.21 103.97 2.36 Favored Glycine 0 N--CA 1.44 -1.071 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.265 177.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.483 ' HB3' ' HE1' ' A' ' 88' ' ' HIS . 81.8 mt -80.42 -30.67 37.67 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 175.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.625 ' HA3' ' HA ' ' A' ' 9' ' ' ASP . . . -166.42 56.49 0.24 Allowed Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 177.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -57.61 -73.34 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.182 -0.509 . . . . 0.0 112.274 -171.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.518 ' CD1' HD11 ' A' ' 48' ' ' LEU . 78.5 m-85 -135.91 156.43 48.77 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.927 0.394 . . . . 0.0 110.686 178.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.419 HG22 ' O ' ' A' ' 12' ' ' VAL . 22.6 m -92.58 -3.02 10.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.335 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.593 ' O ' HG23 ' A' ' 45' ' ' VAL . 23.5 t70 -100.64 129.51 46.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.675 -178.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.52 HD22 ' HB3' ' A' ' 66' ' ' ASP . 51.0 tp -57.47 -52.14 66.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.456 . . . . 0.0 112.056 -174.125 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -68.29 -32.07 71.96 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.796 0.331 . . . . 0.0 110.948 -172.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.3 m -70.68 -33.16 70.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.916 178.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 41' ' ' ASP . 87.4 t -61.97 -44.21 98.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 121.357 0.598 . . . . 0.0 110.067 175.369 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -71.19 -31.79 45.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.269 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -58.65 -37.51 76.11 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 174.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.518 HD11 ' CD1' ' A' ' 39' ' ' TYR . 85.1 mt -69.68 -37.58 76.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.211 177.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.414 ' HG3' ' HB3' ' A' ' 55' ' ' PHE . 23.9 tt0 -71.33 -12.6 61.52 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.663 -177.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -79.76 -47.58 15.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.836 0.351 . . . . 0.0 110.499 173.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.532 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . 76.0 m-85 -75.82 -42.71 49.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.949 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.2 t -71.17 104.69 3.15 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.004 175.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -49.77 -43.74 48.39 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.645 177.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -130.08 104.24 7.22 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.577 175.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.414 ' HB3' ' HG3' ' A' ' 49' ' ' GLU . 74.3 t80 -100.3 121.76 42.01 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.313 -176.075 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.598 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 91.9 m-85 -114.82 108.0 16.17 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -126.12 151.21 17.82 Favored Glycine 0 N--CA 1.442 -0.959 0 C-N-CA 119.872 -1.156 . . . . 0.0 112.734 -175.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -127.69 172.77 14.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 173.028 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.45 ' HB2' ' O ' ' A' ' 71' ' ' LEU . 10.7 t-80 -94.3 118.79 32.12 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.522 -172.191 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.4 ' HA2' ' CD2' ' A' ' 88' ' ' HIS . . . -82.51 -148.25 7.15 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.691 -179.119 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -118.04 120.91 39.22 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.578 0.228 . . . . 0.0 111.512 -176.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 84.4 mtp 73.84 95.78 0.07 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.797 176.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.412 ' OD2' ' HB ' ' A' ' 67' ' ' VAL . 8.4 p-10 -160.4 -173.99 4.27 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.531 -177.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.414 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 15.1 m-30 -77.83 140.99 63.39 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.722 0.296 . . . . 0.0 111.01 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.426 ' O ' ' HB3' ' A' ' 68' ' ' LYS . 51.0 Cg_exo -57.46 -16.0 21.8 Favored 'Trans proline' 0 N--CA 1.474 0.37 0 C-N-CA 123.26 2.64 . . . . 0.0 112.915 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.52 ' HB3' HD22 ' A' ' 42' ' ' LEU . 8.5 m-20 -68.64 -41.57 79.2 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.252 0.548 . . . . 0.0 110.21 177.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.412 ' HB ' ' OD2' ' A' ' 63' ' ' ASP . 25.3 t -73.38 -23.61 19.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.96 -178.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.426 ' HB3' ' O ' ' A' ' 65' ' ' PRO . 63.9 tttp -52.78 -34.15 51.94 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.28 -178.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -108.36 2.31 22.42 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -176.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -98.76 -34.83 10.36 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 175.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.45 ' O ' ' HB2' ' A' ' 59' ' ' HIS . 51.2 mt -107.36 116.13 58.49 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.956 177.41 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -64.11 159.22 43.93 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.999 2.466 . . . . 0.0 112.751 -178.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.428 ' HZ ' HH22 ' A' ' 99' ' ' ARG . 64.7 t80 -79.85 -29.81 40.18 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.494 -176.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.0 p -148.7 126.27 11.7 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.507 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.7 tttm -141.54 128.42 20.58 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 12.0 t -109.65 118.17 56.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.844 0.354 . . . . 0.0 110.149 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 38.7 mt -93.01 153.27 18.82 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.656 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -118.3 108.99 15.77 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 171.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 22.2 t -122.21 102.09 11.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.148 -174.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 56.43 25.0 9.09 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.408 -0.814 . . . . 0.0 112.188 174.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 114.15 -10.57 22.49 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.96 177.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 46.5 t -103.84 134.63 44.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 122.645 -0.326 . . . . 0.0 110.948 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.6 p -93.83 133.35 37.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.656 177.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 27.1 mt -129.01 99.34 4.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.812 0.339 . . . . 0.0 110.357 -176.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -89.59 110.25 3.7 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.852 -0.69 . . . . 0.0 111.785 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.495 ' HG2' ' HB2' ' A' ' 112' ' ' LEU . 32.6 mtm -99.91 123.25 43.96 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 -179.098 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 34.2 t -145.83 163.07 36.2 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.483 ' HE1' ' HB3' ' A' ' 36' ' ' LEU . 7.2 m80 -141.0 -165.27 1.92 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.989 0.423 . . . . 0.0 111.424 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 112.48 169.33 17.85 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -177.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 17.3 p90 -81.81 96.7 7.69 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.502 0.668 . . . . 0.0 110.546 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -122.98 115.66 2.75 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.036 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.45 153.91 81.62 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 178.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.99 -7.45 6.28 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.013 2.475 . . . . 0.0 113.603 -175.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -81.72 -52.78 6.8 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.197 0.522 . . . . 0.0 109.978 -178.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -103.55 -4.87 23.34 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.823 -174.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 40.9 tp -52.41 -56.69 13.3 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.797 -176.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 45.9 pttt -57.39 -42.97 83.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.446 -177.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -69.37 -41.69 76.2 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.642 -178.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.482 ' O ' HG23 ' A' ' 103' ' ' VAL . 42.7 ttt-85 -62.05 -47.53 84.33 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.006 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.524 HD13 HG21 ' A' ' 111' ' ' ILE . 94.2 mt -66.47 -38.41 87.27 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.27 -176.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.798 HD21 HG21 ' A' ' 127' ' ' VAL . 86.6 mt -76.16 -13.25 60.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.011 0.434 . . . . 0.0 110.888 177.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -82.89 -39.89 20.94 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.008 176.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 99' ' ' ARG . 90.8 t -66.24 -50.93 64.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.194 -178.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -87.38 111.92 21.6 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 121.066 -0.254 . . . . 0.0 110.967 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -57.82 -52.89 63.6 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 174.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -80.77 94.96 6.51 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 170.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.702 ' H ' ' HD2' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -59.95 123.15 70.77 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.217 -179.279 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 107' ' ' LYS . 2.2 Cg_endo -82.08 157.15 17.68 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 123.754 2.969 . . . . 0.0 112.699 -172.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -73.51 -44.94 56.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.946 177.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 65.4 t -118.78 140.67 41.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.948 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.524 HG21 HD13 ' A' ' 100' ' ' LEU . 40.9 mt -129.86 131.99 66.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.74 0.305 . . . . 0.0 110.474 177.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.661 HD23 ' HB2' ' A' ' 130' ' ' LEU . 75.3 mt -105.24 127.34 52.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.64 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.405 ' HE1' ' HB3' ' A' ' 129' ' ' PHE . 13.9 p90 -147.21 147.24 30.26 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.686 176.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -130.96 114.79 1.64 Allowed Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.332 -0.937 . . . . 0.0 111.814 179.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 17.2 t60 -178.45 21.59 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 177.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.495 HG22 ' H ' ' A' ' 117' ' ' HIS . 0.2 OUTLIER -101.65 -176.03 3.02 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.142 -174.564 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.495 ' H ' HG22 ' A' ' 116' ' ' THR . 49.4 m-70 -111.63 -43.19 3.69 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.756 0.312 . . . . 0.0 110.562 178.029 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -124.58 149.21 61.23 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.913 175.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.566 ' HG3' HD22 ' A' ' 154' ' ' LEU . 74.4 Cg_endo -74.83 138.51 23.58 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.713 2.275 . . . . 0.0 111.988 178.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -150.58 125.95 10.1 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.374 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -78.26 94.47 4.8 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 177.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.504 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 68.6 p -103.46 119.19 38.4 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.837 -174.376 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.493 HG13 ' O ' ' A' ' 123' ' ' VAL . 8.9 p -107.25 88.89 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 122.336 1.065 . . . . 0.0 109.113 170.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -127.27 146.24 50.5 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.701 -174.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 61.8 15.25 6.89 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 123.724 0.64 . . . . 0.0 110.893 -174.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 83.91 9.87 81.9 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.52 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.798 HG21 HD21 ' A' ' 101' ' ' LEU . 47.7 t -119.21 140.83 41.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.698 0.285 . . . . 0.0 110.307 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.643 ' NH1' HD21 ' A' ' 130' ' ' LEU . 26.9 ttt-85 -89.36 94.16 9.79 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.504 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 89.3 m-85 -83.44 126.14 32.44 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.661 ' HB2' HD23 ' A' ' 112' ' ' LEU . 50.2 mt -112.01 122.43 47.74 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.385 0.612 . . . . 0.0 110.965 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.511 ' HA ' ' HD3' ' A' ' 132' ' ' PRO . 5.1 p30 -129.22 122.95 21.37 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.821 178.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.511 ' HD3' ' HA ' ' A' ' 131' ' ' ASN . 5.4 Cg_endo -87.15 169.64 7.33 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.238 2.625 . . . . 0.0 112.288 179.151 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -89.05 -160.23 36.23 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.27 178.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 48.2 t -88.19 139.3 30.64 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.825 0.345 . . . . 0.0 110.637 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.658 HD12 ' HB3' ' A' ' 10' ' ' SER . 58.3 mt -66.17 -19.74 65.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.28 178.312 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -78.76 -12.53 60.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.348 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -87.52 -4.62 58.98 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.417 -176.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 77.9 25.75 61.71 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.335 178.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 7.3 t -139.46 132.32 29.25 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 178.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -126.32 173.25 9.46 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -177.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.445 ' HB3' ' HB3' ' A' ' 6' ' ' LEU . . . -114.38 134.94 54.61 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.689 -174.094 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.537 HG12 ' HG3' ' A' ' 144' ' ' GLU . 47.3 t -128.83 124.08 60.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.881 176.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.529 HD21 HG13 ' A' ' 150' ' ' VAL . 5.8 tt -101.87 106.47 17.43 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.537 ' HG3' HG12 ' A' ' 142' ' ' VAL . 45.2 mt-10 -113.3 131.42 55.94 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.521 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 21.2 mt -93.07 90.74 7.02 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.887 -178.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -87.54 111.47 21.25 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.832 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.74 -69.02 0.29 Allowed Glycine 0 CA--C 1.52 0.384 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.633 -175.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -171.17 25.46 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 111.665 -0.574 . . . . 0.0 111.665 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -110.37 143.04 41.21 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.529 HG13 HD21 ' A' ' 143' ' ' LEU . 46.5 t -86.03 89.07 2.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 177.204 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 67.6 mtp180 -90.02 98.44 11.77 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.337 0.589 . . . . 0.0 110.644 -175.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -83.37 93.99 7.87 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.12 175.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -97.46 112.52 24.33 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.845 0.355 . . . . 0.0 110.988 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.566 HD22 ' HG3' ' A' ' 119' ' ' PRO . 15.9 tp -83.6 92.4 7.65 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 171.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -83.78 145.69 28.56 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.598 -174.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 18.7 p -91.47 145.05 24.94 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.545 178.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 79.8 mt . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.688 -0.673 . . . . 0.0 110.388 178.714 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.642 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 38.9 t . . . . . 0 N--CA 1.478 0.925 0 CA-C-O 120.879 0.371 . . . . 0.0 110.18 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 55.1 mttm -110.69 142.89 41.98 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.706 178.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 50.3 mtp180 -115.57 123.19 47.85 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.405 ' HE2' HG11 ' A' ' 79' ' ' VAL . 77.6 m-85 -119.52 135.07 54.93 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.979 0.419 . . . . 0.0 110.533 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.428 ' HB2' ' CD2' ' A' ' 30' ' ' TYR . 32.6 tp -89.33 127.2 35.78 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.158 179.133 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.535 ' HB3' ' HB3' ' A' ' 141' ' ' ALA . 47.8 tp -106.84 109.88 21.9 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.974 0.416 . . . . 0.0 110.547 -178.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.433 HG13 ' HA2' ' A' ' 35' ' ' GLY . 7.4 pt -101.35 128.62 53.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.771 177.02 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.3 m -89.4 -171.32 3.18 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.14 -171.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -47.97 117.16 1.77 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.165 -178.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.665 ' HB2' ' HA ' ' A' ' 38' ' ' ASP . 37.0 m -137.35 160.38 39.24 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.856 -1.065 . . . . 0.0 108.806 174.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.61 ' H ' ' HE2' ' A' ' 16' ' ' MET . 32.2 m80 -127.35 58.4 1.46 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.288 0.566 . . . . 0.0 109.579 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.426 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . 2.9 t -108.67 134.02 20.44 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.845 -177.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.426 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 72.4 Cg_endo -103.08 51.82 1.45 Allowed 'Cis proline' 0 N--CA 1.448 -1.183 0 C-N-CA 124.078 -1.218 . . . . 0.0 111.995 -4.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.466 HG22 HG21 ' A' ' 40' ' ' VAL . 10.9 t -58.14 -39.99 75.3 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-O 121.531 0.681 . . . . 0.0 109.999 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 31.9 ttt85 -177.19 -33.97 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.374 -1.285 . . . . 0.0 108.681 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.61 ' HE2' ' H ' ' A' ' 11' ' ' HIS . 32.0 ttp -74.17 122.92 23.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.013 178.125 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -130.13 13.01 5.66 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.085 0.469 . . . . 0.0 110.339 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.0 p -82.66 33.74 0.43 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.418 -177.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.8 tt -99.67 114.22 65.48 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.435 ' HG2' HD22 ' A' ' 157' ' ' LEU . 36.6 Cg_exo -60.95 130.01 31.12 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 123.278 2.652 . . . . 0.0 113.016 -176.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -67.33 -23.36 65.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.271 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -58.87 -34.68 71.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.358 -178.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.43 HG22 ' O ' ' A' ' 20' ' ' PRO . 6.3 tt -65.59 -38.39 82.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.538 0.685 . . . . 0.0 109.662 178.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.681 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 46.0 tp -70.34 -32.01 69.54 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.303 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -71.62 -24.39 61.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.801 178.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.0 m -85.94 7.61 23.58 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -171.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.729 HD13 ' HB3' ' A' ' 52' ' ' SER . 4.3 mt -64.91 -19.77 66.1 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.509 0.671 . . . . 0.0 109.401 178.014 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -56.58 -23.8 43.11 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 114.563 -1.199 . . . . 0.0 111.835 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -82.34 -21.53 35.96 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -178.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.428 ' CD2' ' HB2' ' A' ' 5' ' ' LEU . 30.3 m-85 -113.87 159.75 19.5 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -162.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -71.94 -30.0 64.87 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.637 176.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -175.69 178.59 47.2 Favored Glycine 0 N--CA 1.439 -1.149 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.334 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.425 HG21 HD13 ' A' ' 27' ' ' LEU . 93.3 t -123.58 144.72 32.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 110.305 -0.257 . . . . 0.0 110.305 -178.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.452 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 55.0 mt -113.07 116.45 52.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.071 176.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.433 ' HA2' HG13 ' A' ' 7' ' ' ILE . . . -99.03 124.59 8.28 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.699 176.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.417 HD11 HD11 ' A' ' 6' ' ' LEU . 84.7 mt -98.39 3.19 48.47 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 122.624 -0.339 . . . . 0.0 111.087 -178.374 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 128.98 79.02 0.23 Allowed Glycine 0 CA--C 1.505 -0.582 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 -176.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.665 ' HA ' ' HB2' ' A' ' 10' ' ' SER . 0.4 OUTLIER -135.9 -70.26 0.48 Allowed 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.413 -0.394 . . . . 0.0 111.043 -169.402 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 96.9 m-85 -90.51 105.01 17.52 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 174.315 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.466 HG21 HG22 ' A' ' 14' ' ' VAL . 11.2 m -82.25 -12.36 12.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.298 -173.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.493 ' O ' HG23 ' A' ' 45' ' ' VAL . 11.4 t70 -86.65 127.52 34.94 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.339 -178.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 51.8 tp -61.13 -45.18 95.73 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.689 -174.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -62.87 -36.74 84.29 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.209 0.528 . . . . 0.0 110.252 -178.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.454 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 16.5 m -68.64 -33.26 73.69 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.617 176.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 41' ' ' ASP . 85.0 t -59.97 -41.88 87.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-O 121.109 0.481 . . . . 0.0 110.179 173.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -67.46 -34.8 70.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.185 0.517 . . . . 0.0 110.123 177.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.67 -33.75 75.69 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.062 174.09 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' A' ' 44' ' ' THR . 98.3 mt -64.63 -36.43 84.23 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 175.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.709 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 37.3 mt-10 -77.49 -4.8 47.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.738 176.198 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -86.69 -41.07 14.48 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 173.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.503 ' CB ' HD12 ' A' ' 27' ' ' LEU . 74.5 m-85 -76.79 -51.44 11.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.178 178.397 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.729 ' HB3' HD13 ' A' ' 27' ' ' LEU . 78.6 p -90.62 -25.12 20.3 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 121.071 -0.252 . . . . 0.0 111.616 -178.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.709 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 68.0 mttm 71.6 -50.35 0.69 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.413 0.685 . . . . 0.0 111.712 -177.052 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -105.02 101.89 11.42 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.511 0.672 . . . . 0.0 109.728 175.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.608 ' HB3' ' HG2' ' A' ' 49' ' ' GLU . 89.7 t80 -114.82 124.61 52.19 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.806 -176.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.452 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 93.5 m-85 -112.76 165.8 11.95 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 174.387 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 163.45 174.21 33.05 Favored Glycine 0 N--CA 1.442 -0.959 0 C-N-CA 119.211 -1.471 . . . . 0.0 113.604 176.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.449 HG21 ' HB3' ' A' ' 86' ' ' MET . 2.8 m -146.68 118.75 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 114.791 -0.705 . . . . 0.0 109.167 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -94.53 176.39 6.31 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.167 -175.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -109.44 -171.4 20.57 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.332 -0.937 . . . . 0.0 112.216 -176.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -88.68 40.77 0.98 Allowed 'General case' 0 C--N 1.321 -0.654 0 O-C-N 122.424 -0.456 . . . . 0.0 110.065 178.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 57.5 mtm -132.66 4.8 3.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.524 -179.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -107.87 -169.09 1.46 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.375 -175.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.416 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 95.9 m-85 -81.0 135.85 51.09 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.231 176.476 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 64' ' ' TYR . 50.2 Cg_exo -55.18 -36.53 93.41 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 123.336 2.691 . . . . 0.0 113.386 -177.347 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -69.14 -24.53 64.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.85 0.357 . . . . 0.0 111.306 -177.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.402 HG13 HD21 ' A' ' 71' ' ' LEU . 41.0 t -65.16 -21.69 29.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-O 121.29 0.566 . . . . 0.0 110.388 177.234 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.485 ' HB3' ' NZ ' ' A' ' 68' ' ' LYS . 4.6 ttpm? -62.41 -25.29 67.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.838 -178.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -68.04 -53.85 22.69 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.49 -174.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 22.2 t60 -74.3 -38.09 63.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.659 0.266 . . . . 0.0 110.824 -178.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.402 HD21 HG13 ' A' ' 67' ' ' VAL . 1.0 OUTLIER -133.76 121.87 16.28 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-O 120.865 0.364 . . . . 0.0 110.285 177.056 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -81.24 -160.71 0.13 Allowed 'Trans proline' 0 CA--C 1.529 0.266 0 C-N-CA 123.003 2.469 . . . . 0.0 112.821 -176.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -96.6 -24.9 15.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.331 0.586 . . . . 0.0 109.719 177.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 86' ' ' MET . 15.7 m -142.38 125.39 16.24 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.333 -178.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 22.2 ttmm -150.05 136.62 19.11 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.023 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 13.5 t -105.07 118.67 52.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 177.15 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.541 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 91.5 mt -87.77 136.14 33.08 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.048 177.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 33.9 tp -111.43 97.45 6.76 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 173.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.405 HG11 ' HE2' ' A' ' 4' ' ' PHE . 29.2 t -123.28 111.13 28.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.445 -174.197 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 57.11 33.57 23.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.541 178.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.9 -19.24 55.34 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.713 177.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.622 HG21 HD22 ' A' ' 145' ' ' LEU . 56.9 t -82.0 132.05 32.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.869 0.366 . . . . 0.0 111.179 -176.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.6 p -95.13 116.06 28.23 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.832 176.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.541 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 26.5 mt -111.91 92.83 2.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.988 0.423 . . . . 0.0 110.019 -178.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -81.53 99.81 2.0 Allowed Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.449 ' HB3' HG21 ' A' ' 58' ' ' VAL . 29.7 mtm -97.75 121.57 39.83 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -177.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 47.0 t -146.14 109.76 4.81 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 15.3 t60 -91.79 65.36 4.98 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.224 0.535 . . . . 0.0 110.887 -174.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -103.12 160.84 16.61 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.733 177.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 89.0 m95 -116.1 104.84 11.96 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.993 0.425 . . . . 0.0 110.784 -179.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -155.57 -173.12 23.87 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 178.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.47 142.17 42.92 Favored Pre-proline 0 C--N 1.321 -0.654 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.61 -20.85 59.76 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 123.041 2.494 . . . . 0.0 112.968 -176.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -69.45 -52.1 29.92 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.243 0.544 . . . . 0.0 109.986 -178.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -77.02 -30.79 55.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.079 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.422 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 36.2 tp -50.35 -55.24 16.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.83 -175.361 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.456 ' HG3' ' N ' ' A' ' 98' ' ' ASP . 19.2 pttp -58.28 -41.76 85.08 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.876 0.369 . . . . 0.0 111.098 -177.029 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.456 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 29.5 t70 -69.26 -43.89 73.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.881 -175.032 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.512 ' O ' HG23 ' A' ' 103' ' ' VAL . 82.1 mtp180 -70.53 -41.87 71.97 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.141 -177.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.503 HD13 HD13 ' A' ' 111' ' ' ILE . 85.1 mt -61.49 -39.3 90.44 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.568 0.223 . . . . 0.0 111.505 -177.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 97' ' ' LYS . 87.7 mt -67.04 -22.91 65.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.85 0.357 . . . . 0.0 111.063 179.185 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -91.45 -28.21 17.78 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.962 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 99' ' ' ARG . 89.7 t -67.6 -44.1 86.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.08 0.467 . . . . 0.0 109.837 175.183 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -85.09 168.95 14.4 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.544 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -97.34 -20.26 17.96 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.103 -177.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -135.59 165.98 24.28 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.45 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 13.8 ptmt -74.47 120.21 80.36 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-O 121.021 0.439 . . . . 0.0 110.17 176.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.452 ' HG2' HD11 ' A' ' 111' ' ' ILE . 3.7 Cg_exo -80.69 131.95 8.52 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 122.738 2.292 . . . . 0.0 111.163 176.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -66.3 -39.39 89.29 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 176.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.518 HG21 HG21 ' A' ' 150' ' ' VAL . 94.8 t -124.19 138.61 53.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.393 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.503 HD13 HD13 ' A' ' 100' ' ' LEU . 25.1 mt -129.32 126.41 63.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.907 0.384 . . . . 0.0 110.398 174.217 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.59 HD23 ' HB2' ' A' ' 130' ' ' LEU . 90.3 mt -101.71 119.75 39.27 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.257 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.442 ' CE1' ' HB3' ' A' ' 129' ' ' PHE . 20.0 p90 -133.11 173.45 11.42 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.868 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -122.22 114.67 2.55 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.601 -0.809 . . . . 0.0 111.957 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -166.7 35.95 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.93 ' HA ' HD21 ' A' ' 131' ' ' ASN . 53.3 m -53.21 109.87 0.48 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.55 -1.204 . . . . 0.0 113.819 -169.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 28.4 m80 -111.08 -45.53 3.43 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 162.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -147.67 142.32 16.59 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 114.593 -1.185 . . . . 0.0 109.024 172.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.494 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 16.5 Cg_endo -59.45 113.08 1.46 Allowed 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 122.173 1.916 . . . . 0.0 110.941 173.336 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -146.21 140.04 26.28 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.89 0.376 . . . . 0.0 111.319 -169.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -107.33 122.7 47.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.894 176.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 59.6 p -130.79 130.6 43.89 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -173.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.1 p -99.1 122.63 51.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 172.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.0 ttpm? -151.34 123.05 8.0 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.367 -174.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 66.22 20.68 11.1 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.588 -177.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 80.92 7.79 88.19 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.912 -177.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.482 HG11 HD12 ' A' ' 111' ' ' ILE . 61.2 t -109.46 136.22 46.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 177.054 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -95.47 104.15 16.05 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.196 0.522 . . . . 0.0 110.037 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.442 ' HB3' ' CE1' ' A' ' 113' ' ' PHE . 98.1 m-85 -89.94 124.2 34.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.187 -178.049 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.59 ' HB2' HD23 ' A' ' 112' ' ' LEU . 81.8 mt -109.99 125.38 52.83 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-O 121.333 0.587 . . . . 0.0 111.159 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.93 HD21 ' HA ' ' A' ' 116' ' ' THR . 7.6 t30 -127.9 105.36 20.52 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.579 174.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -86.93 179.18 3.36 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 123.008 2.472 . . . . 0.0 113.112 -177.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -85.46 165.39 38.9 Favored Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.758 178.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.42 ' O ' ' HB3' ' A' ' 137' ' ' GLU . 15.6 m -87.33 156.96 19.39 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.948 0.374 . . . . 0.0 111.534 -175.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -61.95 -44.49 96.66 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.818 0.342 . . . . 0.0 110.959 177.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -68.61 -17.42 64.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.239 0.542 . . . . 0.0 110.738 178.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.42 ' HB3' ' O ' ' A' ' 134' ' ' SER . 77.5 tt0 -79.32 -34.27 42.43 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.03 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.481 ' HA2' HD12 ' A' ' 157' ' ' LEU . . . 107.32 31.79 3.66 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.95 176.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 31.2 p -148.05 154.76 40.67 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.805 0.336 . . . . 0.0 110.81 177.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.422 ' O ' HD12 ' A' ' 154' ' ' LEU . 30.6 p90 -149.75 162.96 39.23 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.77 175.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.535 ' HB3' ' HB3' ' A' ' 6' ' ' LEU . . . -114.43 138.27 50.79 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.18 0.514 . . . . 0.0 111.802 -169.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.763 ' HB ' ' HB2' ' A' ' 153' ' ' GLU . 97.5 t -117.72 124.12 72.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.071 173.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.877 HD21 HG13 ' A' ' 150' ' ' VAL . 1.6 tt -107.34 115.96 31.1 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -178.375 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -107.28 116.81 32.6 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.081 0.467 . . . . 0.0 109.763 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.642 ' O ' ' HA ' ' A' ' 1' ' ' VAL . 74.5 mt -96.79 109.56 22.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.969 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -126.08 120.98 31.61 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.746 -175.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.82 10.93 59.57 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.87 178.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 92.03 5.66 65.8 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.759 -177.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -102.99 145.61 29.61 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.084 0.468 . . . . 0.0 110.496 178.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.877 HG13 HD21 ' A' ' 143' ' ' LEU . 62.1 t -94.85 119.01 42.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.074 -175.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 64.7 mtt180 -124.42 143.05 50.84 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.091 0.472 . . . . 0.0 110.418 178.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' PHE . . . . . 0.428 ' HE2' ' HB2' ' A' ' 154' ' ' LEU . 58.7 t80 -118.3 116.75 27.4 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.291 -168.12 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.763 ' HB2' ' HB ' ' A' ' 142' ' ' VAL . 45.5 mt-10 -102.77 111.2 23.42 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 174.357 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.428 ' HB2' ' HE2' ' A' ' 152' ' ' PHE . 32.5 tp -97.28 115.59 27.92 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.113 179.096 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -105.95 153.13 22.42 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.051 0.453 . . . . 0.0 110.878 -178.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 36.7 p -108.73 152.39 24.91 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.187 -177.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.481 HD12 ' HA2' ' A' ' 138' ' ' GLY . 97.0 mt . . . . . 0 C--O 1.247 0.949 0 CA-C-O 118.475 -0.774 . . . . 0.0 109.835 175.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 93.9 t . . . . . 0 N--CA 1.481 1.094 0 CA-C-O 120.727 0.298 . . . . 0.0 111.051 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -114.17 139.25 49.5 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 171.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 74.0 mtm-85 -110.27 116.18 31.01 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.811 -175.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -110.76 131.32 55.15 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.854 0.359 . . . . 0.0 110.792 178.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.498 ' HB2' ' CD2' ' A' ' 30' ' ' TYR . 38.6 tp -89.23 119.82 30.06 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.451 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.606 HD23 ' HB3' ' A' ' 141' ' ' ALA . 64.6 tp -106.05 115.65 30.58 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.017 0.437 . . . . 0.0 110.494 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.543 HG22 HD13 ' A' ' 23' ' ' ILE . 11.6 pt -101.09 125.8 54.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 177.327 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.0 m -65.43 177.51 1.13 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.2 -172.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -49.02 104.72 0.07 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.748 176.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.85 ' HB2' ' HA ' ' A' ' 38' ' ' ASP . 19.5 m -99.06 166.87 11.05 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.274 -177.109 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 69.9 m-70 -144.7 35.6 1.16 Allowed 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -176.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.657 HG21 HD12 ' A' ' 19' ' ' LEU . 14.6 t -102.68 138.53 19.65 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.493 -174.179 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.8 -56.84 0.14 OUTLIER 'Cis proline' 0 C--N 1.345 0.352 0 C-N-CA 123.382 -1.508 . . . . 0.0 112.242 -3.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.559 HG12 ' HG3' ' A' ' 15' ' ' ARG . 31.5 t 49.68 -94.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 O-C-N 123.815 0.697 . . . . 0.0 111.427 -178.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.559 ' HG3' HG12 ' A' ' 14' ' ' VAL . 54.9 mtp85 -138.44 13.53 2.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.259 0.552 . . . . 0.0 109.763 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 30.2 ttp -142.58 100.57 3.71 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.358 -177.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -101.72 14.33 32.29 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.254 0.55 . . . . 0.0 109.879 177.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.6 m -77.44 54.74 1.18 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.129 -179.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.866 ' HG ' HD13 ' A' ' 135' ' ' LEU . 2.0 tt -107.86 105.57 56.54 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 177.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.815 ' HG2' HD13 ' A' ' 157' ' ' LEU . 77.3 Cg_exo -52.08 123.47 12.6 Favored 'Trans proline' 0 C--O 1.236 0.398 0 C-N-CA 122.913 2.408 . . . . 0.0 112.375 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -68.62 -9.56 50.6 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.612 -178.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -52.88 -38.01 61.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.202 174.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.543 HD13 HG22 ' A' ' 7' ' ' ILE . 0.4 OUTLIER -82.45 -24.74 8.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.597 -179.006 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.472 ' O ' HD23 ' A' ' 27' ' ' LEU . 49.9 tp -81.96 -16.64 49.75 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.924 -177.096 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -86.3 -22.48 26.75 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.132 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.421 ' HB2' ' CE2' ' A' ' 30' ' ' TYR . 1.3 p -84.01 9.36 12.58 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -176.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.648 HD13 HG21 ' A' ' 33' ' ' VAL . 4.5 mm? -61.52 -19.96 62.68 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.234 0.54 . . . . 0.0 110.318 173.256 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 47.5 mttm -98.85 -0.34 42.63 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.857 -176.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -102.43 -49.32 3.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.803 0.335 . . . . 0.0 111.23 -173.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.498 ' CD2' ' HB2' ' A' ' 5' ' ' LEU . 93.4 m-85 -81.44 169.37 17.26 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.839 -173.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -88.24 -17.27 31.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.381 -177.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -168.67 162.27 36.03 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.648 HG21 HD13 ' A' ' 27' ' ' LEU . 61.2 t -132.01 147.47 32.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 -178.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.404 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 42.0 mt -123.73 124.78 70.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 175.15 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -106.48 114.69 4.49 Favored Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 111.564 -0.614 . . . . 0.0 111.564 177.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.605 ' HB3' ' HE1' ' A' ' 88' ' ' HIS . 99.3 mt -84.46 27.04 0.73 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.019 0.438 . . . . 0.0 110.733 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 110.46 60.54 0.49 Allowed Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 -173.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.85 ' HA ' ' HB2' ' A' ' 10' ' ' SER . 0.7 OUTLIER -76.53 -83.2 0.07 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.263 -0.469 . . . . 0.0 112.227 -173.829 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.478 ' HD1' HD11 ' A' ' 48' ' ' LEU . 75.5 m-85 -100.5 128.78 46.46 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.232 0.539 . . . . 0.0 110.995 -177.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.447 HG12 ' HB3' ' A' ' 63' ' ' ASP . 17.4 m -79.08 7.33 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.606 177.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.525 ' O ' HG23 ' A' ' 45' ' ' VAL . 13.6 t70 -110.17 130.01 55.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.964 -179.034 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.51 HD22 ' HB3' ' A' ' 66' ' ' ASP . 57.2 tp -65.63 -42.72 91.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.568 -175.098 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -59.51 -39.46 83.92 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.971 0.415 . . . . 0.0 111.274 -177.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 11.7 m -75.21 -27.02 59.39 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.213 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 41' ' ' ASP . 89.1 t -59.8 -43.3 91.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 121.391 0.615 . . . . 0.0 109.804 173.247 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -70.02 -34.55 60.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.91 178.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -60.94 -40.94 95.2 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.444 174.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.478 HD11 ' HD1' ' A' ' 39' ' ' TYR . 83.2 mt -69.11 -38.68 79.05 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.066 0.46 . . . . 0.0 110.174 179.289 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -62.13 -39.43 92.54 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.471 177.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -69.19 -36.1 76.96 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.752 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -71.61 -64.62 0.89 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.809 178.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.634 ' HB3' HD12 ' A' ' 27' ' ' LEU . 59.9 p -64.11 -40.85 97.1 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.217 -176.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 92.5 mttt 66.06 6.6 4.21 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.416 0.627 . . . . 0.0 110.425 -174.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -171.46 95.41 0.18 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.151 -0.932 . . . . 0.0 109.271 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.466 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 2.4 p90 -145.69 144.97 30.7 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.008 0.433 . . . . 0.0 109.927 178.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.404 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 56.1 m-85 -114.8 136.4 53.12 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 177.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.699 ' HA3' HD22 ' A' ' 71' ' ' LEU . . . -133.08 156.78 22.35 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 119.827 -1.178 . . . . 0.0 112.812 -177.315 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.402 HG13 ' HE3' ' A' ' 86' ' ' MET . 0.2 OUTLIER -136.84 164.25 30.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.132 0.491 . . . . 0.0 110.836 175.698 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.503 ' HB3' ' HA ' ' A' ' 73' ' ' PHE . 74.3 t60 -94.6 104.52 16.46 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.696 -175.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -115.72 -5.58 18.11 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.495 -0.775 . . . . 0.0 113.031 -176.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -115.16 -166.76 1.15 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.102 0.477 . . . . 0.0 110.234 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 97.0 mmm -98.98 34.86 2.0 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 169.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.447 ' HB3' HG12 ' A' ' 40' ' ' VAL . 1.8 p-10 -60.08 157.7 12.5 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.666 -177.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -62.21 155.62 64.46 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.924 -171.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.62 ' HA ' ' HB3' ' A' ' 68' ' ' LYS . 72.5 Cg_exo -50.47 -31.01 29.3 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 123.406 2.737 . . . . 0.0 112.948 178.135 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.51 ' HB3' HD22 ' A' ' 42' ' ' LEU . 32.2 m-20 -56.61 -48.4 77.54 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.342 0.591 . . . . 0.0 110.434 176.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 40.5 t -75.85 -38.94 37.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.819 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.62 ' HB3' ' HA ' ' A' ' 65' ' ' PRO . 48.5 tttp -57.59 -34.0 68.77 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.364 176.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -68.92 -33.94 74.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.069 0.461 . . . . 0.0 110.652 178.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -84.53 -50.89 7.32 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.167 -178.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.699 HD22 ' HA3' ' A' ' 57' ' ' GLY . 22.6 mt -100.38 113.8 65.54 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.899 -177.39 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.677 ' HG2' ' HB2' ' A' ' 75' ' ' LYS . 46.0 Cg_endo -69.42 153.98 69.72 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 122.491 2.127 . . . . 0.0 112.308 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.503 ' HA ' ' HB3' ' A' ' 59' ' ' HIS . 82.6 t80 -61.96 -32.77 73.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.343 0.592 . . . . 0.0 109.952 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.3 t -146.36 137.51 24.42 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.3 176.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.677 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 39.5 tttp -148.92 128.44 13.12 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.507 -176.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.472 ' HA ' ' HA2' ' A' ' 85' ' ' GLY . 46.5 t -99.75 117.03 44.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.095 0.474 . . . . 0.0 109.837 174.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.505 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 86.7 mt -87.71 138.48 31.43 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.408 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 42.9 tp -109.73 99.57 8.71 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 176.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 44.0 t -108.92 91.34 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.364 -177.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 57.33 30.31 18.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.662 175.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 114.54 -23.53 12.08 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.99 178.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.8 t -84.01 126.81 40.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.597 0.237 . . . . 0.0 110.556 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.2 p -95.72 117.96 31.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.944 0.402 . . . . 0.0 111.304 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.505 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 18.1 mt -111.62 93.14 2.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.946 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.472 ' HA2' ' HA ' ' A' ' 76' ' ' VAL . . . -84.02 106.35 2.86 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 111.731 -0.548 . . . . 0.0 111.731 -179.091 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.453 ' HE1' HD11 ' A' ' 77' ' ' LEU . 53.5 mtm -98.93 125.86 44.47 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -178.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 35.3 t -149.97 133.73 16.82 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.605 ' HE1' ' HB3' ' A' ' 36' ' ' LEU . 17.6 m80 -113.31 93.3 4.34 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.099 0.476 . . . . 0.0 111.444 178.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -136.21 154.81 22.14 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 175.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 10.6 p-90 -135.51 152.06 50.96 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 168.5 -137.23 4.46 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 -179.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.482 ' HB1' ' NE1' ' A' ' 94' ' ' TRP . . . -75.54 119.33 76.55 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-O 120.875 0.369 . . . . 0.0 110.578 178.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 92' ' ' ALA . 10.7 Cg_exo -72.48 -23.71 19.88 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.929 2.419 . . . . 0.0 112.933 -177.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.508 ' CE3' ' HB3' ' A' ' 95' ' ' ASP . 57.8 p-90 -70.72 -21.63 62.53 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -176.275 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.508 ' HB3' ' CE3' ' A' ' 94' ' ' TRP . 3.3 p-10 -126.44 20.51 7.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.001 0.429 . . . . 0.0 110.338 176.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 59.3 tp -57.08 -39.77 75.64 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.515 178.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.414 ' HD2' ' HB3' ' A' ' 124' ' ' LYS . 48.8 mtpt -54.4 -51.8 63.73 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.21 174.079 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -62.04 -39.46 92.42 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.767 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' A' ' 95' ' ' ASP . 52.5 mtt180 -63.43 -48.65 76.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.09 179.289 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 76.9 mt -67.65 -34.25 76.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.879 0.371 . . . . 0.0 111.094 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 96.9 mt -80.79 -4.84 56.04 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.858 0.361 . . . . 0.0 110.841 178.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 37.8 mttp -89.57 -22.07 22.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.485 170.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 64.6 t -68.74 -47.68 75.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.97 0.414 . . . . 0.0 110.189 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -108.91 169.87 8.4 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.715 177.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -95.35 -47.33 6.34 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -90.69 137.72 32.13 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.725 175.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.453 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 24.2 pttm -70.21 125.37 91.97 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-O 120.986 0.422 . . . . 0.0 110.629 -178.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 107' ' ' LYS . 9.0 Cg_exo -72.4 134.47 22.71 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.617 2.212 . . . . 0.0 110.368 174.42 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -60.5 -41.84 95.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.964 0.411 . . . . 0.0 110.437 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.8 t -122.46 140.96 44.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.767 177.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.442 HD12 ' CE2' ' A' ' 129' ' ' PHE . 42.0 mt -129.71 137.12 57.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 176.204 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.598 HD23 ' HB2' ' A' ' 130' ' ' LEU . 86.7 mt -114.11 130.57 56.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.326 -177.224 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.523 ' O ' ' HD2' ' A' ' 132' ' ' PRO . 51.4 p90 -155.65 -178.34 7.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.851 172.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -105.78 127.87 9.14 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.552 -0.832 . . . . 0.0 111.784 -177.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.509 ' HB2' ' HB2' ' A' ' 131' ' ' ASN . 1.1 t60 -83.69 -14.65 51.25 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.797 0.332 . . . . 0.0 110.536 -175.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 5.9 m 63.69 12.66 6.77 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.995 0.902 . . . . 0.0 110.18 -176.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.613 ' HB3' ' OE1' ' A' ' 118' ' ' GLU . 34.8 m80 -148.18 -160.76 1.21 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.997 -176.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.613 ' OE1' ' HB3' ' A' ' 117' ' ' HIS . 0.8 OUTLIER -69.32 144.28 94.58 Favored Pre-proline 0 C--N 1.326 -0.434 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.432 -179.917 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.416 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 77.9 Cg_exo -51.68 134.66 47.64 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.161 2.574 . . . . 0.0 112.586 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.46 ' HG2' HG23 ' A' ' 122' ' ' THR . 36.9 tt0 -142.55 127.29 18.12 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.837 -174.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.735 ' HB2' ' HZ ' ' A' ' 152' ' ' PHE . 19.5 t70 -86.92 107.36 18.33 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 177.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.562 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 27.7 p -116.16 118.73 33.63 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.815 -174.31 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.9 p -106.26 106.98 21.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.428 0.632 . . . . 0.0 110.321 176.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.584 ' HB2' ' HE1' ' A' ' 129' ' ' PHE . 62.4 mttm -127.24 129.24 47.4 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.023 -176.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 62.54 22.23 13.16 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 123.347 0.405 . . . . 0.0 111.415 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 87.42 -5.38 85.15 Favored Glycine 0 CA--C 1.518 0.244 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.071 -178.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.405 HG13 ' O ' ' A' ' 108' ' ' PRO . 90.4 t -94.92 135.45 28.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -97.22 107.32 19.81 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.159 0.504 . . . . 0.0 109.912 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.584 ' HE1' ' HB2' ' A' ' 124' ' ' LYS . 75.4 m-85 -92.48 119.06 31.61 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.717 -179.215 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.598 ' HB2' HD23 ' A' ' 112' ' ' LEU . 50.5 mt -103.31 117.37 34.35 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 177.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.509 ' HB2' ' HB2' ' A' ' 115' ' ' HIS . 2.5 p30 -130.03 110.11 16.87 Favored Pre-proline 0 C--N 1.317 -0.843 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.998 -177.081 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.523 ' HD2' ' O ' ' A' ' 113' ' ' PHE . 89.9 Cg_endo -82.46 -172.16 1.35 Allowed 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.783 2.322 . . . . 0.0 111.853 174.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -99.19 -97.65 2.13 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.558 -0.83 . . . . 0.0 112.904 -177.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 41.8 t -161.87 163.5 29.22 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 -176.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.866 HD13 ' HG ' ' A' ' 19' ' ' LEU . 57.3 mt -65.0 -49.75 69.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.115 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -65.1 -26.69 68.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.168 -178.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -88.87 4.3 48.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.875 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.555 ' HA2' HD12 ' A' ' 157' ' ' LEU . . . 58.67 43.67 96.15 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 116.083 -0.508 . . . . 0.0 113.354 175.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 3.9 p -137.24 110.39 7.8 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.039 0.447 . . . . 0.0 111.675 -178.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -132.19 -172.09 2.8 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 175.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.606 ' HB3' HD23 ' A' ' 6' ' ' LEU . . . -143.72 153.09 42.08 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.2 0.524 . . . . 0.0 111.46 -177.301 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 70.9 t -126.23 117.26 48.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 172.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.657 HD21 HG13 ' A' ' 150' ' ' VAL . 2.3 tt -94.62 106.52 18.51 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.254 0.55 . . . . 0.0 109.87 -175.235 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -97.97 119.06 35.92 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.702 177.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.505 ' O ' ' HA ' ' A' ' 1' ' ' VAL . 6.2 mp -95.61 106.45 18.55 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 177.289 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -109.25 110.31 21.47 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.796 177.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 68.05 11.12 60.53 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.108 -176.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 94.55 5.18 61.81 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.758 -0.537 . . . . 0.0 111.758 -177.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -89.2 133.37 34.45 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 178.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.657 HG13 HD21 ' A' ' 143' ' ' LEU . 62.4 t -76.9 103.64 4.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.17 -177.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 78.4 mtt-85 -115.88 89.59 3.14 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.973 178.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' PHE . . . . . 0.735 ' HZ ' ' HB2' ' A' ' 121' ' ' ASP . 3.5 p90 -95.04 123.28 38.44 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.125 0.488 . . . . 0.0 110.682 -178.068 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -91.45 123.56 34.97 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.069 177.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -83.98 81.69 8.67 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 176.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -80.72 131.84 35.49 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.907 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 26.5 p -109.14 150.72 27.45 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.794 -175.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.815 HD13 ' HG2' ' A' ' 20' ' ' PRO . 90.5 mt . . . . . 0 C--N 1.315 -0.905 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 177.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.547 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 98.0 t . . . . . 0 N--CA 1.477 0.889 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.4 tttm -113.72 138.0 50.84 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.677 ' HB3' ' HD1' ' A' ' 30' ' ' TYR . 56.6 mtt-85 -108.29 117.8 35.1 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.618 0.247 . . . . 0.0 111.33 -175.125 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.557 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 67.8 m-85 -112.43 113.94 26.39 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.203 0.525 . . . . 0.0 111.006 177.045 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.53 ' HB3' HG22 ' A' ' 33' ' ' VAL . 32.1 tp -89.24 121.04 31.14 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.021 178.06 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.748 HD11 ' HG ' ' A' ' 36' ' ' LEU . 41.4 tp -107.39 121.09 43.9 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.259 0.552 . . . . 0.0 111.211 -178.33 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.7 pt -101.18 119.38 49.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 171.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.508 ' O ' ' HB2' ' A' ' 36' ' ' LEU . 5.7 p -67.17 -87.71 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -164.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.485 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 36.2 t70 -142.32 94.06 2.61 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.287 0.565 . . . . 0.0 110.226 -176.285 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.46 ' OG ' HD12 ' A' ' 19' ' ' LEU . 23.0 t -107.86 158.47 17.3 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.802 -179.192 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.502 ' H ' ' HE1' ' A' ' 16' ' ' MET . 11.0 m80 -135.09 77.33 1.67 Allowed 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -178.295 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . 9.1 t -129.8 132.26 24.06 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.109 -177.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.47 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 41.2 Cg_endo -95.4 91.58 0.14 OUTLIER 'Cis proline' 0 N--CA 1.449 -1.092 0 C-N-CA 123.403 -1.499 . . . . 0.0 112.554 -2.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.726 HG12 ' H ' ' A' ' 15' ' ' ARG . 2.5 t -114.85 -165.07 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 175.12 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.726 ' H ' HG12 ' A' ' 14' ' ' VAL . 85.1 mtt180 -72.43 75.92 1.04 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 118.611 0.642 . . . . 0.0 110.758 177.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.502 ' HE1' ' H ' ' A' ' 11' ' ' HIS . 28.0 ttp -165.65 -77.12 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.467 178.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 59.2 12.05 2.36 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.554 -178.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.0 m -79.81 35.78 0.31 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.184 -177.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.46 HD12 ' OG ' ' A' ' 10' ' ' SER . 4.1 tt -107.75 111.02 62.7 Favored Pre-proline 0 C--N 1.327 -0.406 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.043 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.548 ' HG3' HD13 ' A' ' 157' ' ' LEU . 60.7 Cg_endo -74.06 133.43 18.09 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.623 2.215 . . . . 0.0 112.014 178.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -77.11 -5.81 50.43 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.925 0.393 . . . . 0.0 110.263 -177.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -55.93 -40.81 73.68 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.543 174.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.0 tt -70.38 -33.39 53.79 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-O 121.748 0.785 . . . . 0.0 109.98 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.526 ' O ' HD23 ' A' ' 27' ' ' LEU . 49.0 tp -66.64 -17.89 65.08 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.842 -178.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -80.47 -24.87 39.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.894 0.378 . . . . 0.0 110.966 177.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.3 m -80.28 2.81 23.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.48 -176.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.653 HD12 ' HB3' ' A' ' 52' ' ' SER . 4.4 mm? -59.98 -22.37 62.45 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.59 178.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -79.4 -14.26 59.06 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.323 -177.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -91.62 -23.61 19.81 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.968 0.413 . . . . 0.0 110.848 -178.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.677 ' HD1' ' HB3' ' A' ' 3' ' ' ARG . 38.3 m-85 -111.49 126.08 54.59 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.949 0.405 . . . . 0.0 110.678 -174.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -78.98 -29.97 44.14 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.868 -176.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.557 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -123.34 138.33 11.52 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 177.274 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.541 HG21 ' CD1' ' A' ' 27' ' ' LEU . 93.5 t -130.37 135.09 61.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 120.845 0.355 . . . . 0.0 110.574 -178.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.566 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 48.1 mt -112.32 131.59 63.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.435 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -118.41 98.28 0.74 Allowed Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.109 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.748 ' HG ' HD11 ' A' ' 6' ' ' LEU . 85.0 mt -77.65 -33.8 53.36 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 175.09 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.485 ' HA3' ' HA ' ' A' ' 9' ' ' ASP . . . -150.47 83.01 0.18 Allowed Glycine 0 N--CA 1.44 -1.087 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.494 177.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -94.75 -145.3 0.26 Allowed 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.447 ' HD1' HD11 ' A' ' 48' ' ' LEU . 78.2 m-85 -73.49 148.87 42.74 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 178.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.7 m -98.06 5.56 9.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.132 0.491 . . . . 0.0 110.748 -177.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.546 ' O ' HG23 ' A' ' 45' ' ' VAL . 17.3 t70 -102.9 132.34 49.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.874 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.539 HD22 ' HB3' ' A' ' 66' ' ' ASP . 65.6 tp -57.84 -54.23 49.22 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.171 -175.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -59.22 -35.71 74.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.156 0.503 . . . . 0.0 111.105 -176.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.429 HG21 ' CD2' ' A' ' 39' ' ' TYR . 17.6 m -72.01 -28.22 63.25 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.312 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.546 HG23 ' O ' ' A' ' 41' ' ' ASP . 94.8 t -65.01 -37.4 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 121.205 0.526 . . . . 0.0 109.913 174.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.521 ' O ' ' HG2' ' A' ' 50' ' ' LYS . 1.7 mp -65.5 -37.15 79.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.56 175.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.447 ' O ' ' HB2' ' A' ' 50' ' ' LYS . 3.2 tm? -61.82 -34.04 75.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.767 174.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.447 HD11 ' HD1' ' A' ' 39' ' ' TYR . 96.4 mt -67.97 -40.44 83.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.324 177.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.562 ' HA ' ' O ' ' A' ' 52' ' ' SER . 44.6 mt-10 -78.68 -2.39 38.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.348 177.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.521 ' HG2' ' O ' ' A' ' 46' ' ' ILE . 32.2 mmtp -75.43 -53.67 8.3 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 170.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -70.95 -66.22 0.64 Allowed 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.101 177.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.653 ' HB3' HD12 ' A' ' 27' ' ' LEU . 15.7 p -95.36 92.99 6.98 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.214 175.275 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.526 ' HG2' ' O ' ' A' ' 49' ' ' GLU . 63.3 mttp -70.41 -15.67 62.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.142 0.496 . . . . 0.0 110.431 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -101.4 68.15 1.19 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.409 171.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -100.37 108.73 20.82 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.173 -178.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.566 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 12.2 m-85 -102.75 108.01 19.09 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.609 ' HA3' HD22 ' A' ' 71' ' ' LEU . . . -125.55 165.03 18.9 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 119.869 -1.158 . . . . 0.0 112.716 -176.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.1 m -141.66 127.63 18.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.557 -0.321 . . . . 0.0 110.341 177.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -129.73 166.97 18.77 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.137 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.605 ' HA2' ' HD1' ' A' ' 73' ' ' PHE . . . -104.3 -169.27 24.86 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.308 -0.948 . . . . 0.0 112.906 -173.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -84.07 5.5 25.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.058 0.456 . . . . 0.0 110.48 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 87.1 mtp -103.55 -5.71 22.45 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.889 178.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -94.38 168.28 10.99 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.058 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -65.33 126.0 90.57 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.155 176.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.56 ' HA ' ' HB3' ' A' ' 68' ' ' LYS . 53.1 Cg_exo -57.04 -25.68 64.54 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.216 2.61 . . . . 0.0 112.507 -179.063 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.539 ' HB3' HD22 ' A' ' 42' ' ' LEU . 2.6 m-20 -58.38 -41.97 85.99 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.916 175.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 84.0 t -78.09 -37.96 23.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.862 177.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.56 ' HB3' ' HA ' ' A' ' 65' ' ' PRO . 63.6 tttm -63.19 -22.06 66.62 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.353 -178.316 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -60.4 -44.02 96.11 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.189 0.519 . . . . 0.0 110.077 173.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 64.6 m-70 -82.04 -39.1 23.98 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.929 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.609 HD22 ' HA3' ' A' ' 57' ' ' GLY . 7.3 mt -115.98 101.16 54.01 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.68 -173.511 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.526 ' HG2' ' HB2' ' A' ' 75' ' ' LYS . 69.4 Cg_endo -74.87 174.98 11.8 Favored 'Trans proline' 0 CA--C 1.528 0.2 0 C-N-CA 122.701 2.267 . . . . 0.0 112.283 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.605 ' HD1' ' HA2' ' A' ' 60' ' ' GLY . 76.7 t80 -81.2 -21.81 39.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.262 0.553 . . . . 0.0 110.502 -178.358 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 39.6 m -144.48 119.14 9.78 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.043 178.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.526 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 40.2 tttp -139.59 135.92 33.85 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.321 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 77.8 t -108.75 132.99 55.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.931 0.396 . . . . 0.0 110.145 174.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.508 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 84.9 mt -106.81 132.82 52.34 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.9 176.202 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 42.2 tp -109.26 100.47 9.59 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.652 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.5 t -116.42 102.94 14.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.585 -175.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 54.57 31.37 14.85 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.705 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.72 -22.27 37.76 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.454 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.541 ' HA ' ' OE1' ' A' ' 109' ' ' GLN . 99.1 t -71.31 122.68 23.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.772 0.32 . . . . 0.0 110.347 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.29 102.94 14.82 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.5 -178.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.508 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 20.4 mt -93.85 110.19 23.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.4 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -93.36 109.47 3.81 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.764 -0.731 . . . . 0.0 111.395 177.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 30.0 mtm -107.11 119.77 40.28 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.716 0.293 . . . . 0.0 110.772 -177.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 49.6 t -145.35 104.43 3.93 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 175.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 49.8 t60 -84.87 66.1 9.51 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.184 0.516 . . . . 0.0 110.368 -177.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -113.78 -145.1 9.03 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.756 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 28.2 t-105 -139.15 164.76 28.94 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -178.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 165.83 161.33 14.62 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.511 -0.852 . . . . 0.0 113.087 177.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.502 ' HB1' ' HD2' ' A' ' 93' ' ' PRO . . . -88.46 162.45 39.54 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 175.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.502 ' HD2' ' HB1' ' A' ' 92' ' ' ALA . 0.9 OUTLIER -43.97 -49.44 8.37 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.366 2.71 . . . . 0.0 113.656 -178.14 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 18.3 p-90 -81.85 -44.18 17.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.877 0.37 . . . . 0.0 111.363 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -59.44 -37.01 77.01 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.543 -177.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 19.9 tp -60.85 -49.18 78.5 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.277 178.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -58.44 -42.62 87.77 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.748 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -64.55 -53.58 45.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.552 -177.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 21.9 ttp-105 -68.79 -40.04 79.84 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -174.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.568 HD13 HG21 ' A' ' 111' ' ' ILE . 65.7 mt -71.71 -32.56 67.91 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.541 -0.464 . . . . 0.0 111.446 -176.161 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.588 HD21 HG21 ' A' ' 127' ' ' VAL . 86.8 mt -80.62 -12.49 59.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.177 0.513 . . . . 0.0 110.268 175.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -79.78 -40.46 28.64 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.523 173.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 80.3 t -73.75 -52.3 21.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.535 177.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -91.41 103.68 16.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.07 0.462 . . . . 0.0 110.874 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -76.9 -22.92 52.67 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.668 -177.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -66.94 -28.51 68.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.019 176.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.484 ' HG3' HD22 ' A' ' 101' ' ' LEU . 39.5 ttpt 63.76 92.84 0.06 OUTLIER Pre-proline 0 CA--C 1.529 0.162 0 O-C-N 123.985 0.803 . . . . 0.0 109.896 -170.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.445 ' O ' HG22 ' A' ' 127' ' ' VAL . 13.6 Cg_exo -69.37 166.75 26.03 Favored 'Trans proline' 0 N--CA 1.464 -0.228 0 C-N-CA 123.023 2.482 . . . . 0.0 112.859 -174.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.541 ' OE1' ' HA ' ' A' ' 82' ' ' VAL . 75.1 mt-30 -85.32 -49.94 7.75 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.273 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 58.7 t -122.67 132.02 72.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.911 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.568 HG21 HD13 ' A' ' 100' ' ' LEU . 35.3 mt -126.71 132.13 70.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.071 0.462 . . . . 0.0 110.911 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.456 ' HB3' HD11 ' A' ' 36' ' ' LEU . 78.2 mt -105.68 121.18 43.48 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.067 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -132.06 -178.77 5.04 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.747 -178.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -125.69 131.97 7.77 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 121.057 -0.592 . . . . 0.0 111.785 178.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 60.5 t-80 -139.57 -68.02 0.43 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 177.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.0 p -143.85 -80.69 0.19 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.851 178.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.435 ' O ' ' HD3' ' A' ' 119' ' ' PRO . 16.5 p-80 -172.24 41.79 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.121 -178.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -103.12 102.02 25.58 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.286 -173.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.698 ' HB3' HD22 ' A' ' 154' ' ' LEU . 59.9 Cg_endo -77.44 41.94 1.06 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.782 2.321 . . . . 0.0 111.469 177.341 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -97.48 132.46 43.16 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.127 -176.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -78.52 107.07 10.9 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.267 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.601 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 67.8 p -105.35 114.49 28.7 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.141 0.496 . . . . 0.0 110.069 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.2 p -136.51 145.05 31.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.691 -175.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -159.28 -55.98 0.06 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.112 175.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.401 ' O ' ' HD2' ' A' ' 107' ' ' LYS . . . -85.1 23.88 1.18 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.939 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 86.92 -16.93 44.21 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 121.083 -0.58 . . . . 0.0 111.707 -176.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.588 HG21 HD21 ' A' ' 101' ' ' LEU . 15.3 t -87.54 134.05 28.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.636 -0.282 . . . . 0.0 110.618 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 76.9 mtp180 -98.92 104.52 16.56 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.051 175.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.601 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 69.4 m-85 -87.72 124.78 33.93 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.423 HD13 ' CD2' ' A' ' 152' ' ' PHE . 67.8 mt -124.8 134.91 52.59 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.937 0.399 . . . . 0.0 111.454 -174.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -118.08 106.05 46.0 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.569 177.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.448 ' HB2' ' HB3' ' A' ' 8' ' ' SER . 61.3 Cg_endo -75.86 146.27 29.52 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 122.239 1.959 . . . . 0.0 112.683 179.316 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -73.35 141.76 30.41 Favored Glycine 0 C--N 1.331 0.279 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.809 177.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.462 ' HA ' ' OG ' ' A' ' 8' ' ' SER . 31.1 t -70.14 159.6 33.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.598 0.713 . . . . 0.0 112.632 -174.038 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.435 ' HG ' ' HG ' ' A' ' 19' ' ' LEU . 3.6 mm? -61.16 -26.65 67.84 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.149 174.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.9 -25.68 67.99 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.344 -178.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -105.02 6.56 33.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.106 0.479 . . . . 0.0 110.351 178.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.435 ' HA2' HD12 ' A' ' 157' ' ' LEU . . . 73.72 44.67 31.06 Favored Glycine 0 N--CA 1.451 -0.352 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.904 177.161 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 24.6 m -132.0 144.15 50.58 Favored 'General case' 0 C--N 1.321 -0.631 0 O-C-N 122.664 -0.315 . . . . 0.0 110.744 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 44.1 p90 -145.02 160.04 41.99 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 173.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.521 ' HB3' HD23 ' A' ' 6' ' ' LEU . . . -115.72 142.81 46.25 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.722 -175.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.8 ' HB ' ' HE3' ' A' ' 155' ' ' LYS . 51.1 t -126.98 124.8 65.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 175.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.537 HD21 HG13 ' A' ' 150' ' ' VAL . 5.3 tt -109.69 108.0 18.22 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.507 ' HG3' HG12 ' A' ' 142' ' ' VAL . 40.3 mt-10 -110.51 127.09 55.01 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.033 -178.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.547 ' O ' ' HA ' ' A' ' 1' ' ' VAL . 6.7 mp -90.79 105.77 18.05 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.894 0.378 . . . . 0.0 110.385 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -105.6 109.2 21.08 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.744 178.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 68.2 10.69 60.06 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.539 -177.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 98.84 -3.2 58.71 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.369 -177.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -85.1 147.26 26.73 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.723 0.297 . . . . 0.0 110.296 177.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.537 HG13 HD21 ' A' ' 143' ' ' LEU . 60.2 t -88.87 102.97 13.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.965 -175.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 47.6 mtp180 -98.66 94.0 6.41 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 176.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' PHE . . . . . 0.423 ' CD2' HD13 ' A' ' 130' ' ' LEU . 73.9 t80 -99.83 99.89 10.75 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.971 -179.301 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.424 ' HB2' ' HE2' ' A' ' 155' ' ' LYS . 49.1 mt-10 -110.88 119.56 39.49 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.203 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.698 HD22 ' HB3' ' A' ' 119' ' ' PRO . 23.2 tp -78.38 109.17 12.3 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 171.26 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.8 ' HE3' ' HB ' ' A' ' 142' ' ' VAL . 73.7 mttt -105.76 138.83 41.3 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.334 -175.091 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.7 p -97.55 155.29 17.03 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.224 0.535 . . . . 0.0 112.294 -171.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.548 HD13 ' HG3' ' A' ' 20' ' ' PRO . 61.5 mt . . . . . 0 C--O 1.247 0.959 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.134 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 87.7 t . . . . . 0 N--CA 1.482 1.146 0 CA-C-O 120.811 0.339 . . . . 0.0 110.57 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.568 ' HB2' HD12 ' A' ' 145' ' ' LEU . 6.1 mtpm? -134.12 161.81 33.84 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 176.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.69 ' HB3' ' CD2' ' A' ' 30' ' ' TYR . 92.9 mtt180 -118.7 129.76 55.46 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.747 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.676 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 85.2 m-85 -125.08 119.78 29.61 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.173 0.511 . . . . 0.0 110.557 176.106 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.562 ' HB3' HG22 ' A' ' 33' ' ' VAL . 23.7 tp -89.19 124.35 34.27 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 178.193 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.527 HD23 ' HB3' ' A' ' 141' ' ' ALA . 33.5 tp -104.22 98.82 8.57 Favored 'General case' 0 C--O 1.241 0.605 0 CA-C-O 121.584 0.707 . . . . 0.0 111.251 -175.501 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.473 ' HB ' HD11 ' A' ' 135' ' ' LEU . 13.6 pt -101.17 110.69 28.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 173.217 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.474 ' HA ' ' HB2' ' A' ' 36' ' ' LEU . 16.2 m -94.36 -97.33 0.16 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -165.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -98.18 120.7 39.05 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.742 0.306 . . . . 0.0 110.365 -171.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.5 ' HB2' HD12 ' A' ' 135' ' ' LEU . 28.8 t -157.45 164.71 37.16 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.946 0.403 . . . . 0.0 111.085 -174.456 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -138.03 74.72 1.49 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.462 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -126.14 138.42 32.16 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-O 120.841 0.353 . . . . 0.0 110.745 174.297 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.431 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 38.2 Cg_endo -96.22 75.08 0.14 OUTLIER 'Cis proline' 0 N--CA 1.451 -1.022 0 C-N-CA 123.445 -1.481 . . . . 0.0 113.027 -2.31 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -103.89 -153.57 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 174.022 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -77.28 82.28 3.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.357 0.598 . . . . 0.0 110.299 178.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 39.2 ttp -161.99 -76.98 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.814 177.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 60.0 10.27 2.13 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.501 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.416 ' O ' ' HD3' ' A' ' 20' ' ' PRO . 3.8 m -80.6 15.25 1.75 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.451 -176.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.406 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 0.7 OUTLIER -102.5 102.59 26.64 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -179.902 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.416 ' HD3' ' O ' ' A' ' 18' ' ' SER . 3.9 Cg_exo -74.32 156.76 46.03 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.879 2.386 . . . . 0.0 112.466 -176.512 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -63.35 -14.56 51.38 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.75 178.073 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -61.09 -21.85 64.07 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.943 -177.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -99.62 -28.76 3.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.218 0.532 . . . . 0.0 110.309 176.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.46 ' O ' HD23 ' A' ' 27' ' ' LEU . 48.8 tp -73.03 -28.38 62.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.038 -173.308 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 -82.06 -11.45 58.78 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.929 0.395 . . . . 0.0 110.425 178.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.477 ' O ' ' HD1' ' A' ' 30' ' ' TYR . 38.8 m -77.78 -5.3 50.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.729 175.002 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.734 HD13 HG21 ' A' ' 33' ' ' VAL . 3.5 mm? -58.37 -27.09 63.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.45 0.643 . . . . 0.0 109.855 170.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -90.43 9.97 27.02 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.495 -178.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -119.23 -16.06 9.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.899 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.69 ' CD2' ' HB3' ' A' ' 3' ' ' ARG . 89.5 m-85 -119.95 135.62 54.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.965 -178.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -81.81 -23.11 36.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.04 0.448 . . . . 0.0 110.707 -179.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.676 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -130.72 144.94 16.38 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.678 175.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.734 HG21 HD13 ' A' ' 27' ' ' LEU . 95.4 t -139.41 141.18 35.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.143 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.56 HG12 ' HB2' ' A' ' 56' ' ' TYR . 48.6 mt -120.55 124.31 72.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.741 -178.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.416 ' HA2' HG13 ' A' ' 7' ' ' ILE . . . -109.19 104.28 1.9 Allowed Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 111.614 -0.594 . . . . 0.0 111.614 177.176 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.474 ' HB2' ' HA ' ' A' ' 8' ' ' SER . 87.5 mt -84.98 4.22 34.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.915 0.388 . . . . 0.0 111.191 -176.353 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 153.52 48.64 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.979 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -127.61 155.79 43.31 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 -178.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.507 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 53.3 m-85 49.91 87.81 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.89 0.852 . . . . 0.0 111.753 -173.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.2 m -80.45 3.18 2.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.496 -174.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.489 ' O ' HG23 ' A' ' 45' ' ' VAL . 21.7 t70 -94.36 121.61 36.06 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.251 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.513 HD22 ' HB3' ' A' ' 66' ' ' ASP . 59.8 tp -58.69 -45.4 89.56 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.598 -174.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -54.7 -46.38 74.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.164 0.506 . . . . 0.0 110.601 178.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.585 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 27.1 m -65.46 -31.12 72.04 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.376 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 41' ' ' ASP . 84.7 t -59.77 -44.38 93.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 121.013 0.435 . . . . 0.0 110.57 177.118 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -67.02 -40.0 84.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-O 121.198 0.523 . . . . 0.0 109.898 177.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -61.32 -35.0 76.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.697 176.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 44' ' ' THR . 83.1 mt -66.39 -35.92 81.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.687 179.136 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -78.0 -13.87 59.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.1 0.476 . . . . 0.0 110.575 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -81.23 -16.38 52.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.124 0.487 . . . . 0.0 110.394 173.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.56 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . 27.8 m-85 -100.52 -58.76 1.83 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.01 174.384 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 41.7 t -77.02 101.44 6.03 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.711 174.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -55.85 -40.09 72.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.824 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -113.71 89.85 3.19 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.037 0.446 . . . . 0.0 109.965 172.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -100.25 121.75 41.96 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.147 0.499 . . . . 0.0 110.77 -177.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.56 ' HB2' HG12 ' A' ' 34' ' ' ILE . 92.6 m-85 -118.88 178.44 4.48 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.426 -0.807 . . . . 0.0 109.307 176.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.441 ' C ' HD12 ' A' ' 71' ' ' LEU . . . 159.65 -179.68 35.06 Favored Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 120.141 -1.028 . . . . 0.0 112.685 176.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 15.8 t -140.51 148.37 22.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 -94.66 104.49 16.42 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.027 0.442 . . . . 0.0 110.316 -175.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -116.05 -5.16 17.85 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.155 177.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.493 ' HB3' ' OD1' ' A' ' 63' ' ' ASP . 6.7 m120 -83.4 133.68 34.92 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 74.1 mtm -96.73 10.23 39.34 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.235 0.54 . . . . 0.0 109.804 176.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.493 ' OD1' ' HB3' ' A' ' 61' ' ' ASN . 4.7 m-20 -66.66 -68.32 0.38 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.069 -177.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.479 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 91.8 m-85 -124.52 131.16 24.12 Favored Pre-proline 0 C--O 1.237 0.418 0 CA-C-O 121.167 0.508 . . . . 0.0 111.383 -177.262 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 64' ' ' TYR . 1.2 Cg_endo -83.74 -3.26 10.54 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 123.725 2.95 . . . . 0.0 112.478 -179.363 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.513 ' HB3' HD22 ' A' ' 42' ' ' LEU . 8.0 m-20 -67.68 -36.25 80.34 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.448 0.642 . . . . 0.0 109.958 179.219 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.525 HG12 HD23 ' A' ' 71' ' ' LEU . 30.3 t -76.36 -13.73 14.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.554 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.445 ' HB3' ' O ' ' A' ' 65' ' ' PRO . 87.6 tttt -70.59 -15.99 62.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.492 -175.054 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -90.36 0.42 57.27 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.82 0.343 . . . . 0.0 111.435 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 44.7 m80 -123.3 -39.04 2.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.03 0.443 . . . . 0.0 110.611 177.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.525 HD23 HG12 ' A' ' 67' ' ' VAL . 3.4 mm? -103.0 124.25 39.19 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 176.584 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -84.88 -175.08 1.93 Allowed 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.86 2.374 . . . . 0.0 113.115 -175.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -80.4 -29.46 37.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.38 0.609 . . . . 0.0 110.066 179.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.523 ' HB3' ' CZ ' ' A' ' 104' ' ' PHE . 26.5 m -152.07 137.51 17.66 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.121 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 34.7 tttp -139.29 116.56 11.16 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.926 -176.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.473 HG22 ' HA2' ' A' ' 85' ' ' GLY . 46.6 t -100.25 125.54 53.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 176.036 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 44.8 mt -103.14 153.58 20.17 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.06 178.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 37.4 tp -115.28 93.45 4.3 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 171.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 46.5 t -106.33 104.2 16.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.354 -173.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 57.21 29.26 16.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.441 178.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.45 -16.18 52.79 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.613 177.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 54.0 t -89.55 123.95 42.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.887 0.375 . . . . 0.0 110.832 -178.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.445 ' HB ' ' HA ' ' A' ' 108' ' ' PRO . 0.0 OUTLIER -80.73 115.87 20.45 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.858 177.259 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 21.0 mt -111.56 99.16 8.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.779 0.324 . . . . 0.0 110.489 -178.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.473 ' HA2' HG22 ' A' ' 76' ' ' VAL . . . -85.12 98.82 2.27 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 178.246 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 48.8 mtm -90.71 126.46 36.0 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.19 0.519 . . . . 0.0 110.896 -176.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.489 ' SG ' ' HB3' ' A' ' 113' ' ' PHE . 28.5 p -135.73 164.91 26.8 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 9.3 t-80 -83.49 -23.68 32.07 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 119.841 -0.743 . . . . 0.0 109.936 178.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.461 ' HA3' ' HB2' ' A' ' 113' ' ' PHE . . . 82.02 118.07 0.5 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.094 176.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 63.2 t90 -156.24 126.84 6.74 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 176.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 133.07 -166.93 23.55 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.425 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . . . -88.08 124.94 65.79 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.024 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 92' ' ' ALA . 33.7 Cg_exo -58.75 -15.61 27.14 Favored 'Trans proline' 0 N--CA 1.475 0.39 0 C-N-CA 123.224 2.616 . . . . 0.0 113.009 -177.153 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 4.4 m0 -66.14 -43.14 87.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.79 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -123.95 13.29 9.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.981 0.419 . . . . 0.0 111.23 -177.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 54.8 tp -66.32 -35.37 80.21 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.815 177.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.511 ' HD3' ' HB3' ' A' ' 124' ' ' LYS . 52.1 mttp -59.64 -49.42 77.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.804 177.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -68.17 -36.35 79.49 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.063 -0.972 . . . . 0.0 111.068 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.429 ' O ' HG23 ' A' ' 103' ' ' VAL . 45.8 ttt180 -64.85 -42.39 94.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.922 178.616 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.509 HD13 HG21 ' A' ' 111' ' ' ILE . 72.9 mt -67.78 -29.19 68.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.683 0.278 . . . . 0.0 111.241 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.512 HD21 HG21 ' A' ' 127' ' ' VAL . 92.2 mt -72.71 -13.72 61.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.014 0.435 . . . . 0.0 110.496 175.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -94.05 -30.88 14.46 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.782 175.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 99' ' ' ARG . 83.9 t -59.59 -50.98 77.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.1 175.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.523 ' CZ ' ' HB3' ' A' ' 74' ' ' SER . 55.8 m-85 -92.34 161.44 14.67 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.389 177.324 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -94.79 -26.73 16.11 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.303 0.573 . . . . 0.0 110.237 -179.136 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.405 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 43.2 mt-10 -111.81 152.36 27.97 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.127 175.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.409 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 45.2 mtmt -83.34 113.87 49.32 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-O 120.797 0.332 . . . . 0.0 110.919 -178.213 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.445 ' HA ' ' HB ' ' A' ' 83' ' ' THR . 2.7 Cg_exo -76.04 124.43 7.96 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.774 2.316 . . . . 0.0 110.465 175.434 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -61.61 -37.12 82.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.988 0.423 . . . . 0.0 111.389 -176.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 88.7 t -123.94 132.59 71.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 175.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.509 HG21 HD13 ' A' ' 100' ' ' LEU . 37.7 mt -125.17 134.62 66.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.923 0.392 . . . . 0.0 110.651 179.437 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.555 HD23 ' HB2' ' A' ' 130' ' ' LEU . 96.2 mt -109.29 139.05 44.73 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.928 178.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.503 ' CZ ' ' HB2' ' A' ' 131' ' ' ASN . 6.5 p90 -155.53 122.96 5.54 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 175.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -122.67 114.5 2.47 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.615 -177.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -173.53 21.04 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.495 0.664 . . . . 0.0 109.365 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.497 HG22 ' H ' ' A' ' 118' ' ' GLU . 16.9 m -117.38 154.38 31.42 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.015 -175.288 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 32.5 m80 -80.85 -27.57 36.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.922 0.391 . . . . 0.0 110.356 -177.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.497 ' H ' HG22 ' A' ' 116' ' ' THR . 46.0 mt-10 -122.03 111.13 32.53 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.263 177.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -57.49 141.94 95.21 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.767 2.312 . . . . 0.0 111.897 177.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -154.68 142.29 19.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.973 0.416 . . . . 0.0 111.367 -173.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -98.24 124.3 42.77 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.382 172.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.562 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 69.8 p -129.11 129.7 45.52 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.06 0.457 . . . . 0.0 111.48 -176.412 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.7 p -126.86 140.66 48.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.668 175.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.511 ' HB3' ' HD3' ' A' ' 97' ' ' LYS . 71.5 tttt -155.79 -56.34 0.09 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.416 0.627 . . . . 0.0 110.308 -179.454 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -94.88 30.85 1.97 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.746 -175.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 79.54 -42.21 2.4 Favored Glycine 0 N--CA 1.451 -0.304 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 -173.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.512 HG21 HD21 ' A' ' 101' ' ' LEU . 89.3 t -60.24 136.68 23.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-N 115.213 -0.494 . . . . 0.0 110.825 176.146 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.402 ' HE ' ' HB2' ' A' ' 128' ' ' ARG . 20.3 ttm180 -97.21 112.55 24.3 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.947 178.494 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.562 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 82.7 m-85 -97.76 108.26 20.94 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.102 -178.497 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.555 ' HB2' HD23 ' A' ' 112' ' ' LEU . 81.9 mt -99.8 115.6 29.93 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.294 -178.195 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.503 ' HB2' ' CZ ' ' A' ' 113' ' ' PHE . 22.7 t-20 -108.2 112.11 61.48 Favored Pre-proline 0 C--N 1.32 -0.713 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.187 -178.116 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -92.1 174.95 2.1 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 123.435 2.757 . . . . 0.0 111.413 169.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -112.85 -172.38 18.54 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.411 -0.899 . . . . 0.0 112.739 -177.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 38.0 m -78.9 153.94 30.1 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.642 0.258 . . . . 0.0 110.508 178.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.5 HD12 ' HB2' ' A' ' 10' ' ' SER . 73.5 mt -78.38 -10.69 59.79 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -173.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -96.49 -60.3 1.64 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.958 0.408 . . . . 0.0 111.412 -177.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -106.02 22.09 16.23 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.216 -173.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.471 ' O ' ' HB2' ' A' ' 157' ' ' LEU . . . -146.72 -164.76 11.23 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.348 -178.608 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 15.2 p -112.66 148.84 33.82 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.722 -0.103 . . . . 0.0 110.722 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -97.2 168.83 10.19 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 -177.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.527 ' HB3' HD23 ' A' ' 6' ' ' LEU . . . -121.27 149.43 42.9 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.016 0.436 . . . . 0.0 111.171 -174.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 69.5 t -122.36 126.98 74.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 173.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.739 HD21 HG13 ' A' ' 150' ' ' VAL . 3.7 tt -110.19 104.55 13.4 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -109.28 143.86 38.2 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.568 HD12 ' HB2' ' A' ' 2' ' ' LYS . 91.1 mt -98.66 101.66 13.15 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.199 0.523 . . . . 0.0 110.667 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.668 ' HB3' ' HE ' ' A' ' 151' ' ' ARG . 12.2 t70 -96.35 114.55 26.24 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.879 178.16 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.83 -69.06 0.3 Allowed Glycine 0 C--N 1.331 0.287 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.596 -175.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -174.92 26.92 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 178.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -126.78 147.01 50.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.834 0.349 . . . . 0.0 110.22 -177.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.739 HG13 HD21 ' A' ' 143' ' ' LEU . 92.2 t -76.83 113.35 15.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.342 -176.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.668 ' HE ' ' HB3' ' A' ' 146' ' ' ASP . 38.8 mmt180 -97.09 108.84 21.65 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.154 176.016 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -90.66 94.5 9.72 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 177.032 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -100.67 102.69 13.87 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.01 -178.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 26.7 tp -83.72 130.51 34.95 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.173 -178.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -123.52 138.89 54.48 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 3.1 m -81.91 156.36 24.82 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.191 0.519 . . . . 0.0 111.705 -169.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.471 ' HB2' ' O ' ' A' ' 138' ' ' GLY . 88.6 mt . . . . . 0 C--O 1.247 0.945 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.496 176.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 47.1 t . . . . . 0 N--CA 1.477 0.896 0 CA-C-O 120.982 0.42 . . . . 0.0 110.867 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.615 ' HB2' ' HB2' ' A' ' 145' ' ' LEU . 92.7 mttt -109.47 151.02 27.27 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 170.261 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.51 ' O ' ' HB3' ' A' ' 30' ' ' TYR . 96.1 mtt180 -133.58 113.89 12.93 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.064 0.459 . . . . 0.0 110.841 178.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.527 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 49.3 m-85 -104.3 125.85 50.9 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.166 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.484 HD22 ' HB2' ' A' ' 26' ' ' SER . 37.8 tp -89.75 120.05 30.68 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.143 176.373 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.542 ' HB3' ' HB3' ' A' ' 141' ' ' ALA . 57.6 tp -102.57 110.74 22.78 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.875 0.369 . . . . 0.0 110.266 178.023 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.572 HG22 HD13 ' A' ' 23' ' ' ILE . 18.1 pt -101.18 122.03 52.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.462 0.649 . . . . 0.0 109.601 177.636 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.3 m -77.81 -165.37 0.62 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.94 -173.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -55.03 122.48 11.02 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.433 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.496 ' HB2' ' O ' ' A' ' 38' ' ' ASP . 19.3 m -126.99 159.23 34.72 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.622 178.63 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.481 ' H ' ' HE1' ' A' ' 16' ' ' MET . 89.4 m-70 -140.49 43.7 1.87 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 -176.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.499 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . 46.0 t -93.1 129.76 38.32 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.147 -179.435 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.499 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 83.8 Cg_endo -103.38 27.75 10.8 Favored 'Cis proline' 0 N--CA 1.455 -0.754 0 C-N-CA 124.44 -1.067 . . . . 0.0 112.36 -3.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.8 t -47.55 -60.74 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 O-C-N 123.744 0.653 . . . . 0.0 111.996 -175.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 62.3 ttt180 -142.49 11.23 1.89 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.722 0.773 . . . . 0.0 109.619 -178.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.481 ' HE1' ' H ' ' A' ' 11' ' ' HIS . 58.0 ttp -143.08 121.52 12.39 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.216 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -117.57 -0.49 11.87 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.994 0.426 . . . . 0.0 110.805 -177.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.0 t -108.4 88.66 2.78 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.623 -178.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.0 tt -107.88 120.45 47.05 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 175.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.577 ' HG2' HD13 ' A' ' 157' ' ' LEU . 76.4 Cg_exo -41.17 116.89 0.49 Allowed 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 124.107 3.205 . . . . 0.0 114.213 -174.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -61.22 -30.37 70.39 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.596 176.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -54.63 -36.71 64.8 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.095 178.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.572 HD13 HG22 ' A' ' 7' ' ' ILE . 0.6 OUTLIER -85.11 -28.69 6.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.192 0.52 . . . . 0.0 110.334 -178.711 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 44.7 tp -70.6 -30.01 66.57 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.944 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -72.48 -21.33 61.23 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.373 175.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.548 ' HB3' ' CD2' ' A' ' 30' ' ' TYR . 59.4 m -71.16 -9.69 58.5 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.566 -178.403 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.521 ' HB3' ' HB3' ' A' ' 51' ' ' PHE . 2.7 mm? -63.48 -24.93 68.03 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 121.159 0.504 . . . . 0.0 109.95 172.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -91.15 -33.2 15.52 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.04 178.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -68.59 -55.52 11.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.644 -178.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.548 ' CD2' ' HB3' ' A' ' 26' ' ' SER . 27.5 m-85 -94.83 150.8 19.81 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.825 -169.156 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -98.61 7.0 46.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.859 -176.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.527 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -154.39 139.03 6.49 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 175.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.51 HG21 HD13 ' A' ' 27' ' ' LEU . 60.5 t -134.75 140.61 45.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 117.259 0.529 . . . . 0.0 110.649 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.609 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 17.3 mt -125.17 132.76 70.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.467 175.186 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.409 ' HA2' HG13 ' A' ' 7' ' ' ILE . . . -116.07 129.66 8.61 Favored Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 174.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 90.9 mt -97.11 -7.2 33.24 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.59 0.709 . . . . 0.0 110.341 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 166.52 58.31 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 -177.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.496 ' O ' ' HB2' ' A' ' 10' ' ' SER . 6.1 p-10 -72.27 -111.42 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 123.371 0.668 . . . . 0.0 112.741 -171.524 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -89.84 148.64 23.06 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.108 -0.331 . . . . 0.0 110.108 -177.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 19.2 m -89.91 -7.78 10.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.265 0.555 . . . . 0.0 110.147 178.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.506 ' O ' HG23 ' A' ' 45' ' ' VAL . 9.2 m-20 -86.6 120.44 27.91 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.666 177.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.559 HD22 ' HB3' ' A' ' 66' ' ' ASP . 43.7 tp -59.74 -42.3 92.87 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.037 0.446 . . . . 0.0 110.12 178.409 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -57.85 -38.92 76.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.964 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.548 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 17.5 m -74.68 -30.44 61.57 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.18 -178.353 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 41' ' ' ASP . 48.7 t -66.44 -40.2 85.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.177 0.513 . . . . 0.0 109.915 176.472 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.17 -35.79 76.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.677 174.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -64.46 -31.58 72.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.007 176.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 44' ' ' THR . 87.9 mt -67.69 -46.91 70.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.947 0.403 . . . . 0.0 110.579 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.51 ' HG2' ' HB3' ' A' ' 55' ' ' PHE . 65.4 mt-10 -70.32 -16.4 62.99 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.499 177.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -81.57 -23.36 37.2 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.057 0.456 . . . . 0.0 109.961 177.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.521 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . 2.0 m-85 -86.51 -67.33 0.82 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.424 178.496 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.504 ' HB3' HD12 ' A' ' 27' ' ' LEU . 70.7 p -73.0 -34.26 66.3 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.972 -177.234 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 34.5 mtmm 66.28 12.94 8.93 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.379 -175.584 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -150.71 102.17 2.99 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.496 178.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.51 ' HB3' ' HG2' ' A' ' 49' ' ' GLU . 74.4 t80 -138.61 121.46 16.54 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.345 0.593 . . . . 0.0 111.275 -173.702 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.609 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 92.2 m-85 -114.81 167.7 10.55 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 171.346 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 145.01 -165.65 27.67 Favored Glycine 0 N--CA 1.438 -1.204 0 C-N-CA 119.13 -1.509 . . . . 0.0 113.502 174.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.0 m -153.21 175.54 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 114.555 -0.823 . . . . 0.0 109.117 -175.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.506 ' CD2' ' HG ' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -125.69 104.26 8.27 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 120.426 -0.51 . . . . 0.0 109.9 171.672 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.705 ' HA2' ' HB3' ' A' ' 88' ' ' HIS . . . -86.36 -28.96 26.12 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.555 -177.045 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 19.9 p30 -85.87 -177.93 6.46 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.93 0.395 . . . . 0.0 111.001 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 64.7 mtt -94.71 127.85 40.98 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.0 0.428 . . . . 0.0 110.791 -176.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.522 ' OD2' ' HB ' ' A' ' 67' ' ' VAL . 4.6 p-10 -149.87 -171.03 3.8 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.936 -175.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -74.23 142.06 78.23 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.737 -176.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.1 -27.95 39.0 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.146 2.564 . . . . 0.0 112.83 -176.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.559 ' HB3' HD22 ' A' ' 42' ' ' LEU . 2.1 m-20 -60.05 -45.31 93.28 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.5 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.522 ' HB ' ' OD2' ' A' ' 63' ' ' ASP . 87.9 t -69.09 -36.28 72.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.104 0.478 . . . . 0.0 110.804 -177.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.653 ' HD3' ' HE1' ' A' ' 73' ' ' PHE . 61.3 mttm -70.75 -2.8 15.86 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.457 -175.237 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -81.89 -42.88 18.93 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 172.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 52.7 t60 -87.53 -30.01 20.9 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.47 -176.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.506 ' HG ' ' CD2' ' A' ' 59' ' ' HIS . 4.2 mm? -103.02 109.31 61.23 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.041 177.682 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 71' ' ' LEU . 22.0 Cg_exo -65.4 165.72 21.63 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 123.101 2.534 . . . . 0.0 112.729 -177.176 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.653 ' HE1' ' HD3' ' A' ' 68' ' ' LYS . 80.3 m-85 -91.28 -23.68 20.08 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.135 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.0 t -155.34 111.83 3.2 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.115 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.0 tttm -131.0 136.98 49.0 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -177.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 14.1 t -117.28 112.25 38.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 120.972 0.415 . . . . 0.0 110.13 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.404 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 63.1 mt -87.77 151.52 22.82 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.5 -178.712 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 49.5 tp -116.71 96.22 5.39 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 173.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.602 HG12 ' HG2' ' A' ' 80' ' ' GLU . 62.1 t -113.91 108.13 24.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.69 -173.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.602 ' HG2' HG12 ' A' ' 79' ' ' VAL . 13.2 mm-40 63.63 16.34 9.61 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.271 176.193 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 109.56 -17.97 30.28 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 121.109 -0.567 . . . . 0.0 111.983 -179.124 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 57.1 t -86.32 133.19 30.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.739 0.304 . . . . 0.0 110.678 -178.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.9 p -89.36 128.16 35.88 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.923 178.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.476 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 36.8 mt -119.72 98.62 6.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.845 0.355 . . . . 0.0 110.244 -177.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -87.39 103.19 2.86 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.974 -0.631 . . . . 0.0 111.697 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 40.7 mtm -101.19 114.77 29.04 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 9.2 t -144.73 162.19 37.34 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.833 0.349 . . . . 0.0 110.817 -173.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.705 ' HB3' ' HA2' ' A' ' 60' ' ' GLY . 41.4 p-80 -84.22 94.54 8.43 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.438 0.637 . . . . 0.0 110.43 178.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -81.0 75.98 2.21 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.461 -0.79 . . . . 0.0 113.005 -176.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -95.11 75.2 3.46 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.893 0.378 . . . . 0.0 110.411 176.163 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -163.26 175.28 39.56 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.866 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.18 151.35 97.27 Favored Pre-proline 0 C--N 1.326 -0.456 0 C-N-CA 122.171 0.188 . . . . 0.0 110.86 178.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -57.28 -18.75 31.66 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.074 2.516 . . . . 0.0 113.188 -178.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -91.64 -52.64 4.66 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.983 0.42 . . . . 0.0 110.05 178.324 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -72.5 -11.62 60.74 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.243 -176.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 24.7 tp -56.53 -43.67 80.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.396 177.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 22.2 ttpt -56.83 -49.25 75.97 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.341 177.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.458 ' O ' ' HB2' ' A' ' 102' ' ' LYS . 16.1 t70 -58.06 -51.06 71.23 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.463 -178.306 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -71.52 -53.22 14.57 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.187 -0.461 . . . . 0.0 112.006 -173.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 49.8 mt -60.63 -48.9 79.71 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 -173.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 90.6 mt -72.68 -11.47 60.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.004 0.431 . . . . 0.0 111.175 -176.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 98' ' ' ASP . 33.6 ttmt -85.47 -26.27 26.4 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.228 0.537 . . . . 0.0 109.633 177.013 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 84.1 t -79.36 -37.79 19.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.138 176.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -76.21 144.57 40.36 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.351 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -82.35 -44.43 16.18 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.865 -179.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.409 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 63.7 mm-40 -111.03 -178.61 3.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.481 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -83.53 112.85 42.8 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.781 177.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.494 ' O ' HG13 ' A' ' 127' ' ' VAL . 1.5 Cg_endo -83.16 119.02 2.72 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.814 2.343 . . . . 0.0 110.969 174.321 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -64.93 -40.73 95.51 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.26 0.553 . . . . 0.0 109.8 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 93.2 t -121.32 129.46 75.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.221 178.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 29.1 mt -118.87 131.76 70.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 175.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.464 HD23 ' HB2' ' A' ' 130' ' ' LEU . 89.0 mt -110.43 124.52 51.89 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.178 179.394 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.445 ' CE1' ' HB3' ' A' ' 129' ' ' PHE . 27.9 p90 -145.49 170.64 15.99 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.254 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -131.18 121.64 3.24 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 176.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -163.0 -36.86 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.929 0.395 . . . . 0.0 110.16 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.57 ' HB ' ' ND2' ' A' ' 131' ' ' ASN . 20.8 m -94.07 149.48 21.2 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.908 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 26.9 m80 -79.99 -47.63 14.64 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.929 0.395 . . . . 0.0 110.268 -178.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -82.96 155.77 67.51 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.648 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.408 ' HB3' ' HG ' ' A' ' 154' ' ' LEU . 15.0 Cg_exo -66.96 128.9 19.57 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.563 2.175 . . . . 0.0 111.492 176.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -145.08 138.75 26.88 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.502 -178.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -118.52 128.82 54.94 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 174.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.579 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 72.2 p -128.5 116.21 19.33 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.212 0.53 . . . . 0.0 111.219 -176.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 127' ' ' VAL . 8.6 p -111.61 117.59 55.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 176.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -126.49 -74.57 0.59 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.083 -174.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -85.12 32.28 0.55 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.892 0.377 . . . . 0.0 111.195 -178.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 83.82 -5.69 77.78 Favored Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 -174.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.494 HG13 ' O ' ' A' ' 108' ' ' PRO . 96.8 t -99.28 134.72 37.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.104 -0.548 . . . . 0.0 109.863 178.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -102.43 105.72 16.34 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.095 0.474 . . . . 0.0 110.43 179.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.579 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 51.6 m-85 -84.85 122.12 28.7 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.21 177.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.464 ' HB2' HD23 ' A' ' 112' ' ' LEU . 87.9 mt -109.34 124.06 50.33 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.826 0.346 . . . . 0.0 110.983 -178.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.57 ' ND2' ' HB ' ' A' ' 116' ' ' THR . 4.7 t30 -113.75 111.64 48.55 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.44 174.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -86.58 165.09 9.27 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.921 2.414 . . . . 0.0 112.052 174.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -89.61 139.89 15.35 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.548 -177.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 15.8 m -59.87 156.16 14.89 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.898 0.38 . . . . 0.0 111.324 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -68.05 -3.77 11.27 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 -174.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -86.78 -60.6 1.94 Allowed 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.589 -177.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -125.1 2.01 7.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.818 0.342 . . . . 0.0 111.657 -177.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -106.76 173.36 19.23 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.758 -173.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.563 ' HB3' ' HA ' ' A' ' 156' ' ' THR . 12.5 p -98.6 134.56 41.37 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.526 0.203 . . . . 0.0 110.62 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -84.48 177.18 8.21 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.387 -178.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.542 ' HB3' ' HB3' ' A' ' 6' ' ' LEU . . . -123.31 135.81 54.38 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.2 0.524 . . . . 0.0 111.962 -176.183 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 74.1 t -118.5 120.33 63.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 173.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.677 ' HA ' ' O ' ' A' ' 151' ' ' ARG . 10.0 mp -111.17 111.08 21.91 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.119 0.485 . . . . 0.0 111.124 -178.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -98.75 134.16 42.05 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.427 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.615 ' HB2' ' HB2' ' A' ' 2' ' ' LYS . 94.2 mt -105.02 102.9 12.38 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.915 177.252 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -135.23 130.38 35.14 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.878 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.89 11.14 60.15 Favored Glycine 0 CA--C 1.517 0.161 0 C-N-CA 121.178 -0.534 . . . . 0.0 112.443 -176.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 96.47 -13.82 65.06 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.791 178.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -95.34 159.5 14.98 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.047 0.451 . . . . 0.0 111.053 -178.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 10.9 t -101.23 138.0 26.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.584 -177.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.677 ' O ' ' HA ' ' A' ' 143' ' ' LEU . 12.5 tpt180 -109.92 99.5 8.61 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -83.84 104.5 13.98 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.638 178.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.456 ' O ' ' HA ' ' A' ' 141' ' ' ALA . 40.0 mt-10 -116.56 128.99 55.92 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.67 0.271 . . . . 0.0 111.03 176.412 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.408 ' HG ' ' HB3' ' A' ' 119' ' ' PRO . 3.7 mm? -102.17 106.81 17.71 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 174.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -102.17 130.53 48.83 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.789 0.328 . . . . 0.0 110.56 -175.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.563 ' HA ' ' HB3' ' A' ' 139' ' ' SER . 14.1 p -81.3 145.69 30.77 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -169.03 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.577 HD13 ' HG2' ' A' ' 20' ' ' PRO . 84.5 mt . . . . . 0 C--O 1.25 1.127 0 CA-C-N 115.142 -0.936 . . . . 0.0 109.68 178.259 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 38.8 t . . . . . 0 N--CA 1.476 0.865 0 CA-C-O 120.935 0.398 . . . . 0.0 110.04 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -108.67 140.71 41.69 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 178.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.446 ' HG2' ' HG2' ' A' ' 144' ' ' GLU . 92.7 mtt180 -126.89 117.45 22.61 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.125 0.488 . . . . 0.0 111.206 -178.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -107.18 129.88 54.79 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.946 178.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.562 ' HB3' HG22 ' A' ' 33' ' ' VAL . 44.0 tp -89.27 113.31 24.54 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.648 -176.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 64.7 tp -99.16 107.6 20.0 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.196 0.522 . . . . 0.0 110.936 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.466 HG13 ' HA2' ' A' ' 35' ' ' GLY . 27.4 pt -101.32 132.38 47.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 173.537 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.7 t -81.66 -168.05 1.74 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.822 0.344 . . . . 0.0 110.238 -178.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -63.62 128.04 34.07 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.715 0.769 . . . . 0.0 111.632 -176.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.525 ' OG ' HG12 ' A' ' 12' ' ' VAL . 33.4 t -100.15 155.38 17.78 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.783 176.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.455 ' H ' ' CE ' ' A' ' 16' ' ' MET . 50.3 m-70 -132.62 23.2 4.32 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.172 -177.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.525 HG12 ' OG ' ' A' ' 10' ' ' SER . 7.8 p -114.65 144.65 32.27 Favored Pre-proline 0 C--O 1.241 0.622 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.308 -176.375 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.435 ' HA ' ' CG2' ' A' ' 12' ' ' VAL . 12.0 Cg_endo -93.59 93.81 0.14 OUTLIER 'Cis proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.847 -1.314 . . . . 0.0 112.816 -5.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.561 HG21 HG11 ' A' ' 40' ' ' VAL . 1.9 t -138.36 -71.89 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.363 0.601 . . . . 0.0 109.678 176.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 40.3 mtp180 -125.08 73.91 1.33 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.297 178.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.455 ' CE ' ' H ' ' A' ' 11' ' ' HIS . 14.4 ttm -177.13 -80.68 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.495 178.147 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 58.08 14.57 2.76 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.969 -176.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.42 ' H ' ' HG2' ' A' ' 16' ' ' MET . 15.4 m -120.0 32.9 5.83 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.532 -176.441 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.598 HD11 HD23 ' A' ' 135' ' ' LEU . 7.5 tt -89.17 120.64 69.84 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.708 -179.144 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 19' ' ' LEU . 16.7 Cg_exo -68.57 126.69 14.45 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 123.114 2.543 . . . . 0.0 112.348 -179.279 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -66.52 -12.24 56.61 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.777 -177.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.531 ' HB2' HD22 ' A' ' 157' ' ' LEU . 43.6 mt-10 -58.48 -38.26 77.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.264 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.456 HD11 HD11 ' A' ' 5' ' ' LEU . 0.4 OUTLIER -67.52 -29.27 44.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.4 0.619 . . . . 0.0 110.282 -178.59 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.53 ' O ' HD23 ' A' ' 27' ' ' LEU . 38.9 tp -78.27 -12.55 60.01 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.264 -177.179 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -84.85 -27.39 26.75 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.735 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.447 ' HB3' ' CE2' ' A' ' 30' ' ' TYR . 15.3 m -69.42 -6.37 29.74 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.934 -175.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.666 HD13 HG21 ' A' ' 33' ' ' VAL . 4.4 mm? -58.35 -26.0 62.64 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.745 0.307 . . . . 0.0 111.594 178.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.7 mttp -85.32 -8.27 58.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.286 -175.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -106.54 -22.46 12.77 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -168.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.509 ' CD2' ' HB2' ' A' ' 5' ' ' LEU . 29.5 m-85 -112.2 156.19 22.73 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.476 -0.489 . . . . 0.0 111.79 -172.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -67.03 -55.15 15.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.616 -177.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -136.2 158.51 23.98 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.569 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.666 HG21 HD13 ' A' ' 27' ' ' LEU . 89.2 t -123.4 136.02 61.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 120.996 0.427 . . . . 0.0 110.415 -179.216 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.466 HG21 ' SD ' ' A' ' 86' ' ' MET . 70.5 mt -115.74 128.88 72.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.919 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.466 ' HA2' HG13 ' A' ' 7' ' ' ILE . . . -121.84 117.82 3.51 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.846 178.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.1 mt -83.69 19.39 1.66 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.418 0.628 . . . . 0.0 110.26 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 153.59 84.78 0.05 OUTLIER Glycine 0 N--CA 1.44 -1.074 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 -177.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.473 ' CG ' ' H ' ' A' ' 39' ' ' TYR . 9.2 t70 -74.75 -165.33 0.35 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.821 0.344 . . . . 0.0 110.829 -173.391 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.473 ' H ' ' CG ' ' A' ' 38' ' ' ASP . 37.2 m-85 -68.82 149.32 49.1 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.089 -0.338 . . . . 0.0 110.089 -177.167 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.561 HG11 HG21 ' A' ' 14' ' ' VAL . 24.6 m -68.46 -17.17 21.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -176.512 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -93.66 125.3 38.2 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.703 0.287 . . . . 0.0 110.481 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.647 HD22 ' HB3' ' A' ' 66' ' ' ASP . 50.8 tp -63.84 -33.46 75.72 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.416 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -59.68 -34.38 72.79 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.36 178.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 20.9 m -78.28 -31.72 49.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.612 178.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.506 HG21 HG13 ' A' ' 67' ' ' VAL . 46.4 t -60.29 -41.38 86.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.38 0.609 . . . . 0.0 109.705 173.288 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.421 HD13 ' O ' ' A' ' 42' ' ' LEU . 1.6 mp -66.27 -34.28 69.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.07 175.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -61.89 -37.13 83.43 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 174.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -71.52 -42.27 68.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.519 178.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -70.85 -19.57 62.63 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.342 0.592 . . . . 0.0 110.605 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.4 tptm -78.27 -46.88 19.12 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.96 178.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.532 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . 32.4 m-85 -73.36 -55.25 6.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.449 176.393 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.589 ' HB2' HD12 ' A' ' 27' ' ' LEU . 22.7 t -90.7 98.87 12.03 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.71 174.466 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -56.14 -35.69 67.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.954 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -110.77 82.75 1.64 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.145 179.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -101.55 124.84 47.87 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.533 -178.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.423 ' HB2' HG12 ' A' ' 34' ' ' ILE . 54.4 m-85 -106.92 117.02 32.95 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.208 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.655 ' HA3' HD22 ' A' ' 71' ' ' LEU . . . -117.98 144.12 18.01 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.079 -1.058 . . . . 0.0 113.028 -175.239 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.414 HG21 ' CB ' ' A' ' 86' ' ' MET . 15.3 t -128.58 144.66 37.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 175.332 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -97.36 112.57 24.34 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.982 -175.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.697 ' HA3' ' HB3' ' A' ' 88' ' ' HIS . . . -152.53 22.9 0.84 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.407 -0.901 . . . . 0.0 112.556 178.079 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 23.9 p-10 -136.48 174.25 10.82 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 110.41 -0.218 . . . . 0.0 110.41 -178.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 66.8 mtm -92.55 119.96 32.53 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.678 ' OD2' ' HB ' ' A' ' 67' ' ' VAL . 17.7 p-10 -149.27 -173.5 4.4 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.77 -169.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -81.34 145.26 55.26 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.87 175.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -57.28 -20.74 40.59 Favored 'Trans proline' 0 CA--C 1.532 0.401 0 C-N-CA 122.89 2.393 . . . . 0.0 113.426 -176.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.647 ' HB3' HD22 ' A' ' 42' ' ' LEU . 3.0 m-20 -70.41 -27.69 64.48 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.31 -0.405 . . . . 0.0 112.037 -177.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.678 ' HB ' ' OD2' ' A' ' 63' ' ' ASP . 38.1 t -74.77 -19.15 16.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.113 0.482 . . . . 0.0 110.539 -178.182 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 63.9 tttt -53.38 -36.39 61.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.702 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -69.84 -27.97 65.29 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.518 -176.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -95.86 -30.65 13.54 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 121.111 -0.235 . . . . 0.0 111.138 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.655 HD22 ' HA3' ' A' ' 57' ' ' GLY . 13.1 mt -110.26 102.36 50.99 Favored Pre-proline 0 C--N 1.326 -0.443 0 C-N-CA 120.931 -0.308 . . . . 0.0 110.755 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.493 ' HD2' ' O ' ' A' ' 57' ' ' GLY . 46.9 Cg_endo -70.12 151.3 66.98 Favored 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.379 2.053 . . . . 0.0 110.734 172.216 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -63.42 -22.54 66.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.84 0.352 . . . . 0.0 111.635 -175.107 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 38.6 m -153.82 141.7 20.15 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 175.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 36.1 tttp -144.33 125.32 14.42 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.345 -177.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 11.4 t -111.65 112.61 41.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.865 0.364 . . . . 0.0 110.574 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.417 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 94.0 mt -87.69 144.81 26.45 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.986 -179.063 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 59.7 tp -112.14 97.37 6.6 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 170.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 41.4 t -110.9 93.45 2.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.091 -176.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 51.18 63.25 2.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.907 179.075 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.16 -9.43 47.31 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.912 -0.661 . . . . 0.0 113.206 176.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 60.8 t -99.89 115.21 40.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.887 0.375 . . . . 0.0 110.732 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.5 p -86.84 127.06 35.02 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.317 176.109 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 18.8 mt -119.36 93.25 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -176.35 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.446 ' O ' HG23 ' A' ' 111' ' ' ILE . . . -81.21 96.09 1.7 Allowed Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.474 ' HG2' HD12 ' A' ' 112' ' ' LEU . 38.3 mtm -96.06 119.13 34.01 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 120.896 0.379 . . . . 0.0 110.242 -176.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 39.2 t -153.22 107.05 3.05 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.993 -178.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.697 ' HB3' ' HA3' ' A' ' 60' ' ' GLY . 64.8 t-80 -91.26 69.27 6.04 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -179.482 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -85.01 178.73 51.03 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.63 -178.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -132.28 142.98 49.59 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 148.74 -172.68 28.86 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 121.081 -0.58 . . . . 0.0 111.808 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.442 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . . . -76.95 146.1 75.06 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 120.519 0.2 . . . . 0.0 110.741 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 92' ' ' ALA . 15.5 Cg_exo -69.2 -10.55 29.3 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.953 2.435 . . . . 0.0 112.859 -178.351 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 5.7 m0 -68.48 -44.47 74.68 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.996 0.427 . . . . 0.0 110.625 -178.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -91.49 11.66 23.29 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.807 -178.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 28.3 tp -58.66 -49.54 77.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.047 -178.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.473 ' HD2' ' HB2' ' A' ' 125' ' ' ALA . 28.5 ttpt -61.89 -50.35 72.56 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.65 179.319 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -60.72 -53.23 59.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.654 -174.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.43 ' O ' HG23 ' A' ' 103' ' ' VAL . 26.8 mtm105 -65.18 -46.36 81.1 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -176.548 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.529 HD13 HG21 ' A' ' 111' ' ' ILE . 83.5 mt -65.8 -36.76 84.41 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.474 -176.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.672 HD21 HG21 ' A' ' 127' ' ' VAL . 79.6 mt -78.77 -15.69 58.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.778 0.323 . . . . 0.0 110.91 178.377 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.467 ' HA ' ' HD2' ' A' ' 102' ' ' LYS . 33.4 tptt -86.21 -34.7 20.4 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.076 0.465 . . . . 0.0 110.039 177.102 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 99' ' ' ARG . 73.8 t -74.19 -43.95 50.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.571 174.45 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -104.54 87.32 2.68 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.88 176.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -71.78 -19.2 62.05 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.423 -173.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -77.4 -14.65 59.66 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.256 -179.127 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt 63.86 99.29 0.04 OUTLIER Pre-proline 0 C--O 1.232 0.182 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.096 -175.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -76.24 144.36 26.25 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.601 2.201 . . . . 0.0 110.938 175.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -72.49 -41.9 65.47 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.137 0.494 . . . . 0.0 109.836 178.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 90.0 t -116.32 130.14 71.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.583 177.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.529 HG21 HD13 ' A' ' 100' ' ' LEU . 30.6 mt -125.08 128.45 72.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 120.774 0.321 . . . . 0.0 110.677 178.3 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.474 HD12 ' HG2' ' A' ' 86' ' ' MET . 92.1 mt -99.98 119.22 37.91 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -138.59 -174.74 3.91 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.81 -175.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.581 ' HA2' ' ND2' ' A' ' 131' ' ' ASN . . . -147.75 151.77 23.96 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 175.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -136.64 179.1 6.57 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 117.195 0.498 . . . . 0.0 109.937 177.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.3 p -73.92 11.26 0.92 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -171.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 -144.75 -172.12 3.76 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 122.131 -0.356 . . . . 0.0 111.045 -178.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -60.6 155.48 49.86 Favored Pre-proline 0 C--N 1.329 -0.316 0 O-C-N 123.839 0.712 . . . . 0.0 112.695 -172.249 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -47.03 144.78 8.09 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 124.441 3.428 . . . . 0.0 113.266 178.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -165.7 144.03 5.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.267 -176.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -102.54 135.78 43.56 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 173.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.479 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 57.8 p -137.72 158.02 45.25 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.908 -174.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.495 ' HA ' ' O ' ' A' ' 127' ' ' VAL . 85.2 t -132.54 115.2 24.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.939 0.4 . . . . 0.0 110.425 176.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.632 ' HB2' ' HE2' ' A' ' 129' ' ' PHE . 75.4 mmtt -125.58 125.62 43.47 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.483 177.47 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.473 ' HB2' ' HD2' ' A' ' 97' ' ' LYS . . . 65.1 9.24 5.36 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 123.64 0.588 . . . . 0.0 111.779 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 104.11 -4.2 44.86 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.409 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.672 HG21 HD21 ' A' ' 101' ' ' LEU . 52.5 t -90.19 134.36 29.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 179.097 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 51.8 ttt180 -96.45 105.82 17.96 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.147 0.499 . . . . 0.0 110.18 -177.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.632 ' HE2' ' HB2' ' A' ' 124' ' ' LYS . 58.7 m-85 -94.63 126.52 39.98 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.88 -178.547 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.449 ' HB2' HD23 ' A' ' 112' ' ' LEU . 53.6 mt -115.26 120.91 41.26 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.754 0.311 . . . . 0.0 110.638 -178.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.581 ' ND2' ' HA2' ' A' ' 114' ' ' GLY . 3.7 t-20 -108.02 115.99 57.72 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.471 174.589 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.413 ' HD2' HD22 ' A' ' 131' ' ' ASN . 85.8 Cg_endo -83.78 164.87 13.84 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.745 2.297 . . . . 0.0 112.234 174.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -73.99 153.71 47.25 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.442 175.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 96.0 p -81.28 160.33 24.25 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.061 0.458 . . . . 0.0 110.999 -176.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.598 HD23 HD11 ' A' ' 19' ' ' LEU . 5.9 mp -74.11 -0.17 15.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.1 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -97.19 -10.57 25.6 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.586 178.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -100.83 -6.03 25.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.108 0.48 . . . . 0.0 110.816 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 74.86 38.45 41.71 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.19 -179.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 25.2 m -139.31 145.84 39.59 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.447 ' O ' HD12 ' A' ' 154' ' ' LEU . 23.9 p90 -139.73 160.03 40.83 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 178.202 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -114.33 125.97 54.48 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.051 0.453 . . . . 0.0 110.352 -175.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 48.0 t -102.99 121.44 54.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 177.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.417 HD21 HG13 ' A' ' 150' ' ' VAL . 6.3 tt -94.67 101.21 13.05 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.353 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.446 ' HG2' ' HG2' ' A' ' 3' ' ' ARG . 60.1 mt-10 -95.32 117.62 30.63 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.459 -178.158 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 72.0 mt -90.67 90.19 7.85 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 172.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.526 ' HB3' ' HD3' ' A' ' 151' ' ' ARG . 35.3 t70 -115.57 130.11 56.75 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.844 -174.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 68.13 -59.51 0.4 Allowed Glycine 0 CA--C 1.521 0.446 0 O-C-N 123.584 0.553 . . . . 0.0 112.337 -171.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 164.9 33.39 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 176.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -126.53 155.55 42.2 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.631 0.253 . . . . 0.0 110.675 -176.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.417 HG13 HD21 ' A' ' 143' ' ' LEU . 29.0 t -86.88 95.03 4.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.524 176.433 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.526 ' HD3' ' HB3' ' A' ' 146' ' ' ASP . 35.0 mtp-105 -105.82 92.31 4.11 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.53 -175.402 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -90.54 122.17 33.12 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.198 0.523 . . . . 0.0 109.774 178.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.461 ' HB2' ' HE3' ' A' ' 155' ' ' LYS . 57.9 mt-10 -116.04 127.38 54.85 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.132 177.436 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.447 HD12 ' O ' ' A' ' 140' ' ' TYR . 38.7 tp -90.49 112.17 23.72 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.172 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.461 ' HE3' ' HB2' ' A' ' 153' ' ' GLU . 85.8 mttt -117.09 145.49 43.73 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.78 -173.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 3.5 p -96.65 150.58 20.51 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.321 0.581 . . . . 0.0 112.37 -171.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.531 HD22 ' HB2' ' A' ' 22' ' ' GLU . 91.1 mt . . . . . 0 C--O 1.249 1.03 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.952 177.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 60.3 t . . . . . 0 N--CA 1.48 1.03 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.662 ' HB2' HD12 ' A' ' 145' ' ' LEU . 98.8 mttt -85.47 130.42 34.59 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.151 0.501 . . . . 0.0 110.288 178.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 56.0 mtp180 -111.2 116.88 31.81 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.947 -178.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.576 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 18.3 m-85 -103.93 125.51 50.38 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.452 0.644 . . . . 0.0 111.102 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.535 ' HB3' HG22 ' A' ' 33' ' ' VAL . 36.0 tp -89.12 133.22 34.47 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.078 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.491 ' HB2' HD21 ' A' ' 143' ' ' LEU . 56.0 tp -121.72 111.96 17.81 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.835 0.35 . . . . 0.0 110.789 178.557 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.446 HG13 ' HA2' ' A' ' 35' ' ' GLY . 27.9 pt -101.45 128.74 53.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 174.016 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.556 ' H ' HD21 ' A' ' 135' ' ' LEU . 12.2 t -76.06 -171.44 1.69 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.852 -174.515 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.654 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 18.0 t0 -62.14 104.46 0.48 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.757 -177.464 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.434 ' H ' ' HA3' ' A' ' 37' ' ' GLY . 26.7 t -97.18 153.79 17.78 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.625 -177.558 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 13.8 m80 -134.8 65.39 1.57 Allowed 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.436 ' O ' HG22 ' A' ' 40' ' ' VAL . 64.8 t -118.8 130.09 25.02 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.617 -176.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -76.41 -52.12 0.16 OUTLIER 'Cis proline' 0 C--N 1.343 0.254 0 C-N-CA 123.192 -1.587 . . . . 0.0 112.21 -3.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 37.9 t 49.14 -93.37 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 O-C-N 123.858 0.724 . . . . 0.0 110.81 -178.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -155.56 25.93 0.4 Allowed 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.453 0.644 . . . . 0.0 109.773 171.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 52.5 ttp -109.75 -75.74 0.62 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 176.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.407 ' HA ' HG22 ' A' ' 12' ' ' VAL . . . 63.45 -6.48 0.21 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.443 -0.799 . . . . 0.0 113.133 175.46 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.3 p -78.63 58.06 2.16 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.64 0.733 . . . . 0.0 111.094 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.8 tt -107.93 112.78 61.59 Favored Pre-proline 0 N--CA 1.447 -0.604 0 CA-C-N 115.116 -0.947 . . . . 0.0 108.544 176.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -53.51 120.62 8.1 Favored 'Trans proline' 0 CA--C 1.528 0.202 0 C-N-CA 123.063 2.509 . . . . 0.0 112.868 -177.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -61.01 -29.8 69.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.174 -177.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -64.78 -25.01 67.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.663 -177.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.509 HD11 ' CG ' ' A' ' 140' ' ' TYR . 1.2 tt -68.49 -32.52 55.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.266 0.555 . . . . 0.0 109.531 178.159 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.566 ' HA ' HD23 ' A' ' 27' ' ' LEU . 24.4 tp -77.79 -35.33 51.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.104 -177.295 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -71.47 -26.44 62.71 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.626 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 42.9 m -81.69 2.05 31.45 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.588 -177.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.566 HD23 ' HA ' ' A' ' 24' ' ' LEU . 2.9 mm? -54.52 -31.31 56.0 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.043 0.449 . . . . 0.0 111.203 177.306 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -74.35 -15.98 60.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.275 -175.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -96.16 5.29 51.39 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.941 0.401 . . . . 0.0 111.679 -175.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -119.67 169.9 9.68 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 177.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -105.19 -56.2 2.21 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.233 0.54 . . . . 0.0 109.913 -178.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.576 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -117.36 146.7 18.79 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 175.525 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.561 HG21 ' CD1' ' A' ' 27' ' ' LEU . 72.8 t -130.03 134.87 62.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 117.315 0.557 . . . . 0.0 111.109 -177.357 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.567 HG12 ' HB2' ' A' ' 56' ' ' TYR . 36.2 mt -114.91 125.71 72.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.373 177.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.446 ' HA2' HG13 ' A' ' 7' ' ' ILE . . . -109.41 103.43 1.76 Allowed Glycine 0 N--CA 1.441 -0.979 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.716 174.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.4 ' HG ' HD11 ' A' ' 6' ' ' LEU . 84.5 mt -74.1 -28.69 61.48 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.08 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.654 ' HA3' ' HA ' ' A' ' 9' ' ' ASP . . . -145.92 109.12 0.49 Allowed Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.063 173.31 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.417 ' OD2' HG22 ' A' ' 45' ' ' VAL . 15.2 p-10 -98.98 -154.39 0.46 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 120.843 0.354 . . . . 0.0 110.893 -175.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.412 ' HE2' HD21 ' A' ' 48' ' ' LEU . 97.3 m-85 -88.83 137.35 32.4 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 -179.193 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.436 HG22 ' O ' ' A' ' 12' ' ' VAL . 11.5 m -76.18 4.83 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.029 0.442 . . . . 0.0 111.611 -174.321 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.513 ' O ' HG23 ' A' ' 45' ' ' VAL . 17.5 t70 -105.63 123.76 48.44 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.148 177.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.491 HD22 ' HB3' ' A' ' 66' ' ' ASP . 44.8 tp -59.04 -43.49 91.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 0.0 112.278 -172.587 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -62.03 -37.72 85.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.1 0.476 . . . . 0.0 110.57 -178.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 20.8 m -70.82 -27.96 64.26 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.844 178.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 41' ' ' ASP . 61.8 t -62.88 -40.71 89.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-O 121.487 0.66 . . . . 0.0 109.588 173.408 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.36 -35.26 74.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.143 177.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.79 -31.92 72.99 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.596 175.39 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.412 HD21 ' HE2' ' A' ' 39' ' ' TYR . 95.3 mt -67.69 -41.74 83.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.098 0.475 . . . . 0.0 110.061 178.191 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -71.97 -14.89 62.03 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.108 176.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -82.47 -45.69 14.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.33 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -70.85 -65.43 0.74 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.991 0.424 . . . . 0.0 110.408 173.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.492 ' HB3' HD12 ' A' ' 27' ' ' LEU . 8.9 p -90.44 96.17 10.53 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.92 174.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -62.31 -33.03 73.89 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.459 -179.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -98.3 79.36 2.53 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.495 0.664 . . . . 0.0 109.457 171.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -100.33 127.6 46.6 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.612 -177.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.567 ' HB2' HG12 ' A' ' 34' ' ' ILE . 76.1 m-85 -117.28 169.94 9.08 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 175.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 153.96 -172.22 32.64 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 119.355 -1.402 . . . . 0.0 113.609 175.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.504 HG13 ' HE3' ' A' ' 86' ' ' MET . 0.2 OUTLIER -144.27 -169.2 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 114.856 -0.672 . . . . 0.0 109.871 -177.494 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.472 ' NE2' ' HG2' ' A' ' 68' ' ' LYS . 57.0 t-80 -94.48 130.83 40.71 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.798 0.332 . . . . 0.0 111.235 -173.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -75.15 -158.83 7.02 Favored Glycine 0 CA--C 1.522 0.471 0 CA-C-N 115.731 -0.668 . . . . 0.0 113.249 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -73.05 -73.12 0.22 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -176.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 50.0 ttm -131.71 129.48 40.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.821 0.344 . . . . 0.0 110.361 -177.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.522 ' OD2' ' HB ' ' A' ' 67' ' ' VAL . 23.0 p-10 -145.52 -162.93 1.61 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.681 -173.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.407 ' HD2' ' O ' ' A' ' 40' ' ' VAL . 76.5 m-85 -103.44 155.19 37.14 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.521 173.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -48.88 -34.47 28.53 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.281 2.654 . . . . 0.0 113.374 -176.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.491 ' HB3' HD22 ' A' ' 42' ' ' LEU . 35.7 m-20 -58.09 -39.18 77.94 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.558 -177.745 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.522 ' HB ' ' OD2' ' A' ' 63' ' ' ASP . 60.7 t -80.08 -31.15 13.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.518 -177.496 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.472 ' HG2' ' NE2' ' A' ' 59' ' ' HIS . 93.5 mttt -60.05 -28.03 67.43 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.494 0.664 . . . . 0.0 110.233 175.379 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -72.8 -47.28 47.87 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.177 177.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -84.16 -35.44 23.58 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.868 -0.606 . . . . 0.0 112.278 -169.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.49 HD23 HG13 ' A' ' 67' ' ' VAL . 4.5 mm? -100.56 117.06 63.54 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-O 120.635 0.255 . . . . 0.0 110.995 -178.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -68.86 146.25 65.14 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.808 2.339 . . . . 0.0 111.398 176.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -72.75 -29.65 63.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.856 0.36 . . . . 0.0 110.931 -176.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 18.1 m -150.02 132.77 15.94 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.404 178.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -150.65 144.35 25.16 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 5.9 t -110.0 133.23 55.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 175.541 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 69.8 mt -111.63 153.97 25.56 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.584 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 45.0 tp -116.69 99.23 6.99 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 174.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 63.8 t -113.58 109.19 27.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.712 -175.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.82 ' HG3' HD13 ' A' ' 145' ' ' LEU . 5.0 mm-40 57.25 30.27 18.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.137 178.063 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.72 -7.91 59.58 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.006 -0.616 . . . . 0.0 113.064 178.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.587 HG21 HG23 ' A' ' 150' ' ' VAL . 61.5 t -101.56 136.19 34.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.864 0.332 . . . . 0.0 111.256 -176.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -88.51 130.15 35.29 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.331 178.231 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 20.0 mt -118.78 99.62 8.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.892 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -84.27 106.66 2.92 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 111.084 -0.807 . . . . 0.0 111.084 177.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.504 ' HE3' HG13 ' A' ' 58' ' ' VAL . 36.5 mtm -104.12 132.05 50.77 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.997 0.427 . . . . 0.0 111.104 -175.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.484 ' O ' ' HA ' ' A' ' 113' ' ' PHE . 37.6 t -155.61 165.17 37.36 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 175.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 31.9 t-80 -76.5 -36.81 57.57 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.52 175.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.2 128.94 1.7 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.473 178.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 31.8 t-105 -156.67 141.08 16.67 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 178.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 123.46 177.53 15.14 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.601 -177.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.14 139.06 92.41 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.637 0.218 . . . . 0.0 110.499 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -56.79 -23.1 48.44 Favored 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 123.126 2.551 . . . . 0.0 113.206 -175.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -77.12 -54.34 6.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.224 0.535 . . . . 0.0 110.294 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -87.73 -8.1 56.5 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.717 -174.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 59.4 tp -59.18 -39.07 81.37 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.416 176.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -60.93 -40.63 93.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.992 178.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -69.62 -39.86 76.92 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.628 177.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.455 ' O ' HG23 ' A' ' 103' ' ' VAL . 78.4 ttt180 -67.89 -41.49 82.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.248 -177.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.536 HD13 HG21 ' A' ' 111' ' ' ILE . 78.1 mt -69.54 -31.64 69.97 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.618 0.247 . . . . 0.0 111.017 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.63 HD21 HG21 ' A' ' 127' ' ' VAL . 83.4 mt -74.62 -23.37 58.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.138 0.494 . . . . 0.0 110.225 174.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -74.6 -33.47 62.63 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.538 175.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 99' ' ' ARG . 98.5 t -71.9 -55.97 11.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.053 175.66 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -92.94 91.95 7.64 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.462 177.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -67.5 -25.26 65.77 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.174 -177.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -67.52 -24.18 65.53 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.942 176.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 32.8 mtmm 62.49 93.98 0.05 OUTLIER Pre-proline 0 N--CA 1.463 0.19 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.721 -177.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -76.8 156.85 35.21 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 123.161 2.574 . . . . 0.0 111.721 -177.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -66.03 -42.66 89.31 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.213 0.53 . . . . 0.0 110.16 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.409 HG11 ' CZ ' ' A' ' 152' ' ' PHE . 53.8 t -128.15 139.3 52.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.605 -178.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.536 HG21 HD13 ' A' ' 100' ' ' LEU . 61.0 mt -125.08 130.52 73.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.949 0.404 . . . . 0.0 110.268 176.29 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.432 HD23 ' HB2' ' A' ' 130' ' ' LEU . 98.0 mt -110.85 131.19 55.25 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.108 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.484 ' HA ' ' O ' ' A' ' 87' ' ' CYS . 37.8 p90 -155.18 172.24 18.47 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.169 -0.468 . . . . 0.0 109.95 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -133.15 114.61 1.41 Allowed Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.385 176.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 63.8 t-80 -171.91 -39.73 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.625 0.25 . . . . 0.0 110.698 -176.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.574 HG22 ' H ' ' A' ' 117' ' ' HIS . 0.2 OUTLIER -75.25 -165.52 0.41 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.987 0.423 . . . . 0.0 111.373 -174.168 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.574 ' H ' HG22 ' A' ' 116' ' ' THR . 93.1 m-70 -94.55 -54.75 3.4 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 111.946 0.351 . . . . 0.0 111.946 -171.13 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -116.24 167.84 9.69 Favored Pre-proline 0 C--N 1.323 -0.578 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.52 -172.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.696 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 16.2 Cg_exo -69.54 76.56 1.05 Allowed 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.641 2.227 . . . . 0.0 110.092 166.631 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.446 ' H ' ' HG2' ' A' ' 120' ' ' GLU . 6.9 pt-20 -108.89 142.03 40.1 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.719 -170.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -94.01 99.99 12.2 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.333 175.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.625 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 80.7 p -104.63 113.07 26.42 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.318 0.58 . . . . 0.0 110.677 -178.392 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 39.6 t -121.81 97.06 4.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.22 -178.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -137.16 33.93 2.57 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.792 177.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.424 ' C ' ' H ' ' A' ' 127' ' ' VAL . . . -166.74 14.88 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.221 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 80.25 -27.64 2.75 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.518 -172.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.63 HG21 HD21 ' A' ' 101' ' ' LEU . 42.3 t -85.82 138.7 18.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.28 -0.46 . . . . 0.0 110.409 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -87.48 107.64 18.66 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 174.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.625 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 92.8 m-85 -88.95 104.18 16.72 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 174.176 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.432 ' HB2' HD23 ' A' ' 112' ' ' LEU . 49.7 mt -109.19 134.66 51.45 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.181 -173.602 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.696 ' O ' ' HA ' ' A' ' 119' ' ' PRO . 5.8 t30 -117.76 104.91 48.55 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.268 178.295 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -70.59 142.72 44.97 Favored 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.805 2.336 . . . . 0.0 112.176 177.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -66.61 152.21 52.4 Favored Glycine 0 N--CA 1.452 -0.285 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.71 -178.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 39.9 m -64.28 138.49 58.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.962 0.411 . . . . 0.0 111.405 -178.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.556 HD21 ' H ' ' A' ' 8' ' ' SER . 74.6 mt -62.47 -31.1 71.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.376 -177.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -66.92 -16.16 64.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.633 -178.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 36.6 tp10 -90.88 1.0 57.34 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.287 0.565 . . . . 0.0 110.478 -178.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 74.94 43.2 28.02 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.248 178.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 57.5 m -152.22 142.17 22.13 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.754 0.311 . . . . 0.0 110.324 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.509 ' CG ' HD11 ' A' ' 23' ' ' ILE . 27.9 p90 -141.43 175.77 9.4 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 177.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.445 ' HB3' HD23 ' A' ' 6' ' ' LEU . . . -114.5 136.66 52.78 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.117 -175.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.477 HG12 ' HG3' ' A' ' 144' ' ' GLU . 21.5 t -118.44 105.86 18.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.879 176.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.742 ' HA ' ' O ' ' A' ' 151' ' ' ARG . 0.3 OUTLIER -95.75 109.4 21.71 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.438 0.637 . . . . 0.0 110.067 176.132 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.477 ' HG3' HG12 ' A' ' 142' ' ' VAL . 47.6 mt-10 -107.11 144.12 34.28 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.157 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.82 HD13 ' HG3' ' A' ' 80' ' ' GLU . 22.0 mt -90.7 90.33 7.91 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.777 -176.065 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -92.14 101.77 14.3 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.397 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.87 10.18 58.04 Favored Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.996 178.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 110.21 -18.14 28.49 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.821 -177.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -85.22 117.91 24.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.792 0.33 . . . . 0.0 110.482 177.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.587 HG23 HG21 ' A' ' 82' ' ' VAL . 5.3 t -80.31 124.39 38.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.2 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.742 ' O ' ' HA ' ' A' ' 143' ' ' LEU . 59.0 ttt85 -119.35 107.85 13.88 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 177.083 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' PHE . . . . . 0.553 ' CE2' HD13 ' A' ' 143' ' ' LEU . 9.3 m-85 -83.16 86.62 6.99 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 177.423 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -102.5 127.72 49.43 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.418 -175.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.632 HD22 ' HG2' ' A' ' 119' ' ' PRO . 9.2 tp -73.29 139.33 46.03 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.478 -178.152 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -118.71 132.02 56.15 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.741 176.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 21.0 p -88.57 146.36 25.18 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.162 -179.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 74.2 mt . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.337 -0.84 . . . . 0.0 109.633 178.517 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 95.2 t . . . . . 0 N--CA 1.48 1.06 0 CA-C-O 120.801 0.334 . . . . 0.0 110.391 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.909 ' HB2' ' HB2' ' A' ' 145' ' ' LEU . 72.4 mmtt -122.4 101.7 7.65 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 173.553 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.518 ' HG2' ' HG2' ' A' ' 144' ' ' GLU . 41.1 mtt180 -110.28 120.59 42.94 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.014 0.435 . . . . 0.0 111.191 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.479 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 86.7 m-85 -116.57 131.25 57.0 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.683 178.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.534 ' HB3' HG22 ' A' ' 33' ' ' VAL . 36.4 tp -89.21 118.78 29.15 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.015 178.547 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.406 HD11 HD11 ' A' ' 36' ' ' LEU . 51.2 tp -106.11 102.01 11.46 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.066 0.46 . . . . 0.0 110.391 -179.326 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.3 pt -101.6 121.66 52.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.928 177.107 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.797 ' HB2' ' HA ' ' A' ' 134' ' ' SER . 16.2 m -68.5 171.17 7.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.039 -179.238 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -64.02 144.06 57.39 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.287 0.565 . . . . 0.0 110.221 -179.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 68.7 m -143.23 178.96 7.37 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.984 -174.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 32.4 m80 -129.22 79.17 1.9 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.154 0.502 . . . . 0.0 110.472 178.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.431 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -139.06 142.65 33.96 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.379 179.525 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.431 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 18.1 Cg_endo -93.72 97.23 0.14 OUTLIER 'Cis proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.299 -1.542 . . . . 0.0 112.056 -3.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.6 t -116.64 -88.09 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 121.19 -0.204 . . . . 0.0 110.896 -178.235 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 15' ' ' ARG . 37.9 ttm180 -134.67 -14.39 2.18 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 120.949 0.404 . . . . 0.0 111.077 178.413 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.58 ' SD ' ' HB2' ' A' ' 136' ' ' ALA . 33.8 ttp -64.9 -71.03 0.2 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.405 177.166 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 63.16 5.6 2.0 Allowed 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.701 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.438 ' H ' ' HG2' ' A' ' 16' ' ' MET . 49.3 m -85.43 15.32 4.54 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.063 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.636 ' HG ' ' HG ' ' A' ' 135' ' ' LEU . 6.2 tt -90.5 111.71 48.99 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.44 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.4 132.41 35.8 Favored 'Trans proline' 0 C--O 1.234 0.318 0 C-N-CA 122.815 2.343 . . . . 0.0 112.703 -174.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -68.66 -19.28 64.39 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.302 177.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -56.37 -44.81 80.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.107 175.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.1 tt -70.22 -29.17 38.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.343 -177.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.491 ' O ' HD23 ' A' ' 27' ' ' LEU . 58.8 tp -71.07 -22.87 62.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.251 179.253 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -82.32 -20.79 36.67 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.184 175.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.8 m -74.02 -9.47 58.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.53 -177.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 1.035 HD13 HG21 ' A' ' 33' ' ' VAL . 2.6 mm? -51.67 -38.66 55.97 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.321 0.582 . . . . 0.0 110.727 176.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -80.36 -17.45 51.9 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.729 -174.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -95.47 2.82 54.58 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -172.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.448 ' HD1' ' HB3' ' A' ' 3' ' ' ARG . 43.2 m-85 -124.27 -176.65 3.56 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.675 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -96.29 -37.99 10.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.034 0.445 . . . . 0.0 110.521 -178.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.479 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -151.58 158.67 27.87 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.035 HG21 HD13 ' A' ' 27' ' ' LEU . 92.3 t -126.36 136.93 59.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 120.938 0.399 . . . . 0.0 110.691 -178.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.511 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 57.4 mt -115.81 112.58 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.097 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -98.21 126.47 8.9 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 178.119 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.406 HD11 HD11 ' A' ' 6' ' ' LEU . 84.7 mt -99.67 10.85 40.62 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.884 0.342 . . . . 0.0 110.884 -177.494 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 122.59 43.31 0.39 Allowed Glycine 0 C--N 1.329 0.143 0 C-N-CA 120.995 -0.621 . . . . 0.0 111.733 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.47 -76.01 0.18 Allowed 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 123.24 0.616 . . . . 0.0 112.369 -174.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.505 ' HD2' HD11 ' A' ' 48' ' ' LEU . 92.9 m-85 -86.19 128.48 34.9 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.994 0.426 . . . . 0.0 110.774 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.1 m -91.26 1.34 8.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.375 0.607 . . . . 0.0 110.311 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.513 ' O ' HG23 ' A' ' 45' ' ' VAL . 26.8 t70 -95.73 126.05 40.73 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.815 -178.355 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.436 HD13 ' HB3' ' A' ' 66' ' ' ASP . 62.3 tp -58.41 -49.64 76.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.589 -176.1 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -58.14 -42.47 85.92 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.987 -177.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.488 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 10.4 m -67.95 -35.34 78.23 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.156 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 41' ' ' ASP . 89.2 t -61.21 -41.13 88.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 121.272 0.558 . . . . 0.0 110.247 175.622 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.51 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 1.7 mp -66.99 -38.11 80.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.026 177.015 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.5 -34.15 73.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.563 176.03 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.505 HD11 ' HD2' ' A' ' 39' ' ' TYR . 94.8 mt -67.68 -35.61 79.15 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.547 0.689 . . . . 0.0 109.432 177.33 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.66 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 13.2 tt0 -78.51 -6.24 54.89 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.869 178.453 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.51 ' HG3' ' O ' ' A' ' 46' ' ' ILE . 29.9 mtpp -95.04 -44.02 7.87 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.605 174.379 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.517 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . 3.8 m-85 -58.66 -67.9 0.31 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.984 -179.225 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 51.5 m -87.09 -26.67 23.55 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.559 179.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.66 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 46.4 mttp 72.47 -47.89 0.67 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.266 0.626 . . . . 0.0 111.082 -178.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -81.79 86.58 6.44 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 172.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -119.69 130.11 54.87 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.942 -175.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.511 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 90.7 m-85 -121.26 131.56 54.29 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.089 174.531 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.475 ' HA3' HD22 ' A' ' 71' ' ' LEU . . . -140.02 151.19 21.99 Favored Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 119.982 -1.104 . . . . 0.0 112.739 -177.228 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.4 HG12 ' H ' ' A' ' 59' ' ' HIS . 0.5 OUTLIER -112.62 176.47 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 174.65 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.637 ' CD2' ' HA ' ' A' ' 68' ' ' LYS . 61.6 t-80 -94.34 135.38 35.81 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.774 0.321 . . . . 0.0 110.409 -177.686 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -82.27 -130.98 1.43 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.997 178.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -101.24 -79.21 0.51 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.712 0.292 . . . . 0.0 111.01 -178.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 67.1 mtt -120.68 107.71 13.13 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.984 0.421 . . . . 0.0 110.587 -178.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -132.93 -167.77 1.97 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.213 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -91.23 148.37 37.62 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.863 -179.065 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.502 ' HA ' ' HB3' ' A' ' 68' ' ' LYS . 6.7 Cg_endo -49.33 -36.43 37.96 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.822 3.015 . . . . 0.0 114.296 -174.286 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.436 ' HB3' HD13 ' A' ' 42' ' ' LEU . 13.1 m-20 -70.22 -36.97 74.91 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.776 0.322 . . . . 0.0 111.251 -178.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 58.6 t -72.11 -41.69 67.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 174.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.637 ' HA ' ' CD2' ' A' ' 59' ' ' HIS . 79.1 tttt -53.99 -35.7 62.13 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.216 -1.356 . . . . 0.0 111.994 177.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -93.9 -24.07 17.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.645 -176.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -82.95 -36.27 25.32 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.445 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.475 HD22 ' HA3' ' A' ' 57' ' ' GLY . 72.4 mt -103.72 110.59 64.18 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.021 177.31 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 71' ' ' LEU . 22.9 Cg_endo -61.05 146.91 97.09 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.965 2.444 . . . . 0.0 112.688 -176.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.591 ' HA ' ' HB3' ' A' ' 59' ' ' HIS . 94.2 m-85 -59.97 -34.37 73.19 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.789 -178.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 63.3 m -152.93 146.46 25.0 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 174.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.521 ' HG2' ' N ' ' A' ' 76' ' ' VAL . 41.7 tttm -150.74 171.54 17.02 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -176.663 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.521 ' N ' ' HG2' ' A' ' 75' ' ' LYS . 38.6 t -125.35 133.77 68.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 169.456 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.757 ' HB2' ' SD ' ' A' ' 86' ' ' MET . 1.9 tp -105.54 111.55 24.29 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.32 -177.648 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 47.8 tp -93.34 103.46 15.69 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.729 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 43.3 t -114.78 109.63 29.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.644 -178.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 61.01 13.45 4.6 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.022 177.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 112.48 -10.07 26.19 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.422 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 60.4 t -87.63 134.54 27.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.708 0.29 . . . . 0.0 110.574 178.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.4 p -91.19 118.98 30.9 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.267 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.583 ' HB ' ' HB3' ' A' ' 77' ' ' LEU . 71.1 mt -118.44 104.14 15.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.034 0.445 . . . . 0.0 110.057 179.35 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -63.31 130.11 40.83 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.708 178.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.757 ' SD ' ' HB2' ' A' ' 77' ' ' LEU . 65.6 mtp -116.73 97.87 6.22 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 -177.61 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.566 ' O ' ' HA ' ' A' ' 113' ' ' PHE . 31.7 t -143.06 157.59 44.39 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 176.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 8.4 t-160 -92.23 -21.15 20.51 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.193 -0.603 . . . . 0.0 110.184 177.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 117.07 -179.08 17.39 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.084 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 75.6 t-105 -140.1 -69.72 0.4 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.914 0.388 . . . . 0.0 110.245 -179.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 173.52 169.91 36.42 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 53.78 82.22 0.25 Allowed Pre-proline 0 CA--C 1.529 0.167 0 C-N-CA 122.773 0.429 . . . . 0.0 111.221 -178.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -52.17 -33.67 55.34 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.269 2.646 . . . . 0.0 113.188 -174.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 35.5 p90 -67.98 -35.31 78.13 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.469 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -102.74 -16.73 15.89 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.255 0.55 . . . . 0.0 110.652 -173.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 39.5 tp -55.45 -35.25 65.27 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.222 -179.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.423 ' H ' ' HG3' ' A' ' 97' ' ' LYS . 42.3 mttm -59.04 -45.9 89.56 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.59 0.71 . . . . 0.0 109.624 178.434 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -69.91 -38.83 76.39 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.346 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.504 ' O ' HG23 ' A' ' 103' ' ' VAL . 29.6 mmt180 -61.15 -48.95 79.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.007 177.161 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.502 HD13 HG21 ' A' ' 111' ' ' ILE . 67.6 mt -61.66 -33.98 74.91 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.692 -177.663 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 70.3 mt -67.21 -15.24 63.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.793 0.33 . . . . 0.0 111.427 177.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 23.4 mtmm -104.71 -6.15 20.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.117 174.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 99' ' ' ARG . 90.0 t -85.22 -40.13 14.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.25 0.548 . . . . 0.0 109.545 175.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -85.12 171.21 12.2 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.889 178.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 30.8 t30 -91.91 -61.38 1.64 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.091 -176.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -107.6 -176.42 3.06 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.401 -177.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.432 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 96.4 mttt -81.34 111.1 21.96 Favored Pre-proline 0 C--O 1.234 0.282 0 CA-C-O 120.768 0.318 . . . . 0.0 111.101 -175.386 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 107' ' ' LYS . 3.8 Cg_endo -85.78 147.97 9.57 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.308 2.672 . . . . 0.0 111.847 179.033 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -81.18 -47.74 13.04 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.259 0.552 . . . . 0.0 110.416 177.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 44.0 t -122.02 147.33 26.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.843 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.502 HG21 HD13 ' A' ' 100' ' ' LEU . 66.3 mt -136.62 130.6 46.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.66 0.267 . . . . 0.0 110.622 175.56 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.634 HD23 ' HB2' ' A' ' 130' ' ' LEU . 95.0 mt -101.32 141.85 33.58 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.013 175.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.566 ' HA ' ' O ' ' A' ' 87' ' ' CYS . 14.3 p90 -155.85 176.65 12.36 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 172.624 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -105.56 135.87 12.86 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.807 -177.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.536 ' HB3' ' HB2' ' A' ' 131' ' ' ASN . 11.5 t-160 -151.47 128.4 11.01 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.599 0.237 . . . . 0.0 110.715 -174.382 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.0 p -74.1 84.3 1.81 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.228 0.537 . . . . 0.0 111.267 178.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 60.7 t60 -176.36 153.55 1.22 Allowed 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -55.97 123.81 55.34 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 174.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.575 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 91.8 Cg_exo -43.13 129.47 5.91 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 124.002 3.134 . . . . 0.0 114.172 -172.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -142.42 155.1 45.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.661 -177.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -95.96 115.44 27.43 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 176.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.517 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 40.5 p -116.41 116.82 28.39 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.121 0.486 . . . . 0.0 112.078 -175.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 43.6 t -114.32 98.25 6.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.969 178.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.425 ' O ' ' HB2' ' A' ' 125' ' ' ALA . 28.4 tptp -144.25 65.44 1.29 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.425 ' HB2' ' O ' ' A' ' 124' ' ' LYS . . . 167.22 -13.07 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.895 -176.206 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.4 ' H ' ' H ' ' A' ' 125' ' ' ALA . . . 101.49 -12.06 58.21 Favored Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -173.167 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 47.3 t -107.18 140.67 24.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 114.965 -0.617 . . . . 0.0 110.061 -178.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 55.7 mtt180 -80.3 108.12 13.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.662 0.268 . . . . 0.0 110.654 176.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.517 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 98.2 m-85 -92.89 107.79 19.49 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 176.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.634 ' HB2' HD23 ' A' ' 112' ' ' LEU . 93.0 mt -99.24 116.71 32.06 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.157 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.575 ' O ' ' HA ' ' A' ' 119' ' ' PRO . 4.3 p30 -122.91 109.79 31.82 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.652 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.564 ' HA ' ' HG3' ' A' ' 119' ' ' PRO . 83.7 Cg_endo -88.86 178.36 2.76 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.072 2.514 . . . . 0.0 111.886 175.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.591 ' HA3' ' OE1' ' A' ' 137' ' ' GLU . . . -90.22 -109.01 1.35 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.216 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.797 ' HA ' ' HB2' ' A' ' 8' ' ' SER . 40.4 t -167.8 162.97 14.06 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.337 -0.246 . . . . 0.0 110.337 -179.147 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.636 ' HG ' ' HG ' ' A' ' 19' ' ' LEU . 3.7 mm? -71.48 -15.67 62.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.093 0.473 . . . . 0.0 109.957 176.264 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.58 ' HB2' ' SD ' ' A' ' 16' ' ' MET . . . -84.52 -6.82 59.4 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.356 175.047 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.591 ' OE1' ' HA3' ' A' ' 133' ' ' GLY . 1.8 tm-20 -113.43 -34.67 5.52 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.883 -178.334 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.537 ' HA2' HD12 ' A' ' 157' ' ' LEU . . . 127.78 -44.53 1.23 Allowed Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.327 -0.939 . . . . 0.0 113.681 175.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.507 ' HB3' HD11 ' A' ' 154' ' ' LEU . 18.6 m -76.81 113.63 14.69 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -175.467 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.467 ' O ' HD12 ' A' ' 154' ' ' LEU . 54.7 p90 -115.71 156.76 25.36 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 172.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -114.4 138.0 51.12 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.206 0.527 . . . . 0.0 112.016 -169.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 38.3 t -114.74 116.47 52.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 173.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.628 HD21 HG13 ' A' ' 150' ' ' VAL . 3.4 tt -94.72 107.46 19.46 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -177.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.518 ' HG2' ' HG2' ' A' ' 3' ' ' ARG . 32.4 mt-10 -104.06 121.58 43.49 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.35 178.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.909 ' HB2' ' HB2' ' A' ' 2' ' ' LYS . 55.3 mt -96.81 89.97 5.09 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.708 174.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -86.8 124.29 32.88 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.674 179.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 68.01 -68.94 0.32 Allowed Glycine 0 CA--C 1.52 0.401 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.381 -174.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -179.89 30.38 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 121.087 -0.577 . . . . 0.0 111.774 179.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -126.93 145.63 50.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.681 0.277 . . . . 0.0 110.608 -179.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.628 HG13 HD21 ' A' ' 143' ' ' LEU . 58.1 t -77.08 111.96 14.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.669 -179.154 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 19.8 mtm180 -115.95 115.81 26.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.379 0.609 . . . . 0.0 110.263 177.137 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -90.92 105.53 17.89 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.948 -176.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.32 113.76 26.69 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -178.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.537 HD22 ' HB2' ' A' ' 119' ' ' PRO . 44.9 tp -94.33 127.15 40.03 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.32 -173.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -114.92 135.42 54.22 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 175.053 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.2 m -108.22 148.93 29.25 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.764 0.316 . . . . 0.0 110.526 -177.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.537 HD12 ' HA2' ' A' ' 138' ' ' GLY . 97.5 mt . . . . . 0 C--O 1.247 0.965 0 CA-C-O 118.284 -0.865 . . . . 0.0 110.319 179.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.603 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 80.1 t . . . . . 0 N--CA 1.476 0.859 0 CA-C-O 120.858 0.361 . . . . 0.0 110.81 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -126.46 138.71 53.55 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.79 174.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.623 ' HB3' ' HD1' ' A' ' 30' ' ' TYR . 47.3 mtt85 -115.62 111.65 20.97 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.113 0.482 . . . . 0.0 110.631 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.495 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 73.7 m-85 -102.11 121.63 42.57 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.892 -178.298 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 38.0 tp -89.35 119.33 29.72 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.068 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.706 HD11 ' HG ' ' A' ' 36' ' ' LEU . 59.8 tp -106.05 112.37 25.38 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.088 0.47 . . . . 0.0 111.3 -176.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 27.8 pt -101.43 140.44 20.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.628 175.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.8 p -99.53 -159.5 0.74 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.43 -176.023 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -48.62 100.6 0.02 OUTLIER 'General case' 0 C--O 1.236 0.375 0 O-C-N 123.803 0.689 . . . . 0.0 112.146 -177.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.47 ' HB2' ' C ' ' A' ' 38' ' ' ASP . 6.9 m -92.51 83.05 4.88 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.963 177.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.539 ' HB2' ' SD ' ' A' ' 16' ' ' MET . 37.2 m80 -76.83 55.68 1.11 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.156 0.503 . . . . 0.0 110.228 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . 2.8 t -127.69 138.31 32.59 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -177.64 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 27.9 Cg_endo -94.84 56.38 0.87 Allowed 'Cis proline' 0 N--CA 1.453 -0.907 0 C-N-CA 123.61 -1.413 . . . . 0.0 112.724 -2.302 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.482 HG22 HG21 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -86.0 -162.53 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 176.527 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.401 ' H ' HG12 ' A' ' 14' ' ' VAL . 66.3 mtt85 -77.31 81.74 3.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.83 0.824 . . . . 0.0 110.828 -176.036 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.539 ' SD ' ' HB2' ' A' ' 11' ' ' HIS . 51.1 ttp -164.04 -70.79 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.186 -1.37 . . . . 0.0 108.15 179.301 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 61.25 2.49 0.62 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.932 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.42 ' H ' ' HG2' ' A' ' 16' ' ' MET . 8.5 m -82.57 38.17 0.55 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.58 -176.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.0 tt -107.96 103.62 50.5 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.483 ' HB2' HD13 ' A' ' 157' ' ' LEU . 23.4 Cg_exo -65.51 126.65 16.55 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.278 1.985 . . . . 0.0 110.89 174.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -64.19 -10.66 24.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.877 -174.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -53.88 -35.29 61.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.986 0.422 . . . . 0.0 110.836 177.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 tt -69.26 -27.98 36.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.453 0.644 . . . . 0.0 110.573 -177.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.413 ' HA ' HD23 ' A' ' 27' ' ' LEU . 55.5 tp -72.64 -29.49 63.5 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.605 -179.102 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -72.73 -31.02 64.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.927 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.7 p -77.79 1.89 18.8 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -176.039 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.458 ' HA ' HD13 ' A' ' 27' ' ' LEU . 2.2 mm? -58.05 -36.14 72.35 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.204 0.526 . . . . 0.0 110.714 176.058 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 32.2 mttt -75.34 -24.43 57.36 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.925 -175.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -88.36 -6.39 57.74 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.162 -165.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.623 ' HD1' ' HB3' ' A' ' 3' ' ' ARG . 98.0 m-85 -122.03 142.04 50.75 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.783 0.325 . . . . 0.0 110.571 -179.57 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -84.79 -12.75 52.99 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.978 -176.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.495 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -138.42 131.83 5.54 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 175.407 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 56.2 t -122.58 128.68 75.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 117.119 0.459 . . . . 0.0 110.554 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.548 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 32.1 mt -120.29 133.57 66.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.745 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.68 120.4 3.99 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.57 177.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.706 ' HG ' HD11 ' A' ' 6' ' ' LEU . 82.0 mt -89.73 7.62 35.85 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.272 0.558 . . . . 0.0 110.071 179.135 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 152.11 78.66 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.229 -178.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.47 ' C ' ' HB2' ' A' ' 10' ' ' SER . 8.4 p-10 -82.38 -146.93 0.07 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.46 0.171 . . . . 0.0 111.107 -175.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.523 ' HD2' HD11 ' A' ' 48' ' ' LEU . 77.1 m-85 -60.64 144.8 51.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.168 0.508 . . . . 0.0 111.739 -173.079 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.482 HG21 HG22 ' A' ' 14' ' ' VAL . 27.7 m -82.55 -1.86 5.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.056 -178.572 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.576 ' O ' HG23 ' A' ' 45' ' ' VAL . 16.0 t70 -103.38 122.16 44.27 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.007 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.502 ' HB2' ' HB3' ' A' ' 66' ' ' ASP . 54.7 tp -55.68 -48.82 74.44 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 123.563 0.54 . . . . 0.0 112.125 -172.575 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -63.88 -32.17 73.6 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.74 0.305 . . . . 0.0 111.291 -176.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.9 m -76.12 -27.31 57.04 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.731 178.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 41' ' ' ASP . 61.6 t -63.32 -47.54 91.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 121.463 0.649 . . . . 0.0 109.962 174.372 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.616 HG22 ' HE3' ' A' ' 50' ' ' LYS . 1.7 mp -65.59 -31.83 55.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.842 179.385 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -57.46 -40.58 78.82 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 173.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.523 HD11 ' HD2' ' A' ' 39' ' ' TYR . 64.3 mt -70.7 -40.72 72.7 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 120.981 0.42 . . . . 0.0 110.316 178.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -61.81 -28.78 69.71 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.785 -178.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.616 ' HE3' HG22 ' A' ' 46' ' ' ILE . 98.4 mttt -72.36 -47.64 47.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.969 177.172 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -65.99 -48.14 72.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.889 0.376 . . . . 0.0 111.041 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 9.1 m -60.29 -43.05 96.63 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.335 177.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 98.0 mttt 69.52 -53.69 0.6 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.678 0.791 . . . . 0.0 109.942 -171.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.4 mm-40 -107.71 84.71 2.0 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.332 173.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -100.33 114.27 27.63 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.897 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.548 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 25.1 m-85 -105.07 107.93 19.17 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 176.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.461 ' O ' ' HD2' ' A' ' 72' ' ' PRO . . . -129.78 154.26 20.38 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 119.666 -1.254 . . . . 0.0 113.57 -173.427 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.65 HG21 ' HB3' ' A' ' 86' ' ' MET . 4.8 m -141.48 157.25 21.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 123.067 0.547 . . . . 0.0 109.719 174.224 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.539 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 64.4 t60 -94.74 104.6 16.52 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.197 0.522 . . . . 0.0 110.373 -178.159 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 1.036 ' HA2' ' HB3' ' A' ' 88' ' ' HIS . . . -113.58 -29.21 2.98 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.231 175.511 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 22.4 p-10 -79.67 -169.11 1.81 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.033 -0.583 . . . . 0.0 110.784 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 67.3 mtt -117.54 90.02 3.24 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.003 175.295 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -107.89 -170.32 1.67 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.022 -177.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -82.44 152.73 67.71 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.52 178.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.605 ' HA ' ' HB3' ' A' ' 68' ' ' LYS . 81.4 Cg_exo -47.07 -32.19 12.91 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.492 2.795 . . . . 0.0 113.772 -178.269 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.502 ' HB3' ' HB2' ' A' ' 42' ' ' LEU . 3.5 m-20 -58.63 -52.37 65.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.327 0.584 . . . . 0.0 110.668 177.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 19.3 t -75.27 -32.97 27.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.709 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.605 ' HB3' ' HA ' ' A' ' 65' ' ' PRO . 87.7 tttt -60.07 -24.17 64.38 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.067 176.714 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -93.84 -30.65 14.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.609 176.061 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -65.56 -43.15 90.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.213 0.53 . . . . 0.0 109.903 175.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.539 ' HB2' ' HB2' ' A' ' 59' ' ' HIS . 78.4 mt -97.89 121.65 57.03 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.326 -179.051 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.461 ' HD2' ' O ' ' A' ' 57' ' ' GLY . 22.0 Cg_exo -65.88 164.57 26.62 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.867 2.378 . . . . 0.0 112.295 178.315 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -78.46 -31.68 48.02 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.044 0.449 . . . . 0.0 110.093 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.5 m -151.72 135.49 16.35 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.214 178.082 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 37.0 tttp -148.37 135.71 20.41 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.294 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 10.5 t -115.3 123.77 71.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.884 0.373 . . . . 0.0 110.256 178.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.551 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 78.2 mt -95.62 139.28 32.1 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.223 178.447 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 37.3 tp -112.31 98.6 7.41 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 174.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.435 HG11 ' CE1' ' A' ' 4' ' ' PHE . 41.0 t -115.1 100.3 10.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.592 -174.198 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 61.51 28.9 18.1 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.35 178.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.64 -15.71 58.3 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.303 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 57.3 t -83.0 121.69 36.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 120.861 0.362 . . . . 0.0 110.365 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.0 p -87.53 123.28 32.26 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.879 178.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.551 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 24.4 mt -116.02 95.63 3.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -178.511 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -84.8 109.44 3.27 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.384 179.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.65 ' HB3' HG21 ' A' ' 58' ' ' VAL . 46.8 mtm -106.52 123.73 48.53 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.795 0.331 . . . . 0.0 110.306 -178.24 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 48.0 t -161.06 165.21 30.08 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.602 -177.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 1.036 ' HB3' ' HA2' ' A' ' 60' ' ' GLY . 10.4 p-80 -88.72 95.81 10.42 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.323 0.582 . . . . 0.0 110.494 176.452 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.593 ' H ' ' HB2' ' A' ' 113' ' ' PHE . . . -83.29 68.22 3.59 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.793 -177.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.433 ' CD1' ' HB2' ' A' ' 88' ' ' HIS . 88.3 m95 -86.13 85.5 7.35 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.225 0.536 . . . . 0.0 110.185 177.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -176.0 -174.96 42.98 Favored Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.565 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -81.24 140.31 49.06 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.123 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -62.85 -14.62 41.99 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.841 2.361 . . . . 0.0 112.522 -176.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 4.0 m0 -73.97 -48.77 28.14 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.489 -178.051 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -96.77 -1.23 46.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.358 178.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 33.6 tp -59.75 -39.32 84.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.509 179.198 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -59.87 -42.59 94.07 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.257 178.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.44 ' O ' ' HB2' ' A' ' 102' ' ' LYS . 10.6 t70 -64.58 -49.11 72.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.299 179.239 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 47.2 ttt85 -60.47 -49.64 76.73 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.735 -176.146 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.516 HD13 HG21 ' A' ' 111' ' ' ILE . 81.6 mt -78.06 -36.11 48.77 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -174.031 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.726 HD21 HG21 ' A' ' 127' ' ' VAL . 85.2 mt -76.53 -18.75 58.54 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.025 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 98' ' ' ASP . 79.6 tttt -74.1 -29.55 61.9 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.373 0.606 . . . . 0.0 109.461 176.419 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 70.9 t -86.89 -45.98 16.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.018 176.149 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -90.99 86.9 6.4 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.847 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -68.27 -21.98 64.77 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.532 -178.366 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -72.55 -18.66 61.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.442 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 78.1 tttt 62.39 95.84 0.05 OUTLIER Pre-proline 0 N--CA 1.465 0.319 0 O-C-N 123.583 0.552 . . . . 0.0 110.636 -173.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.466 ' O ' HG13 ' A' ' 127' ' ' VAL . 5.6 Cg_exo -79.98 134.9 10.84 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.844 2.363 . . . . 0.0 111.851 178.349 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -70.8 -35.9 72.76 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.34 0.591 . . . . 0.0 109.533 177.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.604 HG21 HG11 ' A' ' 150' ' ' VAL . 53.5 t -122.87 128.59 75.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.028 178.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.516 HG21 HD13 ' A' ' 100' ' ' LEU . 24.4 mt -122.89 127.99 75.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 120.91 0.386 . . . . 0.0 110.826 177.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 89.3 mt -104.52 124.84 50.0 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.494 176.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.593 ' HB2' ' H ' ' A' ' 89' ' ' GLY . 5.2 p90 -146.88 160.05 42.78 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.807 0.337 . . . . 0.0 110.684 -178.222 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -105.95 125.74 8.31 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 175.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.475 ' HB2' ' CE2' ' A' ' 113' ' ' PHE . 10.4 t-160 -141.1 -54.84 0.48 Allowed 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 111.744 0.276 . . . . 0.0 111.744 -175.172 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 20.6 p -123.47 -100.03 0.41 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -173.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.48 ' O ' ' HA2' ' A' ' 133' ' ' GLY . 0.1 OUTLIER -166.66 -43.39 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.798 0.333 . . . . 0.0 111.214 -172.442 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -85.17 165.26 37.47 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.3 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.887 ' HG3' HD22 ' A' ' 154' ' ' LEU . 21.6 Cg_exo -63.23 87.38 0.13 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.281 1.987 . . . . 0.0 111.225 174.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.722 ' HB3' ' HB3' ' A' ' 131' ' ' ASN . 19.3 tt0 -82.34 105.59 13.53 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.541 -176.553 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -104.87 99.49 9.12 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.418 -175.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.44 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 77.2 p -121.22 118.74 30.37 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.454 -177.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.4 p -116.51 115.44 49.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.35 0.595 . . . . 0.0 110.667 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -137.3 136.08 37.69 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.912 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 65.81 17.86 10.97 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 123.604 0.565 . . . . 0.0 111.199 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 88.23 -7.0 82.85 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.951 -0.642 . . . . 0.0 111.769 -176.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.726 HG21 HD21 ' A' ' 101' ' ' LEU . 63.3 t -93.82 126.91 46.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 35.7 ttt180 -103.66 111.08 23.4 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.068 0.461 . . . . 0.0 110.844 -176.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.442 ' CE1' HD12 ' A' ' 111' ' ' ILE . 19.3 m-85 -92.08 127.15 37.44 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.231 178.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 88.6 mt -120.2 116.76 26.25 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.758 0.313 . . . . 0.0 111.692 -176.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.722 ' HB3' ' HB3' ' A' ' 120' ' ' GLU . 7.3 t30 -94.8 122.51 60.32 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 170.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.559 ' HG3' HD12 ' A' ' 36' ' ' LEU . 84.1 Cg_endo -81.17 167.48 17.74 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.86 2.373 . . . . 0.0 113.165 -177.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 117' ' ' HIS . . . -77.96 145.99 30.39 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.631 177.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.546 ' HB2' ' HG2' ' A' ' 137' ' ' GLU . 15.5 m -78.58 140.45 38.49 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.858 0.361 . . . . 0.0 111.534 -177.179 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 62.0 mt -56.38 -37.67 70.4 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.476 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.41 -13.79 53.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.835 -176.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.546 ' HG2' ' HB2' ' A' ' 134' ' ' SER . 23.1 mm-40 -97.53 1.1 48.57 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.582 -178.177 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 71.37 35.73 63.36 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.635 -177.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 18.1 m -139.55 132.74 29.76 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.619 0.247 . . . . 0.0 110.371 -179.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -130.94 164.72 24.7 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 176.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -114.24 143.22 45.19 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.924 0.393 . . . . 0.0 110.731 -173.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 63.0 t -130.82 122.96 53.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.869 178.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.416 HD21 HG13 ' A' ' 150' ' ' VAL . 5.8 tt -99.59 105.39 17.25 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 177.019 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -100.26 112.57 24.9 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.458 -178.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.603 ' O ' ' HA ' ' A' ' 1' ' ' VAL . 59.8 mt -90.71 90.33 7.9 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.782 176.001 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.52 ' HA ' HG22 ' A' ' 1' ' ' VAL . 26.7 t70 -101.2 122.63 43.99 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.116 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 68.21 -68.92 0.35 Allowed Glycine 0 CA--C 1.519 0.308 0 C-N-CA 121.462 -0.399 . . . . 0.0 112.151 -173.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -176.1 25.9 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 175.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -105.83 134.87 48.26 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 -177.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.604 HG11 HG21 ' A' ' 110' ' ' VAL . 41.1 t -83.82 89.63 2.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.1 0.476 . . . . 0.0 109.869 177.451 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 27.8 mtp-105 -95.37 96.1 8.9 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.295 -177.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -92.36 104.48 16.81 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.076 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -109.46 154.29 22.84 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.864 -179.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.887 HD22 ' HG3' ' A' ' 119' ' ' PRO . 18.8 tp -114.72 117.16 30.02 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 172.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -104.86 135.12 46.82 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.257 -177.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 16.9 p -96.76 142.08 29.21 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.045 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.483 HD13 ' HB2' ' A' ' 20' ' ' PRO . 82.0 mt . . . . . 0 C--O 1.246 0.895 0 CA-C-O 118.555 -0.736 . . . . 0.0 110.405 -179.362 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.538 HG12 ' H ' ' A' ' 2' ' ' LYS . 1.4 t . . . . . 0 N--CA 1.481 1.094 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.538 ' H ' HG12 ' A' ' 1' ' ' VAL . 46.5 mttp -128.25 111.93 13.94 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.893 0.378 . . . . 0.0 110.048 168.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.524 ' HG2' ' HG2' ' A' ' 144' ' ' GLU . 59.6 mtt180 -115.1 117.3 30.18 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.472 178.551 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.476 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 65.6 m-85 -103.67 132.21 50.13 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.854 -179.127 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.517 HD11 HD11 ' A' ' 23' ' ' ILE . 50.1 tp -88.98 114.32 25.48 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.033 179.309 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 63.3 tp -102.73 107.16 17.95 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.862 0.363 . . . . 0.0 110.703 -178.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.408 ' HB ' HD11 ' A' ' 135' ' ' LEU . 28.7 pt -104.41 126.42 59.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-O 121.342 0.591 . . . . 0.0 109.527 173.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.558 ' HA ' HD12 ' A' ' 36' ' ' LEU . 14.4 m -77.76 -175.57 3.98 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.03 -173.124 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -69.24 119.38 13.44 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.652 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.605 ' HB2' HD12 ' A' ' 135' ' ' LEU . 70.3 m -156.72 80.62 0.94 Allowed 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.388 -0.824 . . . . 0.0 108.819 178.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.553 ' HB3' HG21 ' A' ' 14' ' ' VAL . 24.1 m80 -60.15 106.77 0.55 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.234 -1.348 . . . . 0.0 113.022 -171.182 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.621 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 2.6 p -140.4 138.07 18.49 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.98 176.089 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -89.42 104.06 0.44 Allowed 'Cis proline' 0 N--CA 1.456 -0.701 0 C-N-CA 123.551 -1.437 . . . . 0.0 112.449 -1.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.553 HG21 ' HB3' ' A' ' 11' ' ' HIS . 13.3 t -128.37 -77.25 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.882 178.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 59.2 mtt180 -134.36 -4.78 2.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.502 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.592 ' SD ' ' HB3' ' A' ' 10' ' ' SER . 56.8 ttp -91.94 -64.51 1.11 Allowed 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 173.084 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.605 ' HA ' HG23 ' A' ' 12' ' ' VAL . . . 69.39 -21.16 0.16 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.58 176.269 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.416 ' H ' ' C ' ' A' ' 16' ' ' MET . 22.8 t -105.27 78.55 1.39 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.047 0.451 . . . . 0.0 110.959 -176.166 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.2 tt -108.04 116.78 56.45 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 173.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.423 ' O ' HG22 ' A' ' 23' ' ' ILE . 32.5 Cg_exo -59.74 111.34 0.93 Allowed 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.564 2.176 . . . . 0.0 111.667 177.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -79.48 7.56 7.9 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -172.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -64.76 -35.38 80.9 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.337 0.589 . . . . 0.0 109.794 173.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.517 HD11 HD11 ' A' ' 5' ' ' LEU . 12.9 tt -70.33 -39.92 77.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.758 0.789 . . . . 0.0 109.807 177.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.463 ' O ' HD22 ' A' ' 27' ' ' LEU . 40.5 tp -73.04 -3.99 29.65 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.327 -1.306 . . . . 0.0 110.594 177.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -100.23 -24.81 14.46 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.289 0.566 . . . . 0.0 110.117 175.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 25.9 m -97.03 -6.81 34.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.829 -174.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.918 ' HA ' ' HD2' ' A' ' 30' ' ' TYR . 1.5 pt? -66.45 -13.27 60.55 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.941 0.401 . . . . 0.0 111.316 -175.604 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -65.43 -27.35 68.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.31 -178.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -94.4 -0.67 54.67 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -177.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.918 ' HD2' ' HA ' ' A' ' 27' ' ' LEU . 84.9 m-85 -91.24 138.51 31.53 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 178.205 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -64.62 -36.99 86.03 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.215 0.531 . . . . 0.0 110.257 -178.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -146.3 154.22 25.82 Favored Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 177.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.476 HG22 ' HB3' ' A' ' 5' ' ' LEU . 88.4 t -132.2 134.82 59.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.909 0.355 . . . . 0.0 110.221 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.558 HG12 ' HB2' ' A' ' 56' ' ' TYR . 52.0 mt -115.46 120.65 65.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.724 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -102.73 105.46 2.75 Favored Glycine 0 N--CA 1.444 -0.779 0 N-CA-C 111.019 -0.833 . . . . 0.0 111.019 174.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.558 HD12 ' HA ' ' A' ' 8' ' ' SER . 76.8 mt -75.91 -24.73 55.6 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 122.716 -0.285 . . . . 0.0 111.509 -176.252 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 162.97 57.1 0.02 OUTLIER Glycine 0 CA--C 1.51 -0.242 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.563 -178.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.414 ' CG ' ' H ' ' A' ' 39' ' ' TYR . 1.5 p-10 -99.3 -87.84 0.35 Allowed 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -175.363 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.621 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 93.9 m-85 -82.36 115.49 21.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.362 0.601 . . . . 0.0 110.951 -177.152 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.3 m -91.55 6.43 5.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.509 -0.768 . . . . 0.0 111.634 -177.04 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.516 ' O ' HG23 ' A' ' 45' ' ' VAL . 13.2 t70 -86.44 120.39 27.73 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.3 -0.409 . . . . 0.0 109.949 179.464 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.529 HD22 ' HB3' ' A' ' 66' ' ' ASP . 51.5 tp -54.01 -45.86 71.62 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.851 -174.525 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -63.39 -39.48 94.62 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.133 0.492 . . . . 0.0 110.609 -178.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 24.2 m -68.64 -30.48 69.2 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.021 178.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 41' ' ' ASP . 83.9 t -61.11 -45.82 97.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 121.099 0.476 . . . . 0.0 110.337 176.198 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -67.27 -38.97 81.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.806 177.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.08 -32.88 73.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.465 176.175 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.37 -34.54 76.25 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.961 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -77.35 -15.2 59.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.17 0.509 . . . . 0.0 110.062 177.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -80.43 -48.19 13.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.502 175.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -69.89 -42.41 73.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.009 0.433 . . . . 0.0 110.79 175.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.556 ' HB2' ' HB2' ' A' ' 55' ' ' PHE . 5.4 m -94.39 97.99 10.58 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.617 176.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -61.22 -26.36 67.69 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.844 -176.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -118.81 88.51 2.94 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 166.128 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.556 ' HB2' ' HB2' ' A' ' 52' ' ' SER . 88.6 t80 -100.31 124.28 45.58 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.829 -177.613 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.558 ' HB2' HG12 ' A' ' 34' ' ' ILE . 54.0 m-85 -117.9 146.76 43.7 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 174.035 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.48 ' HA3' HD22 ' A' ' 71' ' ' LEU . . . -158.62 161.83 32.05 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.248 -0.977 . . . . 0.0 112.119 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -140.23 169.37 16.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.916 0.389 . . . . 0.0 111.014 178.279 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.561 ' HB3' ' HA ' ' A' ' 73' ' ' PHE . 53.4 t-80 -94.4 143.71 26.17 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.062 -175.641 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -90.89 -129.93 4.45 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.951 -0.642 . . . . 0.0 111.874 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -88.46 -68.89 0.74 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.827 0.346 . . . . 0.0 110.764 178.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 66.6 mtt -125.71 102.28 7.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.328 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -118.56 179.22 4.19 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.922 -178.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -72.38 140.52 82.32 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 176.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -57.43 -31.55 91.58 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.945 2.43 . . . . 0.0 112.147 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.529 ' HB3' HD22 ' A' ' 42' ' ' LEU . 5.1 m-20 -63.19 -35.97 82.07 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.922 179.362 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 58.4 t -73.6 -27.18 22.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.399 -178.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.9 ttpm? -61.24 -28.21 69.0 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.04 0.448 . . . . 0.0 110.721 179.216 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -75.08 -13.04 60.45 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.163 -175.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -117.58 -38.03 3.37 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.73 179.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.48 HD22 ' HA3' ' A' ' 57' ' ' GLY . 15.8 mt -107.87 107.79 60.69 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.274 -178.453 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -72.04 158.07 53.14 Favored 'Trans proline' 0 N--CA 1.464 -0.228 0 C-N-CA 122.952 2.435 . . . . 0.0 112.003 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.561 ' HA ' ' HB3' ' A' ' 59' ' ' HIS . 91.4 m-85 -62.17 -33.24 74.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.22 0.533 . . . . 0.0 110.56 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 18.2 m -148.58 132.33 16.96 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.574 178.039 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.7 ttmm -140.0 125.7 19.34 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.356 178.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.418 ' HA ' ' HA2' ' A' ' 85' ' ' GLY . 11.8 t -101.07 122.32 52.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 175.386 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.459 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 68.3 mt -87.7 149.55 24.17 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.28 179.163 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 53.4 tp -121.04 94.05 4.22 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 172.172 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.683 HG12 ' HG2' ' A' ' 80' ' ' GLU . 21.6 t -121.87 116.73 50.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.084 -173.475 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.683 ' HG2' HG12 ' A' ' 79' ' ' VAL . 4.2 mm-40 61.46 21.13 11.79 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.278 179.477 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.91 -0.82 67.42 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.209 -179.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 65.9 t -96.55 128.95 47.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.754 0.311 . . . . 0.0 110.342 178.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.9 p -91.2 119.77 31.56 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.765 177.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.459 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 45.7 mt -118.04 98.74 6.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.504 -176.481 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.418 ' HA2' ' HA ' ' A' ' 76' ' ' VAL . . . -86.22 111.52 3.62 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.062 -178.559 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.561 ' HG2' HD12 ' A' ' 112' ' ' LEU . 49.3 mtm -97.4 119.69 36.38 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 49.0 t -144.0 160.71 40.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.062 0.458 . . . . 0.0 110.773 -176.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 25.8 m-70 -119.19 153.32 35.1 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.837 173.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 155.25 -158.33 28.33 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.427 -0.892 . . . . 0.0 112.357 178.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 49.4 p90 -155.25 175.97 13.17 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -178.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 149.12 169.12 15.37 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.912 178.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.454 ' HB1' ' HD2' ' A' ' 93' ' ' PRO . . . -85.06 164.07 43.08 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 177.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.454 ' HD2' ' HB1' ' A' ' 92' ' ' ALA . 90.7 Cg_exo -46.29 -38.29 20.01 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.209 2.606 . . . . 0.0 113.832 -178.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.814 ' HA ' ' HE3' ' A' ' 97' ' ' LYS . 42.0 p90 -79.71 -40.1 29.71 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 121.102 -0.239 . . . . 0.0 111.175 -179.462 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -66.55 -35.08 79.35 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.01 0.433 . . . . 0.0 110.521 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 30.2 tp -54.64 -47.65 73.25 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.908 -177.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.814 ' HE3' ' HA ' ' A' ' 94' ' ' TRP . 8.9 mtmp? -57.86 -56.65 19.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.641 0.734 . . . . 0.0 110.085 178.311 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.63 -48.7 79.69 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.325 -1.307 . . . . 0.0 112.175 -172.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.541 ' O ' HG23 ' A' ' 103' ' ' VAL . 98.1 mtt180 -67.6 -46.53 72.33 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.525 -174.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.547 HD13 HG21 ' A' ' 111' ' ' ILE . 61.2 mt -67.75 -40.75 84.07 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 -177.355 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.724 HD21 HG21 ' A' ' 127' ' ' VAL . 95.3 mt -75.39 -13.32 60.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.777 0.322 . . . . 0.0 111.048 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -90.15 -22.18 21.86 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 175.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 99' ' ' ARG . 73.6 t -78.21 -50.29 19.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.911 174.757 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -96.62 108.26 20.83 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.63 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -82.75 1.49 38.56 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.9 0.381 . . . . 0.0 110.729 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 11.5 mp0 -84.96 -22.62 29.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.473 176.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 87.5 tttt 56.87 85.96 0.18 Allowed Pre-proline 0 N--CA 1.466 0.364 0 O-C-N 123.85 0.719 . . . . 0.0 110.258 -170.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -71.88 152.72 58.21 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.945 2.43 . . . . 0.0 112.366 -177.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -77.27 -37.55 52.71 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.663 176.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.56 HG21 HG21 ' A' ' 150' ' ' VAL . 71.7 t -127.89 137.38 57.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.18 178.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.547 HG21 HD13 ' A' ' 100' ' ' LEU . 55.2 mt -127.43 133.06 68.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.841 0.353 . . . . 0.0 110.599 176.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.614 HD23 ' HB2' ' A' ' 130' ' ' LEU . 93.3 mt -102.08 122.44 44.13 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.704 177.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.463 ' CZ ' ' HB2' ' A' ' 131' ' ' ASN . 36.0 p90 -128.27 124.27 36.18 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.243 0.544 . . . . 0.0 110.631 177.267 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -105.91 114.78 4.6 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.642 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -165.4 -29.65 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.847 0.356 . . . . 0.0 110.526 -177.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.501 HG22 ' OE1' ' A' ' 118' ' ' GLU . 0.2 OUTLIER -92.42 176.97 6.28 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.398 179.969 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 60.3 m80 -105.58 -38.82 6.3 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.103 0.478 . . . . 0.0 110.609 -177.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.501 ' OE1' HG22 ' A' ' 116' ' ' THR . 1.2 pm0 -96.64 144.6 28.12 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.802 -178.62 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.55 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 4.7 Cg_exo -80.4 144.74 16.33 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 123.126 2.551 . . . . 0.0 112.953 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -160.01 146.14 15.71 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.435 177.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.549 ' HB2' ' HZ ' ' A' ' 152' ' ' PHE . 17.3 t70 -96.24 122.19 38.84 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 175.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.603 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 74.7 p -125.54 142.15 51.66 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.735 0.302 . . . . 0.0 111.343 -176.13 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 14.9 p -150.35 138.82 14.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 176.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -141.53 -72.6 0.33 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.847 0.356 . . . . 0.0 111.1 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -89.13 46.82 1.42 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.916 0.389 . . . . 0.0 110.836 -177.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 79.32 -42.31 2.37 Favored Glycine 0 N--CA 1.452 -0.24 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.295 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.724 HG21 HD21 ' A' ' 101' ' ' LEU . 41.7 t -63.72 131.3 29.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.895 0.379 . . . . 0.0 110.747 178.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.412 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 75.9 ttt180 -94.35 114.11 26.11 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.802 179.677 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.603 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 45.8 m-85 -99.09 125.96 44.72 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -178.027 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.614 ' HB2' HD23 ' A' ' 112' ' ' LEU . 64.5 mt -103.47 120.68 41.31 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.431 0.634 . . . . 0.0 110.695 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.55 ' O ' ' HA ' ' A' ' 119' ' ' PRO . 49.3 t30 -104.35 107.83 58.72 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 114.865 -1.062 . . . . 0.0 109.223 176.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -89.63 165.62 5.16 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.806 2.337 . . . . 0.0 113.188 -177.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -88.88 146.3 19.13 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.986 179.363 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.895 ' HB2' ' HG2' ' A' ' 137' ' ' GLU . 9.2 m -68.93 142.83 54.61 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.618 0.209 . . . . 0.0 110.904 -178.657 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.605 HD12 ' HB2' ' A' ' 10' ' ' SER . 21.0 mt -63.85 -35.26 80.05 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.143 0.497 . . . . 0.0 110.177 -178.613 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.432 ' HB2' ' SD ' ' A' ' 16' ' ' MET . . . -65.09 -24.22 67.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.434 178.76 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.895 ' HG2' ' HB2' ' A' ' 134' ' ' SER . 51.8 mm-40 -79.86 -13.81 59.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.869 0.366 . . . . 0.0 110.48 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 89.03 34.26 9.0 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.745 178.083 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 23.0 t -149.84 150.06 31.4 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.743 0.306 . . . . 0.0 110.313 178.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.424 ' CE1' ' HB3' ' A' ' 155' ' ' LYS . 50.3 p90 -145.55 177.68 8.68 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.662 177.547 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -121.51 132.73 54.87 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.084 0.469 . . . . 0.0 111.672 -176.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 44.8 t -104.09 114.3 43.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 172.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 6.5 tt -94.57 104.97 16.91 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -177.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.524 ' HG2' ' HG2' ' A' ' 3' ' ' ARG . 37.4 mt-10 -95.17 124.85 39.43 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.106 178.458 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 81.6 mt -91.38 98.78 11.9 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.133 0.492 . . . . 0.0 110.05 175.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -86.78 100.94 12.88 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.802 -178.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.71 -68.8 0.29 Allowed Glycine 0 CA--C 1.52 0.399 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.446 -172.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -162.31 26.57 0.24 Allowed Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 177.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -123.94 144.14 49.97 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.415 -0.392 . . . . 0.0 110.285 -175.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.56 HG21 HG21 ' A' ' 110' ' ' VAL . 92.8 t -83.37 111.84 20.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.346 -177.437 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -120.65 93.41 4.03 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 177.333 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' PHE . . . . . 0.549 ' HZ ' ' HB2' ' A' ' 121' ' ' ASP . 17.4 p90 -90.29 132.33 35.6 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.058 0.456 . . . . 0.0 110.538 -178.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -116.96 135.37 53.76 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.579 178.292 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -89.83 131.42 35.78 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.892 0.377 . . . . 0.0 110.666 -178.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.424 ' HB3' ' CE1' ' A' ' 140' ' ' TYR . 10.5 tptt -122.05 154.02 37.84 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.403 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 4.2 p -111.15 152.12 27.38 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.923 0.392 . . . . 0.0 111.319 178.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 94.5 mt . . . . . 0 C--O 1.251 1.139 0 CA-C-O 118.29 -0.862 . . . . 0.0 110.346 -179.275 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 46.3 t . . . . . 0 N--CA 1.479 0.989 0 CA-C-O 120.789 0.328 . . . . 0.0 110.238 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.513 ' HD3' ' CZ ' ' A' ' 4' ' ' PHE . 20.9 ttmm -102.43 129.68 48.99 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.248 177.727 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.414 ' HD3' ' OE2' ' A' ' 144' ' ' GLU . 38.8 mtt180 -117.02 125.58 51.58 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.532 -178.621 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.58 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 64.4 m-85 -102.98 124.14 47.92 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.063 0.459 . . . . 0.0 110.695 177.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 48.5 tp -89.27 136.59 32.94 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 175.335 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.501 HD23 ' HB3' ' A' ' 141' ' ' ALA . 50.3 tp -117.68 103.93 10.51 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.285 0.564 . . . . 0.0 112.077 -177.087 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.528 HG13 ' HA2' ' A' ' 35' ' ' GLY . 23.5 pt -101.33 138.65 24.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 168.667 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.643 ' HA ' ' HB2' ' A' ' 36' ' ' LEU . 20.6 m -127.61 -68.18 0.79 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -164.52 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.465 ' HA ' ' HE1' ' A' ' 88' ' ' HIS . 37.3 t70 -111.44 105.49 14.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.417 0.627 . . . . 0.0 111.099 -176.559 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.822 ' HB3' ' HA ' ' A' ' 38' ' ' ASP . 29.5 t -141.05 155.88 46.1 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.285 -0.87 . . . . 0.0 108.874 174.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.871 ' H ' ' HE2' ' A' ' 16' ' ' MET . 11.5 m80 -141.59 57.11 1.51 Allowed 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -174.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.496 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . 40.7 t -110.19 126.95 27.89 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.236 -174.123 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.496 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 60.1 Cg_endo -105.2 91.87 0.06 OUTLIER 'Cis proline' 0 N--CA 1.45 -1.077 0 C-N-CA 124.011 -1.246 . . . . 0.0 112.874 -7.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 41.7 t -92.19 -63.6 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 175.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 58.7 ttm-85 -144.49 12.7 1.53 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.886 0.851 . . . . 0.0 108.758 173.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.871 ' HE2' ' H ' ' A' ' 11' ' ' HIS . 50.6 ttp -131.74 121.88 24.95 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.527 -177.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -126.11 -0.31 7.14 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.916 -0.583 . . . . 0.0 109.959 178.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.5 p -80.77 63.81 5.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.022 -178.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.43 HD12 HG21 ' A' ' 12' ' ' VAL . 4.2 tt -102.1 111.48 64.35 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.584 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 19' ' ' LEU . 23.5 Cg_endo -62.18 125.63 16.81 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.919 2.413 . . . . 0.0 112.744 -177.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -56.62 -28.83 61.33 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.284 177.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -49.87 -50.4 45.91 Favored 'General case' 0 C--N 1.331 -0.225 0 O-C-N 123.438 0.462 . . . . 0.0 111.846 -175.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.0 tt -66.59 -39.93 85.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.848 0.832 . . . . 0.0 110.252 -177.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.486 ' O ' HD22 ' A' ' 27' ' ' LEU . 35.5 tp -73.97 -3.74 30.99 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.107 -1.406 . . . . 0.0 111.036 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -100.3 -41.39 7.08 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.326 0.584 . . . . 0.0 109.741 172.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 56.9 p -69.43 -14.99 63.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.932 -175.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.516 HD12 ' HB3' ' A' ' 52' ' ' SER . 1.1 pt? -68.46 -9.2 47.21 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.799 0.333 . . . . 0.0 111.118 -176.737 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -65.82 -35.08 79.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.47 175.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -72.06 -23.29 61.34 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.204 0.526 . . . . 0.0 110.393 -178.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.504 ' HD2' ' HA ' ' A' ' 27' ' ' LEU . 86.0 m-85 -96.16 114.25 25.93 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.523 -176.359 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -78.31 -4.17 46.64 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.818 -176.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.58 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -142.19 129.58 3.96 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 173.645 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.453 HG21 ' HB3' ' A' ' 52' ' ' SER . 57.7 t -120.26 142.73 34.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 O-C-N 122.391 -0.476 . . . . 0.0 110.558 -179.498 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 70.1 mt -125.56 131.15 72.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.352 -0.386 . . . . 0.0 109.967 178.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.528 ' HA2' HG13 ' A' ' 7' ' ' ILE . . . -122.21 123.28 5.37 Favored Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 111.421 -0.672 . . . . 0.0 111.421 178.367 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.643 ' HB2' ' HA ' ' A' ' 8' ' ' SER . 87.4 mt -95.16 6.4 49.16 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.792 0.296 . . . . 0.0 111.643 -174.479 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 133.97 87.51 0.29 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.783 -0.723 . . . . 0.0 111.411 178.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.822 ' HA ' ' HB3' ' A' ' 10' ' ' SER . 6.2 m-20 -127.38 -66.52 0.88 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.076 0.465 . . . . 0.0 112.117 -169.646 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.434 ' CE2' ' HG ' ' A' ' 48' ' ' LEU . 80.3 m-85 -94.25 131.55 39.73 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.871 -174.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 12.7 m -110.04 7.15 8.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.159 -178.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.558 ' O ' HG23 ' A' ' 45' ' ' VAL . 15.1 t70 -111.96 129.94 56.02 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.172 179.455 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 49.9 tp -60.33 -49.71 76.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.553 -174.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -55.25 -45.38 76.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.999 0.428 . . . . 0.0 111.065 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.7 m -65.68 -29.52 70.09 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.157 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 41' ' ' ASP . 85.1 t -66.43 -42.62 90.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-O 120.891 0.376 . . . . 0.0 110.497 175.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -67.16 -37.93 80.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.285 0.564 . . . . 0.0 110.23 178.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.81 -34.18 76.24 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.393 174.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.434 ' HG ' ' CE2' ' A' ' 39' ' ' TYR . 2.6 tm? -65.72 -35.67 81.4 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 178.249 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.53 ' HA ' ' HE2' ' A' ' 55' ' ' PHE . 0.3 OUTLIER -63.37 -30.54 71.65 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.651 172.767 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.411 ' HD3' ' HA ' ' A' ' 50' ' ' LYS . 42.9 mmtm -70.12 -39.16 75.63 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 120.869 -0.333 . . . . 0.0 110.805 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.428 ' HB3' HD11 ' A' ' 27' ' ' LEU . 82.5 m-85 -73.57 -67.66 0.57 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.855 0.36 . . . . 0.0 110.636 174.367 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.516 ' HB3' HD12 ' A' ' 27' ' ' LEU . 5.1 p -86.98 96.61 10.33 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 175.743 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -71.58 -7.39 47.41 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.253 -172.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -151.73 100.57 2.69 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.123 0.487 . . . . 0.0 109.972 171.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.53 ' HE2' ' HA ' ' A' ' 49' ' ' GLU . 50.4 p90 -127.99 163.09 25.3 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.863 179.525 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.522 ' HE2' ' HE1' ' A' ' 4' ' ' PHE . 37.2 m-85 -117.9 118.59 32.39 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 174.595 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.567 ' O ' ' HD2' ' A' ' 72' ' ' PRO . . . -106.23 149.31 16.63 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.217 -0.992 . . . . 0.0 112.734 -176.469 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.467 HG21 ' CB ' ' A' ' 86' ' ' MET . 3.5 t -129.53 154.54 40.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 174.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.872 ' HB3' ' HA ' ' A' ' 73' ' ' PHE . 24.4 t-80 -99.24 150.88 21.63 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.7 -176.526 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 1.045 ' HA3' ' HB3' ' A' ' 88' ' ' HIS . . . 169.71 53.99 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.128 177.168 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -171.79 160.84 5.74 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 67.0 mtp -80.0 107.3 12.68 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.147 0.499 . . . . 0.0 109.925 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.403 ' OD2' ' HB ' ' A' ' 67' ' ' VAL . 38.1 p-10 -123.47 -156.24 0.7 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.243 -171.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -108.35 154.21 41.54 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.592 175.067 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -46.73 -44.55 21.72 Favored 'Trans proline' 0 N--CA 1.475 0.407 0 C-N-CA 123.46 2.774 . . . . 0.0 114.089 -176.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -63.24 -26.0 68.59 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.862 0.363 . . . . 0.0 111.842 -176.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.403 ' HB ' ' OD2' ' A' ' 63' ' ' ASP . 51.7 t -79.6 -32.18 14.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.777 -176.183 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -62.6 -20.84 65.14 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.412 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -73.47 -47.76 38.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.115 0.484 . . . . 0.0 110.945 178.054 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -85.05 -21.72 29.28 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.426 -173.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.57 ' O ' ' HB2' ' A' ' 59' ' ' HIS . 3.6 mm? -110.99 94.36 20.32 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.48 173.462 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.567 ' HD2' ' O ' ' A' ' 57' ' ' GLY . 26.8 Cg_exo -62.62 138.1 67.94 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.825 2.35 . . . . 0.0 111.85 179.094 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.872 ' HA ' ' HB3' ' A' ' 59' ' ' HIS . 40.4 p90 -52.46 -33.04 42.6 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.307 0.379 . . . . 0.0 111.869 -175.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.5 m -155.14 145.65 22.14 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 175.15 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.4 tttm -144.21 150.24 37.66 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -177.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.5 t -127.34 118.31 49.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 176.06 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 83.0 mt -90.93 147.89 22.82 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.256 178.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 24.9 tp -115.93 95.42 5.1 Favored 'General case' 0 C--N 1.315 -0.935 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 175.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 47.0 t -99.29 93.99 3.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.211 -177.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 64.17 18.24 11.14 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.662 178.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 114.41 -20.91 15.46 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.97 -177.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.547 ' HA ' ' OE1' ' A' ' 109' ' ' GLN . 55.0 t -76.48 114.91 17.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.822 0.344 . . . . 0.0 110.329 177.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.409 ' HB ' ' HB3' ' A' ' 108' ' ' PRO . 0.9 OUTLIER -83.04 125.65 31.69 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.261 178.931 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.8 mt -117.76 94.91 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.582 -179.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.498 ' O ' ' HA ' ' A' ' 111' ' ' ILE . . . -81.87 126.22 7.31 Favored Glycine 0 N--CA 1.442 -0.939 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.012 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.467 ' CB ' HG21 ' A' ' 58' ' ' VAL . 44.0 mtm -126.14 129.8 49.77 Favored 'General case' 0 C--N 1.313 -0.979 0 O-C-N 122.69 -0.3 . . . . 0.0 110.823 -175.077 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 48.5 t -159.57 116.69 2.64 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.652 179.04 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 1.045 ' HB3' ' HA3' ' A' ' 60' ' ' GLY . 3.3 t-160 -84.6 85.16 7.46 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 -177.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -133.59 165.73 24.08 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.094 -177.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 26.2 m-90 -122.28 -174.21 2.85 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.84 0.353 . . . . 0.0 110.897 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 127.01 -163.05 21.03 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 -176.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.443 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . . . -79.17 124.25 84.52 Favored Pre-proline 0 C--N 1.322 -0.599 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 177.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 92' ' ' ALA . 49.2 Cg_exo -55.22 -30.6 72.33 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.053 2.502 . . . . 0.0 112.967 -175.29 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.408 ' CD1' ' HB1' ' A' ' 92' ' ' ALA . 0.1 OUTLIER -70.94 -54.29 11.88 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.215 -179.467 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -69.94 -29.14 66.22 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.943 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.446 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 35.0 tp -59.68 -45.84 90.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.036 -177.198 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.63 ' HD3' ' HB3' ' A' ' 124' ' ' LYS . 79.2 mttt -59.15 -49.3 78.38 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.657 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.13 -27.84 66.8 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.216 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -74.02 -42.34 60.48 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.498 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 95.4 mt -66.64 -29.91 70.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.925 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.451 HD21 HG21 ' A' ' 127' ' ' VAL . 84.0 mt -69.22 -15.43 63.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.813 0.34 . . . . 0.0 111.087 176.253 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -101.27 -2.39 31.27 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.369 0.604 . . . . 0.0 110.119 177.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 64.5 t -92.47 -44.06 13.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 169.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -106.62 90.11 3.23 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.445 172.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -69.17 -15.84 63.49 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.194 -177.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -73.16 -21.85 60.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.14 175.039 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.424 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 94.2 mttt 63.81 99.09 0.04 OUTLIER Pre-proline 0 N--CA 1.465 0.305 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.127 175.128 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 107' ' ' LYS . 4.8 Cg_exo -79.6 163.02 24.34 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 123.546 2.83 . . . . 0.0 112.759 -177.601 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.547 ' OE1' ' HA ' ' A' ' 82' ' ' VAL . 91.1 mt-30 -79.52 -41.6 27.0 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.158 176.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 54.9 t -123.85 140.29 47.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.196 -178.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.498 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 54.9 mt -130.72 130.83 64.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.129 0.49 . . . . 0.0 110.791 176.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 94.0 mt -114.25 135.05 54.48 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.342 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.43 ' CE2' ' HB3' ' A' ' 129' ' ' PHE . 28.6 p90 -151.38 159.11 44.42 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.884 176.426 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -105.91 114.79 4.61 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 173.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -122.61 -82.79 0.65 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.758 0.313 . . . . 0.0 110.808 -172.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 10.8 p -101.57 160.57 14.33 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 177.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.433 ' HB3' ' OE2' ' A' ' 137' ' ' GLU . 34.6 m170 -87.39 71.69 9.87 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.381 0.61 . . . . 0.0 110.902 -177.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -171.47 130.12 0.72 Allowed Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 114.622 -1.172 . . . . 0.0 108.62 176.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.491 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 34.7 Cg_exo -58.71 107.41 0.34 Allowed 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.426 2.084 . . . . 0.0 111.731 178.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.515 ' HG2' HG23 ' A' ' 122' ' ' THR . 43.6 tt0 -121.49 128.07 51.7 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.203 -174.113 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.469 ' HA ' HD23 ' A' ' 130' ' ' LEU . 11.2 t70 -104.41 125.13 50.34 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 175.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.584 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 33.3 p -135.64 154.54 51.28 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.544 0.688 . . . . 0.0 112.431 -175.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 10.0 p -145.09 162.95 13.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.647 175.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.63 ' HB3' ' HD3' ' A' ' 97' ' ' LYS . 64.8 tttm -176.94 -59.85 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.529 0.68 . . . . 0.0 109.82 -179.272 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.426 ' C ' ' H ' ' A' ' 127' ' ' VAL . . . -95.55 30.58 2.24 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.029 -175.321 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 78.55 -33.36 1.84 Allowed Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 121.039 -0.601 . . . . 0.0 111.701 -174.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.451 HG21 HD21 ' A' ' 101' ' ' LEU . 28.7 t -70.88 141.86 16.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 122.978 0.511 . . . . 0.0 110.301 176.592 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -95.49 125.52 40.15 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 177.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.584 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 75.9 m-85 -112.43 128.26 56.26 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -177.173 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.469 HD23 ' HA ' ' A' ' 121' ' ' ASP . 60.3 mt -120.37 132.45 55.28 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.107 0.479 . . . . 0.0 111.604 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.496 ' HB3' ' HB3' ' A' ' 120' ' ' GLU . 25.0 t30 -117.8 105.34 47.76 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.837 176.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.491 ' HG2' ' OG ' ' A' ' 8' ' ' SER . 5.9 Cg_exo -82.36 -172.25 1.38 Allowed 'Trans proline' 0 CA--C 1.531 0.326 0 C-N-CA 123.45 2.767 . . . . 0.0 112.692 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -100.43 -174.12 29.81 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.125 -179.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.623 ' OG ' ' HB2' ' A' ' 137' ' ' GLU . 28.9 p -95.9 160.27 14.56 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 122.605 -0.35 . . . . 0.0 110.951 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 35.7 mt -64.7 -45.58 86.0 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -176.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -75.45 1.69 13.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.316 0.579 . . . . 0.0 111.198 -178.415 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.623 ' HB2' ' OG ' ' A' ' 134' ' ' SER . 10.5 tt0 -95.89 -15.96 22.09 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.711 -178.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.536 ' HA2' ' HB2' ' A' ' 157' ' ' LEU . . . 72.64 43.0 45.31 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.538 179.137 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.8 m -149.17 98.26 2.79 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 176.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.458 ' O ' HD12 ' A' ' 154' ' ' LEU . 27.5 p90 -116.66 164.15 15.05 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.914 -0.315 . . . . 0.0 110.155 -178.324 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.501 ' HB3' HD23 ' A' ' 6' ' ' LEU . . . -114.45 150.77 34.24 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.11 0.481 . . . . 0.0 110.803 -174.179 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.5 HG12 ' HG3' ' A' ' 144' ' ' GLU . 67.1 t -125.74 134.55 66.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.605 177.345 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.7 HD21 HG13 ' A' ' 150' ' ' VAL . 4.5 tt -122.9 103.89 8.91 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.157 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.5 ' HG3' HG12 ' A' ' 142' ' ' VAL . 60.8 mt-10 -108.78 148.26 30.8 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 120.918 0.389 . . . . 0.0 110.461 -177.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.435 HD12 ' HB3' ' A' ' 2' ' ' LYS . 67.2 mt -94.16 90.49 6.38 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.247 0.546 . . . . 0.0 109.61 176.726 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.41 ' HB3' ' HD2' ' A' ' 151' ' ' ARG . 33.4 t70 -124.53 126.17 45.4 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.141 -176.139 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.95 11.19 60.39 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.006 -175.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 81.48 -7.59 60.98 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 111.792 -0.523 . . . . 0.0 111.792 -176.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -84.64 158.65 20.78 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 120.917 0.389 . . . . 0.0 110.547 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.7 HG13 HD21 ' A' ' 143' ' ' LEU . 15.6 t -83.79 100.36 7.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.211 176.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.432 ' O ' ' HA ' ' A' ' 143' ' ' LEU . 32.6 ttt180 -92.5 99.78 12.44 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.093 -171.463 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' PHE . . . . . 0.413 ' HA ' ' O ' ' A' ' 142' ' ' VAL . 43.1 m-85 -93.74 107.75 19.59 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.971 177.292 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -110.39 116.38 31.32 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.561 174.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.458 HD12 ' O ' ' A' ' 140' ' ' TYR . 41.5 tp -89.81 123.17 33.55 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 177.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -120.95 148.15 44.48 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.98 0.419 . . . . 0.0 110.876 -177.126 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 13.7 p -105.83 156.97 17.8 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.005 -174.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.536 ' HB2' ' HA2' ' A' ' 138' ' ' GLY . 79.2 mt . . . . . 0 C--O 1.25 1.099 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.747 178.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 N--CA 1.48 1.035 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 46.1 mttp -90.58 112.4 24.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.745 0.307 . . . . 0.0 110.438 177.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.518 ' HB3' ' HD1' ' A' ' 30' ' ' TYR . 88.0 mtt180 -130.57 115.38 16.68 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.87 -178.213 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.662 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 91.7 m-85 -101.64 114.65 28.88 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.223 0.535 . . . . 0.0 110.669 178.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.531 ' HB3' HG22 ' A' ' 33' ' ' VAL . 47.2 tp -89.55 110.65 21.48 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.333 -179.127 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.653 HD11 ' HG ' ' A' ' 36' ' ' LEU . 60.2 tp -96.02 114.91 26.67 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.018 0.437 . . . . 0.0 111.104 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.428 HG22 HD13 ' A' ' 23' ' ' ILE . 26.9 pt -101.03 125.76 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 171.537 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.584 ' HB3' ' HG2' ' A' ' 132' ' ' PRO . 11.1 p -80.6 -94.21 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -168.055 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.46 75.15 1.0 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.984 0.421 . . . . 0.0 111.673 -173.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.2 m -79.95 119.23 22.51 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 173.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 65.0 m-70 -134.33 73.12 1.48 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.516 0.674 . . . . 0.0 109.33 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.499 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . 48.7 t -120.79 131.15 24.55 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.247 -176.446 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.499 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 70.7 Cg_endo -102.25 90.19 0.08 OUTLIER 'Cis proline' 0 N--CA 1.451 -1.001 0 C-N-CA 123.781 -1.341 . . . . 0.0 112.438 -5.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.512 HG12 ' HG2' ' A' ' 15' ' ' ARG . 27.3 t -97.75 -84.94 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.649 -179.172 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.512 ' HG2' HG12 ' A' ' 14' ' ' VAL . 12.6 mmm180 -121.05 -25.59 5.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.178 0.513 . . . . 0.0 110.204 177.597 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.44 ' C ' ' H ' ' A' ' 18' ' ' SER . 51.1 ttp -80.43 -72.92 0.39 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.117 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 70.3 -33.71 0.27 Allowed 'General case' 0 N--CA 1.469 0.516 0 O-C-N 123.872 0.733 . . . . 0.0 112.077 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.44 ' H ' ' C ' ' A' ' 16' ' ' MET . 29.7 p -75.15 81.84 2.31 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.087 0.47 . . . . 0.0 111.572 -178.66 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.433 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 8.0 tt -107.55 110.68 62.9 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 173.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.603 ' CG ' HD13 ' A' ' 157' ' ' LEU . 19.6 Cg_endo -59.13 142.24 99.04 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 123.152 2.568 . . . . 0.0 112.936 -176.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -71.73 -20.83 61.85 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.109 -173.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -57.17 -46.72 82.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.432 -177.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.428 HD13 HG22 ' A' ' 7' ' ' ILE . 3.5 tt -71.2 -32.14 46.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.466 0.65 . . . . 0.0 110.293 -177.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.468 ' O ' HD23 ' A' ' 27' ' ' LEU . 58.4 tp -72.84 -25.14 61.01 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.69 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -81.47 -29.33 33.76 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.476 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.4 p -83.51 8.82 12.85 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -174.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.597 HD12 ' HB2' ' A' ' 52' ' ' SER . 3.2 mm? -56.31 -27.8 56.75 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.839 0.352 . . . . 0.0 111.494 176.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -78.14 -24.31 47.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.367 -177.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -92.85 -3.74 54.12 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.16 0.505 . . . . 0.0 111.177 -172.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.518 ' HD1' ' HB3' ' A' ' 3' ' ' ARG . 99.0 m-85 -123.44 120.22 32.31 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.28 176.251 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -78.8 -29.93 45.15 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.973 -173.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.662 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -120.91 126.62 6.67 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 174.402 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.531 HG22 ' HB3' ' A' ' 5' ' ' LEU . 97.0 t -119.61 134.71 62.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 117.426 0.613 . . . . 0.0 110.603 -179.285 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.517 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 71.2 mt -116.82 131.76 68.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.234 -177.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -125.77 107.41 0.95 Allowed Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.411 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.653 ' HG ' HD11 ' A' ' 6' ' ' LEU . 95.0 mt -74.2 -22.8 59.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.697 0.761 . . . . 0.0 109.385 176.154 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -152.39 125.06 1.74 Allowed Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 174.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -119.72 -169.57 1.79 Allowed 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -174.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -65.33 145.39 56.26 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.297 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 19.9 m -84.41 27.26 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.12 0.486 . . . . 0.0 111.672 -171.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -146.3 139.35 25.66 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 121.029 0.442 . . . . 0.0 110.389 177.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.741 ' HB2' ' HB3' ' A' ' 66' ' ' ASP . 43.4 tp -66.34 -28.9 69.02 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.519 -173.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.47 -35.63 78.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.175 0.512 . . . . 0.0 110.482 -177.099 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.2 m -83.24 -30.84 27.36 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.341 -178.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 98.2 t -58.43 -42.54 84.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.039 0.447 . . . . 0.0 110.285 174.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.413 HD13 ' O ' ' A' ' 42' ' ' LEU . 1.7 mp -68.85 -35.72 70.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.202 177.639 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -61.25 -37.8 84.41 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.914 175.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 46.8 mt -80.11 -33.33 38.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.732 0.301 . . . . 0.0 110.684 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -65.32 -21.6 66.73 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.129 174.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -81.41 -36.17 29.82 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.043 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.444 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . 39.2 m-85 -75.16 -62.58 1.51 Allowed 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.057 174.059 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.597 ' HB2' HD12 ' A' ' 27' ' ' LEU . 33.4 t -90.8 98.71 11.94 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 173.36 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 42.7 mttm -78.05 15.18 0.95 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.767 -178.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -146.95 77.58 1.46 Allowed 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 168.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -101.82 123.5 45.88 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.532 -175.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.543 ' HE2' ' HE1' ' A' ' 4' ' ' PHE . 26.5 m-85 -104.41 107.9 19.05 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 175.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.826 ' HA3' HD22 ' A' ' 71' ' ' LEU . . . -116.64 156.49 15.59 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.1 -1.047 . . . . 0.0 112.708 -176.391 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 15.0 t -128.08 146.08 34.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 177.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 56.8 t60 -94.57 104.53 16.48 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.459 0.647 . . . . 0.0 109.458 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.61 ' HA3' ' HB2' ' A' ' 88' ' ' HIS . . . -135.38 23.15 3.48 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.966 177.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -121.72 -176.07 3.24 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 51.2 mtp -98.91 36.19 1.73 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.393 0.616 . . . . 0.0 109.36 173.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.436 ' OD2' ' HB ' ' A' ' 67' ' ' VAL . 3.8 p-10 -68.62 156.11 38.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.419 178.342 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.502 ' HB3' ' HD2' ' A' ' 65' ' ' PRO . 89.5 m-85 -70.05 162.97 65.38 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.239 -175.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.528 ' HA ' ' HB3' ' A' ' 68' ' ' LYS . 9.9 Cg_endo -51.91 -23.92 17.65 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.173 2.582 . . . . 0.0 112.602 177.401 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.741 ' HB3' ' HB2' ' A' ' 42' ' ' LEU . 5.9 m-20 -54.83 -50.31 68.92 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.251 0.548 . . . . 0.0 110.412 175.281 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.436 ' HB ' ' OD2' ' A' ' 63' ' ' ASP . 29.1 t -77.94 -34.44 19.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.057 -178.232 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.528 ' HB3' ' HA ' ' A' ' 65' ' ' PRO . 57.8 tttm -62.72 -24.4 67.66 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.105 177.23 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -64.48 -41.09 96.69 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.262 0.553 . . . . 0.0 109.59 175.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -83.42 -38.61 21.69 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.11 -178.381 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.826 HD22 ' HA3' ' A' ' 57' ' ' GLY . 14.8 mt -114.13 120.7 38.05 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.07 -173.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.5 ' HG2' ' HB2' ' A' ' 75' ' ' LYS . 72.6 Cg_endo -79.79 157.76 24.46 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.793 2.329 . . . . 0.0 111.426 175.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -60.03 -34.78 73.85 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.906 0.384 . . . . 0.0 111.061 -177.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 17.3 m -142.8 137.55 29.76 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 174.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.5 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 43.0 tttp -136.24 126.28 26.1 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.549 0.214 . . . . 0.0 110.627 -176.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 26.8 t -103.18 125.07 57.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.787 0.327 . . . . 0.0 110.29 177.103 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.544 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 89.9 mt -100.43 159.72 14.92 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.784 178.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 46.6 tp -130.78 99.61 5.0 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 175.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.544 HG12 ' HG2' ' A' ' 80' ' ' GLU . 58.2 t -117.04 112.67 40.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.684 -176.004 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.544 ' HG2' HG12 ' A' ' 79' ' ' VAL . 4.5 mm-40 60.06 19.57 8.76 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.57 178.104 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.55 -3.7 50.18 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.333 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.3 t -93.68 128.23 45.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.664 0.269 . . . . 0.0 110.56 178.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 33.9 p -88.49 126.72 35.38 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.605 178.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.544 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 19.6 mt -118.33 95.85 3.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.82 0.343 . . . . 0.0 110.218 -178.347 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -80.23 98.12 1.72 Allowed Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 178.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 32.2 mtm -96.8 120.73 37.68 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.135 0.493 . . . . 0.0 110.999 -175.351 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 26.4 t -139.38 165.19 27.85 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 174.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.61 ' HB2' ' HA3' ' A' ' 60' ' ' GLY . 4.6 t60 -81.51 -21.12 38.85 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 119.669 -0.812 . . . . 0.0 109.667 178.186 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.427 ' HA3' ' HB2' ' A' ' 113' ' ' PHE . . . 82.88 -155.5 33.37 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.53 177.768 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 73.8 t-105 -159.74 -73.2 0.07 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.95 0.405 . . . . 0.0 110.513 -177.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 161.77 -174.21 38.24 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 -178.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 55.17 81.86 0.25 Allowed Pre-proline 0 N--CA 1.463 0.21 0 C-N-CA 122.631 0.372 . . . . 0.0 111.341 -179.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -54.77 -30.75 68.8 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.399 2.733 . . . . 0.0 113.262 -173.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -72.53 -13.62 61.45 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.185 -0.461 . . . . 0.0 112.228 -177.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -121.6 -25.18 5.16 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.189 0.519 . . . . 0.0 110.417 177.017 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 48.2 tp -60.19 -41.29 92.6 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.006 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -58.36 -41.62 85.11 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.159 0.504 . . . . 0.0 109.835 178.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.422 ' O ' ' HG3' ' A' ' 102' ' ' LYS . 9.1 m-20 -69.58 -47.67 62.79 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.058 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.536 ' O ' HG23 ' A' ' 103' ' ' VAL . 19.0 ttm180 -58.71 -46.74 86.66 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.151 -177.03 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.501 HD13 HG21 ' A' ' 111' ' ' ILE . 91.7 mt -66.4 -36.45 82.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.72 0.295 . . . . 0.0 111.287 -179.125 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 93.8 mt -75.12 -11.35 60.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.857 0.36 . . . . 0.0 111.127 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.422 ' HG3' ' O ' ' A' ' 98' ' ' ASP . 96.1 mttt -100.07 -8.87 23.26 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.122 0.487 . . . . 0.0 110.179 175.064 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 99' ' ' ARG . 90.9 t -81.29 -48.07 19.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 170.025 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -101.09 106.71 18.01 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.175 173.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 -57.44 -37.7 73.24 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.804 0.335 . . . . 0.0 111.631 -175.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -96.17 133.83 39.98 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 174.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.468 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 60.1 pttt -71.86 126.66 91.35 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-O 121.148 0.499 . . . . 0.0 111.185 -174.383 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 107' ' ' LYS . 3.7 Cg_exo -81.8 169.48 14.95 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 123.393 2.729 . . . . 0.0 111.473 175.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -87.36 -45.33 10.65 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.112 0.482 . . . . 0.0 109.97 178.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 63.3 t -120.63 136.74 56.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.279 178.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.501 HG21 HD13 ' A' ' 100' ' ' LEU . 59.6 mt -130.02 133.87 63.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.881 0.372 . . . . 0.0 110.386 177.084 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.483 HD23 ' HB2' ' A' ' 130' ' ' LEU . 95.3 mt -109.26 146.36 34.38 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.375 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.427 ' HB2' ' HA3' ' A' ' 89' ' ' GLY . 29.8 p90 -155.69 163.79 39.44 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 174.508 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -147.11 125.48 2.19 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.681 -177.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 36.5 t-80 -177.5 -37.14 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 177.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.3 p -79.86 127.34 32.12 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.522 177.282 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.468 ' O ' ' HD3' ' A' ' 119' ' ' PRO . 24.1 m170 -87.71 7.3 30.75 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.263 0.554 . . . . 0.0 110.206 176.656 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -106.4 91.69 6.1 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.756 171.082 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' A' ' 117' ' ' HIS . 22.5 Cg_exo -63.51 129.51 25.4 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.75 2.3 . . . . 0.0 111.661 -175.621 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -149.26 136.74 20.18 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.968 0.414 . . . . 0.0 111.314 -172.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.453 ' OD1' ' HD2' ' A' ' 128' ' ' ARG . 6.7 t70 -90.44 119.78 31.0 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.482 174.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.49 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 44.3 p -132.66 129.52 38.94 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.108 0.48 . . . . 0.0 112.049 -173.497 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 6.2 p -120.54 105.81 17.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 169.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 50.0 mttp -109.11 -67.34 0.99 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.264 -172.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -92.18 33.0 1.1 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.101 0.476 . . . . 0.0 110.992 -176.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 83.03 -14.92 35.57 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 -175.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 41.8 t -96.23 144.87 9.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.453 ' HD2' ' OD1' ' A' ' 121' ' ' ASP . 6.4 tpp180 -87.24 109.54 19.56 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.391 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.49 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 92.0 m-85 -98.15 121.17 39.75 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 177.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.515 HD13 ' CD1' ' A' ' 152' ' ' PHE . 64.8 mt -121.5 129.66 53.07 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.872 0.367 . . . . 0.0 111.327 -174.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.453 ' HA ' ' HD3' ' A' ' 132' ' ' PRO . 8.5 p30 -131.82 122.31 18.5 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.156 177.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.584 ' HG2' ' HB3' ' A' ' 8' ' ' SER . 87.4 Cg_endo -98.41 168.54 0.66 Allowed 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 123.48 2.787 . . . . 0.0 113.057 178.259 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -80.67 166.57 49.24 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.787 -0.721 . . . . 0.0 111.351 175.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.505 ' HA ' ' OG ' ' A' ' 8' ' ' SER . 39.5 m -90.32 177.39 6.42 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 117.2 0.5 . . . . 0.0 111.181 -177.773 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -73.09 -18.13 61.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.335 -176.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -73.26 -47.4 43.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.759 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.498 ' OE1' ' HB2' ' A' ' 134' ' ' SER . 1.8 mp0 -66.49 -32.13 73.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.148 177.082 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.515 ' HA2' HD12 ' A' ' 157' ' ' LEU . . . 96.58 51.75 1.65 Allowed Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.211 178.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 156' ' ' THR . 23.1 t -145.97 153.89 41.3 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 178.247 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -154.36 167.09 31.13 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.779 177.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.436 ' HB3' ' HB3' ' A' ' 6' ' ' LEU . . . -114.26 135.95 53.5 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.849 0.356 . . . . 0.0 111.041 -174.494 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 79.4 t -121.27 120.55 62.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.169 176.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.78 HD21 HG13 ' A' ' 150' ' ' VAL . 5.5 tt -104.5 103.95 13.73 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 177.369 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -106.39 135.91 47.06 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.876 -178.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.487 ' HA ' ' O ' ' A' ' 149' ' ' GLU . 5.1 mp -112.13 98.7 7.51 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.944 0.402 . . . . 0.0 110.512 178.592 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -101.26 121.54 42.06 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.367 0.603 . . . . 0.0 109.426 178.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 68.09 1.56 20.29 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.835 -175.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 104.57 0.58 43.18 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 121.155 -0.545 . . . . 0.0 112.235 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.487 ' O ' ' HA ' ' A' ' 145' ' ' LEU . 8.7 mm-40 -88.76 132.95 34.4 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.925 0.393 . . . . 0.0 110.511 177.13 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.78 HG13 HD21 ' A' ' 143' ' ' LEU . 98.3 t -80.75 113.97 20.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.021 -178.107 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 11.1 mtm180 -110.54 107.07 16.58 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 176.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' PHE . . . . . 0.515 ' CD1' HD13 ' A' ' 130' ' ' LEU . 84.5 t80 -89.45 96.29 10.64 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 176.258 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -107.24 109.49 21.29 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.414 -174.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 33.9 tp -80.02 118.97 22.23 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.557 177.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -111.03 160.45 16.84 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.055 -178.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 139' ' ' SER . 16.5 p -107.39 165.6 11.27 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.334 176.634 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.603 HD13 ' CG ' ' A' ' 20' ' ' PRO . 39.4 mt . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.422 -0.799 . . . . 0.0 110.011 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 70.1 t . . . . . 0 N--CA 1.479 0.982 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.543 ' HB2' HD12 ' A' ' 145' ' ' LEU . 50.1 mttm -105.33 148.62 26.86 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.958 0.409 . . . . 0.0 110.91 178.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.503 ' HB3' ' HD2' ' A' ' 30' ' ' TYR . 88.9 mtt180 -117.2 133.65 55.73 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.163 -178.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.428 ' HB2' ' HG ' ' A' ' 143' ' ' LEU . 93.8 m-85 -120.29 121.14 38.0 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.866 0.365 . . . . 0.0 110.065 175.147 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.442 ' HB3' HG22 ' A' ' 33' ' ' VAL . 38.7 tp -93.0 121.05 33.94 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.863 -178.15 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.558 HD11 ' HG ' ' A' ' 36' ' ' LEU . 51.7 tp -103.98 120.94 42.11 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.952 0.406 . . . . 0.0 110.508 178.252 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.5 pt -101.33 123.96 54.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 173.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.448 ' HB3' ' HB2' ' A' ' 132' ' ' PRO . 5.9 p -66.0 -79.31 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.578 -169.658 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.794 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 26.9 t70 -148.0 124.13 10.79 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.135 -177.688 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.706 ' HB2' HD12 ' A' ' 19' ' ' LEU . 9.0 p -156.91 88.46 1.04 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.123 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 62.4 m-70 -83.69 85.85 7.22 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.307 -0.406 . . . . 0.0 109.973 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.471 ' O ' HG22 ' A' ' 40' ' ' VAL . 59.9 t -107.7 135.04 19.82 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.026 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -78.23 -62.56 0.03 OUTLIER 'Cis proline' 0 C--N 1.345 0.384 0 C-N-CA 123.75 -1.354 . . . . 0.0 112.571 0.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.767 HG12 ' HG3' ' A' ' 15' ' ' ARG . 19.6 t 52.13 -93.0 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 123.464 0.705 . . . . 0.0 112.031 177.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.767 ' HG3' HG12 ' A' ' 14' ' ' VAL . 97.8 mtt180 -134.01 4.37 3.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.869 0.366 . . . . 0.0 110.564 -175.297 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.607 ' SD ' ' HB2' ' A' ' 136' ' ' ALA . 32.3 ttp -137.77 112.46 8.87 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.511 -176.672 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -116.89 19.69 14.26 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.203 0.525 . . . . 0.0 110.344 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 35.6 p -99.9 29.9 3.97 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.379 -176.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.706 HD12 ' HB2' ' A' ' 10' ' ' SER . 7.1 tt -83.27 116.96 67.08 Favored Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 179.266 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -68.86 118.14 5.47 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 122.45 2.1 . . . . 0.0 112.187 178.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.56 -7.8 5.29 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.442 -177.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -61.12 -36.97 81.15 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.808 0.337 . . . . 0.0 110.796 179.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 11.1 tp -64.75 -39.19 84.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.937 0.875 . . . . 0.0 109.761 178.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 44.4 tp -78.37 -10.25 59.61 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.051 -1.432 . . . . 0.0 110.978 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -100.32 -6.55 25.68 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.106 0.479 . . . . 0.0 110.816 -176.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 68.4 m -121.68 0.5 9.86 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.988 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.446 HD12 HG21 ' A' ' 33' ' ' VAL . 1.4 pt? -72.65 -19.26 61.47 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.065 -174.671 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -72.94 -13.9 61.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.961 -177.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -73.77 -26.08 60.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.114 0.483 . . . . 0.0 110.547 177.163 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.503 ' HD2' ' HB3' ' A' ' 3' ' ' ARG . 85.7 m-85 -83.87 156.95 22.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.211 -173.182 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -86.94 -6.6 58.72 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.01 -178.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -174.52 149.01 10.19 Favored Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.726 177.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.446 HG21 HD12 ' A' ' 27' ' ' LEU . 69.7 t -124.71 135.98 62.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-O 120.976 0.417 . . . . 0.0 110.494 -179.617 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.544 HG12 ' HB2' ' A' ' 56' ' ' TYR . 49.4 mt -113.85 134.44 56.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.769 179.178 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -125.6 117.2 2.85 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.14 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.558 ' HG ' HD11 ' A' ' 6' ' ' LEU . 95.9 mt -95.79 -9.96 30.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.854 0.835 . . . . 0.0 109.246 175.212 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.794 ' HA3' ' HA ' ' A' ' 9' ' ' ASP . . . -151.43 60.93 0.41 Allowed Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.238 178.321 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -73.83 178.85 4.59 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.252 -0.474 . . . . 0.0 111.695 -175.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.531 ' HD1' HD11 ' A' ' 48' ' ' LEU . 71.2 m-85 -63.43 145.62 55.24 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.558 179.386 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.551 ' HB ' ' CD1' ' A' ' 64' ' ' TYR . 18.1 m -83.79 -9.01 11.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.802 -173.392 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.493 ' HB2' ' OG1' ' A' ' 44' ' ' THR . 19.4 m-20 -86.62 120.4 27.89 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.013 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.534 HD22 ' HB3' ' A' ' 66' ' ' ASP . 48.9 tp -53.38 -42.24 66.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.026 0.441 . . . . 0.0 110.432 178.362 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -59.06 -38.7 80.02 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.923 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.51 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 7.6 m -75.74 -28.72 58.62 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.663 -178.451 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 41' ' ' ASP . 65.6 t -62.22 -46.77 95.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.055 0.455 . . . . 0.0 110.159 175.514 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.07 -36.34 77.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.844 176.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -59.64 -35.42 74.35 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.785 175.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.531 HD11 ' HD1' ' A' ' 39' ' ' TYR . 91.1 mt -71.25 -38.34 71.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.407 178.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.701 ' HG2' ' HB3' ' A' ' 55' ' ' PHE . 49.2 mt-10 -69.05 -17.1 63.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.984 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -82.53 -41.31 19.81 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.856 176.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -68.83 -46.47 68.47 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.903 0.382 . . . . 0.0 111.536 178.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 51.1 p -83.38 -14.81 51.96 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.544 -176.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 93.5 mttt 70.4 -54.11 0.64 Allowed 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.509 0.723 . . . . 0.0 110.368 -172.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -123.68 109.57 13.88 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.193 0.521 . . . . 0.0 109.735 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.701 ' HB3' ' HG2' ' A' ' 49' ' ' GLU . 84.1 t80 -111.4 139.25 46.96 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.479 -175.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.544 ' HB2' HG12 ' A' ' 34' ' ' ILE . 93.5 m-85 -119.77 116.49 26.02 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 174.745 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.528 ' HA3' HD13 ' A' ' 71' ' ' LEU . . . -124.91 141.89 13.47 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 119.566 -1.302 . . . . 0.0 113.739 -173.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.428 HG23 ' HE3' ' A' ' 86' ' ' MET . 16.5 t -132.24 123.03 49.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 170.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -94.39 147.06 23.61 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 120.095 -0.642 . . . . 0.0 110.339 -173.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.626 ' HA2' ' HB3' ' A' ' 88' ' ' HIS . . . -80.83 -123.06 0.54 Allowed Glycine 0 C--N 1.331 0.261 0 N-CA-C 114.475 0.55 . . . . 0.0 114.475 -171.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -74.23 -164.12 0.23 Allowed 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 122.419 0.288 . . . . 0.0 111.053 -175.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 46.9 mtm -56.46 113.94 1.81 Allowed 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 120.991 0.424 . . . . 0.0 110.264 178.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -141.09 -160.77 1.12 Allowed 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -175.056 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.551 ' CD1' ' HB ' ' A' ' 40' ' ' VAL . 12.3 m-85 -67.04 125.28 90.68 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 121.113 0.482 . . . . 0.0 111.308 -177.373 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 64' ' ' TYR . 52.7 Cg_exo -56.66 -38.36 95.78 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 123.869 3.046 . . . . 0.0 113.797 -174.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.534 ' HB3' HD22 ' A' ' 42' ' ' LEU . 5.4 m-20 -59.5 -36.54 76.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.099 0.476 . . . . 0.0 111.024 -178.603 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 11.9 t -76.53 -26.08 16.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.261 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -63.51 -31.1 72.16 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.194 0.521 . . . . 0.0 110.264 176.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -86.2 -19.47 29.97 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.095 -178.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 11.7 t60 -91.24 -40.31 11.59 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.09 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.528 HD13 ' HA3' ' A' ' 57' ' ' GLY . 31.1 mt -117.74 136.26 23.61 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.985 179.116 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.411 ' HD2' ' O ' ' A' ' 57' ' ' GLY . 63.9 Cg_endo -74.34 177.29 8.51 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 122.486 2.124 . . . . 0.0 112.525 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -95.98 -12.97 24.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.212 0.529 . . . . 0.0 110.172 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 10.0 p -155.63 124.1 5.93 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.321 175.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 40.5 tttp -131.83 132.59 43.83 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.509 0.195 . . . . 0.0 110.674 -176.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 20.3 t -110.83 121.68 63.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.873 0.368 . . . . 0.0 110.498 179.039 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.462 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 72.3 mt -101.28 158.81 15.77 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.337 178.596 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 59.6 tp -127.0 102.11 6.84 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 175.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.525 HG12 ' HG2' ' A' ' 80' ' ' GLU . 35.6 t -124.01 116.12 46.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.468 -177.224 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.525 ' HG2' HG12 ' A' ' 79' ' ' VAL . 20.2 mm-40 59.78 27.16 16.41 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.477 177.614 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.31 -15.32 63.5 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.195 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 52.4 t -87.41 126.37 41.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.76 0.314 . . . . 0.0 110.189 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 40.9 p -85.93 134.35 33.88 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.181 177.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.462 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 37.0 mt -118.17 94.81 3.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -178.77 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -85.29 95.31 1.97 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.444 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.549 ' HG2' HD12 ' A' ' 112' ' ' LEU . 30.0 mtm -95.98 118.93 33.57 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.953 0.406 . . . . 0.0 110.439 -176.305 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.681 ' O ' ' HA ' ' A' ' 113' ' ' PHE . 52.7 t -140.27 153.69 46.59 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 178.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.626 ' HB3' ' HA2' ' A' ' 60' ' ' GLY . 4.1 p-80 -72.23 1.55 7.46 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.879 -0.329 . . . . 0.0 111.849 176.58 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.35 176.72 50.34 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.494 176.138 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -116.73 -99.5 0.44 Allowed 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.548 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -109.69 -94.71 2.32 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.311 -0.947 . . . . 0.0 113.434 -173.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.436 ' HB1' ' HD2' ' A' ' 93' ' ' PRO . . . -112.7 172.67 3.35 Favored Pre-proline 0 C--N 1.321 -0.656 0 C-N-CA 122.456 0.302 . . . . 0.0 110.622 -172.199 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.436 ' HD2' ' HB1' ' A' ' 92' ' ' ALA . 31.5 Cg_exo -61.24 -11.79 20.64 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.612 2.208 . . . . 0.0 113.061 177.227 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 1.5 m0 -77.51 -54.59 6.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.286 0.565 . . . . 0.0 109.701 -179.401 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.476 ' OD2' ' HD2' ' A' ' 99' ' ' ARG . 7.3 p-10 -82.72 -3.32 56.29 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.703 -177.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 28.0 tp -50.51 -56.34 12.06 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.775 178.196 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.9 ptmm? -66.44 -48.28 70.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.264 -178.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -62.49 -59.07 5.48 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.792 -175.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.528 ' O ' HG23 ' A' ' 103' ' ' VAL . 94.3 mtt180 -69.31 -38.21 78.16 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -171.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.51 HD13 HG21 ' A' ' 111' ' ' ILE . 46.5 mt -70.03 -37.13 75.5 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.386 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.542 HD21 HG21 ' A' ' 127' ' ' VAL . 87.0 mt -79.3 -14.23 59.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.81 0.338 . . . . 0.0 111.117 178.547 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.452 ' HA ' ' OD1' ' A' ' 105' ' ' ASN . 97.0 mttt -90.41 -14.54 32.72 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.634 173.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 99' ' ' ARG . 84.2 t -81.43 -49.08 18.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 167.298 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -100.23 75.22 1.8 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.385 174.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.452 ' OD1' ' HA ' ' A' ' 102' ' ' LYS . 74.3 m-20 -60.75 -28.57 68.81 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.5 -173.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -78.23 -6.54 55.24 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.875 0.369 . . . . 0.0 110.686 -178.199 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.426 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 5.0 tmmm? 64.91 109.09 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.468 0 C-N-CA 123.589 0.755 . . . . 0.0 112.444 174.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 107' ' ' LYS . 8.8 Cg_endo -88.39 178.38 2.97 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.392 2.728 . . . . 0.0 112.102 177.488 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 14.4 mp0 -88.73 -45.83 9.48 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.865 0.364 . . . . 0.0 110.414 176.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.4 t -124.29 133.61 68.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.748 -178.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.51 HG21 HD13 ' A' ' 100' ' ' LEU . 58.9 mt -124.15 127.14 73.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.296 176.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.622 HD23 ' HB2' ' A' ' 130' ' ' LEU . 87.4 mt -101.13 134.38 44.24 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 178.152 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.681 ' HA ' ' O ' ' A' ' 87' ' ' CYS . 24.7 p90 -144.03 142.1 30.48 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.937 0.399 . . . . 0.0 110.593 176.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -105.68 135.99 12.94 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.914 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -147.62 157.34 43.51 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.8 p -80.1 61.88 4.09 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.378 0.609 . . . . 0.0 111.084 178.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -154.81 152.6 30.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.653 -176.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -57.76 145.88 68.73 Favored Pre-proline 0 C--N 1.329 -0.307 0 O-C-N 123.574 0.546 . . . . 0.0 111.096 177.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.18 149.09 74.66 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 123.122 2.548 . . . . 0.0 112.693 -178.158 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -151.84 142.38 22.65 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.495 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -78.52 94.04 4.9 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 176.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.8 p -103.5 135.22 45.5 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.998 -176.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 14.1 p -150.34 121.55 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.083 0.468 . . . . 0.0 110.593 176.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.447 ' HB2' ' HE2' ' A' ' 129' ' ' PHE . 95.9 mttt -142.04 144.41 33.59 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.191 -0.458 . . . . 0.0 109.992 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 62.75 19.09 11.18 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 123.5 0.5 . . . . 0.0 111.636 179.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 86.89 -5.7 84.54 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.054 -178.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.542 HG21 HD21 ' A' ' 101' ' ' LEU . 33.0 t -97.6 129.44 47.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 120.833 0.349 . . . . 0.0 110.141 -178.545 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 38.1 ttm-85 -84.19 122.1 28.38 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.574 178.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.447 ' HE2' ' HB2' ' A' ' 124' ' ' LYS . 82.3 m-85 -103.43 138.97 39.44 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 175.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.622 ' HB2' HD23 ' A' ' 112' ' ' LEU . 95.7 mt -128.18 121.45 29.49 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.91 0.386 . . . . 0.0 111.069 -179.158 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.447 ' HB3' ' CZ ' ' A' ' 113' ' ' PHE . 8.1 p30 -121.57 117.36 30.19 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.95 176.157 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.448 ' HB2' ' HB3' ' A' ' 8' ' ' SER . 33.6 Cg_endo -96.82 147.38 0.97 Allowed 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 123.344 2.696 . . . . 0.0 112.627 176.111 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -69.51 152.97 52.24 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.207 175.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 82.8 p -70.65 175.47 4.88 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.435 0.636 . . . . 0.0 111.938 -173.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.409 ' HB2' ' HB3' ' A' ' 10' ' ' SER . 4.5 mm? -69.77 -25.56 63.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.394 176.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.607 ' HB2' ' SD ' ' A' ' 16' ' ' MET . . . -72.99 -31.72 64.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.27 0.557 . . . . 0.0 110.336 177.37 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -83.34 -20.04 35.05 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.109 177.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 89.08 45.94 4.61 Favored Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.944 175.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 156' ' ' THR . 26.4 t -137.0 149.03 47.23 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.841 0.353 . . . . 0.0 110.393 178.293 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.402 ' CD1' ' HG ' ' A' ' 157' ' ' LEU . 7.5 p90 -147.74 178.0 8.84 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 176.113 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.445 ' HB3' ' HB3' ' A' ' 6' ' ' LEU . . . -132.86 135.26 45.51 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.955 0.407 . . . . 0.0 111.18 -179.183 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 99.3 t -119.7 112.01 35.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.871 175.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.696 ' HA ' ' O ' ' A' ' 151' ' ' ARG . 0.2 OUTLIER -102.85 110.83 22.89 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.6 0.714 . . . . 0.0 110.239 175.513 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -105.18 145.0 31.2 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.687 -178.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.543 HD12 ' HB2' ' A' ' 2' ' ' LYS . 87.4 mt -90.8 90.16 7.8 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.527 0.68 . . . . 0.0 109.952 178.323 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -95.04 113.97 25.73 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.556 -179.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 68.48 -69.24 0.38 Allowed Glycine 0 CA--C 1.524 0.628 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.598 -175.131 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -172.52 25.25 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.959 -0.639 . . . . 0.0 111.749 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -124.11 133.6 53.56 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 120.811 0.339 . . . . 0.0 110.404 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.434 HG22 HD21 ' A' ' 145' ' ' LEU . 9.3 t -81.0 98.39 3.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.293 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.696 ' O ' ' HA ' ' A' ' 143' ' ' LEU . 38.8 mtp85 -101.13 106.39 17.63 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.794 0.33 . . . . 0.0 110.939 -175.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' PHE . . . . . 0.522 ' CE2' HD13 ' A' ' 143' ' ' LEU . 18.0 m-85 -83.56 105.49 14.53 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.467 178.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -96.41 112.06 23.94 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.818 0.342 . . . . 0.0 110.719 178.401 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -72.49 124.42 25.15 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 174.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -133.42 171.27 14.29 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -177.401 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 139' ' ' SER . 15.1 p -120.69 150.55 40.77 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.853 0.358 . . . . 0.0 111.729 -176.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.402 ' HG ' ' CD1' ' A' ' 140' ' ' TYR . 92.1 mt . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.447 175.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 54.9 mttp . . . . . 0 CA--C 1.517 -0.291 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.449 ' HG3' ' CD1' ' A' ' 30' ' ' TYR . 0.2 OUTLIER -145.79 132.49 19.96 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.486 0.66 . . . . 0.0 111.539 -174.137 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.751 ' HE2' HD11 ' A' ' 145' ' ' LEU . 87.0 m-85 -101.66 128.01 48.15 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.306 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.566 HD11 HD11 ' A' ' 23' ' ' ILE . 43.5 tp -91.75 108.06 19.65 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.308 177.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.592 ' HB3' ' HB3' ' A' ' 141' ' ' ALA . 51.0 tp -94.39 118.14 31.17 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.566 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.4 ' CG1' ' HA2' ' A' ' 35' ' ' GLY . 22.4 pt -101.12 115.58 43.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 174.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.8 m -54.94 -69.55 0.13 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.692 -1.14 . . . . 0.0 113.104 -169.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.58 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 26.1 t70 -153.19 105.24 2.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.867 0.365 . . . . 0.0 110.417 -175.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.879 ' H ' ' HA3' ' A' ' 37' ' ' GLY . 5.7 m -110.5 134.45 52.35 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.661 -175.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 13.0 m170 -130.76 86.77 2.41 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 173.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.483 ' O ' HG22 ' A' ' 40' ' ' VAL . 48.0 t -128.96 125.68 22.94 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.456 -175.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -78.97 -48.11 0.28 Allowed 'Cis proline' 0 CA--C 1.532 0.389 0 C-N-CA 122.904 -1.707 . . . . 0.0 112.8 -2.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.433 ' CG2' HG11 ' A' ' 40' ' ' VAL . 37.9 t 51.46 -94.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 123.53 0.732 . . . . 0.0 111.605 -178.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.46 ' HA ' ' HD2' ' A' ' 15' ' ' ARG . 17.5 tpt180 -148.43 22.81 1.04 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.535 0.684 . . . . 0.0 109.391 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.455 ' C ' ' H ' ' A' ' 18' ' ' SER . 53.5 ttp -119.63 -72.42 0.69 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.688 178.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 64.67 -12.94 0.11 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.552 0.741 . . . . 0.0 112.788 178.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.455 ' H ' ' C ' ' A' ' 16' ' ' MET . 11.9 m -83.64 58.03 4.39 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.263 0.554 . . . . 0.0 110.875 -177.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.92 ' HG ' HD11 ' A' ' 135' ' ' LEU . 6.5 tt -107.84 119.04 51.45 Favored Pre-proline 0 C--N 1.321 -0.632 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 177.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 19' ' ' LEU . 18.1 Cg_endo -61.1 111.04 0.97 Allowed 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.286 1.99 . . . . 0.0 111.411 176.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -71.65 -7.08 45.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.415 -174.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -56.42 -43.08 79.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.174 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.566 HD11 HD11 ' A' ' 5' ' ' LEU . 9.7 tt -70.82 -35.84 61.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.515 0.674 . . . . 0.0 110.19 -178.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.725 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 59.4 tp -63.0 -32.0 73.27 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.454 177.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -75.27 -19.39 59.74 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.704 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 64.0 m -93.11 12.21 25.03 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.152 -174.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.725 ' HG ' ' O ' ' A' ' 24' ' ' LEU . 9.9 mt -63.96 -19.1 64.9 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.979 0.419 . . . . 0.0 110.349 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -52.88 -36.06 58.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.999 176.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -94.11 3.48 55.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.332 -174.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.472 ' CD1' ' HB2' ' A' ' 5' ' ' LEU . 90.6 m-85 -118.38 106.67 12.98 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.181 0.515 . . . . 0.0 110.341 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -75.62 4.92 6.77 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.873 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.577 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -163.74 109.49 0.38 Allowed Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 175.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 90.8 t -100.08 126.52 53.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 O-C-N 122.458 -0.436 . . . . 0.0 110.119 178.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 51.4 mt -105.33 123.51 59.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 120.87 0.366 . . . . 0.0 110.158 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.4 ' HA2' ' CG1' ' A' ' 7' ' ' ILE . . . -114.64 103.06 1.23 Allowed Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 120.512 -0.852 . . . . 0.0 112.648 -177.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.493 HD21 ' HB3' ' A' ' 86' ' ' MET . 70.9 mt -85.3 -30.95 23.33 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 172.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.879 ' HA3' ' H ' ' A' ' 10' ' ' SER . . . -112.1 123.1 6.21 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 171.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -99.88 164.77 11.87 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.551 0.691 . . . . 0.0 112.754 -169.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.414 ' CD1' HD21 ' A' ' 48' ' ' LEU . 60.0 m-85 -85.85 127.13 34.5 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 168.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.483 HG22 ' O ' ' A' ' 12' ' ' VAL . 3.8 m -80.96 -9.5 11.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -165.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.502 ' O ' HG23 ' A' ' 45' ' ' VAL . 2.3 m-20 -86.9 125.87 34.3 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 176.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 38.9 tp -60.75 -36.0 77.79 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.369 0.604 . . . . 0.0 109.503 178.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -57.28 -44.95 84.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.227 175.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.492 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 14.9 m -71.98 -25.09 61.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.023 -177.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 41' ' ' ASP . 61.0 t -62.66 -42.71 97.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.075 0.464 . . . . 0.0 110.174 175.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.45 -36.55 77.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-O 121.263 0.554 . . . . 0.0 109.724 175.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.59 -32.97 74.6 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.455 175.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 44' ' ' THR . 89.0 mt -64.46 -43.07 95.38 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 176.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.471 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 29.6 tt0 -69.41 -14.87 63.13 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.02 178.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -85.21 -49.73 7.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.662 178.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.457 ' CB ' HD12 ' A' ' 27' ' ' LEU . 28.3 m-85 -65.29 -57.01 9.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.842 178.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.645 ' HB3' HD13 ' A' ' 27' ' ' LEU . 83.0 p -77.62 -38.65 47.55 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.709 0.29 . . . . 0.0 111.214 -175.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.471 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 53.6 mttp 69.67 7.79 6.41 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.721 -178.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 179.0 111.01 0.03 OUTLIER 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.805 174.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -136.71 152.83 50.8 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.999 0.428 . . . . 0.0 110.682 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.545 ' HE2' ' HE1' ' A' ' 4' ' ' PHE . 40.2 m-85 -118.18 113.79 22.08 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 176.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -116.53 152.51 17.87 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.198 -1.001 . . . . 0.0 112.84 -174.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.635 HG21 ' HB2' ' A' ' 86' ' ' MET . 31.0 t -128.92 113.63 29.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 175.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 14.5 t-80 -94.24 104.18 16.19 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.896 -172.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.437 ' HA3' ' O ' ' A' ' 88' ' ' HIS . . . -132.54 32.16 2.86 Favored Glycine 0 N--CA 1.444 -0.816 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 174.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -101.23 154.85 18.41 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.608 -0.796 . . . . 0.0 109.957 -178.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 94.8 mmm -90.47 39.73 0.99 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.497 -172.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.45 ' HB3' ' H ' ' A' ' 64' ' ' TYR . 8.7 m-20 -118.76 -143.81 0.37 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.702 0.287 . . . . 0.0 111.556 -178.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.453 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 78.7 m-85 -69.86 127.33 92.56 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.114 0.483 . . . . 0.0 111.85 -169.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 64' ' ' TYR . 11.8 Cg_exo -71.1 -14.35 31.83 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.353 2.702 . . . . 0.0 111.995 179.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -60.86 -32.91 72.32 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.459 0.647 . . . . 0.0 110.567 178.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.442 HG12 HD21 ' A' ' 71' ' ' LEU . 47.0 t -73.09 -20.07 18.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.678 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.489 ' HE2' ' HB2' ' A' ' 73' ' ' PHE . 64.5 tttm -72.88 -12.44 60.97 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.676 -174.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -84.15 -10.01 58.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.003 0.43 . . . . 0.0 111.001 177.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 57.4 m-70 -103.36 -28.94 11.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.147 0.498 . . . . 0.0 109.861 177.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.442 HD21 HG12 ' A' ' 67' ' ' VAL . 0.3 OUTLIER -138.99 119.51 9.68 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.671 174.708 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -66.56 177.26 3.47 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 123.167 2.578 . . . . 0.0 112.938 -175.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.489 ' HB2' ' HE2' ' A' ' 68' ' ' LYS . 70.5 t80 -70.26 -29.15 65.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.141 0.496 . . . . 0.0 110.552 -177.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.482 ' HA ' HG13 ' A' ' 58' ' ' VAL . 10.2 p -147.74 142.06 26.27 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.948 178.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 32.1 tttm -142.41 141.08 32.19 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.807 -178.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.539 HG23 ' CE1' ' A' ' 104' ' ' PHE . 56.6 t -114.53 139.28 41.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.896 174.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 58.6 mt -114.45 144.22 43.67 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.17 177.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 54.9 tp -109.52 96.24 6.14 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 175.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 24.0 t -111.68 96.09 4.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.914 -173.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.424 ' OE1' ' HA2' ' A' ' 148' ' ' GLY . 42.6 mt-10 54.13 38.66 29.56 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.132 175.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 107.99 -31.57 7.83 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.343 177.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 60.2 t -81.66 115.1 23.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.005 0.431 . . . . 0.0 110.937 -177.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.07 105.64 14.22 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.071 176.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.427 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 15.8 mt -94.8 106.85 18.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.625 -177.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.536 ' HA2' HG22 ' A' ' 76' ' ' VAL . . . -93.09 110.19 3.91 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 176.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.635 ' HB2' HG21 ' A' ' 58' ' ' VAL . 43.5 mtm -107.99 129.71 55.1 Favored 'General case' 0 C--N 1.317 -0.834 0 O-C-N 122.419 -0.46 . . . . 0.0 110.822 -174.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 79.0 m -149.34 116.9 6.17 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.534 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.437 ' O ' ' HA3' ' A' ' 60' ' ' GLY . 41.8 t-80 -97.07 127.88 43.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.233 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 169.32 -125.53 1.27 Allowed Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.395 178.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 29.2 p90 -153.71 165.89 34.56 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.676 0.274 . . . . 0.0 110.488 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 171.61 148.21 6.01 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.877 177.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -76.43 155.36 83.84 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 176.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_exo -51.76 -33.56 50.68 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.67 2.247 . . . . 0.0 112.542 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -76.38 -53.97 7.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.926 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -62.68 -37.68 87.38 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.022 -176.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 30.5 tp -51.42 -60.71 2.83 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 122.705 0.402 . . . . 0.0 112.0 -171.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -60.68 -41.46 95.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.44 -176.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -73.81 -39.52 64.04 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.992 0.425 . . . . 0.0 111.325 -176.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.412 ' O ' HG23 ' A' ' 103' ' ' VAL . 74.5 ttt180 -68.36 -40.96 81.29 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.827 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.551 HD13 HG21 ' A' ' 111' ' ' ILE . 89.5 mt -70.23 -32.6 70.53 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.027 -178.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 96.8 mt -78.21 -11.55 59.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.332 0.587 . . . . 0.0 110.221 175.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -86.21 -47.54 9.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.942 173.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 99' ' ' ARG . 89.0 t -63.21 -46.25 96.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.087 177.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.539 ' CE1' HG23 ' A' ' 76' ' ' VAL . 25.6 m-85 -101.61 102.63 13.37 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.227 176.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -59.8 -36.06 75.97 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.584 -177.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -100.97 125.86 47.58 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 172.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.502 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 0.0 OUTLIER -60.78 126.7 85.97 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.779 -173.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.502 ' HD3' ' HA ' ' A' ' 107' ' ' LYS . 5.4 Cg_exo -75.13 150.18 37.23 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.696 2.264 . . . . 0.0 110.558 173.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -75.54 -48.9 20.44 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.338 0.59 . . . . 0.0 109.66 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 66.0 t -126.68 131.1 71.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.549 178.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.551 HG21 HD13 ' A' ' 100' ' ' LEU . 57.5 mt -114.82 134.25 58.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 120.686 0.279 . . . . 0.0 110.94 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.599 HD23 ' HB2' ' A' ' 130' ' ' LEU . 82.8 mt -105.04 118.52 36.73 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.243 177.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.431 ' CE1' ' HB3' ' A' ' 129' ' ' PHE . 16.9 p90 -133.91 127.47 32.55 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.094 0.473 . . . . 0.0 110.054 177.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -106.11 126.78 8.67 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.777 -0.725 . . . . 0.0 111.805 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 21.6 t60 -172.42 -44.42 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.27 0.557 . . . . 0.0 109.772 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.7 t -92.68 142.11 27.73 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.529 175.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 1.02 ' HA ' ' HA2' ' A' ' 133' ' ' GLY . 23.3 p-80 -97.87 4.66 49.6 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.044 0.45 . . . . 0.0 110.762 -178.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -108.19 106.41 58.54 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.441 174.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.27 127.19 13.85 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.961 2.441 . . . . 0.0 112.603 -174.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -142.27 139.87 32.04 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.361 173.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -78.28 103.91 8.52 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 175.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.532 ' HB ' ' HE2' ' A' ' 124' ' ' LYS . 60.8 p -111.91 121.42 45.0 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.597 -172.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.8 p -106.94 110.31 31.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.294 0.568 . . . . 0.0 110.244 176.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.532 ' HE2' ' HB ' ' A' ' 122' ' ' THR . 72.5 mmtt -123.9 127.36 47.88 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.805 -178.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 65.6 13.14 8.73 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 123.465 0.478 . . . . 0.0 111.773 177.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 94.31 4.46 62.64 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.511 -178.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 43.3 t -106.44 140.26 25.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 177.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -94.0 113.41 25.39 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.86 0.362 . . . . 0.0 110.249 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.513 ' CE1' ' HB2' ' A' ' 124' ' ' LYS . 76.9 m-85 -103.03 124.69 49.0 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.259 -178.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.599 ' HB2' HD23 ' A' ' 112' ' ' LEU . 83.5 mt -108.87 130.86 55.43 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.737 176.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -122.84 111.51 31.0 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.195 -176.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -82.28 152.7 16.04 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.737 2.291 . . . . 0.0 111.568 173.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 1.02 ' HA2' ' HA ' ' A' ' 117' ' ' HIS . . . -67.49 -129.01 0.03 OUTLIER Glycine 0 CA--C 1.524 0.619 0 O-C-N 123.506 0.504 . . . . 0.0 114.138 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 7.9 m -128.44 179.61 5.55 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 122.224 -0.574 . . . . 0.0 111.159 -176.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.92 HD11 ' HG ' ' A' ' 19' ' ' LEU . 1.1 tm? -73.22 -69.3 0.43 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.7 -179.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -75.0 13.2 0.71 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.606 -171.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -107.69 6.97 28.22 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.921 0.391 . . . . 0.0 110.512 177.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 69.47 42.37 73.62 Favored Glycine 0 C--N 1.332 0.346 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.981 174.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 13.0 p -132.98 99.17 4.5 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.901 0.382 . . . . 0.0 111.272 -178.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -113.51 155.5 25.24 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 174.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.592 ' HB3' ' HB3' ' A' ' 6' ' ' LEU . . . -114.49 128.39 56.31 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.115 0.483 . . . . 0.0 111.03 -176.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 40.2 t -111.46 117.48 55.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.6 175.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.749 HD23 ' HA ' ' A' ' 152' ' ' PHE . 57.7 mt -96.67 113.64 25.22 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.077 177.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -108.04 130.55 55.07 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.735 -176.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.751 HD11 ' HE2' ' A' ' 4' ' ' PHE . 74.0 mt -99.14 116.44 31.35 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.028 -177.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.473 ' HB3' ' NH1' ' A' ' 151' ' ' ARG . 27.3 t70 -146.83 130.78 17.19 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.693 177.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.85 11.31 60.35 Favored Glycine 0 CA--C 1.521 0.445 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.974 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.424 ' HA2' ' OE1' ' A' ' 80' ' ' GLU . . . 84.12 30.89 27.16 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.318 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -126.99 135.14 50.44 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.718 0.295 . . . . 0.0 110.817 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 44.3 t -84.38 108.31 16.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 174.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.473 ' NH1' ' HB3' ' A' ' 146' ' ' ASP . 96.5 mtt180 -106.18 120.62 42.3 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.053 0.454 . . . . 0.0 111.011 -174.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . 0.749 ' HA ' HD23 ' A' ' 143' ' ' LEU . 74.0 t80 -92.62 112.89 25.0 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.216 -173.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -122.04 103.8 9.06 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.852 0.358 . . . . 0.0 110.588 173.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 20.2 tp -79.0 100.38 7.29 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 174.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -93.9 138.02 32.49 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.499 -173.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 34.9 p -94.03 150.57 20.22 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.352 -174.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 10.1 mp . . . . . 0 C--O 1.245 0.866 0 CA-C-O 118.62 -0.705 . . . . 0.0 109.49 175.725 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 61.6 mttm . . . . . 0 CA--C 1.518 -0.28 0 CA-C-O 120.752 0.31 . . . . 0.0 110.576 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 89.2 mtt-85 -123.41 132.53 53.99 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.218 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.408 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 74.2 m-85 -118.06 128.06 54.39 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.846 174.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.557 ' HB3' HG22 ' A' ' 33' ' ' VAL . 33.9 tp -89.57 134.23 34.22 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.789 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.408 ' HB3' ' HB3' ' A' ' 141' ' ' ALA . 50.3 tp -119.32 109.16 15.48 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.193 0.521 . . . . 0.0 111.314 -178.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.417 HG13 ' HA2' ' A' ' 35' ' ' GLY . 17.4 pt -102.24 112.39 35.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 172.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.426 ' HB2' ' H ' ' A' ' 9' ' ' ASP . 1.1 m -76.05 -90.17 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -166.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.426 ' H ' ' HB2' ' A' ' 8' ' ' SER . 24.3 t70 -108.54 110.83 22.4 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.611 -173.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.795 ' HB3' ' HA ' ' A' ' 38' ' ' ASP . 42.2 t -123.9 134.08 53.61 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 121.477 0.656 . . . . 0.0 110.215 178.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 26.6 m170 -125.55 38.22 4.21 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.583 HG21 HD12 ' A' ' 19' ' ' LEU . 61.3 t -94.11 138.13 22.69 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.927 -175.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.444 ' HA ' HG13 ' A' ' 12' ' ' VAL . 5.3 Cg_exo -80.27 -60.64 0.04 OUTLIER 'Cis proline' 0 C--N 1.345 0.365 0 C-N-CA 123.526 -1.447 . . . . 0.0 112.072 -3.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 26.4 t 54.16 -86.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 O-C-N 123.882 0.739 . . . . 0.0 111.462 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 29.2 ttt180 -144.73 12.74 1.48 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.163 0.506 . . . . 0.0 109.915 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 43.0 ttp -131.39 105.1 7.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.797 -176.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -97.31 13.25 30.2 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.017 0.437 . . . . 0.0 110.854 177.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.9 m -81.95 40.68 0.62 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.864 -175.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.759 ' HG ' HD13 ' A' ' 135' ' ' LEU . 3.6 tt -107.75 104.3 52.57 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 174.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -61.88 124.57 14.75 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 123.036 2.491 . . . . 0.0 112.564 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -71.93 -8.03 52.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.753 -176.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -61.04 -49.59 76.74 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.253 -177.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.482 HD11 HD11 ' A' ' 5' ' ' LEU . 6.9 tt -71.93 -31.58 41.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.714 0.769 . . . . 0.0 110.085 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.494 ' HA ' HD23 ' A' ' 27' ' ' LEU . 59.1 tp -56.9 -33.09 66.58 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.182 -1.372 . . . . 0.0 110.915 178.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -74.27 -36.45 63.82 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.676 178.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.6 m -76.53 7.75 4.19 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.875 -175.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.908 HD12 ' HB3' ' A' ' 52' ' ' SER . 1.4 mm? -53.68 -33.66 56.12 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.008 0.432 . . . . 0.0 111.579 176.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 28.2 mttp -87.21 7.51 28.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.487 -170.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -95.6 -18.94 20.16 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -176.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -105.63 156.15 18.54 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.926 0.393 . . . . 0.0 111.806 -170.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -60.96 -54.5 44.29 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.854 177.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -143.51 151.57 23.41 Favored Glycine 0 N--CA 1.44 -1.068 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.993 178.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.621 HG21 HD13 ' A' ' 27' ' ' LEU . 99.3 t -122.58 136.4 59.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-O 120.731 0.3 . . . . 0.0 110.216 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.555 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 45.9 mt -107.98 120.97 60.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.376 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.417 ' HA2' HG13 ' A' ' 7' ' ' ILE . . . -108.13 111.14 3.28 Favored Glycine 0 N--CA 1.442 -0.945 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 176.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.522 ' HA ' HG23 ' A' ' 58' ' ' VAL . 81.5 mt -85.91 27.59 0.87 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.903 0.382 . . . . 0.0 110.175 -178.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 117.74 81.91 0.84 Allowed Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -174.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.795 ' HA ' ' HB3' ' A' ' 10' ' ' SER . 3.2 p-10 -96.6 -95.11 0.2 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -173.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.429 ' H ' ' CG ' ' A' ' 38' ' ' ASP . 79.9 m-85 -95.4 138.17 33.45 Favored 'General case' 0 C--N 1.318 -0.792 0 O-C-N 121.897 -0.502 . . . . 0.0 110.313 -178.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.7 m -79.05 -9.88 12.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.364 0.602 . . . . 0.0 109.906 178.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.536 ' O ' HG23 ' A' ' 45' ' ' VAL . 43.0 m-20 -86.59 121.68 29.45 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.598 177.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.51 ' O ' HD13 ' A' ' 46' ' ' ILE . 47.1 tp -57.45 -43.1 83.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.416 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -52.22 -45.02 65.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.561 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.1 m -78.55 -27.45 45.88 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.278 -175.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 41' ' ' ASP . 94.6 t -61.77 -44.43 98.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.174 0.511 . . . . 0.0 109.742 174.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.51 HD13 ' O ' ' A' ' 42' ' ' LEU . 1.7 mp -65.02 -36.58 78.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.7 176.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.36 -37.57 83.8 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.674 175.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 22.9 mt -73.85 -37.09 64.92 Favored 'General case' 0 CA--C 1.514 -0.426 0 C-N-CA 120.434 -0.507 . . . . 0.0 110.158 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.486 ' HA ' ' HB2' ' A' ' 55' ' ' PHE . 32.9 tt0 -63.64 -26.36 68.64 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.824 175.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -84.03 -49.65 8.73 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.513 178.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.524 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . 4.7 m-85 -54.62 -55.61 27.72 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 177.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.908 ' HB3' HD12 ' A' ' 27' ' ' LEU . 78.7 p -77.59 -20.25 54.3 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 52' ' ' SER . 96.5 mttt 72.97 -56.5 0.66 Allowed 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.638 0.775 . . . . 0.0 110.529 -173.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -106.63 90.55 3.36 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.859 177.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.486 ' HB2' ' HA ' ' A' ' 49' ' ' GLU . 58.4 t80 -106.04 117.03 32.97 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.476 -178.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.555 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 87.7 m-85 -108.13 108.07 18.98 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 176.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -125.15 164.51 18.7 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 119.854 -1.165 . . . . 0.0 113.508 -173.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.522 HG23 ' HA ' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -136.12 -174.42 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.115 -0.542 . . . . 0.0 109.914 175.096 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.685 ' CE1' ' HA ' ' A' ' 68' ' ' LYS . 7.0 t60 -94.12 125.52 38.8 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.619 -171.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -98.47 -53.58 1.22 Allowed Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.792 -0.718 . . . . 0.0 113.316 -174.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -110.07 -154.01 0.53 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -176.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 70.3 mtm -71.66 -43.56 65.83 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 164.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 60.45 -173.15 0.12 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 114.537 -1.211 . . . . 0.0 111.515 175.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -92.2 155.19 42.97 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.365 177.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -52.54 -31.94 51.29 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 123.285 2.656 . . . . 0.0 112.999 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.496 ' HB3' HD22 ' A' ' 42' ' ' LEU . 29.2 m-20 -66.62 -42.57 86.58 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.32 0.581 . . . . 0.0 110.371 178.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 42.8 t -72.97 -27.01 23.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.754 177.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.685 ' HA ' ' CE1' ' A' ' 59' ' ' HIS . 88.4 tttt -62.54 -28.4 69.83 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.712 177.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -94.36 -44.87 7.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.375 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -72.32 -30.7 65.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.061 -174.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 58.5 mt -117.56 103.92 50.29 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 177.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -63.65 157.0 53.92 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 123.308 2.672 . . . . 0.0 112.526 -177.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -66.85 -40.32 87.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.618 -177.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.1 m -145.43 130.13 18.05 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.217 177.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.401 ' HG2' ' N ' ' A' ' 76' ' ' VAL . 53.7 tttp -129.66 159.56 36.05 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 12.5 t -134.34 120.41 33.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 177.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.456 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 96.1 mt -98.7 140.89 32.24 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.933 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 51.0 tp -111.62 94.97 5.22 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 173.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 46.4 t -115.26 107.05 21.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.407 -174.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 58.54 31.73 21.36 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.985 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.59 -10.66 70.74 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.582 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.4 t -88.14 125.48 41.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.939 0.4 . . . . 0.0 111.045 -178.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 50.6 p -88.19 125.27 34.53 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.269 176.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.505 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 29.2 mt -116.21 103.98 15.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -83.97 114.17 3.85 Favored Glycine 0 C--O 1.223 -0.563 0 N-CA-C 111.307 -0.717 . . . . 0.0 111.307 177.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.442 ' SD ' ' HG ' ' A' ' 77' ' ' LEU . 21.4 mtp -107.09 118.43 36.68 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.575 0.187 . . . . 0.0 110.897 -174.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 113' ' ' PHE . 11.6 t -148.1 165.08 31.92 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.434 ' HB3' ' O ' ' A' ' 59' ' ' HIS . 3.3 t-160 -156.16 109.51 2.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.618 0.246 . . . . 0.0 110.359 -178.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 152.18 -173.96 31.24 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.363 -0.922 . . . . 0.0 112.336 176.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 6.5 m0 66.59 -173.46 0.19 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.45 0.643 . . . . 0.0 112.168 177.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -170.85 177.63 43.78 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.673 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.486 ' HB1' ' CD1' ' A' ' 94' ' ' TRP . . . 62.59 96.3 0.05 OUTLIER Pre-proline 0 N--CA 1.464 0.262 0 CA-C-O 121.396 0.617 . . . . 0.0 110.65 -175.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.483 ' HA ' ' HB3' ' A' ' 96' ' ' LEU . 7.5 Cg_exo -73.2 7.66 2.05 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 123.375 2.717 . . . . 0.0 113.666 -172.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.486 ' CD1' ' HB1' ' A' ' 92' ' ' ALA . 52.5 m95 -59.31 -54.57 45.25 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.132 0.491 . . . . 0.0 110.544 -178.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -117.44 7.64 12.81 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.321 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.483 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . 29.5 tp -60.85 -46.72 89.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.739 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.527 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 58.7 mttp -58.49 -44.48 89.4 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.174 0.512 . . . . 0.0 110.254 179.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.4 ' HA ' HD12 ' A' ' 101' ' ' LEU . 7.7 m-20 -70.64 -30.65 67.34 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.051 -177.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 25.8 ttm180 -71.74 -40.89 69.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.462 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.495 HD13 HG21 ' A' ' 111' ' ' ILE . 66.7 mt -67.9 -27.34 66.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.803 178.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' A' ' 97' ' ' LYS . 96.6 mt -70.08 -24.29 63.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.038 0.446 . . . . 0.0 110.742 175.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -77.32 -30.61 54.15 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.9 t -76.17 -49.29 25.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.955 174.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -99.67 85.96 3.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.054 177.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -76.79 -2.56 33.8 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.919 -173.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -79.93 -13.14 59.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.357 174.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 14.7 ttpp 57.15 83.2 0.23 Allowed Pre-proline 0 C--O 1.235 0.319 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.728 -171.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.21 174.6 10.49 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.503 2.135 . . . . 0.0 112.715 -174.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -89.63 -49.06 6.88 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.524 177.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.513 HG21 HG11 ' A' ' 150' ' ' VAL . 66.7 t -121.75 131.77 72.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.718 -177.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.495 HG21 HD13 ' A' ' 100' ' ' LEU . 53.2 mt -122.81 125.12 71.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.954 0.407 . . . . 0.0 110.455 174.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 85.7 mt -101.91 115.66 31.02 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.71 177.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.508 ' CZ ' ' HB2' ' A' ' 131' ' ' ASN . 18.2 p90 -127.4 134.75 49.88 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 175.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -105.92 114.87 4.63 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 119.997 -1.097 . . . . 0.0 112.249 -177.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 53.9 t60 -145.16 105.95 4.13 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 176.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 88.0 m -52.7 113.37 1.06 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.974 -177.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 14.3 t-80 -171.25 -79.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.299 177.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.449 ' HA ' ' HD3' ' A' ' 119' ' ' PRO . 50.3 mt-10 -147.69 142.32 16.58 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.24 178.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.654 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 5.6 Cg_exo -78.05 126.72 8.04 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.706 2.27 . . . . 0.0 111.058 172.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -154.6 148.44 25.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.872 0.368 . . . . 0.0 111.299 -179.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -99.66 121.28 41.0 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.723 175.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.541 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 73.3 p -129.01 149.98 50.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.839 0.352 . . . . 0.0 111.879 -173.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.6 p -147.64 149.33 15.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.077 177.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -163.23 -55.56 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.627 0.727 . . . . 0.0 110.309 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.527 ' CB ' HD11 ' A' ' 101' ' ' LEU . . . -93.83 23.58 4.72 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.316 -173.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 74.96 1.07 61.73 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 -173.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 21.9 t -106.12 139.83 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 177.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 51.6 ttt180 -96.31 110.4 22.73 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.062 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.541 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 78.1 m-85 -95.66 117.43 30.47 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.705 -178.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 78.7 mt -113.0 116.26 29.67 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.437 -176.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.654 ' O ' ' HA ' ' A' ' 119' ' ' PRO . 9.1 t30 -109.14 107.82 60.06 Favored Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 172.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -83.11 -173.38 1.66 Allowed 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 123.171 2.581 . . . . 0.0 112.817 -176.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -85.32 161.28 35.51 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.592 -178.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.459 ' HB2' ' HG2' ' A' ' 137' ' ' GLU . 18.1 m -97.37 159.72 14.75 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.703 0.287 . . . . 0.0 110.559 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.76 HD11 ' HB2' ' A' ' 10' ' ' SER . 12.3 mt -61.5 -49.35 77.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.68 -172.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -66.81 -17.08 64.7 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.419 -177.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.459 ' HG2' ' HB2' ' A' ' 134' ' ' SER . 8.2 mm-40 -86.22 -1.36 57.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.724 -178.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 70.8 29.48 69.33 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.466 177.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 22.2 t -138.28 122.01 17.54 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.022 0.439 . . . . 0.0 110.792 -177.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.565 ' CE2' HD22 ' A' ' 135' ' ' LEU . 22.6 m-85 -116.47 177.94 4.51 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.384 175.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.408 ' HB3' ' HB3' ' A' ' 6' ' ' LEU . . . -126.76 132.83 50.98 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.985 0.422 . . . . 0.0 111.198 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 58.9 t -113.54 119.13 60.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 174.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.477 ' HA ' ' O ' ' A' ' 151' ' ' ARG . 3.3 tt -95.9 116.08 28.39 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.772 ' HB2' ' HB2' ' A' ' 151' ' ' ARG . 56.6 mt-10 -100.89 139.87 35.98 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.906 -177.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 47.7 mt -110.57 90.14 3.24 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 166.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -104.93 113.2 26.66 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.293 -176.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.92 -67.51 0.32 Allowed Glycine 0 CA--C 1.52 0.348 0 O-C-N 123.527 0.517 . . . . 0.0 112.288 -174.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -174.77 25.52 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 178.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -110.41 133.81 52.92 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 -177.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.513 HG11 HG21 ' A' ' 110' ' ' VAL . 21.5 t -79.64 103.52 6.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 176.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.772 ' HB2' ' HB2' ' A' ' 144' ' ' GLU . 56.6 mtt180 -110.02 148.03 32.44 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.084 -174.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -143.01 123.3 13.8 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.556 175.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -119.02 132.27 56.04 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.846 0.355 . . . . 0.0 110.334 178.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -76.01 113.63 13.74 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.455 176.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -96.38 119.04 34.14 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.248 -177.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.4 m -93.21 147.21 23.09 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.853 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 10.2 mp . . . . . 0 C--O 1.247 0.957 0 CA-C-O 118.827 -0.606 . . . . 0.0 110.623 -177.716 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.461 ' HD2' HG13 ' A' ' 79' ' ' VAL . 50.0 mttp . . . . . 0 N--CA 1.452 -0.352 0 CA-C-O 121.084 0.469 . . . . 0.0 110.882 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 56.1 mtt180 -107.66 112.32 24.97 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.62 176.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.627 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 53.7 m-85 -101.79 129.49 48.0 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.442 0.639 . . . . 0.0 111.518 -175.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.556 ' HB3' HG22 ' A' ' 33' ' ' VAL . 27.3 tp -89.18 114.76 26.1 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.094 174.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.623 HD11 ' HG ' ' A' ' 36' ' ' LEU . 45.0 tp -100.4 111.9 24.2 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.93 0.395 . . . . 0.0 110.668 -177.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.485 HG13 ' HA2' ' A' ' 35' ' ' GLY . 23.9 pt -100.98 120.12 50.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 176.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.772 ' HB2' ' HA ' ' A' ' 134' ' ' SER . 13.2 m -75.87 -169.04 1.0 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.799 -172.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.776 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 11.2 t70 -59.42 98.6 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.293 -179.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.0 m -109.26 128.46 55.09 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.852 -175.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.72 ' HB3' ' HB ' ' A' ' 14' ' ' VAL . 24.3 m170 -102.26 76.0 1.54 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.421 0.629 . . . . 0.0 109.696 179.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.493 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -135.74 127.14 17.27 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.1 -179.091 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 34.9 Cg_endo -93.19 91.68 0.14 OUTLIER 'Cis proline' 0 N--CA 1.45 -1.055 0 C-N-CA 123.013 -1.661 . . . . 0.0 113.049 -2.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.72 ' HB ' ' HB3' ' A' ' 11' ' ' HIS . 3.0 t -120.27 -170.1 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 173.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.694 ' H ' HG12 ' A' ' 14' ' ' VAL . 55.2 mtt180 -68.73 83.94 0.3 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 118.91 0.777 . . . . 0.0 111.099 177.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 39.9 ttp -165.13 -71.5 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.658 -1.155 . . . . 0.0 108.444 177.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 58.94 9.06 1.1 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.671 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.0 m -76.54 15.82 0.57 Allowed 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 112.432 0.531 . . . . 0.0 112.432 -176.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.1 tt -107.64 102.18 43.53 Favored Pre-proline 0 C--N 1.323 -0.568 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -88.92 167.22 5.73 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.905 2.403 . . . . 0.0 113.548 -175.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -60.59 -23.58 64.78 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.242 178.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -62.07 -13.26 24.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.368 -176.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 tt -102.03 -33.4 3.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.298 0.57 . . . . 0.0 109.869 174.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.657 ' HA ' HD23 ' A' ' 27' ' ' LEU . 47.1 tp -72.13 -30.78 65.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.814 -176.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -66.48 -28.9 68.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.195 0.522 . . . . 0.0 110.338 177.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.9 m -72.96 -8.28 54.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.518 -176.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.757 HD13 HG21 ' A' ' 33' ' ' VAL . 4.3 mm? -58.87 -27.69 65.41 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.012 0.434 . . . . 0.0 110.959 176.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -85.31 -7.88 58.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.848 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -98.58 -39.96 8.45 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.208 -176.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.49 ' CD2' ' HB2' ' A' ' 5' ' ' LEU . 89.0 m-85 -86.98 147.12 25.88 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -92.13 -18.31 23.71 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.886 0.374 . . . . 0.0 110.435 -179.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.627 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -135.92 143.25 14.69 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 175.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.757 HG21 HD13 ' A' ' 27' ' ' LEU . 64.3 t -136.3 137.36 48.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 117.093 0.447 . . . . 0.0 110.485 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.567 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 39.0 mt -121.91 129.24 75.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.843 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.485 ' HA2' HG13 ' A' ' 7' ' ' ILE . . . -112.07 102.26 1.35 Allowed Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.918 177.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.623 ' HG ' HD11 ' A' ' 6' ' ' LEU . 85.8 mt -80.31 -32.61 37.98 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 176.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.776 ' HA3' ' HA ' ' A' ' 9' ' ' ASP . . . -138.16 62.78 0.57 Allowed Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 175.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -70.5 -172.5 0.61 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.024 0.44 . . . . 0.0 111.476 -175.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.578 ' HD1' HD11 ' A' ' 48' ' ' LEU . 81.2 m-85 -58.76 142.18 50.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.095 -177.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.585 ' HB ' ' HB3' ' A' ' 63' ' ' ASP . 15.7 m -85.59 16.14 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.318 0.58 . . . . 0.0 110.816 -176.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.461 ' O ' HG23 ' A' ' 45' ' ' VAL . 12.5 t70 -119.94 124.81 46.9 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.463 -178.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 53.2 tp -61.34 -39.49 90.77 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.079 -174.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -61.08 -42.46 98.55 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.119 0.485 . . . . 0.0 110.588 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.516 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 16.7 m -68.6 -29.43 67.95 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.118 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.564 HG21 HG13 ' A' ' 67' ' ' VAL . 65.5 t -59.25 -43.46 89.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 121.24 0.543 . . . . 0.0 109.965 174.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.497 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 1.7 mp -63.47 -38.74 83.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.027 176.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.23 -33.59 76.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.529 175.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.578 HD11 ' HD1' ' A' ' 39' ' ' TYR . 92.7 mt -67.97 -32.35 72.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.113 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -79.21 -16.28 56.76 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.195 177.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.497 ' HG3' ' O ' ' A' ' 46' ' ' ILE . 53.9 mtpt -76.61 -54.24 6.94 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 174.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.53 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . 62.9 m-85 -65.45 -63.8 1.01 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.716 176.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.535 ' HB2' HD12 ' A' ' 27' ' ' LEU . 41.6 t -84.25 96.56 9.03 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.725 175.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 53.0 mttp -64.01 -35.04 79.43 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.192 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -105.45 75.52 1.15 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.33 0.586 . . . . 0.0 109.704 171.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -101.58 125.18 48.19 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.462 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.567 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 91.3 m-85 -121.81 143.98 49.09 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 176.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.517 ' HA3' HD13 ' A' ' 71' ' ' LEU . . . -159.22 164.83 34.07 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 119.444 -1.36 . . . . 0.0 113.506 -176.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 72' ' ' PRO . 2.3 m -138.0 97.75 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.344 0.592 . . . . 0.0 109.447 176.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.543 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 11.9 t60 -94.38 146.97 23.68 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.377 -167.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -87.49 -163.22 38.76 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.179 179.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.555 ' HB3' ' HD2' ' A' ' 68' ' ' LYS . 2.0 p-10 -124.65 31.72 5.63 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.956 0.407 . . . . 0.0 110.973 -177.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 2.8 mpp? -76.12 -32.25 59.07 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.286 0.565 . . . . 0.0 109.824 178.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.585 ' HB3' ' HB ' ' A' ' 40' ' ' VAL . 3.8 p-10 -104.81 -111.14 0.26 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.759 -177.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.418 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 38.3 m-85 -104.36 135.72 19.29 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.71 0.291 . . . . 0.0 110.78 -174.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 64' ' ' TYR . 31.8 Cg_exo -59.01 -28.2 87.2 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.695 2.264 . . . . 0.0 111.902 178.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -55.77 -38.95 70.55 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.227 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.564 HG13 HG21 ' A' ' 45' ' ' VAL . 16.7 t -76.41 -33.38 23.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.531 -178.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.555 ' HD2' ' HB3' ' A' ' 61' ' ' ASN . 86.3 tttt -73.17 -25.41 60.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.107 0.48 . . . . 0.0 110.374 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -78.28 -19.73 53.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.016 0.436 . . . . 0.0 109.98 173.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 9.3 m80 -84.2 -51.4 7.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.189 176.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.543 ' HB2' ' HB2' ' A' ' 59' ' ' HIS . 11.3 mt -107.5 108.41 61.64 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 176.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.412 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 52.8 Cg_exo -54.76 153.85 22.97 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.758 2.305 . . . . 0.0 112.38 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -70.46 -18.48 62.99 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.12 0.486 . . . . 0.0 110.761 -177.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 51.1 m -150.84 131.27 13.77 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.133 178.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 44.7 tttp -149.45 133.15 16.85 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.373 -178.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 19.7 t -106.43 123.69 61.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 178.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 64.6 mt -102.02 157.22 17.02 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.545 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 60.3 tp -123.43 100.73 6.97 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 175.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.461 HG13 ' HD2' ' A' ' 2' ' ' LYS . 61.6 t -113.4 102.85 14.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.663 -176.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 51.63 42.22 29.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.68 176.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.97 0.15 64.0 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.754 -0.657 . . . . 0.0 113.215 175.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 96.0 t -105.94 129.78 58.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.751 0.31 . . . . 0.0 110.972 178.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.2 p -91.47 123.87 35.21 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.701 176.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.483 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 25.2 mt -116.92 98.28 6.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.451 -176.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.416 ' O ' HG23 ' A' ' 111' ' ' ILE . . . -85.61 98.85 2.31 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.338 178.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 35.8 mtm -90.75 131.81 36.21 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -178.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 34.7 t -149.65 165.07 33.44 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -125.72 29.19 6.01 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -66.9 167.5 38.43 Favored Glycine 0 N--CA 1.451 -0.321 0 CA-C-N 115.341 -0.845 . . . . 0.0 113.576 -175.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 54.3 p-90 -126.27 166.01 17.91 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.814 0.34 . . . . 0.0 110.573 -177.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 127.85 170.64 12.87 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.084 -0.579 . . . . 0.0 111.949 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -89.08 164.86 29.27 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 177.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_exo -53.2 -21.12 16.09 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.995 2.463 . . . . 0.0 113.268 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 11.7 m95 -70.66 -34.05 71.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.886 0.374 . . . . 0.0 110.379 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -101.31 -27.38 13.21 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.556 -178.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 37.4 tp -50.65 -57.29 8.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.175 -173.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -62.12 -44.1 97.39 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.075 -177.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -71.9 -14.76 62.03 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.338 -177.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.415 ' O ' HG23 ' A' ' 103' ' ' VAL . 29.0 ttt85 -95.33 -49.95 5.23 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.538 -178.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.519 HD13 HG21 ' A' ' 111' ' ' ILE . 79.6 mt -70.3 -34.5 72.81 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.62 -176.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.611 HD21 HG21 ' A' ' 127' ' ' VAL . 96.2 mt -75.24 -9.89 58.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.172 0.511 . . . . 0.0 110.411 177.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -91.34 -40.17 11.62 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.854 175.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 99' ' ' ARG . 94.8 t -64.23 -48.12 86.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.108 175.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -87.2 122.89 31.61 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.844 176.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -75.97 -30.83 58.75 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.138 0.494 . . . . 0.0 110.158 -178.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -93.67 179.77 5.26 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.622 175.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -109.35 106.25 58.35 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-O 120.956 0.407 . . . . 0.0 110.917 -178.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -76.51 131.52 12.67 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 123.103 2.535 . . . . 0.0 111.619 178.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -67.84 -40.32 83.74 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.266 178.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.88 HG21 HG21 ' A' ' 150' ' ' VAL . 89.3 t -126.02 135.96 62.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.179 179.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.519 HG21 HD13 ' A' ' 100' ' ' LEU . 44.3 mt -125.48 125.48 68.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.894 0.378 . . . . 0.0 110.406 176.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.699 HD23 ' HB2' ' A' ' 130' ' ' LEU . 95.6 mt -104.05 127.94 51.63 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.075 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -155.6 175.64 13.64 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.613 177.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -145.53 114.72 0.78 Allowed Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.731 178.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -165.72 -57.3 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.775 0.321 . . . . 0.0 110.924 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.6 p -82.88 -23.13 33.76 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -177.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 61.97 85.42 0.12 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 122.728 0.411 . . . . 0.0 110.559 -179.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -127.14 94.69 38.39 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.215 -178.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -68.4 67.23 1.08 Allowed 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.612 2.208 . . . . 0.0 111.793 178.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -161.92 153.59 18.77 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.484 -174.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -78.13 95.01 4.8 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 170.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.5 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 51.2 p -92.17 114.42 26.95 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.51 0.671 . . . . 0.0 110.984 -169.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.2 p -98.96 95.84 4.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-O 121.946 0.879 . . . . 0.0 110.253 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.654 ' HB2' ' CE1' ' A' ' 129' ' ' PHE . 60.8 mttp -110.81 119.01 37.71 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.517 -178.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 64.32 23.26 13.0 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.009 0.433 . . . . 0.0 111.529 178.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 94.64 -12.98 68.06 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.607 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.611 HG21 HD21 ' A' ' 101' ' ' LEU . 43.2 t -93.6 137.9 21.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.662 0.268 . . . . 0.0 110.41 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -91.79 99.44 12.32 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.239 0.542 . . . . 0.0 110.118 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.654 ' CE1' ' HB2' ' A' ' 124' ' ' LYS . 91.1 m-85 -90.83 136.46 33.05 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.156 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.699 ' HB2' HD23 ' A' ' 112' ' ' LEU . 85.4 mt -122.84 109.02 13.66 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.269 0.557 . . . . 0.0 109.849 177.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 -131.33 103.15 15.23 Favored Pre-proline 0 C--N 1.318 -0.764 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.875 177.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -91.45 -177.66 1.05 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.753 2.302 . . . . 0.0 113.906 -170.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -73.98 149.2 40.79 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 173.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.772 ' HA ' ' HB2' ' A' ' 8' ' ' SER . 22.3 m -91.89 170.47 9.84 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 120.963 0.411 . . . . 0.0 111.449 -175.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -60.41 -29.84 69.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.906 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -67.81 -22.81 65.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.022 178.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -94.52 -6.07 44.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.467 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 79.98 39.6 16.25 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.964 -0.562 . . . . 0.0 113.155 176.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 64.5 m -153.73 156.22 37.39 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.714 0.293 . . . . 0.0 110.748 178.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -144.14 168.87 19.0 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 174.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.468 ' HB3' HD23 ' A' ' 6' ' ' LEU . . . -114.58 140.86 48.44 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.045 0.45 . . . . 0.0 111.379 -174.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 40.1 t -112.21 123.75 68.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 173.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.734 HD21 HG13 ' A' ' 150' ' ' VAL . 2.6 tt -107.9 104.76 14.31 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -104.74 113.79 27.59 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.536 -178.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.2 mp -97.1 93.55 6.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.066 0.46 . . . . 0.0 110.454 176.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.535 ' HB3' ' NH1' ' A' ' 151' ' ' ARG . 17.0 t70 -87.72 123.12 32.21 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 175.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 68.14 -62.93 0.38 Allowed Glycine 0 CA--C 1.523 0.534 0 O-C-N 123.403 0.439 . . . . 0.0 112.441 -172.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 171.24 34.5 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.534 -0.626 . . . . 0.0 111.534 177.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -121.96 140.33 52.58 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.88 HG21 HG21 ' A' ' 110' ' ' VAL . 90.6 t -80.97 115.44 23.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.595 -175.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.535 ' NH1' ' HB3' ' A' ' 146' ' ' ASP . 78.9 mtt85 -107.82 101.81 11.07 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.92 173.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -90.11 103.65 16.3 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.996 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -120.57 119.35 32.67 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.117 0.484 . . . . 0.0 110.48 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 24.8 tp -88.98 130.82 35.39 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.093 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -121.94 139.62 53.44 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.04 0.448 . . . . 0.0 110.566 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 9.5 p -84.23 162.85 20.02 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.797 -178.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 75.5 mt . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.529 -0.748 . . . . 0.0 109.865 175.571 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 43.9 mttm . . . . . 0 C--O 1.233 0.235 0 CA-C-O 120.719 0.295 . . . . 0.0 110.353 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.489 ' HG2' ' HG3' ' A' ' 144' ' ' GLU . 49.9 mtm-85 -127.15 124.82 39.96 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.702 178.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 95.4 m-85 -108.18 128.04 54.35 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.226 176.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.552 ' HB3' HG22 ' A' ' 33' ' ' VAL . 48.5 tp -89.31 112.1 23.1 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.577 -176.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.458 HD11 ' HG ' ' A' ' 36' ' ' LEU . 60.4 tp -97.64 110.03 22.67 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.037 0.446 . . . . 0.0 110.518 -179.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.45 HG13 ' HA2' ' A' ' 35' ' ' GLY . 33.2 pt -101.33 134.74 40.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 176.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.6 m -77.05 -167.6 0.91 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.927 -173.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -53.92 117.19 3.0 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.264 178.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.843 ' H ' ' HA3' ' A' ' 37' ' ' GLY . 20.1 m -115.48 127.7 55.5 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.497 -178.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 62.0 m170 -116.39 44.47 1.98 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 175.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.715 HG21 ' HB2' ' A' ' 19' ' ' LEU . 56.1 t -113.12 129.78 24.21 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.871 -175.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 59.3 Cg_endo -103.13 94.43 0.12 OUTLIER 'Cis proline' 0 N--CA 1.449 -1.094 0 C-N-CA 123.574 -1.428 . . . . 0.0 112.61 -7.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.606 HG12 ' HG3' ' A' ' 15' ' ' ARG . 14.6 t -100.23 -77.82 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 175.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.606 ' HG3' HG12 ' A' ' 14' ' ' VAL . 60.6 mtt180 -130.77 15.73 5.31 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.432 ' HG2' ' H ' ' A' ' 18' ' ' SER . 37.1 ttp -143.13 130.07 20.58 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.828 -177.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -122.27 12.08 10.17 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.142 0.496 . . . . 0.0 110.372 178.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.432 ' H ' ' HG2' ' A' ' 16' ' ' MET . 3.9 m -78.73 41.22 0.41 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.978 -176.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.715 ' HB2' HG21 ' A' ' 12' ' ' VAL . 4.5 tt -107.65 106.69 59.06 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.451 ' HD2' ' OH ' ' A' ' 140' ' ' TYR . 51.4 Cg_exo -56.33 122.74 12.31 Favored 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 122.905 2.404 . . . . 0.0 112.515 178.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -73.9 -10.79 60.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.184 -176.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -55.2 -52.01 64.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.357 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.5 tt -69.4 -27.06 32.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.212 0.529 . . . . 0.0 110.446 -177.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.422 ' O ' HD23 ' A' ' 27' ' ' LEU . 52.3 tp -70.37 -16.43 62.97 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.619 178.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -89.59 -25.36 21.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.989 178.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.0 p -83.61 24.31 0.87 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.834 0.349 . . . . 0.0 111.913 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.462 ' CD1' HG21 ' A' ' 33' ' ' VAL . 3.0 mm? -69.58 -8.57 48.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.855 0.359 . . . . 0.0 111.493 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -98.83 -13.13 20.24 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.26 0.552 . . . . 0.0 110.284 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -92.51 -11.32 34.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.185 -175.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -109.46 161.9 14.87 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.799 0.333 . . . . 0.0 110.737 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -86.58 -50.25 6.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.408 0.623 . . . . 0.0 109.894 179.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -139.5 156.55 24.71 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.115 178.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.552 HG22 ' HB3' ' A' ' 5' ' ' LEU . 84.0 t -125.25 137.94 55.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 120.745 0.307 . . . . 0.0 110.412 -179.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.526 HG12 ' HB2' ' A' ' 56' ' ' TYR . 34.0 mt -114.59 126.3 72.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.886 177.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.45 ' HA2' HG13 ' A' ' 7' ' ' ILE . . . -112.49 107.02 1.97 Allowed Glycine 0 N--CA 1.439 -1.132 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.345 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.458 ' HG ' HD11 ' A' ' 6' ' ' LEU . 89.5 mt -73.96 -24.48 59.63 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 171.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.843 ' HA3' ' H ' ' A' ' 10' ' ' SER . . . -140.25 132.59 5.57 Favored Glycine 0 N--CA 1.438 -1.17 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 170.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.522 ' OD2' HG11 ' A' ' 67' ' ' VAL . 18.2 p-10 -112.95 -173.34 2.23 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.311 0.577 . . . . 0.0 111.429 -172.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -84.24 116.7 23.1 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 172.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.85 ' HB ' ' HD2' ' A' ' 64' ' ' TYR . 35.4 m -64.96 -5.87 2.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -168.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.459 ' O ' HG23 ' A' ' 45' ' ' VAL . 19.7 t70 -86.7 120.51 28.07 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 177.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 45.3 tp -56.73 -46.18 81.47 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -172.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -66.34 -33.98 76.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.911 0.386 . . . . 0.0 110.603 -178.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.597 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 30.5 m -67.71 -29.23 68.43 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.658 176.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 41' ' ' ASP . 74.7 t -62.95 -41.82 94.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 121.058 0.456 . . . . 0.0 110.153 175.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.02 -36.06 76.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.808 175.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.56 -29.8 69.28 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.776 175.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.597 ' HG ' ' O ' ' A' ' 44' ' ' THR . 92.0 mt -65.28 -34.54 78.58 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 176.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.414 ' HA ' ' O ' ' A' ' 52' ' ' SER . 36.9 tt0 -76.24 -21.91 55.79 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.958 175.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -72.87 -35.87 67.25 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.749 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.462 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . 70.3 m-85 -81.56 -67.05 0.81 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.18 172.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 49' ' ' GLU . 38.2 t -86.2 96.05 9.79 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.717 176.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.69 ' H ' ' HD2' ' A' ' 53' ' ' LYS . 8.7 mptt -60.18 -31.26 69.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.681 -177.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -110.62 82.85 1.66 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.419 0.628 . . . . 0.0 109.974 169.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -100.48 112.55 24.92 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.966 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.526 ' HB2' HG12 ' A' ' 34' ' ' ILE . 33.5 m-85 -96.55 133.03 41.54 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 177.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -144.76 158.44 27.58 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 119.556 -1.307 . . . . 0.0 112.972 -177.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -136.26 155.2 34.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 122.756 0.422 . . . . 0.0 109.986 175.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.861 ' CE1' ' HB ' ' A' ' 67' ' ' VAL . 0.2 OUTLIER -128.22 171.57 11.83 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -174.317 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 121.94 39.66 0.55 Allowed Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.796 173.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -122.04 -86.92 0.65 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 117.455 0.628 . . . . 0.0 110.992 177.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 67.8 mtt -135.69 31.68 3.06 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.42 ' HB2' ' CE1' ' A' ' 59' ' ' HIS . 1.3 p30 -93.17 -178.32 4.74 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.299 -1.318 . . . . 0.0 112.212 -171.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.85 ' HD2' ' HB ' ' A' ' 40' ' ' VAL . 80.2 m-85 -94.3 138.21 22.54 Favored Pre-proline 0 C--O 1.232 0.182 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.477 176.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 64' ' ' TYR . 21.1 Cg_exo -67.4 -9.15 24.32 Favored 'Trans proline' 0 N--CA 1.474 0.368 0 C-N-CA 123.562 2.842 . . . . 0.0 113.913 -175.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -70.97 -42.38 69.79 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.12 0.486 . . . . 0.0 110.785 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.861 ' HB ' ' CE1' ' A' ' 59' ' ' HIS . 65.4 t -68.71 -11.04 14.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.617 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.48 ' HB3' ' NZ ' ' A' ' 68' ' ' LYS . 5.1 ttpm? -56.88 -30.7 64.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.885 176.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -70.08 -17.55 63.23 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.049 0.452 . . . . 0.0 110.836 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -105.81 -50.63 3.15 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.901 -178.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.6 ' HG ' HG12 ' A' ' 67' ' ' VAL . 4.4 mt -107.98 112.01 61.87 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.397 -178.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -74.08 170.95 18.95 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.768 2.312 . . . . 0.0 111.648 178.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -74.82 -21.11 59.47 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.244 0.545 . . . . 0.0 109.83 178.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.428 ' HA ' ' O ' ' A' ' 86' ' ' MET . 55.1 m -150.63 124.69 9.33 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.022 175.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 42.3 tttp -132.86 129.48 38.5 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.736 -179.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 17.3 t -106.35 122.92 60.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 120.961 0.41 . . . . 0.0 110.221 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.542 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 59.7 mt -99.32 152.51 19.85 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.215 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 47.0 tp -124.63 97.39 5.27 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 174.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 37.6 t -112.8 104.94 17.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.439 -175.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 54.11 43.25 30.97 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.234 178.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.81 -25.73 23.71 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.904 177.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 63.6 t -81.03 129.95 36.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.816 0.341 . . . . 0.0 111.204 -176.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 28.2 p -91.76 129.53 37.71 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.439 177.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.542 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 34.6 mt -124.09 99.22 6.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.88 0.372 . . . . 0.0 110.178 -177.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -87.59 102.05 2.76 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.405 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.525 ' HG2' HD12 ' A' ' 112' ' ' LEU . 22.8 mtm -94.96 127.08 40.74 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 113' ' ' PHE . 42.4 t -141.73 154.72 45.47 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 16.1 p80 -63.46 -26.51 68.76 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 175.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.595 ' HA3' ' HB2' ' A' ' 113' ' ' PHE . . . 57.62 59.69 10.37 Favored Glycine 0 C--N 1.335 0.487 0 CA-C-N 115.965 -0.561 . . . . 0.0 114.432 170.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 81.3 t90 -97.48 127.56 43.54 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 174.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 163.99 -177.27 39.83 Favored Glycine 0 N--CA 1.444 -0.779 0 N-CA-C 111.301 -0.719 . . . . 0.0 111.301 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.54 139.21 44.24 Favored Pre-proline 0 C--N 1.32 -0.693 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 178.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -62.63 -25.83 75.46 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.935 2.423 . . . . 0.0 113.208 -175.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -67.22 -47.2 71.53 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.947 0.404 . . . . 0.0 110.616 -175.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -101.74 9.03 41.28 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.785 -177.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 26.8 tp -60.08 -47.53 85.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.535 -173.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -63.85 -45.48 89.28 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.178 0.513 . . . . 0.0 110.365 -177.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -65.55 -36.65 84.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.909 179.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.514 ' O ' HG23 ' A' ' 103' ' ' VAL . 21.3 ttt180 -67.96 -49.25 62.85 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.254 179.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.655 HD23 HG21 ' A' ' 111' ' ' ILE . 7.6 mp -62.8 -35.45 79.92 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.544 0.202 . . . . 0.0 111.544 -176.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.773 HD21 HG21 ' A' ' 127' ' ' VAL . 84.5 mt -71.77 -16.35 62.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.026 0.441 . . . . 0.0 110.659 176.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 48.5 tttp -96.26 -17.15 20.95 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.354 178.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 99' ' ' ARG . 92.0 t -74.43 -45.86 44.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.11 0.481 . . . . 0.0 109.75 175.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -80.82 155.45 26.61 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.44 176.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -84.0 -22.49 31.35 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.245 0.545 . . . . 0.0 109.94 178.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 14.8 mp0 -105.11 -174.47 2.54 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.461 177.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 47.8 pttt -119.24 91.67 44.26 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-O 121.491 0.662 . . . . 0.0 109.504 172.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.07 154.48 67.06 Favored 'Trans proline' 0 N--CA 1.464 -0.224 0 C-N-CA 123.086 2.524 . . . . 0.0 112.63 -174.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -82.06 -46.34 14.03 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.959 177.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.7 t -116.87 133.32 63.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.903 176.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.655 HG21 HD23 ' A' ' 100' ' ' LEU . 56.0 mt -129.71 134.81 62.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.855 0.359 . . . . 0.0 110.765 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.664 HD23 ' HB2' ' A' ' 130' ' ' LEU . 86.5 mt -108.22 135.05 50.2 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.767 178.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.595 ' HB2' ' HA3' ' A' ' 89' ' ' GLY . 47.1 p90 -142.62 162.64 34.93 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.744 177.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.24 114.97 1.31 Allowed Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.331 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -169.06 -54.56 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.2 p -85.92 159.43 19.66 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.159 171.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 22.0 p-80 -123.99 21.14 9.06 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.174 0.511 . . . . 0.0 110.53 -178.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 11.2 mp0 -87.68 107.96 18.07 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.619 176.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 30.8 Cg_endo -64.66 95.67 0.23 Allowed 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.345 2.03 . . . . 0.0 111.814 -178.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -152.32 141.83 21.7 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.361 -176.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -95.16 123.15 38.5 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 171.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.641 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 73.2 p -112.23 144.97 40.75 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.273 -171.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 14.8 p -148.93 139.74 16.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.011 177.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -158.04 -48.55 0.06 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.13 0.491 . . . . 0.0 110.603 -178.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -97.0 24.43 6.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.395 -177.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 75.02 25.46 69.01 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.749 -0.738 . . . . 0.0 111.903 -175.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.773 HG21 HD21 ' A' ' 101' ' ' LEU . 52.8 t -132.78 137.02 54.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -100.0 104.97 16.6 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.109 0.48 . . . . 0.0 110.19 -177.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.641 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 60.0 m-85 -93.92 135.54 35.15 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.789 -179.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.664 ' HB2' HD23 ' A' ' 112' ' ' LEU . 86.9 mt -118.51 137.05 53.47 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.879 0.371 . . . . 0.0 111.326 -177.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.467 ' HA ' ' HD3' ' A' ' 132' ' ' PRO . 0.1 OUTLIER -150.32 125.64 4.86 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.23 173.388 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 131' ' ' ASN . 88.1 Cg_endo -101.86 -176.71 0.13 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 123.546 2.831 . . . . 0.0 112.56 175.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -81.58 171.14 52.65 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 174.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 75.6 p -85.38 173.9 9.95 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 117.515 0.658 . . . . 0.0 111.259 -177.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.604 HD13 ' HG ' ' A' ' 19' ' ' LEU . 21.2 mt -57.35 -49.54 75.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.718 -174.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -67.83 -10.91 56.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.03 -173.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -92.39 -3.79 54.77 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.981 0.419 . . . . 0.0 110.757 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.528 ' HA2' HD12 ' A' ' 157' ' ' LEU . . . 71.67 34.0 63.15 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.417 178.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 37.4 t -126.32 121.34 32.3 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.935 0.397 . . . . 0.0 110.539 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.451 ' OH ' ' HD2' ' A' ' 20' ' ' PRO . 86.5 m-85 -125.49 159.52 31.78 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.527 174.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.454 ' HB3' HD23 ' A' ' 6' ' ' LEU . . . -121.55 140.18 52.55 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.836 0.351 . . . . 0.0 110.137 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 62.1 t -122.68 121.55 63.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 175.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.818 HD21 HG13 ' A' ' 150' ' ' VAL . 3.5 tt -94.73 105.98 17.95 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.489 ' HG3' ' HG2' ' A' ' 3' ' ' ARG . 29.8 tt0 -102.94 145.55 29.67 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.457 -178.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 58.7 mt -117.23 105.97 12.78 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.975 0.416 . . . . 0.0 111.214 -177.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -118.31 130.57 56.1 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.973 175.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.51 11.01 59.0 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.169 -177.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 84.24 6.62 86.08 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.096 -177.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -97.54 158.09 15.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.825 0.345 . . . . 0.0 110.663 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.818 HG13 HD21 ' A' ' 143' ' ' LEU . 51.7 t -87.52 109.94 20.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.798 -178.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 43.8 ttt180 -107.18 113.66 27.23 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.158 0.504 . . . . 0.0 110.549 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -84.26 108.67 17.26 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.022 177.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -106.65 105.45 15.49 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 23.6 tp -83.66 109.92 17.85 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 119.951 -0.7 . . . . 0.0 110.256 -177.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -88.78 118.88 28.79 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.512 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 21.4 p -111.64 148.46 33.32 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.437 -173.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.528 HD12 ' HA2' ' A' ' 138' ' ' GLY . 74.7 mt . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.576 -0.726 . . . . 0.0 109.644 178.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 60.9 mttp . . . . . 0 N--CA 1.454 -0.242 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.544 ' HG3' ' HA ' ' A' ' 30' ' ' TYR . 0.1 OUTLIER -124.45 129.93 51.55 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.043 -175.765 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.495 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 16.6 m-85 -119.06 132.05 56.0 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.803 -179.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 28.2 tp -89.05 122.84 32.79 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.031 178.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.523 HD11 ' HG ' ' A' ' 36' ' ' LEU . 62.4 tp -104.7 111.79 24.64 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.039 0.447 . . . . 0.0 110.461 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.9 pt -101.16 138.62 24.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.785 176.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.5 m -77.34 -178.59 5.23 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.404 -175.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -63.84 104.61 0.71 Allowed 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.466 -176.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.8 m -95.45 83.99 3.92 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.833 -175.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 28.3 m80 -75.03 76.25 2.22 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 175.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.646 HG21 HD12 ' A' ' 19' ' ' LEU . 40.7 t -125.9 128.36 24.56 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.069 -177.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.414 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 58.2 Cg_endo -76.36 -61.58 0.05 OUTLIER 'Cis proline' 0 CA--C 1.529 0.264 0 C-N-CA 122.818 -1.742 . . . . 0.0 112.928 -1.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 53.4 t 56.81 -87.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 122.865 0.466 . . . . 0.0 111.612 179.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 81.6 mtt180 -139.8 6.63 2.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.941 0.4 . . . . 0.0 110.097 177.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 52.9 ttp -135.79 98.97 4.04 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.782 -173.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -99.66 -1.46 37.91 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.326 0.584 . . . . 0.0 110.354 177.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.0 m -82.72 58.98 4.52 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.403 -176.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.646 HD12 HG21 ' A' ' 12' ' ' VAL . 4.9 tt -107.66 109.75 62.47 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.728 ' HG2' HD13 ' A' ' 157' ' ' LEU . 31.3 Cg_exo -60.64 123.95 14.06 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 123.096 2.531 . . . . 0.0 112.585 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -62.53 -15.33 50.05 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.127 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -56.76 -33.99 67.14 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.379 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.6 tt -75.63 -32.89 25.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.374 0.606 . . . . 0.0 110.086 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.51 ' O ' HD23 ' A' ' 27' ' ' LEU . 45.7 tp -71.99 -17.37 62.06 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.292 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -91.52 -2.01 57.33 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.661 177.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 46.9 m -93.77 -0.7 55.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.662 -176.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.589 ' HG ' ' HB3' ' A' ' 51' ' ' PHE . 4.0 mm? -65.16 -10.34 30.3 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.0 0.429 . . . . 0.0 111.053 179.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.5 mttm -76.41 -30.86 57.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.149 -174.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -111.03 27.26 9.86 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -166.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.544 ' HA ' ' HG3' ' A' ' 3' ' ' ARG . 91.6 m-85 -136.22 152.09 50.39 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.778 178.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.415 ' OD2' ' HG2' ' A' ' 3' ' ' ARG . 10.1 m-20 -79.28 -43.98 22.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.573 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.495 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -138.98 164.19 25.83 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.098 178.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.58 HG21 ' CD1' ' A' ' 27' ' ' LEU . 98.7 t -134.11 137.96 51.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.049 0.452 . . . . 0.0 110.874 -177.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.7 mt -118.43 135.63 58.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.82 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.509 ' O ' ' HA2' ' A' ' 57' ' ' GLY . . . -124.21 123.37 5.13 Favored Glycine 0 N--CA 1.44 -1.04 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.031 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.523 ' HG ' HD11 ' A' ' 6' ' ' LEU . 98.7 mt -81.52 34.63 0.38 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.188 0.518 . . . . 0.0 109.87 177.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 118.7 103.85 2.14 Favored Glycine 0 N--CA 1.44 -1.063 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 -173.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.535 ' OD2' HG13 ' A' ' 45' ' ' VAL . 6.5 p-10 -97.88 -156.25 0.53 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.863 0.332 . . . . 0.0 110.488 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -58.5 153.75 15.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.262 0.553 . . . . 0.0 111.945 -173.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.514 HG22 ' O ' ' A' ' 12' ' ' VAL . 21.2 m -94.84 -1.79 10.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.098 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.641 ' O ' HG23 ' A' ' 45' ' ' VAL . 16.2 t70 -93.45 120.26 33.52 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 173.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.443 HD22 ' HB3' ' A' ' 66' ' ' ASP . 38.3 tp -57.98 -42.63 85.51 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 123.426 0.453 . . . . 0.0 111.888 -170.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -62.21 -44.82 95.73 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.727 0.299 . . . . 0.0 110.53 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.7 m -67.11 -28.8 68.46 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.091 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 41' ' ' ASP . 61.5 t -59.63 -50.39 80.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 121.371 0.605 . . . . 0.0 110.302 175.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.511 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 1.8 mp -68.64 -34.13 63.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.837 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -58.08 -39.11 77.74 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.427 174.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.57 -42.63 70.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.148 0.499 . . . . 0.0 109.777 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.0 tt0 -56.92 -40.26 76.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.754 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.511 ' HG3' ' O ' ' A' ' 46' ' ' ILE . 94.1 mttt -63.72 -45.81 88.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.962 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.589 ' HB3' ' HG ' ' A' ' 27' ' ' LEU . 17.9 m-85 -62.78 -42.75 99.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.834 0.35 . . . . 0.0 111.388 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.526 ' HB2' ' HB2' ' A' ' 55' ' ' PHE . 15.6 m -71.28 -28.11 63.9 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.313 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 68.4 mttm 71.49 -49.52 0.68 Allowed 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.855 0.862 . . . . 0.0 110.557 -175.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -124.46 91.84 3.53 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 172.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.526 ' HB2' ' HB2' ' A' ' 52' ' ' SER . 81.8 t80 -106.33 122.19 45.74 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.881 -176.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -114.67 115.27 26.84 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.665 177.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.509 ' HA2' ' O ' ' A' ' 35' ' ' GLY . . . -121.35 160.17 15.76 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 119.975 -1.107 . . . . 0.0 113.614 -175.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.636 HG21 ' HB3' ' A' ' 86' ' ' MET . 0.1 OUTLIER -140.76 106.99 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 123.251 0.621 . . . . 0.0 110.217 173.222 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.578 ' HB2' ' HG ' ' A' ' 71' ' ' LEU . 52.7 t-80 -102.05 117.29 34.48 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.151 -173.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -107.07 -14.4 18.94 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.454 -0.879 . . . . 0.0 113.444 -175.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -76.74 156.08 32.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.756 0.312 . . . . 0.0 110.389 -179.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 82.4 mtp -108.28 81.27 1.46 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.307 0.575 . . . . 0.0 109.93 175.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -106.9 -78.3 0.59 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.72 179.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.49 ' HD1' ' HB ' ' A' ' 40' ' ' VAL . 92.3 m-85 -107.45 154.37 40.73 Favored Pre-proline 0 C--N 1.323 -0.556 0 N-CA-C 110.318 -0.252 . . . . 0.0 110.318 178.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -74.42 -38.88 1.73 Allowed 'Trans proline' 0 CA--C 1.53 0.279 0 C-N-CA 122.49 2.126 . . . . 0.0 112.799 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.443 ' HB3' HD22 ' A' ' 42' ' ' LEU . 13.0 m-20 -60.38 -45.13 94.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.217 0.532 . . . . 0.0 111.482 -175.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.429 HG21 ' HA ' ' A' ' 40' ' ' VAL . 45.3 t -65.68 -27.94 42.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.546 -174.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 46.6 mttp -64.81 -25.66 68.01 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.871 0.367 . . . . 0.0 110.933 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -85.02 -28.43 25.72 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.795 -176.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.464 ' HB3' HD23 ' A' ' 71' ' ' LEU . 58.9 t-80 -69.79 -45.04 68.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.116 0.484 . . . . 0.0 109.95 177.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.578 ' HG ' ' HB2' ' A' ' 59' ' ' HIS . 1.3 pt? -140.02 113.05 7.55 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.421 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.29 -172.74 1.24 Allowed 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 123.099 2.533 . . . . 0.0 113.209 -176.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.431 ' CZ ' ' HA3' ' A' ' 89' ' ' GLY . 59.7 t80 -75.08 -43.48 52.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.545 -173.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 86' ' ' MET . 22.0 m -136.94 140.78 42.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.967 0.413 . . . . 0.0 111.579 -177.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.0 ttpm? -160.26 132.74 6.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.529 176.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.642 HG23 ' CE1' ' A' ' 104' ' ' PHE . 43.5 t -93.77 131.75 39.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.765 0.317 . . . . 0.0 110.249 173.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 38.5 mt -108.04 152.11 24.94 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 174.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 37.2 tp -122.41 96.11 4.91 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 175.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 60.4 t -102.25 95.45 3.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.685 -175.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 55.52 32.31 18.8 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.634 0.731 . . . . 0.0 111.054 175.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 114.53 -33.59 5.31 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.565 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 85.2 t -72.38 120.09 20.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.826 0.346 . . . . 0.0 110.695 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.9 101.73 13.44 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.048 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 19.0 mt -95.08 105.27 16.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.358 -176.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.569 ' HA2' HG22 ' A' ' 76' ' ' VAL . . . -89.5 94.36 1.98 Allowed Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.783 -0.723 . . . . 0.0 111.347 178.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.636 ' HB3' HG21 ' A' ' 58' ' ' VAL . 35.8 mtm -91.21 107.77 19.43 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.844 0.354 . . . . 0.0 110.687 -176.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 37.0 t -125.53 85.44 2.4 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 175.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 79.9 t60 -84.7 89.7 7.55 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.92 -173.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.431 ' HA3' ' CZ ' ' A' ' 73' ' ' PHE . . . -148.53 172.3 28.76 Favored Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.4 176.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 75.4 t-105 -76.52 106.85 8.41 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.951 0.405 . . . . 0.0 110.525 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -130.06 152.12 19.6 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 177.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -112.06 162.86 19.38 Favored Pre-proline 0 C--N 1.319 -0.721 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.32 -12.72 21.21 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.423 2.082 . . . . 0.0 112.514 178.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 14.0 m95 -80.47 -51.7 8.5 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.275 -178.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.483 ' OD2' ' HD3' ' A' ' 99' ' ' ARG . 12.0 p-10 -94.9 -0.58 53.87 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.159 -176.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 22.5 tp -50.52 -64.84 0.68 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.128 -0.487 . . . . 0.0 112.199 -174.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.485 ' HD2' ' HB2' ' A' ' 125' ' ' ALA . 42.5 mtmt -61.73 -54.37 43.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.365 0.602 . . . . 0.0 110.727 -176.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -61.08 -45.96 92.58 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.818 -1.083 . . . . 0.0 112.28 -171.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.483 ' HD3' ' OD2' ' A' ' 95' ' ' ASP . 34.0 ttt180 -79.37 -46.22 18.04 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.967 -173.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.457 HD13 HG21 ' A' ' 111' ' ' ILE . 47.3 mt -66.09 -29.45 69.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.687 0.279 . . . . 0.0 111.519 -176.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.608 HD22 ' HE3' ' A' ' 107' ' ' LYS . 86.0 mt -78.98 -13.28 59.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.687 0.28 . . . . 0.0 111.149 177.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -84.52 -31.74 24.29 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.83 0.348 . . . . 0.0 110.268 173.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.3 t -63.58 -49.72 81.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.254 177.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.642 ' CE1' HG23 ' A' ' 76' ' ' VAL . 20.3 m-85 -105.68 116.01 31.22 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.551 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -72.87 -29.16 62.96 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 170.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -76.48 97.63 4.37 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.853 171.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.608 ' HE3' HD22 ' A' ' 101' ' ' LEU . 13.0 mptt -63.24 113.93 11.11 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-O 120.996 0.426 . . . . 0.0 110.975 -178.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.493 ' HD3' ' HA ' ' A' ' 107' ' ' LYS . 1.0 OUTLIER -85.32 158.86 11.13 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.581 2.854 . . . . 0.0 112.642 -175.944 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -79.38 -53.24 7.11 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.032 177.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 74.8 t -120.42 128.6 76.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.865 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.476 HD12 ' CE2' ' A' ' 129' ' ' PHE . 48.6 mt -114.65 129.21 71.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.083 0.468 . . . . 0.0 110.797 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.444 HD23 ' HB2' ' A' ' 130' ' ' LEU . 81.4 mt -102.31 120.53 40.64 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.03 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -132.38 -169.61 2.26 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 -178.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -137.03 126.79 3.81 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.634 -0.794 . . . . 0.0 112.645 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 20.4 t60 -167.62 -71.86 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.183 0.516 . . . . 0.0 110.143 176.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.482 HG22 ' H ' ' A' ' 118' ' ' GLU . 6.6 m -83.05 143.2 30.76 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.118 -177.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.422 ' HB3' ' OE1' ' A' ' 137' ' ' GLU . 61.6 m-70 -90.31 -21.46 22.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.304 0.573 . . . . 0.0 110.168 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.482 ' H ' HG22 ' A' ' 116' ' ' THR . 48.6 mt-10 -87.01 121.0 71.78 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.169 173.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.742 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 23.5 Cg_exo -61.76 101.25 0.21 Allowed 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.704 2.269 . . . . 0.0 112.399 -175.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -111.41 127.34 55.64 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.851 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -79.84 103.23 9.59 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 174.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.617 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 38.5 p -99.5 113.81 26.4 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.248 -176.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.407 HG13 ' O ' ' A' ' 123' ' ' VAL . 6.9 p -109.7 97.71 6.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-O 122.168 0.985 . . . . 0.0 109.686 177.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.473 ' HB3' ' HD3' ' A' ' 97' ' ' LYS . 58.5 mttp -129.61 137.37 50.65 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.581 -176.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.485 ' HB2' ' HD2' ' A' ' 97' ' ' LYS . . . 64.96 13.38 8.59 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 123.616 0.572 . . . . 0.0 110.917 -176.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 89.74 -9.59 76.63 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.294 -178.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 38.8 t -93.04 141.34 14.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 128' ' ' ARG . 14.8 ttt180 -100.54 102.16 13.26 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.25 0.548 . . . . 0.0 110.428 -177.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.617 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 18.2 m-85 -92.09 142.86 27.04 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.235 178.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.444 ' HB2' HD23 ' A' ' 112' ' ' LEU . 86.1 mt -124.4 136.45 54.07 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.925 0.393 . . . . 0.0 110.917 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.742 ' O ' ' HA ' ' A' ' 119' ' ' PRO . 4.1 p30 -130.01 103.8 16.99 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.844 176.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -94.37 154.85 2.05 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.002 2.468 . . . . 0.0 113.297 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -71.93 159.06 53.65 Favored Glycine 0 N--CA 1.452 -0.289 0 N-CA-C 111.409 -0.676 . . . . 0.0 111.409 175.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 13.4 t -83.54 176.3 9.14 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 117.304 0.552 . . . . 0.0 111.251 -175.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 20.7 mt -70.81 -34.82 72.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.003 -170.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -77.03 -7.14 55.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.145 0.498 . . . . 0.0 110.69 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.422 ' OE1' ' HB3' ' A' ' 117' ' ' HIS . 42.2 mt-10 -92.6 1.12 57.43 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.003 176.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 73.34 39.6 50.99 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.678 -0.692 . . . . 0.0 113.08 174.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 50.2 m -150.08 144.29 25.65 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.763 0.316 . . . . 0.0 110.678 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -143.95 166.16 25.74 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.591 176.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -114.47 134.89 54.67 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.258 0.551 . . . . 0.0 111.411 -175.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 152' ' ' PHE . 89.4 t -116.47 121.43 67.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.572 175.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 5.2 tt -110.61 107.35 16.92 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -104.87 142.45 34.72 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.961 176.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.0 mp -90.74 94.28 9.61 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.218 0.532 . . . . 0.0 109.689 172.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -87.19 113.38 22.87 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.4 -178.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 68.35 -62.96 0.41 Allowed Glycine 0 CA--C 1.52 0.36 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.562 -169.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 179.38 27.77 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 175.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -127.1 160.53 30.89 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -175.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 47.6 t -77.76 108.88 11.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.844 0.354 . . . . 0.0 111.426 -176.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.429 HH11 ' HD3' ' A' ' 151' ' ' ARG . 15.2 ttm180 -107.7 96.07 6.13 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 173.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . 0.436 ' HA ' ' O ' ' A' ' 142' ' ' VAL . 40.1 p90 -102.41 127.53 49.4 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.928 -178.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -120.32 140.72 50.84 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.849 176.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -100.58 97.54 8.22 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.519 176.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -92.28 140.86 29.18 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.088 -177.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 18.1 p -89.62 155.58 19.15 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.617 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.728 HD13 ' HG2' ' A' ' 20' ' ' PRO . 83.0 mt . . . . . 0 C--O 1.247 0.952 0 CA-C-O 118.334 -0.841 . . . . 0.0 109.865 177.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 60.1 mttp . . . . . 0 N--CA 1.455 -0.21 0 CA-C-O 120.677 0.275 . . . . 0.0 110.293 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.539 ' HG2' ' HG2' ' A' ' 144' ' ' GLU . 79.5 mtt180 -104.92 111.28 23.98 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.629 172.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.545 ' HE2' HG11 ' A' ' 79' ' ' VAL . 70.4 m-85 -101.59 129.73 47.76 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.028 0.442 . . . . 0.0 111.036 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.572 ' HB3' HG22 ' A' ' 33' ' ' VAL . 36.8 tp -89.57 112.25 23.4 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.611 176.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.403 ' HB3' ' HB3' ' A' ' 141' ' ' ALA . 51.5 tp -96.76 102.23 13.98 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.116 0.484 . . . . 0.0 110.045 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.503 HG13 ' HA2' ' A' ' 35' ' ' GLY . 11.5 pt -101.47 126.29 55.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.493 176.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.592 ' HB3' ' OG1' ' A' ' 116' ' ' THR . 14.0 m -68.62 179.65 1.66 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.028 -176.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -78.4 79.82 4.82 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 122.053 0.93 . . . . 0.0 110.811 -177.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.524 ' HB3' HD23 ' A' ' 135' ' ' LEU . 10.6 p -80.53 133.87 35.87 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 176.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 74.3 m-70 -99.57 80.09 2.34 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.363 0.602 . . . . 0.0 109.617 -177.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.476 ' HB ' ' HD1' ' A' ' 39' ' ' TYR . 38.6 t -114.87 137.62 22.93 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.617 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -82.79 -58.71 0.07 OUTLIER 'Cis proline' 0 N--CA 1.461 -0.4 0 C-N-CA 123.666 -1.389 . . . . 0.0 112.887 -2.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER 35.05 -96.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -173.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 40.9 mtm180 -127.33 20.66 6.76 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 15.6 tmm? -144.16 100.25 3.52 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.246 0.546 . . . . 0.0 109.987 173.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -110.08 16.02 22.11 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.825 176.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 27.9 p -84.67 39.33 0.74 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.078 -177.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.0 tt -97.16 119.92 62.26 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.563 ' HG3' HD13 ' A' ' 157' ' ' LEU . 26.9 Cg_endo -61.66 130.39 31.31 Favored 'Trans proline' 0 C--O 1.234 0.291 0 C-N-CA 123.092 2.528 . . . . 0.0 112.552 -178.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -63.44 -18.57 63.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.885 -179.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -52.62 -49.26 65.47 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.769 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.0 tt -70.38 -36.32 66.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.345 0.593 . . . . 0.0 110.34 -176.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.689 HD12 HD23 ' A' ' 27' ' ' LEU . 58.3 tp -69.81 -33.79 72.82 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.131 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -71.09 -36.61 72.27 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.327 178.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 75.6 m -80.69 7.53 10.02 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.752 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.689 HD23 HD12 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -50.56 -41.48 54.2 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.592 0.71 . . . . 0.0 110.724 176.896 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 71.3 mttt -90.99 11.15 23.83 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.173 -171.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -104.28 7.94 35.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.038 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -126.02 158.77 34.48 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.4 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -72.0 -53.19 13.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.176 0.512 . . . . 0.0 109.968 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.539 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -138.12 151.96 21.64 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.194 179.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.572 HG22 ' HB3' ' A' ' 5' ' ' LEU . 97.8 t -118.96 135.89 57.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-O 120.703 0.287 . . . . 0.0 110.482 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.456 HG12 ' HB2' ' A' ' 56' ' ' TYR . 37.0 mt -111.56 116.62 53.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.854 176.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.503 ' HA2' HG13 ' A' ' 7' ' ' ILE . . . -104.25 119.66 6.36 Favored Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 177.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 94.3 mt -92.81 24.07 3.82 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.122 0.487 . . . . 0.0 110.552 -179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 121.55 21.91 2.9 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.828 -178.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.405 ' HB3' HD12 ' A' ' 7' ' ' ILE . 10.9 t70 -81.14 134.03 35.57 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.613 ' HD2' HD11 ' A' ' 48' ' ' LEU . 25.7 m-85 64.6 105.73 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 O-C-N 123.872 0.732 . . . . 0.0 110.924 -175.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.417 HG22 ' O ' ' A' ' 12' ' ' VAL . 35.9 m -86.77 0.22 6.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.332 -176.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.549 ' O ' HG23 ' A' ' 45' ' ' VAL . 16.0 t70 -86.65 135.93 33.22 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.792 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 54.3 tp -62.7 -49.49 74.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.702 -175.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -63.1 -35.31 79.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.823 0.344 . . . . 0.0 110.752 -177.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.451 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 14.1 m -68.6 -33.06 73.4 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.21 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 41' ' ' ASP . 93.4 t -60.2 -46.12 95.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.369 0.604 . . . . 0.0 109.888 175.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.23 -38.0 80.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.89 177.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.24 -33.8 72.79 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.801 176.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.613 HD11 ' HD2' ' A' ' 39' ' ' TYR . 83.3 mt -66.95 -38.13 85.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.26 0.552 . . . . 0.0 109.996 178.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.681 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 35.8 tt0 -77.23 -11.39 59.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.331 176.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -92.5 -36.4 13.09 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.643 0.259 . . . . 0.0 110.945 -178.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.483 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . 6.4 m-30 -65.69 -67.37 0.45 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.4 178.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.49 ' OG ' HD12 ' A' ' 27' ' ' LEU . 5.1 m -73.49 -23.66 60.08 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.53 177.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.681 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 60.7 mttp 70.51 4.01 4.75 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.382 0.673 . . . . 0.0 111.785 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -144.83 105.07 4.07 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 172.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -128.89 133.23 47.85 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.189 0.519 . . . . 0.0 111.242 -173.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.456 ' HB2' HG12 ' A' ' 34' ' ' ILE . 88.1 m-85 -113.7 118.92 35.68 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 173.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -131.12 132.2 6.72 Favored Glycine 0 N--CA 1.44 -1.081 0 C-N-CA 119.606 -1.283 . . . . 0.0 113.925 -171.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.5 m -130.92 147.84 33.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 168.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.566 ' HB3' ' HB2' ' A' ' 71' ' ' LEU . 2.9 p80 -94.34 142.5 27.34 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 119.489 -0.884 . . . . 0.0 110.666 -173.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -81.29 -107.29 0.34 Allowed Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 115.618 -0.719 . . . . 0.0 113.538 -172.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.938 HD21 ' HA ' ' A' ' 115' ' ' HIS . 43.0 m-80 -95.62 -83.95 0.35 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.785 0.326 . . . . 0.0 111.264 -173.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 51.4 ttm -112.74 122.98 49.26 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.232 0.539 . . . . 0.0 110.682 -178.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -145.89 -174.25 4.37 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.288 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -74.88 144.51 79.88 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-O 120.673 0.273 . . . . 0.0 111.372 -176.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -47.06 -38.29 24.14 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.843 3.029 . . . . 0.0 114.161 -175.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -70.11 -46.54 64.61 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.214 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 39.9 t -63.66 -32.6 57.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.594 -177.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.414 ' HE2' ' HB3' ' A' ' 68' ' ' LYS . 31.8 ttpt -50.12 -40.36 45.8 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.809 177.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -104.12 -14.61 15.82 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.121 0.486 . . . . 0.0 110.136 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -75.44 -40.21 57.86 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -179.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.566 ' HB2' ' HB3' ' A' ' 59' ' ' HIS . 80.8 mt -102.64 117.94 59.67 Favored Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 170.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -56.44 156.2 22.66 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 123.129 2.553 . . . . 0.0 113.504 -174.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -77.11 -16.92 59.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.519 177.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.7 p -157.89 139.37 13.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.099 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.2 mttm -144.43 142.49 30.34 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.524 176.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 21.7 t -121.39 110.54 28.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.159 0.504 . . . . 0.0 109.913 172.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 37.3 mt -92.95 147.99 22.38 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.401 -177.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 55.1 tp -117.83 98.01 6.13 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 175.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.545 HG11 ' HE2' ' A' ' 4' ' ' PHE . 48.5 t -105.49 96.26 4.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.629 -174.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 57.31 27.62 14.01 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.624 175.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 114.35 -24.22 11.64 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.542 178.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.5 t -83.04 128.44 38.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.567 0.222 . . . . 0.0 110.809 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 40.0 p -91.48 131.24 37.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.538 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 42.0 mt -124.51 104.72 14.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.883 0.373 . . . . 0.0 110.215 -178.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -91.71 104.8 3.21 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.877 -0.677 . . . . 0.0 111.447 178.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 22.1 mtm -103.95 118.11 35.9 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -178.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 113' ' ' PHE . 46.0 t -156.96 158.29 36.34 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.925 0.393 . . . . 0.0 110.717 -177.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 15.0 t60 -65.64 -32.81 74.58 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.259 175.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.29 -94.88 0.57 Allowed Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 -173.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.423 ' HE3' ' H ' ' A' ' 92' ' ' ALA . 17.0 t90 -173.71 -69.24 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 172.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 155.14 -34.47 0.66 Allowed Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.994 -0.622 . . . . 0.0 111.77 -178.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.452 ' O ' ' HB2' ' A' ' 96' ' ' LEU . . . -78.61 115.1 49.03 Favored Pre-proline 0 C--N 1.327 -0.397 0 N-CA-C 110.487 -0.19 . . . . 0.0 110.487 178.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.469 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . 3.5 Cg_exo -81.22 5.18 6.42 Favored 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 123.427 2.752 . . . . 0.0 113.149 -175.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -80.74 -54.67 5.42 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.267 0.556 . . . . 0.0 109.942 -176.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 38.3 p30 -112.04 19.27 18.0 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.943 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.469 ' HB2' ' HA ' ' A' ' 93' ' ' PRO . 50.8 tp -54.47 -51.13 66.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.478 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -60.53 -45.38 94.07 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.926 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -61.37 -47.12 87.31 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.157 0.503 . . . . 0.0 110.844 -177.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.548 ' O ' HG23 ' A' ' 103' ' ' VAL . 36.3 ttm105 -67.0 -42.15 85.49 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.56 178.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.955 HD21 HG21 ' A' ' 111' ' ' ILE . 17.1 tp -67.57 -41.8 83.59 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.134 -176.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.432 HD21 HG21 ' A' ' 127' ' ' VAL . 93.7 mt -75.8 -5.74 47.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.528 178.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -95.38 -29.94 14.17 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.962 174.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 99' ' ' ARG . 94.8 t -62.68 -53.0 52.68 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 174.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -82.52 146.49 29.2 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 174.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -87.59 -27.11 22.74 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.897 0.38 . . . . 0.0 110.755 -177.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -113.64 177.65 4.56 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.532 177.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.866 ' H ' ' HD2' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -95.91 113.27 61.77 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.08 -175.133 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.478 ' HG2' HD11 ' A' ' 111' ' ' ILE . 1.2 Cg_endo -85.37 156.08 10.84 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.375 2.717 . . . . 0.0 111.854 177.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -90.7 -59.49 2.16 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.95 0.405 . . . . 0.0 110.771 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.635 HG21 HG21 ' A' ' 150' ' ' VAL . 57.3 t -105.15 119.54 54.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.331 -178.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.955 HG21 HD21 ' A' ' 100' ' ' LEU . 55.4 mt -116.46 128.69 73.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.079 0.466 . . . . 0.0 111.202 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.667 HD23 ' HB2' ' A' ' 130' ' ' LEU . 86.9 mt -107.61 124.72 50.37 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.011 176.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.515 ' HA ' ' O ' ' A' ' 87' ' ' CYS . 40.7 p90 -117.15 172.66 7.14 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 119.636 -0.825 . . . . 0.0 111.07 178.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -105.8 -165.18 23.32 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.442 -172.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.938 ' HA ' HD21 ' A' ' 61' ' ' ASN . 18.0 t60 69.06 41.73 1.37 Allowed 'General case' 0 C--O 1.233 0.191 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -173.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.592 ' OG1' ' HB3' ' A' ' 8' ' ' SER . 36.5 p -63.51 119.33 9.58 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 114.263 -1.335 . . . . 0.0 112.113 -171.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.442 ' HA ' ' OE2' ' A' ' 137' ' ' GLU . 0.0 OUTLIER -171.87 128.42 0.62 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.886 179.269 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 59.26 84.67 0.2 Allowed Pre-proline 0 N--CA 1.465 0.287 0 O-C-N 123.543 0.527 . . . . 0.0 110.791 -175.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -61.13 143.35 98.78 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 123.075 2.517 . . . . 0.0 113.014 -175.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -162.13 146.15 12.22 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.924 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -94.12 114.35 26.48 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.586 175.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.482 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 67.5 p -119.82 144.16 47.48 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.694 0.283 . . . . 0.0 111.405 -176.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.7 p -138.8 124.3 22.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.127 0.489 . . . . 0.0 110.976 178.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.481 ' HB2' ' HE2' ' A' ' 129' ' ' PHE . 88.1 mttt -140.9 139.42 34.35 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.536 176.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 66.94 14.04 9.68 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 123.485 0.491 . . . . 0.0 111.626 177.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 90.18 -2.82 81.87 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.234 -177.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.432 HG21 HD21 ' A' ' 101' ' ' LEU . 33.1 t -100.34 137.9 26.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -98.23 120.12 38.09 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.66 -176.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.482 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 34.9 m-85 -108.48 121.15 44.37 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.805 -178.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.667 ' HB2' HD23 ' A' ' 112' ' ' LEU . 78.1 mt -107.88 138.76 43.56 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-O 121.459 0.647 . . . . 0.0 111.146 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.462 ' HB3' ' CZ ' ' A' ' 113' ' ' PHE . 7.4 p30 -139.39 116.16 8.49 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.355 173.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.547 ' HD2' HG22 ' A' ' 116' ' ' THR . 86.2 Cg_endo -88.17 168.62 6.43 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.712 2.275 . . . . 0.0 112.502 178.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -85.28 147.77 22.62 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 176.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.58 ' HA ' ' HB2' ' A' ' 8' ' ' SER . 81.1 p -75.56 168.76 19.4 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.087 0.47 . . . . 0.0 111.077 -176.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.524 HD23 ' HB3' ' A' ' 10' ' ' SER . 4.2 mm? -64.82 -24.16 67.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.068 178.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -75.56 -14.36 60.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.036 0.446 . . . . 0.0 110.676 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.442 ' OE2' ' HA ' ' A' ' 117' ' ' HIS . 33.1 mt-10 -98.39 -2.23 39.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.192 178.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.518 ' HA2' HD12 ' A' ' 157' ' ' LEU . . . 70.78 45.45 52.17 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.925 177.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.6 p -150.81 153.92 36.32 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.597 0.199 . . . . 0.0 110.753 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -154.25 159.59 41.37 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 175.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.403 ' HB3' ' HB3' ' A' ' 6' ' ' LEU . . . -114.6 131.21 56.77 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.826 0.346 . . . . 0.0 111.384 -175.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 61.9 t -108.53 107.78 23.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 173.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.505 ' HA ' ' HA ' ' A' ' 152' ' ' PHE . 6.7 tt -96.97 105.14 17.23 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.196 0.522 . . . . 0.0 110.106 -176.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.539 ' HG2' ' HG2' ' A' ' 3' ' ' ARG . 34.1 mt-10 -100.19 149.75 23.23 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.583 176.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.9 mp -90.49 90.12 7.87 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 166.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -101.23 112.48 24.98 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.732 -170.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.75 10.97 59.49 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.067 -174.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 91.65 5.07 67.1 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.238 -0.506 . . . . 0.0 112.086 -178.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -108.63 161.83 14.72 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 176.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.635 HG21 HG21 ' A' ' 110' ' ' VAL . 50.0 t -81.49 101.61 6.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.08 0.467 . . . . 0.0 110.593 -176.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 31.0 tpt180 -103.57 87.49 2.85 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.077 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . 0.505 ' HA ' ' HA ' ' A' ' 143' ' ' LEU . 12.0 p90 -91.37 101.5 14.18 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.295 0.569 . . . . 0.0 110.02 177.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -91.06 101.49 14.25 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.359 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 48.2 tp -75.62 99.93 4.46 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 175.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -93.94 133.82 36.97 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.912 -177.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.6 m -98.42 150.33 21.74 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.407 -175.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.563 HD13 ' HG3' ' A' ' 20' ' ' PRO . 83.1 mt . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.37 -0.824 . . . . 0.0 109.897 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.2 mptt . . . . . 0 CA--C 1.519 -0.224 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 52.8 mtp180 -106.51 116.57 32.16 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.09 178.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.535 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 73.1 m-85 -105.51 124.06 48.92 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.113 0.482 . . . . 0.0 111.487 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.528 ' HB3' HG22 ' A' ' 33' ' ' VAL . 37.9 tp -89.18 121.35 31.4 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.86 177.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.445 ' HB3' ' HB3' ' A' ' 141' ' ' ALA . 45.0 tp -110.95 106.46 15.57 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.181 0.515 . . . . 0.0 111.207 -177.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 19.7 pt -101.35 129.96 51.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.192 173.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.556 ' H ' HD21 ' A' ' 135' ' ' LEU . 9.1 p -85.27 -177.8 6.59 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.978 0.418 . . . . 0.0 111.954 -173.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.625 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.2 m-20 -65.39 104.22 0.94 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.31 -177.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.658 ' HB3' HD12 ' A' ' 135' ' ' LEU . 10.5 p -104.07 175.38 5.5 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 177.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -135.05 75.42 1.57 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.345 0.593 . . . . 0.0 110.098 176.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.419 ' O ' HG22 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -135.13 147.56 62.96 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.542 178.522 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -87.53 104.0 0.47 Allowed 'Cis proline' 0 N--CA 1.46 -0.463 0 C-N-CA 123.322 -1.532 . . . . 0.0 112.374 -2.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.405 ' H ' ' HA ' ' A' ' 12' ' ' VAL . 2.3 t -135.34 -133.59 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -178.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 22.0 ttm-85 -87.73 4.22 45.04 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.096 0.474 . . . . 0.0 110.812 -177.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.523 ' HG2' ' OG ' ' A' ' 18' ' ' SER . 30.3 ttp -84.86 -76.23 0.32 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 62.72 2.93 1.03 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.222 0.609 . . . . 0.0 112.41 178.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.523 ' OG ' ' HG2' ' A' ' 16' ' ' MET . 12.9 p -95.39 38.42 1.15 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.955 0.407 . . . . 0.0 111.519 -177.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.2 tt -107.84 111.11 62.51 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 177.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -70.57 141.24 41.48 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 122.734 2.289 . . . . 0.0 113.012 -177.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -63.8 -19.76 65.25 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.379 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -52.8 -42.66 65.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.898 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -68.66 -32.21 54.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.121 0.486 . . . . 0.0 110.514 -177.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.447 ' O ' HD23 ' A' ' 27' ' ' LEU . 58.3 tp -76.87 -31.97 57.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.412 -176.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -76.49 -23.47 53.76 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.555 178.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.9 m -78.49 0.85 24.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.766 -177.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.532 ' HB3' ' HB3' ' A' ' 51' ' ' PHE . 2.0 mm? -56.6 -28.98 61.6 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.884 0.373 . . . . 0.0 111.726 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 42.5 mttp -85.14 0.44 51.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.535 -174.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -113.12 17.49 18.7 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -171.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -137.45 168.43 19.66 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.672 0.272 . . . . 0.0 110.71 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -91.28 -52.75 4.66 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-O 121.512 0.672 . . . . 0.0 110.0 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.535 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -129.38 137.63 9.7 Favored Glycine 0 N--CA 1.441 -0.982 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.292 179.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.528 HG22 ' HB3' ' A' ' 5' ' ' LEU . 79.8 t -113.42 129.53 69.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.598 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 38.9 mt -105.99 122.74 59.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.527 -179.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -104.21 103.97 2.36 Favored Glycine 0 N--CA 1.44 -1.071 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.265 177.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.483 ' HB3' ' HE1' ' A' ' 88' ' ' HIS . 81.8 mt -80.42 -30.67 37.67 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 175.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.625 ' HA3' ' HA ' ' A' ' 9' ' ' ASP . . . -166.42 56.49 0.24 Allowed Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 177.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -57.61 -73.34 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.182 -0.509 . . . . 0.0 112.274 -171.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.518 ' CD1' HD11 ' A' ' 48' ' ' LEU . 78.5 m-85 -135.91 156.43 48.77 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.927 0.394 . . . . 0.0 110.686 178.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.419 HG22 ' O ' ' A' ' 12' ' ' VAL . 22.6 m -92.58 -3.02 10.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.335 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.593 ' O ' HG23 ' A' ' 45' ' ' VAL . 23.5 t70 -100.64 129.51 46.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.675 -178.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.52 HD22 ' HB3' ' A' ' 66' ' ' ASP . 51.0 tp -57.47 -52.14 66.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.456 . . . . 0.0 112.056 -174.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -68.29 -32.07 71.96 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.796 0.331 . . . . 0.0 110.948 -172.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.3 m -70.68 -33.16 70.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.916 178.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 41' ' ' ASP . 87.4 t -61.97 -44.21 98.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 121.357 0.598 . . . . 0.0 110.067 175.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -71.19 -31.79 45.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.269 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -58.65 -37.51 76.11 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 174.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.518 HD11 ' CD1' ' A' ' 39' ' ' TYR . 85.1 mt -69.68 -37.58 76.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.211 177.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.414 ' HG3' ' HB3' ' A' ' 55' ' ' PHE . 23.9 tt0 -71.33 -12.6 61.52 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.663 -177.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -79.76 -47.58 15.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.836 0.351 . . . . 0.0 110.499 173.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.532 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . 76.0 m-85 -75.82 -42.71 49.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.949 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.2 t -71.17 104.69 3.15 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.004 175.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -49.77 -43.74 48.39 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.645 177.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -130.08 104.24 7.22 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.577 175.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.414 ' HB3' ' HG3' ' A' ' 49' ' ' GLU . 74.3 t80 -100.3 121.76 42.01 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.313 -176.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.598 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 91.9 m-85 -114.82 108.0 16.17 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -126.12 151.21 17.82 Favored Glycine 0 N--CA 1.442 -0.959 0 C-N-CA 119.872 -1.156 . . . . 0.0 112.734 -175.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -127.69 172.77 14.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 173.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.45 ' HB2' ' O ' ' A' ' 71' ' ' LEU . 10.7 t-80 -94.3 118.79 32.12 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.522 -172.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.4 ' HA2' ' CD2' ' A' ' 88' ' ' HIS . . . -82.51 -148.25 7.15 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.691 -179.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -118.04 120.91 39.22 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.578 0.228 . . . . 0.0 111.512 -176.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 84.4 mtp 73.84 95.78 0.07 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.797 176.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.412 ' OD2' ' HB ' ' A' ' 67' ' ' VAL . 8.4 p-10 -160.4 -173.99 4.27 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.531 -177.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.414 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 15.1 m-30 -77.83 140.99 63.39 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.722 0.296 . . . . 0.0 111.01 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.426 ' O ' ' HB3' ' A' ' 68' ' ' LYS . 51.0 Cg_exo -57.46 -16.0 21.8 Favored 'Trans proline' 0 N--CA 1.474 0.37 0 C-N-CA 123.26 2.64 . . . . 0.0 112.915 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.52 ' HB3' HD22 ' A' ' 42' ' ' LEU . 8.5 m-20 -68.64 -41.57 79.2 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.252 0.548 . . . . 0.0 110.21 177.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.412 ' HB ' ' OD2' ' A' ' 63' ' ' ASP . 25.3 t -73.38 -23.61 19.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.96 -178.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.426 ' HB3' ' O ' ' A' ' 65' ' ' PRO . 63.9 tttp -52.78 -34.15 51.94 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.28 -178.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -108.36 2.31 22.42 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -176.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -98.76 -34.83 10.36 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 175.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.45 ' O ' ' HB2' ' A' ' 59' ' ' HIS . 51.2 mt -107.36 116.13 58.49 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.956 177.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -64.11 159.22 43.93 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.999 2.466 . . . . 0.0 112.751 -178.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.428 ' HZ ' HH22 ' A' ' 99' ' ' ARG . 64.7 t80 -79.85 -29.81 40.18 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.494 -176.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.0 p -148.7 126.27 11.7 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.507 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.7 tttm -141.54 128.42 20.58 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 12.0 t -109.65 118.17 56.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.844 0.354 . . . . 0.0 110.149 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 38.7 mt -93.01 153.27 18.82 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.656 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -118.3 108.99 15.77 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 171.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 22.2 t -122.21 102.09 11.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.148 -174.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 56.43 25.0 9.09 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.408 -0.814 . . . . 0.0 112.188 174.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 114.15 -10.57 22.49 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.96 177.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 46.5 t -103.84 134.63 44.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 122.645 -0.326 . . . . 0.0 110.948 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.6 p -93.83 133.35 37.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.656 177.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 27.1 mt -129.01 99.34 4.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.812 0.339 . . . . 0.0 110.357 -176.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -89.59 110.25 3.7 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.852 -0.69 . . . . 0.0 111.785 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.495 ' HG2' ' HB2' ' A' ' 112' ' ' LEU . 32.6 mtm -99.91 123.25 43.96 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 -179.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 34.2 t -145.83 163.07 36.2 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.483 ' HE1' ' HB3' ' A' ' 36' ' ' LEU . 7.2 m80 -141.0 -165.27 1.92 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.989 0.423 . . . . 0.0 111.424 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 112.48 169.33 17.85 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -177.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 17.3 p90 -81.81 96.7 7.69 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.502 0.668 . . . . 0.0 110.546 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -122.98 115.66 2.75 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.036 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.45 153.91 81.62 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 178.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.99 -7.45 6.28 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.013 2.475 . . . . 0.0 113.603 -175.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -81.72 -52.78 6.8 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.197 0.522 . . . . 0.0 109.978 -178.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -103.55 -4.87 23.34 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.823 -174.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 40.9 tp -52.41 -56.69 13.3 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.797 -176.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 45.9 pttt -57.39 -42.97 83.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.446 -177.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -69.37 -41.69 76.2 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.642 -178.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.482 ' O ' HG23 ' A' ' 103' ' ' VAL . 42.7 ttt-85 -62.05 -47.53 84.33 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.006 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.524 HD13 HG21 ' A' ' 111' ' ' ILE . 94.2 mt -66.47 -38.41 87.27 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.27 -176.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.798 HD21 HG21 ' A' ' 127' ' ' VAL . 86.6 mt -76.16 -13.25 60.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.011 0.434 . . . . 0.0 110.888 177.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -82.89 -39.89 20.94 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.008 176.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 99' ' ' ARG . 90.8 t -66.24 -50.93 64.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.194 -178.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -87.38 111.92 21.6 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 121.066 -0.254 . . . . 0.0 110.967 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -57.82 -52.89 63.6 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 174.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -80.77 94.96 6.51 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 170.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.702 ' H ' ' HD2' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -59.95 123.15 70.77 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.217 -179.279 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 107' ' ' LYS . 2.2 Cg_endo -82.08 157.15 17.68 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 123.754 2.969 . . . . 0.0 112.699 -172.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -73.51 -44.94 56.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.946 177.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 65.4 t -118.78 140.67 41.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.948 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.524 HG21 HD13 ' A' ' 100' ' ' LEU . 40.9 mt -129.86 131.99 66.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.74 0.305 . . . . 0.0 110.474 177.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.661 HD23 ' HB2' ' A' ' 130' ' ' LEU . 75.3 mt -105.24 127.34 52.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.64 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.405 ' HE1' ' HB3' ' A' ' 129' ' ' PHE . 13.9 p90 -147.21 147.24 30.26 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.686 176.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -130.96 114.79 1.64 Allowed Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.332 -0.937 . . . . 0.0 111.814 179.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 17.2 t60 -178.45 21.59 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 177.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.495 HG22 ' H ' ' A' ' 117' ' ' HIS . 0.2 OUTLIER -101.65 -176.03 3.02 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.142 -174.564 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.495 ' H ' HG22 ' A' ' 116' ' ' THR . 49.4 m-70 -111.63 -43.19 3.69 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.756 0.312 . . . . 0.0 110.562 178.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -124.58 149.21 61.23 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.913 175.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.566 ' HG3' HD22 ' A' ' 154' ' ' LEU . 74.4 Cg_endo -74.83 138.51 23.58 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.713 2.275 . . . . 0.0 111.988 178.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -150.58 125.95 10.1 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.374 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -78.26 94.47 4.8 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 177.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.504 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 68.6 p -103.46 119.19 38.4 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.837 -174.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.493 HG13 ' O ' ' A' ' 123' ' ' VAL . 8.9 p -107.25 88.89 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 122.336 1.065 . . . . 0.0 109.113 170.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -127.27 146.24 50.5 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.701 -174.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 61.8 15.25 6.89 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 123.724 0.64 . . . . 0.0 110.893 -174.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 83.91 9.87 81.9 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.52 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.798 HG21 HD21 ' A' ' 101' ' ' LEU . 47.7 t -119.21 140.83 41.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.698 0.285 . . . . 0.0 110.307 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.643 ' NH1' HD21 ' A' ' 130' ' ' LEU . 26.9 ttt-85 -89.36 94.16 9.79 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.504 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 89.3 m-85 -83.44 126.14 32.44 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.661 ' HB2' HD23 ' A' ' 112' ' ' LEU . 50.2 mt -112.01 122.43 47.74 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.385 0.612 . . . . 0.0 110.965 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.511 ' HA ' ' HD3' ' A' ' 132' ' ' PRO . 5.1 p30 -129.22 122.95 21.37 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.821 178.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.511 ' HD3' ' HA ' ' A' ' 131' ' ' ASN . 5.4 Cg_endo -87.15 169.64 7.33 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.238 2.625 . . . . 0.0 112.288 179.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -89.05 -160.23 36.23 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.27 178.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 48.2 t -88.19 139.3 30.64 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.825 0.345 . . . . 0.0 110.637 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.658 HD12 ' HB3' ' A' ' 10' ' ' SER . 58.3 mt -66.17 -19.74 65.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.28 178.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -78.76 -12.53 60.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.348 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -87.52 -4.62 58.98 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.417 -176.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 77.9 25.75 61.71 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.335 178.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 7.3 t -139.46 132.32 29.25 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 178.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -126.32 173.25 9.46 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -177.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.445 ' HB3' ' HB3' ' A' ' 6' ' ' LEU . . . -114.38 134.94 54.61 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.689 -174.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.537 HG12 ' HG3' ' A' ' 144' ' ' GLU . 47.3 t -128.83 124.08 60.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.881 176.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.529 HD21 HG13 ' A' ' 150' ' ' VAL . 5.8 tt -101.87 106.47 17.43 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.537 ' HG3' HG12 ' A' ' 142' ' ' VAL . 45.2 mt-10 -113.3 131.42 55.94 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.521 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 21.2 mt -93.07 90.74 7.02 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.887 -178.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -87.54 111.47 21.25 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.832 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.74 -69.02 0.29 Allowed Glycine 0 CA--C 1.52 0.384 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.633 -175.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -171.17 25.46 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 111.665 -0.574 . . . . 0.0 111.665 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -110.37 143.04 41.21 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.529 HG13 HD21 ' A' ' 143' ' ' LEU . 46.5 t -86.03 89.07 2.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 177.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 67.6 mtp180 -90.02 98.44 11.77 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.337 0.589 . . . . 0.0 110.644 -175.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -83.37 93.99 7.87 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.12 175.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -97.46 112.52 24.33 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.845 0.355 . . . . 0.0 110.988 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.566 HD22 ' HG3' ' A' ' 119' ' ' PRO . 15.9 tp -83.6 92.4 7.65 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 171.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -83.78 145.69 28.56 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.598 -174.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 18.7 p -91.47 145.05 24.94 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.545 178.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 79.8 mt . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.688 -0.673 . . . . 0.0 110.388 178.714 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 55.1 mttm . . . . . 0 N--CA 1.452 -0.358 0 CA-C-O 120.823 0.344 . . . . 0.0 110.706 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 50.3 mtp180 -115.57 123.19 47.85 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.405 ' HE2' HG11 ' A' ' 79' ' ' VAL . 77.6 m-85 -119.52 135.07 54.93 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.979 0.419 . . . . 0.0 110.533 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.428 ' HB2' ' CD2' ' A' ' 30' ' ' TYR . 32.6 tp -89.33 127.2 35.78 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.158 179.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.535 ' HB3' ' HB3' ' A' ' 141' ' ' ALA . 47.8 tp -106.84 109.88 21.9 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.974 0.416 . . . . 0.0 110.547 -178.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.433 HG13 ' HA2' ' A' ' 35' ' ' GLY . 7.4 pt -101.35 128.62 53.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.771 177.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.3 m -89.4 -171.32 3.18 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.14 -171.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -47.97 117.16 1.77 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.165 -178.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.665 ' HB2' ' HA ' ' A' ' 38' ' ' ASP . 37.0 m -137.35 160.38 39.24 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.856 -1.065 . . . . 0.0 108.806 174.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.61 ' H ' ' HE2' ' A' ' 16' ' ' MET . 32.2 m80 -127.35 58.4 1.46 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.288 0.566 . . . . 0.0 109.579 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.426 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . 2.9 t -108.67 134.02 20.44 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.845 -177.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.426 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 72.4 Cg_endo -103.08 51.82 1.45 Allowed 'Cis proline' 0 N--CA 1.448 -1.183 0 C-N-CA 124.078 -1.218 . . . . 0.0 111.995 -4.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.466 HG22 HG21 ' A' ' 40' ' ' VAL . 10.9 t -58.14 -39.99 75.3 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-O 121.531 0.681 . . . . 0.0 109.999 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 31.9 ttt85 -177.19 -33.97 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.374 -1.285 . . . . 0.0 108.681 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.61 ' HE2' ' H ' ' A' ' 11' ' ' HIS . 32.0 ttp -74.17 122.92 23.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.013 178.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -130.13 13.01 5.66 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.085 0.469 . . . . 0.0 110.339 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.0 p -82.66 33.74 0.43 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.418 -177.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.8 tt -99.67 114.22 65.48 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.435 ' HG2' HD22 ' A' ' 157' ' ' LEU . 36.6 Cg_exo -60.95 130.01 31.12 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 123.278 2.652 . . . . 0.0 113.016 -176.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -67.33 -23.36 65.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.271 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -58.87 -34.68 71.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.358 -178.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.43 HG22 ' O ' ' A' ' 20' ' ' PRO . 6.3 tt -65.59 -38.39 82.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.538 0.685 . . . . 0.0 109.662 178.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.681 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 46.0 tp -70.34 -32.01 69.54 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.303 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -71.62 -24.39 61.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.801 178.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.0 m -85.94 7.61 23.58 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -171.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.729 HD13 ' HB3' ' A' ' 52' ' ' SER . 4.3 mt -64.91 -19.77 66.1 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.509 0.671 . . . . 0.0 109.401 178.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -56.58 -23.8 43.11 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 114.563 -1.199 . . . . 0.0 111.835 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -82.34 -21.53 35.96 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -178.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.428 ' CD2' ' HB2' ' A' ' 5' ' ' LEU . 30.3 m-85 -113.87 159.75 19.5 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -162.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -71.94 -30.0 64.87 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.637 176.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -175.69 178.59 47.2 Favored Glycine 0 N--CA 1.439 -1.149 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.334 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.425 HG21 HD13 ' A' ' 27' ' ' LEU . 93.3 t -123.58 144.72 32.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 110.305 -0.257 . . . . 0.0 110.305 -178.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.452 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 55.0 mt -113.07 116.45 52.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.071 176.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.433 ' HA2' HG13 ' A' ' 7' ' ' ILE . . . -99.03 124.59 8.28 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.699 176.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.417 HD11 HD11 ' A' ' 6' ' ' LEU . 84.7 mt -98.39 3.19 48.47 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 122.624 -0.339 . . . . 0.0 111.087 -178.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 128.98 79.02 0.23 Allowed Glycine 0 CA--C 1.505 -0.582 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 -176.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.665 ' HA ' ' HB2' ' A' ' 10' ' ' SER . 0.4 OUTLIER -135.9 -70.26 0.48 Allowed 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.413 -0.394 . . . . 0.0 111.043 -169.402 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 96.9 m-85 -90.51 105.01 17.52 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 174.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.466 HG21 HG22 ' A' ' 14' ' ' VAL . 11.2 m -82.25 -12.36 12.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.298 -173.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.493 ' O ' HG23 ' A' ' 45' ' ' VAL . 11.4 t70 -86.65 127.52 34.94 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.339 -178.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 51.8 tp -61.13 -45.18 95.73 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.689 -174.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -62.87 -36.74 84.29 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.209 0.528 . . . . 0.0 110.252 -178.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.454 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 16.5 m -68.64 -33.26 73.69 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.617 176.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 41' ' ' ASP . 85.0 t -59.97 -41.88 87.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-O 121.109 0.481 . . . . 0.0 110.179 173.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -67.46 -34.8 70.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.185 0.517 . . . . 0.0 110.123 177.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.67 -33.75 75.69 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.062 174.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' A' ' 44' ' ' THR . 98.3 mt -64.63 -36.43 84.23 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 175.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.709 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 37.3 mt-10 -77.49 -4.8 47.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.738 176.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -86.69 -41.07 14.48 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 173.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.503 ' CB ' HD12 ' A' ' 27' ' ' LEU . 74.5 m-85 -76.79 -51.44 11.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.178 178.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.729 ' HB3' HD13 ' A' ' 27' ' ' LEU . 78.6 p -90.62 -25.12 20.3 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 121.071 -0.252 . . . . 0.0 111.616 -178.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.709 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 68.0 mttm 71.6 -50.35 0.69 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.413 0.685 . . . . 0.0 111.712 -177.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -105.02 101.89 11.42 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.511 0.672 . . . . 0.0 109.728 175.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.608 ' HB3' ' HG2' ' A' ' 49' ' ' GLU . 89.7 t80 -114.82 124.61 52.19 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.806 -176.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.452 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 93.5 m-85 -112.76 165.8 11.95 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 174.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 163.45 174.21 33.05 Favored Glycine 0 N--CA 1.442 -0.959 0 C-N-CA 119.211 -1.471 . . . . 0.0 113.604 176.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.449 HG21 ' HB3' ' A' ' 86' ' ' MET . 2.8 m -146.68 118.75 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 114.791 -0.705 . . . . 0.0 109.167 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -94.53 176.39 6.31 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.167 -175.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -109.44 -171.4 20.57 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.332 -0.937 . . . . 0.0 112.216 -176.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -88.68 40.77 0.98 Allowed 'General case' 0 C--N 1.321 -0.654 0 O-C-N 122.424 -0.456 . . . . 0.0 110.065 178.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 57.5 mtm -132.66 4.8 3.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.524 -179.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -107.87 -169.09 1.46 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.375 -175.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.416 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 95.9 m-85 -81.0 135.85 51.09 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.231 176.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 64' ' ' TYR . 50.2 Cg_exo -55.18 -36.53 93.41 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 123.336 2.691 . . . . 0.0 113.386 -177.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -69.14 -24.53 64.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.85 0.357 . . . . 0.0 111.306 -177.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.402 HG13 HD21 ' A' ' 71' ' ' LEU . 41.0 t -65.16 -21.69 29.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-O 121.29 0.566 . . . . 0.0 110.388 177.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.485 ' HB3' ' NZ ' ' A' ' 68' ' ' LYS . 4.6 ttpm? -62.41 -25.29 67.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.838 -178.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -68.04 -53.85 22.69 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.49 -174.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 22.2 t60 -74.3 -38.09 63.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.659 0.266 . . . . 0.0 110.824 -178.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.402 HD21 HG13 ' A' ' 67' ' ' VAL . 1.0 OUTLIER -133.76 121.87 16.28 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-O 120.865 0.364 . . . . 0.0 110.285 177.056 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -81.24 -160.71 0.13 Allowed 'Trans proline' 0 CA--C 1.529 0.266 0 C-N-CA 123.003 2.469 . . . . 0.0 112.821 -176.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -96.6 -24.9 15.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.331 0.586 . . . . 0.0 109.719 177.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 86' ' ' MET . 15.7 m -142.38 125.39 16.24 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.333 -178.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 22.2 ttmm -150.05 136.62 19.11 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.023 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 13.5 t -105.07 118.67 52.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 177.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.541 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 91.5 mt -87.77 136.14 33.08 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.048 177.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 33.9 tp -111.43 97.45 6.76 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 173.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.405 HG11 ' HE2' ' A' ' 4' ' ' PHE . 29.2 t -123.28 111.13 28.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.445 -174.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 57.11 33.57 23.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.541 178.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.9 -19.24 55.34 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.713 177.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.622 HG21 HD22 ' A' ' 145' ' ' LEU . 56.9 t -82.0 132.05 32.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.869 0.366 . . . . 0.0 111.179 -176.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.6 p -95.13 116.06 28.23 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.832 176.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.541 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 26.5 mt -111.91 92.83 2.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.988 0.423 . . . . 0.0 110.019 -178.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -81.53 99.81 2.0 Allowed Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.449 ' HB3' HG21 ' A' ' 58' ' ' VAL . 29.7 mtm -97.75 121.57 39.83 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -177.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 47.0 t -146.14 109.76 4.81 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 15.3 t60 -91.79 65.36 4.98 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.224 0.535 . . . . 0.0 110.887 -174.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -103.12 160.84 16.61 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.733 177.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 89.0 m95 -116.1 104.84 11.96 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.993 0.425 . . . . 0.0 110.784 -179.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -155.57 -173.12 23.87 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 178.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.47 142.17 42.92 Favored Pre-proline 0 C--N 1.321 -0.654 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.61 -20.85 59.76 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 123.041 2.494 . . . . 0.0 112.968 -176.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -69.45 -52.1 29.92 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.243 0.544 . . . . 0.0 109.986 -178.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -77.02 -30.79 55.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.079 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.422 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 36.2 tp -50.35 -55.24 16.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.83 -175.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.456 ' HG3' ' N ' ' A' ' 98' ' ' ASP . 19.2 pttp -58.28 -41.76 85.08 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.876 0.369 . . . . 0.0 111.098 -177.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.456 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 29.5 t70 -69.26 -43.89 73.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.881 -175.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.512 ' O ' HG23 ' A' ' 103' ' ' VAL . 82.1 mtp180 -70.53 -41.87 71.97 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.141 -177.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.503 HD13 HD13 ' A' ' 111' ' ' ILE . 85.1 mt -61.49 -39.3 90.44 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.568 0.223 . . . . 0.0 111.505 -177.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 97' ' ' LYS . 87.7 mt -67.04 -22.91 65.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.85 0.357 . . . . 0.0 111.063 179.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -91.45 -28.21 17.78 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.962 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 99' ' ' ARG . 89.7 t -67.6 -44.1 86.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.08 0.467 . . . . 0.0 109.837 175.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -85.09 168.95 14.4 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.544 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -97.34 -20.26 17.96 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.103 -177.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -135.59 165.98 24.28 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.45 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 13.8 ptmt -74.47 120.21 80.36 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-O 121.021 0.439 . . . . 0.0 110.17 176.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.452 ' HG2' HD11 ' A' ' 111' ' ' ILE . 3.7 Cg_exo -80.69 131.95 8.52 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 122.738 2.292 . . . . 0.0 111.163 176.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -66.3 -39.39 89.29 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 176.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.518 HG21 HG21 ' A' ' 150' ' ' VAL . 94.8 t -124.19 138.61 53.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.393 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.503 HD13 HD13 ' A' ' 100' ' ' LEU . 25.1 mt -129.32 126.41 63.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.907 0.384 . . . . 0.0 110.398 174.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.59 HD23 ' HB2' ' A' ' 130' ' ' LEU . 90.3 mt -101.71 119.75 39.27 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.442 ' CE1' ' HB3' ' A' ' 129' ' ' PHE . 20.0 p90 -133.11 173.45 11.42 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.868 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -122.22 114.67 2.55 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.601 -0.809 . . . . 0.0 111.957 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -166.7 35.95 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.93 ' HA ' HD21 ' A' ' 131' ' ' ASN . 53.3 m -53.21 109.87 0.48 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.55 -1.204 . . . . 0.0 113.819 -169.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 28.4 m80 -111.08 -45.53 3.43 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 162.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -147.67 142.32 16.59 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 114.593 -1.185 . . . . 0.0 109.024 172.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.494 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 16.5 Cg_endo -59.45 113.08 1.46 Allowed 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 122.173 1.916 . . . . 0.0 110.941 173.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -146.21 140.04 26.28 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.89 0.376 . . . . 0.0 111.319 -169.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -107.33 122.7 47.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.894 176.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 59.6 p -130.79 130.6 43.89 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -173.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.1 p -99.1 122.63 51.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 172.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.0 ttpm? -151.34 123.05 8.0 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.367 -174.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 66.22 20.68 11.1 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.588 -177.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 80.92 7.79 88.19 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.912 -177.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.482 HG11 HD12 ' A' ' 111' ' ' ILE . 61.2 t -109.46 136.22 46.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 177.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -95.47 104.15 16.05 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.196 0.522 . . . . 0.0 110.037 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.442 ' HB3' ' CE1' ' A' ' 113' ' ' PHE . 98.1 m-85 -89.94 124.2 34.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.187 -178.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.59 ' HB2' HD23 ' A' ' 112' ' ' LEU . 81.8 mt -109.99 125.38 52.83 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-O 121.333 0.587 . . . . 0.0 111.159 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.93 HD21 ' HA ' ' A' ' 116' ' ' THR . 7.6 t30 -127.9 105.36 20.52 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.579 174.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -86.93 179.18 3.36 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 123.008 2.472 . . . . 0.0 113.112 -177.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -85.46 165.39 38.9 Favored Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.758 178.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.42 ' O ' ' HB3' ' A' ' 137' ' ' GLU . 15.6 m -87.33 156.96 19.39 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.948 0.374 . . . . 0.0 111.534 -175.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -61.95 -44.49 96.66 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.818 0.342 . . . . 0.0 110.959 177.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -68.61 -17.42 64.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.239 0.542 . . . . 0.0 110.738 178.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.42 ' HB3' ' O ' ' A' ' 134' ' ' SER . 77.5 tt0 -79.32 -34.27 42.43 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.03 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.481 ' HA2' HD12 ' A' ' 157' ' ' LEU . . . 107.32 31.79 3.66 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.95 176.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 31.2 p -148.05 154.76 40.67 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.805 0.336 . . . . 0.0 110.81 177.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.422 ' O ' HD12 ' A' ' 154' ' ' LEU . 30.6 p90 -149.75 162.96 39.23 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.77 175.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.535 ' HB3' ' HB3' ' A' ' 6' ' ' LEU . . . -114.43 138.27 50.79 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.18 0.514 . . . . 0.0 111.802 -169.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.763 ' HB ' ' HB2' ' A' ' 153' ' ' GLU . 97.5 t -117.72 124.12 72.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.071 173.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.877 HD21 HG13 ' A' ' 150' ' ' VAL . 1.6 tt -107.34 115.96 31.1 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -178.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -107.28 116.81 32.6 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.081 0.467 . . . . 0.0 109.763 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.622 HD22 HG21 ' A' ' 82' ' ' VAL . 74.5 mt -96.79 109.56 22.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.969 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -126.08 120.98 31.61 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.746 -175.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.82 10.93 59.57 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.87 178.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 92.03 5.66 65.8 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.759 -177.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -102.99 145.61 29.61 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.084 0.468 . . . . 0.0 110.496 178.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.877 HG13 HD21 ' A' ' 143' ' ' LEU . 62.1 t -94.85 119.01 42.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.074 -175.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 64.7 mtt180 -124.42 143.05 50.84 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.091 0.472 . . . . 0.0 110.418 178.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . 0.428 ' HE2' ' HB2' ' A' ' 154' ' ' LEU . 58.7 t80 -118.3 116.75 27.4 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.291 -168.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.763 ' HB2' ' HB ' ' A' ' 142' ' ' VAL . 45.5 mt-10 -102.77 111.2 23.42 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 174.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.428 ' HB2' ' HE2' ' A' ' 152' ' ' PHE . 32.5 tp -97.28 115.59 27.92 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.113 179.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -105.95 153.13 22.42 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.051 0.453 . . . . 0.0 110.878 -178.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 36.7 p -108.73 152.39 24.91 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.187 -177.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.481 HD12 ' HA2' ' A' ' 138' ' ' GLY . 97.0 mt . . . . . 0 C--O 1.247 0.949 0 CA-C-O 118.475 -0.774 . . . . 0.0 109.835 175.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 86.6 mttt . . . . . 0 CA--C 1.52 -0.183 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 74.0 mtm-85 -110.27 116.18 31.01 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.811 -175.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -110.76 131.32 55.15 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.854 0.359 . . . . 0.0 110.792 178.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.498 ' HB2' ' CD2' ' A' ' 30' ' ' TYR . 38.6 tp -89.23 119.82 30.06 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.451 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.606 HD23 ' HB3' ' A' ' 141' ' ' ALA . 64.6 tp -106.05 115.65 30.58 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.017 0.437 . . . . 0.0 110.494 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.543 HG22 HD13 ' A' ' 23' ' ' ILE . 11.6 pt -101.09 125.8 54.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 177.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.0 m -65.43 177.51 1.13 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.2 -172.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -49.02 104.72 0.07 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.748 176.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.85 ' HB2' ' HA ' ' A' ' 38' ' ' ASP . 19.5 m -99.06 166.87 11.05 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.274 -177.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 69.9 m-70 -144.7 35.6 1.16 Allowed 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -176.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.657 HG21 HD12 ' A' ' 19' ' ' LEU . 14.6 t -102.68 138.53 19.65 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.493 -174.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.8 -56.84 0.14 OUTLIER 'Cis proline' 0 C--N 1.345 0.352 0 C-N-CA 123.382 -1.508 . . . . 0.0 112.242 -3.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.559 HG12 ' HG3' ' A' ' 15' ' ' ARG . 31.5 t 49.68 -94.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 O-C-N 123.815 0.697 . . . . 0.0 111.427 -178.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.559 ' HG3' HG12 ' A' ' 14' ' ' VAL . 54.9 mtp85 -138.44 13.53 2.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.259 0.552 . . . . 0.0 109.763 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 30.2 ttp -142.58 100.57 3.71 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.358 -177.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -101.72 14.33 32.29 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.254 0.55 . . . . 0.0 109.879 177.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.6 m -77.44 54.74 1.18 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.129 -179.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.866 ' HG ' HD13 ' A' ' 135' ' ' LEU . 2.0 tt -107.86 105.57 56.54 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 177.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.815 ' HG2' HD13 ' A' ' 157' ' ' LEU . 77.3 Cg_exo -52.08 123.47 12.6 Favored 'Trans proline' 0 C--O 1.236 0.398 0 C-N-CA 122.913 2.408 . . . . 0.0 112.375 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -68.62 -9.56 50.6 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.612 -178.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -52.88 -38.01 61.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.202 174.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.543 HD13 HG22 ' A' ' 7' ' ' ILE . 0.4 OUTLIER -82.45 -24.74 8.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.597 -179.006 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.472 ' O ' HD23 ' A' ' 27' ' ' LEU . 49.9 tp -81.96 -16.64 49.75 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.924 -177.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -86.3 -22.48 26.75 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.132 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.421 ' HB2' ' CE2' ' A' ' 30' ' ' TYR . 1.3 p -84.01 9.36 12.58 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -176.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.648 HD13 HG21 ' A' ' 33' ' ' VAL . 4.5 mm? -61.52 -19.96 62.68 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.234 0.54 . . . . 0.0 110.318 173.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 47.5 mttm -98.85 -0.34 42.63 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.857 -176.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -102.43 -49.32 3.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.803 0.335 . . . . 0.0 111.23 -173.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.498 ' CD2' ' HB2' ' A' ' 5' ' ' LEU . 93.4 m-85 -81.44 169.37 17.26 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.839 -173.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -88.24 -17.27 31.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.381 -177.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -168.67 162.27 36.03 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.648 HG21 HD13 ' A' ' 27' ' ' LEU . 61.2 t -132.01 147.47 32.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 -178.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.404 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 42.0 mt -123.73 124.78 70.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 175.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -106.48 114.69 4.49 Favored Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 111.564 -0.614 . . . . 0.0 111.564 177.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.605 ' HB3' ' HE1' ' A' ' 88' ' ' HIS . 99.3 mt -84.46 27.04 0.73 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.019 0.438 . . . . 0.0 110.733 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 110.46 60.54 0.49 Allowed Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 -173.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.85 ' HA ' ' HB2' ' A' ' 10' ' ' SER . 0.7 OUTLIER -76.53 -83.2 0.07 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.263 -0.469 . . . . 0.0 112.227 -173.829 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.478 ' HD1' HD11 ' A' ' 48' ' ' LEU . 75.5 m-85 -100.5 128.78 46.46 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.232 0.539 . . . . 0.0 110.995 -177.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.447 HG12 ' HB3' ' A' ' 63' ' ' ASP . 17.4 m -79.08 7.33 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.606 177.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.525 ' O ' HG23 ' A' ' 45' ' ' VAL . 13.6 t70 -110.17 130.01 55.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.964 -179.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.51 HD22 ' HB3' ' A' ' 66' ' ' ASP . 57.2 tp -65.63 -42.72 91.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.568 -175.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -59.51 -39.46 83.92 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.971 0.415 . . . . 0.0 111.274 -177.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 11.7 m -75.21 -27.02 59.39 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.213 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 41' ' ' ASP . 89.1 t -59.8 -43.3 91.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 121.391 0.615 . . . . 0.0 109.804 173.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -70.02 -34.55 60.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.91 178.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -60.94 -40.94 95.2 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.444 174.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.478 HD11 ' HD1' ' A' ' 39' ' ' TYR . 83.2 mt -69.11 -38.68 79.05 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.066 0.46 . . . . 0.0 110.174 179.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -62.13 -39.43 92.54 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.471 177.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -69.19 -36.1 76.96 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.752 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -71.61 -64.62 0.89 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.809 178.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.634 ' HB3' HD12 ' A' ' 27' ' ' LEU . 59.9 p -64.11 -40.85 97.1 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.217 -176.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 92.5 mttt 66.06 6.6 4.21 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.416 0.627 . . . . 0.0 110.425 -174.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -171.46 95.41 0.18 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.151 -0.932 . . . . 0.0 109.271 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.466 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 2.4 p90 -145.69 144.97 30.7 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.008 0.433 . . . . 0.0 109.927 178.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.404 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 56.1 m-85 -114.8 136.4 53.12 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 177.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.699 ' HA3' HD22 ' A' ' 71' ' ' LEU . . . -133.08 156.78 22.35 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 119.827 -1.178 . . . . 0.0 112.812 -177.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.402 HG13 ' HE3' ' A' ' 86' ' ' MET . 0.2 OUTLIER -136.84 164.25 30.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.132 0.491 . . . . 0.0 110.836 175.698 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.503 ' HB3' ' HA ' ' A' ' 73' ' ' PHE . 74.3 t60 -94.6 104.52 16.46 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.696 -175.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -115.72 -5.58 18.11 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.495 -0.775 . . . . 0.0 113.031 -176.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -115.16 -166.76 1.15 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.102 0.477 . . . . 0.0 110.234 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 97.0 mmm -98.98 34.86 2.0 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 169.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.447 ' HB3' HG12 ' A' ' 40' ' ' VAL . 1.8 p-10 -60.08 157.7 12.5 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.666 -177.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -62.21 155.62 64.46 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.924 -171.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.62 ' HA ' ' HB3' ' A' ' 68' ' ' LYS . 72.5 Cg_exo -50.47 -31.01 29.3 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 123.406 2.737 . . . . 0.0 112.948 178.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.51 ' HB3' HD22 ' A' ' 42' ' ' LEU . 32.2 m-20 -56.61 -48.4 77.54 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.342 0.591 . . . . 0.0 110.434 176.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 40.5 t -75.85 -38.94 37.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.819 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.62 ' HB3' ' HA ' ' A' ' 65' ' ' PRO . 48.5 tttp -57.59 -34.0 68.77 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.364 176.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -68.92 -33.94 74.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.069 0.461 . . . . 0.0 110.652 178.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.482 ' CE1' HD11 ' A' ' 42' ' ' LEU . 18.9 m80 -84.53 -50.89 7.32 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.167 -178.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.699 HD22 ' HA3' ' A' ' 57' ' ' GLY . 22.6 mt -100.38 113.8 65.54 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.899 -177.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.677 ' HG2' ' HB2' ' A' ' 75' ' ' LYS . 46.0 Cg_endo -69.42 153.98 69.72 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 122.491 2.127 . . . . 0.0 112.308 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.503 ' HA ' ' HB3' ' A' ' 59' ' ' HIS . 82.6 t80 -61.96 -32.77 73.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.343 0.592 . . . . 0.0 109.952 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.3 t -146.36 137.51 24.42 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.3 176.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.677 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 39.5 tttp -148.92 128.44 13.12 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.507 -176.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.472 ' HA ' ' HA2' ' A' ' 85' ' ' GLY . 46.5 t -99.75 117.03 44.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.095 0.474 . . . . 0.0 109.837 174.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.505 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 86.7 mt -87.71 138.48 31.43 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.408 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 42.9 tp -109.73 99.57 8.71 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 176.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 44.0 t -108.92 91.34 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.364 -177.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 57.33 30.31 18.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.662 175.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 114.54 -23.53 12.08 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.99 178.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.8 t -84.01 126.81 40.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.597 0.237 . . . . 0.0 110.556 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.2 p -95.72 117.96 31.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.944 0.402 . . . . 0.0 111.304 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.505 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 18.1 mt -111.62 93.14 2.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.946 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.472 ' HA2' ' HA ' ' A' ' 76' ' ' VAL . . . -84.02 106.35 2.86 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 111.731 -0.548 . . . . 0.0 111.731 -179.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.453 ' HE1' HD11 ' A' ' 77' ' ' LEU . 53.5 mtm -98.93 125.86 44.47 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -178.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 35.3 t -149.97 133.73 16.82 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.605 ' HE1' ' HB3' ' A' ' 36' ' ' LEU . 17.6 m80 -113.31 93.3 4.34 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.099 0.476 . . . . 0.0 111.444 178.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -136.21 154.81 22.14 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 175.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 10.6 p-90 -135.51 152.06 50.96 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 168.5 -137.23 4.46 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 -179.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.482 ' HB1' ' NE1' ' A' ' 94' ' ' TRP . . . -75.54 119.33 76.55 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-O 120.875 0.369 . . . . 0.0 110.578 178.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 92' ' ' ALA . 10.7 Cg_exo -72.48 -23.71 19.88 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.929 2.419 . . . . 0.0 112.933 -177.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.508 ' CE3' ' HB3' ' A' ' 95' ' ' ASP . 57.8 p-90 -70.72 -21.63 62.53 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -176.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.508 ' HB3' ' CE3' ' A' ' 94' ' ' TRP . 3.3 p-10 -126.44 20.51 7.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.001 0.429 . . . . 0.0 110.338 176.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 59.3 tp -57.08 -39.77 75.64 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.515 178.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.414 ' HD2' ' HB3' ' A' ' 124' ' ' LYS . 48.8 mtpt -54.4 -51.8 63.73 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.21 174.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -62.04 -39.46 92.42 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.767 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' A' ' 95' ' ' ASP . 52.5 mtt180 -63.43 -48.65 76.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.09 179.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 76.9 mt -67.65 -34.25 76.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.879 0.371 . . . . 0.0 111.094 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 96.9 mt -80.79 -4.84 56.04 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.858 0.361 . . . . 0.0 110.841 178.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 37.8 mttp -89.57 -22.07 22.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.485 170.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 64.6 t -68.74 -47.68 75.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.97 0.414 . . . . 0.0 110.189 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -108.91 169.87 8.4 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.715 177.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -95.35 -47.33 6.34 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -90.69 137.72 32.13 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.725 175.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.453 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 24.2 pttm -70.21 125.37 91.97 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-O 120.986 0.422 . . . . 0.0 110.629 -178.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 107' ' ' LYS . 9.0 Cg_exo -72.4 134.47 22.71 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.617 2.212 . . . . 0.0 110.368 174.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -60.5 -41.84 95.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.964 0.411 . . . . 0.0 110.437 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.8 t -122.46 140.96 44.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.767 177.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.442 HD12 ' CE2' ' A' ' 129' ' ' PHE . 42.0 mt -129.71 137.12 57.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 176.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.598 HD23 ' HB2' ' A' ' 130' ' ' LEU . 86.7 mt -114.11 130.57 56.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.326 -177.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.523 ' O ' ' HD2' ' A' ' 132' ' ' PRO . 51.4 p90 -155.65 -178.34 7.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.851 172.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -105.78 127.87 9.14 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.552 -0.832 . . . . 0.0 111.784 -177.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.509 ' HB2' ' HB2' ' A' ' 131' ' ' ASN . 1.1 t60 -83.69 -14.65 51.25 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.797 0.332 . . . . 0.0 110.536 -175.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 5.9 m 63.69 12.66 6.77 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.995 0.902 . . . . 0.0 110.18 -176.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.613 ' HB3' ' OE1' ' A' ' 118' ' ' GLU . 34.8 m80 -148.18 -160.76 1.21 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.997 -176.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.613 ' OE1' ' HB3' ' A' ' 117' ' ' HIS . 0.8 OUTLIER -69.32 144.28 94.58 Favored Pre-proline 0 C--N 1.326 -0.434 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.432 -179.917 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.416 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 77.9 Cg_exo -51.68 134.66 47.64 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.161 2.574 . . . . 0.0 112.586 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.46 ' HG2' HG23 ' A' ' 122' ' ' THR . 36.9 tt0 -142.55 127.29 18.12 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.837 -174.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.735 ' HB2' ' HZ ' ' A' ' 152' ' ' PHE . 19.5 t70 -86.92 107.36 18.33 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 177.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.562 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 27.7 p -116.16 118.73 33.63 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.815 -174.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.9 p -106.26 106.98 21.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.428 0.632 . . . . 0.0 110.321 176.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.584 ' HB2' ' HE1' ' A' ' 129' ' ' PHE . 62.4 mttm -127.24 129.24 47.4 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.023 -176.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 62.54 22.23 13.16 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 123.347 0.405 . . . . 0.0 111.415 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 87.42 -5.38 85.15 Favored Glycine 0 CA--C 1.518 0.244 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.071 -178.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.405 HG13 ' O ' ' A' ' 108' ' ' PRO . 90.4 t -94.92 135.45 28.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -97.22 107.32 19.81 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.159 0.504 . . . . 0.0 109.912 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.584 ' HE1' ' HB2' ' A' ' 124' ' ' LYS . 75.4 m-85 -92.48 119.06 31.61 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.717 -179.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.598 ' HB2' HD23 ' A' ' 112' ' ' LEU . 50.5 mt -103.31 117.37 34.35 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 177.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.509 ' HB2' ' HB2' ' A' ' 115' ' ' HIS . 2.5 p30 -130.03 110.11 16.87 Favored Pre-proline 0 C--N 1.317 -0.843 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.998 -177.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.523 ' HD2' ' O ' ' A' ' 113' ' ' PHE . 89.9 Cg_endo -82.46 -172.16 1.35 Allowed 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.783 2.322 . . . . 0.0 111.853 174.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -99.19 -97.65 2.13 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.558 -0.83 . . . . 0.0 112.904 -177.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 41.8 t -161.87 163.5 29.22 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 -176.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.866 HD13 ' HG ' ' A' ' 19' ' ' LEU . 57.3 mt -65.0 -49.75 69.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.115 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -65.1 -26.69 68.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.168 -178.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -88.87 4.3 48.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.875 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.555 ' HA2' HD12 ' A' ' 157' ' ' LEU . . . 58.67 43.67 96.15 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 116.083 -0.508 . . . . 0.0 113.354 175.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 3.9 p -137.24 110.39 7.8 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.039 0.447 . . . . 0.0 111.675 -178.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -132.19 -172.09 2.8 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 175.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.606 ' HB3' HD23 ' A' ' 6' ' ' LEU . . . -143.72 153.09 42.08 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.2 0.524 . . . . 0.0 111.46 -177.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 70.9 t -126.23 117.26 48.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 172.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.657 HD21 HG13 ' A' ' 150' ' ' VAL . 2.3 tt -94.62 106.52 18.51 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.254 0.55 . . . . 0.0 109.87 -175.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -97.97 119.06 35.92 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.702 177.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.2 mp -95.61 106.45 18.55 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 177.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -109.25 110.31 21.47 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.796 177.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 68.05 11.12 60.53 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.108 -176.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 94.55 5.18 61.81 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.758 -0.537 . . . . 0.0 111.758 -177.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -89.2 133.37 34.45 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 178.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.657 HG13 HD21 ' A' ' 143' ' ' LEU . 62.4 t -76.9 103.64 4.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.17 -177.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 78.4 mtt-85 -115.88 89.59 3.14 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.973 178.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . 0.735 ' HZ ' ' HB2' ' A' ' 121' ' ' ASP . 3.5 p90 -95.04 123.28 38.44 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.125 0.488 . . . . 0.0 110.682 -178.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -91.45 123.56 34.97 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.069 177.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -83.98 81.69 8.67 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 176.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -80.72 131.84 35.49 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.907 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 26.5 p -109.14 150.72 27.45 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.794 -175.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.815 HD13 ' HG2' ' A' ' 20' ' ' PRO . 90.5 mt . . . . . 0 C--N 1.315 -0.905 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 177.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.4 tttm . . . . . 0 N--CA 1.452 -0.349 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.677 ' HB3' ' HD1' ' A' ' 30' ' ' TYR . 56.6 mtt-85 -108.29 117.8 35.1 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.618 0.247 . . . . 0.0 111.33 -175.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.557 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 67.8 m-85 -112.43 113.94 26.39 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.203 0.525 . . . . 0.0 111.006 177.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.53 ' HB3' HG22 ' A' ' 33' ' ' VAL . 32.1 tp -89.24 121.04 31.14 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.021 178.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.748 HD11 ' HG ' ' A' ' 36' ' ' LEU . 41.4 tp -107.39 121.09 43.9 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.259 0.552 . . . . 0.0 111.211 -178.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.7 pt -101.18 119.38 49.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 171.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.508 ' O ' ' HB2' ' A' ' 36' ' ' LEU . 5.7 p -67.17 -87.71 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -164.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.485 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 36.2 t70 -142.32 94.06 2.61 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.287 0.565 . . . . 0.0 110.226 -176.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.46 ' OG ' HD12 ' A' ' 19' ' ' LEU . 23.0 t -107.86 158.47 17.3 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.802 -179.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.502 ' H ' ' HE1' ' A' ' 16' ' ' MET . 11.0 m80 -135.09 77.33 1.67 Allowed 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -178.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . 9.1 t -129.8 132.26 24.06 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.109 -177.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.47 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 41.2 Cg_endo -95.4 91.58 0.14 OUTLIER 'Cis proline' 0 N--CA 1.449 -1.092 0 C-N-CA 123.403 -1.499 . . . . 0.0 112.554 -2.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.726 HG12 ' H ' ' A' ' 15' ' ' ARG . 2.5 t -114.85 -165.07 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 175.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.726 ' H ' HG12 ' A' ' 14' ' ' VAL . 85.1 mtt180 -72.43 75.92 1.04 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 118.611 0.642 . . . . 0.0 110.758 177.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.502 ' HE1' ' H ' ' A' ' 11' ' ' HIS . 28.0 ttp -165.65 -77.12 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.467 178.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 59.2 12.05 2.36 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.554 -178.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.0 m -79.81 35.78 0.31 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.184 -177.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.46 HD12 ' OG ' ' A' ' 10' ' ' SER . 4.1 tt -107.75 111.02 62.7 Favored Pre-proline 0 C--N 1.327 -0.406 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.548 ' HG3' HD13 ' A' ' 157' ' ' LEU . 60.7 Cg_endo -74.06 133.43 18.09 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.623 2.215 . . . . 0.0 112.014 178.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -77.11 -5.81 50.43 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.925 0.393 . . . . 0.0 110.263 -177.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -55.93 -40.81 73.68 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.543 174.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.0 tt -70.38 -33.39 53.79 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-O 121.748 0.785 . . . . 0.0 109.98 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.526 ' O ' HD23 ' A' ' 27' ' ' LEU . 49.0 tp -66.64 -17.89 65.08 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.842 -178.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -80.47 -24.87 39.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.894 0.378 . . . . 0.0 110.966 177.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.3 m -80.28 2.81 23.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.48 -176.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.653 HD12 ' HB3' ' A' ' 52' ' ' SER . 4.4 mm? -59.98 -22.37 62.45 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.59 178.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -79.4 -14.26 59.06 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.323 -177.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -91.62 -23.61 19.81 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.968 0.413 . . . . 0.0 110.848 -178.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.677 ' HD1' ' HB3' ' A' ' 3' ' ' ARG . 38.3 m-85 -111.49 126.08 54.59 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.949 0.405 . . . . 0.0 110.678 -174.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -78.98 -29.97 44.14 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.868 -176.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.557 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -123.34 138.33 11.52 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 177.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.541 HG21 ' CD1' ' A' ' 27' ' ' LEU . 93.5 t -130.37 135.09 61.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 120.845 0.355 . . . . 0.0 110.574 -178.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.566 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 48.1 mt -112.32 131.59 63.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.435 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -118.41 98.28 0.74 Allowed Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.109 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.748 ' HG ' HD11 ' A' ' 6' ' ' LEU . 85.0 mt -77.65 -33.8 53.36 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 175.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.485 ' HA3' ' HA ' ' A' ' 9' ' ' ASP . . . -150.47 83.01 0.18 Allowed Glycine 0 N--CA 1.44 -1.087 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.494 177.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -94.75 -145.3 0.26 Allowed 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.447 ' HD1' HD11 ' A' ' 48' ' ' LEU . 78.2 m-85 -73.49 148.87 42.74 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 178.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.7 m -98.06 5.56 9.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.132 0.491 . . . . 0.0 110.748 -177.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.546 ' O ' HG23 ' A' ' 45' ' ' VAL . 17.3 t70 -102.9 132.34 49.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.874 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.539 HD22 ' HB3' ' A' ' 66' ' ' ASP . 65.6 tp -57.84 -54.23 49.22 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.171 -175.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -59.22 -35.71 74.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.156 0.503 . . . . 0.0 111.105 -176.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.429 HG21 ' CD2' ' A' ' 39' ' ' TYR . 17.6 m -72.01 -28.22 63.25 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.312 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.546 HG23 ' O ' ' A' ' 41' ' ' ASP . 94.8 t -65.01 -37.4 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 121.205 0.526 . . . . 0.0 109.913 174.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.521 ' O ' ' HG2' ' A' ' 50' ' ' LYS . 1.7 mp -65.5 -37.15 79.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.56 175.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.447 ' O ' ' HB2' ' A' ' 50' ' ' LYS . 3.2 tm? -61.82 -34.04 75.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.767 174.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.447 HD11 ' HD1' ' A' ' 39' ' ' TYR . 96.4 mt -67.97 -40.44 83.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.324 177.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.562 ' HA ' ' O ' ' A' ' 52' ' ' SER . 44.6 mt-10 -78.68 -2.39 38.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.348 177.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.521 ' HG2' ' O ' ' A' ' 46' ' ' ILE . 32.2 mmtp -75.43 -53.67 8.3 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 170.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -70.95 -66.22 0.64 Allowed 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.101 177.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.653 ' HB3' HD12 ' A' ' 27' ' ' LEU . 15.7 p -95.36 92.99 6.98 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.214 175.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.526 ' HG2' ' O ' ' A' ' 49' ' ' GLU . 63.3 mttp -70.41 -15.67 62.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.142 0.496 . . . . 0.0 110.431 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -101.4 68.15 1.19 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.409 171.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -100.37 108.73 20.82 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.173 -178.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.566 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 12.2 m-85 -102.75 108.01 19.09 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.609 ' HA3' HD22 ' A' ' 71' ' ' LEU . . . -125.55 165.03 18.9 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 119.869 -1.158 . . . . 0.0 112.716 -176.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.1 m -141.66 127.63 18.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.557 -0.321 . . . . 0.0 110.341 177.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -129.73 166.97 18.77 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.137 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.605 ' HA2' ' HD1' ' A' ' 73' ' ' PHE . . . -104.3 -169.27 24.86 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.308 -0.948 . . . . 0.0 112.906 -173.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -84.07 5.5 25.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.058 0.456 . . . . 0.0 110.48 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 87.1 mtp -103.55 -5.71 22.45 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.889 178.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -94.38 168.28 10.99 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.058 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -65.33 126.0 90.57 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.155 176.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.56 ' HA ' ' HB3' ' A' ' 68' ' ' LYS . 53.1 Cg_exo -57.04 -25.68 64.54 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.216 2.61 . . . . 0.0 112.507 -179.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.539 ' HB3' HD22 ' A' ' 42' ' ' LEU . 2.6 m-20 -58.38 -41.97 85.99 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.916 175.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 84.0 t -78.09 -37.96 23.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.862 177.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.56 ' HB3' ' HA ' ' A' ' 65' ' ' PRO . 63.6 tttm -63.19 -22.06 66.62 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.353 -178.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -60.4 -44.02 96.11 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.189 0.519 . . . . 0.0 110.077 173.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 64.6 m-70 -82.04 -39.1 23.98 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.929 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.609 HD22 ' HA3' ' A' ' 57' ' ' GLY . 7.3 mt -115.98 101.16 54.01 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.68 -173.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.526 ' HG2' ' HB2' ' A' ' 75' ' ' LYS . 69.4 Cg_endo -74.87 174.98 11.8 Favored 'Trans proline' 0 CA--C 1.528 0.2 0 C-N-CA 122.701 2.267 . . . . 0.0 112.283 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.605 ' HD1' ' HA2' ' A' ' 60' ' ' GLY . 76.7 t80 -81.2 -21.81 39.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.262 0.553 . . . . 0.0 110.502 -178.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 39.6 m -144.48 119.14 9.78 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.043 178.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.526 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 40.2 tttp -139.59 135.92 33.85 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.321 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 77.8 t -108.75 132.99 55.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.931 0.396 . . . . 0.0 110.145 174.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.508 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 84.9 mt -106.81 132.82 52.34 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.9 176.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 42.2 tp -109.26 100.47 9.59 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.652 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.5 t -116.42 102.94 14.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.585 -175.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 54.57 31.37 14.85 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.705 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.72 -22.27 37.76 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.454 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.541 ' HA ' ' OE1' ' A' ' 109' ' ' GLN . 99.1 t -71.31 122.68 23.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.772 0.32 . . . . 0.0 110.347 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.29 102.94 14.82 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.5 -178.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.508 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 20.4 mt -93.85 110.19 23.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.4 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -93.36 109.47 3.81 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.764 -0.731 . . . . 0.0 111.395 177.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 30.0 mtm -107.11 119.77 40.28 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.716 0.293 . . . . 0.0 110.772 -177.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 49.6 t -145.35 104.43 3.93 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 175.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 49.8 t60 -84.87 66.1 9.51 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.184 0.516 . . . . 0.0 110.368 -177.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -113.78 -145.1 9.03 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.756 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 28.2 t-105 -139.15 164.76 28.94 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -178.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 165.83 161.33 14.62 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.511 -0.852 . . . . 0.0 113.087 177.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.502 ' HB1' ' HD2' ' A' ' 93' ' ' PRO . . . -88.46 162.45 39.54 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 175.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.502 ' HD2' ' HB1' ' A' ' 92' ' ' ALA . 0.9 OUTLIER -43.97 -49.44 8.37 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.366 2.71 . . . . 0.0 113.656 -178.14 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 18.3 p-90 -81.85 -44.18 17.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.877 0.37 . . . . 0.0 111.363 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -59.44 -37.01 77.01 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.543 -177.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 19.9 tp -60.85 -49.18 78.5 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.277 178.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -58.44 -42.62 87.77 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.748 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -64.55 -53.58 45.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.552 -177.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 21.9 ttp-105 -68.79 -40.04 79.84 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -174.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.568 HD13 HG21 ' A' ' 111' ' ' ILE . 65.7 mt -71.71 -32.56 67.91 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.541 -0.464 . . . . 0.0 111.446 -176.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.588 HD21 HG21 ' A' ' 127' ' ' VAL . 86.8 mt -80.62 -12.49 59.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.177 0.513 . . . . 0.0 110.268 175.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -79.78 -40.46 28.64 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.523 173.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 80.3 t -73.75 -52.3 21.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.535 177.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -91.41 103.68 16.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.07 0.462 . . . . 0.0 110.874 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -76.9 -22.92 52.67 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.668 -177.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -66.94 -28.51 68.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.019 176.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.484 ' HG3' HD22 ' A' ' 101' ' ' LEU . 39.5 ttpt 63.76 92.84 0.06 OUTLIER Pre-proline 0 CA--C 1.529 0.162 0 O-C-N 123.985 0.803 . . . . 0.0 109.896 -170.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.445 ' O ' HG22 ' A' ' 127' ' ' VAL . 13.6 Cg_exo -69.37 166.75 26.03 Favored 'Trans proline' 0 N--CA 1.464 -0.228 0 C-N-CA 123.023 2.482 . . . . 0.0 112.859 -174.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.541 ' OE1' ' HA ' ' A' ' 82' ' ' VAL . 75.1 mt-30 -85.32 -49.94 7.75 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.273 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 58.7 t -122.67 132.02 72.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.911 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.568 HG21 HD13 ' A' ' 100' ' ' LEU . 35.3 mt -126.71 132.13 70.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.071 0.462 . . . . 0.0 110.911 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.456 ' HB3' HD11 ' A' ' 36' ' ' LEU . 78.2 mt -105.68 121.18 43.48 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.067 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -132.06 -178.77 5.04 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.747 -178.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -125.69 131.97 7.77 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 121.057 -0.592 . . . . 0.0 111.785 178.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 39.9 t60 -139.57 -68.02 0.43 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 177.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.0 p -143.85 -80.69 0.19 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.851 178.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.435 ' O ' ' HD3' ' A' ' 119' ' ' PRO . 16.5 p-80 -172.24 41.79 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.121 -178.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -103.12 102.02 25.58 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.286 -173.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.698 ' HB3' HD22 ' A' ' 154' ' ' LEU . 59.9 Cg_endo -77.44 41.94 1.06 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.782 2.321 . . . . 0.0 111.469 177.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -97.48 132.46 43.16 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.127 -176.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -78.52 107.07 10.9 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.267 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.601 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 67.8 p -105.35 114.49 28.7 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.141 0.496 . . . . 0.0 110.069 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.2 p -136.51 145.05 31.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.691 -175.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -159.28 -55.98 0.06 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.112 175.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.401 ' O ' ' HD2' ' A' ' 107' ' ' LYS . . . -85.1 23.88 1.18 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.939 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 86.92 -16.93 44.21 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 121.083 -0.58 . . . . 0.0 111.707 -176.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.588 HG21 HD21 ' A' ' 101' ' ' LEU . 15.3 t -87.54 134.05 28.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.636 -0.282 . . . . 0.0 110.618 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 76.9 mtp180 -98.92 104.52 16.56 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.051 175.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.601 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 69.4 m-85 -87.72 124.78 33.93 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.423 HD13 ' CD2' ' A' ' 152' ' ' PHE . 67.8 mt -124.8 134.91 52.59 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.937 0.399 . . . . 0.0 111.454 -174.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -118.08 106.05 46.0 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.569 177.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.448 ' HB2' ' HB3' ' A' ' 8' ' ' SER . 61.3 Cg_endo -75.86 146.27 29.52 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 122.239 1.959 . . . . 0.0 112.683 179.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -73.35 141.76 30.41 Favored Glycine 0 C--N 1.331 0.279 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.809 177.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.462 ' HA ' ' OG ' ' A' ' 8' ' ' SER . 31.1 t -70.14 159.6 33.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.598 0.713 . . . . 0.0 112.632 -174.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.435 ' HG ' ' HG ' ' A' ' 19' ' ' LEU . 3.6 mm? -61.16 -26.65 67.84 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.149 174.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.9 -25.68 67.99 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.344 -178.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -105.02 6.56 33.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.106 0.479 . . . . 0.0 110.351 178.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.435 ' HA2' HD12 ' A' ' 157' ' ' LEU . . . 73.72 44.67 31.06 Favored Glycine 0 N--CA 1.451 -0.352 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.904 177.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 24.6 m -132.0 144.15 50.58 Favored 'General case' 0 C--N 1.321 -0.631 0 O-C-N 122.664 -0.315 . . . . 0.0 110.744 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 44.1 p90 -145.02 160.04 41.99 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 173.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.521 ' HB3' HD23 ' A' ' 6' ' ' LEU . . . -115.72 142.81 46.25 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.722 -175.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.8 ' HB ' ' HE3' ' A' ' 155' ' ' LYS . 51.1 t -126.98 124.8 65.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 175.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.537 HD21 HG13 ' A' ' 150' ' ' VAL . 5.3 tt -109.69 108.0 18.22 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.507 ' HG3' HG12 ' A' ' 142' ' ' VAL . 40.3 mt-10 -110.51 127.09 55.01 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.033 -178.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.7 mp -90.79 105.77 18.05 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.894 0.378 . . . . 0.0 110.385 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -105.6 109.2 21.08 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.744 178.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 68.2 10.69 60.06 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.539 -177.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 98.84 -3.2 58.71 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.369 -177.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -85.1 147.26 26.73 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.723 0.297 . . . . 0.0 110.296 177.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.537 HG13 HD21 ' A' ' 143' ' ' LEU . 60.2 t -88.87 102.97 13.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.965 -175.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 47.6 mtp180 -98.66 94.0 6.41 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 176.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . 0.423 ' CD2' HD13 ' A' ' 130' ' ' LEU . 73.9 t80 -99.83 99.89 10.75 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.971 -179.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.424 ' HB2' ' HE2' ' A' ' 155' ' ' LYS . 49.1 mt-10 -110.88 119.56 39.49 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.203 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.698 HD22 ' HB3' ' A' ' 119' ' ' PRO . 23.2 tp -78.38 109.17 12.3 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 171.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.8 ' HE3' ' HB ' ' A' ' 142' ' ' VAL . 73.7 mttt -105.76 138.83 41.3 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.334 -175.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.7 p -97.55 155.29 17.03 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.224 0.535 . . . . 0.0 112.294 -171.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.548 HD13 ' HG3' ' A' ' 20' ' ' PRO . 61.5 mt . . . . . 0 C--O 1.247 0.959 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.134 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.568 ' HB2' HD12 ' A' ' 145' ' ' LEU . 6.1 mtpm? . . . . . 0 C--O 1.233 0.209 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.69 ' HB3' ' CD2' ' A' ' 30' ' ' TYR . 92.9 mtt180 -118.7 129.76 55.46 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.747 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.676 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 85.2 m-85 -125.08 119.78 29.61 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.173 0.511 . . . . 0.0 110.557 176.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.562 ' HB3' HG22 ' A' ' 33' ' ' VAL . 23.7 tp -89.19 124.35 34.27 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 178.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.527 HD23 ' HB3' ' A' ' 141' ' ' ALA . 33.5 tp -104.22 98.82 8.57 Favored 'General case' 0 C--O 1.241 0.605 0 CA-C-O 121.584 0.707 . . . . 0.0 111.251 -175.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.473 ' HB ' HD11 ' A' ' 135' ' ' LEU . 13.6 pt -101.17 110.69 28.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 173.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.474 ' HA ' ' HB2' ' A' ' 36' ' ' LEU . 16.2 m -94.36 -97.33 0.16 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -165.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -98.18 120.7 39.05 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.742 0.306 . . . . 0.0 110.365 -171.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.5 ' HB2' HD12 ' A' ' 135' ' ' LEU . 28.8 t -157.45 164.71 37.16 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.946 0.403 . . . . 0.0 111.085 -174.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -138.03 74.72 1.49 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.462 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -126.14 138.42 32.16 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-O 120.841 0.353 . . . . 0.0 110.745 174.297 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.431 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 38.2 Cg_endo -96.22 75.08 0.14 OUTLIER 'Cis proline' 0 N--CA 1.451 -1.022 0 C-N-CA 123.445 -1.481 . . . . 0.0 113.027 -2.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -103.89 -153.57 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 174.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -77.28 82.28 3.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.357 0.598 . . . . 0.0 110.299 178.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 39.2 ttp -161.99 -76.98 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.814 177.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 60.0 10.27 2.13 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.501 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.416 ' O ' ' HD3' ' A' ' 20' ' ' PRO . 3.8 m -80.6 15.25 1.75 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.451 -176.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.406 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 0.7 OUTLIER -102.5 102.59 26.64 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -179.902 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.416 ' HD3' ' O ' ' A' ' 18' ' ' SER . 3.9 Cg_exo -74.32 156.76 46.03 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.879 2.386 . . . . 0.0 112.466 -176.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -63.35 -14.56 51.38 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.75 178.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -61.09 -21.85 64.07 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.943 -177.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -99.62 -28.76 3.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.218 0.532 . . . . 0.0 110.309 176.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.46 ' O ' HD23 ' A' ' 27' ' ' LEU . 48.8 tp -73.03 -28.38 62.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.038 -173.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 -82.06 -11.45 58.78 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.929 0.395 . . . . 0.0 110.425 178.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.477 ' O ' ' HD1' ' A' ' 30' ' ' TYR . 38.8 m -77.78 -5.3 50.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.729 175.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.734 HD13 HG21 ' A' ' 33' ' ' VAL . 3.5 mm? -58.37 -27.09 63.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.45 0.643 . . . . 0.0 109.855 170.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -90.43 9.97 27.02 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.495 -178.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -119.23 -16.06 9.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.899 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.69 ' CD2' ' HB3' ' A' ' 3' ' ' ARG . 89.5 m-85 -119.95 135.62 54.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.965 -178.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -81.81 -23.11 36.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.04 0.448 . . . . 0.0 110.707 -179.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.676 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -130.72 144.94 16.38 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.678 175.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.734 HG21 HD13 ' A' ' 27' ' ' LEU . 95.4 t -139.41 141.18 35.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.56 HG12 ' HB2' ' A' ' 56' ' ' TYR . 48.6 mt -120.55 124.31 72.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.741 -178.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.416 ' HA2' HG13 ' A' ' 7' ' ' ILE . . . -109.19 104.28 1.9 Allowed Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 111.614 -0.594 . . . . 0.0 111.614 177.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.474 ' HB2' ' HA ' ' A' ' 8' ' ' SER . 87.5 mt -84.98 4.22 34.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.915 0.388 . . . . 0.0 111.191 -176.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 153.52 48.64 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.979 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -127.61 155.79 43.31 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 -178.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.507 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 53.3 m-85 49.91 87.81 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.89 0.852 . . . . 0.0 111.753 -173.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.2 m -80.45 3.18 2.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.496 -174.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.489 ' O ' HG23 ' A' ' 45' ' ' VAL . 21.7 t70 -94.36 121.61 36.06 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.251 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.513 HD22 ' HB3' ' A' ' 66' ' ' ASP . 59.8 tp -58.69 -45.4 89.56 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.598 -174.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -54.7 -46.38 74.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.164 0.506 . . . . 0.0 110.601 178.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.585 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 27.1 m -65.46 -31.12 72.04 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.376 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 41' ' ' ASP . 84.7 t -59.77 -44.38 93.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 121.013 0.435 . . . . 0.0 110.57 177.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -67.02 -40.0 84.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-O 121.198 0.523 . . . . 0.0 109.898 177.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -61.32 -35.0 76.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.697 176.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 44' ' ' THR . 83.1 mt -66.39 -35.92 81.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.687 179.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -78.0 -13.87 59.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.1 0.476 . . . . 0.0 110.575 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -81.23 -16.38 52.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.124 0.487 . . . . 0.0 110.394 173.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.56 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . 27.8 m-85 -100.52 -58.76 1.83 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.01 174.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 41.7 t -77.02 101.44 6.03 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.711 174.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -55.85 -40.09 72.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.824 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -113.71 89.85 3.19 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.037 0.446 . . . . 0.0 109.965 172.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -100.25 121.75 41.96 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.147 0.499 . . . . 0.0 110.77 -177.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.56 ' HB2' HG12 ' A' ' 34' ' ' ILE . 92.6 m-85 -118.88 178.44 4.48 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.426 -0.807 . . . . 0.0 109.307 176.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.441 ' C ' HD12 ' A' ' 71' ' ' LEU . . . 159.65 -179.68 35.06 Favored Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 120.141 -1.028 . . . . 0.0 112.685 176.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 15.8 t -140.51 148.37 22.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 -94.66 104.49 16.42 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.027 0.442 . . . . 0.0 110.316 -175.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -116.05 -5.16 17.85 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.155 177.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.493 ' HB3' ' OD1' ' A' ' 63' ' ' ASP . 6.7 m120 -83.4 133.68 34.92 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 74.1 mtm -96.73 10.23 39.34 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.235 0.54 . . . . 0.0 109.804 176.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.493 ' OD1' ' HB3' ' A' ' 61' ' ' ASN . 4.7 m-20 -66.66 -68.32 0.38 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.069 -177.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.479 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 91.8 m-85 -124.52 131.16 24.12 Favored Pre-proline 0 C--O 1.237 0.418 0 CA-C-O 121.167 0.508 . . . . 0.0 111.383 -177.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 64' ' ' TYR . 1.2 Cg_endo -83.74 -3.26 10.54 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 123.725 2.95 . . . . 0.0 112.478 -179.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.513 ' HB3' HD22 ' A' ' 42' ' ' LEU . 8.0 m-20 -67.68 -36.25 80.34 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.448 0.642 . . . . 0.0 109.958 179.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.525 HG12 HD23 ' A' ' 71' ' ' LEU . 30.3 t -76.36 -13.73 14.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.554 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.445 ' HB3' ' O ' ' A' ' 65' ' ' PRO . 87.6 tttt -70.59 -15.99 62.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.492 -175.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -90.36 0.42 57.27 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.82 0.343 . . . . 0.0 111.435 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -123.3 -39.04 2.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.03 0.443 . . . . 0.0 110.611 177.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.525 HD23 HG12 ' A' ' 67' ' ' VAL . 3.4 mm? -103.0 124.25 39.19 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 176.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -84.88 -175.08 1.93 Allowed 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.86 2.374 . . . . 0.0 113.115 -175.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -80.4 -29.46 37.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.38 0.609 . . . . 0.0 110.066 179.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.523 ' HB3' ' CZ ' ' A' ' 104' ' ' PHE . 26.5 m -152.07 137.51 17.66 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.121 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 34.7 tttp -139.29 116.56 11.16 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.926 -176.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.473 HG22 ' HA2' ' A' ' 85' ' ' GLY . 46.6 t -100.25 125.54 53.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 176.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 44.8 mt -103.14 153.58 20.17 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.06 178.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 37.4 tp -115.28 93.45 4.3 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 171.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 46.5 t -106.33 104.2 16.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.354 -173.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 57.21 29.26 16.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.441 178.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.45 -16.18 52.79 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.613 177.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 54.0 t -89.55 123.95 42.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.887 0.375 . . . . 0.0 110.832 -178.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.445 ' HB ' ' HA ' ' A' ' 108' ' ' PRO . 0.0 OUTLIER -80.73 115.87 20.45 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.858 177.259 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 21.0 mt -111.56 99.16 8.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.779 0.324 . . . . 0.0 110.489 -178.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.473 ' HA2' HG22 ' A' ' 76' ' ' VAL . . . -85.12 98.82 2.27 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 178.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 48.8 mtm -90.71 126.46 36.0 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.19 0.519 . . . . 0.0 110.896 -176.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.489 ' SG ' ' HB3' ' A' ' 113' ' ' PHE . 28.5 p -135.73 164.91 26.8 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 9.3 t-80 -83.49 -23.68 32.07 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 119.841 -0.743 . . . . 0.0 109.936 178.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.461 ' HA3' ' HB2' ' A' ' 113' ' ' PHE . . . 82.02 118.07 0.5 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.094 176.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 63.2 t90 -156.24 126.84 6.74 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 176.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 133.07 -166.93 23.55 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.425 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . . . -88.08 124.94 65.79 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.024 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 92' ' ' ALA . 33.7 Cg_exo -58.75 -15.61 27.14 Favored 'Trans proline' 0 N--CA 1.475 0.39 0 C-N-CA 123.224 2.616 . . . . 0.0 113.009 -177.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 4.4 m0 -66.14 -43.14 87.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.79 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -123.95 13.29 9.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.981 0.419 . . . . 0.0 111.23 -177.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 54.8 tp -66.32 -35.37 80.21 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.815 177.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.511 ' HD3' ' HB3' ' A' ' 124' ' ' LYS . 52.1 mttp -59.64 -49.42 77.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.804 177.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -68.17 -36.35 79.49 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.063 -0.972 . . . . 0.0 111.068 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.429 ' O ' HG23 ' A' ' 103' ' ' VAL . 45.8 ttt180 -64.85 -42.39 94.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.922 178.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.509 HD13 HG21 ' A' ' 111' ' ' ILE . 72.9 mt -67.78 -29.19 68.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.683 0.278 . . . . 0.0 111.241 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.512 HD21 HG21 ' A' ' 127' ' ' VAL . 92.2 mt -72.71 -13.72 61.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.014 0.435 . . . . 0.0 110.496 175.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -94.05 -30.88 14.46 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.782 175.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 99' ' ' ARG . 83.9 t -59.59 -50.98 77.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.1 175.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.523 ' CZ ' ' HB3' ' A' ' 74' ' ' SER . 55.8 m-85 -92.34 161.44 14.67 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.389 177.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -94.79 -26.73 16.11 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.303 0.573 . . . . 0.0 110.237 -179.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.405 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 43.2 mt-10 -111.81 152.36 27.97 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.127 175.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.409 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 45.2 mtmt -83.34 113.87 49.32 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-O 120.797 0.332 . . . . 0.0 110.919 -178.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.445 ' HA ' ' HB ' ' A' ' 83' ' ' THR . 2.7 Cg_exo -76.04 124.43 7.96 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.774 2.316 . . . . 0.0 110.465 175.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -61.61 -37.12 82.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.988 0.423 . . . . 0.0 111.389 -176.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 88.7 t -123.94 132.59 71.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 175.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.509 HG21 HD13 ' A' ' 100' ' ' LEU . 37.7 mt -125.17 134.62 66.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.923 0.392 . . . . 0.0 110.651 179.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.555 HD23 ' HB2' ' A' ' 130' ' ' LEU . 96.2 mt -109.29 139.05 44.73 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.928 178.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.503 ' CZ ' ' HB2' ' A' ' 131' ' ' ASN . 6.5 p90 -155.53 122.96 5.54 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 175.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -122.67 114.5 2.47 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.615 -177.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -173.53 21.04 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.495 0.664 . . . . 0.0 109.365 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.497 HG22 ' H ' ' A' ' 118' ' ' GLU . 16.9 m -117.38 154.38 31.42 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.015 -175.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 32.5 m80 -80.85 -27.57 36.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.922 0.391 . . . . 0.0 110.356 -177.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.497 ' H ' HG22 ' A' ' 116' ' ' THR . 46.0 mt-10 -122.03 111.13 32.53 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.263 177.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -57.49 141.94 95.21 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.767 2.312 . . . . 0.0 111.897 177.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -154.68 142.29 19.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.973 0.416 . . . . 0.0 111.367 -173.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -98.24 124.3 42.77 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.382 172.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.562 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 69.8 p -129.11 129.7 45.52 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.06 0.457 . . . . 0.0 111.48 -176.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.7 p -126.86 140.66 48.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.668 175.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.511 ' HB3' ' HD3' ' A' ' 97' ' ' LYS . 71.5 tttt -155.79 -56.34 0.09 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.416 0.627 . . . . 0.0 110.308 -179.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -94.88 30.85 1.97 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.746 -175.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 79.54 -42.21 2.4 Favored Glycine 0 N--CA 1.451 -0.304 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 -173.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.512 HG21 HD21 ' A' ' 101' ' ' LEU . 89.3 t -60.24 136.68 23.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-N 115.213 -0.494 . . . . 0.0 110.825 176.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.402 ' HE ' ' HB2' ' A' ' 128' ' ' ARG . 20.3 ttm180 -97.21 112.55 24.3 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.947 178.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.562 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 82.7 m-85 -97.76 108.26 20.94 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.102 -178.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.555 ' HB2' HD23 ' A' ' 112' ' ' LEU . 81.9 mt -99.8 115.6 29.93 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.294 -178.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.503 ' HB2' ' CZ ' ' A' ' 113' ' ' PHE . 22.7 t-20 -108.2 112.11 61.48 Favored Pre-proline 0 C--N 1.32 -0.713 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.187 -178.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -92.1 174.95 2.1 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 123.435 2.757 . . . . 0.0 111.413 169.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -112.85 -172.38 18.54 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.411 -0.899 . . . . 0.0 112.739 -177.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 38.0 m -78.9 153.94 30.1 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.642 0.258 . . . . 0.0 110.508 178.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.5 HD12 ' HB2' ' A' ' 10' ' ' SER . 73.5 mt -78.38 -10.69 59.79 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -173.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -96.49 -60.3 1.64 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.958 0.408 . . . . 0.0 111.412 -177.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -106.02 22.09 16.23 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.216 -173.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.471 ' O ' ' HB2' ' A' ' 157' ' ' LEU . . . -146.72 -164.76 11.23 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.348 -178.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 15.2 p -112.66 148.84 33.82 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.722 -0.103 . . . . 0.0 110.722 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -97.2 168.83 10.19 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 -177.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.527 ' HB3' HD23 ' A' ' 6' ' ' LEU . . . -121.27 149.43 42.9 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.016 0.436 . . . . 0.0 111.171 -174.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 69.5 t -122.36 126.98 74.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 173.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.739 HD21 HG13 ' A' ' 150' ' ' VAL . 3.7 tt -110.19 104.55 13.4 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -109.28 143.86 38.2 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.568 HD12 ' HB2' ' A' ' 2' ' ' LYS . 91.1 mt -98.66 101.66 13.15 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.199 0.523 . . . . 0.0 110.667 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.668 ' HB3' ' HE ' ' A' ' 151' ' ' ARG . 12.2 t70 -96.35 114.55 26.24 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.879 178.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.83 -69.06 0.3 Allowed Glycine 0 C--N 1.331 0.287 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.596 -175.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -174.92 26.92 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 178.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -126.78 147.01 50.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.834 0.349 . . . . 0.0 110.22 -177.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.739 HG13 HD21 ' A' ' 143' ' ' LEU . 92.2 t -76.83 113.35 15.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.342 -176.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.668 ' HE ' ' HB3' ' A' ' 146' ' ' ASP . 38.8 mmt180 -97.09 108.84 21.65 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.154 176.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -90.66 94.5 9.72 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 177.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -100.67 102.69 13.87 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.01 -178.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 26.7 tp -83.72 130.51 34.95 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.173 -178.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -123.52 138.89 54.48 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 3.1 m -81.91 156.36 24.82 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.191 0.519 . . . . 0.0 111.705 -169.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.471 ' HB2' ' O ' ' A' ' 138' ' ' GLY . 88.6 mt . . . . . 0 C--O 1.247 0.945 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.496 176.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.615 ' HB2' ' HB2' ' A' ' 145' ' ' LEU . 92.7 mttt . . . . . 0 CA--C 1.516 -0.329 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.51 ' O ' ' HB3' ' A' ' 30' ' ' TYR . 96.1 mtt180 -133.58 113.89 12.93 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.064 0.459 . . . . 0.0 110.841 178.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.527 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 49.3 m-85 -104.3 125.85 50.9 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.166 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.484 HD22 ' HB2' ' A' ' 26' ' ' SER . 37.8 tp -89.75 120.05 30.68 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.143 176.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.542 ' HB3' ' HB3' ' A' ' 141' ' ' ALA . 57.6 tp -102.57 110.74 22.78 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.875 0.369 . . . . 0.0 110.266 178.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.572 HG22 HD13 ' A' ' 23' ' ' ILE . 18.1 pt -101.18 122.03 52.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.462 0.649 . . . . 0.0 109.601 177.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.3 m -77.81 -165.37 0.62 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.94 -173.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -55.03 122.48 11.02 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.433 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.496 ' HB2' ' O ' ' A' ' 38' ' ' ASP . 19.3 m -126.99 159.23 34.72 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.622 178.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.481 ' H ' ' HE1' ' A' ' 16' ' ' MET . 89.4 m-70 -140.49 43.7 1.87 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 -176.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.499 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . 46.0 t -93.1 129.76 38.32 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.147 -179.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.499 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 83.8 Cg_endo -103.38 27.75 10.8 Favored 'Cis proline' 0 N--CA 1.455 -0.754 0 C-N-CA 124.44 -1.067 . . . . 0.0 112.36 -3.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.8 t -47.55 -60.74 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 O-C-N 123.744 0.653 . . . . 0.0 111.996 -175.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 62.3 ttt180 -142.49 11.23 1.89 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.722 0.773 . . . . 0.0 109.619 -178.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.481 ' HE1' ' H ' ' A' ' 11' ' ' HIS . 58.0 ttp -143.08 121.52 12.39 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.216 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -117.57 -0.49 11.87 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.994 0.426 . . . . 0.0 110.805 -177.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.0 t -108.4 88.66 2.78 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.623 -178.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.0 tt -107.88 120.45 47.05 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 175.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.577 ' HG2' HD13 ' A' ' 157' ' ' LEU . 76.4 Cg_exo -41.17 116.89 0.49 Allowed 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 124.107 3.205 . . . . 0.0 114.213 -174.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -61.22 -30.37 70.39 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.596 176.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -54.63 -36.71 64.8 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.095 178.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.572 HD13 HG22 ' A' ' 7' ' ' ILE . 0.6 OUTLIER -85.11 -28.69 6.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.192 0.52 . . . . 0.0 110.334 -178.711 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 44.7 tp -70.6 -30.01 66.57 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.944 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -72.48 -21.33 61.23 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.373 175.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.548 ' HB3' ' CD2' ' A' ' 30' ' ' TYR . 59.4 m -71.16 -9.69 58.5 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.566 -178.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.521 ' HB3' ' HB3' ' A' ' 51' ' ' PHE . 2.7 mm? -63.48 -24.93 68.03 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 121.159 0.504 . . . . 0.0 109.95 172.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -91.15 -33.2 15.52 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.04 178.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -68.59 -55.52 11.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.644 -178.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.548 ' CD2' ' HB3' ' A' ' 26' ' ' SER . 27.5 m-85 -94.83 150.8 19.81 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.825 -169.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -98.61 7.0 46.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.859 -176.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.527 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -154.39 139.03 6.49 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 175.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.51 HG21 HD13 ' A' ' 27' ' ' LEU . 60.5 t -134.75 140.61 45.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 117.259 0.529 . . . . 0.0 110.649 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.609 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 17.3 mt -125.17 132.76 70.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.467 175.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.409 ' HA2' HG13 ' A' ' 7' ' ' ILE . . . -116.07 129.66 8.61 Favored Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 174.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 90.9 mt -97.11 -7.2 33.24 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.59 0.709 . . . . 0.0 110.341 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 166.52 58.31 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 -177.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.496 ' O ' ' HB2' ' A' ' 10' ' ' SER . 6.1 p-10 -72.27 -111.42 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 123.371 0.668 . . . . 0.0 112.741 -171.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -89.84 148.64 23.06 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.108 -0.331 . . . . 0.0 110.108 -177.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 19.2 m -89.91 -7.78 10.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.265 0.555 . . . . 0.0 110.147 178.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.506 ' O ' HG23 ' A' ' 45' ' ' VAL . 9.2 m-20 -86.6 120.44 27.91 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.666 177.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.559 HD22 ' HB3' ' A' ' 66' ' ' ASP . 43.7 tp -59.74 -42.3 92.87 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.037 0.446 . . . . 0.0 110.12 178.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -57.85 -38.92 76.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.964 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.548 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 17.5 m -74.68 -30.44 61.57 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.18 -178.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 41' ' ' ASP . 48.7 t -66.44 -40.2 85.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.177 0.513 . . . . 0.0 109.915 176.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.17 -35.79 76.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.677 174.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -64.46 -31.58 72.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.007 176.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 44' ' ' THR . 87.9 mt -67.69 -46.91 70.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.947 0.403 . . . . 0.0 110.579 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.51 ' HG2' ' HB3' ' A' ' 55' ' ' PHE . 65.4 mt-10 -70.32 -16.4 62.99 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.499 177.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -81.57 -23.36 37.2 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.057 0.456 . . . . 0.0 109.961 177.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.521 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . 2.0 m-85 -86.51 -67.33 0.82 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.424 178.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.504 ' HB3' HD12 ' A' ' 27' ' ' LEU . 70.7 p -73.0 -34.26 66.3 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.972 -177.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 34.5 mtmm 66.28 12.94 8.93 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.379 -175.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -150.71 102.17 2.99 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.496 178.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.51 ' HB3' ' HG2' ' A' ' 49' ' ' GLU . 74.4 t80 -138.61 121.46 16.54 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.345 0.593 . . . . 0.0 111.275 -173.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.609 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 92.2 m-85 -114.81 167.7 10.55 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 171.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 145.01 -165.65 27.67 Favored Glycine 0 N--CA 1.438 -1.204 0 C-N-CA 119.13 -1.509 . . . . 0.0 113.502 174.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.0 m -153.21 175.54 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 114.555 -0.823 . . . . 0.0 109.117 -175.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.506 ' CD2' ' HG ' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -125.69 104.26 8.27 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 120.426 -0.51 . . . . 0.0 109.9 171.672 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.705 ' HA2' ' HB3' ' A' ' 88' ' ' HIS . . . -86.36 -28.96 26.12 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.555 -177.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 19.9 p30 -85.87 -177.93 6.46 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.93 0.395 . . . . 0.0 111.001 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 64.7 mtt -94.71 127.85 40.98 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.0 0.428 . . . . 0.0 110.791 -176.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.522 ' OD2' ' HB ' ' A' ' 67' ' ' VAL . 4.6 p-10 -149.87 -171.03 3.8 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.936 -175.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -74.23 142.06 78.23 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.737 -176.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.1 -27.95 39.0 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.146 2.564 . . . . 0.0 112.83 -176.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.559 ' HB3' HD22 ' A' ' 42' ' ' LEU . 2.1 m-20 -60.05 -45.31 93.28 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.5 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.522 ' HB ' ' OD2' ' A' ' 63' ' ' ASP . 87.9 t -69.09 -36.28 72.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.104 0.478 . . . . 0.0 110.804 -177.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.653 ' HD3' ' HE1' ' A' ' 73' ' ' PHE . 61.3 mttm -70.75 -2.8 15.86 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.457 -175.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -81.89 -42.88 18.93 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 172.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 52.7 t60 -87.53 -30.01 20.9 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.47 -176.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.506 ' HG ' ' CD2' ' A' ' 59' ' ' HIS . 4.2 mm? -103.02 109.31 61.23 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.041 177.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 71' ' ' LEU . 22.0 Cg_exo -65.4 165.72 21.63 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 123.101 2.534 . . . . 0.0 112.729 -177.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.653 ' HE1' ' HD3' ' A' ' 68' ' ' LYS . 80.3 m-85 -91.28 -23.68 20.08 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.135 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.0 t -155.34 111.83 3.2 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.115 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.0 tttm -131.0 136.98 49.0 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -177.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 14.1 t -117.28 112.25 38.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 120.972 0.415 . . . . 0.0 110.13 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.404 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 63.1 mt -87.77 151.52 22.82 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.5 -178.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 49.5 tp -116.71 96.22 5.39 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 173.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.602 HG12 ' HG2' ' A' ' 80' ' ' GLU . 62.1 t -113.91 108.13 24.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.69 -173.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.602 ' HG2' HG12 ' A' ' 79' ' ' VAL . 13.2 mm-40 63.63 16.34 9.61 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.271 176.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 109.56 -17.97 30.28 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 121.109 -0.567 . . . . 0.0 111.983 -179.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 57.1 t -86.32 133.19 30.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.739 0.304 . . . . 0.0 110.678 -178.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.9 p -89.36 128.16 35.88 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.923 178.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.476 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 36.8 mt -119.72 98.62 6.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.845 0.355 . . . . 0.0 110.244 -177.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -87.39 103.19 2.86 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.974 -0.631 . . . . 0.0 111.697 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 40.7 mtm -101.19 114.77 29.04 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 9.2 t -144.73 162.19 37.34 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.833 0.349 . . . . 0.0 110.817 -173.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.705 ' HB3' ' HA2' ' A' ' 60' ' ' GLY . 41.4 p-80 -84.22 94.54 8.43 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.438 0.637 . . . . 0.0 110.43 178.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -81.0 75.98 2.21 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.461 -0.79 . . . . 0.0 113.005 -176.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -95.11 75.2 3.46 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.893 0.378 . . . . 0.0 110.411 176.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -163.26 175.28 39.56 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.866 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.18 151.35 97.27 Favored Pre-proline 0 C--N 1.326 -0.456 0 C-N-CA 122.171 0.188 . . . . 0.0 110.86 178.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -57.28 -18.75 31.66 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.074 2.516 . . . . 0.0 113.188 -178.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -91.64 -52.64 4.66 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.983 0.42 . . . . 0.0 110.05 178.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -72.5 -11.62 60.74 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.243 -176.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 24.7 tp -56.53 -43.67 80.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.396 177.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 22.2 ttpt -56.83 -49.25 75.97 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.341 177.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.458 ' O ' ' HB2' ' A' ' 102' ' ' LYS . 16.1 t70 -58.06 -51.06 71.23 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.463 -178.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -71.52 -53.22 14.57 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.187 -0.461 . . . . 0.0 112.006 -173.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 49.8 mt -60.63 -48.9 79.71 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 -173.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 90.6 mt -72.68 -11.47 60.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.004 0.431 . . . . 0.0 111.175 -176.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 98' ' ' ASP . 33.6 ttmt -85.47 -26.27 26.4 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.228 0.537 . . . . 0.0 109.633 177.013 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 84.1 t -79.36 -37.79 19.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.138 176.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -76.21 144.57 40.36 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.351 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -82.35 -44.43 16.18 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.865 -179.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.409 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 63.7 mm-40 -111.03 -178.61 3.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.481 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -83.53 112.85 42.8 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.781 177.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.494 ' O ' HG13 ' A' ' 127' ' ' VAL . 1.5 Cg_endo -83.16 119.02 2.72 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.814 2.343 . . . . 0.0 110.969 174.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -64.93 -40.73 95.51 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.26 0.553 . . . . 0.0 109.8 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 93.2 t -121.32 129.46 75.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.221 178.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 29.1 mt -118.87 131.76 70.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 175.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.464 HD23 ' HB2' ' A' ' 130' ' ' LEU . 89.0 mt -110.43 124.52 51.89 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.178 179.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.445 ' CE1' ' HB3' ' A' ' 129' ' ' PHE . 27.9 p90 -145.49 170.64 15.99 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.254 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -131.18 121.64 3.24 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 176.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -163.0 -36.86 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.929 0.395 . . . . 0.0 110.16 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.57 ' HB ' ' ND2' ' A' ' 131' ' ' ASN . 20.8 m -94.07 149.48 21.2 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.908 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 26.9 m80 -79.99 -47.63 14.64 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.929 0.395 . . . . 0.0 110.268 -178.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -82.96 155.77 67.51 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.648 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.408 ' HB3' ' HG ' ' A' ' 154' ' ' LEU . 15.0 Cg_exo -66.96 128.9 19.57 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.563 2.175 . . . . 0.0 111.492 176.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -145.08 138.75 26.88 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.502 -178.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -118.52 128.82 54.94 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 174.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.579 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 72.2 p -128.5 116.21 19.33 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.212 0.53 . . . . 0.0 111.219 -176.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 127' ' ' VAL . 8.6 p -111.61 117.59 55.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 176.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -126.49 -74.57 0.59 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.083 -174.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -85.12 32.28 0.55 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.892 0.377 . . . . 0.0 111.195 -178.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 83.82 -5.69 77.78 Favored Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 -174.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.494 HG13 ' O ' ' A' ' 108' ' ' PRO . 96.8 t -99.28 134.72 37.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.104 -0.548 . . . . 0.0 109.863 178.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -102.43 105.72 16.34 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.095 0.474 . . . . 0.0 110.43 179.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.579 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 51.6 m-85 -84.85 122.12 28.7 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.21 177.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.464 ' HB2' HD23 ' A' ' 112' ' ' LEU . 87.9 mt -109.34 124.06 50.33 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.826 0.346 . . . . 0.0 110.983 -178.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.57 ' ND2' ' HB ' ' A' ' 116' ' ' THR . 4.7 t30 -113.75 111.64 48.55 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.44 174.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -86.58 165.09 9.27 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.921 2.414 . . . . 0.0 112.052 174.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -89.61 139.89 15.35 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.548 -177.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 15.8 m -59.87 156.16 14.89 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.898 0.38 . . . . 0.0 111.324 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -68.05 -3.77 11.27 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 -174.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -86.78 -60.6 1.94 Allowed 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.589 -177.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -125.1 2.01 7.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.818 0.342 . . . . 0.0 111.657 -177.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -106.76 173.36 19.23 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.758 -173.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.563 ' HB3' ' HA ' ' A' ' 156' ' ' THR . 12.5 p -98.6 134.56 41.37 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.526 0.203 . . . . 0.0 110.62 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -84.48 177.18 8.21 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.387 -178.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.542 ' HB3' ' HB3' ' A' ' 6' ' ' LEU . . . -123.31 135.81 54.38 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.2 0.524 . . . . 0.0 111.962 -176.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 74.1 t -118.5 120.33 63.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 173.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.677 ' HA ' ' O ' ' A' ' 151' ' ' ARG . 10.0 mp -111.17 111.08 21.91 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.119 0.485 . . . . 0.0 111.124 -178.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -98.75 134.16 42.05 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.427 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.615 ' HB2' ' HB2' ' A' ' 2' ' ' LYS . 94.2 mt -105.02 102.9 12.38 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.915 177.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -135.23 130.38 35.14 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.878 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.89 11.14 60.15 Favored Glycine 0 CA--C 1.517 0.161 0 C-N-CA 121.178 -0.534 . . . . 0.0 112.443 -176.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 96.47 -13.82 65.06 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.791 178.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -95.34 159.5 14.98 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.047 0.451 . . . . 0.0 111.053 -178.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 10.9 t -101.23 138.0 26.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.584 -177.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.677 ' O ' ' HA ' ' A' ' 143' ' ' LEU . 12.5 tpt180 -109.92 99.5 8.61 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -83.84 104.5 13.98 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.638 178.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.456 ' O ' ' HA ' ' A' ' 141' ' ' ALA . 40.0 mt-10 -116.56 128.99 55.92 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.67 0.271 . . . . 0.0 111.03 176.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.408 ' HG ' ' HB3' ' A' ' 119' ' ' PRO . 3.7 mm? -102.17 106.81 17.71 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 174.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -102.17 130.53 48.83 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.789 0.328 . . . . 0.0 110.56 -175.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.563 ' HA ' ' HB3' ' A' ' 139' ' ' SER . 14.1 p -81.3 145.69 30.77 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -169.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.577 HD13 ' HG2' ' A' ' 20' ' ' PRO . 84.5 mt . . . . . 0 C--O 1.25 1.127 0 CA-C-N 115.142 -0.936 . . . . 0.0 109.68 178.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 95.4 mttt . . . . . 0 CA--C 1.517 -0.296 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.446 ' HG2' ' HG2' ' A' ' 144' ' ' GLU . 92.7 mtt180 -126.89 117.45 22.61 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.125 0.488 . . . . 0.0 111.206 -178.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -107.18 129.88 54.79 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.946 178.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.562 ' HB3' HG22 ' A' ' 33' ' ' VAL . 44.0 tp -89.27 113.31 24.54 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.648 -176.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 64.7 tp -99.16 107.6 20.0 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.196 0.522 . . . . 0.0 110.936 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.466 HG13 ' HA2' ' A' ' 35' ' ' GLY . 27.4 pt -101.32 132.38 47.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 173.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.7 t -81.66 -168.05 1.74 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.822 0.344 . . . . 0.0 110.238 -178.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -63.62 128.04 34.07 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.715 0.769 . . . . 0.0 111.632 -176.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.525 ' OG ' HG12 ' A' ' 12' ' ' VAL . 33.4 t -100.15 155.38 17.78 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.783 176.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.455 ' H ' ' CE ' ' A' ' 16' ' ' MET . 50.3 m-70 -132.62 23.2 4.32 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.172 -177.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.525 HG12 ' OG ' ' A' ' 10' ' ' SER . 7.8 p -114.65 144.65 32.27 Favored Pre-proline 0 C--O 1.241 0.622 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.308 -176.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.435 ' HA ' ' CG2' ' A' ' 12' ' ' VAL . 12.0 Cg_endo -93.59 93.81 0.14 OUTLIER 'Cis proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.847 -1.314 . . . . 0.0 112.816 -5.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.561 HG21 HG11 ' A' ' 40' ' ' VAL . 1.9 t -138.36 -71.89 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.363 0.601 . . . . 0.0 109.678 176.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 40.3 mtp180 -125.08 73.91 1.33 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.297 178.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.455 ' CE ' ' H ' ' A' ' 11' ' ' HIS . 14.4 ttm -177.13 -80.68 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.495 178.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 58.08 14.57 2.76 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.969 -176.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.42 ' H ' ' HG2' ' A' ' 16' ' ' MET . 15.4 m -120.0 32.9 5.83 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.532 -176.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.598 HD11 HD23 ' A' ' 135' ' ' LEU . 7.5 tt -89.17 120.64 69.84 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.708 -179.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 19' ' ' LEU . 16.7 Cg_exo -68.57 126.69 14.45 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 123.114 2.543 . . . . 0.0 112.348 -179.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -66.52 -12.24 56.61 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.777 -177.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.531 ' HB2' HD22 ' A' ' 157' ' ' LEU . 43.6 mt-10 -58.48 -38.26 77.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.264 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.456 HD11 HD11 ' A' ' 5' ' ' LEU . 0.4 OUTLIER -67.52 -29.27 44.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.4 0.619 . . . . 0.0 110.282 -178.59 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.53 ' O ' HD23 ' A' ' 27' ' ' LEU . 38.9 tp -78.27 -12.55 60.01 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.264 -177.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -84.85 -27.39 26.75 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.735 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.447 ' HB3' ' CE2' ' A' ' 30' ' ' TYR . 15.3 m -69.42 -6.37 29.74 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.934 -175.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.666 HD13 HG21 ' A' ' 33' ' ' VAL . 4.4 mm? -58.35 -26.0 62.64 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.745 0.307 . . . . 0.0 111.594 178.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.7 mttp -85.32 -8.27 58.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.286 -175.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -106.54 -22.46 12.77 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -168.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.509 ' CD2' ' HB2' ' A' ' 5' ' ' LEU . 29.5 m-85 -112.2 156.19 22.73 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.476 -0.489 . . . . 0.0 111.79 -172.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -67.03 -55.15 15.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.616 -177.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -136.2 158.51 23.98 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.569 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.666 HG21 HD13 ' A' ' 27' ' ' LEU . 89.2 t -123.4 136.02 61.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 120.996 0.427 . . . . 0.0 110.415 -179.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.466 HG21 ' SD ' ' A' ' 86' ' ' MET . 70.5 mt -115.74 128.88 72.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.919 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.466 ' HA2' HG13 ' A' ' 7' ' ' ILE . . . -121.84 117.82 3.51 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.846 178.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.1 mt -83.69 19.39 1.66 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.418 0.628 . . . . 0.0 110.26 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 153.59 84.78 0.05 OUTLIER Glycine 0 N--CA 1.44 -1.074 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 -177.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.473 ' CG ' ' H ' ' A' ' 39' ' ' TYR . 9.2 t70 -74.75 -165.33 0.35 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.821 0.344 . . . . 0.0 110.829 -173.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.473 ' H ' ' CG ' ' A' ' 38' ' ' ASP . 37.2 m-85 -68.82 149.32 49.1 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.089 -0.338 . . . . 0.0 110.089 -177.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.561 HG11 HG21 ' A' ' 14' ' ' VAL . 24.6 m -68.46 -17.17 21.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -176.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -93.66 125.3 38.2 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.703 0.287 . . . . 0.0 110.481 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.647 HD22 ' HB3' ' A' ' 66' ' ' ASP . 50.8 tp -63.84 -33.46 75.72 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.416 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -59.68 -34.38 72.79 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.36 178.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 20.9 m -78.28 -31.72 49.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.612 178.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.506 HG21 HG13 ' A' ' 67' ' ' VAL . 46.4 t -60.29 -41.38 86.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.38 0.609 . . . . 0.0 109.705 173.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.421 HD13 ' O ' ' A' ' 42' ' ' LEU . 1.6 mp -66.27 -34.28 69.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.07 175.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -61.89 -37.13 83.43 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 174.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -71.52 -42.27 68.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.519 178.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -70.85 -19.57 62.63 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.342 0.592 . . . . 0.0 110.605 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.4 tptm -78.27 -46.88 19.12 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.96 178.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.532 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . 32.4 m-85 -73.36 -55.25 6.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.449 176.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.589 ' HB2' HD12 ' A' ' 27' ' ' LEU . 22.7 t -90.7 98.87 12.03 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.71 174.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -56.14 -35.69 67.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.954 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -110.77 82.75 1.64 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.145 179.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -101.55 124.84 47.87 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.533 -178.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.423 ' HB2' HG12 ' A' ' 34' ' ' ILE . 54.4 m-85 -106.92 117.02 32.95 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.655 ' HA3' HD22 ' A' ' 71' ' ' LEU . . . -117.98 144.12 18.01 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.079 -1.058 . . . . 0.0 113.028 -175.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.414 HG21 ' CB ' ' A' ' 86' ' ' MET . 15.3 t -128.58 144.66 37.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 175.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -97.36 112.57 24.34 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.982 -175.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.697 ' HA3' ' HB3' ' A' ' 88' ' ' HIS . . . -152.53 22.9 0.84 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.407 -0.901 . . . . 0.0 112.556 178.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 23.9 p-10 -136.48 174.25 10.82 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 110.41 -0.218 . . . . 0.0 110.41 -178.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 66.8 mtm -92.55 119.96 32.53 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.678 ' OD2' ' HB ' ' A' ' 67' ' ' VAL . 17.7 p-10 -149.27 -173.5 4.4 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.77 -169.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -81.34 145.26 55.26 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.87 175.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -57.28 -20.74 40.59 Favored 'Trans proline' 0 CA--C 1.532 0.401 0 C-N-CA 122.89 2.393 . . . . 0.0 113.426 -176.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.647 ' HB3' HD22 ' A' ' 42' ' ' LEU . 3.0 m-20 -70.41 -27.69 64.48 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.31 -0.405 . . . . 0.0 112.037 -177.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.678 ' HB ' ' OD2' ' A' ' 63' ' ' ASP . 38.1 t -74.77 -19.15 16.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.113 0.482 . . . . 0.0 110.539 -178.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 63.9 tttt -53.38 -36.39 61.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.702 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -69.84 -27.97 65.29 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.518 -176.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.534 ' CD2' HD11 ' A' ' 42' ' ' LEU . 29.6 m-70 -95.86 -30.65 13.54 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 121.111 -0.235 . . . . 0.0 111.138 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.655 HD22 ' HA3' ' A' ' 57' ' ' GLY . 13.1 mt -110.26 102.36 50.99 Favored Pre-proline 0 C--N 1.326 -0.443 0 C-N-CA 120.931 -0.308 . . . . 0.0 110.755 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.493 ' HD2' ' O ' ' A' ' 57' ' ' GLY . 46.9 Cg_endo -70.12 151.3 66.98 Favored 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.379 2.053 . . . . 0.0 110.734 172.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -63.42 -22.54 66.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.84 0.352 . . . . 0.0 111.635 -175.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 38.6 m -153.82 141.7 20.15 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 175.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 36.1 tttp -144.33 125.32 14.42 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.345 -177.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 11.4 t -111.65 112.61 41.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.865 0.364 . . . . 0.0 110.574 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.417 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 94.0 mt -87.69 144.81 26.45 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.986 -179.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 59.7 tp -112.14 97.37 6.6 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 170.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 41.4 t -110.9 93.45 2.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.091 -176.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 51.18 63.25 2.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.907 179.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.16 -9.43 47.31 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.912 -0.661 . . . . 0.0 113.206 176.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 60.8 t -99.89 115.21 40.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.887 0.375 . . . . 0.0 110.732 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.5 p -86.84 127.06 35.02 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.317 176.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 18.8 mt -119.36 93.25 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -176.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.446 ' O ' HG23 ' A' ' 111' ' ' ILE . . . -81.21 96.09 1.7 Allowed Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.474 ' HG2' HD12 ' A' ' 112' ' ' LEU . 38.3 mtm -96.06 119.13 34.01 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 120.896 0.379 . . . . 0.0 110.242 -176.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 39.2 t -153.22 107.05 3.05 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.993 -178.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.697 ' HB3' ' HA3' ' A' ' 60' ' ' GLY . 64.8 t-80 -91.26 69.27 6.04 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -179.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -85.01 178.73 51.03 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.63 -178.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -132.28 142.98 49.59 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 148.74 -172.68 28.86 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 121.081 -0.58 . . . . 0.0 111.808 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.442 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . . . -76.95 146.1 75.06 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 120.519 0.2 . . . . 0.0 110.741 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 92' ' ' ALA . 15.5 Cg_exo -69.2 -10.55 29.3 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.953 2.435 . . . . 0.0 112.859 -178.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 5.7 m0 -68.48 -44.47 74.68 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.996 0.427 . . . . 0.0 110.625 -178.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -91.49 11.66 23.29 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.807 -178.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 28.3 tp -58.66 -49.54 77.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.047 -178.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.473 ' HD2' ' HB2' ' A' ' 125' ' ' ALA . 28.5 ttpt -61.89 -50.35 72.56 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.65 179.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -60.72 -53.23 59.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.654 -174.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.43 ' O ' HG23 ' A' ' 103' ' ' VAL . 26.8 mtm105 -65.18 -46.36 81.1 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -176.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.529 HD13 HG21 ' A' ' 111' ' ' ILE . 83.5 mt -65.8 -36.76 84.41 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.474 -176.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.672 HD21 HG21 ' A' ' 127' ' ' VAL . 79.6 mt -78.77 -15.69 58.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.778 0.323 . . . . 0.0 110.91 178.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.467 ' HA ' ' HD2' ' A' ' 102' ' ' LYS . 33.4 tptt -86.21 -34.7 20.4 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.076 0.465 . . . . 0.0 110.039 177.102 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 99' ' ' ARG . 73.8 t -74.19 -43.95 50.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.571 174.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -104.54 87.32 2.68 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.88 176.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -71.78 -19.2 62.05 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.423 -173.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -77.4 -14.65 59.66 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.256 -179.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt 63.86 99.29 0.04 OUTLIER Pre-proline 0 C--O 1.232 0.182 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.096 -175.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -76.24 144.36 26.25 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.601 2.201 . . . . 0.0 110.938 175.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -72.49 -41.9 65.47 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.137 0.494 . . . . 0.0 109.836 178.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 90.0 t -116.32 130.14 71.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.583 177.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.529 HG21 HD13 ' A' ' 100' ' ' LEU . 30.6 mt -125.08 128.45 72.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 120.774 0.321 . . . . 0.0 110.677 178.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.474 HD12 ' HG2' ' A' ' 86' ' ' MET . 92.1 mt -99.98 119.22 37.91 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -138.59 -174.74 3.91 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.81 -175.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.581 ' HA2' ' ND2' ' A' ' 131' ' ' ASN . . . -147.75 151.77 23.96 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 175.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -136.64 179.1 6.57 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 117.195 0.498 . . . . 0.0 109.937 177.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.3 p -73.92 11.26 0.92 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -171.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 -144.75 -172.12 3.76 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 122.131 -0.356 . . . . 0.0 111.045 -178.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -60.6 155.48 49.86 Favored Pre-proline 0 C--N 1.329 -0.316 0 O-C-N 123.839 0.712 . . . . 0.0 112.695 -172.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -47.03 144.78 8.09 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 124.441 3.428 . . . . 0.0 113.266 178.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -165.7 144.03 5.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.267 -176.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -102.54 135.78 43.56 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 173.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.479 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 57.8 p -137.72 158.02 45.25 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.908 -174.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.495 ' HA ' ' O ' ' A' ' 127' ' ' VAL . 85.2 t -132.54 115.2 24.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.939 0.4 . . . . 0.0 110.425 176.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.632 ' HB2' ' HE2' ' A' ' 129' ' ' PHE . 75.4 mmtt -125.58 125.62 43.47 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.483 177.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.473 ' HB2' ' HD2' ' A' ' 97' ' ' LYS . . . 65.1 9.24 5.36 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 123.64 0.588 . . . . 0.0 111.779 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 104.11 -4.2 44.86 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.409 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.672 HG21 HD21 ' A' ' 101' ' ' LEU . 52.5 t -90.19 134.36 29.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 179.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 51.8 ttt180 -96.45 105.82 17.96 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.147 0.499 . . . . 0.0 110.18 -177.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.632 ' HE2' ' HB2' ' A' ' 124' ' ' LYS . 58.7 m-85 -94.63 126.52 39.98 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.88 -178.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.449 ' HB2' HD23 ' A' ' 112' ' ' LEU . 53.6 mt -115.26 120.91 41.26 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.754 0.311 . . . . 0.0 110.638 -178.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.581 ' ND2' ' HA2' ' A' ' 114' ' ' GLY . 3.7 t-20 -108.02 115.99 57.72 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.471 174.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.413 ' HD2' HD22 ' A' ' 131' ' ' ASN . 85.8 Cg_endo -83.78 164.87 13.84 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.745 2.297 . . . . 0.0 112.234 174.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -73.99 153.71 47.25 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.442 175.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 96.0 p -81.28 160.33 24.25 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.061 0.458 . . . . 0.0 110.999 -176.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.598 HD23 HD11 ' A' ' 19' ' ' LEU . 5.9 mp -74.11 -0.17 15.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.1 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -97.19 -10.57 25.6 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.586 178.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -100.83 -6.03 25.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.108 0.48 . . . . 0.0 110.816 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 74.86 38.45 41.71 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.19 -179.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 25.2 m -139.31 145.84 39.59 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.447 ' O ' HD12 ' A' ' 154' ' ' LEU . 23.9 p90 -139.73 160.03 40.83 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 178.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -114.33 125.97 54.48 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.051 0.453 . . . . 0.0 110.352 -175.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 48.0 t -102.99 121.44 54.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 177.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.417 HD21 HG13 ' A' ' 150' ' ' VAL . 6.3 tt -94.67 101.21 13.05 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.446 ' HG2' ' HG2' ' A' ' 3' ' ' ARG . 60.1 mt-10 -95.32 117.62 30.63 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.459 -178.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 72.0 mt -90.67 90.19 7.85 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 172.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.526 ' HB3' ' HD3' ' A' ' 151' ' ' ARG . 35.3 t70 -115.57 130.11 56.75 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.844 -174.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 68.13 -59.51 0.4 Allowed Glycine 0 CA--C 1.521 0.446 0 O-C-N 123.584 0.553 . . . . 0.0 112.337 -171.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 164.9 33.39 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 176.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -126.53 155.55 42.2 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.631 0.253 . . . . 0.0 110.675 -176.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.417 HG13 HD21 ' A' ' 143' ' ' LEU . 29.0 t -86.88 95.03 4.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.524 176.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.526 ' HD3' ' HB3' ' A' ' 146' ' ' ASP . 35.0 mtp-105 -105.82 92.31 4.11 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.53 -175.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -90.54 122.17 33.12 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.198 0.523 . . . . 0.0 109.774 178.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.461 ' HB2' ' HE3' ' A' ' 155' ' ' LYS . 57.9 mt-10 -116.04 127.38 54.85 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.132 177.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.447 HD12 ' O ' ' A' ' 140' ' ' TYR . 38.7 tp -90.49 112.17 23.72 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.461 ' HE3' ' HB2' ' A' ' 153' ' ' GLU . 85.8 mttt -117.09 145.49 43.73 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.78 -173.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 3.5 p -96.65 150.58 20.51 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.321 0.581 . . . . 0.0 112.37 -171.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.531 HD22 ' HB2' ' A' ' 22' ' ' GLU . 91.1 mt . . . . . 0 C--O 1.249 1.03 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.952 177.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.662 ' HB2' HD12 ' A' ' 145' ' ' LEU . 98.8 mttt . . . . . 0 N--CA 1.451 -0.418 0 CA-C-O 121.151 0.501 . . . . 0.0 110.288 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 56.0 mtp180 -111.2 116.88 31.81 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.947 -178.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.576 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 18.3 m-85 -103.93 125.51 50.38 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.452 0.644 . . . . 0.0 111.102 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.535 ' HB3' HG22 ' A' ' 33' ' ' VAL . 36.0 tp -89.12 133.22 34.47 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.078 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.491 ' HB2' HD21 ' A' ' 143' ' ' LEU . 56.0 tp -121.72 111.96 17.81 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.835 0.35 . . . . 0.0 110.789 178.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.446 HG13 ' HA2' ' A' ' 35' ' ' GLY . 27.9 pt -101.45 128.74 53.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 174.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.556 ' H ' HD21 ' A' ' 135' ' ' LEU . 12.2 t -76.06 -171.44 1.69 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.852 -174.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.654 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 18.0 t0 -62.14 104.46 0.48 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.757 -177.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.434 ' H ' ' HA3' ' A' ' 37' ' ' GLY . 26.7 t -97.18 153.79 17.78 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.625 -177.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 13.8 m80 -134.8 65.39 1.57 Allowed 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.436 ' O ' HG22 ' A' ' 40' ' ' VAL . 64.8 t -118.8 130.09 25.02 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.617 -176.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -76.41 -52.12 0.16 OUTLIER 'Cis proline' 0 C--N 1.343 0.254 0 C-N-CA 123.192 -1.587 . . . . 0.0 112.21 -3.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 37.9 t 49.14 -93.37 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 O-C-N 123.858 0.724 . . . . 0.0 110.81 -178.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -155.56 25.93 0.4 Allowed 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.453 0.644 . . . . 0.0 109.773 171.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 52.5 ttp -109.75 -75.74 0.62 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 176.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.407 ' HA ' HG22 ' A' ' 12' ' ' VAL . . . 63.45 -6.48 0.21 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.443 -0.799 . . . . 0.0 113.133 175.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.3 p -78.63 58.06 2.16 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.64 0.733 . . . . 0.0 111.094 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.8 tt -107.93 112.78 61.59 Favored Pre-proline 0 N--CA 1.447 -0.604 0 CA-C-N 115.116 -0.947 . . . . 0.0 108.544 176.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -53.51 120.62 8.1 Favored 'Trans proline' 0 CA--C 1.528 0.202 0 C-N-CA 123.063 2.509 . . . . 0.0 112.868 -177.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -61.01 -29.8 69.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.174 -177.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -64.78 -25.01 67.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.663 -177.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.509 HD11 ' CG ' ' A' ' 140' ' ' TYR . 1.2 tt -68.49 -32.52 55.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.266 0.555 . . . . 0.0 109.531 178.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.566 ' HA ' HD23 ' A' ' 27' ' ' LEU . 24.4 tp -77.79 -35.33 51.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.104 -177.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -71.47 -26.44 62.71 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.626 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 42.9 m -81.69 2.05 31.45 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.588 -177.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.566 HD23 ' HA ' ' A' ' 24' ' ' LEU . 2.9 mm? -54.52 -31.31 56.0 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.043 0.449 . . . . 0.0 111.203 177.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -74.35 -15.98 60.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.275 -175.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -96.16 5.29 51.39 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.941 0.401 . . . . 0.0 111.679 -175.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -119.67 169.9 9.68 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 177.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -105.19 -56.2 2.21 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.233 0.54 . . . . 0.0 109.913 -178.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.576 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -117.36 146.7 18.79 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 175.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.561 HG21 ' CD1' ' A' ' 27' ' ' LEU . 72.8 t -130.03 134.87 62.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 117.315 0.557 . . . . 0.0 111.109 -177.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.567 HG12 ' HB2' ' A' ' 56' ' ' TYR . 36.2 mt -114.91 125.71 72.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.373 177.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.446 ' HA2' HG13 ' A' ' 7' ' ' ILE . . . -109.41 103.43 1.76 Allowed Glycine 0 N--CA 1.441 -0.979 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.716 174.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.4 ' HG ' HD11 ' A' ' 6' ' ' LEU . 84.5 mt -74.1 -28.69 61.48 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.654 ' HA3' ' HA ' ' A' ' 9' ' ' ASP . . . -145.92 109.12 0.49 Allowed Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.063 173.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.417 ' OD2' HG22 ' A' ' 45' ' ' VAL . 15.2 p-10 -98.98 -154.39 0.46 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 120.843 0.354 . . . . 0.0 110.893 -175.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.412 ' HE2' HD21 ' A' ' 48' ' ' LEU . 97.3 m-85 -88.83 137.35 32.4 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 -179.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.436 HG22 ' O ' ' A' ' 12' ' ' VAL . 11.5 m -76.18 4.83 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.029 0.442 . . . . 0.0 111.611 -174.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.513 ' O ' HG23 ' A' ' 45' ' ' VAL . 17.5 t70 -105.63 123.76 48.44 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.148 177.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.491 HD22 ' HB3' ' A' ' 66' ' ' ASP . 44.8 tp -59.04 -43.49 91.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 0.0 112.278 -172.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -62.03 -37.72 85.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.1 0.476 . . . . 0.0 110.57 -178.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 20.8 m -70.82 -27.96 64.26 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.844 178.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 41' ' ' ASP . 61.8 t -62.88 -40.71 89.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-O 121.487 0.66 . . . . 0.0 109.588 173.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.36 -35.26 74.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.143 177.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.79 -31.92 72.99 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.596 175.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.412 HD21 ' HE2' ' A' ' 39' ' ' TYR . 95.3 mt -67.69 -41.74 83.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.098 0.475 . . . . 0.0 110.061 178.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -71.97 -14.89 62.03 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.108 176.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -82.47 -45.69 14.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.33 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -70.85 -65.43 0.74 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.991 0.424 . . . . 0.0 110.408 173.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.492 ' HB3' HD12 ' A' ' 27' ' ' LEU . 8.9 p -90.44 96.17 10.53 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.92 174.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -62.31 -33.03 73.89 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.459 -179.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -98.3 79.36 2.53 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.495 0.664 . . . . 0.0 109.457 171.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -100.33 127.6 46.6 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.612 -177.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.567 ' HB2' HG12 ' A' ' 34' ' ' ILE . 76.1 m-85 -117.28 169.94 9.08 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 175.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 153.96 -172.22 32.64 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 119.355 -1.402 . . . . 0.0 113.609 175.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.504 HG13 ' HE3' ' A' ' 86' ' ' MET . 0.2 OUTLIER -144.27 -169.2 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 114.856 -0.672 . . . . 0.0 109.871 -177.494 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.472 ' NE2' ' HG2' ' A' ' 68' ' ' LYS . 57.0 t-80 -94.48 130.83 40.71 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.798 0.332 . . . . 0.0 111.235 -173.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -75.15 -158.83 7.02 Favored Glycine 0 CA--C 1.522 0.471 0 CA-C-N 115.731 -0.668 . . . . 0.0 113.249 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -73.05 -73.12 0.22 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -176.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 50.0 ttm -131.71 129.48 40.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.821 0.344 . . . . 0.0 110.361 -177.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.522 ' OD2' ' HB ' ' A' ' 67' ' ' VAL . 23.0 p-10 -145.52 -162.93 1.61 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.681 -173.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.407 ' HD2' ' O ' ' A' ' 40' ' ' VAL . 76.5 m-85 -103.44 155.19 37.14 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.521 173.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -48.88 -34.47 28.53 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.281 2.654 . . . . 0.0 113.374 -176.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.491 ' HB3' HD22 ' A' ' 42' ' ' LEU . 35.7 m-20 -58.09 -39.18 77.94 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.558 -177.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.522 ' HB ' ' OD2' ' A' ' 63' ' ' ASP . 60.7 t -80.08 -31.15 13.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.518 -177.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.472 ' HG2' ' NE2' ' A' ' 59' ' ' HIS . 93.5 mttt -60.05 -28.03 67.43 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.494 0.664 . . . . 0.0 110.233 175.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -72.8 -47.28 47.87 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.177 177.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -84.16 -35.44 23.58 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.868 -0.606 . . . . 0.0 112.278 -169.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.49 HD23 HG13 ' A' ' 67' ' ' VAL . 4.5 mm? -100.56 117.06 63.54 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-O 120.635 0.255 . . . . 0.0 110.995 -178.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -68.86 146.25 65.14 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.808 2.339 . . . . 0.0 111.398 176.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -72.75 -29.65 63.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.856 0.36 . . . . 0.0 110.931 -176.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 18.1 m -150.02 132.77 15.94 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.404 178.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -150.65 144.35 25.16 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 5.9 t -110.0 133.23 55.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 175.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 69.8 mt -111.63 153.97 25.56 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.584 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 45.0 tp -116.69 99.23 6.99 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 174.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 63.8 t -113.58 109.19 27.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.712 -175.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.82 ' HG3' HD13 ' A' ' 145' ' ' LEU . 5.0 mm-40 57.25 30.27 18.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.137 178.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.72 -7.91 59.58 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.006 -0.616 . . . . 0.0 113.064 178.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.587 HG21 HG23 ' A' ' 150' ' ' VAL . 61.5 t -101.56 136.19 34.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.864 0.332 . . . . 0.0 111.256 -176.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -88.51 130.15 35.29 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.331 178.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 20.0 mt -118.78 99.62 8.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.892 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -84.27 106.66 2.92 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 111.084 -0.807 . . . . 0.0 111.084 177.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.504 ' HE3' HG13 ' A' ' 58' ' ' VAL . 36.5 mtm -104.12 132.05 50.77 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.997 0.427 . . . . 0.0 111.104 -175.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.484 ' O ' ' HA ' ' A' ' 113' ' ' PHE . 37.6 t -155.61 165.17 37.36 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 175.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 31.9 t-80 -76.5 -36.81 57.57 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.52 175.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.2 128.94 1.7 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.473 178.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 31.8 t-105 -156.67 141.08 16.67 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 178.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 123.46 177.53 15.14 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.601 -177.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.14 139.06 92.41 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.637 0.218 . . . . 0.0 110.499 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -56.79 -23.1 48.44 Favored 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 123.126 2.551 . . . . 0.0 113.206 -175.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -77.12 -54.34 6.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.224 0.535 . . . . 0.0 110.294 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -87.73 -8.1 56.5 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.717 -174.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 59.4 tp -59.18 -39.07 81.37 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.416 176.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -60.93 -40.63 93.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.992 178.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -69.62 -39.86 76.92 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.628 177.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.455 ' O ' HG23 ' A' ' 103' ' ' VAL . 78.4 ttt180 -67.89 -41.49 82.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.248 -177.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.536 HD13 HG21 ' A' ' 111' ' ' ILE . 78.1 mt -69.54 -31.64 69.97 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.618 0.247 . . . . 0.0 111.017 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.63 HD21 HG21 ' A' ' 127' ' ' VAL . 83.4 mt -74.62 -23.37 58.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.138 0.494 . . . . 0.0 110.225 174.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -74.6 -33.47 62.63 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.538 175.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 99' ' ' ARG . 98.5 t -71.9 -55.97 11.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.053 175.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -92.94 91.95 7.64 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.462 177.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -67.5 -25.26 65.77 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.174 -177.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -67.52 -24.18 65.53 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.942 176.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 32.8 mtmm 62.49 93.98 0.05 OUTLIER Pre-proline 0 N--CA 1.463 0.19 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.721 -177.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -76.8 156.85 35.21 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 123.161 2.574 . . . . 0.0 111.721 -177.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -66.03 -42.66 89.31 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.213 0.53 . . . . 0.0 110.16 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.409 HG11 ' CZ ' ' A' ' 152' ' ' PHE . 53.8 t -128.15 139.3 52.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.605 -178.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.536 HG21 HD13 ' A' ' 100' ' ' LEU . 61.0 mt -125.08 130.52 73.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.949 0.404 . . . . 0.0 110.268 176.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.432 HD23 ' HB2' ' A' ' 130' ' ' LEU . 98.0 mt -110.85 131.19 55.25 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.108 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.484 ' HA ' ' O ' ' A' ' 87' ' ' CYS . 37.8 p90 -155.18 172.24 18.47 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.169 -0.468 . . . . 0.0 109.95 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -133.15 114.61 1.41 Allowed Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.385 176.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 63.8 t-80 -171.91 -39.73 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.625 0.25 . . . . 0.0 110.698 -176.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.574 HG22 ' H ' ' A' ' 117' ' ' HIS . 0.2 OUTLIER -75.25 -165.52 0.41 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.987 0.423 . . . . 0.0 111.373 -174.168 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.574 ' H ' HG22 ' A' ' 116' ' ' THR . 93.1 m-70 -94.55 -54.75 3.4 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 111.946 0.351 . . . . 0.0 111.946 -171.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -116.24 167.84 9.69 Favored Pre-proline 0 C--N 1.323 -0.578 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.52 -172.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.696 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 16.2 Cg_exo -69.54 76.56 1.05 Allowed 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.641 2.227 . . . . 0.0 110.092 166.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.446 ' H ' ' HG2' ' A' ' 120' ' ' GLU . 6.9 pt-20 -108.89 142.03 40.1 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.719 -170.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -94.01 99.99 12.2 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.333 175.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.625 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 80.7 p -104.63 113.07 26.42 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.318 0.58 . . . . 0.0 110.677 -178.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 39.6 t -121.81 97.06 4.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.22 -178.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -137.16 33.93 2.57 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.792 177.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.424 ' C ' ' H ' ' A' ' 127' ' ' VAL . . . -166.74 14.88 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.221 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 80.25 -27.64 2.75 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.518 -172.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.63 HG21 HD21 ' A' ' 101' ' ' LEU . 42.3 t -85.82 138.7 18.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.28 -0.46 . . . . 0.0 110.409 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -87.48 107.64 18.66 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 174.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.625 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 92.8 m-85 -88.95 104.18 16.72 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 174.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.432 ' HB2' HD23 ' A' ' 112' ' ' LEU . 49.7 mt -109.19 134.66 51.45 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.181 -173.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.696 ' O ' ' HA ' ' A' ' 119' ' ' PRO . 5.8 t30 -117.76 104.91 48.55 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.268 178.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -70.59 142.72 44.97 Favored 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.805 2.336 . . . . 0.0 112.176 177.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -66.61 152.21 52.4 Favored Glycine 0 N--CA 1.452 -0.285 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.71 -178.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 39.9 m -64.28 138.49 58.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.962 0.411 . . . . 0.0 111.405 -178.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.556 HD21 ' H ' ' A' ' 8' ' ' SER . 74.6 mt -62.47 -31.1 71.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.376 -177.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -66.92 -16.16 64.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.633 -178.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 36.6 tp10 -90.88 1.0 57.34 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.287 0.565 . . . . 0.0 110.478 -178.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 74.94 43.2 28.02 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.248 178.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 57.5 m -152.22 142.17 22.13 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.754 0.311 . . . . 0.0 110.324 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.509 ' CG ' HD11 ' A' ' 23' ' ' ILE . 27.9 p90 -141.43 175.77 9.4 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 177.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.445 ' HB3' HD23 ' A' ' 6' ' ' LEU . . . -114.5 136.66 52.78 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.117 -175.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.477 HG12 ' HG3' ' A' ' 144' ' ' GLU . 21.5 t -118.44 105.86 18.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.879 176.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.742 ' HA ' ' O ' ' A' ' 151' ' ' ARG . 0.3 OUTLIER -95.75 109.4 21.71 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.438 0.637 . . . . 0.0 110.067 176.132 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.477 ' HG3' HG12 ' A' ' 142' ' ' VAL . 47.6 mt-10 -107.11 144.12 34.28 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.157 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.82 HD13 ' HG3' ' A' ' 80' ' ' GLU . 22.0 mt -90.7 90.33 7.91 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.777 -176.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -92.14 101.77 14.3 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.397 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.87 10.18 58.04 Favored Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.996 178.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 110.21 -18.14 28.49 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.821 -177.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -85.22 117.91 24.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.792 0.33 . . . . 0.0 110.482 177.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.587 HG23 HG21 ' A' ' 82' ' ' VAL . 5.3 t -80.31 124.39 38.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.2 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.742 ' O ' ' HA ' ' A' ' 143' ' ' LEU . 59.0 ttt85 -119.35 107.85 13.88 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 177.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . 0.553 ' CE2' HD13 ' A' ' 143' ' ' LEU . 9.3 m-85 -83.16 86.62 6.99 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 177.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -102.5 127.72 49.43 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.418 -175.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.632 HD22 ' HG2' ' A' ' 119' ' ' PRO . 9.2 tp -73.29 139.33 46.03 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.478 -178.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -118.71 132.02 56.15 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.741 176.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 21.0 p -88.57 146.36 25.18 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.162 -179.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 74.2 mt . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.337 -0.84 . . . . 0.0 109.633 178.517 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.909 ' HB2' ' HB2' ' A' ' 145' ' ' LEU . 72.4 mmtt . . . . . 0 N--CA 1.452 -0.361 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.518 ' HG2' ' HG2' ' A' ' 144' ' ' GLU . 41.1 mtt180 -110.28 120.59 42.94 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.014 0.435 . . . . 0.0 111.191 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.479 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 86.7 m-85 -116.57 131.25 57.0 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.683 178.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.534 ' HB3' HG22 ' A' ' 33' ' ' VAL . 36.4 tp -89.21 118.78 29.15 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.015 178.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.406 HD11 HD11 ' A' ' 36' ' ' LEU . 51.2 tp -106.11 102.01 11.46 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.066 0.46 . . . . 0.0 110.391 -179.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.3 pt -101.6 121.66 52.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.928 177.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.797 ' HB2' ' HA ' ' A' ' 134' ' ' SER . 16.2 m -68.5 171.17 7.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.039 -179.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -64.02 144.06 57.39 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.287 0.565 . . . . 0.0 110.221 -179.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 68.7 m -143.23 178.96 7.37 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.984 -174.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 32.4 m80 -129.22 79.17 1.9 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.154 0.502 . . . . 0.0 110.472 178.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.431 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -139.06 142.65 33.96 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.379 179.525 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.431 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 18.1 Cg_endo -93.72 97.23 0.14 OUTLIER 'Cis proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.299 -1.542 . . . . 0.0 112.056 -3.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.6 t -116.64 -88.09 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 121.19 -0.204 . . . . 0.0 110.896 -178.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 15' ' ' ARG . 37.9 ttm180 -134.67 -14.39 2.18 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 120.949 0.404 . . . . 0.0 111.077 178.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.58 ' SD ' ' HB2' ' A' ' 136' ' ' ALA . 33.8 ttp -64.9 -71.03 0.2 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.405 177.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 63.16 5.6 2.0 Allowed 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.701 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.438 ' H ' ' HG2' ' A' ' 16' ' ' MET . 49.3 m -85.43 15.32 4.54 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.636 ' HG ' ' HG ' ' A' ' 135' ' ' LEU . 6.2 tt -90.5 111.71 48.99 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.4 132.41 35.8 Favored 'Trans proline' 0 C--O 1.234 0.318 0 C-N-CA 122.815 2.343 . . . . 0.0 112.703 -174.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -68.66 -19.28 64.39 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.302 177.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -56.37 -44.81 80.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.107 175.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.1 tt -70.22 -29.17 38.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.343 -177.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.491 ' O ' HD23 ' A' ' 27' ' ' LEU . 58.8 tp -71.07 -22.87 62.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.251 179.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -82.32 -20.79 36.67 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.184 175.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.8 m -74.02 -9.47 58.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.53 -177.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 1.035 HD13 HG21 ' A' ' 33' ' ' VAL . 2.6 mm? -51.67 -38.66 55.97 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.321 0.582 . . . . 0.0 110.727 176.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -80.36 -17.45 51.9 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.729 -174.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -95.47 2.82 54.58 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -172.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.448 ' HD1' ' HB3' ' A' ' 3' ' ' ARG . 43.2 m-85 -124.27 -176.65 3.56 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.675 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -96.29 -37.99 10.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.034 0.445 . . . . 0.0 110.521 -178.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.479 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -151.58 158.67 27.87 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.035 HG21 HD13 ' A' ' 27' ' ' LEU . 92.3 t -126.36 136.93 59.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 120.938 0.399 . . . . 0.0 110.691 -178.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.511 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 57.4 mt -115.81 112.58 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.097 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -98.21 126.47 8.9 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 178.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.406 HD11 HD11 ' A' ' 6' ' ' LEU . 84.7 mt -99.67 10.85 40.62 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.884 0.342 . . . . 0.0 110.884 -177.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 122.59 43.31 0.39 Allowed Glycine 0 C--N 1.329 0.143 0 C-N-CA 120.995 -0.621 . . . . 0.0 111.733 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.47 -76.01 0.18 Allowed 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 123.24 0.616 . . . . 0.0 112.369 -174.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.505 ' HD2' HD11 ' A' ' 48' ' ' LEU . 92.9 m-85 -86.19 128.48 34.9 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.994 0.426 . . . . 0.0 110.774 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.1 m -91.26 1.34 8.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.375 0.607 . . . . 0.0 110.311 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.513 ' O ' HG23 ' A' ' 45' ' ' VAL . 26.8 t70 -95.73 126.05 40.73 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.815 -178.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.436 HD13 ' HB3' ' A' ' 66' ' ' ASP . 62.3 tp -58.41 -49.64 76.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.589 -176.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -58.14 -42.47 85.92 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.987 -177.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.488 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 10.4 m -67.95 -35.34 78.23 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.156 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 41' ' ' ASP . 89.2 t -61.21 -41.13 88.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 121.272 0.558 . . . . 0.0 110.247 175.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.51 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 1.7 mp -66.99 -38.11 80.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.026 177.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.5 -34.15 73.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.563 176.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.505 HD11 ' HD2' ' A' ' 39' ' ' TYR . 94.8 mt -67.68 -35.61 79.15 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.547 0.689 . . . . 0.0 109.432 177.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.66 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 13.2 tt0 -78.51 -6.24 54.89 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.869 178.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.51 ' HG3' ' O ' ' A' ' 46' ' ' ILE . 29.9 mtpp -95.04 -44.02 7.87 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.605 174.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.517 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . 3.8 m-85 -58.66 -67.9 0.31 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.984 -179.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 51.5 m -87.09 -26.67 23.55 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.559 179.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.66 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 46.4 mttp 72.47 -47.89 0.67 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.266 0.626 . . . . 0.0 111.082 -178.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -81.79 86.58 6.44 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 172.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -119.69 130.11 54.87 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.942 -175.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.511 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 90.7 m-85 -121.26 131.56 54.29 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.089 174.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.475 ' HA3' HD22 ' A' ' 71' ' ' LEU . . . -140.02 151.19 21.99 Favored Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 119.982 -1.104 . . . . 0.0 112.739 -177.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.4 HG12 ' H ' ' A' ' 59' ' ' HIS . 0.5 OUTLIER -112.62 176.47 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 174.65 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.637 ' CD2' ' HA ' ' A' ' 68' ' ' LYS . 61.6 t-80 -94.34 135.38 35.81 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.774 0.321 . . . . 0.0 110.409 -177.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -82.27 -130.98 1.43 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.997 178.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -101.24 -79.21 0.51 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.712 0.292 . . . . 0.0 111.01 -178.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 67.1 mtt -120.68 107.71 13.13 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.984 0.421 . . . . 0.0 110.587 -178.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -132.93 -167.77 1.97 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.213 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -91.23 148.37 37.62 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.863 -179.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.502 ' HA ' ' HB3' ' A' ' 68' ' ' LYS . 6.7 Cg_endo -49.33 -36.43 37.96 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.822 3.015 . . . . 0.0 114.296 -174.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.436 ' HB3' HD13 ' A' ' 42' ' ' LEU . 13.1 m-20 -70.22 -36.97 74.91 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.776 0.322 . . . . 0.0 111.251 -178.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 58.6 t -72.11 -41.69 67.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 174.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.637 ' HA ' ' CD2' ' A' ' 59' ' ' HIS . 79.1 tttt -53.99 -35.7 62.13 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.216 -1.356 . . . . 0.0 111.994 177.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -93.9 -24.07 17.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.645 -176.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -82.95 -36.27 25.32 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.445 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.475 HD22 ' HA3' ' A' ' 57' ' ' GLY . 72.4 mt -103.72 110.59 64.18 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.021 177.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 71' ' ' LEU . 22.9 Cg_endo -61.05 146.91 97.09 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.965 2.444 . . . . 0.0 112.688 -176.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.591 ' HA ' ' HB3' ' A' ' 59' ' ' HIS . 94.2 m-85 -59.97 -34.37 73.19 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.789 -178.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 63.3 m -152.93 146.46 25.0 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 174.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.521 ' HG2' ' N ' ' A' ' 76' ' ' VAL . 41.7 tttm -150.74 171.54 17.02 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -176.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.521 ' N ' ' HG2' ' A' ' 75' ' ' LYS . 38.6 t -125.35 133.77 68.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 169.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.757 ' HB2' ' SD ' ' A' ' 86' ' ' MET . 1.9 tp -105.54 111.55 24.29 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.32 -177.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 47.8 tp -93.34 103.46 15.69 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.729 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 43.3 t -114.78 109.63 29.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.644 -178.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 61.01 13.45 4.6 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.022 177.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 112.48 -10.07 26.19 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.422 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 60.4 t -87.63 134.54 27.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.708 0.29 . . . . 0.0 110.574 178.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.4 p -91.19 118.98 30.9 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.267 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.583 ' HB ' ' HB3' ' A' ' 77' ' ' LEU . 71.1 mt -118.44 104.14 15.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.034 0.445 . . . . 0.0 110.057 179.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -63.31 130.11 40.83 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.708 178.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.757 ' SD ' ' HB2' ' A' ' 77' ' ' LEU . 65.6 mtp -116.73 97.87 6.22 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 -177.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.566 ' O ' ' HA ' ' A' ' 113' ' ' PHE . 31.7 t -143.06 157.59 44.39 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 176.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 8.4 t-160 -92.23 -21.15 20.51 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.193 -0.603 . . . . 0.0 110.184 177.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 117.07 -179.08 17.39 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.084 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 75.6 t-105 -140.1 -69.72 0.4 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.914 0.388 . . . . 0.0 110.245 -179.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 173.52 169.91 36.42 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 53.78 82.22 0.25 Allowed Pre-proline 0 CA--C 1.529 0.167 0 C-N-CA 122.773 0.429 . . . . 0.0 111.221 -178.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -52.17 -33.67 55.34 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.269 2.646 . . . . 0.0 113.188 -174.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 35.5 p90 -67.98 -35.31 78.13 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.469 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -102.74 -16.73 15.89 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.255 0.55 . . . . 0.0 110.652 -173.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 39.5 tp -55.45 -35.25 65.27 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.222 -179.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.423 ' H ' ' HG3' ' A' ' 97' ' ' LYS . 42.3 mttm -59.04 -45.9 89.56 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.59 0.71 . . . . 0.0 109.624 178.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -69.91 -38.83 76.39 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.346 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.504 ' O ' HG23 ' A' ' 103' ' ' VAL . 29.6 mmt180 -61.15 -48.95 79.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.007 177.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.502 HD13 HG21 ' A' ' 111' ' ' ILE . 67.6 mt -61.66 -33.98 74.91 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.692 -177.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 70.3 mt -67.21 -15.24 63.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.793 0.33 . . . . 0.0 111.427 177.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 23.4 mtmm -104.71 -6.15 20.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.117 174.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 99' ' ' ARG . 90.0 t -85.22 -40.13 14.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.25 0.548 . . . . 0.0 109.545 175.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -85.12 171.21 12.2 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.889 178.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 30.8 t30 -91.91 -61.38 1.64 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.091 -176.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -107.6 -176.42 3.06 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.401 -177.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.432 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 96.4 mttt -81.34 111.1 21.96 Favored Pre-proline 0 C--O 1.234 0.282 0 CA-C-O 120.768 0.318 . . . . 0.0 111.101 -175.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 107' ' ' LYS . 3.8 Cg_endo -85.78 147.97 9.57 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.308 2.672 . . . . 0.0 111.847 179.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -81.18 -47.74 13.04 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.259 0.552 . . . . 0.0 110.416 177.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 44.0 t -122.02 147.33 26.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.843 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.502 HG21 HD13 ' A' ' 100' ' ' LEU . 66.3 mt -136.62 130.6 46.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.66 0.267 . . . . 0.0 110.622 175.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.634 HD23 ' HB2' ' A' ' 130' ' ' LEU . 95.0 mt -101.32 141.85 33.58 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.013 175.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.566 ' HA ' ' O ' ' A' ' 87' ' ' CYS . 14.3 p90 -155.85 176.65 12.36 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 172.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -105.56 135.87 12.86 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.807 -177.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.536 ' HB3' ' HB2' ' A' ' 131' ' ' ASN . 11.5 t-160 -151.47 128.4 11.01 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.599 0.237 . . . . 0.0 110.715 -174.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.0 p -74.1 84.3 1.81 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.228 0.537 . . . . 0.0 111.267 178.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 60.7 t60 -176.36 153.55 1.22 Allowed 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -55.97 123.81 55.34 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 174.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.575 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 91.8 Cg_exo -43.13 129.47 5.91 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 124.002 3.134 . . . . 0.0 114.172 -172.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -142.42 155.1 45.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.661 -177.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -95.96 115.44 27.43 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 176.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.517 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 40.5 p -116.41 116.82 28.39 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.121 0.486 . . . . 0.0 112.078 -175.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 43.6 t -114.32 98.25 6.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.969 178.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.425 ' O ' ' HB2' ' A' ' 125' ' ' ALA . 28.4 tptp -144.25 65.44 1.29 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.425 ' HB2' ' O ' ' A' ' 124' ' ' LYS . . . 167.22 -13.07 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.895 -176.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.4 ' H ' ' H ' ' A' ' 125' ' ' ALA . . . 101.49 -12.06 58.21 Favored Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -173.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 47.3 t -107.18 140.67 24.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 114.965 -0.617 . . . . 0.0 110.061 -178.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 55.7 mtt180 -80.3 108.12 13.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.662 0.268 . . . . 0.0 110.654 176.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.517 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 98.2 m-85 -92.89 107.79 19.49 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 176.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.634 ' HB2' HD23 ' A' ' 112' ' ' LEU . 93.0 mt -99.24 116.71 32.06 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.157 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.575 ' O ' ' HA ' ' A' ' 119' ' ' PRO . 4.3 p30 -122.91 109.79 31.82 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.652 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.564 ' HA ' ' HG3' ' A' ' 119' ' ' PRO . 83.7 Cg_endo -88.86 178.36 2.76 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.072 2.514 . . . . 0.0 111.886 175.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.591 ' HA3' ' OE1' ' A' ' 137' ' ' GLU . . . -90.22 -109.01 1.35 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.216 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.797 ' HA ' ' HB2' ' A' ' 8' ' ' SER . 40.4 t -167.8 162.97 14.06 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.337 -0.246 . . . . 0.0 110.337 -179.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.636 ' HG ' ' HG ' ' A' ' 19' ' ' LEU . 3.7 mm? -71.48 -15.67 62.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.093 0.473 . . . . 0.0 109.957 176.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.58 ' HB2' ' SD ' ' A' ' 16' ' ' MET . . . -84.52 -6.82 59.4 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.356 175.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.591 ' OE1' ' HA3' ' A' ' 133' ' ' GLY . 1.8 tm-20 -113.43 -34.67 5.52 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.883 -178.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.537 ' HA2' HD12 ' A' ' 157' ' ' LEU . . . 127.78 -44.53 1.23 Allowed Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.327 -0.939 . . . . 0.0 113.681 175.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.507 ' HB3' HD11 ' A' ' 154' ' ' LEU . 18.6 m -76.81 113.63 14.69 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -175.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.467 ' O ' HD12 ' A' ' 154' ' ' LEU . 54.7 p90 -115.71 156.76 25.36 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 172.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -114.4 138.0 51.12 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.206 0.527 . . . . 0.0 112.016 -169.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 38.3 t -114.74 116.47 52.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 173.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.628 HD21 HG13 ' A' ' 150' ' ' VAL . 3.4 tt -94.72 107.46 19.46 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -177.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.518 ' HG2' ' HG2' ' A' ' 3' ' ' ARG . 32.4 mt-10 -104.06 121.58 43.49 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.35 178.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.909 ' HB2' ' HB2' ' A' ' 2' ' ' LYS . 55.3 mt -96.81 89.97 5.09 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.708 174.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -86.8 124.29 32.88 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.674 179.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 68.01 -68.94 0.32 Allowed Glycine 0 CA--C 1.52 0.401 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.381 -174.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -179.89 30.38 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 121.087 -0.577 . . . . 0.0 111.774 179.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -126.93 145.63 50.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.681 0.277 . . . . 0.0 110.608 -179.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.628 HG13 HD21 ' A' ' 143' ' ' LEU . 58.1 t -77.08 111.96 14.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.669 -179.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 19.8 mtm180 -115.95 115.81 26.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.379 0.609 . . . . 0.0 110.263 177.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -90.92 105.53 17.89 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.948 -176.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.32 113.76 26.69 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -178.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.537 HD22 ' HB2' ' A' ' 119' ' ' PRO . 44.9 tp -94.33 127.15 40.03 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.32 -173.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -114.92 135.42 54.22 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 175.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.2 m -108.22 148.93 29.25 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.764 0.316 . . . . 0.0 110.526 -177.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.537 HD12 ' HA2' ' A' ' 138' ' ' GLY . 97.5 mt . . . . . 0 C--O 1.247 0.965 0 CA-C-O 118.284 -0.865 . . . . 0.0 110.319 179.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 89.8 mttt . . . . . 0 CA--C 1.52 -0.192 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.623 ' HB3' ' HD1' ' A' ' 30' ' ' TYR . 47.3 mtt85 -115.62 111.65 20.97 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.113 0.482 . . . . 0.0 110.631 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.495 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 73.7 m-85 -102.11 121.63 42.57 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.892 -178.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 38.0 tp -89.35 119.33 29.72 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.068 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.706 HD11 ' HG ' ' A' ' 36' ' ' LEU . 59.8 tp -106.05 112.37 25.38 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.088 0.47 . . . . 0.0 111.3 -176.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 27.8 pt -101.43 140.44 20.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.628 175.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.8 p -99.53 -159.5 0.74 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.43 -176.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -48.62 100.6 0.02 OUTLIER 'General case' 0 C--O 1.236 0.375 0 O-C-N 123.803 0.689 . . . . 0.0 112.146 -177.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.47 ' HB2' ' C ' ' A' ' 38' ' ' ASP . 6.9 m -92.51 83.05 4.88 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.963 177.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.539 ' HB2' ' SD ' ' A' ' 16' ' ' MET . 37.2 m80 -76.83 55.68 1.11 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.156 0.503 . . . . 0.0 110.228 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . 2.8 t -127.69 138.31 32.59 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -177.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 27.9 Cg_endo -94.84 56.38 0.87 Allowed 'Cis proline' 0 N--CA 1.453 -0.907 0 C-N-CA 123.61 -1.413 . . . . 0.0 112.724 -2.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.482 HG22 HG21 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -86.0 -162.53 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 176.527 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.401 ' H ' HG12 ' A' ' 14' ' ' VAL . 66.3 mtt85 -77.31 81.74 3.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.83 0.824 . . . . 0.0 110.828 -176.036 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.539 ' SD ' ' HB2' ' A' ' 11' ' ' HIS . 51.1 ttp -164.04 -70.79 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.186 -1.37 . . . . 0.0 108.15 179.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 61.25 2.49 0.62 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.932 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.42 ' H ' ' HG2' ' A' ' 16' ' ' MET . 8.5 m -82.57 38.17 0.55 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.58 -176.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.0 tt -107.96 103.62 50.5 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.483 ' HB2' HD13 ' A' ' 157' ' ' LEU . 23.4 Cg_exo -65.51 126.65 16.55 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.278 1.985 . . . . 0.0 110.89 174.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -64.19 -10.66 24.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.877 -174.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -53.88 -35.29 61.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.986 0.422 . . . . 0.0 110.836 177.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 tt -69.26 -27.98 36.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.453 0.644 . . . . 0.0 110.573 -177.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.413 ' HA ' HD23 ' A' ' 27' ' ' LEU . 55.5 tp -72.64 -29.49 63.5 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.605 -179.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -72.73 -31.02 64.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.927 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.7 p -77.79 1.89 18.8 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -176.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.458 ' HA ' HD13 ' A' ' 27' ' ' LEU . 2.2 mm? -58.05 -36.14 72.35 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.204 0.526 . . . . 0.0 110.714 176.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 32.2 mttt -75.34 -24.43 57.36 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.925 -175.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -88.36 -6.39 57.74 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.162 -165.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.623 ' HD1' ' HB3' ' A' ' 3' ' ' ARG . 98.0 m-85 -122.03 142.04 50.75 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.783 0.325 . . . . 0.0 110.571 -179.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -84.79 -12.75 52.99 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.978 -176.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.495 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -138.42 131.83 5.54 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 175.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 56.2 t -122.58 128.68 75.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 117.119 0.459 . . . . 0.0 110.554 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.548 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 32.1 mt -120.29 133.57 66.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.745 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.68 120.4 3.99 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.57 177.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.706 ' HG ' HD11 ' A' ' 6' ' ' LEU . 82.0 mt -89.73 7.62 35.85 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.272 0.558 . . . . 0.0 110.071 179.135 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 152.11 78.66 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.229 -178.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.47 ' C ' ' HB2' ' A' ' 10' ' ' SER . 8.4 p-10 -82.38 -146.93 0.07 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.46 0.171 . . . . 0.0 111.107 -175.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.523 ' HD2' HD11 ' A' ' 48' ' ' LEU . 77.1 m-85 -60.64 144.8 51.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.168 0.508 . . . . 0.0 111.739 -173.079 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.482 HG21 HG22 ' A' ' 14' ' ' VAL . 27.7 m -82.55 -1.86 5.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.056 -178.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.576 ' O ' HG23 ' A' ' 45' ' ' VAL . 16.0 t70 -103.38 122.16 44.27 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.007 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.502 ' HB2' ' HB3' ' A' ' 66' ' ' ASP . 54.7 tp -55.68 -48.82 74.44 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 123.563 0.54 . . . . 0.0 112.125 -172.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -63.88 -32.17 73.6 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.74 0.305 . . . . 0.0 111.291 -176.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.9 m -76.12 -27.31 57.04 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.731 178.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 41' ' ' ASP . 61.6 t -63.32 -47.54 91.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 121.463 0.649 . . . . 0.0 109.962 174.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.616 HG22 ' HE3' ' A' ' 50' ' ' LYS . 1.7 mp -65.59 -31.83 55.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.842 179.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -57.46 -40.58 78.82 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 173.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.523 HD11 ' HD2' ' A' ' 39' ' ' TYR . 64.3 mt -70.7 -40.72 72.7 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 120.981 0.42 . . . . 0.0 110.316 178.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -61.81 -28.78 69.71 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.785 -178.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.616 ' HE3' HG22 ' A' ' 46' ' ' ILE . 98.4 mttt -72.36 -47.64 47.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.969 177.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -65.99 -48.14 72.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.889 0.376 . . . . 0.0 111.041 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 9.1 m -60.29 -43.05 96.63 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.335 177.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 98.0 mttt 69.52 -53.69 0.6 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.678 0.791 . . . . 0.0 109.942 -171.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.4 mm-40 -107.71 84.71 2.0 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.332 173.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -100.33 114.27 27.63 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.897 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.548 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 25.1 m-85 -105.07 107.93 19.17 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 176.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.461 ' O ' ' HD2' ' A' ' 72' ' ' PRO . . . -129.78 154.26 20.38 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 119.666 -1.254 . . . . 0.0 113.57 -173.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.65 HG21 ' HB3' ' A' ' 86' ' ' MET . 4.8 m -141.48 157.25 21.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 123.067 0.547 . . . . 0.0 109.719 174.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.539 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 64.4 t60 -94.74 104.6 16.52 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.197 0.522 . . . . 0.0 110.373 -178.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 1.036 ' HA2' ' HB3' ' A' ' 88' ' ' HIS . . . -113.58 -29.21 2.98 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.231 175.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 22.4 p-10 -79.67 -169.11 1.81 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.033 -0.583 . . . . 0.0 110.784 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 67.3 mtt -117.54 90.02 3.24 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.003 175.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -107.89 -170.32 1.67 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.022 -177.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -82.44 152.73 67.71 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.52 178.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.605 ' HA ' ' HB3' ' A' ' 68' ' ' LYS . 81.4 Cg_exo -47.07 -32.19 12.91 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.492 2.795 . . . . 0.0 113.772 -178.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.502 ' HB3' ' HB2' ' A' ' 42' ' ' LEU . 3.5 m-20 -58.63 -52.37 65.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.327 0.584 . . . . 0.0 110.668 177.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 19.3 t -75.27 -32.97 27.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.709 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.605 ' HB3' ' HA ' ' A' ' 65' ' ' PRO . 87.7 tttt -60.07 -24.17 64.38 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.067 176.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -93.84 -30.65 14.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.609 176.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -65.56 -43.15 90.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.213 0.53 . . . . 0.0 109.903 175.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.539 ' HB2' ' HB2' ' A' ' 59' ' ' HIS . 78.4 mt -97.89 121.65 57.03 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.326 -179.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.461 ' HD2' ' O ' ' A' ' 57' ' ' GLY . 22.0 Cg_exo -65.88 164.57 26.62 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.867 2.378 . . . . 0.0 112.295 178.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -78.46 -31.68 48.02 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.044 0.449 . . . . 0.0 110.093 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.5 m -151.72 135.49 16.35 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.214 178.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 37.0 tttp -148.37 135.71 20.41 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 10.5 t -115.3 123.77 71.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.884 0.373 . . . . 0.0 110.256 178.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.551 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 78.2 mt -95.62 139.28 32.1 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.223 178.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 37.3 tp -112.31 98.6 7.41 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 174.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.435 HG11 ' CE1' ' A' ' 4' ' ' PHE . 41.0 t -115.1 100.3 10.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.592 -174.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 61.51 28.9 18.1 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.35 178.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.64 -15.71 58.3 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.303 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 57.3 t -83.0 121.69 36.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 120.861 0.362 . . . . 0.0 110.365 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.0 p -87.53 123.28 32.26 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.879 178.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.551 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 24.4 mt -116.02 95.63 3.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -178.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -84.8 109.44 3.27 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.384 179.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.65 ' HB3' HG21 ' A' ' 58' ' ' VAL . 46.8 mtm -106.52 123.73 48.53 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.795 0.331 . . . . 0.0 110.306 -178.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 48.0 t -161.06 165.21 30.08 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.602 -177.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 1.036 ' HB3' ' HA2' ' A' ' 60' ' ' GLY . 10.4 p-80 -88.72 95.81 10.42 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.323 0.582 . . . . 0.0 110.494 176.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.593 ' H ' ' HB2' ' A' ' 113' ' ' PHE . . . -83.29 68.22 3.59 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.793 -177.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.433 ' CD1' ' HB2' ' A' ' 88' ' ' HIS . 88.3 m95 -86.13 85.5 7.35 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.225 0.536 . . . . 0.0 110.185 177.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -176.0 -174.96 42.98 Favored Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.565 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -81.24 140.31 49.06 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -62.85 -14.62 41.99 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.841 2.361 . . . . 0.0 112.522 -176.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 4.0 m0 -73.97 -48.77 28.14 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.489 -178.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -96.77 -1.23 46.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.358 178.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 33.6 tp -59.75 -39.32 84.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.509 179.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -59.87 -42.59 94.07 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.257 178.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.44 ' O ' ' HB2' ' A' ' 102' ' ' LYS . 10.6 t70 -64.58 -49.11 72.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.299 179.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 47.2 ttt85 -60.47 -49.64 76.73 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.735 -176.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.516 HD13 HG21 ' A' ' 111' ' ' ILE . 81.6 mt -78.06 -36.11 48.77 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -174.031 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.726 HD21 HG21 ' A' ' 127' ' ' VAL . 85.2 mt -76.53 -18.75 58.54 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.025 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 98' ' ' ASP . 79.6 tttt -74.1 -29.55 61.9 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.373 0.606 . . . . 0.0 109.461 176.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 70.9 t -86.89 -45.98 16.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.018 176.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -90.99 86.9 6.4 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.847 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -68.27 -21.98 64.77 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.532 -178.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -72.55 -18.66 61.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.442 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 78.1 tttt 62.39 95.84 0.05 OUTLIER Pre-proline 0 N--CA 1.465 0.319 0 O-C-N 123.583 0.552 . . . . 0.0 110.636 -173.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.466 ' O ' HG13 ' A' ' 127' ' ' VAL . 5.6 Cg_exo -79.98 134.9 10.84 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.844 2.363 . . . . 0.0 111.851 178.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -70.8 -35.9 72.76 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.34 0.591 . . . . 0.0 109.533 177.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.604 HG21 HG11 ' A' ' 150' ' ' VAL . 53.5 t -122.87 128.59 75.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.028 178.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.516 HG21 HD13 ' A' ' 100' ' ' LEU . 24.4 mt -122.89 127.99 75.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 120.91 0.386 . . . . 0.0 110.826 177.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 89.3 mt -104.52 124.84 50.0 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.494 176.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.593 ' HB2' ' H ' ' A' ' 89' ' ' GLY . 5.2 p90 -146.88 160.05 42.78 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.807 0.337 . . . . 0.0 110.684 -178.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -105.95 125.74 8.31 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 175.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.475 ' HB2' ' CE2' ' A' ' 113' ' ' PHE . 10.4 t-160 -141.1 -54.84 0.48 Allowed 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 111.744 0.276 . . . . 0.0 111.744 -175.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 20.6 p -123.47 -100.03 0.41 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -173.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.48 ' O ' ' HA2' ' A' ' 133' ' ' GLY . 0.1 OUTLIER -166.66 -43.39 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.798 0.333 . . . . 0.0 111.214 -172.442 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -85.17 165.26 37.47 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.3 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.887 ' HG3' HD22 ' A' ' 154' ' ' LEU . 21.6 Cg_exo -63.23 87.38 0.13 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.281 1.987 . . . . 0.0 111.225 174.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.722 ' HB3' ' HB3' ' A' ' 131' ' ' ASN . 19.3 tt0 -82.34 105.59 13.53 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.541 -176.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -104.87 99.49 9.12 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.418 -175.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.44 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 77.2 p -121.22 118.74 30.37 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.454 -177.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.4 p -116.51 115.44 49.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.35 0.595 . . . . 0.0 110.667 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -137.3 136.08 37.69 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.912 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 65.81 17.86 10.97 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 123.604 0.565 . . . . 0.0 111.199 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 88.23 -7.0 82.85 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.951 -0.642 . . . . 0.0 111.769 -176.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.726 HG21 HD21 ' A' ' 101' ' ' LEU . 63.3 t -93.82 126.91 46.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 35.7 ttt180 -103.66 111.08 23.4 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.068 0.461 . . . . 0.0 110.844 -176.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.442 ' CE1' HD12 ' A' ' 111' ' ' ILE . 19.3 m-85 -92.08 127.15 37.44 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.231 178.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 88.6 mt -120.2 116.76 26.25 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.758 0.313 . . . . 0.0 111.692 -176.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.722 ' HB3' ' HB3' ' A' ' 120' ' ' GLU . 7.3 t30 -94.8 122.51 60.32 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 170.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.559 ' HG3' HD12 ' A' ' 36' ' ' LEU . 84.1 Cg_endo -81.17 167.48 17.74 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.86 2.373 . . . . 0.0 113.165 -177.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 117' ' ' HIS . . . -77.96 145.99 30.39 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.631 177.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.546 ' HB2' ' HG2' ' A' ' 137' ' ' GLU . 15.5 m -78.58 140.45 38.49 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.858 0.361 . . . . 0.0 111.534 -177.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 62.0 mt -56.38 -37.67 70.4 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.476 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.41 -13.79 53.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.835 -176.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.546 ' HG2' ' HB2' ' A' ' 134' ' ' SER . 23.1 mm-40 -97.53 1.1 48.57 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.582 -178.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 71.37 35.73 63.36 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.635 -177.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 18.1 m -139.55 132.74 29.76 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.619 0.247 . . . . 0.0 110.371 -179.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -130.94 164.72 24.7 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 176.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -114.24 143.22 45.19 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.924 0.393 . . . . 0.0 110.731 -173.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 63.0 t -130.82 122.96 53.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.869 178.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.416 HD21 HG13 ' A' ' 150' ' ' VAL . 5.8 tt -99.59 105.39 17.25 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 177.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -100.26 112.57 24.9 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.458 -178.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 59.8 mt -90.71 90.33 7.9 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.782 176.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -101.2 122.63 43.99 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 68.21 -68.92 0.35 Allowed Glycine 0 CA--C 1.519 0.308 0 C-N-CA 121.462 -0.399 . . . . 0.0 112.151 -173.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -176.1 25.9 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 175.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -105.83 134.87 48.26 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 -177.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.604 HG11 HG21 ' A' ' 110' ' ' VAL . 41.1 t -83.82 89.63 2.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.1 0.476 . . . . 0.0 109.869 177.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 27.8 mtp-105 -95.37 96.1 8.9 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.295 -177.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -92.36 104.48 16.81 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.076 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -109.46 154.29 22.84 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.864 -179.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.887 HD22 ' HG3' ' A' ' 119' ' ' PRO . 18.8 tp -114.72 117.16 30.02 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 172.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -104.86 135.12 46.82 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.257 -177.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 16.9 p -96.76 142.08 29.21 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.045 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.483 HD13 ' HB2' ' A' ' 20' ' ' PRO . 82.0 mt . . . . . 0 C--O 1.246 0.895 0 CA-C-O 118.555 -0.736 . . . . 0.0 110.405 -179.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 46.5 mttp . . . . . 0 N--CA 1.452 -0.374 0 CA-C-O 120.893 0.378 . . . . 0.0 110.048 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.524 ' HG2' ' HG2' ' A' ' 144' ' ' GLU . 59.6 mtt180 -115.1 117.3 30.18 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.472 178.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.476 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 65.6 m-85 -103.67 132.21 50.13 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.854 -179.127 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.517 HD11 HD11 ' A' ' 23' ' ' ILE . 50.1 tp -88.98 114.32 25.48 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.033 179.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 63.3 tp -102.73 107.16 17.95 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.862 0.363 . . . . 0.0 110.703 -178.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.408 ' HB ' HD11 ' A' ' 135' ' ' LEU . 28.7 pt -104.41 126.42 59.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-O 121.342 0.591 . . . . 0.0 109.527 173.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.558 ' HA ' HD12 ' A' ' 36' ' ' LEU . 14.4 m -77.76 -175.57 3.98 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.03 -173.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -69.24 119.38 13.44 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.652 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.605 ' HB2' HD12 ' A' ' 135' ' ' LEU . 70.3 m -156.72 80.62 0.94 Allowed 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.388 -0.824 . . . . 0.0 108.819 178.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.553 ' HB3' HG21 ' A' ' 14' ' ' VAL . 24.1 m80 -60.15 106.77 0.55 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.234 -1.348 . . . . 0.0 113.022 -171.182 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.621 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 2.6 p -140.4 138.07 18.49 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.98 176.089 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -89.42 104.06 0.44 Allowed 'Cis proline' 0 N--CA 1.456 -0.701 0 C-N-CA 123.551 -1.437 . . . . 0.0 112.449 -1.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.553 HG21 ' HB3' ' A' ' 11' ' ' HIS . 13.3 t -128.37 -77.25 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.882 178.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 59.2 mtt180 -134.36 -4.78 2.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.502 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.592 ' SD ' ' HB3' ' A' ' 10' ' ' SER . 56.8 ttp -91.94 -64.51 1.11 Allowed 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 173.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.605 ' HA ' HG23 ' A' ' 12' ' ' VAL . . . 69.39 -21.16 0.16 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.58 176.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.416 ' H ' ' C ' ' A' ' 16' ' ' MET . 22.8 t -105.27 78.55 1.39 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.047 0.451 . . . . 0.0 110.959 -176.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.2 tt -108.04 116.78 56.45 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 173.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.423 ' O ' HG22 ' A' ' 23' ' ' ILE . 32.5 Cg_exo -59.74 111.34 0.93 Allowed 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.564 2.176 . . . . 0.0 111.667 177.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -79.48 7.56 7.9 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -172.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -64.76 -35.38 80.9 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.337 0.589 . . . . 0.0 109.794 173.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.517 HD11 HD11 ' A' ' 5' ' ' LEU . 12.9 tt -70.33 -39.92 77.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.758 0.789 . . . . 0.0 109.807 177.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.463 ' O ' HD22 ' A' ' 27' ' ' LEU . 40.5 tp -73.04 -3.99 29.65 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.327 -1.306 . . . . 0.0 110.594 177.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -100.23 -24.81 14.46 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.289 0.566 . . . . 0.0 110.117 175.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 25.9 m -97.03 -6.81 34.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.829 -174.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.918 ' HA ' ' HD2' ' A' ' 30' ' ' TYR . 1.5 pt? -66.45 -13.27 60.55 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.941 0.401 . . . . 0.0 111.316 -175.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -65.43 -27.35 68.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.31 -178.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -94.4 -0.67 54.67 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -177.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.918 ' HD2' ' HA ' ' A' ' 27' ' ' LEU . 84.9 m-85 -91.24 138.51 31.53 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 178.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -64.62 -36.99 86.03 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.215 0.531 . . . . 0.0 110.257 -178.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -146.3 154.22 25.82 Favored Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 177.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.476 HG22 ' HB3' ' A' ' 5' ' ' LEU . 88.4 t -132.2 134.82 59.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.909 0.355 . . . . 0.0 110.221 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.558 HG12 ' HB2' ' A' ' 56' ' ' TYR . 52.0 mt -115.46 120.65 65.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.724 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -102.73 105.46 2.75 Favored Glycine 0 N--CA 1.444 -0.779 0 N-CA-C 111.019 -0.833 . . . . 0.0 111.019 174.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.558 HD12 ' HA ' ' A' ' 8' ' ' SER . 76.8 mt -75.91 -24.73 55.6 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 122.716 -0.285 . . . . 0.0 111.509 -176.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 162.97 57.1 0.02 OUTLIER Glycine 0 CA--C 1.51 -0.242 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.563 -178.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.414 ' CG ' ' H ' ' A' ' 39' ' ' TYR . 1.5 p-10 -99.3 -87.84 0.35 Allowed 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -175.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.621 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 93.9 m-85 -82.36 115.49 21.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.362 0.601 . . . . 0.0 110.951 -177.152 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.3 m -91.55 6.43 5.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.509 -0.768 . . . . 0.0 111.634 -177.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.516 ' O ' HG23 ' A' ' 45' ' ' VAL . 13.2 t70 -86.44 120.39 27.73 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.3 -0.409 . . . . 0.0 109.949 179.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.529 HD22 ' HB3' ' A' ' 66' ' ' ASP . 51.5 tp -54.01 -45.86 71.62 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.851 -174.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -63.39 -39.48 94.62 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.133 0.492 . . . . 0.0 110.609 -178.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 24.2 m -68.64 -30.48 69.2 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.021 178.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 41' ' ' ASP . 83.9 t -61.11 -45.82 97.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 121.099 0.476 . . . . 0.0 110.337 176.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -67.27 -38.97 81.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.806 177.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.08 -32.88 73.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.465 176.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.37 -34.54 76.25 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.961 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -77.35 -15.2 59.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.17 0.509 . . . . 0.0 110.062 177.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -80.43 -48.19 13.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.502 175.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -69.89 -42.41 73.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.009 0.433 . . . . 0.0 110.79 175.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.556 ' HB2' ' HB2' ' A' ' 55' ' ' PHE . 5.4 m -94.39 97.99 10.58 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.617 176.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -61.22 -26.36 67.69 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.844 -176.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -118.81 88.51 2.94 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 166.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.556 ' HB2' ' HB2' ' A' ' 52' ' ' SER . 88.6 t80 -100.31 124.28 45.58 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.829 -177.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.558 ' HB2' HG12 ' A' ' 34' ' ' ILE . 54.0 m-85 -117.9 146.76 43.7 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 174.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.48 ' HA3' HD22 ' A' ' 71' ' ' LEU . . . -158.62 161.83 32.05 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.248 -0.977 . . . . 0.0 112.119 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -140.23 169.37 16.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.916 0.389 . . . . 0.0 111.014 178.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.561 ' HB3' ' HA ' ' A' ' 73' ' ' PHE . 53.4 t-80 -94.4 143.71 26.17 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.062 -175.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -90.89 -129.93 4.45 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.951 -0.642 . . . . 0.0 111.874 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -88.46 -68.89 0.74 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.827 0.346 . . . . 0.0 110.764 178.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 66.6 mtt -125.71 102.28 7.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.328 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -118.56 179.22 4.19 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.922 -178.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -72.38 140.52 82.32 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 176.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -57.43 -31.55 91.58 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.945 2.43 . . . . 0.0 112.147 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.529 ' HB3' HD22 ' A' ' 42' ' ' LEU . 5.1 m-20 -63.19 -35.97 82.07 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.922 179.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 58.4 t -73.6 -27.18 22.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.399 -178.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.9 ttpm? -61.24 -28.21 69.0 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.04 0.448 . . . . 0.0 110.721 179.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -75.08 -13.04 60.45 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.163 -175.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -117.58 -38.03 3.37 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.73 179.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.48 HD22 ' HA3' ' A' ' 57' ' ' GLY . 15.8 mt -107.87 107.79 60.69 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.274 -178.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -72.04 158.07 53.14 Favored 'Trans proline' 0 N--CA 1.464 -0.228 0 C-N-CA 122.952 2.435 . . . . 0.0 112.003 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.561 ' HA ' ' HB3' ' A' ' 59' ' ' HIS . 91.4 m-85 -62.17 -33.24 74.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.22 0.533 . . . . 0.0 110.56 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 18.2 m -148.58 132.33 16.96 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.574 178.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.7 ttmm -140.0 125.7 19.34 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.356 178.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.418 ' HA ' ' HA2' ' A' ' 85' ' ' GLY . 11.8 t -101.07 122.32 52.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 175.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.459 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 68.3 mt -87.7 149.55 24.17 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.28 179.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 53.4 tp -121.04 94.05 4.22 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 172.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.683 HG12 ' HG2' ' A' ' 80' ' ' GLU . 21.6 t -121.87 116.73 50.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.084 -173.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.683 ' HG2' HG12 ' A' ' 79' ' ' VAL . 4.2 mm-40 61.46 21.13 11.79 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.278 179.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.91 -0.82 67.42 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.209 -179.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 65.9 t -96.55 128.95 47.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.754 0.311 . . . . 0.0 110.342 178.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.9 p -91.2 119.77 31.56 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.765 177.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.459 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 45.7 mt -118.04 98.74 6.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.504 -176.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.418 ' HA2' ' HA ' ' A' ' 76' ' ' VAL . . . -86.22 111.52 3.62 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.062 -178.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.561 ' HG2' HD12 ' A' ' 112' ' ' LEU . 49.3 mtm -97.4 119.69 36.38 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 49.0 t -144.0 160.71 40.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.062 0.458 . . . . 0.0 110.773 -176.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 25.8 m-70 -119.19 153.32 35.1 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.837 173.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 155.25 -158.33 28.33 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.427 -0.892 . . . . 0.0 112.357 178.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 49.4 p90 -155.25 175.97 13.17 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -178.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 149.12 169.12 15.37 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.912 178.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.454 ' HB1' ' HD2' ' A' ' 93' ' ' PRO . . . -85.06 164.07 43.08 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 177.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.454 ' HD2' ' HB1' ' A' ' 92' ' ' ALA . 90.7 Cg_exo -46.29 -38.29 20.01 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.209 2.606 . . . . 0.0 113.832 -178.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.814 ' HA ' ' HE3' ' A' ' 97' ' ' LYS . 42.0 p90 -79.71 -40.1 29.71 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 121.102 -0.239 . . . . 0.0 111.175 -179.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -66.55 -35.08 79.35 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.01 0.433 . . . . 0.0 110.521 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 30.2 tp -54.64 -47.65 73.25 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.908 -177.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.814 ' HE3' ' HA ' ' A' ' 94' ' ' TRP . 8.9 mtmp? -57.86 -56.65 19.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.641 0.734 . . . . 0.0 110.085 178.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.63 -48.7 79.69 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.325 -1.307 . . . . 0.0 112.175 -172.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.541 ' O ' HG23 ' A' ' 103' ' ' VAL . 98.1 mtt180 -67.6 -46.53 72.33 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.525 -174.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.547 HD13 HG21 ' A' ' 111' ' ' ILE . 61.2 mt -67.75 -40.75 84.07 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 -177.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.724 HD21 HG21 ' A' ' 127' ' ' VAL . 95.3 mt -75.39 -13.32 60.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.777 0.322 . . . . 0.0 111.048 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -90.15 -22.18 21.86 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 175.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 99' ' ' ARG . 73.6 t -78.21 -50.29 19.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.911 174.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -96.62 108.26 20.83 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.63 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -82.75 1.49 38.56 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.9 0.381 . . . . 0.0 110.729 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 11.5 mp0 -84.96 -22.62 29.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.473 176.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 87.5 tttt 56.87 85.96 0.18 Allowed Pre-proline 0 N--CA 1.466 0.364 0 O-C-N 123.85 0.719 . . . . 0.0 110.258 -170.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -71.88 152.72 58.21 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.945 2.43 . . . . 0.0 112.366 -177.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -77.27 -37.55 52.71 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.663 176.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.56 HG21 HG21 ' A' ' 150' ' ' VAL . 71.7 t -127.89 137.38 57.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.18 178.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.547 HG21 HD13 ' A' ' 100' ' ' LEU . 55.2 mt -127.43 133.06 68.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.841 0.353 . . . . 0.0 110.599 176.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.614 HD23 ' HB2' ' A' ' 130' ' ' LEU . 93.3 mt -102.08 122.44 44.13 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.704 177.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.463 ' CZ ' ' HB2' ' A' ' 131' ' ' ASN . 36.0 p90 -128.27 124.27 36.18 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.243 0.544 . . . . 0.0 110.631 177.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -105.91 114.78 4.6 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.642 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -165.4 -29.65 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.847 0.356 . . . . 0.0 110.526 -177.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.501 HG22 ' OE1' ' A' ' 118' ' ' GLU . 0.2 OUTLIER -92.42 176.97 6.28 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.398 179.969 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 60.3 m80 -105.58 -38.82 6.3 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.103 0.478 . . . . 0.0 110.609 -177.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.501 ' OE1' HG22 ' A' ' 116' ' ' THR . 1.2 pm0 -96.64 144.6 28.12 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.802 -178.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.55 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 4.7 Cg_exo -80.4 144.74 16.33 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 123.126 2.551 . . . . 0.0 112.953 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -160.01 146.14 15.71 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.435 177.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.549 ' HB2' ' HZ ' ' A' ' 152' ' ' PHE . 17.3 t70 -96.24 122.19 38.84 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 175.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.603 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 74.7 p -125.54 142.15 51.66 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.735 0.302 . . . . 0.0 111.343 -176.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 14.9 p -150.35 138.82 14.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 176.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -141.53 -72.6 0.33 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.847 0.356 . . . . 0.0 111.1 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -89.13 46.82 1.42 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.916 0.389 . . . . 0.0 110.836 -177.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 79.32 -42.31 2.37 Favored Glycine 0 N--CA 1.452 -0.24 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.295 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.724 HG21 HD21 ' A' ' 101' ' ' LEU . 41.7 t -63.72 131.3 29.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.895 0.379 . . . . 0.0 110.747 178.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.412 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 75.9 ttt180 -94.35 114.11 26.11 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.802 179.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.603 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 45.8 m-85 -99.09 125.96 44.72 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -178.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.614 ' HB2' HD23 ' A' ' 112' ' ' LEU . 64.5 mt -103.47 120.68 41.31 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.431 0.634 . . . . 0.0 110.695 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.55 ' O ' ' HA ' ' A' ' 119' ' ' PRO . 49.3 t30 -104.35 107.83 58.72 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 114.865 -1.062 . . . . 0.0 109.223 176.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -89.63 165.62 5.16 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.806 2.337 . . . . 0.0 113.188 -177.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -88.88 146.3 19.13 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.986 179.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.895 ' HB2' ' HG2' ' A' ' 137' ' ' GLU . 9.2 m -68.93 142.83 54.61 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.618 0.209 . . . . 0.0 110.904 -178.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.605 HD12 ' HB2' ' A' ' 10' ' ' SER . 21.0 mt -63.85 -35.26 80.05 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.143 0.497 . . . . 0.0 110.177 -178.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.432 ' HB2' ' SD ' ' A' ' 16' ' ' MET . . . -65.09 -24.22 67.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.434 178.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.895 ' HG2' ' HB2' ' A' ' 134' ' ' SER . 51.8 mm-40 -79.86 -13.81 59.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.869 0.366 . . . . 0.0 110.48 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 89.03 34.26 9.0 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.745 178.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 23.0 t -149.84 150.06 31.4 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.743 0.306 . . . . 0.0 110.313 178.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.424 ' CE1' ' HB3' ' A' ' 155' ' ' LYS . 50.3 p90 -145.55 177.68 8.68 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.662 177.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -121.51 132.73 54.87 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.084 0.469 . . . . 0.0 111.672 -176.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 44.8 t -104.09 114.3 43.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 172.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 6.5 tt -94.57 104.97 16.91 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -177.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.524 ' HG2' ' HG2' ' A' ' 3' ' ' ARG . 37.4 mt-10 -95.17 124.85 39.43 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.106 178.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 81.6 mt -91.38 98.78 11.9 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.133 0.492 . . . . 0.0 110.05 175.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -86.78 100.94 12.88 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.802 -178.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.71 -68.8 0.29 Allowed Glycine 0 CA--C 1.52 0.399 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.446 -172.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -162.31 26.57 0.24 Allowed Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 177.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -123.94 144.14 49.97 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.415 -0.392 . . . . 0.0 110.285 -175.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.56 HG21 HG21 ' A' ' 110' ' ' VAL . 92.8 t -83.37 111.84 20.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.346 -177.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -120.65 93.41 4.03 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 177.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . 0.549 ' HZ ' ' HB2' ' A' ' 121' ' ' ASP . 17.4 p90 -90.29 132.33 35.6 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.058 0.456 . . . . 0.0 110.538 -178.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -116.96 135.37 53.76 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.579 178.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -89.83 131.42 35.78 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.892 0.377 . . . . 0.0 110.666 -178.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.424 ' HB3' ' CE1' ' A' ' 140' ' ' TYR . 10.5 tptt -122.05 154.02 37.84 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 4.2 p -111.15 152.12 27.38 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.923 0.392 . . . . 0.0 111.319 178.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 94.5 mt . . . . . 0 C--O 1.251 1.139 0 CA-C-O 118.29 -0.862 . . . . 0.0 110.346 -179.275 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.513 ' HD3' ' CZ ' ' A' ' 4' ' ' PHE . 20.9 ttmm . . . . . 0 C--O 1.235 0.328 0 CA-C-O 120.803 0.335 . . . . 0.0 110.248 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.414 ' HD3' ' OE2' ' A' ' 144' ' ' GLU . 38.8 mtt180 -117.02 125.58 51.58 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.532 -178.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.58 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 64.4 m-85 -102.98 124.14 47.92 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.063 0.459 . . . . 0.0 110.695 177.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 48.5 tp -89.27 136.59 32.94 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 175.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.501 HD23 ' HB3' ' A' ' 141' ' ' ALA . 50.3 tp -117.68 103.93 10.51 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.285 0.564 . . . . 0.0 112.077 -177.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.528 HG13 ' HA2' ' A' ' 35' ' ' GLY . 23.5 pt -101.33 138.65 24.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 168.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.643 ' HA ' ' HB2' ' A' ' 36' ' ' LEU . 20.6 m -127.61 -68.18 0.79 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -164.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.465 ' HA ' ' HE1' ' A' ' 88' ' ' HIS . 37.3 t70 -111.44 105.49 14.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.417 0.627 . . . . 0.0 111.099 -176.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.822 ' HB3' ' HA ' ' A' ' 38' ' ' ASP . 29.5 t -141.05 155.88 46.1 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.285 -0.87 . . . . 0.0 108.874 174.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.871 ' H ' ' HE2' ' A' ' 16' ' ' MET . 11.5 m80 -141.59 57.11 1.51 Allowed 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -174.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.496 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . 40.7 t -110.19 126.95 27.89 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.236 -174.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.496 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 60.1 Cg_endo -105.2 91.87 0.06 OUTLIER 'Cis proline' 0 N--CA 1.45 -1.077 0 C-N-CA 124.011 -1.246 . . . . 0.0 112.874 -7.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 41.7 t -92.19 -63.6 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 175.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 58.7 ttm-85 -144.49 12.7 1.53 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.886 0.851 . . . . 0.0 108.758 173.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.871 ' HE2' ' H ' ' A' ' 11' ' ' HIS . 50.6 ttp -131.74 121.88 24.95 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.527 -177.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -126.11 -0.31 7.14 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.916 -0.583 . . . . 0.0 109.959 178.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.5 p -80.77 63.81 5.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.022 -178.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.43 HD12 HG21 ' A' ' 12' ' ' VAL . 4.2 tt -102.1 111.48 64.35 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 19' ' ' LEU . 23.5 Cg_endo -62.18 125.63 16.81 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.919 2.413 . . . . 0.0 112.744 -177.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -56.62 -28.83 61.33 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.284 177.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -49.87 -50.4 45.91 Favored 'General case' 0 C--N 1.331 -0.225 0 O-C-N 123.438 0.462 . . . . 0.0 111.846 -175.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.0 tt -66.59 -39.93 85.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.848 0.832 . . . . 0.0 110.252 -177.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.486 ' O ' HD22 ' A' ' 27' ' ' LEU . 35.5 tp -73.97 -3.74 30.99 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.107 -1.406 . . . . 0.0 111.036 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -100.3 -41.39 7.08 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.326 0.584 . . . . 0.0 109.741 172.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 56.9 p -69.43 -14.99 63.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.932 -175.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.516 HD12 ' HB3' ' A' ' 52' ' ' SER . 1.1 pt? -68.46 -9.2 47.21 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.799 0.333 . . . . 0.0 111.118 -176.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -65.82 -35.08 79.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.47 175.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -72.06 -23.29 61.34 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.204 0.526 . . . . 0.0 110.393 -178.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.504 ' HD2' ' HA ' ' A' ' 27' ' ' LEU . 86.0 m-85 -96.16 114.25 25.93 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.523 -176.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -78.31 -4.17 46.64 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.818 -176.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.58 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -142.19 129.58 3.96 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 173.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.453 HG21 ' HB3' ' A' ' 52' ' ' SER . 57.7 t -120.26 142.73 34.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 O-C-N 122.391 -0.476 . . . . 0.0 110.558 -179.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 70.1 mt -125.56 131.15 72.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.352 -0.386 . . . . 0.0 109.967 178.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.528 ' HA2' HG13 ' A' ' 7' ' ' ILE . . . -122.21 123.28 5.37 Favored Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 111.421 -0.672 . . . . 0.0 111.421 178.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.643 ' HB2' ' HA ' ' A' ' 8' ' ' SER . 87.4 mt -95.16 6.4 49.16 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.792 0.296 . . . . 0.0 111.643 -174.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 133.97 87.51 0.29 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.783 -0.723 . . . . 0.0 111.411 178.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.822 ' HA ' ' HB3' ' A' ' 10' ' ' SER . 6.2 m-20 -127.38 -66.52 0.88 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.076 0.465 . . . . 0.0 112.117 -169.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.434 ' CE2' ' HG ' ' A' ' 48' ' ' LEU . 80.3 m-85 -94.25 131.55 39.73 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.871 -174.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 12.7 m -110.04 7.15 8.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.159 -178.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.558 ' O ' HG23 ' A' ' 45' ' ' VAL . 15.1 t70 -111.96 129.94 56.02 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.172 179.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 49.9 tp -60.33 -49.71 76.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.553 -174.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -55.25 -45.38 76.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.999 0.428 . . . . 0.0 111.065 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.7 m -65.68 -29.52 70.09 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.157 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 41' ' ' ASP . 85.1 t -66.43 -42.62 90.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-O 120.891 0.376 . . . . 0.0 110.497 175.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -67.16 -37.93 80.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.285 0.564 . . . . 0.0 110.23 178.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.81 -34.18 76.24 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.393 174.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.434 ' HG ' ' CE2' ' A' ' 39' ' ' TYR . 2.6 tm? -65.72 -35.67 81.4 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 178.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.53 ' HA ' ' HE2' ' A' ' 55' ' ' PHE . 0.3 OUTLIER -63.37 -30.54 71.65 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.651 172.767 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.411 ' HD3' ' HA ' ' A' ' 50' ' ' LYS . 42.9 mmtm -70.12 -39.16 75.63 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 120.869 -0.333 . . . . 0.0 110.805 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.428 ' HB3' HD11 ' A' ' 27' ' ' LEU . 82.5 m-85 -73.57 -67.66 0.57 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.855 0.36 . . . . 0.0 110.636 174.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.516 ' HB3' HD12 ' A' ' 27' ' ' LEU . 5.1 p -86.98 96.61 10.33 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 175.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -71.58 -7.39 47.41 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.253 -172.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -151.73 100.57 2.69 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.123 0.487 . . . . 0.0 109.972 171.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.53 ' HE2' ' HA ' ' A' ' 49' ' ' GLU . 50.4 p90 -127.99 163.09 25.3 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.863 179.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.522 ' HE2' ' HE1' ' A' ' 4' ' ' PHE . 37.2 m-85 -117.9 118.59 32.39 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 174.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.567 ' O ' ' HD2' ' A' ' 72' ' ' PRO . . . -106.23 149.31 16.63 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.217 -0.992 . . . . 0.0 112.734 -176.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.467 HG21 ' CB ' ' A' ' 86' ' ' MET . 3.5 t -129.53 154.54 40.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 174.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.872 ' HB3' ' HA ' ' A' ' 73' ' ' PHE . 24.4 t-80 -99.24 150.88 21.63 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.7 -176.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 1.045 ' HA3' ' HB3' ' A' ' 88' ' ' HIS . . . 169.71 53.99 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.128 177.168 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -171.79 160.84 5.74 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 67.0 mtp -80.0 107.3 12.68 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.147 0.499 . . . . 0.0 109.925 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.403 ' OD2' ' HB ' ' A' ' 67' ' ' VAL . 38.1 p-10 -123.47 -156.24 0.7 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.243 -171.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -108.35 154.21 41.54 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.592 175.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -46.73 -44.55 21.72 Favored 'Trans proline' 0 N--CA 1.475 0.407 0 C-N-CA 123.46 2.774 . . . . 0.0 114.089 -176.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -63.24 -26.0 68.59 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.862 0.363 . . . . 0.0 111.842 -176.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.403 ' HB ' ' OD2' ' A' ' 63' ' ' ASP . 51.7 t -79.6 -32.18 14.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.777 -176.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -62.6 -20.84 65.14 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.412 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -73.47 -47.76 38.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.115 0.484 . . . . 0.0 110.945 178.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -85.05 -21.72 29.28 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.426 -173.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.57 ' O ' ' HB2' ' A' ' 59' ' ' HIS . 3.6 mm? -110.99 94.36 20.32 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.48 173.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.567 ' HD2' ' O ' ' A' ' 57' ' ' GLY . 26.8 Cg_exo -62.62 138.1 67.94 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.825 2.35 . . . . 0.0 111.85 179.094 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.872 ' HA ' ' HB3' ' A' ' 59' ' ' HIS . 40.4 p90 -52.46 -33.04 42.6 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.307 0.379 . . . . 0.0 111.869 -175.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.5 m -155.14 145.65 22.14 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 175.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.4 tttm -144.21 150.24 37.66 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -177.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.5 t -127.34 118.31 49.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 176.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 83.0 mt -90.93 147.89 22.82 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.256 178.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 24.9 tp -115.93 95.42 5.1 Favored 'General case' 0 C--N 1.315 -0.935 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 175.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 47.0 t -99.29 93.99 3.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.211 -177.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 64.17 18.24 11.14 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.662 178.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 114.41 -20.91 15.46 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.97 -177.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.547 ' HA ' ' OE1' ' A' ' 109' ' ' GLN . 55.0 t -76.48 114.91 17.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.822 0.344 . . . . 0.0 110.329 177.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.409 ' HB ' ' HB3' ' A' ' 108' ' ' PRO . 0.9 OUTLIER -83.04 125.65 31.69 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.261 178.931 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.8 mt -117.76 94.91 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.582 -179.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.498 ' O ' ' HA ' ' A' ' 111' ' ' ILE . . . -81.87 126.22 7.31 Favored Glycine 0 N--CA 1.442 -0.939 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.467 ' CB ' HG21 ' A' ' 58' ' ' VAL . 44.0 mtm -126.14 129.8 49.77 Favored 'General case' 0 C--N 1.313 -0.979 0 O-C-N 122.69 -0.3 . . . . 0.0 110.823 -175.077 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 48.5 t -159.57 116.69 2.64 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.652 179.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 1.045 ' HB3' ' HA3' ' A' ' 60' ' ' GLY . 3.3 t-160 -84.6 85.16 7.46 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 -177.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -133.59 165.73 24.08 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.094 -177.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 26.2 m-90 -122.28 -174.21 2.85 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.84 0.353 . . . . 0.0 110.897 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 127.01 -163.05 21.03 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 -176.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.443 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . . . -79.17 124.25 84.52 Favored Pre-proline 0 C--N 1.322 -0.599 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 177.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 92' ' ' ALA . 49.2 Cg_exo -55.22 -30.6 72.33 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.053 2.502 . . . . 0.0 112.967 -175.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.408 ' CD1' ' HB1' ' A' ' 92' ' ' ALA . 0.1 OUTLIER -70.94 -54.29 11.88 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.215 -179.467 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -69.94 -29.14 66.22 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.943 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.446 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 35.0 tp -59.68 -45.84 90.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.036 -177.198 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.63 ' HD3' ' HB3' ' A' ' 124' ' ' LYS . 79.2 mttt -59.15 -49.3 78.38 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.657 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.13 -27.84 66.8 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.216 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -74.02 -42.34 60.48 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.498 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 95.4 mt -66.64 -29.91 70.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.925 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.451 HD21 HG21 ' A' ' 127' ' ' VAL . 84.0 mt -69.22 -15.43 63.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.813 0.34 . . . . 0.0 111.087 176.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -101.27 -2.39 31.27 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.369 0.604 . . . . 0.0 110.119 177.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 64.5 t -92.47 -44.06 13.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 169.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -106.62 90.11 3.23 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.445 172.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -69.17 -15.84 63.49 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.194 -177.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -73.16 -21.85 60.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.14 175.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.424 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 94.2 mttt 63.81 99.09 0.04 OUTLIER Pre-proline 0 N--CA 1.465 0.305 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.127 175.128 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 107' ' ' LYS . 4.8 Cg_exo -79.6 163.02 24.34 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 123.546 2.83 . . . . 0.0 112.759 -177.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.547 ' OE1' ' HA ' ' A' ' 82' ' ' VAL . 91.1 mt-30 -79.52 -41.6 27.0 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.158 176.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 54.9 t -123.85 140.29 47.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.196 -178.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.498 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 54.9 mt -130.72 130.83 64.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.129 0.49 . . . . 0.0 110.791 176.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 94.0 mt -114.25 135.05 54.48 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.342 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.43 ' CE2' ' HB3' ' A' ' 129' ' ' PHE . 28.6 p90 -151.38 159.11 44.42 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.884 176.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -105.91 114.79 4.61 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 173.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.653 ' HD2' HG23 ' A' ' 116' ' ' THR . 11.0 t60 -122.61 -82.79 0.65 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.758 0.313 . . . . 0.0 110.808 -172.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.653 HG23 ' HD2' ' A' ' 115' ' ' HIS . 10.8 p -101.57 160.57 14.33 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 177.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.433 ' HB3' ' OE2' ' A' ' 137' ' ' GLU . 34.6 m170 -87.39 71.69 9.87 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.381 0.61 . . . . 0.0 110.902 -177.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -171.47 130.12 0.72 Allowed Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 114.622 -1.172 . . . . 0.0 108.62 176.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.491 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 34.7 Cg_exo -58.71 107.41 0.34 Allowed 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.426 2.084 . . . . 0.0 111.731 178.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.515 ' HG2' HG23 ' A' ' 122' ' ' THR . 43.6 tt0 -121.49 128.07 51.7 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.203 -174.113 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.469 ' HA ' HD23 ' A' ' 130' ' ' LEU . 11.2 t70 -104.41 125.13 50.34 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 175.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.584 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 33.3 p -135.64 154.54 51.28 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.544 0.688 . . . . 0.0 112.431 -175.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 10.0 p -145.09 162.95 13.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.647 175.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.63 ' HB3' ' HD3' ' A' ' 97' ' ' LYS . 64.8 tttm -176.94 -59.85 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.529 0.68 . . . . 0.0 109.82 -179.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.426 ' C ' ' H ' ' A' ' 127' ' ' VAL . . . -95.55 30.58 2.24 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.029 -175.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 78.55 -33.36 1.84 Allowed Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 121.039 -0.601 . . . . 0.0 111.701 -174.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.451 HG21 HD21 ' A' ' 101' ' ' LEU . 28.7 t -70.88 141.86 16.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 122.978 0.511 . . . . 0.0 110.301 176.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -95.49 125.52 40.15 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 177.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.584 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 75.9 m-85 -112.43 128.26 56.26 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -177.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.469 HD23 ' HA ' ' A' ' 121' ' ' ASP . 60.3 mt -120.37 132.45 55.28 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.107 0.479 . . . . 0.0 111.604 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.496 ' HB3' ' HB3' ' A' ' 120' ' ' GLU . 25.0 t30 -117.8 105.34 47.76 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.837 176.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.491 ' HG2' ' OG ' ' A' ' 8' ' ' SER . 5.9 Cg_exo -82.36 -172.25 1.38 Allowed 'Trans proline' 0 CA--C 1.531 0.326 0 C-N-CA 123.45 2.767 . . . . 0.0 112.692 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -100.43 -174.12 29.81 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.125 -179.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.623 ' OG ' ' HB2' ' A' ' 137' ' ' GLU . 28.9 p -95.9 160.27 14.56 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 122.605 -0.35 . . . . 0.0 110.951 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 35.7 mt -64.7 -45.58 86.0 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -176.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -75.45 1.69 13.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.316 0.579 . . . . 0.0 111.198 -178.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.623 ' HB2' ' OG ' ' A' ' 134' ' ' SER . 10.5 tt0 -95.89 -15.96 22.09 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.711 -178.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.536 ' HA2' ' HB2' ' A' ' 157' ' ' LEU . . . 72.64 43.0 45.31 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.538 179.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.8 m -149.17 98.26 2.79 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 176.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.458 ' O ' HD12 ' A' ' 154' ' ' LEU . 27.5 p90 -116.66 164.15 15.05 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.914 -0.315 . . . . 0.0 110.155 -178.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.501 ' HB3' HD23 ' A' ' 6' ' ' LEU . . . -114.45 150.77 34.24 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.11 0.481 . . . . 0.0 110.803 -174.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.5 HG12 ' HG3' ' A' ' 144' ' ' GLU . 67.1 t -125.74 134.55 66.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.605 177.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.7 HD21 HG13 ' A' ' 150' ' ' VAL . 4.5 tt -122.9 103.89 8.91 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.157 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.5 ' HG3' HG12 ' A' ' 142' ' ' VAL . 60.8 mt-10 -108.78 148.26 30.8 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 120.918 0.389 . . . . 0.0 110.461 -177.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.435 HD12 ' HB3' ' A' ' 2' ' ' LYS . 67.2 mt -94.16 90.49 6.38 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.247 0.546 . . . . 0.0 109.61 176.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.41 ' HB3' ' HD2' ' A' ' 151' ' ' ARG . 33.4 t70 -124.53 126.17 45.4 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.141 -176.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.95 11.19 60.39 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.006 -175.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 81.48 -7.59 60.98 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 111.792 -0.523 . . . . 0.0 111.792 -176.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -84.64 158.65 20.78 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 120.917 0.389 . . . . 0.0 110.547 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.7 HG13 HD21 ' A' ' 143' ' ' LEU . 15.6 t -83.79 100.36 7.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.211 176.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.432 ' O ' ' HA ' ' A' ' 143' ' ' LEU . 32.6 ttt180 -92.5 99.78 12.44 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.093 -171.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . 0.413 ' HA ' ' O ' ' A' ' 142' ' ' VAL . 43.1 m-85 -93.74 107.75 19.59 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.971 177.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -110.39 116.38 31.32 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.561 174.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.458 HD12 ' O ' ' A' ' 140' ' ' TYR . 41.5 tp -89.81 123.17 33.55 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 177.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -120.95 148.15 44.48 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.98 0.419 . . . . 0.0 110.876 -177.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 13.7 p -105.83 156.97 17.8 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.005 -174.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.536 ' HB2' ' HA2' ' A' ' 138' ' ' GLY . 79.2 mt . . . . . 0 C--O 1.25 1.099 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.747 178.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 46.1 mttp . . . . . 0 CA--C 1.518 -0.281 0 CA-C-O 120.745 0.307 . . . . 0.0 110.438 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.518 ' HB3' ' HD1' ' A' ' 30' ' ' TYR . 88.0 mtt180 -130.57 115.38 16.68 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.87 -178.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.662 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 91.7 m-85 -101.64 114.65 28.88 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.223 0.535 . . . . 0.0 110.669 178.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.531 ' HB3' HG22 ' A' ' 33' ' ' VAL . 47.2 tp -89.55 110.65 21.48 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.333 -179.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.653 HD11 ' HG ' ' A' ' 36' ' ' LEU . 60.2 tp -96.02 114.91 26.67 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.018 0.437 . . . . 0.0 111.104 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.428 HG22 HD13 ' A' ' 23' ' ' ILE . 26.9 pt -101.03 125.76 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 171.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.584 ' HB3' ' HG2' ' A' ' 132' ' ' PRO . 11.1 p -80.6 -94.21 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -168.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.46 75.15 1.0 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.984 0.421 . . . . 0.0 111.673 -173.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.2 m -79.95 119.23 22.51 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 173.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 65.0 m-70 -134.33 73.12 1.48 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.516 0.674 . . . . 0.0 109.33 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.499 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . 48.7 t -120.79 131.15 24.55 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.247 -176.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.499 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 70.7 Cg_endo -102.25 90.19 0.08 OUTLIER 'Cis proline' 0 N--CA 1.451 -1.001 0 C-N-CA 123.781 -1.341 . . . . 0.0 112.438 -5.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.512 HG12 ' HG2' ' A' ' 15' ' ' ARG . 27.3 t -97.75 -84.94 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.649 -179.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.512 ' HG2' HG12 ' A' ' 14' ' ' VAL . 12.6 mmm180 -121.05 -25.59 5.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.178 0.513 . . . . 0.0 110.204 177.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.44 ' C ' ' H ' ' A' ' 18' ' ' SER . 51.1 ttp -80.43 -72.92 0.39 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.117 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 70.3 -33.71 0.27 Allowed 'General case' 0 N--CA 1.469 0.516 0 O-C-N 123.872 0.733 . . . . 0.0 112.077 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.44 ' H ' ' C ' ' A' ' 16' ' ' MET . 29.7 p -75.15 81.84 2.31 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.087 0.47 . . . . 0.0 111.572 -178.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.433 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 8.0 tt -107.55 110.68 62.9 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 173.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.603 ' CG ' HD13 ' A' ' 157' ' ' LEU . 19.6 Cg_endo -59.13 142.24 99.04 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 123.152 2.568 . . . . 0.0 112.936 -176.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -71.73 -20.83 61.85 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.109 -173.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -57.17 -46.72 82.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.432 -177.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.428 HD13 HG22 ' A' ' 7' ' ' ILE . 3.5 tt -71.2 -32.14 46.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.466 0.65 . . . . 0.0 110.293 -177.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.468 ' O ' HD23 ' A' ' 27' ' ' LEU . 58.4 tp -72.84 -25.14 61.01 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.69 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -81.47 -29.33 33.76 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.476 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.4 p -83.51 8.82 12.85 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -174.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.597 HD12 ' HB2' ' A' ' 52' ' ' SER . 3.2 mm? -56.31 -27.8 56.75 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.839 0.352 . . . . 0.0 111.494 176.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -78.14 -24.31 47.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.367 -177.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -92.85 -3.74 54.12 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.16 0.505 . . . . 0.0 111.177 -172.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.518 ' HD1' ' HB3' ' A' ' 3' ' ' ARG . 99.0 m-85 -123.44 120.22 32.31 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.28 176.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -78.8 -29.93 45.15 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.973 -173.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.662 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -120.91 126.62 6.67 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 174.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.531 HG22 ' HB3' ' A' ' 5' ' ' LEU . 97.0 t -119.61 134.71 62.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 117.426 0.613 . . . . 0.0 110.603 -179.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.517 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 71.2 mt -116.82 131.76 68.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.234 -177.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -125.77 107.41 0.95 Allowed Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.411 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.653 ' HG ' HD11 ' A' ' 6' ' ' LEU . 95.0 mt -74.2 -22.8 59.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.697 0.761 . . . . 0.0 109.385 176.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -152.39 125.06 1.74 Allowed Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 174.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -119.72 -169.57 1.79 Allowed 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -174.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -65.33 145.39 56.26 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 19.9 m -84.41 27.26 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.12 0.486 . . . . 0.0 111.672 -171.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -146.3 139.35 25.66 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 121.029 0.442 . . . . 0.0 110.389 177.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.741 ' HB2' ' HB3' ' A' ' 66' ' ' ASP . 43.4 tp -66.34 -28.9 69.02 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.519 -173.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.47 -35.63 78.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.175 0.512 . . . . 0.0 110.482 -177.099 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.2 m -83.24 -30.84 27.36 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.341 -178.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 98.2 t -58.43 -42.54 84.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.039 0.447 . . . . 0.0 110.285 174.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.413 HD13 ' O ' ' A' ' 42' ' ' LEU . 1.7 mp -68.85 -35.72 70.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.202 177.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -61.25 -37.8 84.41 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.914 175.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 46.8 mt -80.11 -33.33 38.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.732 0.301 . . . . 0.0 110.684 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -65.32 -21.6 66.73 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.129 174.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -81.41 -36.17 29.82 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.043 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.444 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . 39.2 m-85 -75.16 -62.58 1.51 Allowed 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.057 174.059 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.597 ' HB2' HD12 ' A' ' 27' ' ' LEU . 33.4 t -90.8 98.71 11.94 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 173.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 42.7 mttm -78.05 15.18 0.95 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.767 -178.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -146.95 77.58 1.46 Allowed 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 168.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -101.82 123.5 45.88 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.532 -175.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.543 ' HE2' ' HE1' ' A' ' 4' ' ' PHE . 26.5 m-85 -104.41 107.9 19.05 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 175.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.826 ' HA3' HD22 ' A' ' 71' ' ' LEU . . . -116.64 156.49 15.59 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.1 -1.047 . . . . 0.0 112.708 -176.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 15.0 t -128.08 146.08 34.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 177.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 56.8 t60 -94.57 104.53 16.48 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.459 0.647 . . . . 0.0 109.458 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.61 ' HA3' ' HB2' ' A' ' 88' ' ' HIS . . . -135.38 23.15 3.48 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.966 177.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -121.72 -176.07 3.24 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 51.2 mtp -98.91 36.19 1.73 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.393 0.616 . . . . 0.0 109.36 173.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.436 ' OD2' ' HB ' ' A' ' 67' ' ' VAL . 3.8 p-10 -68.62 156.11 38.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.419 178.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.502 ' HB3' ' HD2' ' A' ' 65' ' ' PRO . 89.5 m-85 -70.05 162.97 65.38 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.239 -175.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.528 ' HA ' ' HB3' ' A' ' 68' ' ' LYS . 9.9 Cg_endo -51.91 -23.92 17.65 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.173 2.582 . . . . 0.0 112.602 177.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.741 ' HB3' ' HB2' ' A' ' 42' ' ' LEU . 5.9 m-20 -54.83 -50.31 68.92 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.251 0.548 . . . . 0.0 110.412 175.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.436 ' HB ' ' OD2' ' A' ' 63' ' ' ASP . 29.1 t -77.94 -34.44 19.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.057 -178.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.528 ' HB3' ' HA ' ' A' ' 65' ' ' PRO . 57.8 tttm -62.72 -24.4 67.66 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.105 177.23 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -64.48 -41.09 96.69 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.262 0.553 . . . . 0.0 109.59 175.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -83.42 -38.61 21.69 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.11 -178.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.826 HD22 ' HA3' ' A' ' 57' ' ' GLY . 14.8 mt -114.13 120.7 38.05 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.07 -173.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.5 ' HG2' ' HB2' ' A' ' 75' ' ' LYS . 72.6 Cg_endo -79.79 157.76 24.46 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.793 2.329 . . . . 0.0 111.426 175.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -60.03 -34.78 73.85 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.906 0.384 . . . . 0.0 111.061 -177.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 17.3 m -142.8 137.55 29.76 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 174.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.5 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 43.0 tttp -136.24 126.28 26.1 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.549 0.214 . . . . 0.0 110.627 -176.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 26.8 t -103.18 125.07 57.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.787 0.327 . . . . 0.0 110.29 177.103 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.544 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 89.9 mt -100.43 159.72 14.92 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.784 178.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 46.6 tp -130.78 99.61 5.0 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 175.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.544 HG12 ' HG2' ' A' ' 80' ' ' GLU . 58.2 t -117.04 112.67 40.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.684 -176.004 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.544 ' HG2' HG12 ' A' ' 79' ' ' VAL . 4.5 mm-40 60.06 19.57 8.76 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.57 178.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.55 -3.7 50.18 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.333 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.3 t -93.68 128.23 45.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.664 0.269 . . . . 0.0 110.56 178.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 33.9 p -88.49 126.72 35.38 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.605 178.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.544 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 19.6 mt -118.33 95.85 3.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.82 0.343 . . . . 0.0 110.218 -178.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -80.23 98.12 1.72 Allowed Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 178.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 32.2 mtm -96.8 120.73 37.68 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.135 0.493 . . . . 0.0 110.999 -175.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 26.4 t -139.38 165.19 27.85 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 174.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.61 ' HB2' ' HA3' ' A' ' 60' ' ' GLY . 4.6 t60 -81.51 -21.12 38.85 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 119.669 -0.812 . . . . 0.0 109.667 178.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.427 ' HA3' ' HB2' ' A' ' 113' ' ' PHE . . . 82.88 -155.5 33.37 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.53 177.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 73.8 t-105 -159.74 -73.2 0.07 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.95 0.405 . . . . 0.0 110.513 -177.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 161.77 -174.21 38.24 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 -178.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 55.17 81.86 0.25 Allowed Pre-proline 0 N--CA 1.463 0.21 0 C-N-CA 122.631 0.372 . . . . 0.0 111.341 -179.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -54.77 -30.75 68.8 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.399 2.733 . . . . 0.0 113.262 -173.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -72.53 -13.62 61.45 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.185 -0.461 . . . . 0.0 112.228 -177.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -121.6 -25.18 5.16 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.189 0.519 . . . . 0.0 110.417 177.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 48.2 tp -60.19 -41.29 92.6 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.006 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -58.36 -41.62 85.11 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.159 0.504 . . . . 0.0 109.835 178.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.422 ' O ' ' HG3' ' A' ' 102' ' ' LYS . 9.1 m-20 -69.58 -47.67 62.79 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.058 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.536 ' O ' HG23 ' A' ' 103' ' ' VAL . 19.0 ttm180 -58.71 -46.74 86.66 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.151 -177.03 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.501 HD13 HG21 ' A' ' 111' ' ' ILE . 91.7 mt -66.4 -36.45 82.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.72 0.295 . . . . 0.0 111.287 -179.125 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 93.8 mt -75.12 -11.35 60.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.857 0.36 . . . . 0.0 111.127 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.422 ' HG3' ' O ' ' A' ' 98' ' ' ASP . 96.1 mttt -100.07 -8.87 23.26 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.122 0.487 . . . . 0.0 110.179 175.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 99' ' ' ARG . 90.9 t -81.29 -48.07 19.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 170.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -101.09 106.71 18.01 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.175 173.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 -57.44 -37.7 73.24 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.804 0.335 . . . . 0.0 111.631 -175.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -96.17 133.83 39.98 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 174.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.468 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 60.1 pttt -71.86 126.66 91.35 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-O 121.148 0.499 . . . . 0.0 111.185 -174.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 107' ' ' LYS . 3.7 Cg_exo -81.8 169.48 14.95 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 123.393 2.729 . . . . 0.0 111.473 175.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -87.36 -45.33 10.65 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.112 0.482 . . . . 0.0 109.97 178.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 63.3 t -120.63 136.74 56.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.279 178.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.501 HG21 HD13 ' A' ' 100' ' ' LEU . 59.6 mt -130.02 133.87 63.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.881 0.372 . . . . 0.0 110.386 177.084 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.483 HD23 ' HB2' ' A' ' 130' ' ' LEU . 95.3 mt -109.26 146.36 34.38 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.375 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.427 ' HB2' ' HA3' ' A' ' 89' ' ' GLY . 29.8 p90 -155.69 163.79 39.44 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 174.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -147.11 125.48 2.19 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.681 -177.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 36.5 t-80 -177.5 -37.14 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 177.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.3 p -79.86 127.34 32.12 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.522 177.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.468 ' O ' ' HD3' ' A' ' 119' ' ' PRO . 24.1 m170 -87.71 7.3 30.75 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.263 0.554 . . . . 0.0 110.206 176.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -106.4 91.69 6.1 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.756 171.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' A' ' 117' ' ' HIS . 22.5 Cg_exo -63.51 129.51 25.4 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.75 2.3 . . . . 0.0 111.661 -175.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -149.26 136.74 20.18 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.968 0.414 . . . . 0.0 111.314 -172.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.453 ' OD1' ' HD2' ' A' ' 128' ' ' ARG . 6.7 t70 -90.44 119.78 31.0 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.482 174.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.49 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 44.3 p -132.66 129.52 38.94 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.108 0.48 . . . . 0.0 112.049 -173.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 6.2 p -120.54 105.81 17.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 169.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 50.0 mttp -109.11 -67.34 0.99 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.264 -172.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -92.18 33.0 1.1 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.101 0.476 . . . . 0.0 110.992 -176.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 83.03 -14.92 35.57 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 -175.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 41.8 t -96.23 144.87 9.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.453 ' HD2' ' OD1' ' A' ' 121' ' ' ASP . 6.4 tpp180 -87.24 109.54 19.56 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.391 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.49 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 92.0 m-85 -98.15 121.17 39.75 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 177.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.515 HD13 ' CD1' ' A' ' 152' ' ' PHE . 64.8 mt -121.5 129.66 53.07 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.872 0.367 . . . . 0.0 111.327 -174.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.453 ' HA ' ' HD3' ' A' ' 132' ' ' PRO . 8.5 p30 -131.82 122.31 18.5 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.156 177.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.584 ' HG2' ' HB3' ' A' ' 8' ' ' SER . 87.4 Cg_endo -98.41 168.54 0.66 Allowed 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 123.48 2.787 . . . . 0.0 113.057 178.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -80.67 166.57 49.24 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.787 -0.721 . . . . 0.0 111.351 175.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.505 ' HA ' ' OG ' ' A' ' 8' ' ' SER . 39.5 m -90.32 177.39 6.42 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 117.2 0.5 . . . . 0.0 111.181 -177.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -73.09 -18.13 61.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.335 -176.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -73.26 -47.4 43.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.759 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.498 ' OE1' ' HB2' ' A' ' 134' ' ' SER . 1.8 mp0 -66.49 -32.13 73.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.148 177.082 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.515 ' HA2' HD12 ' A' ' 157' ' ' LEU . . . 96.58 51.75 1.65 Allowed Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.211 178.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 156' ' ' THR . 23.1 t -145.97 153.89 41.3 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 178.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -154.36 167.09 31.13 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.779 177.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.436 ' HB3' ' HB3' ' A' ' 6' ' ' LEU . . . -114.26 135.95 53.5 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.849 0.356 . . . . 0.0 111.041 -174.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 79.4 t -121.27 120.55 62.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.169 176.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.78 HD21 HG13 ' A' ' 150' ' ' VAL . 5.5 tt -104.5 103.95 13.73 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 177.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -106.39 135.91 47.06 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.876 -178.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.487 ' HA ' ' O ' ' A' ' 149' ' ' GLU . 5.1 mp -112.13 98.7 7.51 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.944 0.402 . . . . 0.0 110.512 178.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -101.26 121.54 42.06 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.367 0.603 . . . . 0.0 109.426 178.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 68.09 1.56 20.29 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.835 -175.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 104.57 0.58 43.18 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 121.155 -0.545 . . . . 0.0 112.235 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.487 ' O ' ' HA ' ' A' ' 145' ' ' LEU . 8.7 mm-40 -88.76 132.95 34.4 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.925 0.393 . . . . 0.0 110.511 177.13 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.78 HG13 HD21 ' A' ' 143' ' ' LEU . 98.3 t -80.75 113.97 20.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.021 -178.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 11.1 mtm180 -110.54 107.07 16.58 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 176.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . 0.515 ' CD1' HD13 ' A' ' 130' ' ' LEU . 84.5 t80 -89.45 96.29 10.64 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 176.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -107.24 109.49 21.29 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.414 -174.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 33.9 tp -80.02 118.97 22.23 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.557 177.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -111.03 160.45 16.84 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.055 -178.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 139' ' ' SER . 16.5 p -107.39 165.6 11.27 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.334 176.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.603 HD13 ' CG ' ' A' ' 20' ' ' PRO . 39.4 mt . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.422 -0.799 . . . . 0.0 110.011 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.543 ' HB2' HD12 ' A' ' 145' ' ' LEU . 50.1 mttm . . . . . 0 CA--C 1.518 -0.254 0 CA-C-O 120.958 0.409 . . . . 0.0 110.91 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.503 ' HB3' ' HD2' ' A' ' 30' ' ' TYR . 88.9 mtt180 -117.2 133.65 55.73 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.163 -178.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.428 ' HB2' ' HG ' ' A' ' 143' ' ' LEU . 93.8 m-85 -120.29 121.14 38.0 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.866 0.365 . . . . 0.0 110.065 175.147 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.442 ' HB3' HG22 ' A' ' 33' ' ' VAL . 38.7 tp -93.0 121.05 33.94 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.863 -178.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.558 HD11 ' HG ' ' A' ' 36' ' ' LEU . 51.7 tp -103.98 120.94 42.11 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.952 0.406 . . . . 0.0 110.508 178.252 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.5 pt -101.33 123.96 54.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 173.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.448 ' HB3' ' HB2' ' A' ' 132' ' ' PRO . 5.9 p -66.0 -79.31 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.578 -169.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.794 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 26.9 t70 -148.0 124.13 10.79 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.135 -177.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.706 ' HB2' HD12 ' A' ' 19' ' ' LEU . 9.0 p -156.91 88.46 1.04 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.123 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 62.4 m-70 -83.69 85.85 7.22 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.307 -0.406 . . . . 0.0 109.973 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.471 ' O ' HG22 ' A' ' 40' ' ' VAL . 59.9 t -107.7 135.04 19.82 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.026 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -78.23 -62.56 0.03 OUTLIER 'Cis proline' 0 C--N 1.345 0.384 0 C-N-CA 123.75 -1.354 . . . . 0.0 112.571 0.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.767 HG12 ' HG3' ' A' ' 15' ' ' ARG . 19.6 t 52.13 -93.0 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 123.464 0.705 . . . . 0.0 112.031 177.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.767 ' HG3' HG12 ' A' ' 14' ' ' VAL . 97.8 mtt180 -134.01 4.37 3.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.869 0.366 . . . . 0.0 110.564 -175.297 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.607 ' SD ' ' HB2' ' A' ' 136' ' ' ALA . 32.3 ttp -137.77 112.46 8.87 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.511 -176.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -116.89 19.69 14.26 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.203 0.525 . . . . 0.0 110.344 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 35.6 p -99.9 29.9 3.97 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.379 -176.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.706 HD12 ' HB2' ' A' ' 10' ' ' SER . 7.1 tt -83.27 116.96 67.08 Favored Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 179.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -68.86 118.14 5.47 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 122.45 2.1 . . . . 0.0 112.187 178.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.56 -7.8 5.29 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.442 -177.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -61.12 -36.97 81.15 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.808 0.337 . . . . 0.0 110.796 179.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 11.1 tp -64.75 -39.19 84.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.937 0.875 . . . . 0.0 109.761 178.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 44.4 tp -78.37 -10.25 59.61 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.051 -1.432 . . . . 0.0 110.978 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -100.32 -6.55 25.68 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.106 0.479 . . . . 0.0 110.816 -176.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 68.4 m -121.68 0.5 9.86 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.988 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.446 HD12 HG21 ' A' ' 33' ' ' VAL . 1.4 pt? -72.65 -19.26 61.47 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.065 -174.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -72.94 -13.9 61.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.961 -177.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -73.77 -26.08 60.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.114 0.483 . . . . 0.0 110.547 177.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.503 ' HD2' ' HB3' ' A' ' 3' ' ' ARG . 85.7 m-85 -83.87 156.95 22.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.211 -173.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -86.94 -6.6 58.72 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.01 -178.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -174.52 149.01 10.19 Favored Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.726 177.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.446 HG21 HD12 ' A' ' 27' ' ' LEU . 69.7 t -124.71 135.98 62.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-O 120.976 0.417 . . . . 0.0 110.494 -179.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.544 HG12 ' HB2' ' A' ' 56' ' ' TYR . 49.4 mt -113.85 134.44 56.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.769 179.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -125.6 117.2 2.85 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.14 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.558 ' HG ' HD11 ' A' ' 6' ' ' LEU . 95.9 mt -95.79 -9.96 30.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.854 0.835 . . . . 0.0 109.246 175.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.794 ' HA3' ' HA ' ' A' ' 9' ' ' ASP . . . -151.43 60.93 0.41 Allowed Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.238 178.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -73.83 178.85 4.59 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.252 -0.474 . . . . 0.0 111.695 -175.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.531 ' HD1' HD11 ' A' ' 48' ' ' LEU . 71.2 m-85 -63.43 145.62 55.24 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.558 179.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.551 ' HB ' ' CD1' ' A' ' 64' ' ' TYR . 18.1 m -83.79 -9.01 11.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.802 -173.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.493 ' HB2' ' OG1' ' A' ' 44' ' ' THR . 19.4 m-20 -86.62 120.4 27.89 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.013 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.534 HD22 ' HB3' ' A' ' 66' ' ' ASP . 48.9 tp -53.38 -42.24 66.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.026 0.441 . . . . 0.0 110.432 178.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -59.06 -38.7 80.02 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.923 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.51 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 7.6 m -75.74 -28.72 58.62 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.663 -178.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 41' ' ' ASP . 65.6 t -62.22 -46.77 95.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.055 0.455 . . . . 0.0 110.159 175.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.07 -36.34 77.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.844 176.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -59.64 -35.42 74.35 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.785 175.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.531 HD11 ' HD1' ' A' ' 39' ' ' TYR . 91.1 mt -71.25 -38.34 71.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.407 178.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.701 ' HG2' ' HB3' ' A' ' 55' ' ' PHE . 49.2 mt-10 -69.05 -17.1 63.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.984 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -82.53 -41.31 19.81 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.856 176.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -68.83 -46.47 68.47 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.903 0.382 . . . . 0.0 111.536 178.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 51.1 p -83.38 -14.81 51.96 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.544 -176.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 93.5 mttt 70.4 -54.11 0.64 Allowed 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.509 0.723 . . . . 0.0 110.368 -172.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -123.68 109.57 13.88 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.193 0.521 . . . . 0.0 109.735 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.701 ' HB3' ' HG2' ' A' ' 49' ' ' GLU . 84.1 t80 -111.4 139.25 46.96 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.479 -175.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.544 ' HB2' HG12 ' A' ' 34' ' ' ILE . 93.5 m-85 -119.77 116.49 26.02 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 174.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.528 ' HA3' HD13 ' A' ' 71' ' ' LEU . . . -124.91 141.89 13.47 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 119.566 -1.302 . . . . 0.0 113.739 -173.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.428 HG23 ' HE3' ' A' ' 86' ' ' MET . 16.5 t -132.24 123.03 49.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 170.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -94.39 147.06 23.61 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 120.095 -0.642 . . . . 0.0 110.339 -173.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.626 ' HA2' ' HB3' ' A' ' 88' ' ' HIS . . . -80.83 -123.06 0.54 Allowed Glycine 0 C--N 1.331 0.261 0 N-CA-C 114.475 0.55 . . . . 0.0 114.475 -171.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -74.23 -164.12 0.23 Allowed 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 122.419 0.288 . . . . 0.0 111.053 -175.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 46.9 mtm -56.46 113.94 1.81 Allowed 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 120.991 0.424 . . . . 0.0 110.264 178.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -141.09 -160.77 1.12 Allowed 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -175.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.551 ' CD1' ' HB ' ' A' ' 40' ' ' VAL . 12.3 m-85 -67.04 125.28 90.68 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 121.113 0.482 . . . . 0.0 111.308 -177.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 64' ' ' TYR . 52.7 Cg_exo -56.66 -38.36 95.78 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 123.869 3.046 . . . . 0.0 113.797 -174.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.534 ' HB3' HD22 ' A' ' 42' ' ' LEU . 5.4 m-20 -59.5 -36.54 76.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.099 0.476 . . . . 0.0 111.024 -178.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 11.9 t -76.53 -26.08 16.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.261 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -63.51 -31.1 72.16 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.194 0.521 . . . . 0.0 110.264 176.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -86.2 -19.47 29.97 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.095 -178.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 11.7 t60 -91.24 -40.31 11.59 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.09 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.528 HD13 ' HA3' ' A' ' 57' ' ' GLY . 31.1 mt -117.74 136.26 23.61 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.985 179.116 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.411 ' HD2' ' O ' ' A' ' 57' ' ' GLY . 63.9 Cg_endo -74.34 177.29 8.51 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 122.486 2.124 . . . . 0.0 112.525 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -95.98 -12.97 24.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.212 0.529 . . . . 0.0 110.172 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 10.0 p -155.63 124.1 5.93 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.321 175.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 40.5 tttp -131.83 132.59 43.83 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.509 0.195 . . . . 0.0 110.674 -176.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 20.3 t -110.83 121.68 63.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.873 0.368 . . . . 0.0 110.498 179.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.462 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 72.3 mt -101.28 158.81 15.77 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.337 178.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 59.6 tp -127.0 102.11 6.84 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 175.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.525 HG12 ' HG2' ' A' ' 80' ' ' GLU . 35.6 t -124.01 116.12 46.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.468 -177.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.525 ' HG2' HG12 ' A' ' 79' ' ' VAL . 20.2 mm-40 59.78 27.16 16.41 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.477 177.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.31 -15.32 63.5 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.195 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 52.4 t -87.41 126.37 41.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.76 0.314 . . . . 0.0 110.189 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 40.9 p -85.93 134.35 33.88 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.181 177.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.462 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 37.0 mt -118.17 94.81 3.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -178.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -85.29 95.31 1.97 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.444 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.549 ' HG2' HD12 ' A' ' 112' ' ' LEU . 30.0 mtm -95.98 118.93 33.57 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.953 0.406 . . . . 0.0 110.439 -176.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.681 ' O ' ' HA ' ' A' ' 113' ' ' PHE . 52.7 t -140.27 153.69 46.59 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 178.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.626 ' HB3' ' HA2' ' A' ' 60' ' ' GLY . 4.1 p-80 -72.23 1.55 7.46 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.879 -0.329 . . . . 0.0 111.849 176.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.35 176.72 50.34 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.494 176.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -116.73 -99.5 0.44 Allowed 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.548 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -109.69 -94.71 2.32 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.311 -0.947 . . . . 0.0 113.434 -173.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.436 ' HB1' ' HD2' ' A' ' 93' ' ' PRO . . . -112.7 172.67 3.35 Favored Pre-proline 0 C--N 1.321 -0.656 0 C-N-CA 122.456 0.302 . . . . 0.0 110.622 -172.199 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.436 ' HD2' ' HB1' ' A' ' 92' ' ' ALA . 31.5 Cg_exo -61.24 -11.79 20.64 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.612 2.208 . . . . 0.0 113.061 177.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 1.5 m0 -77.51 -54.59 6.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.286 0.565 . . . . 0.0 109.701 -179.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.476 ' OD2' ' HD2' ' A' ' 99' ' ' ARG . 7.3 p-10 -82.72 -3.32 56.29 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.703 -177.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 28.0 tp -50.51 -56.34 12.06 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.775 178.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.9 ptmm? -66.44 -48.28 70.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.264 -178.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -62.49 -59.07 5.48 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.792 -175.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.528 ' O ' HG23 ' A' ' 103' ' ' VAL . 94.3 mtt180 -69.31 -38.21 78.16 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -171.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.51 HD13 HG21 ' A' ' 111' ' ' ILE . 46.5 mt -70.03 -37.13 75.5 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.386 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.542 HD21 HG21 ' A' ' 127' ' ' VAL . 87.0 mt -79.3 -14.23 59.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.81 0.338 . . . . 0.0 111.117 178.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.602 ' HA ' ' ND2' ' A' ' 105' ' ' ASN . 97.0 mttt -90.41 -14.54 32.72 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.634 173.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 99' ' ' ARG . 84.2 t -81.43 -49.08 18.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 167.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -100.23 75.22 1.8 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.385 174.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.602 ' ND2' ' HA ' ' A' ' 102' ' ' LYS . 7.4 m120 -60.75 -28.57 68.81 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.5 -173.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -78.23 -6.54 55.24 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.875 0.369 . . . . 0.0 110.686 -178.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.426 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 5.0 tmmm? 64.91 109.09 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.468 0 C-N-CA 123.589 0.755 . . . . 0.0 112.444 174.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 107' ' ' LYS . 8.8 Cg_endo -88.39 178.38 2.97 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.392 2.728 . . . . 0.0 112.102 177.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 14.4 mp0 -88.73 -45.83 9.48 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.865 0.364 . . . . 0.0 110.414 176.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.4 t -124.29 133.61 68.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.748 -178.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.51 HG21 HD13 ' A' ' 100' ' ' LEU . 58.9 mt -124.15 127.14 73.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.296 176.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.622 HD23 ' HB2' ' A' ' 130' ' ' LEU . 87.4 mt -101.13 134.38 44.24 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 178.152 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.681 ' HA ' ' O ' ' A' ' 87' ' ' CYS . 24.7 p90 -144.03 142.1 30.48 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.937 0.399 . . . . 0.0 110.593 176.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -105.68 135.99 12.94 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.914 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -147.62 157.34 43.51 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.8 p -80.1 61.88 4.09 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.378 0.609 . . . . 0.0 111.084 178.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -154.81 152.6 30.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.653 -176.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -57.76 145.88 68.73 Favored Pre-proline 0 C--N 1.329 -0.307 0 O-C-N 123.574 0.546 . . . . 0.0 111.096 177.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.18 149.09 74.66 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 123.122 2.548 . . . . 0.0 112.693 -178.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -151.84 142.38 22.65 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.495 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -78.52 94.04 4.9 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 176.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.8 p -103.5 135.22 45.5 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.998 -176.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 14.1 p -150.34 121.55 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.083 0.468 . . . . 0.0 110.593 176.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.447 ' HB2' ' HE2' ' A' ' 129' ' ' PHE . 95.9 mttt -142.04 144.41 33.59 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.191 -0.458 . . . . 0.0 109.992 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 62.75 19.09 11.18 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 123.5 0.5 . . . . 0.0 111.636 179.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 86.89 -5.7 84.54 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.054 -178.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.542 HG21 HD21 ' A' ' 101' ' ' LEU . 33.0 t -97.6 129.44 47.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 120.833 0.349 . . . . 0.0 110.141 -178.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 38.1 ttm-85 -84.19 122.1 28.38 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.574 178.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.447 ' HE2' ' HB2' ' A' ' 124' ' ' LYS . 82.3 m-85 -103.43 138.97 39.44 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 175.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.622 ' HB2' HD23 ' A' ' 112' ' ' LEU . 95.7 mt -128.18 121.45 29.49 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.91 0.386 . . . . 0.0 111.069 -179.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.447 ' HB3' ' CZ ' ' A' ' 113' ' ' PHE . 8.1 p30 -121.57 117.36 30.19 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.95 176.157 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.448 ' HB2' ' HB3' ' A' ' 8' ' ' SER . 33.6 Cg_endo -96.82 147.38 0.97 Allowed 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 123.344 2.696 . . . . 0.0 112.627 176.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -69.51 152.97 52.24 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.207 175.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 82.8 p -70.65 175.47 4.88 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.435 0.636 . . . . 0.0 111.938 -173.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.409 ' HB2' ' HB3' ' A' ' 10' ' ' SER . 4.5 mm? -69.77 -25.56 63.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.394 176.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.607 ' HB2' ' SD ' ' A' ' 16' ' ' MET . . . -72.99 -31.72 64.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.27 0.557 . . . . 0.0 110.336 177.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -83.34 -20.04 35.05 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.109 177.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 89.08 45.94 4.61 Favored Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.944 175.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 156' ' ' THR . 26.4 t -137.0 149.03 47.23 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.841 0.353 . . . . 0.0 110.393 178.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.402 ' CD1' ' HG ' ' A' ' 157' ' ' LEU . 7.5 p90 -147.74 178.0 8.84 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 176.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.445 ' HB3' ' HB3' ' A' ' 6' ' ' LEU . . . -132.86 135.26 45.51 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.955 0.407 . . . . 0.0 111.18 -179.183 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 99.3 t -119.7 112.01 35.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.871 175.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.696 ' HA ' ' O ' ' A' ' 151' ' ' ARG . 0.2 OUTLIER -102.85 110.83 22.89 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.6 0.714 . . . . 0.0 110.239 175.513 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -105.18 145.0 31.2 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.687 -178.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.543 HD12 ' HB2' ' A' ' 2' ' ' LYS . 87.4 mt -90.8 90.16 7.8 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.527 0.68 . . . . 0.0 109.952 178.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -95.04 113.97 25.73 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.556 -179.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 68.48 -69.24 0.38 Allowed Glycine 0 CA--C 1.524 0.628 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.598 -175.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -172.52 25.25 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.959 -0.639 . . . . 0.0 111.749 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -124.11 133.6 53.56 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 120.811 0.339 . . . . 0.0 110.404 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.434 HG22 HD21 ' A' ' 145' ' ' LEU . 9.3 t -81.0 98.39 3.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.696 ' O ' ' HA ' ' A' ' 143' ' ' LEU . 38.8 mtp85 -101.13 106.39 17.63 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.794 0.33 . . . . 0.0 110.939 -175.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . 0.522 ' CE2' HD13 ' A' ' 143' ' ' LEU . 18.0 m-85 -83.56 105.49 14.53 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.467 178.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -96.41 112.06 23.94 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.818 0.342 . . . . 0.0 110.719 178.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -72.49 124.42 25.15 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 174.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -133.42 171.27 14.29 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -177.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 139' ' ' SER . 15.1 p -120.69 150.55 40.77 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.853 0.358 . . . . 0.0 111.729 -176.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.402 ' HG ' ' CD1' ' A' ' 140' ' ' TYR . 92.1 mt . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.447 175.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 83.9 t . . . . . 0 N--CA 1.482 1.164 0 CA-C-O 120.703 0.287 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -85.32 150.89 24.44 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 174.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.449 ' HG3' ' CD1' ' A' ' 30' ' ' TYR . 0.2 OUTLIER -145.79 132.49 19.96 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.486 0.66 . . . . 0.0 111.539 -174.137 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.751 ' HE2' HD11 ' A' ' 145' ' ' LEU . 87.0 m-85 -101.66 128.01 48.15 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.306 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.566 HD11 HD11 ' A' ' 23' ' ' ILE . 43.5 tp -91.75 108.06 19.65 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.308 177.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.592 ' HB3' ' HB3' ' A' ' 141' ' ' ALA . 51.0 tp -94.39 118.14 31.17 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.566 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.4 ' CG1' ' HA2' ' A' ' 35' ' ' GLY . 22.4 pt -101.12 115.58 43.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 174.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.8 m -54.94 -69.55 0.13 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.692 -1.14 . . . . 0.0 113.104 -169.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.58 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 26.1 t70 -153.19 105.24 2.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.867 0.365 . . . . 0.0 110.417 -175.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.879 ' H ' ' HA3' ' A' ' 37' ' ' GLY . 5.7 m -110.5 134.45 52.35 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.661 -175.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 13.0 m170 -130.76 86.77 2.41 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 173.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.483 ' O ' HG22 ' A' ' 40' ' ' VAL . 48.0 t -128.96 125.68 22.94 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.456 -175.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -78.97 -48.11 0.28 Allowed 'Cis proline' 0 CA--C 1.532 0.389 0 C-N-CA 122.904 -1.707 . . . . 0.0 112.8 -2.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.433 ' CG2' HG11 ' A' ' 40' ' ' VAL . 37.9 t 51.46 -94.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 123.53 0.732 . . . . 0.0 111.605 -178.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.46 ' HA ' ' HD2' ' A' ' 15' ' ' ARG . 17.5 tpt180 -148.43 22.81 1.04 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.535 0.684 . . . . 0.0 109.391 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.455 ' C ' ' H ' ' A' ' 18' ' ' SER . 53.5 ttp -119.63 -72.42 0.69 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.688 178.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 64.67 -12.94 0.11 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.552 0.741 . . . . 0.0 112.788 178.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.455 ' H ' ' C ' ' A' ' 16' ' ' MET . 11.9 m -83.64 58.03 4.39 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.263 0.554 . . . . 0.0 110.875 -177.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.92 ' HG ' HD11 ' A' ' 135' ' ' LEU . 6.5 tt -107.84 119.04 51.45 Favored Pre-proline 0 C--N 1.321 -0.632 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 177.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 19' ' ' LEU . 18.1 Cg_endo -61.1 111.04 0.97 Allowed 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.286 1.99 . . . . 0.0 111.411 176.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -71.65 -7.08 45.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.415 -174.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -56.42 -43.08 79.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.174 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.566 HD11 HD11 ' A' ' 5' ' ' LEU . 9.7 tt -70.82 -35.84 61.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.515 0.674 . . . . 0.0 110.19 -178.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.725 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 59.4 tp -63.0 -32.0 73.27 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.454 177.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -75.27 -19.39 59.74 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.704 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 64.0 m -93.11 12.21 25.03 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.152 -174.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.725 ' HG ' ' O ' ' A' ' 24' ' ' LEU . 9.9 mt -63.96 -19.1 64.9 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.979 0.419 . . . . 0.0 110.349 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -52.88 -36.06 58.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.999 176.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -94.11 3.48 55.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.332 -174.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.472 ' CD1' ' HB2' ' A' ' 5' ' ' LEU . 90.6 m-85 -118.38 106.67 12.98 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.181 0.515 . . . . 0.0 110.341 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -75.62 4.92 6.77 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.873 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.577 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -163.74 109.49 0.38 Allowed Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 175.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 90.8 t -100.08 126.52 53.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 O-C-N 122.458 -0.436 . . . . 0.0 110.119 178.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 51.4 mt -105.33 123.51 59.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 120.87 0.366 . . . . 0.0 110.158 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.4 ' HA2' ' CG1' ' A' ' 7' ' ' ILE . . . -114.64 103.06 1.23 Allowed Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 120.512 -0.852 . . . . 0.0 112.648 -177.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.493 HD21 ' HB3' ' A' ' 86' ' ' MET . 70.9 mt -85.3 -30.95 23.33 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 172.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.879 ' HA3' ' H ' ' A' ' 10' ' ' SER . . . -112.1 123.1 6.21 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 171.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -99.88 164.77 11.87 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.551 0.691 . . . . 0.0 112.754 -169.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.414 ' CD1' HD21 ' A' ' 48' ' ' LEU . 60.0 m-85 -85.85 127.13 34.5 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 168.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.483 HG22 ' O ' ' A' ' 12' ' ' VAL . 3.8 m -80.96 -9.5 11.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -165.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.502 ' O ' HG23 ' A' ' 45' ' ' VAL . 2.3 m-20 -86.9 125.87 34.3 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 176.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 38.9 tp -60.75 -36.0 77.79 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.369 0.604 . . . . 0.0 109.503 178.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -57.28 -44.95 84.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.227 175.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.492 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 14.9 m -71.98 -25.09 61.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.023 -177.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 41' ' ' ASP . 61.0 t -62.66 -42.71 97.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.075 0.464 . . . . 0.0 110.174 175.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.45 -36.55 77.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-O 121.263 0.554 . . . . 0.0 109.724 175.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.59 -32.97 74.6 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.455 175.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 44' ' ' THR . 89.0 mt -64.46 -43.07 95.38 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 176.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.471 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 29.6 tt0 -69.41 -14.87 63.13 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.02 178.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -85.21 -49.73 7.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.662 178.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.457 ' CB ' HD12 ' A' ' 27' ' ' LEU . 28.3 m-85 -65.29 -57.01 9.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.842 178.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.645 ' HB3' HD13 ' A' ' 27' ' ' LEU . 83.0 p -77.62 -38.65 47.55 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.709 0.29 . . . . 0.0 111.214 -175.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.471 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 53.6 mttp 69.67 7.79 6.41 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.721 -178.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 179.0 111.01 0.03 OUTLIER 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.805 174.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -136.71 152.83 50.8 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.999 0.428 . . . . 0.0 110.682 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.545 ' HE2' ' HE1' ' A' ' 4' ' ' PHE . 40.2 m-85 -118.18 113.79 22.08 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 176.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -116.53 152.51 17.87 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.198 -1.001 . . . . 0.0 112.84 -174.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.635 HG21 ' HB2' ' A' ' 86' ' ' MET . 31.0 t -128.92 113.63 29.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 175.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 14.5 t-80 -94.24 104.18 16.19 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.896 -172.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.437 ' HA3' ' O ' ' A' ' 88' ' ' HIS . . . -132.54 32.16 2.86 Favored Glycine 0 N--CA 1.444 -0.816 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 174.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -101.23 154.85 18.41 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.608 -0.796 . . . . 0.0 109.957 -178.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 94.8 mmm -90.47 39.73 0.99 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.497 -172.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.45 ' HB3' ' H ' ' A' ' 64' ' ' TYR . 8.7 m-20 -118.76 -143.81 0.37 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.702 0.287 . . . . 0.0 111.556 -178.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.453 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 78.7 m-85 -69.86 127.33 92.56 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.114 0.483 . . . . 0.0 111.85 -169.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 64' ' ' TYR . 11.8 Cg_exo -71.1 -14.35 31.83 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.353 2.702 . . . . 0.0 111.995 179.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -60.86 -32.91 72.32 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.459 0.647 . . . . 0.0 110.567 178.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.442 HG12 HD21 ' A' ' 71' ' ' LEU . 47.0 t -73.09 -20.07 18.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.678 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.489 ' HE2' ' HB2' ' A' ' 73' ' ' PHE . 64.5 tttm -72.88 -12.44 60.97 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.676 -174.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -84.15 -10.01 58.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.003 0.43 . . . . 0.0 111.001 177.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 57.4 m-70 -103.36 -28.94 11.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.147 0.498 . . . . 0.0 109.861 177.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.442 HD21 HG12 ' A' ' 67' ' ' VAL . 0.3 OUTLIER -138.99 119.51 9.68 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.671 174.708 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -66.56 177.26 3.47 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 123.167 2.578 . . . . 0.0 112.938 -175.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.489 ' HB2' ' HE2' ' A' ' 68' ' ' LYS . 70.5 t80 -70.26 -29.15 65.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.141 0.496 . . . . 0.0 110.552 -177.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.482 ' HA ' HG13 ' A' ' 58' ' ' VAL . 10.2 p -147.74 142.06 26.27 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.948 178.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 32.1 tttm -142.41 141.08 32.19 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.807 -178.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.539 HG23 ' CE1' ' A' ' 104' ' ' PHE . 56.6 t -114.53 139.28 41.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.896 174.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 58.6 mt -114.45 144.22 43.67 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.17 177.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 54.9 tp -109.52 96.24 6.14 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 175.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 24.0 t -111.68 96.09 4.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.914 -173.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.424 ' OE1' ' HA2' ' A' ' 148' ' ' GLY . 42.6 mt-10 54.13 38.66 29.56 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.132 175.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 107.99 -31.57 7.83 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.343 177.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 60.2 t -81.66 115.1 23.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.005 0.431 . . . . 0.0 110.937 -177.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.07 105.64 14.22 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.071 176.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.427 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 15.8 mt -94.8 106.85 18.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.625 -177.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.536 ' HA2' HG22 ' A' ' 76' ' ' VAL . . . -93.09 110.19 3.91 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 176.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.635 ' HB2' HG21 ' A' ' 58' ' ' VAL . 43.5 mtm -107.99 129.71 55.1 Favored 'General case' 0 C--N 1.317 -0.834 0 O-C-N 122.419 -0.46 . . . . 0.0 110.822 -174.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 79.0 m -149.34 116.9 6.17 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.534 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.437 ' O ' ' HA3' ' A' ' 60' ' ' GLY . 41.8 t-80 -97.07 127.88 43.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.233 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 169.32 -125.53 1.27 Allowed Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.395 178.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 29.2 p90 -153.71 165.89 34.56 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.676 0.274 . . . . 0.0 110.488 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 171.61 148.21 6.01 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.877 177.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -76.43 155.36 83.84 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 176.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_exo -51.76 -33.56 50.68 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.67 2.247 . . . . 0.0 112.542 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -76.38 -53.97 7.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.926 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -62.68 -37.68 87.38 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.022 -176.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 30.5 tp -51.42 -60.71 2.83 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 122.705 0.402 . . . . 0.0 112.0 -171.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -60.68 -41.46 95.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.44 -176.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -73.81 -39.52 64.04 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.992 0.425 . . . . 0.0 111.325 -176.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.412 ' O ' HG23 ' A' ' 103' ' ' VAL . 74.5 ttt180 -68.36 -40.96 81.29 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.827 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.551 HD13 HG21 ' A' ' 111' ' ' ILE . 89.5 mt -70.23 -32.6 70.53 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.027 -178.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 96.8 mt -78.21 -11.55 59.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.332 0.587 . . . . 0.0 110.221 175.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -86.21 -47.54 9.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.942 173.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 99' ' ' ARG . 89.0 t -63.21 -46.25 96.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.087 177.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.539 ' CE1' HG23 ' A' ' 76' ' ' VAL . 25.6 m-85 -101.61 102.63 13.37 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.227 176.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -59.8 -36.06 75.97 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.584 -177.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -100.97 125.86 47.58 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 172.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.502 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 0.0 OUTLIER -60.78 126.7 85.97 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.779 -173.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.502 ' HD3' ' HA ' ' A' ' 107' ' ' LYS . 5.4 Cg_exo -75.13 150.18 37.23 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.696 2.264 . . . . 0.0 110.558 173.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -75.54 -48.9 20.44 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.338 0.59 . . . . 0.0 109.66 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 66.0 t -126.68 131.1 71.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.549 178.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.551 HG21 HD13 ' A' ' 100' ' ' LEU . 57.5 mt -114.82 134.25 58.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 120.686 0.279 . . . . 0.0 110.94 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.599 HD23 ' HB2' ' A' ' 130' ' ' LEU . 82.8 mt -105.04 118.52 36.73 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.243 177.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.431 ' CE1' ' HB3' ' A' ' 129' ' ' PHE . 16.9 p90 -133.91 127.47 32.55 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.094 0.473 . . . . 0.0 110.054 177.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -106.11 126.78 8.67 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.777 -0.725 . . . . 0.0 111.805 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 21.6 t60 -172.42 -44.42 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.27 0.557 . . . . 0.0 109.772 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.7 t -92.68 142.11 27.73 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.529 175.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 1.02 ' HA ' ' HA2' ' A' ' 133' ' ' GLY . 23.3 p-80 -97.87 4.66 49.6 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.044 0.45 . . . . 0.0 110.762 -178.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -108.19 106.41 58.54 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.441 174.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.27 127.19 13.85 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.961 2.441 . . . . 0.0 112.603 -174.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -142.27 139.87 32.04 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.361 173.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -78.28 103.91 8.52 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 175.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.532 ' HB ' ' HE2' ' A' ' 124' ' ' LYS . 60.8 p -111.91 121.42 45.0 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.597 -172.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.8 p -106.94 110.31 31.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.294 0.568 . . . . 0.0 110.244 176.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.532 ' HE2' ' HB ' ' A' ' 122' ' ' THR . 72.5 mmtt -123.9 127.36 47.88 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.805 -178.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 65.6 13.14 8.73 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 123.465 0.478 . . . . 0.0 111.773 177.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 94.31 4.46 62.64 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.511 -178.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 43.3 t -106.44 140.26 25.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 177.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -94.0 113.41 25.39 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.86 0.362 . . . . 0.0 110.249 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.513 ' CE1' ' HB2' ' A' ' 124' ' ' LYS . 76.9 m-85 -103.03 124.69 49.0 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.259 -178.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.599 ' HB2' HD23 ' A' ' 112' ' ' LEU . 83.5 mt -108.87 130.86 55.43 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.737 176.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -122.84 111.51 31.0 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.195 -176.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -82.28 152.7 16.04 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.737 2.291 . . . . 0.0 111.568 173.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 1.02 ' HA2' ' HA ' ' A' ' 117' ' ' HIS . . . -67.49 -129.01 0.03 OUTLIER Glycine 0 CA--C 1.524 0.619 0 O-C-N 123.506 0.504 . . . . 0.0 114.138 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 7.9 m -128.44 179.61 5.55 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 122.224 -0.574 . . . . 0.0 111.159 -176.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.92 HD11 ' HG ' ' A' ' 19' ' ' LEU . 1.1 tm? -73.22 -69.3 0.43 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.7 -179.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -75.0 13.2 0.71 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.606 -171.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -107.69 6.97 28.22 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.921 0.391 . . . . 0.0 110.512 177.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 69.47 42.37 73.62 Favored Glycine 0 C--N 1.332 0.346 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.981 174.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 13.0 p -132.98 99.17 4.5 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.901 0.382 . . . . 0.0 111.272 -178.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -113.51 155.5 25.24 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 174.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.592 ' HB3' ' HB3' ' A' ' 6' ' ' LEU . . . -114.49 128.39 56.31 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.115 0.483 . . . . 0.0 111.03 -176.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 40.2 t -111.46 117.48 55.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.6 175.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.749 HD23 ' HA ' ' A' ' 152' ' ' PHE . 57.7 mt -96.67 113.64 25.22 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.077 177.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -108.04 130.55 55.07 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.735 -176.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.751 HD11 ' HE2' ' A' ' 4' ' ' PHE . 74.0 mt -99.14 116.44 31.35 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.028 -177.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.473 ' HB3' ' NH1' ' A' ' 151' ' ' ARG . 27.3 t70 -146.83 130.78 17.19 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.693 177.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.85 11.31 60.35 Favored Glycine 0 CA--C 1.521 0.445 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.974 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.424 ' HA2' ' OE1' ' A' ' 80' ' ' GLU . . . 84.12 30.89 27.16 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.318 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -126.99 135.14 50.44 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.718 0.295 . . . . 0.0 110.817 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 44.3 t -84.38 108.31 16.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 174.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.473 ' NH1' ' HB3' ' A' ' 146' ' ' ASP . 96.5 mtt180 -106.18 120.62 42.3 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.053 0.454 . . . . 0.0 111.011 -174.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . 0.749 ' HA ' HD23 ' A' ' 143' ' ' LEU . 74.0 t80 -92.62 112.89 25.0 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.216 -173.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -122.04 103.8 9.06 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.852 0.358 . . . . 0.0 110.588 173.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 20.2 tp -79.0 100.38 7.29 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 174.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -93.9 138.02 32.49 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.499 -173.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 34.9 p -94.03 150.57 20.22 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.352 -174.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 10.1 mp . . . . . 0 C--O 1.245 0.866 0 CA-C-O 118.62 -0.705 . . . . 0.0 109.49 175.725 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 59.2 t . . . . . 0 N--CA 1.479 0.999 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -133.85 155.65 49.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.576 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 89.2 mtt-85 -123.41 132.53 53.99 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.218 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.408 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 74.2 m-85 -118.06 128.06 54.39 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.846 174.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.557 ' HB3' HG22 ' A' ' 33' ' ' VAL . 33.9 tp -89.57 134.23 34.22 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.789 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.408 ' HB3' ' HB3' ' A' ' 141' ' ' ALA . 50.3 tp -119.32 109.16 15.48 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.193 0.521 . . . . 0.0 111.314 -178.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.417 HG13 ' HA2' ' A' ' 35' ' ' GLY . 17.4 pt -102.24 112.39 35.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 172.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.426 ' HB2' ' H ' ' A' ' 9' ' ' ASP . 1.1 m -76.05 -90.17 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -166.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.426 ' H ' ' HB2' ' A' ' 8' ' ' SER . 24.3 t70 -108.54 110.83 22.4 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.611 -173.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.795 ' HB3' ' HA ' ' A' ' 38' ' ' ASP . 42.2 t -123.9 134.08 53.61 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 121.477 0.656 . . . . 0.0 110.215 178.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 26.6 m170 -125.55 38.22 4.21 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.583 HG21 HD12 ' A' ' 19' ' ' LEU . 61.3 t -94.11 138.13 22.69 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.927 -175.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.444 ' HA ' HG13 ' A' ' 12' ' ' VAL . 5.3 Cg_exo -80.27 -60.64 0.04 OUTLIER 'Cis proline' 0 C--N 1.345 0.365 0 C-N-CA 123.526 -1.447 . . . . 0.0 112.072 -3.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 26.4 t 54.16 -86.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 O-C-N 123.882 0.739 . . . . 0.0 111.462 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 29.2 ttt180 -144.73 12.74 1.48 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.163 0.506 . . . . 0.0 109.915 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 43.0 ttp -131.39 105.1 7.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.797 -176.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -97.31 13.25 30.2 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.017 0.437 . . . . 0.0 110.854 177.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.9 m -81.95 40.68 0.62 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.864 -175.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.759 ' HG ' HD13 ' A' ' 135' ' ' LEU . 3.6 tt -107.75 104.3 52.57 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 174.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -61.88 124.57 14.75 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 123.036 2.491 . . . . 0.0 112.564 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -71.93 -8.03 52.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.753 -176.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -61.04 -49.59 76.74 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.253 -177.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.482 HD11 HD11 ' A' ' 5' ' ' LEU . 6.9 tt -71.93 -31.58 41.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.714 0.769 . . . . 0.0 110.085 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.494 ' HA ' HD23 ' A' ' 27' ' ' LEU . 59.1 tp -56.9 -33.09 66.58 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.182 -1.372 . . . . 0.0 110.915 178.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -74.27 -36.45 63.82 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.676 178.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.6 m -76.53 7.75 4.19 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.875 -175.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.908 HD12 ' HB3' ' A' ' 52' ' ' SER . 1.4 mm? -53.68 -33.66 56.12 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.008 0.432 . . . . 0.0 111.579 176.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 28.2 mttp -87.21 7.51 28.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.487 -170.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -95.6 -18.94 20.16 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -176.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -105.63 156.15 18.54 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.926 0.393 . . . . 0.0 111.806 -170.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -60.96 -54.5 44.29 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.854 177.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -143.51 151.57 23.41 Favored Glycine 0 N--CA 1.44 -1.068 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.993 178.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.621 HG21 HD13 ' A' ' 27' ' ' LEU . 99.3 t -122.58 136.4 59.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-O 120.731 0.3 . . . . 0.0 110.216 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.555 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 45.9 mt -107.98 120.97 60.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.376 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.417 ' HA2' HG13 ' A' ' 7' ' ' ILE . . . -108.13 111.14 3.28 Favored Glycine 0 N--CA 1.442 -0.945 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 176.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.522 ' HA ' HG23 ' A' ' 58' ' ' VAL . 81.5 mt -85.91 27.59 0.87 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.903 0.382 . . . . 0.0 110.175 -178.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 117.74 81.91 0.84 Allowed Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -174.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.795 ' HA ' ' HB3' ' A' ' 10' ' ' SER . 3.2 p-10 -96.6 -95.11 0.2 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -173.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.429 ' H ' ' CG ' ' A' ' 38' ' ' ASP . 79.9 m-85 -95.4 138.17 33.45 Favored 'General case' 0 C--N 1.318 -0.792 0 O-C-N 121.897 -0.502 . . . . 0.0 110.313 -178.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.7 m -79.05 -9.88 12.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.364 0.602 . . . . 0.0 109.906 178.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.536 ' O ' HG23 ' A' ' 45' ' ' VAL . 43.0 m-20 -86.59 121.68 29.45 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.598 177.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.51 ' O ' HD13 ' A' ' 46' ' ' ILE . 47.1 tp -57.45 -43.1 83.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.416 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -52.22 -45.02 65.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.561 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.1 m -78.55 -27.45 45.88 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.278 -175.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 41' ' ' ASP . 94.6 t -61.77 -44.43 98.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.174 0.511 . . . . 0.0 109.742 174.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.51 HD13 ' O ' ' A' ' 42' ' ' LEU . 1.7 mp -65.02 -36.58 78.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.7 176.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.36 -37.57 83.8 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.674 175.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 22.9 mt -73.85 -37.09 64.92 Favored 'General case' 0 CA--C 1.514 -0.426 0 C-N-CA 120.434 -0.507 . . . . 0.0 110.158 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.486 ' HA ' ' HB2' ' A' ' 55' ' ' PHE . 32.9 tt0 -63.64 -26.36 68.64 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.824 175.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -84.03 -49.65 8.73 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.513 178.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.524 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . 4.7 m-85 -54.62 -55.61 27.72 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 177.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.908 ' HB3' HD12 ' A' ' 27' ' ' LEU . 78.7 p -77.59 -20.25 54.3 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 52' ' ' SER . 96.5 mttt 72.97 -56.5 0.66 Allowed 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.638 0.775 . . . . 0.0 110.529 -173.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -106.63 90.55 3.36 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.859 177.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.486 ' HB2' ' HA ' ' A' ' 49' ' ' GLU . 58.4 t80 -106.04 117.03 32.97 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.476 -178.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.555 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 87.7 m-85 -108.13 108.07 18.98 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 176.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -125.15 164.51 18.7 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 119.854 -1.165 . . . . 0.0 113.508 -173.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.522 HG23 ' HA ' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -136.12 -174.42 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.115 -0.542 . . . . 0.0 109.914 175.096 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.685 ' CE1' ' HA ' ' A' ' 68' ' ' LYS . 7.0 t60 -94.12 125.52 38.8 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.619 -171.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -98.47 -53.58 1.22 Allowed Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.792 -0.718 . . . . 0.0 113.316 -174.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -110.07 -154.01 0.53 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -176.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 70.3 mtm -71.66 -43.56 65.83 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 164.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 60.45 -173.15 0.12 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 114.537 -1.211 . . . . 0.0 111.515 175.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -92.2 155.19 42.97 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.365 177.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -52.54 -31.94 51.29 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 123.285 2.656 . . . . 0.0 112.999 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.496 ' HB3' HD22 ' A' ' 42' ' ' LEU . 29.2 m-20 -66.62 -42.57 86.58 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.32 0.581 . . . . 0.0 110.371 178.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 42.8 t -72.97 -27.01 23.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.754 177.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.685 ' HA ' ' CE1' ' A' ' 59' ' ' HIS . 88.4 tttt -62.54 -28.4 69.83 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.712 177.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -94.36 -44.87 7.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.375 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -72.32 -30.7 65.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.061 -174.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 58.5 mt -117.56 103.92 50.29 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 177.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -63.65 157.0 53.92 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 123.308 2.672 . . . . 0.0 112.526 -177.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -66.85 -40.32 87.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.618 -177.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.1 m -145.43 130.13 18.05 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.217 177.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.401 ' HG2' ' N ' ' A' ' 76' ' ' VAL . 53.7 tttp -129.66 159.56 36.05 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 12.5 t -134.34 120.41 33.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 177.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.456 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 96.1 mt -98.7 140.89 32.24 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.933 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 51.0 tp -111.62 94.97 5.22 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 173.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 46.4 t -115.26 107.05 21.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.407 -174.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 58.54 31.73 21.36 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.985 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.59 -10.66 70.74 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.582 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.4 t -88.14 125.48 41.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.939 0.4 . . . . 0.0 111.045 -178.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 50.6 p -88.19 125.27 34.53 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.269 176.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.505 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 29.2 mt -116.21 103.98 15.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -83.97 114.17 3.85 Favored Glycine 0 C--O 1.223 -0.563 0 N-CA-C 111.307 -0.717 . . . . 0.0 111.307 177.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.442 ' SD ' ' HG ' ' A' ' 77' ' ' LEU . 21.4 mtp -107.09 118.43 36.68 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.575 0.187 . . . . 0.0 110.897 -174.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 113' ' ' PHE . 11.6 t -148.1 165.08 31.92 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.434 ' HB3' ' O ' ' A' ' 59' ' ' HIS . 3.3 t-160 -156.16 109.51 2.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.618 0.246 . . . . 0.0 110.359 -178.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 152.18 -173.96 31.24 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.363 -0.922 . . . . 0.0 112.336 176.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 6.5 m0 66.59 -173.46 0.19 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.45 0.643 . . . . 0.0 112.168 177.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -170.85 177.63 43.78 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.673 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.486 ' HB1' ' CD1' ' A' ' 94' ' ' TRP . . . 62.59 96.3 0.05 OUTLIER Pre-proline 0 N--CA 1.464 0.262 0 CA-C-O 121.396 0.617 . . . . 0.0 110.65 -175.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.483 ' HA ' ' HB3' ' A' ' 96' ' ' LEU . 7.5 Cg_exo -73.2 7.66 2.05 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 123.375 2.717 . . . . 0.0 113.666 -172.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.486 ' CD1' ' HB1' ' A' ' 92' ' ' ALA . 52.5 m95 -59.31 -54.57 45.25 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.132 0.491 . . . . 0.0 110.544 -178.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -117.44 7.64 12.81 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.321 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.483 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . 29.5 tp -60.85 -46.72 89.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.739 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.527 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 58.7 mttp -58.49 -44.48 89.4 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.174 0.512 . . . . 0.0 110.254 179.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.4 ' HA ' HD12 ' A' ' 101' ' ' LEU . 7.7 m-20 -70.64 -30.65 67.34 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.051 -177.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 25.8 ttm180 -71.74 -40.89 69.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.462 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.495 HD13 HG21 ' A' ' 111' ' ' ILE . 66.7 mt -67.9 -27.34 66.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.803 178.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' A' ' 97' ' ' LYS . 96.6 mt -70.08 -24.29 63.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.038 0.446 . . . . 0.0 110.742 175.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -77.32 -30.61 54.15 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.9 t -76.17 -49.29 25.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.955 174.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -99.67 85.96 3.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.054 177.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -76.79 -2.56 33.8 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.919 -173.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -79.93 -13.14 59.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.357 174.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 14.7 ttpp 57.15 83.2 0.23 Allowed Pre-proline 0 C--O 1.235 0.319 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.728 -171.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.21 174.6 10.49 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.503 2.135 . . . . 0.0 112.715 -174.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -89.63 -49.06 6.88 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.524 177.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.513 HG21 HG11 ' A' ' 150' ' ' VAL . 66.7 t -121.75 131.77 72.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.718 -177.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.495 HG21 HD13 ' A' ' 100' ' ' LEU . 53.2 mt -122.81 125.12 71.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.954 0.407 . . . . 0.0 110.455 174.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 85.7 mt -101.91 115.66 31.02 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.71 177.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.508 ' CZ ' ' HB2' ' A' ' 131' ' ' ASN . 18.2 p90 -127.4 134.75 49.88 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 175.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -105.92 114.87 4.63 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 119.997 -1.097 . . . . 0.0 112.249 -177.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 53.9 t60 -145.16 105.95 4.13 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 176.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 88.0 m -52.7 113.37 1.06 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.974 -177.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 14.3 t-80 -171.25 -79.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.299 177.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.449 ' HA ' ' HD3' ' A' ' 119' ' ' PRO . 50.3 mt-10 -147.69 142.32 16.58 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.24 178.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.654 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 5.6 Cg_exo -78.05 126.72 8.04 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.706 2.27 . . . . 0.0 111.058 172.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -154.6 148.44 25.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.872 0.368 . . . . 0.0 111.299 -179.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -99.66 121.28 41.0 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.723 175.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.541 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 73.3 p -129.01 149.98 50.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.839 0.352 . . . . 0.0 111.879 -173.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.6 p -147.64 149.33 15.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.077 177.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -163.23 -55.56 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.627 0.727 . . . . 0.0 110.309 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.527 ' CB ' HD11 ' A' ' 101' ' ' LEU . . . -93.83 23.58 4.72 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.316 -173.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 74.96 1.07 61.73 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 -173.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 21.9 t -106.12 139.83 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 177.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 51.6 ttt180 -96.31 110.4 22.73 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.062 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.541 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 78.1 m-85 -95.66 117.43 30.47 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.705 -178.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 78.7 mt -113.0 116.26 29.67 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.437 -176.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.654 ' O ' ' HA ' ' A' ' 119' ' ' PRO . 9.1 t30 -109.14 107.82 60.06 Favored Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 172.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -83.11 -173.38 1.66 Allowed 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 123.171 2.581 . . . . 0.0 112.817 -176.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -85.32 161.28 35.51 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.592 -178.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.459 ' HB2' ' HG2' ' A' ' 137' ' ' GLU . 18.1 m -97.37 159.72 14.75 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.703 0.287 . . . . 0.0 110.559 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.76 HD11 ' HB2' ' A' ' 10' ' ' SER . 12.3 mt -61.5 -49.35 77.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.68 -172.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -66.81 -17.08 64.7 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.419 -177.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.459 ' HG2' ' HB2' ' A' ' 134' ' ' SER . 8.2 mm-40 -86.22 -1.36 57.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.724 -178.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 70.8 29.48 69.33 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.466 177.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 22.2 t -138.28 122.01 17.54 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.022 0.439 . . . . 0.0 110.792 -177.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.565 ' CE2' HD22 ' A' ' 135' ' ' LEU . 22.6 m-85 -116.47 177.94 4.51 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.384 175.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.408 ' HB3' ' HB3' ' A' ' 6' ' ' LEU . . . -126.76 132.83 50.98 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.985 0.422 . . . . 0.0 111.198 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 58.9 t -113.54 119.13 60.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 174.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.477 ' HA ' ' O ' ' A' ' 151' ' ' ARG . 3.3 tt -95.9 116.08 28.39 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.772 ' HB2' ' HB2' ' A' ' 151' ' ' ARG . 56.6 mt-10 -100.89 139.87 35.98 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.906 -177.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 47.7 mt -110.57 90.14 3.24 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 166.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -104.93 113.2 26.66 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.293 -176.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.92 -67.51 0.32 Allowed Glycine 0 CA--C 1.52 0.348 0 O-C-N 123.527 0.517 . . . . 0.0 112.288 -174.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -174.77 25.52 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 178.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -110.41 133.81 52.92 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 -177.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.513 HG11 HG21 ' A' ' 110' ' ' VAL . 21.5 t -79.64 103.52 6.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 176.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.772 ' HB2' ' HB2' ' A' ' 144' ' ' GLU . 56.6 mtt180 -110.02 148.03 32.44 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.084 -174.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -143.01 123.3 13.8 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.556 175.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -119.02 132.27 56.04 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.846 0.355 . . . . 0.0 110.334 178.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -76.01 113.63 13.74 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.455 176.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -96.38 119.04 34.14 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.248 -177.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.4 m -93.21 147.21 23.09 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.853 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 10.2 mp . . . . . 0 C--O 1.247 0.957 0 CA-C-O 118.827 -0.606 . . . . 0.0 110.623 -177.716 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 31.4 t . . . . . 0 N--CA 1.476 0.847 0 CA-C-O 121.033 0.444 . . . . 0.0 110.081 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.461 ' HD2' HG13 ' A' ' 79' ' ' VAL . 50.0 mttp -92.03 129.61 37.95 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.084 0.469 . . . . 0.0 110.882 177.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 56.1 mtt180 -107.66 112.32 24.97 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.62 176.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.627 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 53.7 m-85 -101.79 129.49 48.0 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.442 0.639 . . . . 0.0 111.518 -175.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.556 ' HB3' HG22 ' A' ' 33' ' ' VAL . 27.3 tp -89.18 114.76 26.1 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.094 174.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.623 HD11 ' HG ' ' A' ' 36' ' ' LEU . 45.0 tp -100.4 111.9 24.2 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.93 0.395 . . . . 0.0 110.668 -177.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.485 HG13 ' HA2' ' A' ' 35' ' ' GLY . 23.9 pt -100.98 120.12 50.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 176.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.772 ' HB2' ' HA ' ' A' ' 134' ' ' SER . 13.2 m -75.87 -169.04 1.0 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.799 -172.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.776 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 11.2 t70 -59.42 98.6 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.293 -179.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.0 m -109.26 128.46 55.09 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.852 -175.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.72 ' HB3' ' HB ' ' A' ' 14' ' ' VAL . 24.3 m170 -102.26 76.0 1.54 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.421 0.629 . . . . 0.0 109.696 179.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.493 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -135.74 127.14 17.27 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.1 -179.091 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 34.9 Cg_endo -93.19 91.68 0.14 OUTLIER 'Cis proline' 0 N--CA 1.45 -1.055 0 C-N-CA 123.013 -1.661 . . . . 0.0 113.049 -2.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.72 ' HB ' ' HB3' ' A' ' 11' ' ' HIS . 3.0 t -120.27 -170.1 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 173.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.694 ' H ' HG12 ' A' ' 14' ' ' VAL . 55.2 mtt180 -68.73 83.94 0.3 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 118.91 0.777 . . . . 0.0 111.099 177.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 39.9 ttp -165.13 -71.5 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.658 -1.155 . . . . 0.0 108.444 177.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 58.94 9.06 1.1 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.671 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.0 m -76.54 15.82 0.57 Allowed 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 112.432 0.531 . . . . 0.0 112.432 -176.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.1 tt -107.64 102.18 43.53 Favored Pre-proline 0 C--N 1.323 -0.568 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -88.92 167.22 5.73 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.905 2.403 . . . . 0.0 113.548 -175.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -60.59 -23.58 64.78 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.242 178.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -62.07 -13.26 24.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.368 -176.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 tt -102.03 -33.4 3.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.298 0.57 . . . . 0.0 109.869 174.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.657 ' HA ' HD23 ' A' ' 27' ' ' LEU . 47.1 tp -72.13 -30.78 65.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.814 -176.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -66.48 -28.9 68.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.195 0.522 . . . . 0.0 110.338 177.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.9 m -72.96 -8.28 54.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.518 -176.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.757 HD13 HG21 ' A' ' 33' ' ' VAL . 4.3 mm? -58.87 -27.69 65.41 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.012 0.434 . . . . 0.0 110.959 176.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -85.31 -7.88 58.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.848 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -98.58 -39.96 8.45 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.208 -176.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.49 ' CD2' ' HB2' ' A' ' 5' ' ' LEU . 89.0 m-85 -86.98 147.12 25.88 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -92.13 -18.31 23.71 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.886 0.374 . . . . 0.0 110.435 -179.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.627 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -135.92 143.25 14.69 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 175.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.757 HG21 HD13 ' A' ' 27' ' ' LEU . 64.3 t -136.3 137.36 48.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 117.093 0.447 . . . . 0.0 110.485 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.567 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 39.0 mt -121.91 129.24 75.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.843 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.485 ' HA2' HG13 ' A' ' 7' ' ' ILE . . . -112.07 102.26 1.35 Allowed Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.918 177.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.623 ' HG ' HD11 ' A' ' 6' ' ' LEU . 85.8 mt -80.31 -32.61 37.98 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 176.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.776 ' HA3' ' HA ' ' A' ' 9' ' ' ASP . . . -138.16 62.78 0.57 Allowed Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 175.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -70.5 -172.5 0.61 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.024 0.44 . . . . 0.0 111.476 -175.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.578 ' HD1' HD11 ' A' ' 48' ' ' LEU . 81.2 m-85 -58.76 142.18 50.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.095 -177.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.585 ' HB ' ' HB3' ' A' ' 63' ' ' ASP . 15.7 m -85.59 16.14 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.318 0.58 . . . . 0.0 110.816 -176.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.461 ' O ' HG23 ' A' ' 45' ' ' VAL . 12.5 t70 -119.94 124.81 46.9 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.463 -178.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 53.2 tp -61.34 -39.49 90.77 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.079 -174.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -61.08 -42.46 98.55 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.119 0.485 . . . . 0.0 110.588 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.516 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 16.7 m -68.6 -29.43 67.95 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.118 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.564 HG21 HG13 ' A' ' 67' ' ' VAL . 65.5 t -59.25 -43.46 89.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 121.24 0.543 . . . . 0.0 109.965 174.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.497 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 1.7 mp -63.47 -38.74 83.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.027 176.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.23 -33.59 76.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.529 175.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.578 HD11 ' HD1' ' A' ' 39' ' ' TYR . 92.7 mt -67.97 -32.35 72.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.113 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -79.21 -16.28 56.76 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.195 177.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.497 ' HG3' ' O ' ' A' ' 46' ' ' ILE . 53.9 mtpt -76.61 -54.24 6.94 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 174.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.53 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . 62.9 m-85 -65.45 -63.8 1.01 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.716 176.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.535 ' HB2' HD12 ' A' ' 27' ' ' LEU . 41.6 t -84.25 96.56 9.03 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.725 175.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 53.0 mttp -64.01 -35.04 79.43 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.192 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -105.45 75.52 1.15 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.33 0.586 . . . . 0.0 109.704 171.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -101.58 125.18 48.19 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.462 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.567 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 91.3 m-85 -121.81 143.98 49.09 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 176.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.517 ' HA3' HD13 ' A' ' 71' ' ' LEU . . . -159.22 164.83 34.07 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 119.444 -1.36 . . . . 0.0 113.506 -176.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 72' ' ' PRO . 2.3 m -138.0 97.75 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.344 0.592 . . . . 0.0 109.447 176.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.543 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 11.9 t60 -94.38 146.97 23.68 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.377 -167.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -87.49 -163.22 38.76 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.179 179.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.555 ' HB3' ' HD2' ' A' ' 68' ' ' LYS . 2.0 p-10 -124.65 31.72 5.63 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.956 0.407 . . . . 0.0 110.973 -177.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 2.8 mpp? -76.12 -32.25 59.07 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.286 0.565 . . . . 0.0 109.824 178.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.585 ' HB3' ' HB ' ' A' ' 40' ' ' VAL . 3.8 p-10 -104.81 -111.14 0.26 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.759 -177.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.418 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 38.3 m-85 -104.36 135.72 19.29 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.71 0.291 . . . . 0.0 110.78 -174.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 64' ' ' TYR . 31.8 Cg_exo -59.01 -28.2 87.2 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.695 2.264 . . . . 0.0 111.902 178.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -55.77 -38.95 70.55 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.227 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.564 HG13 HG21 ' A' ' 45' ' ' VAL . 16.7 t -76.41 -33.38 23.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.531 -178.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.555 ' HD2' ' HB3' ' A' ' 61' ' ' ASN . 86.3 tttt -73.17 -25.41 60.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.107 0.48 . . . . 0.0 110.374 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -78.28 -19.73 53.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.016 0.436 . . . . 0.0 109.98 173.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 9.3 m80 -84.2 -51.4 7.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.189 176.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.543 ' HB2' ' HB2' ' A' ' 59' ' ' HIS . 11.3 mt -107.5 108.41 61.64 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 176.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.412 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 52.8 Cg_exo -54.76 153.85 22.97 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.758 2.305 . . . . 0.0 112.38 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -70.46 -18.48 62.99 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.12 0.486 . . . . 0.0 110.761 -177.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 51.1 m -150.84 131.27 13.77 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.133 178.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 44.7 tttp -149.45 133.15 16.85 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.373 -178.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 19.7 t -106.43 123.69 61.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 178.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 64.6 mt -102.02 157.22 17.02 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.545 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 60.3 tp -123.43 100.73 6.97 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 175.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.461 HG13 ' HD2' ' A' ' 2' ' ' LYS . 61.6 t -113.4 102.85 14.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.663 -176.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 51.63 42.22 29.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.68 176.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.97 0.15 64.0 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.754 -0.657 . . . . 0.0 113.215 175.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 96.0 t -105.94 129.78 58.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.751 0.31 . . . . 0.0 110.972 178.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.2 p -91.47 123.87 35.21 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.701 176.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.483 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 25.2 mt -116.92 98.28 6.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.451 -176.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.416 ' O ' HG23 ' A' ' 111' ' ' ILE . . . -85.61 98.85 2.31 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.338 178.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 35.8 mtm -90.75 131.81 36.21 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -178.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 34.7 t -149.65 165.07 33.44 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -125.72 29.19 6.01 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -66.9 167.5 38.43 Favored Glycine 0 N--CA 1.451 -0.321 0 CA-C-N 115.341 -0.845 . . . . 0.0 113.576 -175.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 54.3 p-90 -126.27 166.01 17.91 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.814 0.34 . . . . 0.0 110.573 -177.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 127.85 170.64 12.87 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.084 -0.579 . . . . 0.0 111.949 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -89.08 164.86 29.27 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 177.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_exo -53.2 -21.12 16.09 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.995 2.463 . . . . 0.0 113.268 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 11.7 m95 -70.66 -34.05 71.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.886 0.374 . . . . 0.0 110.379 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -101.31 -27.38 13.21 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.556 -178.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 37.4 tp -50.65 -57.29 8.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.175 -173.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -62.12 -44.1 97.39 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.075 -177.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -71.9 -14.76 62.03 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.338 -177.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.415 ' O ' HG23 ' A' ' 103' ' ' VAL . 29.0 ttt85 -95.33 -49.95 5.23 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.538 -178.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.519 HD13 HG21 ' A' ' 111' ' ' ILE . 79.6 mt -70.3 -34.5 72.81 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.62 -176.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.611 HD21 HG21 ' A' ' 127' ' ' VAL . 96.2 mt -75.24 -9.89 58.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.172 0.511 . . . . 0.0 110.411 177.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -91.34 -40.17 11.62 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.854 175.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 99' ' ' ARG . 94.8 t -64.23 -48.12 86.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.108 175.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -87.2 122.89 31.61 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.844 176.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -75.97 -30.83 58.75 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.138 0.494 . . . . 0.0 110.158 -178.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -93.67 179.77 5.26 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.622 175.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -109.35 106.25 58.35 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-O 120.956 0.407 . . . . 0.0 110.917 -178.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -76.51 131.52 12.67 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 123.103 2.535 . . . . 0.0 111.619 178.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -67.84 -40.32 83.74 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.266 178.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.88 HG21 HG21 ' A' ' 150' ' ' VAL . 89.3 t -126.02 135.96 62.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.179 179.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.519 HG21 HD13 ' A' ' 100' ' ' LEU . 44.3 mt -125.48 125.48 68.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.894 0.378 . . . . 0.0 110.406 176.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.699 HD23 ' HB2' ' A' ' 130' ' ' LEU . 95.6 mt -104.05 127.94 51.63 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.075 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -155.6 175.64 13.64 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.613 177.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -145.53 114.72 0.78 Allowed Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.731 178.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -165.72 -57.3 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.775 0.321 . . . . 0.0 110.924 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.6 p -82.88 -23.13 33.76 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -177.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 61.97 85.42 0.12 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 122.728 0.411 . . . . 0.0 110.559 -179.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -127.14 94.69 38.39 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.215 -178.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -68.4 67.23 1.08 Allowed 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.612 2.208 . . . . 0.0 111.793 178.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -161.92 153.59 18.77 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.484 -174.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -78.13 95.01 4.8 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 170.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.5 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 51.2 p -92.17 114.42 26.95 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.51 0.671 . . . . 0.0 110.984 -169.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.2 p -98.96 95.84 4.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-O 121.946 0.879 . . . . 0.0 110.253 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.654 ' HB2' ' CE1' ' A' ' 129' ' ' PHE . 60.8 mttp -110.81 119.01 37.71 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.517 -178.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 64.32 23.26 13.0 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.009 0.433 . . . . 0.0 111.529 178.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 94.64 -12.98 68.06 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.607 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.611 HG21 HD21 ' A' ' 101' ' ' LEU . 43.2 t -93.6 137.9 21.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.662 0.268 . . . . 0.0 110.41 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -91.79 99.44 12.32 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.239 0.542 . . . . 0.0 110.118 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.654 ' CE1' ' HB2' ' A' ' 124' ' ' LYS . 91.1 m-85 -90.83 136.46 33.05 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.156 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.699 ' HB2' HD23 ' A' ' 112' ' ' LEU . 85.4 mt -122.84 109.02 13.66 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.269 0.557 . . . . 0.0 109.849 177.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 -131.33 103.15 15.23 Favored Pre-proline 0 C--N 1.318 -0.764 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.875 177.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -91.45 -177.66 1.05 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.753 2.302 . . . . 0.0 113.906 -170.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -73.98 149.2 40.79 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 173.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.772 ' HA ' ' HB2' ' A' ' 8' ' ' SER . 22.3 m -91.89 170.47 9.84 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 120.963 0.411 . . . . 0.0 111.449 -175.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -60.41 -29.84 69.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.906 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -67.81 -22.81 65.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.022 178.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -94.52 -6.07 44.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.467 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 79.98 39.6 16.25 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.964 -0.562 . . . . 0.0 113.155 176.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 64.5 m -153.73 156.22 37.39 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.714 0.293 . . . . 0.0 110.748 178.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -144.14 168.87 19.0 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 174.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.468 ' HB3' HD23 ' A' ' 6' ' ' LEU . . . -114.58 140.86 48.44 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.045 0.45 . . . . 0.0 111.379 -174.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 40.1 t -112.21 123.75 68.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 173.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.734 HD21 HG13 ' A' ' 150' ' ' VAL . 2.6 tt -107.9 104.76 14.31 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -104.74 113.79 27.59 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.536 -178.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.433 ' O ' ' HA ' ' A' ' 1' ' ' VAL . 4.2 mp -97.1 93.55 6.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.066 0.46 . . . . 0.0 110.454 176.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.535 ' HB3' ' NH1' ' A' ' 151' ' ' ARG . 17.0 t70 -87.72 123.12 32.21 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 175.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 68.14 -62.93 0.38 Allowed Glycine 0 CA--C 1.523 0.534 0 O-C-N 123.403 0.439 . . . . 0.0 112.441 -172.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 171.24 34.5 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.534 -0.626 . . . . 0.0 111.534 177.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -121.96 140.33 52.58 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.88 HG21 HG21 ' A' ' 110' ' ' VAL . 90.6 t -80.97 115.44 23.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.595 -175.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.535 ' NH1' ' HB3' ' A' ' 146' ' ' ASP . 78.9 mtt85 -107.82 101.81 11.07 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.92 173.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -90.11 103.65 16.3 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.996 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -120.57 119.35 32.67 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.117 0.484 . . . . 0.0 110.48 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 24.8 tp -88.98 130.82 35.39 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.093 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -121.94 139.62 53.44 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.04 0.448 . . . . 0.0 110.566 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 9.5 p -84.23 162.85 20.02 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.797 -178.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 75.5 mt . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.529 -0.748 . . . . 0.0 109.865 175.571 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 72.3 t . . . . . 0 N--CA 1.482 1.157 0 CA-C-O 120.746 0.307 . . . . 0.0 111.131 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 43.9 mttm -102.3 159.46 15.39 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.353 171.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.489 ' HG2' ' HG3' ' A' ' 144' ' ' GLU . 49.9 mtm-85 -127.15 124.82 39.96 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.702 178.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 95.4 m-85 -108.18 128.04 54.35 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.226 176.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.552 ' HB3' HG22 ' A' ' 33' ' ' VAL . 48.5 tp -89.31 112.1 23.1 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.577 -176.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.458 HD11 ' HG ' ' A' ' 36' ' ' LEU . 60.4 tp -97.64 110.03 22.67 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.037 0.446 . . . . 0.0 110.518 -179.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.45 HG13 ' HA2' ' A' ' 35' ' ' GLY . 33.2 pt -101.33 134.74 40.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 176.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.6 m -77.05 -167.6 0.91 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.927 -173.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -53.92 117.19 3.0 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.264 178.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.843 ' H ' ' HA3' ' A' ' 37' ' ' GLY . 20.1 m -115.48 127.7 55.5 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.497 -178.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 62.0 m170 -116.39 44.47 1.98 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 175.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.715 HG21 ' HB2' ' A' ' 19' ' ' LEU . 56.1 t -113.12 129.78 24.21 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.871 -175.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 59.3 Cg_endo -103.13 94.43 0.12 OUTLIER 'Cis proline' 0 N--CA 1.449 -1.094 0 C-N-CA 123.574 -1.428 . . . . 0.0 112.61 -7.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.606 HG12 ' HG3' ' A' ' 15' ' ' ARG . 14.6 t -100.23 -77.82 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 175.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.606 ' HG3' HG12 ' A' ' 14' ' ' VAL . 60.6 mtt180 -130.77 15.73 5.31 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.432 ' HG2' ' H ' ' A' ' 18' ' ' SER . 37.1 ttp -143.13 130.07 20.58 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.828 -177.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -122.27 12.08 10.17 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.142 0.496 . . . . 0.0 110.372 178.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.432 ' H ' ' HG2' ' A' ' 16' ' ' MET . 3.9 m -78.73 41.22 0.41 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.978 -176.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.715 ' HB2' HG21 ' A' ' 12' ' ' VAL . 4.5 tt -107.65 106.69 59.06 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.451 ' HD2' ' OH ' ' A' ' 140' ' ' TYR . 51.4 Cg_exo -56.33 122.74 12.31 Favored 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 122.905 2.404 . . . . 0.0 112.515 178.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -73.9 -10.79 60.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.184 -176.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -55.2 -52.01 64.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.357 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.5 tt -69.4 -27.06 32.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.212 0.529 . . . . 0.0 110.446 -177.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.422 ' O ' HD23 ' A' ' 27' ' ' LEU . 52.3 tp -70.37 -16.43 62.97 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.619 178.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -89.59 -25.36 21.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.989 178.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.0 p -83.61 24.31 0.87 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.834 0.349 . . . . 0.0 111.913 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.462 ' CD1' HG21 ' A' ' 33' ' ' VAL . 3.0 mm? -69.58 -8.57 48.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.855 0.359 . . . . 0.0 111.493 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -98.83 -13.13 20.24 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.26 0.552 . . . . 0.0 110.284 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -92.51 -11.32 34.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.185 -175.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -109.46 161.9 14.87 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.799 0.333 . . . . 0.0 110.737 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -86.58 -50.25 6.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.408 0.623 . . . . 0.0 109.894 179.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -139.5 156.55 24.71 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.115 178.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.552 HG22 ' HB3' ' A' ' 5' ' ' LEU . 84.0 t -125.25 137.94 55.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 120.745 0.307 . . . . 0.0 110.412 -179.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.526 HG12 ' HB2' ' A' ' 56' ' ' TYR . 34.0 mt -114.59 126.3 72.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.886 177.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.45 ' HA2' HG13 ' A' ' 7' ' ' ILE . . . -112.49 107.02 1.97 Allowed Glycine 0 N--CA 1.439 -1.132 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.345 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.458 ' HG ' HD11 ' A' ' 6' ' ' LEU . 89.5 mt -73.96 -24.48 59.63 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 171.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.843 ' HA3' ' H ' ' A' ' 10' ' ' SER . . . -140.25 132.59 5.57 Favored Glycine 0 N--CA 1.438 -1.17 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 170.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.522 ' OD2' HG11 ' A' ' 67' ' ' VAL . 18.2 p-10 -112.95 -173.34 2.23 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.311 0.577 . . . . 0.0 111.429 -172.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -84.24 116.7 23.1 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 172.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.85 ' HB ' ' HD2' ' A' ' 64' ' ' TYR . 35.4 m -64.96 -5.87 2.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -168.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.459 ' O ' HG23 ' A' ' 45' ' ' VAL . 19.7 t70 -86.7 120.51 28.07 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 177.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 45.3 tp -56.73 -46.18 81.47 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -172.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -66.34 -33.98 76.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.911 0.386 . . . . 0.0 110.603 -178.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.597 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 30.5 m -67.71 -29.23 68.43 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.658 176.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 41' ' ' ASP . 74.7 t -62.95 -41.82 94.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 121.058 0.456 . . . . 0.0 110.153 175.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.02 -36.06 76.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.808 175.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.56 -29.8 69.28 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.776 175.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.597 ' HG ' ' O ' ' A' ' 44' ' ' THR . 92.0 mt -65.28 -34.54 78.58 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 176.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.414 ' HA ' ' O ' ' A' ' 52' ' ' SER . 36.9 tt0 -76.24 -21.91 55.79 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.958 175.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -72.87 -35.87 67.25 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.749 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.462 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . 70.3 m-85 -81.56 -67.05 0.81 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.18 172.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 49' ' ' GLU . 38.2 t -86.2 96.05 9.79 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.717 176.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.69 ' H ' ' HD2' ' A' ' 53' ' ' LYS . 8.7 mptt -60.18 -31.26 69.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.681 -177.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -110.62 82.85 1.66 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.419 0.628 . . . . 0.0 109.974 169.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -100.48 112.55 24.92 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.966 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.526 ' HB2' HG12 ' A' ' 34' ' ' ILE . 33.5 m-85 -96.55 133.03 41.54 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 177.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -144.76 158.44 27.58 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 119.556 -1.307 . . . . 0.0 112.972 -177.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -136.26 155.2 34.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 122.756 0.422 . . . . 0.0 109.986 175.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.861 ' CE1' ' HB ' ' A' ' 67' ' ' VAL . 0.2 OUTLIER -128.22 171.57 11.83 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -174.317 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 121.94 39.66 0.55 Allowed Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.796 173.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -122.04 -86.92 0.65 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 117.455 0.628 . . . . 0.0 110.992 177.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 67.8 mtt -135.69 31.68 3.06 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.42 ' HB2' ' CE1' ' A' ' 59' ' ' HIS . 1.3 p30 -93.17 -178.32 4.74 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.299 -1.318 . . . . 0.0 112.212 -171.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.85 ' HD2' ' HB ' ' A' ' 40' ' ' VAL . 80.2 m-85 -94.3 138.21 22.54 Favored Pre-proline 0 C--O 1.232 0.182 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.477 176.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 64' ' ' TYR . 21.1 Cg_exo -67.4 -9.15 24.32 Favored 'Trans proline' 0 N--CA 1.474 0.368 0 C-N-CA 123.562 2.842 . . . . 0.0 113.913 -175.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -70.97 -42.38 69.79 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.12 0.486 . . . . 0.0 110.785 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.861 ' HB ' ' CE1' ' A' ' 59' ' ' HIS . 65.4 t -68.71 -11.04 14.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.617 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.48 ' HB3' ' NZ ' ' A' ' 68' ' ' LYS . 5.1 ttpm? -56.88 -30.7 64.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.885 176.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -70.08 -17.55 63.23 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.049 0.452 . . . . 0.0 110.836 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -105.81 -50.63 3.15 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.901 -178.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.6 ' HG ' HG12 ' A' ' 67' ' ' VAL . 4.4 mt -107.98 112.01 61.87 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.397 -178.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -74.08 170.95 18.95 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.768 2.312 . . . . 0.0 111.648 178.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -74.82 -21.11 59.47 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.244 0.545 . . . . 0.0 109.83 178.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.428 ' HA ' ' O ' ' A' ' 86' ' ' MET . 55.1 m -150.63 124.69 9.33 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.022 175.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 42.3 tttp -132.86 129.48 38.5 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.736 -179.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 17.3 t -106.35 122.92 60.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 120.961 0.41 . . . . 0.0 110.221 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.542 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 59.7 mt -99.32 152.51 19.85 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.215 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 47.0 tp -124.63 97.39 5.27 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 174.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 37.6 t -112.8 104.94 17.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.439 -175.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 54.11 43.25 30.97 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.234 178.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.81 -25.73 23.71 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.904 177.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 63.6 t -81.03 129.95 36.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.816 0.341 . . . . 0.0 111.204 -176.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 28.2 p -91.76 129.53 37.71 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.439 177.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.542 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 34.6 mt -124.09 99.22 6.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.88 0.372 . . . . 0.0 110.178 -177.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -87.59 102.05 2.76 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.405 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.525 ' HG2' HD12 ' A' ' 112' ' ' LEU . 22.8 mtm -94.96 127.08 40.74 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 113' ' ' PHE . 42.4 t -141.73 154.72 45.47 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 16.1 p80 -63.46 -26.51 68.76 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 175.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.595 ' HA3' ' HB2' ' A' ' 113' ' ' PHE . . . 57.62 59.69 10.37 Favored Glycine 0 C--N 1.335 0.487 0 CA-C-N 115.965 -0.561 . . . . 0.0 114.432 170.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 81.3 t90 -97.48 127.56 43.54 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 174.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 163.99 -177.27 39.83 Favored Glycine 0 N--CA 1.444 -0.779 0 N-CA-C 111.301 -0.719 . . . . 0.0 111.301 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.54 139.21 44.24 Favored Pre-proline 0 C--N 1.32 -0.693 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 178.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -62.63 -25.83 75.46 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.935 2.423 . . . . 0.0 113.208 -175.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -67.22 -47.2 71.53 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.947 0.404 . . . . 0.0 110.616 -175.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -101.74 9.03 41.28 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.785 -177.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 26.8 tp -60.08 -47.53 85.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.535 -173.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -63.85 -45.48 89.28 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.178 0.513 . . . . 0.0 110.365 -177.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -65.55 -36.65 84.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.909 179.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.514 ' O ' HG23 ' A' ' 103' ' ' VAL . 21.3 ttt180 -67.96 -49.25 62.85 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.254 179.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.655 HD23 HG21 ' A' ' 111' ' ' ILE . 7.6 mp -62.8 -35.45 79.92 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.544 0.202 . . . . 0.0 111.544 -176.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.773 HD21 HG21 ' A' ' 127' ' ' VAL . 84.5 mt -71.77 -16.35 62.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.026 0.441 . . . . 0.0 110.659 176.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 48.5 tttp -96.26 -17.15 20.95 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.354 178.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 99' ' ' ARG . 92.0 t -74.43 -45.86 44.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.11 0.481 . . . . 0.0 109.75 175.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -80.82 155.45 26.61 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.44 176.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -84.0 -22.49 31.35 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.245 0.545 . . . . 0.0 109.94 178.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 14.8 mp0 -105.11 -174.47 2.54 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.461 177.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 47.8 pttt -119.24 91.67 44.26 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-O 121.491 0.662 . . . . 0.0 109.504 172.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.07 154.48 67.06 Favored 'Trans proline' 0 N--CA 1.464 -0.224 0 C-N-CA 123.086 2.524 . . . . 0.0 112.63 -174.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -82.06 -46.34 14.03 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.959 177.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.7 t -116.87 133.32 63.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.903 176.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.655 HG21 HD23 ' A' ' 100' ' ' LEU . 56.0 mt -129.71 134.81 62.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.855 0.359 . . . . 0.0 110.765 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.664 HD23 ' HB2' ' A' ' 130' ' ' LEU . 86.5 mt -108.22 135.05 50.2 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.767 178.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.595 ' HB2' ' HA3' ' A' ' 89' ' ' GLY . 47.1 p90 -142.62 162.64 34.93 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.744 177.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.24 114.97 1.31 Allowed Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.331 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -169.06 -54.56 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.2 p -85.92 159.43 19.66 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.159 171.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 22.0 p-80 -123.99 21.14 9.06 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.174 0.511 . . . . 0.0 110.53 -178.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 11.2 mp0 -87.68 107.96 18.07 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.619 176.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 30.8 Cg_endo -64.66 95.67 0.23 Allowed 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.345 2.03 . . . . 0.0 111.814 -178.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -152.32 141.83 21.7 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.361 -176.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -95.16 123.15 38.5 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 171.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.641 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 73.2 p -112.23 144.97 40.75 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.273 -171.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 14.8 p -148.93 139.74 16.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.011 177.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -158.04 -48.55 0.06 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.13 0.491 . . . . 0.0 110.603 -178.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -97.0 24.43 6.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.395 -177.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 75.02 25.46 69.01 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.749 -0.738 . . . . 0.0 111.903 -175.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.773 HG21 HD21 ' A' ' 101' ' ' LEU . 52.8 t -132.78 137.02 54.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -100.0 104.97 16.6 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.109 0.48 . . . . 0.0 110.19 -177.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.641 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 60.0 m-85 -93.92 135.54 35.15 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.789 -179.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.664 ' HB2' HD23 ' A' ' 112' ' ' LEU . 86.9 mt -118.51 137.05 53.47 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.879 0.371 . . . . 0.0 111.326 -177.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.467 ' HA ' ' HD3' ' A' ' 132' ' ' PRO . 0.1 OUTLIER -150.32 125.64 4.86 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.23 173.388 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 131' ' ' ASN . 88.1 Cg_endo -101.86 -176.71 0.13 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 123.546 2.831 . . . . 0.0 112.56 175.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -81.58 171.14 52.65 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 174.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 75.6 p -85.38 173.9 9.95 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 117.515 0.658 . . . . 0.0 111.259 -177.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.604 HD13 ' HG ' ' A' ' 19' ' ' LEU . 21.2 mt -57.35 -49.54 75.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.718 -174.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -67.83 -10.91 56.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.03 -173.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -92.39 -3.79 54.77 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.981 0.419 . . . . 0.0 110.757 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.528 ' HA2' HD12 ' A' ' 157' ' ' LEU . . . 71.67 34.0 63.15 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.417 178.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 37.4 t -126.32 121.34 32.3 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.935 0.397 . . . . 0.0 110.539 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.451 ' OH ' ' HD2' ' A' ' 20' ' ' PRO . 86.5 m-85 -125.49 159.52 31.78 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.527 174.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.454 ' HB3' HD23 ' A' ' 6' ' ' LEU . . . -121.55 140.18 52.55 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.836 0.351 . . . . 0.0 110.137 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 62.1 t -122.68 121.55 63.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 175.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.818 HD21 HG13 ' A' ' 150' ' ' VAL . 3.5 tt -94.73 105.98 17.95 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.489 ' HG3' ' HG2' ' A' ' 3' ' ' ARG . 29.8 tt0 -102.94 145.55 29.67 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.457 -178.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.502 ' O ' ' HA ' ' A' ' 1' ' ' VAL . 58.7 mt -117.23 105.97 12.78 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.975 0.416 . . . . 0.0 111.214 -177.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -118.31 130.57 56.1 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.973 175.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.51 11.01 59.0 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.169 -177.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 84.24 6.62 86.08 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.096 -177.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -97.54 158.09 15.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.825 0.345 . . . . 0.0 110.663 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.818 HG13 HD21 ' A' ' 143' ' ' LEU . 51.7 t -87.52 109.94 20.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.798 -178.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 43.8 ttt180 -107.18 113.66 27.23 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.158 0.504 . . . . 0.0 110.549 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -84.26 108.67 17.26 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.022 177.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -106.65 105.45 15.49 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 23.6 tp -83.66 109.92 17.85 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 119.951 -0.7 . . . . 0.0 110.256 -177.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -88.78 118.88 28.79 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.512 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 21.4 p -111.64 148.46 33.32 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.437 -173.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.528 HD12 ' HA2' ' A' ' 138' ' ' GLY . 74.7 mt . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.576 -0.726 . . . . 0.0 109.644 178.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 84.4 t . . . . . 0 N--CA 1.481 1.119 0 CA-C-O 120.748 0.309 . . . . 0.0 110.517 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -129.87 125.25 35.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.766 174.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.544 ' HG3' ' HA ' ' A' ' 30' ' ' TYR . 0.1 OUTLIER -124.45 129.93 51.55 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.043 -175.765 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.495 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 16.6 m-85 -119.06 132.05 56.0 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.803 -179.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 28.2 tp -89.05 122.84 32.79 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.031 178.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.523 HD11 ' HG ' ' A' ' 36' ' ' LEU . 62.4 tp -104.7 111.79 24.64 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.039 0.447 . . . . 0.0 110.461 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.9 pt -101.16 138.62 24.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.785 176.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.5 m -77.34 -178.59 5.23 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.404 -175.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -63.84 104.61 0.71 Allowed 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.466 -176.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.8 m -95.45 83.99 3.92 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.833 -175.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 28.3 m80 -75.03 76.25 2.22 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 175.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.646 HG21 HD12 ' A' ' 19' ' ' LEU . 40.7 t -125.9 128.36 24.56 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.069 -177.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.414 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 58.2 Cg_endo -76.36 -61.58 0.05 OUTLIER 'Cis proline' 0 CA--C 1.529 0.264 0 C-N-CA 122.818 -1.742 . . . . 0.0 112.928 -1.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 53.4 t 56.81 -87.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 122.865 0.466 . . . . 0.0 111.612 179.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 81.6 mtt180 -139.8 6.63 2.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.941 0.4 . . . . 0.0 110.097 177.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 52.9 ttp -135.79 98.97 4.04 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.782 -173.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -99.66 -1.46 37.91 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.326 0.584 . . . . 0.0 110.354 177.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.0 m -82.72 58.98 4.52 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.403 -176.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.646 HD12 HG21 ' A' ' 12' ' ' VAL . 4.9 tt -107.66 109.75 62.47 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.728 ' HG2' HD13 ' A' ' 157' ' ' LEU . 31.3 Cg_exo -60.64 123.95 14.06 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 123.096 2.531 . . . . 0.0 112.585 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -62.53 -15.33 50.05 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.127 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -56.76 -33.99 67.14 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.379 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.6 tt -75.63 -32.89 25.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.374 0.606 . . . . 0.0 110.086 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.51 ' O ' HD23 ' A' ' 27' ' ' LEU . 45.7 tp -71.99 -17.37 62.06 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.292 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -91.52 -2.01 57.33 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.661 177.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 46.9 m -93.77 -0.7 55.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.662 -176.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.589 ' HG ' ' HB3' ' A' ' 51' ' ' PHE . 4.0 mm? -65.16 -10.34 30.3 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.0 0.429 . . . . 0.0 111.053 179.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.5 mttm -76.41 -30.86 57.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.149 -174.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -111.03 27.26 9.86 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -166.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.544 ' HA ' ' HG3' ' A' ' 3' ' ' ARG . 91.6 m-85 -136.22 152.09 50.39 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.778 178.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.415 ' OD2' ' HG2' ' A' ' 3' ' ' ARG . 10.1 m-20 -79.28 -43.98 22.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.573 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.495 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -138.98 164.19 25.83 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.098 178.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.58 HG21 ' CD1' ' A' ' 27' ' ' LEU . 98.7 t -134.11 137.96 51.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.049 0.452 . . . . 0.0 110.874 -177.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.7 mt -118.43 135.63 58.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.82 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.509 ' O ' ' HA2' ' A' ' 57' ' ' GLY . . . -124.21 123.37 5.13 Favored Glycine 0 N--CA 1.44 -1.04 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.031 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.523 ' HG ' HD11 ' A' ' 6' ' ' LEU . 98.7 mt -81.52 34.63 0.38 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.188 0.518 . . . . 0.0 109.87 177.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 118.7 103.85 2.14 Favored Glycine 0 N--CA 1.44 -1.063 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 -173.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.535 ' OD2' HG13 ' A' ' 45' ' ' VAL . 6.5 p-10 -97.88 -156.25 0.53 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.863 0.332 . . . . 0.0 110.488 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -58.5 153.75 15.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.262 0.553 . . . . 0.0 111.945 -173.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.514 HG22 ' O ' ' A' ' 12' ' ' VAL . 21.2 m -94.84 -1.79 10.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.098 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.641 ' O ' HG23 ' A' ' 45' ' ' VAL . 16.2 t70 -93.45 120.26 33.52 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 173.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.443 HD22 ' HB3' ' A' ' 66' ' ' ASP . 38.3 tp -57.98 -42.63 85.51 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 123.426 0.453 . . . . 0.0 111.888 -170.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -62.21 -44.82 95.73 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.727 0.299 . . . . 0.0 110.53 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.7 m -67.11 -28.8 68.46 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.091 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 41' ' ' ASP . 61.5 t -59.63 -50.39 80.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 121.371 0.605 . . . . 0.0 110.302 175.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.511 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 1.8 mp -68.64 -34.13 63.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.837 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -58.08 -39.11 77.74 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.427 174.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.57 -42.63 70.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.148 0.499 . . . . 0.0 109.777 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.0 tt0 -56.92 -40.26 76.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.754 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.511 ' HG3' ' O ' ' A' ' 46' ' ' ILE . 94.1 mttt -63.72 -45.81 88.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.962 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.589 ' HB3' ' HG ' ' A' ' 27' ' ' LEU . 17.9 m-85 -62.78 -42.75 99.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.834 0.35 . . . . 0.0 111.388 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.526 ' HB2' ' HB2' ' A' ' 55' ' ' PHE . 15.6 m -71.28 -28.11 63.9 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.313 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 68.4 mttm 71.49 -49.52 0.68 Allowed 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.855 0.862 . . . . 0.0 110.557 -175.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -124.46 91.84 3.53 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 172.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.526 ' HB2' ' HB2' ' A' ' 52' ' ' SER . 81.8 t80 -106.33 122.19 45.74 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.881 -176.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -114.67 115.27 26.84 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.665 177.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.509 ' HA2' ' O ' ' A' ' 35' ' ' GLY . . . -121.35 160.17 15.76 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 119.975 -1.107 . . . . 0.0 113.614 -175.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.636 HG21 ' HB3' ' A' ' 86' ' ' MET . 0.1 OUTLIER -140.76 106.99 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 123.251 0.621 . . . . 0.0 110.217 173.222 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.578 ' HB2' ' HG ' ' A' ' 71' ' ' LEU . 52.7 t-80 -102.05 117.29 34.48 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.151 -173.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -107.07 -14.4 18.94 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.454 -0.879 . . . . 0.0 113.444 -175.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -76.74 156.08 32.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.756 0.312 . . . . 0.0 110.389 -179.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 82.4 mtp -108.28 81.27 1.46 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.307 0.575 . . . . 0.0 109.93 175.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -106.9 -78.3 0.59 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.72 179.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.49 ' HD1' ' HB ' ' A' ' 40' ' ' VAL . 92.3 m-85 -107.45 154.37 40.73 Favored Pre-proline 0 C--N 1.323 -0.556 0 N-CA-C 110.318 -0.252 . . . . 0.0 110.318 178.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -74.42 -38.88 1.73 Allowed 'Trans proline' 0 CA--C 1.53 0.279 0 C-N-CA 122.49 2.126 . . . . 0.0 112.799 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.443 ' HB3' HD22 ' A' ' 42' ' ' LEU . 13.0 m-20 -60.38 -45.13 94.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.217 0.532 . . . . 0.0 111.482 -175.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.429 HG21 ' HA ' ' A' ' 40' ' ' VAL . 45.3 t -65.68 -27.94 42.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.546 -174.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 46.6 mttp -64.81 -25.66 68.01 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.871 0.367 . . . . 0.0 110.933 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -85.02 -28.43 25.72 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.795 -176.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.464 ' HB3' HD23 ' A' ' 71' ' ' LEU . 58.9 t-80 -69.79 -45.04 68.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.116 0.484 . . . . 0.0 109.95 177.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.578 ' HG ' ' HB2' ' A' ' 59' ' ' HIS . 1.3 pt? -140.02 113.05 7.55 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.421 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.29 -172.74 1.24 Allowed 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 123.099 2.533 . . . . 0.0 113.209 -176.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.431 ' CZ ' ' HA3' ' A' ' 89' ' ' GLY . 59.7 t80 -75.08 -43.48 52.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.545 -173.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 86' ' ' MET . 22.0 m -136.94 140.78 42.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.967 0.413 . . . . 0.0 111.579 -177.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.0 ttpm? -160.26 132.74 6.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.529 176.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.642 HG23 ' CE1' ' A' ' 104' ' ' PHE . 43.5 t -93.77 131.75 39.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.765 0.317 . . . . 0.0 110.249 173.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 38.5 mt -108.04 152.11 24.94 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 174.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 37.2 tp -122.41 96.11 4.91 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 175.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 60.4 t -102.25 95.45 3.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.685 -175.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 55.52 32.31 18.8 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.634 0.731 . . . . 0.0 111.054 175.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 114.53 -33.59 5.31 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.565 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 85.2 t -72.38 120.09 20.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.826 0.346 . . . . 0.0 110.695 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.9 101.73 13.44 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.048 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 19.0 mt -95.08 105.27 16.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.358 -176.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.569 ' HA2' HG22 ' A' ' 76' ' ' VAL . . . -89.5 94.36 1.98 Allowed Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.783 -0.723 . . . . 0.0 111.347 178.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.636 ' HB3' HG21 ' A' ' 58' ' ' VAL . 35.8 mtm -91.21 107.77 19.43 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.844 0.354 . . . . 0.0 110.687 -176.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 37.0 t -125.53 85.44 2.4 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 175.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 79.9 t60 -84.7 89.7 7.55 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.92 -173.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.431 ' HA3' ' CZ ' ' A' ' 73' ' ' PHE . . . -148.53 172.3 28.76 Favored Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.4 176.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 75.4 t-105 -76.52 106.85 8.41 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.951 0.405 . . . . 0.0 110.525 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -130.06 152.12 19.6 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 177.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -112.06 162.86 19.38 Favored Pre-proline 0 C--N 1.319 -0.721 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.32 -12.72 21.21 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.423 2.082 . . . . 0.0 112.514 178.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 14.0 m95 -80.47 -51.7 8.5 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.275 -178.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.483 ' OD2' ' HD3' ' A' ' 99' ' ' ARG . 12.0 p-10 -94.9 -0.58 53.87 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.159 -176.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 22.5 tp -50.52 -64.84 0.68 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.128 -0.487 . . . . 0.0 112.199 -174.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.485 ' HD2' ' HB2' ' A' ' 125' ' ' ALA . 42.5 mtmt -61.73 -54.37 43.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.365 0.602 . . . . 0.0 110.727 -176.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -61.08 -45.96 92.58 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.818 -1.083 . . . . 0.0 112.28 -171.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.483 ' HD3' ' OD2' ' A' ' 95' ' ' ASP . 34.0 ttt180 -79.37 -46.22 18.04 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.967 -173.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.457 HD13 HG21 ' A' ' 111' ' ' ILE . 47.3 mt -66.09 -29.45 69.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.687 0.279 . . . . 0.0 111.519 -176.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.608 HD22 ' HE3' ' A' ' 107' ' ' LYS . 86.0 mt -78.98 -13.28 59.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.687 0.28 . . . . 0.0 111.149 177.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -84.52 -31.74 24.29 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.83 0.348 . . . . 0.0 110.268 173.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.3 t -63.58 -49.72 81.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.254 177.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.642 ' CE1' HG23 ' A' ' 76' ' ' VAL . 20.3 m-85 -105.68 116.01 31.22 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.551 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -72.87 -29.16 62.96 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 170.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -76.48 97.63 4.37 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.853 171.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.608 ' HE3' HD22 ' A' ' 101' ' ' LEU . 13.0 mptt -63.24 113.93 11.11 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-O 120.996 0.426 . . . . 0.0 110.975 -178.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.493 ' HD3' ' HA ' ' A' ' 107' ' ' LYS . 1.0 OUTLIER -85.32 158.86 11.13 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.581 2.854 . . . . 0.0 112.642 -175.944 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -79.38 -53.24 7.11 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.032 177.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 74.8 t -120.42 128.6 76.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.865 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.476 HD12 ' CE2' ' A' ' 129' ' ' PHE . 48.6 mt -114.65 129.21 71.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.083 0.468 . . . . 0.0 110.797 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.444 HD23 ' HB2' ' A' ' 130' ' ' LEU . 81.4 mt -102.31 120.53 40.64 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.03 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -132.38 -169.61 2.26 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 -178.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -137.03 126.79 3.81 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.634 -0.794 . . . . 0.0 112.645 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 20.4 t60 -167.62 -71.86 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.183 0.516 . . . . 0.0 110.143 176.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.482 HG22 ' H ' ' A' ' 118' ' ' GLU . 6.6 m -83.05 143.2 30.76 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.118 -177.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.422 ' HB3' ' OE1' ' A' ' 137' ' ' GLU . 61.6 m-70 -90.31 -21.46 22.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.304 0.573 . . . . 0.0 110.168 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.482 ' H ' HG22 ' A' ' 116' ' ' THR . 48.6 mt-10 -87.01 121.0 71.78 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.169 173.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.742 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 23.5 Cg_exo -61.76 101.25 0.21 Allowed 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.704 2.269 . . . . 0.0 112.399 -175.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -111.41 127.34 55.64 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.851 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -79.84 103.23 9.59 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 174.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.617 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 38.5 p -99.5 113.81 26.4 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.248 -176.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.407 HG13 ' O ' ' A' ' 123' ' ' VAL . 6.9 p -109.7 97.71 6.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-O 122.168 0.985 . . . . 0.0 109.686 177.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.473 ' HB3' ' HD3' ' A' ' 97' ' ' LYS . 58.5 mttp -129.61 137.37 50.65 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.581 -176.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.485 ' HB2' ' HD2' ' A' ' 97' ' ' LYS . . . 64.96 13.38 8.59 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 123.616 0.572 . . . . 0.0 110.917 -176.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 89.74 -9.59 76.63 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.294 -178.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 38.8 t -93.04 141.34 14.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 128' ' ' ARG . 14.8 ttt180 -100.54 102.16 13.26 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.25 0.548 . . . . 0.0 110.428 -177.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.617 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 18.2 m-85 -92.09 142.86 27.04 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.235 178.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.444 ' HB2' HD23 ' A' ' 112' ' ' LEU . 86.1 mt -124.4 136.45 54.07 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.925 0.393 . . . . 0.0 110.917 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.742 ' O ' ' HA ' ' A' ' 119' ' ' PRO . 4.1 p30 -130.01 103.8 16.99 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.844 176.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -94.37 154.85 2.05 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.002 2.468 . . . . 0.0 113.297 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -71.93 159.06 53.65 Favored Glycine 0 N--CA 1.452 -0.289 0 N-CA-C 111.409 -0.676 . . . . 0.0 111.409 175.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 13.4 t -83.54 176.3 9.14 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 117.304 0.552 . . . . 0.0 111.251 -175.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 20.7 mt -70.81 -34.82 72.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.003 -170.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -77.03 -7.14 55.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.145 0.498 . . . . 0.0 110.69 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.422 ' OE1' ' HB3' ' A' ' 117' ' ' HIS . 42.2 mt-10 -92.6 1.12 57.43 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.003 176.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 73.34 39.6 50.99 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.678 -0.692 . . . . 0.0 113.08 174.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 50.2 m -150.08 144.29 25.65 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.763 0.316 . . . . 0.0 110.678 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -143.95 166.16 25.74 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.591 176.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -114.47 134.89 54.67 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.258 0.551 . . . . 0.0 111.411 -175.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 152' ' ' PHE . 89.4 t -116.47 121.43 67.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.572 175.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 5.2 tt -110.61 107.35 16.92 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -104.87 142.45 34.72 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.961 176.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.0 mp -90.74 94.28 9.61 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.218 0.532 . . . . 0.0 109.689 172.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -87.19 113.38 22.87 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.4 -178.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 68.35 -62.96 0.41 Allowed Glycine 0 CA--C 1.52 0.36 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.562 -169.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 179.38 27.77 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 175.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -127.1 160.53 30.89 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -175.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 47.6 t -77.76 108.88 11.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.844 0.354 . . . . 0.0 111.426 -176.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.429 HH11 ' HD3' ' A' ' 151' ' ' ARG . 15.2 ttm180 -107.7 96.07 6.13 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 173.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . 0.436 ' HA ' ' O ' ' A' ' 142' ' ' VAL . 40.1 p90 -102.41 127.53 49.4 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.928 -178.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -120.32 140.72 50.84 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.849 176.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -100.58 97.54 8.22 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.519 176.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -92.28 140.86 29.18 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.088 -177.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 18.1 p -89.62 155.58 19.15 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.617 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.728 HD13 ' HG2' ' A' ' 20' ' ' PRO . 83.0 mt . . . . . 0 C--O 1.247 0.952 0 CA-C-O 118.334 -0.841 . . . . 0.0 109.865 177.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 86.5 t . . . . . 0 N--CA 1.479 1.023 0 CA-C-O 120.835 0.35 . . . . 0.0 110.443 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -129.56 146.88 51.33 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.293 177.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.539 ' HG2' ' HG2' ' A' ' 144' ' ' GLU . 79.5 mtt180 -104.92 111.28 23.98 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.629 172.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.545 ' HE2' HG11 ' A' ' 79' ' ' VAL . 70.4 m-85 -101.59 129.73 47.76 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.028 0.442 . . . . 0.0 111.036 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.572 ' HB3' HG22 ' A' ' 33' ' ' VAL . 36.8 tp -89.57 112.25 23.4 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.611 176.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.403 ' HB3' ' HB3' ' A' ' 141' ' ' ALA . 51.5 tp -96.76 102.23 13.98 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.116 0.484 . . . . 0.0 110.045 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.503 HG13 ' HA2' ' A' ' 35' ' ' GLY . 11.5 pt -101.47 126.29 55.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.493 176.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.592 ' HB3' ' OG1' ' A' ' 116' ' ' THR . 14.0 m -68.62 179.65 1.66 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.028 -176.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -78.4 79.82 4.82 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 122.053 0.93 . . . . 0.0 110.811 -177.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.524 ' HB3' HD23 ' A' ' 135' ' ' LEU . 10.6 p -80.53 133.87 35.87 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 176.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 74.3 m-70 -99.57 80.09 2.34 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.363 0.602 . . . . 0.0 109.617 -177.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.476 ' HB ' ' HD1' ' A' ' 39' ' ' TYR . 38.6 t -114.87 137.62 22.93 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.617 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -82.79 -58.71 0.07 OUTLIER 'Cis proline' 0 N--CA 1.461 -0.4 0 C-N-CA 123.666 -1.389 . . . . 0.0 112.887 -2.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER 35.05 -96.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -173.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 40.9 mtm180 -127.33 20.66 6.76 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 15.6 tmm? -144.16 100.25 3.52 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.246 0.546 . . . . 0.0 109.987 173.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -110.08 16.02 22.11 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.825 176.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 27.9 p -84.67 39.33 0.74 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.078 -177.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.0 tt -97.16 119.92 62.26 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.563 ' HG3' HD13 ' A' ' 157' ' ' LEU . 26.9 Cg_endo -61.66 130.39 31.31 Favored 'Trans proline' 0 C--O 1.234 0.291 0 C-N-CA 123.092 2.528 . . . . 0.0 112.552 -178.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -63.44 -18.57 63.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.885 -179.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -52.62 -49.26 65.47 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.769 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.0 tt -70.38 -36.32 66.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.345 0.593 . . . . 0.0 110.34 -176.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.689 HD12 HD23 ' A' ' 27' ' ' LEU . 58.3 tp -69.81 -33.79 72.82 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.131 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -71.09 -36.61 72.27 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.327 178.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 75.6 m -80.69 7.53 10.02 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.752 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.689 HD23 HD12 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -50.56 -41.48 54.2 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.592 0.71 . . . . 0.0 110.724 176.896 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 71.3 mttt -90.99 11.15 23.83 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.173 -171.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -104.28 7.94 35.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.038 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -126.02 158.77 34.48 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.4 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -72.0 -53.19 13.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.176 0.512 . . . . 0.0 109.968 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.539 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -138.12 151.96 21.64 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.194 179.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.572 HG22 ' HB3' ' A' ' 5' ' ' LEU . 97.8 t -118.96 135.89 57.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-O 120.703 0.287 . . . . 0.0 110.482 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.456 HG12 ' HB2' ' A' ' 56' ' ' TYR . 37.0 mt -111.56 116.62 53.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.854 176.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.503 ' HA2' HG13 ' A' ' 7' ' ' ILE . . . -104.25 119.66 6.36 Favored Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 177.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 94.3 mt -92.81 24.07 3.82 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.122 0.487 . . . . 0.0 110.552 -179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 121.55 21.91 2.9 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.828 -178.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.405 ' HB3' HD12 ' A' ' 7' ' ' ILE . 10.9 t70 -81.14 134.03 35.57 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.613 ' HD2' HD11 ' A' ' 48' ' ' LEU . 25.7 m-85 64.6 105.73 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 O-C-N 123.872 0.732 . . . . 0.0 110.924 -175.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.417 HG22 ' O ' ' A' ' 12' ' ' VAL . 35.9 m -86.77 0.22 6.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.332 -176.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.549 ' O ' HG23 ' A' ' 45' ' ' VAL . 16.0 t70 -86.65 135.93 33.22 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.792 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 54.3 tp -62.7 -49.49 74.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.702 -175.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -63.1 -35.31 79.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.823 0.344 . . . . 0.0 110.752 -177.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.451 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 14.1 m -68.6 -33.06 73.4 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.21 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 41' ' ' ASP . 93.4 t -60.2 -46.12 95.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.369 0.604 . . . . 0.0 109.888 175.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.23 -38.0 80.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.89 177.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.24 -33.8 72.79 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.801 176.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.613 HD11 ' HD2' ' A' ' 39' ' ' TYR . 83.3 mt -66.95 -38.13 85.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.26 0.552 . . . . 0.0 109.996 178.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.681 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 35.8 tt0 -77.23 -11.39 59.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.331 176.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -92.5 -36.4 13.09 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.643 0.259 . . . . 0.0 110.945 -178.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.483 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . 6.4 m-30 -65.69 -67.37 0.45 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.4 178.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.49 ' OG ' HD12 ' A' ' 27' ' ' LEU . 5.1 m -73.49 -23.66 60.08 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.53 177.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.681 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 60.7 mttp 70.51 4.01 4.75 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.382 0.673 . . . . 0.0 111.785 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -144.83 105.07 4.07 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 172.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -128.89 133.23 47.85 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.189 0.519 . . . . 0.0 111.242 -173.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.456 ' HB2' HG12 ' A' ' 34' ' ' ILE . 88.1 m-85 -113.7 118.92 35.68 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 173.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -131.12 132.2 6.72 Favored Glycine 0 N--CA 1.44 -1.081 0 C-N-CA 119.606 -1.283 . . . . 0.0 113.925 -171.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.5 m -130.92 147.84 33.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 168.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.566 ' HB3' ' HB2' ' A' ' 71' ' ' LEU . 2.9 p80 -94.34 142.5 27.34 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 119.489 -0.884 . . . . 0.0 110.666 -173.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -81.29 -107.29 0.34 Allowed Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 115.618 -0.719 . . . . 0.0 113.538 -172.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.938 HD21 ' HA ' ' A' ' 115' ' ' HIS . 43.0 m-80 -95.62 -83.95 0.35 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.785 0.326 . . . . 0.0 111.264 -173.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 51.4 ttm -112.74 122.98 49.26 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.232 0.539 . . . . 0.0 110.682 -178.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -145.89 -174.25 4.37 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.288 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -74.88 144.51 79.88 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-O 120.673 0.273 . . . . 0.0 111.372 -176.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -47.06 -38.29 24.14 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.843 3.029 . . . . 0.0 114.161 -175.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -70.11 -46.54 64.61 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.214 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 39.9 t -63.66 -32.6 57.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.594 -177.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.414 ' HE2' ' HB3' ' A' ' 68' ' ' LYS . 31.8 ttpt -50.12 -40.36 45.8 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.809 177.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -104.12 -14.61 15.82 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.121 0.486 . . . . 0.0 110.136 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -75.44 -40.21 57.86 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -179.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.566 ' HB2' ' HB3' ' A' ' 59' ' ' HIS . 80.8 mt -102.64 117.94 59.67 Favored Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 170.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -56.44 156.2 22.66 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 123.129 2.553 . . . . 0.0 113.504 -174.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -77.11 -16.92 59.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.519 177.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.7 p -157.89 139.37 13.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.099 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.2 mttm -144.43 142.49 30.34 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.524 176.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 21.7 t -121.39 110.54 28.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.159 0.504 . . . . 0.0 109.913 172.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 37.3 mt -92.95 147.99 22.38 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.401 -177.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 55.1 tp -117.83 98.01 6.13 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 175.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.545 HG11 ' HE2' ' A' ' 4' ' ' PHE . 48.5 t -105.49 96.26 4.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.629 -174.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 57.31 27.62 14.01 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.624 175.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 114.35 -24.22 11.64 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.542 178.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.5 t -83.04 128.44 38.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.567 0.222 . . . . 0.0 110.809 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 40.0 p -91.48 131.24 37.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.538 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 42.0 mt -124.51 104.72 14.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.883 0.373 . . . . 0.0 110.215 -178.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -91.71 104.8 3.21 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.877 -0.677 . . . . 0.0 111.447 178.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 22.1 mtm -103.95 118.11 35.9 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -178.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 113' ' ' PHE . 46.0 t -156.96 158.29 36.34 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.925 0.393 . . . . 0.0 110.717 -177.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 15.0 t60 -65.64 -32.81 74.58 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.259 175.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.29 -94.88 0.57 Allowed Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 -173.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.423 ' HE3' ' H ' ' A' ' 92' ' ' ALA . 17.0 t90 -173.71 -69.24 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 172.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 155.14 -34.47 0.66 Allowed Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.994 -0.622 . . . . 0.0 111.77 -178.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.452 ' O ' ' HB2' ' A' ' 96' ' ' LEU . . . -78.61 115.1 49.03 Favored Pre-proline 0 C--N 1.327 -0.397 0 N-CA-C 110.487 -0.19 . . . . 0.0 110.487 178.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.469 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . 3.5 Cg_exo -81.22 5.18 6.42 Favored 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 123.427 2.752 . . . . 0.0 113.149 -175.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -80.74 -54.67 5.42 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.267 0.556 . . . . 0.0 109.942 -176.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 38.3 p30 -112.04 19.27 18.0 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.943 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.469 ' HB2' ' HA ' ' A' ' 93' ' ' PRO . 50.8 tp -54.47 -51.13 66.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.478 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -60.53 -45.38 94.07 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.926 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -61.37 -47.12 87.31 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.157 0.503 . . . . 0.0 110.844 -177.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.548 ' O ' HG23 ' A' ' 103' ' ' VAL . 36.3 ttm105 -67.0 -42.15 85.49 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.56 178.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.955 HD21 HG21 ' A' ' 111' ' ' ILE . 17.1 tp -67.57 -41.8 83.59 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.134 -176.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.432 HD21 HG21 ' A' ' 127' ' ' VAL . 93.7 mt -75.8 -5.74 47.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.528 178.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -95.38 -29.94 14.17 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.962 174.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 99' ' ' ARG . 94.8 t -62.68 -53.0 52.68 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 174.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -82.52 146.49 29.2 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 174.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -87.59 -27.11 22.74 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.897 0.38 . . . . 0.0 110.755 -177.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -113.64 177.65 4.56 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.532 177.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.866 ' H ' ' HD2' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -95.91 113.27 61.77 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.08 -175.133 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.478 ' HG2' HD11 ' A' ' 111' ' ' ILE . 1.2 Cg_endo -85.37 156.08 10.84 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.375 2.717 . . . . 0.0 111.854 177.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -90.7 -59.49 2.16 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.95 0.405 . . . . 0.0 110.771 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.635 HG21 HG21 ' A' ' 150' ' ' VAL . 57.3 t -105.15 119.54 54.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.331 -178.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.955 HG21 HD21 ' A' ' 100' ' ' LEU . 55.4 mt -116.46 128.69 73.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.079 0.466 . . . . 0.0 111.202 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.667 HD23 ' HB2' ' A' ' 130' ' ' LEU . 86.9 mt -107.61 124.72 50.37 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.011 176.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.515 ' HA ' ' O ' ' A' ' 87' ' ' CYS . 40.7 p90 -117.15 172.66 7.14 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 119.636 -0.825 . . . . 0.0 111.07 178.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -105.8 -165.18 23.32 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.442 -172.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.938 ' HA ' HD21 ' A' ' 61' ' ' ASN . 18.0 t60 69.06 41.73 1.37 Allowed 'General case' 0 C--O 1.233 0.191 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -173.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.592 ' OG1' ' HB3' ' A' ' 8' ' ' SER . 36.5 p -63.51 119.33 9.58 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 114.263 -1.335 . . . . 0.0 112.113 -171.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.442 ' HA ' ' OE2' ' A' ' 137' ' ' GLU . 0.0 OUTLIER -171.87 128.42 0.62 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.886 179.269 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 59.26 84.67 0.2 Allowed Pre-proline 0 N--CA 1.465 0.287 0 O-C-N 123.543 0.527 . . . . 0.0 110.791 -175.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -61.13 143.35 98.78 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 123.075 2.517 . . . . 0.0 113.014 -175.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -162.13 146.15 12.22 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.924 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -94.12 114.35 26.48 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.586 175.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.482 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 67.5 p -119.82 144.16 47.48 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.694 0.283 . . . . 0.0 111.405 -176.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.7 p -138.8 124.3 22.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.127 0.489 . . . . 0.0 110.976 178.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.481 ' HB2' ' HE2' ' A' ' 129' ' ' PHE . 88.1 mttt -140.9 139.42 34.35 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.536 176.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 66.94 14.04 9.68 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 123.485 0.491 . . . . 0.0 111.626 177.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 90.18 -2.82 81.87 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.234 -177.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.432 HG21 HD21 ' A' ' 101' ' ' LEU . 33.1 t -100.34 137.9 26.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -98.23 120.12 38.09 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.66 -176.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.482 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 34.9 m-85 -108.48 121.15 44.37 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.805 -178.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.667 ' HB2' HD23 ' A' ' 112' ' ' LEU . 78.1 mt -107.88 138.76 43.56 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-O 121.459 0.647 . . . . 0.0 111.146 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.462 ' HB3' ' CZ ' ' A' ' 113' ' ' PHE . 7.4 p30 -139.39 116.16 8.49 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.355 173.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.547 ' HD2' HG22 ' A' ' 116' ' ' THR . 86.2 Cg_endo -88.17 168.62 6.43 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.712 2.275 . . . . 0.0 112.502 178.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -85.28 147.77 22.62 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 176.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.58 ' HA ' ' HB2' ' A' ' 8' ' ' SER . 81.1 p -75.56 168.76 19.4 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.087 0.47 . . . . 0.0 111.077 -176.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.524 HD23 ' HB3' ' A' ' 10' ' ' SER . 4.2 mm? -64.82 -24.16 67.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.068 178.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -75.56 -14.36 60.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.036 0.446 . . . . 0.0 110.676 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.442 ' OE2' ' HA ' ' A' ' 117' ' ' HIS . 33.1 mt-10 -98.39 -2.23 39.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.192 178.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.518 ' HA2' HD12 ' A' ' 157' ' ' LEU . . . 70.78 45.45 52.17 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.925 177.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.6 p -150.81 153.92 36.32 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.597 0.199 . . . . 0.0 110.753 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -154.25 159.59 41.37 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 175.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.403 ' HB3' ' HB3' ' A' ' 6' ' ' LEU . . . -114.6 131.21 56.77 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.826 0.346 . . . . 0.0 111.384 -175.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 61.9 t -108.53 107.78 23.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 173.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.505 ' HA ' ' HA ' ' A' ' 152' ' ' PHE . 6.7 tt -96.97 105.14 17.23 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.196 0.522 . . . . 0.0 110.106 -176.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.539 ' HG2' ' HG2' ' A' ' 3' ' ' ARG . 34.1 mt-10 -100.19 149.75 23.23 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.583 176.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.9 mp -90.49 90.12 7.87 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 166.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -101.23 112.48 24.98 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.732 -170.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.75 10.97 59.49 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.067 -174.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 91.65 5.07 67.1 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.238 -0.506 . . . . 0.0 112.086 -178.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -108.63 161.83 14.72 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 176.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.635 HG21 HG21 ' A' ' 110' ' ' VAL . 50.0 t -81.49 101.61 6.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.08 0.467 . . . . 0.0 110.593 -176.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 31.0 tpt180 -103.57 87.49 2.85 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.077 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . 0.505 ' HA ' ' HA ' ' A' ' 143' ' ' LEU . 12.0 p90 -91.37 101.5 14.18 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.295 0.569 . . . . 0.0 110.02 177.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -91.06 101.49 14.25 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.359 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 48.2 tp -75.62 99.93 4.46 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 175.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -93.94 133.82 36.97 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.912 -177.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.6 m -98.42 150.33 21.74 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.407 -175.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.563 HD13 ' HG3' ' A' ' 20' ' ' PRO . 83.1 mt . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.37 -0.824 . . . . 0.0 109.897 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 50.2 t . . . . . 0 N--CA 1.479 1.017 0 CA-C-O 120.766 0.317 . . . . 0.0 110.853 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -122.23 149.5 43.59 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 171.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 52.8 mtp180 -106.51 116.57 32.16 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.09 178.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.535 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 73.1 m-85 -105.51 124.06 48.92 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.113 0.482 . . . . 0.0 111.487 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.528 ' HB3' HG22 ' A' ' 33' ' ' VAL . 37.9 tp -89.18 121.35 31.4 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.86 177.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.445 ' HB3' ' HB3' ' A' ' 141' ' ' ALA . 45.0 tp -110.95 106.46 15.57 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.181 0.515 . . . . 0.0 111.207 -177.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 19.7 pt -101.35 129.96 51.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.192 173.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.556 ' H ' HD21 ' A' ' 135' ' ' LEU . 9.1 p -85.27 -177.8 6.59 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.978 0.418 . . . . 0.0 111.954 -173.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.625 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.2 m-20 -65.39 104.22 0.94 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.31 -177.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.658 ' HB3' HD12 ' A' ' 135' ' ' LEU . 10.5 p -104.07 175.38 5.5 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 177.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -135.05 75.42 1.57 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.345 0.593 . . . . 0.0 110.098 176.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.419 ' O ' HG22 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -135.13 147.56 62.96 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.542 178.522 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -87.53 104.0 0.47 Allowed 'Cis proline' 0 N--CA 1.46 -0.463 0 C-N-CA 123.322 -1.532 . . . . 0.0 112.374 -2.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.405 ' H ' ' HA ' ' A' ' 12' ' ' VAL . 2.3 t -135.34 -133.59 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -178.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 22.0 ttm-85 -87.73 4.22 45.04 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.096 0.474 . . . . 0.0 110.812 -177.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.523 ' HG2' ' OG ' ' A' ' 18' ' ' SER . 30.3 ttp -84.86 -76.23 0.32 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 62.72 2.93 1.03 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.222 0.609 . . . . 0.0 112.41 178.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.523 ' OG ' ' HG2' ' A' ' 16' ' ' MET . 12.9 p -95.39 38.42 1.15 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.955 0.407 . . . . 0.0 111.519 -177.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.2 tt -107.84 111.11 62.51 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 177.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -70.57 141.24 41.48 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 122.734 2.289 . . . . 0.0 113.012 -177.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -63.8 -19.76 65.25 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.379 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -52.8 -42.66 65.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.898 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -68.66 -32.21 54.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.121 0.486 . . . . 0.0 110.514 -177.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.447 ' O ' HD23 ' A' ' 27' ' ' LEU . 58.3 tp -76.87 -31.97 57.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.412 -176.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -76.49 -23.47 53.76 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.555 178.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.9 m -78.49 0.85 24.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.766 -177.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.532 ' HB3' ' HB3' ' A' ' 51' ' ' PHE . 2.0 mm? -56.6 -28.98 61.6 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.884 0.373 . . . . 0.0 111.726 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 42.5 mttp -85.14 0.44 51.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.535 -174.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -113.12 17.49 18.7 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -171.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -137.45 168.43 19.66 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.672 0.272 . . . . 0.0 110.71 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -91.28 -52.75 4.66 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-O 121.512 0.672 . . . . 0.0 110.0 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.535 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -129.38 137.63 9.7 Favored Glycine 0 N--CA 1.441 -0.982 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.292 179.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.528 HG22 ' HB3' ' A' ' 5' ' ' LEU . 79.8 t -113.42 129.53 69.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.598 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 38.9 mt -105.99 122.74 59.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.527 -179.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -104.21 103.97 2.36 Favored Glycine 0 N--CA 1.44 -1.071 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.265 177.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.483 ' HB3' ' HE1' ' A' ' 88' ' ' HIS . 81.8 mt -80.42 -30.67 37.67 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 175.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.625 ' HA3' ' HA ' ' A' ' 9' ' ' ASP . . . -166.42 56.49 0.24 Allowed Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 177.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -57.61 -73.34 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.182 -0.509 . . . . 0.0 112.274 -171.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.518 ' CD1' HD11 ' A' ' 48' ' ' LEU . 78.5 m-85 -135.91 156.43 48.77 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.927 0.394 . . . . 0.0 110.686 178.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.419 HG22 ' O ' ' A' ' 12' ' ' VAL . 22.6 m -92.58 -3.02 10.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.335 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.593 ' O ' HG23 ' A' ' 45' ' ' VAL . 23.5 t70 -100.64 129.51 46.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.675 -178.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.52 HD22 ' HB3' ' A' ' 66' ' ' ASP . 51.0 tp -57.47 -52.14 66.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.456 . . . . 0.0 112.056 -174.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -68.29 -32.07 71.96 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.796 0.331 . . . . 0.0 110.948 -172.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.3 m -70.68 -33.16 70.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.916 178.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 41' ' ' ASP . 87.4 t -61.97 -44.21 98.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 121.357 0.598 . . . . 0.0 110.067 175.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -71.19 -31.79 45.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.269 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -58.65 -37.51 76.11 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 174.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.518 HD11 ' CD1' ' A' ' 39' ' ' TYR . 85.1 mt -69.68 -37.58 76.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.211 177.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.414 ' HG3' ' HB3' ' A' ' 55' ' ' PHE . 23.9 tt0 -71.33 -12.6 61.52 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.663 -177.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -79.76 -47.58 15.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.836 0.351 . . . . 0.0 110.499 173.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.532 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . 76.0 m-85 -75.82 -42.71 49.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.949 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.2 t -71.17 104.69 3.15 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.004 175.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -49.77 -43.74 48.39 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.645 177.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -130.08 104.24 7.22 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.577 175.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.414 ' HB3' ' HG3' ' A' ' 49' ' ' GLU . 74.3 t80 -100.3 121.76 42.01 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.313 -176.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.598 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 91.9 m-85 -114.82 108.0 16.17 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -126.12 151.21 17.82 Favored Glycine 0 N--CA 1.442 -0.959 0 C-N-CA 119.872 -1.156 . . . . 0.0 112.734 -175.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -127.69 172.77 14.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 173.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.45 ' HB2' ' O ' ' A' ' 71' ' ' LEU . 10.7 t-80 -94.3 118.79 32.12 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.522 -172.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.4 ' HA2' ' CD2' ' A' ' 88' ' ' HIS . . . -82.51 -148.25 7.15 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.691 -179.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -118.04 120.91 39.22 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.578 0.228 . . . . 0.0 111.512 -176.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 84.4 mtp 73.84 95.78 0.07 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.797 176.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.412 ' OD2' ' HB ' ' A' ' 67' ' ' VAL . 8.4 p-10 -160.4 -173.99 4.27 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.531 -177.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.414 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 15.1 m-30 -77.83 140.99 63.39 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.722 0.296 . . . . 0.0 111.01 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.426 ' O ' ' HB3' ' A' ' 68' ' ' LYS . 51.0 Cg_exo -57.46 -16.0 21.8 Favored 'Trans proline' 0 N--CA 1.474 0.37 0 C-N-CA 123.26 2.64 . . . . 0.0 112.915 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.52 ' HB3' HD22 ' A' ' 42' ' ' LEU . 8.5 m-20 -68.64 -41.57 79.2 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.252 0.548 . . . . 0.0 110.21 177.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.412 ' HB ' ' OD2' ' A' ' 63' ' ' ASP . 25.3 t -73.38 -23.61 19.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.96 -178.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.426 ' HB3' ' O ' ' A' ' 65' ' ' PRO . 63.9 tttp -52.78 -34.15 51.94 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.28 -178.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -108.36 2.31 22.42 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -176.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -98.76 -34.83 10.36 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 175.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.45 ' O ' ' HB2' ' A' ' 59' ' ' HIS . 51.2 mt -107.36 116.13 58.49 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.956 177.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -64.11 159.22 43.93 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.999 2.466 . . . . 0.0 112.751 -178.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.428 ' HZ ' HH22 ' A' ' 99' ' ' ARG . 64.7 t80 -79.85 -29.81 40.18 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.494 -176.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.0 p -148.7 126.27 11.7 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.507 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.7 tttm -141.54 128.42 20.58 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 12.0 t -109.65 118.17 56.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.844 0.354 . . . . 0.0 110.149 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 38.7 mt -93.01 153.27 18.82 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.656 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -118.3 108.99 15.77 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 171.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 22.2 t -122.21 102.09 11.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.148 -174.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 56.43 25.0 9.09 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.408 -0.814 . . . . 0.0 112.188 174.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 114.15 -10.57 22.49 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.96 177.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 46.5 t -103.84 134.63 44.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 122.645 -0.326 . . . . 0.0 110.948 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.6 p -93.83 133.35 37.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.656 177.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 27.1 mt -129.01 99.34 4.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.812 0.339 . . . . 0.0 110.357 -176.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -89.59 110.25 3.7 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.852 -0.69 . . . . 0.0 111.785 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.495 ' HG2' ' HB2' ' A' ' 112' ' ' LEU . 32.6 mtm -99.91 123.25 43.96 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 -179.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 34.2 t -145.83 163.07 36.2 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.483 ' HE1' ' HB3' ' A' ' 36' ' ' LEU . 7.2 m80 -141.0 -165.27 1.92 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.989 0.423 . . . . 0.0 111.424 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 112.48 169.33 17.85 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -177.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 17.3 p90 -81.81 96.7 7.69 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.502 0.668 . . . . 0.0 110.546 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -122.98 115.66 2.75 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.036 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.45 153.91 81.62 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 178.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.99 -7.45 6.28 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.013 2.475 . . . . 0.0 113.603 -175.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -81.72 -52.78 6.8 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.197 0.522 . . . . 0.0 109.978 -178.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -103.55 -4.87 23.34 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.823 -174.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 40.9 tp -52.41 -56.69 13.3 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.797 -176.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 45.9 pttt -57.39 -42.97 83.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.446 -177.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -69.37 -41.69 76.2 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.642 -178.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.482 ' O ' HG23 ' A' ' 103' ' ' VAL . 42.7 ttt-85 -62.05 -47.53 84.33 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.006 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.524 HD13 HG21 ' A' ' 111' ' ' ILE . 94.2 mt -66.47 -38.41 87.27 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.27 -176.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.798 HD21 HG21 ' A' ' 127' ' ' VAL . 86.6 mt -76.16 -13.25 60.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.011 0.434 . . . . 0.0 110.888 177.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -82.89 -39.89 20.94 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.008 176.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 99' ' ' ARG . 90.8 t -66.24 -50.93 64.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.194 -178.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -87.38 111.92 21.6 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 121.066 -0.254 . . . . 0.0 110.967 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -57.82 -52.89 63.6 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 174.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -80.77 94.96 6.51 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 170.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.702 ' H ' ' HD2' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -59.95 123.15 70.77 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.217 -179.279 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 107' ' ' LYS . 2.2 Cg_endo -82.08 157.15 17.68 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 123.754 2.969 . . . . 0.0 112.699 -172.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -73.51 -44.94 56.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.946 177.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 65.4 t -118.78 140.67 41.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.948 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.524 HG21 HD13 ' A' ' 100' ' ' LEU . 40.9 mt -129.86 131.99 66.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.74 0.305 . . . . 0.0 110.474 177.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.661 HD23 ' HB2' ' A' ' 130' ' ' LEU . 75.3 mt -105.24 127.34 52.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.64 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.405 ' HE1' ' HB3' ' A' ' 129' ' ' PHE . 13.9 p90 -147.21 147.24 30.26 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.686 176.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -130.96 114.79 1.64 Allowed Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.332 -0.937 . . . . 0.0 111.814 179.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 17.2 t60 -178.45 21.59 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 177.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.495 HG22 ' H ' ' A' ' 117' ' ' HIS . 0.2 OUTLIER -101.65 -176.03 3.02 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.142 -174.564 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.495 ' H ' HG22 ' A' ' 116' ' ' THR . 49.4 m-70 -111.63 -43.19 3.69 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.756 0.312 . . . . 0.0 110.562 178.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -124.58 149.21 61.23 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.913 175.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.566 ' HG3' HD22 ' A' ' 154' ' ' LEU . 74.4 Cg_endo -74.83 138.51 23.58 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.713 2.275 . . . . 0.0 111.988 178.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -150.58 125.95 10.1 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.374 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -78.26 94.47 4.8 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 177.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.504 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 68.6 p -103.46 119.19 38.4 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.837 -174.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.493 HG13 ' O ' ' A' ' 123' ' ' VAL . 8.9 p -107.25 88.89 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 122.336 1.065 . . . . 0.0 109.113 170.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -127.27 146.24 50.5 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.701 -174.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 61.8 15.25 6.89 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 123.724 0.64 . . . . 0.0 110.893 -174.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 83.91 9.87 81.9 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.52 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.798 HG21 HD21 ' A' ' 101' ' ' LEU . 47.7 t -119.21 140.83 41.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.698 0.285 . . . . 0.0 110.307 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.643 ' NH1' HD21 ' A' ' 130' ' ' LEU . 26.9 ttt-85 -89.36 94.16 9.79 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.504 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 89.3 m-85 -83.44 126.14 32.44 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.661 ' HB2' HD23 ' A' ' 112' ' ' LEU . 50.2 mt -112.01 122.43 47.74 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.385 0.612 . . . . 0.0 110.965 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.511 ' HA ' ' HD3' ' A' ' 132' ' ' PRO . 5.1 p30 -129.22 122.95 21.37 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.821 178.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.511 ' HD3' ' HA ' ' A' ' 131' ' ' ASN . 5.4 Cg_endo -87.15 169.64 7.33 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.238 2.625 . . . . 0.0 112.288 179.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -89.05 -160.23 36.23 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.27 178.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 48.2 t -88.19 139.3 30.64 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.825 0.345 . . . . 0.0 110.637 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.658 HD12 ' HB3' ' A' ' 10' ' ' SER . 58.3 mt -66.17 -19.74 65.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.28 178.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -78.76 -12.53 60.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.348 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -87.52 -4.62 58.98 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.417 -176.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 77.9 25.75 61.71 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.335 178.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 7.3 t -139.46 132.32 29.25 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 178.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -126.32 173.25 9.46 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -177.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.445 ' HB3' ' HB3' ' A' ' 6' ' ' LEU . . . -114.38 134.94 54.61 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.689 -174.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.537 HG12 ' HG3' ' A' ' 144' ' ' GLU . 47.3 t -128.83 124.08 60.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.881 176.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.529 HD21 HG13 ' A' ' 150' ' ' VAL . 5.8 tt -101.87 106.47 17.43 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.537 ' HG3' HG12 ' A' ' 142' ' ' VAL . 45.2 mt-10 -113.3 131.42 55.94 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.521 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 21.2 mt -93.07 90.74 7.02 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.887 -178.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -87.54 111.47 21.25 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.832 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.74 -69.02 0.29 Allowed Glycine 0 CA--C 1.52 0.384 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.633 -175.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -171.17 25.46 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 111.665 -0.574 . . . . 0.0 111.665 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -110.37 143.04 41.21 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.529 HG13 HD21 ' A' ' 143' ' ' LEU . 46.5 t -86.03 89.07 2.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 177.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 67.6 mtp180 -90.02 98.44 11.77 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.337 0.589 . . . . 0.0 110.644 -175.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -83.37 93.99 7.87 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.12 175.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -97.46 112.52 24.33 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.845 0.355 . . . . 0.0 110.988 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.566 HD22 ' HG3' ' A' ' 119' ' ' PRO . 15.9 tp -83.6 92.4 7.65 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 171.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -83.78 145.69 28.56 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.598 -174.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 18.7 p -91.47 145.05 24.94 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.545 178.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 79.8 mt . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.688 -0.673 . . . . 0.0 110.388 178.714 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.642 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 38.9 t . . . . . 0 N--CA 1.478 0.925 0 CA-C-O 120.879 0.371 . . . . 0.0 110.18 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 55.1 mttm -110.69 142.89 41.98 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.706 178.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 50.3 mtp180 -115.57 123.19 47.85 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.405 ' HE2' HG11 ' A' ' 79' ' ' VAL . 77.6 m-85 -119.52 135.07 54.93 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.979 0.419 . . . . 0.0 110.533 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.428 ' HB2' ' CD2' ' A' ' 30' ' ' TYR . 32.6 tp -89.33 127.2 35.78 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.158 179.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.535 ' HB3' ' HB3' ' A' ' 141' ' ' ALA . 47.8 tp -106.84 109.88 21.9 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.974 0.416 . . . . 0.0 110.547 -178.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.433 HG13 ' HA2' ' A' ' 35' ' ' GLY . 7.4 pt -101.35 128.62 53.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.771 177.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.3 m -89.4 -171.32 3.18 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.14 -171.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -47.97 117.16 1.77 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.165 -178.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.665 ' HB2' ' HA ' ' A' ' 38' ' ' ASP . 37.0 m -137.35 160.38 39.24 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.856 -1.065 . . . . 0.0 108.806 174.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.61 ' H ' ' HE2' ' A' ' 16' ' ' MET . 32.2 m80 -127.35 58.4 1.46 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.288 0.566 . . . . 0.0 109.579 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.426 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . 2.9 t -108.67 134.02 20.44 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.845 -177.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.426 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 72.4 Cg_endo -103.08 51.82 1.45 Allowed 'Cis proline' 0 N--CA 1.448 -1.183 0 C-N-CA 124.078 -1.218 . . . . 0.0 111.995 -4.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.466 HG22 HG21 ' A' ' 40' ' ' VAL . 10.9 t -58.14 -39.99 75.3 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-O 121.531 0.681 . . . . 0.0 109.999 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 31.9 ttt85 -177.19 -33.97 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.374 -1.285 . . . . 0.0 108.681 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.61 ' HE2' ' H ' ' A' ' 11' ' ' HIS . 32.0 ttp -74.17 122.92 23.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.013 178.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -130.13 13.01 5.66 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.085 0.469 . . . . 0.0 110.339 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.0 p -82.66 33.74 0.43 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.418 -177.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.8 tt -99.67 114.22 65.48 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.435 ' HG2' HD22 ' A' ' 157' ' ' LEU . 36.6 Cg_exo -60.95 130.01 31.12 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 123.278 2.652 . . . . 0.0 113.016 -176.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -67.33 -23.36 65.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.271 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -58.87 -34.68 71.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.358 -178.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.43 HG22 ' O ' ' A' ' 20' ' ' PRO . 6.3 tt -65.59 -38.39 82.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.538 0.685 . . . . 0.0 109.662 178.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.681 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 46.0 tp -70.34 -32.01 69.54 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.303 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -71.62 -24.39 61.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.801 178.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.0 m -85.94 7.61 23.58 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -171.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.729 HD13 ' HB3' ' A' ' 52' ' ' SER . 4.3 mt -64.91 -19.77 66.1 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.509 0.671 . . . . 0.0 109.401 178.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -56.58 -23.8 43.11 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 114.563 -1.199 . . . . 0.0 111.835 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -82.34 -21.53 35.96 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -178.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.428 ' CD2' ' HB2' ' A' ' 5' ' ' LEU . 30.3 m-85 -113.87 159.75 19.5 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -162.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -71.94 -30.0 64.87 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.637 176.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -175.69 178.59 47.2 Favored Glycine 0 N--CA 1.439 -1.149 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.334 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.425 HG21 HD13 ' A' ' 27' ' ' LEU . 93.3 t -123.58 144.72 32.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 110.305 -0.257 . . . . 0.0 110.305 -178.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.452 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 55.0 mt -113.07 116.45 52.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.071 176.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.433 ' HA2' HG13 ' A' ' 7' ' ' ILE . . . -99.03 124.59 8.28 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.699 176.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.417 HD11 HD11 ' A' ' 6' ' ' LEU . 84.7 mt -98.39 3.19 48.47 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 122.624 -0.339 . . . . 0.0 111.087 -178.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 128.98 79.02 0.23 Allowed Glycine 0 CA--C 1.505 -0.582 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 -176.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.665 ' HA ' ' HB2' ' A' ' 10' ' ' SER . 0.4 OUTLIER -135.9 -70.26 0.48 Allowed 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.413 -0.394 . . . . 0.0 111.043 -169.402 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 96.9 m-85 -90.51 105.01 17.52 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 174.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.466 HG21 HG22 ' A' ' 14' ' ' VAL . 11.2 m -82.25 -12.36 12.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.298 -173.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.493 ' O ' HG23 ' A' ' 45' ' ' VAL . 11.4 t70 -86.65 127.52 34.94 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.339 -178.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 51.8 tp -61.13 -45.18 95.73 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.689 -174.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -62.87 -36.74 84.29 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.209 0.528 . . . . 0.0 110.252 -178.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.454 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 16.5 m -68.64 -33.26 73.69 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.617 176.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 41' ' ' ASP . 85.0 t -59.97 -41.88 87.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-O 121.109 0.481 . . . . 0.0 110.179 173.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -67.46 -34.8 70.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.185 0.517 . . . . 0.0 110.123 177.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.67 -33.75 75.69 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.062 174.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' A' ' 44' ' ' THR . 98.3 mt -64.63 -36.43 84.23 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 175.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.709 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 37.3 mt-10 -77.49 -4.8 47.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.738 176.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -86.69 -41.07 14.48 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 173.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.503 ' CB ' HD12 ' A' ' 27' ' ' LEU . 74.5 m-85 -76.79 -51.44 11.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.178 178.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.729 ' HB3' HD13 ' A' ' 27' ' ' LEU . 78.6 p -90.62 -25.12 20.3 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 121.071 -0.252 . . . . 0.0 111.616 -178.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.709 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 68.0 mttm 71.6 -50.35 0.69 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.413 0.685 . . . . 0.0 111.712 -177.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -105.02 101.89 11.42 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.511 0.672 . . . . 0.0 109.728 175.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.608 ' HB3' ' HG2' ' A' ' 49' ' ' GLU . 89.7 t80 -114.82 124.61 52.19 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.806 -176.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.452 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 93.5 m-85 -112.76 165.8 11.95 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 174.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 163.45 174.21 33.05 Favored Glycine 0 N--CA 1.442 -0.959 0 C-N-CA 119.211 -1.471 . . . . 0.0 113.604 176.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.449 HG21 ' HB3' ' A' ' 86' ' ' MET . 2.8 m -146.68 118.75 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 114.791 -0.705 . . . . 0.0 109.167 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -94.53 176.39 6.31 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.167 -175.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -109.44 -171.4 20.57 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.332 -0.937 . . . . 0.0 112.216 -176.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -88.68 40.77 0.98 Allowed 'General case' 0 C--N 1.321 -0.654 0 O-C-N 122.424 -0.456 . . . . 0.0 110.065 178.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 57.5 mtm -132.66 4.8 3.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.524 -179.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -107.87 -169.09 1.46 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.375 -175.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.416 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 95.9 m-85 -81.0 135.85 51.09 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.231 176.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 64' ' ' TYR . 50.2 Cg_exo -55.18 -36.53 93.41 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 123.336 2.691 . . . . 0.0 113.386 -177.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -69.14 -24.53 64.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.85 0.357 . . . . 0.0 111.306 -177.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.402 HG13 HD21 ' A' ' 71' ' ' LEU . 41.0 t -65.16 -21.69 29.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-O 121.29 0.566 . . . . 0.0 110.388 177.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.485 ' HB3' ' NZ ' ' A' ' 68' ' ' LYS . 4.6 ttpm? -62.41 -25.29 67.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.838 -178.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -68.04 -53.85 22.69 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.49 -174.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 22.2 t60 -74.3 -38.09 63.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.659 0.266 . . . . 0.0 110.824 -178.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.402 HD21 HG13 ' A' ' 67' ' ' VAL . 1.0 OUTLIER -133.76 121.87 16.28 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-O 120.865 0.364 . . . . 0.0 110.285 177.056 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -81.24 -160.71 0.13 Allowed 'Trans proline' 0 CA--C 1.529 0.266 0 C-N-CA 123.003 2.469 . . . . 0.0 112.821 -176.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -96.6 -24.9 15.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.331 0.586 . . . . 0.0 109.719 177.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 86' ' ' MET . 15.7 m -142.38 125.39 16.24 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.333 -178.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 22.2 ttmm -150.05 136.62 19.11 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.023 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 13.5 t -105.07 118.67 52.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 177.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.541 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 91.5 mt -87.77 136.14 33.08 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.048 177.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 33.9 tp -111.43 97.45 6.76 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 173.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.405 HG11 ' HE2' ' A' ' 4' ' ' PHE . 29.2 t -123.28 111.13 28.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.445 -174.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 57.11 33.57 23.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.541 178.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.9 -19.24 55.34 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.713 177.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.622 HG21 HD22 ' A' ' 145' ' ' LEU . 56.9 t -82.0 132.05 32.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.869 0.366 . . . . 0.0 111.179 -176.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.6 p -95.13 116.06 28.23 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.832 176.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.541 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 26.5 mt -111.91 92.83 2.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.988 0.423 . . . . 0.0 110.019 -178.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -81.53 99.81 2.0 Allowed Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.449 ' HB3' HG21 ' A' ' 58' ' ' VAL . 29.7 mtm -97.75 121.57 39.83 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -177.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 47.0 t -146.14 109.76 4.81 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 15.3 t60 -91.79 65.36 4.98 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.224 0.535 . . . . 0.0 110.887 -174.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -103.12 160.84 16.61 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.733 177.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 89.0 m95 -116.1 104.84 11.96 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.993 0.425 . . . . 0.0 110.784 -179.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -155.57 -173.12 23.87 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 178.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.47 142.17 42.92 Favored Pre-proline 0 C--N 1.321 -0.654 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.61 -20.85 59.76 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 123.041 2.494 . . . . 0.0 112.968 -176.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -69.45 -52.1 29.92 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.243 0.544 . . . . 0.0 109.986 -178.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -77.02 -30.79 55.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.079 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.422 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 36.2 tp -50.35 -55.24 16.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.83 -175.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.456 ' HG3' ' N ' ' A' ' 98' ' ' ASP . 19.2 pttp -58.28 -41.76 85.08 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.876 0.369 . . . . 0.0 111.098 -177.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.456 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 29.5 t70 -69.26 -43.89 73.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.881 -175.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.512 ' O ' HG23 ' A' ' 103' ' ' VAL . 82.1 mtp180 -70.53 -41.87 71.97 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.141 -177.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.503 HD13 HD13 ' A' ' 111' ' ' ILE . 85.1 mt -61.49 -39.3 90.44 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.568 0.223 . . . . 0.0 111.505 -177.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 97' ' ' LYS . 87.7 mt -67.04 -22.91 65.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.85 0.357 . . . . 0.0 111.063 179.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -91.45 -28.21 17.78 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.962 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 99' ' ' ARG . 89.7 t -67.6 -44.1 86.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.08 0.467 . . . . 0.0 109.837 175.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -85.09 168.95 14.4 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.544 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -97.34 -20.26 17.96 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.103 -177.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -135.59 165.98 24.28 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.45 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 13.8 ptmt -74.47 120.21 80.36 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-O 121.021 0.439 . . . . 0.0 110.17 176.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.452 ' HG2' HD11 ' A' ' 111' ' ' ILE . 3.7 Cg_exo -80.69 131.95 8.52 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 122.738 2.292 . . . . 0.0 111.163 176.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -66.3 -39.39 89.29 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 176.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.518 HG21 HG21 ' A' ' 150' ' ' VAL . 94.8 t -124.19 138.61 53.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.393 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.503 HD13 HD13 ' A' ' 100' ' ' LEU . 25.1 mt -129.32 126.41 63.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.907 0.384 . . . . 0.0 110.398 174.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.59 HD23 ' HB2' ' A' ' 130' ' ' LEU . 90.3 mt -101.71 119.75 39.27 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.442 ' CE1' ' HB3' ' A' ' 129' ' ' PHE . 20.0 p90 -133.11 173.45 11.42 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.868 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -122.22 114.67 2.55 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.601 -0.809 . . . . 0.0 111.957 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -166.7 35.95 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.93 ' HA ' HD21 ' A' ' 131' ' ' ASN . 53.3 m -53.21 109.87 0.48 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.55 -1.204 . . . . 0.0 113.819 -169.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 28.4 m80 -111.08 -45.53 3.43 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 162.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -147.67 142.32 16.59 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 114.593 -1.185 . . . . 0.0 109.024 172.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.494 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 16.5 Cg_endo -59.45 113.08 1.46 Allowed 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 122.173 1.916 . . . . 0.0 110.941 173.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -146.21 140.04 26.28 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.89 0.376 . . . . 0.0 111.319 -169.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -107.33 122.7 47.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.894 176.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 59.6 p -130.79 130.6 43.89 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -173.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.1 p -99.1 122.63 51.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 172.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.0 ttpm? -151.34 123.05 8.0 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.367 -174.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 66.22 20.68 11.1 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.588 -177.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 80.92 7.79 88.19 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.912 -177.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.482 HG11 HD12 ' A' ' 111' ' ' ILE . 61.2 t -109.46 136.22 46.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 177.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -95.47 104.15 16.05 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.196 0.522 . . . . 0.0 110.037 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.442 ' HB3' ' CE1' ' A' ' 113' ' ' PHE . 98.1 m-85 -89.94 124.2 34.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.187 -178.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.59 ' HB2' HD23 ' A' ' 112' ' ' LEU . 81.8 mt -109.99 125.38 52.83 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-O 121.333 0.587 . . . . 0.0 111.159 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.93 HD21 ' HA ' ' A' ' 116' ' ' THR . 7.6 t30 -127.9 105.36 20.52 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.579 174.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -86.93 179.18 3.36 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 123.008 2.472 . . . . 0.0 113.112 -177.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -85.46 165.39 38.9 Favored Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.758 178.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.42 ' O ' ' HB3' ' A' ' 137' ' ' GLU . 15.6 m -87.33 156.96 19.39 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.948 0.374 . . . . 0.0 111.534 -175.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -61.95 -44.49 96.66 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.818 0.342 . . . . 0.0 110.959 177.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -68.61 -17.42 64.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.239 0.542 . . . . 0.0 110.738 178.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.42 ' HB3' ' O ' ' A' ' 134' ' ' SER . 77.5 tt0 -79.32 -34.27 42.43 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.03 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.481 ' HA2' HD12 ' A' ' 157' ' ' LEU . . . 107.32 31.79 3.66 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.95 176.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 31.2 p -148.05 154.76 40.67 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.805 0.336 . . . . 0.0 110.81 177.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.422 ' O ' HD12 ' A' ' 154' ' ' LEU . 30.6 p90 -149.75 162.96 39.23 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.77 175.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.535 ' HB3' ' HB3' ' A' ' 6' ' ' LEU . . . -114.43 138.27 50.79 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.18 0.514 . . . . 0.0 111.802 -169.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.763 ' HB ' ' HB2' ' A' ' 153' ' ' GLU . 97.5 t -117.72 124.12 72.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.071 173.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.877 HD21 HG13 ' A' ' 150' ' ' VAL . 1.6 tt -107.34 115.96 31.1 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -178.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -107.28 116.81 32.6 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.081 0.467 . . . . 0.0 109.763 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.642 ' O ' ' HA ' ' A' ' 1' ' ' VAL . 74.5 mt -96.79 109.56 22.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.969 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -126.08 120.98 31.61 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.746 -175.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.82 10.93 59.57 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.87 178.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 92.03 5.66 65.8 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.759 -177.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -102.99 145.61 29.61 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.084 0.468 . . . . 0.0 110.496 178.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.877 HG13 HD21 ' A' ' 143' ' ' LEU . 62.1 t -94.85 119.01 42.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.074 -175.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 64.7 mtt180 -124.42 143.05 50.84 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.091 0.472 . . . . 0.0 110.418 178.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . 0.428 ' HE2' ' HB2' ' A' ' 154' ' ' LEU . 58.7 t80 -118.3 116.75 27.4 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.291 -168.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.763 ' HB2' ' HB ' ' A' ' 142' ' ' VAL . 45.5 mt-10 -102.77 111.2 23.42 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 174.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.428 ' HB2' ' HE2' ' A' ' 152' ' ' PHE . 32.5 tp -97.28 115.59 27.92 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.113 179.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -105.95 153.13 22.42 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.051 0.453 . . . . 0.0 110.878 -178.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 36.7 p -108.73 152.39 24.91 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.187 -177.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.481 HD12 ' HA2' ' A' ' 138' ' ' GLY . 97.0 mt . . . . . 0 C--O 1.247 0.949 0 CA-C-O 118.475 -0.774 . . . . 0.0 109.835 175.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 93.9 t . . . . . 0 N--CA 1.481 1.094 0 CA-C-O 120.727 0.298 . . . . 0.0 111.051 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -114.17 139.25 49.5 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 171.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 74.0 mtm-85 -110.27 116.18 31.01 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.811 -175.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -110.76 131.32 55.15 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.854 0.359 . . . . 0.0 110.792 178.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.498 ' HB2' ' CD2' ' A' ' 30' ' ' TYR . 38.6 tp -89.23 119.82 30.06 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.451 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.606 HD23 ' HB3' ' A' ' 141' ' ' ALA . 64.6 tp -106.05 115.65 30.58 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.017 0.437 . . . . 0.0 110.494 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.543 HG22 HD13 ' A' ' 23' ' ' ILE . 11.6 pt -101.09 125.8 54.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 177.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.0 m -65.43 177.51 1.13 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.2 -172.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -49.02 104.72 0.07 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.748 176.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.85 ' HB2' ' HA ' ' A' ' 38' ' ' ASP . 19.5 m -99.06 166.87 11.05 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.274 -177.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 69.9 m-70 -144.7 35.6 1.16 Allowed 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -176.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.657 HG21 HD12 ' A' ' 19' ' ' LEU . 14.6 t -102.68 138.53 19.65 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.493 -174.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.8 -56.84 0.14 OUTLIER 'Cis proline' 0 C--N 1.345 0.352 0 C-N-CA 123.382 -1.508 . . . . 0.0 112.242 -3.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.559 HG12 ' HG3' ' A' ' 15' ' ' ARG . 31.5 t 49.68 -94.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 O-C-N 123.815 0.697 . . . . 0.0 111.427 -178.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.559 ' HG3' HG12 ' A' ' 14' ' ' VAL . 54.9 mtp85 -138.44 13.53 2.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.259 0.552 . . . . 0.0 109.763 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 30.2 ttp -142.58 100.57 3.71 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.358 -177.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -101.72 14.33 32.29 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.254 0.55 . . . . 0.0 109.879 177.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.6 m -77.44 54.74 1.18 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.129 -179.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.866 ' HG ' HD13 ' A' ' 135' ' ' LEU . 2.0 tt -107.86 105.57 56.54 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 177.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.815 ' HG2' HD13 ' A' ' 157' ' ' LEU . 77.3 Cg_exo -52.08 123.47 12.6 Favored 'Trans proline' 0 C--O 1.236 0.398 0 C-N-CA 122.913 2.408 . . . . 0.0 112.375 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -68.62 -9.56 50.6 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.612 -178.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -52.88 -38.01 61.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.202 174.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.543 HD13 HG22 ' A' ' 7' ' ' ILE . 0.4 OUTLIER -82.45 -24.74 8.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.597 -179.006 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.472 ' O ' HD23 ' A' ' 27' ' ' LEU . 49.9 tp -81.96 -16.64 49.75 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.924 -177.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -86.3 -22.48 26.75 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.132 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.421 ' HB2' ' CE2' ' A' ' 30' ' ' TYR . 1.3 p -84.01 9.36 12.58 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -176.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.648 HD13 HG21 ' A' ' 33' ' ' VAL . 4.5 mm? -61.52 -19.96 62.68 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.234 0.54 . . . . 0.0 110.318 173.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 47.5 mttm -98.85 -0.34 42.63 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.857 -176.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -102.43 -49.32 3.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.803 0.335 . . . . 0.0 111.23 -173.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.498 ' CD2' ' HB2' ' A' ' 5' ' ' LEU . 93.4 m-85 -81.44 169.37 17.26 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.839 -173.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -88.24 -17.27 31.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.381 -177.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -168.67 162.27 36.03 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.648 HG21 HD13 ' A' ' 27' ' ' LEU . 61.2 t -132.01 147.47 32.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 -178.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.404 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 42.0 mt -123.73 124.78 70.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 175.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -106.48 114.69 4.49 Favored Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 111.564 -0.614 . . . . 0.0 111.564 177.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.605 ' HB3' ' HE1' ' A' ' 88' ' ' HIS . 99.3 mt -84.46 27.04 0.73 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.019 0.438 . . . . 0.0 110.733 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 110.46 60.54 0.49 Allowed Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 -173.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.85 ' HA ' ' HB2' ' A' ' 10' ' ' SER . 0.7 OUTLIER -76.53 -83.2 0.07 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.263 -0.469 . . . . 0.0 112.227 -173.829 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.478 ' HD1' HD11 ' A' ' 48' ' ' LEU . 75.5 m-85 -100.5 128.78 46.46 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.232 0.539 . . . . 0.0 110.995 -177.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.447 HG12 ' HB3' ' A' ' 63' ' ' ASP . 17.4 m -79.08 7.33 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.606 177.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.525 ' O ' HG23 ' A' ' 45' ' ' VAL . 13.6 t70 -110.17 130.01 55.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.964 -179.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.51 HD22 ' HB3' ' A' ' 66' ' ' ASP . 57.2 tp -65.63 -42.72 91.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.568 -175.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -59.51 -39.46 83.92 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.971 0.415 . . . . 0.0 111.274 -177.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 11.7 m -75.21 -27.02 59.39 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.213 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 41' ' ' ASP . 89.1 t -59.8 -43.3 91.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 121.391 0.615 . . . . 0.0 109.804 173.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -70.02 -34.55 60.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.91 178.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -60.94 -40.94 95.2 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.444 174.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.478 HD11 ' HD1' ' A' ' 39' ' ' TYR . 83.2 mt -69.11 -38.68 79.05 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.066 0.46 . . . . 0.0 110.174 179.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -62.13 -39.43 92.54 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.471 177.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -69.19 -36.1 76.96 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.752 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -71.61 -64.62 0.89 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.809 178.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.634 ' HB3' HD12 ' A' ' 27' ' ' LEU . 59.9 p -64.11 -40.85 97.1 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.217 -176.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 92.5 mttt 66.06 6.6 4.21 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.416 0.627 . . . . 0.0 110.425 -174.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -171.46 95.41 0.18 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.151 -0.932 . . . . 0.0 109.271 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.466 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 2.4 p90 -145.69 144.97 30.7 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.008 0.433 . . . . 0.0 109.927 178.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.404 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 56.1 m-85 -114.8 136.4 53.12 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 177.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.699 ' HA3' HD22 ' A' ' 71' ' ' LEU . . . -133.08 156.78 22.35 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 119.827 -1.178 . . . . 0.0 112.812 -177.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.402 HG13 ' HE3' ' A' ' 86' ' ' MET . 0.2 OUTLIER -136.84 164.25 30.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.132 0.491 . . . . 0.0 110.836 175.698 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.503 ' HB3' ' HA ' ' A' ' 73' ' ' PHE . 74.3 t60 -94.6 104.52 16.46 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.696 -175.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -115.72 -5.58 18.11 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.495 -0.775 . . . . 0.0 113.031 -176.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -115.16 -166.76 1.15 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.102 0.477 . . . . 0.0 110.234 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 97.0 mmm -98.98 34.86 2.0 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 169.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.447 ' HB3' HG12 ' A' ' 40' ' ' VAL . 1.8 p-10 -60.08 157.7 12.5 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.666 -177.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -62.21 155.62 64.46 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.924 -171.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.62 ' HA ' ' HB3' ' A' ' 68' ' ' LYS . 72.5 Cg_exo -50.47 -31.01 29.3 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 123.406 2.737 . . . . 0.0 112.948 178.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.51 ' HB3' HD22 ' A' ' 42' ' ' LEU . 32.2 m-20 -56.61 -48.4 77.54 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.342 0.591 . . . . 0.0 110.434 176.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 40.5 t -75.85 -38.94 37.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.819 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.62 ' HB3' ' HA ' ' A' ' 65' ' ' PRO . 48.5 tttp -57.59 -34.0 68.77 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.364 176.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -68.92 -33.94 74.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.069 0.461 . . . . 0.0 110.652 178.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.482 ' CE1' HD11 ' A' ' 42' ' ' LEU . 18.9 m80 -84.53 -50.89 7.32 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.167 -178.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.699 HD22 ' HA3' ' A' ' 57' ' ' GLY . 22.6 mt -100.38 113.8 65.54 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.899 -177.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.677 ' HG2' ' HB2' ' A' ' 75' ' ' LYS . 46.0 Cg_endo -69.42 153.98 69.72 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 122.491 2.127 . . . . 0.0 112.308 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.503 ' HA ' ' HB3' ' A' ' 59' ' ' HIS . 82.6 t80 -61.96 -32.77 73.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.343 0.592 . . . . 0.0 109.952 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.3 t -146.36 137.51 24.42 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.3 176.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.677 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 39.5 tttp -148.92 128.44 13.12 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.507 -176.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.472 ' HA ' ' HA2' ' A' ' 85' ' ' GLY . 46.5 t -99.75 117.03 44.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.095 0.474 . . . . 0.0 109.837 174.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.505 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 86.7 mt -87.71 138.48 31.43 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.408 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 42.9 tp -109.73 99.57 8.71 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 176.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 44.0 t -108.92 91.34 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.364 -177.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 57.33 30.31 18.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.662 175.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 114.54 -23.53 12.08 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.99 178.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.8 t -84.01 126.81 40.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.597 0.237 . . . . 0.0 110.556 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.2 p -95.72 117.96 31.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.944 0.402 . . . . 0.0 111.304 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.505 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 18.1 mt -111.62 93.14 2.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.946 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.472 ' HA2' ' HA ' ' A' ' 76' ' ' VAL . . . -84.02 106.35 2.86 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 111.731 -0.548 . . . . 0.0 111.731 -179.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.453 ' HE1' HD11 ' A' ' 77' ' ' LEU . 53.5 mtm -98.93 125.86 44.47 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -178.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 35.3 t -149.97 133.73 16.82 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.605 ' HE1' ' HB3' ' A' ' 36' ' ' LEU . 17.6 m80 -113.31 93.3 4.34 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.099 0.476 . . . . 0.0 111.444 178.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -136.21 154.81 22.14 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 175.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 10.6 p-90 -135.51 152.06 50.96 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 168.5 -137.23 4.46 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 -179.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.482 ' HB1' ' NE1' ' A' ' 94' ' ' TRP . . . -75.54 119.33 76.55 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-O 120.875 0.369 . . . . 0.0 110.578 178.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 92' ' ' ALA . 10.7 Cg_exo -72.48 -23.71 19.88 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.929 2.419 . . . . 0.0 112.933 -177.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.508 ' CE3' ' HB3' ' A' ' 95' ' ' ASP . 57.8 p-90 -70.72 -21.63 62.53 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -176.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.508 ' HB3' ' CE3' ' A' ' 94' ' ' TRP . 3.3 p-10 -126.44 20.51 7.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.001 0.429 . . . . 0.0 110.338 176.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 59.3 tp -57.08 -39.77 75.64 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.515 178.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.414 ' HD2' ' HB3' ' A' ' 124' ' ' LYS . 48.8 mtpt -54.4 -51.8 63.73 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.21 174.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -62.04 -39.46 92.42 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.767 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' A' ' 95' ' ' ASP . 52.5 mtt180 -63.43 -48.65 76.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.09 179.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 76.9 mt -67.65 -34.25 76.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.879 0.371 . . . . 0.0 111.094 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 96.9 mt -80.79 -4.84 56.04 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.858 0.361 . . . . 0.0 110.841 178.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 37.8 mttp -89.57 -22.07 22.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.485 170.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 64.6 t -68.74 -47.68 75.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.97 0.414 . . . . 0.0 110.189 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -108.91 169.87 8.4 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.715 177.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -95.35 -47.33 6.34 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -90.69 137.72 32.13 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.725 175.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.453 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 24.2 pttm -70.21 125.37 91.97 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-O 120.986 0.422 . . . . 0.0 110.629 -178.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 107' ' ' LYS . 9.0 Cg_exo -72.4 134.47 22.71 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.617 2.212 . . . . 0.0 110.368 174.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -60.5 -41.84 95.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.964 0.411 . . . . 0.0 110.437 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.8 t -122.46 140.96 44.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.767 177.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.442 HD12 ' CE2' ' A' ' 129' ' ' PHE . 42.0 mt -129.71 137.12 57.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 176.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.598 HD23 ' HB2' ' A' ' 130' ' ' LEU . 86.7 mt -114.11 130.57 56.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.326 -177.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.523 ' O ' ' HD2' ' A' ' 132' ' ' PRO . 51.4 p90 -155.65 -178.34 7.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.851 172.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -105.78 127.87 9.14 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.552 -0.832 . . . . 0.0 111.784 -177.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.509 ' HB2' ' HB2' ' A' ' 131' ' ' ASN . 1.1 t60 -83.69 -14.65 51.25 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.797 0.332 . . . . 0.0 110.536 -175.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 5.9 m 63.69 12.66 6.77 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.995 0.902 . . . . 0.0 110.18 -176.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.613 ' HB3' ' OE1' ' A' ' 118' ' ' GLU . 34.8 m80 -148.18 -160.76 1.21 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.997 -176.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.613 ' OE1' ' HB3' ' A' ' 117' ' ' HIS . 0.8 OUTLIER -69.32 144.28 94.58 Favored Pre-proline 0 C--N 1.326 -0.434 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.432 -179.917 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.416 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 77.9 Cg_exo -51.68 134.66 47.64 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.161 2.574 . . . . 0.0 112.586 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.46 ' HG2' HG23 ' A' ' 122' ' ' THR . 36.9 tt0 -142.55 127.29 18.12 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.837 -174.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.735 ' HB2' ' HZ ' ' A' ' 152' ' ' PHE . 19.5 t70 -86.92 107.36 18.33 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 177.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.562 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 27.7 p -116.16 118.73 33.63 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.815 -174.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.9 p -106.26 106.98 21.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.428 0.632 . . . . 0.0 110.321 176.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.584 ' HB2' ' HE1' ' A' ' 129' ' ' PHE . 62.4 mttm -127.24 129.24 47.4 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.023 -176.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 62.54 22.23 13.16 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 123.347 0.405 . . . . 0.0 111.415 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 87.42 -5.38 85.15 Favored Glycine 0 CA--C 1.518 0.244 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.071 -178.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.405 HG13 ' O ' ' A' ' 108' ' ' PRO . 90.4 t -94.92 135.45 28.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -97.22 107.32 19.81 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.159 0.504 . . . . 0.0 109.912 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.584 ' HE1' ' HB2' ' A' ' 124' ' ' LYS . 75.4 m-85 -92.48 119.06 31.61 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.717 -179.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.598 ' HB2' HD23 ' A' ' 112' ' ' LEU . 50.5 mt -103.31 117.37 34.35 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 177.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.509 ' HB2' ' HB2' ' A' ' 115' ' ' HIS . 2.5 p30 -130.03 110.11 16.87 Favored Pre-proline 0 C--N 1.317 -0.843 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.998 -177.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.523 ' HD2' ' O ' ' A' ' 113' ' ' PHE . 89.9 Cg_endo -82.46 -172.16 1.35 Allowed 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.783 2.322 . . . . 0.0 111.853 174.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -99.19 -97.65 2.13 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.558 -0.83 . . . . 0.0 112.904 -177.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 41.8 t -161.87 163.5 29.22 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 -176.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.866 HD13 ' HG ' ' A' ' 19' ' ' LEU . 57.3 mt -65.0 -49.75 69.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.115 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -65.1 -26.69 68.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.168 -178.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -88.87 4.3 48.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.875 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.555 ' HA2' HD12 ' A' ' 157' ' ' LEU . . . 58.67 43.67 96.15 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 116.083 -0.508 . . . . 0.0 113.354 175.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 3.9 p -137.24 110.39 7.8 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.039 0.447 . . . . 0.0 111.675 -178.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -132.19 -172.09 2.8 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 175.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.606 ' HB3' HD23 ' A' ' 6' ' ' LEU . . . -143.72 153.09 42.08 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.2 0.524 . . . . 0.0 111.46 -177.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 70.9 t -126.23 117.26 48.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 172.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.657 HD21 HG13 ' A' ' 150' ' ' VAL . 2.3 tt -94.62 106.52 18.51 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.254 0.55 . . . . 0.0 109.87 -175.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -97.97 119.06 35.92 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.702 177.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.505 ' O ' ' HA ' ' A' ' 1' ' ' VAL . 6.2 mp -95.61 106.45 18.55 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 177.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -109.25 110.31 21.47 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.796 177.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 68.05 11.12 60.53 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.108 -176.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 94.55 5.18 61.81 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.758 -0.537 . . . . 0.0 111.758 -177.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -89.2 133.37 34.45 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 178.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.657 HG13 HD21 ' A' ' 143' ' ' LEU . 62.4 t -76.9 103.64 4.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.17 -177.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 78.4 mtt-85 -115.88 89.59 3.14 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.973 178.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . 0.735 ' HZ ' ' HB2' ' A' ' 121' ' ' ASP . 3.5 p90 -95.04 123.28 38.44 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.125 0.488 . . . . 0.0 110.682 -178.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -91.45 123.56 34.97 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.069 177.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -83.98 81.69 8.67 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 176.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -80.72 131.84 35.49 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.907 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 26.5 p -109.14 150.72 27.45 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.794 -175.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.815 HD13 ' HG2' ' A' ' 20' ' ' PRO . 90.5 mt . . . . . 0 C--N 1.315 -0.905 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 177.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.547 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 98.0 t . . . . . 0 N--CA 1.477 0.889 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.4 tttm -113.72 138.0 50.84 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.677 ' HB3' ' HD1' ' A' ' 30' ' ' TYR . 56.6 mtt-85 -108.29 117.8 35.1 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.618 0.247 . . . . 0.0 111.33 -175.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.557 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 67.8 m-85 -112.43 113.94 26.39 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.203 0.525 . . . . 0.0 111.006 177.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.53 ' HB3' HG22 ' A' ' 33' ' ' VAL . 32.1 tp -89.24 121.04 31.14 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.021 178.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.748 HD11 ' HG ' ' A' ' 36' ' ' LEU . 41.4 tp -107.39 121.09 43.9 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.259 0.552 . . . . 0.0 111.211 -178.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.7 pt -101.18 119.38 49.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 171.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.508 ' O ' ' HB2' ' A' ' 36' ' ' LEU . 5.7 p -67.17 -87.71 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -164.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.485 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 36.2 t70 -142.32 94.06 2.61 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.287 0.565 . . . . 0.0 110.226 -176.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.46 ' OG ' HD12 ' A' ' 19' ' ' LEU . 23.0 t -107.86 158.47 17.3 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.802 -179.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.502 ' H ' ' HE1' ' A' ' 16' ' ' MET . 11.0 m80 -135.09 77.33 1.67 Allowed 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -178.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . 9.1 t -129.8 132.26 24.06 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.109 -177.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.47 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 41.2 Cg_endo -95.4 91.58 0.14 OUTLIER 'Cis proline' 0 N--CA 1.449 -1.092 0 C-N-CA 123.403 -1.499 . . . . 0.0 112.554 -2.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.726 HG12 ' H ' ' A' ' 15' ' ' ARG . 2.5 t -114.85 -165.07 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 175.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.726 ' H ' HG12 ' A' ' 14' ' ' VAL . 85.1 mtt180 -72.43 75.92 1.04 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 118.611 0.642 . . . . 0.0 110.758 177.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.502 ' HE1' ' H ' ' A' ' 11' ' ' HIS . 28.0 ttp -165.65 -77.12 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.467 178.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 59.2 12.05 2.36 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.554 -178.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.0 m -79.81 35.78 0.31 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.184 -177.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.46 HD12 ' OG ' ' A' ' 10' ' ' SER . 4.1 tt -107.75 111.02 62.7 Favored Pre-proline 0 C--N 1.327 -0.406 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.548 ' HG3' HD13 ' A' ' 157' ' ' LEU . 60.7 Cg_endo -74.06 133.43 18.09 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.623 2.215 . . . . 0.0 112.014 178.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -77.11 -5.81 50.43 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.925 0.393 . . . . 0.0 110.263 -177.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -55.93 -40.81 73.68 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.543 174.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.0 tt -70.38 -33.39 53.79 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-O 121.748 0.785 . . . . 0.0 109.98 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.526 ' O ' HD23 ' A' ' 27' ' ' LEU . 49.0 tp -66.64 -17.89 65.08 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.842 -178.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -80.47 -24.87 39.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.894 0.378 . . . . 0.0 110.966 177.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.3 m -80.28 2.81 23.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.48 -176.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.653 HD12 ' HB3' ' A' ' 52' ' ' SER . 4.4 mm? -59.98 -22.37 62.45 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.59 178.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -79.4 -14.26 59.06 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.323 -177.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -91.62 -23.61 19.81 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.968 0.413 . . . . 0.0 110.848 -178.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.677 ' HD1' ' HB3' ' A' ' 3' ' ' ARG . 38.3 m-85 -111.49 126.08 54.59 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.949 0.405 . . . . 0.0 110.678 -174.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -78.98 -29.97 44.14 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.868 -176.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.557 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -123.34 138.33 11.52 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 177.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.541 HG21 ' CD1' ' A' ' 27' ' ' LEU . 93.5 t -130.37 135.09 61.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 120.845 0.355 . . . . 0.0 110.574 -178.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.566 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 48.1 mt -112.32 131.59 63.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.435 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -118.41 98.28 0.74 Allowed Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.109 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.748 ' HG ' HD11 ' A' ' 6' ' ' LEU . 85.0 mt -77.65 -33.8 53.36 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 175.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.485 ' HA3' ' HA ' ' A' ' 9' ' ' ASP . . . -150.47 83.01 0.18 Allowed Glycine 0 N--CA 1.44 -1.087 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.494 177.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -94.75 -145.3 0.26 Allowed 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.447 ' HD1' HD11 ' A' ' 48' ' ' LEU . 78.2 m-85 -73.49 148.87 42.74 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 178.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.7 m -98.06 5.56 9.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.132 0.491 . . . . 0.0 110.748 -177.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.546 ' O ' HG23 ' A' ' 45' ' ' VAL . 17.3 t70 -102.9 132.34 49.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.874 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.539 HD22 ' HB3' ' A' ' 66' ' ' ASP . 65.6 tp -57.84 -54.23 49.22 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.171 -175.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -59.22 -35.71 74.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.156 0.503 . . . . 0.0 111.105 -176.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.429 HG21 ' CD2' ' A' ' 39' ' ' TYR . 17.6 m -72.01 -28.22 63.25 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.312 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.546 HG23 ' O ' ' A' ' 41' ' ' ASP . 94.8 t -65.01 -37.4 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 121.205 0.526 . . . . 0.0 109.913 174.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.521 ' O ' ' HG2' ' A' ' 50' ' ' LYS . 1.7 mp -65.5 -37.15 79.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.56 175.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.447 ' O ' ' HB2' ' A' ' 50' ' ' LYS . 3.2 tm? -61.82 -34.04 75.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.767 174.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.447 HD11 ' HD1' ' A' ' 39' ' ' TYR . 96.4 mt -67.97 -40.44 83.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.324 177.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.562 ' HA ' ' O ' ' A' ' 52' ' ' SER . 44.6 mt-10 -78.68 -2.39 38.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.348 177.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.521 ' HG2' ' O ' ' A' ' 46' ' ' ILE . 32.2 mmtp -75.43 -53.67 8.3 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 170.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -70.95 -66.22 0.64 Allowed 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.101 177.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.653 ' HB3' HD12 ' A' ' 27' ' ' LEU . 15.7 p -95.36 92.99 6.98 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.214 175.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.526 ' HG2' ' O ' ' A' ' 49' ' ' GLU . 63.3 mttp -70.41 -15.67 62.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.142 0.496 . . . . 0.0 110.431 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -101.4 68.15 1.19 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.409 171.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -100.37 108.73 20.82 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.173 -178.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.566 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 12.2 m-85 -102.75 108.01 19.09 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.609 ' HA3' HD22 ' A' ' 71' ' ' LEU . . . -125.55 165.03 18.9 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 119.869 -1.158 . . . . 0.0 112.716 -176.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.1 m -141.66 127.63 18.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.557 -0.321 . . . . 0.0 110.341 177.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -129.73 166.97 18.77 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.137 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.605 ' HA2' ' HD1' ' A' ' 73' ' ' PHE . . . -104.3 -169.27 24.86 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.308 -0.948 . . . . 0.0 112.906 -173.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -84.07 5.5 25.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.058 0.456 . . . . 0.0 110.48 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 87.1 mtp -103.55 -5.71 22.45 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.889 178.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -94.38 168.28 10.99 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.058 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -65.33 126.0 90.57 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.155 176.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.56 ' HA ' ' HB3' ' A' ' 68' ' ' LYS . 53.1 Cg_exo -57.04 -25.68 64.54 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.216 2.61 . . . . 0.0 112.507 -179.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.539 ' HB3' HD22 ' A' ' 42' ' ' LEU . 2.6 m-20 -58.38 -41.97 85.99 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.916 175.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 84.0 t -78.09 -37.96 23.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.862 177.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.56 ' HB3' ' HA ' ' A' ' 65' ' ' PRO . 63.6 tttm -63.19 -22.06 66.62 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.353 -178.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -60.4 -44.02 96.11 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.189 0.519 . . . . 0.0 110.077 173.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 64.6 m-70 -82.04 -39.1 23.98 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.929 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.609 HD22 ' HA3' ' A' ' 57' ' ' GLY . 7.3 mt -115.98 101.16 54.01 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.68 -173.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.526 ' HG2' ' HB2' ' A' ' 75' ' ' LYS . 69.4 Cg_endo -74.87 174.98 11.8 Favored 'Trans proline' 0 CA--C 1.528 0.2 0 C-N-CA 122.701 2.267 . . . . 0.0 112.283 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.605 ' HD1' ' HA2' ' A' ' 60' ' ' GLY . 76.7 t80 -81.2 -21.81 39.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.262 0.553 . . . . 0.0 110.502 -178.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 39.6 m -144.48 119.14 9.78 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.043 178.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.526 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 40.2 tttp -139.59 135.92 33.85 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.321 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 77.8 t -108.75 132.99 55.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.931 0.396 . . . . 0.0 110.145 174.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.508 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 84.9 mt -106.81 132.82 52.34 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.9 176.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 42.2 tp -109.26 100.47 9.59 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.652 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.5 t -116.42 102.94 14.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.585 -175.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 54.57 31.37 14.85 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.705 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.72 -22.27 37.76 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.454 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.541 ' HA ' ' OE1' ' A' ' 109' ' ' GLN . 99.1 t -71.31 122.68 23.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.772 0.32 . . . . 0.0 110.347 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.29 102.94 14.82 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.5 -178.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.508 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 20.4 mt -93.85 110.19 23.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.4 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -93.36 109.47 3.81 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.764 -0.731 . . . . 0.0 111.395 177.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 30.0 mtm -107.11 119.77 40.28 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.716 0.293 . . . . 0.0 110.772 -177.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 49.6 t -145.35 104.43 3.93 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 175.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 49.8 t60 -84.87 66.1 9.51 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.184 0.516 . . . . 0.0 110.368 -177.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -113.78 -145.1 9.03 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.756 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 28.2 t-105 -139.15 164.76 28.94 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -178.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 165.83 161.33 14.62 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.511 -0.852 . . . . 0.0 113.087 177.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.502 ' HB1' ' HD2' ' A' ' 93' ' ' PRO . . . -88.46 162.45 39.54 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 175.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.502 ' HD2' ' HB1' ' A' ' 92' ' ' ALA . 0.9 OUTLIER -43.97 -49.44 8.37 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.366 2.71 . . . . 0.0 113.656 -178.14 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 18.3 p-90 -81.85 -44.18 17.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.877 0.37 . . . . 0.0 111.363 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -59.44 -37.01 77.01 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.543 -177.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 19.9 tp -60.85 -49.18 78.5 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.277 178.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -58.44 -42.62 87.77 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.748 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -64.55 -53.58 45.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.552 -177.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 21.9 ttp-105 -68.79 -40.04 79.84 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -174.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.568 HD13 HG21 ' A' ' 111' ' ' ILE . 65.7 mt -71.71 -32.56 67.91 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.541 -0.464 . . . . 0.0 111.446 -176.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.588 HD21 HG21 ' A' ' 127' ' ' VAL . 86.8 mt -80.62 -12.49 59.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.177 0.513 . . . . 0.0 110.268 175.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -79.78 -40.46 28.64 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.523 173.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 80.3 t -73.75 -52.3 21.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.535 177.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -91.41 103.68 16.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.07 0.462 . . . . 0.0 110.874 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -76.9 -22.92 52.67 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.668 -177.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -66.94 -28.51 68.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.019 176.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.484 ' HG3' HD22 ' A' ' 101' ' ' LEU . 39.5 ttpt 63.76 92.84 0.06 OUTLIER Pre-proline 0 CA--C 1.529 0.162 0 O-C-N 123.985 0.803 . . . . 0.0 109.896 -170.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.445 ' O ' HG22 ' A' ' 127' ' ' VAL . 13.6 Cg_exo -69.37 166.75 26.03 Favored 'Trans proline' 0 N--CA 1.464 -0.228 0 C-N-CA 123.023 2.482 . . . . 0.0 112.859 -174.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.541 ' OE1' ' HA ' ' A' ' 82' ' ' VAL . 75.1 mt-30 -85.32 -49.94 7.75 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.273 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 58.7 t -122.67 132.02 72.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.911 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.568 HG21 HD13 ' A' ' 100' ' ' LEU . 35.3 mt -126.71 132.13 70.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.071 0.462 . . . . 0.0 110.911 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.456 ' HB3' HD11 ' A' ' 36' ' ' LEU . 78.2 mt -105.68 121.18 43.48 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.067 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -132.06 -178.77 5.04 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.747 -178.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -125.69 131.97 7.77 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 121.057 -0.592 . . . . 0.0 111.785 178.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 39.9 t60 -139.57 -68.02 0.43 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 177.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.0 p -143.85 -80.69 0.19 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.851 178.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.435 ' O ' ' HD3' ' A' ' 119' ' ' PRO . 16.5 p-80 -172.24 41.79 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.121 -178.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -103.12 102.02 25.58 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.286 -173.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.698 ' HB3' HD22 ' A' ' 154' ' ' LEU . 59.9 Cg_endo -77.44 41.94 1.06 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.782 2.321 . . . . 0.0 111.469 177.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -97.48 132.46 43.16 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.127 -176.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -78.52 107.07 10.9 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.267 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.601 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 67.8 p -105.35 114.49 28.7 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.141 0.496 . . . . 0.0 110.069 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.2 p -136.51 145.05 31.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.691 -175.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -159.28 -55.98 0.06 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.112 175.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.401 ' O ' ' HD2' ' A' ' 107' ' ' LYS . . . -85.1 23.88 1.18 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.939 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 86.92 -16.93 44.21 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 121.083 -0.58 . . . . 0.0 111.707 -176.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.588 HG21 HD21 ' A' ' 101' ' ' LEU . 15.3 t -87.54 134.05 28.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.636 -0.282 . . . . 0.0 110.618 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 76.9 mtp180 -98.92 104.52 16.56 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.051 175.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.601 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 69.4 m-85 -87.72 124.78 33.93 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.423 HD13 ' CD2' ' A' ' 152' ' ' PHE . 67.8 mt -124.8 134.91 52.59 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.937 0.399 . . . . 0.0 111.454 -174.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -118.08 106.05 46.0 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.569 177.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.448 ' HB2' ' HB3' ' A' ' 8' ' ' SER . 61.3 Cg_endo -75.86 146.27 29.52 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 122.239 1.959 . . . . 0.0 112.683 179.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -73.35 141.76 30.41 Favored Glycine 0 C--N 1.331 0.279 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.809 177.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.462 ' HA ' ' OG ' ' A' ' 8' ' ' SER . 31.1 t -70.14 159.6 33.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.598 0.713 . . . . 0.0 112.632 -174.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.435 ' HG ' ' HG ' ' A' ' 19' ' ' LEU . 3.6 mm? -61.16 -26.65 67.84 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.149 174.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.9 -25.68 67.99 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.344 -178.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -105.02 6.56 33.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.106 0.479 . . . . 0.0 110.351 178.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.435 ' HA2' HD12 ' A' ' 157' ' ' LEU . . . 73.72 44.67 31.06 Favored Glycine 0 N--CA 1.451 -0.352 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.904 177.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 24.6 m -132.0 144.15 50.58 Favored 'General case' 0 C--N 1.321 -0.631 0 O-C-N 122.664 -0.315 . . . . 0.0 110.744 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 44.1 p90 -145.02 160.04 41.99 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 173.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.521 ' HB3' HD23 ' A' ' 6' ' ' LEU . . . -115.72 142.81 46.25 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.722 -175.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.8 ' HB ' ' HE3' ' A' ' 155' ' ' LYS . 51.1 t -126.98 124.8 65.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 175.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.537 HD21 HG13 ' A' ' 150' ' ' VAL . 5.3 tt -109.69 108.0 18.22 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.507 ' HG3' HG12 ' A' ' 142' ' ' VAL . 40.3 mt-10 -110.51 127.09 55.01 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.033 -178.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.547 ' O ' ' HA ' ' A' ' 1' ' ' VAL . 6.7 mp -90.79 105.77 18.05 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.894 0.378 . . . . 0.0 110.385 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -105.6 109.2 21.08 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.744 178.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 68.2 10.69 60.06 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.539 -177.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 98.84 -3.2 58.71 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.369 -177.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -85.1 147.26 26.73 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.723 0.297 . . . . 0.0 110.296 177.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.537 HG13 HD21 ' A' ' 143' ' ' LEU . 60.2 t -88.87 102.97 13.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.965 -175.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 47.6 mtp180 -98.66 94.0 6.41 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 176.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . 0.423 ' CD2' HD13 ' A' ' 130' ' ' LEU . 73.9 t80 -99.83 99.89 10.75 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.971 -179.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.424 ' HB2' ' HE2' ' A' ' 155' ' ' LYS . 49.1 mt-10 -110.88 119.56 39.49 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.203 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.698 HD22 ' HB3' ' A' ' 119' ' ' PRO . 23.2 tp -78.38 109.17 12.3 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 171.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.8 ' HE3' ' HB ' ' A' ' 142' ' ' VAL . 73.7 mttt -105.76 138.83 41.3 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.334 -175.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.7 p -97.55 155.29 17.03 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.224 0.535 . . . . 0.0 112.294 -171.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.548 HD13 ' HG3' ' A' ' 20' ' ' PRO . 61.5 mt . . . . . 0 C--O 1.247 0.959 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.134 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 87.7 t . . . . . 0 N--CA 1.482 1.146 0 CA-C-O 120.811 0.339 . . . . 0.0 110.57 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.568 ' HB2' HD12 ' A' ' 145' ' ' LEU . 6.1 mtpm? -134.12 161.81 33.84 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 176.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.69 ' HB3' ' CD2' ' A' ' 30' ' ' TYR . 92.9 mtt180 -118.7 129.76 55.46 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.747 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.676 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 85.2 m-85 -125.08 119.78 29.61 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.173 0.511 . . . . 0.0 110.557 176.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.562 ' HB3' HG22 ' A' ' 33' ' ' VAL . 23.7 tp -89.19 124.35 34.27 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 178.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.527 HD23 ' HB3' ' A' ' 141' ' ' ALA . 33.5 tp -104.22 98.82 8.57 Favored 'General case' 0 C--O 1.241 0.605 0 CA-C-O 121.584 0.707 . . . . 0.0 111.251 -175.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.473 ' HB ' HD11 ' A' ' 135' ' ' LEU . 13.6 pt -101.17 110.69 28.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 173.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.474 ' HA ' ' HB2' ' A' ' 36' ' ' LEU . 16.2 m -94.36 -97.33 0.16 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -165.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -98.18 120.7 39.05 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.742 0.306 . . . . 0.0 110.365 -171.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.5 ' HB2' HD12 ' A' ' 135' ' ' LEU . 28.8 t -157.45 164.71 37.16 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.946 0.403 . . . . 0.0 111.085 -174.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -138.03 74.72 1.49 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.462 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -126.14 138.42 32.16 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-O 120.841 0.353 . . . . 0.0 110.745 174.297 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.431 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 38.2 Cg_endo -96.22 75.08 0.14 OUTLIER 'Cis proline' 0 N--CA 1.451 -1.022 0 C-N-CA 123.445 -1.481 . . . . 0.0 113.027 -2.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -103.89 -153.57 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 174.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -77.28 82.28 3.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.357 0.598 . . . . 0.0 110.299 178.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 39.2 ttp -161.99 -76.98 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.814 177.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 60.0 10.27 2.13 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.501 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.416 ' O ' ' HD3' ' A' ' 20' ' ' PRO . 3.8 m -80.6 15.25 1.75 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.451 -176.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.406 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 0.7 OUTLIER -102.5 102.59 26.64 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -179.902 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.416 ' HD3' ' O ' ' A' ' 18' ' ' SER . 3.9 Cg_exo -74.32 156.76 46.03 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.879 2.386 . . . . 0.0 112.466 -176.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -63.35 -14.56 51.38 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.75 178.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -61.09 -21.85 64.07 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.943 -177.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -99.62 -28.76 3.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.218 0.532 . . . . 0.0 110.309 176.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.46 ' O ' HD23 ' A' ' 27' ' ' LEU . 48.8 tp -73.03 -28.38 62.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.038 -173.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 -82.06 -11.45 58.78 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.929 0.395 . . . . 0.0 110.425 178.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.477 ' O ' ' HD1' ' A' ' 30' ' ' TYR . 38.8 m -77.78 -5.3 50.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.729 175.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.734 HD13 HG21 ' A' ' 33' ' ' VAL . 3.5 mm? -58.37 -27.09 63.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.45 0.643 . . . . 0.0 109.855 170.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -90.43 9.97 27.02 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.495 -178.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -119.23 -16.06 9.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.899 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.69 ' CD2' ' HB3' ' A' ' 3' ' ' ARG . 89.5 m-85 -119.95 135.62 54.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.965 -178.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -81.81 -23.11 36.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.04 0.448 . . . . 0.0 110.707 -179.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.676 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -130.72 144.94 16.38 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.678 175.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.734 HG21 HD13 ' A' ' 27' ' ' LEU . 95.4 t -139.41 141.18 35.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.56 HG12 ' HB2' ' A' ' 56' ' ' TYR . 48.6 mt -120.55 124.31 72.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.741 -178.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.416 ' HA2' HG13 ' A' ' 7' ' ' ILE . . . -109.19 104.28 1.9 Allowed Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 111.614 -0.594 . . . . 0.0 111.614 177.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.474 ' HB2' ' HA ' ' A' ' 8' ' ' SER . 87.5 mt -84.98 4.22 34.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.915 0.388 . . . . 0.0 111.191 -176.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 153.52 48.64 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.979 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -127.61 155.79 43.31 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 -178.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.507 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 53.3 m-85 49.91 87.81 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.89 0.852 . . . . 0.0 111.753 -173.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.2 m -80.45 3.18 2.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.496 -174.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.489 ' O ' HG23 ' A' ' 45' ' ' VAL . 21.7 t70 -94.36 121.61 36.06 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.251 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.513 HD22 ' HB3' ' A' ' 66' ' ' ASP . 59.8 tp -58.69 -45.4 89.56 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.598 -174.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -54.7 -46.38 74.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.164 0.506 . . . . 0.0 110.601 178.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.585 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 27.1 m -65.46 -31.12 72.04 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.376 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 41' ' ' ASP . 84.7 t -59.77 -44.38 93.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 121.013 0.435 . . . . 0.0 110.57 177.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -67.02 -40.0 84.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-O 121.198 0.523 . . . . 0.0 109.898 177.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -61.32 -35.0 76.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.697 176.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 44' ' ' THR . 83.1 mt -66.39 -35.92 81.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.687 179.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -78.0 -13.87 59.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.1 0.476 . . . . 0.0 110.575 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -81.23 -16.38 52.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.124 0.487 . . . . 0.0 110.394 173.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.56 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . 27.8 m-85 -100.52 -58.76 1.83 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.01 174.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 41.7 t -77.02 101.44 6.03 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.711 174.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -55.85 -40.09 72.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.824 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -113.71 89.85 3.19 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.037 0.446 . . . . 0.0 109.965 172.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -100.25 121.75 41.96 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.147 0.499 . . . . 0.0 110.77 -177.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.56 ' HB2' HG12 ' A' ' 34' ' ' ILE . 92.6 m-85 -118.88 178.44 4.48 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.426 -0.807 . . . . 0.0 109.307 176.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.441 ' C ' HD12 ' A' ' 71' ' ' LEU . . . 159.65 -179.68 35.06 Favored Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 120.141 -1.028 . . . . 0.0 112.685 176.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 15.8 t -140.51 148.37 22.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 -94.66 104.49 16.42 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.027 0.442 . . . . 0.0 110.316 -175.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -116.05 -5.16 17.85 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.155 177.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.493 ' HB3' ' OD1' ' A' ' 63' ' ' ASP . 6.7 m120 -83.4 133.68 34.92 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 74.1 mtm -96.73 10.23 39.34 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.235 0.54 . . . . 0.0 109.804 176.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.493 ' OD1' ' HB3' ' A' ' 61' ' ' ASN . 4.7 m-20 -66.66 -68.32 0.38 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.069 -177.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.479 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 91.8 m-85 -124.52 131.16 24.12 Favored Pre-proline 0 C--O 1.237 0.418 0 CA-C-O 121.167 0.508 . . . . 0.0 111.383 -177.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 64' ' ' TYR . 1.2 Cg_endo -83.74 -3.26 10.54 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 123.725 2.95 . . . . 0.0 112.478 -179.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.513 ' HB3' HD22 ' A' ' 42' ' ' LEU . 8.0 m-20 -67.68 -36.25 80.34 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.448 0.642 . . . . 0.0 109.958 179.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.525 HG12 HD23 ' A' ' 71' ' ' LEU . 30.3 t -76.36 -13.73 14.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.554 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.445 ' HB3' ' O ' ' A' ' 65' ' ' PRO . 87.6 tttt -70.59 -15.99 62.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.492 -175.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -90.36 0.42 57.27 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.82 0.343 . . . . 0.0 111.435 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -123.3 -39.04 2.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.03 0.443 . . . . 0.0 110.611 177.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.525 HD23 HG12 ' A' ' 67' ' ' VAL . 3.4 mm? -103.0 124.25 39.19 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 176.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -84.88 -175.08 1.93 Allowed 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.86 2.374 . . . . 0.0 113.115 -175.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -80.4 -29.46 37.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.38 0.609 . . . . 0.0 110.066 179.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.523 ' HB3' ' CZ ' ' A' ' 104' ' ' PHE . 26.5 m -152.07 137.51 17.66 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.121 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 34.7 tttp -139.29 116.56 11.16 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.926 -176.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.473 HG22 ' HA2' ' A' ' 85' ' ' GLY . 46.6 t -100.25 125.54 53.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 176.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 44.8 mt -103.14 153.58 20.17 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.06 178.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 37.4 tp -115.28 93.45 4.3 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 171.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 46.5 t -106.33 104.2 16.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.354 -173.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 57.21 29.26 16.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.441 178.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.45 -16.18 52.79 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.613 177.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 54.0 t -89.55 123.95 42.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.887 0.375 . . . . 0.0 110.832 -178.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.445 ' HB ' ' HA ' ' A' ' 108' ' ' PRO . 0.0 OUTLIER -80.73 115.87 20.45 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.858 177.259 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 21.0 mt -111.56 99.16 8.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.779 0.324 . . . . 0.0 110.489 -178.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.473 ' HA2' HG22 ' A' ' 76' ' ' VAL . . . -85.12 98.82 2.27 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 178.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 48.8 mtm -90.71 126.46 36.0 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.19 0.519 . . . . 0.0 110.896 -176.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.489 ' SG ' ' HB3' ' A' ' 113' ' ' PHE . 28.5 p -135.73 164.91 26.8 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 9.3 t-80 -83.49 -23.68 32.07 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 119.841 -0.743 . . . . 0.0 109.936 178.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.461 ' HA3' ' HB2' ' A' ' 113' ' ' PHE . . . 82.02 118.07 0.5 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.094 176.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 63.2 t90 -156.24 126.84 6.74 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 176.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 133.07 -166.93 23.55 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.425 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . . . -88.08 124.94 65.79 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.024 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 92' ' ' ALA . 33.7 Cg_exo -58.75 -15.61 27.14 Favored 'Trans proline' 0 N--CA 1.475 0.39 0 C-N-CA 123.224 2.616 . . . . 0.0 113.009 -177.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 4.4 m0 -66.14 -43.14 87.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.79 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -123.95 13.29 9.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.981 0.419 . . . . 0.0 111.23 -177.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 54.8 tp -66.32 -35.37 80.21 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.815 177.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.511 ' HD3' ' HB3' ' A' ' 124' ' ' LYS . 52.1 mttp -59.64 -49.42 77.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.804 177.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -68.17 -36.35 79.49 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.063 -0.972 . . . . 0.0 111.068 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.429 ' O ' HG23 ' A' ' 103' ' ' VAL . 45.8 ttt180 -64.85 -42.39 94.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.922 178.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.509 HD13 HG21 ' A' ' 111' ' ' ILE . 72.9 mt -67.78 -29.19 68.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.683 0.278 . . . . 0.0 111.241 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.512 HD21 HG21 ' A' ' 127' ' ' VAL . 92.2 mt -72.71 -13.72 61.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.014 0.435 . . . . 0.0 110.496 175.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -94.05 -30.88 14.46 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.782 175.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 99' ' ' ARG . 83.9 t -59.59 -50.98 77.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.1 175.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.523 ' CZ ' ' HB3' ' A' ' 74' ' ' SER . 55.8 m-85 -92.34 161.44 14.67 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.389 177.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -94.79 -26.73 16.11 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.303 0.573 . . . . 0.0 110.237 -179.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.405 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 43.2 mt-10 -111.81 152.36 27.97 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.127 175.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.409 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 45.2 mtmt -83.34 113.87 49.32 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-O 120.797 0.332 . . . . 0.0 110.919 -178.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.445 ' HA ' ' HB ' ' A' ' 83' ' ' THR . 2.7 Cg_exo -76.04 124.43 7.96 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.774 2.316 . . . . 0.0 110.465 175.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -61.61 -37.12 82.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.988 0.423 . . . . 0.0 111.389 -176.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 88.7 t -123.94 132.59 71.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 175.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.509 HG21 HD13 ' A' ' 100' ' ' LEU . 37.7 mt -125.17 134.62 66.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.923 0.392 . . . . 0.0 110.651 179.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.555 HD23 ' HB2' ' A' ' 130' ' ' LEU . 96.2 mt -109.29 139.05 44.73 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.928 178.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.503 ' CZ ' ' HB2' ' A' ' 131' ' ' ASN . 6.5 p90 -155.53 122.96 5.54 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 175.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -122.67 114.5 2.47 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.615 -177.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -173.53 21.04 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.495 0.664 . . . . 0.0 109.365 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.497 HG22 ' H ' ' A' ' 118' ' ' GLU . 16.9 m -117.38 154.38 31.42 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.015 -175.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 32.5 m80 -80.85 -27.57 36.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.922 0.391 . . . . 0.0 110.356 -177.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.497 ' H ' HG22 ' A' ' 116' ' ' THR . 46.0 mt-10 -122.03 111.13 32.53 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.263 177.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -57.49 141.94 95.21 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.767 2.312 . . . . 0.0 111.897 177.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -154.68 142.29 19.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.973 0.416 . . . . 0.0 111.367 -173.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -98.24 124.3 42.77 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.382 172.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.562 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 69.8 p -129.11 129.7 45.52 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.06 0.457 . . . . 0.0 111.48 -176.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.7 p -126.86 140.66 48.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.668 175.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.511 ' HB3' ' HD3' ' A' ' 97' ' ' LYS . 71.5 tttt -155.79 -56.34 0.09 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.416 0.627 . . . . 0.0 110.308 -179.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -94.88 30.85 1.97 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.746 -175.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 79.54 -42.21 2.4 Favored Glycine 0 N--CA 1.451 -0.304 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 -173.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.512 HG21 HD21 ' A' ' 101' ' ' LEU . 89.3 t -60.24 136.68 23.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-N 115.213 -0.494 . . . . 0.0 110.825 176.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.402 ' HE ' ' HB2' ' A' ' 128' ' ' ARG . 20.3 ttm180 -97.21 112.55 24.3 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.947 178.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.562 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 82.7 m-85 -97.76 108.26 20.94 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.102 -178.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.555 ' HB2' HD23 ' A' ' 112' ' ' LEU . 81.9 mt -99.8 115.6 29.93 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.294 -178.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.503 ' HB2' ' CZ ' ' A' ' 113' ' ' PHE . 22.7 t-20 -108.2 112.11 61.48 Favored Pre-proline 0 C--N 1.32 -0.713 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.187 -178.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -92.1 174.95 2.1 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 123.435 2.757 . . . . 0.0 111.413 169.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -112.85 -172.38 18.54 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.411 -0.899 . . . . 0.0 112.739 -177.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 38.0 m -78.9 153.94 30.1 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.642 0.258 . . . . 0.0 110.508 178.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.5 HD12 ' HB2' ' A' ' 10' ' ' SER . 73.5 mt -78.38 -10.69 59.79 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -173.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -96.49 -60.3 1.64 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.958 0.408 . . . . 0.0 111.412 -177.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -106.02 22.09 16.23 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.216 -173.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.471 ' O ' ' HB2' ' A' ' 157' ' ' LEU . . . -146.72 -164.76 11.23 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.348 -178.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 15.2 p -112.66 148.84 33.82 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.722 -0.103 . . . . 0.0 110.722 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -97.2 168.83 10.19 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 -177.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.527 ' HB3' HD23 ' A' ' 6' ' ' LEU . . . -121.27 149.43 42.9 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.016 0.436 . . . . 0.0 111.171 -174.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 69.5 t -122.36 126.98 74.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 173.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.739 HD21 HG13 ' A' ' 150' ' ' VAL . 3.7 tt -110.19 104.55 13.4 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -109.28 143.86 38.2 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.568 HD12 ' HB2' ' A' ' 2' ' ' LYS . 91.1 mt -98.66 101.66 13.15 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.199 0.523 . . . . 0.0 110.667 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.668 ' HB3' ' HE ' ' A' ' 151' ' ' ARG . 12.2 t70 -96.35 114.55 26.24 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.879 178.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.83 -69.06 0.3 Allowed Glycine 0 C--N 1.331 0.287 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.596 -175.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -174.92 26.92 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 178.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -126.78 147.01 50.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.834 0.349 . . . . 0.0 110.22 -177.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.739 HG13 HD21 ' A' ' 143' ' ' LEU . 92.2 t -76.83 113.35 15.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.342 -176.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.668 ' HE ' ' HB3' ' A' ' 146' ' ' ASP . 38.8 mmt180 -97.09 108.84 21.65 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.154 176.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -90.66 94.5 9.72 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 177.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -100.67 102.69 13.87 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.01 -178.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 26.7 tp -83.72 130.51 34.95 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.173 -178.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -123.52 138.89 54.48 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 3.1 m -81.91 156.36 24.82 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.191 0.519 . . . . 0.0 111.705 -169.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.471 ' HB2' ' O ' ' A' ' 138' ' ' GLY . 88.6 mt . . . . . 0 C--O 1.247 0.945 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.496 176.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 47.1 t . . . . . 0 N--CA 1.477 0.896 0 CA-C-O 120.982 0.42 . . . . 0.0 110.867 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.615 ' HB2' ' HB2' ' A' ' 145' ' ' LEU . 92.7 mttt -109.47 151.02 27.27 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 170.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.51 ' O ' ' HB3' ' A' ' 30' ' ' TYR . 96.1 mtt180 -133.58 113.89 12.93 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.064 0.459 . . . . 0.0 110.841 178.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.527 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 49.3 m-85 -104.3 125.85 50.9 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.166 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.484 HD22 ' HB2' ' A' ' 26' ' ' SER . 37.8 tp -89.75 120.05 30.68 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.143 176.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.542 ' HB3' ' HB3' ' A' ' 141' ' ' ALA . 57.6 tp -102.57 110.74 22.78 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.875 0.369 . . . . 0.0 110.266 178.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.572 HG22 HD13 ' A' ' 23' ' ' ILE . 18.1 pt -101.18 122.03 52.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.462 0.649 . . . . 0.0 109.601 177.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.3 m -77.81 -165.37 0.62 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.94 -173.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -55.03 122.48 11.02 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.433 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.496 ' HB2' ' O ' ' A' ' 38' ' ' ASP . 19.3 m -126.99 159.23 34.72 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.622 178.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.481 ' H ' ' HE1' ' A' ' 16' ' ' MET . 89.4 m-70 -140.49 43.7 1.87 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 -176.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.499 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . 46.0 t -93.1 129.76 38.32 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.147 -179.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.499 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 83.8 Cg_endo -103.38 27.75 10.8 Favored 'Cis proline' 0 N--CA 1.455 -0.754 0 C-N-CA 124.44 -1.067 . . . . 0.0 112.36 -3.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.8 t -47.55 -60.74 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 O-C-N 123.744 0.653 . . . . 0.0 111.996 -175.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 62.3 ttt180 -142.49 11.23 1.89 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.722 0.773 . . . . 0.0 109.619 -178.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.481 ' HE1' ' H ' ' A' ' 11' ' ' HIS . 58.0 ttp -143.08 121.52 12.39 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.216 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -117.57 -0.49 11.87 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.994 0.426 . . . . 0.0 110.805 -177.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.0 t -108.4 88.66 2.78 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.623 -178.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.0 tt -107.88 120.45 47.05 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 175.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.577 ' HG2' HD13 ' A' ' 157' ' ' LEU . 76.4 Cg_exo -41.17 116.89 0.49 Allowed 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 124.107 3.205 . . . . 0.0 114.213 -174.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -61.22 -30.37 70.39 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.596 176.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -54.63 -36.71 64.8 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.095 178.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.572 HD13 HG22 ' A' ' 7' ' ' ILE . 0.6 OUTLIER -85.11 -28.69 6.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.192 0.52 . . . . 0.0 110.334 -178.711 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 44.7 tp -70.6 -30.01 66.57 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.944 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -72.48 -21.33 61.23 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.373 175.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.548 ' HB3' ' CD2' ' A' ' 30' ' ' TYR . 59.4 m -71.16 -9.69 58.5 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.566 -178.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.521 ' HB3' ' HB3' ' A' ' 51' ' ' PHE . 2.7 mm? -63.48 -24.93 68.03 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 121.159 0.504 . . . . 0.0 109.95 172.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -91.15 -33.2 15.52 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.04 178.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -68.59 -55.52 11.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.644 -178.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.548 ' CD2' ' HB3' ' A' ' 26' ' ' SER . 27.5 m-85 -94.83 150.8 19.81 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.825 -169.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -98.61 7.0 46.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.859 -176.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.527 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -154.39 139.03 6.49 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 175.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.51 HG21 HD13 ' A' ' 27' ' ' LEU . 60.5 t -134.75 140.61 45.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 117.259 0.529 . . . . 0.0 110.649 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.609 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 17.3 mt -125.17 132.76 70.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.467 175.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.409 ' HA2' HG13 ' A' ' 7' ' ' ILE . . . -116.07 129.66 8.61 Favored Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 174.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 90.9 mt -97.11 -7.2 33.24 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.59 0.709 . . . . 0.0 110.341 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 166.52 58.31 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 -177.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.496 ' O ' ' HB2' ' A' ' 10' ' ' SER . 6.1 p-10 -72.27 -111.42 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 123.371 0.668 . . . . 0.0 112.741 -171.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -89.84 148.64 23.06 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.108 -0.331 . . . . 0.0 110.108 -177.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 19.2 m -89.91 -7.78 10.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.265 0.555 . . . . 0.0 110.147 178.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.506 ' O ' HG23 ' A' ' 45' ' ' VAL . 9.2 m-20 -86.6 120.44 27.91 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.666 177.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.559 HD22 ' HB3' ' A' ' 66' ' ' ASP . 43.7 tp -59.74 -42.3 92.87 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.037 0.446 . . . . 0.0 110.12 178.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -57.85 -38.92 76.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.964 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.548 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 17.5 m -74.68 -30.44 61.57 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.18 -178.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 41' ' ' ASP . 48.7 t -66.44 -40.2 85.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.177 0.513 . . . . 0.0 109.915 176.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.17 -35.79 76.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.677 174.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -64.46 -31.58 72.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.007 176.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 44' ' ' THR . 87.9 mt -67.69 -46.91 70.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.947 0.403 . . . . 0.0 110.579 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.51 ' HG2' ' HB3' ' A' ' 55' ' ' PHE . 65.4 mt-10 -70.32 -16.4 62.99 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.499 177.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -81.57 -23.36 37.2 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.057 0.456 . . . . 0.0 109.961 177.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.521 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . 2.0 m-85 -86.51 -67.33 0.82 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.424 178.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.504 ' HB3' HD12 ' A' ' 27' ' ' LEU . 70.7 p -73.0 -34.26 66.3 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.972 -177.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 34.5 mtmm 66.28 12.94 8.93 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.379 -175.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -150.71 102.17 2.99 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.496 178.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.51 ' HB3' ' HG2' ' A' ' 49' ' ' GLU . 74.4 t80 -138.61 121.46 16.54 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.345 0.593 . . . . 0.0 111.275 -173.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.609 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 92.2 m-85 -114.81 167.7 10.55 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 171.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 145.01 -165.65 27.67 Favored Glycine 0 N--CA 1.438 -1.204 0 C-N-CA 119.13 -1.509 . . . . 0.0 113.502 174.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.0 m -153.21 175.54 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 114.555 -0.823 . . . . 0.0 109.117 -175.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.506 ' CD2' ' HG ' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -125.69 104.26 8.27 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 120.426 -0.51 . . . . 0.0 109.9 171.672 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.705 ' HA2' ' HB3' ' A' ' 88' ' ' HIS . . . -86.36 -28.96 26.12 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.555 -177.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 19.9 p30 -85.87 -177.93 6.46 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.93 0.395 . . . . 0.0 111.001 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 64.7 mtt -94.71 127.85 40.98 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.0 0.428 . . . . 0.0 110.791 -176.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.522 ' OD2' ' HB ' ' A' ' 67' ' ' VAL . 4.6 p-10 -149.87 -171.03 3.8 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.936 -175.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -74.23 142.06 78.23 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.737 -176.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.1 -27.95 39.0 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.146 2.564 . . . . 0.0 112.83 -176.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.559 ' HB3' HD22 ' A' ' 42' ' ' LEU . 2.1 m-20 -60.05 -45.31 93.28 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.5 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.522 ' HB ' ' OD2' ' A' ' 63' ' ' ASP . 87.9 t -69.09 -36.28 72.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.104 0.478 . . . . 0.0 110.804 -177.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.653 ' HD3' ' HE1' ' A' ' 73' ' ' PHE . 61.3 mttm -70.75 -2.8 15.86 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.457 -175.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -81.89 -42.88 18.93 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 172.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 52.7 t60 -87.53 -30.01 20.9 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.47 -176.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.506 ' HG ' ' CD2' ' A' ' 59' ' ' HIS . 4.2 mm? -103.02 109.31 61.23 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.041 177.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 71' ' ' LEU . 22.0 Cg_exo -65.4 165.72 21.63 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 123.101 2.534 . . . . 0.0 112.729 -177.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.653 ' HE1' ' HD3' ' A' ' 68' ' ' LYS . 80.3 m-85 -91.28 -23.68 20.08 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.135 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.0 t -155.34 111.83 3.2 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.115 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.0 tttm -131.0 136.98 49.0 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -177.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 14.1 t -117.28 112.25 38.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 120.972 0.415 . . . . 0.0 110.13 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.404 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 63.1 mt -87.77 151.52 22.82 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.5 -178.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 49.5 tp -116.71 96.22 5.39 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 173.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.602 HG12 ' HG2' ' A' ' 80' ' ' GLU . 62.1 t -113.91 108.13 24.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.69 -173.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.602 ' HG2' HG12 ' A' ' 79' ' ' VAL . 13.2 mm-40 63.63 16.34 9.61 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.271 176.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 109.56 -17.97 30.28 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 121.109 -0.567 . . . . 0.0 111.983 -179.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 57.1 t -86.32 133.19 30.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.739 0.304 . . . . 0.0 110.678 -178.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.9 p -89.36 128.16 35.88 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.923 178.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.476 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 36.8 mt -119.72 98.62 6.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.845 0.355 . . . . 0.0 110.244 -177.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -87.39 103.19 2.86 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.974 -0.631 . . . . 0.0 111.697 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 40.7 mtm -101.19 114.77 29.04 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 9.2 t -144.73 162.19 37.34 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.833 0.349 . . . . 0.0 110.817 -173.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.705 ' HB3' ' HA2' ' A' ' 60' ' ' GLY . 41.4 p-80 -84.22 94.54 8.43 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.438 0.637 . . . . 0.0 110.43 178.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -81.0 75.98 2.21 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.461 -0.79 . . . . 0.0 113.005 -176.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -95.11 75.2 3.46 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.893 0.378 . . . . 0.0 110.411 176.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -163.26 175.28 39.56 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.866 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.18 151.35 97.27 Favored Pre-proline 0 C--N 1.326 -0.456 0 C-N-CA 122.171 0.188 . . . . 0.0 110.86 178.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -57.28 -18.75 31.66 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.074 2.516 . . . . 0.0 113.188 -178.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -91.64 -52.64 4.66 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.983 0.42 . . . . 0.0 110.05 178.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -72.5 -11.62 60.74 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.243 -176.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 24.7 tp -56.53 -43.67 80.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.396 177.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 22.2 ttpt -56.83 -49.25 75.97 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.341 177.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.458 ' O ' ' HB2' ' A' ' 102' ' ' LYS . 16.1 t70 -58.06 -51.06 71.23 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.463 -178.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -71.52 -53.22 14.57 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.187 -0.461 . . . . 0.0 112.006 -173.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 49.8 mt -60.63 -48.9 79.71 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 -173.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 90.6 mt -72.68 -11.47 60.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.004 0.431 . . . . 0.0 111.175 -176.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 98' ' ' ASP . 33.6 ttmt -85.47 -26.27 26.4 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.228 0.537 . . . . 0.0 109.633 177.013 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 84.1 t -79.36 -37.79 19.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.138 176.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -76.21 144.57 40.36 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.351 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -82.35 -44.43 16.18 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.865 -179.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.409 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 63.7 mm-40 -111.03 -178.61 3.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.481 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -83.53 112.85 42.8 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.781 177.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.494 ' O ' HG13 ' A' ' 127' ' ' VAL . 1.5 Cg_endo -83.16 119.02 2.72 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.814 2.343 . . . . 0.0 110.969 174.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -64.93 -40.73 95.51 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.26 0.553 . . . . 0.0 109.8 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 93.2 t -121.32 129.46 75.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.221 178.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 29.1 mt -118.87 131.76 70.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 175.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.464 HD23 ' HB2' ' A' ' 130' ' ' LEU . 89.0 mt -110.43 124.52 51.89 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.178 179.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.445 ' CE1' ' HB3' ' A' ' 129' ' ' PHE . 27.9 p90 -145.49 170.64 15.99 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.254 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -131.18 121.64 3.24 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 176.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -163.0 -36.86 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.929 0.395 . . . . 0.0 110.16 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.57 ' HB ' ' ND2' ' A' ' 131' ' ' ASN . 20.8 m -94.07 149.48 21.2 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.908 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 26.9 m80 -79.99 -47.63 14.64 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.929 0.395 . . . . 0.0 110.268 -178.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -82.96 155.77 67.51 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.648 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.408 ' HB3' ' HG ' ' A' ' 154' ' ' LEU . 15.0 Cg_exo -66.96 128.9 19.57 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.563 2.175 . . . . 0.0 111.492 176.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -145.08 138.75 26.88 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.502 -178.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -118.52 128.82 54.94 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 174.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.579 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 72.2 p -128.5 116.21 19.33 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.212 0.53 . . . . 0.0 111.219 -176.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 127' ' ' VAL . 8.6 p -111.61 117.59 55.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 176.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -126.49 -74.57 0.59 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.083 -174.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -85.12 32.28 0.55 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.892 0.377 . . . . 0.0 111.195 -178.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 83.82 -5.69 77.78 Favored Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 -174.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.494 HG13 ' O ' ' A' ' 108' ' ' PRO . 96.8 t -99.28 134.72 37.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.104 -0.548 . . . . 0.0 109.863 178.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -102.43 105.72 16.34 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.095 0.474 . . . . 0.0 110.43 179.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.579 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 51.6 m-85 -84.85 122.12 28.7 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.21 177.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.464 ' HB2' HD23 ' A' ' 112' ' ' LEU . 87.9 mt -109.34 124.06 50.33 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.826 0.346 . . . . 0.0 110.983 -178.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.57 ' ND2' ' HB ' ' A' ' 116' ' ' THR . 4.7 t30 -113.75 111.64 48.55 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.44 174.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -86.58 165.09 9.27 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.921 2.414 . . . . 0.0 112.052 174.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -89.61 139.89 15.35 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.548 -177.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 15.8 m -59.87 156.16 14.89 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.898 0.38 . . . . 0.0 111.324 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -68.05 -3.77 11.27 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 -174.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -86.78 -60.6 1.94 Allowed 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.589 -177.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -125.1 2.01 7.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.818 0.342 . . . . 0.0 111.657 -177.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -106.76 173.36 19.23 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.758 -173.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.563 ' HB3' ' HA ' ' A' ' 156' ' ' THR . 12.5 p -98.6 134.56 41.37 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.526 0.203 . . . . 0.0 110.62 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -84.48 177.18 8.21 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.387 -178.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.542 ' HB3' ' HB3' ' A' ' 6' ' ' LEU . . . -123.31 135.81 54.38 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.2 0.524 . . . . 0.0 111.962 -176.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 74.1 t -118.5 120.33 63.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 173.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.677 ' HA ' ' O ' ' A' ' 151' ' ' ARG . 10.0 mp -111.17 111.08 21.91 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.119 0.485 . . . . 0.0 111.124 -178.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -98.75 134.16 42.05 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.427 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.615 ' HB2' ' HB2' ' A' ' 2' ' ' LYS . 94.2 mt -105.02 102.9 12.38 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.915 177.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -135.23 130.38 35.14 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.878 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.89 11.14 60.15 Favored Glycine 0 CA--C 1.517 0.161 0 C-N-CA 121.178 -0.534 . . . . 0.0 112.443 -176.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 96.47 -13.82 65.06 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.791 178.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -95.34 159.5 14.98 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.047 0.451 . . . . 0.0 111.053 -178.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 10.9 t -101.23 138.0 26.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.584 -177.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.677 ' O ' ' HA ' ' A' ' 143' ' ' LEU . 12.5 tpt180 -109.92 99.5 8.61 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -83.84 104.5 13.98 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.638 178.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.456 ' O ' ' HA ' ' A' ' 141' ' ' ALA . 40.0 mt-10 -116.56 128.99 55.92 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.67 0.271 . . . . 0.0 111.03 176.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.408 ' HG ' ' HB3' ' A' ' 119' ' ' PRO . 3.7 mm? -102.17 106.81 17.71 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 174.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -102.17 130.53 48.83 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.789 0.328 . . . . 0.0 110.56 -175.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.563 ' HA ' ' HB3' ' A' ' 139' ' ' SER . 14.1 p -81.3 145.69 30.77 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -169.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.577 HD13 ' HG2' ' A' ' 20' ' ' PRO . 84.5 mt . . . . . 0 C--O 1.25 1.127 0 CA-C-N 115.142 -0.936 . . . . 0.0 109.68 178.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 38.8 t . . . . . 0 N--CA 1.476 0.865 0 CA-C-O 120.935 0.398 . . . . 0.0 110.04 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -108.67 140.71 41.69 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 178.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.446 ' HG2' ' HG2' ' A' ' 144' ' ' GLU . 92.7 mtt180 -126.89 117.45 22.61 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.125 0.488 . . . . 0.0 111.206 -178.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -107.18 129.88 54.79 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.946 178.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.562 ' HB3' HG22 ' A' ' 33' ' ' VAL . 44.0 tp -89.27 113.31 24.54 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.648 -176.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 64.7 tp -99.16 107.6 20.0 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.196 0.522 . . . . 0.0 110.936 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.466 HG13 ' HA2' ' A' ' 35' ' ' GLY . 27.4 pt -101.32 132.38 47.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 173.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.7 t -81.66 -168.05 1.74 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.822 0.344 . . . . 0.0 110.238 -178.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -63.62 128.04 34.07 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.715 0.769 . . . . 0.0 111.632 -176.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.525 ' OG ' HG12 ' A' ' 12' ' ' VAL . 33.4 t -100.15 155.38 17.78 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.783 176.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.455 ' H ' ' CE ' ' A' ' 16' ' ' MET . 50.3 m-70 -132.62 23.2 4.32 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.172 -177.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.525 HG12 ' OG ' ' A' ' 10' ' ' SER . 7.8 p -114.65 144.65 32.27 Favored Pre-proline 0 C--O 1.241 0.622 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.308 -176.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.435 ' HA ' ' CG2' ' A' ' 12' ' ' VAL . 12.0 Cg_endo -93.59 93.81 0.14 OUTLIER 'Cis proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.847 -1.314 . . . . 0.0 112.816 -5.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.561 HG21 HG11 ' A' ' 40' ' ' VAL . 1.9 t -138.36 -71.89 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.363 0.601 . . . . 0.0 109.678 176.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 40.3 mtp180 -125.08 73.91 1.33 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.297 178.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.455 ' CE ' ' H ' ' A' ' 11' ' ' HIS . 14.4 ttm -177.13 -80.68 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.495 178.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 58.08 14.57 2.76 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.969 -176.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.42 ' H ' ' HG2' ' A' ' 16' ' ' MET . 15.4 m -120.0 32.9 5.83 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.532 -176.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.598 HD11 HD23 ' A' ' 135' ' ' LEU . 7.5 tt -89.17 120.64 69.84 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.708 -179.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 19' ' ' LEU . 16.7 Cg_exo -68.57 126.69 14.45 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 123.114 2.543 . . . . 0.0 112.348 -179.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -66.52 -12.24 56.61 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.777 -177.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.531 ' HB2' HD22 ' A' ' 157' ' ' LEU . 43.6 mt-10 -58.48 -38.26 77.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.264 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.456 HD11 HD11 ' A' ' 5' ' ' LEU . 0.4 OUTLIER -67.52 -29.27 44.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.4 0.619 . . . . 0.0 110.282 -178.59 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.53 ' O ' HD23 ' A' ' 27' ' ' LEU . 38.9 tp -78.27 -12.55 60.01 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.264 -177.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -84.85 -27.39 26.75 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.735 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.447 ' HB3' ' CE2' ' A' ' 30' ' ' TYR . 15.3 m -69.42 -6.37 29.74 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.934 -175.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.666 HD13 HG21 ' A' ' 33' ' ' VAL . 4.4 mm? -58.35 -26.0 62.64 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.745 0.307 . . . . 0.0 111.594 178.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.7 mttp -85.32 -8.27 58.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.286 -175.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -106.54 -22.46 12.77 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -168.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.509 ' CD2' ' HB2' ' A' ' 5' ' ' LEU . 29.5 m-85 -112.2 156.19 22.73 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.476 -0.489 . . . . 0.0 111.79 -172.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -67.03 -55.15 15.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.616 -177.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -136.2 158.51 23.98 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.569 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.666 HG21 HD13 ' A' ' 27' ' ' LEU . 89.2 t -123.4 136.02 61.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 120.996 0.427 . . . . 0.0 110.415 -179.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.466 HG21 ' SD ' ' A' ' 86' ' ' MET . 70.5 mt -115.74 128.88 72.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.919 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.466 ' HA2' HG13 ' A' ' 7' ' ' ILE . . . -121.84 117.82 3.51 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.846 178.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.1 mt -83.69 19.39 1.66 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.418 0.628 . . . . 0.0 110.26 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 153.59 84.78 0.05 OUTLIER Glycine 0 N--CA 1.44 -1.074 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 -177.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.473 ' CG ' ' H ' ' A' ' 39' ' ' TYR . 9.2 t70 -74.75 -165.33 0.35 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.821 0.344 . . . . 0.0 110.829 -173.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.473 ' H ' ' CG ' ' A' ' 38' ' ' ASP . 37.2 m-85 -68.82 149.32 49.1 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.089 -0.338 . . . . 0.0 110.089 -177.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.561 HG11 HG21 ' A' ' 14' ' ' VAL . 24.6 m -68.46 -17.17 21.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -176.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -93.66 125.3 38.2 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.703 0.287 . . . . 0.0 110.481 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.647 HD22 ' HB3' ' A' ' 66' ' ' ASP . 50.8 tp -63.84 -33.46 75.72 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.416 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -59.68 -34.38 72.79 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.36 178.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 20.9 m -78.28 -31.72 49.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.612 178.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.506 HG21 HG13 ' A' ' 67' ' ' VAL . 46.4 t -60.29 -41.38 86.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.38 0.609 . . . . 0.0 109.705 173.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.421 HD13 ' O ' ' A' ' 42' ' ' LEU . 1.6 mp -66.27 -34.28 69.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.07 175.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -61.89 -37.13 83.43 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 174.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -71.52 -42.27 68.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.519 178.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -70.85 -19.57 62.63 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.342 0.592 . . . . 0.0 110.605 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.4 tptm -78.27 -46.88 19.12 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.96 178.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.532 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . 32.4 m-85 -73.36 -55.25 6.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.449 176.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.589 ' HB2' HD12 ' A' ' 27' ' ' LEU . 22.7 t -90.7 98.87 12.03 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.71 174.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -56.14 -35.69 67.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.954 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -110.77 82.75 1.64 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.145 179.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -101.55 124.84 47.87 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.533 -178.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.423 ' HB2' HG12 ' A' ' 34' ' ' ILE . 54.4 m-85 -106.92 117.02 32.95 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.655 ' HA3' HD22 ' A' ' 71' ' ' LEU . . . -117.98 144.12 18.01 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.079 -1.058 . . . . 0.0 113.028 -175.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.414 HG21 ' CB ' ' A' ' 86' ' ' MET . 15.3 t -128.58 144.66 37.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 175.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -97.36 112.57 24.34 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.982 -175.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.697 ' HA3' ' HB3' ' A' ' 88' ' ' HIS . . . -152.53 22.9 0.84 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.407 -0.901 . . . . 0.0 112.556 178.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 23.9 p-10 -136.48 174.25 10.82 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 110.41 -0.218 . . . . 0.0 110.41 -178.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 66.8 mtm -92.55 119.96 32.53 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.678 ' OD2' ' HB ' ' A' ' 67' ' ' VAL . 17.7 p-10 -149.27 -173.5 4.4 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.77 -169.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -81.34 145.26 55.26 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.87 175.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -57.28 -20.74 40.59 Favored 'Trans proline' 0 CA--C 1.532 0.401 0 C-N-CA 122.89 2.393 . . . . 0.0 113.426 -176.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.647 ' HB3' HD22 ' A' ' 42' ' ' LEU . 3.0 m-20 -70.41 -27.69 64.48 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.31 -0.405 . . . . 0.0 112.037 -177.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.678 ' HB ' ' OD2' ' A' ' 63' ' ' ASP . 38.1 t -74.77 -19.15 16.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.113 0.482 . . . . 0.0 110.539 -178.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 63.9 tttt -53.38 -36.39 61.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.702 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -69.84 -27.97 65.29 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.518 -176.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.534 ' CD2' HD11 ' A' ' 42' ' ' LEU . 29.6 m-70 -95.86 -30.65 13.54 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 121.111 -0.235 . . . . 0.0 111.138 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.655 HD22 ' HA3' ' A' ' 57' ' ' GLY . 13.1 mt -110.26 102.36 50.99 Favored Pre-proline 0 C--N 1.326 -0.443 0 C-N-CA 120.931 -0.308 . . . . 0.0 110.755 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.493 ' HD2' ' O ' ' A' ' 57' ' ' GLY . 46.9 Cg_endo -70.12 151.3 66.98 Favored 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.379 2.053 . . . . 0.0 110.734 172.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -63.42 -22.54 66.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.84 0.352 . . . . 0.0 111.635 -175.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 38.6 m -153.82 141.7 20.15 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 175.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 36.1 tttp -144.33 125.32 14.42 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.345 -177.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 11.4 t -111.65 112.61 41.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.865 0.364 . . . . 0.0 110.574 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.417 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 94.0 mt -87.69 144.81 26.45 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.986 -179.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 59.7 tp -112.14 97.37 6.6 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 170.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 41.4 t -110.9 93.45 2.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.091 -176.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 51.18 63.25 2.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.907 179.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.16 -9.43 47.31 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.912 -0.661 . . . . 0.0 113.206 176.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 60.8 t -99.89 115.21 40.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.887 0.375 . . . . 0.0 110.732 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.5 p -86.84 127.06 35.02 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.317 176.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 18.8 mt -119.36 93.25 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -176.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.446 ' O ' HG23 ' A' ' 111' ' ' ILE . . . -81.21 96.09 1.7 Allowed Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.474 ' HG2' HD12 ' A' ' 112' ' ' LEU . 38.3 mtm -96.06 119.13 34.01 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 120.896 0.379 . . . . 0.0 110.242 -176.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 39.2 t -153.22 107.05 3.05 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.993 -178.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.697 ' HB3' ' HA3' ' A' ' 60' ' ' GLY . 64.8 t-80 -91.26 69.27 6.04 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -179.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -85.01 178.73 51.03 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.63 -178.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -132.28 142.98 49.59 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 148.74 -172.68 28.86 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 121.081 -0.58 . . . . 0.0 111.808 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.442 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . . . -76.95 146.1 75.06 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 120.519 0.2 . . . . 0.0 110.741 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 92' ' ' ALA . 15.5 Cg_exo -69.2 -10.55 29.3 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.953 2.435 . . . . 0.0 112.859 -178.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 5.7 m0 -68.48 -44.47 74.68 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.996 0.427 . . . . 0.0 110.625 -178.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -91.49 11.66 23.29 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.807 -178.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 28.3 tp -58.66 -49.54 77.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.047 -178.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.473 ' HD2' ' HB2' ' A' ' 125' ' ' ALA . 28.5 ttpt -61.89 -50.35 72.56 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.65 179.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -60.72 -53.23 59.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.654 -174.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.43 ' O ' HG23 ' A' ' 103' ' ' VAL . 26.8 mtm105 -65.18 -46.36 81.1 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -176.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.529 HD13 HG21 ' A' ' 111' ' ' ILE . 83.5 mt -65.8 -36.76 84.41 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.474 -176.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.672 HD21 HG21 ' A' ' 127' ' ' VAL . 79.6 mt -78.77 -15.69 58.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.778 0.323 . . . . 0.0 110.91 178.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.467 ' HA ' ' HD2' ' A' ' 102' ' ' LYS . 33.4 tptt -86.21 -34.7 20.4 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.076 0.465 . . . . 0.0 110.039 177.102 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 99' ' ' ARG . 73.8 t -74.19 -43.95 50.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.571 174.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -104.54 87.32 2.68 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.88 176.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -71.78 -19.2 62.05 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.423 -173.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -77.4 -14.65 59.66 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.256 -179.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt 63.86 99.29 0.04 OUTLIER Pre-proline 0 C--O 1.232 0.182 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.096 -175.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -76.24 144.36 26.25 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.601 2.201 . . . . 0.0 110.938 175.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -72.49 -41.9 65.47 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.137 0.494 . . . . 0.0 109.836 178.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 90.0 t -116.32 130.14 71.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.583 177.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.529 HG21 HD13 ' A' ' 100' ' ' LEU . 30.6 mt -125.08 128.45 72.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 120.774 0.321 . . . . 0.0 110.677 178.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.474 HD12 ' HG2' ' A' ' 86' ' ' MET . 92.1 mt -99.98 119.22 37.91 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -138.59 -174.74 3.91 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.81 -175.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.581 ' HA2' ' ND2' ' A' ' 131' ' ' ASN . . . -147.75 151.77 23.96 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 175.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -136.64 179.1 6.57 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 117.195 0.498 . . . . 0.0 109.937 177.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.3 p -73.92 11.26 0.92 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -171.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 -144.75 -172.12 3.76 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 122.131 -0.356 . . . . 0.0 111.045 -178.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -60.6 155.48 49.86 Favored Pre-proline 0 C--N 1.329 -0.316 0 O-C-N 123.839 0.712 . . . . 0.0 112.695 -172.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -47.03 144.78 8.09 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 124.441 3.428 . . . . 0.0 113.266 178.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -165.7 144.03 5.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.267 -176.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -102.54 135.78 43.56 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 173.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.479 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 57.8 p -137.72 158.02 45.25 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.908 -174.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.495 ' HA ' ' O ' ' A' ' 127' ' ' VAL . 85.2 t -132.54 115.2 24.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.939 0.4 . . . . 0.0 110.425 176.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.632 ' HB2' ' HE2' ' A' ' 129' ' ' PHE . 75.4 mmtt -125.58 125.62 43.47 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.483 177.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.473 ' HB2' ' HD2' ' A' ' 97' ' ' LYS . . . 65.1 9.24 5.36 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 123.64 0.588 . . . . 0.0 111.779 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 104.11 -4.2 44.86 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.409 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.672 HG21 HD21 ' A' ' 101' ' ' LEU . 52.5 t -90.19 134.36 29.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 179.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 51.8 ttt180 -96.45 105.82 17.96 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.147 0.499 . . . . 0.0 110.18 -177.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.632 ' HE2' ' HB2' ' A' ' 124' ' ' LYS . 58.7 m-85 -94.63 126.52 39.98 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.88 -178.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.449 ' HB2' HD23 ' A' ' 112' ' ' LEU . 53.6 mt -115.26 120.91 41.26 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.754 0.311 . . . . 0.0 110.638 -178.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.581 ' ND2' ' HA2' ' A' ' 114' ' ' GLY . 3.7 t-20 -108.02 115.99 57.72 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.471 174.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.413 ' HD2' HD22 ' A' ' 131' ' ' ASN . 85.8 Cg_endo -83.78 164.87 13.84 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.745 2.297 . . . . 0.0 112.234 174.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -73.99 153.71 47.25 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.442 175.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 96.0 p -81.28 160.33 24.25 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.061 0.458 . . . . 0.0 110.999 -176.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.598 HD23 HD11 ' A' ' 19' ' ' LEU . 5.9 mp -74.11 -0.17 15.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.1 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -97.19 -10.57 25.6 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.586 178.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -100.83 -6.03 25.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.108 0.48 . . . . 0.0 110.816 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 74.86 38.45 41.71 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.19 -179.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 25.2 m -139.31 145.84 39.59 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.447 ' O ' HD12 ' A' ' 154' ' ' LEU . 23.9 p90 -139.73 160.03 40.83 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 178.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -114.33 125.97 54.48 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.051 0.453 . . . . 0.0 110.352 -175.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 48.0 t -102.99 121.44 54.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 177.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.417 HD21 HG13 ' A' ' 150' ' ' VAL . 6.3 tt -94.67 101.21 13.05 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.446 ' HG2' ' HG2' ' A' ' 3' ' ' ARG . 60.1 mt-10 -95.32 117.62 30.63 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.459 -178.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 72.0 mt -90.67 90.19 7.85 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 172.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.526 ' HB3' ' HD3' ' A' ' 151' ' ' ARG . 35.3 t70 -115.57 130.11 56.75 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.844 -174.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 68.13 -59.51 0.4 Allowed Glycine 0 CA--C 1.521 0.446 0 O-C-N 123.584 0.553 . . . . 0.0 112.337 -171.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 164.9 33.39 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 176.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -126.53 155.55 42.2 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.631 0.253 . . . . 0.0 110.675 -176.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.417 HG13 HD21 ' A' ' 143' ' ' LEU . 29.0 t -86.88 95.03 4.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.524 176.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.526 ' HD3' ' HB3' ' A' ' 146' ' ' ASP . 35.0 mtp-105 -105.82 92.31 4.11 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.53 -175.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -90.54 122.17 33.12 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.198 0.523 . . . . 0.0 109.774 178.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.461 ' HB2' ' HE3' ' A' ' 155' ' ' LYS . 57.9 mt-10 -116.04 127.38 54.85 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.132 177.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.447 HD12 ' O ' ' A' ' 140' ' ' TYR . 38.7 tp -90.49 112.17 23.72 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.461 ' HE3' ' HB2' ' A' ' 153' ' ' GLU . 85.8 mttt -117.09 145.49 43.73 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.78 -173.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 3.5 p -96.65 150.58 20.51 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.321 0.581 . . . . 0.0 112.37 -171.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.531 HD22 ' HB2' ' A' ' 22' ' ' GLU . 91.1 mt . . . . . 0 C--O 1.249 1.03 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.952 177.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 60.3 t . . . . . 0 N--CA 1.48 1.03 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.662 ' HB2' HD12 ' A' ' 145' ' ' LEU . 98.8 mttt -85.47 130.42 34.59 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.151 0.501 . . . . 0.0 110.288 178.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 56.0 mtp180 -111.2 116.88 31.81 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.947 -178.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.576 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 18.3 m-85 -103.93 125.51 50.38 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.452 0.644 . . . . 0.0 111.102 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.535 ' HB3' HG22 ' A' ' 33' ' ' VAL . 36.0 tp -89.12 133.22 34.47 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.078 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.491 ' HB2' HD21 ' A' ' 143' ' ' LEU . 56.0 tp -121.72 111.96 17.81 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.835 0.35 . . . . 0.0 110.789 178.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.446 HG13 ' HA2' ' A' ' 35' ' ' GLY . 27.9 pt -101.45 128.74 53.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 174.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.556 ' H ' HD21 ' A' ' 135' ' ' LEU . 12.2 t -76.06 -171.44 1.69 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.852 -174.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.654 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 18.0 t0 -62.14 104.46 0.48 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.757 -177.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.434 ' H ' ' HA3' ' A' ' 37' ' ' GLY . 26.7 t -97.18 153.79 17.78 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.625 -177.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 13.8 m80 -134.8 65.39 1.57 Allowed 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.436 ' O ' HG22 ' A' ' 40' ' ' VAL . 64.8 t -118.8 130.09 25.02 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.617 -176.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -76.41 -52.12 0.16 OUTLIER 'Cis proline' 0 C--N 1.343 0.254 0 C-N-CA 123.192 -1.587 . . . . 0.0 112.21 -3.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 37.9 t 49.14 -93.37 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 O-C-N 123.858 0.724 . . . . 0.0 110.81 -178.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -155.56 25.93 0.4 Allowed 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.453 0.644 . . . . 0.0 109.773 171.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 52.5 ttp -109.75 -75.74 0.62 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 176.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.407 ' HA ' HG22 ' A' ' 12' ' ' VAL . . . 63.45 -6.48 0.21 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.443 -0.799 . . . . 0.0 113.133 175.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.3 p -78.63 58.06 2.16 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.64 0.733 . . . . 0.0 111.094 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.8 tt -107.93 112.78 61.59 Favored Pre-proline 0 N--CA 1.447 -0.604 0 CA-C-N 115.116 -0.947 . . . . 0.0 108.544 176.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -53.51 120.62 8.1 Favored 'Trans proline' 0 CA--C 1.528 0.202 0 C-N-CA 123.063 2.509 . . . . 0.0 112.868 -177.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -61.01 -29.8 69.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.174 -177.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -64.78 -25.01 67.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.663 -177.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.509 HD11 ' CG ' ' A' ' 140' ' ' TYR . 1.2 tt -68.49 -32.52 55.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.266 0.555 . . . . 0.0 109.531 178.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.566 ' HA ' HD23 ' A' ' 27' ' ' LEU . 24.4 tp -77.79 -35.33 51.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.104 -177.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -71.47 -26.44 62.71 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.626 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 42.9 m -81.69 2.05 31.45 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.588 -177.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.566 HD23 ' HA ' ' A' ' 24' ' ' LEU . 2.9 mm? -54.52 -31.31 56.0 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.043 0.449 . . . . 0.0 111.203 177.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -74.35 -15.98 60.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.275 -175.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -96.16 5.29 51.39 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.941 0.401 . . . . 0.0 111.679 -175.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -119.67 169.9 9.68 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 177.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -105.19 -56.2 2.21 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.233 0.54 . . . . 0.0 109.913 -178.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.576 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -117.36 146.7 18.79 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 175.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.561 HG21 ' CD1' ' A' ' 27' ' ' LEU . 72.8 t -130.03 134.87 62.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 117.315 0.557 . . . . 0.0 111.109 -177.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.567 HG12 ' HB2' ' A' ' 56' ' ' TYR . 36.2 mt -114.91 125.71 72.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.373 177.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.446 ' HA2' HG13 ' A' ' 7' ' ' ILE . . . -109.41 103.43 1.76 Allowed Glycine 0 N--CA 1.441 -0.979 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.716 174.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.4 ' HG ' HD11 ' A' ' 6' ' ' LEU . 84.5 mt -74.1 -28.69 61.48 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.654 ' HA3' ' HA ' ' A' ' 9' ' ' ASP . . . -145.92 109.12 0.49 Allowed Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.063 173.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.417 ' OD2' HG22 ' A' ' 45' ' ' VAL . 15.2 p-10 -98.98 -154.39 0.46 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 120.843 0.354 . . . . 0.0 110.893 -175.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.412 ' HE2' HD21 ' A' ' 48' ' ' LEU . 97.3 m-85 -88.83 137.35 32.4 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 -179.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.436 HG22 ' O ' ' A' ' 12' ' ' VAL . 11.5 m -76.18 4.83 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.029 0.442 . . . . 0.0 111.611 -174.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.513 ' O ' HG23 ' A' ' 45' ' ' VAL . 17.5 t70 -105.63 123.76 48.44 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.148 177.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.491 HD22 ' HB3' ' A' ' 66' ' ' ASP . 44.8 tp -59.04 -43.49 91.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 0.0 112.278 -172.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -62.03 -37.72 85.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.1 0.476 . . . . 0.0 110.57 -178.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 20.8 m -70.82 -27.96 64.26 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.844 178.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 41' ' ' ASP . 61.8 t -62.88 -40.71 89.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-O 121.487 0.66 . . . . 0.0 109.588 173.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.36 -35.26 74.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.143 177.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.79 -31.92 72.99 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.596 175.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.412 HD21 ' HE2' ' A' ' 39' ' ' TYR . 95.3 mt -67.69 -41.74 83.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.098 0.475 . . . . 0.0 110.061 178.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -71.97 -14.89 62.03 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.108 176.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -82.47 -45.69 14.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.33 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -70.85 -65.43 0.74 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.991 0.424 . . . . 0.0 110.408 173.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.492 ' HB3' HD12 ' A' ' 27' ' ' LEU . 8.9 p -90.44 96.17 10.53 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.92 174.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -62.31 -33.03 73.89 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.459 -179.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -98.3 79.36 2.53 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.495 0.664 . . . . 0.0 109.457 171.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -100.33 127.6 46.6 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.612 -177.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.567 ' HB2' HG12 ' A' ' 34' ' ' ILE . 76.1 m-85 -117.28 169.94 9.08 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 175.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 153.96 -172.22 32.64 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 119.355 -1.402 . . . . 0.0 113.609 175.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.504 HG13 ' HE3' ' A' ' 86' ' ' MET . 0.2 OUTLIER -144.27 -169.2 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 114.856 -0.672 . . . . 0.0 109.871 -177.494 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.472 ' NE2' ' HG2' ' A' ' 68' ' ' LYS . 57.0 t-80 -94.48 130.83 40.71 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.798 0.332 . . . . 0.0 111.235 -173.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -75.15 -158.83 7.02 Favored Glycine 0 CA--C 1.522 0.471 0 CA-C-N 115.731 -0.668 . . . . 0.0 113.249 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -73.05 -73.12 0.22 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -176.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 50.0 ttm -131.71 129.48 40.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.821 0.344 . . . . 0.0 110.361 -177.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.522 ' OD2' ' HB ' ' A' ' 67' ' ' VAL . 23.0 p-10 -145.52 -162.93 1.61 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.681 -173.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.407 ' HD2' ' O ' ' A' ' 40' ' ' VAL . 76.5 m-85 -103.44 155.19 37.14 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.521 173.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -48.88 -34.47 28.53 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.281 2.654 . . . . 0.0 113.374 -176.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.491 ' HB3' HD22 ' A' ' 42' ' ' LEU . 35.7 m-20 -58.09 -39.18 77.94 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.558 -177.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.522 ' HB ' ' OD2' ' A' ' 63' ' ' ASP . 60.7 t -80.08 -31.15 13.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.518 -177.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.472 ' HG2' ' NE2' ' A' ' 59' ' ' HIS . 93.5 mttt -60.05 -28.03 67.43 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.494 0.664 . . . . 0.0 110.233 175.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -72.8 -47.28 47.87 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.177 177.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -84.16 -35.44 23.58 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.868 -0.606 . . . . 0.0 112.278 -169.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.49 HD23 HG13 ' A' ' 67' ' ' VAL . 4.5 mm? -100.56 117.06 63.54 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-O 120.635 0.255 . . . . 0.0 110.995 -178.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -68.86 146.25 65.14 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.808 2.339 . . . . 0.0 111.398 176.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -72.75 -29.65 63.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.856 0.36 . . . . 0.0 110.931 -176.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 18.1 m -150.02 132.77 15.94 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.404 178.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -150.65 144.35 25.16 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 5.9 t -110.0 133.23 55.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 175.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 69.8 mt -111.63 153.97 25.56 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.584 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 45.0 tp -116.69 99.23 6.99 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 174.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 63.8 t -113.58 109.19 27.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.712 -175.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.82 ' HG3' HD13 ' A' ' 145' ' ' LEU . 5.0 mm-40 57.25 30.27 18.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.137 178.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.72 -7.91 59.58 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.006 -0.616 . . . . 0.0 113.064 178.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.587 HG21 HG23 ' A' ' 150' ' ' VAL . 61.5 t -101.56 136.19 34.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.864 0.332 . . . . 0.0 111.256 -176.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -88.51 130.15 35.29 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.331 178.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 20.0 mt -118.78 99.62 8.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.892 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -84.27 106.66 2.92 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 111.084 -0.807 . . . . 0.0 111.084 177.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.504 ' HE3' HG13 ' A' ' 58' ' ' VAL . 36.5 mtm -104.12 132.05 50.77 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.997 0.427 . . . . 0.0 111.104 -175.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.484 ' O ' ' HA ' ' A' ' 113' ' ' PHE . 37.6 t -155.61 165.17 37.36 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 175.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 31.9 t-80 -76.5 -36.81 57.57 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.52 175.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.2 128.94 1.7 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.473 178.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 31.8 t-105 -156.67 141.08 16.67 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 178.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 123.46 177.53 15.14 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.601 -177.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.14 139.06 92.41 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.637 0.218 . . . . 0.0 110.499 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -56.79 -23.1 48.44 Favored 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 123.126 2.551 . . . . 0.0 113.206 -175.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -77.12 -54.34 6.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.224 0.535 . . . . 0.0 110.294 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -87.73 -8.1 56.5 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.717 -174.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 59.4 tp -59.18 -39.07 81.37 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.416 176.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -60.93 -40.63 93.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.992 178.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -69.62 -39.86 76.92 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.628 177.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.455 ' O ' HG23 ' A' ' 103' ' ' VAL . 78.4 ttt180 -67.89 -41.49 82.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.248 -177.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.536 HD13 HG21 ' A' ' 111' ' ' ILE . 78.1 mt -69.54 -31.64 69.97 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.618 0.247 . . . . 0.0 111.017 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.63 HD21 HG21 ' A' ' 127' ' ' VAL . 83.4 mt -74.62 -23.37 58.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.138 0.494 . . . . 0.0 110.225 174.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -74.6 -33.47 62.63 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.538 175.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 99' ' ' ARG . 98.5 t -71.9 -55.97 11.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.053 175.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -92.94 91.95 7.64 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.462 177.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -67.5 -25.26 65.77 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.174 -177.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -67.52 -24.18 65.53 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.942 176.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 32.8 mtmm 62.49 93.98 0.05 OUTLIER Pre-proline 0 N--CA 1.463 0.19 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.721 -177.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -76.8 156.85 35.21 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 123.161 2.574 . . . . 0.0 111.721 -177.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -66.03 -42.66 89.31 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.213 0.53 . . . . 0.0 110.16 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.409 HG11 ' CZ ' ' A' ' 152' ' ' PHE . 53.8 t -128.15 139.3 52.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.605 -178.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.536 HG21 HD13 ' A' ' 100' ' ' LEU . 61.0 mt -125.08 130.52 73.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.949 0.404 . . . . 0.0 110.268 176.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.432 HD23 ' HB2' ' A' ' 130' ' ' LEU . 98.0 mt -110.85 131.19 55.25 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.108 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.484 ' HA ' ' O ' ' A' ' 87' ' ' CYS . 37.8 p90 -155.18 172.24 18.47 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.169 -0.468 . . . . 0.0 109.95 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -133.15 114.61 1.41 Allowed Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.385 176.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 63.8 t-80 -171.91 -39.73 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.625 0.25 . . . . 0.0 110.698 -176.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.574 HG22 ' H ' ' A' ' 117' ' ' HIS . 0.2 OUTLIER -75.25 -165.52 0.41 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.987 0.423 . . . . 0.0 111.373 -174.168 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.574 ' H ' HG22 ' A' ' 116' ' ' THR . 93.1 m-70 -94.55 -54.75 3.4 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 111.946 0.351 . . . . 0.0 111.946 -171.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -116.24 167.84 9.69 Favored Pre-proline 0 C--N 1.323 -0.578 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.52 -172.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.696 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 16.2 Cg_exo -69.54 76.56 1.05 Allowed 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.641 2.227 . . . . 0.0 110.092 166.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.446 ' H ' ' HG2' ' A' ' 120' ' ' GLU . 6.9 pt-20 -108.89 142.03 40.1 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.719 -170.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -94.01 99.99 12.2 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.333 175.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.625 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 80.7 p -104.63 113.07 26.42 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.318 0.58 . . . . 0.0 110.677 -178.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 39.6 t -121.81 97.06 4.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.22 -178.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -137.16 33.93 2.57 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.792 177.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.424 ' C ' ' H ' ' A' ' 127' ' ' VAL . . . -166.74 14.88 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.221 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 80.25 -27.64 2.75 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.518 -172.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.63 HG21 HD21 ' A' ' 101' ' ' LEU . 42.3 t -85.82 138.7 18.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.28 -0.46 . . . . 0.0 110.409 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -87.48 107.64 18.66 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 174.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.625 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 92.8 m-85 -88.95 104.18 16.72 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 174.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.432 ' HB2' HD23 ' A' ' 112' ' ' LEU . 49.7 mt -109.19 134.66 51.45 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.181 -173.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.696 ' O ' ' HA ' ' A' ' 119' ' ' PRO . 5.8 t30 -117.76 104.91 48.55 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.268 178.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -70.59 142.72 44.97 Favored 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.805 2.336 . . . . 0.0 112.176 177.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -66.61 152.21 52.4 Favored Glycine 0 N--CA 1.452 -0.285 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.71 -178.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 39.9 m -64.28 138.49 58.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.962 0.411 . . . . 0.0 111.405 -178.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.556 HD21 ' H ' ' A' ' 8' ' ' SER . 74.6 mt -62.47 -31.1 71.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.376 -177.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -66.92 -16.16 64.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.633 -178.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 36.6 tp10 -90.88 1.0 57.34 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.287 0.565 . . . . 0.0 110.478 -178.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 74.94 43.2 28.02 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.248 178.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 57.5 m -152.22 142.17 22.13 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.754 0.311 . . . . 0.0 110.324 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.509 ' CG ' HD11 ' A' ' 23' ' ' ILE . 27.9 p90 -141.43 175.77 9.4 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 177.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.445 ' HB3' HD23 ' A' ' 6' ' ' LEU . . . -114.5 136.66 52.78 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.117 -175.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.477 HG12 ' HG3' ' A' ' 144' ' ' GLU . 21.5 t -118.44 105.86 18.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.879 176.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.742 ' HA ' ' O ' ' A' ' 151' ' ' ARG . 0.3 OUTLIER -95.75 109.4 21.71 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.438 0.637 . . . . 0.0 110.067 176.132 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.477 ' HG3' HG12 ' A' ' 142' ' ' VAL . 47.6 mt-10 -107.11 144.12 34.28 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.157 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.82 HD13 ' HG3' ' A' ' 80' ' ' GLU . 22.0 mt -90.7 90.33 7.91 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.777 -176.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -92.14 101.77 14.3 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.397 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.87 10.18 58.04 Favored Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.996 178.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 110.21 -18.14 28.49 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.821 -177.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -85.22 117.91 24.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.792 0.33 . . . . 0.0 110.482 177.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.587 HG23 HG21 ' A' ' 82' ' ' VAL . 5.3 t -80.31 124.39 38.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.2 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.742 ' O ' ' HA ' ' A' ' 143' ' ' LEU . 59.0 ttt85 -119.35 107.85 13.88 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 177.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . 0.553 ' CE2' HD13 ' A' ' 143' ' ' LEU . 9.3 m-85 -83.16 86.62 6.99 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 177.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -102.5 127.72 49.43 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.418 -175.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.632 HD22 ' HG2' ' A' ' 119' ' ' PRO . 9.2 tp -73.29 139.33 46.03 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.478 -178.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -118.71 132.02 56.15 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.741 176.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 21.0 p -88.57 146.36 25.18 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.162 -179.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 74.2 mt . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.337 -0.84 . . . . 0.0 109.633 178.517 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 95.2 t . . . . . 0 N--CA 1.48 1.06 0 CA-C-O 120.801 0.334 . . . . 0.0 110.391 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.909 ' HB2' ' HB2' ' A' ' 145' ' ' LEU . 72.4 mmtt -122.4 101.7 7.65 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 173.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.518 ' HG2' ' HG2' ' A' ' 144' ' ' GLU . 41.1 mtt180 -110.28 120.59 42.94 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.014 0.435 . . . . 0.0 111.191 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.479 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 86.7 m-85 -116.57 131.25 57.0 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.683 178.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.534 ' HB3' HG22 ' A' ' 33' ' ' VAL . 36.4 tp -89.21 118.78 29.15 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.015 178.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.406 HD11 HD11 ' A' ' 36' ' ' LEU . 51.2 tp -106.11 102.01 11.46 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.066 0.46 . . . . 0.0 110.391 -179.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.3 pt -101.6 121.66 52.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.928 177.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.797 ' HB2' ' HA ' ' A' ' 134' ' ' SER . 16.2 m -68.5 171.17 7.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.039 -179.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -64.02 144.06 57.39 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.287 0.565 . . . . 0.0 110.221 -179.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 68.7 m -143.23 178.96 7.37 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.984 -174.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 32.4 m80 -129.22 79.17 1.9 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.154 0.502 . . . . 0.0 110.472 178.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.431 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -139.06 142.65 33.96 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.379 179.525 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.431 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 18.1 Cg_endo -93.72 97.23 0.14 OUTLIER 'Cis proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.299 -1.542 . . . . 0.0 112.056 -3.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.6 t -116.64 -88.09 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 121.19 -0.204 . . . . 0.0 110.896 -178.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 15' ' ' ARG . 37.9 ttm180 -134.67 -14.39 2.18 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 120.949 0.404 . . . . 0.0 111.077 178.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.58 ' SD ' ' HB2' ' A' ' 136' ' ' ALA . 33.8 ttp -64.9 -71.03 0.2 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.405 177.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 63.16 5.6 2.0 Allowed 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.701 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.438 ' H ' ' HG2' ' A' ' 16' ' ' MET . 49.3 m -85.43 15.32 4.54 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.636 ' HG ' ' HG ' ' A' ' 135' ' ' LEU . 6.2 tt -90.5 111.71 48.99 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.4 132.41 35.8 Favored 'Trans proline' 0 C--O 1.234 0.318 0 C-N-CA 122.815 2.343 . . . . 0.0 112.703 -174.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -68.66 -19.28 64.39 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.302 177.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -56.37 -44.81 80.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.107 175.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.1 tt -70.22 -29.17 38.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.343 -177.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.491 ' O ' HD23 ' A' ' 27' ' ' LEU . 58.8 tp -71.07 -22.87 62.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.251 179.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -82.32 -20.79 36.67 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.184 175.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.8 m -74.02 -9.47 58.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.53 -177.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 1.035 HD13 HG21 ' A' ' 33' ' ' VAL . 2.6 mm? -51.67 -38.66 55.97 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.321 0.582 . . . . 0.0 110.727 176.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -80.36 -17.45 51.9 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.729 -174.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -95.47 2.82 54.58 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -172.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.448 ' HD1' ' HB3' ' A' ' 3' ' ' ARG . 43.2 m-85 -124.27 -176.65 3.56 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.675 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -96.29 -37.99 10.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.034 0.445 . . . . 0.0 110.521 -178.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.479 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -151.58 158.67 27.87 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.035 HG21 HD13 ' A' ' 27' ' ' LEU . 92.3 t -126.36 136.93 59.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 120.938 0.399 . . . . 0.0 110.691 -178.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.511 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 57.4 mt -115.81 112.58 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.097 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -98.21 126.47 8.9 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 178.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.406 HD11 HD11 ' A' ' 6' ' ' LEU . 84.7 mt -99.67 10.85 40.62 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.884 0.342 . . . . 0.0 110.884 -177.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 122.59 43.31 0.39 Allowed Glycine 0 C--N 1.329 0.143 0 C-N-CA 120.995 -0.621 . . . . 0.0 111.733 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.47 -76.01 0.18 Allowed 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 123.24 0.616 . . . . 0.0 112.369 -174.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.505 ' HD2' HD11 ' A' ' 48' ' ' LEU . 92.9 m-85 -86.19 128.48 34.9 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.994 0.426 . . . . 0.0 110.774 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.1 m -91.26 1.34 8.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.375 0.607 . . . . 0.0 110.311 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.513 ' O ' HG23 ' A' ' 45' ' ' VAL . 26.8 t70 -95.73 126.05 40.73 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.815 -178.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.436 HD13 ' HB3' ' A' ' 66' ' ' ASP . 62.3 tp -58.41 -49.64 76.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.589 -176.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -58.14 -42.47 85.92 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.987 -177.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.488 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 10.4 m -67.95 -35.34 78.23 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.156 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 41' ' ' ASP . 89.2 t -61.21 -41.13 88.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 121.272 0.558 . . . . 0.0 110.247 175.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.51 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 1.7 mp -66.99 -38.11 80.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.026 177.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.5 -34.15 73.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.563 176.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.505 HD11 ' HD2' ' A' ' 39' ' ' TYR . 94.8 mt -67.68 -35.61 79.15 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.547 0.689 . . . . 0.0 109.432 177.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.66 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 13.2 tt0 -78.51 -6.24 54.89 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.869 178.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.51 ' HG3' ' O ' ' A' ' 46' ' ' ILE . 29.9 mtpp -95.04 -44.02 7.87 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.605 174.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.517 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . 3.8 m-85 -58.66 -67.9 0.31 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.984 -179.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 51.5 m -87.09 -26.67 23.55 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.559 179.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.66 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 46.4 mttp 72.47 -47.89 0.67 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.266 0.626 . . . . 0.0 111.082 -178.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -81.79 86.58 6.44 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 172.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -119.69 130.11 54.87 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.942 -175.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.511 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 90.7 m-85 -121.26 131.56 54.29 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.089 174.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.475 ' HA3' HD22 ' A' ' 71' ' ' LEU . . . -140.02 151.19 21.99 Favored Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 119.982 -1.104 . . . . 0.0 112.739 -177.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.4 HG12 ' H ' ' A' ' 59' ' ' HIS . 0.5 OUTLIER -112.62 176.47 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 174.65 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.637 ' CD2' ' HA ' ' A' ' 68' ' ' LYS . 61.6 t-80 -94.34 135.38 35.81 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.774 0.321 . . . . 0.0 110.409 -177.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -82.27 -130.98 1.43 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.997 178.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -101.24 -79.21 0.51 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.712 0.292 . . . . 0.0 111.01 -178.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 67.1 mtt -120.68 107.71 13.13 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.984 0.421 . . . . 0.0 110.587 -178.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -132.93 -167.77 1.97 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.213 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -91.23 148.37 37.62 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.863 -179.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.502 ' HA ' ' HB3' ' A' ' 68' ' ' LYS . 6.7 Cg_endo -49.33 -36.43 37.96 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.822 3.015 . . . . 0.0 114.296 -174.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.436 ' HB3' HD13 ' A' ' 42' ' ' LEU . 13.1 m-20 -70.22 -36.97 74.91 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.776 0.322 . . . . 0.0 111.251 -178.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 58.6 t -72.11 -41.69 67.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 174.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.637 ' HA ' ' CD2' ' A' ' 59' ' ' HIS . 79.1 tttt -53.99 -35.7 62.13 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.216 -1.356 . . . . 0.0 111.994 177.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -93.9 -24.07 17.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.645 -176.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -82.95 -36.27 25.32 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.445 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.475 HD22 ' HA3' ' A' ' 57' ' ' GLY . 72.4 mt -103.72 110.59 64.18 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.021 177.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 71' ' ' LEU . 22.9 Cg_endo -61.05 146.91 97.09 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.965 2.444 . . . . 0.0 112.688 -176.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.591 ' HA ' ' HB3' ' A' ' 59' ' ' HIS . 94.2 m-85 -59.97 -34.37 73.19 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.789 -178.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 63.3 m -152.93 146.46 25.0 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 174.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.521 ' HG2' ' N ' ' A' ' 76' ' ' VAL . 41.7 tttm -150.74 171.54 17.02 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -176.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.521 ' N ' ' HG2' ' A' ' 75' ' ' LYS . 38.6 t -125.35 133.77 68.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 169.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.757 ' HB2' ' SD ' ' A' ' 86' ' ' MET . 1.9 tp -105.54 111.55 24.29 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.32 -177.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 47.8 tp -93.34 103.46 15.69 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.729 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 43.3 t -114.78 109.63 29.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.644 -178.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 61.01 13.45 4.6 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.022 177.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 112.48 -10.07 26.19 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.422 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 60.4 t -87.63 134.54 27.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.708 0.29 . . . . 0.0 110.574 178.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.4 p -91.19 118.98 30.9 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.267 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.583 ' HB ' ' HB3' ' A' ' 77' ' ' LEU . 71.1 mt -118.44 104.14 15.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.034 0.445 . . . . 0.0 110.057 179.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -63.31 130.11 40.83 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.708 178.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.757 ' SD ' ' HB2' ' A' ' 77' ' ' LEU . 65.6 mtp -116.73 97.87 6.22 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 -177.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.566 ' O ' ' HA ' ' A' ' 113' ' ' PHE . 31.7 t -143.06 157.59 44.39 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 176.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 8.4 t-160 -92.23 -21.15 20.51 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.193 -0.603 . . . . 0.0 110.184 177.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 117.07 -179.08 17.39 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.084 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 75.6 t-105 -140.1 -69.72 0.4 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.914 0.388 . . . . 0.0 110.245 -179.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 173.52 169.91 36.42 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 53.78 82.22 0.25 Allowed Pre-proline 0 CA--C 1.529 0.167 0 C-N-CA 122.773 0.429 . . . . 0.0 111.221 -178.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -52.17 -33.67 55.34 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.269 2.646 . . . . 0.0 113.188 -174.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 35.5 p90 -67.98 -35.31 78.13 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.469 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -102.74 -16.73 15.89 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.255 0.55 . . . . 0.0 110.652 -173.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 39.5 tp -55.45 -35.25 65.27 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.222 -179.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.423 ' H ' ' HG3' ' A' ' 97' ' ' LYS . 42.3 mttm -59.04 -45.9 89.56 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.59 0.71 . . . . 0.0 109.624 178.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -69.91 -38.83 76.39 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.346 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.504 ' O ' HG23 ' A' ' 103' ' ' VAL . 29.6 mmt180 -61.15 -48.95 79.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.007 177.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.502 HD13 HG21 ' A' ' 111' ' ' ILE . 67.6 mt -61.66 -33.98 74.91 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.692 -177.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 70.3 mt -67.21 -15.24 63.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.793 0.33 . . . . 0.0 111.427 177.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 23.4 mtmm -104.71 -6.15 20.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.117 174.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 99' ' ' ARG . 90.0 t -85.22 -40.13 14.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.25 0.548 . . . . 0.0 109.545 175.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -85.12 171.21 12.2 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.889 178.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 30.8 t30 -91.91 -61.38 1.64 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.091 -176.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -107.6 -176.42 3.06 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.401 -177.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.432 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 96.4 mttt -81.34 111.1 21.96 Favored Pre-proline 0 C--O 1.234 0.282 0 CA-C-O 120.768 0.318 . . . . 0.0 111.101 -175.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 107' ' ' LYS . 3.8 Cg_endo -85.78 147.97 9.57 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.308 2.672 . . . . 0.0 111.847 179.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -81.18 -47.74 13.04 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.259 0.552 . . . . 0.0 110.416 177.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 44.0 t -122.02 147.33 26.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.843 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.502 HG21 HD13 ' A' ' 100' ' ' LEU . 66.3 mt -136.62 130.6 46.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.66 0.267 . . . . 0.0 110.622 175.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.634 HD23 ' HB2' ' A' ' 130' ' ' LEU . 95.0 mt -101.32 141.85 33.58 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.013 175.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.566 ' HA ' ' O ' ' A' ' 87' ' ' CYS . 14.3 p90 -155.85 176.65 12.36 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 172.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -105.56 135.87 12.86 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.807 -177.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.536 ' HB3' ' HB2' ' A' ' 131' ' ' ASN . 11.5 t-160 -151.47 128.4 11.01 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.599 0.237 . . . . 0.0 110.715 -174.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.0 p -74.1 84.3 1.81 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.228 0.537 . . . . 0.0 111.267 178.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 60.7 t60 -176.36 153.55 1.22 Allowed 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -55.97 123.81 55.34 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 174.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.575 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 91.8 Cg_exo -43.13 129.47 5.91 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 124.002 3.134 . . . . 0.0 114.172 -172.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -142.42 155.1 45.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.661 -177.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -95.96 115.44 27.43 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 176.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.517 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 40.5 p -116.41 116.82 28.39 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.121 0.486 . . . . 0.0 112.078 -175.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 43.6 t -114.32 98.25 6.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.969 178.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.425 ' O ' ' HB2' ' A' ' 125' ' ' ALA . 28.4 tptp -144.25 65.44 1.29 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.425 ' HB2' ' O ' ' A' ' 124' ' ' LYS . . . 167.22 -13.07 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.895 -176.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.4 ' H ' ' H ' ' A' ' 125' ' ' ALA . . . 101.49 -12.06 58.21 Favored Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -173.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 47.3 t -107.18 140.67 24.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 114.965 -0.617 . . . . 0.0 110.061 -178.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 55.7 mtt180 -80.3 108.12 13.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.662 0.268 . . . . 0.0 110.654 176.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.517 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 98.2 m-85 -92.89 107.79 19.49 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 176.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.634 ' HB2' HD23 ' A' ' 112' ' ' LEU . 93.0 mt -99.24 116.71 32.06 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.157 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.575 ' O ' ' HA ' ' A' ' 119' ' ' PRO . 4.3 p30 -122.91 109.79 31.82 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.652 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.564 ' HA ' ' HG3' ' A' ' 119' ' ' PRO . 83.7 Cg_endo -88.86 178.36 2.76 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.072 2.514 . . . . 0.0 111.886 175.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.591 ' HA3' ' OE1' ' A' ' 137' ' ' GLU . . . -90.22 -109.01 1.35 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.216 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.797 ' HA ' ' HB2' ' A' ' 8' ' ' SER . 40.4 t -167.8 162.97 14.06 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.337 -0.246 . . . . 0.0 110.337 -179.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.636 ' HG ' ' HG ' ' A' ' 19' ' ' LEU . 3.7 mm? -71.48 -15.67 62.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.093 0.473 . . . . 0.0 109.957 176.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.58 ' HB2' ' SD ' ' A' ' 16' ' ' MET . . . -84.52 -6.82 59.4 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.356 175.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.591 ' OE1' ' HA3' ' A' ' 133' ' ' GLY . 1.8 tm-20 -113.43 -34.67 5.52 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.883 -178.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.537 ' HA2' HD12 ' A' ' 157' ' ' LEU . . . 127.78 -44.53 1.23 Allowed Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.327 -0.939 . . . . 0.0 113.681 175.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.507 ' HB3' HD11 ' A' ' 154' ' ' LEU . 18.6 m -76.81 113.63 14.69 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -175.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.467 ' O ' HD12 ' A' ' 154' ' ' LEU . 54.7 p90 -115.71 156.76 25.36 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 172.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -114.4 138.0 51.12 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.206 0.527 . . . . 0.0 112.016 -169.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 38.3 t -114.74 116.47 52.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 173.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.628 HD21 HG13 ' A' ' 150' ' ' VAL . 3.4 tt -94.72 107.46 19.46 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -177.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.518 ' HG2' ' HG2' ' A' ' 3' ' ' ARG . 32.4 mt-10 -104.06 121.58 43.49 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.35 178.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.909 ' HB2' ' HB2' ' A' ' 2' ' ' LYS . 55.3 mt -96.81 89.97 5.09 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.708 174.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -86.8 124.29 32.88 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.674 179.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 68.01 -68.94 0.32 Allowed Glycine 0 CA--C 1.52 0.401 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.381 -174.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -179.89 30.38 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 121.087 -0.577 . . . . 0.0 111.774 179.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -126.93 145.63 50.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.681 0.277 . . . . 0.0 110.608 -179.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.628 HG13 HD21 ' A' ' 143' ' ' LEU . 58.1 t -77.08 111.96 14.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.669 -179.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 19.8 mtm180 -115.95 115.81 26.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.379 0.609 . . . . 0.0 110.263 177.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -90.92 105.53 17.89 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.948 -176.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.32 113.76 26.69 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -178.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.537 HD22 ' HB2' ' A' ' 119' ' ' PRO . 44.9 tp -94.33 127.15 40.03 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.32 -173.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -114.92 135.42 54.22 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 175.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.2 m -108.22 148.93 29.25 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.764 0.316 . . . . 0.0 110.526 -177.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.537 HD12 ' HA2' ' A' ' 138' ' ' GLY . 97.5 mt . . . . . 0 C--O 1.247 0.965 0 CA-C-O 118.284 -0.865 . . . . 0.0 110.319 179.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.603 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 80.1 t . . . . . 0 N--CA 1.476 0.859 0 CA-C-O 120.858 0.361 . . . . 0.0 110.81 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -126.46 138.71 53.55 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.79 174.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.623 ' HB3' ' HD1' ' A' ' 30' ' ' TYR . 47.3 mtt85 -115.62 111.65 20.97 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.113 0.482 . . . . 0.0 110.631 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.495 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 73.7 m-85 -102.11 121.63 42.57 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.892 -178.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 38.0 tp -89.35 119.33 29.72 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.068 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.706 HD11 ' HG ' ' A' ' 36' ' ' LEU . 59.8 tp -106.05 112.37 25.38 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.088 0.47 . . . . 0.0 111.3 -176.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 27.8 pt -101.43 140.44 20.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.628 175.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.8 p -99.53 -159.5 0.74 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.43 -176.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -48.62 100.6 0.02 OUTLIER 'General case' 0 C--O 1.236 0.375 0 O-C-N 123.803 0.689 . . . . 0.0 112.146 -177.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.47 ' HB2' ' C ' ' A' ' 38' ' ' ASP . 6.9 m -92.51 83.05 4.88 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.963 177.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.539 ' HB2' ' SD ' ' A' ' 16' ' ' MET . 37.2 m80 -76.83 55.68 1.11 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.156 0.503 . . . . 0.0 110.228 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . 2.8 t -127.69 138.31 32.59 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -177.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 27.9 Cg_endo -94.84 56.38 0.87 Allowed 'Cis proline' 0 N--CA 1.453 -0.907 0 C-N-CA 123.61 -1.413 . . . . 0.0 112.724 -2.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.482 HG22 HG21 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -86.0 -162.53 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 176.527 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.401 ' H ' HG12 ' A' ' 14' ' ' VAL . 66.3 mtt85 -77.31 81.74 3.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.83 0.824 . . . . 0.0 110.828 -176.036 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.539 ' SD ' ' HB2' ' A' ' 11' ' ' HIS . 51.1 ttp -164.04 -70.79 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.186 -1.37 . . . . 0.0 108.15 179.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 61.25 2.49 0.62 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.932 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.42 ' H ' ' HG2' ' A' ' 16' ' ' MET . 8.5 m -82.57 38.17 0.55 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.58 -176.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.0 tt -107.96 103.62 50.5 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.483 ' HB2' HD13 ' A' ' 157' ' ' LEU . 23.4 Cg_exo -65.51 126.65 16.55 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.278 1.985 . . . . 0.0 110.89 174.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -64.19 -10.66 24.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.877 -174.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -53.88 -35.29 61.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.986 0.422 . . . . 0.0 110.836 177.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 tt -69.26 -27.98 36.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.453 0.644 . . . . 0.0 110.573 -177.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.413 ' HA ' HD23 ' A' ' 27' ' ' LEU . 55.5 tp -72.64 -29.49 63.5 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.605 -179.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -72.73 -31.02 64.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.927 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.7 p -77.79 1.89 18.8 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -176.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.458 ' HA ' HD13 ' A' ' 27' ' ' LEU . 2.2 mm? -58.05 -36.14 72.35 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.204 0.526 . . . . 0.0 110.714 176.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 32.2 mttt -75.34 -24.43 57.36 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.925 -175.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -88.36 -6.39 57.74 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.162 -165.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.623 ' HD1' ' HB3' ' A' ' 3' ' ' ARG . 98.0 m-85 -122.03 142.04 50.75 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.783 0.325 . . . . 0.0 110.571 -179.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -84.79 -12.75 52.99 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.978 -176.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.495 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -138.42 131.83 5.54 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 175.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 56.2 t -122.58 128.68 75.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 117.119 0.459 . . . . 0.0 110.554 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.548 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 32.1 mt -120.29 133.57 66.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.745 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.68 120.4 3.99 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.57 177.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.706 ' HG ' HD11 ' A' ' 6' ' ' LEU . 82.0 mt -89.73 7.62 35.85 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.272 0.558 . . . . 0.0 110.071 179.135 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 152.11 78.66 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.229 -178.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.47 ' C ' ' HB2' ' A' ' 10' ' ' SER . 8.4 p-10 -82.38 -146.93 0.07 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.46 0.171 . . . . 0.0 111.107 -175.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.523 ' HD2' HD11 ' A' ' 48' ' ' LEU . 77.1 m-85 -60.64 144.8 51.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.168 0.508 . . . . 0.0 111.739 -173.079 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.482 HG21 HG22 ' A' ' 14' ' ' VAL . 27.7 m -82.55 -1.86 5.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.056 -178.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.576 ' O ' HG23 ' A' ' 45' ' ' VAL . 16.0 t70 -103.38 122.16 44.27 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.007 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.502 ' HB2' ' HB3' ' A' ' 66' ' ' ASP . 54.7 tp -55.68 -48.82 74.44 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 123.563 0.54 . . . . 0.0 112.125 -172.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -63.88 -32.17 73.6 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.74 0.305 . . . . 0.0 111.291 -176.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.9 m -76.12 -27.31 57.04 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.731 178.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 41' ' ' ASP . 61.6 t -63.32 -47.54 91.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 121.463 0.649 . . . . 0.0 109.962 174.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.616 HG22 ' HE3' ' A' ' 50' ' ' LYS . 1.7 mp -65.59 -31.83 55.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.842 179.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -57.46 -40.58 78.82 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 173.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.523 HD11 ' HD2' ' A' ' 39' ' ' TYR . 64.3 mt -70.7 -40.72 72.7 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 120.981 0.42 . . . . 0.0 110.316 178.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -61.81 -28.78 69.71 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.785 -178.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.616 ' HE3' HG22 ' A' ' 46' ' ' ILE . 98.4 mttt -72.36 -47.64 47.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.969 177.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -65.99 -48.14 72.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.889 0.376 . . . . 0.0 111.041 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 9.1 m -60.29 -43.05 96.63 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.335 177.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 98.0 mttt 69.52 -53.69 0.6 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.678 0.791 . . . . 0.0 109.942 -171.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.4 mm-40 -107.71 84.71 2.0 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.332 173.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -100.33 114.27 27.63 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.897 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.548 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 25.1 m-85 -105.07 107.93 19.17 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 176.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.461 ' O ' ' HD2' ' A' ' 72' ' ' PRO . . . -129.78 154.26 20.38 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 119.666 -1.254 . . . . 0.0 113.57 -173.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.65 HG21 ' HB3' ' A' ' 86' ' ' MET . 4.8 m -141.48 157.25 21.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 123.067 0.547 . . . . 0.0 109.719 174.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.539 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 64.4 t60 -94.74 104.6 16.52 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.197 0.522 . . . . 0.0 110.373 -178.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 1.036 ' HA2' ' HB3' ' A' ' 88' ' ' HIS . . . -113.58 -29.21 2.98 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.231 175.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 22.4 p-10 -79.67 -169.11 1.81 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.033 -0.583 . . . . 0.0 110.784 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 67.3 mtt -117.54 90.02 3.24 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.003 175.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -107.89 -170.32 1.67 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.022 -177.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -82.44 152.73 67.71 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.52 178.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.605 ' HA ' ' HB3' ' A' ' 68' ' ' LYS . 81.4 Cg_exo -47.07 -32.19 12.91 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.492 2.795 . . . . 0.0 113.772 -178.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.502 ' HB3' ' HB2' ' A' ' 42' ' ' LEU . 3.5 m-20 -58.63 -52.37 65.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.327 0.584 . . . . 0.0 110.668 177.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 19.3 t -75.27 -32.97 27.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.709 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.605 ' HB3' ' HA ' ' A' ' 65' ' ' PRO . 87.7 tttt -60.07 -24.17 64.38 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.067 176.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -93.84 -30.65 14.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.609 176.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -65.56 -43.15 90.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.213 0.53 . . . . 0.0 109.903 175.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.539 ' HB2' ' HB2' ' A' ' 59' ' ' HIS . 78.4 mt -97.89 121.65 57.03 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.326 -179.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.461 ' HD2' ' O ' ' A' ' 57' ' ' GLY . 22.0 Cg_exo -65.88 164.57 26.62 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.867 2.378 . . . . 0.0 112.295 178.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -78.46 -31.68 48.02 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.044 0.449 . . . . 0.0 110.093 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.5 m -151.72 135.49 16.35 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.214 178.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 37.0 tttp -148.37 135.71 20.41 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 10.5 t -115.3 123.77 71.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.884 0.373 . . . . 0.0 110.256 178.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.551 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 78.2 mt -95.62 139.28 32.1 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.223 178.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 37.3 tp -112.31 98.6 7.41 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 174.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.435 HG11 ' CE1' ' A' ' 4' ' ' PHE . 41.0 t -115.1 100.3 10.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.592 -174.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 61.51 28.9 18.1 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.35 178.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.64 -15.71 58.3 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.303 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 57.3 t -83.0 121.69 36.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 120.861 0.362 . . . . 0.0 110.365 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.0 p -87.53 123.28 32.26 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.879 178.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.551 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 24.4 mt -116.02 95.63 3.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -178.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -84.8 109.44 3.27 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.384 179.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.65 ' HB3' HG21 ' A' ' 58' ' ' VAL . 46.8 mtm -106.52 123.73 48.53 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.795 0.331 . . . . 0.0 110.306 -178.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 48.0 t -161.06 165.21 30.08 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.602 -177.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 1.036 ' HB3' ' HA2' ' A' ' 60' ' ' GLY . 10.4 p-80 -88.72 95.81 10.42 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.323 0.582 . . . . 0.0 110.494 176.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.593 ' H ' ' HB2' ' A' ' 113' ' ' PHE . . . -83.29 68.22 3.59 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.793 -177.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.433 ' CD1' ' HB2' ' A' ' 88' ' ' HIS . 88.3 m95 -86.13 85.5 7.35 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.225 0.536 . . . . 0.0 110.185 177.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -176.0 -174.96 42.98 Favored Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.565 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -81.24 140.31 49.06 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -62.85 -14.62 41.99 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.841 2.361 . . . . 0.0 112.522 -176.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 4.0 m0 -73.97 -48.77 28.14 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.489 -178.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -96.77 -1.23 46.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.358 178.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 33.6 tp -59.75 -39.32 84.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.509 179.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -59.87 -42.59 94.07 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.257 178.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.44 ' O ' ' HB2' ' A' ' 102' ' ' LYS . 10.6 t70 -64.58 -49.11 72.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.299 179.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 47.2 ttt85 -60.47 -49.64 76.73 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.735 -176.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.516 HD13 HG21 ' A' ' 111' ' ' ILE . 81.6 mt -78.06 -36.11 48.77 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -174.031 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.726 HD21 HG21 ' A' ' 127' ' ' VAL . 85.2 mt -76.53 -18.75 58.54 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.025 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 98' ' ' ASP . 79.6 tttt -74.1 -29.55 61.9 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.373 0.606 . . . . 0.0 109.461 176.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 70.9 t -86.89 -45.98 16.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.018 176.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -90.99 86.9 6.4 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.847 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -68.27 -21.98 64.77 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.532 -178.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -72.55 -18.66 61.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.442 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 78.1 tttt 62.39 95.84 0.05 OUTLIER Pre-proline 0 N--CA 1.465 0.319 0 O-C-N 123.583 0.552 . . . . 0.0 110.636 -173.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.466 ' O ' HG13 ' A' ' 127' ' ' VAL . 5.6 Cg_exo -79.98 134.9 10.84 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.844 2.363 . . . . 0.0 111.851 178.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -70.8 -35.9 72.76 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.34 0.591 . . . . 0.0 109.533 177.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.604 HG21 HG11 ' A' ' 150' ' ' VAL . 53.5 t -122.87 128.59 75.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.028 178.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.516 HG21 HD13 ' A' ' 100' ' ' LEU . 24.4 mt -122.89 127.99 75.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 120.91 0.386 . . . . 0.0 110.826 177.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 89.3 mt -104.52 124.84 50.0 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.494 176.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.593 ' HB2' ' H ' ' A' ' 89' ' ' GLY . 5.2 p90 -146.88 160.05 42.78 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.807 0.337 . . . . 0.0 110.684 -178.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -105.95 125.74 8.31 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 175.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.475 ' HB2' ' CE2' ' A' ' 113' ' ' PHE . 10.4 t-160 -141.1 -54.84 0.48 Allowed 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 111.744 0.276 . . . . 0.0 111.744 -175.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 20.6 p -123.47 -100.03 0.41 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -173.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.48 ' O ' ' HA2' ' A' ' 133' ' ' GLY . 0.1 OUTLIER -166.66 -43.39 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.798 0.333 . . . . 0.0 111.214 -172.442 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -85.17 165.26 37.47 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.3 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.887 ' HG3' HD22 ' A' ' 154' ' ' LEU . 21.6 Cg_exo -63.23 87.38 0.13 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.281 1.987 . . . . 0.0 111.225 174.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.722 ' HB3' ' HB3' ' A' ' 131' ' ' ASN . 19.3 tt0 -82.34 105.59 13.53 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.541 -176.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -104.87 99.49 9.12 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.418 -175.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.44 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 77.2 p -121.22 118.74 30.37 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.454 -177.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.4 p -116.51 115.44 49.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.35 0.595 . . . . 0.0 110.667 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -137.3 136.08 37.69 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.912 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 65.81 17.86 10.97 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 123.604 0.565 . . . . 0.0 111.199 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 88.23 -7.0 82.85 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.951 -0.642 . . . . 0.0 111.769 -176.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.726 HG21 HD21 ' A' ' 101' ' ' LEU . 63.3 t -93.82 126.91 46.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 35.7 ttt180 -103.66 111.08 23.4 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.068 0.461 . . . . 0.0 110.844 -176.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.442 ' CE1' HD12 ' A' ' 111' ' ' ILE . 19.3 m-85 -92.08 127.15 37.44 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.231 178.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 88.6 mt -120.2 116.76 26.25 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.758 0.313 . . . . 0.0 111.692 -176.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.722 ' HB3' ' HB3' ' A' ' 120' ' ' GLU . 7.3 t30 -94.8 122.51 60.32 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 170.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.559 ' HG3' HD12 ' A' ' 36' ' ' LEU . 84.1 Cg_endo -81.17 167.48 17.74 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.86 2.373 . . . . 0.0 113.165 -177.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 117' ' ' HIS . . . -77.96 145.99 30.39 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.631 177.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.546 ' HB2' ' HG2' ' A' ' 137' ' ' GLU . 15.5 m -78.58 140.45 38.49 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.858 0.361 . . . . 0.0 111.534 -177.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 62.0 mt -56.38 -37.67 70.4 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.476 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.41 -13.79 53.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.835 -176.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.546 ' HG2' ' HB2' ' A' ' 134' ' ' SER . 23.1 mm-40 -97.53 1.1 48.57 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.582 -178.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 71.37 35.73 63.36 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.635 -177.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 18.1 m -139.55 132.74 29.76 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.619 0.247 . . . . 0.0 110.371 -179.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -130.94 164.72 24.7 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 176.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -114.24 143.22 45.19 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.924 0.393 . . . . 0.0 110.731 -173.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 63.0 t -130.82 122.96 53.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.869 178.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.416 HD21 HG13 ' A' ' 150' ' ' VAL . 5.8 tt -99.59 105.39 17.25 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 177.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -100.26 112.57 24.9 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.458 -178.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.603 ' O ' ' HA ' ' A' ' 1' ' ' VAL . 59.8 mt -90.71 90.33 7.9 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.782 176.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.52 ' HA ' HG22 ' A' ' 1' ' ' VAL . 26.7 t70 -101.2 122.63 43.99 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 68.21 -68.92 0.35 Allowed Glycine 0 CA--C 1.519 0.308 0 C-N-CA 121.462 -0.399 . . . . 0.0 112.151 -173.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -176.1 25.9 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 175.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -105.83 134.87 48.26 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 -177.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.604 HG11 HG21 ' A' ' 110' ' ' VAL . 41.1 t -83.82 89.63 2.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.1 0.476 . . . . 0.0 109.869 177.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 27.8 mtp-105 -95.37 96.1 8.9 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.295 -177.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -92.36 104.48 16.81 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.076 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -109.46 154.29 22.84 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.864 -179.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.887 HD22 ' HG3' ' A' ' 119' ' ' PRO . 18.8 tp -114.72 117.16 30.02 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 172.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -104.86 135.12 46.82 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.257 -177.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 16.9 p -96.76 142.08 29.21 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.045 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.483 HD13 ' HB2' ' A' ' 20' ' ' PRO . 82.0 mt . . . . . 0 C--O 1.246 0.895 0 CA-C-O 118.555 -0.736 . . . . 0.0 110.405 -179.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.538 HG12 ' H ' ' A' ' 2' ' ' LYS . 1.4 t . . . . . 0 N--CA 1.481 1.094 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.538 ' H ' HG12 ' A' ' 1' ' ' VAL . 46.5 mttp -128.25 111.93 13.94 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.893 0.378 . . . . 0.0 110.048 168.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.524 ' HG2' ' HG2' ' A' ' 144' ' ' GLU . 59.6 mtt180 -115.1 117.3 30.18 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.472 178.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.476 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 65.6 m-85 -103.67 132.21 50.13 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.854 -179.127 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.517 HD11 HD11 ' A' ' 23' ' ' ILE . 50.1 tp -88.98 114.32 25.48 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.033 179.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 63.3 tp -102.73 107.16 17.95 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.862 0.363 . . . . 0.0 110.703 -178.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.408 ' HB ' HD11 ' A' ' 135' ' ' LEU . 28.7 pt -104.41 126.42 59.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-O 121.342 0.591 . . . . 0.0 109.527 173.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.558 ' HA ' HD12 ' A' ' 36' ' ' LEU . 14.4 m -77.76 -175.57 3.98 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.03 -173.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -69.24 119.38 13.44 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.652 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.605 ' HB2' HD12 ' A' ' 135' ' ' LEU . 70.3 m -156.72 80.62 0.94 Allowed 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.388 -0.824 . . . . 0.0 108.819 178.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.553 ' HB3' HG21 ' A' ' 14' ' ' VAL . 24.1 m80 -60.15 106.77 0.55 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.234 -1.348 . . . . 0.0 113.022 -171.182 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.621 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 2.6 p -140.4 138.07 18.49 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.98 176.089 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -89.42 104.06 0.44 Allowed 'Cis proline' 0 N--CA 1.456 -0.701 0 C-N-CA 123.551 -1.437 . . . . 0.0 112.449 -1.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.553 HG21 ' HB3' ' A' ' 11' ' ' HIS . 13.3 t -128.37 -77.25 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.882 178.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 59.2 mtt180 -134.36 -4.78 2.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.502 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.592 ' SD ' ' HB3' ' A' ' 10' ' ' SER . 56.8 ttp -91.94 -64.51 1.11 Allowed 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 173.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.605 ' HA ' HG23 ' A' ' 12' ' ' VAL . . . 69.39 -21.16 0.16 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.58 176.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.416 ' H ' ' C ' ' A' ' 16' ' ' MET . 22.8 t -105.27 78.55 1.39 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.047 0.451 . . . . 0.0 110.959 -176.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.2 tt -108.04 116.78 56.45 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 173.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.423 ' O ' HG22 ' A' ' 23' ' ' ILE . 32.5 Cg_exo -59.74 111.34 0.93 Allowed 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.564 2.176 . . . . 0.0 111.667 177.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -79.48 7.56 7.9 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -172.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -64.76 -35.38 80.9 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.337 0.589 . . . . 0.0 109.794 173.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.517 HD11 HD11 ' A' ' 5' ' ' LEU . 12.9 tt -70.33 -39.92 77.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.758 0.789 . . . . 0.0 109.807 177.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.463 ' O ' HD22 ' A' ' 27' ' ' LEU . 40.5 tp -73.04 -3.99 29.65 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.327 -1.306 . . . . 0.0 110.594 177.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -100.23 -24.81 14.46 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.289 0.566 . . . . 0.0 110.117 175.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 25.9 m -97.03 -6.81 34.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.829 -174.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.918 ' HA ' ' HD2' ' A' ' 30' ' ' TYR . 1.5 pt? -66.45 -13.27 60.55 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.941 0.401 . . . . 0.0 111.316 -175.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -65.43 -27.35 68.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.31 -178.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -94.4 -0.67 54.67 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -177.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.918 ' HD2' ' HA ' ' A' ' 27' ' ' LEU . 84.9 m-85 -91.24 138.51 31.53 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 178.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -64.62 -36.99 86.03 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.215 0.531 . . . . 0.0 110.257 -178.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -146.3 154.22 25.82 Favored Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 177.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.476 HG22 ' HB3' ' A' ' 5' ' ' LEU . 88.4 t -132.2 134.82 59.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.909 0.355 . . . . 0.0 110.221 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.558 HG12 ' HB2' ' A' ' 56' ' ' TYR . 52.0 mt -115.46 120.65 65.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.724 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -102.73 105.46 2.75 Favored Glycine 0 N--CA 1.444 -0.779 0 N-CA-C 111.019 -0.833 . . . . 0.0 111.019 174.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.558 HD12 ' HA ' ' A' ' 8' ' ' SER . 76.8 mt -75.91 -24.73 55.6 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 122.716 -0.285 . . . . 0.0 111.509 -176.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 162.97 57.1 0.02 OUTLIER Glycine 0 CA--C 1.51 -0.242 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.563 -178.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.414 ' CG ' ' H ' ' A' ' 39' ' ' TYR . 1.5 p-10 -99.3 -87.84 0.35 Allowed 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -175.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.621 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 93.9 m-85 -82.36 115.49 21.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.362 0.601 . . . . 0.0 110.951 -177.152 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.3 m -91.55 6.43 5.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.509 -0.768 . . . . 0.0 111.634 -177.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.516 ' O ' HG23 ' A' ' 45' ' ' VAL . 13.2 t70 -86.44 120.39 27.73 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.3 -0.409 . . . . 0.0 109.949 179.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.529 HD22 ' HB3' ' A' ' 66' ' ' ASP . 51.5 tp -54.01 -45.86 71.62 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.851 -174.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -63.39 -39.48 94.62 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.133 0.492 . . . . 0.0 110.609 -178.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 24.2 m -68.64 -30.48 69.2 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.021 178.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 41' ' ' ASP . 83.9 t -61.11 -45.82 97.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 121.099 0.476 . . . . 0.0 110.337 176.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -67.27 -38.97 81.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.806 177.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.08 -32.88 73.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.465 176.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.37 -34.54 76.25 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.961 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -77.35 -15.2 59.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.17 0.509 . . . . 0.0 110.062 177.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -80.43 -48.19 13.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.502 175.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -69.89 -42.41 73.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.009 0.433 . . . . 0.0 110.79 175.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.556 ' HB2' ' HB2' ' A' ' 55' ' ' PHE . 5.4 m -94.39 97.99 10.58 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.617 176.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -61.22 -26.36 67.69 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.844 -176.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -118.81 88.51 2.94 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 166.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.556 ' HB2' ' HB2' ' A' ' 52' ' ' SER . 88.6 t80 -100.31 124.28 45.58 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.829 -177.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.558 ' HB2' HG12 ' A' ' 34' ' ' ILE . 54.0 m-85 -117.9 146.76 43.7 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 174.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.48 ' HA3' HD22 ' A' ' 71' ' ' LEU . . . -158.62 161.83 32.05 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.248 -0.977 . . . . 0.0 112.119 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -140.23 169.37 16.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.916 0.389 . . . . 0.0 111.014 178.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.561 ' HB3' ' HA ' ' A' ' 73' ' ' PHE . 53.4 t-80 -94.4 143.71 26.17 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.062 -175.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -90.89 -129.93 4.45 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.951 -0.642 . . . . 0.0 111.874 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -88.46 -68.89 0.74 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.827 0.346 . . . . 0.0 110.764 178.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 66.6 mtt -125.71 102.28 7.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.328 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -118.56 179.22 4.19 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.922 -178.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -72.38 140.52 82.32 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 176.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -57.43 -31.55 91.58 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.945 2.43 . . . . 0.0 112.147 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.529 ' HB3' HD22 ' A' ' 42' ' ' LEU . 5.1 m-20 -63.19 -35.97 82.07 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.922 179.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 58.4 t -73.6 -27.18 22.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.399 -178.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.9 ttpm? -61.24 -28.21 69.0 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.04 0.448 . . . . 0.0 110.721 179.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -75.08 -13.04 60.45 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.163 -175.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -117.58 -38.03 3.37 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.73 179.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.48 HD22 ' HA3' ' A' ' 57' ' ' GLY . 15.8 mt -107.87 107.79 60.69 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.274 -178.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -72.04 158.07 53.14 Favored 'Trans proline' 0 N--CA 1.464 -0.228 0 C-N-CA 122.952 2.435 . . . . 0.0 112.003 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.561 ' HA ' ' HB3' ' A' ' 59' ' ' HIS . 91.4 m-85 -62.17 -33.24 74.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.22 0.533 . . . . 0.0 110.56 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 18.2 m -148.58 132.33 16.96 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.574 178.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.7 ttmm -140.0 125.7 19.34 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.356 178.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.418 ' HA ' ' HA2' ' A' ' 85' ' ' GLY . 11.8 t -101.07 122.32 52.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 175.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.459 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 68.3 mt -87.7 149.55 24.17 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.28 179.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 53.4 tp -121.04 94.05 4.22 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 172.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.683 HG12 ' HG2' ' A' ' 80' ' ' GLU . 21.6 t -121.87 116.73 50.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.084 -173.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.683 ' HG2' HG12 ' A' ' 79' ' ' VAL . 4.2 mm-40 61.46 21.13 11.79 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.278 179.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.91 -0.82 67.42 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.209 -179.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 65.9 t -96.55 128.95 47.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.754 0.311 . . . . 0.0 110.342 178.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.9 p -91.2 119.77 31.56 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.765 177.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.459 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 45.7 mt -118.04 98.74 6.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.504 -176.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.418 ' HA2' ' HA ' ' A' ' 76' ' ' VAL . . . -86.22 111.52 3.62 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.062 -178.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.561 ' HG2' HD12 ' A' ' 112' ' ' LEU . 49.3 mtm -97.4 119.69 36.38 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 49.0 t -144.0 160.71 40.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.062 0.458 . . . . 0.0 110.773 -176.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 25.8 m-70 -119.19 153.32 35.1 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.837 173.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 155.25 -158.33 28.33 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.427 -0.892 . . . . 0.0 112.357 178.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 49.4 p90 -155.25 175.97 13.17 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -178.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 149.12 169.12 15.37 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.912 178.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.454 ' HB1' ' HD2' ' A' ' 93' ' ' PRO . . . -85.06 164.07 43.08 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 177.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.454 ' HD2' ' HB1' ' A' ' 92' ' ' ALA . 90.7 Cg_exo -46.29 -38.29 20.01 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.209 2.606 . . . . 0.0 113.832 -178.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.814 ' HA ' ' HE3' ' A' ' 97' ' ' LYS . 42.0 p90 -79.71 -40.1 29.71 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 121.102 -0.239 . . . . 0.0 111.175 -179.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -66.55 -35.08 79.35 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.01 0.433 . . . . 0.0 110.521 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 30.2 tp -54.64 -47.65 73.25 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.908 -177.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.814 ' HE3' ' HA ' ' A' ' 94' ' ' TRP . 8.9 mtmp? -57.86 -56.65 19.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.641 0.734 . . . . 0.0 110.085 178.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.63 -48.7 79.69 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.325 -1.307 . . . . 0.0 112.175 -172.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.541 ' O ' HG23 ' A' ' 103' ' ' VAL . 98.1 mtt180 -67.6 -46.53 72.33 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.525 -174.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.547 HD13 HG21 ' A' ' 111' ' ' ILE . 61.2 mt -67.75 -40.75 84.07 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 -177.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.724 HD21 HG21 ' A' ' 127' ' ' VAL . 95.3 mt -75.39 -13.32 60.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.777 0.322 . . . . 0.0 111.048 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -90.15 -22.18 21.86 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 175.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 99' ' ' ARG . 73.6 t -78.21 -50.29 19.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.911 174.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -96.62 108.26 20.83 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.63 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -82.75 1.49 38.56 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.9 0.381 . . . . 0.0 110.729 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 11.5 mp0 -84.96 -22.62 29.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.473 176.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 87.5 tttt 56.87 85.96 0.18 Allowed Pre-proline 0 N--CA 1.466 0.364 0 O-C-N 123.85 0.719 . . . . 0.0 110.258 -170.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -71.88 152.72 58.21 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.945 2.43 . . . . 0.0 112.366 -177.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -77.27 -37.55 52.71 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.663 176.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.56 HG21 HG21 ' A' ' 150' ' ' VAL . 71.7 t -127.89 137.38 57.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.18 178.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.547 HG21 HD13 ' A' ' 100' ' ' LEU . 55.2 mt -127.43 133.06 68.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.841 0.353 . . . . 0.0 110.599 176.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.614 HD23 ' HB2' ' A' ' 130' ' ' LEU . 93.3 mt -102.08 122.44 44.13 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.704 177.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.463 ' CZ ' ' HB2' ' A' ' 131' ' ' ASN . 36.0 p90 -128.27 124.27 36.18 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.243 0.544 . . . . 0.0 110.631 177.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -105.91 114.78 4.6 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.642 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -165.4 -29.65 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.847 0.356 . . . . 0.0 110.526 -177.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.501 HG22 ' OE1' ' A' ' 118' ' ' GLU . 0.2 OUTLIER -92.42 176.97 6.28 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.398 179.969 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 60.3 m80 -105.58 -38.82 6.3 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.103 0.478 . . . . 0.0 110.609 -177.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.501 ' OE1' HG22 ' A' ' 116' ' ' THR . 1.2 pm0 -96.64 144.6 28.12 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.802 -178.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.55 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 4.7 Cg_exo -80.4 144.74 16.33 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 123.126 2.551 . . . . 0.0 112.953 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -160.01 146.14 15.71 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.435 177.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.549 ' HB2' ' HZ ' ' A' ' 152' ' ' PHE . 17.3 t70 -96.24 122.19 38.84 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 175.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.603 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 74.7 p -125.54 142.15 51.66 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.735 0.302 . . . . 0.0 111.343 -176.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 14.9 p -150.35 138.82 14.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 176.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -141.53 -72.6 0.33 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.847 0.356 . . . . 0.0 111.1 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -89.13 46.82 1.42 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.916 0.389 . . . . 0.0 110.836 -177.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 79.32 -42.31 2.37 Favored Glycine 0 N--CA 1.452 -0.24 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.295 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.724 HG21 HD21 ' A' ' 101' ' ' LEU . 41.7 t -63.72 131.3 29.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.895 0.379 . . . . 0.0 110.747 178.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.412 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 75.9 ttt180 -94.35 114.11 26.11 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.802 179.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.603 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 45.8 m-85 -99.09 125.96 44.72 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -178.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.614 ' HB2' HD23 ' A' ' 112' ' ' LEU . 64.5 mt -103.47 120.68 41.31 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.431 0.634 . . . . 0.0 110.695 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.55 ' O ' ' HA ' ' A' ' 119' ' ' PRO . 49.3 t30 -104.35 107.83 58.72 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 114.865 -1.062 . . . . 0.0 109.223 176.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -89.63 165.62 5.16 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.806 2.337 . . . . 0.0 113.188 -177.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -88.88 146.3 19.13 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.986 179.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.895 ' HB2' ' HG2' ' A' ' 137' ' ' GLU . 9.2 m -68.93 142.83 54.61 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.618 0.209 . . . . 0.0 110.904 -178.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.605 HD12 ' HB2' ' A' ' 10' ' ' SER . 21.0 mt -63.85 -35.26 80.05 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.143 0.497 . . . . 0.0 110.177 -178.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.432 ' HB2' ' SD ' ' A' ' 16' ' ' MET . . . -65.09 -24.22 67.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.434 178.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.895 ' HG2' ' HB2' ' A' ' 134' ' ' SER . 51.8 mm-40 -79.86 -13.81 59.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.869 0.366 . . . . 0.0 110.48 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 89.03 34.26 9.0 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.745 178.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 23.0 t -149.84 150.06 31.4 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.743 0.306 . . . . 0.0 110.313 178.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.424 ' CE1' ' HB3' ' A' ' 155' ' ' LYS . 50.3 p90 -145.55 177.68 8.68 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.662 177.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -121.51 132.73 54.87 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.084 0.469 . . . . 0.0 111.672 -176.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 44.8 t -104.09 114.3 43.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 172.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 6.5 tt -94.57 104.97 16.91 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -177.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.524 ' HG2' ' HG2' ' A' ' 3' ' ' ARG . 37.4 mt-10 -95.17 124.85 39.43 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.106 178.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 81.6 mt -91.38 98.78 11.9 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.133 0.492 . . . . 0.0 110.05 175.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -86.78 100.94 12.88 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.802 -178.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.71 -68.8 0.29 Allowed Glycine 0 CA--C 1.52 0.399 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.446 -172.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -162.31 26.57 0.24 Allowed Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 177.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -123.94 144.14 49.97 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.415 -0.392 . . . . 0.0 110.285 -175.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.56 HG21 HG21 ' A' ' 110' ' ' VAL . 92.8 t -83.37 111.84 20.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.346 -177.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -120.65 93.41 4.03 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 177.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . 0.549 ' HZ ' ' HB2' ' A' ' 121' ' ' ASP . 17.4 p90 -90.29 132.33 35.6 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.058 0.456 . . . . 0.0 110.538 -178.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -116.96 135.37 53.76 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.579 178.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -89.83 131.42 35.78 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.892 0.377 . . . . 0.0 110.666 -178.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.424 ' HB3' ' CE1' ' A' ' 140' ' ' TYR . 10.5 tptt -122.05 154.02 37.84 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 4.2 p -111.15 152.12 27.38 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.923 0.392 . . . . 0.0 111.319 178.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 94.5 mt . . . . . 0 C--O 1.251 1.139 0 CA-C-O 118.29 -0.862 . . . . 0.0 110.346 -179.275 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 46.3 t . . . . . 0 N--CA 1.479 0.989 0 CA-C-O 120.789 0.328 . . . . 0.0 110.238 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.513 ' HD3' ' CZ ' ' A' ' 4' ' ' PHE . 20.9 ttmm -102.43 129.68 48.99 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.248 177.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.414 ' HD3' ' OE2' ' A' ' 144' ' ' GLU . 38.8 mtt180 -117.02 125.58 51.58 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.532 -178.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.58 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 64.4 m-85 -102.98 124.14 47.92 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.063 0.459 . . . . 0.0 110.695 177.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 48.5 tp -89.27 136.59 32.94 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 175.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.501 HD23 ' HB3' ' A' ' 141' ' ' ALA . 50.3 tp -117.68 103.93 10.51 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.285 0.564 . . . . 0.0 112.077 -177.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.528 HG13 ' HA2' ' A' ' 35' ' ' GLY . 23.5 pt -101.33 138.65 24.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 168.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.643 ' HA ' ' HB2' ' A' ' 36' ' ' LEU . 20.6 m -127.61 -68.18 0.79 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -164.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.465 ' HA ' ' HE1' ' A' ' 88' ' ' HIS . 37.3 t70 -111.44 105.49 14.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.417 0.627 . . . . 0.0 111.099 -176.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.822 ' HB3' ' HA ' ' A' ' 38' ' ' ASP . 29.5 t -141.05 155.88 46.1 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.285 -0.87 . . . . 0.0 108.874 174.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.871 ' H ' ' HE2' ' A' ' 16' ' ' MET . 11.5 m80 -141.59 57.11 1.51 Allowed 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -174.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.496 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . 40.7 t -110.19 126.95 27.89 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.236 -174.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.496 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 60.1 Cg_endo -105.2 91.87 0.06 OUTLIER 'Cis proline' 0 N--CA 1.45 -1.077 0 C-N-CA 124.011 -1.246 . . . . 0.0 112.874 -7.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 41.7 t -92.19 -63.6 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 175.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 58.7 ttm-85 -144.49 12.7 1.53 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.886 0.851 . . . . 0.0 108.758 173.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.871 ' HE2' ' H ' ' A' ' 11' ' ' HIS . 50.6 ttp -131.74 121.88 24.95 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.527 -177.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -126.11 -0.31 7.14 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.916 -0.583 . . . . 0.0 109.959 178.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.5 p -80.77 63.81 5.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.022 -178.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.43 HD12 HG21 ' A' ' 12' ' ' VAL . 4.2 tt -102.1 111.48 64.35 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 19' ' ' LEU . 23.5 Cg_endo -62.18 125.63 16.81 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.919 2.413 . . . . 0.0 112.744 -177.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -56.62 -28.83 61.33 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.284 177.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -49.87 -50.4 45.91 Favored 'General case' 0 C--N 1.331 -0.225 0 O-C-N 123.438 0.462 . . . . 0.0 111.846 -175.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.0 tt -66.59 -39.93 85.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.848 0.832 . . . . 0.0 110.252 -177.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.486 ' O ' HD22 ' A' ' 27' ' ' LEU . 35.5 tp -73.97 -3.74 30.99 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.107 -1.406 . . . . 0.0 111.036 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -100.3 -41.39 7.08 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.326 0.584 . . . . 0.0 109.741 172.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 56.9 p -69.43 -14.99 63.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.932 -175.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.516 HD12 ' HB3' ' A' ' 52' ' ' SER . 1.1 pt? -68.46 -9.2 47.21 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.799 0.333 . . . . 0.0 111.118 -176.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -65.82 -35.08 79.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.47 175.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -72.06 -23.29 61.34 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.204 0.526 . . . . 0.0 110.393 -178.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.504 ' HD2' ' HA ' ' A' ' 27' ' ' LEU . 86.0 m-85 -96.16 114.25 25.93 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.523 -176.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -78.31 -4.17 46.64 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.818 -176.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.58 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -142.19 129.58 3.96 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 173.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.453 HG21 ' HB3' ' A' ' 52' ' ' SER . 57.7 t -120.26 142.73 34.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 O-C-N 122.391 -0.476 . . . . 0.0 110.558 -179.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 70.1 mt -125.56 131.15 72.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.352 -0.386 . . . . 0.0 109.967 178.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.528 ' HA2' HG13 ' A' ' 7' ' ' ILE . . . -122.21 123.28 5.37 Favored Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 111.421 -0.672 . . . . 0.0 111.421 178.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.643 ' HB2' ' HA ' ' A' ' 8' ' ' SER . 87.4 mt -95.16 6.4 49.16 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.792 0.296 . . . . 0.0 111.643 -174.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 133.97 87.51 0.29 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.783 -0.723 . . . . 0.0 111.411 178.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.822 ' HA ' ' HB3' ' A' ' 10' ' ' SER . 6.2 m-20 -127.38 -66.52 0.88 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.076 0.465 . . . . 0.0 112.117 -169.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.434 ' CE2' ' HG ' ' A' ' 48' ' ' LEU . 80.3 m-85 -94.25 131.55 39.73 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.871 -174.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 12.7 m -110.04 7.15 8.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.159 -178.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.558 ' O ' HG23 ' A' ' 45' ' ' VAL . 15.1 t70 -111.96 129.94 56.02 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.172 179.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 49.9 tp -60.33 -49.71 76.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.553 -174.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -55.25 -45.38 76.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.999 0.428 . . . . 0.0 111.065 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.7 m -65.68 -29.52 70.09 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.157 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 41' ' ' ASP . 85.1 t -66.43 -42.62 90.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-O 120.891 0.376 . . . . 0.0 110.497 175.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -67.16 -37.93 80.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.285 0.564 . . . . 0.0 110.23 178.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.81 -34.18 76.24 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.393 174.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.434 ' HG ' ' CE2' ' A' ' 39' ' ' TYR . 2.6 tm? -65.72 -35.67 81.4 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 178.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.53 ' HA ' ' HE2' ' A' ' 55' ' ' PHE . 0.3 OUTLIER -63.37 -30.54 71.65 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.651 172.767 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.411 ' HD3' ' HA ' ' A' ' 50' ' ' LYS . 42.9 mmtm -70.12 -39.16 75.63 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 120.869 -0.333 . . . . 0.0 110.805 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.428 ' HB3' HD11 ' A' ' 27' ' ' LEU . 82.5 m-85 -73.57 -67.66 0.57 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.855 0.36 . . . . 0.0 110.636 174.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.516 ' HB3' HD12 ' A' ' 27' ' ' LEU . 5.1 p -86.98 96.61 10.33 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 175.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -71.58 -7.39 47.41 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.253 -172.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -151.73 100.57 2.69 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.123 0.487 . . . . 0.0 109.972 171.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.53 ' HE2' ' HA ' ' A' ' 49' ' ' GLU . 50.4 p90 -127.99 163.09 25.3 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.863 179.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.522 ' HE2' ' HE1' ' A' ' 4' ' ' PHE . 37.2 m-85 -117.9 118.59 32.39 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 174.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.567 ' O ' ' HD2' ' A' ' 72' ' ' PRO . . . -106.23 149.31 16.63 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.217 -0.992 . . . . 0.0 112.734 -176.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.467 HG21 ' CB ' ' A' ' 86' ' ' MET . 3.5 t -129.53 154.54 40.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 174.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.872 ' HB3' ' HA ' ' A' ' 73' ' ' PHE . 24.4 t-80 -99.24 150.88 21.63 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.7 -176.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 1.045 ' HA3' ' HB3' ' A' ' 88' ' ' HIS . . . 169.71 53.99 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.128 177.168 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -171.79 160.84 5.74 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 67.0 mtp -80.0 107.3 12.68 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.147 0.499 . . . . 0.0 109.925 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.403 ' OD2' ' HB ' ' A' ' 67' ' ' VAL . 38.1 p-10 -123.47 -156.24 0.7 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.243 -171.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -108.35 154.21 41.54 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.592 175.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -46.73 -44.55 21.72 Favored 'Trans proline' 0 N--CA 1.475 0.407 0 C-N-CA 123.46 2.774 . . . . 0.0 114.089 -176.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -63.24 -26.0 68.59 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.862 0.363 . . . . 0.0 111.842 -176.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.403 ' HB ' ' OD2' ' A' ' 63' ' ' ASP . 51.7 t -79.6 -32.18 14.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.777 -176.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -62.6 -20.84 65.14 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.412 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -73.47 -47.76 38.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.115 0.484 . . . . 0.0 110.945 178.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -85.05 -21.72 29.28 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.426 -173.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.57 ' O ' ' HB2' ' A' ' 59' ' ' HIS . 3.6 mm? -110.99 94.36 20.32 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.48 173.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.567 ' HD2' ' O ' ' A' ' 57' ' ' GLY . 26.8 Cg_exo -62.62 138.1 67.94 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.825 2.35 . . . . 0.0 111.85 179.094 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.872 ' HA ' ' HB3' ' A' ' 59' ' ' HIS . 40.4 p90 -52.46 -33.04 42.6 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.307 0.379 . . . . 0.0 111.869 -175.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.5 m -155.14 145.65 22.14 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 175.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.4 tttm -144.21 150.24 37.66 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -177.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.5 t -127.34 118.31 49.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 176.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 83.0 mt -90.93 147.89 22.82 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.256 178.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 24.9 tp -115.93 95.42 5.1 Favored 'General case' 0 C--N 1.315 -0.935 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 175.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 47.0 t -99.29 93.99 3.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.211 -177.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 64.17 18.24 11.14 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.662 178.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 114.41 -20.91 15.46 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.97 -177.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.547 ' HA ' ' OE1' ' A' ' 109' ' ' GLN . 55.0 t -76.48 114.91 17.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.822 0.344 . . . . 0.0 110.329 177.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.409 ' HB ' ' HB3' ' A' ' 108' ' ' PRO . 0.9 OUTLIER -83.04 125.65 31.69 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.261 178.931 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.8 mt -117.76 94.91 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.582 -179.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.498 ' O ' ' HA ' ' A' ' 111' ' ' ILE . . . -81.87 126.22 7.31 Favored Glycine 0 N--CA 1.442 -0.939 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.467 ' CB ' HG21 ' A' ' 58' ' ' VAL . 44.0 mtm -126.14 129.8 49.77 Favored 'General case' 0 C--N 1.313 -0.979 0 O-C-N 122.69 -0.3 . . . . 0.0 110.823 -175.077 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 48.5 t -159.57 116.69 2.64 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.652 179.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 1.045 ' HB3' ' HA3' ' A' ' 60' ' ' GLY . 3.3 t-160 -84.6 85.16 7.46 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 -177.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -133.59 165.73 24.08 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.094 -177.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 26.2 m-90 -122.28 -174.21 2.85 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.84 0.353 . . . . 0.0 110.897 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 127.01 -163.05 21.03 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 -176.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.443 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . . . -79.17 124.25 84.52 Favored Pre-proline 0 C--N 1.322 -0.599 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 177.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 92' ' ' ALA . 49.2 Cg_exo -55.22 -30.6 72.33 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.053 2.502 . . . . 0.0 112.967 -175.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.408 ' CD1' ' HB1' ' A' ' 92' ' ' ALA . 0.1 OUTLIER -70.94 -54.29 11.88 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.215 -179.467 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -69.94 -29.14 66.22 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.943 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.446 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 35.0 tp -59.68 -45.84 90.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.036 -177.198 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.63 ' HD3' ' HB3' ' A' ' 124' ' ' LYS . 79.2 mttt -59.15 -49.3 78.38 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.657 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.13 -27.84 66.8 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.216 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -74.02 -42.34 60.48 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.498 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 95.4 mt -66.64 -29.91 70.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.925 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.451 HD21 HG21 ' A' ' 127' ' ' VAL . 84.0 mt -69.22 -15.43 63.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.813 0.34 . . . . 0.0 111.087 176.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -101.27 -2.39 31.27 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.369 0.604 . . . . 0.0 110.119 177.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 64.5 t -92.47 -44.06 13.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 169.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -106.62 90.11 3.23 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.445 172.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -69.17 -15.84 63.49 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.194 -177.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -73.16 -21.85 60.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.14 175.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.424 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 94.2 mttt 63.81 99.09 0.04 OUTLIER Pre-proline 0 N--CA 1.465 0.305 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.127 175.128 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 107' ' ' LYS . 4.8 Cg_exo -79.6 163.02 24.34 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 123.546 2.83 . . . . 0.0 112.759 -177.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.547 ' OE1' ' HA ' ' A' ' 82' ' ' VAL . 91.1 mt-30 -79.52 -41.6 27.0 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.158 176.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 54.9 t -123.85 140.29 47.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.196 -178.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.498 ' HA ' ' O ' ' A' ' 85' ' ' GLY . 54.9 mt -130.72 130.83 64.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.129 0.49 . . . . 0.0 110.791 176.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 94.0 mt -114.25 135.05 54.48 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.342 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.43 ' CE2' ' HB3' ' A' ' 129' ' ' PHE . 28.6 p90 -151.38 159.11 44.42 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.884 176.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -105.91 114.79 4.61 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 173.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.653 ' HD2' HG23 ' A' ' 116' ' ' THR . 11.0 t60 -122.61 -82.79 0.65 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.758 0.313 . . . . 0.0 110.808 -172.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.653 HG23 ' HD2' ' A' ' 115' ' ' HIS . 10.8 p -101.57 160.57 14.33 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 177.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.433 ' HB3' ' OE2' ' A' ' 137' ' ' GLU . 34.6 m170 -87.39 71.69 9.87 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.381 0.61 . . . . 0.0 110.902 -177.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -171.47 130.12 0.72 Allowed Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 114.622 -1.172 . . . . 0.0 108.62 176.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.491 ' HA ' ' O ' ' A' ' 131' ' ' ASN . 34.7 Cg_exo -58.71 107.41 0.34 Allowed 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.426 2.084 . . . . 0.0 111.731 178.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.515 ' HG2' HG23 ' A' ' 122' ' ' THR . 43.6 tt0 -121.49 128.07 51.7 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.203 -174.113 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.469 ' HA ' HD23 ' A' ' 130' ' ' LEU . 11.2 t70 -104.41 125.13 50.34 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 175.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.584 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 33.3 p -135.64 154.54 51.28 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.544 0.688 . . . . 0.0 112.431 -175.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 10.0 p -145.09 162.95 13.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.647 175.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.63 ' HB3' ' HD3' ' A' ' 97' ' ' LYS . 64.8 tttm -176.94 -59.85 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.529 0.68 . . . . 0.0 109.82 -179.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.426 ' C ' ' H ' ' A' ' 127' ' ' VAL . . . -95.55 30.58 2.24 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.029 -175.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 78.55 -33.36 1.84 Allowed Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 121.039 -0.601 . . . . 0.0 111.701 -174.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.451 HG21 HD21 ' A' ' 101' ' ' LEU . 28.7 t -70.88 141.86 16.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 122.978 0.511 . . . . 0.0 110.301 176.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -95.49 125.52 40.15 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 177.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.584 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 75.9 m-85 -112.43 128.26 56.26 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -177.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.469 HD23 ' HA ' ' A' ' 121' ' ' ASP . 60.3 mt -120.37 132.45 55.28 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.107 0.479 . . . . 0.0 111.604 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.496 ' HB3' ' HB3' ' A' ' 120' ' ' GLU . 25.0 t30 -117.8 105.34 47.76 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.837 176.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.491 ' HG2' ' OG ' ' A' ' 8' ' ' SER . 5.9 Cg_exo -82.36 -172.25 1.38 Allowed 'Trans proline' 0 CA--C 1.531 0.326 0 C-N-CA 123.45 2.767 . . . . 0.0 112.692 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -100.43 -174.12 29.81 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.125 -179.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.623 ' OG ' ' HB2' ' A' ' 137' ' ' GLU . 28.9 p -95.9 160.27 14.56 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 122.605 -0.35 . . . . 0.0 110.951 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 35.7 mt -64.7 -45.58 86.0 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -176.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -75.45 1.69 13.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.316 0.579 . . . . 0.0 111.198 -178.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.623 ' HB2' ' OG ' ' A' ' 134' ' ' SER . 10.5 tt0 -95.89 -15.96 22.09 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.711 -178.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.536 ' HA2' ' HB2' ' A' ' 157' ' ' LEU . . . 72.64 43.0 45.31 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.538 179.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.8 m -149.17 98.26 2.79 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 176.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.458 ' O ' HD12 ' A' ' 154' ' ' LEU . 27.5 p90 -116.66 164.15 15.05 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.914 -0.315 . . . . 0.0 110.155 -178.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.501 ' HB3' HD23 ' A' ' 6' ' ' LEU . . . -114.45 150.77 34.24 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.11 0.481 . . . . 0.0 110.803 -174.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.5 HG12 ' HG3' ' A' ' 144' ' ' GLU . 67.1 t -125.74 134.55 66.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.605 177.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.7 HD21 HG13 ' A' ' 150' ' ' VAL . 4.5 tt -122.9 103.89 8.91 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.157 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.5 ' HG3' HG12 ' A' ' 142' ' ' VAL . 60.8 mt-10 -108.78 148.26 30.8 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 120.918 0.389 . . . . 0.0 110.461 -177.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.435 HD12 ' HB3' ' A' ' 2' ' ' LYS . 67.2 mt -94.16 90.49 6.38 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.247 0.546 . . . . 0.0 109.61 176.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.41 ' HB3' ' HD2' ' A' ' 151' ' ' ARG . 33.4 t70 -124.53 126.17 45.4 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.141 -176.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.95 11.19 60.39 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.006 -175.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 81.48 -7.59 60.98 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 111.792 -0.523 . . . . 0.0 111.792 -176.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -84.64 158.65 20.78 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 120.917 0.389 . . . . 0.0 110.547 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.7 HG13 HD21 ' A' ' 143' ' ' LEU . 15.6 t -83.79 100.36 7.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.211 176.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.432 ' O ' ' HA ' ' A' ' 143' ' ' LEU . 32.6 ttt180 -92.5 99.78 12.44 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.093 -171.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . 0.413 ' HA ' ' O ' ' A' ' 142' ' ' VAL . 43.1 m-85 -93.74 107.75 19.59 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.971 177.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -110.39 116.38 31.32 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.561 174.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.458 HD12 ' O ' ' A' ' 140' ' ' TYR . 41.5 tp -89.81 123.17 33.55 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 177.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -120.95 148.15 44.48 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.98 0.419 . . . . 0.0 110.876 -177.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 13.7 p -105.83 156.97 17.8 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.005 -174.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.536 ' HB2' ' HA2' ' A' ' 138' ' ' GLY . 79.2 mt . . . . . 0 C--O 1.25 1.099 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.747 178.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 N--CA 1.48 1.035 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 46.1 mttp -90.58 112.4 24.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.745 0.307 . . . . 0.0 110.438 177.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.518 ' HB3' ' HD1' ' A' ' 30' ' ' TYR . 88.0 mtt180 -130.57 115.38 16.68 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.87 -178.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.662 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 91.7 m-85 -101.64 114.65 28.88 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.223 0.535 . . . . 0.0 110.669 178.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.531 ' HB3' HG22 ' A' ' 33' ' ' VAL . 47.2 tp -89.55 110.65 21.48 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.333 -179.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.653 HD11 ' HG ' ' A' ' 36' ' ' LEU . 60.2 tp -96.02 114.91 26.67 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.018 0.437 . . . . 0.0 111.104 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.428 HG22 HD13 ' A' ' 23' ' ' ILE . 26.9 pt -101.03 125.76 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 171.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.584 ' HB3' ' HG2' ' A' ' 132' ' ' PRO . 11.1 p -80.6 -94.21 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -168.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.46 75.15 1.0 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.984 0.421 . . . . 0.0 111.673 -173.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.2 m -79.95 119.23 22.51 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 173.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 65.0 m-70 -134.33 73.12 1.48 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.516 0.674 . . . . 0.0 109.33 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.499 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . 48.7 t -120.79 131.15 24.55 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.247 -176.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.499 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 70.7 Cg_endo -102.25 90.19 0.08 OUTLIER 'Cis proline' 0 N--CA 1.451 -1.001 0 C-N-CA 123.781 -1.341 . . . . 0.0 112.438 -5.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.512 HG12 ' HG2' ' A' ' 15' ' ' ARG . 27.3 t -97.75 -84.94 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.649 -179.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.512 ' HG2' HG12 ' A' ' 14' ' ' VAL . 12.6 mmm180 -121.05 -25.59 5.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.178 0.513 . . . . 0.0 110.204 177.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.44 ' C ' ' H ' ' A' ' 18' ' ' SER . 51.1 ttp -80.43 -72.92 0.39 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.117 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 70.3 -33.71 0.27 Allowed 'General case' 0 N--CA 1.469 0.516 0 O-C-N 123.872 0.733 . . . . 0.0 112.077 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.44 ' H ' ' C ' ' A' ' 16' ' ' MET . 29.7 p -75.15 81.84 2.31 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.087 0.47 . . . . 0.0 111.572 -178.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.433 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 8.0 tt -107.55 110.68 62.9 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 173.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.603 ' CG ' HD13 ' A' ' 157' ' ' LEU . 19.6 Cg_endo -59.13 142.24 99.04 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 123.152 2.568 . . . . 0.0 112.936 -176.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -71.73 -20.83 61.85 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.109 -173.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -57.17 -46.72 82.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.432 -177.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.428 HD13 HG22 ' A' ' 7' ' ' ILE . 3.5 tt -71.2 -32.14 46.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.466 0.65 . . . . 0.0 110.293 -177.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.468 ' O ' HD23 ' A' ' 27' ' ' LEU . 58.4 tp -72.84 -25.14 61.01 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.69 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -81.47 -29.33 33.76 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.476 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.4 p -83.51 8.82 12.85 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -174.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.597 HD12 ' HB2' ' A' ' 52' ' ' SER . 3.2 mm? -56.31 -27.8 56.75 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.839 0.352 . . . . 0.0 111.494 176.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -78.14 -24.31 47.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.367 -177.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -92.85 -3.74 54.12 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.16 0.505 . . . . 0.0 111.177 -172.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.518 ' HD1' ' HB3' ' A' ' 3' ' ' ARG . 99.0 m-85 -123.44 120.22 32.31 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.28 176.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -78.8 -29.93 45.15 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.973 -173.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.662 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -120.91 126.62 6.67 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 174.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.531 HG22 ' HB3' ' A' ' 5' ' ' LEU . 97.0 t -119.61 134.71 62.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 117.426 0.613 . . . . 0.0 110.603 -179.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.517 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 71.2 mt -116.82 131.76 68.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.234 -177.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -125.77 107.41 0.95 Allowed Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.411 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.653 ' HG ' HD11 ' A' ' 6' ' ' LEU . 95.0 mt -74.2 -22.8 59.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.697 0.761 . . . . 0.0 109.385 176.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -152.39 125.06 1.74 Allowed Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 174.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -119.72 -169.57 1.79 Allowed 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -174.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -65.33 145.39 56.26 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 19.9 m -84.41 27.26 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.12 0.486 . . . . 0.0 111.672 -171.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -146.3 139.35 25.66 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 121.029 0.442 . . . . 0.0 110.389 177.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.741 ' HB2' ' HB3' ' A' ' 66' ' ' ASP . 43.4 tp -66.34 -28.9 69.02 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.519 -173.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.47 -35.63 78.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.175 0.512 . . . . 0.0 110.482 -177.099 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.2 m -83.24 -30.84 27.36 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.341 -178.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 98.2 t -58.43 -42.54 84.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.039 0.447 . . . . 0.0 110.285 174.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.413 HD13 ' O ' ' A' ' 42' ' ' LEU . 1.7 mp -68.85 -35.72 70.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.202 177.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -61.25 -37.8 84.41 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.914 175.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 46.8 mt -80.11 -33.33 38.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.732 0.301 . . . . 0.0 110.684 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -65.32 -21.6 66.73 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.129 174.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -81.41 -36.17 29.82 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.043 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.444 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . 39.2 m-85 -75.16 -62.58 1.51 Allowed 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.057 174.059 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.597 ' HB2' HD12 ' A' ' 27' ' ' LEU . 33.4 t -90.8 98.71 11.94 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 173.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 42.7 mttm -78.05 15.18 0.95 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.767 -178.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -146.95 77.58 1.46 Allowed 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 168.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -101.82 123.5 45.88 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.532 -175.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.543 ' HE2' ' HE1' ' A' ' 4' ' ' PHE . 26.5 m-85 -104.41 107.9 19.05 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 175.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.826 ' HA3' HD22 ' A' ' 71' ' ' LEU . . . -116.64 156.49 15.59 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.1 -1.047 . . . . 0.0 112.708 -176.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 15.0 t -128.08 146.08 34.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 177.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 56.8 t60 -94.57 104.53 16.48 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.459 0.647 . . . . 0.0 109.458 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.61 ' HA3' ' HB2' ' A' ' 88' ' ' HIS . . . -135.38 23.15 3.48 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.966 177.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -121.72 -176.07 3.24 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 51.2 mtp -98.91 36.19 1.73 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.393 0.616 . . . . 0.0 109.36 173.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.436 ' OD2' ' HB ' ' A' ' 67' ' ' VAL . 3.8 p-10 -68.62 156.11 38.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.419 178.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.502 ' HB3' ' HD2' ' A' ' 65' ' ' PRO . 89.5 m-85 -70.05 162.97 65.38 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.239 -175.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.528 ' HA ' ' HB3' ' A' ' 68' ' ' LYS . 9.9 Cg_endo -51.91 -23.92 17.65 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.173 2.582 . . . . 0.0 112.602 177.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.741 ' HB3' ' HB2' ' A' ' 42' ' ' LEU . 5.9 m-20 -54.83 -50.31 68.92 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.251 0.548 . . . . 0.0 110.412 175.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.436 ' HB ' ' OD2' ' A' ' 63' ' ' ASP . 29.1 t -77.94 -34.44 19.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.057 -178.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.528 ' HB3' ' HA ' ' A' ' 65' ' ' PRO . 57.8 tttm -62.72 -24.4 67.66 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.105 177.23 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -64.48 -41.09 96.69 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.262 0.553 . . . . 0.0 109.59 175.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -83.42 -38.61 21.69 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.11 -178.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.826 HD22 ' HA3' ' A' ' 57' ' ' GLY . 14.8 mt -114.13 120.7 38.05 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.07 -173.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.5 ' HG2' ' HB2' ' A' ' 75' ' ' LYS . 72.6 Cg_endo -79.79 157.76 24.46 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.793 2.329 . . . . 0.0 111.426 175.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -60.03 -34.78 73.85 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.906 0.384 . . . . 0.0 111.061 -177.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 17.3 m -142.8 137.55 29.76 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 174.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.5 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 43.0 tttp -136.24 126.28 26.1 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.549 0.214 . . . . 0.0 110.627 -176.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 26.8 t -103.18 125.07 57.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.787 0.327 . . . . 0.0 110.29 177.103 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.544 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 89.9 mt -100.43 159.72 14.92 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.784 178.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 46.6 tp -130.78 99.61 5.0 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 175.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.544 HG12 ' HG2' ' A' ' 80' ' ' GLU . 58.2 t -117.04 112.67 40.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.684 -176.004 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.544 ' HG2' HG12 ' A' ' 79' ' ' VAL . 4.5 mm-40 60.06 19.57 8.76 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.57 178.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.55 -3.7 50.18 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.333 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.3 t -93.68 128.23 45.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.664 0.269 . . . . 0.0 110.56 178.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 33.9 p -88.49 126.72 35.38 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.605 178.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.544 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 19.6 mt -118.33 95.85 3.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.82 0.343 . . . . 0.0 110.218 -178.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -80.23 98.12 1.72 Allowed Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 178.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 32.2 mtm -96.8 120.73 37.68 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.135 0.493 . . . . 0.0 110.999 -175.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 26.4 t -139.38 165.19 27.85 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 174.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.61 ' HB2' ' HA3' ' A' ' 60' ' ' GLY . 4.6 t60 -81.51 -21.12 38.85 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 119.669 -0.812 . . . . 0.0 109.667 178.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.427 ' HA3' ' HB2' ' A' ' 113' ' ' PHE . . . 82.88 -155.5 33.37 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.53 177.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 73.8 t-105 -159.74 -73.2 0.07 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.95 0.405 . . . . 0.0 110.513 -177.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 161.77 -174.21 38.24 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 -178.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 55.17 81.86 0.25 Allowed Pre-proline 0 N--CA 1.463 0.21 0 C-N-CA 122.631 0.372 . . . . 0.0 111.341 -179.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -54.77 -30.75 68.8 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.399 2.733 . . . . 0.0 113.262 -173.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -72.53 -13.62 61.45 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.185 -0.461 . . . . 0.0 112.228 -177.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -121.6 -25.18 5.16 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.189 0.519 . . . . 0.0 110.417 177.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 48.2 tp -60.19 -41.29 92.6 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.006 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -58.36 -41.62 85.11 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.159 0.504 . . . . 0.0 109.835 178.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.422 ' O ' ' HG3' ' A' ' 102' ' ' LYS . 9.1 m-20 -69.58 -47.67 62.79 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.058 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.536 ' O ' HG23 ' A' ' 103' ' ' VAL . 19.0 ttm180 -58.71 -46.74 86.66 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.151 -177.03 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.501 HD13 HG21 ' A' ' 111' ' ' ILE . 91.7 mt -66.4 -36.45 82.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.72 0.295 . . . . 0.0 111.287 -179.125 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 93.8 mt -75.12 -11.35 60.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.857 0.36 . . . . 0.0 111.127 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.422 ' HG3' ' O ' ' A' ' 98' ' ' ASP . 96.1 mttt -100.07 -8.87 23.26 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.122 0.487 . . . . 0.0 110.179 175.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 99' ' ' ARG . 90.9 t -81.29 -48.07 19.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 170.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -101.09 106.71 18.01 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.175 173.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 -57.44 -37.7 73.24 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.804 0.335 . . . . 0.0 111.631 -175.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -96.17 133.83 39.98 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 174.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.468 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 60.1 pttt -71.86 126.66 91.35 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-O 121.148 0.499 . . . . 0.0 111.185 -174.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 107' ' ' LYS . 3.7 Cg_exo -81.8 169.48 14.95 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 123.393 2.729 . . . . 0.0 111.473 175.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -87.36 -45.33 10.65 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.112 0.482 . . . . 0.0 109.97 178.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 63.3 t -120.63 136.74 56.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.279 178.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.501 HG21 HD13 ' A' ' 100' ' ' LEU . 59.6 mt -130.02 133.87 63.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.881 0.372 . . . . 0.0 110.386 177.084 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.483 HD23 ' HB2' ' A' ' 130' ' ' LEU . 95.3 mt -109.26 146.36 34.38 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.375 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.427 ' HB2' ' HA3' ' A' ' 89' ' ' GLY . 29.8 p90 -155.69 163.79 39.44 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 174.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -147.11 125.48 2.19 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.681 -177.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 36.5 t-80 -177.5 -37.14 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 177.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.3 p -79.86 127.34 32.12 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.522 177.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.468 ' O ' ' HD3' ' A' ' 119' ' ' PRO . 24.1 m170 -87.71 7.3 30.75 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.263 0.554 . . . . 0.0 110.206 176.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -106.4 91.69 6.1 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.756 171.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' A' ' 117' ' ' HIS . 22.5 Cg_exo -63.51 129.51 25.4 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.75 2.3 . . . . 0.0 111.661 -175.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -149.26 136.74 20.18 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.968 0.414 . . . . 0.0 111.314 -172.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.453 ' OD1' ' HD2' ' A' ' 128' ' ' ARG . 6.7 t70 -90.44 119.78 31.0 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.482 174.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.49 ' OG1' ' HB2' ' A' ' 129' ' ' PHE . 44.3 p -132.66 129.52 38.94 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.108 0.48 . . . . 0.0 112.049 -173.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 6.2 p -120.54 105.81 17.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 169.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 50.0 mttp -109.11 -67.34 0.99 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.264 -172.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -92.18 33.0 1.1 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.101 0.476 . . . . 0.0 110.992 -176.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 83.03 -14.92 35.57 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 -175.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 41.8 t -96.23 144.87 9.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.453 ' HD2' ' OD1' ' A' ' 121' ' ' ASP . 6.4 tpp180 -87.24 109.54 19.56 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.391 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.49 ' HB2' ' OG1' ' A' ' 122' ' ' THR . 92.0 m-85 -98.15 121.17 39.75 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 177.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.515 HD13 ' CD1' ' A' ' 152' ' ' PHE . 64.8 mt -121.5 129.66 53.07 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.872 0.367 . . . . 0.0 111.327 -174.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.453 ' HA ' ' HD3' ' A' ' 132' ' ' PRO . 8.5 p30 -131.82 122.31 18.5 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.156 177.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.584 ' HG2' ' HB3' ' A' ' 8' ' ' SER . 87.4 Cg_endo -98.41 168.54 0.66 Allowed 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 123.48 2.787 . . . . 0.0 113.057 178.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -80.67 166.57 49.24 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.787 -0.721 . . . . 0.0 111.351 175.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.505 ' HA ' ' OG ' ' A' ' 8' ' ' SER . 39.5 m -90.32 177.39 6.42 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 117.2 0.5 . . . . 0.0 111.181 -177.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -73.09 -18.13 61.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.335 -176.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -73.26 -47.4 43.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.759 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.498 ' OE1' ' HB2' ' A' ' 134' ' ' SER . 1.8 mp0 -66.49 -32.13 73.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.148 177.082 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.515 ' HA2' HD12 ' A' ' 157' ' ' LEU . . . 96.58 51.75 1.65 Allowed Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.211 178.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 156' ' ' THR . 23.1 t -145.97 153.89 41.3 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 178.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -154.36 167.09 31.13 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.779 177.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.436 ' HB3' ' HB3' ' A' ' 6' ' ' LEU . . . -114.26 135.95 53.5 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.849 0.356 . . . . 0.0 111.041 -174.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 79.4 t -121.27 120.55 62.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.169 176.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.78 HD21 HG13 ' A' ' 150' ' ' VAL . 5.5 tt -104.5 103.95 13.73 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 177.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -106.39 135.91 47.06 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.876 -178.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.487 ' HA ' ' O ' ' A' ' 149' ' ' GLU . 5.1 mp -112.13 98.7 7.51 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.944 0.402 . . . . 0.0 110.512 178.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -101.26 121.54 42.06 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.367 0.603 . . . . 0.0 109.426 178.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 68.09 1.56 20.29 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.835 -175.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 104.57 0.58 43.18 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 121.155 -0.545 . . . . 0.0 112.235 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.487 ' O ' ' HA ' ' A' ' 145' ' ' LEU . 8.7 mm-40 -88.76 132.95 34.4 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.925 0.393 . . . . 0.0 110.511 177.13 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.78 HG13 HD21 ' A' ' 143' ' ' LEU . 98.3 t -80.75 113.97 20.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.021 -178.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 11.1 mtm180 -110.54 107.07 16.58 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 176.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . 0.515 ' CD1' HD13 ' A' ' 130' ' ' LEU . 84.5 t80 -89.45 96.29 10.64 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 176.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -107.24 109.49 21.29 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.414 -174.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 33.9 tp -80.02 118.97 22.23 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.557 177.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -111.03 160.45 16.84 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.055 -178.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 139' ' ' SER . 16.5 p -107.39 165.6 11.27 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.334 176.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.603 HD13 ' CG ' ' A' ' 20' ' ' PRO . 39.4 mt . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.422 -0.799 . . . . 0.0 110.011 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 70.1 t . . . . . 0 N--CA 1.479 0.982 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.543 ' HB2' HD12 ' A' ' 145' ' ' LEU . 50.1 mttm -105.33 148.62 26.86 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.958 0.409 . . . . 0.0 110.91 178.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.503 ' HB3' ' HD2' ' A' ' 30' ' ' TYR . 88.9 mtt180 -117.2 133.65 55.73 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.163 -178.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.428 ' HB2' ' HG ' ' A' ' 143' ' ' LEU . 93.8 m-85 -120.29 121.14 38.0 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.866 0.365 . . . . 0.0 110.065 175.147 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.442 ' HB3' HG22 ' A' ' 33' ' ' VAL . 38.7 tp -93.0 121.05 33.94 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.863 -178.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.558 HD11 ' HG ' ' A' ' 36' ' ' LEU . 51.7 tp -103.98 120.94 42.11 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.952 0.406 . . . . 0.0 110.508 178.252 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.5 pt -101.33 123.96 54.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 173.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.448 ' HB3' ' HB2' ' A' ' 132' ' ' PRO . 5.9 p -66.0 -79.31 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.578 -169.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.794 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 26.9 t70 -148.0 124.13 10.79 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.135 -177.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.706 ' HB2' HD12 ' A' ' 19' ' ' LEU . 9.0 p -156.91 88.46 1.04 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.123 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 62.4 m-70 -83.69 85.85 7.22 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.307 -0.406 . . . . 0.0 109.973 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.471 ' O ' HG22 ' A' ' 40' ' ' VAL . 59.9 t -107.7 135.04 19.82 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.026 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -78.23 -62.56 0.03 OUTLIER 'Cis proline' 0 C--N 1.345 0.384 0 C-N-CA 123.75 -1.354 . . . . 0.0 112.571 0.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.767 HG12 ' HG3' ' A' ' 15' ' ' ARG . 19.6 t 52.13 -93.0 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 123.464 0.705 . . . . 0.0 112.031 177.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.767 ' HG3' HG12 ' A' ' 14' ' ' VAL . 97.8 mtt180 -134.01 4.37 3.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.869 0.366 . . . . 0.0 110.564 -175.297 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.607 ' SD ' ' HB2' ' A' ' 136' ' ' ALA . 32.3 ttp -137.77 112.46 8.87 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.511 -176.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -116.89 19.69 14.26 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.203 0.525 . . . . 0.0 110.344 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 35.6 p -99.9 29.9 3.97 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.379 -176.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.706 HD12 ' HB2' ' A' ' 10' ' ' SER . 7.1 tt -83.27 116.96 67.08 Favored Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 179.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -68.86 118.14 5.47 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 122.45 2.1 . . . . 0.0 112.187 178.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.56 -7.8 5.29 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.442 -177.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -61.12 -36.97 81.15 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.808 0.337 . . . . 0.0 110.796 179.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 11.1 tp -64.75 -39.19 84.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.937 0.875 . . . . 0.0 109.761 178.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 44.4 tp -78.37 -10.25 59.61 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.051 -1.432 . . . . 0.0 110.978 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -100.32 -6.55 25.68 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.106 0.479 . . . . 0.0 110.816 -176.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 68.4 m -121.68 0.5 9.86 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.988 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.446 HD12 HG21 ' A' ' 33' ' ' VAL . 1.4 pt? -72.65 -19.26 61.47 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.065 -174.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -72.94 -13.9 61.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.961 -177.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -73.77 -26.08 60.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.114 0.483 . . . . 0.0 110.547 177.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.503 ' HD2' ' HB3' ' A' ' 3' ' ' ARG . 85.7 m-85 -83.87 156.95 22.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.211 -173.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -86.94 -6.6 58.72 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.01 -178.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 4' ' ' PHE . . . -174.52 149.01 10.19 Favored Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.726 177.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.446 HG21 HD12 ' A' ' 27' ' ' LEU . 69.7 t -124.71 135.98 62.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-O 120.976 0.417 . . . . 0.0 110.494 -179.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.544 HG12 ' HB2' ' A' ' 56' ' ' TYR . 49.4 mt -113.85 134.44 56.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.769 179.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -125.6 117.2 2.85 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.14 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.558 ' HG ' HD11 ' A' ' 6' ' ' LEU . 95.9 mt -95.79 -9.96 30.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.854 0.835 . . . . 0.0 109.246 175.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.794 ' HA3' ' HA ' ' A' ' 9' ' ' ASP . . . -151.43 60.93 0.41 Allowed Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.238 178.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -73.83 178.85 4.59 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.252 -0.474 . . . . 0.0 111.695 -175.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.531 ' HD1' HD11 ' A' ' 48' ' ' LEU . 71.2 m-85 -63.43 145.62 55.24 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.558 179.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.551 ' HB ' ' CD1' ' A' ' 64' ' ' TYR . 18.1 m -83.79 -9.01 11.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.802 -173.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.493 ' HB2' ' OG1' ' A' ' 44' ' ' THR . 19.4 m-20 -86.62 120.4 27.89 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.013 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.534 HD22 ' HB3' ' A' ' 66' ' ' ASP . 48.9 tp -53.38 -42.24 66.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.026 0.441 . . . . 0.0 110.432 178.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -59.06 -38.7 80.02 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.923 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.51 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 7.6 m -75.74 -28.72 58.62 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.663 -178.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 41' ' ' ASP . 65.6 t -62.22 -46.77 95.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.055 0.455 . . . . 0.0 110.159 175.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.07 -36.34 77.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.844 176.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -59.64 -35.42 74.35 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.785 175.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.531 HD11 ' HD1' ' A' ' 39' ' ' TYR . 91.1 mt -71.25 -38.34 71.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.407 178.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.701 ' HG2' ' HB3' ' A' ' 55' ' ' PHE . 49.2 mt-10 -69.05 -17.1 63.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.984 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -82.53 -41.31 19.81 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.856 176.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -68.83 -46.47 68.47 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.903 0.382 . . . . 0.0 111.536 178.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 51.1 p -83.38 -14.81 51.96 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.544 -176.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 93.5 mttt 70.4 -54.11 0.64 Allowed 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.509 0.723 . . . . 0.0 110.368 -172.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -123.68 109.57 13.88 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.193 0.521 . . . . 0.0 109.735 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.701 ' HB3' ' HG2' ' A' ' 49' ' ' GLU . 84.1 t80 -111.4 139.25 46.96 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.479 -175.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.544 ' HB2' HG12 ' A' ' 34' ' ' ILE . 93.5 m-85 -119.77 116.49 26.02 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 174.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.528 ' HA3' HD13 ' A' ' 71' ' ' LEU . . . -124.91 141.89 13.47 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 119.566 -1.302 . . . . 0.0 113.739 -173.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.428 HG23 ' HE3' ' A' ' 86' ' ' MET . 16.5 t -132.24 123.03 49.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 170.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -94.39 147.06 23.61 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 120.095 -0.642 . . . . 0.0 110.339 -173.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.626 ' HA2' ' HB3' ' A' ' 88' ' ' HIS . . . -80.83 -123.06 0.54 Allowed Glycine 0 C--N 1.331 0.261 0 N-CA-C 114.475 0.55 . . . . 0.0 114.475 -171.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -74.23 -164.12 0.23 Allowed 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 122.419 0.288 . . . . 0.0 111.053 -175.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 46.9 mtm -56.46 113.94 1.81 Allowed 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 120.991 0.424 . . . . 0.0 110.264 178.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -141.09 -160.77 1.12 Allowed 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -175.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.551 ' CD1' ' HB ' ' A' ' 40' ' ' VAL . 12.3 m-85 -67.04 125.28 90.68 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 121.113 0.482 . . . . 0.0 111.308 -177.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 64' ' ' TYR . 52.7 Cg_exo -56.66 -38.36 95.78 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 123.869 3.046 . . . . 0.0 113.797 -174.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.534 ' HB3' HD22 ' A' ' 42' ' ' LEU . 5.4 m-20 -59.5 -36.54 76.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.099 0.476 . . . . 0.0 111.024 -178.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 11.9 t -76.53 -26.08 16.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.261 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -63.51 -31.1 72.16 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.194 0.521 . . . . 0.0 110.264 176.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -86.2 -19.47 29.97 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.095 -178.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 11.7 t60 -91.24 -40.31 11.59 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.09 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.528 HD13 ' HA3' ' A' ' 57' ' ' GLY . 31.1 mt -117.74 136.26 23.61 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.985 179.116 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.411 ' HD2' ' O ' ' A' ' 57' ' ' GLY . 63.9 Cg_endo -74.34 177.29 8.51 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 122.486 2.124 . . . . 0.0 112.525 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -95.98 -12.97 24.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.212 0.529 . . . . 0.0 110.172 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 10.0 p -155.63 124.1 5.93 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.321 175.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 40.5 tttp -131.83 132.59 43.83 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.509 0.195 . . . . 0.0 110.674 -176.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 20.3 t -110.83 121.68 63.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.873 0.368 . . . . 0.0 110.498 179.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.462 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 72.3 mt -101.28 158.81 15.77 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.337 178.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 59.6 tp -127.0 102.11 6.84 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 175.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.525 HG12 ' HG2' ' A' ' 80' ' ' GLU . 35.6 t -124.01 116.12 46.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.468 -177.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.525 ' HG2' HG12 ' A' ' 79' ' ' VAL . 20.2 mm-40 59.78 27.16 16.41 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.477 177.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.31 -15.32 63.5 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.195 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 52.4 t -87.41 126.37 41.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.76 0.314 . . . . 0.0 110.189 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 40.9 p -85.93 134.35 33.88 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.181 177.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.462 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 37.0 mt -118.17 94.81 3.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -178.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -85.29 95.31 1.97 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.444 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.549 ' HG2' HD12 ' A' ' 112' ' ' LEU . 30.0 mtm -95.98 118.93 33.57 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.953 0.406 . . . . 0.0 110.439 -176.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.681 ' O ' ' HA ' ' A' ' 113' ' ' PHE . 52.7 t -140.27 153.69 46.59 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 178.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.626 ' HB3' ' HA2' ' A' ' 60' ' ' GLY . 4.1 p-80 -72.23 1.55 7.46 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.879 -0.329 . . . . 0.0 111.849 176.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.35 176.72 50.34 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.494 176.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -116.73 -99.5 0.44 Allowed 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.548 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -109.69 -94.71 2.32 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.311 -0.947 . . . . 0.0 113.434 -173.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.436 ' HB1' ' HD2' ' A' ' 93' ' ' PRO . . . -112.7 172.67 3.35 Favored Pre-proline 0 C--N 1.321 -0.656 0 C-N-CA 122.456 0.302 . . . . 0.0 110.622 -172.199 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.436 ' HD2' ' HB1' ' A' ' 92' ' ' ALA . 31.5 Cg_exo -61.24 -11.79 20.64 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.612 2.208 . . . . 0.0 113.061 177.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 1.5 m0 -77.51 -54.59 6.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.286 0.565 . . . . 0.0 109.701 -179.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.476 ' OD2' ' HD2' ' A' ' 99' ' ' ARG . 7.3 p-10 -82.72 -3.32 56.29 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.703 -177.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 28.0 tp -50.51 -56.34 12.06 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.775 178.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.9 ptmm? -66.44 -48.28 70.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.264 -178.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -62.49 -59.07 5.48 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.792 -175.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.528 ' O ' HG23 ' A' ' 103' ' ' VAL . 94.3 mtt180 -69.31 -38.21 78.16 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -171.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.51 HD13 HG21 ' A' ' 111' ' ' ILE . 46.5 mt -70.03 -37.13 75.5 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.386 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.542 HD21 HG21 ' A' ' 127' ' ' VAL . 87.0 mt -79.3 -14.23 59.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.81 0.338 . . . . 0.0 111.117 178.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.602 ' HA ' ' ND2' ' A' ' 105' ' ' ASN . 97.0 mttt -90.41 -14.54 32.72 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.634 173.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 99' ' ' ARG . 84.2 t -81.43 -49.08 18.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 167.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -100.23 75.22 1.8 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.385 174.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.602 ' ND2' ' HA ' ' A' ' 102' ' ' LYS . 7.4 m120 -60.75 -28.57 68.81 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.5 -173.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -78.23 -6.54 55.24 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.875 0.369 . . . . 0.0 110.686 -178.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.426 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 5.0 tmmm? 64.91 109.09 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.468 0 C-N-CA 123.589 0.755 . . . . 0.0 112.444 174.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 107' ' ' LYS . 8.8 Cg_endo -88.39 178.38 2.97 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.392 2.728 . . . . 0.0 112.102 177.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 14.4 mp0 -88.73 -45.83 9.48 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.865 0.364 . . . . 0.0 110.414 176.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.4 t -124.29 133.61 68.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.748 -178.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.51 HG21 HD13 ' A' ' 100' ' ' LEU . 58.9 mt -124.15 127.14 73.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.296 176.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.622 HD23 ' HB2' ' A' ' 130' ' ' LEU . 87.4 mt -101.13 134.38 44.24 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 178.152 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.681 ' HA ' ' O ' ' A' ' 87' ' ' CYS . 24.7 p90 -144.03 142.1 30.48 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.937 0.399 . . . . 0.0 110.593 176.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -105.68 135.99 12.94 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.914 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -147.62 157.34 43.51 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.8 p -80.1 61.88 4.09 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.378 0.609 . . . . 0.0 111.084 178.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -154.81 152.6 30.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.653 -176.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -57.76 145.88 68.73 Favored Pre-proline 0 C--N 1.329 -0.307 0 O-C-N 123.574 0.546 . . . . 0.0 111.096 177.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.18 149.09 74.66 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 123.122 2.548 . . . . 0.0 112.693 -178.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -151.84 142.38 22.65 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.495 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -78.52 94.04 4.9 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 176.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.8 p -103.5 135.22 45.5 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.998 -176.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 14.1 p -150.34 121.55 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.083 0.468 . . . . 0.0 110.593 176.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.447 ' HB2' ' HE2' ' A' ' 129' ' ' PHE . 95.9 mttt -142.04 144.41 33.59 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.191 -0.458 . . . . 0.0 109.992 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 62.75 19.09 11.18 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 123.5 0.5 . . . . 0.0 111.636 179.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 86.89 -5.7 84.54 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.054 -178.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.542 HG21 HD21 ' A' ' 101' ' ' LEU . 33.0 t -97.6 129.44 47.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 120.833 0.349 . . . . 0.0 110.141 -178.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 38.1 ttm-85 -84.19 122.1 28.38 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.574 178.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.447 ' HE2' ' HB2' ' A' ' 124' ' ' LYS . 82.3 m-85 -103.43 138.97 39.44 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 175.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.622 ' HB2' HD23 ' A' ' 112' ' ' LEU . 95.7 mt -128.18 121.45 29.49 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.91 0.386 . . . . 0.0 111.069 -179.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.447 ' HB3' ' CZ ' ' A' ' 113' ' ' PHE . 8.1 p30 -121.57 117.36 30.19 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.95 176.157 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.448 ' HB2' ' HB3' ' A' ' 8' ' ' SER . 33.6 Cg_endo -96.82 147.38 0.97 Allowed 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 123.344 2.696 . . . . 0.0 112.627 176.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -69.51 152.97 52.24 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.207 175.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 82.8 p -70.65 175.47 4.88 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.435 0.636 . . . . 0.0 111.938 -173.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.409 ' HB2' ' HB3' ' A' ' 10' ' ' SER . 4.5 mm? -69.77 -25.56 63.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.394 176.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.607 ' HB2' ' SD ' ' A' ' 16' ' ' MET . . . -72.99 -31.72 64.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.27 0.557 . . . . 0.0 110.336 177.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -83.34 -20.04 35.05 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.109 177.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 89.08 45.94 4.61 Favored Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.944 175.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 156' ' ' THR . 26.4 t -137.0 149.03 47.23 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.841 0.353 . . . . 0.0 110.393 178.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.402 ' CD1' ' HG ' ' A' ' 157' ' ' LEU . 7.5 p90 -147.74 178.0 8.84 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 176.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.445 ' HB3' ' HB3' ' A' ' 6' ' ' LEU . . . -132.86 135.26 45.51 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.955 0.407 . . . . 0.0 111.18 -179.183 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 99.3 t -119.7 112.01 35.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.871 175.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.696 ' HA ' ' O ' ' A' ' 151' ' ' ARG . 0.2 OUTLIER -102.85 110.83 22.89 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.6 0.714 . . . . 0.0 110.239 175.513 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -105.18 145.0 31.2 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.687 -178.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.543 HD12 ' HB2' ' A' ' 2' ' ' LYS . 87.4 mt -90.8 90.16 7.8 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.527 0.68 . . . . 0.0 109.952 178.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -95.04 113.97 25.73 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.556 -179.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 68.48 -69.24 0.38 Allowed Glycine 0 CA--C 1.524 0.628 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.598 -175.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -172.52 25.25 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.959 -0.639 . . . . 0.0 111.749 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -124.11 133.6 53.56 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 120.811 0.339 . . . . 0.0 110.404 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.434 HG22 HD21 ' A' ' 145' ' ' LEU . 9.3 t -81.0 98.39 3.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.696 ' O ' ' HA ' ' A' ' 143' ' ' LEU . 38.8 mtp85 -101.13 106.39 17.63 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.794 0.33 . . . . 0.0 110.939 -175.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . 0.522 ' CE2' HD13 ' A' ' 143' ' ' LEU . 18.0 m-85 -83.56 105.49 14.53 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.467 178.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -96.41 112.06 23.94 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.818 0.342 . . . . 0.0 110.719 178.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -72.49 124.42 25.15 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 174.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -133.42 171.27 14.29 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -177.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 139' ' ' SER . 15.1 p -120.69 150.55 40.77 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.853 0.358 . . . . 0.0 111.729 -176.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.402 ' HG ' ' CD1' ' A' ' 140' ' ' TYR . 92.1 mt . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.447 175.642 . . . . . . . . 1 1 . 1 stop_ save_